PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	El-Gazzar, A; Cai, X; Reeves, RS; Dai, Z; Caballero-Benitez, A; McDonald, DL; Vazquez, J; Gooley, TA; Sale, GE; Spies, T; Groh, V				El-Gazzar, A.; Cai, X.; Reeves, R. S.; Dai, Z.; Caballero-Benitez, A.; McDonald, D. L.; Vazquez, J.; Gooley, T. A.; Sale, G. E.; Spies, T.; Groh, V.			Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells	ONCOGENE			English	Article						NKG2D receptor; breast cancer; xenotransplant; angiogenesis; metastasis	NK CELLS; T-CELLS; ACTIVATION; LIGANDS; INHIBITION; APOPTOSIS; GROWTH; MICA	The stimulatory NKG2D lymphocyte receptor together with its tumor-associated ligands enable the immune system to recognize and destroy cancer cells. However, with dynamic changes unfolding, cancers exploit NKG2D and its ligands for immune evasion and suppression. Recent findings have added yet another functional dimension, wherein cancer cells themselves co-opt NKG2D for their own benefit to complement the presence of its ligands for self-stimulation of parameters of tumorigenesis. Those findings are here extended to in vivo tumorigenicity testing by employing orthotopic xenotransplant breast cancer models in mice. Using human cancer lines with ectopic NKG2D expression and RNA interference (RNAi)-mediated protein depletion among other controls, we show that NKG2D self-stimulation has tumor-promoting capacity. NKG2D signals had no notable effects on cancer cell proliferation and survival but acted at the level of angiogenesis, thus promoting tumor growth, tumor cell intravasation and dissemination. NKG2D-mediated effects on tumor initiation may represent another factor in the observed overall enhancement of tumor development. Altogether, these results may have an impact on immunotherapy approaches, which currently do not account for such NKG2D effects in cancer patients and thus could be misdirected as underlying assumptions are incomplete.	[El-Gazzar, A.; Cai, X.; Reeves, R. S.; Dai, Z.; Caballero-Benitez, A.; McDonald, D. L.; Vazquez, J.; Gooley, T. A.; Sale, G. E.; Spies, T.; Groh, V.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98112 USA	Fred Hutchinson Cancer Center	Spies, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave North, Seattle, WA 98112 USA.	tspies@fhcrc.org		El-Gazzar, Ahmed/0000-0002-2859-7246	Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF) [J3078]; NIH/NCI Pacific Ovarian Cancer Research Consortium (POCRC) SPORE [P50 CA083636]; NIH/NCI [R01 CA174470]; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA174470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF); NIH/NCI Pacific Ovarian Cancer Research Consortium (POCRC) SPORE; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs Steven Kelly and Sue Knoblaugh and all members of the Comparative Medicine Shared Resource laboratory for their expert veterinarian, pathology and histopathology support; Drs Julie Randolph-Habecker and Peggy Porter for their expert immunohistochemistry and histopathology advice, and all members of the Experimental Histopathology Shared Resource laboratory for their outstanding technical support. AE-G was supported by an Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF; project number J3078). This study was supported by an NIH/NCI Pacific Ovarian Cancer Research Consortium (POCRC) SPORE (P50 CA083636) developmental research program grant (to VG) and NIH/NCI grant R01 CA174470 (to TS).	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Ben-Batalla I, 2010, J CLIN INVEST, V120, P4289, DOI 10.1172/JCI42015; Benitez AC, 2011, P NATL ACAD SCI USA, V108, P4081, DOI 10.1073/pnas.1018603108; Cho HM, 2010, CANCER RES, V70, P10121, DOI 10.1158/0008-5472.CAN-10-1047; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lehner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031210; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; NOEL A, 1992, BIOCHEM PHARMACOL, V43, P1263, DOI 10.1016/0006-2952(92)90501-9; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Song DG, 2013, HUM GENE THER, V24, P295, DOI 10.1089/hum.2012.143; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; von Strandmann EP, 2006, BLOOD, V107, P1955, DOI 10.1182/blood-2005-05-2177; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang T, 2011, CANCER RES, V71, P2066, DOI 10.1158/0008-5472.CAN-10-3200	21	10	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4932	4940		10.1038/onc.2013.435	http://dx.doi.org/10.1038/onc.2013.435			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24141776	Green Accepted			2022-12-25	WOS:000343767900006
J	Gohil, VM; Zhu, L; Baker, CD; Cracan, V; Yaseen, A; Jain, M; Clish, CB; Brookes, PS; Bakovic, M; Mootha, VK				Gohil, Vishal M.; Zhu, Lin; Baker, Charli D.; Cracan, Valentin; Yaseen, Abbas; Jain, Mohit; Clish, Clary B.; Brookes, Paul S.; Bakovic, Marica; Mootha, Vamsi K.			Meclizine Inhibits Mitochondria! Respiration through Direct Targeting of Cytosolic Phosphoethanolamine Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Metabolomics; Mitochondria; Phosphatidylethanolamine; Respiration; Meclizine; Phosphoethanolamine	PHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE; PHOSPHATIDYLSERINE; CARDIOLIPIN; CTP; PATHWAY; GENE; RNAI	We recently identified meclizine, an over-the-counter drug, as an inhibitor of mitochondrial respiration. Curiously, meclizine blunted respiration in intact cells but not in isolated mitochondria, suggesting an unorthodox mechanism. Using a metabolic profiling approach, we now show that treatment with meclizine leads to a sharp elevation of cellular phosphoethanolamine, an intermediate in the ethanolamine branch of the Kennedy pathway of phosphatidylethanolamine biosynthesis. Metabolic labeling and in vitro enzyme assays confirmed direct inhibition of the cytosolic enzyme CTP:phosphoethanolamine cytidylyltransferase (PCYT2). Inhibition of PCYT2 by meclizine led to rapid accumulation of its substrate, phosphoethanolamine, which is itself an inhibitor of mitochondrial respiration. Our work identifies the first pharmacologic inhibitor of the Kennedy pathway, demonstrates that its biosynthetic intermediate is an endogenous inhibitor of respiration, and provides key mechanistic insights that may facilitate repurposing meclizine for disorders of energy metabolism.	[Gohil, Vishal M.; Cracan, Valentin; Yaseen, Abbas; Jain, Mohit; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Mol Biol, Boston, MA 02114 USA; [Gohil, Vishal M.; Cracan, Valentin; Yaseen, Abbas; Jain, Mohit; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Med, Boston, MA 02114 USA; [Gohil, Vishal M.; Cracan, Valentin; Jain, Mohit; Clish, Clary B.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Gohil, Vishal M.; Cracan, Valentin; Jain, Mohit; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Gohil, Vishal M.; Baker, Charli D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Zhu, Lin; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Texas A&M University System; Texas A&M University College Station; University of Guelph; University of Rochester	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, ILSB Rm 2146A,301 Old Main Dr, College Stn, TX 77843 USA.	vgohil@tamu.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Brookes, Paul/0000-0002-8639-8413; Cracan, Valentin/0000-0002-3280-0593; Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health [5K08HL107451]; American Diabetes Association/Smith Family Foundation; Welch Foundation [A-1810]; Canadian Institutes of Health Research; Ontario President Research Excellence Award; Texas AM University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association/Smith Family Foundation(American Diabetes Association); Welch Foundation(The Welch Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario President Research Excellence Award; Texas AM University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K08HL107451 (to M. J.). This work was also supported by a grant from the American Diabetes Association/Smith Family Foundation (to V. K. M.). V. K. M. and V. M. G. are listed as inventors on a patent application filed by the Massachusetts General Hospital.; Supported by Welch Foundation Grant A-1810 and discretionary funds from Texas A&M University.; Supported by grants from the Canadian Institutes of Health Research and Ontario President Research Excellence Award.	Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; COHEN B, 1972, ARCH NEUROL-CHICAGO, V27, P129, DOI 10.1001/archneur.1972.00490140033006; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Ferreira AK, 2012, ANTICANCER RES, V32, P95; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Gohil VM, 2011, HUM MOL GENET, V20, P294, DOI 10.1093/hmg/ddq464; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Huang WD, 2004, MOL ENDOCRINOL, V18, P2402, DOI 10.1210/me.2004-0046; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Maheshwari S, 2013, BIOCHEM J, V450, P159, DOI 10.1042/BJ20121480; Modica-Napolitano JS, 2004, BIOL PSYCHIAT, V55, P273, DOI 10.1016/S0006-3223(03)00784-4; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Wang ZJ, 2012, J CLIN PHARMACOL, V52, P1343, DOI 10.1177/0091270011414575; Watkins SM, 2002, CURR OPIN MOL THER, V4, P224; Webhofer C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.56; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	36	31	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35387	35395		10.1074/jbc.M113.489237	http://dx.doi.org/10.1074/jbc.M113.489237			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142790	Green Published, hybrid			2022-12-25	WOS:000329867600035
J	Zhu, H; Xu, BL; Liang, XL; Yang, YR; Tang, XF; Tang, B				Zhu, Hui; Xu, Bi-Lin; Liang, Xiaoliang; Yang, Yi-Ran; Tang, Xiao-Feng; Tang, Bing			Molecular Basis for Auto- and Hetero-catalytic Maturation of a Thermostable Subtilase from Thermophilic Bacillus sp WF146	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Enzyme Structure; Protein Processing; Protein Stability; Serine Protease; Maturation; Propeptide; Subtilase	SERINE-CARBOXYL PROTEINASE; ANGSTROM CRYSTAL-STRUCTURE; INTRAMOLECULAR CHAPERONE; HYPERTHERMOPHILIC ARCHAEON; SUBTILISIN; PROPEPTIDE; PROTEASE; MECHANISMS; ENZYMES; SITE	Background: The autocatalytic maturation mechanisms of subtilases are well known, but little is known about their hetero-catalytic maturation. Results: The N-terminal propeptide of the WF146 protease can be removed via both cis- and trans-processing reaction-initiated maturation pathways. Conclusion: The WF146 protease is intrinsically able to mature either autocatalytically or hetero-catalytically. Significance: Our work provides new insights into maturation mechanisms of subtilases. The proform of the WF146 protease, an extracellular subtilase produced by thermophilic Bacillus sp. WF146, matures efficiently at high temperatures. Here we report that the proform, which contains an N-terminal propeptide composed of a core domain (N*) and a linker peptide, is intrinsically able to mature via multiple pathways. One autocatalytic pathway is initiated by cis-processing of N* to generate an autoprocessed complex N*-I-WT, and this step is followed by truncation of the linker peptide and degradation of N*. Another autocatalytic pathway is initiated by trans-processing of the linker peptide followed by degradation of N*. Unlike most reported subtilases, the maturation of the WF146 protease occurs not only autocatalytically but also hetero-catalytically whereby heterogeneous proteases accelerate the maturation of the WF146 protease via trans-processing of the proform and N*-I-WT. Although N* acts as an intramolecular chaperone and an inhibitor of the mature enzyme, the linker peptide is susceptible to proteolysis, allowing the trans-processing reaction to occur auto- and hetero-catalytically. These studies also demonstrate that the WF146 protease undergoes subtle structural adjustments during the maturation process and that the binding of Ca2+ is required for routing the proform to mature properly at high temperatures. Interestingly, under Ca2+-free conditions, the proform is cis-processed into a unique propeptide-intermediate complex (N*-I-E) capable of re-synthesis of the proform. Based on the basic catalytic principle of serine proteases and these experimental results, a mechanism for the cis-processing/re-synthesis equilibrium of the proform and the role of the linker peptide in regulation of this equilibrium has been proposed.	[Zhu, Hui; Xu, Bi-Lin; Liang, Xiaoliang; Yang, Yi-Ran; Tang, Xiao-Feng; Tang, Bing] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Tang, B (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	tangb@whu.edu.cn			National Natural Science Foundation of China [30870052, 31270099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported the National Natural Science Foundation of China (30870052 and 31270099).	Almog O, 2003, J MOL BIOL, V332, P1071, DOI 10.1016/j.jmb.2003.07.011; Bian Y, 2006, FEBS LETT, V580, P6007, DOI 10.1016/j.febslet.2006.09.068; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; Cheng GY, 2009, MICROBIOL-SGM, V155, P3661, DOI 10.1099/mic.0.031336-0; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; EGNELL P, 1992, MOL MICROBIOL, V6, P1115, DOI 10.1111/j.1365-2958.1992.tb01549.x; Fang N, 2010, APPL MICROBIOL BIOT, V85, P1473, DOI 10.1007/s00253-009-2183-5; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Han X, 2012, PLOS ONE, V7; Hu ZX, 1996, J BIOL CHEM, V271, P3375; JAMES GT, 1978, ANAL BIOCHEM, V86, P574, DOI 10.1016/0003-2697(78)90784-4; Khan AR, 1998, PROTEIN SCI, V7, P815; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Li YY, 1996, J MOL BIOL, V262, P591, DOI 10.1006/jmbi.1996.0537; Okubo A, 2006, FEBS J, V273, P2563, DOI 10.1111/j.1742-4658.2006.05266.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; Pulido M, 2006, APPL ENVIRON MICROB, V72, P4154, DOI 10.1128/AEM.02696-05; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Tanaka SI, 2007, J MOL BIOL, V372, P1055, DOI 10.1016/j.jmb.2007.07.027; Tanaka SI, 2007, J BIOL CHEM, V282, P8246, DOI 10.1074/jbc.M610137200; Tang B, 2002, BBA-PROTEIN STRUCT M, V1596, P16, DOI 10.1016/S0167-4838(01)00315-6; Tsuruoka N, 2003, APPL ENVIRON MICROB, V69, P162, DOI 10.1128/AEM.69.1.162-169.2003; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Volkov A, 1996, J MOL BIOL, V262, P595, DOI 10.1006/jmbi.1996.0538; Wu J, 2004, FEMS MICROBIOL LETT, V230, P251, DOI 10.1016/S0378-1097(03)00914-5; Yabuta Y, 2002, J BIOCHEM, V131, P31, DOI 10.1093/oxfordjournals.jbchem.a003074; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; Yang YR, 2008, FEBS LETT, V582, P2620, DOI 10.1016/j.febslet.2008.06.041	34	12	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34826	34838		10.1074/jbc.M113.498774	http://dx.doi.org/10.1074/jbc.M113.498774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145031	hybrid, Green Published			2022-12-25	WOS:000329812800050
J	Jiang, YH; Peng, CH; Liu, HT; Kuo, HC				Jiang, Yuan-Hong; Peng, Chung-Hsin; Liu, Hsin-Tzu; Kuo, Hann-Chorng			Increased Pro-Inflammatory Cytokines, C-Reactive Protein and Nerve Growth Factor Expressions in Serum of Patients with Interstitial Cystitis/Bladder Pain Syndrome	PLOS ONE			English	Article							NATIONAL INSTITUTE; BLADDER; CELL; PATHOGENESIS; FEATURES; MARKERS; URINE; RAT	Objective: The etiology and pathogenesis of interstitial cystitis/bladder pain syndrome (IC/BPS) are unclear. Chronic inflammation is considered the main pathology of IC/BPS. This study measured the serum c-reactive protein (CRP), nerve growth factor (NGF) and pro-inflammatory cytokine/chemokine interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha, and IL-8 expression in patients with IC/BPS to elucidate the involvement of systemic inflammation in IC/BPS. Methods: Serum samples were collected from 30 IC/BPS patients and 26 control subjects. The concentrations of serum nerve growth factor (NGF), IL-1 beta, IL-6, TNF-alpha, and IL-8 were quantified using a bead-based, human serum adipokine panel kit. Serum C-reactive protein (CRP) was also assessed. Differences of serum CRP, NGF, IL-1 beta, IL-6, TNF-alpha, and IL-8 levels between the IC/BPS patients and controls were compared, and correlations between CRP and pro-inflammatory cytokines and chemokine were also evaluated. Results: The results showed that CRP level (p = 0.031), NGF (p = 0.015) and pro-inflammatory cytokines/chemokine IL-1 beta, IL-6, TNF-alpha, and IL-8 levels were significantly higher in the patients with IC/BPS than among controls (all p<0.001). Significant associations were observed between IL-1 beta and IL-8 (p<0.001), IL-6 and CRP (p = 0.01), IL-6 and IL-8 (p = 0.02), and IL-6 and TNF-alpha (p = 0.03). Conclusion: Increased pro-inflammatory cytokines/chemokine (IL-1 beta, IL-6, TNF-alpha, and IL-8) expression in the sera of IC/BPS patients implies not only mast cell activation, but also that other inflammatory mediators play important roles in the pathogenesis of IC/BPS. Thus, for some patients, IC/BPS is considered a chronic inflammatory disease.	[Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Peng, Chung-Hsin; Kuo, Hann-Chorng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Peng, Chung-Hsin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Urol, New Taipei City, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Sch Med, Dept Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bouchelouche K, 2003, CURR OPIN UROL, V13, P309, DOI 10.1097/00042307-200307000-00007; Bouchelouche K, 2001, J UROLOGY, V166, P2121, DOI 10.1016/S0022-5347(05)65518-8; Chancellor MB, 2004, UROLOGY, V63, P85, DOI 10.1016/j.urology.2003.10.034; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Dodd LG, 1998, ACTA CYTOL, V42, P923, DOI 10.1159/000331969; Dupont MC, 2001, J UROLOGY, V166, P1111, DOI 10.1016/S0022-5347(05)65931-9; Erickson DR, 2008, J UROLOGY, V179, P1850, DOI 10.1016/j.juro.2008.01.047; Erickson DR, 2005, J UROLOGY, V173, P93, DOI 10.1097/01.ju.0000146466.71311.ab; Erickson DR, 1997, J UROLOGY, V158, P790, DOI 10.1016/S0022-5347(01)64317-9; Hanno PM, 2001, UROLOGY, V57, P2, DOI 10.1016/S0090-4295(01)01112-8; Lamale LM, 2006, UROLOGY, V68, P702, DOI 10.1016/j.urology.2006.04.033; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MARTINS SM, 1994, J UROLOGY, V151, P1198, DOI 10.1016/S0022-5347(17)35212-6; Nickel JC, 2010, J UROLOGY, V184, P1358, DOI 10.1016/j.juro.2010.06.005; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Peters EMJ, 2011, J INVEST DERMATOL, V131, P735, DOI 10.1038/jid.2010.317; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Smaldone MC, 2009, UROLOGY, V73, P421, DOI 10.1016/j.urology.2008.07.031; Tseng-Rogenski S, 2009, AM J PHYSIOL-RENAL, V297, pF816, DOI 10.1152/ajprenal.90733.2008; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; Wilkinson David R, 2006, Curr Urol Rep, V7, P414, DOI 10.1007/s11934-006-0013-1	27	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76779	10.1371/journal.pone.0076779	http://dx.doi.org/10.1371/journal.pone.0076779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146927	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200020
J	Gordon, M; El-Kalla, M; Zhao, YW; Fiteih, Y; Law, J; Volodko, N; Mohamed, A; El-Kadi, AOS; Liu, L; Odenbach, J; Thiesen, A; Onyskiw, C; Abu Ghazaleh, H; Park, J; Lee, SB; Yu, VC; Fernandez-Patron, C; Alexander, RT; Wine, E; Baksh, S				Gordon, Marilyn; El-Kalla, Mohamed; Zhao, Yuewen; Fiteih, Yahya; Law, Jennifer; Volodko, Natalia; Mohamed, Anwar; El-Kadi, Ayman O. S.; Liu, Lei; Odenbach, Jeff; Thiesen, Aducio; Onyskiw, Christina; Abu Ghazaleh, Haya; Park, Jikyoung; Lee, Sean Bong; Yu, Victor C.; Fernandez-Patron, Carlos; Alexander, R. Todd; Wine, Eytan; Baksh, Shairaz			The Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; STEM-CELL PROLIFERATION; NF-KAPPA-B; C-ABL; DNA METHYLTRANSFERASE-1; YAP; P53; APOPTOSIS; PROMOTES; PHOSPHORYLATION	Ras association domain family protein 1A (RASSF1A) is a tumor suppressor gene silenced in cancer. Here we report that RASSF1A is a novel regulator of intestinal inflammation as Rassf1a(+/-), Rassf1a(-/-) and an intestinal epithelial cell specific knockout mouse (Rassf1a(IEC-KO)) rapidly became sick following dextran sulphate sodium (DSS) administration, a chemical inducer of colitis. Rassf1a knockout mice displayed clinical symptoms of inflammatory bowel disease including: increased intestinal permeability, enhanced cytokine/chemokine production, elevated nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF kappa B) activity, elevated colonic cell death and epithelial cell injury. Furthermore, epithelial restitution/repair was inhibited in DSS-treated Rassf1a(-/-) mice with reduction of several makers of proliferation including Yes associated protein (YAP)-driven proliferation. Surprisingly, tyrosine phosphorylation of YAP was detected which coincided with increased nuclear p73 association, Bax-driven epithelial cell death and p53 accumulation resulting in enhanced apoptosis and poor survival of DSS-treated Rassf1a knockout mice. We can inhibit these events and promote the survival of DSS-treated Rassf1a knockout mice with intraperitoneal injection of the c-Abl and c-Abl related protein tyrosine kinase inhibitor, imatinib/gleevec. However, p53 accumulation was not inhibited by imatinib/gleevec in the Rassf1a(-/-) background which revealed the importance of p53-dependent cell death during intestinal inflammation. These observations suggest that tyrosine phosphorylation of YAP (to drive p73 association and up-regulation of pro-apoptotic genes such as Bax) and accumulation of p53 are consequences of inflammation-induced injury in DSS-treated Rassf1a(-/-) mice. Mechanistically, we can detect robust associations of RASSF1A with membrane proximal Toll-like receptor (TLR) components to suggest that RASSF1A may function to interfere and restrict TLR-driven activation of NF kappa B. Failure to restrict NF kappa B resulted in the inflammation-induced DNA damage driven tyrosine phosphorylation of YAP, subsequent p53 accumulation and loss of intestinal epithelial homeostasis.	[Gordon, Marilyn; El-Kalla, Mohamed; Fiteih, Yahya; Volodko, Natalia; Onyskiw, Christina; Abu Ghazaleh, Haya; Alexander, R. Todd; Wine, Eytan; Baksh, Shairaz] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Zhao, Yuewen; Law, Jennifer; Odenbach, Jeff; Fernandez-Patron, Carlos; Baksh, Shairaz] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Mohamed, Anwar; El-Kadi, Ayman O. S.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Liu, Lei; Wine, Eytan] Univ Alberta, Fac Med & Dent, CEGIIR, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med & Pathol, Fac Med & Dent, Edmonton, AB, Canada; [Park, Jikyoung; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Yu, Victor C.] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore 117548, Singapore; [Alexander, R. Todd] Univ Alberta, Dept Nephrol, Edmonton, AB, Canada; [Wine, Eytan; Baksh, Shairaz] Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National University of Singapore; University of Alberta; University of Alberta	Baksh, S (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	sbaksh@ualberta.ca	Alexander, R. Todd/G-1373-2012; Fiteih, Yahya/AAO-8298-2020; Yu, Victor/A-7899-2015; Baksh, Shairaz/GRX-2106-2022; Anwar-Mohamed, Anwar/J-6973-2015	Yu, Victor/0000-0003-3270-4734; Anwar-Mohamed, Anwar/0000-0001-9214-7859; Lee, Sean/0000-0001-6211-3498; Zhao, Yuewen/0000-0002-8765-1839	Canadian Institutes of Health Research; Women and Children's Health Research Institute; Canadian Breast Cancer Foundation (Prairies/NWT); Alberta Heritage Foundation for Medical Research; Canadian Foundation for Innovation/Alberta Small Equipment Grants Program; Stollery Children's Foundation/Hair Massacure Donation Fund; Alberta Innovates [201201237] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute; Canadian Breast Cancer Foundation (Prairies/NWT); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Foundation for Innovation/Alberta Small Equipment Grants Program; Stollery Children's Foundation/Hair Massacure Donation Fund; Alberta Innovates	This work was supported by grants from Canadian Institutes of Health Research, The Women and Children's Health Research Institute, the Canadian Breast Cancer Foundation (Prairies/NWT), the Alberta Heritage Foundation for Medical Research, the Canadian Foundation for Innovation/Alberta Small Equipment Grants Program and The Stollery Children's Foundation/Hair Massacure Donation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid HE, 2010, TUMOR BIOL, V32, P845; Al-Sohaily S, 2012, J GASTROEN HEPATOL, V27, P1423, DOI 10.1111/j.1440-1746.2012.07200.x; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Anwar A, 2009, J LEUKOCYTE BIOL, V86, P73, DOI [10.1189/jlb.0608334, 10.1189/JLB.0608334]; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Avruch J, 2010, BRIT J CANCER, V104, P24; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azer SA, 2012, EUR J GASTROENTEROL; BAKSH S, 1992, PROTEIN EXPRES PURIF, V3, P322, DOI 10.1016/1046-5928(92)90008-K; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Biasi F, 2013, ANTIOXID REDOX SIGNA, V2013; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Dirisina R, 2011, GASTROENTEROLOGY, V141, P1036, DOI 10.1053/j.gastro.2011.05.032; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Fausti Francesca, 2012, Mol Biol Int, V2012, P307628, DOI 10.1155/2012/307628; Fernandes MS, 2013, INT J CANCER, V132, P251, DOI 10.1002/ijc.27696; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Gordon M., 2010, SMALL GTPASES, V2, P148; Goretsky T, 2012, AM J PATHOL, V181, P1306, DOI 10.1016/j.ajpath.2012.06.016; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Law Jennifer, 2012, Mol Biol Int, V2012, P536802, DOI 10.1155/2012/536802; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liao XY, 2008, INT J CANCER, V123, P296, DOI 10.1002/ijc.23494; Lin Q, 2012, BIOCHEM J, V445, P255, DOI 10.1042/BJ20111575; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Loncar MB, 2003, GUT, V52, P1297, DOI 10.1136/gut.52.9.1297; Machuy N, 2004, CELL DEATH DIFFER, V11, P290, DOI 10.1038/sj.cdd.4401336; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Park J, 2010, J BIOL CHEM, V285, P35029, DOI 10.1074/jbc.M110.165506; PRINGAULT E, 1991, P NATL ACAD SCI USA, V88, P10811, DOI 10.1073/pnas.88.23.10811; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Scrace Simon F, 2012, Mol Biol Int, V2012, P141732, DOI 10.1155/2012/141732; Song H, 2012, EMBO J, V31, P1147, DOI 10.1038/emboj.2011.480; Stamos JL, 2012, COLD SPRING HARB PER, V5; Stenson WF, 2010, CURR OPIN GASTROEN, V26, P85, DOI 10.1097/MOG.0b013e328334b417; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tommasi S, 2005, CANCER RES, V65, P92; Tommasi S, 2011, ONCOGENE, V30, P690, DOI 10.1038/onc.2010.440; Udenigwe CC, 2008, NUTR REV, V66, P445, DOI 10.1111/j.1753-4887.2008.00076.x; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van der Weyden L, 2008, ONCOGENE, V27, P4503, DOI 10.1038/onc.2008.94; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2012, CANCER RES, V72, P3817, DOI 10.1158/0008-5472.CAN-11-3343; van Limbergen J, 2011, GASTROENTEROLOGY, V141, P1566, DOI 10.1053/j.gastro.2011.09.018; Vos MD, 2005, J BIOL CHEM; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zhang HL, 2013, FASEB J, V27, P232, DOI 10.1096/fj.12-215491; Zhang H, 2011, APOPTOSIS, V16, P808, DOI 10.1007/s10495-011-0608-y; Zheng L, 2009, GASTROENTEROLOGY, V137, P2041, DOI 10.1053/j.gastro.2009.08.055; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	77	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75483	10.1371/journal.pone.0075483	http://dx.doi.org/10.1371/journal.pone.0075483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146755	gold, Green Published			2022-12-25	WOS:000326019400008
J	King, KM; West, JS; Brunner, PC; Dyer, PS; Fitt, BDL				King, Kevin M.; West, Jonathan S.; Brunner, Patrick C.; Dyer, Paul S.; Fitt, Bruce D. L.			Evolutionary Relationships between Rhynchosporium lolii sp nov and Other Rhynchosporium Species on Grasses	PLOS ONE			English	Article							RAMULARIA-COLLO-CYGNI; TAPESIA-YALLUNDAE; OILSEED RAPE; 1ST REPORT; REAL-TIME; PATHOGEN; SCALD; RESISTANCE; INFECTION; SECALIS	The fungal genus Rhynchosporium (causative agent of leaf blotch) contains several host-specialised species, including R. commune (colonising barley and brome-grass), R. agropyri (couch-grass), R. secalis (rye and triticale) and the more distantly related R. orthosporum (cocksfoot). This study used molecular fingerprinting, multilocus DNA sequence data, conidial morphology, host range tests and scanning electron microscopy to investigate the relationship between Rhynchosporium species on ryegrasses, both economically important forage grasses and common wild grasses in many cereal growing areas, and other plant species. Two different types of Rhynchosporium were found on ryegrasses in the UK. Firstly, there were isolates of R. commune that were pathogenic to both barley and Italian ryegrass. Secondly, there were isolates of a new species, here named R. lolii, that were pathogenic only to ryegrass species. R. lolii was most closely related to R. orthosporum, but exhibited clear molecular, morphological and host range differences. The species was estimated to have diverged from R. orthosporum ca. 5735 years before the present. The colonisation all the different Rhynchosporium species involved extensive hyphal growth in the sub-cuticular regions of the leaves. Finally, new species-specific PCR diagnostic tests were developed that could distinguish between these five closely related Rhynchosporium species.	[King, Kevin M.; West, Jonathan S.; Fitt, Bruce D. L.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [King, Kevin M.; Dyer, Paul S.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [West, Jonathan S.; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England; [Brunner, Patrick C.] ETH, Plant Pathol Grp, Zurich, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nottingham; University of Hertfordshire; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitt, BDL (corresponding author), Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England.	b.fitt@herts.ac.uk	West, Jonathan S/D-6098-2011	West, Jonathan S/0000-0002-5211-2405; Dyer, Paul/0000-0003-0237-026X; King, Kevin/0000-0002-9928-1353; Bruce D. L., Fitt/0000-0003-3981-6456	Perry Foundation; University of Hertfordshire; Biotechnology and Biological Sciences Research Council; BBSRC [BBS/E/C/00005203, BB/D015200/1, BB/I017585/1, BB/I017585/2, BB/E001610/1] Funding Source: UKRI; EPSRC [TS/I000747/2, TS/I000747/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017585/2, BB/E001610/1, BBS/E/C/00004693, BB/I017585/1, BB/D015200/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [TS/I000747/1, TS/I000747/2] Funding Source: researchfish	Perry Foundation; University of Hertfordshire; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the Perry Foundation (http://www.perryfoundation.co.uk) and the University of Hertfordshire (http://www.herts.ac.uk). Rothamsted Research (http://www.rothamsted.ac.uk) receives strategic funding from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrova A, 2012, MOL PLANT PATHOL, V13, P986, DOI 10.1111/j.1364-3703.2012.00811.x; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Barrs VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064871; Boys EF, 2007, EUR J PLANT PATHOL, V118, P307, DOI 10.1007/s10658-007-9141-9; Boys EF, 2012, PLANT PATHOL, V61, P543, DOI 10.1111/j.1365-3059.2011.02529.x; BROOKS F. T., 1928, New Phytologist, V27, P215, DOI 10.1111/j.1469-8137.1928.tb06739.x; Brunner PC, 2007, J EVOLUTION BIOL, V20, P1311, DOI 10.1111/j.1420-9101.2007.01347.x; Caldwell RM, 1937, J AGRIC RES, V55, P0175; Charmet G, 1996, GENET RESOUR CROP EV, V43, P319, DOI 10.1007/BF00132951; Crouch JA, 2009, MOL ECOL, V18, P123, DOI 10.1111/j.1365-294X.2008.04008.x; DAVIS H, 1990, MYCOL RES, V94, P557, DOI 10.1016/S0953-7562(10)80023-1; Dettman JR, 2003, EVOLUTION, V57, P2721; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer PS, 2002, PLANT PATHOL, V51, P806, DOI 10.1046/j.1365-3059.2002.00774.x; FERNANDEZ JP, 1991, MYCOLOGIA, V83, P774, DOI 10.2307/3760434; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Fountaine JA, 2007, PHYTOPATHOLOGY, V97, P297, DOI 10.1094/PHYTO-97-3-0297; Gachomo EW, 2009, ANN APPL BIOL, V154, P259, DOI 10.1111/j.1744-7348.2008.00297.x; Goodwin SB, 2002, MYCOL RES, V106, P645, DOI 10.1017/S0953756202006007; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Holland SL, 2011, FUNGAL BIOL-UK, V115, P909, DOI 10.1016/j.funbio.2011.07.004; HOWLETT SG, 1987, T BRIT MYCOL SOC, V88, P547, DOI 10.1016/S0007-1536(87)80038-4; Kastelein P., 2002, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V67, P257; LANGE BJ, 1968, PHYTOPATHOLOGY, V58, P1711; LEHNACKERS H, 1990, CAN J BOT, V68, P1953, DOI 10.1139/b90-257; Lutman PJW, 2009, ASPECTS APPL BIOL, V91, P163; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Nicholson P, 1997, PLANT PATHOL, V46, P842, DOI 10.1046/j.1365-3059.1997.d01-74.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Payne R.W., 2009, GENSTAT WINDOWS, V12nd; Preston C, 2009, WEED SCI, V57, P435, DOI 10.1614/WS-08-181.1; SHIPTON W A, 1974, Review of Plant Pathology, V53, P839; Stukenbrock EH, 2012, MYCOLOGIA, V104, P1397, DOI 10.3852/11-374; Taylor JMG, 2010, LETT APPL MICROBIOL, V50, P493, DOI 10.1111/j.1472-765X.2010.02826.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Taylor JW, 2006, FUNGI ENV, P313; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Walters DR, 2008, FEMS MICROBIOL LETT, V279, P1, DOI 10.1111/j.1574-6968.2007.00986.x; Welty RE, 1996, PLANT DIS, V80, P1220, DOI 10.1094/PD-80-1220; WILKINS P, 1973, PLANT PATHOL, V22, P107, DOI 10.1111/j.1365-3059.1973.tb01784.x; Zaffarano PL, 2008, EVOLUTION, V62, P1418, DOI 10.1111/j.1558-5646.2008.00390.x; Zaffarano PL, 2011, MYCOLOGIA, V103, P195, DOI 10.3852/10-119; Zaffarano PL, 2009, MOL ECOL, V18, P279, DOI 10.1111/j.1365-294X.2008.04013.x; Zhan J, 2008, PLANT PATHOL, V57, P1, DOI 10.1111/j.1365-3059.2007.01691.x	47	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e72536	10.1371/journal.pone.0072536	http://dx.doi.org/10.1371/journal.pone.0072536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146740	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400001
J	Rout, TM; McDonald-Madden, E; Martin, TG; Mitchell, NJ; Possingham, HP; Armstrong, DP				Rout, Tracy M.; McDonald-Madden, Eve; Martin, Tara G.; Mitchell, Nicola J.; Possingham, Hugh P.; Armstrong, Doug P.			How to Decide Whether to Move Species Threatened by Climate Change	PLOS ONE			English	Article							ASSISTED COLONIZATION; MANAGED RELOCATION; RISK-ASSESSMENT; BIODIVERSITY CONSERVATION; SEX DETERMINATION; HABITAT MODELS; REINTRODUCTION; ECOSYSTEMS; MIGRATION; TUATARA	Introducing species to areas outside their historical range to secure their future under climate change is a controversial strategy for preventing extinction. While the debate over the wisdom of this strategy continues, such introductions are already taking place. Previous frameworks for analysing the decision to introduce have lacked a quantifiable management objective and mathematically rigorous problem formulation. Here we develop the first rigorous quantitative framework for deciding whether or not a particular introduction should go ahead, which species to prioritize for introduction, and where and how to introduce them. It can also be used to compare introduction with alternative management actions, and to prioritise questions for future research. We apply the framework to a case study of tuatara (Sphenodon punctatus) in New Zealand. While simple and accessible, this framework can accommodate uncertainty in predictions and values. It provides essential support for the existing IUCN guidelines by presenting a quantitative process for better decision-making about conservation introductions.	[Rout, Tracy M.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Rout, Tracy M.; McDonald-Madden, Eve; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [McDonald-Madden, Eve; Martin, Tara G.; Possingham, Hugh P.] Univ Queensland, Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [McDonald-Madden, Eve; Martin, Tara G.] CSIRO, Climate Adaptat Flagship, Brisbane, Qld, Australia; [Mitchell, Nicola J.] Univ Western Australia, Ctr Evolutionary Biol, Perth, WA 6009, Australia; [Possingham, Hugh P.] Univ Queensland, Dept Math & Phys, Brisbane, Qld, Australia; [Armstrong, Doug P.] Massey Univ, Wildlife Ecol Grp, Palmerston North, New Zealand; [Armstrong, Doug P.] Int Union Conservat Nat Species Survival Commiss, Reintro Specialist Grp, Oceania Chair, Abu Dhabi, U Arab Emirates	University of Melbourne; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Queensland; Massey University	Rout, TM (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	tmrout@unimelb.edu.au	Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Mitchell, Nicola/AAE-4132-2020; Mitchell, Nicola J/K-5277-2012; McDonald-Madden, Eve/A-5186-2012; Martin, Tara/M-1897-2016; Rout, Tracy/AGS-0555-2022	Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Mitchell, Nicola J/0000-0003-0744-984X; McDonald-Madden, Eve/0000-0001-7755-2338; Martin, Tara/0000-0001-7165-9812; Rout, Tracy/0000-0002-5976-8255	Australian Research Council through Australian Post-Doctoral Fellowships; Centre of Excellence for Environmental Decisions; Australian Government's National Environmental Research Program; Commonwealth Scientific and Industrial Research Organisation	Australian Research Council through Australian Post-Doctoral Fellowships(Australian Research Council); Centre of Excellence for Environmental Decisions; Australian Government's National Environmental Research Program(Australian Government); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by the Australian Research Council (www.arc.gov.au) through Australian Post-Doctoral Fellowships to TMR and EM-M, and the Centre of Excellence for Environmental Decisions (to HPP, TGM, and EM-M). It was also supported by the Australian Government's National Environmental Research Program (to HPP, TGM, and EM-M), and the Commonwealth Scientific and Industrial Research Organisation (through a Julius Career award to TGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Catford JA, 2012, GLOBAL CHANGE BIOL, V18, P44, DOI 10.1111/j.1365-2486.2011.02549.x; Chauvenet ALM, 2013, ANIM CONSERV, V16, P161, DOI 10.1111/j.1469-1795.2012.00589.x; DANTZIG GB, 1957, OPER RES, V5, P266, DOI 10.1287/opre.5.2.266; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Fordham DA, 2013, NATURE CLIM IN PRESS; Fox D, 2007, WORLDS COLLIDE CONSE; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hewitt N, 2011, BIOL CONSERV, V144, P2560, DOI 10.1016/j.biocon.2011.04.031; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; HOWARD RA, 1966, IEEE T SYST SCI CYB, VSSC2, P22, DOI 10.1109/TSSC.1966.300074; IUCN, 1998, IUCN GUID REINTR; IUCN, 2013, GUID REINTR OTH CONS; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Laycock H, 2009, BIOL CONSERV, V142, P3120, DOI 10.1016/j.biocon.2009.08.010; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Martin TG, 2005, ECOL APPL, V15, P266, DOI 10.1890/03-5400; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Mitchell Nicola J, 2006, Front Zool, V3, P9, DOI 10.1186/1742-9994-3-9; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; Pannell DJ, 2012, LAND USE POLICY, V29, P377, DOI 10.1016/j.landusepol.2011.08.002; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Seddon PJ, 2009, CONSERV BIOL, V23, P788, DOI 10.1111/j.1523-1739.2009.01200.x; Springborn M, 2011, ECOL ECON, V70, P2145, DOI 10.1016/j.ecolecon.2011.06.016; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; Willis SG, 2009, CONSERV LETT, V2, P45, DOI 10.1111/j.1755-263X.2008.00043.x; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x	39	40	40	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75814	10.1371/journal.pone.0075814	http://dx.doi.org/10.1371/journal.pone.0075814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146778	gold, Green Published			2022-12-25	WOS:000326019400018
J	Schag, K; Teufel, M; Junne, F; Preissl, H; Hautzinger, M; Zipfel, S; Giel, KE				Schag, Kathrin; Teufel, Martin; Junne, Florian; Preissl, Hubert; Hautzinger, Martin; Zipfel, Stephan; Giel, Katrin Elisabeth			Impulsivity in Binge Eating Disorder: Food Cues Elicit Increased Reward Responses and Disinhibition	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; INHIBITORY CONTROL; ATTENTION BIAS; OBESITY; PREVALENCE; ACTIVATION; OVERWEIGHT; PICTURES; IMAGES; WOMEN	Background: Binge eating disorder (BED) represents a distinct eating disorder diagnosis. Current approaches assume increased impulsivity to be one factor leading to binge eating and weight gain. We used eye tracking to investigate both components of impulsivity, namely reward sensitivity and rash-spontaneous behaviour towards food in BED for the first time. Methods: Overweight and obese people with BED (BED+; n = 25), without BED (BED-; n = 26) and healthy normal-weight controls (NWC; n = 25) performed a free exploration paradigm measuring reward sensitivity (experiment 1) and a modified antisaccade paradigm measuring disinhibited, rash-spontaneous behaviour (experiment 2) using food and nonfood stimuli. Additionally, trait impulsivity was assessed. Results: In experiment 1, all participants located their initial fixations more often on food stimuli and BED+ participants gazed longer on food stimuli in comparison with BED- and NWC participants. In experiment 2, BED+ participants had more difficulties inhibiting saccades towards food and nonfood stimuli compared with both other groups in first saccades, and especially towards food stimuli in second saccades and concerning sequences of first and second saccades. BED- participants did not differ significantly from NWC participants in both experiments. Additionally, eye tracking performance was associated with self-reported reward responsiveness and self-control. Conclusions: According to these results, food-related reward sensitivity and rash-spontaneous behaviour, as the two components of impulsivity, are increased in BED in comparison with weight-matched and normal-weight controls. This indicates that BED represents a neurobehavioural phenotype of obesity that is characterised by increased impulsivity. Interventions for BED should target these special needs of affected patients.	[Schag, Kathrin; Teufel, Martin; Junne, Florian; Zipfel, Stephan; Giel, Katrin Elisabeth] Univ Tubingen, Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Preissl, Hubert] Univ Tubingen, Univ Hosp Tubingen, FMEG Ctr, Tubingen, Germany; [Preissl, Hubert] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Hautzinger, Martin] Univ Tubingen, Dept Psychol Clin & Dev Psychol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Schag, K (corresponding author), Univ Tubingen, Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany.	kathrin.schag@med.uni-tuebingen.de	Preißl, Hubert/E-9070-2012; Junne, Florian/ABI-7343-2020	Preißl, Hubert/0000-0002-8859-4661; Zipfel, Stephan/0000-0003-1659-4440	fortune programme of the Medical Faculty Tubingen [F1292005]; Deutsche Forschungsgemeinschaft; Tubingen University	fortune programme of the Medical Faculty Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University	The authors are grateful for funding support from a grant of the fortune programme of the Medical Faculty Tubingen (project number F1292005) (URL: http://www.med.uni-tuebingen.de/Forschung/Forschung+_+F%C3%B6rderung+an+der+Medizinischen+Fakult%C3%A4t/fort%C3%BCne.html). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University, (URL: http://www.uni-tuebingen.de/einrichtungen/universitaetsbibliothek/lernen-lehren-forschen/open-access-publikationsfonds.html.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert DS, 2012, J CLIN EXP NEUROPSYC, V34, P1016, DOI 10.1080/13803395.2012.706261; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2013, BING EAT DIS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; de Zwaan M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-220; Fielding J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030475; Fischer B, 1997, BRAIN RES PROTOC, V2, P47, DOI 10.1016/S1385-299X(97)00027-5; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Giel KE, EUROPEAN EA IN PRESS, V21; Graham R, 2011, APPETITE, V56, P577, DOI 10.1016/j.appet.2011.01.029; Guerrieri R., 2008, PSIHOLOGIJSKE TEME, V17, P265; Hautzinger M., 2006, BECK DEPRESSIONS INV; Hilbert A., 2006, EATING DISORDER EXAM; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Jones A, 2012, EXPT CLIN PSYCHOPHAR; Manwaring JL, 2011, PSYCHOL REC, V61, P561, DOI 10.1007/BF03395777; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Mitchell KS, 2010, PSYCHOL MED, V40, P1899, DOI 10.1017/S0033291710000139; Mobbs O, 2011, APPETITE, V57, P263, DOI 10.1016/j.appet.2011.04.023; Mosconi MW, 2009, PSYCHOL MED, V39, P1559, DOI 10.1017/S0033291708004984; Mueller SC, 2012, J CHILD PSYCHOL PSYC, V53, P856, DOI 10.1111/j.1469-7610.2012.02541.x; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nummenmaa L, 2011, PLOS ONE, V6; Preuss UW, 2008, NERVENARZT, V79, P305, DOI 10.1007/s00115-007-2360-7; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; SensoMotoricInstruments, 2010, BEGAZE; SensoMotoricInstruments, 2010, IVIEWX; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Smith DG, 2013, BIOL PSYCHIAT, V73, P804, DOI 10.1016/j.biopsych.2012.08.026; Smyrnis N, 2008, BRAIN COGNITION, V68, P341, DOI 10.1016/j.bandc.2008.08.022; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Striegel-Moore RH, 2008, ANNU REV CLIN PSYCHO, V4, P305, DOI 10.1146/annurev.clinpsy.4.022007.141149; Strobel A., 2001, DIFFER DIAGNOST PSYC, V22, P216, DOI [10.1024//0170-1789.22.3.216, DOI 10.1024//0170-1789.22.3.216]; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Tammela LI, 2010, CLIN PHYSIOL FUNCT I, V30, P135, DOI 10.1111/j.1475-097X.2009.00916.x; Waxman SE, 2009, EUR EAT DISORD REV, V17, P408, DOI 10.1002/erv.952; Werthmann J, 2011, HEALTH PSYCHOL, V30, P561, DOI 10.1037/a0024291; Wittchen H-U, 1997, SKID 1 STRUKTURIERTE; Wonderlich SA, 2009, INT J EAT DISORDER, V42, P687, DOI 10.1002/eat.20719	48	128	128	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76542	10.1371/journal.pone.0076542	http://dx.doi.org/10.1371/journal.pone.0076542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146885	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400070
J	Schel, AM; Townsend, SW; Machanda, Z; Zuberbuhler, K; Slocombe, KE				Schel, Anne Marijke; Townsend, Simon W.; Machanda, Zarin; Zuberbuehler, Klaus; Slocombe, Katie E.			Chimpanzee Alarm Call Production Meets Key Criteria for Intentionality	PLOS ONE			English	Article							GESTURAL COMMUNICATION; SEMANTIC COMMUNICATION; ATTENTIONAL STATUS; DIFFERENTIAL USE; GROUP MEMBERS; LANGUAGE; ELABORATION; PERSISTENCE; PRIMATES; ANIMALS	Determining the intentionality of primate communication is critical to understanding the evolution of human language. Although intentional signalling has been claimed for some great ape gestural signals, comparable evidence is currently lacking for their vocal signals. We presented wild chimpanzees with a python model and found that two of three alarm call types exhibited characteristics previously used to argue for intentionality in gestural communication. These alarm calls were: (i) socially directed and given to the arrival of friends, (ii) associated with visual monitoring of the audience and gaze alternations, and (iii) goal directed, as calling only stopped when recipients were safe from the predator. Our results demonstrate that certain vocalisations of our closest living relatives qualify as intentional signals, in a directly comparable way to many great ape gestures. We conclude that our results undermine a central argument of gestural theories of language evolution and instead support a multimodal origin of human language.	[Schel, Anne Marijke; Slocombe, Katie E.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Schel, Anne Marijke; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda; [Townsend, Simon W.] Univ Zurich, Anim Behav Grp, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Machanda, Zarin] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Zuberbuehler, Klaus] Univ Neuchatel, Dept Comparat Cognit, CH-2000 Neuchatel, Switzerland; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of York - UK; University of Zurich; Harvard University; University of Neuchatel; University of St Andrews	Slocombe, KE (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	katie.slocombe@york.ac.uk	Slocombe, Katie E/B-8788-2016; Zuberbühler, Klaus/A-9053-2011	Slocombe, Katie E/0000-0002-7310-1887; Zuberbühler, Klaus/0000-0001-8378-088X	BBSRC; Wenner-Gren Hunt Fellowship; University of Zurich; Leverhulme Trust [F/00 268/AP]; Biotechnology and Biological Sciences Research Council [BB/G00613X/1] Funding Source: researchfish; BBSRC [BB/G00613X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wenner-Gren Hunt Fellowship; University of Zurich; Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by a BBSRC project grant to KS. ZM was supported by a Wenner-Gren Hunt Fellowship, ST was supported by the University of Zurich, and KZ was supported by the Leverhulme Trust (F/00 268/AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arbib MA., 2012, BRAIN GOT LANGUAGE; Bates D., 2009, LME4 LINEAR MIXED EF; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byrne RW, 2006, CURR BIOL, V16, pR445, DOI 10.1016/j.cub.2006.05.040; Casar C, 2012, ANIM BEHAV, V84, P405, DOI 10.1016/j.anbehav.2012.05.010; Call J., 2007, GESTURAL COMMUNICATI; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Cartmill EA, 2010, ANIM COGN, V13, P793, DOI 10.1007/s10071-010-0328-7; CHENEY D, 1990, ANIM BEHAV, V40, P742, DOI 10.1016/S0003-3472(05)80703-1; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Cheney DL, 2005, LINGUIST REV, V22, P135, DOI 10.1515/tlir.2005.22.2-4.135; CHENEY DL, 1985, BEHAVIOUR, V94, P150, DOI 10.1163/156853985X00316; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Corballis MC, 1999, AM SCI, V87, P138, DOI 10.1511/1999.2.138; Crawley M. J, 2002, STAT COMPUTING INTRO; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; Dennett Daniel C., 1987, INTENTIONAL STANCE; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Faraway J. J., 2006, LINEAR MODELS R; GEMBA H, 1995, BRAIN RES, V697, P143, DOI 10.1016/0006-8993(95)00797-T; Genty E, 2010, ANIM COGN, V13, P287, DOI 10.1007/s10071-009-0266-4; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Golabek KA, 2012, ANIM BEHAV, V83, P613, DOI 10.1016/j.anbehav.2011.11.034; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRICE HP, 1957, PHILOS REV, V66, P377, DOI 10.2307/2182440; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Hooff JARAM van, 2013, DEV PRIMATE GESTURE; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Leavens DA, 1996, J COMP PSYCHOL, V110, P346, DOI 10.1037/0735-7036.110.4.346; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 1998, DEV PSYCHOL, V34, P813, DOI 10.1037/0012-1649.34.5.813; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, PRIMATE COMMUNICATIO; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; McFarland D., 1995, COMP APPROACHES COGN, P415; Meguerditchian A, 2010, CORTEX, V46, P40, DOI 10.1016/j.cortex.2009.02.013; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; PIERCE J D JR, 1985, Primates, V26, P202, DOI 10.1007/BF02382019; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; Reynolds V., 2005, CHIMPANZEES BUDONGO; Ristau C.A., 1991, P91; Roberts AI, 2013, ANIM COGN, V16, P187, DOI 10.1007/s10071-012-0563-1; Schel AM, ANIM BEHAV IN PRESS; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Slocombe Katie, 2010, P192; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2011, ANIM BEHAV, V81, P919, DOI 10.1016/j.anbehav.2011.02.002; Slocombe KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1959, DOI 10.1007/s00265-010-1006-0; Taglialatela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018852; Tomasello M, 2008, JEAN NICOD LECT, P1; Townsend SW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002431; Vauclair Jacques, 2004, Interaction Studies, V5, P365, DOI 10.1075/is.5.3.04vau; Wich SA, 2006, P ROY SOC B-BIOL SCI, V273, P735, DOI 10.1098/rspb.2005.3320; Wich SA, 2003, AM J PRIMATOL, V60, P155, DOI 10.1002/ajp.10102; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Zuberbuhler K, 2003, ADV STUD BEHAV, V33, P265, DOI 10.1016/S0065-3454(03)33006-2	71	179	180	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76674	10.1371/journal.pone.0076674	http://dx.doi.org/10.1371/journal.pone.0076674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146908	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400080
J	Mitter, N; Koundal, V; Williams, S; Pappu, H				Mitter, Neena; Koundal, Vikas; Williams, Sarah; Pappu, Hanu			Differential Expression of Tomato Spotted Wilt Virus-Derived Viral Small RNAs in Infected Commercial and Experimental Host Plants	PLOS ONE			English	Article							SMALL INTERFERING RNAS; DICER-LIKE PROTEINS; NICOTIANA-BENTHAMIANA; SILENCING SUPPRESSOR; THRIPS TRANSMISSION; ANTIVIRAL DEFENSE; NSM PROTEIN; TOSPOVIRUS; GENE; SEQUENCE	Background: Viral small RNAs (vsiRNAs) in the infected host can be generated from viral double-stranded RNA replicative intermediates, self-complementary regions of the viral genome or from the action of host RNA-dependent RNA polymerases on viral templates. The vsiRNA abundance and profile as well as the endogenous small RNA population can vary between different hosts infected by the same virus influencing viral pathogenicity and host response. There are no reports on the analysis of vsiRNAs of Tomato spotted wilt virus (TSWV), a segmented negative stranded RNA virus in the family Bunyaviridae, with two of its gene segments showing ambisense gene arrangement. The virus causes significant economic losses to numerous field and horticultural crops worldwide. Principal Findings: Tomato spotted wilt virus (TSWV)-specific vsiRNAs were characterized by deep sequencing in virus-infected experimental host Nicotiana benthamiana and a commercial, susceptible host tomato. The total small (s) RNA reads in TSWV-infected tomato sample showed relatively equal distribution of 21, 22 and 24 nt, whereas N. benthamiana sample was dominated by 24 nt total sRNAs. The number of vsiRNA reads detected in tomato was many a magnitude (similar to 350: 1) higher than those found in N. benthamiana, however the profile of vsiRNAs in terms of relative abundance 21, 22 and 24 nt class size was similar in both the hosts. Maximum vsiRNA reads were obtained for the M RNA segment of TSWV while the largest L RNA segment had the least number of vsiRNAs in both tomato and N. benthamiana. Only the silencing suppressor, NSs, of TSWV recorded higher antisense vsiRNA with respect to the coding frame among all the genes of TSWV. Significance: Details of the origin, distribution and abundance of TSWV vsiRNAs could be useful in designing efficient targets for exploiting RNA interference for virus resistance. It also has major implications toward our understanding of the differential processing of vsiRNAs in antiviral defense and viral pathogenicity.	[Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Koundal, Vikas; Pappu, Hanu] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Williams, Sarah] Univ Queensland, Inst Mol Biol, St Lucia, Qld, Australia	University of Queensland; Washington State University; University of Queensland	Pappu, H (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	hrp@wsu.edu	mitter, neena/D-1862-2013	mitter, neena/0000-0001-6146-6179	Agricultural Research Center, Washington State University; USDA National Institute of Food and Agriculture Specialty Crops Research Institute	Agricultural Research Center, Washington State University; USDA National Institute of Food and Agriculture Specialty Crops Research Institute	This work was financed by Agricultural Research Center, Washington State University and USDA National Institute of Food and Agriculture Specialty Crops Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/j.1364-3703.2000.00022.x; Bag S, 2012, EUR J PLANT PATHOL, V134, P97, DOI 10.1007/s10658-012-0026-1; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Bucher E, 2006, J GEN VIROL, V87, P3697, DOI 10.1099/vir.0.82276-0; Chellappan P, 2005, PLANT PHYSIOL, V138, P1828, DOI 10.1104/pp.105.066563; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Garcia S, 2006, J GEN VIROL, V87, P1985, DOI 10.1099/vir.0.81827-0; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Jan FJ, 2000, J GEN VIROL, V81, P235, DOI 10.1099/0022-1317-81-1-235; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2007, METHOD ENZYMOL, V427, P215, DOI 10.1016/S0076-6879(07)27012-0; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Lin KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011928; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nagata T, 2000, PHYTOPATHOLOGY, V90, P454, DOI 10.1094/PHYTO.2000.90.5.454; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pang SZ, 1997, P NATL ACAD SCI USA, V94, P8261, DOI 10.1073/pnas.94.15.8261; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; PAPPU HR, 2008, ENCY VIROLOGY, V5, P133; Prabha K, 2013, INDIAN J VIROL, V24, P157, DOI 10.1007/s13337-013-0133-4; Prins M, 1996, MOL PLANT MICROBE IN, V9, P416, DOI 10.1094/MPMI-9-0416; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qiu WP, 1998, VIROLOGY, V244, P186, DOI 10.1006/viro.1998.9131; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reavy B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-18; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Silva TF, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-40; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tsompana M., 2008, ENCY VIROLOGY, V5, P157; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	84	53	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76276	10.1371/journal.pone.0076276	http://dx.doi.org/10.1371/journal.pone.0076276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143182	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100017
J	Speakman, A; Rodger, A; Phillips, AN; Gilson, R; Johnson, M; Fisher, M; Wilkins, E; Anderson, J; O'Connell, R; Lascar, M; Aderogba, K; Edwards, S; McDonnell, J; Perry, N; Sherr, L; Collins, S; Hart, G; Johnson, AM; Miners, A; Elford, J; Geretti, AM; Burman, WJ; Lampe, FC				Speakman, Andrew; Rodger, Alison; Phillips, Andrew N.; Gilson, Richard; Johnson, Margaret; Fisher, Martin; Wilkins, Ed; Anderson, Jane; O'Connell, Rebecca; Lascar, Monica; Aderogba, Kazeem; Edwards, Simon; McDonnell, Jeffrey; Perry, Nicky; Sherr, Lorraine; Collins, Simon; Hart, Graham; Johnson, Anne M.; Miners, Alec; Elford, Jonathan; Geretti, Anna-Maria; Burman, William J.; Lampe, Fiona C.			The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) Study. Design, Methods and Participant Characteristics	PLOS ONE			English	Article							HIV-INFECTION; HOMOSEXUAL-MEN; COMMUNITY SAMPLES; LIFE EXPECTANCY; VIRAL LOAD; GAY MEN; BEHAVIOR; LONDON; THERAPY; PREVENTION	Life expectancy for people diagnosed with HIV has improved dramatically however the number of new infections in the UK remains high. Understanding patterns of sexual behaviour among people living with diagnosed HIV, and the factors associated with having condom-less sex, is important for informing HIV prevention strategies and clinical care. In addition, in view of the current interest in a policy of early antiretroviral treatment (ART) for all people diagnosed with HIV in the UK, it is of particular importance to assess whether ART use is associated with increased levels of condom-less sex. In this context the ASTRA study was designed to investigate current sexual activity, and attitudes to HIV transmission risk, in a large unselected sample of HIV-infected patients under care in the UK. The study also gathered background information on demographic, socio-economic, lifestyle and disease-related characteristics, and physical and psychological symptoms, in order to identify other key factors impacting on HIV patients and the behaviours which underpin transmission. In this paper we describe the study rationale, design, methods, response rate and the demographic characteristics of the participants. People diagnosed with HIV infection attending 8 UK HIV out-patient clinics in 2011-2012 were invited to participate in the study. Those who agreed to participate completed a confidential, self-administered pen-and-paper questionnaire, and their latest CD4 count and viral load test results were recorded. During the study period, 5112 eligible patients were invited to take part in the study and 3258 completed questionnaires were obtained, representing a response rate of 64% of eligible patients. The study includes 2248 men who have sex with men (MSM), 373 heterosexual men and 637 women. Future results from ASTRA will be a key resource for understanding HIV transmission within the UK, targeting prevention efforts, and informing clinical care of individuals living with HIV.	[Speakman, Andrew; Rodger, Alison; Phillips, Andrew N.; Gilson, Richard; McDonnell, Jeffrey; Sherr, Lorraine; Hart, Graham; Johnson, Anne M.; Lampe, Fiona C.] UCL, Res Dept Infect & Populat Hlth, London, England; [Johnson, Margaret] Royal Free Hosp, Ian Charleson Day Ctr, Royal Free Ctr HIV Med, London NW3 2QG, England; [Fisher, Martin; Perry, Nicky] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Wilkins, Ed] Pennine Acute Hosp NHS Trust, Manchester, Lancs, England; [Anderson, Jane] Homerton Univ Hosp, London, England; [O'Connell, Rebecca; Lascar, Monica] Barts Hlth NHS Trust, London, England; [Aderogba, Kazeem] Eastbourne Sexual Hlth Ctr, Eastbourne, England; [Edwards, Simon] Cent & North West London Community Fdn Trust, Mortimer Market Ctr, London, England; [Collins, Simon] HIV I Base, London, England; [Miners, Alec] London Sch Hyg & Trop Med, London WC1, England; [Elford, Jonathan] City Univ London, London EC1V 0HB, England; [Geretti, Anna-Maria] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Burman, William J.] Denver Publ Hlth, Denver, CO USA	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of London; Queen Mary University London; Barts Health NHS Trust; University of London; London School of Hygiene & Tropical Medicine; City University London; University of Liverpool	Speakman, A (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	a.speakman@ucl.ac.uk	Anderson, Jane/A-1632-2012; Lampe, Fiona/I-5826-2019; Phillips, Andrew N/B-4427-2008; Collins, Simon/AAB-5123-2022	Anderson, Jane/0000-0001-5294-8707; Lampe, Fiona/0000-0001-6851-5471; Phillips, Andrew N/0000-0003-2384-4807; Sherr, Lorraine/0000-0002-5902-8011; Speakman, Andrew/0000-0003-1386-0627; Geretti, Anna Maria/0000-0002-3670-6588; Johnson, Anne/0000-0003-1330-7100; Hart, Graham/0000-0001-9676-6577; Collins, Simon/0000-0002-3537-2432	National Institute for Health Research (NIHR) [RP-PG-0608-10142]; National Institute for Health Research, through the Comprehensive Clinical Research Network; National Institute for Health Research [RP-PG-0608-10142, NF-SI-0611-10255] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The ASTRA study presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10142). The ASTRA Study Group acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, COMMUNICATION; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bernard E, 2008, NAM AIDSMAP; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Burman W, 2008, JAIDS-J ACQ IMM DEF, V49, P142, DOI 10.1097/QAI.0b013e318183a9ad; Burns FM, 2009, AIDS, V23, P262, DOI 10.1097/QAD.0b013e32831c546b; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Das M, 2010, PLOS ONE, V5, P9; Dave SS, 2006, SEX TRANSM INFECT, V82, P117, DOI 10.1136/sti.2005.015396; Dodds JP, 2004, SEX TRANSM INFECT, V80, P236, DOI 10.1136/sti.2003.007286; Dodds JP, 2007, SEX TRANSM INFECT, V83, P392, DOI 10.1136/sti.2006.021782; Elford J, 2004, SEX TRANSM INFECT, V80, P451, DOI 10.1136/sti.2004.010785; Elford J, 2005, AIDS, V19, P205, DOI 10.1097/00002030-200501280-00014; Elford J, 2002, AIDS, V16, P1537, DOI 10.1097/00002030-200207260-00011; Elford J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-150; Elford J, 2007, AIDS, V21, pS63, DOI 10.1097/01.aids.0000255087.62223.ff; Fenton KA, 2002, SEX TRANSM INFECT, V78, P241, DOI 10.1136/sti.78.4.241; Glass TR, 2004, AIDS, V18, P1707, DOI 10.1097/01.aids.0000131396.21963.81; Hart GJ, 2005, SEX TRANSM INFECT, V81, P367, DOI 10.1136/sti.2004.013995; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Health Protection Agency, 2012, HIV UK 2012 REP; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Kozal MJ, 2004, AIDS, V18, P2185, DOI 10.1097/00002030-200411050-00011; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; May Margaret, 2011, BMJ, V343, pd6016, DOI 10.1136/bmj.d6016; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Mercer CH, 2004, AIDS, V18, P1453, DOI 10.1097/01.aids.0000131331.36386.de; MOCROFT A, 2003, LANCET, V166, P2572; Moses SH, 2012, INT J STD AIDS, V23, P282, DOI 10.1258/ijsa.2009.009094; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neaton JD, 2008, CURR OPIN HIV AIDS, V3, P112, DOI 10.1097/COH.0b013e3282f3808b; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Rodkjaer L, 2010, HIV MED, V11, P46, DOI 10.1111/j.1468-1293.2009.00741.x; Sadler KE, 2007, SEX TRANSM INFECT, V83, P523, DOI 10.1136/sti.2007.027128; Sherr L, 2007, INT J STD AIDS, V18, P700, DOI 10.1258/095646207782193821; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stephenson JM, 2003, SEX TRANSM INFECT, V79, P7, DOI 10.1136/sti.79.1.7; Vernazza P, 2008, B MED SUISSES, V89, P165; VOGL D, 1999, SYMPTOM PREVALENCE C, P34965; Weatherburn P., 2009, WHAT DO YOU NEED 200; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson LM, 2008, AIDS, V22, P1063, DOI 10.1097/QAD.0b013e3282f8af9b	44	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77230	10.1371/journal.pone.0077230	http://dx.doi.org/10.1371/journal.pone.0077230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143214	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100050
J	Zhang, ZJ; Almeida, S; Lu, YB; Nishimura, AL; Peng, LT; Sun, DQ; Wu, B; Karydas, AM; Tartaglia, MC; Fong, JC; Miller, BL; Farese, RV; Moore, MJ; Shaw, CE; Gao, FB				Zhang, Zhijun; Almeida, Sandra; Lu, Yubing; Nishimura, Agnes L.; Peng, Lingtao; Sun, Danqiong; Wu, Bei; Karydas, Anna M.; Tartaglia, Maria C.; Fong, Jamie C.; Miller, Bruce L.; Farese, Robert V., Jr.; Moore, Melissa J.; Shaw, Christopher E.; Gao, Fen-Biao			Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PLURIPOTENT STEM-CELLS; HEXANUCLEOTIDE REPEAT; RNA TARGETS; ALS; PROTEIN; DEMENTIA; DISEASE; GENE; INCLUSIONS	Transactive response DNA-binding protein 43 (TDP-43) is a major pathological protein in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). There are many disease-associated mutations in TDP-43, and several cellular and animal models with ectopic overexpression of mutant TDP-43 have been established. Here we sought to study altered molecular events in FTD and ALS by using induced pluripotent stem cell (iPSC) derived patient neurons. We generated multiple iPSC lines from an FTD/ALS patient with the TARDBP A90V mutation and from an unaffected family member who lacked the mutation. After extensive characterization, two to three iPSC lines from each subject were selected, differentiated into postmitotic neurons, and screened for relevant cell-autonomous phenotypes. Patient-derived neurons were more sensitive than control neurons to 100 nM straurosporine but not to other inducers of cellular stress. Three disease-relevant cellular phenotypes were revealed under staurosporine-induced stress. First, TDP-43 was localized in the cytoplasm of a higher percentage of patient neurons than control neurons. Second, the total TDP-43 level was lower in patient neurons with the A90V mutation. Third, the levels of microRNA-9 (miR-9) and its precursor pri-miR-9-2 decreased in patient neurons but not in control neurons. The latter is likely because of reduced TDP-43, as shRNA-mediated TDP-43 knockdown in rodent primary neurons also decreased the pri-miR-9-2 level. The reduction in miR-9 expression was confirmed in human neurons derived from iPSC lines containing the more pathogenic TARDBP M337V mutation, suggesting miR-9 downregulation might be a common pathogenic event in FTD/ALS. These results show that iPSC models of FTD/ALS are useful for revealing stress-dependent cellular defects of human patient neurons containing rare TDP-43 mutations in their native genetic contexts.	[Zhang, Zhijun; Almeida, Sandra; Lu, Yubing; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Nishimura, Agnes L.; Shaw, Christopher E.] Inst Psychiat, Dept Clin Neurosci, London, England; [Peng, Lingtao; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Biol Chem & Mol Pharmacol, Worcester, MA USA; [Peng, Lingtao; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Sun, Danqiong; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Wu, Bei] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA USA; [Karydas, Anna M.; Tartaglia, Maria C.; Fong, Jamie C.; Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gao, FB (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	fen-biao.gao@umassmed.edu	Nishimura, Agnes L/B-2905-2011; Lu, Yubing/G-2644-2011	Lu, Yubing/0000-0002-7715-9867; Nishimura, Agnes/0000-0001-5295-797X; Shaw, Christopher/0000-0003-0251-0146	California Institute for Regenerative Medicine [RL1-00650]; University of Massachusetts Medical School; ALS Therapy Alliance; Consortium for FTD Research; National Institutes of Health [NS066586, NS057553, AG019724, AG023501]; MRC [MC_G1000733, G0300329, G0900688] Funding Source: UKRI; Medical Research Council [G0900688, MC_G1000733, G0300329, G0500289B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS057553, R01NS066586, R01NS057553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, P01AG019724] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); University of Massachusetts Medical School; ALS Therapy Alliance; Consortium for FTD Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was initiated with a grant from the California Institute for Regenerative Medicine (RL1-00650 to FBG and RVF Jr.) and was subsequently supported by funds from the University of Massachusetts Medical School and the ALS Therapy Alliance (FBG). The work was also supported by the Consortium for FTD Research (FBG) and the National Institutes of Health (NS066586 and NS057553, FBG; AG019724 and AG023501, BLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2012, P NATL ACAD SCI USA, V109, P1913, DOI 10.1073/pnas.1117158109; Almeida S, 2012, ACTA NEUROPATHOL; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Chiang HH, 2012, J HUM GENET, V57, P316, DOI 10.1038/jhg.2012.24; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Gascon E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00048; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Iguchi Y, 2013, BRAIN, V136, P1371, DOI 10.1093/brain/awt029; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee JA, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-37; Li ZD, 2013, HUM MOL GENET, V22, P218, DOI 10.1093/hmg/dds420; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu XL, 2011, J NEUROSCI, V31, P13705, DOI 10.1523/JNEUROSCI.2827-11.2011; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019	58	51	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76055	10.1371/journal.pone.0076055	http://dx.doi.org/10.1371/journal.pone.0076055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143176	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100011
J	Zhang, HL; Zhang, YZ; Yang, WH; Feng, Y; Nasci, RS; Yang, J; Liu, YH; Dong, CL; Li, S; Zhang, BS; Yin, ZL; Wang, PY; Fu, SH; Li, MH; Liu, F; Zhang, J; Sun, J; Li, CW; Gao, XY; Liu, H; Wang, HY; Petersen, LR; Liang, GD				Zhang, Hai-Lin; Zhang, Yu-Zhen; Yang, Wei-Hong; Feng, Yun; Nasci, Roger S.; Yang, Jie; Liu, Yong-Hua; Dong, Chao-Liang; Li, Shi; Zhang, Bao-Sen; Yin, Zheng-Liu; Wang, Pi-Yu; Fu, Shi-Hong; Li, Ming-Hua; Liu, Fen; Zhang, Juan; Sun, Jie; Li, Can-Wei; Gao, Xiao-Yan; Liu, Hong; Wang, Huan-Yu; Petersen, Lyle R.; Liang, Guo-Dong			Mosquitoes of Western Yunnan Province, China: Seasonal Abundance, Diversity, and Arbovirus Associations	PLOS ONE			English	Article							JAPANESE-ENCEPHALITIS-VIRUS; SOUTH-EASTERN; GENOTYPE-I; INFECTION; SEQUENCE; IDENTIFICATION; DENSOVIRUS; GRADIENT	Objective: The western borderland between Yunnan Province, China, and Myanmar is characterized by a climate that facilitates year-round production of mosquitoes. Numerous mosquito-transmitted viruses, including Japanese encephalitis virus circulate in this area. This project was to describe seasonal patterns in mosquito species abundance and arbovirus activity in the mosquito populations. Methods: Mosquitoes were collected in Mangshi and Ruili cities of Dehong Prefecture near the border of China and Burma in Yunnan Province, the Peoples Republic of China in 2010. We monitored mosquito species abundance for a 12-month period using ultraviolet light, carbon dioxide baited CDC light and gravid traps; and tested the captured mosquitoes for the presence of virus to evaluate mosquito-virus associations in rural/agricultural settings in the area. Results: A total of 43 species of mosquitoes from seven genera were collected, including 15 Culex species, 15 Anopheles spp., four Aedes spp., three Armigeres spp., one Mimomyia spp., two Uranotaenia spp. and three Mansonia spp.. Species richness and diversity varied between Mangshi and Ruili. Culex tritaeniorhynchus, Culex quinquefasciatus, Anopheles sinensis and Anopheles peditaeniatus were the most abundant species in both sampling sites. Ultraviolet light traps collected more specimens than CDC light traps baited with dry ice, though both collected the same variety of mosquito species. The CDC gravid trap was the most effective trap for capture of Culex quinquefasciatus, a species underrepresented in light trap collections. A total of 26 virus strains were isolated, which included 13 strains of Japanese encephalitis virus, four strains of Getah virus, one strain of Oya virus, one strain from the orbivirus genus, and seven strains of Culex pipien pallens densovirus. Conclusions: The present study illustrates the value of monitoring mosquito populations and mosquito-transmitted viruses year-round in areas where the climate supports year-round adult mosquito activity.	[Zhang, Hai-Lin; Zhang, Yu-Zhen; Yang, Wei-Hong; Feng, Yun; Liu, Fen; Zhang, Juan; Sun, Jie; Li, Can-Wei] Yunnan Prov Ctr Virus & Rickettsia Res, Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China; [Nasci, Roger S.; Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Yang, Jie; Dong, Chao-Liang; Zhang, Bao-Sen] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan, Peoples R China; [Liu, Yong-Hua; Li, Shi; Yin, Zheng-Liu] Ruili City Ctr Dis Control & Prevent, Ruili, Yunnan, Peoples R China; [Wang, Pi-Yu] Yunnan Inst Parasit Dis, Simao, Yunnan, Peoples R China; [Fu, Shi-Hong; Li, Ming-Hua; Gao, Xiao-Yan; Liu, Hong; Wang, Huan-Yu; Liang, Guo-Dong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Yunnan Institute for Endemic Disease Control & Prevention; Centers for Disease Control & Prevention - USA; Chinese Center for Disease Control & Prevention	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	Yang, Wei/HIA-0360-2022; Li, Minghua/M-8776-2016; Yang, Wei/GWV-4107-2022		China Centers for Disease Control and Prevention - U.S. Centers for Disease Control and Prevention [U-19-GH000004]; Ministry of Science and Technology, China [2011CB504702]; State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	China Centers for Disease Control and Prevention - U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Ministry of Science and Technology, China(Ministry of Science and Technology, China); State Key Laboratory for Infectious Disease Prevention and Control	This study was supported by from China Centers for Disease Control and Prevention - U.S. Centers for Disease Control and Prevention Cooperative Agreement U-19-GH000004; The Ministry of Science and Technology, China (2011CB504702); and Development grant of the State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2005, J GEN VIROL, V86, P1, DOI [10.1099/vir.0.80466-0, DOI 10.1099/VIR.0.80466-0.PUBMED:15604425]; Berge T, 1975, GETAH, P278; Brown CM, 1998, TROP ANIM HEALTH PRO, V30, P241, DOI 10.1023/A:1005079229232; Bryant JE, 2005, AM J TROP MED HYG, V73, P470, DOI 10.4269/ajtmh.2005.73.470; CARESTIA RALPH R., 1967, MOSQUITONEWS, V27, P90; [邓淑珍 DENG Shu-zhen], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P344; Deng SZ, 2009, ENDEM DIS B, V24, P1; Devi N. Pemola, 2004, Journal of Vector Borne Diseases, V41, P17; Feng Y, 2013, EMERG INFECT DIS, V19, P672, DOI 10.3201/eid1904.120137; Feng Y, 2012, JPN J INFECT DIS, V65, P215, DOI 10.7883/yoken.65.215; Feng Yun, 2011, Jishengchong Yu Yixue Kunchong Xuebao, V18, P15, DOI 10.3969/j.issn.1005-0507.2011.01.004; Fu ShiHong, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P432; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; KAMADA M, 1980, AM J TROP MED HYG, V29, P984, DOI 10.4269/ajtmh.1980.29.984; Kavazos CRJ, 2012, LANDSCAPE URBAN PLAN, V106, P183, DOI 10.1016/j.landurbplan.2012.03.002; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; Kono Y, 2002, ARCH VIROL, V147, P1623, DOI 10.1007/s00705-002-0838-y; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Kuwata R, 2013, AM J TROP MED HYG, V88, P681, DOI 10.4269/ajtmh.12-0407; Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016; Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160; Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x; Mi ZQ, 2002, CHIN J PESTS CONTROL, V18, P367; Molaei G, 2007, AM J TROP MED HYG, V77, P73; Nitatpattana N, 2008, EMERG INFECT DIS, V14, P1762, DOI 10.3201/eid1411.080542; Nitatpattana Narong, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P875; Pan XL, 2011, J VIROL, V85, P9847, DOI 10.1128/JVI.00825-11; Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709; REITER P, 1983, MOSQ NEWS, V43, P496; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Spitzer K, 1999, J INSECT CONSERV, V3, P97, DOI 10.1023/A:1009634611130; Sun J, 2011, GUOJI BINGDUXUE ZAZH, V18, P125; Sun XH, 2009, VECTOR-BORNE ZOONOT, V9, P623, DOI 10.1089/vbz.2008.0145; Sun YuJie, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P436; Tao San-ju, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P322; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Wang Jing-jing, 2008, Virologica Sinica, V23, P31, DOI 10.1007/s12250-008-2891-5; Wang Jing-lin, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P87; Wang Jing-lin, 2008, Chinese Journal of Zoonoses, V24, P636; Wang Jing-lin, 2008, Chinese Journal of Zoonoses, V24, P1; Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294; Wang LH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-345; XU P, 1988, Chinese Journal of Virology, V4, P218; Xu PuTing, 1990, Chinese Journal of Virology, V6, P27; Yang Du-juan, 2011, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V22, P304; Zhai YG, 2008, J GEN VIROL, V89, P1446, DOI 10.1099/vir.0.83607-0; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0; ZHANG H, 1989, Chinese Journal of Virology, V5, P31; Zhang Hai-lin, 2002, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V13, P101; Zhang Hai-lin, 2005, Chinese Journal of Zoonoses, V21, P548; Zhang Hailin, 1999, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V10, P192; Zhang Hailin, 1998, Difangbing Tongbao, V13, P78; Zhang Hailin, 1999, Difangbing Tongbao, V14, P50; Zhang HL, 1990, CHIN J PREV MED, V24, P265; Zhang HL, 2000, CHINESE J PREVENTIVE, V22, P81; Zhang HL, 2000, CHIN J PESTS CONTROL, V16, P113; Zhang HL, 1999, CHIN J PESTS CONTROL, V15, P23; Zhang HL, 1999, CHIN J PESTS CONTROL, V15, P59; Zhang YZ, 2001, CHIN J VECTOR BIOL C, V12, P28	61	20	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77017	10.1371/journal.pone.0077017	http://dx.doi.org/10.1371/journal.pone.0077017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146951	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400094
J	He, NP; Yu, Q; Wang, RM; Zhang, YH; Gao, Y; Yu, GR				He, Nianpeng; Yu, Qiang; Wang, Ruomeng; Zhang, Yunhai; Gao, Yang; Yu, Guirui			Enhancement of Carbon Sequestration in Soil in the Temperature Grasslands of Northern China by Addition of Nitrogen and Phosphorus	PLOS ONE			English	Article							LAND-USE; DEPOSITION; STORAGE; ECOSYSTEMS; DYNAMICS; LITTER; MINERALIZATION; ACIDIFICATION; PERSPECTIVE; IMPACT	Increased nitrogen (N) deposition is common worldwide. Questions of where, how, and if reactive N-input influences soil carbon (C) sequestration in terrestrial ecosystems are of great concern. To explore the potential for soil C sequestration in steppe region under N and phosphorus (P) addition, we conducted a field experiment between 2006 and 2012 in the temperate grasslands of northern China. The experiment examined 6 levels of N (0-56 g N m(-2) yr(-1)), 6 levels of P (0-12.4 g P m(-2) yr(-1)), and a control scenario. Our results showed that addition of both N and P enhanced soil total C storage in grasslands due to significant increases of C input from litter and roots. Compared with control plots, soil organic carbon (SOC) in the 0-100 cm soil layer varied quadratically, from 156.8 to 1352.9 g C m(-2) with N addition gradient (R-2 = 0.99, P < 0.001); and logarithmically, from 293.6 to 788.6 g C m(-2) with P addition gradient (R-2 = 0.56, P = 0.087). Soil inorganic carbon (SIC) decreased quadratically with N addition. The net C sequestration on grassland (including plant, roots, SIC, and SOC) increased linearly from -128.6 to 729.0 g C m(-2) under N addition (R-2 = 0.72, P = 0.023); and increased logarithmically, from 248.5 to 698 g C m(-2) under P addition (R-2 = 0.82, P = 0.014). Our study implies that N addition has complex effects on soil carbon dynamics, and future studies of soil C sequestration on grasslands should include evaluations of both SOC and SIC under various scenarios.	[He, Nianpeng; Wang, Ruomeng; Gao, Yang; Yu, Guirui] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Yu, Qiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yu, Qiang] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Zhang, Yunhai] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Colorado State University; Chinese Academy of Sciences; Institute of Botany, CAS	He, NP (corresponding author), Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	henp@igsnrr.ac.cn; yugr@igsnrr.ac.cn	Gao, Yang/A-4128-2017; 于, 贵瑞/C-1768-2014; Yu, Qiang/E-2097-2011; Zhang, Yunhai/F-7318-2019	Gao, Yang/0000-0002-2053-0418; 于, 贵瑞/0000-0002-1859-8966; Yu, Qiang/0000-0002-5480-0623; Zhang, Yunhai/0000-0003-0613-3624; he, nianpeng/0000-0002-0458-5953	Natural Science Foundation of China [31270519]; special fund for scientific research in the public interest [201209028]; strategic program of state eco-environmental investigation and evaluation in China [STSN-02-03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for scientific research in the public interest; strategic program of state eco-environmental investigation and evaluation in China	This work was partly funded by the Natural Science Foundation of China (31270519), by special fund for scientific research in the public interest (201209028), and by the strategic program of state eco-environmental investigation and evaluation in China (STSN-02-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann C, 2009, AGR ECOSYST ENVIRON, V133, P150, DOI 10.1016/j.agee.2009.05.006; Fornara DA, 2012, ECOLOGY, V93, P2030, DOI 10.1890/12-0292.1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gamboa AM, 2010, RESTOR ECOL, V18, P252, DOI 10.1111/j.1526-100X.2008.00432.x; Goulding KWT, 1998, AGR ECOSYST ENVIRON, V67, P135, DOI 10.1016/S0167-8809(97)00111-4; Grandy AS, 2007, ECOSYSTEMS, V10, P58, DOI 10.1007/s10021-006-9010-y; Grandy A, 2008, BIOGEOCHEMISTRY, V91, P37, DOI 10.1007/s10533-008-9257-9; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo LB, 2005, PLANT SOIL, V272, P1, DOI 10.1007/s11104-004-3611-z; Hagedorn F, 2003, SOIL BIOL BIOCHEM, V35, P1683, DOI 10.1016/j.soilbio.2003.08.015; Hagedorn F, 2012, GLOBAL CHANGE BIOL, V18, P1412, DOI 10.1111/j.1365-2486.2011.02603.x; He NP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00017.1; He NP, 2012, J GEOGR SCI, V22, P859, DOI 10.1007/s11442-012-0968-4; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.1890/1540-9295(2004)002[0522:CCIS]2.0.CO;2; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Li LJ, 2012, PLANT SOIL ENVIRON, V58, P446, DOI 10.17221/6339-PSE; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu M, 2011, AGR ECOSYST ENVIRON, V140, P234, DOI 10.1016/j.agee.2010.12.010; Lu FM, 2011, BIOL FERT SOILS, V47, P187, DOI 10.1007/s00374-010-0522-4; MARION GM, 1985, SOIL SCI, V139, P468, DOI 10.1097/00010694-198505000-00014; Mi N, 2008, GLOBAL CHANGE BIOL, V14, P2380, DOI 10.1111/j.1365-2486.2008.01642.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Noble AD, 2008, GEODERMA, V144, P248, DOI 10.1016/j.geoderma.2007.11.019; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Yang YH, 2012, GLOBAL CHANGE BIOL, V18, P3672, DOI 10.1111/gcb.12025; Yang YH, 2012, GLOBAL CHANGE BIOL, V18, P2292, DOI 10.1111/j.1365-2486.2012.02694.x; Yang YH, 2011, PLANT SOIL, V343, P393, DOI 10.1007/s11104-011-0736-8; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zeng DH, 2010, BIOGEOCHEMISTRY, V98, P185, DOI 10.1007/s10533-009-9385-x	39	17	19	15	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77241	10.1371/journal.pone.0077241	http://dx.doi.org/10.1371/journal.pone.0077241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130863	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200073
J	Dudley, A; Sater, M; Le, PU; Trinh, G; Sadr, MS; Bergeron, J; Deleavey, GF; Bedell, B; Damha, MJ; Petrecca, K				Dudley, A.; Sater, M.; Le, P. U.; Trinh, G.; Sadr, M. S.; Bergeron, J.; Deleavey, G. F.; Bedell, B.; Damha, M. J.; Petrecca, K.			DRR regulates AKT activation to drive brain cancer invasion	ONCOGENE			English	Article						brain cancer; glioblastoma; invasion; AKT; DRR	TYROSINE KINASE INHIBITOR; FOCAL ADHESION KINASE; PHASE I/II TRIAL; GLIOBLASTOMA-MULTIFORME; GROWTH; PATHWAY; CELLS; THERAPY; AKT/PKB; SRC	Glioblastoma (GBM) is the most common and invasive adult brain cancer. The rapid invasion of cancer cells into the normal brain is a major cause of treatment failure, yet the mechanisms that regulate this process are poorly understood. We have identified a novel mechanism of brain cancer invasion. We show that downregulated in renal cell carcinoma (DRR), which is newly expressed in invasive gliomas, recruits AKT to focal adhesions. This DRR-induced pathological relocalization of AKT bypasses commonly altered upstream signaling events and leads to AKT activation and invasion. We also developed an oligonucleotide therapeutic that reduces DRR expression and prevents glioma invasion in an in vivo preclinical model of the disease. Our findings identify DRR as a novel GBM target and show that oligonucleotides targeting DRR is a novel therapeutic approach for the treatment of DRR-positive GBMs.	[Dudley, A.; Sater, M.; Le, P. U.; Trinh, G.; Sadr, M. S.; Bergeron, J.; Bedell, B.; Petrecca, K.] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Deleavey, G. F.; Damha, M. J.] McGill Univ, Dept Chem, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Petrecca, K (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, 3801 Univ Ave,Suite 109c, Montreal, PQ H3A 2B4, Canada.	kevin.petrecca@mcgill.ca			Industry Canada, Centre of Excellence for Commercialization; Canadian Institutes for Health Research-Proof-of-Principle Grant; Canadian Institutes for Health Research-Operating Grant; McGill University Faculty of Medicine Scholarship; Vanier Canada Graduate Scholarship	Industry Canada, Centre of Excellence for Commercialization; Canadian Institutes for Health Research-Proof-of-Principle Grant; Canadian Institutes for Health Research-Operating Grant(Canadian Institutes of Health Research (CIHR)); McGill University Faculty of Medicine Scholarship; Vanier Canada Graduate Scholarship	This work was supported in part by grants from Industry Canada, Centre of Excellence for Commercialization (KP), Canadian Institutes for Health Research-Proof-of-Principle Grant (KP and MJD) and Canadian Institutes for Health Research-Operating Grant (MJD). AD was supported by a McGill University Faculty of Medicine Scholarship. GT was supported by a McGill University Faculty of Medicine Scholarship. GFD was supported by a Vanier Canada Graduate Scholarship.	AHMED NN, 1993, ONCOGENE, V8, P1957; Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Asano Y, 2010, BIOCHEM BIOPH RES CO, V394, P829, DOI 10.1016/j.bbrc.2010.03.085; Barkovich KJ, 2012, CANCER DISCOV, V2, P450, DOI 10.1158/2159-8290.CD-11-0287; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Brown PD, 2008, J CLIN ONCOL, V26, P5603, DOI 10.1200/JCO.2008.18.0612; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Franceschi E, 2012, NEURO-ONCOLOGY, V14, P1503, DOI 10.1093/neuonc/nos256; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Le PU, 2010, ONCOGENE, V29, P4636, DOI 10.1038/onc.2010.216; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu Q, 2009, ONCOL REP, V22, P1069, DOI 10.3892/or_00000538; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lu-Emerson C, 2011, J NEURO-ONCOL, V104, P287, DOI 10.1007/s11060-010-0489-x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Milano V, 2009, MOL CANCER THER, V8, P394, DOI 10.1158/1535-7163.MCT-08-0669; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Petrecca K, 2013, J NEURO-ONCOL, V111, P19, DOI 10.1007/s11060-012-0983-4; Rexer BN, 2009, CLIN CANCER RES, V15, P4518, DOI 10.1158/1078-0432.CCR-09-0872; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; Villavicencio AT, 2009, NEUROSURG REV, V32, P417, DOI 10.1007/s10143-009-0212-6; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wang L, 2000, GENE CHROMOSOME CANC, V27, P1, DOI 10.1002/(SICI)1098-2264(200001)27:1<1::AID-GCC1>3.0.CO;2-6; Wang SY, 2011, ANTI-CANCER AGENT ME, V11, P993, DOI 10.2174/187152011797927661; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82	53	20	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4952	4960		10.1038/onc.2013.436	http://dx.doi.org/10.1038/onc.2013.436			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24141773				2022-12-25	WOS:000343767900008
J	Casanal, A; Zander, U; Munoz, C; Dupeux, F; Luque, I; Botella, MA; Schwab, W; Valpuesta, V; Marquez, JA				Casanal, Ana; Zander, Ulrich; Munoz, Cristina; Dupeux, Florine; Luque, Irene; Angel Botella, Miguel; Schwab, Wilfried; Valpuesta, Victoriano; Marquez, Jose A.			The Strawberry Pathogenesis-related 10 (PR-10) Fra a Proteins Control Flavonoid Biosynthesis by Binding to Metabolic Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Flavonoids; Plant Biochemistry; Plant Molecular Biology; Secondary Metabolism	BET V 1; ALLERGIC CROSS-REACTIVITY; MEDICAGO-TRUNCATULA; X-RAY; PROANTHOCYANIDIN BIOSYNTHESIS; CRYSTAL-STRUCTURE; LIPID TRANSPORT; LIGAND-BINDING; START PROTEINS; DATA-BANK	Pathogenesis-related 10 (PR-10) proteins are involved in many aspects of plant biology but their molecular function is still unclear. They are related by sequence and structural homology to mammalian lipid transport and plant abscisic acid receptor proteins and are predicted to have cavities for ligand binding. Recently, three new members of the PR-10 family, the Fra a proteins, have been identified in strawberry, where they are required for the activity of the flavonoid biosynthesis pathway, which is essential for the development of color and flavor in fruits. Here, we show that Fra a proteins bind natural flavonoids with different selectivity and affinities in the low m range. The structural analysis of Fra a 1 E and a Fra a 3-catechin complex indicates that loops L3, L5, and L7 surrounding the ligand-binding cavity show significant flexibility in the apo forms but close over the ligand in the Fra a 3-catechin complex. Our findings provide mechanistic insight on the function of Fra a proteins and suggest that PR-10 proteins, which are widespread in plants, may play a role in the control of secondary metabolic pathways by binding to metabolic intermediates.	[Casanal, Ana; Munoz, Cristina; Angel Botella, Miguel; Valpuesta, Victoriano] Univ Malaga, Dept Biol Mol & Bioquim, IHSM UMA Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea, E-29071 Malaga, Spain; [Zander, Ulrich; Dupeux, Florine; Marquez, Jose A.] Grenoble Outstat, European Mol Biol Lab, F-38042 Grenoble, France; [Zander, Ulrich; Dupeux, Florine; Marquez, Jose A.] Univ Grenoble Alpes EMBL CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Luque, Irene] Univ Granada, Dept Phys Chem, E-18071 Granada, Spain; [Luque, Irene] Univ Granada, Inst Biotechnol, E-18071 Granada, Spain; [Schwab, Wilfried] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Granada; University of Granada; Technical University of Munich	Valpuesta, V (corresponding author), Univ Malaga, Dept Biol Mol & Bioquim, IHSM UMA Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea, E-29071 Malaga, Spain.	valpuesta@uma.es; marquez@embl.fr	Botella, Miguel Ángel/S-3676-2019; Marquez, Jose/C-5826-2015; Botella, Miguel A/B-5734-2012; Luque, Inmaculada/K-9464-2014; Casañal, Ana/B-1002-2018; Luque, Irene/K-4758-2012; /R-5462-2019	Botella, Miguel Ángel/0000-0002-8867-1831; Botella, Miguel A/0000-0002-8867-1831; Luque, Inmaculada/0000-0003-1838-2636; Casañal, Ana/0000-0002-0334-0591; Luque, Irene/0000-0003-2757-4779; Valpuesta, Victoriano/0000-0003-0922-6615	European Commission [227764]; Ministerio de Ciencia e Innovacion (Spain) [BIO2010-15630]; Deutsche Forschungsgemeinschaft (Germany) [SFB 924]; Spanish government	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported in part by the P-CUBE project of the European Commission (FP7/2007-2013; Grant 227764), Ministerio de Ciencia e Innovacion Grant BIO2010-15630 (Spain), and Deutsche Forschungsgemeinschaft SFB 924 (Germany).; Recipient of a Formacion de Personal Investigador (FPI) fellowship from the Spanish government.	Aaby K, 2007, J AGR FOOD CHEM, V55, P4395, DOI 10.1021/jf0702592; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuning LL, 2004, PLANT MOL BIOL, V55, P369, DOI 10.1007/s11103-004-0904-9; Blount JW, 2000, PLANT PHYSIOL, V122, P107, DOI 10.1104/pp.122.1.107; Botton A, 2009, J AGR FOOD CHEM, V57, P724, DOI 10.1021/jf802709k; Casanal A, 2013, ACTA CRYSTALLOGR F, V69, P510, DOI 10.1107/S1744309113006945; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x; Fraser C. M., 2011, ARABIDOPSIS BOOK, V9, pe0152; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Ghasemzadeh A, 2011, J MED PLANTS RES, V5, P6697, DOI 10.5897/JMPR11.1404; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Halbwirth H, 2006, J AGR FOOD CHEM, V54, P1479, DOI 10.1021/jf0524170; Hanhineva K, 2008, PHYTOCHEMISTRY, V69, P2463, DOI 10.1016/j.phytochem.2008.07.009; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hierno K, 2006, PROTEOMICS, V6, P1574, DOI 10.1002/pmic.200500469; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson AL, 2004, ALLERGY, V59, P1277, DOI 10.1111/j.1398-9995.2004.00585.x; Kobayashi H, 2004, MOL MICROBIOL, V51, P335, DOI 10.1046/j.1365-2958.2003.03841.x; Kosar M, 2004, J AGR FOOD CHEM, V52, P1586, DOI 10.1021/jf035093t; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Mahajan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028315; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Munoz C, 2011, J AGR FOOD CHEM, V59, P12598, DOI 10.1021/jf203965j; Munoz C, 2010, MOL PLANT, V3, P113, DOI 10.1093/mp/ssp087; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Olsen KM, 2008, J PLANT PHYSIOL, V165, P1491, DOI 10.1016/j.jplph.2007.11.005; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Spangfort MD, 1997, INT ARCH ALLERGY IMM, V113, P243, DOI 10.1159/000237559; Spangfort MD, 1999, ALLERGY, V54, P23, DOI 10.1111/j.1398-9995.1999.tb05021.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; von Loetzen CS, 2012, BIOSCIENCE REP, V32, P567, DOI 10.1042/BSR20120058; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Yin R, 2012, J EXP BOT, V63, P2465, DOI 10.1093/jxb/err416; Zhao J, 2011, PLANT CELL, V23, P1536, DOI 10.1105/tpc.110.080804; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819	71	55	63	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35322	35332		10.1074/jbc.M113.501528	http://dx.doi.org/10.1074/jbc.M113.501528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133217	Green Published, hybrid			2022-12-25	WOS:000329867600030
J	Shugg, RPP; Thomson, A; Tanabe, N; Kashishian, A; Steiner, BH; Puri, KD; Pereverzev, A; Lannutti, BJ; Jirik, FR; Dixon, SJ; Sims, SM				Shugg, Ryan P. P.; Thomson, Ashley; Tanabe, Natsuko; Kashishian, Adam; Steiner, Bart H.; Puri, Kamal D.; Pereverzev, Alexey; Lannutti, Brian J.; Jirik, Frank R.; Dixon, S. Jeffrey; Sims, Stephen M.			Effects of isoform-selective Phosphatidylinositol 3-Kinase Inhibitors on Osteoclasts ACTIONS ON CYTOSKELETAL ORGANIZATION, SURVIVAL, AND RESORPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Bone; Cytoskeleton; Osteoclast; Phosphatidylinositol 3-Kinase; GS-9820; Bone Resorption; Lamellipod	PHOSPHOINOSITIDE 3-KINASE; RAT OSTEOCLASTS; PI3K ISOFORMS; CLASS-I; ROLES; DELTA; RETRACTION; MECHANISMS; P110-ALPHA; PI3-KINASE	Phosphatidylinositol 3-kinases (PI3K) participate in numerous signaling pathways, and control distinct biological functions. Studies using pan-PI3K inhibitors suggest roles for PI3K in osteoclasts, but little is known about specific PI3K isoforms in these cells. Our objective was to determine effects of isoform-selective PI3K inhibitors on osteoclasts. The following inhibitors were investigated (targets in parentheses): wortmannin and LY294002 (pan-p110), PIK75 (), GDC0941 (, ), TGX221 (), AS252424 (), and IC87114 (). In addition, we characterized a new potent and selective PI3K inhibitor, GS-9820, and explored roles of PI3K isoforms in regulating osteoclast function. Osteoclasts were isolated from long bones of neonatal rats and rabbits. Wortmannin, LY294002, GDC0941, IC87114, and GS-9820 induced a dramatic retraction of osteoclasts within 15-20 min to 65-75% of the initial area. In contrast, there was no significant retraction in response to vehicle, PIK75, TGX221, or AS252424. Moreover, wortmannin and GS-9820, but not PIK75 or TGX221, disrupted actin belts. We examined effects of PI3K inhibitors on osteoclast survival. Whereas PIK75, TGX221, and GS-9820 had no significant effect on basal survival, all blocked RANKL-stimulated survival. When studied on resorbable substrates, osteoclastic resorption was suppressed by wortmannin and inhibitors of PI3K and PI3K, but not other isoforms. These data are consistent with a critical role for PI3K in regulating osteoclast cytoskeleton and resorptive activity. In contrast, multiple PI3K isoforms contribute to the control of osteoclast survival. Thus, the PI3K isoform, which is predominantly expressed in cells of hematopoietic origin, is an attractive target for anti-resorptive therapeutics.	[Shugg, Ryan P. P.; Thomson, Ashley; Pereverzev, Alexey; Dixon, S. Jeffrey; Sims, Stephen M.] Western Univ, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Tanabe, Natsuko] Nihon Univ, Sch Dent, Tokyo 101, Japan; [Kashishian, Adam; Steiner, Bart H.; Puri, Kamal D.; Lannutti, Brian J.] Gilead Sci Inc, Seattle, WA 98102 USA; [Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Western University (University of Western Ontario); Nihon University; Gilead Sciences; University of Calgary	Sims, SM (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	smsims@uwo.ca	Sims, Stephen/G-4510-2013; Dixon, S. Jeffrey/G-3657-2013	Dixon, S. Jeffrey/0000-0001-9162-1686	Canadian Institutes of Health Research [64453]; Alberta Cancer Research Institute [24428]; CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 64453 and Alberta Cancer Research Institute Grant 24428.; Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR.	Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Golden LH, 2004, BONE, V34, P3, DOI 10.1016/j.bone.2003.09.005; Grey A, 2010, BIOCHEM BIOPH RES CO, V391, P564, DOI 10.1016/j.bbrc.2009.11.099; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hayakawa M, 2007, BIOORGAN MED CHEM, V15, P403, DOI 10.1016/j.bmc.2006.09.047; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lakkakorpi PT, 1997, EXP CELL RES, V237, P296, DOI 10.1006/excr.1997.3797; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Lapierre DM, 2010, J BIOL CHEM, V285, P25792, DOI 10.1074/jbc.M110.109322; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Mouchemore KA, 2013, FEBS J, V280, P5228, DOI 10.1111/febs.12316; Naemsch LN, 1999, J CELL SCI, V112, P4425; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Palacio S, 2001, EUR J ENDOCRINOL, V144, P431, DOI 10.1530/eje.0.1440431; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Pilkington MF, 1998, J BONE MINER RES, V13, P688, DOI 10.1359/jbmr.1998.13.4.688; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WOOD DA, 1991, J BIOL CHEM, V266, P15369	48	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35346	35357		10.1074/jbc.M113.507525	http://dx.doi.org/10.1074/jbc.M113.507525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133210	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000329867600032
J	Adgent, MA; Flake, GP; Umbach, DM; Stallings, VA; Bernbaum, JC; Rogan, WJ				Adgent, Margaret A.; Flake, Gordon P.; Umbach, David M.; Stallings, Virginia A.; Bernbaum, Judy C.; Rogan, Walter J.			Urogenital Epithelial Cells as Simple Markers of Estrogen Response in Infants: Methods and Applications	PLOS ONE			English	Article							URINARY SEDIMENT; CHILDHOOD; CYTOLOGY; SMEARS	Exposure to estrogen-mimicking chemicals during critical periods of development, such as infancy, may have adverse effects. However, these effects can be difficult to characterize in most epidemiologic studies. For example, growth of reproductive organs may be susceptible to estrogenic chemicals, but measuring it requires skilled ultrasound examination; timing of pubertal onset may be altered, but observing it requires long-term follow up. To address the need for a simple marker of response to estrogenic exposures in infants, we propose a novel application of a classic marker of estrogen response in adult women: cytological evaluation of urogenital epithelial cells. In this cross-sectional study of 34 female and 41 male infants, we demonstrate that epithelial cells can be obtained from swabs of the vaginal introitus (females) and urethral meatus (males), as well as from spun urine, and that these cells respond to differential estrogenic conditions, as indicated by the relative abundance of the superficial epithelial cell type. To model varying estrogen exposure, we sampled from infants who were either newborn (highly exposed to maternal estrogens), or 12 weeks old (12W) (negligibly exposed to estrogen). Newborns had a higher percentage of superficial cells (%S), as compared to 12W (mean +/- standard error: 8.3 +/- 1.8 vs. 0.9 +/- 0.2) (p < 0.01), consistent with an estrogen response. This difference in %S from newborn to 12W was observed similarly for swab (-7.6 +/- 1.7) and urine (-7.3 +/- 2.6) specimens and for males (-9.6 +/- 2.9) and females (-5.2 +/- 2.1). Examination of urogenital epithelial cells can successfully demonstrate estrogen response in both sexes, using cell specimens collected from either swab or urine sampling. In future studies, this simple, non-invasive method may be applied to assess whether estrogen-mimicking chemicals produce an estrogenic response in infants.	[Adgent, Margaret A.; Rogan, Walter J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Flake, Gordon P.] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Umbach, David M.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Stallings, Virginia A.; Bernbaum, Judy C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Stallings, Virginia A.; Bernbaum, Judy C.] Univ Penn, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Rogan, WJ (corresponding author), NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.	rogan@niehs.nih.gov	Rogan, Walter/I-6034-2012	Rogan, Walter/0000-0002-9302-0160	NIH, National Institute of Environmental Health Sciences; National Institutes of Health [ES044006]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044006, ZIAES049004] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported (in part) by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The funding for this study was provided by the intramural research program of the National Institutes of Health (Intramural Project ES044006), where Drs. Rogan, Adgent, Umbach and Flake work. Drs. Stallings and Bernbaum and the data collection activities were supported by a contract between Children's Hospital of Philadelphia and NIH. The work was carried out collaboratively.	Arbuckle TE, 2008, ENVIRON HEALTH PERSP, V116, P948, DOI 10.1289/ehp.11226; Bernbaum JC, 2008, ENVIRON HEALTH PERSP, V116, P416, DOI 10.1289/ehp.10409; Cibas ES, 1996, CYTOLOGY DIAGNOSTIC, P1; COLLETTSOLBERG PR, 1965, J PEDIATR-US, V66, P883, DOI 10.1016/S0022-3476(65)80063-4; Currie AW, 1988, BASIC HISTOLOGY CYTO; DELCASTILLO EB, 1948, J CLIN ENDOCRINOL, V8, P76; DeMay RM, 1999, PRACTICAL PRINCIPLES, P1; ELSTEIN M, 1963, J OBSTET GYN BR COMM, V70, P1050; Farage Miranda, 2006, Archives of Gynecology and Obstetrics, V273, P195, DOI 10.1007/s00404-005-0079-x; FOREST MG, 1976, CLIN ENDOCRINOL, V5, P551, DOI 10.1111/j.1365-2265.1976.tb01985.x; Fraenkel L, 1938, AM J ANAT, V62, P427, DOI 10.1002/aja.1000620402; Hedberg GT, 1950, BR J UROL, V22, P26, DOI [DOI 10.1111/J.1464-410X.1950.TB09223.X, 10.1111/j.1464-410X.1950.tb09223.x]; HOLSTEIN AF, 1991, CELL TISSUE RES, V264, P23, DOI 10.1007/BF00305719; McEndree B., 1999, NURSE PRACT, V24, P51; Moore KL, 2003, DEV HUMAN CLIN ORIEN, P287; Naib ZM, 1976, EXFOLIATIVE CYTOPATH; Nguyen RHN, 2011, PEDIATR RADIOL, V41, P633, DOI 10.1007/s00247-010-1895-0; Papanicolaou GN, 1933, AM J ANAT, V52, P519, DOI 10.1002/aja.1000520402; ROBINE N, 1988, BIOL NEONATE, V54, P93; SILVER HK, 1960, PEDIATRICS, V26, P255; SILVER HK, 1966, PEDIATRICS, V38, P886; VINCZE LO, 1959, J CLIN ENDOCR METAB, V19, P281, DOI 10.1210/jcem-19-3-281; WIED GL, 1991, COMPREHENSIVE CYTOPA, P85	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77061	10.1371/journal.pone.0077061	http://dx.doi.org/10.1371/journal.pone.0077061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146956	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400092
J	Nunn, BL; Faux, JF; Hippmann, AA; Maldonado, MT; Harvey, HR; Goodlett, DR; Boyd, PW; Strzepek, RF				Nunn, Brook L.; Faux, Jessica F.; Hippmann, Anna A.; Maldonado, Maria T.; Harvey, H. Rodger; Goodlett, David R.; Boyd, Philip W.; Strzepek, Robert F.			Diatom Proteomics Reveals Unique Acclimation Strategies to Mitigate Fe Limitation	PLOS ONE			English	Article							SUB-ARCTIC PACIFIC; SOUTHERN-OCEAN PHYTOPLANKTON; IRON LIMITATION; MARINE DIATOM; THALASSIOSIRA-PSEUDONANA; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; BIOCHEMICAL PATHWAYS; PARTICLES TEP; CELL-SIZE	Phytoplankton growth rates are limited by the supply of iron (Fe) in approximately one third of the open ocean, with major implications for carbon dioxide sequestration and carbon (C) biogeochemistry. To date, understanding how alteration of Fe supply changes phytoplankton physiology has focused on traditional metrics such as growth rate, elemental composition, and biophysical measurements such as photosynthetic competence (F-v/F-m). Researchers have subsequently employed transcriptomics to probe relationships between changes in Fe supply and phytoplankton physiology. Recently, studies have investigated longer-term (i.e. following acclimation) responses of phytoplankton to various Fe conditions. In the present study, the coastal diatom, Thalassiosira pseudonana, was acclimated (10 generations) to either low or high Fe conditions, i.e. Fe-limiting and Fe-replete. Quantitative proteomics and a newly developed proteomic profiling technique that identifies low abundance proteins were employed to examine the full complement of expressed proteins and consequently the metabolic pathways utilized by the diatom under the two Fe conditions. A total of 1850 proteins were confidently identified, nearly tripling previous identifications made from differential expression in diatoms. Given sufficient time to acclimate to Fe limitation, T. pseudonana up-regulates proteins involved in pathways associated with intracellular protein recycling, thereby decreasing dependence on extracellular nitrogen (N), C and Fe. The relative increase in the abundance of photorespiration and pentose phosphate pathway proteins reveal novel metabolic shifts, which create substrates that could support other well-established physiological responses, such as heavily silicified frustules observed for Fe-limited diatoms. Here, we discovered that proteins and hence pathways observed to be down-regulated in short-term Fe starvation studies are constitutively expressed when T. pseudonana is acclimated (i.e., nitrate and nitrite transporters, Photosystem II and Photosystem I complexes). Acclimation of the diatom to the desired Fe conditions and the comprehensive proteomic approach provides a more robust interpretation of this dynamic proteome than previous studies.	[Nunn, Brook L.; Goodlett, David R.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Nunn, Brook L.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Faux, Jessica F.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Hippmann, Anna A.; Maldonado, Maria T.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Harvey, H. Rodger] Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA USA; [Boyd, Philip W.] Univ Otago, Dept Chem, NIWA Ctr Chem & Phys Oceanog, Dunedin, New Zealand; [Strzepek, Robert F.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Center for Environmental Science; University of British Columbia; Old Dominion University; University of Otago; Australian National University	Nunn, BL (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	brookh@uw.edu	Maldonado, Maria T/N-2877-2017; Boyd, Philip W/J-7624-2014; Strzepek, Robert Francis/A-1216-2011; Strzepek, Robert/GQH-8703-2022	Maldonado, Maria T/0000-0001-8134-9375; Boyd, Philip W/0000-0001-7850-1911; Strzepek, Robert Francis/0000-0002-6442-7121; Nunn, Brook/0000-0002-7361-4359; Hippmann, Anna/0000-0002-9495-7414	National Science Foundation [OCE1233014]; Office of Polar Programs Postdoctoral Fellowship [0444148]; National Institutes of Health [5P30ES007033-10]; Natural Sciences and Engineering Research Council of Canada; New Zealand Royal Society Marsden Fund; Ministry of Science; University of Washington's Proteomics Computer Resource Centre [UWPR95794]; Division Of Ocean Sciences [1233014] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Polar Programs Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); University of Washington's Proteomics Computer Resource Centre; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation grants OCE1233014 (BLN) and the Office of Polar Programs Postdoctoral Fellowship grant 0444148 (BLN). DRG was supported by National Institutes of Health 5P30ES007033-10. AH and MTM were supported by Natural Sciences and Engineering Research Council of Canada. RFS and PWB were supported by the New Zealand Royal Society Marsden Fund and the Ministry of Science. This work is supported in part by the University of Washington's Proteomics Computer Resource Centre (UWPR95794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arrigo KR, 2000, J GEOPHYS RES-OCEANS, V105, P8827, DOI 10.1029/1998JC000289; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Boyd PW, 2005, LIMNOL OCEANOGR, V50, P1872, DOI 10.4319/lo.2005.50.6.1872; Boyd PW, 1996, MAR ECOL PROG SER, V136, P179, DOI 10.3354/meps136179; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Carvalho RN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-159; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Coale KH, 2003, DEEP-SEA RES PT II, V50, P635, DOI 10.1016/S0967-0645(02)00588-X; De Nisi P, 2000, J EXP BOT, V51, P1903, DOI 10.1093/jexbot/51.352.1903; Durkin CA, 2011, J PHYCOL, V47, pS28; Durkin CA, 2012, LIMNOL OCEANOGR, V57, P1619, DOI 10.4319/lo.2012.57.6.1619; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Egleston ES, 2008, LIMNOL OCEANOGR, V53, P2462, DOI 10.4319/lo.2008.53.6.2462; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Espen L, 2000, PLANTA, V210, P985, DOI 10.1007/s004250050707; Fernie AR, 2012, PLANT PHYSIOL, V158, P1139, DOI 10.1104/pp.112.193235; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Hassler CS, 2011, P NATL ACAD SCI USA, V108, P1076, DOI 10.1073/pnas.1010963108; Hassler CS, 2009, LIMNOL OCEANOGR, V54, P987, DOI 10.4319/lo.2009.54.3.0987; Jackson GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023180; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Konopka A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00184; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; KUMA K, 1995, WATER RES, V29, P1559, DOI 10.1016/0043-1354(94)00289-J; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v; LaRoche J, 1996, NATURE, V382, P802; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Lehninger AL, 1965, BIOENERGETICS, P258; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Leynaert A, 2004, LIMNOL OCEANOGR, V49, P1134; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Marchetti A, 2009, GEOBIOLOGY, V7, P419, DOI 10.1111/j.1472-4669.2009.00207.x; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Mari X, 2005, HARMFUL ALGAE, V4, P895, DOI 10.1016/j.hal.2004.12.014; Mari X, 2012, ESTUAR COAST SHELF S, V96, P151, DOI 10.1016/j.ecss.2011.10.028; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; Milligan AJ, 2000, J PHYCOL, V36, P78, DOI 10.1046/j.1529-8817.2000.99013.x; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Moore EK, 2012, GEOCHIM COSMOCHIM AC, V83, P324, DOI 10.1016/j.gca.2012.01.002; Muggli DL, 1996, MAR ECOL PROG SER, V132, P215, DOI 10.3354/meps132215; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Nunn BL, 2007, MAR ECOL PROG SER, V332, P281, DOI 10.3354/meps332281; Nunn BL, 2010, LIMNOL OCEANOGR, V55, P1790, DOI 10.4319/lo.2010.55.4.1790; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ozturk M, 2004, DEEP-SEA RES PT II, V51, P2841, DOI 10.1016/j.dsr2.2000.10.001; Panchaud A, 2009, ANAL CHEM, V81, P6481, DOI 10.1021/ac900888s; Passow U, 2001, CONT SHELF RES, V21, P327, DOI 10.1016/S0278-4343(00)00101-1; PRICE N M, 1988, Biological Oceanography, V6, P443; PRICE NM, 1991, LIMNOL OCEANOGR, V36, P1071, DOI 10.4319/lo.1991.36.6.1071; PRICE NM, 1988, LIMNOL OCEANOGR, V33, P528, DOI 10.4319/lo.1988.33.4.0528; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Reinhardt I, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P371, DOI 10.1007/1-4020-4743-6_19; Rijkenberg MJA, 2005, MAR CHEM, V93, P119, DOI 10.1016/j.marchem.2004.03.021; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P3593, DOI 10.5194/bg-7-3593-2010; Scheele U, 2002, FEBS LETT, V514, P355, DOI 10.1016/S0014-5793(02)02439-0; Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f; Steigenberger S, 2010, BIOGEOSCIENCES, V7, P109, DOI 10.5194/bg-7-109-2010; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Timmermans KR, 2004, LIMNOL OCEANOGR, V49, P2141, DOI 10.4319/lo.2004.49.6.2141; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; WESTALL JC, 1976, ABSTR PAP AM CHEM S, V172, P8; Whitney LP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00234; Wilken S, 2011, LIMNOL OCEANOGR, V56, P1399, DOI 10.4319/lo.2011.56.4.1399; Wood AM., 2005, ALGAL CULTURING TECH, P269, DOI DOI 10.1016/B978-012088426-1/50019-6; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313	88	63	64	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75653	10.1371/journal.pone.0075653	http://dx.doi.org/10.1371/journal.pone.0075653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146769	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400014
J	Hill, RW; Muhich, TE; Humphries, MM				Hill, Richard W.; Muhich, Timothy E.; Humphries, Murray M.			City-Scale Expansion of Human Thermoregulatory Costs	PLOS ONE			English	Article							CRITICAL-TEMPERATURE; BODY-TEMPERATURE; METABOLIC-RATE; PEROMYSCUS; ENERGETICS; MAMMALS	The physiological maintenance of a stable internal temperature by mammals and birds - the phenomenon termed homeothermy - is well known to be energetically expensive. The annual energy requirements of free-living mammals and birds are estimated to be 15-30 times higher than those of similar-size ectothermic vertebrates like lizards. Contemporary humans also use energy to accomplish thermoregulation. They are unique, however, in having shifted thermoregulatory control from the body to the occupied environment, with most people living in cities in dwellings that are temperature-regulated by furnaces and air conditioners powered by exogenous energy sources. The energetic implications of this strategy remain poorly defined. Here we comparatively quantify energy costs in cities, dwellings, and individual human bodies. Thermoregulation persists as a major driver of energy expenditure across these three scales, resulting in energy-versus- ambient-temperature relationships remarkably similar in shape. Incredibly, despite the many and diversified uses of network-delivered energy in modern societies, the energy requirements of six North American cities are as temperature-dependent as the energy requirements of isolated, individual homeotherms. However, the annual per-person energy cost of exogenously powered thermoregulation in cities and dwellings is 9-28 times higher than the cost of endogenous, metabolic thermoregulation of the human body. Shifting the locus of thermoregulatory control from the body to the dwelling achieves climate-independent thermal comfort. However, in an era of amplifying climate change driven by the carbon footprint of humanity, we must acknowledge the energetic extravagance of contemporary, city-scale thermoregulation, which prioritizes heat production over heat conservation.	[Hill, Richard W.; Muhich, Timothy E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Humphries, Murray M.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada	Michigan State University; McGill University	Hill, RW (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	hillr@msu.edu		Muhich, Timothy/0000-0002-5642-0181				BATESON G, 1963, EVOLUTION, V17, P529, DOI 10.2307/2407104; Berry B.J.L., 2008, URBAN ECOLOGY INT PE, P25, DOI [10.1007/978-0-387-73412-5_3, DOI 10.1007/978-0-387-73412-5_3]; BONACCORSO FJ, 1992, J MAMMAL, V73, P365, DOI 10.2307/1382071; Burnside WR, 2012, BIOL REV, V87, P194, DOI 10.1111/j.1469-185X.2011.00192.x; Burton A.C., 1955, MAN COLD ENV; Bynum R. T., 2001, INSULATION HDB; DEAVERS DR, 1981, PHYSIOL ZOOL, V54, P94, DOI 10.1086/physzool.54.1.30155808; ERIKSON H, 1956, ACTA PHYSIOL SCAND, V37, P35, DOI 10.1111/j.1748-1716.1956.tb01339.x; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; FLEMING MR, 1985, AUST J ZOOL, V33, P667, DOI 10.1071/ZO9850667; Gagge AP, 1941, SCIENCE, V94, P428, DOI 10.1126/science.94.2445.428; Galloway JA, 1996, ECON HIST REV, V49, P447; GOLIGHTLY RT, 1983, J MAMMAL, V64, P624, DOI 10.2307/1380518; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Hill R., 2012, ANIMAL PHYSL, V3; HINDS DS, 1973, J MAMMAL, V54, P708, DOI 10.2307/1378969; Huang SL, 2005, ECOL MODEL, V189, P49, DOI 10.1016/j.ecolmodel.2005.03.004; Kadulski R, 1987, SOLPLAN REV, P8; Lofquist Daphne, 2012, HOUSEHOLDS FAMILIES; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1963, ECOL MONOGR, V33, P63, DOI 10.2307/1948477; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; Meehan TD, 2012, AM J HUM BIOL, V24, P713, DOI 10.1002/ajhb.22278; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; North D, 1986, J LONDONS CABIN; ODUM HT, 1971, ENV POWER SOC; PROSSER CL, 1955, BIOL REV, V30, P229, DOI 10.1111/j.1469-185X.1955.tb01208.x; Rodahl K, 1958, CI T 5 C, P177; SCHOLANDER PF, 1957, J APPL PHYSIOL, V10, P231, DOI 10.1152/jappl.1957.10.2.231; SCHOLANDER PF, 1958, J APPL PHYSIOL, V12, P1; SENDROY J, 1954, J APPL PHYSIOL, V7, P1; Shelton J, 1976, WOODBURNERS ENCY; Shurin JB, 2005, J ANIM ECOL, V74, P1029, DOI 10.1111/j.1365-2656.2005.00999.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; WILKERSON JE, 1972, J APPL PHYSIOL, V33, P451, DOI 10.1152/jappl.1972.33.4.451; Wulsin FR, 1949, PHYSL HEAT REGULATIO, P3; Yan YY, 1996, INT J CLIMATOL, V16, P1045, DOI 10.1002/(SICI)1097-0088(199609)16:9<1045::AID-JOC73>3.0.CO;2-O	40	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76238	10.1371/journal.pone.0076238	http://dx.doi.org/10.1371/journal.pone.0076238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143181	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100016
J	Cai, XT; Lu, WG; Yang, Y; Yang, J; Ye, J; Gu, ZH; Hu, CP; Wang, XN; Cao, P				Cai, Xueting; Lu, Wuguang; Yang, Yang; Yang, Jie; Ye, Juan; Gu, Zhenhua; Hu, Chunping; Wang, Xiaoning; Cao, Peng			Digitoflavone Inhibits I kappa B alpha Kinase and Enhances Apoptosis Induced by TNF alpha through Downregulation of Expression of Nuclear Factor kappa B-Regulated Gene Products in Human Pancreatic Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BLOCKS INTERLEUKIN-1-BETA-INDUCED ACTIVATION; MULTIPLE-MYELOMA CELLS; CURCUMIN DIFERULOYLMETHANE; CARCINOMA-CELLS; CONSTITUTIVE ACTIVATION; LEUKEMIA-CELLS; ONCOGENIC RAS; CYCLE ARREST; LUTEOLIN	Tumor necrosis factor-alpha (TNF alpha) activates both cell death and cell survival pathways. The activation of survival pathway renders most cancer cells resistant to TNF-induced cytotoxicity. We found that pretreatment with digitoflavone, a plant flavonoid, greatly sensitized TNF alpha-induced apoptotic cell death in several human pancreatic cancer cells. In search of the molecular basis of the sensitization effect of digitoflavone, digitoflavone was found to inhibit TNF alpha-induced activation of nuclear transcription factor-kappa B (NF-kappa B) which is the main survival factor in TNF alpha signaling. NF-kappa B suppression occurred through inhibition of I kappa B alpha kinase activation, I kappa B alpha phosphorylation, I kappa B alpha degradation, and NF-kappa B nuclear translocation. This inhibition correlated with suppression of NF-kappa B-dependent genes involved in antiapoptosis (mcl-1, bcl-2, bcl-xl, c-iap1, c-iap2, flip, and survivin), proliferation (c-myc, cyclin d1), and angiogenesis (vegf, cox-2, and mmp-9). In addition, digitoflavone can activate JNK through inhibition of NF-kappa B signaling, provide a continuous blockade of the feed-back inhibitory mechanism by JNK-induced NF-kappa B activation. This study found a novel function of digitoflavone and enhanced the value of digitoflavone as an anticancer agent.	[Cai, Xueting; Lu, Wuguang; Yang, Yang; Yang, Jie; Ye, Juan; Gu, Zhenhua; Hu, Chunping; Wang, Xiaoning; Cao, Peng] China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China; [Cai, Xueting; Lu, Wuguang; Yang, Yang; Yang, Jie; Ye, Juan; Gu, Zhenhua; Hu, Chunping; Wang, Xiaoning; Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China	China Academy of Chinese Medical Sciences; Nanjing University of Chinese Medicine	Cao, P (corresponding author), China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China.	pcao79@yahoo.com	Sheng, Lei/HDO-1972-2022	, Peng/0000-0002-2044-3074	National Natural Science Foundation of China [30701098, 30873410, 81073101]; Natural Science Foundation of Zhejiang Province [Y2090676]; Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	This work was supported by the National Natural Science Foundation of China (Nos. 30701098, 30873410 and 81073101), Natural Science Foundation of Zhejiang Province (No. Y2090676) and Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Ashokkumar P, 2008, BIOMED PHARMACOTHER, V62, P590, DOI 10.1016/j.biopha.2008.06.031; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Blaszkowsky Lawrence, 1998, Frontiers in Bioscience, V3, pE214; Bonizzi G, 1997, J IMMUNOL, V159, P5264; Brown JE, 1998, BIOCHEM J, V330, P1173; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cai XT, 2011, TOXICOL IN VITRO, V25, P1385, DOI 10.1016/j.tiv.2011.05.009; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Chen S, 2002, J DENT RES, V81, P98, DOI 10.1177/154405910208100203; Estrov Z, 1999, BLOOD, V94, P2844, DOI 10.1182/blood.V94.8.2844.420k43_2844_2853; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Galati G, 2001, FREE RADICAL BIO MED, V30, P370, DOI 10.1016/S0891-5849(00)00481-0; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Hu LP, 2003, BLOOD, V101, P3126, DOI 10.1182/blood-2002-08-2640; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lee HJ, 2005, TOXICOL APPL PHARM, V203, P124, DOI 10.1016/j.taap.2004.08.004; Lee WJ, 2006, CHEM-BIOL INTERACT, V160, P123, DOI 10.1016/j.cbi.2006.01.002; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Lim DY, 2007, AM J PHYSIOL-GASTR L, V292, pG66, DOI 10.1152/ajpgi.00248.2006; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Plaumann B, 1996, ONCOGENE, V13, P1605; Sasaki N, 2003, CHEM-BIOL INTERACT, V145, P101, DOI 10.1016/S0009-2797(02)00248-X; Schutte ME, 2008, FOOD CHEM TOXICOL, V46, P557, DOI 10.1016/j.fct.2007.08.038; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Watanabe N, 1996, PANCREAS, V13, P395, DOI 10.1097/00006676-199611000-00009; WATANABE N, 1994, ONCOLOGY, V51, P360; Xavier CPR, 2009, CANCER LETT, V281, P162, DOI 10.1016/j.canlet.2009.02.041; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yee SB, 2003, ARCH PHARM RES, V26, P151, DOI 10.1007/BF02976662; Zhang Q, 2008, FOOD CHEM TOXICOL, V46, P2042, DOI 10.1016/j.fct.2008.01.049	47	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77126	10.1371/journal.pone.0077126	http://dx.doi.org/10.1371/journal.pone.0077126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146961	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400099
J	Deepa, D; Achanta, S; Jaju, J; Rao, K; Samyukta, R; Claassens, M; Kumar, AMV; Vishnu, PH				Deepa, Dorai; Achanta, Shanta; Jaju, Jyoti; Rao, Koteswara; Samyukta, Rani; Claassens, Mareli; Kumar, Ajay M. V.; Vishnu, P. H.			The Impact of Isoniazid Resistance on the Treatment Outcomes of Smear Positive Re-Treatment Tuberculosis Patients in the State of Andhra Pradesh, India	PLOS ONE			English	Article								Background: Multi drug resistant and rifampicin resistant TB patients in India are treated with the World Health Organization (WHO) recommended standardized treatment regimens but no guidelines are available for the management of isoniazid (INH) resistant TB patients. There have been concerns that the standard eight-month retreatment regimen being used in India (2H(3)R(3)Z(3)E(3)S(3)/1H(3)R(3)Z(3)E(3)/5H(3)R(3)E(3); H-Isoniazid; R-Rifampicin; Z-Pyrazinamide; E-Ethambutol; S-Streptomycin) may be inadequate to treat INH resistant TB cases and leads to poor treatment outcomes. We aimed to assess if INH resistance is associated with unfavorable treatment outcomes (death, default, failure and transferred out) among a cohort of smear positive retreatment TB patients registered in three districts of Andhra Pradesh, India. Methods: We conducted a retrospective record review of all smear positive retreatment TB patients without rifampicin resistance registered during April-December 2011. Results: Of 1,947 TB patients, 1,127 (58%) were tested with LPA-50 (4%) were rifampicin resistant, 933 (84%) were sensitive to INH and rifampicin and 144 (12%) were INH resistant. Of 144 INH resistant cases, 64 (44%) had poor treatment outcomes (25 (17%) default, 22 (15%) death, 12 (8%) failure and 5 (3%) transfer out) as compared to 287 (31%) among INH sensitive cases [aRR 1.46; 95% CI (1.19-1.78)]. Conclusion: Our study confirms that INH resistance is independently associated with unfavorable treatment outcomes among smear positive retreatment TB patients, indicating that the current treatment regimen may be inadequate. These findings call for an urgent need for randomized controlled trials to discover the most effective treatment regimen for managing INH resistant TB.	[Deepa, Dorai; Rao, Koteswara; Vishnu, P. H.] Govt Andhra Pradesh, Directorate Gen Hlth Serv, State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India; [Achanta, Shanta; Jaju, Jyoti] World Hlth Org WHO Country Off India, New Delhi, India; [Samyukta, Rani] Govt Andhra Pradesh, Minist Hlth & Family Welf, State TB Cell Directorate Gen Hlth Serv, Hyderabad, Andhra Pradesh, India; [Claassens, Mareli] Univ Stellenbosch, Dept Pediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa; [Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India	World Health Organization; Stellenbosch University	Deepa, D (corresponding author), Govt Andhra Pradesh, Directorate Gen Hlth Serv, State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India.	dr.ddeepa@gmail.com	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Revised National Tuberculosis Control Programme(RNTCP) of India	Revised National Tuberculosis Control Programme(RNTCP) of India	Funding for the research was by Revised National Tuberculosis Control Programme(RNTCP) of India. Funders had no role in study design, data collection, analysis decision to publish, or preparation of the manuscript.	Central TBDivision, 2011, TB IND 2011 REV NAT; Central TBDivision, 2011, MAN RNTCP YOUR AR TR; Central TBDivision, 2012, REV NAT TUB CONTR PR; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC; Vijay S., 2002, Indian Journal of Tuberculosis, V49, P195; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, WORLD HLTH REP 2008; World Health Organization, 2008, WHOHTMTB2008402, P1	14	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76189	10.1371/journal.pone.0076189	http://dx.doi.org/10.1371/journal.pone.0076189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146839	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400046
J	Jiang, JJ; Zhang, NN; Shiba, H; Li, LY; Wang, Z				Jiang, Junjun; Zhang, Nannan; Shiba, Hiroshi; Li, Liyuan; Wang, Zhao			Spermatogenesis Associated 4 Promotes Sertoli Cell Proliferation Modulated Negatively by Regulatory Factor X1	PLOS ONE			English	Article							DNA-BINDING PROTEINS; B-VIRUS ENHANCER; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CPG ISLANDS; RFX1; EVOLUTION; CLONING; SPATA4; FAMILY	Spermatogenesis associated 4 (Spata4), a testis-specific and CpG island associated gene, is involved in regulating cell proliferation, differentiation and apoptosis. To obtain insight into the role of Spata4 in cell cycling control, we characterized the promoter region of Spata4 and investigated its transcriptional regulation mechanism. The Spata4 promoter is unidirectional transcribed and possesses multiple transcription start sites. Moreover, we present evidence that regulatory factor X1 (RFX1) could bind the typical 14-bp cis-elements of Spata4 promoter, modulate transcriptional activity and endogenous expression of Spata4, and further regulate the proliferation of Sertoli cells. Overexpression of RFX1 was shown to down-regulate both the promoter activity and mRNA expression of Spata4, whereas knockdown of RFX1 demonstrated the opposite effects. Our studies provide insight into Spata4 gene regulation and imply the potential role of RFX1 in growth of Sertoli cells. RFX1 may have negative effect on cell proliferation of Sertoli cells via modulating Spata4 expression levels by binding the conserved 14-bp cis-elements of Spata4 promoter.	[Jiang, Junjun; Zhang, Nannan; Shiba, Hiroshi; Li, Liyuan; Wang, Zhao] Tsinghua Univ, Sch Med, Dept Pharmacol, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Shiba, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioinformat, Tokyo 152, Japan	Tsinghua University; Tokyo Institute of Technology	Wang, Z (corresponding author), Tsinghua Univ, Sch Med, Dept Pharmacol, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn			National Basic Research Program (973 Project) of China [2007CB507406, 2013CB530802]; National Natural Science Foundation of China [81270425]	National Basic Research Program (973 Project) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program (973 Project) of China (Nos. 2007CB507406, 2013CB530802) and the National Natural Science Foundation of China (No. 81270425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen L, 2000, J BIOL CHEM, V275, P32227, DOI 10.1074/jbc.M002645200; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Imai-Senga Y, 2002, GENE, V289, P7, DOI 10.1016/S0378-1119(02)00542-5; Katan Y, 1997, NUCLEIC ACIDS RES, V25, P3621, DOI 10.1093/nar/25.18.3621; Kistler WS, 2009, GENE EXPR PATTERNS, V9, P515, DOI 10.1016/j.gep.2009.07.004; KOUSKOFF V, 1991, J IMMUNOL, V146, P3197; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Liu SF, 2005, J BIOCHEM MOL BIOL, V38, P739; Liu SF, 2004, BIOL PHARM BULL, V27, P1867, DOI 10.1248/bpb.27.1867; Liu SF, 2004, BIOCHEM BIOPH RES CO, V319, P32, DOI 10.1016/j.bbrc.2004.04.160; Loots Gabriela G., 2007, V395, P237; Morotami-Yano K, 2002, J BIOL CHEM, V277, P836, DOI 10.1074/jbc.M108638200; Ogi T, 2001, GENES CELLS, V6, P943, DOI 10.1046/j.1365-2443.2001.00478.x; Olesen C, 2001, MOL CELL ENDOCRINOL, V184, P25, DOI 10.1016/S0303-7207(01)00666-9; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ray SK, 1997, J BIOL CHEM, V272, P7546, DOI 10.1074/jbc.272.11.7546; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; Wang KR, 2007, J BIOL CHEM, V282, P26167, DOI 10.1074/jbc.M703448200; Wang XY, 2011, J BONE MINER RES, V26, P1964, DOI 10.1002/jbmr.394; Weitzel JM, 2003, BIOL REPROD, V68, P699, DOI 10.1095/biolreprod.102.008540	38	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75933	10.1371/journal.pone.0075933	http://dx.doi.org/10.1371/journal.pone.0075933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146794	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400027
J	Giaouris, E; Chorianopoulos, N; Doulgeraki, A; Nychas, GJ				Giaouris, Efstathios; Chorianopoulos, Nikos; Doulgeraki, Agapi; Nychas, George-John			Co-Culture with Listeria monocytogenes within a Dual-Species Biofilm Community Strongly Increases Resistance of Pseudomonas putida to Benzalkonium Chloride	PLOS ONE			English	Article							QUATERNARY AMMONIUM-COMPOUNDS; EXTRACELLULAR POLYMERIC SUBSTANCES; STAINLESS-STEEL SURFACES; ESCHERICHIA-COLI O157H7; MIXED-CULTURE BIOFILMS; DAIRY PROCESSING LINES; MULTISPECIES BIOFILMS; BACTERIAL BIOFILMS; ANTIMICROBIAL AGENTS; PATHOGENIC BACTERIA	Biofilm formation is a phenomenon occurring almost wherever microorganisms and surfaces exist in close proximity. This study aimed to evaluate the possible influence of bacterial interactions on the ability of Listeria monocytogenes and Pseudomonas putida to develop a dual-species biofilm community on stainless steel (SS), as well as on the subsequent resistance of their sessile cells to benzalkonium chloride (BC) used in inadequate (sub-lethal) concentration (50 ppm). The possible progressive adaptability of mixed-culture biofilms to BC was also investigated. To accomplish these, 3 strains per species were left to develop mixed-culture biofilms on SS coupons, incubated in daily renewable growth medium for a total period of 10 days, under either mono- or dual-species conditions. Each day, biofilm cells were exposed to disinfection treatment. Results revealed that the simultaneous presence of L. monocytogenes strongly increased the resistance of P. putida biofilm cells to BC, while culture conditions (mono-/dual-species) did not seem to significantly influence the resistance of L. monocytogenes biofilm cells. BC mainly killed L. monocytogenes cells when this was applied against the dual-species sessile community during the whole incubation period, despite the fact that from the 2nd day this community was mainly composed (>90%) of P. putida cells. No obvious adaptation to BC was observed in either L. monocytogenes or P. putida biofilm cells. Pulsed field gel electrophoresis (PFGE) analysis showed that the different strains behaved differently with regard to biofilm formation and antimicrobial resistance. Such knowledge on the physiological behavior of mixed-culture biofilms could provide the information necessary to control their formation.	[Giaouris, Efstathios; Doulgeraki, Agapi] Univ Aegean, Dept Food Sci & Nutr, Myrina, Lemnos Island, Greece; [Chorianopoulos, Nikos] Greek Agr Org Demeter, Vet Res Inst Athens, Aghia Paraskeui, Greece; [Doulgeraki, Agapi; Nychas, George-John] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece	Agricultural University of Athens	Giaouris, E (corresponding author), Univ Aegean, Dept Food Sci & Nutr, Myrina, Lemnos Island, Greece.	stagiaouris@aegean.gr	Nychas, George/B-2734-2009; Giaouris, Efstathios/J-8082-2015	Nychas, George/0000-0002-2673-6425; Giaouris, Efstathios/0000-0002-6019-5204	Action THALIS "Biological Investigation Of the Forces that Influence the Life of pathogens having as Mission to Survive in various lifestyles; BIOFILMS", which falls under the Operational Programme (OP) "Education and Lifelong Learning (EdLL)"; European Social Fund (ESF); National Resources	Action THALIS "Biological Investigation Of the Forces that Influence the Life of pathogens having as Mission to Survive in various lifestyles; BIOFILMS", which falls under the Operational Programme (OP) "Education and Lifelong Learning (EdLL)"; European Social Fund (ESF)(European Social Fund (ESF)); National Resources	This work received funding through the following sources: Action THALIS "Biological Investigation Of the Forces that Influence the Life of pathogens having as Mission to Survive in various lifestyles; BIOFILMS", which falls under the Operational Programme (OP) "Education and Lifelong Learning (EdLL)", cofinanced by the European Social Fund (ESF) and National Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; Antoniou K, 2005, J FOOD PROTECT, V68, P277, DOI 10.4315/0362-028X-68.2.277; Auerbach ID, 2000, J BACTERIOL, V182, P3809, DOI 10.1128/JB.182.13.3809-3815.2000; AUSTIN JW, 1995, J DAIRY RES, V62, P509, DOI 10.1017/S0022029900031204; Bagge-Ravn D, 2003, INT J FOOD MICROBIOL, V87, P239, DOI 10.1016/S0168-1605(03)00067-9; Behnke S, 2011, APPL ENVIRON MICROB, V77, P7176, DOI 10.1128/AEM.05514-11; Bourion F, 1996, SCI ALIMENT, V16, P151; Bremer PJ, 2001, J FOOD PROTECT, V64, P1369, DOI 10.4315/0362-028X-64.9.1369; Bremer PJ, 2002, LETT APPL MICROBIOL, V35, P321, DOI 10.1046/j.1472-765X.2002.01198.x; Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899; Brooks JD, 2008, INT J FOOD SCI TECH, V43, P2163, DOI 10.1111/j.1365-2621.2008.01839.x; Buffet-Bataillon S, 2012, INT J ANTIMICROB AG, V39, P381, DOI 10.1016/j.ijantimicag.2012.01.011; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Carpentier B, 2004, INT J FOOD MICROBIOL, V97, P111, DOI 10.1016/j.ijfoodmicro.2004.03.031; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Chorianopoulos NG, 2008, J APPL MICROBIOL, V104, P1586, DOI 10.1111/j.1365-2672.2007.03694.x; Chumkhunthod P, 1998, J FOOD PROTECT, V61, P1043, DOI 10.4315/0362-028X-61.8.1043; Cocolin L, 2005, INT J FOOD MICROBIOL, V103, P167, DOI 10.1016/j.ijfoodmicro.2004.12.027; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Cruz CD, 2011, FOOD MICROBIOL, V28, P1387, DOI 10.1016/j.fm.2011.06.014; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; De Jonghe V, 2011, APPL ENVIRON MICROB, V77, P460, DOI 10.1128/AEM.00521-10; Didienne R, 2012, INT J FOOD MICROBIOL, V156, P91, DOI 10.1016/j.ijfoodmicro.2012.03.007; Doulgeraki AI, 2013, FOOD MICROBIOL, V34, P62, DOI 10.1016/j.fm.2012.11.017; Dynes JJ, 2009, CAN J MICROBIOL, V55, P163, DOI [10.1139/w08-109, 10.1139/W08-109]; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Fatemi P, 1999, J FOOD PROTECT, V62, P761, DOI 10.4315/0362-028X-62.7.761; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Goller CC, 2008, CURR TOP MICROBIOL, V322, P37; Habimana O, 2011, BIOFOULING, V27, P1065, DOI 10.1080/08927014.2011.626124; Habimana O, 2010, APPL ENVIRON MICROB, V76, P4557, DOI 10.1128/AEM.02707-09; Habimana O, 2009, APPL ENVIRON MICROB, V75, P7814, DOI 10.1128/AEM.01333-09; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Hassan AN, 2004, J FOOD PROTECT, V67, P322, DOI 10.4315/0362-028X-67.2.322; Hegstad K, 2010, MICROB DRUG RESIST, V16, P91, DOI 10.1089/mdr.2009.0120; Holah JT, 2004, J APPL MICROBIOL, V97, P68, DOI 10.1111/j.1365-2672.2004.02272.x; Hood SK, 1997, J FOOD PROTECT, V60, P1135, DOI 10.4315/0362-028X-60.9.1135; Ibusquiza PS, 2012, FOOD CONTROL, V25, P202, DOI 10.1016/j.foodcont.2011.10.002; Irie Y, 2005, FEMS MICROBIOL LETT, V250, P237, DOI 10.1016/j.femsle.2005.07.012; JAMES GA, 1995, J IND MICROBIOL, V15, P257, DOI 10.1007/BF01569978; Janek T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-24; JEONG DK, 1994, FOOD SCI TECHNOL-LEB, V27, P415; Joynson JA, 2002, J APPL MICROBIOL, V93, P96, DOI 10.1046/j.1365-2672.2002.01667.x; Kalmokoff ML, 2001, J APPL MICROBIOL, V91, P725, DOI 10.1046/j.1365-2672.2001.01419.x; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; Klayman BJ, 2009, ENVIRON SCI TECHNOL, V43, P2105, DOI 10.1021/es802218q; Kostaki M, 2012, APPL ENVIRON MICROB, V78, P2586, DOI 10.1128/AEM.07099-11; Kruijt M, 2009, J APPL MICROBIOL, V107, P546, DOI 10.1111/j.1365-2672.2009.04244.x; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Langsrud S, 1997, J APPL MICROBIOL, V82, P705, DOI 10.1046/j.1365-2672.1997.00186.x; Langsrud S, 2003, J APPL MICROBIOL, V95, P874, DOI 10.1046/j.1365-2672.2003.02064.x; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; Lebert I, 2007, FOOD MICROBIOL, V24, P281, DOI 10.1016/j.fm.2006.04.011; Leriche V, 2000, J APPL MICROBIOL, V88, P594, DOI 10.1046/j.1365-2672.2000.01000.x; Leriche V, 2003, ENVIRON MICROBIOL, V5, P64, DOI 10.1046/j.1462-2920.2003.00394.x; Leriche V, 1999, INT J FOOD MICROBIOL, V51, P169, DOI 10.1016/S0168-1605(99)00128-2; Licitra G, 2007, APPL ENVIRON MICROB, V73, P6980, DOI 10.1128/AEM.00835-07; Lindsay D, 2002, J APPL MICROBIOL, V92, P352, DOI 10.1046/j.1365-2672.2002.01538.x; Lourenco A, 2011, J FOOD SCI, V76, pM143, DOI 10.1111/j.1750-3841.2010.02011.x; Lunden JM, 2000, J FOOD PROTECT, V63, P1204, DOI 10.4315/0362-028X-63.9.1204; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mangalappalli-Illathu AK, 2008, ANTIMICROB AGENTS CH, V52, P3669, DOI 10.1128/AAC.00073-08; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marouani-Gadri N, 2009, INT J FOOD MICROBIOL, V133, P62, DOI 10.1016/j.ijfoodmicro.2009.04.028; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mereghetti L, 2000, APPL ENVIRON MICROB, V66, P5083, DOI 10.1128/AEM.66.11.5083-5086.2000; Meyer B, 2006, INT J FOOD MICROBIOL, V112, P275, DOI 10.1016/j.ijfoodmicro.2006.04.012; Meylheuc T, 2006, INT J FOOD MICROBIOL, V109, P71, DOI 10.1016/j.ijfoodmicro.2006.01.013; Midelet G, 2002, APPL ENVIRON MICROB, V68, P4015, DOI 10.1128/AEM.68.8.4015-4024.2002; Minei CC, 2008, J FOOD PROTECT, V71, P634, DOI 10.4315/0362-028X-71.3.634; Moons P, 2006, APPL ENVIRON MICROB, V72, P7294, DOI 10.1128/AEM.01708-06; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nielsen L, 2011, ENVIRON MICROBIOL, V13, P1342, DOI 10.1111/j.1462-2920.2011.02432.x; Nilsson RE, 2011, INT J FOOD MICROBIOL, V150, P14, DOI 10.1016/j.ijfoodmicro.2011.07.012; Norwood DE, 2001, LETT APPL MICROBIOL, V33, P320, DOI 10.1046/j.1472-765X.2001.01004.x; Norwood DE, 2000, J APPL MICROBIOL, V88, P512, DOI 10.1046/j.1365-2672.2000.00990.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pagedar A, 2012, J DAIRY RES, V6, P1; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Pan YW, 2009, APPL ENVIRON MICROB, V75, P5846, DOI 10.1128/AEM.00816-09; Papadopoulou OS, 2012, MEAT SCI, V90, P865, DOI 10.1016/j.meatsci.2011.11.008; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Remis JP, 2010, ISME J, V4, P1085, DOI 10.1038/ismej.2010.105; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rieu A, 2008, INT J FOOD MICROBIOL, V126, P76, DOI 10.1016/j.ijfoodmicro.2008.05.006; Russell A. D., 1996, UNDERSTANDING ANTIBA; Russell AD, 2004, J HOSP INFECT, V57, P97, DOI 10.1016/j.jhin.2004.01.004; Russell AD, 2001, AM J INFECT CONTROL, V29, P259, DOI 10.1067/mic.2001.115671; Ibusquiza PS, 2011, FOOD MICROBIOL, V28, P418, DOI 10.1016/j.fm.2010.09.014; SASAHARA KC, 1993, J FOOD PROTECT, V56, P1022, DOI 10.4315/0362-028X-56.12.1022; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Sharma M, 2002, FOOD MICROBIOL, V19, P627, DOI 10.1006/fmic.2002.0472; Shi XM, 2009, TRENDS FOOD SCI TECH, V20, P407, DOI 10.1016/j.tifs.2009.01.054; Sidhu MS, 2002, MICROB DRUG RESIST, V8, P393, DOI 10.1089/10766290260469679; Simoes LC, 2011, BIOFOULING, V27, P337, DOI 10.1080/08927014.2011.575935; Simoes LC, 2007, APPL ENVIRON MICROB, V73, P6192, DOI 10.1128/AEM.00837-07; Simoes M, 2009, WATER RES, V43, P229, DOI 10.1016/j.watres.2008.10.010; Simos M, 2008, INT J FOOD MICROBIOL, V128, P309, DOI 10.1016/j.ijfoodmicro.2008.09.003; Skandamis PN, 2012, APPL ENVIRON MICROB, V78, P5473, DOI 10.1128/AEM.00468-12; Soumet C, 2005, LETT APPL MICROBIOL, V41, P291, DOI 10.1111/j.1472-765X.2005.01763.x; Takahashi H, 2009, J FOOD PROTECT, V72, P1476, DOI 10.4315/0362-028X-72.7.1476; Timke M, 2005, APPL ENVIRON MICROB, V71, P6446, DOI 10.1128/AEM.71.10.6446-6452.2005; Tischer M, 2012, CHEMMEDCHEM, V7, P22, DOI 10.1002/cmdc.201100404; To MS, 2002, APPL ENVIRON MICROB, V68, P5258, DOI 10.1128/AEM.68.11.5258-5264.2002; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Tresse O, 2007, J FOOD PROTECT, V70, P1569, DOI 10.4315/0362-028X-70.7.1569; Tryfinopoulou P, 2002, APPL ENVIRON MICROB, V68, P65, DOI 10.1128/AEM.68.1.65-72.2002; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; Uhlich GA, 2010, FOODBORNE PATHOG DIS, V7, P935, DOI 10.1089/fpd.2009.0503; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Zhang W, 2013, FEMS MICROBIOL ECOL, V84, P344, DOI 10.1111/1574-6941.12066; Zhao T, 2004, APPL ENVIRON MICROB, V70, P3996, DOI 10.1128/AEM.70.7.3996-4003.2004; Zhao T, 2006, APPL ENVIRON MICROB, V72, P3314, DOI 10.1128/Aem.72.5.3314-3320.2006; Zhao T, 2013, J FOOD PROTECT, V76, P601, DOI 10.4315/0362-028X.JFP-12-323	127	85	89	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77276	10.1371/journal.pone.0077276	http://dx.doi.org/10.1371/journal.pone.0077276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130873	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200080
J	Romacho, T; Villalobos, LA; Cercas, E; Carraro, R; Sanchez-Ferrer, CF; Peiro, C				Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion			Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; EPICARDIAL ADIPOSE-TISSUE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; MMP-2/9 PRODUCTION; GENE-EXPRESSION; PLASMA VISFATIN; LIFE-SPAN; KAPPA-B; ATHEROSCLEROSIS; PROTEIN	Background: Visfatin is a multifaceted adipokine whose circulating levels are enhanced in different metabolic diseases. Extracellular visfatin can exert various deleterious effects on vascular cells, including inflammation and proliferation. Limited evidence exists, however, on the capacity of human vascular cells to synthesize and release visfatin by themselves, under basal or pro-inflammatory conditions. Methods and Results: Intracellular visfatin was detected by Western blot in non-stimulated human umbilical vein endothelial cells (HUVEC). However, exposing HUVEC for 18 h to a series of pro-inflammatory stimulus, such as interleukin (IL)-1 beta (1 to 10 ng/mL), tumor necrosis factor-alpha (1 to 10 ng/mL) or angiotensin II (10 pmol/L to 1 mu mol/L) markedly enhanced intracellular visfatin content. Using IL-1 beta (10 ng/mL; 18 h), it was determined that the increase in intracellular visfatin, which was paralleled by enhanced visfatin mRNA levels, relied on a signalling mechanism involving both nuclear factor-kappa B and poly (ADP ribose) polymerase-1 activation. Moreover, IL-1 beta modified the subcellular localization of visfatin; while in non-stimulated HUVEC immunoreactive visfatin predominantly showed an intra-nuclear granular pattern, in IL-1 beta-inflamed cells an extra-nuclear filamentous staining, co-localising with F-actin fibers and suggesting a secretory pattern, was mainly found. Indeed, IL-1 beta promoted visfatin secretion, as determined by both ELISA and immunocytochemistry. Conclusions: Human endothelial cells synthesize and release visfatin, particularly in response to inflammation. We suggest that the inflamed endothelium can be a source of visfatin, which arises as a local inflammatory mediator and a potential therapeutic target to interfere with vascular inflammation.	[Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Univ Autonoma Madrid, Dept Farmacol & Terapeut, Madrid, Spain; [Carraro, Raffaele] Hosp Univ La Princesa, Serv Endocrinol, Madrid, Spain; [Carraro, Raffaele] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Romacho, Tania; Villalobos, Laura A.; Cercas, Elena; Carraro, Raffaele; Sanchez-Ferrer, Carlos F.; Peiro, Concepcion] Hosp La Princesa, Inst Invest Sanitaria, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Autonomous University of Madrid	Peiro, C (corresponding author), Univ Autonoma Madrid, Dept Farmacol & Terapeut, Madrid, Spain.	concha.peiro@uam.es	Romacho, Tania/AAB-3306-2021; Peiro, Concepcion/B-9545-2017; Romacho, Tania/B-2663-2016	Romacho, Tania/0000-0002-0962-7163; Peiro, Concepcion/0000-0002-9690-7816; Romacho, Tania/0000-0002-0962-7163; Carraro, Raffaele/0000-0002-5874-8076	Plan Nacional de I+D [SAF2011-28011, SAF2011-24648]; Sociedad Espanola de Farmacologia-Almirall; Fundacion Eugenio Rodriguez Pascual; Caja Madrid Foundation; CONACYT (Mexico)	Plan Nacional de I+D; Sociedad Espanola de Farmacologia-Almirall; Fundacion Eugenio Rodriguez Pascual; Caja Madrid Foundation; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Plan Nacional de I+D [SAF2011-28011, SAF2011-24648], Sociedad Espanola de Farmacologia-Almirall and Fundacion Eugenio Rodriguez Pascual. TR is the recipient of a fellowship from Caja Madrid Foundation. LV is supported by a fellowship from CONACYT (Mexico). CP and CFSF are engaged in the COST Action BM1005 ENOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Adya R, 2008, DIABETES CARE, V31, P758, DOI 10.2337/dc07-1544; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Borradaile NM, 2010, AM J PHYSIOL-CELL PH, V298, pC66, DOI 10.1152/ajpcell.00357.2009; Borradaile NM, 2009, AGING CELL, V8, P100, DOI 10.1111/j.1474-9726.2009.00453.x; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Filippatos TD, 2010, CURR VASC PHARMACOL, V8, P12, DOI 10.2174/157016110790226679; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Jeske NA, 2004, J NEUROCHEM, V90, P819, DOI 10.1111/j.1471-4159.2004.02557.x; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kadoglou NPE, 2010, EXP CLIN ENDOCR DIAB, V118, P75, DOI 10.1055/s-0029-1237360; Kato A, 2009, AM J NEPHROL, V29, P31, DOI 10.1159/000148648; Kendal CE, 2007, PLACENTA, V28, P305, DOI 10.1016/j.placenta.2006.03.011; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Liu SW, 2009, HORM METAB RES, V41, P281, DOI 10.1055/s-0028-1102914; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008; Niinaka Y, 1998, CANCER RES, V58, P2667; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Ognjanovic S, 2005, AM J OBSTET GYNECOL, V193, P273, DOI 10.1016/j.ajog.2004.11.003; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Stephens JM, 2006, CURR OPIN LIPIDOL, V17, P128, DOI 10.1097/01.mol.0000217893.77746.4b; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; Vallejo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027299; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727	42	45	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78283	10.1371/journal.pone.0078283	http://dx.doi.org/10.1371/journal.pone.0078283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130902	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200098
J	Cheong, JLY; Anderson, PJ; Roberts, G; Burnett, AC; Lee, KJ; Thompson, DK; Molloy, C; Wilson-Ching, M; Connelly, A; Seal, ML; Wood, SJ; Doyle, LW				Cheong, Jeanie L. Y.; Anderson, Peter J.; Roberts, Gehan; Burnett, Alice C.; Lee, Katherine J.; Thompson, Deanne K.; Molloy, Carly; Wilson-Ching, Michelle; Connelly, Alan; Seal, Marc L.; Wood, Stephen J.; Doyle, Lex W.			Contribution of Brain Size to IQ and Educational Underperformance in Extremely Preterm Adolescents	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; HUMAN CEREBRAL-CORTEX; CHILDREN BORN; MATTER INJURY; AGE; SEGMENTATION; INTELLIGENCE; CHILDHOOD; OUTCOMES; VOLUMES	Objectives: Extremely preterm (EP) survivors have smaller brains, lower IQ, and worse educational achievement than their term-born peers. The contribution of smaller brain size to the IQ and educational disadvantages of EP is unknown. This study aimed (i) to compare brain volumes from multiple brain tissues and structures between EP-born (<28weeks) and term-born (>= 37weeks) control adolescents, (ii) to explore the relationships of brain tissue volumes with IQ and basic educational skills and whether this differed by group, and (iii) to explore how much total brain tissue volume explains the underperformance of EP adolescents compared with controls. Methods: Longitudinal cohort study of 148 EP and 132 term controls born in Victoria, Australia in 1991-92. At age 18, magnetic resonance imaging-determined brain volumes of multiple tissues and structures were calculated. IQ and educational skills were measured using the Wechsler Abbreviated Scale of Intelligence (WASI) and the Wide Range Achievement Test(WRAT-4), respectively. Results: Brain volumes were smaller in EP adolescents compared with controls (mean difference [95% confidence interval] of -5.9% [-8.0, -3.7%] for total brain tissue volume). The largest relative differences were noted in the thalamus and hippocampus. The EP group had lower IQs(-11.9 [-15.4, -8.5]), spelling(-8.0 [-11.5, -4.6]), math computation(-10.3 [-13.7, -6.9]) and word reading(-5.6 [-8.8, -2.4]) scores than controls; all p-values<0.001. Volumes of total brain tissue and other brain tissues and structures correlated positively with IQ and educational skills, a relationship that was similar for both the EP and controls. Total brain tissue volume explained between 20-40% of the IQ and educational outcome differences between EP and controls. Conclusions: EP adolescents had smaller brain volumes, lower IQs and poorer educational performance than controls. Brain volumes of multiple tissues and structures are related to IQ and educational outcomes. Smaller total brain tissue volume is an important contributor to the cognitive and educational underperformance of adolescents born EP.	[Cheong, Jeanie L. Y.; Doyle, Lex W.] Royal Womens Hosp, Neonatal Serv, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.; Anderson, Peter J.; Roberts, Gehan; Burnett, Alice C.; Lee, Katherine J.; Thompson, Deanne K.; Molloy, Carly; Wilson-Ching, Michelle; Seal, Marc L.; Doyle, Lex W.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cheong, Jeanie L. Y.; Doyle, Lex W.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Anderson, Peter J.; Burnett, Alice C.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Roberts, Gehan] Royal Childrens Hosp, Melbourne, Vic, Australia; [Anderson, Peter J.; Roberts, Gehan; Lee, Katherine J.; Seal, Marc L.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Thompson, Deanne K.; Connelly, Alan] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Wood, Stephen J.] Univ Birmingham, Sch Psychol, Edgbaston, W Midlands, England	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Birmingham	Cheong, JLY (corresponding author), Royal Womens Hosp, Neonatal Serv, Melbourne, Vic, Australia.	jeanie.cheong@thewomens.org.au	Tager-Flusberg, Helen B/D-5265-2009; Anderson, Peter J/B-6839-2015; Thompson, Deanne K/A-9502-2018; Thompson, Deanne/W-7177-2019; Wood, Stephen J/M-8652-2014; Doyle, Lex/AAJ-5205-2021; Lee, Katherine J/A-2519-2016; Connelly, Alan/A-9065-2013; Anderson, Peter John/O-5302-2019; Seal, Marc L/J-9290-2019; Wood, Stephen/ABF-4086-2020; Roberts, Gehan/I-6372-2015	Anderson, Peter J/0000-0001-7430-868X; Thompson, Deanne K/0000-0001-8017-5756; Thompson, Deanne/0000-0001-8017-5756; Wood, Stephen J/0000-0003-4186-5919; Doyle, Lex/0000-0002-7667-7312; Connelly, Alan/0000-0001-7159-8079; Anderson, Peter John/0000-0001-7430-868X; Seal, Marc L/0000-0002-8396-140X; Wood, Stephen/0000-0003-4186-5919; Roberts, Gehan/0000-0002-2151-1630; Cheong, Jeanie/0000-0001-5901-0455	Australian National Health and Medical Research Council [491246, 546519, 628371, 1053787, 1012236, 1053609]; Victorian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by the Australian National Health and Medical Research Council (Project Grant ID 491246 to LD, PA, SW, JC, as well as C. Robertson, S. Hope, and D. Hacking; Centre of Clinical Research Excellence Grant ID 546519; Senior Research Fellowship ID 628371 to PA; Early Career Fellowship ID 1053787 to JC; Early Career Fellowship ID 1012236 to DT; Career Development Fellowship ID 1053609 to KJL) and the Victorian Government Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy LJ, 2002, ARCH DIS CHILD, V87, P279, DOI 10.1136/adc.87.4.279; Afifi A, 2005, FUNCTIONAL NEUROANAT; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doyle LW, 2005, ARCH DIS CHILD-FETAL, V90, pF484, DOI 10.1136/adc.2004.063362; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Lawlor DA, 2006, PAEDIATR PERINAT EP, V20, P148, DOI 10.1111/j.1365-3016.2006.00704.x; Martinussen M, 2009, J PEDIATR-US, V155, P848, DOI 10.1016/j.jpeds.2009.06.015; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Northam GB, 2011, ANN NEUROL, V69, P702, DOI 10.1002/ana.22263; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Parker J, 2008, BRAIN, V131, P1344, DOI 10.1093/brain/awn062; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Scott FE, 2011, NEUROPSYCHOLOGIA, V49, P2685, DOI 10.1016/j.neuropsychologia.2011.05.016; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Xie YH, 2012, J CHILD NEUROL, V27, P325, DOI 10.1177/0883073811419260	41	61	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77475	10.1371/journal.pone.0077475	http://dx.doi.org/10.1371/journal.pone.0077475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130887	gold, Green Published			2022-12-25	WOS:000325810900137
J	Minde, DP; Radli, M; Forneris, F; Maurice, MM; Rudiger, SGD				Minde, David P.; Radli, Martina; Forneris, Federico; Maurice, Madelon M.; Ruediger, Stefan G. D.			Large Extent of Disorder in Adenomatous Polyposis Coli Offers a Strategy to Guard Wnt Signalling against Point Mutations	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN DEGRADATION; ARMADILLO REPEAT DOMAIN; CRYSTAL-STRUCTURE; INTRINSIC DISORDER; SCAFFOLD PROTEINS; STRUCTURAL BASIS; APC; AXIN; PHOSPHORYLATION	Mutations in the central region of the signalling hub Adenomatous Polyposis Coli (APC) cause colorectal tumourigenesis. The structure of this region remained unknown. Here, we characterise the Mutation Cluster Region in APC (APC-MCR) as intrinsically disordered and propose a model how this structural feature may contribute to regulation of Wnt signalling by phosphorylation. APC-MCR was susceptible to proteolysis, lacked alpha-helical secondary structure and did not display thermal unfolding transition. It displayed an extended conformation in size exclusion chromatography and was accessible for phosphorylation by CK1 epsilon in vitro. The length of disordered regions in APC increases with species complexity, from C. elegans to H. sapiens. We speculate that the large disordered region harbouring phosphorylation sites could be a successful strategy to stabilise tight regulation of Wnt signalling against single missense mutations.	[Minde, David P.; Radli, Martina; Forneris, Federico; Ruediger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; s.g.d.rudiger@uu.nl	Minde, David Paul/D-3847-2012; Forneris, Federico/AAL-5361-2020; Forneris, Federico/B-1145-2011; Rüdiger, Stefan GD/G-4906-2012	Minde, David Paul/0000-0002-2985-622X; Forneris, Federico/0000-0002-7818-1804; Forneris, Federico/0000-0002-7818-1804; Rüdiger, Stefan GD/0000-0002-1807-2972; Maurice, Madelon/0000-0001-6885-5361	European Union [MEXT-CT-2005-025651, 317371]; VIDI by the Netherlands Organization for Scientific Research (NWO) [700.55.421]; Utrecht University; European Research Council (ERC-StG) [242958]	European Union(European Commission); VIDI by the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University; European Research Council (ERC-StG)(European Research Council (ERC))	SGDR was supported by the European Union's Sixth Framework Programme (FP6) by a Marie-Curie Excellence Grant (MEXT-CT-2005-025651) and by the Seventh Framework Programme (FP7) under grant agreement ManiFold no317371, by a VIDI career development grant (700.55.421) by the Netherlands Organization for Scientific Research (NWO) and by a High Potential Grant of Utrecht University. MMM was supported by the European Research Council (ERC-StG no. 242958) and by a High Potential Grant of Utrecht University. URLs of funders: NWO: http://www.nwo.nl/; EU: http://europa.eu/index_en.htm; Utrecht University: http://www.uu.nl/; ERC: http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRESCU AT, 1994, J MOL BIOL, V235, P587, DOI 10.1006/jmbi.1994.1015; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Balazs A, 2009, FEBS J, V276, P3744, DOI 10.1111/j.1742-4658.2009.07090.x; Bark SJ, 2001, J AM CHEM SOC, V123, P1774, DOI 10.1021/ja002909n; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bruschweiler S, 2009, J AM CHEM SOC, V131, P3063, DOI 10.1021/ja809947w; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dahlberg CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004766; Day CL, 2000, J MOL BIOL, V301, P147, DOI 10.1006/jmbi.2000.3895; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kurnik M, 2012, P NATL ACAD SCI USA, V109, P5705, DOI 10.1073/pnas.1118640109; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Minde DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046147; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Morishita EC, 2011, STRUCTURE, V19, P1496, DOI 10.1016/j.str.2011.07.013; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Quint S, 2010, BIOPHYS J, V99, P2541, DOI 10.1016/j.bpj.2010.08.031; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Shibata N, 2007, ACTA CRYSTALLOGR F, V63, P529, DOI 10.1107/S1744309107022579; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tickenbrock L, 2003, J MOL BIOL, V327, P359, DOI 10.1016/S0022-2836(03)00144-X; Tickenbrock L, 2002, J BIOL CHEM, V277, P32332, DOI 10.1074/jbc.M203990200; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Xue B, 2013, FEBS LETT, V587, P1587, DOI 10.1016/j.febslet.2013.04.006; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2012, J BIOMOL STRUCT DYN, V29, P843, DOI 10.1080/073911012010525024; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yiu CPB, 2000, CHEMBIOCHEM, V1, P49, DOI 10.1002/1439-7633(20000703)1:1<49::AID-CBIC49>3.0.CO;2-A; Zhang ZY, 2012, CELL RES, V22, P372, DOI 10.1038/cr.2011.119; Zhang ZY, 2011, BIOCHEM BIOPH RES CO, V412, P732, DOI 10.1016/j.bbrc.2011.08.044	70	37	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77257	10.1371/journal.pone.0077257	http://dx.doi.org/10.1371/journal.pone.0077257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130866	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900130
J	Puppa, MJ; Gao, S; Narsale, AA; Carson, JA				Puppa, Melissa J.; Gao, Song; Narsale, Aditi A.; Carson, James A.			Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia	FASEB JOURNAL			English	Article						inflammation; cancer; STAT3; protein turnover; C2C12 myotube; IL-6	CANCER CACHEXIA; KAPPA-B; IL-6; INHIBITION; EXPRESSION; CYTOKINES; ANTIBODY; ATROPHY; GROWTH; GP130	Chronic inflammation is associated with cachexia-induced skeletal muscle mass loss in cancer. Levels of IL-6 cytokine family members are increased during cancer-related cachexia and induce intracellular signaling through glycoprotein130 (gp130). Although muscle STAT3 and circulating IL-6 are implicated in cancer-induced muscle wasting, there is limited understanding of muscle gp130's role in this process. Therefore, we investigated the role of skeletal muscle gp130 (skm-gp130) in cancer-induced alterations in the regulation of muscle protein turnover. Lewis lung carcinoma (LLC) cells were injected into 8-wk-old skm-gp130-knockout (KO) mice or wild-type mice. Skeletal muscle loss was attenuated by 16% in gp130-KO mice, which coincided with attenuated LLC-induced phosphorylation of muscle STAT3, p38, and FOXO3. gp130 KO did not restore mTOR inhibition or alter AMP-activated protein kinase (AMPK) expression. The induction of atrogin expression and p38 phosphorylation in C2C12 myotubes exposed to LLC-treated medium was attenuated by gp130 inhibition, but mTOR inhibition was not restored. STAT signaling inhibition in LLC-treated myotubes did not attenuate the induction of p38 or AMPK phosphorylation. We concluded that, during LLC-induced cachexia, skm-gp130 regulates muscle mass signaling through STAT3 and p38 for the activation of FOXO3 and atrogin, but does not directly regulate the suppression of mTOR.Puppa, M. J., Gao, S., Narsale, A. A., Carson, J. A. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.	[Puppa, Melissa J.; Gao, Song; Narsale, Aditi A.; Carson, James A.] Univ S Carolina, Dept Exercise Sci, Integrat Muscle Biol Lab, Columbia, SC 29208 USA; [Carson, James A.] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Carson, JA (corresponding author), Univ S Carolina, Dept Exercise Sci, Publ Hlth Res Ctr, Room 405,921 Assembly St, Columbia, SC 29208 USA.	carsonj@mailbox.sc.edu	Narsale, Aditi/U-4643-2019; Carson, James/Q-5693-2019	Carson, James/0000-0003-3733-8796; Puppa, Melissa/0000-0003-3826-0003; Narsale, Aditi/0000-0002-1421-5104	U.S. NIH/NCI [R01 CA121249]; NATIONAL CANCER INSTITUTE [R01CA121249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103336] Funding Source: NIH RePORTER	U.S. NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Ms. Tia Davis and Dr. Marj Pena for technical assistance with the animal breeding. The skeletal muscle-specific Cre-expressing mice were a gift from Dr. Steven Burden (New York University, New York, NY, USA). The gp130 fl/fl mice were a gift from Drs. Colin Stuart [Laboratory of Cancer and Developmental Biology, National Cancer Institute (NCI), U. S. National Institutes of Health (NIH), Frederick, MD, USA] and Lothar Hennighausen (Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, USA). The research described in this report was supported by U.S. NIH/NCI research grant R01 CA121249 to J.A.C.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Ando K, 2013, J CLIN ONCOL, V31, pE69, DOI 10.1200/JCO.2012.44.2020; Argiles JM, 2003, CURR OPIN CLIN NUTR, V6, P401, DOI 10.1097/01.mco.0000078983.18774.cc; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Barton BE, 2001, CYTOKINE, V16, P251, DOI 10.1006/cyto.2001.0968; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Dworzak F, 1998, CANCER, V82, P42, DOI 10.1002/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Fortunati N, 2007, ONCOL REP, V18, P1521; Frost RA, 2011, PHYSIOLOGY, V26, P83, DOI 10.1152/physiol.00044.2010; Frost RA, 2009, J CELL BIOCHEM, V108, P1192, DOI 10.1002/jcb.22349; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hariri G, 2010, CLIN CANCER RES, V16, P4968, DOI 10.1158/1078-0432.CCR-10-0969; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hirata H, 2013, J PAIN SYMPTOM MANAG, V46, pE9, DOI 10.1016/j.jpainsymman.2013.01.009; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Kamoshida S, 2006, BIOMED RES-TOKYO, V27, P275, DOI 10.2220/biomedres.27.275; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; MATTHYS P, 1991, EUR J CANCER, V27, P182, DOI 10.1016/0277-5379(91)90483-T; MORI M, 1991, CANCER RES, V51, P6656; Murphy KT, 2011, AM J PHYSIOL-REG I, V301, pR716, DOI 10.1152/ajpregu.00121.2011; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Nai YJ, 2007, JPEN-PARENTER ENTER, V31, P18, DOI 10.1177/014860710703100118; Pfeilschifter W, 2010, NEUROCHEM RES, V35, P1391, DOI 10.1007/s11064-010-0197-0; Puppa MJ, 2012, J CACHEXIA SARCOPENI, V3, P117, DOI 10.1007/s13539-011-0047-1; Puppa MJ, 2011, BBA-MOL BASIS DIS, V1812, P1601, DOI 10.1016/j.bbadis.2011.08.010; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tazaki E, 2011, EXP THER MED, V2, P887, DOI 10.3892/etm.2011.286; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Toledo-Corral CM, 2012, ACTA HISTOCHEM, V114, P159, DOI 10.1016/j.acthis.2011.04.003; Washington TA, 2011, ACTA PHYSIOL, V202, P657, DOI 10.1111/j.1748-1716.2011.02281.x; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; White J, 2012, ITE J, V82, P14; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zhang GH, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-20; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhao L, 2004, J BIOL CHEM, V279, P44093, DOI 10.1074/jbc.M313131200	58	94	94	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					998	1009		10.1096/fj.13-240580	http://dx.doi.org/10.1096/fj.13-240580			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24145720	Green Published			2022-12-25	WOS:000331072200043
J	Marrero, I; Hamm, DE; Davies, JD				Marrero, Idania; Hamm, David E.; Davies, Joanna D.			High-Throughput Sequencing of Islet-Infiltrating Memory CD4(+) T Cells Reveals a Similar Pattern of TCR V beta Usage in Prediabetic and Diabetic NOD Mice	PLOS ONE			English	Article							PANCREATIC-ISLETS; PERIPHERAL-BLOOD; ANTIBODY THERAPY; AUTOIMMUNE; DIVERSITY; CLONES; TRANSPLANTATION; REPERTOIRE; LYMPHOCYTE; RECURRENCE	Autoreactive memory CD4(+) T cells play a critical role in the development of type 1 diabetes, but it is not yet known how the clonotypic composition and TCR beta repertoire of the memory CD4(+) T cell compartment changes during the transition from prediabetes to diabetes. In this study, we used high-throughput sequencing to analyze the TCR beta repertoire of sorted islet-infiltrating memory CD4(+)CD44(high) T cells in 10-week-old prediabetic and recently diabetic NOD mice. We show that most clonotypes of islet-infiltrating CD4(+)CD44(high) T cells were rare, but high-frequency clonotypes were significantly more common in diabetic than in prediabetic mice. Moreover, although the CD4(+)CD44(high) TCR beta repertoires were highly diverse at both stages of disease development, dominant use of TRBV1 (V beta 2), TRBV13-3 (V beta 8.1), and TRBV19 (V beta 6) was evident in both prediabetic and diabetic mice. Our findings strongly suggest that therapeutic targeting of cells specifically expressing the dominant TCR beta might reduce pancreatic infiltration in prediabetic mice and attenuate the progression to diabetes.	[Marrero, Idania; Davies, Joanna D.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Hamm, David E.] Adapt Biotechnol Corp, Seattle, WA USA	Torrey Pines Institute for Molecular Studies, California	Marrero, I (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA USA.	imarrero@tpims.org			American Diabetes Association Junior Faculty Award Grant [1-11-JF-29]; National Institutes of Health [R01AI065937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065937] Funding Source: NIH RePORTER	American Diabetes Association Junior Faculty Award Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an American Diabetes Association Junior Faculty Award Grant (1-11-JF-29) and by the National Institutes of Health Grant (R01AI065937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Axelsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029008; BACELJ A, 1989, DIABETES, V38, P1492, DOI 10.2337/diabetes.38.11.1492; BACELJ A, 1992, TRANSPLANT P, V24, P220; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; BERSCHICK P, 1993, J AUTOIMMUN, V6, P405, DOI 10.1006/jaut.1993.1034; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1567, DOI 10.1073/pnas.1018975108; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cohen J., 2003, APPL MULTIPLE REGRES; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Diz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052054; DREXLER K, 1993, IMMUNOL LETT, V37, P187, DOI 10.1016/0165-2478(93)90030-6; EDOUARD P, 1993, EUR J IMMUNOL, V23, P727, DOI 10.1002/eji.1830230324; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fohse L, 2011, EUR J IMMUNOL, V41, P3101, DOI 10.1002/eji.201141986; Fousteri G, 2010, DIABETOLOGIA, V53, P1958, DOI 10.1007/s00125-010-1777-x; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; GALLEY KA, 1995, J IMMUNOL, V154, P2969; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; HEROLD KC, 1995, DIABETES, V44, P354, DOI 10.2337/diabetes.44.3.354; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Jasinski JM, 2006, DIABETES, V55, P1978, DOI 10.2337/db06-0058; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Laughlin E, 2008, CLIN IMMUNOL, V128, P23, DOI 10.1016/j.clim.2008.03.459; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Leiter Edward H, 2005, Curr Diab Rep, V5, P141, DOI 10.1007/s11892-005-0042-z; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Li L, 2009, J IMMUNOL, V183, P7585, DOI 10.4049/jimmunol.0901587; Liu ZJ, 2012, DIABETES, V61, P1160, DOI 10.2337/db11-0867; Marrero I, 2012, MOL IMMUNOL, V52, P9, DOI 10.1016/j.molimm.2012.04.004; MILLER BJ, 1988, J IMMUNOL, V140, P52; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Oling V, 2012, CELL IMMUNOL, V273, P133, DOI 10.1016/j.cellimm.2011.12.008; QIAN T, 1993, DIABETES, V42, P1544, DOI 10.2337/diabetes.42.10.1544; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sarukhan A., 1994, INT IMMUNOL, V17, P139; Siebert JC, 2008, CYTOM PART A, V73A, P289, DOI 10.1002/cyto.a.20509; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Tikochinski Y, 1999, INT IMMUNOL, V11, P951, DOI 10.1093/intimm/11.6.951; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Wong CP, 2007, J IMMUNOL, V178, P1388, DOI 10.4049/jimmunol.178.3.1388; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Zhang L, 2009, J AUTOIMMUN, V33, P42, DOI 10.1016/j.jaut.2009.02.003	57	20	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76546	10.1371/journal.pone.0076546	http://dx.doi.org/10.1371/journal.pone.0076546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146886	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200015
J	Cattoni, DI; Fiche, JB; Valeri, A; Mignot, T; Nollmann, M				Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Mignot, Tam; Noellmann, Marcelo			Super-Resolution Imaging of Bacteria in a Microfluidics Device	PLOS ONE			English	Article							GENE-EXPRESSION; LOCALIZATION MICROSCOPY; BACILLUS-SUBTILIS; CELL; DNA; SPOIIIE; MOLECULES; QUANTIFICATION; SPORULATION; PROTEINS	Bacteria have evolved complex, highly-coordinated, multi-component cellular engines to achieve high degrees of efficiency, accuracy, adaptability, and redundancy. Super-resolution fluorescence microscopy methods are ideally suited to investigate the internal composition, architecture, and dynamics of molecular machines and large cellular complexes. These techniques require the long-term stability of samples, high signal-to-noise-ratios, low chromatic aberrations and surface flatness, conditions difficult to meet with traditional immobilization methods. We present a method in which cells are functionalized to a microfluidics device and fluorophores are injected and imaged sequentially. This method has several advantages, as it permits the long-term immobilization of cells and proper correction of drift, avoids chromatic aberrations caused by the use of different filter sets, and allows for the flat immobilization of cells on the surface. In addition, we show that different surface chemistries can be used to image bacteria at different time-scales, and we introduce an automated cell detection and image analysis procedure that can be used to obtain cell-to-cell, single-molecule localization and dynamic heterogeneity as well as average properties at the super-resolution level.	[Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Ctr Natl Rech Sci, Ctr Biochim Struct, Unite Mixte Rech 5048, Montpellier, France; [Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Inst Natl Sante & Rech Med, U1054, Montpellier, France; [Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Univ Montpellier I, Montpellier, France; [Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Univ Montpellier 2, Montpellier, France; [Mignot, Tam] Aix Marseille Univ, Lab Chim Bacterienne, Ctr Natl Rech Sci, Unite Mixte Rech 7283, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier	Nollmann, M (corresponding author), Ctr Natl Rech Sci, Ctr Biochim Struct, Unite Mixte Rech 5048, Montpellier, France.	marcelo.nollmann@cbs.cnrs.fr		Nollmann, Marcelo/0000-0003-3339-2349; Cattoni, Diego I./0000-0002-0048-8531; Mignot, Tam/0000-0003-4338-9063	Human Frontiers Science Program [00017/2009]; Institut National de la Sante et la Recherche Medicale; European Research Council [260787]	Human Frontiers Science Program(Human Frontier Science Program); Institut National de la Sante et la Recherche Medicale; European Research Council(European Research Council (ERC)European Commission)	Financial support was provided by the Human Frontiers Science Program (Career Development Award 00017/2009 to M.N.), the Institut National de la Sante et la Recherche Medicale (Avenir programme to M.N.) and the European Research Council (Starting Grant 260787 to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118; Beta C, 2011, EUR J CELL BIOL, V90, P811, DOI 10.1016/j.ejcb.2011.05.006; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000448; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Cattoni DI, 2012, CURR OPIN MICROBIOL, V15, P758, DOI 10.1016/j.mib.2012.10.007; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Chung BG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-60; Churchman L Stirling, 2012, Cold Spring Harb Protoc, V2012, P141, DOI 10.1101/pdb.top067918; Churchman L Stirling, 2012, Cold Spring Harb Protoc, V2012, P242, DOI 10.1101/pdb.prot067926; Cozzarelli NR, 2006, NAT REV MOL CELL BIO, V7, P580, DOI 10.1038/nrm1982; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Ducret Adrien, 2013, Methods Mol Biol, V966, P97, DOI 10.1007/978-1-62703-245-2_6; Ducret A, 2012, P NATL ACAD SCI USA, V109, P10036, DOI 10.1073/pnas.1120979109; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Eswaramoorthy P, 2011, MBIO, V2, DOI 10.1128/mBio.00257-11; Ferguson ML, 2011, ANAL BIOCHEM, V419, P250, DOI 10.1016/j.ab.2011.08.017; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; FOULGER D, 1989, MOL MICROBIOL, V3, P1247, DOI 10.1111/j.1365-2958.1989.tb00275.x; Gahlmann A, 2013, NANO LETT, V13, P987, DOI 10.1021/nl304071h; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Jeon H, 2009, BIOMED MICRODEVICES, V11, P1135, DOI 10.1007/s10544-009-9330-8; Joyce Graham, 2011, BMC Res Notes, V4, P73, DOI 10.1186/1756-0500-4-73; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lew MD, 2011, P NATL ACAD SCI USA, V108, pE1102, DOI 10.1073/pnas.1114444108; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; McEvoy AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051314; Pandey R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058972; Pelletier J, 2012, P NATL ACAD SCI USA, V109, pE2649, DOI 10.1073/pnas.1208689109; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schoen I, 2011, NANO LETT, V11, P4008, DOI 10.1021/nl2025954; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Uphoff S, 2013, P NATL ACAD SCI USA, V110, P8063, DOI 10.1073/pnas.1301804110; Walden M, 2011, CURR OPIN BIOTECH, V22, P81, DOI 10.1016/j.copbio.2010.10.004; Wong I, 2010, LAB CHIP, V10, P2710, DOI 10.1039/c004719h; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432	57	26	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76268	10.1371/journal.pone.0076268	http://dx.doi.org/10.1371/journal.pone.0076268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146850	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400050
J	Hawking, MKD; Lecky, DM; Verlander, NQ; McNulty, CAM				Hawking, Meredith K. D.; Lecky, Donna M.; Verlander, Neville Q.; McNulty, Cliodna A. M.			Fun on the Farm: Evaluation of a Lesson to Teach Students about the Spread of Infection on School Farm Visits	PLOS ONE			English	Article							ESCHERICHIA-COLI O157; CAMPYLOBACTER-JEJUNI; SAFETY KNOWLEDGE; RISK-FACTORS; E-BUG; CATTLE; HYGIENE; PERSISTENCE; BEHAVIORS	Background: School visits to farms are a positive educational experience but pose risks due to the spread of zoonotic infections. A lesson plan to raise awareness about microbes on the farm and preventative behaviours was developed in response to the Griffin Investigation into the E. coli outbreak associated with Godstone Farm in 2009. This study evaluated the effectiveness of the delivery of the lesson plan in increasing knowledge about the spread of infection on the farm, amongst school students. Methods: Two hundred and twenty-five 9-11 year old students from seven junior schools in England participated. Two hundred and ten students filled in identical questionnaires covering microbes, hand hygiene, and farm hygiene before and after the lesson. Statistical analysis assessed knowledge change using difference in percentage correct answers. Results: Significant knowledge improvement was observed for all sections. In the 'Farm Hygiene' section, girls and boys demonstrated 18% (p<0.001) and 11% (p<0.001) improvement, respectively (girls vs. boys p<0.004). As girls had lower baseline knowledge the greater percentage improvement resulted in similar post intervention knowledge scores between genders (girls 80%, boys 83%). Conclusions: The lesson plan was successful at increasing awareness of microbes on the farm and infection prevention measures and should be used by teachers in preparation for a farm visit.	[Hawking, Meredith K. D.; Lecky, Donna M.; McNulty, Cliodna A. M.] Gloucestershire Royal Hosp, Dept Microbiol, Publ Hlth England, Primary Care Unit, Gloucester GL1 3NN, England; [Verlander, Neville Q.] Publ Hlth England Ctr Infect, Stat Modelling & Econ Dept, London, England	Gloucestershire Royal Hospital; Public Health England; Public Health England	Hawking, MKD (corresponding author), Gloucestershire Royal Hosp, Dept Microbiol, Publ Hlth England, Primary Care Unit, Gloucester GL1 3NN, England.	meredith.hawking@phe.gov.uk	Lecky, Donna Marie/AAB-6849-2019; Hawking, Meredith KD/E-7692-2015	Lecky, Donna Marie/0000-0002-1223-9356; Hawking, Meredith KD/0000-0003-1519-2458	Health Protection Agency, UK	Health Protection Agency, UK	This work was supported by the Health Protection Agency, UK (http://www.hpa.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belongia EA, 2003, J INFECT DIS, V187, P1460, DOI 10.1086/374622; Berry DS, 2006, J SAFETY RES, V37, P333, DOI 10.1016/j.jsr.2006.05.003; Charlett A, 2003, EPIDEMIOL INFECT, V130, P367; Crump JA, 2003, EPIDEMIOL INFECT, V131, P1055, DOI 10.1017/S0950268803001237; Ejemot-Nwadiaro R. I., 2012, COCHRANE DB SYST REV, V2, P1; Eves A, 2010, HEALTH EDUC J, V69, P21, DOI 10.1177/0017896910363313; Farming and Countryside Education, 2011, PREV CONTR ILL HLTH; Farming and Countryside Education, 2012, CONTR INF FARMS; Farming and Countryside Education, 2011, RES SCH BENCHM VIEWS; GARBER LP, 1995, J AM VET MED ASSOC, V207, P46; Goode B, 2009, ARCH PEDIAT ADOL MED, V163, P42, DOI 10.1001/archpediatrics.2008.525; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Health and Safety Executive, 2007, KIDS SAF HELP CHILDR; Health Protection Agency, 2011, AV INF FARM VIS ADV; Health Protection Agency, 2010, REV MAJ OUTBR E COLI; Health Protection Agency, 2011, MAN AC BLOOD DIARRH; Health Protection Scotland, 2010, SIMPL PREC RED RISK; Heuvelink AE, 2007, EPIDEMIOL INFECT, V135, P1174, DOI 10.1017/S0950268807008072; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Jones DL, 1999, SOIL USE MANAGE, V15, P76, DOI 10.1111/j.1475-2743.1999.tb00069.x; Lecky DM, 2010, J ANTIMICROB CHEMOTH, V65, P2674, DOI 10.1093/jac/dkq356; Lee MB, 2010, J SCH HLTH, V80, P589; LeJeune JT, 2001, APPL ENVIRON MICROB, V67, P3053, DOI 10.1128/AEM.67.7.3053-3057.2001; McMillian M, 2007, JAVMA-J AM VET MED A, V231, P1036, DOI 10.2460/javma.231.7.1036; McNulty CAM, 2011, J ANTIMICROB CHEMOTH, V66, pV3, DOI 10.1093/jac/dkr119; Nichols GL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001179; Paiba GA, 2003, VET REC, V153, P347, DOI 10.1136/vr.153.12.347; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Rahn K, 1997, EPIDEMIOL INFECT, V119, P251, DOI 10.1017/S0950268897007929; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Stanley K, 1998, J APPL MICROBIOL, V85, P187; Thomson JA, 2005, J EXP PSYCHOL-APPL, V11, P175, DOI 10.1037/1076-898X.11.3.175; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000	33	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75641	10.1371/journal.pone.0075641	http://dx.doi.org/10.1371/journal.pone.0075641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146765	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400011
J	Bicego, GT; Nkambule, R; Peterson, I; Reed, J; Donnell, D; Ginindza, H; Duong, YT; Patel, H; Bock, N; Philip, N; Mao, C; Justman, J				Bicego, George T.; Nkambule, Rejoice; Peterson, Ingrid; Reed, Jason; Donnell, Deborah; Ginindza, Henry; Duong, Yen T.; Patel, Hetal; Bock, Naomi; Philip, Neena; Mao, Cherry; Justman, Jessica			Recent Patterns in Population-Based HIV Prevalence in Swaziland	PLOS ONE			English	Article							MALE CIRCUMCISION; TRIAL	Background: The 2011 Swaziland HIV Incidence Measurement Survey (SHIMS) was conducted as part of a national study to evaluate the scale up of key HIV prevention programs. Methods: From a randomly selected sample of all Swazi households, all women and men aged 18-49 were considered eligible, and all consenting adults were enrolled and received HIV testing and counseling. In this analysis, population-based measures of HIV prevalence were produced and compared against similarly measured HIV prevalence estimates from the 2006-7 Swaziland Demographic and Health. Also, measures of HIV service utilization in both HIV infected and uninfected populations were documented and discussed. Results: HIV prevalence among adults aged 18-49 has remained unchanged between 2006-2011 at 31-32%, with substantial differences in current prevalence between women (39%) and men (24%). In both men and women, between since 2006-7 and 2011, prevalence has fallen in the young age groups and risen in the older age groups. Over a third (38%) of the HIV-infected population was unaware of their infection status, and this differed markedly between men (50%) and women (31%). Of those aware of their HIV-positive status, a higher percentage of men (63%) than women (49%) reported ART use. Conclusions: While overall HIV prevalence remains roughly constant, age-specific changes strongly suggest both improved survival of the HIV-infected and a reduction in new HIV infections. Awareness of HIV status and entry into ART services has improved in recent years but remains too low. This study identifies opportunities to improve both HIV preventive and care services in Swaziland.	[Bicego, George T.] Ctr Dis Control & Prevent CDC, Mbabane, Swaziland; [Nkambule, Rejoice; Ginindza, Henry] Minist Hlth, Mbabane, Swaziland; [Peterson, Ingrid; Ginindza, Henry] Columbia Univ, Int Ctr AIDS Care & Treatment Programs ICAP, Mbabane, Swaziland; [Donnell, Deborah; Mao, Cherry] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Reed, Jason; Duong, Yen T.; Patel, Hetal; Bock, Naomi] CDC Atlanta, Div Global HIV AIDS, Atlanta, GA USA; [Philip, Neena; Justman, Jessica] Columbia Univ, ICAP, New York, NY USA	Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA; Columbia University	Bicego, GT (corresponding author), Ctr Dis Control & Prevent CDC, Mbabane, Swaziland.	gpb4@cdc.gov	Justman, Jessica/AAA-3572-2020	Donnell, Deborah/0000-0002-0587-7480	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The CDC funded the SHIMS study and participated in the design, data analysis, and preparation of manuscript.	[Anonymous], 2009, 2007 SWAZ POP CENS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Central Statistical Office (CSO) [Swaziland] and Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Gray RH, 2007, LANCET, V369, P9562; Ministry of Health, 2012, SWAZ INC MEAS SURV S; Ministry of Health (MOH), 2011, ROUND HIV SENT SER S, P2010; Ministry of Health (MOH), 2012, ART PROGR ANN REP MB; Ministry of Health (MOH), 2012, SWAZ NAT ART PROGR E; National Emergency Response Council on HIV and AIDS (NERCHA), 2010, NAT MULTISECTORAL ST; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298	11	81	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77101	10.1371/journal.pone.0077101	http://dx.doi.org/10.1371/journal.pone.0077101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143205	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100040
J	Stevenson, JC; Stresman, GH; Gitonga, CW; Gillig, J; Owaga, C; Marube, E; Odongo, W; Okoth, A; China, P; Oriango, R; Brooker, SJ; Bousema, T; Drakeley, C; Cox, J				Stevenson, Jennifer C.; Stresman, Gillian H.; Gitonga, Caroline W.; Gillig, Jonathan; Owaga, Chrispin; Marube, Elizabeth; Odongo, Wycliffe; Okoth, Albert; China, Pauline; Oriango, Robin; Brooker, Simon J.; Bousema, Teun; Drakeley, Chris; Cox, Jonathan			Reliability of School Surveys in Estimating Geographic Variation in Malaria Transmission in the Western Kenyan Highlands	PLOS ONE			English	Article							HIGHER-RISK; AGE; SURVEILLANCE; PREVALENCE; ANTIBODIES; INTENSITY; EXPOSURE	Background: School surveys provide an operational approach to assess malaria transmission through parasite prevalence. There is limited evidence on the comparability of prevalence estimates obtained from school and community surveys carried out at the same locality. Methods: Concurrent school and community cross-sectional surveys were conducted in 46 school/community clusters in the western Kenyan highlands and households of school children were geolocated. Malaria was assessed by rapid diagnostic test (RDT) and combined seroprevalence of antibodies to bloodstage Plasmodium falciparum antigens. Results: RDT prevalence in school and community populations was 25.7% (95% CI: 24.4-26.8) and 15.5% (95% CI: 14.4-16.7), respectively. Seroprevalence in the school and community populations was 51.9% (95% CI: 50.5-53.3) and 51.5% (95% CI: 49.5-52.9), respectively. RDT prevalence in schools could differentiate between low (<7%, 95% CI: 0-19%) and high (>39%, 95% CI: 25-49%) transmission areas in the community and, after a simple adjustment, were concordant with the community estimates. Conclusions: Estimates of malaria prevalence from school surveys were consistently higher than those from community surveys and were strongly correlated. School-based estimates can be used as a reliable indicator of malaria transmission intensity in the wider community and may provide a basis for identifying priority areas for malaria control.	[Stevenson, Jennifer C.; Gitonga, Caroline W.; Brooker, Simon J.; Cox, Jonathan] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Stresman, Gillian H.; Bousema, Teun; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Gitonga, Caroline W.; Brooker, Simon J.] Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya; [Gillig, Jonathan] Univ Notre Dame, Eck Inst Global Hlth, South Bend, IN USA; [Owaga, Chrispin; Marube, Elizabeth; Odongo, Wycliffe; Okoth, Albert; China, Pauline; Oriango, Robin] Ctr Dis Control & Prevent, Kenya Med Res Inst, Ctr Global Hlth Res, Kisumu, Kenya; [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Notre Dame; Kenya Medical Research Institute; Radboud University Nijmegen	Cox, J (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	jonathan.cox@lshtm.ac.uk	Bousema, Teun/N-3574-2014	Bousema, Teun/0000-0003-2666-094X; Stresman, Gillian/0000-0002-6897-5459	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [45114]; Wellcome trust [091924]; Commonwealth Ph.D. scholarship; Wellcome Trust Senior Fellowship in Basic Biomedical Science [098045]; Grant Challenge Grant by the Bill and Melinda Gates Foundation [OPP1024438]	Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium; Wellcome trust(Wellcome TrustEuropean Commission); Commonwealth Ph.D. scholarship; Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); Grant Challenge Grant by the Bill and Melinda Gates Foundation	This work was supported by the Bill and Melinda Gates Foundation, under the Malaria Transmission Consortium [grant number 45114]. CD is supported by the Wellcome trust [grant number 091924], CWG is supported by a Commonwealth Ph.D. scholarship, and SJB is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science [grant number 098045]. TB is supported by a Grant Challenge Grant by the Bill and Melinda Gates Foundation [grant number OPP1024438]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Ashton RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-25; BEADLE C, 1995, J INFECT DIS, V172, P1047, DOI 10.1093/infdis/172.4.1047; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; BRADLEY EL, 1989, AM STAT, V43, P234, DOI 10.2307/2685368; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Cox J, 2007, TRENDS PARASITOL, V23, P142, DOI 10.1016/j.pt.2007.02.002; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Gitonga CW, 2012, AM J TROP MED HYG, V87, P1004, DOI 10.4269/ajtmh.2012.12-0215; Gitonga CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-306; Governement of Kenya, 2006, KEN INT HOUS BUDG SU; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Guyatt HL, 1999, PARASITOLOGY, V118, P257, DOI 10.1017/S0031182098003862; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Icks A, 2012, WIEN KLIN WOCHENSCHR, V124, P391, DOI 10.1007/s00508-012-0188-z; Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lucas AM, 2012, J AFR ECON, V21, P691, DOI 10.1093/jae/ejs021; Ministry of Public Health and Sanitation, 2010, NAT GUID HIV TEST CO; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sexton CJ, 2012, AIDS RES HUM RETROV, V28, P866, DOI [10.1089/aid.2011.0221, 10.1089/AID.2011.0221]; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4; Stuckey EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-357; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77641	10.1371/journal.pone.0077641	http://dx.doi.org/10.1371/journal.pone.0077641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143250	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100089
J	Dragowska, WH; Weppler, SA; Wang, JC; Wong, LY; Kapanen, AI; Rawji, JS; Warburton, C; Qadir, MA; Donohue, E; Roberge, M; Gorski, SM; Gelmon, KA; Bally, MB				Dragowska, Wieslawa H.; Weppler, Sherry A.; Wang, Jun Chih; Wong, Ling Yan; Kapanen, Anita I.; Rawji, Jenna S.; Warburton, Corinna; Qadir, Mohammed A.; Donohue, Elizabeth; Roberge, Michel; Gorski, Sharon M.; Gelmon, Karen A.; Bally, Marcel B.			Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; LAPATINIB RESISTANCE; INDUCED CYTOTOXICITY; CELLS; TRASTUZUMAB; ZD1839; EXPRESSION; APOPTOSIS; IRESSA	Gefitinib (Iressa (R), ZD1839) is a small molecule inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. We report on an early cellular response to gefitinib that involves induction of functional autophagic flux in phenotypically diverse breast cancer cells that were sensitive (BT474 and SKBR3) or insensitive (MCF7-GFPLC3 and JIMT-1) to gefitinib. Our data show that elevation of autophagy in gefitinib-treated breast cancer cells correlated with downregulation of AKT and ERK1/2 signaling early in the course of treatment. Inhibition of autophagosome formation by BECLIN-1 or ATG7 siRNA in combination with gefitinib reduced the abundance of autophagic organelles and sensitized SKBR3 but not MCF7-GFPLC3 cells to cell death. However, inhibition of the late stage of gefitinib-induced autophagy with hydroxychloroquine (HCQ) or bafilomycin A1 significantly increased (p<0.05) cell death in gefitinib-sensitive SKBR3 and BT474 cells, as well as in gefitinib-insensitive JIMT-1 and MCF7-GFPLC3 cells, relative to the effects observed with the respective single agents. Treatment with the combination of gefitinib and HCQ was more effective (p<0.05) in delaying tumor growth than either monotherapy (p>0.05), when compared to vehicle-treated controls. Our results also show that elevated autophagosome content following short-term treatment with gefitinib is a reversible response that ceases upon removal of the drug. In aggregate, these data demonstrate that elevated autophagic flux is an early response to gefitinib and that targeting EGFR and autophagy should be considered when developing new therapeutic strategies for EGFR expressing breast cancers.	[Dragowska, Wieslawa H.; Weppler, Sherry A.; Wang, Jun Chih; Wong, Ling Yan; Kapanen, Anita I.; Rawji, Jenna S.; Warburton, Corinna; Qadir, Mohammed A.; Bally, Marcel B.] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Donohue, Elizabeth; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Roberge, Michel; Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Gorski, Sharon M.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Gorski, Sharon M.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Gelmon, Karen A.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Gelmon, Karen A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Bally, Marcel B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Dragowska, WH (corresponding author), British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada.	vdragows@bccrc.ca	Gorski, Sharon M/E-9375-2012	Gorski, Sharon M/0000-0002-3821-8289; Bally, Marcel/0000-0002-1994-4787	Canadian Institutes of Health Research [MOP 106638, MOP 78882, GPG 102167]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research grant# MOP 106638, MOP 78882 and GPG 102167. High content screening equipment was obtained with the support of an equipment grant from the Canadian Institutes of Health Research. TEM imaging was performed with equipment obtained through the Canadian Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Anido J, 2003, CLIN CANCER RES, V9, P1274; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bernardini M, 2005, NEOPLASIA, V7, P603, DOI 10.1593/neo.04760; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Brehmer D, 2005, CANCER RES, V65, P379; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Chen SN, 2011, MED HYPOTHESES, V77, P206, DOI 10.1016/j.mehy.2011.04.013; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Cooper RG, 2008, INDIAN J MED RES, V127, P305; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Dragowska WH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-420; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gelmon Karen A, 2004, Clin Breast Cancer, V5, P52, DOI 10.3816/CBC.2004.n.010; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; Hu YL, 2012, CANCER RES, V72, P4294, DOI 10.1158/0008-5472.CAN-12-1076; Jahanzeb M, 2008, CLIN BREAST CANCER, V8, P324, DOI 10.3816/CBC.2008.n.037; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Moasser MM, 2001, CANCER RES, V61, P7184; Moulder SL, 2001, CANCER RES, V61, P8887; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Prasad M, 2008, GENE CHROMOSOME CANC, V47, P427, DOI 10.1002/gcc.20547; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; SAITO H, 1993, CANCER RES, V53, P3382; Saxena R, 2012, MED RES REV, V32, P166, DOI 10.1002/med.20209; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1165, DOI 10.2165/00003088-200544110-00004; Swampillai AL, 2012, CLIN ONCOL-UK, V24, P387, DOI 10.1016/j.clon.2011.09.010; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Tanner M, 2004, MOL CANCER THER, V3, P1585; Tevaarwerk AJ, 2009, CLIN THER, V31, P2332, DOI 10.1016/j.clinthera.2009.11.029; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Warburton C, 2004, CLIN CANCER RES, V10, P2512, DOI 10.1158/1078-0432.CCR-03-0244; Weigelt B, 2011, ONCOGENE; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang L, 2004, P NATL ACAD SCI USA, V101, P10296, DOI 10.1073/pnas.0403175101; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	65	74	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76503	10.1371/journal.pone.0076503	http://dx.doi.org/10.1371/journal.pone.0076503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146879	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400062
J	Khattar, R; Luft, O; Yavorska, N; Shalev, I; Phillips, MJ; Adeyi, O; Gao, D; Bartczak, A; Urbanellis, P; Shyu, W; Zhang, JH; Manuel, J; Levy, GA; Selzner, N				Khattar, Ramzi; Luft, Olga; Yavorska, Nataliya; Shalev, Itay; Phillips, M. James; Adeyi, Oyedele; Gao, Darrin; Bartczak, Agata; Urbanellis, Peter; Shyu, Wendy; Zhang, Jianhua; Manuel, Justin; Levy, Gary A.; Selzner, Nazia			Targeted Deletion of FGL2 Leads to Increased Early Viral Replication and Enhanced Adaptive Immunity in a Murine Model of Acute Viral Hepatitis Caused by LCMV WE	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOTOXIC T-CELLS; C-VIRUS; ANTIVIRAL THERAPY; PLUS RIBAVIRIN; INFECTION; MICE; EFFECTOR; PERSISTENCE; RESPONSES	Mounting effective innate and adaptive immune responses are critical for viral clearance and the generation of long lasting immunity. It is known that production of inhibitory factors may result in the inability of the host to clear viruses, resulting in chronic viral persistence. Fibrinogen-like protein 2 (FGL2) has been identified as a novel effector molecule of CD4(+)CD25(+) Foxp3(+) regulatory T (Treg) cells that inhibits immune activity by binding to FC gamma RIIB expressed primarily on antigen presenting cells (APC). In this study, we show that infection of mice with Lymphocytic Choriomeningitis Virus WE (LCMV WE) leads to increased plasma levels of FGL2, which were detected as early as 2 days post-infection (pi) and persisted until day 50 pi. Mice deficient in FGL2 (fgl2(-/-)) had increased viral titers of LCMV WE in the liver early p.i but cleared the virus by day 12 similar to wild type mice. Dendritic cells (DC) isolated from the spleens of LCMV WE infected fgl2(-/-) had increased expression of the DC maturation markers CD80 and MHC Class II compared to wild type (fgl2(+/+)). Frequencies of CD8(+) and CD4(+) T cells producing IFN gamma in response to ex vivo peptide re-stimulation isolated from the spleen and lymph nodes were also increased in LCMV WE infected fgl2(-/-) mice. Increased frequencies of CD8(+) T cells specific for LCMV tetramers GP(33) and NP396 were detected within the liver of fgl2(-/-) mice. Plasma from fgl2(-/-) mice contained higher titers of total and neutralizing anti-LCMV antibody. Enhanced anti-viral immunity in fgl2(-/-) mice was associated with increased levels of serum alanine transaminase (ALT), hepatic necrosis and inflammation following LCMV WE infection. These data demonstrate that targeting FGL2 leads to early increased viral replication but enhanced anti-viral adaptive T & B cell responses. Targeting FGL2 may enhance the efficacy of current anti-viral therapies for hepatotropic viruses.	[Khattar, Ramzi; Luft, Olga; Yavorska, Nataliya; Shalev, Itay; Phillips, M. James; Adeyi, Oyedele; Gao, Darrin; Bartczak, Agata; Urbanellis, Peter; Shyu, Wendy; Zhang, Jianhua; Manuel, Justin; Levy, Gary A.; Selzner, Nazia] Univ Toronto, Inst Transplantat, Toronto, ON, Canada	University of Toronto	Selzner, N (corresponding author), Univ Toronto, Inst Transplantat, Toronto, ON, Canada.	nazia.selzner@uhn.ca	Selzner, Nazia/AAI-1469-2020	Selzner, Nazia/0000-0002-9435-2597; Adeyi, Oyedele/0000-0003-4272-1095				AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; ALTHAGE A, 1992, EUR J IMMUNOL, V22, P1803, DOI 10.1002/eji.1830220720; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Burton JR, 2008, J HEPATOL, V49, P329, DOI 10.1016/j.jhep.2008.05.020; Chen WJ, 2006, CLIN INFECT DIS, V42, P1561, DOI 10.1086/503843; Ciurea A, 1999, P NATL ACAD SCI USA, V96, P11964, DOI 10.1073/pnas.96.21.11964; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Foerster K, 2010, J HEPATOL, V53, P608, DOI 10.1016/j.jhep.2010.04.020; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fried M, 2002, AM POETRY REV, V31, P36; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Lang PA, 2010, HEPATOLOGY, V52, P25, DOI 10.1002/hep.23640; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Muth S, 2012, P NATL ACAD SCI USA, V109, P9059, DOI 10.1073/pnas.1110620109; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; ROOST H, 1988, EUR J IMMUNOL, V18, P511, DOI 10.1002/eji.1830180404; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Takimoto K, 2008, EXP ANIM TOKYO, V57, P357, DOI 10.1538/expanim.57.357; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Zhu CL, 2006, HUM GENE THER, V17, P589, DOI 10.1089/hum.2006.17.589; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e72309	10.1371/journal.pone.0072309	http://dx.doi.org/10.1371/journal.pone.0072309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146739	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400001
J	Nordberg, V; Peralta, AQ; Galindo, T; Turlej-Rogacka, A; Iversen, A; Giske, CG; Naver, L				Nordberg, Viveka; Peralta, Arturo Quizhpe; Galindo, Telmo; Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.; Naver, Lars			High Proportion of Intestinal Colonization with Successful Epidemic Clones of ESBL-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Ecuador	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE ACQUISITION; RISK-FACTORS; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; OUTBREAK; NEWBORNS; INFANTS	Background and Aims: Neonatal infections caused by Extended-spectrum beta-lactamase (ESBL)-producing bacteria are associated with increased morbidity and mortality. No data are available on neonatal colonization with ESBL-producing bacteria in Ecuador. The aim of this study was to determine the proportion of intestinal colonization with ESBL-producing Enterobacteriaceae, their resistance pattern and risk factors of colonization in a neonatal intensive care unit in Ecuador. Methods: During a three month period, stool specimens were collected every two weeks from hospitalized neonates. Species identification and susceptibility testing were performed with Vitek2, epidemiologic typing with automated repetitive PCR. Associations between groups were analyzed using the Pearson chi(2) test and Fisher exact test. A forward step logistic regression model identified significant predictors for colonization. Results: Fifty-six percent of the neonates were colonized with ESBL-producing Enterobacteriaceae. Length of stay longer than 20 days and enteral feeding with a combination of breastfeeding and formula feeding were significantly associated with ESBL-colonization. The strains found were E. coli (EC, 89%) and K. pneumoniae (KP, 11%) and epidemiological typing divided these isolates in two major clusters. All EC and KP had bla(CTX-M) group 1 except for a unique EC isolate that had bla(CTX-M) group 9. Multi-locus sequence typing performed on the K. pneumoniae strains showed that the strains belonged to ST855 and ST897. The two detected STs belong to two different epidemic clonal complexes (CC), CC11 and CC14, which previously have been associated with dissemination of carbapenemases. None of the E. coli strains belonged to the epidemic ST 131 clone. Conclusions: More than half of the neonates were colonized with ESBL-producing Enterobacteriaceae where the main risk factor for colonization was length of hospital stay. Two of the isolated clones were epidemic and known to disseminate carbapenemases. The results underline the necessity for improved surveillance and infection control in this context.	[Nordberg, Viveka; Naver, Lars] Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden; [Nordberg, Viveka; Naver, Lars] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Peralta, Arturo Quizhpe; Galindo, Telmo] Univ Cuenca, Fac Med Sci, Dept Microbiol, Cuenca, Ecuador; [Peralta, Arturo Quizhpe] Radboud Univ Nijmegen, Med Ctr, Nijmegen Int Ctr Hlth Syst Res & Educ, NL-6525 ED Nijmegen, Netherlands; [Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.] Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Universidad de Cuenca; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet	Nordberg, V (corresponding author), Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden.	Viveka.yao-nordberg@karolinska.se	Navér, Lars/E-5085-2013	Naver, Lars/0000-0001-6027-0211	ReAct, Uppsala; research foundation Allmanna BB, Sweden	ReAct, Uppsala; research foundation Allmanna BB, Sweden	This work was supported in part by a grant from ReAct, Uppsala, http://www.reactgroup.org/ and research foundation Allmanna BB, Sweden, www.allmannabb.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya E, 2010, J CHEMOTHERAPY, V22, P25; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Boo NY, 2005, J HOSP INFECT, V61, P68, DOI 10.1016/j.jhin.2005.01.025; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Cassettari VC, 2009, J HOSP INFECT, V71, P340, DOI 10.1016/j.jhin.2008.11.019; Crivaro V, 2007, J HOSP INFECT, V67, P135, DOI 10.1016/j.jhin.2007.07.026; Desimoni MC, 2004, ENFERM INFEC MICR CL, V22, P507, DOI 10.1157/13067617; Duman M, 2005, PEDIATR INT, V47, P267, DOI 10.1111/j.1442-200x.2005.02064.x; Perez JAE, 2013, ANTIMICROB AGENTS CH, V57, P1957, DOI 10.1128/AAC.01447-12; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Lautenbach E, 2005, ANTIMICROB AGENTS CH, V49, P798, DOI 10.1128/AAC.49.2.798-800.2005; Mammina C, 2007, AM J INFECT CONTROL, V35, P222, DOI 10.1016/j.ajic.2006.04.210; Murki S, 2010, INDIAN PEDIAT; Nair V, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/874726; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Rettedal S, 2013, SCAND J INFECT DIS, V45, P54, DOI 10.3109/00365548.2012.713116; Shakil S, 2010, J TROP PEDIATRICS, V56, P90, DOI 10.1093/tropej/fmp060; Valverde A, 2004, J CLIN MICROBIOL, V42, P4769, DOI 10.1128/JCM.42.10.4769-4775.2004; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; World Health Organisation, 2002, PREV NOS INF PRACT G; Zingg W, 2008, CURR OPIN INFECT DIS, V21, P228, DOI 10.1097/QCO.0b013e3282fcec5f	24	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76597	10.1371/journal.pone.0076597	http://dx.doi.org/10.1371/journal.pone.0076597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146896	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400066
J	Woolnough, CA; Yee, LH; Charlton, TS; Foster, LJR				Woolnough, Catherine Anne; Yee, Lachlan Hartley; Charlton, Timothy Stuart; Foster, Leslie John Ray			A Tuneable Switch for Controlling Environmental Degradation of Bioplastics: Addition of Isothiazolinone to Polyhydroxyalkanoates	PLOS ONE			English	Article							POLYMER DEGRADATION; BIODEGRADATION; FILMS; POLY(3-HYDROXYBUTYRATE); PLASTICS; COPPER; SC	Controlling the environmental degradation of polyhydroxybutyrate (PHB) and polyhydroxyvalerate (P(HB-co-HV)) bioplastics would expand the range of their potential applications. Combining PHB and P(HB-co-HV) films with the anti-fouling agent 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one (DCOI, <10% w/w) restricted microbial colonisation in soil, but did not significantly affect melting temperature or the tensile strength of films. DCOI films showed reduced biofouling and postponed the onset of weight loss by up to 100 days, a 10-fold increase compared to unmodified films where the microbial coverage was significant. In addition, the rate of PHA-DCOI weight loss, post-onset, reduced by about 150%; in contrast a recorded weight loss of only 0.05% per day for P(HB-co-HV) with a 10% DCOI loading was observed. This is in stark contrast to the unmodified PHB film, where a recorded weight loss of only 0.75% per day was made. The 'switch' that initiates film weight loss, and its subsequent reduced rate, depended on the DCOI loading to control biofouling. The control of biofouling and environmental degradation for these DCOI modified bioplastics increases their potential use in biodegradable applications.	[Woolnough, Catherine Anne; Foster, Leslie John Ray] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymer Res Grp, Sydney, NSW, Australia; [Woolnough, Catherine Anne; Foster, Leslie John Ray] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Sydney, NSW, Australia; [Yee, Lachlan Hartley] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Charlton, Timothy Stuart] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Southern Cross University; University of New South Wales Sydney	Yee, LH (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia.	Lachlan.yee@scu.edu.au	Yee, Lachlan H./B-6856-2008	Yee, Lachlan H./0000-0002-7258-2076; Foster, Leslie John Ray/0000-0001-5728-4479	Environmental Biotechnology Cooperative Research Centre, Australia; Australian Postgraduate Award; University of NSW Faculty	Environmental Biotechnology Cooperative Research Centre, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Postgraduate Award(Australian Government); University of NSW Faculty	An Australian Postgraduate Award supported Dr Woolnough and a University of NSW Faculty Grant to Associate Professor Foster. Dr Yee was supported by a postdoctoral fellowship from the Environmental Biotechnology Cooperative Research Centre, Australia. Glenda Scibilia provided librarian and editorial support for this study. Professors G. George and J. Vanclay provided academic discussion on the manuscript.	Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P1379, DOI 10.1163/156856205774472308; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chinga G, 2004, J PULP PAP SCI, V30, P307; Chinga G, 2007, J MICROSC-OXFORD, V227, P254, DOI 10.1111/j.1365-2818.2007.01809.x; DOI Y, 1992, POLYM DEGRAD STABIL, V36, P173, DOI 10.1016/0141-3910(92)90154-W; Foster LJR, 2006, BIOMACROMOLECULES, V7, P1344, DOI 10.1021/bm050969l; Funhoff AM, 2004, PHARM RES-DORDR, V21, P170, DOI 10.1023/B:PHAM.0000012165.68765.e6; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; Gravenmier JJ, 2005, ENVIRON TOXICOL, V20, P150, DOI 10.1002/tox.20089; Ishigaki T, 2004, CHEMOSPHERE, V54, P225, DOI 10.1016/S0045-6535(03)00750-1; JACOBSON A, 1993, ACS SYM SER, V522, P138; Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1; KUNIOKA M, 1989, APPL MICROBIOL BIOT, V30, P569, DOI 10.1007/BF00255361; LEONG K, 2002, PHOSPHATE BASED BIOD; Li X, 2005, BIOMACROMOLECULES, V6, P2740, DOI 10.1021/bm050234g; Li Z, 2004, MACROMOL BIOSCI, V4, P699, DOI 10.1002/mabi.200400009; Lu DD, 2008, EUR POLYM J, V44, P2140, DOI 10.1016/j.eurpolymj.2008.04.014; MERGAERT J, 1993, APPL ENVIRON MICROB, V59, P3233, DOI 10.1128/AEM.59.10.3233-3238.1993; Modelli A, 1999, J ENVIRON POLYM DEGR, V7, P109, DOI 10.1023/A:1021864402395; Nagai N, 2005, POLYM DEGRAD STABIL, V88, P224, DOI 10.1016/j.polymdegradstab.2004.11.001; Rasmussen K, 2010, ACS APPL MATER INTER, V2, P1879, DOI 10.1021/am100219z; Roberts DA, 2006, ENVIRON TOXICOL CHEM, V25, P2470, DOI 10.1897/05-661R.1; Sakkas VA, 2002, J CHROMATOGR A, V959, P215, DOI 10.1016/S0021-9673(02)00430-2; SCANDOLA M, 1992, MACROMOLECULES, V25, P6441, DOI 10.1021/ma00050a009; SEPPALA J, 2009, NOVEL BIODEGRADABLE, P76943; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Steen RJCA, 2004, CHEMOSPHERE, V57, P513, DOI 10.1016/j.chemosphere.2004.06.043; Thouvenin M, 2003, BIOFOULING, V19, P177, DOI 10.1080/08927014.2003.10382980; WILLINGHAM GL, 1993, P 3 AS PAC C PAINT R; Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444; Woolnough CA, 2010, POLYM INT, V59, P658, DOI 10.1002/pi.2746; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001	33	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75817	10.1371/journal.pone.0075817	http://dx.doi.org/10.1371/journal.pone.0075817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146779	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400021
J	Dalisay, DS; Williams, DE; Wang, XL; Centko, R; Chen, J; Andersen, RJ				Dalisay, Doralyn S.; Williams, David E.; Wang, Xiao Ling; Centko, Ryan; Chen, Jessie; Andersen, Raymond J.			Marine Sediment-Derived Streptomyces Bacteria from British Columbia, Canada Are a Promising Microbiota Resource for the Discovery of Antimicrobial Natural Products	PLOS ONE			English	Article							DNA GYRASE; ANTITUMOR-ACTIVITY; DRUG DEVELOPMENT; NOVOBIOCIN; ANTIMYCIN; INHIBITORS; BINDING; HSP90; MICROMONOSPORA; MICROORGANISMS	Representatives of the genus Streptomyces from terrestrial sources have been the focus of intensive research for the last four decades because of their prolific production of chemically diverse and biologically important compounds. However, metabolite research from this ecological niche had declined significantly in the past years because of the rediscovery of the same bioactive compounds and redundancy of the sample strains. More recently, a new picture has begun to emerge in which marine-derived Streptomyces bacteria have become the latest hot spot as new source for unique and biologically active compounds. Here, we investigated the marine sediments collected in the temperate cold waters from British Columbia, Canada as a valuable source for new groups of marine-derived Streptomyces with antimicrobial activities. We performed culture dependent isolation from 49 marine sediments samples and obtained 186 Streptomyces isolates, 47 of which exhibited antimicrobial activities. Phylogenetic analyses of the active isolates resulted in the identification of four different clusters of bioactive Streptomyces including a cluster with isolates that appear to represent novel species. Moreover, we explored whether these marine-derived Streptomyces produce new secondary metabolites with antimicrobial properties. Chemical analyses revealed structurally diverse secondary metabolites, including four new antibacterial novobiocin analogues. We conducted structure-activity relationships (SAR) studies of these novobiocin analogues against methicillin-resistant Staphylococcus aureus (MRSA). In this study, we revealed the importance of carbamoyl and OMe moieties at positions 3 '' and 4 '' of novobiose as well as the hydrogen substituent at position 5 of hydroxybenzoate ring for the anti-MRSA activity. Changes in the substituents at these positions dramatically impede or completely eliminate the inhibitory activity of novobiocins against MRSA.	[Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Andersen, RJ (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	raymond.andersen@ubc.ca	Dalisay, Doralyn S/I-7558-2016	Dalisay, Doralyn/0000-0003-2850-7797	National Cancer Institute-National Cooperative Drug Discovery Group [CA 67786]; NATIONAL CANCER INSTITUTE [U19CA067786] Funding Source: NIH RePORTER	National Cancer Institute-National Cooperative Drug Discovery Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute-National Cooperative Drug Discovery Group grant CA 67786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDI SL, 1988, J CHROMATOGR, V447, P65, DOI 10.1016/S0021-9673(01)91457-8; ALEXANDRE A, 1984, BIOCHIM BIOPHYS ACTA, V767, P120, DOI 10.1016/0005-2728(84)90086-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARCAMONE F. M., 1959, GIORN MICROBIOL, V7, P207; Baz JP, 1997, J ANTIBIOT, V50, P738, DOI 10.7164/antibiotics.50.738; BERGER J, 1951, J AM CHEM SOC, V73, P5295, DOI 10.1021/ja01155a084; Bernan VS, 1997, ADV APPL MICROBIOL, V43, P57, DOI 10.1016/S0065-2164(08)70223-5; Blunt JW, 2012, NAT PROD REP, V29, P144, DOI 10.1039/c2np00090c; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Calfee DP, 2012, CURR OPIN INFECT DIS, V25, P385, DOI 10.1097/QCO.0b013e3283553441; Charan RD, 2004, J NAT PROD, V67, P1431, DOI 10.1021/np040042r; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Cho KW, 2001, J NAT PROD, V64, P664, DOI 10.1021/np000599g; Crow FW, 1999, J HETEROCYCLIC CHEM, V36, P365, DOI 10.1002/jhet.5570360206; Egan S, 2001, ANTON LEEUW INT J G, V79, P127, DOI 10.1023/A:1010296220929; Erba E, 1999, BRIT J CANCER, V80, P971, DOI 10.1038/sj.bjc.6690451; Feldgarden M, 2003, MICROBIOL-SGM, V149, P3565, DOI 10.1099/mic.0.26457-0; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fenical W, 2009, BIOORGAN MED CHEM, V17, P2175, DOI 10.1016/j.bmc.2008.10.075; FIEDLER HP, 1981, J ANTIBIOT, V34, P1107, DOI 10.7164/antibiotics.34.1107; Flatman RH, 2006, ANTIMICROB AGENTS CH, V50, P1136, DOI 10.1128/AAC.50.4.1136-1142.2006; Gourdeau H, 2008, CANCER CHEMOTH PHARM, V61, P911, DOI 10.1007/s00280-007-0544-2; GRIMMELIKHUIJZEN CJP, 1975, BIOCHIM BIOPHYS ACTA, V376, P533, DOI 10.1016/0005-2728(75)90173-5; Gulder TAM, 2010, ANGEW CHEM INT EDIT, V49, P9346, DOI 10.1002/anie.201000728; HARNED RL, 1951, ANTIBIOT CHEMOTHER, V1, P594; HAROLD FM, 1968, J BACTERIOL, V95, P816, DOI 10.1128/JB.95.3.816-823.1968; Heide L, 2009, NAT PROD REP, V26, P1241, DOI 10.1039/b808333a; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Imhoff JF, 2011, BIOTECHNOL ADV, V29, P468, DOI 10.1016/j.biotechadv.2011.03.001; Jabes D, 2011, CURR OPIN MICROBIOL, V14, P564, DOI 10.1016/j.mib.2011.08.002; JUKES T H, 1969, P21; Kataoka M, 1997, FEMS MICROBIOL LETT, V151, P249, DOI 10.1016/S0378-1097(97)00169-9; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KLUEPFEL D, 1970, J ANTIBIOT, V23, P75, DOI 10.7164/antibiotics.23.75; Laatsch H, 2007, ANTIBASE 2007 SCIDEX; Lafitte D, 2002, BIOCHEMISTRY-US, V41, P7217, DOI 10.1021/bi0159837; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Meyers CLF, 2004, ANGEW CHEM INT EDIT, V43, P67, DOI 10.1002/anie.200352626; Meyers CLF, 2003, BIOCHEMISTRY-US, V42, P4179, DOI 10.1021/bi0340088; Mincer TJ, 2005, APPL ENVIRON MICROB, V71, P7019, DOI 10.1128/AEM.71.11.7019-7028.2005; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Mukku VJRV, 2000, J NAT PROD, V63, P1570, DOI 10.1021/np0001676; NAKAYAMA K, 1956, J ANTIBIOT, V9, P63; Pathom-aree W, 2006, EXTREMOPHILES, V10, P181, DOI 10.1007/s00792-005-0482-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHUNK CH, 1956, J AM CHEM SOC, V78, P1770, DOI 10.1021/ja01589a084; Strohl WR, 1997, BIOTECHNOLOGY ANTIBI, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOSHIMA K, 1986, TETRAHEDRON LETT, V27, P4741, DOI 10.1016/S0040-4039(00)85053-4; Westley JW, 1983, POLYETHER ANTIBIOTIC; Williams DE, 2013, ORG LETT, V15, P414, DOI 10.1021/ol303416k; Williams DE, 2011, ORG LETT, V13, P3936, DOI 10.1021/ol2014494; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158; Zotchev SB, 2012, J BIOTECHNOL, V158, P168, DOI 10.1016/j.jbiotec.2011.06.002	64	45	49	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77078	10.1371/journal.pone.0077078	http://dx.doi.org/10.1371/journal.pone.0077078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130838	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200055
J	Haddad, M; Walters, P; Phillips, R; Tsakok, J; Williams, P; Mann, A; Tylee, A				Haddad, Mark; Walters, Paul; Phillips, Rachel; Tsakok, Jacqueline; Williams, Paul; Mann, Anthony; Tylee, Andre			Detecting Depression in Patients with Coronary Heart Disease: a Diagnostic Evaluation of the PHQ-9 and HADS-D in Primary Care, Findings From the UPBEAT-UK Study	PLOS ONE			English	Article							HOSPITAL ANXIETY; MAJOR DEPRESSION; HEALTH QUESTIONNAIRE; GENERAL-PRACTICE; ARTERY-DISEASE; PREVALENCE; DISORDERS; SEVERITY; VALIDITY; ASSOCIATION	Objective: People with coronary heart disease (CHD) are at heightened risk of depression, and this co-occurrence of conditions is associated with poorer outcomes including raised mortality. This study compares the diagnostic accuracy of two depression case finding instruments in CHD patients relative to a diagnostic standard, the revised Clinical Interview Schedule (CIS-R). Methods: The Patient Health Questionnaire (PHQ-9), the Hospital Anxiety and Depression Scale depression subscale (HADS-D) and the CIS-R depression module were administered to 803 patients identified from the CHD registers of GP practices in Greater London. Results: Of 730 recruited patients without previously identified depression, 32 (4.4%) met ICD-10 depressive episode criteria according to the CIS-R. For the PHQ-9 and HADS-D lower cut-points than those routinely recommended were associated with improved case identifying properties. The PHQ-9 appeared the superior instrument using a cut-point of >= 8 (sensitivity=94%; specificity=84%). Using categorical scoring the PHQ-9 was 59% sensitive and 95% specific. For the HADS-D using cut-point >= 5, sensitivity was 81% and specificity was 77%. Areas under the curves (AUC) (standard error) were 0.95 (0.01) and 0.88 (0.02) for the PHQ-9 and HADS-D, and 0.91 (0.02) for PHQ-9 using the categorical algorithm. Statistically significant differences between AUCs of the PHQ-9 and the HADS-D favoured the former. Severity ratings compared across measures indicated inconsistency between recommended bandings: the PHQ-9 categorised a larger proportion of participants with mild and moderate depression. Conclusion: This is the first large-scale investigation of the accuracy of these commonly used measures within a primary care CHD population. Our results suggest that although both scales have acceptable abilities and can be used as case identification instruments for depression in patients with CHD, the PHQ-9 appeared diagnostically superior. Importantly, optimal cut-off points for depression identification in this population appear to differ from standard values, and severity ratings differ between these measures.	[Haddad, Mark] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Walters, Paul; Phillips, Rachel; Tsakok, Jacqueline; Williams, Paul; Mann, Anthony; Tylee, Andre] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England	City University London; University of London; King's College London	Tylee, A (corresponding author), Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England.	andre.tylee@kcl.ac.uk	Haddad, Mark/A-9866-2011; Williams, Paul/C-8914-2013	Haddad, Mark/0000-0002-4822-5482; Williams, Paul/0000-0001-6259-0390; Phillips, Rachel/0000-0002-3634-7845	National Institute for Health Research (NIHR) [RPPG-0606-1048]; National Institute for Health Research [RP-PG-0606-1048, MET-08-08-101] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This protocol presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RPPG-0606-1048). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Barth Jurgen, 2005, Health Qual Life Outcomes, V3, P15, DOI 10.1186/1477-7525-3-15; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blumenthal JA, 2001, AM J CARDIOL, V88, P316; Brugha T, 2009, ADULT PSYCHIAT MORBI; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Egede LE, 2007, J GEN INTERN MED, V22, P701, DOI 10.1007/s11606-007-0170-z; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Hasnain M, 2011, J PSYCHOSOM RES, V71, P6, DOI 10.1016/j.jpsychores.2010.10.009; Jordanova V, 2004, PSYCHOL MED, V34, P1013, DOI 10.1017/S0033291703001727; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; *MACARTHUR FDN, 2004, MACARTHUR IN DEPR PR; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Menchetti M, 2009, J PSYCHOSOM RES, V66, P335, DOI 10.1016/j.jpsychores.2008.10.008; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; *NICE, 2009, NICE NAT CLIN PRACT; *NICE, 2009, NICE NAT CLIN PRACT, V90; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Rost K, 2000, ARCH FAM MED, V9, P150, DOI 10.1001/archfami.9.2.150; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Rutledge T, 2013, PSYCHOSOM MED, V75, P335, DOI 10.1097/PSY.0b013e318291d798; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stafford L, 2007, GEN HOSP PSYCHIAT, V29, P417, DOI 10.1016/j.genhosppsych.2007.06.005; Strik JJMH, 2001, PSYCHOSOMATICS, V42, P423, DOI 10.1176/appi.psy.42.5.423; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; Thombs BD, 2008, J GEN INTERN MED, V23, P2014, DOI 10.1007/s11606-008-0802-y; Townsend N, 2012, CORONARY HEART DIS S; Tylee A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-38; U.S. Preventive Services Task Force, 2009, SCREEN DEPR AD REC S; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; Wittkampf K, 2009, GEN HOSP PSYCHIAT, V31, P451, DOI 10.1016/j.genhosppsych.2009.06.001; World Health Organization, 2008, GLOBAL BURDEN DIS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	65	65	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78493	10.1371/journal.pone.0078493	http://dx.doi.org/10.1371/journal.pone.0078493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130903	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000325814200099
J	Bautista-Lozada, A; Espinosa-Garcia, FJ				Bautista-Lozada, Alicia; Javier Espinosa-Garcia, Francisco			Odor Uniformity among Tomato Individuals in Response to Herbivore Depends on Insect Species	PLOS ONE			English	Article							JASMONATE; PLANTS; PHENOTYPES; VOLATILES; EVOLUTION; DEFENSES; ECOLOGY	Plants produce specific volatile organic compound (VOC) blends in response to herbivory. Herbivore-induced blends may prime the plant for future attack or attract carnivorous insects; these responses have been considered adaptive for plants. If herbivores differentially modify the VOC emission among individuals within a group of plants they feed upon, then plant responses to herbivores will not only produce specific blends but also variation in odor among individuals, i.e. individuals smell the same, then having a uniform odor. We investigated the VOC emission variation or uniformity among tomato individuals (Solanum lycopersicum L. cv. Castlemart) in response to moderate wounding by (1) nymphs of the psyllid Bactericera cockerelli (Sulc.) (TP); (2) Lepidoptera chewing-feeding larvae of Fall Armyworm (Spodoptera frugiperda Smith) (FAW) and (3) of Cabbage Looper (Trichoplusia ni Hubner) (CL), and (4) mechanical damage (MD). We used a ratio-based analysis to compare the fold-change in concentration from constitutive to induced VOC emission. We also used size and shape analysis to compare the emission of damaged and non-damaged individuals. Aside of finding herbivore-specific blends in line with other studies, we found patterns not described previously. We detected constitutive and induced odor variation among individuals attacked by the same herbivore, with the induced odor uniformity depending on the herbivore identity. We also showed that the fold-change of VOCs from constitutive to induced state differed among individuals independently of the uniformity of the blends before herbivore attack. We discuss our findings in the context of the ecological roles of VOCs in plant-plant and plant-carnivore insects' interactions.	[Bautista-Lozada, Alicia] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Bautista-Lozada, Alicia; Javier Espinosa-Garcia, Francisco] Univ Nacl Autonoma Mexico, Lab Ecol Quim, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Espinosa-Garcia, FJ (corresponding author), Univ Nacl Autonoma Mexico, Lab Ecol Quim, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	espinosa@cieco.unam.mx	Espinosa-García, F. J./B-4040-2016	Espinosa-García, F. J./0000-0001-9173-1957	Universidad Nacional Autonoma de Mexico [UNAM-PAPIIT IN227607]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This study was supported by Universidad Nacional Autonoma de Mexico by the grant UNAM-PAPIIT IN227607 given to FJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Cooper WR, 2005, ENTOMOL EXP APPL, V115, P107, DOI 10.1111/j.1570-7458.2005.00289.x; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Gols R, 2007, BASIC APPL ECOL, V8, P421, DOI 10.1016/j.baae.2006.09.005; Heil M, 2012, PLANT SIGNAL BEHAV, V7, P576, DOI 10.4161/psb.19921; Heil M, 2010, BIOL LETTERS, V6, P843, DOI 10.1098/rsbl.2010.0440; Heil M, 2010, EVOL ECOL, V24, P555, DOI 10.1007/s10682-009-9348-7; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Janssen A, 2002, OIKOS, V97, P134, DOI 10.1034/j.1600-0706.2002.970114.x; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Miresmailli S, 2012, PEST MANAG SCI, V68, P101, DOI 10.1002/ps.2229; Morris WF, 2006, OIKOS, V112, P102, DOI 10.1111/j.0030-1299.2006.14253.x; Raghava T, 2010, PLANT SCI, V179, P520, DOI 10.1016/j.plantsci.2010.07.020; Rodriguez-Saona C, 2005, OECOLOGIA, V143, P566, DOI 10.1007/s00442-005-0006-7; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Sanchez-Hernandez C, 2006, PLANT CELL ENVIRON, V29, P546, DOI 10.1111/j.1365-3040.2005.01431.x; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; SHOREY HH, 1963, J ECON ENTOMOL, V56, P536, DOI 10.1093/jee/56.4.536a; Stout MJ, 1998, OECOLOGIA, V113, P74, DOI 10.1007/s004420050355; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Torres-Gurrola G, 2011, BIOCHEM SYST ECOL, V39, P102, DOI 10.1016/j.bse.2011.01.011; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; Viswanathan DV, 2008, ECOL ENTOMOL, V33, P86, DOI 10.1111/j.1365-2311.2007.00943.x; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Yarnes CT, 2006, CAN J BOT, V84, P1233, DOI 10.1139/B06-076	31	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77199	10.1371/journal.pone.0077199	http://dx.doi.org/10.1371/journal.pone.0077199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130855	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900125
J	Mitchell, CJ; Churchward-Venne, TA; Bellamy, L; Parise, G; Baker, SK; Phillips, SM				Mitchell, Cameron J.; Churchward-Venne, Tyler A.; Bellamy, Leeann; Parise, Gianni; Baker, Steven K.; Phillips, Stuart M.			Muscular and Systemic Correlates of Resistance Training-Induced Muscle Hypertrophy	PLOS ONE			English	Article							ANDROGEN RECEPTOR EXPRESSION; SKELETAL-MUSCLE; MYOFIBER HYPERTROPHY; CLUSTER-ANALYSIS; IGF-I; LENGTHENING CONTRACTIONS; HORMONAL ADAPTATIONS; PROTEIN-SYNTHESIS; YOUNG MEN; EXERCISE	Purpose: To determine relationships between post-exercise changes in systemic [testosterone, growth hormone (GH), insulin like grow factor 1 (IGF-1) and interleukin 6 (IL-6)], or intramuscular [skeletal muscle androgen receptor (AR) protein content and p70S6K phosphorylation status] factors in a moderately-sized cohort of young men exhibiting divergent resistance training-mediated muscle hypertrophy. Methods: Twenty three adult males completed 4 sessions.wk(-1) of resistance training for 16 wk. Muscle biopsies were obtained before and after the training period and acutely 1 and 5 h after the first training session. Serum hormones and cytokines were measured immediately, 15, 30 and 60 minutes following the first and last training sessions of the study. Results: Mean fiber area increased by 20% (range: -7 to 80%; P<0.001). Protein content of the AR was unchanged with training (fold change = 1.17 +/- 0.61; P = 0.19); however, there was a significant correlation between the changes in AR content and fiber area (r = 0.60, P = 0.023). Phosphorylation of p70S6K was elevated 5 hours following exercise, which was correlated with gains in mean fiber area (r = 0.54, P = 0.007). There was no relationship between the magnitude of the pre- or post-training exercise-induced changes in free testosterone, GH, or IGF-1 concentration and muscle fiber hypertrophy; however, the magnitude of the post exercise IL-6 response was correlated with muscle hypertrophy (r = 0.48, P = 0.019). Conclusion: Post-exercise increases in circulating hormones are not related to hypertrophy following training. Exercise-induced changes in IL-6 correlated with hypertrophy, but the mechanism for the role of IL-6 in hypertrophy is not known. Acute increases, in p70S6K phosphorylation and changes in muscle AR protein content correlated with muscle hypertrophy implicating intramuscular rather than systemic processes in mediating hypertrophy.	[Mitchell, Cameron J.; Churchward-Venne, Tyler A.; Bellamy, Leeann; Parise, Gianni; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Baker, Steven K.] McMaster Univ, Sch Med, Dept Neurol, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Phillips, SM (corresponding author), McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada.	phillis@mcmaster.ca	Mitchell, Cameron/I-4423-2019; Phillips, Stuart/B-2343-2009	Mitchell, Cameron/0000-0003-3843-6806; Phillips, Stuart/0000-0002-1956-4098; Churchward-Venne, Tyler/0000-0001-6006-5461	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to SMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Ahtiainen JP, 2005, J STRENGTH COND RES, V19, P572, DOI 10.1519/00124278-200508000-00015; Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; Ahtiainen JP, 2011, STEROIDS, V76, P183, DOI 10.1016/j.steroids.2010.10.012; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bamman MM, 2007, J APPL PHYSIOL, V102, P2232, DOI 10.1152/japplphysiol.00024.2007; Bamman MM, 2001, AM J PHYSIOL-ENDOC M, V280, pE383; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101; Burd NA, 2012, J PHYSIOL-LONDON, V590, P351, DOI 10.1113/jphysiol.2011.221200; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Burd NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012033; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Churchward-Venne TA, 2012, J PHYSIOL-LONDON, V590, P2751, DOI 10.1113/jphysiol.2012.228833; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; DAYNES RA, 1993, J IMMUNOL, V150, P5219; de Souza TP, 2010, J STRENGTH COND RES, V24, P1843, DOI 10.1519/JSC.0b013e3181ddae4a; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Hartman JW, 2007, AM J CLIN NUTR, V86, P373, DOI 10.1093/ajcn/86.2.373; Kraemer WJ, 2010, CURR SPORT MED REP, V9, P242, DOI 10.1249/JSR.0b013e3181e976df; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McCall GE, 1999, CAN J APPL PHYSIOL, V24, P96, DOI 10.1139/h99-009; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Nindl BC, 2012, AM J PHYSIOL-REG I, V303, pR1080, DOI 10.1152/ajpregu.00275.2012; Orsatti FL, 2012, J STRENGTH COND RES, V26, P2130, DOI 10.1519/JSC.0b013e318239f837; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2004, NUTRITION, V20, P689, DOI 10.1016/j.nut.2004.04.009; Phillips SM, 2000, CAN J APPL PHYSIOL, V25, P185, DOI 10.1139/h00-014; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Thalacker-Mercer AE, 2009, APPL PHYSIOL NUTR ME, V34, P632, DOI 10.1139/H09-038; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Vingren JL, 2010, SPORTS MED, V40, P1037, DOI 10.2165/11536910-000000000-00000; West DWD, 2012, EUR J APPL PHYSIOL, V112, P2693, DOI 10.1007/s00421-011-2246-z; West DWD, 2010, J APPL PHYSIOL, V108, P60, DOI 10.1152/japplphysiol.01147.2009; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P1499, DOI 10.1249/01.MSS.0000139795.83030.D1	43	115	117	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e78636	10.1371/journal.pone.0078636	http://dx.doi.org/10.1371/journal.pone.0078636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130904	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900144
J	Pang, CL; Toh, SY; He, P; Teissier, S; Ben Khalifa, Y; Xue, Y; Thierry, F				Pang, C. L.; Toh, S. Y.; He, P.; Teissier, S.; Ben Khalifa, Y.; Xue, Y.; Thierry, F.			A functional interaction of E7 with B-Myb-MuvB complex promotes acute cooperative transcriptional activation of both S- and M-phase genes	ONCOGENE			English	Article						B-Myb-MuvB complex; HPV E7; B-Myb; FoxM1; mitosis; cervical carcinoma	HUMAN-PAPILLOMAVIRUS E7; CERVICAL-CANCER CELLS; DROSOPHILA-MYB; MITOTIC PATHWAY; CARCINOMA CELLS; E2 PROTEIN; EXPRESSION; FOXM1; PROGRESSION; SENESCENCE	High-risk human papillomaviruses are causative agents of cervical cancer. Viral protein E7 is required to establish and maintain the pro-oncogenic phenotype in infected cells, but the molecular mechanisms by which E7 promotes carcinogenesis are only partially understood. Our transcriptome analyses in primary human fibroblasts transduced with the viral protein revealed that E7 activates a group of mitotic genes via the activator B-Myb-MuvB complex. We show that E7 interacts with the B-Myb, FoxM1 and LIN9 components of this activator complex, leading to cooperative transcriptional activation of mitotic genes in primary cells and E7 recruitment to the corresponding promoters. E7 interaction with LIN9 and FoxM1 depended on the LXCXE motif, which is also required for pocket protein interaction and degradation. Using E7 mutants for the degradation of pocket proteins but intact for the LXCXE motif, we demonstrate that E7 functional interaction with the B-Myb-MuvB complex and pocket protein degradation are two discrete functions of the viral protein that cooperate to promote acute transcriptional activation of mitotic genes. Transcriptional level of E7 in patient's cervical lesions at different stages of progression was shown to correlate with those of B-Myb and FoxM1 as well as other mitotic gene transcripts, thereby linking E7 with cellular proliferation and progression in cervical cancer in vivo. E7 thus can directly activate the transcriptional levels of cell cycle genes independently of pocket protein stability.	[Pang, C. L.; Toh, S. Y.; He, P.; Teissier, S.; Xue, Y.; Thierry, F.] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Pang, C. L.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Ben Khalifa, Y.] Inst Pasteur, Paris, France	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thierry, F (corresponding author), ASTAR, Inst Med Biol, Immunos 06-05,8A Biomed Grove, Singapore 138648, Singapore.	francoise.thierry@imb.a-star.edu.sg		Toh, Shen Yon/0000-0002-6421-0862	Biomedical Sciences Institutes of A-star, Singapore	Biomedical Sciences Institutes of A-star, Singapore	We thank Dr DeCaprio for the generous gift of LIN9 and LIN54 antibodies and Birgit lane's lab for providing the primary human fibroblasts. We also thank Dr Perou for plasmid pBABE-B-Myb; Dr Teh for plasmid pSIN-CMV-FoxM1B; Dr Galloway for plasmids pLXSN-16E7, pLXSN-16E7D6 - 10 and pLXSN-16E7D21 - 24; Dr Manser for plasmid pXJ-Flag; Dr Colamonici for plasmid pEGFP-C3-LIN9; Dr Roman for plasmid pHA-p130; Dr Sage for shRNA vectors for pRB, p107 and p130. We would like to express our thanks to Dr Diana Lim from National University Hospital for providing us with the clinical specimens, Drs Zhi Liang and Jean-Pierre Abastado for help in the nanostring experiment design and analyses and John Connolly from SIgN Immunomonitoring Core. We would like to express our thanks to Dr Philipp Kaldis for valuable suggestions. We also greatly appreciate the careful reading of the manuscript by Dr Neil McCarthy of Insight Editing London. This work was supported by Biomedical Sciences Institutes of A-star, Singapore and Chai Ling Pang was a scholar of the National University of Singapore Graduate School for Integrative Science and Engineering.	Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Balsitis SJ, 2003, MOL CELL BIOL, V23, P9094, DOI 10.1128/MCB.23.24.9094-9103.2003; Buitrago-Perez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041743; Caldeira S, 2000, ONCOGENE, V19, P821, DOI 10.1038/sj.onc.1203375; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; Fung SM, 2002, DEVELOPMENT, V129, P347; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Katzen AL, 1998, GENE DEV, V12, P831, DOI 10.1101/gad.12.6.831; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; LAM EWF, 1994, EMBO J, V13, P871, DOI 10.1002/j.1460-2075.1994.tb06330.x; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Luscher-Firzlaff JM, 1999, ONCOGENE, V18, P5620, DOI 10.1038/sj.onc.1202967; Manak R, 2007, NAT CELL BIOL, V9, P581, DOI 10.1038/ncb1580; Martinez I, 2011, CANCER RES, V71, P5370, DOI 10.1158/0008-5472.CAN-11-1044; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Rashid NN, 2011, J GEN VIROL, V92, P2620, DOI 10.1099/vir.0.035352-0; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Shin MK, 2012, CANCER RES, V72, P5418, DOI 10.1158/0008-5472.CAN-12-2083; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Teh MT, 2002, CANCER RES, V62, P4773; Teissier S, 2010, ONCOGENE, V29, P5061, DOI 10.1038/onc.2010.246; Teissier S, 2007, J VIROL, V81, P9368, DOI 10.1128/JVI.00427-07; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; Ueno T, 2006, ONCOGENE, V25, P4155, DOI 10.1038/sj.onc.1209445; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wells SI, 2003, P NATL ACAD SCI USA, V100, P7093, DOI 10.1073/pnas.1232309100; Xue Yuezhen, 2012, Open Virol J, V6, P163, DOI 10.2174/1874357901206010163	46	28	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4039	4049		10.1038/onc.2013.426	http://dx.doi.org/10.1038/onc.2013.426			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24141769				2022-12-25	WOS:000340595300003
J	Hedger, SC; Nusbaum, HC; Hoeckner, B				Hedger, Stephen C.; Nusbaum, Howard C.; Hoeckner, Berthold			Conveying Movement in Music and Prosody	PLOS ONE			English	Article							ACOUSTIC PROPERTIES; SOUND SYMBOLISM; LANGUAGE; ATTENTION; MOTION; PERCEPTION	We investigated whether acoustic variation of musical properties can analogically convey descriptive information about an object. Specifically, we tested whether information from the temporal structure in music interacts with perception of a visual image to form an analog perceptual representation as a natural part of music perception. In Experiment 1, listeners heard music with an accelerating or decelerating temporal pattern, and then saw a picture of a still or moving object and decided whether it was animate or inanimate - a task unrelated to the patterning of the music. Object classification was faster when musical motion matched visually depicted motion. In Experiment 2, participants heard spoken sentences that were accompanied by accelerating or decelerating music, and then were presented with a picture of a still or moving object. When motion information in the music matched motion information in the picture, participants were similarly faster to respond. Fast and slow temporal patterns without acceleration and deceleration, however, did not make participants faster when they saw a picture depicting congruent motion information (Experiment 3), suggesting that understanding temporal structure information in music may depend on specific metaphors about motion in music. Taken together, these results suggest that visuo-spatial referential information can be analogically conveyed and represented by music and can be integrated with speech or influence the understanding of speech.	[Hedger, Stephen C.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Hoeckner, Berthold] Univ Chicago, Dept Mus, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Hedger, SC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	shedger@uchicago.edu	Van Hedger, Stephen Charles/V-3248-2019	Van Hedger, Stephen Charles/0000-0002-2448-9088	Andrew W. Mellon Foundation; Social Sciences Division of the University of Chicago	Andrew W. Mellon Foundation; Social Sciences Division of the University of Chicago	This research was supported by a New Directions Fellowship from the Andrew W. Mellon Foundation (to author BH) and the Social Sciences Division of the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveyard ME, 2012, MEM COGNITION, V40, P83, DOI 10.3758/s13421-011-0139-3; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bartolomeo P, 2002, CORTEX, V38, P357, DOI 10.1016/S0010-9452(08)70665-8; Beilock SL, 2008, P NATL ACAD SCI USA, V105, P13269, DOI 10.1073/pnas.0803424105; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Eitan Z, 2006, MUSIC PERCEPT, V23, P221, DOI 10.1525/mp.2006.23.3.221; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; Gentner D, 2006, CURR DIR PSYCHOL SCI, V15, P297, DOI 10.1111/j.1467-8721.2006.00456.x; GOLDSTEIN AG, 1957, J EXP PSYCHOL, V54, P457, DOI 10.1037/h0044965; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kourtzi Z, 2000, TRENDS COGN SCI, V4, P295, DOI 10.1016/S1364-6613(00)01512-6; Lakoff G., 2003, METAPHORS WE LIVE; Levitin DJ, 1996, PERCEPT PSYCHOPHYS, V58, P927, DOI 10.3758/BF03205494; MARKS LE, 1987, J EXP PSYCHOL HUMAN, V13, P384, DOI 10.1037/0096-1523.13.3.384; McNeill D., 1992, HAND MIND WHAT GESTU; MELARA RD, 1990, MEM COGNITION, V18, P477, DOI 10.3758/BF03198481; Meyer L., 1956, EMOTION MEANING MUSI; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Painter JG, 2011, PSYCHOPHYSIOLOGY, V48, P645, DOI 10.1111/j.1469-8986.2010.01134.x; Parise CV, 2011, EXP BRAIN RES, V214, P373, DOI 10.1007/s00221-011-2836-3; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Shintel H, 2008, COGNITIVE SCI, V32, P1063, DOI 10.1080/03640210801897831; Shintel H, 2007, COGNITION, V105, P681, DOI 10.1016/j.cognition.2006.11.005; Shintel H, 2006, J MEM LANG, V55, P167, DOI 10.1016/j.jml.2006.03.002; Slevc LR, 2012, WIRES COGN SCI, V3, P483, DOI 10.1002/wcs.1186; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; TREISMAN AM, 1969, J EXP PSYCHOL, V79, P27, DOI 10.1037/h0026890; Tubul ZEN, 2010, MUSIC SCI, P89; Winawer J, 2008, PSYCHOL SCI, V19, P276, DOI 10.1111/j.1467-9280.2008.02080.x; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430	36	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76744	10.1371/journal.pone.0076744	http://dx.doi.org/10.1371/journal.pone.0076744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239JR	24146920	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400085
J	Shimizu, H; Kubo, A; Uchibe, K; Hashimoto, M; Yokoyama, S; Takada, S; Mitsuoka, K; Asahara, H				Shimizu, Hirohito; Kubo, Atsushi; Uchibe, Kenta; Hashimoto, Megumi; Yokoyama, Shigetoshi; Takada, Shuji; Mitsuoka, Kazuhiko; Asahara, Hiroshi			The AERO System: A 3D-Like Approach for Recording Gene Expression Patterns in the Whole Mouse Embryo	PLOS ONE			English	Article							UPDATE; ATLAS; LIMB	We have recently constructed a web-based database of gene expression in the mouse whole embryo, EMBRYS (http://embrys.jp/embrys/html/MainMenu.html). To allow examination of gene expression patterns to the fullest extent possible, this database provides both photo images and annotation data. However, since embryos develop via an intricate process of morphogenesis, it would be of great value to track embryonic gene expression from a three dimensional perspective. In fact, several methods have been developed to achieve this goal, but highly laborious procedures and specific operational skills are generally required. We utilized a novel microscopic technique that enables the easy capture of rotational, 3D-like images of the whole embryo. In this method, a rotary head equipped with two mirrors that are designed to obtain an image tilted at 45 degrees to the microscope stage captures serial images at 2-degree intervals. By a simple operation, 180 images are automatically collected. These 2D images obtained at multiple angles are then used to reconstruct 3D-like images, termed AERO images. By means of this system, over 800 AERO images of 191 gene expression patterns were captured. These images can be easily rotated on the computer screen using the EMBRYS database so that researchers can view an entire embryo by a virtual viewing on a computer screen in an unbiased or non-predetermined manner. The advantages afforded by this approach make it especially useful for generating data viewed in public databases.	[Shimizu, Hirohito; Uchibe, Kenta; Hashimoto, Megumi; Yokoyama, Shigetoshi; Takada, Shuji; Mitsuoka, Kazuhiko; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Tokyo, Japan; [Kubo, Atsushi; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst Biomed, Tokyo, Japan; [Uchibe, Kenta] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama 7008530, Japan	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Okayama University	Asahara, H (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Syst Biomed, Tokyo, Japan.	asahara.syst@tmd.ac.jp		Takada, Shuji/0000-0002-9406-4683	Health and Labor Sciences research grants; Genome Network Project (MEXT); MEXT; Grant of National Center for Child Health and Development; Japan Health Sciences Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23249071] Funding Source: KAKEN	Health and Labor Sciences research grants(Ministry of Health, Labour and Welfare, Japan); Genome Network Project (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant of National Center for Child Health and Development; Japan Health Sciences Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health and Labor Sciences research grants, Genome Network Project (MEXT), grants-in-aid for Scientific Research (MEXT), the Grant of National Center for Child Health and Development, Japan Health Sciences Foundation and Takeda Science Foundation. This work was performed in part under the Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Fisher ME, 2008, DEV BIOL, V317, P13, DOI 10.1016/j.ydbio.2008.01.031; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hecksher-Sorensen J, 2001, MECH DEVELOP, V100, P59, DOI 10.1016/S0925-4773(00)00508-6; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shimizu H, 2009, METHODS MOL BIOL, V577, P167, DOI 10.1007/978-1-60761-232-2_13; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Streicher J, 2000, NAT GENET, V25, P147, DOI 10.1038/75989; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Uchibe K, 2012, DEV DYNAM, V241, P1217, DOI 10.1002/dvdy.23808; Venkataraman S, 2008, NUCLEIC ACIDS RES, V36, pD860, DOI 10.1093/nar/gkm938; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75754	10.1371/journal.pone.0075754	http://dx.doi.org/10.1371/journal.pone.0075754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146773	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400016
J	Alzugaray, ME; Adami, ML; Diambra, LA; Hernandez-Martinez, S; Damborenea, C; Noriega, FG; Ronderos, JR				Eugenia Alzugaray, Maria; Laura Adami, Mariana; Anibal Diambra, Luis; Hernandez-Martinez, Salvador; Damborenea, Cristina; Noriega, Fernando Gabriel; Rafael Ronderos, Jorge			Allatotropin: An Ancestral Myotropic Neuropeptide Involved in Feeding	PLOS ONE			English	Article							MANDUCA-SEXTA ALLATOTROPIN; MOLECULAR CHARACTERIZATION; AEDES-AEGYPTI; NERVOUS-SYSTEM; PEPTIDE; IDENTIFICATION; EVOLUTION; ALLATOSTATIN; CNIDARIAN; RECEPTOR	Background: Cell-cell interactions are a basic principle for the organization of tissues and organs allowing them to perform integrated functions and to organize themselves spatially and temporally. Peptidic molecules secreted by neurons and epithelial cells play fundamental roles in cell-cell interactions, acting as local neuromodulators, neurohormones, as well as endocrine and paracrine messengers. Allatotropin (AT) is a neuropeptide originally described as a regulator of Juvenile Hormone synthesis, which plays multiple neural, endocrine and myoactive roles in insects and other organisms. Methods: A combination of immunohistochemistry using AT-antibodies and AT-Qdot nanocrystal conjugates was used to identify immunoreactive nerve cells containing the peptide and epithelial-muscular cells targeted by AT in Hydra plagiodesmica. Physiological assays using AT and AT-antibodies revealed that while AT stimulated the extrusion of the hypostome in a dose-response fashion in starved hydroids, the activity of hypostome in hydroids challenged with food was blocked by treatments with different doses of AT-antibodies. Conclusions: AT antibodies immunolabeled nerve cells in the stalk, pedal disc, tentacles and hypostome. AT-Qdot conjugates recognized epithelial-muscular cell in the same tissues, suggesting the existence of anatomical and functional relationships between these two cell populations. Physiological assays indicated that the AT-like peptide is facilitating food ingestion. Significance: Immunochemical, physiological and bioinformatics evidence advocates that AT is an ancestral neuropeptide involved in myoregulatory activities associated with meal ingestion and digestion.	[Eugenia Alzugaray, Maria; Laura Adami, Mariana; Rafael Ronderos, Jorge] UNLP, FCNyM, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina; [Laura Adami, Mariana; Damborenea, Cristina] UNLP, FCNyM, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina; [Anibal Diambra, Luis; Rafael Ronderos, Jorge] UNLP, CREG, La Plata, Buenos Aires, Argentina; [Hernandez-Martinez, Salvador] INSP, CISEI, Cuernavaca, Morelos, Mexico; [Noriega, Fernando Gabriel] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	National University of La Plata; National University of La Plata; National University of La Plata; State University System of Florida; Florida International University	Ronderos, JR (corresponding author), UNLP, FCNyM, Catedra Histol & Embriol Anim, La Plata, Buenos Aires, Argentina.	jrondero@museo.fcnym.unlp.edu.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; Hernandez-Martinez, Salvador/0000-0003-1276-9397	 [PICT 01287];  [FCNyM-UNLP(N673)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was financed with founds from the PICT 01287 (SECyT - Argentina) and and FCNyM-UNLP(N673) Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2003, INSECT BIOCHEM MOLEC, V33, P467, DOI 10.1016/S0965-1748(03)00005-5; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Duve H, 1999, J COMP NEUROL, V413, P405, DOI 10.1002/(SICI)1096-9861(19991025)413:3&lt;405::AID-CNE4&gt;3.0.CO;2-R; Duve H, 2000, CELL TISSUE RES, V300, P153, DOI 10.1007/s004410050056; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; GRIMMELIKHUIJZEN CJP, 1991, HYDROBIOLOGIA, V216, P555, DOI 10.1007/BF00026513; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hernandez-Martinez S, 2005, CELL TISSUE RES, V321, P105, DOI 10.1007/s00441-005-1133-5; Hoffmeister SAH, 1996, DEVELOPMENT, V122, P1941; Hoffmeister-Ullerich SAH, 2001, MECH DEVELOP, V106, P37, DOI 10.1016/S0925-4773(01)00401-4; Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kass-Simon G, 2007, COMP BIOCHEM PHYS A, V146, P9, DOI 10.1016/j.cbpa.2006.09.008; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Koladich PM, 2002, PEPTIDES, V23, P645, DOI 10.1016/S0196-9781(01)00658-1; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Adami ML, 2012, ZOOMORPHOLOGY, V131, P1, DOI 10.1007/s00435-012-0146-3; Adami ML, 2011, TISSUE CELL, V43, P377, DOI 10.1016/j.tice.2011.07.005; Lee KY, 1998, J EXP BIOL, V201, P3067; LEITZ T, 1994, DEV BIOL, V163, P440, DOI 10.1006/dbio.1994.1160; LENTZ TL, 1966, J EXP ZOOL, V162, P171, DOI 10.1002/jez.1401620204; LEROITH D, 1980, P NATL ACAD SCI-BIOL, V77, P6184; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Lwalaba D, 2010, ARCH INSECT BIOCHEM, V73, P14, DOI 10.1002/arch.20332; MACKIE GO, 1968, J GEN PHYSIOL, V52, P600; Matthews HJ, 2007, J INSECT PHYSIOL, V53, P75, DOI 10.1016/j.jinsphys.2006.10.007; MCFARLANE ID, 1987, J EXP BIOL, V133, P157; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Morishita F, 2003, PEPTIDES, V24, P17, DOI 10.1016/S0196-9781(02)00272-3; Nouzova M, 2012, PEPTIDES, V34, P201, DOI 10.1016/j.peptides.2011.07.025; PAEMEN L, 1991, PEPTIDES, V12, P7, DOI 10.1016/0196-9781(91)90158-L; Park C, 2002, ZOOL SCI, V19, P287, DOI 10.2108/zsj.19.287; Petri B, 2002, J EXP BIOL, V205, P1459; Riccillo FL, 2010, TISSUE CELL, V42, P355, DOI 10.1016/j.tice.2010.07.011; Rudwall AJ, 2000, J COMP NEUROL, V428, P159, DOI 10.1002/1096-9861(20001204)428:1<159::AID-CNE11>3.0.CO;2-Y; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Santini MS, 2009, GEN COMP ENDOCR, V160, P243, DOI 10.1016/j.ygcen.2008.12.002; SCHALLER HC, 1981, P NATL ACAD SCI-BIOL, V78, P7000, DOI 10.1073/pnas.78.11.7000; SCHUCHERT P, 1993, ACTA ZOOL-STOCKHOLM, V74, P115, DOI 10.1111/j.1463-6395.1993.tb01227.x; Sheng ZT, 2007, INSECT BIOCHEM MOLEC, V37, P90, DOI 10.1016/j.ibmb.2006.09.007; Shimizu H, 2004, J COMP PHYSIOL A, V190, P623, DOI 10.1007/s00359-004-0518-3; Santini MS, 2009, BIOL RHYTHM RES, V40, P299, DOI 10.1080/09291010802214583; Squecco R, 2011, J PHYSIOL-LONDON, V589, P5231, DOI 10.1113/jphysiol.2011.214940; Sterkel M, 2010, COMP BIOCHEM PHYS A, V155, P371, DOI 10.1016/j.cbpa.2009.12.002; Takahashi T, 2008, ACTA BIOL HUNG, V59, P227, DOI 10.1556/ABiol.59.2008.Suppl.32; Takahashi T, 2000, DEVELOPMENT, V127, P997; Takahashi T, 2003, COMP BIOCHEM PHYS B, V135, P309, DOI 10.1016/S1096-4959(03)00088-5; Takahashi T, 2009, BIOESSAYS, V31, P610, DOI 10.1002/bies.200800163; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Tortiglione C, 2007, BIOCONJUGATE CHEM, V18, P829, DOI 10.1021/bc060355t; Truesdell PF, 2000, INSECT BIOCHEM MOLEC, V30, P691, DOI 10.1016/S0965-1748(00)00040-0; Veenstra JA, 1999, PEPTIDES, V20, P1145, DOI 10.1016/S0196-9781(99)00117-5; VEENSTRA JA, 1994, J EXP BIOL, V188, P347; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Vuerinckx K, 2011, INSECT BIOCHEM MOLEC, V41, P815, DOI 10.1016/j.ibmb.2011.06.003; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weyrer Simon, 1999, Memoirs of the Queensland Museum, V44, P659; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yum S, 1998, BIOCHEM BIOPH RES CO, V248, P584, DOI 10.1006/bbrc.1998.8831; Zega G, 2007, INT J DEV BIOL, V51, P307, DOI 10.1387/ijdb.062195gz; Zhang JS, 2001, DEVELOPMENT, V128, P1607	69	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77520	10.1371/journal.pone.0077520	http://dx.doi.org/10.1371/journal.pone.0077520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143240	Green Published, gold			2022-12-25	WOS:000325894100078
J	Guziewicz, KE; Zangerl, B; Komaromy, AM; Iwabe, S; Chiodo, VA; Boye, SL; Hauswirth, WW; Beltran, WA; Aguirre, GD				Guziewicz, Karina E.; Zangerl, Barbara; Komaromy, Andras M.; Iwabe, Simone; Chiodo, Vincent A.; Boye, Sanford L.; Hauswirth, William W.; Beltran, William A.; Aguirre, Gustavo D.			Recombinant AAV-Mediated BEST1 Transfer to the Retinal Pigment Epithelium: Analysis of Serotype-Dependent Retinal Effects	PLOS ONE			English	Article							CANINE MULTIFOCAL RETINOPATHY; LEBERS CONGENITAL AMAUROSIS; MACULAR DYSTROPHY; GENE-THERAPY; SUBRETINAL INJECTION; CHILDHOOD BLINDNESS; MISSENSE MUTATIONS; RPE65 MUTATIONS; IN-VIVO; MODEL	Mutations in the BEST1 gene constitute an underlying cause of juvenile macular dystrophies, a group of retinal disorders commonly referred to as bestrophinopathies and usually diagnosed in early childhood or adolescence. The disease primarily affects macular and paramacular regions of the eye leading to major declines in central vision later in life. Currently, there is no cure or surgical management for BEST1-associated disorders. The recently characterized human disease counterpart, canine multifocal retinopathy (cmr), recapitulates a full spectrum of clinical and molecular features observed in human bestrophinopathies and offers a valuable model system for development and testing of therapeutic strategies. In this study, the specificity, efficiency and safety of rAAV-mediated transgene expression driven by the human VMD2 promoter were assessed in wild-type canine retinae. While the subretinal delivery of rAAV2/1 vector serotype was associated with cone damage in the retina when BEST1 and GFP were co-expressed, the rAAV2/2 vector serotype carrying either GFP reporter or BEST1 transgene under control of human VMD2 promoter was safe, and enabled specific transduction of the RPE cell monolayer that was stable for up to 6 months post injection. These encouraging studies with the rAAV2/2 vector lay the groundwork for development of gene augmentation therapy for human bestrophinopathies.	[Guziewicz, Karina E.; Zangerl, Barbara; Komaromy, Andras M.; Iwabe, Simone; Beltran, William A.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA; [Zangerl, Barbara] Univ New S Wales, Ctr Eye Hlth, Kensington, NSW 2033, Australia; [Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Chiodo, Vincent A.; Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	University of Pennsylvania; University of New South Wales Sydney; Michigan State University; State University System of Florida; University of Florida	Guziewicz, KE (corresponding author), Univ Penn, Sch Vet Med, Sect Ophthalmol, Philadelphia, PA 19104 USA.	karinag@vet.upenn.edu; gda@vet.upenn.edu	Zangerl, Barbara/K-7433-2016	Zangerl, Barbara/0000-0002-7470-6298; hauswirth, william/0000-0002-3244-4947; Aguirre, Gustavo/0000-0002-5228-256X	The Foundation Fighting Blindness; Macula Vision Research Foundation; National Eye Institute/National Institutes of Health [EY06855, EY17549, EY019304, EY001583, EY021721, P30 EY001583, R24EY-022012]; NATIONAL EYE INSTITUTE [U01EY006855, R01EY006855, R01EY019304, P30EY001583, P30EY021721, R24EY022012, R01EY017549] Funding Source: NIH RePORTER	The Foundation Fighting Blindness; Macula Vision Research Foundation; National Eye Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by The Foundation Fighting Blindness, Macula Vision Research Foundation, National Eye Institute/National Institutes of Health Grants EY06855, EY17549, EY019304, EY001583, EY021721, P30 EY001583, R24EY-022012, The Van Sloun Fund for Canine Genetic Research, Hope for Vision and Research to Prevent Blindness Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GD, 2006, COLD SPRING HARB MON, V44, P291; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Beltran WA, 2005, MOL VIS, V11, P232; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Best, 1905, Z AUGENHEILKD, V13, P199, DOI [10.1159/000290318, DOI 10.1159/000290318]; Bitner H, 2012, AM J OPHTHALMOL, V154, P403, DOI 10.1016/j.ajo.2012.02.036; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Guziewicz KE, 2012, ADV EXP MED BIOL, V723, P611, DOI 10.1007/978-1-4614-0631-0_78; Guziewicz KE, 2011, INVEST OPHTH VIS SCI, V52, P4497, DOI 10.1167/iovs.10-6385; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kiang AS, 2005, MOL THER, V12, P555, DOI 10.1016/j.ymthe.2005.03.028; Kinnick TR, 2011, RETINA-J RET VIT DIS, V31, P581, DOI 10.1097/IAE.0b013e318203ee60; Komaromy AM, 2006, CELL TRANSPLANT, V15, P511, DOI 10.3727/000000006783981701; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Milenkovic VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019364; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Mowat FM, 2008, MOL VIS, V14, P2518; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pianta MJ, 2003, EXP EYE RES, V76, P203, DOI 10.1016/S0014-4835(02)00280-4; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Zangerl B, 2010, MOL VIS, V16, P2791; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	36	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75666	10.1371/journal.pone.0075666	http://dx.doi.org/10.1371/journal.pone.0075666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143172	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100007
J	Gaudin, A; Farnoux, C; Bonnard, A; Alison, M; Maury, L; Biran, V; Baud, O				Gaudin, Aurelie; Farnoux, Caroline; Bonnard, Arnaud; Alison, Marianne; Maury, Laure; Biran, Valerie; Baud, Olivier			Necrotizing Enterocolitis (NEC) and the Risk of Intestinal Stricture: The Value of C-Reactive Protein	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; SURGICAL-MANAGEMENT; UNITED-STATES; EPIDEMIOLOGY; PERFORATION; MORTALITY; OUTCOMES; NEWBORN; TRENDS	Necrotizing enterocolitis (NEC) is a severe complication frequently seen during the neonatal period associated with high mortality rate and severe and prolonged morbidity including Post-NEC intestinal stricture. The aim of this study is to define the incidence and risk factors of these post-NEC strictures, in order to better orient their medicosurgical care. Sixty cases of NEC were retrospectively reviewed from a single tertiary center with identical treatment protocols throughout the period under study, including systematic X-ray contrast study. This study reports a high rate of post-NEC intestinal stricture (n = 27/48; 57% of survivors), either in cases treated surgically (91%) and after the medical treatment of NEC (47%). A colonic localization of the strictures was more frequent in medically-treated patients than in those with NEC treated surgically (87% vs. 50%). The length of the strictures was significantly shorter in case of NEC treated medically. No deaths were attributable to the presence of post-NEC stricture. The mean hospitalization time in NICU and the median age at discontinuation of parenteral nutrition were longer in the group with stricture, but this difference was not significant. The median age at discharge was significantly higher in the group with stricture (p = 0.02). The occurrence of post-NEC stricture was significantly associated with the presence of parietal signs of inflammation and thrombopenia (<100 000 platelets/mm(3)). The mean maximum CRP concentration during acute phase was significantly higher in infants who developed stricture (p<0.001), as was the mean duration of the elevation of CRP levels (p<0.001). The negative predictive value of CRP levels continually <10 mg/dL for the appearance of stricture was 100% in our study. In conclusion, this retrospective and monocentric study demonstrates the correlation between the intensity of the inflammatory syndrome and the risk of secondary intestinal stricture, when systematic contrast study is performed following NEC.	[Gaudin, Aurelie; Farnoux, Caroline; Maury, Laure; Biran, Valerie; Baud, Olivier] Robert Debre Children Univ Hosp, Neonatal Intens Care Unit, Paris, France; [Gaudin, Aurelie; Farnoux, Caroline; Bonnard, Arnaud; Alison, Marianne; Maury, Laure; Biran, Valerie; Baud, Olivier] Denis Diderot Paris Univ, APHP, Paris, France; [Bonnard, Arnaud] Robert Debre Children Univ Hosp, Dept Gen Pediat Surg, Paris, France; [Alison, Marianne] Robert Debre Children Univ Hosp, Dept Pediat Radiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Baud, O (corresponding author), Robert Debre Children Univ Hosp, Neonatal Intens Care Unit, Paris, France.	olivier.baud@rdb.aphp.fr	Biran, Valerie/GQY-8192-2022; Alison, Marianne/A-2253-2016	Alison, Marianne/0000-0002-9245-9390				Baudon JJ, 1997, ARCH PEDIATRIE, V4, P305, DOI 10.1016/S0929-693X(97)86445-7; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; BELL MJ, 1976, J PEDIATR SURG, V11, P319, DOI 10.1016/S0022-3468(76)80185-6; Bisquera JA, 2002, PEDIATRICS, V109, P423, DOI 10.1542/peds.109.3.423; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Bohnhorst B, 2003, J PEDIATR-US, V143, P484, DOI 10.1067/S0022-3476(03)00443-8; BORN M, 1985, J PEDIATR SURG, V20, P461, DOI 10.1016/S0022-3468(85)80242-6; EVRARD J, 1991, EUR J PEDIATR, V150, P757, DOI 10.1007/BF02026705; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; HARTMAN GE, 1988, J PEDIATR SURG, V23, P562, DOI 10.1016/S0022-3468(88)80369-5; HELOURY Y, 1987, CHIR PEDIATR, V28, P209; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; HORWITZ JR, 1995, J PEDIATR SURG, V30, P994, DOI 10.1016/0022-3468(95)90328-3; Hunter CJ, 2008, J PERINATOL, V28, pS14, DOI 10.1038/jp.2008.44; JANIK JS, 1981, J PEDIATR SURG, V16, P438, DOI 10.1016/S0022-3468(81)80002-4; Kafetzis DA, 2003, CURR OPIN INFECT DIS, V16, P349, DOI 10.1097/00001432-200308000-00007; KOSLOSKE AM, 1980, ANN SURG, V192, P202, DOI 10.1097/00000658-198008000-00013; KRASNA IH, 1970, J PEDIATR SURG, V5, P200, DOI 10.1016/0022-3468(70)90276-9; Lamireau T, 1996, ARCH PEDIATRIE, V3, P9, DOI 10.1016/S0929-693X(96)80002-9; Lapillonne A, 1997, ARCH PEDIATRIE, V4, P1150, DOI 10.1016/S0929-693X(97)88994-4; LEMELLE JL, 1994, ACTA PAEDIATR, V83, P70, DOI 10.1111/j.1651-2227.1994.tb13248.x; Llanos AR, 2002, PAEDIATR PERINAT EP, V16, P342, DOI 10.1046/j.1365-3016.2002.00445.x; Luig M, 2005, J PAEDIATR CHILD H, V41, P174, DOI 10.1111/j.1440-1754.2005.00583.x; Luzzatto C, 1996, EUR J PEDIATR SURG, V6, P92, DOI 10.1055/s-2008-1066479; Moss RL, 2008, J PERINATOL, V28, P665, DOI 10.1038/jp.2008.119; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Petty John K, 2005, Semin Pediatr Surg, V14, P191, DOI 10.1053/j.sempedsurg.2005.05.009; Pierro A, 2005, EARLY HUM DEV, V81, P79, DOI 10.1016/j.earlhumdev.2004.10.018; Pourcyrous M, 2005, PEDIATRICS, V116, P1064, DOI 10.1542/peds.2004-1806; RABINOWITZ JG, 1968, AMER J ROENTGENOL RA, V103, P359, DOI 10.2214/ajr.103.2.359; Rees CM, 2008, ARCH DIS CHILD-FETAL, V93, pF395, DOI 10.1136/adc.2007.136994; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Rees CM, 2005, ARCH DIS CHILD-FETAL, V90, P152, DOI 10.1136/adc.2004.051862; RYDER RW, 1980, AM J EPIDEMIOL, V112, P113, DOI 10.1093/oxfordjournals.aje.a112960; SANTULLI TV, 1975, PEDIATRICS, V55, P376; SCHIMPL G, 1994, ACTA PAEDIATR, V83, P80, DOI 10.1111/j.1651-2227.1994.tb13251.x; SCHWARTZ MA, 1980, J AM CHEM SOC, V102, P890, DOI 10.1021/ja00522a603; SCHWARTZ MZ, 1982, J PEDIATR SURG, V17, P764, DOI 10.1016/S0022-3468(82)80443-0; STOLL BJ, 1980, J PEDIATR-US, V96, P447; Thyoka M, 2011, J PEDIATR SURG, V46, P1041, DOI 10.1016/j.jpedsurg.2011.03.024; Walsh M, 2006, FANAROFF MARTINS NEO, P1403; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	46	19	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76858	10.1371/journal.pone.0076858	http://dx.doi.org/10.1371/journal.pone.0076858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146936	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400087
J	Kutscher, S; Dembek, CJ; Deckert, S; Russo, C; Korber, N; Bogner, JR; Geisler, F; Umgelter, A; Neuenhahn, M; Albrecht, J; Cosma, A; Protzer, U; Bauer, T				Kutscher, Sarah; Dembek, Claudia J.; Deckert, Simone; Russo, Carolina; Koerber, Nina; Bogner, Johannes R.; Geisler, Fabian; Umgelter, Andreas; Neuenhahn, Michael; Albrecht, Julia; Cosma, Antonio; Protzer, Ulrike; Bauer, Tanja			Overnight Resting of PBMC Changes Functional Signatures of Antigen Specific T-Cell Responses: Impact for Immune Monitoring within Clinical Trials	PLOS ONE			English	Article							OPTIMIZATION; SENSITIVITY; VACCINE	Polyfunctional CD4 or CD8 T cells are proposed to represent a correlate of immune control for persistent viruses as well as for vaccine mediated protection against infection. A well-suited methodology to study complex functional phenotypes of antiviral T cells is the combined staining of intracellular cytokines and phenotypic marker expression using polychromatic flow cytometry. In this study we analyzed the effect of an overnight resting period at 37 degrees C on the quantity and functionality of HIV-1, EBV, CMV, HBV and HCV specific CD4 and CD8 T-cell responses in a cohort of 21 individuals. We quantified total antigen specific T cells by multimer staining and used 10-color intracellular cytokine staining (ICS) to determine IFN gamma, TNF alpha, IL2 and MIP1 beta production. After an overnight resting significantly higher numbers of functionally active T cells were detectable by ICS for all tested antigen specificities, whereas the total number of antigen specific T cells determined by multimer staining remained unchanged. Overnight resting shifted the quality of T-cell responses towards polyfunctionality and increased antigen sensitivity of T cells. Our data suggest that the observed effect is mediated by T cells rather than by antigen presenting cells. We conclude that overnight resting of PBMC prior to ex vivo analysis of antiviral T-cell responses represents an efficient method to increase sensitivity of ICS-based methods and has a prominent impact on the functional phenotype of T cells.	[Kutscher, Sarah; Dembek, Claudia J.; Deckert, Simone; Russo, Carolina; Koerber, Nina; Protzer, Ulrike; Bauer, Tanja] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Kutscher, Sarah; Dembek, Claudia J.; Deckert, Simone; Neuenhahn, Michael; Albrecht, Julia; Protzer, Ulrike; Bauer, Tanja] Helmholtz Zentrum Munchen, Cooperat Grp Immune Monitoring, Munich, Germany; [Bogner, Johannes R.] Univ Munich, Dept Infect Dis, Med Klin & Poliklin, Univ Hosp Munich, Munich, Germany; [Geisler, Fabian; Umgelter, Andreas] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany; [Neuenhahn, Michael; Albrecht, Julia] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Cosma, Antonio] CEA, Div Immunovirol, Paris, France; [Dembek, Claudia J.] German Ctr Infect Res DZIF, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Technical University of Munich; CEA; German Center for Infection Research	Bauer, T (corresponding author), Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany.	tanja.bauer@helmholtz-muenchen.de	Protzer, Ulrike/D-5915-2015	Protzer, Ulrike/0000-0002-9421-1911; Cosma, Antonio/0000-0002-3686-8034				Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Britten CM, 2011, CANCER IMMUNOL IMMUN, V60, P15, DOI 10.1007/s00262-010-0940-z; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Gascoigne NRJ, 2008, NAT REV IMMUNOL, V8, P895, DOI 10.1038/nri2431; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kutscher S, 2010, GENE THER, V17, P1372, DOI 10.1038/gt.2010.90; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Malnati MS, 2012, J IMMUNOL METHODS, V375, P46, DOI 10.1016/j.jim.2011.09.005; Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173; Owen RE, 2007, J IMMUNOL METHODS, V326, P93, DOI 10.1016/j.jim.2007.07.012; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Suni Maria A, 2003, BMC Immunol, V4, P9, DOI 10.1186/1471-2172-4-9; van der Burg SH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002785; Vigano S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/153863; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	23	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76215	10.1371/journal.pone.0076215	http://dx.doi.org/10.1371/journal.pone.0076215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146841	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400048
J	Quester, K; Avalos-Borja, M; Vilchis-Nestor, AR; Camacho-Lopez, MA; Castro-Longoria, E				Quester, Katrin; Avalos-Borja, Miguel; Rafael Vilchis-Nestor, Alfredo; Antonio Camacho-Lopez, Marco; Castro-Longoria, Ernestina			SERS Properties of Different Sized and Shaped Gold Nanoparticles Biosynthesized under Different Environmental Conditions by Neurospora crassa Extract	PLOS ONE			English	Article							ENHANCED RAMAN-SPECTROSCOPY; SURFACE-PLASMON RESONANCE; SILVER NANOPARTICLES; METAL NANOPARTICLES; BIOLOGICAL SYNTHESIS; SCATTERING; AG; NANOWIRES; PRINCIPLE; THIONINE	Surface-enhanced Raman scattering (SERS) is a surface-sensitive technique that enhances Raman scattering by molecules adsorbed on rough metal surfaces. It is known that metal nanoparticles, especially gold and silver nanoparticles, exhibit great SERS properties, which make them very attractive for the development of biosensors and biocatalysts. On the other hand, the development of ecofriendly methods for the synthesis of metallic nanostructures has become the focus of research in several countries, and many microorganisms and plants have already been used to biosynthesize metallic nanostructures. However, the majority of these are pathogenic to plants or humans. Here, we report gold nanoparticles with good SERS properties, biosynthesized by Neurospora crassa extract under different environmental conditions, increasing Raman signals up to 40 times using methylene blue as a target molecule. Incubation of tetrachloroauric acid solution with the fungal extract at 60 degrees C and a pH value of a) 3, b) 5.5, and c) 10 resulted in the formation of gold nanoparticles of a) different shapes like triangles, hexagons, pentagons etc. in a broad size range of about 10-200 nm, b) mostly quasi-spheres with some different shapes in a main size range of 6-23 nm, and c) only quasi-spheres of 3-12 nm. Analyses included TEM, HRTEM, and EDS in order to corroborate the shape and the elemental character of the gold nanoparticles, respectively. The results presented here show that these 'green' synthesized gold nanoparticles might have potential applicability in the field of biological sensing.	[Quester, Katrin; Castro-Longoria, Ernestina] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Avalos-Borja, Miguel] UNAM, CNyN, Ensenada, Baja California, Mexico; [Rafael Vilchis-Nestor, Alfredo] UAEM UNAM, CCIQS, Toluca, Mexico; [Antonio Camacho-Lopez, Marco] UAEMex, Fac Quim, Secc Espect, Lab Invest & Desarollo Mat Avanzados, Toluca, Estado De Mexic, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Mexico	Castro-Longoria, E (corresponding author), CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	VILCHIS-NESTOR, ALFREDO R/B-6776-2016; Castro-Longoria, Ernestina/GYV-4776-2022	VILCHIS-NESTOR, ALFREDO R/0000-0001-8490-0900; CAMACHO LOPEZ, MARCO/0000-0003-0779-968X; Avalos-Borja, Miguel/0000-0003-4515-6415	SEP-CONACyT [CB2011/169154]; CONACyT	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this project was provided by a SEP-CONACyT (www.conacyt.mx) grant (CB2011/169154) to ECL. We also thank CONACyT for a grant to KQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armendariz V, 2004, J NANOPART RES, V6, P377, DOI 10.1007/s11051-004-0741-4; Basavaraja S, 2008, MATER RES BULL, V43, P1164, DOI 10.1016/j.materresbull.2007.06.020; Bfilainsa KC, 2006, COLLOID SURFACE B, V47, P160, DOI 10.1016/j.colsurfb.2005.11.026; Binupriya AR, 2010, J HAZARD MATER, V177, P539, DOI 10.1016/j.jhazmat.2009.12.066; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castro-Longoria E, 2012, J MICROBIOL BIOTECHN, V22, P1000, DOI 10.4014/jmb.1110.10085; Castro-Longoria E, 2011, Colloids Surf B Biointerfaces, V83, P42, DOI 10.1016/j.colsurfb.2010.10.035; Das P, 2012, J PHYS CHEM C, V116, P25969, DOI 10.1021/jp3103782; Fayaz AM, 2009, COLLOID SURFACE B, V74, P123, DOI 10.1016/j.colsurfb.2009.07.002; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; Govender Y, 2009, BIOTECHNOL LETT, V31, P95, DOI 10.1007/s10529-008-9825-z; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; He SY, 2008, BIOTECHNOL PROGR, V24, P476, DOI 10.1021/bp0703174; Iosin M, 2008, J OPTOELECTRON ADV M, V10, P2285; Jarvis RM, 2008, ANAL CHEM, V80, P6741, DOI 10.1021/ac800838v; Joerger R, 2000, ADV MATER, V12, P407, DOI 10.1002/(SICI)1521-4095(200003)12:6<407::AID-ADMA407>3.0.CO;2-O; Kah JCY, 2007, INT J NANOMED, V2, P785; Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289; Kathiresan K, 2010, CAN J MICROBIOL, V56, P1050, DOI 10.1139/W10-094; Kim YC, 2003, CATAL TODAY, V87, P153, DOI 10.1016/j.cattod.2003.09.012; Kottmann JP, 2001, CHEM PHYS LETT, V341, P1, DOI 10.1016/S0009-2614(01)00171-3; Kottmann JP, 2000, OPT EXPRESS, V6, P213, DOI 10.1364/OE.6.000213; Kowshik M, 2003, NANOTECHNOLOGY, V14, P95, DOI 10.1088/0957-4484/14/1/321; Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g; Liu M, 2013, ANAL BIOANAL CHEM, V405, P6131, DOI 10.1007/s00216-013-7016-9; Lu L, 2006, CHEM MATER, V18, P4894, DOI 10.1021/cm0615875; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Mukherjee P, 2002, CHEMBIOCHEM, V3, P461, DOI 10.1002/1439-7633(20020503)3:5<461::AID-CBIC461>3.0.CO;2-X; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; Pastoriza-Santos I, 2007, ADV FUNCT MATER, V17, P1443, DOI 10.1002/adfm.200601071; Philip D, 2009, SPECTROCHIM ACTA A, V73, P374, DOI 10.1016/j.saa.2009.02.037; Prusinkiewicz MA, 2012, ANALYST, V137, P4934, DOI 10.1039/c2an35620a; Rodriguez-Fernandez J, 2009, J PHYS CHEM C, V113, P18623, DOI 10.1021/jp907646d; Ruan CM, 2007, LANGMUIR, V23, P5757, DOI 10.1021/la0636356; Sanghi R., 2010, ADV MAT LETT, V1, P193, DOI [10.5185/amlett.2010.5124, DOI 10.5185/AMLETT.2010.5124]; Sau TK, 2010, ADV MATER, V22, P1805, DOI 10.1002/adma.200902557; Thomas S, 2013, SPECTROCHIM ACTA A, V112, P27, DOI 10.1016/j.saa.2013.04.047; Vigneshwaran N, 2007, LANGMUIR, V23, P7113, DOI 10.1021/la063627p; Vilchis-Nestor AR, 2008, MATER LETT, V62, P3103, DOI 10.1016/j.matlet.2008.01.138; VIRDEE HR, 1988, LASER CHEM, V9, P401, DOI 10.1155/LC.9.401; Xiao GN, 2007, CHEM PHYS LETT, V447, P305, DOI 10.1016/j.cplett.2007.09.045; Xie J, 2007, J PHYS CHEM C, V111, P16858, DOI 10.1021/jp0752668; Xie JP, 2008, ACS NANO, V2, P2473, DOI 10.1021/nn800442q; Xu W, 2004, J PHYS CHEM B, V108, P5588, DOI 10.1021/jp037994a; Yoosaf K, 2007, J PHYS CHEM C, V111, P12839, DOI 10.1021/jp073923q; Zhang J. Z., 2009, OPTICAL PROPERTIES S, P205; Zhang YX, 2011, INT J NANOMED, V6, P2899, DOI 10.2147/IJN.S24785; Zhong L, 2009, CLEO PAC RIM C	48	55	55	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77486	10.1371/journal.pone.0077486	http://dx.doi.org/10.1371/journal.pone.0077486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130891	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900140
J	Murata, JM; Behnke-Parks, WM; Major, J; Petersen, KJ; Goulet, A; Moores, CA; Thomas, DD; Rosenfeld, SS				Murata, Joseph M.; Behnke-Parks, William M.; Major, Jennifer; Petersen, Karl J.; Goulet, Adeline; Moores, Carolyn A.; Thomas, David D.; Rosenfeld, Steven S.			Loop L5 Assumes Three Distinct Orientations during the ATPase Cycle of the Mitotic Kinesin Eg5 A TRANSIENT AND TIME-RESOLVED FLUORESCENCE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Fluorescence; Kinesin; Kinetics; Microtubules; Eg5; Anisotropy Decay; Cryo-EM; Stopped Flow; Time-resolved Fluorescence	INHIBITION; MECHANISM; MOTOR; CONFORMATION; ACTIVATION; MYOSIN	Background: Loop L5 shapes the enzymology of kinesin motors to meet specific physiologic roles. Results: L5 is in a dynamic equilibrium of three conformations whose relative proportions shift during the ATPase cycle. Conclusion: Interactions between L5 and helix 3 modulate the kinetics of microtubule binding. Significance: Combining transient kinetics with time-resolved fluorescence reveals important insights in the structural dynamics of molecular motors. Members of the kinesin superfamily of molecular motors differ in several key structural domains, which probably allows these molecular motors to serve the different physiologies required of them. One of the most variable of these is a stem-loop motif referred to as L5. This loop is longest in the mitotic kinesin Eg5, and previous structural studies have shown that it can assume different conformations in different nucleotide states. However, enzymatic domains often consist of a mixture of conformations whose distribution shifts in response to substrate binding or product release, and this information is not available from the static images that structural studies provide. We have addressed this issue in the case of Eg5 by attaching a fluorescent probe to L5 and examining its fluorescence, using both steady state and time-resolved methods. This reveals that L5 assumes an equilibrium mixture of three orientations that differ in their local environment and segmental mobility. Combining these studies with transient state kinetics demonstrates that there is a major shift in this distribution during transitions that interconvert weak and strong microtubule binding states. Finally, in conjunction with previous cryo-EM reconstructions of Eg5microtubule complexes, these fluorescence studies suggest a model in which L5 regulates both nucleotide and microtubule binding through a set of reversible interactions with helix 3. We propose that these features facilitate the production of sustained opposing force by Eg5, which underlies its role in supporting formation of a bipolar spindle in mitosis.	[Murata, Joseph M.; Petersen, Karl J.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Behnke-Parks, William M.] Columbia Univ, Dept Biol, New York, NY 10027 USA; [Major, Jennifer; Rosenfeld, Steven S.] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Goulet, Adeline; Moores, Carolyn A.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	University of Minnesota System; University of Minnesota Twin Cities; Columbia University; Cleveland Clinic Foundation; University of London; Birkbeck University London	Rosenfeld, SS (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.			Thomas, David D./0000-0002-8822-2040; Goulet, Adeline/0000-0002-5971-9488	National Institutes of Health [GM102875, AR032961, AR057220, AR056191]; Biotechnology and Biological Sciences Research Council [BB/H005137/1]; BBSRC [BB/H005137/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057220, R01AR032961, R37AR032961, F32AR056191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102875 (to S.S.R.), AR032961 and AR057220 (to D.D.T.), and AR056191 (to J.M.M.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/H005137/1 (to A.G. and C. M.).	BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Goulet A, 2012, J BIOL CHEM, V287, P44654, DOI 10.1074/jbc.M112.404228; Kaan HYK, 2013, J BIOL CHEM, V288, P18588, DOI 10.1074/jbc.M113.462648; KINOSITA K, 1982, BIOPHYS J, V37, P461, DOI 10.1016/S0006-3495(82)84692-4; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P134; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032	27	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34839	34849		10.1074/jbc.M113.518845	http://dx.doi.org/10.1074/jbc.M113.518845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145034	Green Published, hybrid			2022-12-25	WOS:000329812800051
J	Zhang, QC; Flynn, GC				Zhang, Qingchun; Flynn, Gregory C.			Cysteine Racemization on IgG Heavy and Light Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Disulfide; Mass Spectrometry (MS); Post Translational Modification; Protein Chemical Modification; Chirality; Light Chain; Thioether	MONOCLONAL-ANTIBODY; HINGE REGION; CROSS-LINKS; FRAGMENTATION; SUBCLASSES; REDUCTION; ISOFORMS; STORAGE	Background: Cysteine racemization occurs at heavy chain position 220 of an IgG1under high pH stress. Results: d-Cysteine forms on both heavy and light chains of an IgGs under mild conditions. Conclusion: The terminal cysteine impairs racemization on the light chain. Significance: Because d-cysteine is naturally occurring on antibodies, its presence on therapeutic antibodies poses less of a safety concern. Under basic pH conditions, the heavy chain 220-light chain 214 (H220-L214) disulfide bond, found in the flexible hinge region of an IgG1, can convert to a thioether. Similar conditions also result in racemization of the H220 cysteine. Here, we report that racemization occurs on both H220 and L214 on an IgG1 with a light chain (IgG1) but almost entirely on H220 of an IgGl with a light chain (IgG1) under similar conditions. Likewise, racemization was detected at significant levels on H220 and L214 on endogenous human IgG1 but only at the H220 position on IgG1. Low but measurable levels of d-cysteines were found on IgG2 cysteines in the hinge region, both with monoclonal antibodies incubated under basic pH conditions and on antibodies isolated from human serum. A simplified reaction mechanism involving reversible -elimination on the cysteine is presented that accounts for both base-catalyzed racemization and thioether formation at the hinge disulfide.	[Zhang, Qingchun; Flynn, Gregory C.] Amgen Inc, Dept Proc & Prod Dev, Thousand Oaks, CA 91320 USA	Amgen	Flynn, GC (corresponding author), Amgen Inc, Mail Stop 30E-1-C,Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com						Alyanakian MA, 2003, VOX SANG, V84, P188, DOI 10.1046/j.1423-0410.2003.00278.x; Amano M, 2011, ANAL CHEM, V83, P3857, DOI 10.1021/ac200321v; BESSEMS GJH, 1987, EXP EYE RES, V44, P691, DOI 10.1016/S0014-4835(87)80139-2; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Eon-Duval A, 2012, BIOTECHNOL PROGR, V28, P608, DOI 10.1002/btpr.1548; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Linetsky M, 2004, EXP EYE RES, V79, P499, DOI 10.1016/j.exer.2004.06.026; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Maggon K, 2007, CURR MED CHEM, V14, P1978; Mozziconacci O, 2010, CHEM RES TOXICOL, V23, P1310, DOI 10.1021/tx100193b; OUT TA, 1984, CLIN CHIM ACTA, V144, P115, DOI 10.1016/0009-8981(84)90044-5; Pan H, 2009, ANAL BIOCHEM, V388, P273, DOI 10.1016/j.ab.2009.02.037; Tous GI, 2005, ANAL CHEM, V77, P2675, DOI 10.1021/ac0500582; VLUG A, 1994, ANN BIOL CLIN-PARIS, V52, P561; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147; Zhang QC, 2013, J BIOL CHEM, V288, P16371, DOI 10.1074/jbc.M113.468397	23	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34325	34335		10.1074/jbc.M113.506915	http://dx.doi.org/10.1074/jbc.M113.506915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142697	hybrid, Green Published			2022-12-25	WOS:000329812800004
J	De Pasquale, M; Kourteva, Y; Allos, T; D'Aquila, RT				De Pasquale, MariaPia; Kourteva, Yordanka; Allos, Tara; D'Aquila, Richard T.			Lower HIV Provirus Levels Are Associated with More APOBEC3G Protein in Blood Resting Memory CD4+T Lymphocytes of Controllers In Vivo	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; NATURAL-KILLER-CELLS; ELITE CONTROLLERS; ANTIRETROVIRAL THERAPY; EX-VIVO; EXPRESSION; REPLICATION; INFECTION; VIF	Immunodeficiency does not progress for prolonged periods in some HLA B57- and/or B27-positive subjects with human immunodeficiency virus type 1 (HIV) infection, even in the absence of antiretroviral therapy (ART). These "controllers'' have fewer HIV provirus-containing peripheral blood mononuclear cells than "non-controller'' subjects, but lymphocytes that harbor latent proviruses were not specifically examined in studies to date. Provirus levels in resting memory cells that can serve as latent reservoirs of HIV in blood were compared here between controllers and ART-suppressed non-controllers. APOBEC3G (A3G), a cellular factor that blocks provirus formation at multiple steps if not antagonized by HIV virion infectivity factor (Vif), was also studied. HLA-linked HIV control was associated with less provirus and more A3G protein in resting CD4+ T central memory (Tcm) and effector memory (Tem) lymphocytes (provirus: p = 0.01 for Tcm and p = 0.02 for Tem; A3G: p = 0.02 for Tcm and p = 0.02 for Tem). Resting memory T cells with the highest A3G protein levels (>0.5 RLU per unit of actin) had the lowest levels of provirus (<1,000 copies of DNA per million cells) in vivo (p = 0.03, Fisher's exact test). Using two different experimental approaches, Vif-positive viruses with more A3G were found to have decreased virion infectivity ex vivo. These results raise the hypothesis that HIV control is associated with increased cellular A3G that may be packaged into Vif-positive virions to add that mode of inhibition of provirus formation to previously described adaptive immune mechanisms for HIV control.	[De Pasquale, MariaPia; Kourteva, Yordanka; Allos, Tara] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, Nashville, TN 37212 USA; [D'Aquila, Richard T.] Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA; [D'Aquila, Richard T.] Northwestern Univ, Dept Med, Feinberg Sch Med, Northwestern HIV Translat Res Ctr, Chicago, IL 60611 USA	Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	D'Aquila, RT (corresponding author), Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA.	richard.daquila@northwestern.edu			National Institutes of Health (NIH) [P30 AI 54999]; Vanderbilt Meharry Center for AIDS Research via Developmental Core Awards; NIH [UL1 RR024975-01]; Merck Investigator-initiated grant; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Meharry Center for AIDS Research via Developmental Core Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Investigator-initiated grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health (NIH) P30 AI 54999, Vanderbilt Meharry Center for AIDS Research via Developmental Core Awards to MPD and YK, NIH UL1 RR024975-01 Vanderbilt Institute for Clinical and Translational Research (infrastructure support, including database) and Merck Investigator-initiated grant to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2012, CHEMMEDCHEM, V7, P1217, DOI 10.1002/cmdc.201200079; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Ananworanich J., 2013, 20 C RETR OPP INF AT; Anderson JL, 2008, VIROLOGY, V375, P1, DOI 10.1016/j.virol.2008.01.042; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; Carbone J, 2003, AIDS, V17, P133, DOI 10.1097/00002030-200301030-00021; Casartelli N, 2010, J EXP MED, V207, P39, DOI 10.1084/jem.20091933; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; Champiat S, 2013, J VIROL, V87, P6073, DOI 10.1128/JVI.00579-12; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chen H, 2010, INT J MOL SCI, V11, P3501, DOI 10.3390/ijms11093501; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Ejima T, 2011, INT J MOL MED, V28, P613, DOI 10.3892/ijmm.2011.737; Eyzaguirre LM, 2013, VIROLOGY, V443, P306, DOI 10.1016/j.virol.2013.05.019; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fourati S, 2010, AIDS, V24, P2313, DOI 10.1097/QAD.0b013e32833e515a; Gourraud PA, 2011, HUM IMMUNOL, V72, P207, DOI 10.1016/j.humimm.2010.12.008; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Granier C, 2013, J VIROL; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kourteva Y, 2012, VIROLOGY, V430, P1, DOI 10.1016/j.virol.2012.03.018; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; Lisovsky I, 2013, INTERVIROLOGY; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Peng J, 2013, J MOL BIOL; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Persaud D, 2013, 20 C RETR OPP INF AT; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Ruiz-Mateos E, 2010, CURR HIV RES, V8, P471, DOI 10.2174/157016210793499268; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Vetter ML, 2009, J VIROL, V83, P8646, DOI 10.1128/JVI.00020-09; Vetter ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000292; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WONG JT, 1992, HUM IMMUNOL, V35, P200, DOI 10.1016/0198-8859(92)90106-W; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414	63	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76002	10.1371/journal.pone.0076002	http://dx.doi.org/10.1371/journal.pone.0076002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146808	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400030
J	Gakamsky, A; Oron, E; Valente, D; Mitra, PP; Segal, D; Benjamini, Y; Golani, I				Gakamsky, Anna; Oron, Efrat; Valente, Dan; Mitra, Partha P.; Segal, Daniel; Benjamini, Yoav; Golani, Ilan			The Angular Interval between the Direction of Progression and Body Orientation in Normal, Alcohol- and Cocaine Treated Fruit Flies	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; FREE EXPLORATION; DROSOPHILA; BEHAVIOR; ETHANOL; COMPLEX; SENSITIZATION; COORDINATION; RESPONSES; MOVEMENT	In this study we characterize the coordination between the direction a fruit-fly walks and the direction it faces, as well as offer a methodology for isolating and validating key variables with which we phenotype fly locomotor behavior. Our fundamental finding is that the angular interval between the direction a fly walks and the direction it faces is actively managed in intact animals and modulated in a patterned way with drugs. This interval is small in intact flies, larger with alcohol and much larger with cocaine. The dynamics of this interval generates six coordinative modes that flow smoothly into each other. Under alcohol and much more so under cocaine, straight path modes dwindle and modes involving rotation proliferate. To obtain these results we perform high content analysis of video-tracked open field locomotor behavior. Presently there is a gap between the quality of descriptions of insect behaviors that unfold in circumscribed situations, and descriptions that unfold in extended time and space. While the first describe the coordination between low-level kinematic variables, the second quantify cumulative measures and subjectively defined behavior patterns. Here we reduce this gap by phenotyping extended locomotor behavior in terms of the coordination between low-level kinematic variables, which we quantify, combining into a single field two disparate fields, that of high content phenotyping and that of locomotor coordination. This will allow the study of the genes/brain/locomotor coordination interface in genetically engineered and pharmacologically manipulated animal models of human diseases.	[Gakamsky, Anna; Oron, Efrat; Golani, Ilan] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Valente, Dan; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Segal, Daniel] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Benjamini, Yoav] Tel Aviv Univ, Dept Stat & OR, IL-69978 Tel Aviv, Israel; [Gakamsky, Anna; Oron, Efrat; Segal, Daniel; Benjamini, Yoav; Golani, Ilan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Cold Spring Harbor Laboratory; Tel Aviv University; Tel Aviv University; Tel Aviv University	Golani, I (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	ilan99@post.tau.ac.il		Mitra, Partha/0000-0001-8818-6804; Segal, Daniel/0000-0002-6777-505X	Israel Science Foundation [760/08]	Israel Science Foundation(Israel Science Foundation)	This study was funded by the Israel Science Foundation (grant No 760/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANI N, 1991, NEUROSCI BIOBEHAV R, V15, P455, DOI 10.1016/S0149-7634(05)80131-9; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Beer CG, 1980, COMP METHODS PSYCHOL, P17; BELL WJ, 1985, J INSECT PHYSIOL, V31, P837, DOI 10.1016/0022-1910(85)90101-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2011, P NATL ACAD SCI USA, V108, P15580, DOI 10.1073/pnas.1014837108; Benjamini Y, 2010, NEUROSCI BIOBEHAV R, V34, P1351, DOI 10.1016/j.neubiorev.2010.04.004; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BURNET B, 1988, HEREDITY, V61, P111, DOI 10.1038/hdy.1988.96; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; EILAM D, 1988, DEV PSYCHOBIOL, V21, P679, DOI 10.1002/dev.420210707; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P369, DOI 10.1016/S0003-3472(63)80128-1; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Gruntman E, 2007, J COMP PHYSIOL A, V193, P331, DOI 10.1007/s00359-006-0187-5; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Horev G, 2007, GENES BRAIN BEHAV, V6, P30, DOI 10.1111/j.1601-183X.2006.00216.x; Kafkafi N, 2005, GENES BRAIN BEHAV, V4, P431, DOI 10.1111/j.1601-183X.2005.00126.x; Kafkafi N, 1998, BIOL CYBERN, V78, P441, DOI 10.1007/s004220050448; Lebreton S, 2009, J NEUROGENET, V23, P225, DOI 10.1080/01677060802509160; Likitlersuang J, 2012, JOVE-J VIS EXP, V2012, P17; Lipkind D, 2004, J APPL PHYSIOL, V97, P347, DOI 10.1152/japplphysiol.00148.2004; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Mittelstaedt H., 1957, P51; Olberg RM, 2012, CURR OPIN NEUROBIOL, V22, P267, DOI 10.1016/j.conb.2011.11.015; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Ritzmann RE, 2007, COLD SPRING HARB MON, V49, P229; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Stephens GJ, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0013914; Stephens GJ, 2011, P NATL ACAD SCI USA, V108, P7286, DOI 10.1073/pnas.1007868108; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Wilson E.O., 1975, P1; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolf FW, 2002, J NEUROSCI, V22, P11035; Yang P, 2000, GENETICS, V155, P1161; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034	49	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76257	10.1371/journal.pone.0076257	http://dx.doi.org/10.1371/journal.pone.0076257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146845	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400047
J	Graciani, FS; Ximenes, VF				Graciani, Fernanda S.; Ximenes, Valdecir F.			Investigation of Human Albumin-Induced Circular Dichroism in Dansylglycine	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; DRUG BINDING-SITES; FLUORESCENCE; WARFARIN; OXIDATION	Induced circular dichroism (ICD), or induced chirality, is a phenomenon caused by the fixation of an achiral substance inside a chiral microenvironment, such as the hydrophobic cavities in proteins. Dansylglycine belongs to a class of dansylated amino acids, which are largely used as fluorescent probes for the characterization of the binding sites in albumin. Here, we investigated the ICD in dansylglycine provoked by its binding to human serum albumin (HSA). We found that the complexation of HSA with dansylglycine resulted in the appearance of an ICD band centred at 346 nm. Using this ICD signal and site-specific ligands of HSA, we confirmed that dansylglycine is a site II ligand. The intensity of the ICD signal was dependent on the temperature and revealed that the complexation between the protein and the ligand was reversible. The induced chirality of dansylglycine was susceptive to the alteration caused by the oxidation of the protein. A comparison was made between hypochlorous acid (HOCl) and hypobromous acid (HOBr), and revealed that site II in the protein is more susceptible to alteration provoked by the latter oxidant. These findings suggest the relevance of the aromatic amino acids in the site II, since HOBr is a more efficient oxidant of these residues in proteins than HOCl. The three-dimensional structure of HSA is pH-dependent, and different conformations have been characterised. We found that HSA in its basic form at pH 9.0, which causes the protein to be less rigid, lost the capacity to bind dansylglycine. At pH 3.5, HSA retained almost all of its capacity for binding to dansylglycine. Since the structure of HSA at pH 3.5 is expanded, separating the domain IIIA from the rest of the molecule, we concluded that this separation did not alter its binding capacity to dansylglycine.	[Graciani, Fernanda S.; Ximenes, Valdecir F.] Univ Estadual Paulista, Dept Quim, Fac Ciencias, Bauru, SP, Brazil; [Graciani, Fernanda S.; Ximenes, Valdecir F.] Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Anal Clin, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Ximenes, VF (corresponding author), Univ Estadual Paulista, Dept Quim, Fac Ciencias, Bauru, SP, Brazil.	vfximenes@fc.unesp.br	Ximenes, Valdecir/A-5323-2008	Ximenes, Valdecir/0000-0003-2636-3080	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [2011/50652-9]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (Capes)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp), process 2011/50652-9 and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (Capes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOS OJM, 1988, BIOCHEM PHARMACOL, V37, P3905, DOI 10.1016/0006-2952(88)90072-X; BREE F, 1990, EUR J DRUG METAB PH, V15, P303, DOI 10.1007/BF03190219; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Di Bari L, 2010, CHIRALITY, V22, P593, DOI 10.1002/chir.20794; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; Domotor O, 2013, J BIOL INORG CHEM, V18, P9, DOI 10.1007/s00775-012-0944-6; Faizul FM, 2008, J PHOTOCH PHOTOBIO B, V90, P1, DOI 10.1016/j.jphotobiol.2007.10.002; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Liu XP, 2010, EUR J MED CHEM, V45, P4043, DOI 10.1016/j.ejmech.2010.05.063; Maciazek-Jurczyk M, 2011, SPECTROCHIM ACTA A, V82, P181, DOI 10.1016/j.saa.2011.07.030; Marin M, 2011, J PHYS CHEM B, V115, P2910, DOI 10.1021/jp2009463; MULLER N, 1994, J PHARM PHARMACOL, V46, P300, DOI 10.1111/j.2042-7158.1994.tb03798.x; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petronio MS, 2012, BBA-PROTEINS PROTEOM, V1824, P1090, DOI 10.1016/j.bbapap.2012.06.013; Petronio MS, 2013, BR J PHARM RES, V3, P147; Petronio MS, 2012, LUMINESCENCE, DOI [10.1002/bio.2445, DOI 10.1002/BI0.2445.[]; Petronio MS, 2013, PROTEIN PEPT LETT; Pistolozzi M, 2008, CHIRALITY, V20, P552, DOI 10.1002/chir.20521; Qi Z, 2008, J PHARMACEUT BIOMED, V46, P699, DOI 10.1016/j.jpba.2007.10.016; Rosenbaum S., 2011, BASIC PHARMACOKINETI, V1st ed.; Roy S, 2004, METHOD ENZYMOL, V379, P175; Ryan AJ, 2011, J STRUCT BIOL, V174, P84, DOI 10.1016/j.jsb.2010.10.004; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sun CX, 2005, BIOPHYS J, V88, P3518, DOI 10.1529/biophysj.104.051516; Thumser AEA, 1998, J LIPID RES, V39, P1033; van de Weert M, 2011, J MOL STRUCT, V998, P144, DOI 10.1016/j.molstruc.2011.05.023; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Wu XH, 2011, SPECTROCHIM ACTA A, V79, P1202, DOI 10.1016/j.saa.2011.04.043; Ximenes VF, 2011, ARCH BIOCHEM BIOPHYS, V507, P315, DOI 10.1016/j.abb.2010.12.026; Ximenes VF, 2005, BRAZ J MED BIOL RES, V38, P1575, DOI 10.1590/S0100-879X2005001100003; Zhang XY, 2013, PLOS ONE, V8	36	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76849	10.1371/journal.pone.0076849	http://dx.doi.org/10.1371/journal.pone.0076849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146932	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400088
J	Huang, B; Huang, SG; Chen, Y; Zheng, HQ; Shen, JL; Lun, ZR; Wang, Y; Kasper, LH; Lu, FL				Huang, Bo; Huang, Shiguang; Chen, Ying; Zheng, Huanqin; Shen, Jilong; Lun, Zhao-Rong; Wang, Yong; Kasper, Lloyd H.; Lu, Fangli			Mast Cells Modulate Acute Toxoplasmosis in Murine Models	PLOS ONE			English	Article							CALOMYS-CALLOSUS RODENTIA; T-LYMPHOCYTES; HOST-DEFENSE; GONDII; GAMMA; INTERLEUKIN-10; LOCALIZATION; ENCEPHALITIS; PATHOGENESIS; INFLAMMATION	The role of mast cells (MCs) in Toxoplasma gondii infection is poorly known. Kunming outbred mice were infected intraperitoneally with RH strain T. gondii, either treated with compound 48/80 (C48/80, MC activator) or disodium cromoglycate (DSCG, MC inhibitor). Compared with infected controls, infected mice treated with C48/80 exhibited significantly increased inflammation in the liver (P < 0.01), spleen (P < 0.05), and mesentery (P < 0.05) tissues, higher parasite burden in the peritoneal lavage fluids (P < 0.01), and increased levels of mRNA transcripts of T. gondii tachyzoite surface antigen 1 (SAG1) gene in the spleen and liver tissues (P < 0.01), accompanied with significantly increased Th1 cytokine (IFN-gamma, IL-12p40, and TNF-alpha) (P < 0.01) and decreased IL-10 (P < 0.01) mRNA expressions in the liver, and increased IFN-gamma (P < 0.01) and IL-12p40 (P < 0.01) but decreased TNF-alpha (P < 0.01) and IL-4 (P < 0.01) in the spleens of infected mice treated with C48/80 at day 9-10 p.i. Whereas mice treated with DSCG had significantly decreased tissue lesions (P < 0.01), lower parasite burden in the peritoneal lavage fluids (P < 0.01) and decreased SAG1 expressions in the spleen and liver tissues (P < 0.01), accompanied with significantly increased IFN-gamma (P < 0.01) and IL-12p40 (P < 0.05) in the liver, and decreased IFN-gamma (P < 0.05) and TNF-alpha (P < 0.01) in the spleens; IL-4 and IL-10 expressions in both the spleen and liver were significantly increased (P < 0.01) in the infected mice treated with DSCG. These findings suggest that mediators associated with the MC activation may play an important role in modulating acute inflammatory pathogenesis and parasite clearance during T. gondii infection in this strain of mice. Thus, MC activation/inhibition mechanisms are potential novel targets for the prevention and control of T. gondii infection.	[Huang, Bo; Chen, Ying; Zheng, Huanqin; Lu, Fangli] Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Bo; Chen, Ying; Zheng, Huanqin; Lun, Zhao-Rong; Lu, Fangli] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Shiguang] Jinan Univ, Dept Periodontol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Shen, Jilong] Anhui Med Univ, Anhui Prov Lab Pathogen Biol, Hefei, Anhui, Peoples R China; [Lun, Zhao-Rong] Sun Yat Sen Univ, Ctr Parasit Organisms, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Kasper, Lloyd H.] Dartmouth Med Sch, Dept Microbiol, Lebanon, NH USA	Sun Yat Sen University; Sun Yat Sen University; Jinan University; Anhui Medical University; Sun Yat Sen University; Nanjing Medical University; Dartmouth College	Lu, FL (corresponding author), Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	fanglilu@yahoo.com			National Basic Research Program of China (973 Program) [2010CB530001]; Natural Science Foundation of China [81071387, 81271854]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Basic Research Program of China (973 Program) [grant number 2010CB530001] and the Natural Science Foundation of China to F. L. [grant numbers 81071387 and 81271854]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff SC, 1999, GUT, V44, P643, DOI 10.1136/gut.44.5.643; Carlos D, 2007, J INFECT DIS, V196, P1361, DOI 10.1086/521830; Cavalcanti MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025259; Collington SJ, 2011, TRENDS IMMUNOL, V32, P478, DOI 10.1016/j.it.2011.08.002; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Ferreira GLS, 2004, MICROBES INFECT, V6, P172, DOI 10.1016/j.micinf.2003.11.007; GATTI S, 1993, INT J IMMUNOPHARMACO, V15, P551, DOI 10.1016/0192-0561(93)90071-6; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Gil CD, 2002, PARASITOL RES, V88, P557, DOI 10.1007/s00436-002-0593-8; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Gupta S, 2013, INDIAN J PHARMACOL, V45, P83, DOI 10.4103/0253-7613.106442; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Henderson WR, 1998, J INFECT DIS, V177, P1437, DOI 10.1086/517833; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Huang SG, 2013, J PERIODONTOL, V84, P248, DOI 10.1902/jop.2012.120066; Im SJ, 2011, PARASITE, V18, P49, DOI 10.1051/parasite/2011181049; Jash A, 2011, J ETHNOPHARMACOL, V133, P654, DOI 10.1016/j.jep.2010.10.054; Jones LA, 2010, EUR J IMMUNOL, V40, P426, DOI 10.1002/eji.200939705; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Lu FL, 2003, INFECT IMMUN, V71, P7159, DOI 10.1128/IAI.71.12.7159-7163.2003; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Matowicka-Karna J, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/374696; Matsuguchi T, 2012, CURR MED CHEM, V19, P1432, DOI 10.2174/092986712799828319; Maurer M, 2006, FASEB J, V20, P2460, DOI 10.1096/fj.06-5860com; Messina A, 2000, LAB INVEST, V80, P423, DOI 10.1038/labinvest.3780047; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miyatake Akihiko, 2007, Allergol Int, V56, P231, DOI 10.2332/allergolint.O-06-444; Nickdel MB, 2004, PARASITE IMMUNOL, V26, P75, DOI 10.1111/j.0141-9838.2004.00686.x; Norose K, 2003, INVEST OPHTH VIS SCI, V44, P4375, DOI 10.1167/iovs.03-0156; OKAYAMA Y, 1995, INT ARCH ALLERGY IMM, V107, P158, DOI 10.1159/000236963; Oldenburg PJ, 2005, J PHARMACOL EXP THER, V313, P319, DOI 10.1124/jpet.104.071720; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Roffe E, 2012, J IMMUNOL, V188, P649, DOI 10.4049/jimmunol.1003845; SUBAUSTE CS, 1991, J IMMUNOL, V147, P3955; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Suzuki Y, 1996, J IMMUNOL, V157, P2564; Suzuki Y, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002018; Swedenborg J, 2011, ARTERIOSCL THROM VAS, V31, P734, DOI 10.1161/ATVBAHA.110.213157; Theoharides TC, 2000, J PHARMACOL EXP THER, V294, P810; Woolley DE, 2003, NEW ENGL J MED, V348, P1709, DOI 10.1056/NEJMcibr023206; Wu B, 2013, PARASITOL RES, V112, P2511, DOI 10.1007/s00436-013-3416-1; Yamamoto YI, 1998, ANN TROP MED PARASIT, V92, P23, DOI 10.1080/00034989860139; Zhao J, 2011, ANTIOXID REDOX SIGN, V14, P1589, DOI 10.1089/ars.2010.3583	44	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77327	10.1371/journal.pone.0077327	http://dx.doi.org/10.1371/journal.pone.0077327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146978	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400102
J	Kamiya, K; Shimizu, K; Igarashi, A; Kobashi, H				Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Kobashi, Hidenaga			Time Course of Optical Quality and Intraocular Scattering after Refractive Lenticule Extraction	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; FEMTOSECOND LASER; CLINICAL-EVALUATION; MYOPIC ASTIGMATISM; PUPIL SIZE; SURGERY; ZONE; INSTRUMENT; MICROSCOPY; EFFICACY	Purpose: To assess the time course of optical quality and intraocular scattering in relation to visual acuity after femtosecond lenticule extraction (FLEx) for the correction of myopia. Methods: This study evaluated 36 eyes of 36 patients with spherical equivalents of -4.38 +/- 1.53 D [mean +/- standard deviation] who underwent FLEx. Before surgery, and 1 week and 1, 3 and 6 months after surgery, we assessed the modulation transfer function (MTF) cutoff frequency, Strehl ratio, objective scattering index (OSI), and OQAS values (OVs), using a double-pass instrument. We also investigated the relationship of the OSI with corrected distance visual acuity (CDVA) preoperatively and postoperatively. Results: The mean changes in MTF cutoff frequency, Strehl ratio, OSI, OV100%, OV20%, and OV9% preoperatively and 6 months postoperatively were -5.51 +/- 15.01, -0.03 +/- 0.07, 0.35 +/- 0.83, -0.17 +/- 0.48, -0.14 +/- 0.38, and -0.09 +/- 0.22, respectively. We found no significant preoperative correlation between the OSI and logMAR CDVA (Spearman rank correlation coefficient r = 0.068, p = 0.69), and modest, but significant correlations 1 week and 1, 3, and 6 months postoperatively (r = 0.572, r = 0.562, r = 0.542, r = 0.540, p < 0.001, respectively). Conclusions: FLEx induced a transient decrease in optical quality in association with an increase in intraocular scattering in the early postoperative period, possibly due to mild interface haze formation, but gradually recovered with time. It is suggested that this transient degradation in optical quality related to an increase in the intraocular scattering may result in a slight delay of CDVA recovery in the early postoperative period.	[Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Kobashi, Hidenaga] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Ang M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-75; Artal P, 2000, J REFRACT SURG, V16, pS560; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Blum M, 2010, KLIN MONATSBL AUGENH, V227, P961, DOI 10.1055/s-0029-1245894; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Fang LH, 2013, OPT EXPRESS, V21, P1404, DOI 10.1364/OE.21.001404; Fankhauser Franz, 2004, Technol Health Care, V12, P443; Freedman KA, 2003, J CATARACT REFR SURG, V29, P1924, DOI 10.1016/S0886-3350(03)00214-1; Gertnere J, 2012, GRAEFES ARCH CLIN EX; Guell JL, 2004, J CATARACT REFR SURG, V30, P1598, DOI 10.1016/j.jcrs.2004.04.031; Guirao A, 1999, INVEST OPHTH VIS SCI, V40, P203; Heichel J, 2011, OPHTHALMIC RES, V46, P107, DOI 10.1159/000323814; Kamiya K, 2012, J CATARACT REFR SURG, V38, P1996, DOI 10.1016/j.jcrs.2012.06.052; Kamiya K, 2012, INVEST OPHTH VIS SCI, V53, P3161, DOI 10.1167/iovs.12-9650; Krueger RR, 1998, J REFRACT SURG, V14, P467; Kunert KS, 2011, GRAEF ARCH CLIN EXP, V249, P1417, DOI 10.1007/s00417-010-1578-4; Ratkay-Traub I, 2003, J REFRACT SURG, V19, P94; ROBERTS CW, 1993, INVEST OPHTH VIS SCI, V34, P2275; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; SANTAMARIA J, 1987, J OPT SOC AM A, V4, P1109, DOI 10.1364/JOSAA.4.001109; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P1636, DOI 10.1016/j.jcrs.2011.03.056; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Vestergaard A, 2012, ACTA OPHTHALMOL; Vestergaard A, 2012, J CATARACT REFR SURG, V38, P2003, DOI 10.1016/j.jcrs.2012.07.021; Wang BG, 2008, LASER SURG MED, V40, P247, DOI 10.1002/lsm.20628; Wang BG, 2006, ANN ANAT, V188, P395, DOI 10.1016/j.aanat.2006.02.006	30	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76738	10.1371/journal.pone.0076738	http://dx.doi.org/10.1371/journal.pone.0076738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146917	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400083
J	Beukers, W; Kandimalla, R; van Houwelingen, D; Kovacic, H; Chin, JFD; Lingsma, HF; Dyrskjot, L; Zwarthoff, EC				Beukers, Willemien; Kandimalla, Raju; van Houwelingen, Diandra; Kovacic, Hrvoje; Chin, Jie-Fen D.; Lingsma, Hester F.; Dyrskjot, Lars; Zwarthoff, Ellen C.			The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria	PLOS ONE			English	Article							BLADDER-CANCER; ASSAY; IMMUNOCYTOLOGY; MULTICENTER; CYTOLOGY; IMPACT	Introduction: Patients presenting with painless hematuria form a large part of the urological patient population. In many cases, especially in younger patients, the cause of hematuria is harmless. Nonetheless, hematuria could be a symptom of malignant disease and hence most patients will be subject to cystoscopy. In this study, we aimed to develop a prediction model based on methylation markers in combination with clinical variables, in order to stratify patients with high risk for bladder cancer. Material and Methods: Patients (n=169) presenting with painless hematuria were included. 54 patients were diagnosed with bladder cancer. In the remaining 115 patients, the cause of hematuria was non-malignant. Urine samples were collected prior to cystoscopy. Urine DNA was analyzed for methylation of OSR1, SIM2, OTX1, MEIS1 and ONECUT2. Methylation percentages were calculated and were combined with clinical variables into a logistic regression model. Results: Logistic regression analysis based on the five methylation markers, age, gender and type of hematuria resulted in an area under the curve (AUC) of 0.88 and an optimism corrected AUC of 0.84 after internal validation by bootstrapping. Using a cut-off value of 0.307 allowed stratification of patients in a low-risk and high-risk group, resulting in a sensitivity of 82% (44/54) and a specificity of 82% (94/115). Most aggressive tumors were found in patients in the high-risk group. The addition of cytology to the prediction model, improved the AUC from 0.88 to 0.89, with a sensitivity and specificity of 85% (39/46) and 87% (80/92), retrospectively. Conclusions: This newly developed prediction model could be a helpful tool in risk stratification of patients presenting with painless hematuria. Accurate risk prediction might result in less extensive examination of low risk patients and thereby, reducing patient burden and costs. Further validation in a large prospective patient cohort is necessary to prove the true clinical value of this model.	[Beukers, Willemien; Kandimalla, Raju; van Houwelingen, Diandra; Kovacic, Hrvoje; Chin, Jie-Fen D.; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Dyrskjot, Lars] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Aarhus University	Zwarthoff, EC (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl	Kandimalla, Raju/C-1400-2016	Kandimalla, Raju/0000-0002-0342-5229; Kovacic, Herve/0000-0001-6509-4210; Dyrskjot, Lars/0000-0001-7061-9851	Erasmus Medical Center (MRace); European Community [201663]	Erasmus Medical Center (MRace); European Community(European Commission)	This study was funded by Erasmus Medical Center (MRace 2007) and European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogunrin F, 2012, CANCER-AM CANCER SOC, V118, P2641, DOI 10.1002/cncr.26544; Cha EK, 2012, EUR UROL, V61, P185, DOI 10.1016/j.eururo.2011.08.073; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; Jocham D, 2005, J UROLOGY, V174, P862, DOI 10.1097/01.ju.0000169257.19841.2a; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Karakiewicz PI, 2006, BJU INT, V97, P997, DOI 10.1111/j.1464-410X.2006.06036.x; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; Lotan Y, 2009, BJU INT, V103, P1368, DOI 10.1111/j.1464-410X.2009.08360.x; MARIANI AJ, 1989, J UROLOGY, V141, P350, DOI 10.1016/S0022-5347(17)40763-4; O'Sullivan P, 2012, J UROLOGY, V188, P741, DOI 10.1016/j.juro.2012.05.003; Roobol MJ, 2010, UROL ONCOL-SEMIN ORI, V28, P686, DOI 10.1016/j.urolonc.2009.12.002; Sarosdy MF, 2006, J UROLOGY, V176, P44, DOI 10.1016/S0022-5347(06)00576-3; Schmitz-Drager BJ, 2007, EUR UROL, V51, P1582, DOI 10.1016/j.eururo.2006.10.046; Shariat SF, 2010, BJU INT, V105, P300, DOI 10.1111/j.1464-410X.2009.09076.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Summerton N, 2002, BRIT J GEN PRACT, V52, P284; Witjes JA, 2007, NAT CLIN PRACT UROL, V4, P542, DOI 10.1038/ncpuro0917	17	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77657	10.1371/journal.pone.0077657	http://dx.doi.org/10.1371/journal.pone.0077657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143252	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100091
J	Choudhury, AR; Bhattacharjee, P; Prasad, GS				Choudhury, Anirban Roy; Bhattacharjee, Paramita; Prasad, Gandham S.			Development of Suitable Solvent System for Downstream Processing of Biopolymer Pullulan Using Response Surface Methodology	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; POLYSACCHARIDE; BIOSYNTHESIS; OPTIMIZATION	Downstream processing is an important aspect of all biotechnological processes and has significant implications on quality and yield of the final product. Several solvents were examined for their efficacy on pullulan precipitation from fermentation broth. Interactions among four selected solvents and their effect on pullulan yield were studied using response surface methodology. A polynomial model was developed using D-optimal design and three contour plots were generated by performing 20 different experiments and the model was validated by performing optimization experiments. The results indicated that lower concentration of ethanol in combination with the other three solvents has resulted in higher yield of polymer from fermentation broth and the optimized solvent system was able to recover 1.44 times more pullulan as compared to the conventional ethanolic precipitation method. These observations may help in enhancing efficiency of pullulan recovery from fermentation broth and also result in reduced cost of production for the final product.	[Choudhury, Anirban Roy; Prasad, Gandham S.] CSIR, CSIR Inst Microbial Technol, Chandigarh, India; [Bhattacharjee, Paramita] Jadavpur Univ, Dept Food Technol & Biochem Engn, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Jadavpur University	Choudhury, AR (corresponding author), CSIR, CSIR Inst Microbial Technol, Chandigarh, India.	anirban@imtech.res.in		BHATTACHARJEE, PARAMITA/0000-0002-5620-1675; Prasad, Gandham S/0000-0002-8557-8789	Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to Council of Scientific and Industrial Research (CSIR), Government of India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATLEY BJ, 1980, J GEN MICROBIOL, V120, P265; Chen J, 2012, CARBOHYD POLYM, V87, P771, DOI 10.1016/j.carbpol.2011.08.062; Chi ZM, 2003, ENZYME MICROB TECH, V33, P206, DOI 10.1016/S0141-0229(03)00119-4; Choudhury AR, 2012, BIOCATAL AGRIC BIOTE, V1, P232, DOI 10.1016/j.bcab.2012.02.003; Choudhury AR, 2011, CARBOHYD POLYM, V83, P1547, DOI 10.1016/j.carbpol.2010.10.003; FINKELMAN MAJ, 1982, APPL ENVIRON MICROB, V44, P121, DOI 10.1128/AEM.44.1.121-127.1982; Forabosco A, 2006, CARBOHYD POLYM, V63, P535, DOI 10.1016/j.carbpol.2005.10.005; Israilides CJ, 1998, APPL MICROBIOL BIOT, V49, P613, DOI 10.1007/s002530051222; Jakovljevic D, 2001, J SERB CHEM SOC, V66, P377, DOI 10.2298/JSC0106377J; Kachhawa DK, 2003, CARBOHYD POLYM, V52, P25, DOI 10.1016/S0144-8617(02)00261-8; Kumar D, 2012, INT J BASIC APPL SCI, V1, P202, DOI [DOI 10.14419/IJBAS.V1I3.101, 10.14419/ijbas.v1i3.101]; Lee JH, 2001, BIOTECHNOL LETT, V23, P817, DOI 10.1023/A:1010365706691; POLLOCK TJ, 1992, APPL ENVIRON MICROB, V58, P877, DOI 10.1128/AEM.58.3.877-883.1992; Raymond HM, 1995, RESPONSE SURFACE MET; Reddy PRM, 2003, PROCESS BIOCHEM, V39, P267, DOI 10.1016/S0032-9592(03)00193-0; Rekha MR, 2007, TRENDS BIOMATER ARTI, V20; SHABTAI Y, 1995, APPL MICROBIOL BIOT, V43, P595, DOI [10.1007/s002530050457, 10.1007/BF00164760]; Sharma N, 2013, CARBOHYD POLYM, V93, P95, DOI 10.1016/j.carbpol.2012.06.059; Shingel KI, 2004, CARBOHYD RES, V339, P447, DOI 10.1016/j.carres.2003.10.034; Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003; Singh RS, 2010, BRAZ ARCH BIOL TECHN, V53, P1005, DOI 10.1590/S1516-89132010000500002; Weuster-Botz D, 2000, J BIOSCI BIOENG, V90, P473, DOI 10.1263/jbb.90.473	22	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77071	10.1371/journal.pone.0077071	http://dx.doi.org/10.1371/journal.pone.0077071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143200	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100035
J	Gu, H; Jiang, JH; Li, JY; Zhang, YN; Dong, XS; Huang, YY; Son, XM; Lu, XY; Chen, Z				Gu, Heng; Jiang, Jian-hui; Li, Jian-ying; Zhang, Ya-nan; Dong, Xing-sheng; Huang, Yang-yu; Son, Xin-ming; Lu, Xinyan; Chen, Zheng			A Familial Cri-du-Chat/5p Deletion Syndrome Resulted from Rare Maternal Complex Chromosomal Rearrangements (CCRs) and/or Possible Chromosome 5p Chromothripsis	PLOS ONE			English	Article							DU-CHAT-SYNDROME; CAT-LIKE CRY; PRENATAL-DIAGNOSIS; MOLECULAR CHARACTERIZATION; ABNORMALITIES; PATIENT; GENES	Cri-du-Chat syndrome (MIM 123450) is a chromosomal syndrome characterized by the characteristic features, including catlike cry and chromosome 5p deletions. We report a family with five individuals showing chromosomal rearrangements involving 5p, resulting from rare maternal complex chromosomal rearrangements (CCRs), diagnosed post-and pre-natally by comprehensive molecular and cytogenetic analyses. Two probands, including a 4 1/2-year-old brother and his 2 1/2-year-old sister, showed no diagnostic cat cry during infancy, but presented with developmental delay, dysmorphic and autistic features. Both patients had an interstitial deletion del(5)(p13.3p15.33) spanning similar to 26.22 Mb. The phenotypically normal mother had de novo CCRs involving 11 breakpoints and three chromosomes: ins(11;5)(q23;p14.1p15.31),ins(21;5)(q21;p13.3p14.1),ins(21;5)(q21;p15.31p15.33),inv(7)(p22q32)dn. In addition to these two children, she had three first-trimester miscarriages, two terminations due to the identification of the 5p deletion and one delivery of a phenotypically normal daughter. The unaffected daughter had the maternal ins(11; 5) identified prenatally and an identical maternal allele haplotype of 5p. Array CGH did not detect any copy number changes in the mother, and revealed three interstitial deletions within 5p15.33-p13.3, in the unaffected daughter, likely products of the maternal insertions ins(21; 5). Chromothripsis has been recently reported as a mechanism drives germline CCRs in pediatric patients with congenital defects. We postulate that the unique CCRs in the phenotypically normal mother could resulted from chromosome 5p chromothripsis, that further resulted in the interstitial 5p deletions in the unaffected daughter. Further high resolution sequencing based analysis is needed to determine whether chromothripsis is also present as a germline structural variation in phenotypically normal individuals in this family.	[Gu, Heng; Son, Xin-ming; Chen, Zheng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Med Genet, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Jian-hui] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Jian-ying] Sun Yat Sen Univ, Affiliated Hosp 3, Child Dev Behav Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Ya-nan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infertil & Sexol, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Xing-sheng] Boai Hosp, Prenatal Diag Ctr, Zhongshan, Peoples R China; [Huang, Yang-yu] Chaozhou Women & Children Hosp, Guangzhou, Guangdong, Peoples R China; [Lu, Xinyan] UT MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Gu, Heng] Family Planning Res Inst Guangdong, Guangzhou, Guangdong, Peoples R China; [Lu, Xinyan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Lu, XY (corresponding author), UT MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	xlu4@mdanderson.org; zhengchen19@hotmail.com			National Natural Science Foundation of China [30640028, 30971601]; Natural Science Foundation of Guangdong Province, China [9151008901000089]; Science and Technology Planning Project of Guangdong Province, China [2010B031600039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	This work was supported by National Natural Science Foundation of China (Grant numbers: 30640028, 30971601), Natural Science Foundation of Guangdong Province, China (9151008901000089), and by Science and Technology Planning Project of Guangdong Province, China (Grant number: 2010B031600039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astbury C, 2004, HUM GENET, V114, P448, DOI 10.1007/s00439-003-1079-1; BELL JA, 1981, AUST NZ J OBSTET GYN, V21, P207, DOI 10.1111/j.1479-828X.1981.tb00132.x; Cerruti MP, 2006, ORPHANET J RARE DIS, V1, P1; Chen CP, 2013, GENE, V524, P407, DOI 10.1016/j.gene.2013.03.003; Cornish KM, 1996, ARCH DIS CHILD, V75, P448, DOI 10.1136/adc.75.5.448; de Smith Adam J, 2010, Hugo J, V4, P1, DOI 10.1007/s11568-010-9144-z; Fang JS, 2008, CLIN GENET, V73, P585, DOI 10.1111/j.1399-0004.2008.00995.x; GENEST P, 1979, CLIN GENET, V16, P387; Gow M, 2013, J CELL MOL MED, V17, P657, DOI 10.1111/jcmm.12048; Gruchy N, 2010, AM J MED GENET A, V152A, P185, DOI 10.1002/ajmg.a.33154; Houge G, 2003, AM J MED GENET A, V118A, P235, DOI 10.1002/ajmg.a.10106; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kondoh T, 2005, J HUM GENET, V50, P26, DOI 10.1007/s10038-004-0213-9; KORNER H, 1983, ZBL GYNAKOL, V105, P934; de Carvalho AFL, 2008, HUM GENET, V124, P387, DOI 10.1007/s00439-008-0557-x; Lee MH, 2002, PRENATAL DIAG, V22, P102, DOI 10.1002/pd.224; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Mainardi PC, 2006, EUR J MED GENET, V49, P363, DOI 10.1016/j.ejmg.2005.12.004; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Marinescu RC, 1999, AM J MED GENET, V86, P258, DOI 10.1002/(SICI)1096-8628(19990917)86:3<258::AID-AJMG12>3.0.CO;2-Q; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Patsalis PC, 2007, GENET COUNSEL, V18, P57; Pellestor F, 2011, HUM REPROD UPDATE, V17, P476, DOI 10.1093/humupd/dmr010; Roberti MC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-17; Rodriguez-Caballero A, 2010, MED ORAL PATOL ORAL, V15, pE473, DOI 10.4317/medoral.15.e473; Sreekantaiah C, 1999, AM J MED GENET, V86, P264, DOI 10.1002/(SICI)1096-8628(19990917)86:3<264::AID-AJMG13>3.0.CO;2-Y; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tsao CY, 2005, AM J MED GENET A, V134A, P198, DOI 10.1002/ajmg.a.30592; Tullu M S, 1998, J Postgrad Med, V44, P101; Vera-Carbonell A, 2009, AM J MED GENET A, V149A, P2513, DOI 10.1002/ajmg.a.33055; Wu QF, 2005, EUR J HUM GENET, V13, P475, DOI 10.1038/sj.ejhg.5201345	35	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76985	10.1371/journal.pone.0076985	http://dx.doi.org/10.1371/journal.pone.0076985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143197	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100032
J	Illa, M; Eixarch, E; Batalle, D; Arbat-Plana, A; Munoz-Moreno, E; Figueras, F; Gratacos, E				Illa, Miriam; Eixarch, Elisenda; Batalle, Dafnis; Arbat-Plana, Ariadna; Munoz-Moreno, Emma; Figueras, Francesc; Gratacos, Eduard			Long-Term Functional Outcomes and Correlation with Regional Brain Connectivity by MRI Diffusion Tractography Metrics in a Near-Term Rabbit Model of Intrauterine Growth Restriction	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; WHITE-MATTER ABNORMALITIES; ANTERIOR CINGULATE CORTEX; OBJECT-RECOGNITION MEMORY; PREFRONTAL CORTEX; FETAL-GROWTH; BORN SMALL; STRUCTURAL CONNECTIVITY; DEVELOPMENTAL-CHANGES	Background: Intrauterine growth restriction (IUGR) affects 5-10% of all newborns and is associated with increased risk of memory, attention and anxiety problems in late childhood and adolescence. The neurostructural correlates of long-term abnormal neurodevelopment associated with IUGR are unknown. Thus, the aim of this study was to provide a comprehensive description of the long-term functional and neurostructural correlates of abnormal neurodevelopment associated with IUGR in a near-term rabbit model (delivered at 30 days of gestation) and evaluate the development of quantitative imaging biomarkers of abnormal neurodevelopment based on diffusion magnetic resonance imaging (MRI) parameters and connectivity. Methodology: At + 70 postnatal days, 10 cases and 11 controls were functionally evaluated with the Open Field Behavioral Test which evaluates anxiety and attention and the Object Recognition Task that evaluates short-term memory and attention. Subsequently, brains were collected, fixed and a high resolution MRI was performed. Differences in diffusion parameters were analyzed by means of voxel-based and connectivity analysis measuring the number of fibers reconstructed within anxiety, attention and short-term memory networks over the total fibers. Principal Findings: The results of the neurobehavioral and cognitive assessment showed a significant higher degree of anxiety, attention and memory problems in cases compared to controls in most of the variables explored. Voxel-based analysis (VBA) revealed significant differences between groups in multiple brain regions mainly in grey matter structures, whereas connectivity analysis demonstrated lower ratios of fibers within the networks in cases, reaching the statistical significance only in the left hemisphere for both networks. Finally, VBA and connectivity results were also correlated with functional outcome. Conclusions: The rabbit model used reproduced long-term functional impairments and their neurostructural correlates of abnormal neurodevelopment associated with IUGR. The description of the pattern of microstructural changes underlying functional defects may help to develop biomarkers based in diffusion MRI and connectivity analysis.	[Illa, Miriam; Eixarch, Elisenda; Figueras, Francesc; Gratacos, Eduard] Hosp Clin Barcelona, Dept Maternal Fetal Med, Inst Clin Ginecol Obstet & Neonatol ICGON, Barcelona, Spain; [Illa, Miriam; Eixarch, Elisenda; Batalle, Dafnis; Arbat-Plana, Ariadna; Munoz-Moreno, Emma; Figueras, Francesc; Gratacos, Eduard] Univ Barcelona, Fetal & Perinatal Med Res Grp, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Eixarch, Elisenda; Figueras, Francesc; Gratacos, Eduard] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gratacos, E (corresponding author), Hosp Clin Barcelona, Dept Maternal Fetal Med, Inst Clin Ginecol Obstet & Neonatol ICGON, Barcelona, Spain.	egratacos@clinic.ub.es	Batalle, Dafnis/H-7531-2019; Muñoz-Moreno, Emma/A-2363-2016; Muñoz-Moreno, Emma/ABD-6424-2021; Gratacos, Eduard/AAR-4939-2020	Batalle, Dafnis/0000-0003-2097-979X; Muñoz-Moreno, Emma/0000-0003-2104-7265; Muñoz-Moreno, Emma/0000-0003-2104-7265; Gratacos, Eduard/0000-0002-7405-7224; Arbat-Plana, Ariadna/0000-0003-0479-8323; Illa, Miriam/0000-0002-8366-830X; Eixarch, Elisenda/0000-0001-7379-9608	Fondo de Investigacion Sanitaria [PI08/0230, PI12/00851]; Rio Hortega grant [CM11/00032]; Sara Borrell grant [CD11/00048]; Instituto de Salud Carlos III; Obra Social "la Caixa"; Hospital Clinic	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Rio Hortega grant; Sara Borrell grant; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Obra Social "la Caixa"(La Caixa Foundation); Hospital Clinic	This work was supported by Fondo de Investigacion Sanitaria (PI08/0230 and PI12/00851), Rio Hortega grant (CM11/00032 to M. I.) and Sara Borrell grant (CD11/00048 to E. M.) from Instituto de Salud Carlos III; "Obra Social "la Caixa"; and Emili Letang fellowship by Hospital Clinic (to M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Alati R, 2009, INT J EPIDEMIOL, V38, P1390, DOI 10.1093/ije/dyp252; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Balasch J, 2011, FETAL DIAGN THER, V29, P263, DOI 10.1159/000323142; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Bassan H, 2011, PEDIATR NEUROL, V44, P122, DOI 10.1016/j.pediatrneurol.2010.09.012; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Battaglia FP, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00036; Berman J I, 2011, AJNR Am J Neuroradiol, V32, pE21, DOI 10.3174/ajnr.A1975; Bouet V, 2003, BEHAV BRAIN RES, V139, P97, DOI 10.1016/S0166-4328(02)00085-2; Brown MW, 2010, HIPPOCAMPUS, V20, P1228, DOI 10.1002/hipo.20858; Butler RK, 2012, EXP NEUROL, V238, P52, DOI 10.1016/j.expneurol.2012.08.002; Cowan N, 1999, CHILD DEV, V70, P1082, DOI 10.1111/1467-8624.00080; D'Arceuil H, 2008, DEV NEUROSCI-BASEL, V30, P262, DOI 10.1159/000110503; Daenen EWPM, 2001, BRAIN RES, V918, P153, DOI 10.1016/S0006-8993(01)02987-0; de Bruin N, 2006, PHARMACOL BIOCHEM BE, V85, P253, DOI 10.1016/j.pbb.2006.08.007; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Delatour B, 2002, EUR J NEUROSCI, V15, P1400, DOI 10.1046/j.1460-9568.2002.01973.x; Delcour M, 2012, BEHAV BRAIN RES, V232, P233, DOI 10.1016/j.bbr.2012.03.029; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Dere E, 2006, NEUROSCI BIOBEHAV R, V30, P1206, DOI 10.1016/j.neubiorev.2006.09.005; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Duncan GE, 1996, BRAIN RES, V713, P79, DOI 10.1016/0006-8993(95)01486-1; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Einarsson EO, 2012, LEARN MEMORY, V19, P449, DOI 10.1101/lm.027227.112; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Emond V, 2009, ENCEPHALE, V35, P107, DOI 10.1016/j.encep.2008.01.005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Feldman R, 2006, PEDIATRICS, V118, pE869, DOI 10.1542/peds.2005-2040; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hall FS, 2012, PHYSIOL BEHAV, V107, P623, DOI 10.1016/j.physbeh.2012.05.014; Hardee JE, 2008, SOC COGN AFFECT NEUR, V3, P47, DOI 10.1093/scan/nsn001; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders, 2011, SEX DIFF IMPL TRANSL; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; KOOB GF, 1993, CIBA F SYMP, V172, P277; Kowalska D BP, 2008, ETH WELF 2008 9 WORL; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Marsal K, 2002, CURR OPIN OBSTET GYN, V14, P127, DOI 10.1097/00001703-200204000-00005; Martin-Fernandez M, 2007, MAGN RESON IMAGING, V25, P278, DOI 10.1016/j.mri.2006.05.001; McCarton CM, 1996, PEDIATRICS, V98, P1167; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Miller MM, 2012, BEHAV BRAIN RES, V229, P280, DOI 10.1016/j.bbr.2012.01.029; Modi S, 2013, BEHAV BRAIN RES, V238, P188, DOI 10.1016/j.bbr.2012.10.007; Moorman WJ, 2000, ANDROLOGIA, V32, P285, DOI 10.1046/j.1439-0272.2000.00400.x; Morsing E, 2011, PEDIATRICS, V127, pE874, DOI 10.1542/peds.2010-1821; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Munoz-Moreno E, 2009, COMPUT BIOL MED, V39, P251, DOI 10.1016/j.compbiomed.2008.12.011; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; OLTON DS, 1981, EXP BRAIN RES, V41, P380; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Ortibus E, 2012, DEV MED CHILD NEUROL, V54, P38, DOI 10.1111/j.1469-8749.2011.04147.x; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Powell HWR, 2004, NEUROIMAGE, V22, P740, DOI 10.1016/j.neuroimage.2004.01.011; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rha DW, 2012, NEURORADIOLOGY, V54, P615, DOI 10.1007/s00234-011-0996-2; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; ROYSTON P, 1993, STAT MED, V12, P181, DOI 10.1002/sim.4780120209; Roze E, 2012, NEURORADIOLOGY, V54, P507, DOI 10.1007/s00234-011-0969-5; Salami M, 2003, P NATL ACAD SCI USA, V100, P6174, DOI 10.1073/pnas.0937380100; Sanz-Cortes M, 2013, FETAL DIAGN THER, V33, P122, DOI 10.1159/000346566; Sanz-Cortes M, 2010, ULTRASOUND OBST GYN, V36, P159, DOI 10.1002/uog.7724; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Scherjon S, 2000, PEDIATRICS, V105, P385, DOI 10.1542/peds.105.2.385; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Spampinato MV, 2009, J NEUROPSYCH CLIN N, V21, P199, DOI 10.1176/appi.neuropsych.21.2.199; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tideman E, 2007, ULTRASOUND OBST GYN, V29, P614, DOI 10.1002/uog.4042; Toft PB, 1999, PEDIATR NEUROL, V21, P602, DOI 10.1016/S0887-8994(99)00046-6; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Toussaint N., 2007, P MICCAI 07 WORKSH I; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Vasiliadis HM, 2010, DEPRESS ANXIETY, V27, P1066, DOI 10.1002/da.20739; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; WALSH RN, 1975, PSYCHOL BULL, V82, P986; Wang S, 2009, AM J NEURORADIOL, V30, P1907, DOI 10.3174/ajnr.A1697; Wang Y, 2012, PSYCHIAT RES-NEUROIM, V202, P245, DOI 10.1016/j.pscychresns.2012.01.005; Wang Y, 2012, BBA-MOL BASIS DIS, V1822, P423, DOI 10.1016/j.bbadis.2011.08.002; Watanabe Y, 2012, NEUROSCI BIOBEHAV R, V36, P134, DOI 10.1016/j.neubiorev.2011.05.003; Weible AP, 2012, J NEUROSCI, V32, P5598, DOI 10.1523/JNEUROSCI.5265-11.2012; Weible AP, 2009, J NEUROPHYSIOL, V102, P2055, DOI 10.1152/jn.00214.2009; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477; Zhao P, 2005, NEUROBIOL DIS, V20, P871, DOI 10.1016/j.nbd.2005.05.024; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	127	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76453	10.1371/journal.pone.0076453	http://dx.doi.org/10.1371/journal.pone.0076453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143189	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100024
J	Li, M; Gao, JP; Feng, RH; Wang, YL; Chen, XH; Sun, JY; Zhang, DQ; Zhu, ZG; Ellis, LM; Lu, M; Lee, JE; Feng, ZQ; Liu, BY				Li, Ming; Gao, Jianpeng; Feng, Runhua; Wang, Yuling; Chen, Xuehua; Sun, Jianyu; Zhang, Dongqing; Zhu, Zhenggang; Ellis, Lee M.; Lu, Mason; Lee, Jeffrey E.; Feng, Zhenqing; Liu, Bingya			Generation of Monoclonal Antibody MS17-57 Targeting Secreted Alkaline Phosphatase Ectopically Expressed on the Surface of Gastrointestinal Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ANTIGEN; INHIBITION; BIOMARKERS; ISOENZYMES; DIAGNOSIS; FEATURES; REGIONS; MARKER	Background: Therapeutic antibody development is one of the fastest growing areas of the pharmaceutical industry. Generating high-quality monoclonal antibodies against a given therapeutic target is crucial for successful drug development. However, due to immune tolerance, making it difficult to generate antibodies using conventional approaches. Methodology/Findings: Mixed four human gastric cancer (GC) cell lines were used as the immunogen in A/J mice; sixteen highly positive hybridoma colonies were selected via fluorescence-activated cell sorting-high throughput screening (FACS-HTS) using a total of 20,000 colonies in sixty-seven 96-well plates against live cells (mixed human GC cells versus human PBMC controls). MS17-57 and control commercial Alkaline Phosphatase (ALP) mAbs were used to confirm the target antigens (Ags), which were identified as ALPs expressed on the GC cell surface through a combination of western blot, immunoprecipitation and mass spectrometry (MS). MS identified the Ags recognized by MS17-57 to be two variants of a secreted ALP, PALP and IALP (Placental and intestinal ALP). These proteins belong to a hydrolase enzyme family responsible for removing phosphate groups from many types of molecules. Immunofluorescence staining using MS17-57 demonstrated higher staining of gastrointestinal (GI) cancer tissues compared to normal GI tissues (P<0.03), and confirmed binding of MS17-57 to be restricted to a functional epitope expressed on the cancer cell surface. Proliferation assays using the PALP/IALP-expressing GC cell lines demonstrated that MS17-57 inhibited cell growth by 32 +/- 8%. Transwell cell migration assays documented that MS17-57 can inhibit PALP/IALP-expressing GI cancer cell migration by 25 +/- 5%. MS17-57 mAb inhibited tumor growth in nude mice. Conclusions: Our findings indicate that PALP and IALP can be ectopically expressed on extracellular matrix of GI cancers, and that MS17-57 directed against PALP/IALP can inhibit GI cancer cells growth and migration in vitro and in vivo. This investigation provides an example of identification of cancer biomarkers representing promising therapeutic targets using mAb generated through a novel HTS technology.	[Li, Ming; Feng, Zhenqing] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Gao, Jianpeng; Feng, Runhua; Chen, Xuehua; Zhu, Zhenggang; Liu, Bingya] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Shanghai Inst Digest Surg, Ruijing Hosp,Sch Med, Shanghai 200030, Peoples R China; [Feng, Runhua; Wang, Yuling; Ellis, Lee M.; Lu, Mason; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Sun, Jianyu; Lu, Mason] Shanghai MabStar Inc, Shanghai, Peoples R China; [Zhang, Dongqing] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Shanghai Jiao Tong University	Feng, ZQ (corresponding author), Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China.	fengzhenqing@njmu.edu.cn; byliu@sjtu.edu.cn	Liu, Bingya/GMW-5655-2022; Gao, Jianpeng/ABA-5373-2020	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81201596, 81101847, 81172324, 91229106, 31270963]; Key Projects in the National Science & Technology Pillar Program of China [2011BA203191]; Science and Technology Commission of Shanghai Municipality [12XD1403700, 12PJ1406300]; Research Fund for the Doctoral Program of Higher Education of China [20110073110071]; Key Project of Shanghai Education Committee [12ZZ105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Shanghai Education Committee	This work was supported by the National Natural Science Foundation of China (grant numbers 81201596, 81101847, 81172324, 91229106, 31270963); Key Projects in the National Science & Technology Pillar Program of China (2011BA203191); Science and Technology Commission of Shanghai Municipality (12XD1403700, 12PJ1406300); Research Fund for the Doctoral Program of Higher Education of China (20110073110071); Key Project of Shanghai Education Committee (12ZZ105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDPIRAK E, 1988, J NATL CANCER I, V80, P1605, DOI 10.1093/jnci/80.20.1605; Akagi M, 2003, BRIT J CANCER, V88, P796, DOI 10.1038/sj.bjc.6600811; Arvy L, 1969, Int Rev Cytol, V25, P333, DOI 10.1016/S0074-7696(08)60207-7; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Ferianec V, 2011, NEUROENDOCRINOL LETT, V32, P154; GALAM L, 2007, HIGH THROUGHPUT ASSA; Gotoh A, 2008, CLIN CHIM ACTA, V397, P13, DOI 10.1016/j.cca.2008.07.006; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Honda K, 2013, JPN J CLIN ONCOL, V43, P103, DOI 10.1093/jjco/hys200; Hong CW, 2012, CANCER RES, V72, P3715, DOI 10.1158/0008-5472.CAN-12-0063; Iqbal SJ, 2000, ANN CLIN BIOCHEM, V37, P775, DOI 10.1258/0004563001900093; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kotloff KL, 1996, VACCINE, V14, P1174; Krieg R, 2003, CELL MOL BIOL, V49, P547; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Li JJ, 2013, TRANSL ONCOL, V6, P42, DOI 10.1593/tlo.12367; Li L, 2012, ASIAN PAC J CANCER P, V13, P2069, DOI 10.7314/APJCP.2012.13.5.2069; LINDHOLM L, 1983, INT ARCH ALLER A IMM, V71, P178, DOI 10.1159/000233384; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; Mehan MR, 2013, ADV EXP MED BIOL, V735, P283, DOI 10.1007/978-1-4614-4118-2_20; Motwani M, 2003, MOL CANCER THER, V2, P549; Ofran Y, 2008, J IMMUNOL, V181, P6230, DOI 10.4049/jimmunol.181.9.6230; Ozyoruk F, 2001, CLIN DIAGN LAB IMMUN, V8, P44, DOI 10.1128/CDLI.8.1.44-51.2001; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peters E, 2013, J PHARMACOL EXP THER, V344, P2, DOI 10.1124/jpet.112.198226; Prassas I, 2008, CLIN CANCER RES, V14, P5778, DOI 10.1158/1078-0432.CCR-08-0706; RATHJEN DA, 1986, HYBRIDOMA, V5, P255, DOI 10.1089/hyb.1986.5.255; Siddique A, 2012, CLIN LIVER DIS, V16, P199, DOI 10.1016/j.cld.2012.03.012; Song JG, 2006, NEOPLASIA, V8, P995, DOI 10.1593/neo.06592; Takahashi Y, 2000, INT J CANCER, V85, P243, DOI 10.1002/(SICI)1097-0215(20000115)85:2<243::AID-IJC15>3.0.CO;2-2; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Wong HH, 2012, J GASTROINTEST ONCOL, V3, P262, DOI 10.3978/j.issn.2078-6891.2012.019; Wu HR, 1999, J MOL BIOL, V294, P151, DOI 10.1006/jmbi.1999.3141; Yang XQ, 2009, HEPATO-GASTROENTEROL, V56, P1388; Yoshinari K, 1999, CYTOTECHNOLOGY, V31, P255, DOI 10.1023/A:1008061424281	37	5	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77398	10.1371/journal.pone.0077398	http://dx.doi.org/10.1371/journal.pone.0077398			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143229	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100066
J	Provenzano, JC; Siqueira, JF; Rocas, IN; Domingues, RR; Leme, AFP; Silva, MRS				Provenzano, Jose Claudio; Siqueira, Jose F., Jr.; Rocas, Isabela N.; Domingues, Romenia R.; Paes Leme, Adriana F.; Silva, Marcia R. S.			Metaproteome Analysis of Endodontic Infections in Association with Different Clinical Conditions	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXIDATIVE-STRESS; ANTIBIOTIC-RESISTANCE; BACTERIA; MICROBIOTA; PROTEOMICS; PATHOGENESIS; REDUCTION; DIVERSITY; COMMUNITY	Analysis of the metaproteome of microbial communities is important to provide an insight of community physiology and pathogenicity. This study evaluated the metaproteome of endodontic infections associated with acute apical abscesses and asymptomatic apical periodontitis lesions. Proteins persisting or expressed after root canal treatment were also evaluated. Finally, human proteins associated with these infections were identified. Samples were taken from root canals of teeth with asymptomatic apical periodontitis before and after chemomechanical treatment using either NaOCl or chlorhexidine as the irrigant. Samples from abscesses were taken by aspiration of the purulent exudate. Clinical samples were processed for analysis of the exoproteome by using two complementary mass spectrometry platforms: nanoflow liquid chromatography coupled with linear ion trap quadrupole Velos Orbitrap and liquid chromatography-quadrupole time-of-flight. A total of 308 proteins of microbial origin were identified. The number of proteins in abscesses was higher than in asymptomatic cases. In canals irrigated with chlorhexidine, the number of identified proteins decreased substantially, while in the NaOCl group the number of proteins increased. The large majority of microbial proteins found in endodontic samples were related to metabolic and housekeeping processes, including protein synthesis, energy metabolism and DNA processes. Moreover, several other proteins related to pathogenicity and resistance/ survival were found, including proteins involved with adhesion, biofilm formation and antibiotic resistance, stress proteins, exotoxins, invasins, proteases and endopeptidases ( mostly in abscesses), and an archaeal protein linked to methane production. The majority of human proteins detected were related to cellular processes and metabolism, as well as immune defense. Interrogation of the metaproteome of endodontic microbial communities provides information on the physiology and pathogenicity of the community at the time of sampling. There is a growing need for expanded and more curated protein databases that permit more accurate identifications of proteins in metaproteomic studies.	[Provenzano, Jose Claudio; Silva, Marcia R. S.] Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, Rio De Janeiro, RJ, Brazil; [Provenzano, Jose Claudio; Siqueira, Jose F., Jr.; Rocas, Isabela N.] Estacio de Sa Univ, Fac Dent, Dept Endodont, Rio De Janeiro, RJ, Brazil; [Domingues, Romenia R.; Paes Leme, Adriana F.] LNBio, Brazilian Biosci Natl Lab, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro	Provenzano, JC (corresponding author), Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, Rio De Janeiro, RJ, Brazil.	odontojcp@gmail.com	Leme, Adriana F Paes/C-9679-2012	Leme, Adriana F Paes/0000-0001-7959-147X; Soares, Marcia/0000-0001-9272-9488	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Governmental Institutions	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Governmental Institutions	This study was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Governmental Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; [Anonymous], 2007, BIOFILM PRIMER; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Goulhen F, 2003, CRIT REV ORAL BIOL M, V14, P399, DOI 10.1177/154411130301400603; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Hernandez F, 2012, ANAL BIOANAL CHEM, V403, P1251, DOI 10.1007/s00216-012-5844-7; HESS HH, 1978, ANAL BIOCHEM, V85, P295, DOI 10.1016/0003-2697(78)90304-4; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; Jungermann GB, 2011, J ENDODONT, V37, P1337, DOI 10.1016/j.joen.2011.06.028; Kawakami R, 2004, J BIOCHEM, V136, P541, DOI 10.1093/jb/mvh157; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Leme AFP, 2008, CARIES RES, V42, P435, DOI 10.1159/000159607; Li YF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S4; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Nandakumar R, 2009, ORAL MICROBIOL IMMUN, V24, P347, DOI 10.1111/j.1399-302X.2009.00520.x; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Ribeiro AC, 2011, J ENDODONT, V37, P922, DOI 10.1016/j.joen.2011.04.007; Ricucci D, 2010, J ENDODONT, V36, P1277, DOI 10.1016/j.joen.2010.04.007; Rocas IN, 2012, ANAEROBE, V18, P576, DOI 10.1016/j.anaerobe.2012.10.001; Rudney JD, 2010, MOL ORAL MICROBIOL, V25, P38, DOI 10.1111/j.2041-1014.2009.00558.x; Sakamoto M, 2007, ORAL MICROBIOL IMMUN, V22, P19, DOI 10.1111/j.1399-302X.2007.00315.x; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Sato I, 1996, INT ENDOD J, V29, P118, DOI 10.1111/j.1365-2591.1996.tb01172.x; Schneider T, 2010, PROTEOMICS, V10, P785, DOI 10.1002/pmic.200900450; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira Jr José F., 2007, Braz. Dent. J., V18, P267, DOI 10.1590/S0103-64402007000400001; Siqueira JF, 2013, CLIN MICROBIOL REV, V26, P255, DOI 10.1128/CMR.00082-12; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P870, DOI 10.1016/j.tripleo.2009.01.044; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Torabinejad M, 2003, J ENDODONT, V29, P170, DOI 10.1097/00004770-200303000-00002; Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d	53	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76108	10.1371/journal.pone.0076108	http://dx.doi.org/10.1371/journal.pone.0076108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143178	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100013
J	Spangenberg, L; Correa, A; Dallagiovanna, B; Naya, H				Spangenberg, Lucia; Correa, Alejandro; Dallagiovanna, Bruno; Naya, Hugo			Role of Alternative Polyadenylation during Adipogenic Differentiation: An In Silico Approach	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; 3' UNTRANSLATED REGIONS; MESSENGER-RNAS; EXPRESSION; MICRORNAS; MOUSE; TRANSCRIPTOME; PLURIPOTENCY; DETERMINANTS; NETWORKS	Post-transcriptional regulation of stem cell differentiation is far from being completely understood. Changes in protein levels are not fully correlated with corresponding changes in mRNAs; the observed differences might be partially explained by post-transcriptional regulation mechanisms, such as alternative polyadenylation. This would involve changes in protein binding, transcript usage, miRNAs and other non-coding RNAs. In the present work we analyzed the distribution of alternative transcripts during adipogenic differentiation and the potential role of miRNAs in post-transcriptional regulation. Our in silico analysis suggests a modest, consistent, bias in 3'UTR lengths during differentiation enabling a fine-tuned transcript regulation via small non-coding RNAs. Including these effects in the analyses partially accounts for the observed discrepancies in relative abundance of protein and mRNA.	[Spangenberg, Lucia; Naya, Hugo] Inst Pasteur Montevideo, Bioinformat Unit, Montevideo, Uruguay; [Correa, Alejandro; Dallagiovanna, Bruno] Fiocruz Parana, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Naya, Hugo] Univ Republ, Dept Prod Anim & Pasturas, Fac Agron, Curitiba, Parana, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Fundacao Oswaldo Cruz	Naya, H (corresponding author), Inst Pasteur Montevideo, Bioinformat Unit, Montevideo, Uruguay.	naya@pasteur.edu.uy	Dallagiovanna, Bruno/AAA-3603-2019	Dallagiovanna, Bruno/0000-0001-6992-7048; Naya, Hugo/0000-0001-6982-4399	Ministerio da Saude; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; FIOCRUZ-Pasteur Research Program; Fundacao Araucaria; ANII (Agencia Nacional de Investigacion e Innovacion, Uruguay)	Ministerio da Saude; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-Pasteur Research Program; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); ANII (Agencia Nacional de Investigacion e Innovacion, Uruguay)	This work was supported by grants from Ministerio da Saude and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, FIOCRUZ-Pasteur Research Program and Fundacao Araucaria. Lucia Spangenberg received a fellowship from ANII (Agencia Nacional de Investigacion e Innovacion, Uruguay); Bruno Dallagiovanna was supported by CNPq, Hugo Naya by FIOCRUZ-Pasteur and Alejandro Correa received a fellowship from Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fernandez-Tresguerres B, 2010, P NATL ACAD SCI USA, V107, P19955, DOI 10.1073/pnas.1010708107; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Fromm-Dornieden C, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-9; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gentleman R, 2012, MICRORNA DATA FUNCTI; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hu ZH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-594; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaager K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038833; Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kasashima K, 2004, BIOCHEM BIOPH RES CO, V322, P403, DOI 10.1016/j.bbrc.2004.07.130; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Kolle G, 2011, GENOME RES, V21, P2014, DOI 10.1101/gr.119321.110; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liaw HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056958; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Meenhuis A, 2011, BLOOD, V118, P916, DOI 10.1182/blood-2011-02-336487; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Rosenbaum Andrew J, 2008, Organogenesis, V4, P23; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Spangenberg L, 2013, STEM CELL RES, V1, P341; Stevens SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057625; Tae SK, 2006, J CELLULAR PHYSL, V1, P341; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuller T, 2007, PLOS COMPUTATIONAL B, V3, P10; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Uccelli A, 2008, AUTOIMMUNITY, V41, P592, DOI 10.1080/08916930802200166; Zambelli F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-534; Zhang J, 2012, J BIOL CHEM; Zhang R, 2013, FRONT MED-PRC, V7, P223, DOI 10.1007/s11684-013-0252-8	50	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75578	10.1371/journal.pone.0075578	http://dx.doi.org/10.1371/journal.pone.0075578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143171	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100006
J	Chang, JM; Taly, JF; Erb, I; Sung, TY; Hsu, WL; Tang, CY; Notredame, C; Su, ECY				Chang, Jia-Ming; Taly, Jean-Francois; Erb, Ionas; Sung, Ting-Yi; Hsu, Wen-Lian; Tang, Chuan Yi; Notredame, Cedric; Su, Emily Chia-Yu			Efficient and Interpretable Prediction of Protein Functional Classes by Correspondence Analysis and Compact Set Relations	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION PREDICTION; MULTIPLE SEQUENCE ALIGNMENT; SUPPORT VECTOR MACHINES; CLASSIFICATION; ALGORITHM; BINDING; SIGNALP	Predicting protein functional classes such as localization sites and modifications plays a crucial role in function annotation. Given a tremendous amount of sequence data yielded from high-throughput sequencing experiments, the need of efficient and interpretable prediction strategies has been rapidly amplified. Our previous approach for subcellular localization prediction, PSLDoc, archives high overall accuracy for Gram-negative bacteria. However, PSLDoc is computational intensive due to incorporation of homology extension in feature extraction and probabilistic latent semantic analysis in feature reduction. Besides, prediction results generated by support vector machines are accurate but generally difficult to interpret. In this work, we incorporate three new techniques to improve efficiency and interpretability. First, homology extension is performed against a compact non-redundant database using a fast search model to reduce running time. Second, correspondence analysis (CA) is incorporated as an efficient feature reduction to generate a clear visual separation of different protein classes. Finally, functional classes are predicted by a combination of accurate compact set (CS) relation and interpretable one-nearest neighbor (1-NN) algorithm. Besides localization data sets, we also apply a human protein kinase set to validate generality of our proposed method. Experiment results demonstrate that our method make accurate prediction in a more efficient and interpretable manner. First, homology extension using a fast search on a compact database can greatly accelerate traditional running time up to twenty-five times faster without sacrificing prediction performance. This suggests that computational costs of many other predictors that also incorporate homology information can be largely reduced. In addition, CA can not only efficiently identify discriminative features but also provide a clear visualization of different functional classes. Moreover, predictions based on CS achieve 100% precision. When combined with 1-NN on unpredicted targets by CS, our method attains slightly better or comparable performance compared with the state-of-the-art systems.	[Chang, Jia-Ming; Erb, Ionas; Notredame, Cedric] CRG, Barcelona, Spain; [Chang, Jia-Ming; Taly, Jean-Francois; Erb, Ionas; Notredame, Cedric] UPF, Barcelona, Spain; [Taly, Jean-Francois] CRG, Bioinformat Core Facil, Barcelona, Spain; [Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Bioinformat Lab, Taipei, Taiwan; [Tang, Chuan Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Tang, Chuan Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Su, Emily Chia-Yu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Academia Sinica - Taiwan; National Tsing Hua University; Providence University - Taiwan; Taipei Medical University	Su, ECY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.	emilysu@tmu.edu.tw	Sung, Ting-Yi/AAQ-5413-2021; Chang, Jia-Ming/A-5642-2008; Hsu, Wen-Lian/ABB-2851-2020; notredame, cedric/G-3868-2010	Sung, Ting-Yi/0000-0002-6028-0409; Chang, Jia-Ming/0000-0002-6711-1739; Hsu, Wen-Lian/0000-0001-7061-3513; notredame, cedric/0000-0003-1461-0988; Erb, Ionas/0000-0002-2331-9714	National Science Council [NSC101-2221-E-038-014]; "Caixa'' pre-doctoral fellowship; Centre de Regulacio Genomica (CRG); Plan Nacional [BFU2011-28575]; Ministerio de Economia y Competitividad	National Science Council(Ministry of Science and Technology, Taiwan); "Caixa'' pre-doctoral fellowship; Centre de Regulacio Genomica (CRG); Plan Nacional; Ministerio de Economia y Competitividad(Spanish Government)	The research was supported in part by National Science Council under grant NSC101-2221-E-038-014 to Emily Chia-Yu Su. Jia-Ming Chang and Cedric Notredame are funded by "a Caixa'' pre-doctoral fellowship, the Centre de Regulacio Genomica (CRG) and the Plan Nacional (BFU2011-28575) funded by the Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Chang JM, 2008, PROTEINS, V72, P693, DOI 10.1002/prot.21944; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Chang JM, 2002, COMPACT SET NEIGHBOR; Chang JM, 2002, COMPACT SET RELATION; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; DEKEL E, 1992, INFORM PROCESS LETT, V44, P285, DOI 10.1016/0020-0190(92)90215-H; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fleissner R, 2005, SYST BIOL, V54, P548, DOI 10.1080/10635150590950371; Greenacre M., 2010, BIPLOTS PRACTICE; Greenacre M.J., 1984, THEORY APPL CORRES A; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hawkins J, 2007, J PROTEOME RES, V6, P1402, DOI 10.1021/pr060564n; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karypis G, 2006, PROTEINS, V64, P575, DOI 10.1002/prot.21036; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kim SK, 1996, INFORM PROCESS LETT, V57, P335, DOI 10.1016/0020-0190(96)00017-8; Korf I., 2003, BLAST OREILLY MEDIA; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leiserson CE, 2001, INTRO ALGORITHMS; Lin HN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S8; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; SCHIEBER B, 1988, SIAM J COMPUT, V17, P1253, DOI 10.1137/0217079; Su ECY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-330; Su ECY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S13; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang SL, 2012, J BIOMOL STRUCT DYN, V29, P634, DOI 10.1080/07391102.2011.672627; ZIVKOVIC D, 1991, INFORM PROCESS LETT, V38, P339, DOI 10.1016/0020-0190(91)90092-V	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75542	10.1371/journal.pone.0075542	http://dx.doi.org/10.1371/journal.pone.0075542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146760	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400011
J	Fang, NF; Shi, ZH; Yue, BJ; Wang, L				Fang, Nu-Fang; Shi, Zhi-Hua; Yue, Ben-Jiang; Wang, Ling			The Characteristics of Extreme Erosion Events in a Small Mountainous Watershed	PLOS ONE			English	Article							SUSPENDED SEDIMENT TRANSPORT; LAND-USE CHANGE; ABANDONED FARMLAND CATCHMENT; CENTRAL SPANISH PYRENEES; SOIL-EROSION; AGRICULTURAL CATCHMENT; EPHEMERAL CHANNELS; RAINFALL EVENTS; SE SPAIN; RUNOFF	A large amount of soil loss is caused by a small number of extreme events that are mainly responsible for the time compression of geomorphic processes. The aim of this study was to analyze suspended sediment transport during extreme erosion events in a mountainous watershed. Field measurements were conducted in Wangjiaqiao, a small agricultural watershed (16.7 km(2)) in the Three Gorges Area (TGA) of China. Continuous records were used to analyze suspended sediment transport regimes and assess the sediment loads of 205 rainfall-runoff events during a period of 16 hydrological years (1989-2004). Extreme events were defined as the largest events, ranked in order of their absolute magnitude (representing the 95th percentile). Ten extreme erosion events from 205 erosion events, representing 83.8% of the total suspended sediment load, were selected for study. The results of canonical discriminant analysis indicated that extreme erosion events are characterized by high maximum flood-suspended sediment concentrations, high runoff coefficients, and high flood peak discharge, which could possibly be explained by the transport of deposited sediment within the stream bed during previous events or bank collapses.	[Fang, Nu-Fang; Shi, Zhi-Hua] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Fang, Nu-Fang; Shi, Zhi-Hua; Yue, Ben-Jiang; Wang, Ling] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Fang, Nu-Fang; Shi, Zhi-Hua; Yue, Ben-Jiang; Wang, Ling] Minist Water Resources, Yangling, Peoples R China; [Shi, Zhi-Hua] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Huazhong Agricultural University	Shi, ZH (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	pengshi@mail.hzau.edu.cn	Shi, Zhiahua/S-9311-2019; Shi, ZH/F-7342-2012; Wang, Lingqing/AAF-7692-2020	Shi, ZH/0000-0002-6961-1518; 	National Natural Science Foundation of China [41071190]; Program for New Century Excellent Talents in University [NCET-10-0423]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support for this research was provided by the National Natural Science Foundation of China (41071190) and the Program for New Century Excellent Talents in University (NCET-10-0423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, STUDY SOIL EROSION 3; Bakker MM, 2008, GEOMORPHOLOGY, V98, P213, DOI 10.1016/j.geomorph.2006.12.027; Bathurst JC, 2010, WATER INT, V35, P114, DOI 10.1080/02508061003660714; Belmonte AMC, 2001, CATENA, V45, P229; Bull LJ, 2000, CATENA, V38, P191, DOI 10.1016/S0341-8162(99)00071-5; Gonzalez-Hidalgo JC, 2012, CATENA, V95, P85, DOI 10.1016/j.catena.2012.03.006; Chen LD, 2001, AGR ECOSYST ENVIRON, V86, P163, DOI 10.1016/S0167-8809(00)00271-1; Chu ZX, 2008, J COASTAL RES, V24, P30, DOI 10.2112/05-0547.1; Coppus R, 2002, EARTH SURF PROC LAND, V27, P1365, DOI 10.1002/esp.435; Dai ZJ, 2011, AMBIO, V40, P496, DOI 10.1007/s13280-011-0148-2; Estrany J, 2010, J HYDROL, V380, P180, DOI 10.1016/j.jhydrol.2009.10.035; Fang NF, 2011, GEOMORPHOLOGY, V135, P158, DOI 10.1016/j.geomorph.2011.08.013; Fu ZY, 2011, GEODERMA, V167-68, P41, DOI 10.1016/j.geoderma.2011.08.013; Garcia-Ruiz JM, 2005, CATENA, V59, P79, DOI 10.1016/j.catena.2004.05.006; Gonzalez-Hidalgo JC, 2007, CATENA, V71, P193, DOI 10.1016/j.catena.2007.03.005; Hewlett J.D., 1967, FOREST HYDROLOGY, V1, P275; Hooke JM, 2000, GEOMORPHOLOGY, V34, P163, DOI 10.1016/S0169-555X(00)00005-2; Kirkby MJ, 2005, CATENA, V62, P136, DOI 10.1016/j.catena.2005.05.002; KLEIN M, 1984, CATENA, V11, P251, DOI 10.1016/S0341-8162(84)80024-7; Lana-Renault N, 2007, NORD HYDROL, V38, P139, DOI 10.2166/nh.2007.003; Lana-Renault N, 2009, EARTH SURF PROC LAND, V34, P1291, DOI 10.1002/esp.1825; Larson WE, 1997, J SOIL WATER CONSERV, V52, P90; Lenzi MA, 2003, HYDROLOG SCI J, V48, P899, DOI 10.1623/hysj.48.6.899.51425; Lu XX, 2001, GEOMORPHOLOGY, V41, P157, DOI 10.1016/S0169-555X(01)00113-1; Mano V, 2009, HYDROL PROCESS, V23, P777, DOI 10.1002/hyp.7178; McBroom MW, 2008, J ENVIRON QUAL, V37, P114, DOI 10.2134/jeq2006.0552; Ministry of Water Resources of the People's Republic of China (MWRPRC), 2002, TECHN COD PRACT WAT; Nadal-Romero E, 2008, CATENA, V74, P127, DOI 10.1016/j.catena.2008.03.014; Nearing MA, 2005, CATENA, V61, P131, DOI 10.1016/j.catena.2005.03.007; Ng SL, 2008, AGROFOREST SYST, V74, P279, DOI 10.1007/s10457-008-9158-x; Nunes JP, 2005, CATENA, V61, P210, DOI 10.1016/j.catena.2005.03.005; Oeurng C, 2010, EARTH SURF PROC LAND, V35, P1289, DOI 10.1002/esp.1971; Old GH, 2003, SCI TOTAL ENVIRON, V314, P495, DOI 10.1016/S0048-9697(03)00070-6; Osterkamp WR, 2000, HYDROL PROCESS, V14, P2817, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2817::AID-HYP121&gt;3.0.CO;2-B; Poesen JWA, 1997, PROG PHYS GEOG, V21, P157, DOI 10.1177/030913339702100201; Seeger M, 2004, J HYDROL, V288, P299, DOI 10.1016/j.jhydrol.2003.10.012; Shi DM, 1992, RESOURCES ENV YANGTZ, V1, P62; Shi ZH, 2004, CATENA, V55, P33, DOI 10.1016/S0341-8162(03)00088-2; Shi ZH, 2009, CATENA, V77, P1, DOI 10.1016/j.catena.2008.11.006; Si JJ, 2009, CHINA ACAD J; Siriwardena L, 2006, J HYDROL, V326, P199, DOI 10.1016/j.jhydrol.2005.10.030; Soler M, 2007, CATENA, V71, P164, DOI 10.1016/j.catena.2006.06.009; Stroosnijder L, 2005, CATENA, V64, P162, DOI 10.1016/j.catena.2005.08.004; [涂恩强 Tu Enqiang], 2010, [水土保持通报, Bulletin of Soil and Water Conservation], V30, P7; White S, 1998, AMBIO, V27, P300; WILLIAMS GP, 1989, J HYDROL, V111, P89, DOI 10.1016/0022-1694(89)90254-0; WOLMAN MG, 1960, J GEOL, V68, P54, DOI 10.1086/626637; [吴从林 Wu Conglin], 2002, [长江流域资源与环境, Resources and Environment in the Yangtze Valley], V11, P165; Zabaleta A, 2007, CATENA, V71, P179, DOI 10.1016/j.catena.2006.06.007; Zhang XinBao, 2006, Journal of Soil and Water Conservation (China), V20, P1	50	10	11	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76610	10.1371/journal.pone.0076610	http://dx.doi.org/10.1371/journal.pone.0076610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146898	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400067
J	Otte, JC; Keiter, S; Fassbender, C; Higley, EB; Rocha, PS; Brinkmann, M; Wahrendorf, DS; Manz, W; Wetzel, MA; Braunbeck, T; Giesy, JP; Hecker, M; Hollert, H				Otte, Jens C.; Keiter, Steffen; Fassbender, Christopher; Higley, Eric B.; Rocha, Paula Suares; Brinkmann, Markus; Wahrendorf, Dierk-Steffen; Manz, Werner; Wetzel, Markus A.; Braunbeck, Thomas; Giesy, John P.; Hecker, Markus; Hollert, Henner			Contribution of Priority PAHs and POPs to Ah Receptor-Mediated Activities in Sediment Samples from the River Elbe Estuary, Germany	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EFFECT-DIRECTED ANALYSIS; DIBENZO-P-DIOXINS; O-DEETHYLASE INDUCTION; SUSPENDED PARTICULATE MATTER; TRACE ORGANIC CONTAMINANTS; IN-VITRO BIOASSAY; POLYCHLORINATED NAPHTHALENES; RELATIVE POTENCIES; MASAN BAY	The estuary of the River Elbe between Hamburg and the North Sea (Germany) is a sink for contaminated sediment and suspended particulate matter (SPM). One major concern is the effect of human activities on the hydrodynamics, particularly the intensive dredging activities in this area that may result in remobilization of sediment-bound pollutants. The aim of this study was to identify pollutants contributing to the toxicological risk associated with re-suspension of sediments in the Elbe Estuary by use of an effect-directed analysis that combines chemical and biological analyses in with specific fractionation techniques. Sediments were collected from sites along the Elbe Estuary and a site from a small harbor basin of the Elbe Estuary that is known to be polluted. The sixteen priority EPA-PAHs were quantified in organic extracts of sediments. In addition, dioxin equivalents of sediments were investigated by use of the 7-ethoxyresorufin O-deethylase assay with RTL-W1 cells and the Ah receptor-mediated luciferase transactivation assay with H4IIE-luc cells. Quantification of the 16 priority PAHs revealed that sediments were moderately contaminated at all of the sites in the Elbe River Estuary (<0.02-0.906 mu g/g dw). Sediments contained relatively small concentrations of dioxin equivalents (Bio-TEQ) with concentrations ranging from 15.5 to 322 pg/g dw, which were significantly correlated with dioxin equivalents calculated based on toxicity reference values and concentrations of PAH. The concentration of Bio-TEQ at the reference site exceeded 200,000 pg/g dw. In a potency balance the 16 PAHs explained between 47 and 118% of the Bio-TEQ in the luciferase assay, which can be explained by the constant input of PAHs bound to SPM from the upper course of the Elbe River into its estuary. Successful identification of a significant portion of dioxin-like activity to priority PAHs in complex environmental samples such as sediments has rarely been reported.	[Otte, Jens C.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Fassbender, Christopher; Rocha, Paula Suares; Braunbeck, Thomas] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Keiter, Steffen; Brinkmann, Markus; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Aachen, Germany; [Wahrendorf, Dierk-Steffen] Fed Inst Hydrol, Dept Biochem & Ecotoxicol, Koblenz, Germany; [Wetzel, Markus A.] Fed Inst Hydrol, Dept Anim Ecol, Koblenz, Germany; [Manz, Werner] Univ Koblenz Landau, Inst Integrierte Nat Wissensch, Koblenz, Germany; [Higley, Eric B.; Giesy, John P.; Hecker, Markus] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Hecker, Markus] Univ Saskatchewan, Sch,Environm & Sustainabil, Saskatoon, SK, Canada; [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Giesy, John P.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Giesy, John P.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Giesy, John P.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] City Univ Hong Kong, State Key Lab Marine Pollut, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; RWTH Aachen University; University of Koblenz & Landau; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Michigan State University; Michigan State University; City University of Hong Kong; City University of Hong Kong; University of Hong Kong	Otte, JC (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany.	Jens.Otte@kit.edu; Henner.Hollert@bio5.rwth-aachen.de	Brinkmann, Markus/L-3879-2013; Hollert, Henner/A-1027-2009	Brinkmann, Markus/0000-0002-4985-263X; Hollert, Henner/0000-0001-5776-5619; Giesy, John/0000-0003-1931-9962; Wetzel, Markus/0000-0001-6321-5269; Keiter, Steffen/0000-0002-2356-6686	Canada Foundation for Infrastructure; Canada Research Chair program	Canada Foundation for Infrastructure; Canada Research Chair program(Canada Research Chairs)	The authors wish to acknowledge the support of an instrumentation grant from the Canada Foundation for Infrastructure. Profs. Giesy and Hecker were supported by the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlf Wolfgang, 2002, Journal of Soils and Sediments, V2, P37, DOI 10.1007/BF02991249; [Anonymous], 2005, DINISO16703S; Barron MG, 2004, TOXICOL SCI, V78, P60, DOI 10.1093/toxsci/kfh051; Benedetti M, 2012, ENVIRON INT, V38, P17, DOI 10.1016/j.envint.2011.08.003; BfG, 2008, WSV SED TID STRAT PO; Birnbaum LS, 2003, ENVIRON INT, V29, P855, DOI 10.1016/S0160-4120(03)00106-5; Bittner M, 2006, ENVIRON TOXICOL, V21, P338, DOI 10.1002/tox.20185; Blahova J, 2010, ENVIRON TOXICOL CHEM, V29, P541, DOI 10.1002/etc.89; Bols NC, 1999, ECOTOX ENVIRON SAFE, V44, P118, DOI 10.1006/eesa.1999.1808; Brack W, 2000, ENVIRON TOXICOL CHEM, V19, P2493, DOI 10.1002/etc.5620191015; Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z; Brack W, 2005, ENVIRON TOXICOL CHEM, V24, P2445, DOI 10.1897/05-078R.1; Brack W, 2008, ENVIRON TOXICOL CHEM, V27, P519, DOI 10.1897/07-400.1; Brunstrom B, 1998, COMP BIOCHEM PHYS C, V121, P213, DOI 10.1016/S0742-8413(98)10042-7; Cameron P., 1990, P281; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; Eklund B, 2010, J SOIL SEDIMENT, V10, P127, DOI 10.1007/s11368-009-0149-y; FGG-Elbe, 2012, FACH FIS FGG ELB; Fischnetz, 2004, TRAIL DECL FISH STOC; Gaumert T, 2002, HIST ZUSTAND ELBE BE; GOTZ R, 1990, CHEMOSPHERE, V20, P51, DOI 10.1016/0045-6535(90)90087-A; Gustavsson LK, 2004, ENVIRON SCI POLLUT R, V11, P379, DOI 10.1007/BF02979656; Hecker M, 2009, ENVIRON SCI POLLUT R, V16, P607, DOI 10.1007/s11356-009-0229-y; Heimann W, 2011, J SOIL SEDIMENT, V11, P1279, DOI 10.1007/s11368-011-0416-6; Heise S., 2005, STUDIE SCHADSTOFFBEL; Heise S, 2007, J ENVIRON MONITOR, V9, P943, DOI 10.1039/b704071g; Hilscherova K, 2000, ENVIRON SCI POLLUT R, V7, P159, DOI 10.1065/espr2000.02.017; Hinger G, 2011, ENVIRON SCI POLLUT R, V18, P1297, DOI 10.1007/s11356-011-0483-7; Hollert H, 2002, ECOTOXICOLOGY, V11, P323, DOI 10.1023/A:1020549103898; Huuskonen SE, 1998, CHEMOSPHERE, V36, P2921, DOI 10.1016/S0045-6535(97)10248-X; Jarosova B, 2012, ENVIRON INT, V45, P22, DOI 10.1016/j.envint.2012.04.001; Kannan K, 1998, ENVIRON SCI TECHNOL, V32, P2507, DOI 10.1021/es980167g; Keiter S, 2008, ANAL BIOANAL CHEM, V390, P2009, DOI 10.1007/s00216-007-1652-x; Keiter S, 2009, J SOIL SEDIMENT, V9, P168, DOI 10.1007/s11368-009-0087-8; Khim JS, 1999, ENVIRON SCI TECHNOL, V33, P4206, DOI 10.1021/es990449w; Khim JS, 1999, ENVIRON SCI TECHNOL, V33, P4199, DOI 10.1021/es9904484; King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027; Koh CH, 2004, ENVIRON POLLUT, V132, P489, DOI 10.1016/j.envpol.2004.05.001; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; LORENZEN A, 1993, ANAL BIOCHEM, V214, P346, DOI 10.1006/abio.1993.1504; Machala M, 2001, MUTAT RES-GEN TOX EN, V497, P49, DOI 10.1016/S1383-5718(01)00240-6; Murk AJ, 1996, FUND APPL TOXICOL, V33, P149, DOI 10.1006/faat.1996.0152; Olsman H, 2007, ENVIRON TOXICOL CHEM, V26, P2448, DOI 10.1897/07-004R.1; Otte JC, 2008, ENVIRON INT, V34, P1176, DOI 10.1016/j.envint.2008.05.004; Pinkney AE, 2001, ENVIRON TOXICOL CHEM, V20, P1196, DOI 10.1002/etc.5620200608; Reincke H., 2003, HOCHWASSER AUGUST 20; Rocha PS, 2010, ECOTOX ENVIRON SAFE, V73, P550, DOI 10.1016/j.ecoenv.2009.12.017; Sanderson JT, 1996, TOXICOL APPL PHARM, V137, P316, DOI 10.1006/taap.1996.0086; Schuettrumpf Holger, 2011, Environmental Sciences Europe, V23, P39, DOI 10.1186/2190-4715-23-39; Stachel B, 2006, SCI TOTAL ENVIRON, V364, P96, DOI 10.1016/j.scitotenv.2005.07.004; Stachel B, 2005, J ENVIRON SCI HEAL A, V40, P265, DOI 10.1081/ESE-200045531; Umlauf G, 2011, JRC TECHNICAL SCI RE; US-EPA, 1982, LAB TEST PROT 610; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Villeneuve DL, 2002, ENVIRON TOXICOL, V17, P128, DOI 10.1002/tox.10041; Villeneuve DL, 2001, AQUAT TOXICOL, V54, P125, DOI 10.1016/S0166-445X(00)00171-5; Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131; Wetzel MA, 2013, SCI TOTAL ENVIRON, V449, P199, DOI 10.1016/j.scitotenv.2013.01.016; Wetzel MA, 2012, ECOL INDIC, V19, P118, DOI 10.1016/j.ecolind.2011.08.007; Willett KL, 1997, ARCH ENVIRON CON TOX, V32, P442, DOI 10.1007/s002449900211; Wolz J, 2010, SCI TOTAL ENVIRON, V408, P3327, DOI 10.1016/j.scitotenv.2010.03.029; Wolz J, 2008, ENVIRON SCI POLLUT R, V15, P536, DOI 10.1007/s11356-008-0056-6	64	32	34	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75596	10.1371/journal.pone.0075596	http://dx.doi.org/10.1371/journal.pone.0075596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146763	gold, Green Published			2022-12-25	WOS:000325819400013
J	Vokaer, BT; Charbonnier, LM; Lemaitre, PH; Spilleboudt, C; Le Moine, A				Vokaer, Benoi T.; Charbonnier, Louis-Marie; Lemaitre, Philippe H.; Spilleboudt, Chloe; Le Moine, Alain			IL-17A and IL-2-Expanded Regulatory T Cells Cooperate to Inhibit Th1-Mediated Rejection of MHC II Disparate Skin Grafts	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; TH17 CELLS; INTERLEUKIN-2; COMPLEXES; MODEL	Several evidences suggest that regulatory T cells (Treg) promote Th17 differentiation. Based on this hypothesis, we tested the effect of IL-17A neutralization in a model of skin transplantation in which long-term graft survival depends on a strong in vivo Treg expansion induced by transient exogenous IL-2 administration. As expected, IL-2 supplementation prevented rejection of MHC class II disparate skin allografts but, surprisingly, not in IL-17A-deficient recipients. We attested that IL-17A was not required for IL-2-mediated Treg expansion, intragraft recruitment or suppressive capacities. Instead, IL-17A prevented allograft rejection by inhibiting Th1 alloreactivity independently of Tregs. Indeed, T-bet expression of naive alloreactive CD4+ T cells and the subsequent Th1 immune response was significantly enhanced in IL-17A deficient mice. Our results illustrate for the first time a protective role of IL-17A in CD4+-mediated allograft rejection process.	[Vokaer, Benoi T.; Charbonnier, Louis-Marie; Lemaitre, Philippe H.; Spilleboudt, Chloe; Le Moine, Alain] Univ Libre Brussels, Inst Med Immunol, Gosselies, Belgium		Vokaer, BT (corresponding author), Univ Libre Brussels, Inst Med Immunol, Gosselies, Belgium.	bvokaer@ulb.ac.be; alemoine@ulb.ac.be		Charbonnier, Louis-Marie/0000-0002-4594-7893	Roche Organ Transplantation Research Foundation (ROTRF); Walloon Region; FNRS-Belgium; GlaxoSmithKline Biologicals	Roche Organ Transplantation Research Foundation (ROTRF); Walloon Region; FNRS-Belgium(Fonds de la Recherche Scientifique - FNRS); GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was funded by the Roche Organ Transplantation Research Foundation (ROTRF) http://www.rotrf.org/. The Institute for Medical Immunology is funded by research grants of the Walloon Region (www.wallonie.be), the FNRS-Belgium and GlaxoSmithKline Biologicals (www.gsk.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Auerbach MB, 2009, AM J PATHOL, V174, P2172, DOI 10.2353/ajpath.2009.080516; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burrell BE, 2008, J IMMUNOL, V181, P3906, DOI 10.4049/jimmunol.181.6.3906; Charbonnier LM, 2012, AM J TRANSPLANT, V12, P2313, DOI 10.1111/j.1600-6143.2012.04184.x; Cunnusamy K, 2011, J IMMUNOL, V186, P6737, DOI 10.4049/jimmunol.1100101; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Koga S, 1999, J IMMUNOL, V163, P4878; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Toh ML, 2010, ANN RHEUM DIS, V69, P1562, DOI 10.1136/ard.2009.111757; Toh ML, 2009, CYTOKINE, V48, P226, DOI 10.1016/j.cyto.2009.07.013; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Yang ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008922; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937	20	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76040	10.1371/journal.pone.0076040	http://dx.doi.org/10.1371/journal.pone.0076040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146810	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400034
J	Wang, Q; Jia, PL; Cuenco, KT; Feingold, E; Marazita, ML; Wang, LL; Zhao, ZM				Wang, Quan; Jia, Peilin; Cuenco, Karen T.; Feingold, Eleanor; Marazita, Mary L.; Wang, Lily; Zhao, Zhongming			Multi-Dimensional Prioritization of Dental Caries Candidate Genes and Its Enriched Dense Network Modules	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MATRIX METALLOPROTEINASES; HUMAN ODONTOBLASTS; PULP COMPLEX; TOOTH-PULP; EXPRESSION; DISEASE; CYTOKINES; HEALTHY; AMELX	A number of genetic studies have suggested numerous susceptibility genes for dental caries over the past decade with few definite conclusions. The rapid accumulation of relevant information, along with the complex architecture of the disease, provides a challenging but also unique opportunity to review and integrate the heterogeneous data for follow-up validation and exploration. In this study, we collected and curated candidate genes from four major categories: association studies, linkage scans, gene expression analyses, and literature mining. Candidate genes were prioritized according to the magnitude of evidence related to dental caries. We then searched for dense modules enriched with the prioritized candidate genes through their protein-protein interactions (PPIs). We identified 23 modules comprising of 53 genes. Functional analyses of these 53 genes revealed three major clusters: cytokine network relevant genes, matrix metalloproteinases (MMPs) family, and transforming growth factor-beta (TGF-beta) family, all of which have been previously implicated to play important roles in tooth development and carious lesions. Through our extensive data collection and an integrative application of gene prioritization and PPI network analyses, we built a dental caries-specific sub-network for the first time. Our study provided insights into the molecular mechanisms underlying dental caries. The framework we proposed in this work can be applied to other complex diseases.	[Wang, Quan; Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Cuenco, Karen T.; Feingold, Eleanor; Marazita, Mary L.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Cuenco, Karen T.; Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Dept Oral Biol, Pittsburgh, PA USA; [Feingold, Eleanor] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Wang, Lily] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Wang, Lily; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, ZM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Wang, Quan/K-4540-2017	Wang, Quan/0000-0002-7056-0519; Feingold, Eleanor/0000-0003-2898-6484	National Institutes of Health [R03DE022093, R01LM011177, R21HG006037]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899, R03DE022093] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from National Institutes of Health (R03DE022093, R01LM011177, and R21HG006037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2007, J DENT RES, V86, P1217, DOI 10.1177/154405910708601215; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azevedo LF, 2010, J APPL ORAL SCI, V18, P166, DOI 10.1590/S1678-77572010000200011; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BEGUEKIRN C, 1994, INT J DEV BIOL, V38, P405; BORAAS JC, 1988, J DENT RES, V67, P1150, DOI 10.1177/00220345880670090201; Brancher JA, 2011, INT J DENT, V2011, DOI 10.1155/2011/571726; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Caron C, 2001, J DENT RES, V80, P1660, DOI 10.1177/00220345010800071201; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104; Culp DJ, 2005, CARIES RES, V39, P448, DOI 10.1159/000088179; Doncheva NT, 2012, WIRES SYST BIOL MED, V4, P429, DOI 10.1002/wsbm.1177; Featherstone J D B, 2004, J Dent Res, V83 Spec No C, pC39; Fischer CL, 2012, ANTIMICROB AGENTS CH, V56, P1157, DOI 10.1128/AAC.05151-11; Garcia-Alonso L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks699; Gasse B, 2013, J DENT RES, V92, P418, DOI 10.1177/0022034513482941; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gornowicz A, 2012, ANN AGR ENV MED, V19, P711; GRAHN E, 1988, ACTA ODONTOL SCAND, V46, P67, DOI 10.3109/00016358809004749; Hannas AR, 2007, ACTA ODONTOL SCAND, V65, P1, DOI 10.1080/00016350600963640; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Horst OV, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-9; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jia PL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002587; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696; Kulkarni GV, 2013, CARIES RES, V47, P219, DOI 10.1159/000345652; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; McLachlan JL, 2003, ARCH ORAL BIOL, V48, P273, DOI 10.1016/S0003-9969(03)00003-7; McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007; Menezes-Silva R, 2012, J ENDODONT, V38, P604, DOI 10.1016/j.joen.2012.02.009; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Morgan CR, 2005, J OROFAC PAIN, V19, P248; Nakahara Y, 2012, TOXICOL PATHOL; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Olszowski T, 2012, ORAL DIS, V18, P389, DOI 10.1111/j.1601-0825.2011.01887.x; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Paakkonen V, 2005, EUR J ORAL SCI, V113, P369, DOI 10.1111/j.1600-0722.2005.00237.x; Palosaari H, 2000, J DENT RES, V79, P77, DOI 10.1177/00220345000790011401; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Schork NJ, 1997, AM J RESP CRIT CARE, V156, pS103, DOI 10.1164/ajrccm.156.4.12-tac-5; Shaffer JR, 2013, J DENT RES, V92, P38, DOI 10.1177/0022034512463579; Shaffer JR, 2011, J DENT RES, V90, P1457, DOI 10.1177/0022034511422910; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Shimada Y, 2009, AUST DENT J, V54, P347, DOI 10.1111/j.1834-7819.2009.01161.x; Sloan AJ, 1999, HISTOCHEM J, V31, P565, DOI 10.1023/A:1003852409574; Sloan AJ, 2000, HISTOCHEM J, V32, P247, DOI 10.1023/A:1004007202404; Sloan AJ, 1999, ARCH ORAL BIOL, V44, P149, DOI 10.1016/S0003-9969(98)00106-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Tannure PN, 2012, CARIES RES, V46, P401, DOI 10.1159/000339379; Tannure PN, 2012, J DENT, V40, P381, DOI 10.1016/j.jdent.2012.01.015; Tjaderhane L, 1998, J DENT RES, V77, P1486, DOI 10.1177/00220345980770070301; Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001; Toledano M, 2010, J DENT, V38, P635, DOI 10.1016/j.jdent.2010.05.001; Townsend GC, 1998, AUST DENT J, V43, P269, DOI 10.1111/j.1834-7819.1998.tb00176.x; Valarini N, 2012, CARIES RES, V46, P530, DOI 10.1159/000341188; Vieira AR, 2008, J DENT RES, V87, P435, DOI 10.1177/154405910808700506; WALLENGREN ML, 1991, ORAL MICROBIOL IMMUN, V6, P292, DOI 10.1111/j.1399-302X.1991.tb00495.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072653; Wang X, 2012, CARIES RES, V46, P177, DOI 10.1159/000337282; Wang X, 2010, CARIES RES, V44, P277, DOI 10.1159/000314676; Wang XJ, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-57; Wendell S, 2010, J DENT RES, V89, P1198, DOI 10.1177/0022034510381502; Werneck RI, 2010, ORAL DIS, V16, P613, DOI 10.1111/j.1601-0825.2010.01675.x; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhao ZM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S16	81	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76666	10.1371/journal.pone.0076666	http://dx.doi.org/10.1371/journal.pone.0076666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146904	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400070
J	Xu, JL; Yin, ZQ; Gao, W; Liu, LX; Yin, YM; Liu, P; Shu, YQ				Xu, Jiali; Yin, Zhiqiang; Gao, Wen; Liu, Lingxiang; Yin, Yongmei; Liu, Ping; Shu, Yongqian			Genetic Variation in a MicroRNA-502 Minding Site in SET8 Gene Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; HISTONE METHYLTRANSFERASE SET8; 3' UNTRANSLATED REGION; MIR-502 BINDING-SITE; 3'-UNTRANSLATED REGION; S-PHASE; EXPRESSION; H4; SURVIVAL; PR-SET7	Background: Genetic variants may influence microRNA-target interaction through modulate their binding affinity, creating or destroying miRNA-binding sites. SET8, a member of the SET domain-containing methyltransferase, has been implicated in a variety array of biological processes. Methods: Using Taqman assay, we genotyped a polymorphism rs16917496 T>C within the miR-502 binding site in the 3'-untranslated region of the SET8 gene in 576 non-small cell lung cancer (NSCLC) patients. Functions of rs16917496 were investigated using luciferase activity assay and validated by immunostaining. Results: Log-rank test and cox regression indicated that the CC genotype was associated with a longer survival and a reduced risk of death for NSCLC [58.0 vs. 41.0 months, P = 0.031; hazard ratio = 0.44, 95% confidential interval: 0.26-0.74]. Further stepwise regression analysis suggested rs16917496 was an independently favorable factor for prognosis and the protective effect more prominent in never smokers, patients without diabetes and patients who received chemotherapy. A significant interaction was observed between rs16917496 and smoking status in relation to NSCLC survival (P<0.001). Luciferase activity assay showed a lower expression level for C allele as compared with T allele, and the miR-502 had an effect on modulation of SET8 gene in vitro. The CC genotype was associated with reduced SET8 protein expression based on immunostaining of 192 NSCLC tissue sample (P = 0.007). Lower levels of SET8 were associated with a non-significantly longer survival (55.0 vs. 43.1 months). Conclusion: Our data suggested that the rs16917496 T>C located at miR-502 binding site contributes to NSCLC survival by altering SET8 expression through modulating miRNA-target interaction.	[Xu, Jiali; Gao, Wen; Liu, Lingxiang; Yin, Yongmei; Liu, Ping; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Zhiqiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	shuyongqian@csco.org.cn	Liu, Lingxiang/I-7538-2016; Shu, Yongqian/ABD-5698-2021	Liu, Lingxiang/0000-0001-8689-1788; 	National Natural Science Foundation of China [81172140, 81272532]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; Jiangsu Province Clinical science and technology projects (Clinical Research Center) [BL2012008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province Clinical science and technology projects (Clinical Research Center)	This work was supported by National Natural Science Foundation of China (81172140, 81272532), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801) and Jiangsu Province Clinical science and technology projects (Clinical Research Center, BL2012008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Ding CM, 2012, EXP THER MED, V3, P689, DOI 10.3892/etm.2012.469; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skrzypski M, 2011, MUTAT RES-FUND MOL M, V717, P25, DOI 10.1016/j.mrfmmm.2011.04.002; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Sweeney C, 2003, CANCER EPIDEM BIOMAR, V12, P527; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang CJ, 2012, CANCER GENET-NY, V205, P373, DOI 10.1016/j.cancergen.2012.04.010; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang K, 2012, CARCINOGENESIS, V33, P2147, DOI 10.1093/carcin/bgs259; WESTRA WH, 1993, AM J SURG PATHOL, V17, P213, DOI 10.1097/00000478-199303000-00001; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Xing JL, 2012, CANCER EPIDEM BIOMAR, V21, P217, DOI 10.1158/1055-9965.EPI-11-0624; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Xu JL, 2012, ASIAN PAC J CANCER P, V13, P851, DOI 10.7314/APJCP.2012.13.3.851; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhai H, 2013, ONCOGENE, V32, P1570, DOI 10.1038/onc.2012.167	50	27	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77024	10.1371/journal.pone.0077024	http://dx.doi.org/10.1371/journal.pone.0077024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146953	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400096
J	Aronin, A; Amsili, S; Prigozhina, TB; Tzdaka, K; Rachmilewitz, J; Shani, N; Tykocinski, ML; Elhalel, MD				Aronin, Alexandra; Amsili, Shira; Prigozhina, Tatyana B.; Tzdaka, Kobi; Rachmilewitz, Jacob; Shani, Noam; Tykocinski, Mark L.; Elhalel, Michal Dranitzki			Fn14.Trail Effectively Inhibits Hepatocellular Carcinoma Growth	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; CELL-DEATH; TRAIL RECEPTORS; FUSION PROTEINS; WEAK INDUCER; TUMOR-GROWTH; TWEAK; TNF; ACTIVATION	Background: New strategies for the treatment of hepatocellular carcinoma (HCC) are needed, given that currently available chemotherapeutics are inefficient. Since tumor growth reflects the net balance between pro-proliferative and death signaling, agents shifting the equilibrium toward the latter are of considerable interest. The TWEAK: Fn14 signaling axis promotes tumor cell proliferation and tumor angiogenesis, while TRAIL: TRAIL-receptor (TRAIL-R) interactions selectively induce apoptosis in malignant cells. Fn14.TRAIL, a fusion protein bridging these two pathways, has the potential to inhibit tumor growth, by interfering with TWEAK: Fn14 signaling, while at the same time enforcing TRAIL: TRAIL-R-mediated apoptosis. Consequently, Fn14.TRAIL's capacity to inhibit HCC growth was tested. Results: Fn14.TRAIL induced robust apoptosis of multiple HCC cell lines, while sparing non-malignant hepatocyte cell lines. Differential susceptibility to this agent did not correlate with expression levels of TRAIL, TRAIL-R, TWEAK and Fn14 by these lines. Fn14.TRAIL was more potent than soluble TRAIL, soluble Fn14, or a combination of the two. The requirement of both of Fn14.TRAIL's molecular domains for function was established using blocking antibodies directed against each of them. Subcutaneous injection of Fn14.TRAIL abrogated HCC growth in a xenograft model, and was well tolerated by the mice. Conclusions: In this study, Fn14.TRAIL, a multifunctional fusion protein originally designed to treat autoimmunity, was shown to inhibit the growth of HCC, both in vitro and in vivo. The demonstration of this fusion protein's potent anti-tumor activity suggests that simultaneous targeting of two signaling axes by a single fusion can serve as a basis for highly effective anti-cancer therapies.	[Aronin, Alexandra; Prigozhina, Tatyana B.; Tzdaka, Kobi; Elhalel, Michal Dranitzki] Hadassah Hebrew Univ Med Ctr, Serv Nephrol, Jerusalem, Israel; [Aronin, Alexandra; Prigozhina, Tatyana B.; Tzdaka, Kobi; Elhalel, Michal Dranitzki] Hadassah Hebrew Univ Med Ctr, Hypertens Serv, Jerusalem, Israel; [Rachmilewitz, Jacob] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Amsili, Shira; Shani, Noam] KAHR Med LTD, Jerusalem, Israel; [Tykocinski, Mark L.] Thomas Jefferson Univ, Jefferson Med Coll, Off Dean, Philadelphia, PA 19107 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Jefferson University	Elhalel, MD (corresponding author), Hadassah Hebrew Univ Med Ctr, Serv Nephrol, Jerusalem, Israel.	michale@hadassah.org.il			KAHR Medical LTD.	KAHR Medical LTD.	This study was funded be KAHR Medical LTD. The funders had no role in study design, data collection and analysis, decision to publish or preperation of manuscript. All authors, including KAHR Medical employees saw the paper before submission.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Chen XP, 2003, WORLD J GASTROENTERO, V9, P2433; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Dranitzki-Elhalel M, 2007, INT IMMUNOL, V19, P355, DOI 10.1093/intimm/dxm001; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Grunert M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.154; Herr I, 2007, HEPATOLOGY, V46, P266, DOI 10.1002/hep.21740; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Kobayashi N, 2000, TRANSPL P, V32, P2368, DOI 10.1016/S0041-1345(00)01702-4; Kriegl L, 2010, CLIN CANCER RES, V16, P5529, DOI 10.1158/1078-0432.CCR-09-3403; Malhi H, 2002, J CELL SCI, V115, P2679; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Orbach A, 2010, AM J PATHOL, V177, P3159, DOI 10.2353/ajpath.2010.100301; Razmara M, 2009, AM J PATHOL, V174, P460, DOI 10.2353/ajpath.2009.080462; Rosevear HM, 2010, CURR OPIN INVEST DR, V11, P688; Schattenberg JM, 2011, J GASTROEN HEPATOL, V26, P213, DOI 10.1111/j.1440-1746.2010.06582.x; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Siegemund M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.29; Sung ES, 2009, MOL CANCER THER, V8, P2276, DOI 10.1158/1535-7163.MCT-09-0235; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wahl K, 2013, HEPATOLOGY, V57, P625, DOI 10.1002/hep.26082; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001	45	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77050	10.1371/journal.pone.0077050	http://dx.doi.org/10.1371/journal.pone.0077050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130833	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200052
J	Carvalho, GMD; Brazil, RP; Ramos, MCDF; Meira, PCLSE; Zenobio, APLD; Botelho, HA; Sanguinette, CD; Saraiva, L; Andrade, JD				de Lima Carvalho, Gustavo Mayr; Brazil, Reginaldo Pecanha; das Neves Farah Ramos, Mariana Campos; Lamy Serra e Meira, Paula Cavalcante; Lusardo de Almeida Zenobio, Ana Paula; Botelho, Helbert Antnio; Sanguinette, Cristiani de Castilho; Saraiva, Lara; Andrade Filho, Jose Dilermando			Ecological Aspects of Phlebotomine Sandflies (Diptera: Psychodidae) from a Cave of the Speleological Province of Bambu, Brazil	PLOS ONE			English	Article							MINAS-GERAIS STATE; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; SPECIES DIPTERA; SAND FLY; VECTORS; TOCANTINS; DIVERSITY; AREAS; FOCUS	Phlebotomines are invertebrate hosts of Leishmania genus species which are etiological agents of leishmaniases in humans and other mammals. Sandflies are often collected in entomological studies of caves both in the inner area and the adjacent environments. Caves are ecotypes clearly different from the external environment. Several caves have been opened to public visitation before any studies were performed and the places do not have scientific monitoring of the fauna, flora, geological and geographical characteristics. These events can lead to the loss of geological and biological information. Considering these aspects, this study aimed to describe the sand fly fauna, including the ecological features, in a limestone cave at the Speleological Province of Bambu (Minas Gerais State, Brazil). A total of 8,354 specimens of sandflies belonging to 29 species were analyzed: Lutzomyia cavernicola (20%), Nyssomyia intermedia (15%), Martinsmyia oliveirai (13%), Evandromyia spelunca (12%), Evandromyia sallesi (11%), Migonemyia migonei (9%), Nyssomyia whitmani (9%), Sciopemyia sordellii (4%) and Lutzomyia longipalpis (2%). The others species represent 5% of the total. This manuscript presents data found on richness, diversity, evenness and seasonality, comparing the sand fly fauna trapped in the cave and its surroundings.	[de Lima Carvalho, Gustavo Mayr; das Neves Farah Ramos, Mariana Campos; Lamy Serra e Meira, Paula Cavalcante; Lusardo de Almeida Zenobio, Ana Paula; Botelho, Helbert Antnio; Sanguinette, Cristiani de Castilho; Saraiva, Lara; Andrade Filho, Jose Dilermando] Fundacao Oswaldo Cruz, Grp Estudos Leishmanioses, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [de Lima Carvalho, Gustavo Mayr; Brazil, Reginaldo Pecanha] Fundacao Oswaldo Cruz, Dept Fisiol & Bioquim Insetos, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Andrade, JD (corresponding author), Fundacao Oswaldo Cruz, Grp Estudos Leishmanioses, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	lecojandrade@hotmail.com	Andrade Filho, José Dilermando/B-7852-2013; Brazil, Reginaldo Peçanha/AAF-6777-2019	Andrade Filho, José Dilermando/0000-0002-9754-8464; 	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-0235709]; Programa Pesquisador Mineiro (FAPEMIG) [00130-12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa Pesquisador Mineiro (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Process: APQ-0235709); Programa Pesquisador Mineiro (FAPEMIG)-00130-12; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR GM, 1984, MEM I O CRUZ, V79, P179; Aguiar GM, 2003, FLEBOTOMINEOS BRASIL; Almeida Paulo Silva de, 2010, Rev. Bras. entomol., V54, P304, DOI 10.1590/S0085-56262010000200014; Alves VR, 2008, MEM I OSWALDO CRUZ, V103, P251, DOI 10.1590/S0074-02762008005000012; Alves VR, 2011, MEM I OSWALDO CRUZ, V106, P353, DOI 10.1590/S0074-02762011000300016; Andrade Filho José Dilermando, 2004, Rev. Bras. entomol., V48, P583, DOI 10.1590/S0085-56262004000400024; Andrade JD, 2001, MEM I OSWALDO CRUZ, V96, P1085, DOI 10.1590/S0074-02762001000800010; Andrade JD, 2007, MEM I OSWALDO CRUZ, V102, P481, DOI 10.1590/S0074-02762007005000035; Auler A., 2002, B SOC VENEZ ESPELEOL, V36, P29; AZEVEDO ACR, 1991, MEM I OSWALDO CRUZ, V86, P405, DOI 10.1590/S0074-02761991000400005; Barata RA, 2008, NEOTROP ENTOMOL, V37, P226, DOI 10.1590/S1519-566X2008000200018; Barata RA, 2012, MEM I OSWALDO CRUZ, V107, P1006, DOI 10.1590/S0074-02762012000800007; Barata RA, 2012, MEM I OSWALDO CRUZ, V107, P1016, DOI 10.1590/S0074-02762012000800009; CALLISTO M., 2000, ACTA LIMNOL BRAS, V12, P55; Carvalho GML, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-158; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Culver DC, 1982, CAVE LIFE EVOLUTION; de Andrade AJ, 2010, NEOTROP ENTOMOL, V39, P115, DOI 10.1590/S1519-566X2010000100016; Carvalho GMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052254; Carvalho GMD, 2010, MEM I OSWALDO CRUZ, V105, P336, DOI 10.1590/S0074-02762010000300017; de Pita-Pereira D, 2005, T ROY SOC TROP MED H, V99, P905, DOI 10.1016/j.trstmh.2005.06.019; Deane L.M., 1965, REV BRAS BIOL, V15, P83; DEQUEIROZ RG, 1994, AM J TROP MED HYG, V50, P693, DOI 10.4269/ajtmh.1994.50.693; Elliott W. R., 1981, CAVING INT, V10, P38; FORATTINI O. P., 1973, Entomologia Medica. Vol. 4. Psychodidae. Phle-botominae. Leishmanioses. Bartonelose.; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 2006, MEM I OSWALDO CRUZ, V101, P175, DOI 10.1590/S0074-02762006000200010; Galati EAB, 1997, REV SAUDE PUBL, V31, P378, DOI 10.1590/S0034-89101997000400007; Galati Eunice A. B., 2003, Rev. Bras. entomol., V47, P283, DOI 10.1590/S0085-56262003000200017; Galati Eunice A. Bianchi, 2003, Rev. Bras. entomol., V47, P455, DOI 10.1590/S0085-56262003000300016; Galati Eunice Aparecida Bianchi, 2003, Rev. Bras. entomol., V47, P63, DOI 10.1590/S0085-56262003000100010; GOMES A D C, 1987, Memorias do Instituto Oswaldo Cruz, V82, P467, DOI 10.1590/S0074-02761987000400004; HOLSINGER JR, 1988, BRIMLEYANA, P1; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; LENG YJ, 1987, ANN TROP MED PARASIT, V81, P311, DOI 10.1080/00034983.1987.11812125; Lewis JJ, 1982, NATL CAVE MANAGEMENT, P73; LISOWSKI EA, 1981, CAVE RES FDN ANN REP, P48; Machado TO, 2012, MEM I OSWALDO CRUZ, V107, P955, DOI 10.1590/S0074-02762012000700021; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; McCarthy CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058645; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; POULSON TL, 1969, SCIENCE, V165, P971; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; RODRIGUES W. C., 2005, DIVES DIVERSIDADE ES; Saraiva L, 2008, MEM I OSWALDO CRUZ, V103, P843, DOI 10.1590/S0074-02762008000800018; Sherlok IA, 2003, FLEBOTOMINEOS BRASIL, P15; Vilela ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027721; WHO, 2010, WHO TECH REP SER, V949, P1; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	51	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77158	10.1371/journal.pone.0077158	http://dx.doi.org/10.1371/journal.pone.0077158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130847	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900123
J	Durand, JD; Guinand, B; Dodson, JJ; Lecomte, F				Durand, Jean-Dominique; Guinand, Bruno; Dodson, Julian J.; Lecomte, Frederic			Pelagic Life and Depth: Coastal Physical Features in West Africa Shape the Genetic Structure of the Bonga Shad, Ethmalosa fimbriata	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; ESTUARINE FISH; CLIMATE-CHANGE; GEOGRAPHIC DISTANCE; HISTORY TRAITS; POPULATION; DISPERSAL; FISHERIES; NUCLEAR; FLOW	The bonga shad, Ethmalosa fimbriata, is a West African pelagic species still abundant in most habitats of its distribution range and thought to be only recently affected by anthropogenic pressure (habitat destruction or fishing pressure). Its presence in a wide range of coastal habitats characterised by different hydrodynamic processes, represents a case study useful for evaluating the importance of physical structure of the west African shoreline on the genetic structure of a small pelagic species. To investigate this question, the genetic diversity of E. fimbriata was assessed at both regional and species range scales, using mitochondrial (mt) and nuclear DNA markers. Whereas only three panmictic units were identified with mtDNA at the large spatial scale, nuclear genetic markers (EPIC: exon-primed intron-crossing) indicated a more complex genetic pattern at the regional scale. In the northern-most section of shad's distribution range, up to 4 distinct units were identified. Bayesian inference as well as spatial autocorrelation methods provided evidence that gene flow is impeded by the presence of deep-water areas near the coastline (restricting the width of the coastal shelf), such as the Cap Timiris and the Kayar canyons in Mauritania and Senegal, respectively. The added discriminatory power provided by the use of EPIC markers proved to be essential to detect the influence of more subtle, contemporary processes (e.g. gene flow, barriers, etc.) acting within the glacial refuges identified previously by mtDNA.	[Durand, Jean-Dominique] Univ Montpellier 2, Inst Rech Dev, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France; [Guinand, Bruno] Univ Montpellier 2, Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France; [Dodson, Julian J.] Univ Laval, Dept Biol, Laval, PQ, Canada; [Lecomte, Frederic] Minist Dev Durable Environm Faune & Parcs Quebec, Direct Expertise Faune & Ses Habitats, Direct Faune Aquat, Quebec City, PQ, Canada	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Laval University	Durand, JD (corresponding author), Univ Montpellier 2, Inst Rech Dev, Lab Ecol Syst Marins Cotiers, UMR 5119, Montpellier, France.	Jean-Dominique.Durand@ird.fr	Durand, Jean-Dominique/G-3713-2016; Lecomte, Frederic/AAN-7766-2021	Durand, Jean-Dominique/0000-0002-0261-0377; Lecomte, Frederic/0000-0002-8845-1249; GUINAND, Bruno/0000-0002-6934-1677	IRD	IRD	IRD funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J., 2004, Journal of Environment & Development, V13, P156, DOI 10.1177/1070496504266092; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ama-Abasi D, 2004, FISH RES, V68, P225, DOI 10.1016/j.fishres.2003.12.002; Angelini R, 2011, SCI MAR, V75, P309, DOI 10.3989/scimar.2011.75n2309; Atarhouch T, 2006, MOL PHYLOGENET EVOL, V39, P373, DOI 10.1016/j.ympev.2005.08.003; Atkinson LJ, 2011, AFR J MAR SCI, V33, P157, DOI 10.2989/1814232X.2011.572378; BARRYGERARD M, 1990, RECHERCHES, P34; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2008, TECHNICAL REPORT; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Berumen ML, 2010, CORAL REEFS, V29, P883, DOI 10.1007/s00338-010-0652-z; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; BLAY J, 1982, J FISH BIOL, V21, P485, DOI 10.1111/j.1095-8649.1982.tb02854.x; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Bradbury IR, 2008, CAN J FISH AQUAT SCI, V65, P147, DOI 10.1139/F07-154; Bradbury IR, 2011, MAR ECOL PROG SER, V438, P207, DOI 10.3354/meps09286; Bradbury IR, 2007, MAR ECOL PROG SER, V340, P245, DOI 10.3354/meps340245; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Cadrin S. X., 2005, STOCK IDENTIFICATION; Canino MF, 2010, MAR COAST FISH, V2, P375, DOI 10.1577/C09-024.1; Castric V, 2003, GENETICS, V163, P983; Charles-Dominique E, 2003, AM FISH S S, V35, P27; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Chikhi L, 1998, J FISH BIOL, V52, P861, DOI 10.1111/j.1095-8649.1998.tb00588.x; Chlaida M, 2009, ICES J MAR SCI, V66, P264, DOI 10.1093/icesjms/fsn206; Chow S, 1998, FISHERIES SCI, V64, P397, DOI 10.2331/fishsci.64.397; CHRISTENSEN V, 2004, W AFRICAN MARINE ECO, V12, P215; CROW JF, 1984, P NATL ACAD SCI-BIOL, V81, P6073, DOI 10.1073/pnas.81.19.6073; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DuBois C, 2012, MAR POLICY, V36, P1211, DOI 10.1016/j.marpol.2012.03.007; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Durand JD, 2005, MOL PHYLOGENET EVOL, V36, P277, DOI 10.1016/j.ympev.2005.01.019; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gascuel D, 2007, AFR J MAR SCI, V29, P331, DOI 10.2989/AJMS.2007.29.3.3.333; Gascuel D, 1997, AQUAT LIVING RESOUR, V10, P281, DOI 10.1051/alr:1997031; GOURENE B, 1993, J IVOIR OCEANOL LIMN, V2, P69; Gray CA, 2012, AQUAT BIOL, V16, P53, DOI 10.3354/ab00428; Guinand B, 2003, CR BIOL, V326, pS61, DOI 10.1016/S1631-0691(03)00039-8; Hassan M, 2002, MOL ECOL NOTES, V2, P334, DOI 10.1046/j.1471-8286.2002.00236.x; Hasselman DJ, 2013, MOL ECOL, V22, P1558, DOI 10.1111/mec.12197; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauser L, 2008, FISH FISH, V9, P473, DOI 10.1111/j.1467-2979.2008.00306.x; Henriques R, 2012, AFR J MAR SCI, V34, P585, DOI 10.2989/1814232X.2012.749809; HOOGHIEMSTRA H, 1986, METEOR FORSCHUNGSE C, V0040; Hooghiemstra H, 2006, QUATERN INT, V148, P29, DOI 10.1016/j.quaint.2005.11.005; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; Larmuseau MHD, 2010, HEREDITY, V105, P532, DOI 10.1038/hdy.2010.9; Laurans M, 2004, AQUAT LIVING RESOUR, V17, P163, DOI 10.1051/alr:2004023; Longhurst A. R., 1960, Bull Inst franc Aft noire, V22A, P1337; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; N'goran Ya Nestor, 1991, Journal Ivoirien d'Oceanologie et de Limnologie, V1, P23; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; Panfili J, 2004, MAR ECOL PROG SER, V270, P241, DOI 10.3354/meps270241; Panfili J, 2004, AQUAT LIVING RESOUR, V17, P65, DOI 10.1051/alr:2004002; PAULY D, 2003, PERFECT OCEAN STATE, P208; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Perry RI, 2011, FISH FISH, V12, P427, DOI 10.1111/j.1467-2979.2010.00402.x; POUYAUD L, 1996, ICLARM C P, V41, P408; POUYAUD L, 1995, COMPTES RENDUS ATELI, P60; Puebla O, 2012, MOL ECOL, V21, P5675, DOI 10.1111/j.1365-294X.2012.05734.x; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sardinha MI, 2002, S AFR J MARINE SCI, V24, P49, DOI 10.2989/025776102784528303; SCHEFFERS WJ, 1976, DOC SCI PROVIS CTR R, V59, P19; SCHEFFERS WJ, 1972, DOC SCI PROVIS CTR R, V44, P21; SEVRINREYSSAC J, 1985, OCEANOGRAPHIE TROPIC, V1, P85; Simier M, 2004, ESTUAR COAST SHELF S, V59, P69, DOI 10.1016/j.ecss.2003.08.002; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sokal RR, 1995, BIOMETRY PRINCIPLES, P937; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; TORESEN R, 2002, SURVEY PELAGIC FISH; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S, 1951, ANN EUGENIC, V15, P323	94	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77483	10.1371/journal.pone.0077483	http://dx.doi.org/10.1371/journal.pone.0077483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130890	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900139
J	Martinez-Lopez, A; Garcia-Valtanen, P; Ortega-Villaizan, MD; Chico, V; Medina-Gali, RM; Perez, L; Coll, J; Estepa, A				Martinez-Lopez, Alicia; Garcia-Valtanen, Pablo; del Mar Ortega-Villaizan, Maria; Chico, Veronica; Maria Medina-Gali, Regla; Perez, Luis; Coll, Julio; Estepa, Amparo			Increasing Versatility of the DNA Vaccines through Modification of the Subcellular Location of Plasmid-Encoded Antigen Expression in the In Vivo Transfected Cells	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; RAINBOW-TROUT; RHABDOVIRUS VHSV; GLYCOPROTEIN-G; PROTEIN-G; VIRUS; FUSION; PLEUROCIDIN; VACCINATION; PEPTIDES	The route of administration of DNA vaccines can play a key role in the magnitude and quality of the immune response triggered after their administration. DNA vaccines containing the gene of the membrane-anchored glycoprotein (gpG) of the fish rhabdoviruses infectious haematopoietic necrosis virus (IHNV) or viral haematopoietic septicaemia virus (VHSV), perhaps the most effective DNA vaccines generated so far, confer maximum protection when injected intramuscularly in contrast to their low efficacy when injected intraperitoneally. In this work, taking as a model the DNA vaccine against VHSV, we focused on developing a more versatile DNA vaccine capable of inducing protective immunity regardless of the administration route used. For that, we designed two alternative constructs to gpG(1-507) (the wild type membrane-anchored gpG of VHSV) encoding either a soluble (gpG(1-462)) or a secreted soluble (gpG(LmPle20-462)) form of the VHSV-gpG. In vivo immunisation/challenge assays showed that only gpG(LmPle20-462) (the secreted soluble form) conferred protective immunity against VHSV lethal challenge via both intramuscular and intraperitoneal injection, being this the first description of a fish viral DNA vaccine that confers protection when administered intraperitoneally. Moreover, this new DNA vaccine construct also conferred protection when administered in the presence of an oil adjuvant suggesting that DNA vaccines against rhabdoviruses could be included in the formulation of current multicomponent-intaperitoneally injectable fish vaccines formulated with an oil adjuvant. On the other hand, a strong recruitment of membrane immunoglobulin expressing B cells, mainly membrane IgT, as well as t-bet expressing T cells, at early times post-immunisation, was specifically observed in the fish immunised with the secreted soluble form of the VHSV-gpG protein; this may indicate that the subcellular location of plasmid-encoded antigen expression in the in vivo transfected cells could be an important factor in determining the ways in which DNA vaccines prime the immune response.	[Martinez-Lopez, Alicia; Garcia-Valtanen, Pablo; del Mar Ortega-Villaizan, Maria; Chico, Veronica; Maria Medina-Gali, Regla; Perez, Luis; Estepa, Amparo] Miguel Hernandez Univ, IBMC, Elche, Spain; [Coll, Julio] INIA SIGT Biotecnol, Madrid, Spain; [Maria Medina-Gali, Regla] LABIOFAM Pharmaceut Labs, Havana, Cuba	Universidad Miguel Hernandez de Elche	Estepa, A (corresponding author), Miguel Hernandez Univ, IBMC, Elche, Spain.	aestepa@umh.es	Coll, julio/M-6071-2019; Del Mar Ortega-villaizan Romo, Maria/Q-9233-2018; Gali, Regla María M Medina/D-6958-2018; Coll, Julio M/G-4533-2010; del Mar Ortega-Villaizan Romo, Maria/K-3649-2014; Gali, Regla María Medina/AAH-9742-2020; Valtanen, Pablo Garcia/U-2921-2018	Coll, julio/0000-0001-8496-3493; Del Mar Ortega-villaizan Romo, Maria/0000-0003-2065-0601; Gali, Regla María M Medina/0000-0001-9401-8292; Coll, Julio M/0000-0001-8496-3493; Gali, Regla María Medina/0000-0001-9401-8292; Valtanen, Pablo Garcia/0000-0003-4382-6446; Martinez Lopez, Alicia/0000-0003-3347-0394; Perez Garcia-Estan, Luis/0000-0003-4078-8763	Spanish Ministry of Economy and Competence [AGL2011-28921-C03-01, AGL2011-28921-C03-02]; CONSOLIDER INGENIO [2010-CSD2007-00002]; Generalitat Valenciana [ISIC-2012-003 ACOMP/2013/230]	Spanish Ministry of Economy and Competence(Spanish Government); CONSOLIDER INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by Spanish Ministry of Economy and Competence grants AGL2011-28921-C03-01 and -02 and CONSOLIDER INGENIO 2010-CSD2007-00002 to AE and JC as well as by the Generalitat Valenciana grant ISIC-2012-003 ACOMP/2013/230 to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2011, FISH SHELLFISH IMMUN, V30, P815, DOI 10.1016/j.fsi.2011.01.001; Basurco B., 1989, Bulletin of the European Association of Fish Pathologists, V9, P92; Becker PD, 2008, HUM VACCINES, V4, P189, DOI 10.4161/hv.4.3.6314; Boshra H, 2004, FISH SHELLFISH IMMUN, V17, P293, DOI 10.1016/j.fsi.2004.04.002; Brocal I, 2006, APPL MICROBIOL BIOT, V72, P1217, DOI 10.1007/s00253-006-0393-7; Carlson C, 1997, VIROLOGY, V239, P198, DOI 10.1006/viro.1997.8892; Chico V, 2010, J VIROL, V84, P7140, DOI 10.1128/JVI.00023-10; Chico V, 2009, VACCINE, V27, P1938, DOI 10.1016/j.vaccine.2009.01.103; Coban C, 2011, CURR GENE THER, V11, P479, DOI 10.2174/156652311798192815; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Corbeil S, 2000, FISH SHELLFISH IMMUN, V10, P711, DOI 10.1006/fsim.2000.0286; DEKINKELIN P, 1977, CR ACAD SCI D NAT, V284, P101; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Estepa AM, 2001, J BIOL CHEM, V276, P46268, DOI 10.1074/jbc.M108682200; Falco A, 2007, ANTIVIR RES, V76, P111, DOI 10.1016/j.antiviral.2007.06.006; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gupta PK, 2005, VET MICROBIOL, V108, P207, DOI 10.1016/j.vetmic.2005.04.007; Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI 10.1586/ERV.10.57; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lorenzo G, 1996, J VIROL METHODS, V58, P1, DOI 10.1016/0166-0934(95)01972-3; Mas V, 2004, J VIROL, V78, P1936, DOI 10.1128/JVI.78.4.1936-1944.2004; Mas V, 2002, J GEN VIROL, V83, P2671, DOI 10.1099/0022-1317-83-11-2671; McLauchlan PE, 2003, FISH SHELLFISH IMMUN, V15, P39, DOI 10.1016/S1050-4648(02)00137-7; Mitta G, 2000, J CELL SCI, V113, P2759; Nunez E, 1998, VIROLOGY, V243, P322, DOI 10.1006/viro.1998.9076; Rocha A, 2002, VET IMMUNOL IMMUNOP, V86, P89, DOI 10.1016/S0165-2427(02)00016-8; Rush C, 2002, J IMMUNOL, V169, P4951, DOI 10.4049/jimmunol.169.9.4951; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schijns VEJC, 2005, DEV BIOLOGICALS, V121, P127; Sunyer JO, 2005, VET IMMUNOL IMMUNOP, V108, P77, DOI 10.1016/j.vetimm.2005.07.009; Vera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024041; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; Zwollo P, 2008, DEV COMP IMMUNOL, V32, P1482, DOI 10.1016/j.dci.2008.06.008	34	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77426	10.1371/journal.pone.0077426	http://dx.doi.org/10.1371/journal.pone.0077426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130884	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900136
J	Nadalutti, CA; Korponay-Szabo, IR; Kaukinen, K; Wang, Z; Griffin, M; Maki, M; Lindfors, K				Nadalutti, Cristina Antonella; Korponay-Szabo, Ilma Rita; Kaukinen, Katri; Wang, Zhuo; Griffin, Martin; Maki, Markku; Lindfors, Katri			Thioredoxin Is Involved in Endothelial Cell Extracellular Transglutaminase 2 Activation Mediated by Celiac Disease Patient IgA	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; ENZYMATIC-ACTIVITY; AUTOANTIBODIES; EXPRESSION; IDENTIFICATION; ADHESION	Purpose: To investigate the role of thioredoxin (TRX), a novel regulator of extracellular transglutaminase 2 (TG2), in celiac patients IgA (CD IgA) mediated TG2 enzymatic activation. Methods: TG2 enzymatic activity was evaluated in endothelial cells (HUVECs) under different experimental conditions by ELISA and Western blotting. Extracellular TG2 expression was studied by ELISA and immunofluorescence. TRX was analysed by Western blotting and ELISA. Serum immunoglobulins class A from healthy subjects (H IgA) were used as controls. Extracellular TG2 enzymatic activity was inhibited by R281. PX12, a TRX inhibitor, was also employed in the present study. Results: We have found that in HUVECs CD IgA is able to induce the activation of extracellular TG2 in a dose-dependent manner. Particularly, we noted that the extracellular modulation of TG2 activity mediated by CD IgA occurred only under reducing conditions, also needed to maintain antibody binding. Furthermore, CD IgA-treated HUVECs were characterized by a slightly augmented TG2 surface expression which was independent from extracellular TG2 activation. We also observed that HUVECs cultured in the presence of CD IgA evinced decreased TRX surface expression, coupled with increased secretion of the protein into the culture medium. Intriguingly, inhibition of TRX after CD IgA treatment was able to overcome most of the CD IgA-mediated effects including the TG2 extracellular transamidase activity. Conclusions: Altogether our findings suggest that in endothelial cells CD IgA mediate the constitutive activation of extracellular TG2 by a mechanism involving the redox sensor protein TRX.	[Nadalutti, Cristina Antonella; Maki, Markku; Lindfors, Katri] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Nadalutti, Cristina Antonella; Maki, Markku; Lindfors, Katri] Tampere Univ Hosp, Tampere, Finland; [Korponay-Szabo, Ilma Rita] Heim Palm Childrens Hosp, Celiac Dis Ctr, Budapest, Hungary; [Korponay-Szabo, Ilma Rita] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pediat, Debrecen, Hungary; [Kaukinen, Katri] Univ Tampere, Dept GastroenterologyandAlimentary Tract Surg, Tampere Univ Hosp, Sch Med, FIN-33101 Tampere, Finland; [Wang, Zhuo; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Tampere University; Tampere University; Tampere University Hospital; University of Debrecen; Tampere University; Tampere University Hospital; Aston University	Lindfors, K (corresponding author), Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	Katri.lindfors@uta.fi	Korponay-Szabó, Ilma/AFK-1690-2022; Nadalutti, Cristina/ABA-5652-2021; Korponay-Szabó, Ilma/AAF-9048-2022	Nadalutti, Cristina/0000-0002-4721-6904; WANG, ZHUO/0000-0002-2212-8318; Griffin, Martin/0000-0003-3824-306X	Academy of Finland; Tampere Graduate Program in Biomedicine and Biotechnology; Sigrid Juselius Foundation; Finnish Coeliac Society; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9P020, 9P033]; Pediatric Research Foundation; European Commission IAPP grant TRANSCOM [PIA-GA-2010-251506]; Hungarian scientific research grant Orszagos Tudomanyos Kutatasi (OTKA) [K101788, NK105046]	Academy of Finland(Academy of Finland); Tampere Graduate Program in Biomedicine and Biotechnology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Coeliac Society; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Pediatric Research Foundation; European Commission IAPP grant TRANSCOM; Hungarian scientific research grant Orszagos Tudomanyos Kutatasi (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The Coeliac Disease Study Group was financially supported by the Academy of Finland, the Tampere Graduate Program in Biomedicine and Biotechnology, the Sigrid Juselius Foundation, the Research Fund of the Finnish Coeliac Society, the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (grant numbers 9P020 and 9P033) and the Pediatric Research Foundation and the European Commission IAPP grant TRANSCOM (Contract number PIA-GA-2010-251506). Further, the Hungarian scientific research grant Orszagos Tudomanyos Kutatasi (OTKA) K101788, NK105046 and the Theoretical Atomic-Molecular Optical Physics (TAMOP)4.2.2.11/1/KONV-2012-0023 are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Caja S, 2010, SCAND J GASTROENTERO, V45, P421, DOI 10.3109/00365520903540822; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Dieterich W, 2003, GUT, V52, P1562, DOI 10.1136/gut.52.11.1562; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; DiRaimondo TR, 2012, J PHARMACOL EXP THER, V341, P104, DOI 10.1124/jpet.111.187385; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; FOLK JE, 1966, J BIOL CHEM, V241, P5518; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Jones RA, 1997, J CELL SCI, V110, P2461; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Lindfors K, 2010, AUTOIMMUN REV, V9, P744, DOI 10.1016/j.autrev.2010.06.003; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77277	10.1371/journal.pone.0077277	http://dx.doi.org/10.1371/journal.pone.0077277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130874	Green Published, Green Accepted, gold			2022-12-25	WOS:000325810900132
J	Liu, T; Wang, N; Cao, J; Sofiadis, A; Dinets, A; Zedenius, J; Larsson, C; Xu, D				Liu, T.; Wang, N.; Cao, J.; Sofiadis, A.; Dinets, A.; Zedenius, J.; Larsson, C.; Xu, D.			The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas	ONCOGENE			English	Article						TERT promoter mutation; telomere shortening; telomerase; thyroid cancer	REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; GENE-EXPRESSION; DIAGNOSIS; SURVIVAL; SAMPLES; LENGTH; TUMORS; PCR	Telomerase activation through induction of its catalytic component telomerase reverse transcriptase (TERT) expression is essential for malignant transformation. TERT promoter mutations namely C228T and C250T that stimulate TERT transcription and telomerase activation have recently been identified in many human malignancies. We thus determined these mutations and their biological and clinical implications in thyroid carcinomas in the present study. The TERT promoter was sequenced in 10 thyroid cancer cell lines and 144 tumors from 20 patients with anaplastic thyroid carcinoma (ATC), 51 with papillary thyroid carcinoma (PTC), 36 with follicular thyroid carcinoma (FTC), and 37 with medullary thyroid carcinoma (MTC). We identified C228T or C250T mutation in 6/8 of ATC cell lines, as well as in tumor tissue from 10/20, 13/51, 8/36 and 0/37 patients with ATC, PTC, FTC and MTC, respectively. In PTC patients, these mutations were exclusively present in the group with age 445 years (P<0.0001), and highly correlated shorter telomeres (P<0.0001) and distant metastasis (P = 0.028). The previous radioactivity exposure did not induce the mutation. The presence of C228T or C250T was an independent predictor associated with shorter disease-related survival (DRS) in the entire cohort (P<0.0001), as well as among patients 445 years (P = 0.021). ATC patients carrying the mutation survived shorter than those without mutations, although not statistically significant (P = 0.129). The TERT promoter mutation was associated with overall survival (P = 0.038) and DRS (P = 0.058) of FTC patients. Taken together, age-and shorter telomere-dependent TERT promoter mutations occur frequently in follicular cell-derived thyroid carcinoma (ATC, PTC and FTC) but not in parafollicular cell-originated MTC, and may serve as a marker for aggressive disease and poor outcome.	[Liu, T.; Xu, D.] Karolinska Inst, Dept Med, Div Hematol, S-17176 Stockholm, Sweden; [Liu, T.; Xu, D.] Karolinska Inst, Dept Med, Ctr Mol Med, S-17176 Stockholm, Sweden; [Liu, T.; Wang, N.; Cao, J.; Sofiadis, A.; Dinets, A.; Zedenius, J.; Larsson, C.; Xu, D.] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Wang, N.; Sofiadis, A.; Larsson, C.] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Wang, N.; Sofiadis, A.; Larsson, C.] Karolinska Inst, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Cao, J.] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Cao, J.] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Dinets, A.; Zedenius, J.] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Larsson, C (corresponding author), Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden.	catharina.larsson@ki.se; Dawei.Xu@ki.se	Dinets, Andrii/AAA-3494-2019	Dinets, Andrii/0000-0001-9680-7519; Xu, Dawei/0000-0003-3141-4524; Sofiadis, Anastasios/0000-0003-4057-7739	Swedish Cancer Society, the Swedish Research Council; Cancer Society in Stockholm, the Stockholm County Council; Karolinska Institutet	Swedish Cancer Society, the Swedish Research Council(Swedish Research CouncilSwedish Cancer Society); Cancer Society in Stockholm, the Stockholm County Council; Karolinska Institutet(Karolinska Institutet)	We thank Drs N-E Heldin (Uppsala University, Sweden), and BG Robinson and Mr. E Wennerberg (University of Sydney, Australia) for cell lines. The study was funded by grants from the Swedish Cancer Society, the Swedish Research Council, Cancer Society in Stockholm, the Stockholm County Council and Karolinska Institutet. Dr M Hulchiy (Kyiv CIty Teaching Endocrinological Center, Ukraine) for help with retrieval of Ukraine PTC tissue samples.	Aogi K, 1998, CLIN CANCER RES, V4, P1965; Asaad Nancy Y, 2006, J Egypt Natl Canc Inst, V18, P8; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bornstein-Quevedo L, 2003, ENDOCR PATHOL, V14, P213, DOI 10.1007/s12022-003-0013-3; Brousset P, 1997, J CLIN ENDOCR METAB, V82, P4214, DOI 10.1210/jc.82.12.4214; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheng AJ, 1998, BRIT J CANCER, V77, P2177, DOI 10.1038/bjc.1998.363; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Dinets A, 2012, EUR J ENDOCRINOL, V166, P1049, DOI 10.1530/EJE-12-0144; Domomt J, 2005, J CLIN ONCOL, V23, P3086, DOI 10.1200/JCO.2005.06.944; Foukakis T, 2007, ENDOCR-RELAT CANCER, V14, P381, DOI 10.1677/ERC-06-0023; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Guerra LN, 2006, CLIN CHIM ACTA, V370, P180, DOI 10.1016/j.cca.2006.02.009; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoang-Vu C, 2002, INT J ONCOL, V21, P265; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kammori M, 2003, INT J ONCOL, V22, P985; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Lerma E, 2005, CANCER CYTOPATHOL, V105, P492, DOI 10.1002/cncr.21380; Liu XL, 2013, ENDOCR-RELAT CANCER, V20, P603, DOI 10.1530/ERC-13-0210; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Saji M, 1999, CLIN CANCER RES, V5, P1483; Sanders RP, 2004, J CLIN ONCOL, V22, P3790, DOI 10.1200/JCO.2004.03.043; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sputova Klara, 2013, Genome Integr, V4, P4, DOI 10.1186/2041-9414-4-4; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Straight AM, 2002, J ENDOCRINOL INVEST, V25, P302, DOI 10.1007/BF03344009; Tallet A, 2014, ONCOGENE, V33, P3748, DOI 10.1038/onc.2013.351; Umbricht CB, 1997, CANCER RES, V57, P2144; Wang YC, 2008, THYROID, V18, P1055, DOI 10.1089/thy.2008.0101; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431	35	168	174	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					4978	4984		10.1038/onc.2013.446	http://dx.doi.org/10.1038/onc.2013.446			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24141777				2022-12-25	WOS:000343768000002
J	Wang, YH; Zankovs, DP; Jiang, M; Zhang, M; Henderson, SC; Tseng, GN				Wang, Yuhong; Zankovs, Dimitar P.; Jiang, Min; Zhang, Mei; Henderson, Scott C.; Tseng, Gea-Ny			[Ca2+]i Elevation and Oxidative Stress Induce KCNQ1 Protein Trans location from the Cytosol to the Cell Surface and Increase Slow Delayed Rectifier (I-Ks) in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Endoplasmic Reticulum (ER); Potassium Channels; Stress Response; Trafficking; Confocal Microscopy; Stress Response; Trafficking	POTASSIUM CHANNEL; VENTRICULAR MYOCYTES; CURRENT AMPLITUDE; QT-SYNDROME; HERG; KCNE1; HEART; MUTATIONS; MINK; CARDIOMYOCYTES	Our goals are to simultaneously determine the three-dimensional distribution patterns of KCNQ1 and KCNE1 in cardiac myocytes and to study the mechanism and functional implications for variations in KCNQ1/KCNE1 colocalization in myocytes. We monitored the distribution patterns of KCNQ1, KCNE1, and markers for subcellular compartments/organelles using immunofluorescence/confocal microscopy and confirmed the findings in ventricular myocytes by directly observing fluorescently tagged KCNQ1-GFP and KCNE1-dsRed expressed in these cells. We also monitored the effects of stress on KCNQ1-GFP and endoplasmic reticulum (ER) remodeling during live cell imaging. The data showed that 1) KCNE1 maintained a stable cell surface localization, whereas KCNQ1 exhibited variations in the cytosolic compartment (striations versus vesicles) and the degree of presence on the cell surface; 2) the degree of cell surface KCNQ1/KCNE1 colocalization was positively correlated with slow delayed rectifier (I-Ks) current density; 3) KCNQ1 and calnexin (an ER marker) shared a cytosolic compartment; and 4) in response to stress ([Ca2+](i) elevation, oxidative overload, or AT1R stimulation), KCNQ1 exited the cytosolic compartment and trafficked to the cell periphery in vesicles. This was accompanied by partial ER fragmentation. We conclude that the cellular milieu regulates KCNQ1 distribution in cardiac myocytes and that stressful conditions can increase I-Ks by inducing KCNQ1 movement to the cell surface. This represents a hitherto unrecognized mechanism by which I-Ks fulfills its function as a repolarization reserve in ventricular myocytes.	[Wang, Yuhong; Zankovs, Dimitar P.; Jiang, Min; Zhang, Mei; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Henderson, Scott C.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Tseng, GN (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, 1101 E Marshall St,Sanger Hall,3-042a, Richmond, VA 23298 USA.	gtseng@vcu.edu	Henderson, Scott/AAP-2785-2021	Henderson, Scott/0000-0002-1076-3867	National Institutes of Health [RO1 HL107294]; NINDS National Institutes of Health Center [5P30NS047463]; American Heart Association/Mid-Atlantic Affiliate Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS National Institutes of Health Center; American Heart Association/Mid-Atlantic Affiliate Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported, in whole or in part, by National Institutes of Health Grant RO1 HL107294 (to G. N. T.) and NINDS National Institutes of Health Center Core Grant 5P30NS047463 (for microscopy performed at the Virginia Commonwealth University Department of Neurobiology and Anatomy Microscopy Facility). This work was also supported by an American Heart Association/Mid-Atlantic Affiliate Postdoctoral Fellowship (to D. P. Z.).	Abraham RL, 2010, J MOL CELL CARDIOL, V48, P181, DOI 10.1016/j.yjmcc.2009.07.020; Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Borggrefe M, 2005, J ELECTROCARDIOL, V38, P75, DOI 10.1016/j.jelectrocard.2005.06.009; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; ELLINGSEN O, 1993, AM J PHYSIOL, V265, pH747, DOI 10.1152/ajpheart.1993.265.2.H747; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Haitin Y, 2009, EMBO J, V28, P1994, DOI 10.1038/emboj.2009.157; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jiang M, 2009, J BIOL CHEM, V284, P16452, DOI 10.1074/jbc.M808262200; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Melnyk P, 2005, CARDIOVASC RES, V65, P104, DOI 10.1016/j.cardiores.2004.08.014; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; Nguyen N, 2013, AM J PHYSIOL-GASTR L, V304, pG157, DOI 10.1152/ajpgi.00346.2012; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Olesen MS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-24; Organ-Darling LE, 2013, AM J PHYSIOL-HEART C, V304, pH589, DOI 10.1152/ajpheart.00385.2012; Qu JH, 2001, CIRC RES, V89, pE8, DOI 10.1161/hh1301.094395; Rasmussen HB, 2004, AM J PHYSIOL-HEART C, V286, pH1300, DOI 10.1152/ajpheart.00344.2003; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200, DOI 10.1152/ajpheart.1990.258.4.H1200; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019; Zhang M, 2012, AM J PHYSIOL-HEART C, V302, pH910, DOI 10.1152/ajpheart.00691.2011	35	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35358	35371		10.1074/jbc.M113.504746	http://dx.doi.org/10.1074/jbc.M113.504746			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142691	hybrid, Green Published			2022-12-25	WOS:000329867600033
J	Dodero, L; Damiano, M; Galbusera, A; Bifone, A; Tsaftsaris, SA; Scattoni, ML; Gozzi, A				Dodero, Luca; Damiano, Mario; Galbusera, Alberto; Bifone, Angelo; Tsaftsaris, Sotirios A.; Scattoni, Maria Luisa; Gozzi, Alessandro			Neuroimaging Evidence of Major Morpho-Anatomical and Functional Abnormalities in the BTBR T plus TF/J Mouse Model of Autism	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CEREBRAL BLOOD-VOLUME; CORTICAL THICKNESS; CORPUS-CALLOSUM; SPECTRUM DISORDERS; PROBST BUNDLE; IN-VIVO; BRAIN; AGENESIS; CONNECTIVITY	BTBR T+tf/J (BTBR) mice display prominent behavioural deficits analogous to the defining symptoms of autism, a feature that has prompted a widespread use of the model in preclinical autism research. Because neuro-behavioural traits are described with respect to reference populations, multiple investigators have examined and described the behaviour of BTBR mice against that exhibited by C57BL/6J (B6), a mouse line characterised by high sociability and low self-grooming. In an attempt to probe the translational relevance of this comparison for autism research, we used Magnetic Resonance Imaging (MRI) to map in both strain multiple morpho-anatomical and functional neuroimaging readouts that have been extensively used in patient populations. Diffusion tensor tractography confirmed previous reports of callosal agenesis and lack of hippocampal commissure in BTBR mice, and revealed a concomitant rostro-caudal reorganisation of major cortical white matter bundles. Intact inter-hemispheric tracts were found in the anterior commissure, ventro-medial thalamus, and in a strain-specific white matter formation located above the third ventricle. BTBR also exhibited decreased fronto-cortical, occipital and thalamic gray matter volume and widespread reductions in cortical thickness with respect to control B6 mice. Foci of increased gray matter volume and thickness were observed in the medial prefrontal and insular cortex. Mapping of resting-state brain activity using cerebral blood volume weighted fMRI revealed reduced cortico-thalamic function together with foci of increased activity in the hypothalamus and dorsal hippocampus of BTBR mice. Collectively, our results show pronounced functional and structural abnormalities in the brain of BTBR mice with respect to control B6 mice. The large and widespread white and gray matter abnormalities observed do not appear to be representative of the neuroanatomical alterations typically observed in autistic patients. The presence of reduced fronto-cortical metabolism is of potential translational relevance, as this feature recapitulates previously-reported clinical observations.	[Dodero, Luca; Damiano, Mario; Galbusera, Alberto; Bifone, Angelo; Gozzi, Alessandro] Ctr Neurosci & Cognit Syst UniTn, Ist Italiano Tecnol, Rovereto, Italy; [Tsaftsaris, Sotirios A.] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL USA; [Scattoni, Maria Luisa] Ist Super Sanita, Neurotoxicol & Neuroendocrinol Sect, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Italiano di Tecnologia - IIT; Northwestern University; Istituto Superiore di Sanita (ISS)	Gozzi, A (corresponding author), Ctr Neurosci & Cognit Syst UniTn, Ist Italiano Tecnol, Rovereto, Italy.	alessandro.gozzi@iit.it	Scattoni, Maria Luisa/K-4116-2016; Gozzi, Alessandro/K-6342-2016; Galbusera, Alberto/N-5531-2016	Scattoni, Maria Luisa/0000-0002-6659-0280; Gozzi, Alessandro/0000-0002-5731-4137; Galbusera, Alberto/0000-0001-7213-0013	Istituto Italiano di Tecnologia	Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT)	The study was funded by the Istituto Italiano di Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Babineau BA, 2013, PHYSIOL BEHAV, V114, P49, DOI 10.1016/j.physbeh.2013.03.006; Badaruddin DH, 2007, CHILD PSYCHIAT HUM D, V38, P287, DOI 10.1007/s10578-007-0065-6; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Brown WS, 2005, NEUROPSYCHOLOGIA, V43, P906, DOI 10.1016/j.neuropsychologia.2004.09.008; Damiano M, 2013, VOXEL BASED MO UNPUB; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Devinsky O, 2003, EPILEPSY BEHAV, V4, P607, DOI 10.1016/j.yebeh.2003.08.029; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Ferrari L, 2012, J NEUROSCI METH, V204, P9, DOI 10.1016/j.jneumeth.2011.10.020; Ferrari L, 2010, J NEUROSCI METH, V186, P143, DOI 10.1016/j.jneumeth.2009.11.005; Frazier TW, 2009, BIOL PSYCHIAT, V66, P935, DOI 10.1016/j.biopsych.2009.07.022; GEORGE MS, 1992, J NERV MENT DIS, V180, P413, DOI 10.1097/00005053-199207000-00002; GONZALEZ RG, 1995, AM J NEURORADIOL, V16, P1763; Gozzi A, 2007, MAGN RESON IMAGING, V25, P826, DOI 10.1016/j.mri.2007.03.003; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Gozzi A, 2011, NEUROPSYCHOPHARMACOL, V36, P2431, DOI 10.1038/npp.2011.129; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hardan AY, 2009, BIOL PSYCHIAT, V66, P320, DOI 10.1016/j.biopsych.2009.04.024; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Haznedar MM, 1997, AM J PSYCHIAT, V154, P1047; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Ito H, 2005, J MED INVESTIG, V52, P49, DOI 10.2152/jmi.52.49; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Lau YC, 2012, J AUTISM DEV DISORD; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lerch JP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00006; Magnuson M, 2010, J MAGN RESON IMAGING, V32, P584, DOI 10.1002/jmri.22295; Meyer BU, 1998, J NEUROL NEUROSUR PS, V64, P138, DOI 10.1136/jnnp.64.1.138; Miller VM, 2013, BRAIN RES, V1513, P26, DOI 10.1016/j.brainres.2013.04.001; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MOUNTZ JM, 1995, J NUCL MED, V36, P1156; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Ren T, 2007, J NEUROSCI, V27, P10345, DOI 10.1523/JNEUROSCI.2787-07.2007; Sasaki M, 2010, BRAIN DEV-JPN, V32, P776, DOI 10.1016/j.braindev.2010.06.003; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Sforazzini F, 2013, NEUROIMAGE UNPUB; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178; Turk AA, 2010, NEUROPSYCHOLOGIA, V48, P43, DOI 10.1016/j.neuropsychologia.2009.08.009; Utsunomiya H, 2006, ACTA RADIOL, V47, P1063, DOI 10.1080/02841850600930025; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yang M, 2012, PHYSIOL BEHAV, V107, P649, DOI 10.1016/j.physbeh.2011.12.025; Yang M, 2009, EUR J NEUROSCI, V29, P1663, DOI 10.1111/j.1460-9568.2009.06714.x; Zaharchuk G, 1999, STROKE, V30, P2197, DOI 10.1161/01.STR.30.10.2197; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zilbovicius M, 2000, AM J PSYCHIAT, V157, P1988, DOI 10.1176/appi.ajp.157.12.1988	76	79	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76655	10.1371/journal.pone.0076655	http://dx.doi.org/10.1371/journal.pone.0076655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146902	Green Accepted, Green Published, gold			2022-12-25	WOS:000326019400078
J	Yin, J; Zhang, JX; Xie, J; Zou, ZL; Huang, XT				Yin, Jie; Zhang, John X.; Xie, Jing; Zou, Zhiling; Huang, Xiting			Gender Differences in Perception of Romance in Chinese College Students	PLOS ONE			English	Article							FACE PERCEPTION; SEX-DIFFERENCES; EMOTION REGULATION; NEURAL BASIS; LOVE; ATTITUDES; CORTEX; MEMORY; WOMEN; FMRI	Women often complain that their partners are not romantic enough. This raises the question: how romance is recognized and evaluated in a love relationship? However, there has been essentially no empirical research bearing on this issue. The present set of studies examined possible gender differences in perceptions of romance and the associated neural mechanisms in Chinese college students. In Study 1, 303 participants (198 women, 105 men) were administrated a questionnaire consisting of 60 sentences and required to rate the romance level of each sentence. Results showed higher rating scores in males than females for low romance items, but not for high or medium romance items. In Study 2, 69 participants (37 women, 32 men) were recruited to judge the degree of romance in sentences presented on a computer screen one by one. Compared with females, males again showed higher scores and responded more slowly only to low romance items. In Study 3, 36 participants (18 women, 18 men) currently in love with someone were scanned with functional MRI while they did the romance judgment task from Study 2. Compared with females, greater brain activation was found for males in the frontal lobe, precentral gyrus, precuneus and parahippocampal gyrus for low romance items. The results provide the first piece of evidence for gender differences in romance perception, suggesting enhanced cognitive processing in males when evaluating the degree of romance in romantic scenes.	[Yin, Jie; Xie, Jing; Zou, Zhiling; Huang, Xiting] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Zhang, John X.] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	Southwest University - China; Fudan University	Zou, ZL (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	zouzl@swu.edu.cn		Zou, Zhiling/0000-0003-4497-2947	Fundamental Research for the Central Universities [SWU1009104]; Key Discipline Fund of the National 211 Project, China [TR201203-4, NSKD11001]; Social Science Fund of Chongqing, China [2010CQZDW07]	Fundamental Research for the Central Universities; Key Discipline Fund of the National 211 Project, China; Social Science Fund of Chongqing, China	This research was supported by the Fundamental Research for the Central Universities (SWU1009104), Key Discipline Fund of the National 211 Project, China (# TR201203-4, #NSKD11001), the Social Science Fund of Chongqing, China (2010CQZDW07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2009, REV GEN PSYCHOL, V13, P59, DOI 10.1037/a0014226; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; [Anonymous], 1981, AM CHINESE PASSAGE D; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Aron A, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P595, DOI 10.1017/CBO9780511606632.033; Banyard Victoria L, 2007, Violence Vict, V22, P52, DOI 10.1891/vv-v22i1a004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BAXTER LA, 1986, J SOC PERS RELAT, V3, P289, DOI 10.1177/0265407586033003; Beauregard M., 2001, J NEUROSCI, V21, P6993, DOI [DOI 10.1523/JNEUROSCI.21-18-J0001.2001, DOI 10.1523/JNEUROSCI.21-18-j0001.2001]; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Capellanus Andreas, 1990, ART COURTLY LOVE; Chiao JY, 2008, J COGNITIVE NEUROSCI, V20, P2167, DOI 10.1162/jocn.2008.20151; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Dion K., 1988, PSYCHOL LOVE, P264; DION KK, 1993, J SOC ISSUES, V49, P53, DOI 10.1111/j.1540-4560.1993.tb01168.x; Feeney JA, 1990, ATTACHMENT STYLE PRE, V2, P281, DOI DOI 10.1037/0022-3514.58.2.281; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Gao G, 2001, INT J INTERCULT REL, V25, P329, DOI 10.1016/S0147-1767(01)00007-4; Geer JH, 2005, ARCH SEX BEHAV, V34, P671, DOI 10.1007/s10508-005-7923-8; Gross AM, 2006, VIOLENCE AGAINST WOM, V12, P288, DOI 10.1177/1077801205277358; Halsband U, 1998, BEHAV BRAIN RES, V97, P69, DOI 10.1016/S0166-4328(98)00028-X; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Hatfield E., 1978, A NEW LOOK AT LOVE; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Hedden T, 2008, PSYCHOL SCI, V19, P12, DOI 10.1111/j.1467-9280.2008.02038.x; Hendrick S., 1992, ROMANTIC LOVE; Henson RNA, 1999, J NEUROSCI, V19, P3962; Impett EA, 2002, PSYCHOL WOMEN QUART, V26, P360, DOI 10.1111/1471-6402.t01-1-00075; Jackson T, 2006, J CROSS CULT PSYCHOL, V37, P446, DOI 10.1177/0022022106288480; JANKOWIAK WR, 1992, ETHNOLOGY, V31, P149, DOI 10.2307/3773618; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 1995, J NEUROPHYSIOL, V74, P1192; KEPHART WM, 1967, J MARRIAGE FAM, V29, P470, DOI 10.2307/349585; KNOX DH, 1968, J MARRIAGE FAM, V30, P638, DOI 10.2307/349508; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; KOMAKI G, 2006, INT C SER, V1287, P135; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Lu WY, 2010, STUDIES CULTURE ART, V3, P62; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Najib A, 2004, AM J PSYCHIAT, V161, P2245, DOI 10.1176/appi.ajp.161.12.2245; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Pines AM, 1998, PERS INDIV DIFFER, V25, P147, DOI 10.1016/S0191-8869(98)00054-3; Riehl-Emde A, 2003, FAM PROCESS, V42, P253, DOI 10.1111/j.1545-5300.2003.42205.x; RUBIN Z, 1970, J PERS SOC PSYCHOL, V16, P265, DOI 10.1037/h0029841; RUBIN Z, 1981, SEX ROLES, V7, P821, DOI 10.1007/BF00287767; Shulman S, 2000, J RES ADOLESCENCE, V10, P99, DOI 10.1207/SJRA1001_5; SIMPSON JA, 1986, PERS SOC PSYCHOL B, V12, P363, DOI 10.1177/0146167286123011; SPRECHER S, 1994, PERS RELATIONSHIP, V1, P349, DOI 10.1111/j.1475-6811.1994.tb00070.x; Sternberg R.J., 1988, PSYCHOL LOVE; Sternberg R.J, 1988, THE TRIANGLE OF LOVE; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang L. P., 2005, J SW CHINA NORMAL U, V31, P43; Wang LZ, 2003, TV RATINGS YB 2003; Wei G, 2006, FAMILY LIFE GUIDE, V4, P22; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Wojciulik E., 1997, Society for Neuroscience Abstracts, V23, P299; Xu WW, 2008, THESIS NE NORMAL U C; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Zhang GZ, 2011, CHINESE MED ETHICS, V24, P657; Zhang W, 2007, CHINA J HLTH PSYCHOL, V15, P63; Zhong DP, 2003, YOUTH STUDIES, V5, P37; Zuo XY, 2012, J ADOLESCENT HEALTH, V50, pS18, DOI 10.1016/j.jadohealth.2011.12.001; 宿建沛, 2002, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V11, P693	76	43	43	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76294	10.1371/journal.pone.0076294	http://dx.doi.org/10.1371/journal.pone.0076294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146853	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400052
J	Kopec, KO; Lupas, AN				Kopec, Klaus O.; Lupas, Andrei N.			beta-Propeller Blades as Ancestral Peptides in Protein Evolution	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; UNFOLDED PROTEIN; DNA GYRASE; HOMOLOGY DETECTION; GALANTHUS-NIVALIS; WW DOMAINS; SEQUENCE; LECTINS; ORIGIN	Proteins of the beta-propeller fold are ubiquitous in nature and widely used as structural scaffolds for ligand binding and enzymatic activity. This fold comprises between four and twelve four-stranded beta-meanders, the so called blades that are arranged circularly around a central funnel-shaped pore. Despite the large size range of beta-propellers, their blades frequently show sequence similarity indicative of a common ancestry and it has been proposed that the majority of beta-propellers arose divergently by amplification and diversification of an ancestral blade. Given the structural versatility of beta-propellers and the hypothesis that the first folded proteins evolved from a simpler set of peptides, we investigated whether this blade may have given rise to other folds as well. Using sequence comparisons, we identified proteins of four other folds as potential homologs of beta-propellers: the luminal domain of inositol-requiring enzyme 1 (IRE1-LD), type II beta-prisms, beta-pinwheels, and WW domains. Because, with increasing evolutionary distance and decreasing sequence length, the statistical significance of sequence comparisons becomes progressively harder to distinguish from the background of convergent similarities, we complemented our analyses with a new method that evaluates possible homology based on the correlation between sequence and structure similarity. Our results indicate a homologous relationship of IRE1-LD and type II beta-prisms with beta-propellers, and an analogous one for beta-pinwheels and WW domains. Whereas IRE1-LD most likely originated by fold-changing mutations from a fully formed PQQ motif beta-propeller, type II beta-prisms originated by amplification and differentiation of a single blade, possibly also of the PQQ type. We conclude that both beta-propellers and type II beta-prisms arose by independent amplification of a blade-sized fragment, which represents a remnant of an ancient peptide world.	[Kopec, Klaus O.; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Baden Wurttembe, Germany	Max Planck Society	Lupas, AN (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Baden Wurttembe, Germany.	andrei.lupas@tuebingen.mpg.de			Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	This work was supported by institutional funds from the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2008, CURR OPIN STRUC BIOL, V18, P358, DOI 10.1016/j.sbi.2008.02.006; Alva V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-17; Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Coles M, 2006, STRUCTURE, V14, P1489, DOI 10.1016/j.str.2006.08.005; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Fetrow J S, 1998, Pac Symp Biocomput, P485; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; HOFMANN K, 1995, FEBS LETT, V358, P153, DOI 10.1016/0014-5793(94)01415-W; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoorelbeke B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-10; Hsieh TJ, 2004, J BIOL CHEM, V279, P55587, DOI 10.1074/jbc.M408934200; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Jones E., 2001, SCIPY OPEN SOURCE SC; Kalev I, 2012, BIOINFORMATICS, V28, P2996, DOI 10.1093/bioinformatics/bts538; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200; Kurimoto E, 2007, J BIOL CHEM, V282, P33252, DOI 10.1074/jbc.C700174200; Li YH, 2009, J INSECT PHYSIOL, V55, P135, DOI 10.1016/j.jinsphys.2008.10.015; Liu W, 2005, J BIOL CHEM, V280, P14865, DOI 10.1074/jbc.M411634200; Lupas AN, 2001, J STRUCT BIOL, V134, P191, DOI 10.1006/jsbi.2001.4393; Lupas AN, 2008, COMPUTATIONAL STRUCT; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Qi Y, 2002, PROTEINS, V47, P258, DOI 10.1002/prot.10090; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharma A, 2007, J BIOSCIENCES, V32, P1089, DOI 10.1007/s12038-007-0111-3; Shetty KN, 2012, GLYCOBIOLOGY, V22, P56, DOI 10.1093/glycob/cwr100; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Stevens TJ, 2008, PROTEINS, V70, P378, DOI 10.1002/prot.21521; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	60	57	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77074	10.1371/journal.pone.0077074	http://dx.doi.org/10.1371/journal.pone.0077074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143202	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100037
J	Altemeier, WA; Liles, WC; Villagra-Garcia, A; Matute-Bello, G; Glenny, RW				Altemeier, William A.; Liles, W. Conrad; Villagra-Garcia, Ana; Matute-Bello, Gustavo; Glenny, Robb W.			Ischemia-Reperfusion Lung Injury Is Attenuated in MyD88-Deficient Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MEDIATES ISCHEMIA/REPERFUSION INJURY; PRIMARY GRAFT DYSFUNCTION; KAPPA-B; TRANSPLANTATION; TOLL-LIKE-RECEPTOR-4; INHIBITION; TLR2; PROTECTION; PATHWAYS	Ischemia-reperfusion lung injury is a common cause of acute morbidity and mortality in lung transplant recipients and has been associated with subsequent development of bronchiolitis obliterans syndrome. Recognition of endogenous ligands released during cellular injury (damage-associated molecular patterns; DAMPs) by Toll-like receptors (TLRs), especially TLR4, has increasingly been recognized as a mechanism for inflammation resulting from tissue damage. TLR4 is implicated in the pathogenesis of ischemia-reperfusion injury of multiple organs including heart, liver, kidney and lung. Additionally, activation of TLRs other than TLR4 by DAMPs has been identified in tissues other than the lung. Because all known TLRs, with the exception of TLR3, signal via the MyD88 adapter protein, we hypothesized that lung ischemia-reperfusion injury was mediated by MyD88-dependent signaling. To test this hypothesis, we subjected C57BL/6 wildtype, Myd88(-)/-, and Tlr4(-/-) mice to 1 hr of left lung warm ischemia followed by 4 hr of reperfusion. We found that Myd88(-/-) mice had significantly less MCP-1/CCL2 in the left lung following ischemia-reperfusion as compared with wildtype mice. This difference was associated with dramatically reduced lung permeability. Interestingly, Tlr4(-/-) mice had only partial protection from ischemia-reperfusion as compared to Myd88(-/-) mice, implicating other MyD88-dependent pathways in lung injury following ischemia-reperfusion. We also found that left lung ischemia-reperfusion caused remote inflammation in the right lung. Finally, using chimeric mice with MyD88 expression restricted to either myeloid or non-myeloid cells, we found that MyD88-dependent signaling in myeloid cells was necessary for ischemia-reperfusion induced lung permeability. We conclude that MyD88-dependent signaling through multiple receptors is important in the pathogenesis of acute lung inflammation and injury following ischemia and reperfusion.	[Altemeier, William A.; Liles, W. Conrad; Matute-Bello, Gustavo] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Altemeier, William A.; Liles, W. Conrad; Matute-Bello, Gustavo; Glenny, Robb W.] Univ Washington, Dept Med, Seattle, WA USA; [Liles, W. Conrad; Villagra-Garcia, Ana] Univ Toronto, Toronto Gen Res Inst, McLaughlin Rotman Ctr Global Hlth, Dept Med, Toronto, ON, Canada; [Glenny, Robb W.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle	Altemeier, WA (corresponding author), Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA.	billa@u.washington.edu		Altemeier, William/0000-0001-8860-405X	National Institutes of Health [HL71020, HL086883, HL73996]; Centro de Investigacion Biomedica en Red Enfermedades Respiratorias (CIBERES); Instituto de Salud de Carlos III (ISC III) [F1S01F015]; Canada Research Chair in Infectious Disease and Inflammation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073996, R01HL086883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centro de Investigacion Biomedica en Red Enfermedades Respiratorias (CIBERES); Instituto de Salud de Carlos III (ISC III)(Instituto de Salud Carlos III); Canada Research Chair in Infectious Disease and Inflammation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by: National Institutes of Health (HL71020, HL086883 and HL73996; www.nih.gov), Centro de Investigacion Biomedica en Red Enfermedades Respiratorias (CIBERES - www.ciberes.org) and Instituto de Salud de Carlos III (ISC III - www.isciii.es) (F1S01F015), and Canada Research Chair in Infectious Disease and Inflammation (www.chairs-chaires.gc.ca). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Belperio JA, 2005, J IMMUNOL, V175, P6931, DOI 10.4049/jimmunol.175.10.6931; Chong AJ, 2004, J THORAC CARDIOV SUR, V128, P170, DOI 10.1016/j.jtcvs.2003.11.036; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; EPPINGER MJ, 1995, J SURG RES, V58, P713, DOI 10.1006/jsre.1995.1112; Farrar CA, 2012, FASEB J, V26, P799, DOI 10.1096/fj.11-195396; Fiser SM, 2002, ANN THORAC SURG, V73, P1041, DOI 10.1016/S0003-4975(01)03606-2; Haddad JJ, 2003, CRIT CARE, V7, P47, DOI 10.1186/cc1840; Henderson WR, 2002, J IMMUNOL, V169, P5294, DOI 10.4049/jimmunol.169.9.5294; Hoffman SA, 2009, AM J TRANSPLANT, V9, P389, DOI 10.1111/j.1600-6143.2008.02497.x; Hua F, 2007, J IMMUNOL, V178, P7317, DOI 10.4049/jimmunol.178.11.7317; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kim KH, 2005, AM J RESP CELL MOL, V33, P271, DOI 10.1165/rcmb.2005-0111OC; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Land WG, 2005, TRANSPLANTATION, V79, P505, DOI 10.1097/01.TP.0000153160.82975.86; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Mathur S, 2011, SHOCK, V36, P478, DOI 10.1097/SHK.0b013e31822d6442; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Naidu BV, 2003, J HEART LUNG TRANSPL, V22, P784, DOI 10.1016/S1053-2498(02)00556-9; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Ross SD, 2000, AM J PHYSIOL-LUNG C, V279, pL528, DOI 10.1152/ajplung.2000.279.3.L528; Shah RJ, 2012, TRANSL RES, V160, P435, DOI 10.1016/j.trsl.2012.08.003; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shimamoto A, 2006, ANN THORAC SURG, V82, P2017, DOI 10.1016/j.athoracsur.2006.06.079; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Stapel H, 2006, EUR J HEART FAIL, V8, P665, DOI 10.1016/j.ejheart.2006.03.005; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wu He-Shui, 2004, Hepatobiliary Pancreat Dis Int, V3, P250; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zanotti G, 2009, AM J PHYSIOL-LUNG C, V297, pL52, DOI 10.1152/ajplung.90406.2008; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200	46	23	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77123	10.1371/journal.pone.0077123	http://dx.doi.org/10.1371/journal.pone.0077123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146959	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400098
J	Angeler, DG; Allen, CR; Rojo, C; Alvarez-Cobelas, M; Rodrigo, MA; Sanchez-Carrillo, S				Angeler, David G.; Allen, Craig R.; Rojo, Carmen; Alvarez-Cobelas, Miguel; Rodrigo, Maria A.; Sanchez-Carrillo, Salvador			Inferring the Relative Resilience of Alternative States	PLOS ONE			English	Article							WHOLE-ECOSYSTEM EXPERIMENT; WETLAND CENTRAL SPAIN; REGIME SHIFTS; COMPLEX-SYSTEMS; SHALLOW LAKES; STABLE STATES; DIVERSITY; DROUGHT; DISCONTINUITIES; RESPONSES	Ecological systems may occur in alternative states that differ in ecological structures, functions and processes. Resilience is the measure of disturbance an ecological system can absorb before changing states. However, how the intrinsic structures and processes of systems that characterize their states affects their resilience remains unclear. We analyzed time series of phytoplankton communities at three sites in a floodplain in central Spain to assess the dominant frequencies or "temporal scales" in community dynamics and compared the patterns between a wet and a dry alternative state. The identified frequencies and cross-scale structures are expected to arise from positive feedbacks that are thought to reinforce processes in alternative states of ecological systems and regulate emergent phenomena such as resilience. Our analyses show a higher species richness and diversity but lower evenness in the dry state. Time series modeling revealed a decrease in the importance of short-term variability in the communities, suggesting that community dynamics slowed down in the dry relative to the wet state. The number of temporal scales at which community dynamics manifested, and the explanatory power of time series models, was lower in the dry state. The higher diversity, reduced number of temporal scales and the lower explanatory power of time series models suggest that species dynamics tended to be more stochastic in the dry state. From a resilience perspective our results highlight a paradox: increasing species richness may not necessarily enhance resilience. The loss of cross-scale structure (i.e. the lower number of temporal scales) in community dynamics across sites suggests that resilience erodes during drought. Phytoplankton communities in the dry state are therefore likely less resilient than in the wet state. Our case study demonstrates the potential of time series modeling to assess attributes that mediate resilience. The approach is useful for assessing resilience of alternative states across ecological and other complex systems.	[Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Allen, Craig R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA; [Rojo, Carmen; Rodrigo, Maria A.] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Alvarez-Cobelas, Miguel; Sanchez-Carrillo, Salvador] Spanish Natl Res Council, Natl Museum Nat Hist, Madrid, Spain	Swedish University of Agricultural Sciences; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC)	Angeler, DG (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	david.angeler@slu.se	Rojo, Carmen/L-5358-2014; Rodrigo, Maria/K-9079-2014; Sanchez-Carrillo, Salvador/L-1098-2014	Rodrigo, Maria/0000-0003-4106-0643; SANCHEZ-CARRILLO, SALVADOR/0000-0002-5471-977X	August T. Larsson Foundation of the Swedish University of Agricultural Sciences; Spanish Ministry of Economy and Competitiveness [2009 10292]; Spanish Ministry of Environment and National Parks Authority [001/2008]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service; Wildlife Management Institute	August T. Larsson Foundation of the Swedish University of Agricultural Sciences; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Environment and National Parks Authority; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	The authors acknowledge financial support from the August T. Larsson Foundation of the Swedish University of Agricultural Sciences. This study was also funded by the projects CGL 2009 10292 (Spanish Ministry of Economy and Competitiveness) and 001/2008 (Spanish Ministry of Environment and National Parks Authority). The Nebraska Cooperative Fish and Wildlife Research Unit is jointly supported by a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the United States Fish and Wildlife Service, and the Wildlife Management Institute. Reference to trade names does not imply endorsement by the authors or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Allen CR, 2005, ECOSYSTEMS, V8, P958, DOI 10.1007/s10021-005-0147-x; Allen CR., 2008, DISCONTINUITIES ECOS; Angeler DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069174; Angeler DG, 2013, J APPL ECOL, V50, P572, DOI 10.1111/1365-2664.12092; Angeler DG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04928-170232; Angeler DG, 2011, ECOL SOC, V16, DOI 10.5751/ES-04175-160305; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Angeler DG, 2000, J PLANKTON RES, V22, P2075, DOI 10.1093/plankt/22.11.2075; [Anonymous], 2001, PANARCHY UNDERSTANDI; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Downing AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046135; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Foti R, 2012, P NATL ACAD SCI USA, V109, P19596, DOI 10.1073/pnas.1218056109; Garmestani AS, 2009, ECOL SOC, V14; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Heinrich G, 2012, INT J CLIMATOL, V32, P1951, DOI 10.1002/joc.2421; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Ireland AW, 2012, WETLANDS, V32, P989, DOI 10.1007/s13157-012-0324-6; Ireland AW, 2011, ECOLOGY, V92, P11, DOI 10.1890/10-0770.1; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jiang L, 2011, J ANIM ECOL, V80, P577, DOI 10.1111/j.1365-2656.2010.01799.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Loverde-Oliveira SM, 2009, ECOSYSTEMS, V12, P807, DOI 10.1007/s10021-009-9258-0; Middleton B., 1999, WETLAND RESTORATION; Mitsch W., 2000, WETLANDS, V3rd; Newbery DM, 2009, PLANT ECOL, V201, P147, DOI 10.1007/s11258-008-9533-8; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Peterson TJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012150; Peterson TJ, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006886; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Rojo C, 2000, HYDROBIOLOGIA, V424, P133, DOI 10.1023/A:1003917414959; Rojo C, 2012, BIODIVERS CONSERV, V21, P2453, DOI 10.1007/s10531-012-0307-1; Sanchez-Carrillo S, 2004, ADV WATER RESOUR, V27, P643, DOI 10.1016/j.advwatres.2004.02.018; SanchezCarrillo S, 2010, WETL ECOL CONSERV MA, V2, P1; Sandgren C.D., 1988, GROWTH REPROD STRATE; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Seekell DA, 2013, THEOR ECOL-NETH, V6, P385, DOI 10.1007/s12080-013-0183-7; Seekell DA, 2012, ECOSYSTEMS, V15, P741, DOI 10.1007/s10021-012-9542-2; Stow C, 2007, ECOL SOC, V12; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Walker B, 2004, ECOL SOC, V9; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Yang T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015192	69	19	19	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77338	10.1371/journal.pone.0077338	http://dx.doi.org/10.1371/journal.pone.0077338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146980	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400110
J	Han, AW; Sandy, M; Fishman, B; Trindade-Silva, AE; Soares, CAG; Distel, DL; Butler, A; Haygood, MG				Han, Andrew W.; Sandy, Moriah; Fishman, Brian; Trindade-Silva, Amaro E.; Soares, Carlos A. G.; Distel, Daniel L.; Butler, Alison; Haygood, Margo G.			Turnerbactin, a Novel Triscatecholate Siderophore from the Shipworm Endosymbiont Teredinibacter turnerae T7901	PLOS ONE			English	Article							NATURAL ORGANIC-LIGANDS; IRON TRANSPORT; ESCHERICHIA-COLI; GENE-CLUSTER; BIOSYNTHESIS; ENTEROBACTIN; SEQUENCE; BIVALVIA; COMPLEXATION; POLYKETIDE	Shipworms are marine bivalve mollusks (Family Teredinidae) that use wood for shelter and food. They harbor a group of closely related, yet phylogenetically distinct, bacterial endosymbionts in bacteriocytes located in the gills. This endosymbiotic community is believed to support the host's nutrition in multiple ways, through the production of cellulolytic enzymes and the fixation of nitrogen. The genome of the shipworm endosymbiont Teredinibacter turnerae T7901 was recently sequenced and in addition to the potential for cellulolytic enzymes and diazotrophy, the genome also revealed a rich potential for secondary metabolites. With nine distinct biosynthetic gene clusters, nearly 7% of the genome is dedicated to secondary metabolites. Bioinformatic analyses predict that one of the gene clusters is responsible for the production of a catecholate siderophore. Here we describe this gene cluster in detail and present the siderophore product from this cluster. Genes similar to the entCEBA genes of enterobactin biosynthesis involved in the production and activation of dihydroxybenzoic acid (DHB) are present in this cluster, as well as a two-module non-ribosomal peptide synthetase (NRPS). A novel triscatecholate siderophore, turnerbactin, was isolated from the supernatant of iron-limited T. turnerae T7901 cultures. Turnerbactin is a trimer of N-(2,3-DHB)-L-Orn-L-Ser with the three monomeric units linked by Ser ester linkages. A monomer, dimer, dehydrated dimer, and dehydrated trimer of 2,3-DHB-L-Orn-L-Ser were also found in the supernatant. A link between the gene cluster and siderophore product was made by constructing a NRPS mutant, TtAH03. Siderophores could not be detected in cultures of TtAH03 by HPLC analysis and Fe-binding activity of culture supernatant was significantly reduced. Regulation of the pathway by iron is supported by identification of putative Fur box sequences and observation of increased Fe-binding activity under iron restriction. Evidence of a turnerbactin fragment was found in shipworm extracts, suggesting the production of turnerbactin in the symbiosis.	[Han, Andrew W.; Fishman, Brian; Haygood, Margo G.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Beaverton, OR USA; [Sandy, Moriah; Butler, Alison] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Trindade-Silva, Amaro E.; Soares, Carlos A. G.] Univ Fed Rio de Janeiro, Inst Biol, Ilha Fundao, CCS, Rio De Janeiro, Brazil; [Distel, Daniel L.] Ocean Genome Legacy Inc, Ipswich, MA USA	Oregon Health & Science University; University of California System; University of California Santa Barbara; Universidade Federal do Rio de Janeiro	Haygood, MG (corresponding author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Beaverton, OR USA.	haygoodm@ebs.ogi.edu	Soares, Carlos A G/H-9464-2016; Trindade-Silva, Amaro/AAO-5685-2020; Distel, Daniel/A-8047-2017; Butler, Alison/D-5094-2015	Soares, Carlos A G/0000-0001-9058-9266; Trindade-Silva, Amaro/0000-0003-4321-065X; Distel, Daniel/0000-0002-3860-194X; Butler, Alison/0000-0002-3525-7864	United States National Institutes of Health [1U01TW008163]; United States National Science Foundation [1059067]; FOGARTY INTERNATIONAL CENTER [U19TW008163, U01TW008163] Funding Source: NIH RePORTER; Direct For Biological Sciences [1442676] Funding Source: National Science Foundation; Division Of Chemistry [1059067] Funding Source: National Science Foundation	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	1. Agency: United States National Institutes of Health, Grant number: 1U01TW008163 (URL: http://grants.nih.gov/grants/oer.htm); 2. Agency: United States National Science Foundation, Grant number: 1059067 (URL: http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; BACHHAWAT AK, 1987, J GEN MICROBIOL, V133, P1759; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Betcher MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045309; Bister B, 2004, BIOMETALS, V17, P471, DOI 10.1023/B:BIOM.0000029432.69418.6a; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Dertz EA, 2006, J AM CHEM SOC, V128, P22, DOI 10.1021/ja055898c; Dias GM, 2012, J BACTERIOL, V194, P904, DOI 10.1128/JB.06583-11; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; Drummond A. J., 2011, GENEIOUS V5 4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshahawi SI, 2013, P NATL ACAD SCI USA, V110, pE295, DOI 10.1073/pnas.1213892110; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; HOFFMANN K, 1994, J BIOL CHEM, V269, P12710; Homann VV, 2009, J NAT PROD, V72, P884, DOI 10.1021/np800640h; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; KLOEPPER JW, 1980, NATURE, V286, P885, DOI 10.1038/286885a0; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P585, DOI 10.1007/BF02908687; Matsuo Y, 2011, J NAT PROD, V74, P2371, DOI 10.1021/np200290j; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nishizawa T, 1999, J BIOCHEM-TOKYO, V126, P520, DOI 10.1093/oxfordjournals.jbchem.a022481; Nishizawa T, 2000, J BIOCHEM, V127, P779, DOI 10.1093/oxfordjournals.jbchem.a022670; OBRIEN IG, 1970, BIOCHIM BIOPHYS ACTA, V215, P393, DOI 10.1016/0304-4165(70)90038-3; PERSMARK M, 1989, J BIOL CHEM, V264, P3187; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; RAYMOND KN, 1984, TOP CURR CHEM, V123, P49; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Sandy M, 2011, J NAT PROD, V74, P1207, DOI 10.1021/np200126z; Sandy M, 2010, J NAT PROD, V73, P1038, DOI 10.1021/np900750g; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; SCARROW RC, 1991, INORG CHEM, V30, P900, DOI 10.1021/ic00005a007; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Soengas RG, 2006, TETRAHEDRON LETT, V47, P7113, DOI 10.1016/j.tetlet.2006.07.104; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Wilson MK, 2006, BIOCHEM BIOPH RES CO, V348, P320, DOI 10.1016/j.bbrc.2006.07.055; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085	66	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76151	10.1371/journal.pone.0076151	http://dx.doi.org/10.1371/journal.pone.0076151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146831	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400043
J	Pan, S; Liu, C; Zhang, WP; Xu, SS; Wang, N; Li, Y; Gao, J; Wang, Y; Wang, GX				Pan, Sha; Liu, Chao; Zhang, Weiping; Xu, Shanshan; Wang, Nan; Li, Yan; Gao, Jing; Wang, Yang; Wang, Genxuan			The Scaling Relationships between Leaf Mass and Leaf Area of Vascular Plant Species Change with Altitude	PLOS ONE			English	Article							ALLOMETRIC RELATIONSHIPS; BIOMASS INVESTMENT; SIZE; SUPPORT; DISPLAY; LAMINA; LEAVES; FORM	The scaling relationship between leaf dry mass and leaf surface area has important implications for understanding the ability of plants to harvest sunlight and grow. Whether and how the scaling relationships vary across environmental gradients are poorly understood. We analyzed the scaling relationships between leaf mass and leaf area of 121 vascular plant species along an altitudinal gradient in a subtropical monsoon forest. The slopes increased significantly with altitude, it varied from less than 1 at low altitude to more than 1 at high altitude. This means that plants growing at high altitude allocate proportionately more biomass to support tissues in larger leaves and less in smaller leaves, whereas the reverse is true at low altitude. This pattern can be explained by different leaf strategies in response to environmental pressure and constrains.	[Pan, Sha; Liu, Chao; Xu, Shanshan; Wang, Nan; Li, Yan; Gao, Jing; Wang, Yang; Wang, Genxuan] Zhejiang Univ, Coll Life Sci, Inst Ecol, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Weiping] China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant & Soil Interact, Beijing 100094, Peoples R China	Zhejiang University; China Agricultural University	Wang, GX (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Ecol, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	wang-gx@zju.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LZ13C030002]; Natural Science Fund of China [31330010]; Ministry of Science and Technology of China [2011AA100503]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The study was financially supported by Zhejiang Provincial Natural Science Foundation of China (LZ13C030002), Natural Science Fund of China (31330010) and Ministry of Science and Technology of China (2011AA100503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Calvo-Alvarado JC, 2008, TREE PHYSIOL, V28, P1601, DOI 10.1093/treephys/28.11.1601; Falster D.S., 2006, USERS GUIDE SMATR ST; Givnish TJ., 1986, P 6 MAR MOORS CAB S, V6; Li GY, 2008, FUNCT ECOL, V22, P557, DOI 10.1111/j.1365-2435.2008.01407.x; Milla R, 2008, FUNCT ECOL, V22, P565, DOI 10.1111/j.1365-2435.2008.01406.x; Milla R, 2007, P ROY SOC B-BIOL SCI, V274, P2109, DOI 10.1098/rspb.2007.0417; Niinemets U, 2004, TREE PHYSIOL, V24, P141, DOI 10.1093/treephys/24.2.141; NIINEMETS U, 1994, FOREST ECOL MANAG, V70, P1, DOI 10.1016/0378-1127(94)90070-1; Niinemets U, 1999, TREE PHYSIOL, V19, P349; Niinemets U, 2007, PLANT CELL ENVIRON, V30, P1052, DOI 10.1111/j.1365-3040.2007.01683.x; Niinemets U, 2007, ANN BOT-LONDON, V100, P283, DOI 10.1093/aob/mcm107; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2007, P NATL ACAD SCI USA, V104, P8891, DOI 10.1073/pnas.0701135104; Niklas KJ, 2011, AM J BOT, V98, P1381, DOI 10.3732/ajb.1100106; Niklas KJ, 2009, AM J BOT, V96, P531, DOI 10.3732/ajb.0800250; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2008, OECOLOGIA, V158, P35, DOI 10.1007/s00442-008-1131-x; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Takenaka A, 2001, FUNCT ECOL, V15, P660, DOI 10.1046/j.0269-8463.2001.00562.x; Tomlinson KW, 2013, J ECOL, V101, P430, DOI 10.1111/1365-2745.12056; Zhang WP, 2012, ECOL RES, V27, P819, DOI 10.1007/s11284-012-0959-z; Zhang WP, 2011, ECOL RES, V26, P819, DOI 10.1007/s11284-011-0843-2	27	27	31	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76872	10.1371/journal.pone.0076872	http://dx.doi.org/10.1371/journal.pone.0076872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146938	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400088
J	Ranea, LM; Marques, AD; Moller, S; Gupta, Y; Ibrahim, SM				Ranea, Laura Mellado; Marques, Andreia de Castro; Moeller, Steffen; Gupta, Yask; Ibrahim, Saleh M.			Genetic Control of Spontaneous Arthritis in a Four-Way Advanced Intercross Line	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; QUANTITATIVE TRAIT LOCI; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; MURINE MODEL; IDENTIFICATION; MICE; ALLELES; DISEASE; STRAIN	Identifying the genetic basis of complex diseases, such as rheumatoid arthritis, remains a challenge that requires experimental models to reduce the genetic and environmental variability. Numerous loci for arthritis have been identified in induced animal models; however, few spontaneous models have been genetically studied. Therefore, we generated a four-way advanced intercross line (AIL) from four inbred strains, including BXD2/TyJ which spontaneously develops autoimmune arthritis. A genome-wide scan for spontaneous arthritis was performed in a cohort of 366 mice of the fourth generation (G4) of this cross. Five loci contributing to clinical phenotypes were identified in chromosomes 3, 7, 13, 18, and X. Three of the loci found in this study, confirm previously identified loci; whereas two of them are novel loci. Interesting candidate genes for the loci are highlighted. This study provides a genetic overview of spontaneous arthritis in mice and aids to solve the genetic etiology of rheumatoid arthritis and to gain a better understanding of the disease.	[Ranea, Laura Mellado; Marques, Andreia de Castro; Moeller, Steffen; Gupta, Yask; Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany	University of Lubeck	Ibrahim, SM (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	Saleh.Ibrahim@uksh.de	Möller, Steffen/B-5368-2013; Ibrahim, Saleh/AAO-9541-2020	Möller, Steffen/0000-0002-7187-4683; Ibrahim, Saleh/0000-0001-7827-2290	DFG [DFG IB 24/6-1, DFG GRK 1727/1]; Excellence Cluster Inflammation at Interfaces [DFG EXC 306/1-2]; BMBF [IMPAM 01EC1008F]	DFG(German Research Foundation (DFG)); Excellence Cluster Inflammation at Interfaces; BMBF(Federal Ministry of Education & Research (BMBF))	This research was supported by grants from DFG (DFG IB 24/6-1, DFG GRK 1727/1), Excellence Cluster Inflammation at Interfaces (DFG EXC 306/1-2), and BMBF (IMPAM 01EC1008F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarichev VA, 2003, J IMMUNOL, V170, P2283, DOI 10.4049/jimmunol.170.5.2283; Asghari F, 2011, J MED GENET, V48, P557, DOI 10.1136/jmg.2011.089730; BAKER D, 1995, J IMMUNOL, V155, P4046; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; DARVASI A, 1995, GENETICS, V141, P1199; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; Holmdahl R, 1998, HUMAN GENOME METHODS, P215; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Imboden JB, 2009, ANNU REV PATHOL-MECH, V4, P417, DOI 10.1146/annurev.pathol.4.110807.092254; Jirholt J, 2002, INT IMMUNOL, V14, P79, DOI 10.1093/intimm/14.1.79; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; Ludwig RJ, 2012, J INVEST DERMATOL, V132, P1409, DOI 10.1038/jid.2011.466; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Merriman TR, 2001, DIABETES, V50, P184, DOI 10.2337/diabetes.50.1.184; Moller S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S5; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Otto JM, 1999, ARTHRITIS RHEUM, V42, P2524, DOI 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rankin J, 2007, J IMMUNOL, V178, P4395, DOI 10.4049/jimmunol.178.7.4395; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiroiwa W, 2007, INT IMMUNOL, V19, P175, DOI 10.1093/intimm/dxl134; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Vegvari A, 2005, J IMMUNOL, V175, P2475, DOI 10.4049/jimmunol.175.4.2475; Weyand CM, 1998, SPRINGER SEMIN IMMUN, V20, P5, DOI 10.1007/BF00831996; Xie S, 2002, GENES IMMUN, V3, pS13, DOI 10.1038/sj.gene.6363886; Yang HT, 1999, J IMMUNOL, V163, P2916	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75611	10.1371/journal.pone.0075611	http://dx.doi.org/10.1371/journal.pone.0075611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146764	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400014
J	Li, ZG; Chen, YP; Zhang, SW; Chen, SL; Li, WF; Yan, LM; Shi, LG; Wu, LM; Sohr, A; Su, SK				Li, Zhiguo; Chen, Yanping; Zhang, Shaowu; Chen, Shenglu; Li, Wenfeng; Yan, Limin; Shi, Liangen; Wu, Lyman; Sohr, Alex; Su, Songkun			Viral Infection Affects Sucrose Responsiveness and Homing Ability of Forager Honey Bees, Apis mellifera L.	PLOS ONE			English	Article							ACUTE PARALYSIS VIRUS; DEFORMED-WING VIRUS; DICISTROVIRUS AFFECTING HONEYBEES; VARROA-DESTRUCTOR; RESPONSE THRESHOLDS; PROBOSCIS EXTENSION; RT-PCR; HYMENOPTERA APIDAE; 1ST DETECTION; BEHAVIOR	Honey bee health is mainly affected by Varroa destructor, viruses, Nosema spp., pesticide residues and poor nutrition. Interactions between these proposed factors may be responsible for the colony losses reported worldwide in recent years. In the present study, the effects of a honey bee virus, Israeli acute paralysis virus (IAPV), on the foraging behaviors and homing ability of European honey bees (Apis mellifera L.) were investigated based on proboscis extension response (PER) assays and radio frequency identification (RFID) systems. The pollen forager honey bees originated from colonies that had no detectable level of honey bee viruses and were manually inoculated with IAPV to induce the viral infection. The results showed that IAPV-inoculated honey bees were more responsive to low sucrose solutions compared to that of non-infected foragers. After two days of infection, around 107 copies of IAPV were detected in the heads of these honey bees. The homing ability of IAPV-infected foragers was depressed significantly in comparison to the homing ability of uninfected foragers. The data provided evidence that IAPV infection in the heads may enable the virus to disorder foraging roles of honey bees and to interfere with brain functions that are responsible for learning, navigation, and orientation in the honey bees, thus, making honey bees have a lower response threshold to sucrose and lose their way back to the hive.	[Li, Zhiguo; Zhang, Shaowu; Chen, Shenglu; Li, Wenfeng; Yan, Limin; Shi, Liangen; Su, Songkun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yanping] ARS, USDA, Bee Res Lab, Beltsville, MD USA; [Zhang, Shaowu] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Wu, Lyman; Sohr, Alex] Univ Maryland, Coll Comp Math & Nat Sci, College Pk, MD 20742 USA; [Su, Songkun] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Fujian, Peoples R China	Zhejiang University; United States Department of Agriculture (USDA); Australian National University; University System of Maryland; University of Maryland College Park; Fujian Agriculture & Forestry University	Su, SK (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	susongkun@zju.edu.cn		LI, WENFENG/0000-0001-8819-6009	earmarked funds for Modern Agro-industry Technology Research System [CARS-45-KXJ3]; Nature and Science Foundation Commission of Zhejiang Province [R3080306]	earmarked funds for Modern Agro-industry Technology Research System; Nature and Science Foundation Commission of Zhejiang Province	This study was supported by earmarked funds for Modern Agro-industry Technology Research System (No. CARS-45-KXJ3), Nature and Science Foundation Commission of Zhejiang Province (R3080306) to SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abbadi AA, 2010, APPL ENTOMOL ZOOL, V45, P183, DOI 10.1303/aez.2010.183; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Bakonyi T, 2002, APIDOLOGIE, V33, P63, DOI 10.1051/apido:2001004; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Chen Y. P., 2012, VIRUS TAXONOMY, V95, P840; Chen YP, 2007, AM BEE J, V147, P1027; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Dyer FC, 1996, J EXP BIOL, V199, P147; Felsenberg J, 2011, JOVE-J VIS EXP, DOI 10.3791/2282; Frost EH, 2011, J INSECT PHYSIOL, V57, P1385, DOI 10.1016/j.jinsphys.2011.07.001; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2005, VET J, V169, P121, DOI 10.1016/j.tvjl.2004.01.004; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pahl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019669; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, BEHAV ECOL SOCIOBIOL, V54, P458, DOI 10.1007/s00265-003-0640-1; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Sanpa S, 2009, J INVERTEBR PATHOL, V100, P116, DOI 10.1016/j.jip.2008.11.010; Scheiner R, 2004, J COMP PHYSIOL A, V190, P727, DOI 10.1007/s00359-004-0531-6; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Si A, 2005, PHARMACOL BIOCHEM BE, V82, P664, DOI 10.1016/j.pbb.2005.11.009; Streit S, 2003, ZOOLOGY, V106, P169, DOI 10.1078/0944-2006-00113; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; Todd JH, 2007, APIDOLOGIE, V38, P354, DOI 10.1051/apido:2007021; Tsuruda JM, 2009, BEHAV BRAIN RES, V205, P132, DOI 10.1016/j.bbr.2009.07.022; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Yan X, 2009, SOCIOBIOLOGY, V54, P95; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	55	39	44	1	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77354	10.1371/journal.pone.0077354	http://dx.doi.org/10.1371/journal.pone.0077354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130876	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200082
J	Bessonov, K; Walkey, CJ; Shelp, BJ; van Vuuren, HJJ; Chiu, D; van der Merwe, G				Bessonov, Kyrylo; Walkey, Christopher J.; Shelp, Barry J.; van Vuuren, Hennie J. J.; Chiu, David; van der Merwe, George			Functional Analyses of NSF1 in Wine Yeast Using Interconnected Correlation Clustering and Molecular Analyses	PLOS ONE			English	Article							SACCHAROMYCES GENOME DATABASE; GENE REGULATORY NETWORKS; EXPRESSION DATA; TRANSCRIPTIONAL ACTIVATION; BAYESIAN NETWORKS; CEREVISIAE; STRESS; METABOLISM; PATTERNS; PATHWAY	Analyzing time-course expression data captured in microarray datasets is a complex undertaking as the vast and complex data space is represented by a relatively low number of samples as compared to thousands of available genes. Here, we developed the Interdependent Correlation Clustering (ICC) method to analyze relationships that exist among genes conditioned on the expression of a specific target gene in microarray data. Based on Correlation Clustering, the ICC method analyzes a large set of correlation values related to gene expression profiles extracted from given microarray datasets. ICC can be applied to any microarray dataset and any target gene. We applied this method to microarray data generated from wine fermentations and selected NSF1, which encodes a C2H2 zinc finger-type transcription factor, as the target gene. The validity of the method was verified by accurate identifications of the previously known functional roles of NSF1. In addition, we identified and verified potential new functions for this gene; specifically, NSF1 is a negative regulator for the expression of sulfur metabolism genes, the nuclear localization of Nsf1 protein (Nsf1p) is controlled in a sulfur-dependent manner, and the transcription of NSF1 is regulated by Met4p, an important transcriptional activator of sulfur metabolism genes. The inter-disciplinary approach adopted here highlighted the accuracy and relevancy of the ICC method in mining for novel gene functions using complex microarray datasets with a limited number of samples.	[Bessonov, Kyrylo; van der Merwe, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Bessonov, Kyrylo; Chiu, David] Univ Guelph, Sch Comp Sci, Guelph, ON N1G 2W1, Canada; [Walkey, Christopher J.; van Vuuren, Hennie J. J.] Univ British Columbia, Wine Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Shelp, Barry J.] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph; University of British Columbia; University of Guelph	van der Merwe, G (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	gvanderm@uoguelph.ca			Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) [SR9231, 026480]; OMAFRA URL: Natural Science and Engineering Research Council (NSERC) [217271-09, 42718-2009]; Genome Canada; GvdM [151WIN]; Genome Canada URL; Ontario Graduate Scholarship	Ontario Ministry of Agriculture and Rural Affairs (OMAFRA); OMAFRA URL: Natural Science and Engineering Research Council (NSERC); Genome Canada(Genome Canada); GvdM; Genome Canada URL; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by: 1) Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grants awarded to GvdM (SR9231) and BS (026480), OMAFRA URL: http://www.omafra.gov.on.ca/english/research/index.html.2) Natural Science and Engineering Research Council (NSERC) Individual Discovery grants awarded to HJJvV (217271-09) and BJS (42718-2009), NSERC URL: http://www.nserc-crsng.gc.ca.3) Genome Canada grant awarded to HJJvV and GvdM (151WIN), Genome Canada URL: http://www.genomecanada.ca/, and an Ontario Graduate Scholarship awarded to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bansal N, 2002, ANN IEEE SYMP FOUND, P238, DOI 10.1109/SFCS.2002.1181947; Barreto L, 2006, EUKARYOT CELL, V5, P1748, DOI 10.1128/EC.00216-06; Bhattacharya A, 2008, BIOINFORMATICS, V24, P1359, DOI 10.1093/bioinformatics/btn133; Bhattacharya A, 2010, J BIOMED INFORM, V43, P560, DOI 10.1016/j.jbi.2010.02.001; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Bulmer AG, 1979, PRINCIPLES STAT; Cheng C, 1997, YEAST, V13, P1; Cherest H, 1997, GENETICS, V145, P627; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cormier L, 2010, NUCLEIC ACIDS RES, V38, P4998, DOI 10.1093/nar/gkq257; Dojer N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-249; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hlynialuk C, 2008, MICROBIOL-SGM, V154, P2482, DOI 10.1099/mic.0.2008/019976-0; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; MESTL T, 1995, J THEOR BIOL, V176, P291, DOI 10.1006/jtbi.1995.0199; MOUNTAIN HA, 1993, MOL MICROBIOL, V9, P221, DOI 10.1111/j.1365-2958.1993.tb01684.x; MOUNTAIN HA, 1991, YEAST, V7, P781, DOI 10.1002/yea.320070804; NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.0.CO;2-X; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; van der Merwe GK, 2001, CURR GENET, V39, P156; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Williams-Hart T, 2002, GENETICS, V160, P1423	45	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77192	10.1371/journal.pone.0077192	http://dx.doi.org/10.1371/journal.pone.0077192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130853	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900124
J	Chaisi, ME; Janssens, ME; Vermeiren, L; Oosthuizen, MC; Collins, NE; Geysen, D				Chaisi, Mamohale E.; Janssens, Michiel E.; Vermeiren, Lieve; Oosthuizen, Marinda C.; Collins, Nicola E.; Geysen, Dirk			Evaluation of a Real-Time PCR Test for the Detection and Discrimination of Theileria Species in the African Buffalo (Syncerus caffer)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PARVA; BABESIA; PROBES; SPP.	A quantitative real-time PCR (qPCR) assay based on the cox III gene was evaluated for the simultaneous detection and discrimination of Theileria species in buffalo and cattle blood samples from South Africa and Mozambique using melting curve analysis. The results obtained were compared to those of the reverse line blot (RLB) hybridization assay for the simultaneous detection and differentiation of Theileria spp. in mixed infections, and to the 18S rRNA qPCR assay results for the specific detection of Theileria parva. Theileria parva, Theileria sp. (buffalo), Theileria taurotragi, Theileria buffeli and Theileria mutans were detected by the cox III assay. Theileria velifera was not detected from any of the samples analysed. Seventeen percent of the samples had non-species specific melting peaks and 4.5% of the samples were negative or below the detection limit of the assay. The cox III assay identified more T. parva and Theileria sp. (buffalo) positive samples than the RLB assay, and also detected more T. parva infections than the 18S assay. However, only a small number of samples were positive for the benign Theileria spp. To our knowledge T. taurotragi has never been identified from the African buffalo, its identification in some samples by the qPCR assay was unexpected. Because of these discrepancies in the results, cox III qPCR products were cloned and sequenced. Sequence analysis indicated extensive inter-and intra-species variations in the probe target regions of the cox III gene sequences of the benign Theileria spp. and therefore explains their low detection. The cox III assay is specific for the detection of T. parva infections in cattle and buffalo. Sequence data generated from this study can be used for the development of a more inclusive assay for detection and differentiation of all variants of the mildly pathogenic and benign Theileria spp. of buffalo and cattle.	[Chaisi, Mamohale E.; Oosthuizen, Marinda C.; Collins, Nicola E.] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Chaisi, Mamohale E.] Natl Univ Lesotho, Dept Biol, Roma, Lesotho; [Janssens, Michiel E.; Vermeiren, Lieve; Geysen, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Janssens, Michiel E.] Therapeut Syst Cent Europe, Ikaroslaan, Zaventm, Belgium	University of Pretoria; Institute of Tropical Medicine (ITM)	Chaisi, ME (corresponding author), Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa.	mechaisi@yahoo.co.uk	Collins, Nicola/O-6342-2014; Oosthuizen, Marinda C/N-8706-2014	Collins, Nicola/0000-0001-7296-3912; Oosthuizen, Marinda C/0000-0002-1893-0818; Chaisi, Mamohale/0000-0002-2365-1039	South African National Research Foundation [NRF ICD2006072000009]; UP Research Development Programme	South African National Research Foundation(National Research Foundation - South Africa); UP Research Development Programme	This work was part of a PhD project that was funded by the South African National Research Foundation (NRF ICD2006072000009) and UP Research Development Programme. It also falls under the Belgian Directorate General for Development Co-operation Framework agreement ITM/DGCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALLSOPP BA, 1993, PARASITOLOGY, V107, P157, DOI 10.1017/S0031182000067263; Bell AS, 2002, TRENDS PARASITOL, V18, P337, DOI 10.1016/S1471-4922(02)02331-0; Bhoora R, 2009, VET PARASITOL, V159, P112, DOI 10.1016/j.vetpar.2008.10.004; Chaisi ME, 2013, VET PARASITOL, V191, P132, DOI 10.1016/j.vetpar.2012.08.005; Chaisi ME, 2011, VET PARASITOL, V182, P150, DOI 10.1016/j.vetpar.2011.05.041; Collins Nicola E, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS217, DOI 10.1016/S0035-9203(02)90079-9; Criado-Fornelio A, 2009, VET PARASITOL, V159, P73, DOI 10.1016/j.vetpar.2008.10.012; De Vos AJ, 1984, ONDESTEPOORT J VET R, V8, P149; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIGUEROA JV, 1995, VET PARASITOL, V57, P75, DOI 10.1016/0304-4017(94)03112-A; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782, DOI 10.1128/JCM.37.6.1782-1789.1999; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Janssens ME, 2009, THESIS U ANWERPEN BE; Jaton K, 2006, J MED MICROBIOL, V55, P1667, DOI 10.1099/jmm.0.46675-0; KAIRO A, 1994, EMBO J, V13, P898, DOI 10.1002/j.1460-2075.1994.tb06333.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Mans BJ, 2011, PARASITOLOGY, V138, P766, DOI 10.1017/S0031182011000187; Norval R. A. I., 1992, The epidemiology of theileriosis in Africa.; Op den Buijsch RAM, 2005, PHARMACOGENOMICS J, V5, P72, DOI 10.1038/sj.tpj.6500299; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reuter M, 2005, J GENET, V84, P341, DOI 10.1007/BF02715807; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saidu S. N. A., 1981, Advances in the control of theileriosis. Proc. Internat. Conf., 9-13 Feb. 1981, Nairobi., P86; Seifert HSH, 1996, TROPICAL ANIMAL HLTH, P193; Sibeko KP, 2008, VET PARASITOL, V155, P37, DOI 10.1016/j.vetpar.2008.03.033; Staden R, 2000, Methods Mol Biol, V132, P115; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uilenberg G, 1999, TROP MED INT HEALTH, V4, pA12, DOI 10.1046/j.1365-3156.1999.00446.x; UILENBERG G., 1964, REV ELEVAGE MED VETERINAIRE PAYS TROP, V17, P655; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; Zarlenga DS, 2001, VET PARASITOL, V101, P215, DOI 10.1016/S0304-4017(01)00568-4; [No title captured]	34	18	19	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75827	10.1371/journal.pone.0075827	http://dx.doi.org/10.1371/journal.pone.0075827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146782	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200003
J	Ma, YQ; Vilanova, D; Atalar, K; Delfour, O; Edgeworth, J; Ostermann, M; Hernandez-Fuentes, M; Razafimahatratra, S; Michot, B; Persing, DH; Ziegler, I; Toros, B; Molling, P; Olcen, P; Beale, R; Lord, GM				Ma, Yuqian; Vilanova, David; Atalar, Kerem; Delfour, Olivier; Edgeworth, Jonathan; Ostermann, Marlies; Hernandez-Fuentes, Maria; Razafimahatratra, Sandrine; Michot, Bernard; Persing, David H.; Ziegler, Ingrid; Toros, Bianca; Molling, Paula; Olcen, Per; Beale, Richard; Lord, Graham M.			Genome-Wide Sequencing of Cellular microRNAs Identifies a Combinatorial Expression Signature Diagnostic of Sepsis	PLOS ONE			English	Article							SURVIVING SEPSIS; TRANSCRIPTOME; BIOMARKERS; DISCOVERY; MODELS	Rationale: Sepsis is a common cause of death in the intensive care unit with mortality up to 70% when accompanied by multiple organ dysfunction. Rapid diagnosis and the institution of appropriate antibiotic therapy and pressor support are therefore critical for survival. MicroRNAs are small non-coding RNAs that play an important role in the regulation of numerous cellular processes, including inflammation and immunity. Objectives: We hypothesized changes in expression of microRNAs during sepsis may be of diagnostic value in the intensive care unit (ICU). Methods: Massively parallel sequencing of microRNAs was utilised for screening microRNA candidates. Putative microRNAs were validated using quantitative real-time PCR (qRT-PCR). This study includes data from both a training cohort (UK) and an independent validation cohort (Sweden). A linear discriminant statistical model was employed to construct a diagnostic microRNA signature. Results: A panel of known and novel microRNAs were detectable in the blood of patients with sepsis. After qRT-PCR validation, microRNA miR-150 and miR-4772-5p-iso were able to discriminate between patients who have systemic inflammatory response syndrome and patients with sepsis. This finding was also validated in independent cohort with an average diagnostic accuracy of 86%. Fractionating the cellular components of blood reveals miR-4772-5p-iso is expressed differentially in monocytes. Functional experiments using primary human monocytes demonstrate that it expressed in response to TLR ligation. Conclusions: Taken together, these data provide a novel microRNA signature of sepsis that should allow rapid point-of-care diagnostic assessment of patients on ICU and also provide greater insight into the pathobiology of this severe disease.	[Ma, Yuqian; Atalar, Kerem; Hernandez-Fuentes, Maria; Lord, Graham M.] Kings Coll London, Dept Expt Immunobiol, London, England; [Beale, Richard] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England; [Ma, Yuqian; Atalar, Kerem; Edgeworth, Jonathan; Ostermann, Marlies; Hernandez-Fuentes, Maria; Beale, Richard; Lord, Graham M.] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Ma, Yuqian; Atalar, Kerem; Edgeworth, Jonathan; Ostermann, Marlies; Hernandez-Fuentes, Maria; Beale, Richard; Lord, Graham M.] Kings Coll London, London, England; [Vilanova, David; Delfour, Olivier; Razafimahatratra, Sandrine; Michot, Bernard] Cepheid Europe, R&D, Maurens Scopont, France; [Edgeworth, Jonathan; Ostermann, Marlies; Beale, Richard; Lord, Graham M.] Guys & St Thomas NHS Fdn Trust, London, England; [Persing, David H.] Cepheid, Sunnyvale, CA USA; [Ziegler, Ingrid] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Toros, Bianca; Molling, Paula; Olcen, Per] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Orebro University; Orebro University	Lord, GM (corresponding author), Kings Coll London, Dept Expt Immunobiol, London, England.	graham.lord@kcl.ac.uk	Fuentes, Maria/HGA-8617-2022; Maria, Hernandez-Fuentes/B-5011-2010; Ostermann, Marlies/AAH-8160-2021; Abraham, Sabu/E-1144-2019; Ostermann, Marlies/B-8777-2015	Maria, Hernandez-Fuentes/0000-0002-7558-9441; Abraham, Sabu/0000-0002-0916-5827; Atalar, Kerem/0000-0003-2338-8629; Stenmark, Bianca/0000-0003-4637-8626; Lord, Graham/0000-0003-2069-4743; Ostermann, Marlies/0000-0001-9500-9080	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; Guy's and St. Thomas Charity; MRC/Kidney Research UK [G0800413]; MRC [G0800413, G0600698] Funding Source: UKRI; British Heart Foundation [PG/12/36/29444] Funding Source: researchfish; Medical Research Council [G0800413, G0600698, G1000758B, MR/J006742/1, G1000758] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); Guy's and St. Thomas Charity; MRC/Kidney Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Y. Ma was funded by a graduate research fellowship from the Guy's and St. Thomas Charity. K. Atalar was funded by an MRC/Kidney Research UK Clinical Research Training Fellowship G0800413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2011, TRIZOL REAG TRIZOL L; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrigan SD, 2004, CLIN CHEM, V50, P1301, DOI 10.1373/clinchem.2004.032144; Cid J, 2010, J INFECTION, V60, P313, DOI 10.1016/j.jinf.2010.02.013; Deitch EA, 2005, SHOCK, V24, P19, DOI 10.1097/01.shk.0000191386.18818.0a; Delfour O VD, 2007, MICROARN BIOL FUNCTI, V5, P38; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Gaieski DF, 2009, CRIT CARE MED; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Ivady B, 2011, CURR MED CHEM, V18, P3211, DOI 10.2174/092986711796391598; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; SIMMS HH, 1989, J CLIN INVEST, V83, P252, DOI 10.1172/JCI113867; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Ugras S, 2011, CANCER RES, V71, P5659, DOI 10.1158/0008-5472.CAN-11-0890; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731	41	73	78	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75918	10.1371/journal.pone.0075918	http://dx.doi.org/10.1371/journal.pone.0075918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146790	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400024
J	Leinartaite, L; Johansson, AS				Leinartaite, Lina; Johansson, Ann-Sofi			Disulfide Scrambling in Superoxide Dismutase 1 Reduces Its Cytotoxic Effect in Cultured Cells and Promotes Protein Aggregation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SOD1; FAMILIAL FORM; SPINAL-CORDS; WILD-TYPE; ALS; APO; MUTATIONS; GENE; SUPEROXIDE-DISMUTASE-1	Mutations in the gene coding for superoxide dismutase 1 (SOD1) are associated with familiar forms of the neurodegenerative disease amyotrophic lateral sclerosis (ALS). These mutations are believed to result in a "gain of toxic function", leading to neuronal degeneration. The exact mechanism is still unknown, but misfolding/aggregation events are generally acknowledged as important pathological events in this process. Recently, we observed that demetallated apoSOD1, with cysteine 6 and 111 substituted for alanine, is toxic to cultured neuroblastoma cells. This toxicity depended on an intact, high affinity Zn2+ site. It was therefor contradictory to discover that wild-type apoSOD1 was not toxic, despite of its high affinity for Zn2+. This inconsistency was hypothesized to originate from erroneous disulfide formation involving C6 and C111. Using high resolution non-reducing SDS-PAGE, we have in this study demonstrated that the inability of wild-type apoSOD1 to cause cell death stems from formation of non-native intramolecular disulfides. Moreover, monomeric apoSOD1 variants capable of such disulfide scrambling aggregated into ThT positive oligomers under physiological conditions without agitation. The oligomers were stabilized by intermolecular disulfides and morphologically resembled what has in other neurodegenerative diseases been termed protofibrils. Disulfide scrambling thus appears to be an important event for misfolding and aggregation of SOD1, but may also be significant for protein function involving cysteines, e. g. mitochondrial import and copper loading.	[Leinartaite, Lina; Johansson, Ann-Sofi] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Johansson, AS (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	ann-sofij@dbb.su.se			Swedish Research Council; Swedish Brain Foundation; Ahlen stiftelsen; Petrus och Augusta Hedlunds stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Ahlen stiftelsen; Petrus och Augusta Hedlunds stiftelse	The work was supported by the Swedish Research Council (www.vr.se), the Swedish Brain Foundation (www.hjarnfonden.se), Ahlen stiftelsen (www.ahlen-stiftelsen.se) and Petrus och Augusta Hedlunds stiftelse (www.hedlundsstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; BIEDLER JL, 1978, CANCER RES, V38, P3751; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Brotherton T, 2011, AMYOTROPH LATERAL SC, V12, P215, DOI 10.3109/17482968.2010.531279; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Di Noto L, 2005, J BIOL CHEM, V280, P39907, DOI 10.1074/jbc.M506247200; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dokholyan NV, 2002, PHYSICA A, V314, P600, DOI 10.1016/S0378-4371(02)01079-8; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Johansson AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036104; Jonsson PA, 2008, ANN NEUROL, V63, P671, DOI 10.1002/ana.21356; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kohno S, 1999, NEUROSCI LETT, V276, P135, DOI 10.1016/S0304-3940(99)00803-4; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Morita M, 1996, NEUROSCI LETT, V205, P79, DOI 10.1016/0304-3940(96)12378-8; Nakamura A, 2012, AMYOTROPH LATERAL SC, V13, P479, DOI 10.3109/17482968.2011.656311; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Pires RH, 2011, J MOL RECOGNIT, V24, P467, DOI 10.1002/jmr.1112; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104	44	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78060	10.1371/journal.pone.0078060	http://dx.doi.org/10.1371/journal.pone.0078060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143259	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100098
J	Macdonald, M; Campbell, K				Macdonald, Margaret; Campbell, Kenneth			Event-Related Potential Measures of a Violation of an Expected Increase and Decrease in Intensity	PLOS ONE			English	Article							MISMATCH-NEGATIVITY; ATTENTION; INFORMATION; MECHANISMS; SEQUENCES; NOVELTY; WINDOW; MMN	Unexpected physical increases in the intensity of a frequently occurring "standard" auditory stimulus are experienced as obtrusive. This could either be because of a physical change, the increase in intensity of the "deviant" stimulus, or a psychological change, the violation of the expectancy for the occurrence of the lower intensity standard stimulus. Two experiments were run in which event-related potentials (ERPs) were recorded to determine whether "psychological" increments (violation of an expectancy for a lower intensity) would be processed differently than psychological decrements (violation of an expectancy for a higher intensity). Event-related potentials (ERPs) were recorded while subjects were presented with auditory tones that alternated between low and high intensity. The subjects ignored the auditory stimuli while watching a video. Deviants were created by repeating the same stimulus. In the first experiment, pairs of stimuli alternating in intensity, were presented in separate increment (H-L...H-L...H-(H) under bar...H-L, in which H = 80 dB SPL and L = 60 dB SPL) and decrement conditions (L-H...L-H...L-(L) under bar...L-H, in which H = 90 dB SPL and L = 80 dB SPL). The paradigm employed in the second experiment consisted of an alternating intensity pattern (H-L-H-L-H-(H) under bar -H-L) or (H-L-H-L-(L) under bar -L-H-L). Importantly, the stimulus prior to the deviant (the standard) and the actual deviants in both increment and decrement conditions in both experiments were physically identical (80 dB SPL tones). The repetition of the lower intensity tone therefore acted as a psychological rather than a physical decrement (a higher intensity tone was expected) while the repetition of the higher intensity tone acted as a psychological increment (a lower intensity tone was expected). The psychological increments in both experiments elicited a larger amplitude mismatch negativity (MMN) than the decrements. Thus, regardless of whether an acoustic change signals a physical increase in intensity or violates an expected decrease in intensity, a large MMN will be elicited.	[Macdonald, Margaret; Campbell, Kenneth] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Campbell, K (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	kcampbel@uottawa.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this research was provided by an operating grant to K. C. by the Natural Sciences and Engineering Research Council of Canada (NSERC) and by a doctoral scholarship to MM by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, NEUROREPORT, V6, P140, DOI 10.1097/00001756-199412300-00036; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Bregman A.S., 1990, AUDITORY SCENE ANAL; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Freiberg K, 2001, BRIT J DEV PSYCHOL, V19, P1, DOI 10.1348/026151001165903; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Jacobsen T, 2003, AUDIOL NEURO-OTOL, V8, P338, DOI 10.1159/000073518; Macdonald M, 2008, NEUROREPORT, V19, P309, DOI 10.1097/WNR.0b013e3282f4ede8; Macdonald M, 2011, BRAIN COGNITION, V77, P438, DOI 10.1016/j.bandc.2011.08.014; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Makeig S, 1996, ADV NEUR IN, V8, P145; Muller-Gass A, 2007, BRAIN RES, V1170, P71, DOI 10.1016/j.brainres.2007.07.023; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; NORDBY H, 1988, PSYCHOPHYSIOLOGY, V25, P262, DOI 10.1111/j.1469-8986.1988.tb01239.x; Paavilainen P, 1998, PSYCHOPHYSIOLOGY, V35, P483, DOI 10.1017/S0048577298970895; Paavilainen P, 2003, NEUROREPORT, V14, P715, DOI 10.1097/00001756-200304150-00011; Paavilainen P, 2013, INT J PSYCHOPHYSIOL, V88, P109, DOI 10.1016/j.ijpsycho.2013.03.015; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Rinne T, 2006, BRAIN RES, V1077, P135, DOI 10.1016/j.brainres.2006.01.043; Sculthorpe LD, 2008, BRAIN RES, V1234, P78, DOI 10.1016/j.brainres.2008.07.031; Wetzel N, 2011, BIOL PSYCHOL, V86, P39, DOI 10.1016/j.biopsycho.2010.10.005; Winer BJ, 1971, STAT PRINCIPLES EXPT; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; WOESTENBURG JC, 1983, BIOL PSYCHOL, V16, P127, DOI 10.1016/0301-0511(83)90059-5; Yabe H, 1997, NEUROREPORT, V8, P1971, DOI 10.1097/00001756-199705260-00035	32	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76897	10.1371/journal.pone.0076897	http://dx.doi.org/10.1371/journal.pone.0076897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143195	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100030
J	Mutevedzi, PC; Rodger, AJ; Kowal, P; Nyirenda, M; Newell, ML				Mutevedzi, Portia C.; Rodger, Alison J.; Kowal, Paul; Nyirenda, Makandwe; Newell, Marie-Louise			Decreased Chronic Morbidity but Elevated HIV Associated Cytokine Levels in HIV-Infected Older Adults Receiving HIV Treatment: Benefit of Enhanced Access to Care?	PLOS ONE			English	Article							SOUTH-AFRICA; INFLAMMATORY MARKERS; OBESITY; INTERLEUKIN-6; PREVALENCE; PREDICTORS; DISEASE; PEOPLE; HEALTH	Background: The association of HIV with chronic morbidity and inflammatory markers (cytokines) in older adults (50+years) is potentially relevant for clinical care, but data from African populations is scarce. Objective: To examine levels of chronic morbidity by HIV and ART status in older adults (50+years) and subsequent associations with selected pro-inflammatory cytokines and body mass index. Methods: Ordinary, ordered and generalized ordered logistic regression techniques were employed to compare chronic morbidity (heart disease (angina), arthritis, stroke, hypertension, asthma and diabetes) and cytokines (Interleukins-1 and -6, C-Reactive Protein and Tumor Necrosis Factor-alpha) by HIV and ART status on a cross-sectional random sample of 422 older adults nested within a defined rural South African population based demographic surveillance. Results: Using a composite measure of all morbidities, controlling for age, gender, BMI, smoking and wealth quintile, HIV-infected individuals on ART had 51% decreased odds (95% CI: 0.26-0.92) of current morbidity compared to HIV-uninfected. In adjusted regression, compared to HIV-uninfected, the proportional odds (aPOR) of having elevated inflammation markers of IL6 (>1.56pg/mL) was nearly doubled in HIV-infected individuals on (aPOR 1.84; 95% CI: 1.05-3.21) and not on (aPOR 1.94; 95% CI: 1.11-3.41) ART. Compared to HIV-uninfected, HIV-infected individuals on ART had >twice partial proportional odds (apPOR=2.30; p=0.004) of having non-clinically significant raised hsCRP levels(>1ug/mL); ART-naive HIV-infected individuals had >double apPOR of having hsCRP levels indicative of increased heart disease risk(>3.9ug/mL; p=0.008). Conclusions: Although HIV status was associated with increased inflammatory markers, our results highlight reduced morbidity in those receiving ART and underscore the need of pro-actively extending these services to HIV-uninfected older adults, beyond mere provision at fixed clinics. Providing health services through regular community chronic disease screening would ensure health care reaches all older adults in need.	[Mutevedzi, Portia C.; Nyirenda, Makandwe; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Mutevedzi, Portia C.; Rodger, Alison J.] UCL, Dept Infect & Populat Hlth, London, England; [Kowal, Paul] World Hlth Org Solid Act Globalizat & Environm, Geneva, Switzerland; [Kowal, Paul] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia; [Nyirenda, Makandwe] Univ Southampton, Sch Social Sci, Southampton, Hants, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, London, England	University of Kwazulu Natal; University of London; University College London; World Health Organization; University of Newcastle; University of Southampton; University of London; University College London	Mutevedzi, PC (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	pmutevedzi@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Nyirenda, Makandwe/R-4080-2018; Nyirenda, Makandwe/B-2963-2015	Newell, Marie-Louise/0000-0002-1074-7699; Nyirenda, Makandwe/0000-0002-1839-877X; Kowal, Paul/0000-0002-6314-8753	WHO's Study on global AGEing and adult health (SAGE); United States National Institute on Aging Division of Behavioral and Social Research (BSR) [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01]; Wellcome Trust United Kingdom [65377]	WHO's Study on global AGEing and adult health (SAGE); United States National Institute on Aging Division of Behavioral and Social Research (BSR); Wellcome Trust United Kingdom(Wellcome Trust)	This work was supported by WHO's Study on global AGEing and adult health (SAGE), with funding from the United States National Institute on Aging Division of Behavioral and Social Research (BSR) through an Interagency Agreement (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01). The Africa Centre core and surveillance is supported by the Wellcome Trust United Kingdom through grant number 65377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew C, 2000, LANCET, V356, P1423, DOI DOI 10.1016/S0140-6736(00)02854-3.PUBMED:11052597; [Anonymous], 2000, INT LOG REGR ALL ITS; [Anonymous], 2008, TODAYS RES AGING USE; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Cheymol G, 2000, CLIN PHARMACOKINET, V39, P215, DOI 10.2165/00003088-200039030-00004; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Dobriansky PJ, 2007, WHY POPULATION AGING; Gebo KA, 2006, DRUG AGING, V23, P897, DOI 10.2165/00002512-200623110-00005; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Goldman N, 2007, FUTURE DIRECTIONS IN; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; He W, 2012, SHADES GRAY CROSS CO; HOBER D, 1989, CLIN EXP IMMUNOL, V78, P329; Houlihan CF, 2010, INT J EPIDEMIOL, V40; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Lessells RJ, 2011, J ACQ IMMUN DEF SYND, P56; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P1105, DOI 10.1111/j.1532-5415.2004.52308.x; Puts MTE, 2005, CLIN ENDOCRINOL, V63, P403, DOI 10.1111/j.1365-2265.2005.02355.x; Rhee MS, 2008, J CLIN PHARMACOL, V48, P1212, DOI 10.1177/0091270008322177; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Targher G, 2001, DIABETES CARE, V24, P956, DOI 10.2337/diacare.24.5.956; Trayhurn P, 2005, ENDOCRINOLOGY, V146, P1003, DOI 10.1210/en.2004-1597; UCLA, STAT DAT AN EX ORD L; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wallrauch C, 2010, SAMJ, P100; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2012, WHO GLOB DAT BOD MAS; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77379	10.1371/journal.pone.0077379	http://dx.doi.org/10.1371/journal.pone.0077379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143226	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100063
J	Alm, PA; Karlsson, R; Sundberg, M; Axelson, HW				Alm, Per A.; Karlsson, Ragnhild; Sundberg, Madeleine; Axelson, Hans W.			Hemispheric Lateralization of Motor Thresholds in Relation to Stuttering	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; NON-SPEECH; FLUENT; ADULTS	Stuttering is a complex speech disorder. Previous studies indicate a tendency towards elevated motor threshold for the left hemisphere, as measured using transcranial magnetic stimulation (TMS). This may reflect a monohemispheric motor system impairment. The purpose of the study was to investigate the relative side-to-side difference (asymmetry) and the absolute levels of motor threshold for the hand area, using TMS in adults who stutter (n = 15) and in controls (n = 15). In accordance with the hypothesis, the groups differed significantly regarding the relative side-to-side difference of finger motor threshold (p = 0.0026), with the stuttering group showing higher motor threshold of the left hemisphere in relation to the right. Also the absolute level of the finger motor threshold for the left hemisphere differed between the groups (p = 0.049). The obtained results, together with previous investigations, provide support for the hypothesis that stuttering tends to be related to left hemisphere motor impairment, and possibly to a dysfunctional state of bilateral speech motor control.	[Alm, Per A.; Karlsson, Ragnhild; Sundberg, Madeleine] Uppsala Univ, Dept Neurosci Speech & Language Pathol, Uppsala, Sweden; [Axelson, Hans W.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Alm, PA (corresponding author), Uppsala Univ, Dept Neurosci Speech & Language Pathol, Uppsala, Sweden.	per.alm@neuro.uu.se	Axelson, Hans/K-2246-2019	Alm, Per/0000-0003-1506-5897	Uppsala University	Uppsala University	The study was funded by Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awiszus F., 2010, TMS MOTOR THRESHOLD; Borckardt JJ, 2006, J ECT, V22, P169, DOI 10.1097/01.yct.0000235923.52741.72; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Choo AL, 2010, FOLIA PHONIATR LOGO, V62, P143, DOI 10.1159/000287213; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; de Felicio CM, 2007, INT J PEDIATR OTORHI, V71, P1187, DOI 10.1016/j.ijporl.2007.04.008; HELMESTABROOKS N, 1986, NEUROLOGY, V36, P1109, DOI 10.1212/WNL.36.8.1109; Johnson W., 1948, SPEECH HANDICAPPED S, V2nd; JONES RK, 1966, J NEUROL NEUROSUR PS, V29, P192, DOI 10.1136/jnnp.29.3.192; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; MILLER AE, 1985, NEUROLOGY, V35, P1341, DOI 10.1212/WNL.35.9.1341; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Neef NE, 2011, CLIN NEUROPHYSIOL, V122, P1802, DOI 10.1016/j.clinph.2011.02.003; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Riley G., 1994, STUTTERING SEVERITY; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; Sandbrink F, 2008, OXFORD HDB TRANSCRAN, P237, DOI DOI 10.1093/OXFORDHB/9780198568926.001.0001; Smith A, 1996, J SPEECH HEAR RES, V39, P329, DOI 10.1044/jshr.3902.329; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2003, MOVEMENT DISORD, V18, P826, DOI 10.1002/mds.10443; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stier E, 1911, UNTERSUCHUNGEN UNKSH; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Zelaznik HN, 1997, ACTA PSYCHOL, V96, P229, DOI 10.1016/S0001-6918(97)00014-0	28	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76824	10.1371/journal.pone.0076824	http://dx.doi.org/10.1371/journal.pone.0076824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146930	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400084
J	Cheng, L; Wang, GH; Li, J; Zhang, TJ; Xu, PG; Wang, YD				Cheng, Liang; Wang, Guohua; Li, Jie; Zhang, Tianjiao; Xu, Peigang; Wang, Yadong			SIDD: A Semantically Integrated Database towards a Global View of Human Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE; KNOWLEDGEBASE; ONTOLOGY; BIOINFORMATICS; PHENOTYPE; CYTOSCAPE; NETWORKS; PROTEINS; MICRORNA	Background: A number of databases have been developed to collect disease-related molecular, phenotypic and environmental features (DR-MPEs), such as genes, non-coding RNAs, genetic variations, drugs, phenotypes and environmental factors. However, each of current databases focused on only one or two DR-MPEs. There is an urgent demand to develop an integrated database, which can establish semantic associations among disease-related databases and link them to provide a global view of human disease at the biological level. This database, once developed, will facilitate researchers to query various DR-MPEs through disease, and investigate disease mechanisms from different types of data. Methodology: To establish an integrated disease-associated database, disease vocabularies used in different databases are mapped to Disease Ontology (DO) through semantic match. 4,284 and 4,186 disease terms from Medical Subject Headings (MeSH) and Online Mendelian Inheritance in Man (OMIM) respectively are mapped to DO. Then, the relationships between DR-MPEs and diseases are extracted and merged from different source databases for reducing the data redundancy. Conclusions: A semantically integrated disease-associated database (SIDD) is developed, which integrates 18 disease-associated databases, for researchers to browse multiple types of DR-MPEs in a view. A web interface allows easy navigation for querying information through browsing a disease ontology tree or searching a disease term. Furthermore, a network visualization tool using Cytoscape Web plugin has been implemented in SIDD. It enhances the SIDD usage when viewing the relationships between diseases and DR-MPEs. The current version of SIDD (Jul 2013) documents 4,465,131 entries relating to 139,365 DR-MPEs, and to 3,824 human diseases. The database can be freely accessed from: http://mlg.hit.edu.cn/SIDD.	[Cheng, Liang; Wang, Guohua; Li, Jie; Zhang, Tianjiao; Xu, Peigang; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China	Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn	Wang, Guohua/GLR-7939-2022; Zhang, Tianjiao/CVB-2759-2022; Cheng, Liang/ABY-7421-2022	Zhang, Tianjiao/0000-0001-9807-8620; Cheng, Liang/0000-0002-6665-6710	China National 863 High-Tech Program [2012AA020404, 2012AA02A602]; National Natural Science Foundation of China [60901075, 60973078, 61173085]; Natural Science Foundation of Heilongjiang Province of China [LC2009C35]; Special Research Foundation for technological Innovation Talents of Harbin [2011RFLXG011]; China National 863 High-Tech Program	China National 863 High-Tech Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Special Research Foundation for technological Innovation Talents of Harbin; China National 863 High-Tech Program(National High Technology Research and Development Program of China)	This work was supported by the China National 863 High-Tech Program (2012AA020404, 2012AA02A602); National Natural Science Foundation of China (60901075, 60973078 and 61173085); Natural Science Foundation of Heilongjiang Province of China (LC2009C35) and the Special Research Foundation for technological Innovation Talents of Harbin (2011RFLXG011). Funding for open access charge: The China National 863 High-Tech Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RB, 2007, NAT GENET, V39, P426, DOI 10.1038/ng0407-426; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bello D. A., 2011, P INT C BIOM ONT ICB, P231; Berriz GF, 2008, BIOINFORMATICS, V24, P2272, DOI 10.1093/bioinformatics/btn424; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Boutet Emmanuel, 2007, V406, P89; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; Davis Allan Peter, 2012, DATABASE; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Furuta T, 2013, BRAIN TUMOR IN PRESS; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang HZ, 2011, BIOINFORMATICS, V27, P1190, DOI 10.1093/bioinformatics/btr101; Iragne F, 2004, BIOINFORMATICS, V20, P2331, DOI 10.1093/bioinformatics/bth241; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jonquet Clement, 2010, J Biomed Semantics, V1 Suppl 1, pS1, DOI 10.1186/2041-1480-1-S1-S1; Kong FL, 2011, NUCLEIC ACIDS RES, V39, pD895, DOI 10.1093/nar/gkq1038; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mottaz A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S3; Neveol A, 2012, LINKING MULTIPLE DIS, P767; Osborne J.D., 2007, GENERIF IS MORE COMP; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Palleja A, 2012, NUCLEIC ACIDS RES, V40, pD1036, DOI 10.1093/nar/gkr899; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Schully SD, 2011, EUR J HUM GENET, V19, P928, DOI 10.1038/ejhg.2011.53; Shah SP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-34; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Wang J, 2012, NUCLEIC ACIDS RES, V40, pD1055, DOI 10.1093/nar/gkr1171; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049686; Zhao X, 2012, NUCLEIC ACIDS RES, V40, pD1041, DOI 10.1093/nar/gkr1142	39	36	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75504	10.1371/journal.pone.0075504	http://dx.doi.org/10.1371/journal.pone.0075504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146757	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400009
J	Feng, WW; Malpica, A; Skaland, I; Gudlaugsson, E; Robboy, SJ; Dalen, I; Hua, KQ; Zhou, XR; Baak, JPA				Feng, Weiwei; Malpica, Anais; Skaland, Ivar; Gudlaugsson, Einar; Robboy, Stanley J.; Dalen, Ingvild; Hua, Keqin; Zhou, Xianrong; Baak, Jan P. A.			Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade?	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; FACTOR RECEPTOR EGFR; UTERINE SARCOMAS; PROGNOSTIC VALUE; BETA-CATENIN; CYCLIN D1; STAGES I; EXPRESSION; MANAGEMENT; TARGETS	An estimated 1500-3000 invasive Endometrial Stromal Sarcomas (ESS) cases annually occur worldwide. Before 2003, ESS was divided as low and high grade ESS based on mitotic activity. In 2003 the WHO changed the names, excluded mitoses and made nuclear atypia and necrosis the essential diagnostic criteria to distinguish ESS, Low Grade (ESS-LG, recurrence-free survival >90%) and Undifferentiated Endometrial Sarcoma (UES, poor prognosis). We have evaluated in WHO2003 defined ESS-LG whether proliferation biomarkers predict recurrence. Using survival analysis, the prognostic value of classical mitosis counts (Mitotic Activity Index, MAI) in haematoxyllin-eosin (H&E) sections, and immunohistochemical proliferation biomarkers (Ki-67 and PhosphoHistone-3 (PPH3)) were examined in 24 invasive endometrial stromal sarcomas. Three of 24 (12.5%) ESS-LG recurred. The MAI, PPH3 and Ki-67 were all prognostic (P = 0.001, 0.002 and 0.03). MAI values were >3 in the recurrent cases, but never exceeded 10 (the classical threshold for low and high grade). Non-recurrent cases had 0 <= MAI <= 3. PPH3 and Ki67 counts can be easier to perform than MAI and therefore helpful in the diagnosis of ESS, Low Grade. In conclusion, in this small study of WHO2003 defined ESS-LG, high levels of proliferation as measured by MAI, PPH3 and Ki-67 are predictive of recurrence. Larger studies are required to confirm these results.	[Feng, Weiwei; Hua, Keqin] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China; [Feng, Weiwei; Hua, Keqin] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200433, Peoples R China; [Zhou, Xianrong] Fudan Univ, Dept Pathol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Malpica, Anais] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Malpica, Anais] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Skaland, Ivar; Gudlaugsson, Einar; Baak, Jan P. A.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Dalen, Ingvild] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Baak, Jan P. A.] Univ Bergen, Med Odontol Fac, Inst Clin, Bergen, Norway; [Robboy, Stanley J.] Duke Univ Med Ctr, Dept Pathol, Durham, NC USA; [Robboy, Stanley J.] Duke Univ Med Ctr, Dept Obstet & Gynecol, Durham, NC USA	Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Stavanger University Hospital; Stavanger University Hospital; University of Bergen; Duke University; Duke University	Feng, WW (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200433, Peoples R China.	jingsakura@gmail.com; jpabaak47@yahoo.com			Pujiang Talents Plan, Shanghai Science and Technology Committee, Shanghai, China [08PJ14026]; Norwegian Research Council; Stavanger Hospital; Stichting Bevordering Diagnostische Morfometrie, Middelburg, The Netherlands	Pujiang Talents Plan, Shanghai Science and Technology Committee, Shanghai, China; Norwegian Research Council(Research Council of NorwayEuropean Commission); Stavanger Hospital; Stichting Bevordering Diagnostische Morfometrie, Middelburg, The Netherlands(Netherlands Government)	This work was supported by the Pujiang Talents Plan, Shanghai Science and Technology Committee, (Grant No. 08PJ14026), Shanghai, China and a travel grant from the Norwegian Research Council to Dr. Feng; a sabbatical year grant of the Stavanger Hospital and grants from the Stichting Bevordering Diagnostische Morfometrie, Middelburg, The Netherlands to Prof. Baak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler VM, 2009, HISTOPATHOLOGY, V54, P355, DOI 10.1111/j.1365-2559.2009.03231.x; Amant F, 2006, GYNECOL ONCOL, V103, P1137, DOI 10.1016/j.ygyno.2006.07.013; [Anonymous], 2009, INT J GYNECOL OBSTET, V104, P179, DOI 10.1016/j.ijgo.2008.12.009; Ashraf-Ganjoei T, 2006, WORLD J SURG ONCOL, V9, P45; Capobianco G, 2012, EUR J GYNAECOL ONCOL, V33, P629; Chiang S, 2011, AM J SURG PATHOL, V35, P1364, DOI 10.1097/PAS.0b013e3182262743; Cossu-Rocca P, 2012, INT J GYNECOL PATHOL, V31, P570, DOI 10.1097/PGP.0b013e31824fe289; Croce S, 2013, MOD PATHOL; EVANS HL, 1982, CANCER-AM CANCER SOC, V50, P2170, DOI 10.1002/1097-0142(19821115)50:10<2170::AID-CNCR2820501033>3.0.CO;2-K; Feng WW, 2013, INT J GYNECOL PATHOL, V32, P299, DOI 10.1097/PGP.0b013e318229adfb; Feng WW, 2013, HISTOPATHOLOGY, V62, P675, DOI 10.1111/j.1365-2559.2011.04115.x; Feng WW, 2013, INT J GYNECOL CANCER, V23, P488, DOI 10.1097/IGC.0b013e318247aa14; Gadducci A, 1996, GYNECOL ONCOL, V63, P247, DOI 10.1006/gyno.1996.0314; Iwasaki S, 2013, ARCH GYNECOL OBSTET, V288, P385, DOI 10.1007/s00404-013-2766-3; Jakate K, 2013, MODERN PATHOL, V26, P95, DOI 10.1038/modpathol.2012.136; Kildal W, 2009, EUR J CANCER, V45, P2412, DOI 10.1016/j.ejca.2009.06.017; Kir G, 2005, INT J GYNECOL CANCER, V15, P337, DOI 10.1111/j.1525-1438.2005.15226.x; Koivisto-Korander R, 2012, MATURITAS, V72, P56, DOI 10.1016/j.maturitas.2012.01.021; Koivisto-Korander R, 2011, TUMOR BIOL, V32, P451, DOI 10.1007/s13277-010-0138-1; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Koskas M, 2009, ANTICANCER RES, V29, P4147; Kurihara S, 2008, AM J SURG PATHOL, V32, P1228, DOI 10.1097/PAS.0b013e31816a3b42; Kurihara S, 2010, MODERN PATHOL, V23, P225, DOI 10.1038/modpathol.2009.162; Lee CH, 2012, AM J SURG PATHOL, V36, P1562, DOI 10.1097/PAS.0b013e31825fa931; Lee CH, 2012, AM J SURG PATHOL, V36, P641, DOI 10.1097/PAS.0b013e31824a7b1a; Lee CH, 2012, P NATL ACAD SCI USA, V109, P929, DOI 10.1073/pnas.1115528109; Lende TH, 2011, J CLIN ONCOL, V29, P852, DOI 10.1200/JCO.2009.25.0407; Li N, 2008, GYNECOL ONCOL, V108, P306, DOI 10.1016/j.ygyno.2007.10.023; Malouf GG, 2010, ANN ONCOL, V21, P2102, DOI 10.1093/annonc/mdq064; Moinfar F, 2005, AM J SURG PATHOL, V29, P485, DOI 10.1097/01.pas.0000155149.83541.24; NORRIS HJ, 1966, CANCER, V19, P755, DOI 10.1002/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U; Park JY, 2013, INT J GYNECOL CANCER, V23, P81, DOI 10.1097/IGC.0b013e3182738361; Popiolek D, 2003, GYNECOL ONCOL, V90, P353, DOI 10.1016/S0090-8258(03)00281-6; Reich O, 2000, EUR J CANCER, V36, pS93; Sardinha R, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-3; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Tavassoli FA, 2003, WHO CLASSIFICATION T	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75899	10.1371/journal.pone.0075899	http://dx.doi.org/10.1371/journal.pone.0075899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146786	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400024
J	Han, S; Lee, CW; Trevino, JG; Hughes, SJ; Sarosi, GA				Han, Song; Lee, Constance W.; Trevino, Jose G.; Hughes, Steven J.; Sarosi, George A., Jr.			Autocrine Extra-Pancreatic Trypsin 3 Secretion Promotes Cell Proliferation and Survival in Esophageal Adenocarcinoma	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-2; COLON-CANCER CELL; NAFAMOSTAT MESILATE; EXPRESSION; GROWTH; FIBRONECTIN; GEMCITABINE; ADHESION	Trypsin or Tumor associated trypsin (TAT) activation of Protease-activated receptor 2 (PAR-2) promotes tumor cell proliferation in gastrointestinal cancers. The role of the trypsin/PAR-2 network in esophageal adenocarcinoma (EA) development has not yet been investigated. The aim of this study is to investigate the role of trypsin/PAR-2 activation in EA tumorogenesis and therapy. We found that esophageal adenocarcinoma cells (EACs) and Barrett's Metaplasia (BART) expressed high levels of type 3 extra-pancreatic trypsinogen (PRSS3), a novel type of TAT. Activity of secreted trypsin was detected in cultured media from EA OE19 and OE33 cultures but not from BART culture. Surface PAR-2 expression in BART and EACs was confirmed by both flow cytometry and immunofluorescence. Trypsin induced cell proliferation (similar to 2 fold; P<0.01) in all tested cell lines at a concentration of 10 nM. Inhibition of PAR-2 activity in EACs via the PAR-2 antagonist ENMD (500 mu M), anti-PAR2 antibody SAM-11 (2 mu g/ml), or siRNA PAR-2 knockdown, reduced cell proliferation and increased apoptosis by up to 4 fold (P<0.01). Trypsin stimulation led to phosphorylation of ERK1/2, suggesting involvement of MAPK pathway in PAR-2 signal transduction. Inhibition of PAR-2 activation or siRNA PAR-2 knockdown in EACs prior to treatment with 5 FU reduced cell viability of EACs by an additional 30% (P<0.01) compared to chemotherapy alone. Our data suggest that extra-pancreatic trypsinogen 3 is produced by EACs and activates PAR-2 in an autocrine manner. PAR-2 activation increases cancer cell proliferation, and promotes cancer cell survival. Targeting the trypsin activated PAR-2 pathway in conjunction with current chemotherapeutic agents may be a viable therapeutic strategy in EA.	[Han, Song; Lee, Constance W.; Trevino, Jose G.; Hughes, Steven J.; Sarosi, George A., Jr.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA; [Sarosi, George A., Jr.] North Florida South Georgia VA Med Ctr, Gainesville, FL USA	State University System of Florida; University of Florida	Sarosi, GA (corresponding author), Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA.	george.sarosi@surgery.ufl.edu	Sarosi, George/M-2977-2019	Han, Song/0000-0002-6542-335X; Hughes, Steven/0000-0002-5688-6942	VA Merit Review; Cracchiolo Family Foundation at the University of Florida; University of Florida Foundation	VA Merit Review(US Department of Veterans Affairs); Cracchiolo Family Foundation at the University of Florida; University of Florida Foundation(University of Florida)	George A. Sarosi: The VA Merit Review; University of Florida Foundation. Steven J. Hughes: The Cracchiolo Family Foundation at the University of Florida. Jose G. Trevino: The University of Florida Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Inci K, 2009, SCAND J GASTROENTERO, V44, P664, DOI 10.1080/00365520902783683; Jaiswal K, 2006, AM J PHYSIOL-GASTR L, V290, pG335, DOI 10.1152/ajpgi.00167.2005; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Kandulski A, 2010, AM J GASTROENTEROL, V105, P1934, DOI 10.1038/ajg.2010.265; KOIVUNEN E, 1989, J BIOL CHEM, V264, P14095; Maeda K, 2005, PANCREAS, V31, P54, DOI 10.1097/01.mpa.0000163178.37050.0d; Miyata S, 1998, CLIN EXP METASTAS, V16, P613, DOI 10.1023/A:1006576313979; Miyata S, 2000, J BIOL CHEM, V275, P4592, DOI 10.1074/jbc.275.7.4592; Nakanuma S, 2010, INT J ONCOL, V36, P793, DOI 10.3892/ijo_00000555; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Perini R, 2005, DIGEST DIS SCI, V50, pS12, DOI 10.1007/s10620-005-2801-8; Phillips WA, 2011, J GASTROEN HEPATOL, V26, P639, DOI 10.1111/j.1440-1746.2010.06602.x; Rajendra S, 2012, THER ADV GASTROENTER, V5, P285, DOI 10.1177/1756283X12446668; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Shimamoto R, 2004, INT J ONCOL, V24, P1401; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Tajima H, 2001, INT J CANCER, V94, P699, DOI 10.1002/ijc.1531.abs; TERADA T, 1995, HUM PATHOL, V26, P746, DOI 10.1016/0046-8177(95)90222-8; Uchima Y, 2007, J PANCREAS, V8, P479; Uwagawa T, 2009, ANN ONCOL, V20, P239, DOI 10.1093/annonc/mdn640; Uwagawa T, 2011, AM J CLIN ONCOL; Uwagawa T, 2007, CANCER-AM CANCER SOC, V109, P2142, DOI 10.1002/cncr.22658; Uwagawa T, 2009, ANTICANCER RES, V29, P3173; Williams SJ, 2001, INT J CANCER, V93, P67, DOI 10.1002/ijc.1304	34	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76667	10.1371/journal.pone.0076667	http://dx.doi.org/10.1371/journal.pone.0076667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146905	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400071
J	do Nascimento, PRP; Martins, DRA; Monteiro, GRG; Queiroz, PV; Freire-Neto, FP; Queiroz, JW; Lima, ALM; Jeronimo, SMB				Porfirio do Nascimento, Paulo Ricardo; Arantes Martins, Daniella Regina; Gois Monteiro, Gloria Regina; Queiroz, Paula Vivianne; Freire-Neto, Francisco Paulo; Queiroz, Jose Wilton; Morais Lima, Adila Lorena; Bezerra Jeronimo, Selma Maria			Association of Pro-Inflammatory Cytokines and Iron Regulatory Protein 2 (IRP2) with Leishmania Burden in Canine Visceral Leishmaniasis	PLOS ONE			English	Article							IFN-GAMMA; INFECTION; DISEASE; BRAZIL; STEROIDOGENESIS; EPIDEMIOLOGY; REPLICATION; SUPPRESSION; INFANTUM; CHAGASI	Leishmania infantum infection in humans and dogs can evolve with a wide range of clinical presentations, varying from asymptomatic infections to visceral leishmaniasis. We hypothesized that the immune response elicited by L. infantum infection could modulate whether the host will remain asymptomatic or progress to disease. A total of 44 dogs naturally infected with L. infantum were studied. Leishmania burden was estimated in the blood and spleen by qPCR. The expression of IFN-gamma, TNF-alpha, IL-10 and Iron Regulatory Protein 2 (IRP2) were determined in the spleen by quantitative PCR. Sera cytokines were evaluated by ELISA. Dogs were grouped in quartiles according parasite burden. Increased expression of IFN-gamma and TNF-alpha was associated with reduced Leishmania burden, whereas increased IL-10 and IRP2 expressions were associated with higher Leishmania load. Increased plasma albumin and IFN-gamma expression explained 22.8% of the decrease in parasite burden in the spleen. These data confirm that lower IFN-gamma response and higher IL-10 correlated with increased parasite load and severity of the visceral leishmaniasis in dogs. The balance between the branches of immune response and the intracellular iron availability could determine, in part, the course of Leishmania infection.	[Porfirio do Nascimento, Paulo Ricardo; Freire-Neto, Francisco Paulo; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil; [Porfirio do Nascimento, Paulo Ricardo; Arantes Martins, Daniella Regina; Gois Monteiro, Gloria Regina; Freire-Neto, Francisco Paulo; Queiroz, Jose Wilton; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59072970 Natal, RN, Brazil; [Arantes Martins, Daniella Regina] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biol & Genet, BR-59072970 Natal, RN, Brazil; [Gois Monteiro, Gloria Regina; Morais Lima, Adila Lorena; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Hlth Grad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil; [Queiroz, Paula Vivianne] State Univ Rio Grande Norte, Coll Med, Mossoro, RN, Brazil; [Queiroz, Jose Wilton; Bezerra Jeronimo, Selma Maria] Inst Sci & Technol Trop Dis INCT DT, Salvador, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade do Estado do Rio Grande do Norte (UERN)	Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.	smbj@cb.ufrn.br	Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020	Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904	National Institutes of Health [AI030639-20]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded in part with a grant from the National Institutes of Health (AI030639-20) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; Baneth G, 2008, VET J, V175, P14, DOI 10.1016/j.tvjl.2006.11.011; Bern C, 2007, AM J TROP MED HYG, V76, P909; Boggiatto PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001019; Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344; COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003; Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005; EVANS TG, 1990, J PARASITOL, V76, P212, DOI 10.2307/3283018; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; Figueroa F, 2012, LIFE SCI, V90, P733, DOI 10.1016/j.lfs.2012.03.019; Gorski S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000705; HARRISON LH, 1986, REV INFECT DIS, V8, P447; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X; Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492; Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Manna L, 2009, VET J, V182, P441, DOI 10.1016/j.tvjl.2008.08.009; MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Olakanmi O, 2002, J BIOL CHEM, V277, P49727, DOI 10.1074/jbc.M209768200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; Qian G, 1999, Pac Symp Biocomput, P314; Rose NR, 2011, J INTERF CYTOK RES, V31, P705, DOI 10.1089/jir.2011.0057; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salomon OD, 2009, MEM I OSWALDO CRUZ, V104, P801, DOI 10.1590/S0074-02762009000500024; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Wilson ME, 1996, J IMMUNOL, V156, P2231	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e73873	10.1371/journal.pone.0073873	http://dx.doi.org/10.1371/journal.pone.0073873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146743	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400002
J	Barry, KL				Barry, Katherine L.			You Are What You Eat: Food Limitation Affects Reproductive Fitness in a Sexually Cannibalistic Praying Mantid	PLOS ONE			English	Article							DEVELOPMENTAL TRADE-OFFS; RISKY MATE SEARCH; STAGMOMANTIS-LIMBATA; RESOURCE-ALLOCATION; SPERM COMPETITION; LIFE-HISTORIES; REACTION NORMS; BODY CONDITION; ALLOMETRY; SELECTION	Resource limitation during the juvenile stages frequently results in developmental delays and reduced size at maturity, and dietary restriction during adulthood can affect longevity and reproductive output. Variation in food intake can also result in alteration to the normal pattern of resource allocation among body parts or life-history stages. My primary aim in this study was to determine how varying juvenile and/or adult feeding regimes affect particular female and male traits in the sexually cannibalistic praying mantid Pseudomantis albofimbriata. Praying mantids are sit-and-wait predators whose resource intake can vary dramatically depending on environmental conditions within and across seasons, making them useful for studying the effects of feeding regime on various facets of reproductive fitness. In this study, there was a significant trend/difference in development and morphology for males and females as a result of juvenile feeding treatment, however, its effect on the fitness components measured for males was much greater than on those measured for females. Food-limited males were less likely to find a female during field enclosure experiments and smaller males were slower at finding a female in field-based experiments, providing some of the first empirical evidence of a large male size advantage for scrambling males. Only adult food limitation affected female fecundity, and the ability of a female to chemically attract males was also most notably affected by adult feeding regime (although juvenile food limitation did play a role). Furthermore, the significant difference/trend in all male traits and the lack of difference in male trait ratios between treatments suggests a proportional distribution of resources and, therefore, no trait conservation by food-limited males. This study provides evidence that males and females are under different selective pressures with respect to resource acquisition and is also one of very few to show an effect of juvenile food quantity on adult reproductive fitness in a hemimetabolous insect.	Macquarie Univ, Dept Biol Sci, Macquarie Pk, NSW, Australia	Macquarie University	Barry, KL (corresponding author), Macquarie Univ, Dept Biol Sci, Macquarie Pk, NSW, Australia.	kate.barry@mq.edu.au			The Department of Biological Sciences at Macquarie University; Linnean Society of NSW	The Department of Biological Sciences at Macquarie University; Linnean Society of NSW	The Department of Biological Sciences at Macquarie University (http://bio.mq.edu.au) and the Joyce W. Vickery Scientific Research Fund from the Linnean Society of NSW (http://linneansocietynsw.org.au/grants.html) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Allen LE, 2014, INSECT SCI, V21, P227, DOI 10.1111/1744-7917.12016; Allen LE, 2011, ANIM BEHAV, V82, P1201, DOI 10.1016/j.anbehav.2011.09.009; Andersson Malte, 1994; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Barry KL, 2010, ANIM BEHAV, V80, P405, DOI 10.1016/j.anbehav.2010.05.024; Barry KL, 2008, BEHAV ECOL, V19, P710, DOI 10.1093/beheco/arm156; Barry KL, 2011, EVOL ECOL, V25, P107, DOI 10.1007/s10682-010-9384-3; Barry KL, 2010, ANIM BEHAV, V79, P1165, DOI 10.1016/j.anbehav.2010.02.025; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; BIRKHEAD TR, 1988, BEHAVIOUR, V106, P112, DOI 10.1163/156853988X00115; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Brown WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035377; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; Dmitriew C, 2009, CAN J ZOOL, V87, P175, DOI 10.1139/Z09-001; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; Dusse K, 1997, P ENTOMOL SOC WASH, V99, P490; Eberhard WG, 2002, CAN ENTOMOL, V134, P667, DOI 10.4039/Ent134667-5; EISENBERG RM, 1981, AM MIDL NAT, V106, P209, DOI 10.2307/2425157; Engels S, 2007, J INSECT PHYSIOL, V53, P633, DOI 10.1016/j.jinsphys.2007.05.003; Foellmer MW, 2005, J EVOLUTION BIOL, V18, P629, DOI 10.1111/j.1420-9101.2005.00868.x; Geister TL, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-10; Holwell GI, 2007, BIOL J LINN SOC, V91, P307, DOI 10.1111/j.1095-8312.2007.00788.x; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P9169, DOI 10.1073/pnas.96.16.9169; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Kaspi R, 2000, ECOL ENTOMOL, V25, P279, DOI 10.1046/j.1365-2311.2000.00266.x; Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x; Kasumovic MM, 2007, BEHAV ECOL, V18, P189, DOI 10.1093/beheco/arl072; Kasumovic MM, 2006, CURR BIOL, V16, pR242, DOI 10.1016/j.cub.2006.03.017; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; KYNASTON SE, 1994, ANIM BEHAV, V47, P739, DOI 10.1006/anbe.1994.1103; Lelito JP, 2008, BEHAV ECOL SOCIOBIOL, V63, P313, DOI 10.1007/s00265-008-0663-8; Maxwell MR, 2010, ECOL ENTOMOL, V35, P775, DOI 10.1111/j.1365-2311.2010.01239.x; Maxwell MR, 2010, ANN ENTOMOL SOC AM, V103, P120, DOI 10.1603/008.103.0115; Maxwell MR, 1998, ENVIRON ENTOMOL, V27, P318, DOI 10.1093/ee/27.2.318; MOOK LJ, 1966, CAN ENTOMOL, V98, P913, DOI 10.4039/Ent98913-9; Moya-Larano J, 2009, J EVOLUTION BIOL, V22, P954, DOI 10.1111/j.1420-9101.2009.01707.x; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Prokop P, 2005, ETHOLOGY, V111, P836, DOI 10.1111/j.1439-0310.2005.01113.x; Shine R, 2003, BEHAV ECOL SOCIOBIOL, V54, P162, DOI 10.1007/s00265-003-0620-5; SLIFER EH, 1968, J MORPHOL, V124, P105, DOI 10.1002/jmor.1051240107; Stevens DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1049, DOI 10.1098/rspb.1999.0742; Stevens DJ, 2000, P ROY SOC B-BIOL SCI, V267, P1511, DOI 10.1098/rspb.2000.1172; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Thornhill R., 1983, pi; Vencl FV, 2004, INTEGR COMP BIOL, V44, P242, DOI 10.1093/icb/44.3.242	53	18	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78164	10.1371/journal.pone.0078164	http://dx.doi.org/10.1371/journal.pone.0078164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130901	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200097
J	Srinivasan, S; Spear, J; Chandran, K; Joseph, J; Kalyanaraman, B; Avadhani, NG				Srinivasan, Satish; Spear, Joseph; Chandran, Karunakaran; Joseph, Joy; Kalyanaraman, Balaraman; Avadhani, Narayan G.			Oxidative Stress Induced Mitochondrial Protein Kinase A Mediates Cytochrome C Oxidase Dysfunction	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; ENDOPLASMIC-RETICULUM; CARDIAC MITOCHONDRIA; MACROPHAGE FUNCTIONS; ELECTRON-TRANSPORT; REPERFUSION DAMAGE; COMPLEX ACTIVITY; SUBUNIT-VB; PHOSPHORYLATION; HYPOXIA	Previously we showed that Protein kinase A (PKA) activated in hypoxia and myocardial ischemia/reperfusion mediates phosphorylation of subunits I, IVi1 and Vb of cytochrome c oxidase. However, the mechanism of activation of the kinase under hypoxia remains unclear. It is also unclear if hypoxic stress activated PKA is different from the cAMP dependent mitochondrial PKA activity reported under normal physiological conditions. In this study using RAW 264.7 macrophages and in vitro perfused mouse heart system we investigated the nature of PKA activated under hypoxia. Limited protease treatment and digitonin fractionation of intact mitochondria suggests that higher mitochondrial PKA activity under hypoxia is mainly due to increased sequestration of PKA Catalytic alpha (PKA alpha) subunit in the mitochondrial matrix compartment. The increase in PKA activity is independent of mitochondrial cAMP and is not inhibited by adenylate cyclase inhibitor, KH7. Instead, activation of hypoxia-induced PKA is dependent on reactive oxygen species (ROS). H89, an inhibitor of PKA activity and the antioxidant Mito-CP prevented loss of CcO activity in macrophages under hypoxia and in mouse heart under ischemia/reperfusion injury. Substitution of wild type subunit Vb of CcO with phosphorylation resistant S40A mutant subunit attenuated the loss of CcO activity and reduced ROS production. These results provide a compelling evidence for hypoxia induced phosphorylation as a signal for CcO dysfunction. The results also describe a novel mechanism of mitochondrial PKA activation which is independent of mitochondrial cAMP, but responsive to ROS.	[Srinivasan, Satish; Spear, Joseph; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Srinivasan, Satish; Spear, Joseph; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Chandran, Karunakaran; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Chandran, Karunakaran; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Ctr Free Radical Biol, Milwaukee, WI 53226 USA	University of Pennsylvania; University of Pennsylvania; Medical College of Wisconsin; Medical College of Wisconsin	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB001980] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Agnes RS, 2010, J AM CHEM SOC, V132, P6075, DOI 10.1021/ja909652q; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; BHAT NK, 1982, BIOCHEMISTRY-US, V21, P2452, DOI 10.1021/bi00539a026; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Corso M, 2001, PLACENTA, V22, P432, DOI 10.1053/plac.2001.0672; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; DUAN JM, 1989, CAN J PHYSIOL PHARM, V67, P704, DOI 10.1139/y89-114; Eisel F, 2013, BIOCHEM PHARMACOL, V85, P101, DOI 10.1016/j.bcp.2012.10.017; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; FLAMENG W, 1991, J MOL CELL CARDIOL, V23, P1, DOI 10.1016/0022-2828(91)90034-J; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Helling S, 2012, PROTEOMICS, V12, P950, DOI 10.1002/pmic.201100618; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Kanamaru Y., 2012, SIGNAL TRANSDUCT, V2012; KLEITKE B, 1976, ACTA BIOL MED GER, V35, pK9; Kohr MJ, 2010, J MOL CELL CARDIOL, V48, P645, DOI 10.1016/j.yjmcc.2010.01.007; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Maggie Pui Chi, 2012, Open Biochem J, V6, P23, DOI 10.2174/1874091X01206010023; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Miura T, 2010, CARDIOVASC RES, V88, P7, DOI 10.1093/cvr/cvq206; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Papa S, 1999, FEBS LETT, V444, P245, DOI 10.1016/S0014-5793(99)00070-8; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Prieto-Martin A, 2004, NUCLEIC ACIDS RES, V32, P2059, DOI 10.1093/nar/gkh528; Riboldi E, 2013, INT IMMUNOL, V25, P67, DOI 10.1093/intimm/dxs110; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200; SCHWOCH G, 1990, BIOCHEM J, V270, P181, DOI 10.1042/bj2700181; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Spear JF, 2007, AM J PHYSIOL-HEART C, V292, pH2459, DOI 10.1152/ajpheart.00459.2006; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Torii S, 2009, J BIOCHEM, V146, P839, DOI 10.1093/jb/mvp129; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Zhang YL, 2010, AM J PHYSIOL-HEART C, V299, pH225, DOI 10.1152/ajpheart.01073.2009	70	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77129	10.1371/journal.pone.0077129	http://dx.doi.org/10.1371/journal.pone.0077129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130844	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200061
J	De Angelis, M; Piccolo, M; Vannini, L; Siragusa, S; De Giacomo, A; Serrazzanetti, DI; Cristofori, F; Guerzoni, ME; Gobbetti, M; Francavilla, R				De Angelis, Maria; Piccolo, Maria; Vannini, Lucia; Siragusa, Sonya; De Giacomo, Andrea; Serrazzanetti, Diana Isabella; Cristofori, Fernanda; Guerzoni, Maria Elisabetta; Gobbetti, Marco; Francavilla, Ruggiero			Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified	PLOS ONE			English	Article							GUT MICROBIOTA; SPECTRUM; BACTERIA; BEHAVIOR; HEALTH; FLORA; EPIDEMIOLOGY; MICROFLORA; SEARCH; MODEL	This study aimed at investigating the fecal microbiota and metabolome of children with Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and autism (AD) in comparison to healthy children (HC). Bacterial tag-encoded FLX-titanium amplicon pyrosequencing (bTEFAP) of the 16S rDNA and 16S rRNA analyses were carried out to determine total bacteria (16S rDNA) and metabolically active bacteria (16S rRNA), respectively. The main bacterial phyla (Firmicutes, Bacteroidetes, Fusobacteria and Verrucomicrobia) significantly (P<0.05) changed among the three groups of children. As estimated by rarefaction, Chao and Shannon diversity index, the highest microbial diversity was found in AD children. Based on 16S-rRNA and culture-dependent data, Faecalibacterium and Ruminococcus were present at the highest level in fecal samples of PDD-NOS and HC children. Caloramator, Sarcina and Clostridium genera were the highest in AD children. Compared to HC, the composition of Lachnospiraceae family also differed in PDD-NOS and, especially, AD children. Except for Eubacterium siraeum, the lowest level of Eubacteriaceae was found on fecal samples of AD children. The level of Bacteroidetes genera and some Alistipes and Akkermansia species were almost the highest in PDD-NOS or AD children as well as almost all the identified Sutterellaceae and Enterobacteriaceae were the highest in AD. Compared to HC children, Bifidobacterium species decreased in AD. As shown by Canonical Discriminant Analysis of Principal Coordinates, the levels of free amino acids and volatile organic compounds of fecal samples were markedly affected in PDD-NOS and, especially, AD children. If the gut microbiota differences among AD and PDD-NOS and HC children are one of the concomitant causes or the consequence of autism, they may have implications regarding specific diagnostic test, and/or for treatment and prevention.	[De Angelis, Maria; Piccolo, Maria; Siragusa, Sonya; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Vannini, Lucia; Serrazzanetti, Diana Isabella] Univ Cesena, Interdept Ctr Ind Agri Food Res, Cesena, Italy; [Vannini, Lucia; Guerzoni, Maria Elisabetta] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [De Giacomo, Andrea] Univ Bari Aldo Moro, Child Neurol & Psychiat Unit, Dept Neurol & Psychiat Sci, Bari, Italy; [Cristofori, Fernanda; Francavilla, Ruggiero] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Bologna; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	De Angelis, M (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	maria.deangelis@uniba.it	De Angelis, Maria/AAA-9909-2019; FRANCAVILLA, RUGGIERO/S-1391-2019; Gobbetti, Marco/K-4138-2014	FRANCAVILLA, RUGGIERO/0000-0002-4603-974X; Vannini, Lucia/0000-0002-9417-8410; Gobbetti, Marco/0000-0003-0869-2737; De Angelis, Maria/0000-0002-2010-884X; De Giacomo, Andrea/0000-0002-3454-1679	Department of Soil, Plant and Food Science	Department of Soil, Plant and Food Science	The work was funded by the Department of Soil, Plant and Food Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; APA, 1994, DIAGN STAT MAN MENT; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Benach JL, 2012, MBIO, V3, DOI 10.1128/mBio.00019-12; Blaser MJ, 2010, P NATL ACAD SCI USA, V107, P6125, DOI 10.1073/pnas.1002112107; Bolte ER, 1998, MED HYPOTHESES, V51, P133, DOI 10.1016/S0306-9877(98)90107-4; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Giacomo A, 2009, NEUROPSYCH DIS TREAT, V5, P355; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Di Cagno R, 2009, APPL ENVIRON MICROB, V75, P3963, DOI 10.1128/AEM.02793-08; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Dietert Rodney R, 2011, Emerg Health Threats J, V4, P7111, DOI 10.3402/ehtj.v4i0.7111; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Finegold SM, 2008, MED HYPOTHESES, V70, P508, DOI 10.1016/j.mehy.2007.07.019; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2011, ANAEROBE, V17, P367, DOI 10.1016/j.anaerobe.2011.03.007; Finegold SM, 2011, MED HYPOTHESES, V77, P270, DOI 10.1016/j.mehy.2011.04.032; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Flint H. J., 2010, TOOBESJ, V2, P50; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gondalia SV, 2010, E J APPL PHYSIOL, V6, P24, DOI [10.7790/ejap.v6i2.213, DOI 10.7790/EJAP.V6I2.213]; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gowen CM, 2010, BIOTECHNOL J, V5, P759, DOI 10.1002/biot.201000084; Heberling CA, 2013, MED HYPOTHESES, V80, P264, DOI 10.1016/j.mehy.2012.11.044; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Louis P, 2012, DIGEST DIS SCI, V57, P1987, DOI 10.1007/s10620-012-2286-1; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Macfarlane S, 1998, FEMS MICROBIOL ECOL, V26, P231, DOI 10.1111/j.1574-6941.1998.tb00508.x; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Medina M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-19; Mulloy A, 2010, RES AUTISM SPECT DIS, V4, P328, DOI 10.1016/j.rasd.2009.10.008; Ndagijimana M, 2009, INT J FOOD MICROBIOL, V134, P147, DOI 10.1016/j.ijfoodmicro.2009.04.016; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Persico AM, 2013, NEUROTOXICOL TERATOL, V36, P82, DOI 10.1016/j.ntt.2012.09.002; Petrof EO, 2013, BENEF MICROBES, V4, P53, DOI 10.3920/BM2012.0039; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Prizant B, 1992, 11 MENTAL MEASUREMEN, P170; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Razack R, 2007, CURR OPIN GASTROEN, V23, P400, DOI 10.1097/MOG.0b013e3281ddb2a3; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Sandler RH, 2000, J CHILD NEUROL, V15, P429, DOI 10.1177/088307380001500701; Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Shannon CE, 1949, AT&T TECH J, V27, P359; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Strassburg CP, 2002, GUT, V50, P259, DOI 10.1136/gut.50.2.259; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Wall R, 2012, LIPIDS TECHNOL, V24, P10, DOI DOI 10.1002/LITE.201200232; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Williams BL, 2012, PLOS ONE, V6; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	77	465	488	4	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76993	10.1371/journal.pone.0076993	http://dx.doi.org/10.1371/journal.pone.0076993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130822	Green Submitted, Green Published			2022-12-25	WOS:000325810900114
J	Beltran, AS; Graves, LM; Blancafort, P				Beltran, A. S.; Graves, L. M.; Blancafort, P.			Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function	ONCOGENE			English	Article						Engrailed 1; inflammatory breast cancer; triple-negative breast cancer; dopaminergic neuron; reprogramming; interference peptides	TRANSFER-RNA SYNTHETASE; TUMOR-INITIATING CELLS; DOPAMINERGIC-NEURONS; MUTATIONAL PROCESSES; MOLECULAR PORTRAITS; GENE-EXPRESSION; OVARIAN-CANCER; TARGETING HOX; PBX; SUBTYPES	Basal-like breast tumors are aggressive cancers associated with high proliferation and metastasis. Chemotherapy is currently the only treatment option; however, resistance often occurs resulting in recurrence and patient death. Some extremely aggressive cancers are also associated with hypoxia, inflammation and high leukocyte infiltration. Herein, we discovered that the neural-specific transcription factor, Engrailed 1 (EN1), is exclusively overexpressed in these tumors. Short hairpin RNA (shRNA)-mediated knockdown of EN1 triggered potent and selective cell death. In contrast, ectopic overexpression of EN1 in normal cells activated survival pathways and conferred resistance to chemotherapeutic agents. Exogenous expression of EN1 cDNA reprogrammed the breast epithelial cells toward a long-lived, neural-like phenotype displaying dopaminergic markers. Gene expression microarrays demonstrated that the EN1 cDNA altered transcription of a high number of inflammatory molecules, notably chemokines and chemokine receptors, which could mediate prosurvival pathways. To block EN1 function, we engineered synthetic interference peptides (iPeps) comprising the EN1-specific sequences that mediate essential protein-protein interactions necessary for EN1 function and an N-terminal cell-penetrating peptide/nuclear localization sequence. These EN1-iPeps rapidly mediated a strong apoptotic response in tumor cells overexpressing EN1, with no toxicity to normal or non EN1-expressing cells. Delivery of EN1-iPeps into basal-like cancer cells significantly decreased the fifty percent inhibitory concentrations (IC50) of chemotherapeutic drugs routinely used to treat breast cancer. Lastly, matrix-assisted laser desorption/ionization-time of flight mass spectrometry and immunoprecipitation assays demonstrated that EN1-iPeps captured targets involved in transcriptional and post-transcriptional regulation. Importantly, the EN1-iPeps bound the glutamyl-prolyl tRNA synthetase (EPRS) target, which has been associated with the transcript-specific translational control of inflammatory proteins and activation of amino-acid stress pathways. This work unveils EN1 as an activator of intrinsic inflammatory pathways associated with prosurvival in basal-like breast cancer. We further build upon these results and describe the engineering of iPeps targeting EN1 (EN1-iPeps) as a novel and selective therapeutic strategy to combat these lethal forms of breast cancer.	[Beltran, A. S.; Graves, L. M.; Blancafort, P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Blancafort, P.] Univ Western Australia, Sch Anat Physiol & Human Biol, Canc Epigenet Grp, Crawley, WA 6009, Australia	University of North Carolina; University of North Carolina Chapel Hill; University of Western Australia	Blancafort, P (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Canc Epigenet Grp, 35 Stirling Highway, Crawley, WA 6009, Australia.	pilar.blancafort@uwa.edu.au	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022	Blancafort, Pilar/0000-0002-3881-7396	NIH-NCI [CA016086, 1R01CA125273, 3R01CA125273-03S1]; DOD [W81XWH-10-1-0265]; NATIONAL CANCER INSTITUTE [R01CA170370, P30CA016086, R01CA125273] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is based in part upon work conducted using the UNC Michael Hooker Proteomics Center, which is supported in part by the NIH-NCI Grant No. CA016086 to the Lineberger Comprehensive Cancer Center and by NHI-NCI Grants 1R01CA125273, 3R01CA125273-03S1 and DOD W81XWH-10-1-0265 to PB. We thank Drs DC Connolly, L Vartikovski and JE Green for providing the murine cell lines from genetically engineered mouse models.	Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bell D, 2012, CANCER-AM CANCER SOC, V118, P1288, DOI 10.1002/cncr.26412; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Beltran AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024595; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Craig DW, 2012, MOL CANCER THER, V2, P104; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; dos Santos MTMA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-23; Eiro N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24010; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Gray J, 2012, NATURE, V486, P328, DOI 10.1038/486328a; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jiang X, 2013, MOL CELL ENDOCRINOL; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kim J., 2013, SCI WORLD J, V2013, P1, DOI DOI 10.5607/EN.2013.22.1.38; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Morgan R, 2007, CANCER RES, V67, P5806, DOI 10.1158/0008-5472.CAN-06-4231; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morrison BE, 2012, J IMMUNOL, V189, P5498, DOI 10.4049/jimmunol.1102150; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nokes BT, 2013, J CANCER, V4, P104, DOI 10.7150/jca.5002; Nolan YM, 2013, TRENDS MOL MED, V19, P187, DOI 10.1016/j.molmed.2012.12.003; Pandha H, 2012, BJU INT, V110, pE287, DOI 10.1111/j.1464-410X.2012.11208.x; Peltenburg LTC, 1996, EMBO J, V15, P3385, DOI 10.1002/j.1460-2075.1996.tb00704.x; Peltenburg LTC, 1997, DEVELOPMENT, V124, P1089; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Sasaki Y, 2009, BREAST CANCER-TOKYO, V16, P254, DOI 10.1007/s12282-009-0153-5; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shears L, 2008, J UROLOGY, V180, P2196, DOI 10.1016/j.juro.2008.07.018; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Varticovski L, 2007, CLIN CANCER RES, V13, P2168, DOI 10.1158/1078-0432.CCR-06-0918; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wright MH, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-29; Yao P, 2012, CELL CYCLE, V11, P1868, DOI 10.4161/cc.20417; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	55	59	61	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4767	4777		10.1038/onc.2013.422	http://dx.doi.org/10.1038/onc.2013.422			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24141779	Green Published, hybrid			2022-12-25	WOS:000343239500007
J	Sabit, I; Hashimoto, N; Matsumoto, Y; Yamaji, T; Furukawa, K; Furukawa, K				Sabit, Ilhamjan; Hashimoto, Noboru; Matsumoto, Yasuyuki; Yamaji, Toshiyuki; Furukawa, Keiko; Furukawa, Koichi			Binding of a Sialic Acid-recognizing Lectin Siglec-9 Modulates Adhesion Dynamics of Cancer Cells via Calpain-mediated Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Calpain; Focal Adhesion Kinase; Lectin; Protein Degradation; Sialic Acid	MALIGNANT PROPERTIES; GANGLIOSIDE GD3; MELANOMA-CELLS; KINASE FAK; MIGRATION; MECHANISMS; APOPTOSIS; PATHWAYS; PAXILLIN; INSIGHT	Although regulatory mechanisms for immune cells with inhibitory signals via immunoreceptor tyrosine-based inhibitory motifs are well known, signals transduced via interaction between Siglecs and sialyl compounds on their counterreceptors into target cells have not been reported to date. In this study, we found that an astrocytoma cell line, AS, showed detachment from culture plates when co-cultured with Siglec-9-expressing cells and/or soluble Siglec-9. Moreover, detached AS cells regrew as co-cultured cells with Siglec-9-deficient cells. They also showed increased motility and invasiveness upon Siglec-9 binding. In immunoblotting, rapid degradation of focal adhesion kinase (FAK) and related signaling molecules such as Akt, paxillin, and p130Cas was observed immediately after the co-culture. Despite degradation of these molecules, increased p-Akt was found at the front region of the cytoplasm, probably reflecting increased cell motility. Calpain was considered to be a responsible protease for the protein degradation by the inhibition experiments. These results suggest that protein degradation of FAK and related molecules was induced by Siglec-9 binding to its counterreceptors via sialylglycoconjugates, leading to the modulation of adhesion kinetics of cancer cells. Thus, this might be a mechanism by which cancer cells utilize Siglec-9-derived signals to escape from immunosurveillance.	[Sabit, Ilhamjan; Hashimoto, Noboru; Matsumoto, Yasuyuki; Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; [Yamaji, Toshiyuki] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; National Institute of Infectious Diseases (NIID); Chubu University	Furukawa, K (corresponding author), 65 Tsurumai,Showa Ku, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Sabit, Ilhamjan/E-6002-2018; Shabiti, Yilihamujiang/E-9361-2015	Sabit, Ilhamjan/0000-0001-8983-9491; Shabiti, Yilihamujiang/0000-0002-6790-5141	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21390076, 24390078, 23590371, 23110008]; Toyoaki Shogaku-kai Foundation; Kobayashi Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toyoaki Shogaku-kai Foundation; Kobayashi Foundation	This work was supported by Grants-in-aid for Scientific Research 21390076, 24390078, and 23590371; Grant-in-aid for Scientific Research on Innovative Areas 23110008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); and grants from the Toyoaki Shogaku-kai Foundation and Kobayashi Foundation.	Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Golubovskaya VM, 2010, ANTI-CANCER AGENT ME, V10, P735; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Li B, 2002, GENE THER, V9, P233, DOI 10.1038/sj.gt.3301641; Mitsuki M, 2010, GLYCOBIOLOGY, V20, P395, DOI 10.1093/glycob/cwp195; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sieg DJ, 1999, J CELL SCI, V112, P2677; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; WATANABE T, 1982, J EXP MED, V156, P1884, DOI 10.1084/jem.156.6.1884; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	22	6	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35417	35427		10.1074/jbc.M113.513192	http://dx.doi.org/10.1074/jbc.M113.513192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145038	Green Published, hybrid			2022-12-25	WOS:000329867600038
J	Bryant, KL; Antonyak, MA; Cerione, RA; Baird, B; Holowka, D				Bryant, Kirsten L.; Antonyak, Marc A.; Cerione, Richard A.; Baird, Barbara; Holowka, David			Mutations in the Polybasic Juxtamembrane Sequence of Both Plasma Membrane- and Endoplasmic Reticulum-localized Epidermal Growth Factor Receptors Confer Ligand-independent Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Epidermal Growth Factor Receptor (EGFR); Oncogene; PI 3-Kinase (PI3K); Transformation	EGF RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SUBCELLULAR-LOCALIZATION; CONSTITUTIVE ACTIVATION; ENHANCED EXPRESSION; TYROSINE KINASES; EGFRVIII; DOMAIN; GENE; AMPLIFICATION	Background: Deregulation of EGF receptor (EGFR) signaling leads to cellular transformation. Results: Reduction of net charge in the EGFR juxtamembrane region generates constitutively active EGFR, and activity is maintained when this receptor is ER-retained. Conclusion: Wholly ER-retained, constitutively active EGFRs can drive transformation through PI3K activation. Significance: The polybasic juxtamembrane sequence plays an important role in regulating EGFR signaling leading to oncogenic transformation. Deregulation of ErbB receptor-tyrosine kinases is a hallmark of many human cancers. Conserved in the ErbB family is a cluster of basic amino acid residues in the cytoplasmic juxtamembrane region. We found that charge-silencing mutagenesis within this juxtamembrane region of the epidermal growth factor receptor (EGFR) results in the generation of a mutant receptor (EGFR Mut R1-6) that spontaneously transforms NIH 3T3 cells in a ligand-independent manner. A similar mutant with one additional basic residue, EGFR Mut R1-5, fails to exhibit ligand-independent transformation. The capacity of EGFR Mut R1-6 to mediate this transformation is maintained when this mutant is retained in the endoplasmic reticulum via a single point mutation, L393H, which we describe. We show that EGFR Mut R1-6 with or without L393H exhibits enhanced basal tyrosine phosphorylation when ectopically expressed, and the ligand-independent transforming activity of EGFR Mut R1-6 is sensitive to inhibition of EGFR kinase activity and is particularly dependent on PI3K and mTOR activity. Similar to EGFR Mut R1-6/L393H in NIH 3T3 cells, EGFR variant type III, a highly oncogenic mutant form of EGFR linked to human brain cancers, confers transforming activity while it is wholly endoplasmic reticulum-retained in U87 cells. Our findings highlight the importance of the polybasic juxtamembrane sequence in regulating the oncogenic potential of EGFR signaling.	[Bryant, Kirsten L.; Cerione, Richard A.; Baird, Barbara; Holowka, David] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, NYS Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Baird, B (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bab13@cornell.edu		Bryant, Kirsten/0000-0003-4026-0942	National Institutes of Health Chemistry/Biology Interface Training Grant [5T32GM008500, R01A1022449]; PhRMA Foundation Predoctoral Fellowship in Pharmacology/Toxicology; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, T32GM008500] Funding Source: NIH RePORTER	National Institutes of Health Chemistry/Biology Interface Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation Predoctoral Fellowship in Pharmacology/Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Chemistry/Biology Interface Training Grant 5T32GM008500 (to K.B.) and Grant R01A1022449 (NIAID). This work was also supported by a PhRMA Foundation Predoctoral Fellowship in Pharmacology/Toxicology (to K.B.).	Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Chu CT, 1997, BIOCHEM J, V324, P855, DOI 10.1042/bj3240855; Cvrljevic AN, 2011, J CELL SCI, V124, P2938, DOI 10.1242/jcs.083295; EKSTRAND AJ, 1995, ONCOGENE, V10, P1455; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; GAMOU S, 1989, EXP CELL RES, V183, P197, DOI 10.1016/0014-4827(89)90429-1; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Gupta P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-72; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; He C, 2002, J BIOL CHEM, V277, P38284, DOI 10.1074/jbc.M104646200; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Morrison P, 1996, BIOCHEMISTRY-US, V35, P14618, DOI 10.1021/bi961630+; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Moscatello DK, 1996, ONCOGENE, V13, P85; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; PRIVALSKY ML, 1984, VIROLOGY, V135, P356, DOI 10.1016/0042-6822(84)90192-2; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Sato T, 2006, BIOCHEMISTRY-US, V45, P12704, DOI 10.1021/bi061264m; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; USHIRO H, 1980, J BIOL CHEM, V255, P8363; Ward CW, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-4; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wikstrand CJ, 1997, CANCER RES, V57, P4130; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308	55	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34930	34942		10.1074/jbc.M113.513333	http://dx.doi.org/10.1074/jbc.M113.513333			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142702	Green Published, hybrid			2022-12-25	WOS:000329812800059
J	Hu, LY; Pandey, AV; Eggimann, S; Rufenacht, V; Moslinger, D; Nuoffer, JM; Haberle, J				Hu, Liyan; Pandey, Amit V.; Eggimann, Sandra; Ruefenacht, Veronique; Moeslinger, Dorothea; Nuoffer, Jean-Marc; Haeberle, Johannes			Understanding the Role of Argininosuccinate Lyase Transcript Variants in the Clinical and Biochemical Variability of the Urea Cycle Disorder Argininosuccinic Aciduria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Metabolic Diseases; Recombinant Protein Expression; Transfection; Urea Cycle; Argininosuccinate Lyase (ASL); Argininosuccinic Aciduria (ASA); Homomeric; Heterotetrameric Protein; Transcript Variants	INTRAGENIC COMPLEMENTATION; MUTATION ANALYSIS; DELTA-CRYSTALLIN; GENE; DEFICIENCY; METABOLISM; ARGININE; ENZYMES; MUTANT; BRAIN	Background: The role of argininosuccinate lyase (ASL) transcripts in disease variability is unclear. Results: The most common ASL transcript variants decrease the functional enzymatic activity after co-expression with wild type or mutant ASL. Conclusion: ASL transcripts expressed at high levels can contribute to the variable phenotype in ASL-deficient patients. Significance: A new explanation of the molecular basis adds to our understanding of the clinical variability in patients. Argininosuccinic aciduria (ASA) is an autosomal recessive urea cycle disorder caused by deficiency of argininosuccinate lyase (ASL) with a wide clinical spectrum from asymptomatic to severe hyperammonemic neonatal onset life-threatening courses. We investigated the role of ASL transcript variants in the clinical and biochemical variability of ASA. Recombinant proteins for ASL wild type, mutant p.E189G, and the frequently occurring transcript variants with exon 2 or 7 deletions were (co-)expressed in human embryonic kidney 293T cells. We found that exon 2-deleted ASL forms a stable truncated protein with no relevant activity but a dose-dependent dominant negative effect on enzymatic activity after co-expression with wild type or mutant ASL, whereas exon 7-deleted ASL is unstable but seems to have, nevertheless, a dominant negative effect on mutant ASL. These findings were supported by structural modeling predictions for ASL heterotetramer/homotetramer formation. Illustrating the physiological relevance, the predominant occurrence of exon 7-deleted ASL was found in two patients who were both heterozygous for the ASL mutant p.E189G. Our results suggest that ASL transcripts can contribute to the highly variable phenotype in ASA patients if expressed at high levels. Especially, the exon 2-deleted ASL variant may form a heterotetramer with wild type or mutant ASL, causing markedly reduced ASL activity.	[Hu, Liyan; Ruefenacht, Veronique; Haeberle, Johannes] Univ Childrens Hosp Zurich, Div Metab, CH-8032 Zurich, Switzerland; [Hu, Liyan; Ruefenacht, Veronique; Haeberle, Johannes] Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Pandey, Amit V.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Eggimann, Sandra; Nuoffer, Jean-Marc] Univ Bern, Univ Inst Clin Chem, CH-3010 Bern, Switzerland; [Eggimann, Sandra; Nuoffer, Jean-Marc] Univ Bern, Univ Childrens Hosp, CH-3010 Bern, Switzerland; [Moeslinger, Dorothea] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria	University Children's Hospital Zurich; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Medical University of Vienna	Haberle, J (corresponding author), Univ Childrens Hosp Zurich, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Johannes.Haeberle@kispi.uzh.ch	Pandey, Amit V/AAO-6442-2020; Pandey, Amit V/A-7223-2008; Nuoffer, Jean-Marc/C-8936-2009	Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902; Nuoffer, Jean-Marc/0000-0003-3650-6153; Haberle, Johannes/0000-0003-0635-091X	Swiss National Science Foundation [310030_127184/1, 31003A-134926]; Schweizerische Mobiliar Genossenschaft Jubilaumsstiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schweizerische Mobiliar Genossenschaft Jubilaumsstiftung	This work was supported by Swiss National Science Foundation Grants 310030_127184/1 (to J. H.) and 31003A-134926 (to A. V. P.) and a grant from Schweizerische Mobiliar Genossenschaft Jubilaumsstiftung (to A. V. P.).	ABRAMSON RD, 1991, GENOMICS, V10, P126, DOI 10.1016/0888-7543(91)90492-W; ALLAN JD, 1958, LANCET, V1, P182; BARBOSA P, 1991, J BIOL CHEM, V266, P5286; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; Brusilow S W, 1996, Adv Pediatr, V43, P127; De Jonge WJ, 1998, PEDIATR RES, V43, P442, DOI 10.1203/00006450-199804000-00002; Doimo M, 2012, J INHERIT METAB DIS, V35, P557, DOI 10.1007/s10545-011-9402-9; Engel K, 2012, J INHERIT METAB DIS, V35, P133, DOI 10.1007/s10545-011-9357-x; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Erez A, 2011, AM J MED GENET C, V157C, P45, DOI 10.1002/ajmg.c.30289; Ficicioglu C, 2009, MOL GENET METAB, V98, P273, DOI 10.1016/j.ymgme.2009.06.011; Flynn NE, 1999, J NUTR, V129, P799, DOI 10.1093/jn/129.4.799; GLICK NR, 1976, AM J HUM GENET, V28, P22; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Howell PL, 1998, J INHERIT METAB DIS, V21, P72, DOI 10.1023/A:1005361724967; HUSSON A, 1990, EUR J BIOCHEM, V192, P677, DOI 10.1111/j.1432-1033.1990.tb19275.x; JONES ME, 1961, ARCH BIOCHEM BIOPHYS, V95, P499, DOI 10.1016/0003-9861(61)90182-5; Kretz R, 2012, MOL GENET METAB, V106, P375, DOI 10.1016/j.ymgme.2012.04.011; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2011, MOL GENET METAB, V103, P148, DOI 10.1016/j.ymgme.2011.03.003; Linnebank M, 2000, J INHERIT METAB DIS, V23, P308, DOI 10.1023/A:1005690005439; Linnebank M, 2002, HUM GENET, V111, P350, DOI 10.1007/s00439-002-0793-4; Liu HY, 2001, PROTEINS, V44, P484, DOI 10.1002/prot.1114; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MATSUBASA T, 1989, P NATL ACAD SCI USA, V86, P592, DOI 10.1073/pnas.86.2.592; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; Mercimek-Mahmutoglu S, 2010, MOL GENET METAB, V100, P24, DOI 10.1016/j.ymgme.2010.01.013; NAYLOR SL, 1978, P NATL ACAD SCI USA, V75, P6159, DOI 10.1073/pnas.75.12.6159; Neill MA, 2009, MOL GENET METAB, V97, P121, DOI 10.1016/j.ymgme.2009.02.009; OBRIEN WE, 1981, BIOCHEMISTRY-US, V20, P2056, DOI 10.1021/bi00510a049; PERRY TL, 1980, CLIN CHIM ACTA, V105, P257, DOI 10.1016/0009-8981(80)90468-4; Piatigorsky J, 1996, BBA-PROTEIN STRUCT M, V1295, P158, DOI 10.1016/0167-4838(96)00030-1; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; PISARENKO SI, 1980, B EXP BIOL MED+, V89, P138; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RATNER S, 1960, ARCH BIOCHEM BIOPHYS, V91, P280, DOI 10.1016/0003-9861(60)90502-6; RATNER S, 1973, ADV ENZYMOL RAMB, V39, P1; RATNER S, 1953, J BIOL CHEM, V200, P175; Renouf S, 1998, BIOL NEONATE, V73, P190, DOI 10.1159/000013977; Sampaleanu LM, 2002, J BIOL CHEM, V277, P4166, DOI 10.1074/jbc.M107465200; SIMARD L, 1986, AM J HUM GENET, V39, P38; TODD S, 1989, GENOMICS, V4, P53, DOI 10.1016/0888-7543(89)90314-5; TOMLINSON S, 1964, CLIN SCI, V26, P261; Trevisson E, 2009, J BIOL CHEM, V284, P28926, DOI 10.1074/jbc.M109.050195; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; Vallee F, 1999, BIOCHEMISTRY-US, V38, P2425, DOI 10.1021/bi982149h; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walker DC, 1997, J BIOL CHEM, V272, P6777, DOI 10.1074/jbc.272.10.6777; WALKER DC, 1990, P NATL ACAD SCI USA, V87, P9625, DOI 10.1073/pnas.87.24.9625; WALKER JB, 1958, P SOC EXP BIOL MED, V98, P7, DOI 10.3181/00379727-98-23922; WONG LTK, 1979, CLIN BIOCHEM, V12, P167, DOI 10.1016/S0009-9120(79)80083-1	55	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34599	34611		10.1074/jbc.M113.503128	http://dx.doi.org/10.1074/jbc.M113.503128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24136197	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000329812800028
J	Danyagri, G; Dang, QL				Danyagri, Gabriel; Dang, Qing-Lai			Effects of Elevated [CO2] and Low Soil Moisture on the Physiological Responses of Mountain Maple (Acer spicatum L.) Seedlings to Light	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATION; ATMOSPHERIC CO2; ARISAEMA-HETEROPHYLLUM; FUNCTIONAL-RESPONSES; NET PHOTOSYNTHESIS; WATER AVAILABILITY; SHADE TOLERANCE; GAS-EXCHANGE; FOREST; GROWTH	Global climate change is expected to affect how plants respond to their physical and biological environments. In this study, we examined the effects of elevated CO2 ([CO2]) and low soil moisture on the physiological responses of mountain maple (Acer spicatum L.) seedlings to light availability. The seedlings were grown at ambient (392 mu mol mol(-1)) and elevated (784 mu mol mol(-1)) [CO2], low and high soil moisture (M) regimes, at high light (100%) and low light (30%) in the greenhouse for one growing season. We measured net photosynthesis (A), stomatal conductance (g(s)), instantaneous water use efficiency (IWUE), maximum rate of carboxylation (V-cmax), rate of photosynthetic electron transport (J), triose phosphate utilization (TPU)), leaf respiration (R-d), light compensation point (LCP) and mid-day shoot water potential (Psi(x)). A and g(s) did not show significant responses to light treatment in seedlings grown at low soil moisture treatment, but the high light significantly decreased the C-i/C-a in those seedlings. IWUE was significantly higher in the elevated compared with the ambient [CO2], and the effect was greater at high than the low light treatment. LCP did not respond to the soil moisture treatments when seedlings were grown in high light under both [CO2]. The low soil moisture significantly reduced Psi(x) but had no significant effect on the responses of other physiological traits to light or [CO2]. These results suggest that as the atmospheric [CO2] rises, the physiological performance of mountain maple seedlings in high light environments may be enhanced, particularly when soil moisture conditions are favourable.	[Danyagri, Gabriel; Dang, Qing-Lai] Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada	Lakehead University	Danyagri, G (corresponding author), Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada.	gdery@lakeheadu.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada grant to Q-LD. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, TREE PHYSIOL, V6, P305, DOI 10.1093/treephys/6.3.305; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ambebe TF, 2010, TREE PHYSIOL, V30, P234, DOI 10.1093/treephys/tpp109; Ambebe TF, 2009, TREE PHYSIOL, V29, P1341, DOI 10.1093/treephys/tpp079; Archambault L, 1998, FOREST ECOL MANAG, V102, P61, DOI 10.1016/S0378-1127(97)00109-6; Aubin I, 2005, ECOSCIENCE, V12, P540, DOI 10.2980/i1195-6860-12-4-540.1; Aubin I, 2000, CAN J FOREST RES, V30, P168, DOI 10.1139/cjfr-30-1-168; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dawes MA, 2011, NEW PHYTOL, V191, P806, DOI 10.1111/j.1469-8137.2011.03722.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Eermak J, 1993, TREE PHYSIOL, V12, P281; Eermak J, 1993, WATER TRANSPORT PLAN; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; GAUTHIER S, 1993, J VEG SCI, V4, P783, DOI 10.2307/3235615; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Korner C, 2003, PHILOS T ROY SOC A, V361, P2023, DOI 10.1098/rsta.2003.1241; Kubiske ME, 1996, TREE PHYSIOL, V16, P351; KUBISKE ME, 1994, OECOLOGIA, V98, P303, DOI 10.1007/BF00324218; Kubiske ME, 1997, FUNCT ECOL, V11, P24, DOI 10.1046/j.1365-2435.1997.00050.x; Lambers H, 2008, PLANT PHYSL ECLOGY; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LEI TT, 1990, OECOLOGIA, V84, P224, DOI 10.1007/BF00318275; Lei TT, 1997, PHOTOSYNTHETICA, V33, P277, DOI 10.1023/A:1022124732716; Liang NH, 2001, TREE PHYSIOL, V21, P1047, DOI 10.1093/treephys/21.14.1047; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; Meehl GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030948; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Moore BD, 1999, PLANT CELL ENVIRON, V22, P567, DOI 10.1046/j.1365-3040.1999.00432.x; Muraoka H, 1997, OECOLOGIA, V112, P26, DOI 10.1007/s004420050279; Muraoka H, 2002, J PLANT RES, V115, P419, DOI 10.1007/s10265-002-0052-8; NORBY RJ, 1991, NEW PHYTOL, V117, P515, DOI 10.1111/j.1469-8137.1991.tb00956.x; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Osborne CP, 1997, PLANT PHYSIOL, V114, P337, DOI 10.1104/pp.114.1.337; Paula MP, 2004, PLANT PHYSIOL, P195; PEARCY RW, 1990, ANNU REV PLANT PHYS, V41, P421, DOI 10.1146/annurev.pp.41.060190.002225; POORTER L, 1993, OECOLOGIA, V96, P193, DOI 10.1007/BF00317732; Pothier D, 2002, TREES-STRUCT FUNCT, V16, P365, DOI 10.1007/s00468-001-0158-y; Pregitzer KS, 2005, NUTR ACQUISITION PLA; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Sullivan J, 1993, FIRE EFFECTS INFORM; Takeuchi Y, 2001, PLANT CELL ENVIRON, V24, P1257, DOI 10.1046/j.0016-8025.2001.00787.x; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Tognetti R, 2000, PLANT CELL ENVIRON, V23, P1341, DOI 10.1046/j.1365-3040.2000.00645.x; TSCHAPLINSKI TJ, 1995, NEW PHYTOL, V129, P63, DOI 10.1111/j.1469-8137.1995.tb03010.x; TSCHAPLINSKI TJ, 1993, TREE PHYSIOL, V13, P283, DOI 10.1093/treephys/13.3.283; Watanabe M, 2011, TREE PHYSL; WAYNE PM, 1993, OECOLOGIA, V94, P235, DOI 10.1007/BF00341322; Wertin TM, 2012, TREE PHYSIOL, V32, P847, DOI 10.1093/treephys/tps051; Wertin TM, 2010, GLOBAL CHANGE BIOL, V16, P2089, DOI 10.1111/j.1365-2486.2009.02053.x; Wullschleger SD, 1998, TREE PHYSIOL, V18, P71; Wullschleger SD, 1998, TREE PHYSIOL, V18, P499	61	13	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76586	10.1371/journal.pone.0076586	http://dx.doi.org/10.1371/journal.pone.0076586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146894	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200018
J	Nguyen, TY; Liew, CG; Liu, HN				Thanh Yen Nguyen; Liew, Chee Gee; Liu, Huinan			An In Vitro Mechanism Study on the Proliferation and Pluripotency of Human Embryonic Stems Cells in Response to Magnesium Degradation	PLOS ONE			English	Article							ELECTROCHEMICAL DEPOSITION; CORROSION; ALLOYS; CYTOTOXICITY; CYTOCOMPATIBILITY; DIFFERENTIATION; MANAGEMENT; DERIVATION; ECLAMPSIA; IMPLANTS	Magnesium (Mg) is a promising biodegradable metallic material for applications in cellular/tissue engineering and biomedical implants/devices. To advance clinical translation of Mg-based biomaterials, we investigated the effects and mechanisms of Mg degradation on the proliferation and pluripotency of human embryonic stem cells (hESCs). We used hESCs as the in vitro model system to study cellular responses to Mg degradation because they are sensitive to toxicants and capable of differentiating into any cell types of interest for regenerative medicine. In a previous study when hESCs were cultured in vitro with either polished metallic Mg (99.9% purity) or pre-degraded Mg, cell death was observed within the first 30 hours of culture. Excess Mg ions and hydroxide ions induced by Mg degradation may have been the causes for the observed cell death; hence, their respective effects on hESCs were investigated for the first time to reveal the potential mechanisms. For this purpose, the mTeSR (R) 1 hESC culture media was either modified to an alkaline pH of 8.1 or supplemented with 0.4-40 mM of Mg ions. We showed that the initial increase of media pH to 8.1 had no adverse effect on hESC proliferation. At all tested Mg ion dosages, the hESCs grew to confluency and retained pluripotency as indicated by the expression of OCT4, SSEA3, and SOX2. When the supplemental Mg ion dosages increased to greater than 10 mM, however, hESC colony morphology changed and cell counts decreased. These results suggest that Mg-based implants or scaffolds are promising in combination with hESCs for regenerative medicine applications, providing their degradation rate is moderate. Additionally, the hESC culture system could serve as a standard model for cytocompatibility studies of Mg in vitro, and an identified 10 mM critical dosage of Mg ions could serve as a design guideline for safe degradation of Mg-based implants/scaffolds.	[Thanh Yen Nguyen; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Liew, Chee Gee; Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA; [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Liu, HN (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	huinan.liu@ucr.edu	Liu, Huinan H/N-2891-2015	Liu, Huinan H/0000-0001-9366-6204	Hellman Faculty Fellowship; University of California Regents Faculty Fellowship	Hellman Faculty Fellowship; University of California Regents Faculty Fellowship(University of California System)	Hellman Faculty Fellowship and University of California Regents Faculty Fellowship supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Aal DEM, 2012, INT J GYNECOL OBSTET, V116, P232, DOI 10.1016/j.ijgo.2011.10.018; Chatterjee P, 2011, JOVE-J VIS EXP, DOI 10.3791/3110; Cipriano AF, 2013, J MATER SCI-MATER M, V24, P989, DOI 10.1007/s10856-013-4853-1; Cipriano AF, 2012, IEEE ENG MED BIO, P2432, DOI 10.1109/EMBC.2012.6346455; di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024; Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020; Grillo CA, 2011, COLLOID SURFACE B, V88, P471, DOI 10.1016/j.colsurfb.2011.07.035; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; Guan RG, 2012, J BIOMED MATER RES A, V100A, P999, DOI 10.1002/jbm.a.34042; Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008; Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530; Johnson I., 2012, BIOMATERIALS FORUM, V34, P9; Johnson I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065603; Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290; Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014; Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223; Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004; Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Luo XL, 2011, ACTA BIOMATER, V7, P441, DOI 10.1016/j.actbio.2010.09.006; Ma L, 2010, BRAIN INJURY, V24, P730, DOI 10.3109/02699051003610516; Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c; MIKI H, 1987, CARCINOGENESIS, V8, P1757, DOI 10.1093/carcin/8.11.1757; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Sebaa MA, 2013, J MATER SCI-MATER M, V24, P307, DOI 10.1007/s10856-012-4796-y; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Nguyen TY, 2012, IEEE ENG MED BIO, P723, DOI 10.1109/EMBC.2012.6346033; Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543; Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Wu WL, 2011, NEUROSCI LETT, V491, P73, DOI 10.1016/j.neulet.2011.01.009; Yang JX, 2011, ANN BIOMED ENG, V39, P1857, DOI 10.1007/s10439-011-0300-y; Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]; Yun Y, 2009, MAT SCI ENG C-MATER, V29, P1814, DOI 10.1016/j.msec.2009.02.008	36	57	57	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76547	10.1371/journal.pone.0076547	http://dx.doi.org/10.1371/journal.pone.0076547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146887	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200016
J	He, XH; Patfield, S; Hnasko, R; Rasooly, R; Mandrell, RE				He, Xiaohua; Patfield, Stephanie; Hnasko, Robert; Rasooly, Reuven; Mandrell, Robert E.			A Polyclonal Antibody Based Immunoassay Detects Seven Subtypes of Shiga Toxin 2 Produced by Escherichia coli in Human and Environmental Samples	PLOS ONE			English	Article							UNITED-STATES; VARIANTS; NON-O157; INFECTIONS; PROFILES; STRAINS; ASSAY	Background: Shiga toxin-producing Escherichia coli (STEC) are frequent causes of severe human diseases ranging from diarrhea to hemolytic uremic syndrome. The existing strategy for detection of STEC relies on the unique sorbitol-negative fermentation property of the O157 strains, the most commonly identified serotype has been E. coli O157. It is becoming increasingly evident, however, that numerous non-O157 STEC serotypes also cause outbreaks and severe illnesses. It is necessary to have new methods that are capable of detecting all STEC strains. Methods and Findings: Here we describe the development of a sandwich ELISA assay for detecting both O157 and non-O157 STECs by incorporating a novel polyclonal antibody (pAb) against Stx2. The newly established immunoassay was capable of detecting Stx2a spiked in environmental samples with a limit of detection between 10 and 100 pg/mL in soil and between 100 and 500 pg/mL in feces. When applied to 36 bacterial strains isolated from human and environmental samples, this assay detected Stx2 in all strains that were confirmed to be stx2-positive by real-time PCR, demonstrating a 100% sensitivity and specificity. Conclusions: The sandwich ELISA developed in this study will enable any competent laboratory to identify and characterize Stx2-producing O157 and non-O157 strains in human and environmental samples, resulting in rapid diagnosis and patient care. The results of epitope mapping from this study will be useful for further development of a peptide-based antibody and vaccine.	[He, Xiaohua; Patfield, Stephanie; Hnasko, Robert; Rasooly, Reuven; Mandrell, Robert E.] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	xiaohua.he@ars.usda.gov	Mandrell, Robert E/O-9814-2018		USDA-ARS [5325-42000-048-00D, 5325-42000-046-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the USDA-ARS National Program NP108 CRIS projects 5325-42000-048-00D and 5325-42000-046-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; CAPRIOLI A, 1994, J INFECT DIS, V169, P208, DOI 10.1093/infdis/169.1.208; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P489; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; He X, 2012, J IMMUNOL METHODS; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KHINE AA, 1994, J CELL PHYSIOL, V161, P319, DOI 10.1002/jcp.1041610217; Klein EJ, 2002, J PEDIATR-US, V141, P172, DOI 10.1067/mpd.2002.125908; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; OJEDA A, 1995, J CLIN MICROBIOL, V33, P2199, DOI 10.1128/JCM.33.8.2199-2201.1995; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Sonntag AK, 2005, APPL ENVIRON MICROB, V71, P8855, DOI 10.1128/AEM.71.12.8855-8863.2005; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Starr M, 1998, CLIN INFECT DIS, V27, P310, DOI 10.1086/514656; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741	28	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76368	10.1371/journal.pone.0076368	http://dx.doi.org/10.1371/journal.pone.0076368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146860	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400056
J	Johnsen, AB; Rolim, NPL; Stolen, T; Alves, M; Sousa, MML; Slupphaug, G; Britton, SL; Koch, LG; Smith, GL; Wisloff, U; Hoydal, MA				Johnsen, Anne Berit; Rolim, Natale P. L.; Stolen, Tomas; Alves, Marcia; Sousa, Mirta M. L.; Slupphaug, Geir; Britton, Steven L.; Koch, Lauren G.; Smith, Godfrey L.; Wisloff, Ulrik; Hoydal, Morten A.			Atrial Myocyte Function and Ca2+ Handling Is Associated with Inborn Aerobic Capacity	PLOS ONE			English	Article							RETICULUM CALCIUM LEAK; HEART-FAILURE; ARTIFICIAL SELECTION; RYANODINE RECEPTORS; EJECTION FRACTION; PROTEIN-KINASE; EXERCISE; CARDIOMYOCYTES; MYOCARDIUM; RELEASE	Background: Although high aerobic capacity is associated with effective cardiac function, the effect of aerobic capacity on atrial function, especially in terms of cellular mechanisms, is not known. We aimed to investigate whether rats with low inborn maximal oxygen uptake (VO2 max) had impaired atrial myocyte contractile function when compared to rats with high inborn VO2 max. Methods and Results: Atrial myocyte function was depressed in Low Capacity Runners (LCR) relative to High Capacity Runners (HCR) which was associated with impaired Ca2+ handling. Fractional shortening was 52% lower at 2 Hz and 60% lower at 5 Hz stimulation while time to 50% relengthening was 43% prolonged and 55% prolonged, respectively. Differences in Ca2+ amplitude and diastolic Ca2+ level were observed at 5 Hz stimulation where Ca2+ amplitude was 70% lower and diastolic Ca2+ level was 11% higher in LCR rats. Prolonged time to 50% Ca2+ decay was associated with reduced sarcoplasmic reticulum (SR) Ca2+ ATPase function in LCR (39%). Na+/Ca2+ exchanger activity was comparable between the groups. Diastolic SR Ca2+ leak was increased by 109%. This could be partly explained by increased ryanodine receptors phosphorylation at the Ca2+-calmodulin-dependent protein kinase-II specific Ser-2814 site in LCR rats. T-tubules were present in 68% of HCR cells whereas only 33% LCR cells had these structures. In HCR, the significantly higher numbers of cells with T-tubules were combined with greater numbers of myocytes where Ca2+ release in the cell occurred simultaneously in central and peripheral regions, giving rise to faster and more spatial homogenous Ca2+-signal onset. Conclusion: This data demonstrates that contrasting for low or high aerobic capacity leads to diverse functional and structural remodelling of atrial myocytes, with impaired contractile function in LCR compared to HCR rats.	[Johnsen, Anne Berit; Rolim, Natale P. L.; Stolen, Tomas; Alves, Marcia; Smith, Godfrey L.; Wisloff, Ulrik; Hoydal, Morten A.] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Norwegian Univ Sci & Technol, Prote & Metabol Core Facil, N-7034 Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Cent Norway Reg Hlth Author, Trondheim, Norway; [Britton, Steven L.; Koch, Lauren G.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Smith, Godfrey L.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; University of Glasgow	Johnsen, AB (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	anne.b.johnsen@ntnu.no	Høydal, Morten A/K-2806-2012; Wisloff, Ulrik/K-2899-2012; Slupphaug, Geir/AAN-3794-2020	Høydal, Morten A/0000-0003-1804-2578; Wisloff, Ulrik/0000-0002-7211-3587; Slupphaug, Geir/0000-0002-7498-3500	K.G. Jebsen Foundation; Norwegian Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	K.G. Jebsen Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the K.G. Jebsen Foundation and the Norwegian Research Council Funding for Outstanding Young investigators (to U. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; Chelu MG, 2007, BIOCHEM SOC T, V35, P952, DOI 10.1042/BST0350952; CLAUSEN JP, 1977, PHYSIOL REV, V57, P779, DOI 10.1152/physrev.1977.57.4.779; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; Hoydal MA, 2007, EUR J CARDIOV PREV R, V14, P319, DOI 10.1097/01.hjr.0b013e3280128bef; Kemi OJ, 2010, ACTA PHYSIOL, V199, P425, DOI 10.1111/j.1748-1716.2010.02132.x; Kirk MM, 2003, J PHYSIOL-LONDON, V547, P441, DOI 10.1113/jphysiol.2002.034355; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kusunose K, 2012, HEART, V98, P1311, DOI 10.1136/heartjnl-2012-302007; Lehnart SE, 2007, CURR OPIN PHARMACOL, V7, P225, DOI 10.1016/j.coph.2006.09.010; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Picht E, 2007, J MOL CELL CARDIOL, V42, P196, DOI 10.1016/j.yjmcc.2006.09.007; Seidler T, 2003, CIRC RES, V93, P132, DOI 10.1161/01.RES.0000081596.90205.E2; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Sheehan KA, 2003, J PHYSIOL-LONDON, V546, P119, DOI 10.1113/jphysiol.2002.026963; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Smyrnias I, 2010, CELL CALCIUM; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Tan YT, 2010, HEART, V96, P1017, DOI 10.1136/hrt.2009.189118; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76568	10.1371/journal.pone.0076568	http://dx.doi.org/10.1371/journal.pone.0076568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146891	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400072
J	Dey, N; Young, B; Abramovitz, M; Bouzyk, M; Barwick, B; De, P; Leyland-Jones, B				Dey, Nandini; Young, Brandon; Abramovitz, Mark; Bouzyk, Mark; Barwick, Benjamin; De, Pradip; Leyland-Jones, Brian			Differential Activation of Wnt-beta-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-7; CELL-LINES; MOLECULAR PORTRAITS; COLORECTAL-CANCER; SIGNALING PATHWAY; CARCINOMA-CELLS; IN-VIVO; EXPRESSION; TUMORS; MATRILYSIN	Mutations of genes in tumor cells of Triple Negative subset of Breast Cancer (TNBC) deregulate pathways of signal transduction. The loss of tumor suppressor gene PTEN is the most common first event associated with basal-like subtype (Martins, De, Almendro, Gonen, and Park, 2012). Here we report for the first time that the functional upregulation of secreted-MMP7, a transcriptional target of Wnt-beta-catenin signature pathway in TNBC is associated to the loss of PTEN. We identified differential expression of mRNAs in several key-components genes, and transcriptional target genes of the Wnt-beta-catenin pathway (WP), including beta-catenin, FZD7, DVL1, MMP7, c-MYC, BIRC5, CD44, PPARD, c-MET, and NOTCH1 in FFPE tumors samples from TNBC patients of two independent cohorts. A similar differential upregulation of mRNA/protein for beta-catenin, the functional readout of WP, and for MMP7, a transcriptional target gene of beta-catenin was observed in TNBC cell line models. Genetic or pharmacological attenuation of beta-catenin by SiRNA or WP modulators (XAV939 and sulindac sulfide) and pharmacological mimicking of PTEN following LY294002 treatment downregulated MMP7 levels as well as enzymatic function of the secreted MMP7 in MMP7 positive PTEN-null TNBC cells. Patient data revealed that MMP7 mRNA was high in only a subpopulation of TNBC, and this subpopulation was characterized by a concurrent low expression of PTEN mRNA. In cell lines, a high expression of casein-zymograph-positive MMP7 was distinguished by an absence of functional PTEN. A similar inverse relationship between MMP7 and PTEN mRNA levels was observed in the PAM50 data set (a correlation coefficient of -0.54). The PAM50 subtype and outcome data revealed that the high MMP7 group had low pCR (25%) and High Rd (74%) in clinical stage T3 pathologic response in contrast to the high pCR (40%) and low residual disease (RD) (60%) of the low MMP7 group.	[Dey, Nandini; Young, Brandon; De, Pradip; Leyland-Jones, Brian] Sanford Res, Edith Sanford Breast Canc, Sioux Falls, SD USA; [Abramovitz, Mark] VM Inst Res, Montreal, PQ, Canada; [Bouzyk, Mark] Emory Univ, Atlanta, GA 30322 USA; [Barwick, Benjamin] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Young, Brandon] Scripps Res Inst Jupiter, Jupiter, FL USA; [Dey, Nandini; De, Pradip; Leyland-Jones, Brian] Univ S Dakota, Sioux Falls, SD USA	Sanford Health; Emory University; Emory University; University of South Dakota	Dey, N (corresponding author), Sanford Res, Edith Sanford Breast Canc, Sioux Falls, SD USA.	nandini.dey@sanfordhealth.org; brian.leyland-jones@sanfordhealth.org	Barwick, Benjamin/O-5185-2019	Barwick, Benjamin/0000-0001-9810-3566	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitz M, 2011, BRIT J CANCER, V105, P1574, DOI 10.1038/bjc.2011.355; Abramovitz M, 2009, IDENTIFICATION MATRI; Abramovitz Mark, 2007, Cancer Genomics & Proteomics, V4, P135; Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bao RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048670; Barwick BG, 2008, DIFFERENTIAL WNT PAT; Bastien RRL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-44; Beeghly-Fadiel A, 2008, CANCER RES, V68, P6453, DOI 10.1158/0008-5472.CAN-08-0636; Benhaj K, 2006, ONCOL REP, V15, P701; Bi Z, 2012, HEPATO-GASTROENTEROL, P60; Bilici A, 2012, J BUON, V17, P209; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Conlin AK, 2008, CLIN BREAST CANCER, V8, P215, DOI 10.3816/CBC.2008.n.024; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Criscitiello C, 2012, ANN ONCOL, V23, P13, DOI 10.1093/annonc/mds188; De P, 2013, CANCER CHEMOTH PHARM, V71, P867, DOI 10.1007/s00280-013-2078-0; Dey N, 2005, EXP CELL RES, V307, P1, DOI 10.1016/j.yexcr.2005.02.029; Dey N, 2013, BMC CANC IN PRESS; Dey N, 2009, CELL LINE BASED MODE; Dey N, 2007, MOL CELL BIOL, V27, P4179, DOI 10.1128/MCB.01352-06; Dreyer G, 2013, BREAST EDINBURGH SCO; Dunn BK, 2010, BREAST CANCER RES TR, V121, P281, DOI 10.1007/s10549-010-0827-x; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Ii M, 2006, EXP BIOL MED, V231, P20; Jiang WG, 2005, CLIN CANCER RES, V11, P6012, DOI 10.1158/1078-0432.CCR-05-0275; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lehmann BD, 2011, J CLIN INVESTIGATION; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Matono H, 2008, HUM PATHOL, V39, P1802, DOI 10.1016/j.humpath.2008.05.005; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Moulder SL, 2010, CLIN BREAST CANCER, V10, pS66, DOI 10.3816/CBC.2010.s.014; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pires MM, 2013, CANCER BIOL THER, V14, P246, DOI 10.4161/cbt.23297; Pradip D, 2013, AM J CANCER RES, V3, P173; PRAT A, 2010, MOL ONCOL; Preet R, 2013, CARCINOGENESIS, V34, P277, DOI 10.1093/carcin/bgs351; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Shiu KK, 2008, EXPERT OPIN THER TAR, V12, P1123, DOI [10.1517/14728222.12.9.1123, 10.1517/14728222.12.9.1123 ]; Sievers S, 2006, BIOMARKERS, V11, P270, DOI 10.1080/13547500600633954; Stambolic V, 2002, TRENDS PHARMACOL SCI, V23, P104, DOI 10.1016/S0165-6147(00)01984-2; Su JD, 2003, CANCER RES, V63, P3585; Tinsley HN, 2011, CANCER PREV RES, V4, P1275, DOI 10.1158/1940-6207.CAPR-11-0095; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Wen-hua B, 2011, HEILONGJIANG MED PHA; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Yamashita K, 1998, INT J CANCER, V79, P187; Yang L, 2011, ONCOGENE; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zeng ZS, 2002, CLIN CANCER RES, V8, P144; Zheng HC, 2003, PATHOL INT, V53, P659, DOI 10.1046/j.1440-1827.2003.01542.x	75	55	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77425	10.1371/journal.pone.0077425	http://dx.doi.org/10.1371/journal.pone.0077425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143235	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100072
J	Harrison, XA; Hodgson, DJ; Inger, R; Colhoun, K; Gudmundsson, GA; McElwaine, G; Tregenza, T; Bearhop, S				Harrison, Xavier A.; Hodgson, David J.; Inger, Richard; Colhoun, Kendrew; Gudmundsson, Gudmundur A.; McElwaine, Graham; Tregenza, Tom; Bearhop, Stuart			Environmental Conditions during Breeding Modify the Strength of Mass-Dependent Carry-Over Effects in a Migratory Bird	PLOS ONE			English	Article							LONG-DISTANCE MIGRANT; NORTH-ATLANTIC OSCILLATION; BRANTA-BERNICLA; REPRODUCTIVE-PERFORMANCE; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; HABITAT QUALITY; MODEL SELECTION; CLIMATE INDEXES; SITE FIDELITY	In many animals, processes occurring in one season carry over to influence reproductive success and survival in future seasons. The strength of such carry-over effects is unlikely to be uniform across years, yet our understanding of the processes that are capable of modifying their strength remains limited. Here we show that female light-bellied Brent geese with higher body mass prior to spring migration successfully reared more offspring during breeding, but only in years where environmental conditions during breeding were favourable. In years of bad weather during breeding, all birds suffered reduced reproductive output irrespective of pre-migration mass. Our results suggest that the magnitude of reproductive benefits gained by maximising body stores to fuel breeding fluctuates markedly among years in concert with conditions during the breeding season, as does the degree to which carry-over effects are capable of driving variance in reproductive success among individuals. Therefore while carry-over effects have considerable power to drive fitness asymmetries among individuals, our ability to interpret these effects in terms of their implications for population dynamics is dependent on knowledge of fitness determinants occurring in subsequent seasons.	[Harrison, Xavier A.; Hodgson, David J.; Inger, Richard; Tregenza, Tom; Bearhop, Stuart] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England; [Harrison, Xavier A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Colhoun, Kendrew] Wildfowl & Wetlands Trust, Comber, County Down, North Ireland; [Gudmundsson, Gudmundur A.] Iceland Inst Nat Hist, Reykjavik, Iceland	University of Exeter; Zoological Society of London	Harrison, XA (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Exeter, Cornwall, England.	xav.harrison@gmail.com; s.bearhop@ex.ac.uk	Inger, Richard/D-3445-2009; Bearhop, Stuart/G-3105-2012; Harrison, Xavier/F-6420-2011	Inger, Richard/0000-0003-1660-3706; Bearhop, Stuart/0000-0002-5864-0129; Harrison, Xavier/0000-0002-2004-3601; Tregenza, Thomas/0000-0003-4182-2222; Colhoun, Kendrew/0000-0003-4451-695X	NERC with a Wildfowl AMP; Wetlands Trust CASE partnership [NE/F008058/1]; RI by NERC [NE/F021690/1]; ERC [STATEMIG 310820]; NERC [NE/F021690/1] Funding Source: UKRI; Natural Environment Research Council [NE/F021690/1] Funding Source: researchfish	NERC with a Wildfowl AMP; Wetlands Trust CASE partnership; RI by NERC; ERC(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	XAH was funded by NERC grant (NE/F008058/1) with a Wildfowl & Wetlands Trust CASE partnership and RI by NERC grant (NE/F021690/1), both awarded to SB. SB is funded by an ERC Consolidator's Grant: STATEMIG 310820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barton K, 2009, UMIN MULTIMODEL INFE; Bates D, 2012, IME4 LINEAR MIXED EF; Betini GS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0110; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Bety J, 2004, BEHAV ECOL SOCIOBIOL; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; EBBINGE BS, 1995, J AVIAN BIOL, V26, P105, DOI 10.2307/3677058; EBBINGE BS, 1989, IBIS, V131, P196, DOI 10.1111/j.1474-919X.1989.tb02762.x; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; GUDMUNDSSON GA, 1995, P ROY SOC B-BIOL SCI, V261, P73, DOI 10.1098/rspb.1995.0119; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Harrison XA, 2010, MOL ECOL, V19, P5484, DOI 10.1111/j.1365-294X.2010.04852.x; Harrison XA, 2010, CONSERV GENET RESOUR, V2, P365, DOI 10.1007/s12686-010-9257-7; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; Kery M., 2010, INTRO WINBUGS ECOLOG; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Legagneux P, 2012, P ROY SOC B-BIOL SCI, V279, P876, DOI 10.1098/rspb.2011.1351; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; Madsen J, 2007, POLAR BIOL, V30, P1363, DOI 10.1007/s00300-007-0296-9; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Norris DR, 2007, CONDOR, V109, P535; O'Briain M, 1998, ARCTIC, V51, P350; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; PROP J, 1993, ORNIS SCAND, V24, P110, DOI 10.2307/3676360; R Foundation for Statistical Computing, 2013, R LANG ENV STAT COMP; Ratikainen II, 2008, ECOL LETT, V11, P184, DOI 10.1111/j.1461-0248.2007.01122.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robson D, 2008, J ORNITHOL, V149, P473, DOI 10.1007/s10336-008-0297-7; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sedinger JS, 2011, AM NAT, V178, pE110, DOI 10.1086/662165; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Trinder MN, 2009, OIKOS, V118, P1093, DOI 10.1111/j.1600-0706.2009.17429.x; Votier SC, 2008, BIOL LETTERS, V4, P204, DOI 10.1098/rsbl.2007.0558; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	46	31	31	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77783	10.1371/journal.pone.0077783	http://dx.doi.org/10.1371/journal.pone.0077783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143258	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100097
J	Hellstrand, E; Nowacka, A; Topgaard, D; Linse, S; Sparr, E				Hellstrand, Erik; Nowacka, Agnieszka; Topgaard, Daniel; Linse, Sara; Sparr, Emma			Membrane Lipid Co-Aggregation with alpha-Synuclein Fibrils	PLOS ONE			English	Article							SOLID-STATE NMR; POLARIZATION TRANSFER; PARKINSONS-DISEASE; AMYLOID FIBRILS; PHOSPHOLIPID-BILAYERS; LEWY BODY; VESICLES; BINDING; PHOSPHATIDYLSERINE; DISRUPTION	Amyloid deposits from several human diseases have been found to contain membrane lipids. Co-aggregation of lipids and amyloid proteins in amyloid aggregates, and the related extraction of lipids from cellular membranes, can influence structure and function in both the membrane and the formed amyloid deposit. Co-aggregation can therefore have important implications for the pathological consequences of amyloid formation. Still, very little is known about the mechanism behind co-aggregation and molecular structure in the formed aggregates. To address this, we study in vitro co-aggregation by incubating phospholipid model membranes with the Parkinson's disease-associated protein, a-synuclein, in monomeric form. After aggregation, we find spontaneous uptake of phospholipids from anionic model membranes into the amyloid fibrils. Phospholipid quantification, polarization transfer solid-state NMR and cryo-TEM together reveal co-aggregation of phospholipids and a-synuclein in a saturable manner with a strong dependence on lipid composition. At low lipid to protein ratios, there is a close association of phospholipids to the fibril structure, which is apparent from reduced phospholipid mobility and morphological changes in fibril bundling. At higher lipid to protein ratios, additional vesicles adsorb along the fibrils. While interactions between lipids and amyloid-protein are generally discussed within the perspective of different protein species adsorbing to and perturbing the lipid membrane, the current work reveals amyloid formation in the presence of lipids as a co-aggregation process. The interaction leads to the formation of lipid-protein co-aggregates with distinct structure, dynamics and morphology compared to assemblies formed by either lipid or protein alone.	[Hellstrand, Erik] Lund Univ, Ctr Chem & Chem Engn, Div Biophys Chem, S-22100 Lund, Sweden; [Nowacka, Agnieszka; Topgaard, Daniel; Sparr, Emma] Lund Univ, Ctr Chem & Chem Engn, Div Phys Chem, S-22100 Lund, Sweden; [Linse, Sara] Lund Univ, Ctr Chem & Chem Engn, Div Biochem, S-22100 Lund, Sweden	Lund University; Lund University; Lund University	Hellstrand, E (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Div Biophys Chem, S-22100 Lund, Sweden.	erik.hellstrand@bpc.lu.se		Topgaard, Daniel/0000-0001-9373-6348; Linse, Sara/0000-0001-9629-7109; Sparr, Emma/0000-0001-8343-9657	Linnaeus Center of Excellence; Swedish Foundation for Strategic Research; Crafoord Foundation; Royal Physiographic Society;  [2011 4334];  [2005-2936];  [2008-4281];  [2012-3932]	Linnaeus Center of Excellence; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Crafoord Foundation; Royal Physiographic Society; ; ; ; 	The Swedish Research Council (VR) is gratefully acknowledged for financial support both through regular grants 2011 4334 (DT), 2005-2936 (DT), 2008-4281 (SL), 2012-3932 (ES) and the Linnaeus Center of Excellence "Organizing molecular matter" 2009-6794 (DT, SL, ES). ES, SL and EH also acknowledges The Swedish Foundation for Strategic Research (ES), the Crafoord Foundation (SL) and the Royal Physiographic Society (EH) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1483, P199, DOI 10.1016/S1388-1981(99)00188-2; Chen L, 2002, J MAGN RESON, V158, P164, DOI 10.1016/S1090-7807(02)00069-1; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dimitrievski K, 2010, LANGMUIR, V26, P3008, DOI 10.1021/la904743d; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Evans D.F., 1999, COLLOIDAL DOMAIN; Ferreira TM, 2013, PHYS CHEM CHEM PHYS, V15, P1976, DOI 10.1039/c2cp42738a; Gai WP, 2000, SOC NEUR ABSTR; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Grey M, 2011, J PARKINSON DIS, V1, P359, DOI 10.3233/JPD-2011-11067; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nowacka A, 2013, J MAGN RESON, V230, P165, DOI 10.1016/j.jmr.2013.02.016; Nowacka A, 2012, SOFT MATTER, V8, P1482, DOI 10.1039/c1sm06273e; Nowacka A, 2010, LANGMUIR, V26, P16848, DOI 10.1021/la102935t; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; PINES A, 1972, J CHEM PHYS, V56, P1776, DOI 10.1063/1.1677439; Reviakine I, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3687351; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SEELIG J, 1978, BIOCHEMISTRY-US, V17, P3310, DOI 10.1021/bi00609a021; Shvadchak VV, 2011, J BIOL CHEM, V286, P13023, DOI 10.1074/jbc.M110.204776; Song C, 2008, BIOPHYS CHEM, V134, P47, DOI 10.1016/j.bpc.2008.01.002; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Warschawski DE, 2000, J MAGN RESON, V145, P367, DOI 10.1006/jmre.2000.2135; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	41	80	81	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77235	10.1371/journal.pone.0077235	http://dx.doi.org/10.1371/journal.pone.0077235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146972	gold, Green Published			2022-12-25	WOS:000325819400107
J	Luebbering, N; Charlton-Perkins, M; Kumar, JP; Rollmann, SM; Cook, T; Cleghon, V				Luebbering, Nathan; Charlton-Perkins, Mark; Kumar, Justin P.; Rollmann, Stephanie M.; Cook, Tiffany; Cleghon, Vaughn			Drosophila Dyrk2 Plays a Role in the Development of the Visual System	PLOS ONE			English	Article							PROTEIN-KINASE; OLFACTORY BEHAVIOR; CELL; GENE; SPECIFICITY; DIFFERENTIATION; EXPRESSION; MNB/DYRK1A; FAMILY; GROWTH	The DYRKs (dual-specificity tyrosine phosphorylation-regulated kinases) are a conserved family of protein kinases that are associated with a number of neurological disorders, but whose biological targets are poorly understood. Drosophila encodes three Dyrks: minibrain/Dyrk1A, DmDyrk2, and DmDyrk3. Here we describe the creation and characterization of a DmDyrk2 null allele, DmDyrk2(1w17). We provide evidence that the smell impaired allele smi35A(1), is likely to encode DmDyrk2. We also demonstrate that DmDyrk2 is expressed late in the developing third antennal segment, an anatomical structure associated with smell. In addition, we find that DmDyrk2 is expressed in the morphogenetic furrow of the developing eye, that loss of DmDyrk2 in the eye produced a subtle but measurable defect, and that ectopic DmDyrk2 expression in the eye produced a strong rough eye phenotype characterized by increased secondary, tertiary and bristle interommatidial cells. This phenotype was dependent on DmDyrk2 kinase activity and was only manifest when expressed in post-mitotic non-neuronal progenitors. Together, these data indicate that DmDyrk2 is expressed in developing sensory systems, that it is required for the development of the visual system, and that the eye is a good model to identify DmDyrk2 targets.	[Luebbering, Nathan; Charlton-Perkins, Mark; Cook, Tiffany; Cleghon, Vaughn] Cincinnati Childrens Hosp Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA; [Charlton-Perkins, Mark; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Opthalmol, Cincinnati, OH 45229 USA; [Rollmann, Stephanie M.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Kumar, Justin P.] Indiana Univ, Dept Biol, Bloomington, IN USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University Bloomington	Cleghon, V (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA.	vaughn.cleghon@cchmc.org		Charlton-Perkins, Mark/0000-0002-7597-1130; Cook, Tiffany/0000-0002-3100-5248; Charlton-Perkins, Mark/0000-0002-5602-6109	National Institutes of Health [R01GM087374-01A1]; NATIONAL EYE INSTITUTE [R56EY014863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by a grant from the National Institutes of Health (R01GM087374-01A1 to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 1996, GENETICS, V143, P293; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Ashburner M, 1999, GENETICS, V153, P179; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Charlton-Perkins M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-20; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Goodwin SF, 1997, J NEUROSCI, V17, P8817; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Han JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029702; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Oegema R, 2010, MOL SYNDROMOL, V1, P113, DOI 10.1159/000320113; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Raich WB, 2003, GENETICS, V163, P571; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Richgels PK, 2012, CHEM SENSES, V37, P229, DOI 10.1093/chemse/bjr097; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Souza GM, 1998, DEVELOPMENT, V125, P2291; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; YAO KM, 1994, J NEUROCHEM, V63, P41	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76775	10.1371/journal.pone.0076775	http://dx.doi.org/10.1371/journal.pone.0076775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146926	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400082
J	Moore, P; He, KY; Tsai, B				Moore, Paul; He, Kaiyu; Tsai, Billy			Establishment of an In Vitro Transport Assay That Reveals Mechanistic Differences in Cytosolic Events Controlling Cholera Toxin and T-Cell Receptor alpha Retro-Translocation	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; HEAVY-CHAINS; P97; RETROTRANSLOCATION; ATPASE	Following retrograde trafficking to the endoplasmic reticulum (ER), cholera toxin A1 (CTA1) subunit hijacks ER-associated degradation (ERAD) machinery and retro-translocates into the cytosol to induce toxicity. We previously established a cell-based in vivo assay to identify ER components that regulate this process. However, elucidating cytosolic events that govern CTA1 retro-translocation using this assay is difficult as manipulating cytosolic factors often perturbs toxin retrograde transport to the ER. To circumvent this problem, we developed an in vitro assay in semi-permeabilized cells that directly monitors CTA1 release from the ER into the cytosol. We demonstrate CTA1 is released into the cytosol as a folded molecule in a p97- and proteasome-independent manner. Release nonetheless involves a GTP-dependent reaction. Upon extending this assay to the canonical ERAD substrate T-cell receptor alpha (TCR alpha), we found the receptor is unfolded when released into the cytosol and degraded by membrane-associated proteasome. In this reaction, p97 initially extracts TCR alpha from the ER membrane, followed by TCR alpha discharge into the cytosol that requires additional energy-dependent cytosolic activities. Our results reveal mechanistic insights into cytosolic events controlling CTA1 and TCR alpha retro-translocation, and provide a reliable tool to further probe this process.	[Moore, Paul; He, Kaiyu; Tsai, Billy] Univ Michigan Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Tsai, B (corresponding author), Univ Michigan Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI USA.	btsai@umich.edu			National Institutes of Health [RO1 083252-04]; Burroughs Wellcome Fund [1006277]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health (RO1 083252-04) and the Burroughs Wellcome Fund (1006277) for support during the early part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuJarour RJ, 2005, J BIOL CHEM, V280, P15865, DOI 10.1074/jbc.M406316200; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Badizadegan K, 2004, AM J PHYSIOL-CELL PH, V287, pC1453, DOI 10.1152/ajpcell.00189.2004; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Chinnapen DJF, 2012, DEV CELL, V23, P573, DOI 10.1016/j.devcel.2012.08.002; Cho JA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00051; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Geiger R, 2013, TRAFFIC, V14, P36, DOI 10.1111/tra.12018; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Goodwin EC, 2011, MBIO, V2, DOI 10.1128/mBio.00101-11; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Inoue T, 2011, ANNU REV MICROBIOL, V65, P287, DOI 10.1146/annurev-micro-090110-102855; Inoue T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002037; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Lass A, 2007, ARCH BIOCHEM BIOPHYS, V462, P62, DOI 10.1016/j.abb.2007.04.010; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Olzmann JA, 2012, COLD SPRING HARB PER; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	50	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75801	10.1371/journal.pone.0075801	http://dx.doi.org/10.1371/journal.pone.0075801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146777	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400020
J	Bonner, MK; Han, BH; Skop, A				Bonner, Mary Kate; Han, Bo Hwa; Skop, Ahna			Profiling of the Mammalian Mitotic Spindle Proteome Reveals an ER Protein, OSTD-1, as Being Necessary for Cell Division and ER Morphology	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; NUCLEAR-ENVELOPE; PLASMA-MEMBRANE; FUNCTIONAL-ANALYSIS; CLEAVAGE FURROW; N-GLYCOSYLATION; VULVAL MORPHOGENESIS; CYTOKINESIS; RNAI	Cell division is important for many cellular processes including cell growth, reproduction, wound healing and stem cell renewal. Failures in cell division can often lead to tumors and birth defects. To identify factors necessary for this process, we implemented a comparative profiling strategy of the published mitotic spindle proteome from our laboratory. Of the candidate mammalian proteins, we determined that 77% had orthologs in Caenorhabditis elegans and 18% were associated with human disease. Of the C. elegans candidates (n=146), we determined that 34 genes functioned in embryonic development and 56% of these were predicted to be membrane trafficking proteins. A secondary, visual screen to detect distinct defects in cell division revealed 21 genes that were necessary for cytokinesis. One of these candidates, OSTD-1, an ER resident protein, was further characterized due to the aberrant cleavage furrow placement and failures in division. We determined that OSTD-1 plays a role in maintaining the dynamic morphology of the ER during the cell cycle. In addition, 65% of all ostd-1 RNAi-treated embryos failed to correctly position cleavage furrows, suggesting that proper ER morphology plays a necessary function during animal cell division.	[Bonner, Mary Kate; Han, Bo Hwa; Skop, Ahna] Univ Wisconsin, Lab Genet & Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Skop, A (corresponding author), Univ Wisconsin, Lab Genet & Med Genet, Madison, WI 53706 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019	Skop, Ahna Renee/0000-0003-3522-4939	NSF [MCB 1158003]; NIH [K01HL092583]; Div Of Molecular and Cellular Bioscience [1158003] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092583] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NSF MCB 1158003 award and a NIH K01HL092583 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2012, CELL, V150, P521, DOI 10.1016/j.cell.2012.05.048; AHRINGER J, 2006, EVERSE GENET WORMBOO; Ai EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019020; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Audhya A, 2007, J CELL BIOL, V178, P1309, DOI 10.1083/jcb.20070113920070911c; Austin GE, 1998, AM J CLIN PATHOL, V110, P575, DOI 10.1093/ajcp/110.5.575; Belloni G, 2012, J CELL SCI, V125, P5441, DOI 10.1242/jcs.108878; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bonner MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020489; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; BURGE S, 2012, DATABASE-OXFORD, V2012, P1074; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Casey AK, 2012, GENETICS, V192, P441, DOI 10.1534/genetics.112.141465; Chang F, 1996, J CELL SCI, V109, P131; Donoso I, 2005, MOL GENET GENOMICS, V274, P155, DOI 10.1007/s00438-005-0005-8; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fernandez AG, 2005, GENOME RES, V15, P250, DOI 10.1101/gr.3194805; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Green RA, 2008, METHOD CELL BIOL, V85, P179, DOI 10.1016/S0091-679X(08)85009-1; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; Kurashige J, 2012, BRIT J CANCER, V107, P1233, DOI 10.1038/bjc.2012.396; Lacroix B, 2012, J PATHOL, V226, P338, DOI 10.1002/path.3013; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Qin C, 2013, PLANT CELL PHYSIOL, V54, P129, DOI 10.1093/pcp/pcs159; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1985, J EXP ZOOL, V234, P167, DOI 10.1002/jez.1402340120; Rojas AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031813; Rosnoblet C, 2013, GLYCOCONJUGATE J, V30, P23, DOI 10.1007/s10719-012-9389-y; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlaitz AL, 2013, DEV CELL, V26, P315, DOI 10.1016/j.devcel.2013.06.016; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stevens J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063687; Takahashi S, 2011, GENES CELLS, V16, P938, DOI 10.1111/j.1365-2443.2011.01538.x; Tang BL, 2012, CELL PHYSIOL BIOCHEM, V30, P1097, DOI 10.1159/000343301; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vleugels W, 2009, BIOCHEM BIOPH RES CO, V390, P769, DOI 10.1016/j.bbrc.2009.10.047; Wainman A, 2012, J CELL SCI, V125, P4014, DOI 10.1242/jcs.099820; Wang H, 2005, MOL BIOL CELL, V16, P4202, DOI 10.1091/mbc.E05-05-0472; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Willis DE, 2010, MOL CELL PROTEOMICS, V9, P952, DOI 10.1074/mcp.R900005-MCP200; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Zhang D, 2013, CURR OPIN CELL BIOL, V25, P142, DOI 10.1016/j.ceb.2012.09.001; Zhang D, 2010, CURR BIOL, V20, P1029, DOI 10.1016/j.cub.2010.04.017; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862; Zhou JG, 2007, CURR MICROBIOL, V55, P198, DOI 10.1007/s00284-006-0585-5	101	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77051	10.1371/journal.pone.0077051	http://dx.doi.org/10.1371/journal.pone.0077051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130834	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200053
J	Nasman, A; Andersson, E; Marklund, L; Tertipis, N; Hammarstedt-Nordenvall, L; Attner, P; Nyberg, T; Masucci, GV; Munck-Wikland, E; Ramqvist, T; Dalianis, T				Nasman, Anders; Andersson, Emilia; Marklund, Linda; Tertipis, Nikolaos; Hammarstedt-Nordenvall, Lalle; Attner, Per; Nyberg, Tommy; Masucci, Giuseppe V.; Munck-Wikland, Eva; Ramqvist, Torbjorn; Dalianis, Tina			HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome	PLOS ONE			English	Article							MHC CLASS-I; ANTIGEN-PROCESSING MACHINERY; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; TONSILLAR CARCINOMA; CERVICAL-CANCER; DOWN-REGULATION; DR EXPRESSION; HEAD; MOLECULES	HPV-DNA positive (HPVDNA+) oropharyngeal squamous cell carcinoma (OSCC) has better clinical outcome than HPV-DNA negative (HPVDNA-) OSCC. Current treatment may be unnecessarily extensive for most HPV+ OSCC, but before de-escalation, additional markers are needed together with HPV status to better predict treatment response. Here the influence of HLA class I/HLA class II expression was explored. Pre-treatment biopsies, from 439/484 OSCC patients diagnosed 2000-2009 and treated curatively, were analyzed for HLA I and II expression, p16(INK4a) and HPV DNA. Absent/weak as compared to high HLA class I intensity correlated to a very favorable disease-free survival (DFS), disease-specific survival (DSS) and overall survival (OS) in HPVDNA+ OSCC, both in univariate and multivariate analysis, while HLA class II had no impact. Notably, HPVDNA+ OSCC with absent/weak HLA class I responded equally well when treated with induction-chemo-radiotherapy (CRT) or radiotherapy (RT) alone. In patients with HPVDNA- OSCC, high HLA class I/class II expression correlated in general to a better clinical outcome. p16(INK4a) overexpression correlated to a better clinical outcome in HPVDNA+ OSCC. Absence of HLA class I intensity in HPVDNA+ OSCC suggests a very high survival independent of treatment and could possibly be used clinically to select patients for randomized trials de-escalating therapy.	[Nasman, Anders; Andersson, Emilia; Tertipis, Nikolaos; Nyberg, Tommy; Masucci, Giuseppe V.; Ramqvist, Torbjorn; Dalianis, Tina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Marklund, Linda; Hammarstedt-Nordenvall, Lalle; Attner, Per; Munck-Wikland, Eva] Karolinska Inst, Karolinska Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Nasman, A (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	anders.nasman@ki.se	Nyberg, Tommy/AGG-2330-2022; Marklunf, Linda/L-1913-2015; Masucci, Giuseppe/A-5597-2008	Nyberg, Tommy/0000-0002-9436-0626; Masucci, Giuseppe/0000-0002-9583-2306; Hammarstedt-Nordenvall, Lalle/0000-0003-1660-9737; Dalianis, Tina/0000-0001-7022-2424; Nasman, Anders/0000-0003-4602-4297	Swedish Cancer Society; Swedish Medical Research Council; Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet; Stockholm County Council; King Gustaf V Jubilee Fund; Laryngfonden	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); King Gustaf V Jubilee Fund; Laryngfonden	This work was supported by The Swedish Cancer Society; The Swedish Medical Research Council; The Stockholm Cancer Society; Henning and Ida Perssons Foundation; Karolinska Institutet; the Stockholm County Council; the King Gustaf V Jubilee Fund and Laryngfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2012, CANCER IMMUNOL IMMUN, V61, P1243, DOI 10.1007/s00262-012-1201-0; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Anichini A, 2006, CANCER RES, V66, P6405, DOI 10.1158/0008-5472.CAN-06-0854; Armstrong TD, 1998, J IMMUNOL, V160, P661; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; Braakhuis BJM, 2009, ORAL ONCOL, V45, pE85, DOI 10.1016/j.oraloncology.2009.03.010; Campo MS, 2010, VIROLOGY, V407, P137, DOI 10.1016/j.virol.2010.07.044; Cancela MD, 2012, ORAL ONCOL, V48, P484, DOI 10.1016/j.oraloncology.2011.12.013; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chiriva-Internati M, 2006, IN VITRO CELL DEV-AN, V42, P89; Chung CH, 2012, OTOLARYNG CLIN N AM, V45, P795, DOI 10.1016/j.otc.2012.04.002; Dahlstrand H, 2008, ANTICANCER RES, V28, P1133; Dahlstrand HM, 2005, ANTICANCER RES, V25, P4375; ESTEBAN F, 1990, CLIN EXP METASTAS, V8, P319, DOI 10.1007/BF01810678; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; GLEW SS, 1992, CANCER RES, V52, P4009; GLEW SS, 1993, EUR J CANCER, V29A, P1963, DOI 10.1016/0959-8049(93)90453-M; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; Hutter H, 1996, CELL TISSUE RES, V286, P439, DOI 10.1007/s004410050713; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Lewis JS, 2012, HEAD NECK PATHOL, V6, pS75, DOI 10.1007/s12105-012-0369-0; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Lindquist D, 2007, MOL ONCOL, V1, P350, DOI 10.1016/j.molonc.2007.08.005; Madjd Z, 2005, INT J CANCER, V117, P248, DOI 10.1002/ijc.21163; Marklund L, 2012, CANCER MED-US, V1, P82, DOI 10.1002/cam4.2; Matoba K, 2005, INT J CANCER, V115, P231, DOI 10.1002/ijc.20860; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; MOMBURG F, 1987, INT J CANCER, V40, P598, DOI 10.1002/ijc.2910400504; Nasman A, 2013, INT J CANCER, V132, P72, DOI 10.1002/ijc.27635; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Ogino T, 2006, CANCER RES, V66, P9281, DOI 10.1158/0008-5472.CAN-06-0488; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Pryor DI, 2011, ASIA-PAC J CLIN ONCO, V7, P236, DOI 10.1111/j.1743-7563.2011.01420.x; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Ramqvist T, 2011, SCAND J INFECT DIS, V43, P115, DOI 10.3109/00365548.2010.526957; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; TEMPONI M, 1993, J IMMUNOL METHODS, V161, P239, DOI 10.1016/0022-1759(93)90300-V; VANDUINEN SG, 1988, CANCER RES, V48, P1019; Zehbe I, 2005, INT J CANCER, V117, P807, DOI 10.1002/ijc.21226	43	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77025	10.1371/journal.pone.0077025	http://dx.doi.org/10.1371/journal.pone.0077025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130830	gold, Green Submitted, Green Published			2022-12-25	WOS:000325814200051
J	Sena, A; Grishina, I; Thai, A; Goulart, L; Macal, M; Fenton, A; Li, J; Prindiville, T; Oliani, SM; Dandekar, S; Goulart, L; Sankaran-Walters, S				Sena, Angela; Grishina, Irina; Thai, Anne; Goulart, Larissa; Macal, Monica; Fenton, Anne; Li, Jay; Prindiville, Thomas; Oliani, Sonia Maria; Dandekar, Satya; Goulart, Luiz; Sankaran-Walters, Sumathi			Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS-INFECTION; GENE-EXPRESSION; PERIPHERAL-BLOOD; LIPOCORTIN 1; INNATE; NEUTROPHILS; MODULATION; LEUKOCYTES	Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic factors with the host immune system. Mechanisms contributing to immune dysregulation in IBD are not fully defined. Development of novel therapeutic strategies is focused on controlling aberrant immune response in IBD. Current IBD therapy utilizes a combination of immunomodulators and biologics to suppress pro-inflammatory effectors of IBD. However, the role of immunomodulatory factors such as annexin A1 (ANXA1) is not well understood. The goal of this study was to examine the association between ANXA1 and IBD, and the effects of anti-TNF-alpha, Infliximab (IFX), therapy on ANXA1 expression. Methods: ANXA1 and TNF-alpha transcript levels in PBMC were measured by RT PCR. Clinical follow up included the administration of serial ibdQs. ANXA1 expression in the gut mucosa was measured by IHC. Plasma ANXA1 levels were measured by ELISA. Results: We found that the reduction in ANXA1 protein levels in plasma coincided with a decrease in the ANXA1 mRNA expression in peripheral blood of IBD patients. ANXA1 expression is upregulated during IFX therapy in patients with a successful intervention but not in clinical non-responders. The IFX therapy also modified the cellular immune activation in the peripheral blood of IBD patients. Decreased expression of ANXA1 was detected in the colonic mucosa of IBD patients with incomplete resolution of inflammation during continuous therapy, which correlated with increased levels of TNF-alpha transcripts. Gut mucosal epithelial barrier disruption was evident by increased plasma bacterial 16S levels. Conclusion: Loss of ANXA1 expression may support inflammation during IBD and can serve as a biomarker of disease progression. Changes in ANXA1 levels may be predictive of therapeutic efficacy.	[Sena, Angela; Grishina, Irina; Goulart, Larissa; Macal, Monica; Fenton, Anne; Li, Jay; Dandekar, Satya; Goulart, Luiz; Sankaran-Walters, Sumathi] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Sena, Angela; Goulart, Luiz] Univ Fed Uberlandia, Inst Genet & Biochem, Nanobiotechnol Lab, BR-38400 Uberlandia, MG, Brazil; [Thai, Anne; Prindiville, Thomas] Univ Calif Davis, UCDHS Div Hepatol & Gastroenterol, Davis, CA 95616 USA; [Oliani, Sonia Maria] Sao Paulo State Univ, Dept Biol, UNESP, Sao Jose Do Rio Preto, SP, Brazil	University of California System; University of California Davis; Universidade Federal de Uberlandia; University of California System; University of California Davis; Universidade Estadual Paulista	Sankaran-Walters, S (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ssankara@ucdavis.edu	Goulart, Luiz R/G-7357-2012; Oliani, Sonia Maria/E-3476-2012	Goulart, Luiz R/0000-0002-1803-4861; Oliani, Sonia Maria/0000-0003-0918-2130	FAPEMIG, Brazil [APQ-02613-10]; CAPES, Brazil; National Institute of Health (NIH) [R01 DK61297, AI43274]; Building Interdisciplinary Research Careers in Women's Health award [K12 HD051958]; NICHD; ORWH; NIA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061297] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Building Interdisciplinary Research Careers in Women's Health award; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ORWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from FAPEMIG, Brazil (APQ-02613-10), CAPES, Brazil (A.A.S. scholarship), and the National Institute of Health (NIH) R01 DK61297, AI43274). Dr. Sankaran is supported by a Building Interdisciplinary Research Careers in Women's Health award (K12 HD051958) funded by the NICHD, ORWH, and the NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Faria PCB, 2010, ORAL ONCOL, V46, P25, DOI 10.1016/j.oraloncology.2009.09.003; BEATTIE RM, 1995, ALIMENT PHARM THERAP, V9, P541; Beverley P C, 1992, Semin Immunol, V4, P35; Boxer Laurence A, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE17, DOI 10.1097/01.mpg.0000313830.01466.21; Caviglia R, 2008, EXPERT OPIN DRUG SAF, V7, P617, DOI 10.1517/14740338.7.5.617 ; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; CIRINO G, 1987, PROSTAGLANDINS, V34, P59, DOI 10.1016/0090-6980(87)90262-0; CIRINO G, 1987, NATURE, V328, P270, DOI 10.1038/328270a0; Clarke K, 2012, INFLAMM BOWEL DIS, V18, P174, DOI 10.1002/ibd.21792; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; D'Acquisto F, 2007, EUR J IMMUNOL, V37, P3131, DOI 10.1002/eji.200636792; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; D'Amico M, 2000, FASEB J, V14, P1867; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; de Coupade C, 2001, AM J PATHOL, V159, P1435, DOI 10.1016/S0002-9440(10)62530-8; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gavins FNE, 2007, FASEB J, V21, P1751, DOI 10.1096/fj.06-7842com; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Macfarlane S, 2009, CRIT REV CL LAB SCI, V46, P25, DOI [10.1080/10408360802485792, 10.1080/10408360802485792 ]; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Maurice MM, 1999, ARTHRITIS RHEUM-US, V42, P2166, DOI 10.1002/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K; MCCARTHY DA, 1991, CLIN EXP IMMUNOL, V86, P489; Meuwis MA, 2008, CLIN BIOCHEM, V41, P960, DOI 10.1016/j.clinbiochem.2008.04.021; Miehsler W, 2010, J CROHNS COLITIS, V4, P221, DOI 10.1016/j.crohns.2009.12.001; Musch MW, 2002, J CLIN INVEST, V110, P1739, DOI 10.1172/JCI200215695; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rakoff-Nahoum S, 2010, CURR OPIN GASTROEN, V26, P572, DOI 10.1097/MOG.0b013e32833f126d; Roda G, 2010, INFLAMM BOWEL DIS, V16, P1239, DOI 10.1002/ibd.21212; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1442, DOI 10.1053/j.gastro.2008.09.053; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Sankaran-Walters S, 2011, J CLIN VIROL, V50, P31, DOI 10.1016/j.jcv.2010.09.011; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Siegmund B, 2011, WORLD J GASTROENTERO, V17, P3178, DOI 10.3748/wjg.v17.i27.3178; Stallmach A, 2010, BEST PRACT RES CL GA, V24, P167, DOI 10.1016/j.bpg.2010.01.002; STEVENS TRJ, 1993, CLIN SCI, V84, P381, DOI 10.1042/cs0840381; Vergnolle N, 2004, INFLAMM BOWEL DIS, V10, P584, DOI 10.1097/00054725-200409000-00013; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Vong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039244; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yona S, 2006, BRIT J PHARMACOL, V148, P469, DOI 10.1038/sj.bjp.0706730	53	40	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e76969	10.1371/journal.pone.0076969	http://dx.doi.org/10.1371/journal.pone.0076969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130820	Green Published, gold			2022-12-25	WOS:000325814200046
J	Xia, YF; Entman, ML; Wang, YL				Xia, Yunfeng; Entman, Mark L.; Wang, Yanlin			CCR2 Regulates the Uptake of Bone Marrow-Derived Fibroblasts in Renal Fibrosis	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; TO-MESENCHYMAL TRANSITION; CIRCULATING FIBROCYTES; TUBULOINTERSTITIAL FIBROSIS; MEDIATE FIBROSIS; KIDNEY FIBROSIS; TISSUE-REPAIR; CELLS; DIFFERENTIATION; MYOFIBROBLASTS	Recent studies have shown that bone marrow-derived fibroblasts contribute significantly to the pathogenesis of renal fibrosis. However, the molecular mechanisms underlying the recruitment of bone marrow-derived fibroblasts into the kidney are incompletely understood. Bone marrow-derived fibroblasts express the chemokine receptor - CCR2. In this study, we tested the hypothesis that CCR2 participates in the recruitment of fibroblasts into the kidney during the development of renal fibrosis. Bone marrow-derived collagen-expressing GFP(+) fibroblasts were detected in the obstructed kidneys of chimeric mice transplanted with donor bone marrow from collagen alpha 1(I)-GFP reporter mice. These bone marrow-derived fibroblasts expressed PDGFR-beta and CCR2. CCR2 knockout mice accumulated significantly fewer bone marrow-derived fibroblast precursors expressing the hematopoietic marker-CD45 and the mesenchymal markers-PDGFR-beta or procollagen I in the obstructed kidneys compared with wild-type mice. Furthermore, CCR2 knockout mice displayed fewer bone marrow-derived myofibroblasts and expressed less alpha-SMA or FSP-1 in the obstructed kidneys compared with wild-type mice. Consistent with these findings, genetic deletion of CCR2 inhibited total collagen deposition and suppressed expression of collagen I and fibronectin. Moreover, genetic deletion of CCR2 inhibits MCP-1 and CXCL16 gene expression associated with a reduction of inflammatory cytokine expression and macrophage infiltration, suggesting a linear interaction between two chemokines/ligand receptors in tubular epithelial cells. Taken together, our results demonstrate that CCR2 signaling plays an important role in the pathogenesis of renal fibrosis through regulation of bone marrow-derived fibroblasts. These data suggest that inhibition of CCR2 signaling could constitute a novel therapeutic approach for fibrotic kidney disease.	[Xia, Yunfeng; Wang, Yanlin] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Xia, Yunfeng] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Med, Div Nephrol, Guangzhou, Guangdong, Peoples R China; [Entman, Mark L.] Baylor Coll Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Entman, Mark L.] Baylor Coll Med, Dept Med, DeBakey Heart Ctr, Houston, TX 77030 USA; [Entman, Mark L.] Methodist Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; The Methodist Hospital System; The Methodist Hospital - Houston	Wang, YL (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	yanlinw@bcm.edu			NIH [K08HL092958, R01DK095835, R01HL89792]; AHA [BGIA7840054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092958, R01HL089792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants - K08HL092958 and R01DK095835, an AHA grant - BGIA7840054 (to YW). MLE was supported by a NIH Grant - R01HL89792. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Chesney J, 1997, BIOCHEM SOC T, V25, P520, DOI 10.1042/bst0250520; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Picard N, 2008, HISTOCHEM CELL BIOL, V130, P141, DOI 10.1007/s00418-008-0433-8; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Xu J, 2011, AM J PHYSIOL-HEART C, V301, pH538, DOI 10.1152/ajpheart.01114.2010; Yang J, 2013, J AM SOC NEPHROL; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052415; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	39	37	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77493	10.1371/journal.pone.0077493	http://dx.doi.org/10.1371/journal.pone.0077493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130892	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200090
J	Balsanelli, E; Tuleski, TR; de Baura, VA; Yates, MG; Chubatsu, LS; Pedrosa, FD; de Souza, EM; Monteiro, RA				Balsanelli, Eduardo; Tuleski, Thalita Regina; de Baura, Valter Antonio; Yates, Marshall Geoffrey; Chubatsu, Leda Satie; Pedrosa, Fabio de Oliveira; de Souza, Emanuel Maltempi; Monteiro, Rose Adele			Maize Root Lectins Mediate the Interaction with Herbaspirillum seropedicae via N-Acetyl Glucosamine Residues of Lipopolysaccharides	PLOS ONE			English	Article							AZOSPIRILLUM-BRASILENSE; NIF GENES; O-ANTIGEN; COLONIZATION; BIOSYNTHESIS; IDENTIFICATION; RHIZOSPHERE; INVOLVEMENT; EXPRESSION; SEQUENCES	Herbaspirillum seropedicae is a plant growth-promoting diazotrophic betaproteobacterium which associates with important crops, such as maize, wheat, rice and sugar-cane. We have previously reported that intact lipopolysaccharide (LPS) is required for H. seropedicae attachment and endophytic colonization of maize roots. In this study, we present evidence that the LPS biosynthesis gene waaL (codes for the O-antigen ligase) is induced during rhizosphere colonization by H. seropedicae. Furthermore a waaL mutant strain lacking the O-antigen portion of the LPS is severely impaired in colonization. Since N-acetyl glucosamine inhibits H. seropedicae attachment to maize roots, lectin-like proteins from maize roots (MRLs) were isolated and mass spectrometry (MS) analysis showed that MRL-1 and MRL-2 correspond to maize proteins with a jacalin-like lectin domain, while MRL-3 contains a B-chain lectin domain. These proteins showed agglutination activity against wild type H. seropedicae, but failed to agglutinate the waaL mutant strain. The agglutination reaction was severely diminished in the presence of N-acetyl glucosamine. Moreover addition of the MRL proteins as competitors in H. seropedicae attachment assays decreased 80-fold the adhesion of the wild type to maize roots. The results suggest that N-acetyl glucosamine residues of the LPS O-antigen bind to maize root lectins, an essential step for efficient bacterial attachment and colonization.	[Balsanelli, Eduardo; Tuleski, Thalita Regina; de Baura, Valter Antonio; Yates, Marshall Geoffrey; Chubatsu, Leda Satie; Pedrosa, Fabio de Oliveira; de Souza, Emanuel Maltempi; Monteiro, Rose Adele] Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Monteiro, RA (corresponding author), Univ Fed Parana, Dept Biochem & Mol Biol, BR-80060000 Curitiba, Parana, Brazil.	roseadele@gmail.com	Pedrosa, Fabio 0/C-1938-2013; Chubatsu, Leda S./H-2603-2012; Balsanelli, Eduardo/O-8831-2014	Chubatsu, Leda S./0000-0002-8687-2816; Monteiro, Rose Adele/0000-0001-8226-0700	Brazilian Program of National Institutes of Science and Technology-INCT/Biological Nitrogen Fixation/Brazilian Research Council-CNPq/MCT; Fundacao Araucaria	Brazilian Program of National Institutes of Science and Technology-INCT/Biological Nitrogen Fixation/Brazilian Research Council-CNPq/MCT; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by the Brazilian Program of National Institutes of Science and Technology-INCT/Biological Nitrogen Fixation/Brazilian Research Council-CNPq/MCT and Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldani JI, 1996, INT J SYST BACTERIOL, V46, P802, DOI 10.1099/00207713-46-3-802; BALDANI VLD, 1992, SYMBIOSIS, V13, P65; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; BARANY F, 1985, P NATL ACAD SCI USA, V82, P4202, DOI 10.1073/pnas.82.12.4202; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; Bhattacharya I, 2002, GLYCOCONJUGATE J, V19, P395, DOI 10.1023/B:GLYC.0000004011.54822.ea; BODDEY RM, 1995, PLANT SOIL, V174, P195, DOI 10.1007/BF00032247; Bolanos L, 2004, MOL PLANT MICROBE IN, V17, P216, DOI 10.1094/MPMI.2004.17.2.216; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burlat V, 2001, PHYTOCHEMISTRY, V57, P883, DOI 10.1016/S0031-9422(01)00117-0; Collins PM, 1995, MONOSACHARIDES THEIR, P463; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; DELGALLO M, 1989, J BACTERIOL, V171, P3504, DOI 10.1128/jb.171.6.3504-3510.1989; Duijff BJ, 1997, NEW PHYTOL, V135, P325, DOI 10.1046/j.1469-8137.1997.00646.x; Egener T, 1999, MOL PLANT MICROBE IN, V12, P813, DOI 10.1094/MPMI.1999.12.9.813; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; James EK, 1997, J EXP BOT, V48, P785, DOI 10.1093/jxb/48.3.785; Jayaraman V, 1998, BBA-GEN SUBJECTS, V1381, P7, DOI 10.1016/S0304-4165(98)00031-2; Jofre E, 2004, FEMS MICROBIOL LETT, V231, P267, DOI 10.1016/S0378-1097(04)00003-5; Klassen G, 1997, CAN J MICROBIOL, V43, P887, DOI 10.1139/m97-129; KONNOVA SA, 1994, FEMS MICROBIOL LETT, V118, P93, DOI 10.1111/j.1574-6968.1994.tb06809.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; MISHKIND ML, 1983, SCIENCE, V220, P1290, DOI 10.1126/science.220.4603.1290; Olivares FL, 1997, NEW PHYTOL, V135, P723, DOI 10.1046/j.1469-8137.1997.00684.x; Ormeno-Orrillo E, 2008, ENVIRON MICROBIOL, V10, P1271, DOI 10.1111/j.1462-2920.2007.01541.x; PEDROSA FO, 1984, FEMS MICROBIOL LETT, V23, P95, DOI 10.1016/0378-1097(84)90080-6; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raval S, 2004, GLYCOBIOLOGY, V14, P1247, DOI 10.1093/glycob/cwh140; Ruan X, 2012, GLYCOBIOLOGY, V22, P288, DOI 10.1093/glycob/cwr150; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Chaves DFS, 2009, J PROTEOMICS, V73, P50, DOI 10.1016/j.jprot.2009.07.012; SERRATO RV, 2012, INT J BIOL MACROMOL, DOI [10.1016/j.ijbiomac.2012.05.034, DOI 10.1016/J.IJBI0MAC.2012.05.034]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Simons M, 1996, MOL PLANT MICROBE IN, V9, P600, DOI 10.1094/MPMI-9-0600; STINISSEN HM, 1985, PLANTA, V164, P278, DOI 10.1007/BF00396093; SUTHERLAND IW, 1985, ANNU REV MICROBIOL, V39, P243; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Westermeier R, 2002, PROTEOMICS PRACTICE; Woodley P, 1996, FEMS MICROBIOL LETT, V135, P213	44	31	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77001	10.1371/journal.pone.0077001	http://dx.doi.org/10.1371/journal.pone.0077001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130823	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900115
J	Ortica, S; Tarantino, N; Aulner, N; Israel, A; Gupta-Rossi, N				Ortica, Sara; Tarantino, Nadine; Aulner, Nathalie; Israel, Alain; Gupta-Rossi, Neetu			The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors	FASEB JOURNAL			English	Article						CDK inhibitors; hepatoblasts; polyploidy; paralogs; bipotential stem cells	HUMAN HEPATOCELLULAR-CARCINOMA; BILE-DUCT DEVELOPMENT; ALAGILLE-SYNDROME; CELL LINES; HUMAN HOMOLOG; HUMAN JAGGED1; KINASE 1; MUTATIONS; TRANSCRIPTION; HYPERPLASIA	The Notch signaling pathway is involved in liver development and regeneration. Here, we investigate the role of the 4 mammalian Notch paralogs in the regulation of hepatoblast proliferation and hepatocytic differentiation. Our model is based on bipotential mouse embryonic liver (BMEL) progenitors that can differentiate into hepatocytes or cholangiocytes in vitro and in vivo. BMEL cells were subjected to Notch antagonists or agonists. Blocking Notch activation with a -secretase inhibitor, at 50 M for 48 h, reduced cell growth by 50%. S-phase entry was impaired, but no apoptosis was induced. A systematic paralog-specific strategy was set using lentiviral transduction with constitutively active forms of each Notch receptor along with inhibition of endogenous Notch signaling. This assay demonstrates that proliferation of BMEL cells requires Notch2 and Notch4 activity, resulting in significant down-regulation of p27(Kip1) and p57(Kip2) cyclin-dependent kinase inhibitors. Conversely, Notch3-expressing cells proliferate less and express 3-fold higher levels of p57(Kip2). The Notch3 cells present a hepatocyte-like morphology, enhanced multinucleation, and a ploidy shift. Moreover, Notch3 activity is conducive to hepatocytic differentiation in vitro, while its paralogs impede this fate. Our study provides the first evidence of a functional diversity among the mammalian Notch homologues in the proliferation and hepatocytic-lineage commitment of liver progenitors.Ortica, S., Tarantino, N., Aulner, N., Israel, A., Gupta-Rossi, N. The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors.	[Ortica, Sara; Tarantino, Nadine; Israel, Alain; Gupta-Rossi, Neetu] Inst Pasteur, CNRS, Unite Rech Associee URA 2582, Unite Signalisat Mol & Activat Cellulaire, F-75724 Paris 15, France; [Aulner, Nathalie] Inst Pasteur, Imagopole, F-75724 Paris 15, France; [Ortica, Sara] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Gupta-Rossi, N (corresponding author), Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, 25 Rue Dr Roux, F-75724 Paris 15, France.	neetu.gupta@pasteur.fr	Gupta-Rossi, Neetu/AAE-3117-2022	Gupta-Rossi, Neetu/0000-0003-0043-264X	French National Research Agency [ANR 10-INSB-04-01]; Soutien aux Equipes Scientifiques pour l'Acquisition de Moyens Experimentaux (SESAME); Conseil de la Region Ile-de-France; Fondation pour la Recherche Medicale (FRM); Domaine d'Interet Majeur (DIM)-Stem Cells and Cell Therapy (STEM)-Pole (Ile-de-France); U.S. National Institute of Child Health and Human Development; University of Iowa (Iowa City, IA, USA)	French National Research Agency(French National Research Agency (ANR)); Soutien aux Equipes Scientifiques pour l'Acquisition de Moyens Experimentaux (SESAME); Conseil de la Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Domaine d'Interet Majeur (DIM)-Stem Cells and Cell Therapy (STEM)-Pole (Ile-de-France)(Region Ile-de-France); U.S. National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Iowa (Iowa City, IA, USA)	The authors thank Mary Weiss and Helene Strick-Marchand (Institut Pasteur, Paris, France) for the kind gift of bipotential mouse embryonic liver cells and helpful discussions. The authors are grateful to M. Bocchetta (Loyola University Medical Center, Chicago, IL, USA), I. Screpanti (Sapienza University of Rome, Rome, Italy), J. Kitajewski (Columbia University Medical Center, New York, NY, USA), Y. Jacob and E. Birlouez (Institut Pasteur, Paris, France), and M. X. Ilagan (Washington University School of Medicine, St. Louis, MO, USA) for constructs. The authors thank S. Cairo, P. Falanga, P. Mourikis, S. Yennek, F. Logeat, D. Ndiaye, and D. Kachaner (Institut Pasteur) for materials and advice. The authors especially thank P. H. Commere and A. Danckaert (Imagopole, Institut Pasteur). The authors acknowledge the Imagopole-Plateforme d'Imagerie Dynamique (PFID) France-BioImaging infrastructure, supported by the French National Research Agency (ANR 10-INSB-04-01, Investments for the Future), for advice and access to the Opera system. The Imagopole was sponsored by the Soutien aux Equipes Scientifiques pour l'Acquisition de Moyens Experimentaux (SESAME) 2007 program, Conseil de la Region Ile-de-France, and by a grant from the Fondation pour la Recherche Medicale (FRM). S.O. was supported by grants from the Domaine d'Interet Majeur (DIM)-Stem Cells and Cell Therapy (STEM)-Pole (Ile-de-France) and the FRM. Notch2 (Artavanis- Tsakonas) antibody was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the U.S. National Institute of Child Health and Human Development and maintained by the University of Iowa (Iowa City, IA, USA).	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bellavia D, 2008, ONCOGENE, V27, P5092, DOI 10.1038/onc.2008.230; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Croquelois A, 2005, HEPATOLOGY, V41, P487, DOI 10.1002/hep.20571; Diermeier-Daucher S., 2010, CURR PROTOC CELL BIO, V48; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fitz JG, 2002, SEMIN LIVER DIS, V22, P241, DOI 10.1055/s-2002-34502; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Funahashi Y, 2008, CANCER RES, V68, P4727, DOI 10.1158/0008-5472.CAN-07-6499; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Giovannini C, 2006, ANTICANCER RES, V26, P2123; Giovannini C, 2012, AM J PATHOL, V181, P413, DOI 10.1016/j.ajpath.2012.04.019; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Guo H, 2011, CARCINOGENESIS, V32, P1897, DOI 10.1093/carcin/bgr220; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Gupta-Rossi N, 2011, J BIOL CHEM, V286, P18720, DOI 10.1074/jbc.M110.190769; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Lemaigre FP, 2008, HEPATOLOGY, V48, P358, DOI 10.1002/hep.22480; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Litten JB, 2011, PEDIATR DEVEL PATHOL, V14, P378, DOI 10.2350/10-09-0900-OA.1; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Mizuguchi T, 2001, J CELL PHYSIOL, V189, P106, DOI 10.1002/jcp.1136; Mok WC, 2012, WORLD J GASTROENTERO, V18, P3527, DOI 10.3748/wjg.v18.i27.3527; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; NADAL C, 1966, EXP CELL RES, V42, P99, DOI 10.1016/0014-4827(66)90324-7; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Oda T, 1997, GENOMICS, V43, P376, DOI 10.1006/geno.1997.4820; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ou YY, 2002, J CELL SCI, V115, P1825; Rogler LE, 1997, AM J PATHOL, V150, P591; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Shiojiri N, 1997, MICROSC RES TECHNIQ, V39, P328, DOI 10.1002/(SICI)1097-0029(19971115)39:4<328::AID-JEMT3>3.0.CO;2-D; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Suwanjunee S, 2008, ANTI-CANCER DRUG, V19, P477, DOI 10.1097/CAD.0b013e3282fc6cdd; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Tchorz JS, 2009, HEPATOLOGY, V50, P871, DOI 10.1002/hep.23048; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; van Zijl F, 2010, WORLD J HEPATOL, V2, P1, DOI 10.4254/wjh.v2.i1.1; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Wang L, 2009, HEPATOLOGY, V49, P268, DOI 10.1002/hep.22579; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	64	25	27	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					603	614		10.1096/fj.13-235903	http://dx.doi.org/10.1096/fj.13-235903			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24145721				2022-12-25	WOS:000331072200009
J	Preuss, E; Hugle, M; Reimann, R; Schlecht, M; Fulda, S				Preuss, Ellen; Hugle, Manuela; Reimann, Romy; Schlecht, Marcel; Fulda, Simone			Pan-Mammalian Target of Rapamycin (mTOR) Inhibitor AZD8055 Primes Rhabdomyosarcoma Cells for ABT-737-induced Apoptosis by Down-regulating Mcl-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cell Death; mTOR; Rhabdomyosarcoma	BH3 MIMETIC ABT-737; CANCER-THERAPY; BCL-2 FAMILY; IN-VITRO; RESISTANCE; SURVIVAL; NEUROBLASTOMA; ACTIVATION; MECHANISMS; CHILDREN	The PI3K/mammalian Target of Rapamycin (mTOR) pathway is often aberrantly activated in rhabdomyosarcoma (RMS) and represents a promising therapeutic target. Recent evaluation of AZD8055, an ATP-competitive mTOR inhibitor, by the Preclinical Pediatric Testing Program showed in vivo antitumor activity against childhood solid tumors, including RMS. Therefore, in the present study, we searched for AZD8055-based combination therapies. Here, we identify a new synergistic lethality of AZD8055 together with ABT-737, a BH3 mimetic that antagonizes Bcl-2, Bcl-x(L), and Bcl-w but not Mcl-1. AZD8055 and ABT-737 cooperate to induce apoptosis in alveolar and embryonal RMS cells in a highly synergistic fashion (combination index < 0.2). Synergistic induction of apoptosis by AZD8055 and ABT-737 is confirmed on the molecular level, as AZD8055 and ABT-737 cooperate to trigger loss of mitochondrial membrane potential, activation of caspases, and caspase-dependent apoptosis that is blocked by the pan-caspase inhibitor Z-VAD-fmk. Similar to AZD8055, the PI3K/mTOR inhibitor NVP-BEZ235, the PI3K inhibitor NVP-BKM120 and Akt inhibitor synergize with ABT-737 to trigger apoptosis, whereas no cooperativity is found for the mTOR complex 1 inhibitor RAD001. Interestingly, molecular studies reveal a correlation between the ability of different PI3K/mTOR inhibitors to potentiate ABT-737-induced apoptosis and to suppress Mcl-1 protein levels. Importantly, knockdown of Mcl-1 increases ABT-737-induced apoptosis similar to AZD8055/ABT-737 cotreatment. This indicates that AZD8055-mediated suppression of Mcl-1 protein plays an important role in the synergistic drug interaction. By identifying a novel synergistic interaction of AZD8055 and ABT-737, our findings have important implications for the development of molecular targeted therapies for RMS.	[Preuss, Ellen; Hugle, Manuela; Reimann, Romy; Schlecht, Marcel; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany	Goethe University Frankfurt	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported in part by a grant from the Deutsche Krebshilfe (to S. F.).	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Armistead PM, 2007, CANCER, V110, P2293, DOI 10.1002/cncr.23038; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chou TC, 1991, SYNERGISM ANTAGONISM, P61; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Dagher R, 1999, Oncologist, V4, P34; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S., 2012, SARCOMA, V2012; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Fulda S, 2008, CURR CANCER DRUG TAR, V8, P536, DOI 10.2174/156800908785699333; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Geoerger B, 2012, EUR J CANCER, V48, P253, DOI 10.1016/j.ejca.2011.09.021; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P191, DOI 10.1002/pbc.22935; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pazzaglia L, 2009, HISTOL HISTOPATHOL, V24, P61, DOI 10.14670/HH-24.61; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35287	35296		10.1074/jbc.M113.495986	http://dx.doi.org/10.1074/jbc.M113.495986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133218	Green Published, hybrid			2022-12-25	WOS:000329867600027
J	Phillips, CM; Dillon, C; Harrington, JM; McCarthy, VJC; Kearney, PM; Fitzgerald, AP; Perry, IJ				Phillips, Catherine M.; Dillon, Christina; Harrington, Janas M.; McCarthy, Vera J. C.; Kearney, Patricia M.; Fitzgerald, Anthony P.; Perry, Ivan J.			Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle Factors	PLOS ONE			English	Article							BODY-MASS INDEX; NORMAL-WEIGHT; RISK; POPULATION; WOMEN; MEN; IDENTIFICATION; INFLAMMATION; INDIVIDUALS; PREVALENCE	Background: There is a current lack of consensus on defining metabolically healthy obesity (MHO). Limited data on dietary and lifestyle factors and MHO exist. The aim of this study is to compare the prevalence, dietary factors and lifestyle behaviours of metabolically healthy and unhealthy obese and non-obese subjects according to different metabolic health criteria. Method: Cross-sectional sample of 1,008 men and 1,039 women aged 45-74 years participated in the study. Participants were classified as obese (BMI >= 30kg/m(2)) and non-obese (BMI <30kg/m(2)). Metabolic health status was defined using five existing MH definitions based on a range of cardiometabolic abnormalities. Dietary composition and quality, food pyramid servings, physical activity, alcohol and smoking behaviours were examined. Results: The prevalence of MHO varied considerably between definitions (2.2% to 11.9%), was higher among females and generally increased with age. Agreement between MHO classifications was poor. Among the obese, prevalence of MH was 6.8% to 36.6%. Among the non-obese, prevalence of metabolically unhealthy subjects was 21.8% to 87%. Calorie intake, dietary macronutrient composition, physical activity, alcohol and smoking behaviours were similar between the metabolically healthy and unhealthy regardless of BMI. Greater compliance with food pyramid recommendations and higher dietary quality were positively associated with metabolic health in obese (OR 1.45-1.53 unadjusted model) and non-obese subjects (OR 1.37-1.39 unadjusted model), respectively. Physical activity was associated with MHO defined by insulin resistance (OR 1.87, 95% CI 1.19-2.92, p = 0.006). Conclusion: A standard MHO definition is required. Moderate and high levels of physical activity and compliance with food pyramid recommendations increase the likelihood of MHO. Stratification of obese individuals based on their metabolic health phenotype may be important in ascertaining the appropriate therapeutic or intervention strategy.	[Phillips, Catherine M.; Dillon, Christina; Harrington, Janas M.; McCarthy, Vera J. C.; Kearney, Patricia M.; Fitzgerald, Anthony P.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Hlth Res Board Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland	University College Cork; University College Cork	Phillips, CM (corresponding author), Natl Univ Ireland Univ Coll Cork, Hlth Res Board Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland.	c.phillips@ucc.ie	Fitzgerald, Tony/AAB-5331-2020; Harrington, Janas/AAV-8123-2021; Kearney, Patricia M/AAE-8501-2020	Harrington, Janas/0000-0002-6238-7031; Perry, Ivan/0000-0002-4965-9792; Phillips, Catherine/0000-0003-4916-4463; Kearney, Patricia/0000-0001-9599-3540; Fitzgerald, Tony/0000-0001-6437-5686	Irish Health Research Board [HRC/2007/13]	Irish Health Research Board	This work was supported by a research grant from the Irish Health Research Board (reference HRC/2007/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Choi J, 2012, NUTR METAB CARDIOVAS, V22, P567, DOI 10.1016/j.numecd.2010.09.001; Ekelund U, 2011, AM J CLIN NUTR, V93, P826, DOI 10.3945/ajcn.110.006593; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Hankinson AL, 2012, OBESITY; Harrington J, 2013, CURR DIABETES REP; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; International Physical Activity Questionnaire, GUID DAT PROC AN INT; Janiszewski PM, 2010, DIABETES CARE, V33, P1957, DOI 10.2337/dc10-0547; Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kearney PM, 2013, INT J EPIDEMIOL, V42, P1253, DOI 10.1093/ije/dys131; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Manu P, 2012, OBES RES CLIN PRACT, V6, pE9, DOI 10.1016/j.orcp.2011.04.003; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pataky Z, 2010, INT J OBESITY, V34, pS18, DOI 10.1038/ijo.2010.235; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; PHILLIPS CM, 2013, OBESITY, V21, pE154, DOI DOI 10.1038/OBY.2012.188; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7; Yoo HK, 2013, KOREAN J FAM MED, V34, P19, DOI 10.4082/kjfm.2013.34.1.19	45	150	156	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76188	10.1371/journal.pone.0076188	http://dx.doi.org/10.1371/journal.pone.0076188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146838	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200011
J	Kwon, S; Weiden, MD; Echevarria, GC; Comfort, AL; Naveed, B; Prezant, DJ; Rom, WN; Nolan, A				Kwon, Sophia; Weiden, Michael D.; Echevarria, Ghislaine C.; Comfort, Ashley L.; Naveed, Bushra; Prezant, David J.; Rom, William N.; Nolan, Anna			Early Elevation of Serum MMP-3 and MMP-12 Predicts Protection from World Trade Center-Lung Injury in New York City Firefighters: A Nested Case-Control Study	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CENTER DUST; ALPHA(1)-ANTITRYPSIN DEFICIENCY; RESCUE WORKERS; CENTER SITE; EXPOSURE; DISEASE; HEALTH; EXPRESSION; BIOMARKERS	Objective: After 9/11/2001, some Fire Department of New York (FDNY) workers had excessive lung function decline. We hypothesized that early serum matrix metalloproteinases (MMP) expression predicts World Trade Center-Lung Injury (WTC-LI) years later. Methods: This is a nested case-control analysis of never-smoking male firefighters with normal pre-exposure Forced Expiratory Volume in one second (FEV1) who had serum drawn up to 155 days post 9/11/2001. Serum MMP-1, 2,3,7,8, 9, 12 and 13 were measured. Cases of WTC-LI (N = 70) were defined as having an FEV1 one standard deviation below the mean (FEV1 <= 77%) at subspecialty pulmonary evaluation (SPE) which was performed 32 months (IQR 21-53) post-9/11. Controls (N = 123) were randomly selected. We modeled MMP's ability as a predictor of cases status with logistic regression adjusted for time to blood draw, exposure intensity, weight gain and pre-9/11 FEV1. Results: Each log-increase in MMP-3 and MMP-12 showed reduced odds of developing WTC-LI by 73% and 54% respectively. MMP-3 and MMP-12 consistently clustered together in cases, controls, and the cohort. Increasing time to blood draw significantly and independently increased the risk of WTC-LI. Conclusions: Elevated serum levels of MMP-3 and MMP-12 reduce the risk of developing WTC-LI. At any level of MMP-3 or 12, increased time to blood draw is associated with a diminished protective effect.	[Kwon, Sophia; Weiden, Michael D.; Echevarria, Ghislaine C.; Comfort, Ashley L.; Naveed, Bushra; Rom, William N.; Nolan, Anna] NYU, Sch Med, Div Pulm Crit Care & Sleep, New York, NY USA; [Weiden, Michael D.; Rom, William N.; Nolan, Anna] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Weiden, Michael D.; Prezant, David J.; Nolan, Anna] Bur Hlth Serv, Brooklyn, NY USA; [Weiden, Michael D.; Prezant, David J.; Nolan, Anna] Fire Dept New York, Off Med Affairs, Brooklyn, NY USA; [Prezant, David J.] Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; [Prezant, David J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Echevarria, Ghislaine C.] Pontificia Univ Catolica Chile, Div Anestesiol, Escuela Med, Santiago, Chile	New York University; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Pontificia Universidad Catolica de Chile	Nolan, A (corresponding author), NYU, Sch Med, Div Pulm Crit Care & Sleep, New York, NY USA.	anna.nolan@med.nyu.edu	Nolan, Anna/C-2796-2012	Nolan, Anna/0000-0002-0631-1171; Comfort, Ashley/0000-0002-8213-8374; Rom, William/0000-0002-8793-7028; Kwon, Sophia/0000-0003-3639-5107	NIH-NHLBI [K23HL084191]; NIAID [K24A1080298, NIH-R01HL057879]; NIOSH [U10-OH008243, U10-OH008242, UL1RR029893]; NYU-HHC Clinical and Translational Science Institute; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000038];  [NIEHST32ES007267]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057879, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008243, U10OH008242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER; NIOSH [3U10OH008243-05S1] Funding Source: Federal RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NYU-HHC Clinical and Translational Science Institute; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by NIEHST32ES007267 (BN), NIH-NHLBI K23HL084191(AN), NIAID (MDW) K24A1080298, NIH-R01HL057879 (MDW), and NIOSH (U10-OH008243, U10-OH008242) and UL1RR029893 (DJP). This work was also partially funded by the NYU-HHC Clinical and Translational Science Institute and is supported in part by grant UL1TR000038 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The funding agencies did not participate in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Banauch GI, 2005, CURR OPIN PULM MED, V11, P160, DOI 10.1097/01.mcp.0000151716.96241.0a; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Banauch Gisela I, 2005, Crit Care Med, V33, pS102, DOI 10.1097/01.CCM.0000151138.10586.3A; Banauch GI, 2010, CHEST, V138, P1116, DOI 10.1378/chest.10-0187; Claudio L, 2001, ENVIRON HEALTH PERSP, V109, pA528, DOI 10.2307/3454848; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Death AK, 2002, J AM COLL CARDIOL, V39, P1943, DOI 10.1016/S0735-1097(02)01907-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Kelly KJ, 2002, ARCH ENVIRON HEALTH, V57, P282, DOI 10.1080/00039890209601411; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Landrigan PJ, 2001, ENVIRON HEALTH PERSP, V109, pA514, DOI 10.1289/ehp.109-a514; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lioy PJ, 2006, ENVIRON SCI TECHNOL, V40, P6876, DOI 10.1021/es062980e; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Nolan A, 2012, CHEST, V142, P412, DOI 10.1378/chest.11-1202; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Posthumus MD, 1999, RHEUMATOLOGY, V38, P1081, DOI 10.1093/rheumatology/38.11.1081; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Prezant D, 2008, 9 11 HLTH EFFECTS FE; Prezant DJ, 2008, MT SINAI J MED, V75, P89, DOI 10.1002/msj.20028; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Rundle AG, 2005, CANCER EPIDEM BIOMAR, V14, P1899, DOI 10.1158/1055-9965.EPI-04-0860; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411; Weiden MD, 2012, EUR RESP J; Weiden MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040016; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76099	10.1371/journal.pone.0076099	http://dx.doi.org/10.1371/journal.pone.0076099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146820	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400036
J	Severino, V; Malorni, L; Cicatiello, AE; D'Esposito, V; Longobardi, S; Colacurci, N; Miraglia, N; Sannolo, N; Farina, A; Chambery, A				Severino, Valeria; Malorni, Livia; Cicatiello, Anna Emilia; D'Esposito, Vittoria; Longobardi, Salvatore; Colacurci, Nicola; Miraglia, Nadia; Sannolo, Nicola; Farina, Annarita; Chambery, Angela			An Integrated Approach Based on Multiplexed Protein Array and iTRAQ Labeling for In-Depth Identification of Pathways Associated to IVF Outcome	PLOS ONE			English	Article							HUMAN FOLLICULAR-FLUID; MATURE HUMAN FOLLICLES; LARGE GENE LISTS; PROTEOMIC ANALYSIS; POTENTIAL BIOMARKERS; MASS-SPECTROMETRY; COMPLEMENT; CYTOKINES; ACTIVATION; GENERATION	The emergence of high-throughput protein quantification methodologies has enabled the comprehensive characterization by longitudinal and cross-sectional studies of biological fluids under physiological and pathological conditions. In particular, the simultaneous investigation of cytokines and growth factors signaling pathways and their associated downstream effectors by integrated multiplexed approaches offers a powerful strategy to gain insights into biological networks and processes in living systems. A growing body of research indicates that bioactive molecules of human reproductive fluids, including human follicular fluid (hFF), may affect oocyte quality, fertilization and embryo development, thus potentially influencing the physiopathology of pregnancy-related conditions. In this work, an iTRAQ labeling strategy has been complemented with a multiplexed protein array approach to analyze hFFs with the aim to investigate biological processes and pathways related to in vitro fertilization (IVF) outcome. The iTRAQ labeling strategy lead to the quantification of 89 proteins, 30 of which were differentially expressed in hFFs with successful compared to unsuccessful IVF outcome. The targeted study, based on multiplexed antibody protein arrays, allowed the simultaneous quantification of 27 low abundance proteins, including growth factors, chemokines and cytokines endowed with pro-and anti-inflammatory activity. A significant number of differentially regulated proteins were involved in biological functions related to blood coagulation, acute phase response signaling and complement system. Overall, the present results provide an integrated overview of protein changes in hFFs associated to IVF outcome, thus improving current knowledge in reproductive medicine and fertility research.	[Severino, Valeria; Cicatiello, Anna Emilia; Chambery, Angela] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Severino, Valeria] CNR, IBB, I-80125 Naples, Italy; [Malorni, Livia; Miraglia, Nadia; Sannolo, Nicola] Univ Naples 2, Sch Med, Dept Expt Med, Sect Hyg Occupat Med & Forens Med, Naples, Italy; [D'Esposito, Vittoria] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Longobardi, Salvatore] MerckSerono SpA, Dept Med, Rome, Italy; [Colacurci, Nicola] Univ Naples 2, Dept Obstet Gynaecol & Reprod Sci, Naples, Italy; [Farina, Annarita] Univ Geneva, Biomed Prote Res Grp, Dept Bioinformat & Struct Biol, Geneva, Switzerland; [Severino, Valeria; Chambery, Angela] CIRPEB Ctr Interuniv Ric Peptidi Bioattivi, Naples, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universita della Campania Vanvitelli; University of Naples Federico II; Universita della Campania Vanvitelli; University of Geneva	Chambery, A (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy.	angela.chambery@unina2.it	Farina, Annarita/Y-7835-2019; D'Esposito, Vittoria/K-7633-2016; Malorni, Livia/AAB-9710-2022	Farina, Annarita/0000-0002-0099-4557; D'Esposito, Vittoria/0000-0002-3675-8062; Severino, Valeria/0000-0001-5275-1007; Chambery, Angela/0000-0002-5136-0941	Second University of Naples; National Insurance Institute against Work Accidents (INAIL-Istituto Nazionale Assicurazioni Infortuni sul Lavoro); MerckSerono S.p.A	Second University of Naples; National Insurance Institute against Work Accidents (INAIL-Istituto Nazionale Assicurazioni Infortuni sul Lavoro); MerckSerono S.p.A	This work was partially supported by funds from Second University of Naples, National Insurance Institute against Work Accidents (INAIL-Istituto Nazionale Assicurazioni Infortuni sul Lavoro) and MerckSerono S.p.A. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anahory T, 2002, ELECTROPHORESIS, V23, P1197, DOI 10.1002/1522-2683(200204)23:7/8<1197::AID-ELPS1197>3.0.CO;2-2; Angelucci S, 2006, BBA-PROTEINS PROTEOM, V1764, P1775, DOI 10.1016/j.bbapap.2006.09.001; Bianchi L, 2013, J PROTEOMICS, DOI [10.1016/j.jprot.2013.1002.1025, DOI 10.1016/J.JPR0T.2013.1002.1025]; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Bungay SD, 2006, B MATH BIOL, V68, P2283, DOI 10.1007/s11538-006-9115-7; Buscher U, 1999, HUM REPROD, V14, P162, DOI 10.1093/humrep/14.1.162; Celis JE, 2005, MOL CELL PROTEOMICS, V4, P492, DOI 10.1074/mcp.M500030-MCP200; Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9; de Agostini AI, 2008, J BIOL CHEM, V283, P28115, DOI 10.1074/jbc.M805338200; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Farina A, 2011, PROTEOMICS, V11, P3972, DOI 10.1002/pmic.201100063; FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225; Gadher SJ, 2009, EXPERT REV PROTEOMIC, V6, P591, DOI [10.1586/epr.09.79, 10.1586/EPR.09.79]; Gentry PA, 2000, FERTIL STERIL, V73, P848, DOI 10.1016/S0015-0282(99)00635-4; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; Gluck F, 2013, J PROTEOMICS, V79, P146, DOI 10.1016/j.jprot.2012.12.012; GOROSPE WC, 1993, BIOL REPROD, V48, P538, DOI 10.1095/biolreprod48.3.538; Hammadeh ME, 2002, AM J REPROD IMMUNOL, V47, P82, DOI 10.1034/j.1600-0897.2002.1o024.x; Hanrieder J, 2008, J PROTEOME RES, V7, P443, DOI 10.1021/pr070277z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jarkovska K, 2010, J PROTEOME RES, V9, P1289, DOI 10.1021/pr900802u; Kim YS, 2006, PROTEOMICS, V6, P3445, DOI 10.1002/pmic.200500775; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181; Kolialexi A, 2007, PROTEOM CLIN APPL, V1, P853, DOI 10.1002/prca.200700040; Kushnir MM, 2012, J PROTEOME RES, V11, P5090, DOI 10.1021/pr300535g; Ledee N, 2013, HUM REPROD, V28, P406, DOI 10.1093/humrep/des354; Lee HC, 2005, J KOREAN MED SCI, V20, P456, DOI 10.3346/jkms.2005.20.3.456; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Li HB, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-146; Liu AX, 2007, BBA-GEN SUBJECTS, V1770, P29, DOI 10.1016/j.bbagen.2006.06.017; Melton L, 2004, NATURE, V429, P101, DOI 10.1038/429101a; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Overgaard Anne Julie, 2010, Clin Proteomics, V6, P105; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rocco M, 2011, J PROTEOME RES, V10, P4703, DOI 10.1021/pr200511f; Sarapik A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/606459; Schweigert FJ, 2006, HUM REPROD, V21, P2960, DOI 10.1093/humrep/del257; Severino Valeria, 2013, Methods Mol Biol, V1002, P37, DOI 10.1007/978-1-62703-360-2_4; Shimada H, 2001, BIOL REPROD, V64, P1739, DOI 10.1095/biolreprod64.6.1739; Terranova PF, 1997, AM J REPROD IMMUNOL, V37, P50; Terranova PF, 1997, DOMEST ANIM ENDOCRIN, V14, P1, DOI 10.1016/S0739-7240(96)00094-X; Twigt J, 2012, PROTEOMICS, V12, P1463, DOI 10.1002/pmic.201100240	47	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77303	10.1371/journal.pone.0077303	http://dx.doi.org/10.1371/journal.pone.0077303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146976	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400100
J	Fozouni, N; Chopp, M; Nejad-Davarani, SP; Zhang, ZG; Lehman, NL; Gu, S; Ueno, Y; Lu, M; Ding, GL; Li, L; Hu, JN; Bagher-Ebadian, H; Hearshen, D; Jiang, Q				Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Lehman, Norman L.; Gu, Steven; Ueno, Yuji; Lu, Mei; Ding, Guangliang; Li, Lian; Hu, Jiani; Bagher-Ebadian, Hassan; Hearshen, David; Jiang, Quan			Characterizing Brain Structures and Remodeling after TBI Based on Information Content, Diffusion Entropy	PLOS ONE			English	Article							WATER DIFFUSION; NERVOUS-SYSTEM; TENSOR; MRI; ANISOTROPY; COEFFICIENT; MODEL; RECOVERY; TISSUES; INDEXES	Background: To overcome the limitations of conventional diffusion tensor magnetic resonance imaging resulting from the assumption of a Gaussian diffusion model for characterizing voxels containing multiple axonal orientations, Shannon's entropy was employed to evaluate white matter structure in human brain and in brain remodeling after traumatic brain injury (TBI) in a rat. Methods: Thirteen healthy subjects were investigated using a Q-ball based DTI data sampling scheme. FA and entropy values were measured in white matter bundles, white matter fiber crossing areas, different gray matter (GM) regions and cerebrospinal fluid (CSF). Axonal densities' from the same regions of interest (ROIs) were evaluated in Bielschowsky and Luxol fast blue stained autopsy (n = 30) brain sections by light microscopy. As a case demonstration, a Wistar rat subjected to TBI and treated with bone marrow stromal cells (MSC) 1 week after TBI was employed to illustrate the superior ability of entropy over FA in detecting reorganized crossing axonal bundles as confirmed by histological analysis with Bielschowsky and Luxol fast blue staining. Results: Unlike FA, entropy was less affected by axonal orientation and more affected by axonal density. A significant agreement (r = 0.91) was detected between entropy values from in vivo human brain and histologically measured axonal density from post mortum from the same brain structures. The MSC treated TBI rat demonstrated that the entropy approach is superior to FA in detecting axonal remodeling after injury. Compared with FA, entropy detected new axonal remodeling regions with crossing axons, confirmed with immunohistological staining. Conclusions: Entropy measurement is more effective in distinguishing axonal remodeling after injury, when compared with FA. Entropy is also more sensitive to axonal density than axonal orientation, and thus may provide a more accurate reflection of axonal changes that occur in neurological injury and disease.	[Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Gu, Steven; Ueno, Yuji; Ding, Guangliang; Li, Lian; Bagher-Ebadian, Hassan; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Lehman, Norman L.] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Hearshen, David] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Hu, Jiani] Harper Hospita, MR Ctr, Detroit, MI USA; [Fozouni, Niloufar; Chopp, Michael; Zhang, Zheng Gang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	zhang, zheng/HCH-9684-2022; Lehman, Norman L/A-7351-2015; Ueno, Yuji/ABB-2492-2020; Nejad-Davarani, Siamak/AAH-8399-2021	Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689; Li, Lian/0000-0003-0097-1184; Lehman, Norman/0000-0001-8394-2607	National Institutes of Health [RO1 NS64134, RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants RO1 NS64134, RO1 AG037506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, BIOESSAYS, V30, P1235, DOI 10.1002/bies.20851; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bastin ME, 1999, NEUROREPORT, V10, P1385, DOI 10.1097/00001756-199905140-00001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chen Y, 2005, LECT NOTES COMPUT SC, V3565, P246; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Horsfield MA, 1998, J NEUROL NEUROSUR PS, V64, pS80; Inglis BA, 1999, AM J NEURORADIOL, V20, P713; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Metwalli Nader S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2260; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Shannon CE, 1997, M D COMPUT, V14, P306; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wieshmann UC, 1999, NEUROIMAGE, V10, P225, DOI 10.1006/nimg.1999.0456; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zivadinov R, 2008, J NEUROL, V255, P61, DOI 10.1007/s00415-008-1009-1	54	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76343	10.1371/journal.pone.0076343	http://dx.doi.org/10.1371/journal.pone.0076343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143186	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100021
J	Shen, F; Huang, W; Qi, JH; Yuan, BF; Huang, JT; Zhou, X; Feng, YQ; Liu, YJ; Liu, SM				Shen, Fan; Huang, Wei; Qi, Jia-Hui; Yuan, Bi-Feng; Huang, Jing-Tao; Zhou, Xin; Feng, Yu-Qi; Liu, Ying-Juan; Liu, Song-Mei			Association of 5-Methylcytosine and 5-Hydroxymethylcytosine with Mitochondrial DNA Content and Clinical and Biochemical Parameters in Hepatocellular Carcinoma	PLOS ONE			English	Article							COPY NUMBER; GENOME INSTABILITY; COLORECTAL ADENOMA; TET PROTEINS; METHYLATION; CANCER; DEPLETION; HYPOMETHYLATION; RISK; PROGRESSION	Increasing epidemiological evidence has indicated that inherited variations of mitochondrial DNA (mtDNA) copy number affect the genetic susceptibility of many malignancies in a tumour-specific manner and that DNA methylation also plays an important role in controlling gene expression during the differentiation and development of hepatocellular carcinoma (HCC). Our previous study demonstrated that HCC tissues showed a lower 5-hydroxymethylcytosine (5-hmC) content when compared to tumour-adjacent tissues, but the relationship among 5-hmC, 5-methylcytosine (5-mC) and mtDNA content in HCC patients is still unknown. This study aimed to clarify the correlation among mtDNA content, 5-mC and 5-hmC by quantitative real-time PCR and liquid chromatography tandem mass spectrometry analysis. We demonstrated that 5-hmC correlated with tumour size [odds ratio (OR) 0.847, 95% confidence interval (CI) 0.746-0.962, P = 0.011], and HCC patients with a tumour size >= 5.0 cm showed a lower 5-hmC content and higher levels of fasting plasma aspartate aminotransferase, the ratio of alanine amiotransferase to aspartate aminotransferase, c-glutamyltransferase, alpha-fetoprotein than those with a tumour size <5 cm (all P<0.05). We further revealed that the mtDNA content of HCC tumour tissues was 225.97(105.42, 430.54) [median (25th Percentile, 75th Percentile)] and was negatively correlated with 5-mC content (P = 0.035), but not 5-hmC content, in genomic DNA from HCC tumour tissues.	[Shen, Fan; Qi, Jia-Hui; Huang, Jing-Tao; Zhou, Xin; Liu, Ying-Juan; Liu, Song-Mei] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Med Res Ctr, Wuhan 430072, Hubei, Peoples R China; [Huang, Wei; Yuan, Bi-Feng; Feng, Yu-Qi] Wuhan Univ, Dept Chem, Key Lab Analyt Chem Biol & Med, Minist Educ, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Liu, SM (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Med Res Ctr, Wuhan 430072, Hubei, Peoples R China.	liu_sm@126.com	Yuan, Bi-Feng/K-5803-2013; Feng, Yu-Qi/H-1479-2011	Yuan, Bi-Feng/0000-0001-5223-4659; Feng, Yu-Qi/0000-0003-1107-5385; Shen, Fan/0000-0001-7432-8891	National Basic Research Program of China (973 Program) [2012CB720600, 2012CB720601, 2012CB720605]; National Natural Science Foundation of China [81271919, 91217309, 21205091, 21228501]; Fundamental Research Funds for the Central Universities [2012303020209]; Natural Science Foundation of Hubei Province [2012FFB04405]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The work described in this paper was supported by the National Basic Research Program of China (973 Program) (2012CB720600, 2012CB720601, 2012CB720605), the National Natural Science Foundation of China (81271919, 91217309, 21205091, 21228501), the Fundamental Research Funds for the Central Universities (2012303020209) and the Natural Science Foundation of Hubei Province (2012FFB04405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A, 2007, HUM REPROD, V22, P1585, DOI 10.1093/humrep/dem030; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bai RK, 2011, J ONCOL, V2011, DOI 10.1155/2011/496189; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; Chang CM, 2011, LAB CHIP, V11, P2693, DOI 10.1039/c1lc20317g; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng S, 2012, MOL MED REP, V6, P125, DOI 10.3892/mmr.2012.870; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hann HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047687; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; Liu CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062828; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019; Navratil M, 2007, ANAL CHEM, V79, P7691, DOI 10.1021/ac0709192; Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; THOMAS GA, 1992, CARCINOGENESIS, V13, P1039, DOI 10.1093/carcin/13.6.1039; Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68; Villa AM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.046001; Wen CP, 2012, J NATL CANCER I, V104, P1599, DOI 10.1093/jnci/djs372; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002; Yamauchi A, 2005, GENETICS, V171, P1387, DOI 10.1534/genetics.104.036350; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2009, EUR J CANCER PREV, V18, P445, DOI 10.1097/CEJ.0b013e32832f9bd6; Zhao SY, 2011, CANCER SCI, V102, P1553, DOI 10.1111/j.1349-7006.2011.01968.x; Zheng SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031322; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	52	10	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76967	10.1371/journal.pone.0076967	http://dx.doi.org/10.1371/journal.pone.0076967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143196	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100031
J	Sole, M; Lenoir, M; Durfort, M; Lopez-Bejar, M; Lombarte, A; Andre, M				Sole, Marta; Lenoir, Marc; Durfort, Merce; Lopez-Bejar, Manel; Lombarte, Antoni; Andre, Michel			Ultrastructural Damage of Loligo vulgaris and Illex coindetii statocysts after Low Frequency Sound Exposure	PLOS ONE			English	Article							HIGH-INTENSITY; EVOKED-POTENTIALS; THRESHOLD SHIFTS; NOISE; FISH; HEARING; CEPHALOPODS; SONAR; EAR; INVERTEBRATE	There is a considerable lack of information concerning marine invertebrate sensitivity to sound exposure. However, recent findings on cuttlefish and octopi showed that exposure to artificial noise had a direct consequence on the functionality and physiology of the statocysts, sensory organs, which are responsible for their equilibrium and movements in the water column. Owing to a lack of available data on deep diving cephalopod species, we conducted a noise exposure comparative experiment on one Mediterranean squid, Illex coindetii, and on the European squid Loligo vulgaris. Scanning electron microscopy (SEM) revealed similar injuries in the inner structure of the statocysts, as those found in cuttlefish and octopi. In addition to the ultrastructural description of the lesions, we publish here the first images of the crista-cupula system and inner statocyst cavity of I. coindetii.	[Sole, Marta; Andre, Michel] Tech Univ Catalonia, Lab Appl Bioacoust, Barcelona, Spain; [Lenoir, Marc] Inst Neurosci Montpellier, INSERM U1051, Montpellier, France; [Durfort, Merce] Univ Barcelona, Fac Biol, Dept Cellular Biol, Barcelona, Spain; [Lopez-Bejar, Manel] Univ Autonoma Barcelona, Fac Vet Sci, Dept Anim Hlth & Anat, Bellaterra, Cerdanyola Del, Spain; [Lombarte, Antoni] Marine Sci Inst ICM CMIMA CSIC, Renewable Marine Resources Dept, Barcelona, Spain	Universitat Politecnica de Catalunya; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Andre, M (corresponding author), Tech Univ Catalonia, Lab Appl Bioacoust, Barcelona, Spain.	michel.andre@upc.edu	Lopez-Bejar, Manel A/E-8200-2012; Lopez-Bejar, Manel/S-2429-2019; Lombarte, Antoni/D-3142-2013	Lopez-Bejar, Manel A/0000-0001-9490-6126; Lopez-Bejar, Manel/0000-0001-9490-6126; Lombarte, Antoni/0000-0001-5215-4587; Andre, Michel/0000-0002-0091-7279; DURFORT, M./0000-0003-3640-9580; Sole, Marta/0000-0002-7704-5157	Spanish Ministry of the Environment [083/SDGTB/2007]	Spanish Ministry of the Environment(Spanish Government)	The Spanish Ministry of the Environment kindly funded this work (contract 083/SDGTB/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2011, FRONT ECOL ENVIRON, V9, P489, DOI 10.1890/100124; Andre M, 2009, NUCL INSTRUM METH A, V602, P262, DOI 10.1016/j.nima.2008.12.223; BIGELOW KA, 1992, MAR ECOL PROG SER, V82, P31, DOI 10.3354/meps082031; Budelmann B.U., 1990, P421; Budelmann B.-U., 1988, P757; BUDELMANN BU, 1987, PHILOS T R SOC B, V315, P305, DOI 10.1098/rstb.1987.0010; BUDELMANN BU, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P141; Budelmann BU, 1996, MICROSCOPIC ANATOMY, P119; Casper BM, 2013, COMP BIOCHEM PHYS A, V166, P352, DOI 10.1016/j.cbpa.2013.07.008; COLMERS WF, 1984, CELL TISSUE RES, V236, P505; Edren SMC, 2010, MAR MAMMAL SCI, V26, P614, DOI 10.1111/j.1748-7692.2009.00364.x; Enger P.S., 1981, HEARING SOUND COMMUN, P243, DOI DOI 10.1007/978-1-4615-7186-5_12; Fewtrell JL, 2012, MAR POLLUT BULL, V64, P984, DOI 10.1016/j.marpolbul.2012.02.009; Finneran JJ, 2007, J ACOUST SOC AM, V122, P1249, DOI 10.1121/1.2749447; Guerra A, 2004, REV RECORDS GIANT SQ, pCC 29; GUERRA A, 2004, INVESTIGACION CIENCI, V334, P35; Guerra A, 2011, BIOL CONSERV, V144, P1989, DOI 10.1016/j.biocon.2011.04.021; Guerra Angel, 1992, FAUNA IBERICA, VI; HAMERNIK RP, 1994, J ACOUST SOC AM, V95, P444, DOI 10.1121/1.408338; Hastings MC, 1996, J ACOUST SOC AM, V99, P1759, DOI 10.1121/1.414699; Hastings MC, 1995, PROCEEDINGS OF INTER-NOISE 95 - THE 1995 INTERNATIONAL CONGRESS ON NOISE CONTROL ENGINEERING, VOLS 1 AND 2, P979; Henderson Donald, 2008, V31, P195; Hu MY, 2009, COMP BIOCHEM PHYS A, V153, P278, DOI 10.1016/j.cbpa.2009.02.040; Kane AS, 2010, J FISH BIOL, V76, P1825, DOI 10.1111/j.1095-8649.2010.02626.x; LAGARDERE JP, 1982, MAR BIOL, V71, P177, DOI 10.1007/BF00394627; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; Lovell JM, 2006, J EXP BIOL, V209, P2480, DOI 10.1242/jeb.02211; Lovell JM, 2005, COMP BIOCHEM PHYS A, V140, P89, DOI 10.1016/j.cbpb.2004.11.003; Lucke K, 2009, J ACOUST SOC AM, V125, P4060, DOI 10.1121/1.3117443; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McCauley RD, 2003, J ACOUST SOC AM, V113, P638, DOI 10.1121/1.1527962; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Nachtigall PE, 2004, MAR MAMMAL SCI, V20, P673, DOI 10.1111/j.1748-7692.2004.tb01187.x; PACKARD A, 1990, J COMP PHYSIOL A, V166, P501; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper AN, 2005, J ACOUST SOC AM, V117, P3958, DOI 10.1121/1.1904386; Popper AN, 2007, J ACOUST SOC AM, V122, P623, DOI 10.1121/1.2735115; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Puel JL, 2002, ADV OTO-RHINO-LARYNG, V59, P124; REGNAULT M, 1983, MAR ECOL PROG SER, V11, P71; Schlundt CE, 2006, J ACOUST SOC AM, V120, P3227; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Sole M, 2013, DEEP-SEA RES PT II, V95, P160, DOI 10.1016/j.dsr2.2012.10.006; STEPHENS PR, 1982, J ZOOL, V197, P241, DOI 10.1111/jzo.1982.197.2.241; Williamson R, 1995, CEPHALOPOD NEUROBIOL, P542; Williamson R, 2007, PHILOS T R SOC B, V362, P473, DOI 10.1098/rstb.2006.1975	48	27	28	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78825	10.1371/journal.pone.0078825	http://dx.doi.org/10.1371/journal.pone.0078825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143265	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100104
J	Thomas, MA; Song, R; Demberg, T; Vargas-Inchaustegui, DA; Venzon, D; Robert-Guroff, M				Thomas, Michael A.; Song, Rui; Demberg, Thorsten; Vargas-Inchaustegui, Diego A.; Venzon, David; Robert-Guroff, Marjorie			Effects of the Deletion of Early Region 4 (E4) Open Reading Frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on Virus-Host Cell Interaction, Transgene Expression, and Immunogenicity of Replicating Adenovirus HIV Vaccine Vectors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIGEN PRESENTATION; CYCLIN-E; DNA-REPLICATION; RHESUS MACAQUES; DENDRITIC CELLS; T-LYMPHOCYTES; GENE-PRODUCTS; RANGE MUTANT; PROTECTION	The global health burden engendered by human immunodeficiency virus (HIV)-induced acquired immunodeficiency syndrome (AIDS) is a sobering reminder of the pressing need for a preventative vaccine. In non-human primate models replicating adenovirus (Ad)-HIV/SIV recombinant vaccine vectors have been shown to stimulate potent immune responses culminating in protection against challenge exposures. Nonetheless, an increase in the transgene carrying capacity of these Ad vectors, currently limited to approximately 3000 base pairs, would greatly enhance their utility. Using a replicating, E3-deleted Ad type 5 host range mutant (Ad5 hr) encoding full-length single-chain HIV(BaL)gp120 linked to the D1 and D2 domains of rhesus macaque CD4 (rhFLSC) we systematically deleted the genes encoding early region 4 open reading frame 1 (E4orf1) through E4orf4. All the Ad-rhFLSC vectors produced similar levels of viral progeny. Cell cycle analysis of infected human and monkey cells revealed no differences in virus-host interaction. The parental and E4-deleted viruses expressed comparable levels of the transgene with kinetics similar to Ad late proteins. Similar levels of cellular immune responses and transgene-specific antibodies were elicited in vaccinated mice. However, differences in recognition of Ad proteins and induced antibody subtypes were observed, suggesting that the E4 gene products might modulate antibody responses by as yet unknown mechanisms. In short, we have improved the transgene carrying capacity by one thousand base pairs while preserving the replicability, levels of transgene expression, and immunogenicity critical to these vaccine vectors. This additional space allows for flexibility in vaccine design that could not be obtained with the current vector and as such should facilitate the goal of improving vaccine efficacy. To the best of our knowledge, this is the first report describing the effects of these E4 deletions on transgene expression and immunogenicity in a replicating Ad vector.	[Thomas, Michael A.; Song, Rui; Demberg, Thorsten; Vargas-Inchaustegui, Diego A.; Robert-Guroff, Marjorie] NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Robert-Guroff, M (corresponding author), NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD 20892 USA.	guroffm@mail.nih.gov			National Institutes of Health (NIH), National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011063] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RLP, 1967, J BIOL CHEM, V242, P1314; Alexander J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031177; Bennett EM, 1999, J IMMUNOL, V162, P5049; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; BRAITHWAITE AW, 1981, J VIROL, V39, P331, DOI 10.1128/JVI.39.2.331-340.1981; BRIDGE E, 1989, J VIROL, V63, P631, DOI 10.1128/JVI.63.2.631-638.1989; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; CHANDA PK, 1990, VIROLOGY, V175, P535, DOI 10.1016/0042-6822(90)90438-W; Chang SK, 2002, MOL CELLS, V14, P130; CHENG SM, 1992, J VIROL, V66, P6721, DOI 10.1128/JVI.66.11.6721-6727.1992; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; GaherySegard H, 1997, EUR J IMMUNOL, V27, P653, DOI 10.1002/eji.1830270312; Gurwith M, 2013, LANCET INFECT DIS; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hidajat R, 2010, VACCINE, V28, P3963, DOI 10.1016/j.vaccine.2010.03.046; HUANG MM, 1989, J VIROL, V63, P2605, DOI 10.1128/JVI.63.6.2605-2615.1989; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; Kaplan JM, 1999, J VIROL, V73, P4489, DOI 10.1128/JVI.73.5.4489-4492.1999; LEMAY P, 1984, J GEN VIROL, V65, P1419, DOI 10.1099/0022-1317-65-8-1419; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Lusky M, 1999, J VIROL, V73, P8308, DOI 10.1128/JVI.73.10.8308-8319.1999; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Medghalchi S, 1997, VIROLOGY, V236, P8, DOI 10.1006/viro.1997.8737; MURRAY JD, 1981, J GEN VIROL, V57, P221, DOI 10.1099/0022-1317-57-1-221; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Parreno M, 2001, ONCOGENE, V20, P4793, DOI 10.1038/sj.onc.1204644; Patterson LJ, 2008, EXPERT OPIN BIOL TH, V8, P1347, DOI [10.1517/14712598.8.9.1347, 10.1517/14712598.8.9.1347 ]; Patterson LJ, 2012, CLIN VACCINE IMMUNOL, V19, P629, DOI 10.1128/CVI.00010-12; Patterson LJ, 2002, VIROLOGY, V292, P107, DOI 10.1006/viro.2001.1248; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Peng B, 2005, J VIROL, V79, P10200, DOI 10.1128/JVI.79.16.10200-10209.2005; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Robert-Guroff M, 1998, J VIROL, V72, P10275, DOI 10.1128/JVI.72.12.10275-10280.1998; Samstag Y, 2003, ADV ENZYME REGUL, V43, P197, DOI 10.1016/S0065-2571(02)00031-6; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Shepard RN, 2004, J VIROL, V78, P9924, DOI 10.1128/JVI.78.18.9924-9935.2004; SHEPHERD SE, 1993, J VIROL, V67, P2944, DOI 10.1128/JVI.67.5.2944-2949.1993; Shurin GV, 2005, J IMMUNOL, V174, P3394, DOI 10.4049/jimmunol.174.6.3394; Sohn SY, 2012, J VIROL, V86, P9656, DOI 10.1128/JVI.01273-12; Song WX, 1997, INT IMMUNOL, V9, P1709, DOI 10.1093/intimm/9.11.1709; Spitkovsky D, 1996, ONCOGENE, V12, P2549; Thomas MA, 2009, J VIROL, V83, P2406, DOI 10.1128/JVI.01972-08; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zheng X, 2008, J VIROL, V82, P3415, DOI 10.1128/JVI.01708-07	54	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76344	10.1371/journal.pone.0076344	http://dx.doi.org/10.1371/journal.pone.0076344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143187	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100022
J	Warne, RW; Kardon, A; Crespi, EJ				Warne, Robin W.; Kardon, Adam; Crespi, Erica J.			Physiological, Behavioral and Maternal Factors That Contribute to Size Variation in Larval Amphibian Populations	PLOS ONE			English	Article							FROG RANA-SYLVATICA; CHEMICAL INTERFERENCE COMPETITION; WOOD FROG; LIFE-HISTORY; EGG SIZE; INDIVIDUAL-DIFFERENCES; ADAPTIVE PLASTICITY; ANIMAL PERSONALITY; STRESS HORMONES; GROWTH-RATE	Size variance among similarly aged individuals within populations is a pattern common to many organisms that is a result of interactions between intrinsic and extrinsic traits of individuals. While genetic and maternal effects, as well as physiological and behavioral traits have been shown to contribute to size variation in animal populations, teasing apart the influence of such factors on individual growth rates remain a challenge. Furthermore, tracing the effects of these interactions across life stages and in shaping adult phenotypes also requires further exploration. In this study we investigated the relationship between genetics, hatching patterns, behaviors, neuroendocrine stress axis activity and variance in growth and metamorphosis among same-aged larval amphibians. Through parallel experiments we found that in the absence of conspecific interactions, hatch time and to a lesser extent egg clutch identity (i.e. genetics and maternal effects) influenced the propensity for growth and development in individual tadpoles and determined metamorphic traits. Within experimental groups we found that variance in growth rates was associated with size-dependent foraging behaviors and responses to food restriction. We also found an inverse relationship between glucocorticoid (GC) hormone levels and body mass and developmental stage among group-reared tadpoles, which suggests that GC expression plays a role in regulating differing within-population growth trajectories in response to density-dependent conditions. Taken together these findings suggest that factors that influence hatching conditions can have long-term effects on growth and development. These results also raise compelling questions regarding the extent to which maternal and genetic factors influence physiological and behavioral profiles in amphibians.	[Warne, Robin W.; Kardon, Adam; Crespi, Erica J.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA	Vassar College	Warne, RW (corresponding author), So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA.	rwarne@siu.edu			National Science Foundation [IOS-0818212]; Vassar College Undergraduate Research Summer Institute	National Science Foundation(National Science Foundation (NSF)); Vassar College Undergraduate Research Summer Institute	This research was funded by a National Science Foundation grant IOS-0818212 and the Vassar College Undergraduate Research Summer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph EF, 1931, BIOL BULL-US, V61, P350, DOI 10.2307/1536953; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Belden LK, 2007, PHYSIOL BIOCHEM ZOOL, V80, P444, DOI 10.1086/518375; Bernardo J, 1996, AM ZOOL, V36, P216; BERVEN KA, 1982, OECOLOGIA, V52, P360, DOI 10.1007/BF00367960; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; BIESTERFELDT JM, 1993, COPEIA, P688; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; BREDEN F, 1982, ECOLOGY, V63, P1682, DOI 10.2307/1940110; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Chambers DL, 2011, COPEIA, P530, DOI 10.1643/CP-09-180; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Crespi EJ, 2005, COMP BIOCHEM PHYS A, V141, P381, DOI 10.1016/j.cbpb.2004.12.007; Crespi EJ, 2004, HORM BEHAV, V46, P399, DOI 10.1016/j.yhbeh.2004.03.011; Crespi EJ, 2013, INTEGRATIVE COMP BIO; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; CRUMP ML, 1981, OECOLOGIA, V49, P167, DOI 10.1007/BF00349184; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; Denver RJ, 2009, GEN COMP ENDOCRINOLO; Denver RJ, 2006, NEOREVIEWS, V7, pe183, DOI [DOI 10.1542/NEO.7-4-E183, 10.1542/NEO.7-4-E183]; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; Glennemeier KA, 2002, J EXP ZOOL, V292, P32, DOI 10.1002/jez.1140; Gosner K. L., 1960, Herpetologica, V16, P183; Haenel GJ, 2002, OIKOS, V96, P70, DOI 10.1034/j.1600-0706.2002.10915.x; Hayes TB, 1997, AM ZOOL, V37, P185; HOKIT DG, 1994, EVOLUTION, V48, P1383, DOI 10.1111/j.1558-5646.1994.tb05322.x; Hu F, 2008, ENDOCRINOLOGY, V149, P5470, DOI 10.1210/en.2008-0767; Huss M, 2008, OECOLOGIA, V158, P249, DOI 10.1007/s00442-008-1140-9; Huss M, 2010, OIKOS, V119, P384, DOI 10.1111/j.1600-0706.2009.17897.x; JASIENSKI M, 1988, OECOLOGIA, V77, P407, DOI 10.1007/BF00378052; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koprivnikar J, 2012, P ROY SOC B-BIOL SCI, V279, P1544, DOI 10.1098/rspb.2011.2156; Laurila A, 2002, EVOLUTION, V56, P617; Ledon-Rettig CC, 2009, J EXP BIOL, V212, P3743, DOI 10.1242/jeb.034066; McClure KV, 2009, ACTA HERPETOL, V4, P103; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Pakkasmaa S, 2003, OIKOS, V100, P55, DOI 10.1034/j.1600-0706.2003.11815.x; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; PETRANKA JW, 1989, COPEIA, P921, DOI 10.2307/1445978; Pfister CA, 2002, ECOLOGY, V83, P59; Reeves B., 2013, ENVIRON BEHAV, V20, P1; Relyea RA, 2002, ECOL MONOGR, V72, P523, DOI 10.1890/0012-9615(2002)072[0523:CIPITC]2.0.CO;2; Rot-Nikcevic I, 2006, BEHAV ECOL SOCIOBIOL, V60, P19, DOI 10.1007/s00265-005-0133-5; Rot-Nikcevic I, 2005, FUNCT ECOL, V19, P1008, DOI 10.1111/j.1365-2435.2005.01051.x; Saino N, 2001, J AVIAN BIOL, V32, P263, DOI 10.1111/j.0908-8857.2001.320309.x; SAS Institute, 1999, SAS STAT US GUID VER; Schmidt BR, 2012, ECOLOGY, V93, P657, DOI 10.1890/11-0892.1; SEMLITSCH RD, 1994, COPEIA, P406; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; Spear L, 1994, J ANIM ECOL, P283; TRAVIS J, 1984, ECOLOGY, V65, P1155, DOI 10.2307/1938323; UCHMANSKI J, 1985, PHILOS T ROY SOC B, V310, P1, DOI 10.1098/rstb.1985.0099; Vasconcelos D, 2004, J HERPETOL, V38, P551, DOI 10.1670/157-03A; WALDMAN B, 1984, BEHAV ECOL SOCIOBIOL, V14, P171, DOI 10.1007/BF00299616; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WERNER EE, 1992, COPEIA, P26, DOI 10.2307/1446532; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson ADM, 2012, TRENDS ECOL EVOL, V27, P529, DOI 10.1016/j.tree.2012.07.003	65	13	13	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76364	10.1371/journal.pone.0076364	http://dx.doi.org/10.1371/journal.pone.0076364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143188	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100023
J	Bot, AM; Debski, KJ; Lukasiuk, K				Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna			Alterations in miRNA Levels in the Dentate Gyrus in Epileptic Rats	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MICROARRAY ANALYSIS; EXPRESSION PROFILE; NEURONAL-ACTIVITY; MICRORNAS; EPILEPTOGENESIS; NEUROPROTECTION; BIOINFORMATICS; PLASTICITY; CYTOKINES	The aim of this study was to characterize changes in miRNA expression in the epileptic dentate gyrus. Status epilepticus evoked by amygdala stimulation was used to induce epilepsy in rats. The dentate gyri were isolated at 7 d, 14 d, 30 d and 90 d after stimulation (n=5). Sham-operated time-matched controls were prepared for each time point (n=5). The miRNA expression was evaluated using Exiqon microarrays. Additionally, mRNA from the same animals was profiled using Affymetrix microarrays. We detected miRNA expression signatures that differentiate between control and epileptic animals. Significant changes in miRNA expression between stimulated and sham operated animals were observed at 7 and 30 d following stimulation. Moreover, we found that there are ensembles of miRNAs that change expression levels over time. Analysis of the mRNA expression from the same animals revealed that the expression of several mRNAs that are potential targets for miRNA with altered expression level is regulated in the expected direction. The functional characterization of miRNAs and their potential mRNA targets indicate that miRNA can participate in several molecular events that occur in epileptic tissue, including immune response and neuronal plasticity. This is the first report on changes in the expression of miRNA and the potential functional impact of these changes in the dentate gyrus of epileptic animals. Complex changes in the expression of miRNAs suggest an important role for miRNA in the molecular mechanisms of epilepsy.	[Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Lukasiuk, K (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland.	k.lukasiuk@nencki.gov.pl	Lukasiuk, Katarzyna/F-4636-2010	Bot, Anna/0000-0003-1811-3647; Lukasiuk, Katarzyna/0000-0002-1582-0920; Debski, Konrad/0000-0001-5949-9211	National Research Centre [2011/01/M/NZ3/02139]; Ministry of Science and Education [DNP/N119/ESF-EuroEPINOMICS/2012]	National Research Centre(National Research Centre (NRC)); Ministry of Science and Education	This work was supported by National Research Centre grant 2011/01/M/NZ3/02139 and Ministry of Science and Education grant DNP/N119/ESF-EuroEPINOMICS/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zeid A, 2013, GENET TESTS MOL BIOM, V15, P807; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Banerjee P. N., 2008, EPILEPSY COMPREHENSI, P45; Banigan MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048814; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Futschik M., 2012, MFUZZ SOFT CLUSTERIN; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorter JA, 2007, EPILEPSIA, V48, P53, DOI 10.1111/j.1528-1167.2007.01290.x; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Guzik-Kornacka A, 2011, ACTA NEUROBIOL EXP, V71, P193; Hansen KF, 2013, BRAIN STRUCT FUNCT, V218, P817, DOI 10.1007/s00429-012-0431-4; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Houser CR, 2012, EPILEPSIA, V53, P67, DOI 10.1111/j.1528-1167.2012.03477.x; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Lehtimaki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X; Leite JP, 2005, EPILEPSIA, V46, P134, DOI 10.1111/j.1528-1167.2005.01021.x; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Malan-Muller S, 2013, MOL NEUROBIOL, V47, P726, DOI 10.1007/s12035-012-8374-6; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; R Core Team, 2012, LANG ENV STAT COMP; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Sakar D., 2008, LATTICE MULTIVARIATE; Sano T, 2012, DROSOPHILA INF SERV, V3, pe287; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schouten M, 2013, NEUROSCIENCE, V241, P188, DOI 10.1016/j.neuroscience.2013.02.065; Scott HL, 2012, EUR J NEUROSCI, V36, P2941, DOI 10.1111/j.1460-9568.2012.08220.x; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sisodiya S, 2007, NAT CLIN PRACT NEURO, V3, P320, DOI 10.1038/ncpneuro0521; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Wang RY, 2013, HIPPOCAMPUS, V23, P625, DOI 10.1002/hipo.22123; Wang WY, 2012, LEARN MEMORY, V19, P359, DOI 10.1101/lm.026492.112; Wang Y, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/276540; Warnes GR, 2012, GPLOTS VARIOUS R PRO; Wei T, 2012, CORRPLOT VISUALIZATI; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164	66	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76051	10.1371/journal.pone.0076051	http://dx.doi.org/10.1371/journal.pone.0076051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146813	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400035
J	Glotzbach, B; Reinwarth, M; Weber, N; Fabritz, S; Tomaszowski, M; Fittler, H; Christmann, A; Avrutina, O; Kolmar, H				Glotzbach, Bernhard; Reinwarth, Michael; Weber, Niklas; Fabritz, Sebastian; Tomaszowski, Michael; Fittler, Heiko; Christmann, Andreas; Avrutina, Olga; Kolmar, Harald			Combinatorial Optimization of Cystine-Knot Peptides towards High-Affinity Inhibitors of Human Matriptase-1	PLOS ONE			English	Article							ELATERIUM TRYPSIN-INHIBITOR; FACTOR ACTIVATOR INHIBITOR-1; SERINE-PROTEASE MATRIPTASE; YEAST SURFACE DISPLAY; MOMORDICA-COCHINCHINENSIS; ALPHA(V)BETA(3) INTEGRIN; PLASMINOGEN ACTIVATION; ENVELOPE GLYCOPROTEIN; PLATELET-AGGREGATION; SELECTIVE INHIBITORS	Cystine-knot miniproteins define a class of bioactive molecules with several thousand natural members. Their eponymous motif comprises a rigid structured core formed by six disulfide-connected cysteine residues, which accounts for its exceptional stability towards thermic or proteolytic degradation. Since they display a remarkable sequence tolerance within their disulfide-connected loops, these molecules are considered promising frameworks for peptide-based pharmaceuticals. Natural open-chain cystine-knot trypsin inhibitors of the MCoTI (Momordica cochinchinensis trypsin inhibitor) and SOTI (Spinacia oleracea trypsin inhibitor) families served as starting points for the generation of inhibitors of matriptase-1, a type II transmembrane serine protease with possible clinical relevance in cancer and arthritic therapy. Yeast surface-displayed libraries of miniproteins were used to select unique and potent matriptase-1 inhibitors. To this end, a knowledge-based library design was applied that makes use of detailed information on binding and folding behavior of cystine-knot peptides. Five inhibitor variants, four of the MCoTI family and one of the SOTI family, were identified, chemically synthesized and oxidatively folded towards the bioactive conformation. Enzyme assays revealed inhibition constants in the low nanomolar range for all candidates. One subnanomolar binder (K-i = 0.83 nM) with an inverted selectivity towards trypsin and matriptase-1 was identified.	[Glotzbach, Bernhard; Reinwarth, Michael; Weber, Niklas; Tomaszowski, Michael; Fittler, Heiko; Christmann, Andreas; Avrutina, Olga; Kolmar, Harald] Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany; [Fabritz, Sebastian] AB SCIEX Germany GmbH, Darmstadt, Germany	Technical University of Darmstadt	Kolmar, H (corresponding author), Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany.	Kolmar@Biochemie-TUD.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993	Deutsche Forschungsgemeinschaft [KO-1390/9-1, SPP 1623, 1390/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) through grants KO-1390/9-1 and SPP 1623 grant 1390/10-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Avrutina O, 2005, BIOL CHEM, V386, P1301, DOI 10.1515/BC.2005.148; Avrutina O, 2012, ORG BIOMOL CHEM; Avrutina O, 2008, CHEMBIOCHEM, V9, P33, DOI 10.1002/cbic.200700452; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen JZ, 2012, J AM SOC MASS SPECTR, V23, P225, DOI 10.1007/s13361-011-0294-6; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Domoto T, 2012, CANCER SCI, V103, P448, DOI 10.1111/j.1349-7006.2011.02162.x; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; Gera N, 2012, PROTEIN SELECTION US; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Glotzbach B, 2013, ACTA CRYSTALLOGR D, V69, P114, DOI 10.1107/S0907444912043880; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Jiang L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/368075; Jiang L, 2010, J NUCL MED, V51, P251, DOI 10.2967/jnumed.109.069831; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Kowalska J, 2007, PHYTOCHEMISTRY, V68, P1487, DOI 10.1016/j.phytochem.2007.03.012; Kratzner R, 2005, ACTA CRYSTALLOGR D, V61, P1255, DOI 10.1107/S0907444905021207; Lahti JL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000499; LeBeau AM, 2013, P NATL ACAD SCI USA, V110, P93, DOI 10.1073/pnas.1218694110; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; LENGUYEN D, 1993, PROTEIN SCI, V2, P165; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Puttamadappa SS, 2010, ANGEW CHEM INT EDIT, V49, P7030, DOI 10.1002/anie.201002906; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Reinwarth M, 2013, CHEMBIOCHEM, V14, P137, DOI 10.1002/cbic.201200604; Reinwarth M, 2012, MOLECULES, V17, P12533, DOI 10.3390/molecules171112533; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Silverman AP, 2009, J MOL BIOL, V385, P1064, DOI 10.1016/j.jmb.2008.11.004; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Steinmetzer T, 2006, J MED CHEM, V49, P4116, DOI 10.1021/jm051272l; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; TAN MH, 1981, J NATL CANCER I, V67, P563; Thongyoo P, 2007, CHEMBIOCHEM, V8, P1107, DOI 10.1002/cbic.200700187; Tischler M, 2012, ANGEW CHEM INT EDIT, V51, P3708, DOI 10.1002/anie.201108983; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Uhland K, 2009, INT J ONCOL, V35, P347, DOI 10.3892/ijo_00000346; Van den Brulle J, 2008, BIOTECHNIQUES, V45, P340, DOI 10.2144/000112953; Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wentzel A, 1999, J BIOL CHEM, V274, P21037, DOI 10.1074/jbc.274.30.21037; Werle M, 2007, INT J PHARMACEUT, V332, P72, DOI 10.1016/j.ijpharm.2006.09.028; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Yamasaki Y, 2003, J NUTR SCI VITAMINOL, V49, P27, DOI 10.3177/jnsv.49.27; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	79	41	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76956	10.1371/journal.pone.0076956	http://dx.doi.org/10.1371/journal.pone.0076956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146945	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400091
J	Kompaniez, E; Abbey, CK; Boone, JM; Webster, MA				Kompaniez, Elysse; Abbey, Craig K.; Boone, John M.; Webster, Michael A.			Adaptation Aftereffects in the Perception of Radiological Images	PLOS ONE			English	Article							VISUAL-ADAPTATION; TEXTURE DENSITY; MAMMOGRAPHIC DENSITY; CONTRAST ADAPTATION; NATURAL IMAGES; BREAST-CANCER; SEARCH; SENSITIVITY; MECHANISMS; AMPLITUDE	Radiologists must classify and interpret medical images on the basis of visual inspection. We examined how the perception of radiological scans might be affected by common processes of adaptation in the visual system. Adaptation selectively adjusts sensitivity to the properties of the stimulus in current view, inducing an aftereffect in the appearance of stimuli viewed subsequently. These perceptual changes have been found to affect many visual attributes, but whether they are relevant to medical image perception is not well understood. To examine this we tested whether aftereffects could be generated by the characteristic spatial structure of radiological scans, and whether this could bias their appearance along dimensions that are routinely used to classify them. Measurements were focused on the effects of adaptation to images of normal mammograms, and were tested in observers who were not radiologists. Tissue density in mammograms is evaluated visually and ranges from "dense" to "fatty." Arrays of images varying in intermediate levels between these categories were created by blending dense and fatty images with different weights. Observers first adapted by viewing image samples of dense or fatty tissue, and then judged the appearance of the intermediate images by using a texture matching task. This revealed pronounced perceptual aftereffects - prior exposure to dense images caused an intermediate image to appear more fatty and vice versa. Moreover, the appearance of the adapting images themselves changed with prolonged viewing, so that they became less distinctive as textures. These aftereffects could not be accounted for by the contrast differences or power spectra of the images, and instead tended to follow from the phase spectrum. Our results suggest that observers can selectively adapt to the properties of radiological images, and that this selectivity could strongly impact the perceived textural characteristics of the images.	[Kompaniez, Elysse; Webster, Michael A.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA; [Abbey, Craig K.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Boone, John M.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Abbey, Craig K.; Boone, John M.] Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Santa Barbara; University of California System; University of California Davis; University of California System; University of California Davis	Kompaniez, E (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	ekompaniez@unr.edu		Webster, Michael/0000-0001-8262-7525	National Eye Institute [RO1-EY10834]; National Institute of Biomedical Imaging and Bioengineering [RO1-EB002138]; NATIONAL EYE INSTITUTE [R01EY010834] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the following: National Eye Institute (RO1-EY10834 to MW), and National Institute of Biomedical Imaging and Bioengineering (RO1-EB002138 to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Radiology, 1998, BREAST IM REP DAT SY, V3rd; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Belmore SC, 2011, VISION RES, V51, P362, DOI 10.1016/j.visres.2010.11.011; Bex PJ, 2009, J VISION, V9, DOI 10.1167/9.10.1; Bochud FO, 1999, OPT EXPRESS, V4, P33, DOI 10.1364/OE.4.000033; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2011, JNCI-J NATL CANCER I, V103, P704, DOI 10.1093/jnci/djr115; Burgess AE, 1997, J OPT SOC AM A, V14, P2420, DOI 10.1364/JOSAA.14.002420; Burgess AE, 2001, MED PHYS, V28, P419, DOI 10.1118/1.1355308; Chen L, 2012, MED PHYS, V39, P7; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Delahunt PB, 2004, VISUAL NEUROSCI, V21, P301, DOI 10.1017/S0952523804213025; Drew T, 2013, RADIOGRAPHICS, V33, P263, DOI 10.1148/rg.331125023; Durgin FH, 1997, VISION RES, V37, P3273, DOI 10.1016/S0042-6989(97)00126-0; Durgin FH, 1996, SPATIAL VISION, V9, P423, DOI 10.1163/156856896X00204; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Eckstein M. P., 2000, HDB MED IMAGING, V1, P593, DOI [10.1117/3.832716, DOI 10.1117/3.832716]; ECKSTEIN MP, 2011, J VIS, V11, P9816, DOI DOI 10.1167/11.5.14; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Gale A, 1984, ELSEVIER SCI PUB, V295; Greene MR, 2010, J EXP PSYCHOL HUMAN, V36, P1430, DOI 10.1037/a0019058; Harris H, 2012, CURR BIOL, V22, P1813, DOI 10.1016/j.cub.2012.07.059; Hersh M, 2004, APPL RADIOL, V33, P23; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Krupinski EA, 2011, SEMIN NUCL MED, V41, P392, DOI 10.1053/j.semnuclmed.2011.05.002; Kundel HL, 2004, PROC SPIE, V5372, P1, DOI 10.1117/12.542717; Kwon MY, 2009, J VISION, V9, DOI 10.1167/9.2.20; Manning DJ, 2005, BRIT J RADIOL, V78, P683, DOI 10.1259/bjr/72087985; McDermott KC, 2010, J VISION, V10, DOI 10.1167/10.13.17; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Ouhnana M, 2013, J VISION, V13, DOI 10.1167/13.8.18; PIOTROWSKI LN, 1982, PERCEPTION, V11, P337, DOI 10.1068/p110337; Rhodes G., 2005, FITTING MIND WORLD A, P213, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0009; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; TADMOR Y, 1993, VISION RES, V33, P141, DOI 10.1016/0042-6989(93)90067-7; Thompson P, 2009, CURR BIOL, V19, pR11, DOI 10.1016/j.cub.2008.10.014; Vul E, 2008, J VISION, V8, DOI 10.1167/8.12.4; Webster MA, 1997, J OPT SOC AM A, V14, P2355, DOI 10.1364/JOSAA.14.002355; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Webster MA, 2013, 86518621 SPIE; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360; Webster MA, 2008, J OPT SOC AM A, V25, P2817, DOI 10.1364/JOSAA.25.002817; Wissig SC, 2013, J VISION, V13, DOI 10.1167/13.2.6; Yehezkel O, 2010, VISION RES, V50, P1550, DOI 10.1016/j.visres.2010.05.014	48	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76175	10.1371/journal.pone.0076175	http://dx.doi.org/10.1371/journal.pone.0076175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146833	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400045
J	Tam, ZY; Gruber, J; Halliwell, B; Gunawan, R				Tam, Zhi Yang; Gruber, Jan; Halliwell, Barry; Gunawan, Rudiyanto			Mathematical Modeling of the Role of Mitochondrial Fusion and Fission in Mitochondrial DNA Maintenance	PLOS ONE			English	Article							IN-VIVO; DELETION MUTATIONS; CLONAL EXPANSION; HUMAN-CELLS; TURNOVER; DYNAMICS; MTDNA; COMPLEMENTATION; NUCLEOIDS; MUSCLE	Accumulation of mitochondrial DNA (mtDNA) mutations has been implicated in a wide range of human pathologies, including neurodegenerative diseases, sarcopenia, and the aging process itself. In cells, mtDNA molecules are constantly turned over (i.e. replicated and degraded) and are also exchanged among mitochondria during the fusion and fission of these organelles. While the expansion of a mutant mtDNA population is believed to occur by random segregation of these molecules during turnover, the role of mitochondrial fusion-fission in this context is currently not well understood. In this study, an in silico modeling approach is taken to investigate the effects of mitochondrial fusion and fission dynamics on mutant mtDNA accumulation. Here we report model simulations suggesting that when mitochondrial fusion-fission rate is low, the slow mtDNA mixing can lead to an uneven distribution of mutant mtDNA among mitochondria in between two mitochondrial autophagic events leading to more stochasticity in the outcomes from a single random autophagic event. Consequently, slower mitochondrial fusion-fission results in higher variability in the mtDNA mutation burden among cells in a tissue over time, and mtDNA mutations have a higher propensity to clonally expand due to the increased stochasticity. When these mutations affect cellular energetics, nuclear retrograde signalling can upregulate mtDNA replication, which is expected to slow clonal expansion of these mutant mtDNA. However, our simulations suggest that the protective ability of retrograde signalling depends on the efficiency of fusion-fission process. Our results thus shed light on the interplay between mitochondrial fusion-fission and mtDNA turnover and may explain the mechanism underlying the experimentally observed increase in the accumulation of mtDNA mutations when either mitochondrial fusion or fission is inhibited.	[Tam, Zhi Yang; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Ctr Life Sci, Singapore 117548, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore	Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Halliwell, Barry/C-8318-2009; Gunawan, Rudiyanto/D-4650-2009	Gunawan, Rudiyanto/0000-0002-6480-7976; Halliwell, Barry/0000-0002-3560-7123	ETH Zurich; National University of Singapore (FRC) [R-279-000-299-112]; Ministry of Education Singapore [MOE2010-T2-2-048]	ETH Zurich(ETH Zurich); National University of Singapore (FRC)(National University of Singapore); Ministry of Education Singapore(Ministry of Education, Singapore)	This study was supported by funding from ETH Zurich, the National University of Singapore (FRC Grant R-279-000-299-112) and the Ministry of Education Singapore (MOE2010-T2-2-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Hori A, 2011, GENES CELLS, V16, P527, DOI 10.1111/j.1365-2443.2011.01504.x; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; HUEMER RP, 1971, EXP GERONTOL, V6, P259, DOI 10.1016/0531-5565(71)90038-6; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7; Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572; Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Saunter CD, 2009, FEBS LETT, V583, P1267, DOI 10.1016/j.febslet.2009.02.041; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com	50	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76230	10.1371/journal.pone.0076230	http://dx.doi.org/10.1371/journal.pone.0076230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146842	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400049
J	Guay, C; Joly, E; Pepin, E; Barbeau, A; Hentsch, L; Pineda, M; Madiraju, SRM; Brunengraber, H; Prentki, M				Guay, Claudiane; Joly, Erik; Pepin, Emilie; Barbeau, Annie; Hentsch, Lisa; Pineda, Marco; Madiraju, S. R. Murthy; Brunengraber, Henri; Prentki, Marc			A Role for Cytosolic Isocitrate Dehydrogenase as a Negative Regulator of Glucose Signaling for Insulin Secretion in Pancreatic beta-Cells	PLOS ONE			English	Article							CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE; TRICARBOXYLIC-ACID CYCLE; ATP-CITRATE LYASE; MALIC ENZYME; PYRUVATE-CARBOXYLASE; OXIDATIVE DAMAGE; MALONYL-COA; CA2+-DEPENDENT EXOCYTOSIS; MASS-SPECTROMETRY; CELLULAR DEFENSE	Cytosolic NADPH may act as one of the signals that couple glucose metabolism to insulin secretion in the pancreatic beta-cell. NADPH levels in the cytoplasm are largely controlled by the cytosolic isoforms of malic enzyme and isocitrate dehydrogenase (IDHc). Some studies have provided evidence for a role of malic enzyme in glucose-induced insulin secretion (GIIS) via pyruvate cycling, but the role of IDHc in beta-cell signaling is unsettled. IDHc is an established component of the isocitrate/alpha-ketoglutarate shuttle that transfers reducing equivalents (NADPH) from the mitochondrion to the cytosol. This shuttle is energy consuming since it is coupled to nicotinamide nucleotide transhydrogenase that uses the mitochondrial proton gradient to produce mitochondrial NADPH and NAD(+) from NADP(+) and NADH. To determine whether flux through IDHc is positively or negatively linked to GIIS, we performed RNAi knockdown experiments in beta-cells. Reduced IDHc expression in INS 832/13 cells and isolated rat islet beta-cells resulted in enhanced GIIS. This effect was mediated at least in part via the K-ATP-independent amplification arm of GIIS. IDHc knockdown in INS 832/13 cells did not alter glucose oxidation but it reduced fatty acid oxidation and increased lipogenesis from glucose. Metabolome profiling in INS 832/13 cells showed that IDHc knockdown increased isocitrate and NADP(+) levels. It also increased the cellular contents of several metabolites linked to GIIS, in particular some Krebs cycle intermediates, acetyl-CoA, glutamate, cAMP and ATP. The results identify IDHc as a component of the emerging pathways that negatively regulate GIIS.	[Guay, Claudiane; Joly, Erik; Pepin, Emilie; Barbeau, Annie; Hentsch, Lisa; Pineda, Marco; Madiraju, S. R. Murthy; Prentki, Marc] CR CHUM, Ctr Hosp Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada; [Guay, Claudiane; Joly, Erik; Pepin, Emilie; Barbeau, Annie; Hentsch, Lisa; Pineda, Marco; Madiraju, S. R. Murthy; Prentki, Marc] CR CHUM, Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Brunengraber, Henri] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Case Western Reserve University	Guay, C (corresponding author), CR CHUM, Ctr Hosp Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada.	marc.prentki@umontreal.ca	Guay, Claudiane/AAF-5381-2019; Hentsch, Lisa/AAA-5081-2022	Hentsch, Lisa/0000-0002-3430-370X; Guay, Claudiane/0000-0002-6478-8744	Canadian Institute of Health Research; National Institutes of Health Roadmap [R33DK070291]; Fonds de Recherche en Sante du Quebec; Programmes de Biologie Moleculaire de l'Universite de Montreal; Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Programmes de Biologie Moleculaire de l'Universite de Montreal; Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Canadian Institute of Health Research (to M. Prentki) and by the National Institutes of Health Roadmap Grant R33DK070291 (to H. B.). M. Prentki is a recipient of a Canada research chair in diabetes and metabolism. C. Guay was supported by a graduate studentships from the Fonds de Recherche en Sante du Quebec and from Programmes de Biologie Moleculaire de l'Universite de Montreal. E. Pepin was supported by a graduate studentship from Programmes de Biologie Moleculaire de l'Universite de Montreal and from Diabete Quebec. A. Barbeau was supported by a graduate studentship from Diabete Quebec.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fulgencio JP, 1996, DIABETES, V45, P1556, DOI 10.2337/diabetes.45.11.1556; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; HEDESKOV CJ, 1987, BIOCHEM J, V241, P161, DOI 10.1042/bj2410161; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HENQUIN JC, 1992, ENDOCRINOLOGY, V131, P127, DOI 10.1210/en.131.1.127; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Icyuz M, 2009, TRANSPLANTATION, V87, P821, DOI 10.1097/TP.0b013e318199c686; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; KHAN A, 1990, DIABETES, V39, P456, DOI 10.2337/diabetes.39.4.456; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim SY, 2007, MOL CELL BIOCHEM, V302, P27, DOI 10.1007/s11010-007-9421-x; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lee SM, 2009, FREE RADICAL RES, V43, P165, DOI 10.1080/10715760802653661; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Li CH, 2010, J BIOL CHEM, V285, P31806, DOI 10.1074/jbc.M110.123638; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lorenz MA, 2013, J BIOL CHEM; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Massie B, 1998, J VIROL, V72, P2289, DOI 10.1128/JVI.72.3.2289-2296.1998; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MCGARRY JD, 1976, J LIPID RES, V17, P277; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Pepin E, 2010, J DIABETES, V2, P157, DOI 10.1111/j.1753-0407.2010.00076.x; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Qian TX, 2004, ANAL BIOCHEM, V325, P77, DOI 10.1016/j.ab.2003.10.028; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SIES H, 1977, EUR J BIOCHEM, V72, P301, DOI 10.1111/j.1432-1033.1977.tb11253.x; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Xu J, 2008, DIABETOLOGIA, V51, P2281, DOI 10.1007/s00125-008-1155-0	80	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77097	10.1371/journal.pone.0077097	http://dx.doi.org/10.1371/journal.pone.0077097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130841	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200058
J	Wadhwa, R; Singh, R; Gao, R; Shah, N; Widodo, N; Nakamoto, T; Ishida, Y; Terao, K; Kaul, SC				Wadhwa, Renu; Singh, Rumani; Gao, Ran; Shah, Navjot; Widodo, Nashi; Nakamoto, Tomoko; Ishida, Yoshiyuki; Terao, Keiji; Kaul, Sunil C.			Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action	PLOS ONE			English	Article							SOMNIFERA ROOT EXTRACT; NF-KAPPA-B; WITHANIA-SOMNIFERA; CANCER-CELLS; WITHANOLIDE-A; LEAF EXTRACT; BALB/C MICE; WITHAFERIN; APOPTOSIS; DISEASE	Background: Cancer is a leading cause of death accounting for 15-20% of global mortality. Although advancements in diagnostic and therapeutic technologies have improved cancer survival statistics, 75% of the world population live in underdeveloped regions and have poor access to the advanced medical remedies. Natural therapies hence become an alternative choice of treatment. Ashwagandha, a tropical herb used in Indian Ayurvedic medicine, has a long history of its health promoting and therapeutic effects. In the present study, we have investigated an anticancer activity in the water extract of Ashwagandha leaves (ASH-WEX). Methodology/Principal Findings: Anticancer activity in the water extract of Ashwagandha leaves (ASH-WEX) was detected by in vitro and in vivo assays. Bioactivity-based size fractionation and NMR analysis were performed to identify the active anticancer component(s). Mechanism of anticancer activity in the extract and its purified component was investigated by biochemical assays. We report that the ASH-WEX is cytotoxic to cancer cells selectively, and causes tumor suppression in vivo. Its active anticancer component was identified as triethylene glycol (TEG). Molecular analysis revealed activation of tumor suppressor proteins p53 and pRB by ASH-WEX and TEG in cancer cells. In contrast to the hypophosphorylation of pRB, decrease in cyclin B1 and increase in cyclin D1 in ASH-WEX and TEG-treated cancer cells (undergoing growth arrest), normal cells showed increase in pRB phosphorylation and cyclin B1, and decrease in cyclin D1 (signifying their cell cycle progression). We also found that the MMP-3 and MMP-9 that regulate metastasis were down regulated in ASH-WEX and TEG-treated cancer cells; normal cells remained unaffected. Conclusion: We provide the first molecular evidence that the ASH-WEX and TEG have selective cancer cell growth arrest activity and hence may offer natural and economic resources for anticancer medicine.	[Wadhwa, Renu; Singh, Rumani; Gao, Ran; Shah, Navjot; Widodo, Nashi; Nakamoto, Tomoko; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Ishida, Yoshiyuki; Terao, Keiji] Brawijaya Univ, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia; [Widodo, Nashi] CycloChem Co Ltd, Chuo Ku, Kobe, Hyogo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Brawijaya University	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; widodo, nashi/X-4595-2019	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; widodo, nashi/0000-0002-1126-498X; Gao, Ran/0000-0001-8712-429X	Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan; Innovation School Post-doctoral Fellowship, National Institute of Advanced Industrial Science & Technology (AIST), Japan	Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan; Innovation School Post-doctoral Fellowship, National Institute of Advanced Industrial Science & Technology (AIST), Japan	Rumani Singh was supported by the Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarship, Japan. Ran Gao was supported by Innovation School Post-doctoral Fellowship, National Institute of Advanced Industrial Science & Technology (AIST), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2010, EVID-BASED COMPL ALT, V7, P177, DOI 10.1093/ecam/nem184; Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Ali NAA, 2001, J ETHNOPHARMACOL, V74, P173, DOI 10.1016/S0378-8741(00)00364-0; Bolleddula J, 2012, RAPID COMMUN MASS SP, V26, P1277, DOI 10.1002/rcm.6221; Davis L, 2001, J ETHNOPHARMACOL, V75, P165, DOI 10.1016/S0378-8741(00)00404-9; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Gupta SK, 2004, MOL CELL BIOCHEM, V260, P39; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Khan S, 2009, VACCINE, V27, P6080, DOI 10.1016/j.vaccine.2009.07.011; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni SK, 2008, INDIAN J EXP BIOL, V46, P633; Kumar P, 2009, J MED FOOD, V12, P591, DOI 10.1089/jmf.2008.0028; Kushwaha S, 2012, VACCINE, V30, P1083, DOI 10.1016/j.vaccine.2011.12.031; Lee W, 2012, TOXICOL APPL PHARM, V262, P91, DOI 10.1016/j.taap.2012.04.025; Liu JH, 2008, BIOMED PHARMACOTHER, V62, P480, DOI 10.1016/j.biopha.2007.11.003; LLanos GG, 2012, EUR J MED CHEM, V54, P499, DOI 10.1016/j.ejmech.2012.05.032; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Malik F, 2009, EUR J CANCER, V45, P1494, DOI 10.1016/j.ejca.2009.01.034; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Maurya R, 2010, J PHARM PHARMACOL, V62, P153, DOI 10.1211/jpp.62.02.0001; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034277; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; NITSCHKE L, 1994, FRESEN J ANAL CHEM, V349, P451, DOI 10.1007/BF00322932; Owais M, 2005, PHYTOMEDICINE, V12, P229, DOI 10.1016/j.phymed.2003.07.012; OWEN LN, 1962, BRIT J CANCER, V16, P441, DOI 10.1038/bjc.1962.49; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Park HJ, 2008, BIOFACTORS, V33, P137, DOI 10.1002/biof.5520330206; Pawar P, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-34; RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044; Rasool M, 2006, CHEM-BIOL INTERACT, V164, P174, DOI 10.1016/j.cbi.2006.09.011; Rudnick SN, 2009, AM J INFECT CONTROL, V37, P813, DOI 10.1016/j.ajic.2009.06.007; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Singh D, 2007, PHYTOTHER RES, V21, P905, DOI 10.1002/ptr.2180; Singh G, 2011, INDIAN J PHARM SCI, V73, P473, DOI 10.4103/0250-474X.95656; Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Winters M, 2006, ALTERN MED REV, V11, P269; Xu YM, 2011, PHYTOCHEMISTRY, V72, P518, DOI 10.1016/j.phytochem.2010.12.020; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Zhang X, 2012, GYNECOL ONCOL, V124, P606, DOI 10.1016/j.ygyno.2011.11.044; Zhang X, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-84	51	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77189	10.1371/journal.pone.0077189	http://dx.doi.org/10.1371/journal.pone.0077189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130852	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200067
J	Shimato, S; Anderson, LM; Asslaber, M; Bruce, JN; Canoll, P; Anderson, DE; Anderson, RCE				Shimato, Shinji; Anderson, Lisa M.; Asslaber, Martin; Bruce, Jeffrey N.; Canoll, Peter; Anderson, David E.; Anderson, Richard C. E.			Inhibition of Caveolin-1 Restores Myeloid Cell Function in Human Glioblastoma	PLOS ONE			English	Article							GLIOMA-INFILTRATING MICROGLIA/MACROPHAGES; IMMUNOHISTOCHEMICAL ANALYSIS; MALIGNANT GLIOMAS; IN-VITRO; LYMPHOCYTES; MACROPHAGES; EXPRESSION; PHENOTYPE; TUMORS	Background: Gliomas are the most common primary brain tumor in both children and adults. The prognosis for glioblastoma (GBM), the most common type of malignant glioma, has remained dismal, with median survival a little over one year despite maximal therapy with surgery, chemotherapy, and radiation. Although immunotherapy has become increasingly successful against many systemic tumors, clinical efficacy against brain tumors has been limited. One reason for this is an incomplete understanding of the local immunologic tumor microenvironment, particularly the function of large numbers of infiltrating myeloid derived cells. Monocytes/microglia are myeloid derived immunomodulatory cells, and they represent the predominant infiltrating immune cell population in gliomas. Our group has previously demonstrated using complementary in vitro and in vivo approaches that GBM tumor cells polarize tumor-associated myeloid cells (TAMs) and suppress their immunostimulatory function. Methods and Results: To better understand the mechanisms responsible for this immunosuppression, we used gene expression profiling of stimulated monocytes in the presence or absence of GBM tumor cells. Our analysis identified caveolin-1 (CAV1), a plasma membrane molecule with pleiotropic functions, as significantly up-regulated in monocytes in the presence of GBMs. We validated these findings ex vivo by confirming up-regulation of CAV1 in TAMs isolated from GBMs immediately after surgical resection. Finally, we demonstrate that siRNA inhibition of CAV1 restores myeloid cell function, as measured by TNF-alpha secretion, in the presence of GBMs. Conclusions: Restoration of TAM function through pharmacologic blockage of CAV1 may facilitate more successful immunotherapeutic strategies directed against a variety of solid human tumors infiltrated by TAMs.	[Shimato, Shinji; Bruce, Jeffrey N.; Canoll, Peter; Anderson, Richard C. E.] Columbia Univ, Dept Neurosurg, Gabriele Bartoli Brain Tumor Res Lab, New York, NY 10027 USA; [Anderson, Lisa M.; Anderson, David E.] Erinyes Biotechnol LLC, Boston, MA USA; [Asslaber, Martin] Med Univ Graz, Dept Pathol, Graz, Austria; [Canoll, Peter] Columbia Univ, Dept Pathol, New York, NY USA	Columbia University; Medical University of Graz; Columbia University	Anderson, RCE (corresponding author), Columbia Univ, Dept Neurosurg, Gabriele Bartoli Brain Tumor Res Lab, New York, NY 10027 USA.	rca24@columbia.edu	Bruce, Jeffrey N/AAC-5307-2022		Meghan Rose Bradley Foundation; Matthew Larson Foundation	Meghan Rose Bradley Foundation; Matthew Larson Foundation	This work was supported in part by the Meghan Rose Bradley Foundation and the Matthew Larson Foundation (RCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2002, CLIN IMMUNOL, V102, P84, DOI 10.1006/clim.2001.5152; ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Anderson RCE, 2007, NEUROSURGERY, V60, P1129, DOI 10.1227/01.NEU.0000255460.91892.44; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BROOKS WH, 1978, ANN NEUROL, V4, P219, DOI 10.1002/ana.410040305; de Almeida CJ, 2011, CELL CYCLE, V10, P2151, DOI 10.4161/cc.10.13.16234; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9; Guruswamy S, 2009, INT J ONCOL, V35, P1037, DOI 10.3892/ijo_00000418; Harris J, 2002, IMMUNOLOGY, V105, P190, DOI 10.1046/j.1365-2567.2002.01362.x; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Held-Feindt J, 2010, EXP CELL RES, V316, P1553, DOI 10.1016/j.yexcr.2010.02.018; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Hussain SF, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-15; Hussain SF, 2005, EXPERT REV ANTICANC, V5, P777, DOI 10.1586/14737140.5.5.777; Kennedy BC, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-11; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; KUPPNER MC, 1988, CANCER RES, V48, P6926; PAINE JT, 1986, NEUROSURGERY, V18, P766, DOI 10.1227/00006123-198606000-00015; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; RIDLEY A, 1971, BRAIN, V94, P117, DOI 10.1093/brain/94.1.117; SAITO T, 1988, SURG NEUROL, V29, P435, DOI 10.1016/0090-3019(88)90137-1; Santizo RA, 2002, STROKE, V33, P613, DOI 10.1161/hs0202.102363; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Yamanaka R, 2008, TRENDS MOL MED, V14, P228, DOI 10.1016/j.molmed.2008.03.003	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77397	10.1371/journal.pone.0077397	http://dx.doi.org/10.1371/journal.pone.0077397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130882	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900135
J	Ma, XL; Hibbert, B; McNulty, M; Hu, TQ; Zhao, XL; Ramirez, FD; Simard, T; de Belleroche, JS; O'Brien, ER				Ma, Xiaoli; Hibbert, Benjamin; McNulty, Melissa; Hu, Tieqiang; Zhao, Xiaoling; Ramirez, F. Daniel; Simard, Trevor; de Belleroche, Jacqueline S.; O'Brien, Edward R.			Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: importance of vascular endothelial growth factor up-regulation	FASEB JOURNAL			English	Article						VEGF; restenosis; progenitor cell	ZOTAROLIMUS-ELUTING STENT; PROGENITOR CELLS; RE-ENDOTHELIALIZATION; MOUSE MODEL; FOLLOW-UP; HEAT-SHOCK-PROTEIN-27; APOPTOSIS; ATHEROSCLEROSIS; MIGRATION; ESTROGEN	Elevated serum heat shock protein 27 (HSP27) levels are atheroprotective; however, the role of HSP27 after arterial injury is unknown. Human endothelial progenitor cells (EPCs) were treated with recombinant (r)HSP27 (50 g/ml) or its inactive C1 terminus, and gene expression was characterized before functional studies were performed in vitro and in vivo. Vascular endothelial growth factor (VEGF) was markedly up-regulated by rHSP27 (10- and 6-fold increases in mRNA and secretion, respectively). Pretreatment of EPCs with rHSP27 resulted in a 60% reduction in reendothelialization (RE) time in a scratch assay, an effect that was blocked with VEGF-neutralizing antibodies. Mice overexpressing HSP27 demonstrated more robust mobilization of EPCs at the time of arterial injury, as well as a 67% increase in RE and a 45% reduction in neointima (NI) formation at 28 d. Implantation of rHSP27-eluting stents in rabbit carotid arteries resulted in a marked improvement in RE at 7 and 28 d and transient attenuation of NI formation by 42% at 7 d. Hence, extracellular HSP27 up-regulated VEGF and improved EPC migration in vitro. Augmented systemic or local levels of HSP27 markedly improved RE after vascular injury, an effect that is of particular relevance to the safety profile of vascular stents.Ma, X., Hibbert, B., McNulty, M., Hu, T., Zhao, X., Ramirez, F. D., Simard, T., de Belleroche, J. S., O'Brien, E. R. Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: importance of vascular endothelial growth factor up-regulation.	[Ma, Xiaoli; Hibbert, Benjamin; McNulty, Melissa; Hu, Tieqiang; Zhao, Xiaoling; Ramirez, F. Daniel; Simard, Trevor; O'Brien, Edward R.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [de Belleroche, Jacqueline S.] Univ London Imperial Coll Sci Technol & Med, London, England; [O'Brien, Edward R.] Libin Cardiovasc Inst Alberta, Calgary, AB T2N 2T9, Canada	University of Ottawa; University of Ottawa Heart Institute; Imperial College London; Libin Cardiovascular Institute Of Alberta	O'Brien, ER (corresponding author), Libin Cardiovasc Inst Alberta, Foothills Med Ctr, Room C823,1403-29th St NW, Calgary, AB T2N 2T9, Canada.	ed.obrien@albertahealthservices.ca	O'Brien, Edward R/J-6621-2013	O'Brien, Edward R/0000-0003-1039-9425	Heart and Stroke Foundation of Ontario [T7217]; Canadian Institute for Health Research (CIHR) [ISO 110836]; Medtronic Canada [ISO 110836]; CIHR [IRC57093]; Medtronic [IRC57093]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medtronic Canada(Medtronic); CIHR(Canadian Institutes of Health Research (CIHR)); Medtronic(Medtronic)	This work was supported by operating grants funded by the Heart and Stroke Foundation of Ontario (T7217) and by joint funding from the Canadian Institute for Health Research (CIHR) and Medtronic Canada (ISO 110836). CIHR and Medtronic also collectively fund a peer-reviewed research chair (IRC57093) to E.R.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen HF, 2009, MOL CELL BIOCHEM, V327, P1, DOI 10.1007/s11010-009-0034-4; Chen YX, 2004, CIRCULATION, V110, P3721, DOI 10.1161/01.CIR.0000146790.51331.BA; Chen YX, 2003, CAN J PHYSIOL PHARM, V81, P730, DOI 10.1139/Y03-066; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; Douglas G., 2012, EUR HEART J, DOI 10.1093/eurheartj/ehs240; Garg S, 2009, JACC-CARDIOVASC INTE, V2, P1190, DOI 10.1016/j.jcin.2009.10.002; Hibbert B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016413; Hibbert B, 2009, CARDIOVASC RES, V83, P16, DOI 10.1093/cvr/cvp156; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hutter R, 2004, CIRCULATION, V110, P2430, DOI 10.1161/01.CIR.0000145120.37891.8A; Kato K, 2011, INT J MOL MED, V27, P423, DOI 10.3892/ijmm.2011.595; Keezer SM, 2003, CANCER RES, V63, P6405; Kirtane AJ, 2013, JACC-CARDIOVASC INTE, V6, P325, DOI 10.1016/j.jcin.2012.12.123; Kubo M., 2012, PLOS ONE, V7; Leon MB, 2010, J AM COLL CARDIOL, V55, P543, DOI 10.1016/j.jacc.2009.08.067; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Ma XL, 2010, CARDIOVASC RES, V86, P338, DOI 10.1093/cvr/cvq047; Ma XL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001894; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pourdjabbar Ali, 2011, Cardiovascular & Hematological Disorders - Drug Targets, V11, P30; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Rayner K, 2010, TRENDS CARDIOVAS MED, V20, P53, DOI 10.1016/j.tcm.2010.03.008; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b	40	17	19	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					594	602		10.1096/fj.13-230417	http://dx.doi.org/10.1096/fj.13-230417			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24142570				2022-12-25	WOS:000331072200008
J	Matsuyama, M; Tanaka, H; Inoko, A; Goto, H; Yonemura, S; Kobori, K; Hayashi, Y; Kondo, E; Itohara, S; Izawa, I; Inagaki, M				Matsuyama, Makoto; Tanaka, Hiroki; Inoko, Akihito; Goto, Hidemasa; Yonemura, Shigenobu; Kobori, Kyoko; Hayashi, Yuko; Kondo, Eisaku; Itohara, Shigeyoshi; Izawa, Ichiro; Inagaki, Masaki			Defect of Mitotic Vimentin Phosphorylation Causes Microophthalmia and Cataract via Aneuploidy and Senescence in Lens Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cataract; Cell Division; Cytokinesis; Mitosis; Phosphorylation; Senescence; Aneuploidy; Chromosomal Instability; Vimentin	RHO-ASSOCIATED KINASE; INTERMEDIATE-FILAMENTS; CLEAVAGE FURROW; AURORA-B; PROTEIN; SITE; CYTOKINESIS; DYNAMICS; ROLES; SEGREGATION	Background: Vimentin, an intermediate filament (IF) protein, is phosphorylated in mitosis. Results: Disruption of vimentin phosphorylation during cell division leads to chromosomal instability (CIN) and premature aging in mouse lens tissue. Conclusion: Our data document the first physiological importance of vimentin phosphorylation during mitosis for organogenesis and tissue homeostasis. Significance: Our data suggest a possible causal relationship between CIN and premature aging. Vimentin, a type III intermediate filament (IF) protein, is phosphorylated predominantly in mitosis. The expression of a phosphorylation-compromised vimentin mutant in T24 cultured cells leads to cytokinetic failure, resulting in binucleation (multinucleation). The physiological significance of intermediate filament phosphorylation during mitosis for organogenesis and tissue homeostasis was uncertain. Here, we generated knock-in mice expressing vimentin that have had the serine sites phosphorylated during mitosis substituted by alanine residues. Homozygotic mice (VIMSA/SA) presented with microophthalmia and cataracts in the lens, whereas heterozygotic mice (VIMWT/SA) were indistinguishable from WT (VIMWT/WT) mice. In VIMSA/SA mice, lens epithelial cell number was not only reduced but the cells also exhibited chromosomal instability, including binucleation and aneuploidy. Electron microscopy revealed fiber membranes that were disorganized in the lenses of VIMSA/SA, reminiscent of similar characteristic changes seen in age-related cataracts. Because the mRNA level of the senescence (aging)-related gene was significantly elevated in samples from VIMSA/SA, the lens phenotype suggests a possible causal relationship between chromosomal instability and premature aging.	[Matsuyama, Makoto; Tanaka, Hiroki; Inoko, Akihito; Goto, Hidemasa; Kobori, Kyoko; Hayashi, Yuko; Izawa, Ichiro; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan; [Kondo, Eisaku] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Nagoya, Aichi 4648681, Japan; [Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan; [Kondo, Eisaku] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Nagoya, Aichi 4668550, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan; [Itohara, Shigeyoshi] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan	Aichi Cancer Center; Aichi Cancer Center; Nagoya University; Nagoya University; RIKEN; RIKEN	Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	minagaki@aichi-cc.jp	Itohara, Shigeyoshi/I-8769-2012; Inagaki, Masaki/B-9920-2016	Itohara, Shigeyoshi/0000-0002-2410-9989; Goto, Hidemasa/0000-0002-6796-4467; TANAKA, HIROKI/0000-0003-3469-6555; Inoko, Akihito/0000-0002-6739-2948; Matsuyama, Makoto/0000-0003-2606-059X	Japan Society for the Promotion of Science; Ministry of Education, Science, Technology, Sports and Culture of Japan; Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan; Uehara Memorial Foundation; Naito Foundation; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23247035] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and from the Ministry of Education, Science, Technology, Sports and Culture of Japan, a grant-in-aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan, the Uehara Memorial Foundation, the Naito Foundation, a research grant from the Princess Takamatsu Cancer Research Fund, and the Takeda Science Foundation.	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Bassuk JA, 1999, EXP EYE RES, V68, P321, DOI 10.1006/exer.1998.0608; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; Boyle Daniel L, 2003, BMC Ophthalmol, V3, P3, DOI 10.1186/1471-2415-3-3; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chang B, 2002, HUM MOL GENET, V11, P507, DOI 10.1093/hmg/11.5.507; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2000, MICROSC RES TECHNIQ, V49, P173, DOI 10.1002/(SICI)1097-0029(20000415)49:2<173::AID-JEMT10>3.0.CO;2-A; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kosako H, 1997, J BIOL CHEM, V272, P10333; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; MATSUOKA Y, 1992, EMBO J, V11, P2895, DOI 10.1002/j.1460-2075.1992.tb05358.x; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Song SH, 2009, J CLIN INVEST, V119, P1837, DOI 10.1172/JCI38277; Tanaka H, 2011, CANCER SCI, V102, P784, DOI 10.1111/j.1349-7006.2011.01850.x; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]	47	47	47	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35626	35635		10.1074/jbc.M113.514737	http://dx.doi.org/10.1074/jbc.M113.514737			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24142690	hybrid, Green Published			2022-12-25	WOS:000329814700001
J	Stephens, DN; Klein, RH; Salmans, ML; Gordon, W; Ho, H; Andersen, B				Stephens, Denise N.; Klein, Rachel Herndon; Salmans, Michael L.; Gordon, William; Ho, Hsiang; Andersen, Bogi			The Ets Transcription Factor EHF as a Regulator of Cornea Epithelial Cell Identity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Chromatin Immunoprecipitation (ChiP); Cornea; Development; DNA Transcription; Epithelium; Eye; Gene Expression; Transcription; Developmental Factors	GENE-EXPRESSION PATTERNS; AGE-RELATED-CHANGES; ADULT-MOUSE CORNEA; IN-VITRO; ORGANIZATION; MICROARRAY; FAMILY; MICE; REVEALS; CLONING	Background: Cornea development requires precise, coordinated gene expression; few regulators have been characterized. Results: Ets factor EHF collaborates with Kruppel-like factors to activate cornea epithelial genes while repressing non-epithelial genes. Conclusion: EHF, in collaboration with other transcription factors, promotes cornea epithelial identity. Significance: We generated a comprehensive data set on cornea gene expression over the lifetime of the mouse, identifying novel regulators of cornea epithelial identity. The cornea is the clear, outermost portion of the eye composed of three layers: an epithelium that provides a protective barrier while allowing transmission of light into the eye, a collagen-rich stroma, and an endothelium monolayer. How cornea development and aging is controlled is poorly understood. Here we characterize the mouse cornea transcriptome from early embryogenesis through aging and compare it with transcriptomes of other epithelial tissues, identifying cornea-enriched genes, pathways, and transcriptional regulators. Additionally, we profiled cornea epithelium and stroma, defining genes enriched in these layers. Over 10,000 genes are differentially regulated in the mouse cornea across the time course, showing dynamic expression during development and modest expression changes in fewer genes during aging. A striking transition time point for gene expression between postnatal days 14 and 28 corresponds with completion of cornea development at the transcriptional level. Clustering classifies co-expressed, and potentially co-regulated, genes into biologically informative categories, including groups that exhibit epithelial or stromal enriched expression. Based on these findings, and through loss of function studies and ChIP-seq, we show that the Ets transcription factor EHF promotes cornea epithelial fate through complementary gene activating and repressing activities. Furthermore, we identify potential interactions between EHF, KLF4, and KLF5 in promoting cornea epithelial differentiation. These data provide insights into the mechanisms underlying epithelial development and aging, identifying EHF as a regulator of cornea epithelial identity and pointing to interactions between Ets and KLF factors in promoting epithelial fate. Furthermore, this comprehensive gene expression data set for the cornea is a powerful tool for discovery of novel cornea regulators and pathways.	[Stephens, Denise N.; Klein, Rachel Herndon; Salmans, Michael L.; Gordon, William; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Ho, Hsiang; Andersen, Bogi] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Klein, Rachel Herndon; Salmans, Michael L.; Andersen, Bogi] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), Sprague Hall,Rm 250,839 Hlth Sci Dr, Irvine, CA USA.	bogi@uci.edu			National Institutes of Health [R01EY019413, RO1AR44882, T32-HD60555, T15LM00744]; California Institute for Regenerative Medicine [TG2-01152]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY019413 and RO1AR44882 (to B. A.), T32-HD60555 (to W. G.), and T15LM00744 (to R. H. K. and M. L. S.). This work was also supported by California Institute for Regenerative Medicine Grant TG2-01152 (to D. S. and M. L S.).	Adachi W, 2000, INVEST OPHTH VIS SCI, V41, P2900; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beggs ML, 2004, AGING CELL, V3, P353, DOI 10.1111/j.1474-9728.2004.00135.x; Berk RS, 2001, INVEST OPHTH VIS SCI, V42, P1561; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bochert MA, 1998, BIOCHEM BIOPH RES CO, V246, P176, DOI 10.1006/bbrc.1998.8560; Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cavallotti C., 2010, AGE RELATED CHANGES, P45; Chakravarti S, 2004, INVEST OPHTH VIS SCI, V45, P3475, DOI 10.1167/iovs.04-0343; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Davis J, 2008, INVEST OPHTH VIS SCI, V49, P1814, DOI 10.1167/iovs.07-1057; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Dudoit S, 2003, BIOTECHNIQUES, P45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FITCH KL, 1986, EXP GERONTOL, V21, P31, DOI 10.1016/0531-5565(86)90015-X; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GIPSON IK, 1982, INVEST OPHTH VIS SCI, V23, P269; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Govindarajan V, 2001, DEVELOPMENT, V128, P1617; Grassel S, 1999, EUR J BIOCHEM, V263, P471, DOI 10.1046/j.1432-1327.1999.00523.x; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Gupta D, 2011, INVEST OPHTH VIS SCI, V52, P4951, DOI 10.1167/iovs.10-7068; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hanlon SD, 2011, EXP EYE RES, V93, P363, DOI 10.1016/j.exer.2011.04.013; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; HIGBEE RG, 1983, EXP EYE RES, V36, P171, DOI 10.1016/0014-4835(83)90003-9; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HW, 2012, BIOINFORMATICS, V28, P1182, DOI 10.1093/bioinformatics/bts096; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; Ikoma T, 2012, BIOCHEM BIOPH RES CO, V420, P217, DOI 10.1016/j.bbrc.2012.01.157; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Kenchegowda D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044771; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kobberup S, 2007, DEV DYNAM, V236, P3100, DOI 10.1002/dvdy.21292; Kohman RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022654; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Lustig A, 2009, INT J MED SCI, V6, P51; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Marsden MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1768; Mastropasqua L, 2006, AM J OPHTHALMOL, V142, P736, DOI 10.1016/j.ajo.2006.06.057; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007; Nakamura H, 2005, INVEST OPHTH VIS SCI, V46, P4092, DOI 10.1167/iovs.05-0324; Nakamura H, 2004, INVEST OPHTH VIS SCI, V45, P4327, DOI 10.1167/iovs.04-0353; Nakamura T, 2008, STEM CELLS, V26, P1265, DOI 10.1634/stemcells.2007-1067; Norman B, 2004, INVEST OPHTH VIS SCI, V45, P429, DOI 10.1167/iovs.03-0449; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; PEI YF, 1971, INVEST OPHTH VISUAL, V10, P811; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sax CM, 1996, J BIOL CHEM, V271, P33568, DOI 10.1074/jbc.271.52.33568; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sevel D, 1988, Trans Am Ophthalmol Soc, V86, P178; SHELDON H, 1956, J BIOPHYS BIOCHEM CY, V2, P253, DOI 10.1083/jcb.2.3.253; Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090; Song J, 2003, INVEST OPHTH VIS SCI, V44, P548, DOI 10.1167/iovs.02-0592; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Swindell W. R., 2012, PLOS ONE, V7; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; TOMASEK JJ, 1982, DEV BIOL, V92, P107, DOI 10.1016/0012-1606(82)90155-5; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Weaving L, 2010, INVEST OPHTH VIS SCI, V51, P5561, DOI 10.1167/iovs.09-5123; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wu F, 2008, EXP EYE RES, V87, P214, DOI 10.1016/j.exer.2008.06.001; Yoshida N, 2000, MECH DEVELOP, V97, P27, DOI 10.1016/S0925-4773(00)00419-6; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	105	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34304	34324		10.1074/jbc.M113.504399	http://dx.doi.org/10.1074/jbc.M113.504399			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142692	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000329812800003
J	Kalev, I; Habeck, M				Kalev, Ivan; Habeck, Michael			Confidence-Guided Local Structure Prediction with HHfrag	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SECONDARY STRUCTURE PREDICTION; ALGORITHM; LIBRARY	We present a method to assess the reliability of local structure prediction from sequence. We introduce a greedy algorithm for filtering and enrichment of dynamic fragment libraries, compiled with remote-homology detection methods such as HHfrag. After filtering false hits at each target position, we reduce the fragment library to a minimal set of representative fragments, which are guaranteed to have correct local structure in regions of detectable conservation. We demonstrate that the location of conserved motifs in a protein sequence can be predicted by examining the recurrence and structural homogeneity of detected fragments. The resulting confidence score correlates with the local RMSD of the representative fragments and allows us to predict torsion angles from sequence with better accuracy compared to existing machine learning methods.	[Kalev, Ivan] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany; [Habeck, Michael] Univ Gottingen, Inst Math Stochast, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Kalev, I (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany.	ivan.kalev@tuebingen.mpg.de; mhabeck@gwdg.de		Habeck, Michael/0000-0002-2188-5667	contract research "Methoden in den Lebenswissenschaften" of the Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG) [HA 5918/1-1]; Max Planck Society	contract research "Methoden in den Lebenswissenschaften" of the Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work has been supported by contract research "Methoden in den Lebenswissenschaften" of the Baden-Wurttemberg Stiftung, by Deutsche Forschungsgemeinschaft (DFG) grant HA 5918/1-1, and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2009, PROTEIN SCI, V18, P1961, DOI 10.1002/pro.207; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Bystroff C, 1996, CURR OPIN BIOTECH, V7, P417, DOI 10.1016/S0958-1669(96)80117-0; Bystroff C., 2002, BIOINFORMATICS, V18, pS54; Bystroff C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-429; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, P2085, DOI 10.1093/nar/gkl156; Fernandez-Fuentes N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000750; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalev I, 2012, BIOINFORMATICS, V28, P2996, DOI 10.1093/bioinformatics/bts538; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030361; Wu ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003400; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179	24	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76512	10.1371/journal.pone.0076512	http://dx.doi.org/10.1371/journal.pone.0076512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146881	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400067
J	Cayetano, L; Vorburger, C				Cayetano, Luis; Vorburger, Christoph			Effects of Heat Shock on Resistance to Parasitoids and on Life History Traits in an Aphid/Endosymbiont System	PLOS ONE			English	Article							FACULTATIVE BACTERIAL ENDOSYMBIONTS; SYMBIONT-CONFERRED RESISTANCE; GENETIC-VARIATION; PEA APHIDS; HOST; TEMPERATURE; SPECIFICITY; MAINTENANCE; ENVIRONMENT; VIRULENCE	Temperature variation is an important factor determining the outcomes of interspecific interactions, including those involving hosts and parasites. This can apply to variation in average temperature or to relatively short but intense bouts of extreme temperature. We investigated the effect of heat shock on the ability of aphids (Aphis fabae) harbouring protective facultative endosymbionts (Hamiltonella defensa) to resist parasitism by Hymenopteran parasitoids (Lysiphlebus fabarum). Furthermore, we investigated whether heat shocks can modify previously observed genotype-by-genotype (G x G) interactions between different endosymbiont isolates and parasitoid genotypes. Lines of genetically identical aphids possessing different isolates of H. defensa were exposed to one of two heat shock regimes (35 degrees C and 39 degrees C) or to a control temperature (20 degrees C) before exposure to three different asexual lines of the parasitoids. We observed strong G x G interactions on parasitism rates, reflecting the known genetic specificity of symbiont-conferred resistance, and we observed a significant G x G x E interaction induced by heat shocks. However, this three-way interaction was mainly driven by the more extreme heat shock (39 degrees C), which had devastating effects on aphid lifespan and reproduction. Restricting the analysis to the more realistic heat shock of 35 degrees C, the G x G x E interaction was weaker (albeit still significant), and it did not lead to any reversals of the aphid lines' susceptibility rankings to different parasitoids. Thus, under conditions feasibly encountered in the field, the relative fitness of different parasitoid genotypes on hosts protected by particular symbiont strains remains mostly uncomplicated by heat stress, which should simplify biological control programs dealing with this system.	[Cayetano, Luis; Vorburger, Christoph] ETH, Inst Integrat Biol, Zurich, Switzerland; [Cayetano, Luis; Vorburger, Christoph] Swiss Fed Inst Aquat Sci & Technol, EAWAG, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Cayetano, L (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	luis.cayetano@eawag.ch	Vorburger, Christoph/A-1650-2008	Vorburger, Christoph/0000-0002-3627-0841	Swiss National Science Foundation (SNSF Professorship) [PP00P3_123376]	Swiss National Science Foundation (SNSF Professorship)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNSF Professorship PP00P3_123376 to CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DE, 2011, EVOL ECOL, V25, P499, DOI 10.1007/s10682-010-9413-2; Amice G, 2008, ECOL ENTOMOL, V33, P701, DOI 10.1111/j.1365-2311.2008.01019.x; Belshaw R, 2003, GENOME, V46, P170, DOI 10.1139/G02-112; Belshaw R, 1999, EVOLUTION, V53, P1189, DOI [10.2307/2640822, 10.1111/j.1558-5646.1999.tb04532.x]; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; Bryner SF, 2011, AM NAT, V177, P65, DOI 10.1086/657620; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CARRUTHERS RI, 1992, ECOLOGY, V73, P190, DOI 10.2307/1938731; Cayetano L, 2013, J EVOLUTION IN PRESS; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Denis D, 2011, ECOL MODEL, V222, P1604, DOI 10.1016/j.ecolmodel.2011.02.023; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fels D, 2006, P ROY SOC B-BIOL SCI, V273, P1031, DOI 10.1098/rspb.2005.3404; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.2307/1165127; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JUDSON OP, 1995, GENET RES, V65, P175, DOI 10.1017/S0016672300033267; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; Laine AL, 2008, OIKOS, V117, P1281, DOI 10.1111/j.0030-1299.2008.16563.x; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lukasik P, 2013, OECOLOGIA; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Mostowy R, 2011, P ROY SOC B-BIOL SCI, V278, P2283, DOI 10.1098/rspb.2010.2359; OHTAKA C, 1991, SYMBIOSIS, V11, P19; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Outreman Y, 2005, BEHAV PROCESS, V70, P93, DOI 10.1016/j.beproc.2005.04.004; Rouchet R, 2012, J EVOLUTION BIOL, V25, P2369, DOI 10.1111/j.1420-9101.2012.02608.x; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sandrock C, 2010, J EVOLUTION BIOL, V23, P578, DOI 10.1111/j.1420-9101.2009.01925.x; Sandrock C, 2011, MOL ECOL, V20, P4165, DOI 10.1111/j.1365-294X.2011.05242.x; Schmid M, 2012, FUNCT ECOL, V26, P207, DOI 10.1111/j.1365-2435.2011.01904.x; Stary P, 2006, APHID PARASITOIDS CZ; Tetard-Jones C, 2007, AM NAT, V170, P492, DOI 10.1086/520115; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; van Baaren J, 2005, ANIM BEHAV, V70, P153, DOI 10.1016/j.anbehav.2004.10.016; Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Vorburger C, 2013, ECOL EVOL, V3, P706, DOI 10.1002/ece3.491; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	57	14	14	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75966	10.1371/journal.pone.0075966	http://dx.doi.org/10.1371/journal.pone.0075966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143175	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100010
J	D'Souza, E; Patankar, V; Arthur, R; Alcoverro, T; Kelkar, N				D'Souza, Elrika; Patankar, Vardhan; Arthur, Rohan; Alcoverro, Teresa; Kelkar, Nachiket			Long-Term Occupancy Trends in a Data-Poor Dugong Population in the Andaman and Nicobar Archipelago	PLOS ONE			English	Article							MARINE MAMMALS; LIFE-HISTORY; SEAGRASS; CONSERVATION; LANDSCAPE; ISLANDS; QUEENSLAND; MOVEMENT; DYNAMICS; HOTSPOTS	Prioritizing efforts for conserving rare and threatened species with limited past data and lacking population estimates is predicated on robust assessments of their occupancy rates. This is particularly challenging for elusive, long-lived and wide-ranging marine mammals. In this paper we estimate trends in long-term (over 50years) occupancy, persistence and extinction of a vulnerable and data-poor dugong (Dugong dugon) population across multiple seagrass meadows in the Andaman and Nicobar archipelago (India). For this we use hierarchical Bayesian dynamic occupancy models accounting for false negatives (detection probability, 1), persistence and extinction, to two datasets: a) fragmentary long-term occurrence records from multiple sources (1959-2004, n = 40 locations), and b) systematic detection/non-detection data from current surveys (2010-2012, n = 57). Dugong occupancy across the archipelago declined by 60% (from 0.45 to 0.18) over the last 20 years and present distribution was largely restricted to sheltered bays and channels with seagrass meadows dominated by Halophila and Halodule sp. Dugongs were not found in patchy meadows with low seagrass cover. In general, seagrass habitat availability was not limiting for dugong occupancy, suggesting that anthropogenic factors such as entanglement in gillnets and direct hunting may have led to local extinction of dugongs from locations where extensive seagrass meadows still thrive. Effective management of these remnant dugong populations will require a multi-pronged approach, involving 1) protection of areas where dugongs still persist, 2) monitoring of seagrass habitats that dugongs could recolonize, 3) reducing gillnet use in areas used by dugongs, and 4) engaging with indigenous/settler communities to reduce impacts of hunting.	[D'Souza, Elrika; Patankar, Vardhan; Arthur, Rohan; Alcoverro, Teresa; Kelkar, Nachiket] Nat Conservat Fdn, Oceans & Coasts Program, Mysore, Karnataka, India; [Alcoverro, Teresa] Spanish Natl Res Council, Ctr Estudis Avancats Blanes, Blanes, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Kelkar, N (corresponding author), Nat Conservat Fdn, Oceans & Coasts Program, Mysore, Karnataka, India.	nachiket@ncf-india.org	Alcoverro, Teresa/J-9258-2012	Alcoverro, Teresa/0000-0002-3910-9594; Arthur, Rohan/0000-0003-4267-9720	Conservation Leadership Program (Future Conservationist Award); Ministry of Environment and Forests (Species Recovery Program); Mohammed Bin Zayed Species Conservation Fund; Ravi Sankaran Inlaks Small Grants Program; Nature Conservation Foundation (Oceans and Coasts program); Plan Nacional I+D+I, Spain [CTM2010-22273-C02]	Conservation Leadership Program (Future Conservationist Award); Ministry of Environment and Forests (Species Recovery Program); Mohammed Bin Zayed Species Conservation Fund; Ravi Sankaran Inlaks Small Grants Program; Nature Conservation Foundation (Oceans and Coasts program); Plan Nacional I+D+I, Spain	This research was supported and funded by the Conservation Leadership Program (Future Conservationist Award), Ministry of Environment and Forests (Species Recovery Program), Mohammed Bin Zayed Species Conservation Fund, the Ravi Sankaran Inlaks Small Grants Program and Nature Conservation Foundation (Oceans and Coasts program). TA was partially funded by the project CTM2010-22273-C02 (Plan Nacional I+D+I, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aing C, 2011, J APPL ECOL, V48, P1508, DOI 10.1111/j.1365-2664.2011.02037.x; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], 1956, ANDAMAN NICOBAR ISLA; Aragones Lemnuel, 2000, Pacific Conservation Biology, V5, P277; Aragones LV, 2006, OECOLOGIA, V149, P635, DOI 10.1007/s00442-006-0477-1; Aragones Lemnuel V., 1997, Asian Marine Biology, V14, P15; Aragones Lemnuel V., 2012, P179; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Carr MH, 2003, ECOL APPL, V13, pS90; D'Souza Elrika, 2010, P443; D'souza Elrika, 2009, Journal of Threatened Taxa, V1, P49; Das H. S., 1999, Journal of the Bombay Natural History Society, V96, P195; Das HS, 1996, STATUS SEAGRASS HABI; Davidar P., 1999, P IUFRO S HELD CHIAN, P287; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; De Iongh HH, 1998, MAR ECOL-P S Z N I, V19, P179; DEIONGH HH, 1995, AQUAT BOT, V50, P1, DOI 10.1016/0304-3770(94)00438-R; Director-Census Operations, 2011, PROV POP TOT RUR URB, V2; EBERHARDT LL, 1979, WILDLIFE MONOGR, P6; Garrigue C, 2008, MAR MAMMAL SCI, V24, P81, DOI 10.1111/j.1748-7692.2007.00173.x; Grech A, 2009, THESIS; Herben T, 2006, J ECOL, V94, P131, DOI 10.1111/j.1365-2745.2005.01063.x; Hines Ellen, 2012, P58; Hines EM, 2005, MAR MAMMAL SCI, V21, P536, DOI 10.1111/j.1748-7692.2005.tb01247.x; Hodgson AJ, 2007, J EXP MAR BIOL ECOL, V340, P50, DOI 10.1016/j.jembe.2006.08.006; Issaris Y, 2012, MAR ECOL PROG SER, V453, P95, DOI 10.3354/meps09668; JAGTAP TG, 1992, INDIAN J MAR SCI, V21, P56; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Kwan D, 2006, ENVIRON CONSERV, V33, P164, DOI 10.1017/S0376892906002992; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKenzie DI., 2006, OCCUPANCY ESTIMATION; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Marsh H, 2005, ECOL APPL, V15, P481, DOI 10.1890/04-0673; MARSH H, 1981, BIOL CONSERV, V19, P255, DOI 10.1016/0006-3207(81)90002-1; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H., 2002, DUGONG DUGONG DUGON; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Marsh Helene, 2003, P383; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; Moore SE, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P137; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakaoka M, 1999, MAR ECOL PROG SER, V184, P97, DOI 10.3354/meps184097; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; O'Shea TJ, 2008, J MAMMAL, V89, P529, DOI 10.1644/07-MAMM-S-416R.1; Pillay R, 2011, BIOL CONSERV, V144, P1567, DOI 10.1016/j.biocon.2011.01.026; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; PREEN A, 1995, J MAMMAL, V76, P163, DOI 10.2307/1382325; Preen A, 1993, THESIS J COOK U NO Q; Preen Anthony, 2012, P91; R Development Core Team, 2012, R LANG ENV STAT COMP; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Rivadeneira MM, 2009, ECOLOGY, V90, P1291, DOI 10.1890/08-0316.1; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Royle JA, 2008, HIERARCHICAL MODELIN, P297; Sankaran R, 2005, GROUND BENEATH WAVES, VII; Saracco JF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00132.1; Sathasivam K, 2004, MARINE MAMMALS INDIA; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sheppard JK, 2007, ESTUAR COAST SHELF S, V71, P117, DOI 10.1016/j.ecss.2006.07.006; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Tun T, 2007, ASSESSMENT DUG UNPUB; van der Heide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042060	72	19	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76181	10.1371/journal.pone.0076181	http://dx.doi.org/10.1371/journal.pone.0076181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143180	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100015
J	Miller, KA; Gordon, CT; Welfare, MF; Caruana, G; Bertram, JF; Bateman, JF; Farlie, PG				Miller, Kerry A.; Gordon, Christopher T.; Welfare, Megan F.; Caruana, Georgina; Bertram, John F.; Bateman, John F.; Farlie, Peter G.			bfb, a Novel ENU-Induced blebs Mutant Resulting from a Missense Mutation in Fras1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; RENAL AGENESIS; PALATE FUSION; CLEFT-PALATE; MICE; LIMB; IDENTIFICATION; ADHESION; PROTEIN; GENES	Fras1 is an extracellular matrix associated protein with essential roles in adhesion of epithelia and mesenchyme during early embryonic development. The adhesive function of Fras1 is achieved through interaction with a group of related proteins, Frem 1-3, and a cytoplasmic adaptor protein Grip1. Mutation of each of these proteins results in characteristic epithelial blistering and have therefore become known as "blebs" proteins. Human Fraser syndrome presents with a similar phenotype and the blebs mice have been instrumental in identification of the genetic basis of Fraser syndrome. We have identified a new ENU-induced blebs allele resulting from a novel missense mutation in Fras1. The resulting mouse strain, blood filled blisters (bfb), presents with a classic blebs phenotype but does not exhibit embryonic lethality typical of other blebs mutants and in addition, we report novel palate and sternal defects. Analysis of the bfb phenotype confirms the presence of epithelial-mesenchymal adhesion defects but also supports the emerging role of blebs proteins in regulating signalling during organogenesis. The bfb strain provides new opportunities to investigate the role of Fras1 in development.	[Miller, Kerry A.; Gordon, Christopher T.; Welfare, Megan F.; Bateman, John F.; Farlie, Peter G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Mol Biol, Parkville, Vic 3052, Australia; [Caruana, Georgina; Bertram, John F.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Monash University	Farlie, PG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	peter.farlie@mcri.edu.au	Bertram, John F/I-2588-2014; Gordon, Chris/F-1267-2017	Bertram, John F/0000-0001-5863-6464; Gordon, Chris/0000-0002-9300-8399; Bateman, John/0000-0001-8542-0730	NHMRC Australia [1002660]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by NHMRC Australia grant 1002660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caruana G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055429; Cavalcanti DP, 2007, AM J MED GENET A, V143A, P241, DOI 10.1002/ajmg.a.31426; CHEN JM, 1953, J ANAT, V87, P130; CHEN JM, 1952, J ANAT, V86, P373; Chiotaki R, 2007, GENE EXPR PATTERNS, V7, P381, DOI 10.1016/j.modgep.2006.12.001; EIJGELAAR A, 1970, THORAX, V25, P490, DOI 10.1136/thx.25.4.490; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Hoefele J, 2013, GENE, V520, P194, DOI 10.1016/j.gene.2013.02.031; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Kiyozumi D, 2006, P NATL ACAD SCI USA, V103, P11981, DOI 10.1073/pnas.0601011103; Kiyozumi D, 2012, J CELL BIOL, V197, P677, DOI 10.1083/jcb.201203065; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Little CaB HJ, 1923, AM J ROENTGENOL, V10, P975; Martinez-Sanz E, 2008, DIFFERENTIATION, V76, P417, DOI 10.1111/j.1432-0436.2007.00226.x; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Ng WY, 2013, CLIN GENET, V83, P162, DOI 10.1111/j.1399-0004.2012.01851.x; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; Ogur G, 2011, GENET COUNSEL, V22, P233; Petrou P, 2007, MATRIX BIOL, V26, P652, DOI 10.1016/j.matbio.2007.05.008; Pitera JE, 2012, GENESIS, V50, P892, DOI 10.1002/dvg.22045; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Saisawat P, 2012, KIDNEY INT, V81, P196, DOI 10.1038/ki.2011.315; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Smyth I, 2005, HUM MOL GENET, V14, pR269, DOI 10.1093/hmg/ddi262; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tavares AT, 2001, INT J DEV BIOL, V45, P707; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tudela C, 2002, INT J DEV BIOL, V46, P333; van Haelst MM, 2008, AM J MED GENET A, V146A, P2252, DOI 10.1002/ajmg.a.32440; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; WALLIN J, 1994, DEVELOPMENT, V120, P1109	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76342	10.1371/journal.pone.0076342	http://dx.doi.org/10.1371/journal.pone.0076342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143185	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100020
J	Rugman-Jones, PF; Hoddle, CD; Hoddle, MS; Stouthamer, R				Rugman-Jones, Paul F.; Hoddle, Christina D.; Hoddle, Mark S.; Stouthamer, Richard			The Lesser of Two Weevils: Molecular-Genetics of Pest Palm Weevil Populations Confirm Rhynchophorus vulneratus (Panzer 1798) as a Valid Species Distinct from R. ferrugineus (Olivier 1790), and Reveal the Global Extent of Both	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE; MAXIMUM-LIKELIHOOD; DNA; EVOLUTION; SEQUENCES	The red palm weevil (RPW) is a major pest of palms. It is native to southeast Asia and Melanesia, but in recent decades has vastly expanded its range as the result of multiple accidental anthropogenic introductions into the Middle East, Mediterranean Basin, Caribbean, and U. S. A. Currently regarded as a single species, Rhynchophorus ferrugineus (Olivier), RPW displays remarkable color variation across its range, and consequently has a taxonomic history littered with new species descriptions and synonymization. We compared DNA sequences of the mitochondrial cytochrome oxidase subunit I (COI) gene from RPW populations throughout the native and invaded ranges, to investigate the specific status and invasion history of this serious economic pest, and to identify possible common routes of entry. Analyses of COI haplotype data provide conclusive support, corroborated by sequences of additional nuclear gene regions, for the existence of at least two predominantly allopatric species. The true R. ferrugineus is native only to the northern and western parts of continental southeast Asia, Sri Lanka and the Philippines, and is responsible for almost all invasive populations worldwide. In contrast, the second species, which is currently synonymized under R. ferrugineus and should be resurrected under the name R. vulneratus (Panzer), has a more southern distribution across Indonesia, and is responsible for only one invasive population; that in California, U. S. A. The distribution of COI haplotypes is used to discuss the possible existence of further cryptic species, sources and routes of entry of different invasive populations, and the implications of our findings for current control methods.	[Rugman-Jones, Paul F.; Hoddle, Christina D.; Hoddle, Mark S.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Rugman-Jones, Paul F.; Hoddle, Christina D.; Hoddle, Mark S.; Stouthamer, Richard] Univ Calif Riverside, Ctr Invas Species Res, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Rugman-Jones, PF (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	paulrj@ucr.edu			California Department of Food and Agriculture [SCB 11061]	California Department of Food and Agriculture	This work was supported, in part, by funds from the California Department of Food and Agriculture's Specialty Crops Block Grant SCB 11061 (http://www.cdfa.ca.gov/Specialty_Crop_Competitiveness_Grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas MST, 2010, INTEGR MANAG PLANT P, V5, P209, DOI 10.1007/978-90-481-8606-8_9; Abulyazid I., 2002, Journal of the Egyptian German Society of Zoology, V38, P1; Al-Ayied H.Y., 2006, Archives of Phytopathology and Plant Protection, V39, P303, DOI 10.1080/03235400500222461; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2008, NATION; Cox M. L., 1993, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V41, P30; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Mergawy R.A.A.M., 2011, J AGR SCI TECH-IRAN, V1, P1; El-Mergawy RAAM, 2011, J AGR SCI TECHNOLO B, VB1, P189; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P631; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P227; Faleiro J. R., 2006, International Journal of Tropical Insect Science, V26, P135, DOI 10.1079/IJT2006113; Ferry M, 2002, RED PALM WEEVIL MEDI, V4; Gadelhak G. G., 2005, International Journal of Agriculture and Biology, V7, P395; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallett RH, 2004, J NAT HIST, V38, P2863, DOI 10.1080/00222930310001657874; HALLETT RH, 1993, NATURWISSENSCHAFTEN, V80, P328, DOI 10.1007/BF01141908; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hoddle M. S., 2011, Pakistan Entomologist, V33, P77; Huis A., 2013, EDIBLE INSECTS FUTUR; Kehat M, 1999, PHYTOPARASITICA, V27, P241, DOI 10.1007/BF02981465; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Molet T, 2011, CPHST PEST DATASHEET; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; NAPPO, 2010, 1 US DET RED PALM WE; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Perez AL, 1996, J CHEM ECOL, V22, P357, DOI 10.1007/BF02055104; Rugman-Jones PF, 2010, J ECON ENTOMOL, V103, P877, DOI 10.1603/EC09300; Salama H.S., 2002, Archives of Phytopathology and Plant Protection, V35, P299, DOI 10.1080/03235400216136; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang L, 2013, INSECT SCI, V20, P689, DOI 10.1111/j.1744-7917.2012.01561.x; Wattanapongsiri A., 1966, Sci Bull Dep Agric Bangkok, V1, P1; Woodruff DS, 1993, J BIOGEOGR, V30, P551	39	72	77	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78379	10.1371/journal.pone.0078379	http://dx.doi.org/10.1371/journal.pone.0078379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143263	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100102
J	Schrunder, S; Schnack-Schiel, SB; Auel, H; Sartoris, FJ				Schruender, Sabine; Schnack-Schiel, Sigrid B.; Auel, Holger; Sartoris, Franz Josef			Control of Diapause by Acidic pH and Ammonium Accumulation in the Hemolymph of Antarctic Copepods	PLOS ONE			English	Article							INVERTEBRATE SIPUNCULUS-NUDUS; CALANUS-PROPINQUUS COPEPODA; LIFE-CYCLE STRATEGIES; MARGINAL ICE-ZONE; CALANOIDES-ACUTUS; WEDDELL-SEA; METABOLIC DEPRESSION; BUOYANCY MECHANISM; MARINE ZOOPLANKTON; RHINCALANUS-GIGAS	Life-cycles of polar herbivorous copepods are characterised by seasonal/ontogenetic vertical migrations and diapause to survive periods of food shortage during the long winter season. However, the triggers of vertical migration and diapause are still far from being understood. In this study, we test the hypothesis that acidic pH and the accumulation of ammonium (NH4+) in the hemolymph contribute to the control of diapause in certain Antarctic copepod species. In a recent study, it was already hypothesized that the replacement of heavy ions by ammonium is necessary for diapausing copepods to achieve neutral buoyancy at overwintering depth. The current article extends the hypothesis of ammonium-aided buoyancy by highlighting recent findings of low pH values in the hemolymph of diapausing copepods with elevated ammonium concentrations. Since ammonia (NH3) is toxic to most organisms, a low hemolymph pH is required to maintain ammonium in the less toxic ionized form (NH4+). Recognizing that low pH values are a relevant factor reducing metabolic rate in other marine invertebrates, the low pH values found in overwintering copepods might not only be a precondition for ammonium accumulation, but in addition, it may insure metabolic depression throughout diapause.	[Schruender, Sabine; Auel, Holger] Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany; [Schnack-Schiel, Sigrid B.; Sartoris, Franz Josef] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Schrunder, S (corresponding author), Univ Bremen, BreMarE Bremen Marine Ecol, D-28359 Bremen, Germany.	sabines@uni-bremen.de		Sartoris, Franz-Josef/0000-0001-7228-3220	Deutsche Forschungsgemeinschaft (DFG) [AU 175/6, SA 1713/3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the priority programme 'Antarctic Research with comparative investigations in Arctic ice areas' (grant numbers AU 175/6 and SA 1713/3). http://www.spp-antarktisforschung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON A, 1991, MAR BIOL, V109, P79, DOI 10.1007/BF01320234; Atkinson A, 1998, J MARINE SYST, V15, P289, DOI 10.1016/S0924-7963(97)00081-X; Auel H, 2005, DEEP-SEA RES PT I, V52, P1272, DOI 10.1016/j.dsr.2005.01.005; Ben-Yaakov S, 1970, LIMNOL OCEANOGR, P326; Bocher P, 2002, J PLANKTON RES, V24, P1317, DOI 10.1093/plankt/24.12.1317; BOWER CE, 1978, J FISH RES BOARD CAN, V35, P1012, DOI 10.1139/f78-165; Boyd CM, 2002, MAR BIOL, V141, P605, DOI 10.1007/s00227-002-0872-z; BUSA WB, 1983, SCIENCE, V221, P366, DOI 10.1126/science.221.4608.366; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; CHEN JC, 1992, AQUACULTURE, V104, P249, DOI 10.1016/0044-8486(92)90207-2; CLARKE A, 1991, POLAR RES, V10, P355, DOI 10.1111/j.1751-8369.1991.tb00659.x; CLARKE MR, 1979, J MAR BIOL ASSOC UK, V59, P259, DOI 10.1017/S0025315400042570; Conover R.J., 1991, Journal of Marine Systems, V2, P1, DOI 10.1016/0924-7963(91)90011-I; DENTON EJ, 1974, PROC R SOC SER B-BIO, V185, P273, DOI 10.1098/rspb.1974.0020; DENTON EJ, 1969, PROC R SOC SER B-BIO, V174, P271, DOI 10.1098/rspb.1969.0093; DONNELLY J, 1994, POLAR BIOL, V14, P171; Fofonoff N.P., 1983, UNESCO TECH PAP MAR, V36, P17; Hagen W, 2001, ZOOL-ANAL COMPLEX SY, V104, P313, DOI 10.1078/0944-2006-00037; HAGEN W, 1996, RES PAP, V43, P139; HAND SC, 1988, SCIENCE, V239, P1425, DOI 10.1126/science.239.4846.1425; Heath MR, 2004, ICES J MAR SCI, V61, P698, DOI 10.1016/j.icesjms.2004.03.013; HOPKINS TL, 1989, DEEP-SEA RES, V36, P543, DOI 10.1016/0198-0149(89)90005-8; HOPKINS TL, 1993, DEEP-SEA RES PT I, V40, P81, DOI 10.1016/0967-0637(93)90054-7; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Langenbuch M, 2002, J EXP BIOL, V205, P1153; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Lin YC, 2001, J EXP MAR BIOL ECOL, V259, P109, DOI 10.1016/S0022-0981(01)00227-1; MARIN VH, 1993, POLAR BIOL, V13, P35; Metz C, 1995, MAR ECOL PROG SER, V129, P71, DOI 10.3354/meps129071; OSTRENSKY A, 1995, AQUACULTURE, V132, P339, DOI 10.1016/0044-8486(94)00343-M; Pasternak AF, 2001, HYDROBIOLOGIA, V453, P25, DOI 10.1023/A:1013147413136; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; Pond DW, 2012, DEEP-SEA RES PT II, V59, P93, DOI 10.1016/j.dsr2.2011.05.009; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; Portner HO, 2000, J EXP BIOL, V203, P2417; Prosser, 1973, COMP ANIMAL PHYSL, P966; Randall DJ, 2002, MAR POLLUT BULL, V45, P17, DOI 10.1016/S0025-326X(02)00227-8; REES BB, 1990, J EXP BIOL, V152, P77; Reipschlager A, 1996, J EXP BIOL, V199, P1801; SANDERS NK, 1988, J EXP BIOL, V138, P333; Sartoris FJ, 2010, LIMNOL OCEANOGR, V55, P1860, DOI 10.4319/lo.2010.55.5.1860; Schnack-Schiel SB, 2001, HYDROBIOLOGIA, V453, P9, DOI 10.1023/A:1013195329066; SCHNACKSCHIEL SB, 1991, MAR ECOL PROG SER, V70, P17, DOI 10.3354/meps070017; SCHNACKSCHIEL SB, 1995, ICES J MAR SCI, V52, P541, DOI 10.1016/1054-3139(95)80068-9; Seibel BA, 2004, J EXP MAR BIOL ECOL, V313, P375, DOI 10.1016/j.jembe.2004.08.015; SWIFT DJ, 1981, J FISH BIOL, V19, P45, DOI 10.1111/j.1095-8649.1981.tb05810.x; Visser Andre W., 1999, Fisheries Oceanography, V8, P100, DOI 10.1046/j.1365-2419.1999.00001.x; Voight JR, 1994, MAR FRESHW BEHAV PHY, V25, P193, DOI 10.1080/10236249409378917; Voronina N. M., 1970, P162; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Yamada Yuichiro, 1999, Plankton Biology and Ecology, V46, P62	51	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77498	10.1371/journal.pone.0077498	http://dx.doi.org/10.1371/journal.pone.0077498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143238	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100076
J	Egger, J				Egger, Jan			PCG-Cut: Graph Driven Segmentation of the Prostate Central Gland	PLOS ONE			English	Article							IMAGE SEGMENTATION; AUTOMATIC SEGMENTATION; MR-IMAGES; MODELS	Prostate cancer is the most abundant cancer in men, with over 200,000 expected new cases and around 28,000 deaths in 2012 in the US alone. In this study, the segmentation results for the prostate central gland (PCG) in MR scans are presented. The aim of this research study is to apply a graph-based algorithm to automated segmentation (i.e. delineation) of organ limits for the prostate central gland. The ultimate goal is to apply automated segmentation approach to facilitate efficient MR-guided biopsy and radiation treatment planning. The automated segmentation algorithm used is graph-driven based on a spherical template. Therefore, rays are sent through the surface points of a polyhedron to sample the graph's nodes. After graph construction - which only requires the center of the polyhedron defined by the user and located inside the prostate center gland - the minimal cost closed set on the graph is computed via a polynomial time s-t-cut, which results in the segmentation of the prostate center gland's boundaries and volume. The algorithm has been realized as a C++ module within the medical research platform MeVisLab and the ground truth of the central gland boundaries were manually extracted by clinical experts (interventional radiologists) with several years of experience in prostate treatment. For evaluation the automated segmentations of the proposed scheme have been compared with the manual segmentations, yielding an average Dice Similarity Coefficient (DSC) of 78.94 +/- 10.85%.	Univ Hosp Marburg UKGM, Dept Med, Marburg, Hesse, Germany	University Hospital of Giessen & Marburg	Egger, J (corresponding author), Univ Hosp Marburg UKGM, Dept Med, Marburg, Hesse, Germany.	egger@med.uni-marburg.de						Artan Y, 2011, I S BIOMED IMAGING, P1459, DOI 10.1109/ISBI.2011.5872675; Birkbecky N, 2012, REGION SPECIFIC HIER; Bowes M., 2012, FULLY AUTOMATIC SEGM; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cootes T., 2005, 16 BRIT MACH VIS C, V2, P879; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; D'Amico AV, 2001, NEW ENGL J MED, V344, P776, DOI 10.1056/NEJM200103083441017; Dowling JA, 2011, LECT NOTES COMPUT SC, V6963, P10, DOI 10.1007/978-3-642-23944-1_2; Egger J, 2010, P INT BIOS PROC C BE, P1; Egger J., 2010, LNCS, V6376, P383; Egger J, 2007, COMP MED SY, P177, DOI 10.1109/CBMS.2007.5; Egger J, 2012, J MED SYST, V36, P2829, DOI 10.1007/s10916-011-9761-7; Egger J, 2012, J MED SYST, V36, P2097, DOI 10.1007/s10916-011-9673-6; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fedorov A, 2012, J MAGN RESON IMAGING, V36, P987, DOI 10.1002/jmri.23688; Gao Q, 2012, MED IMAGE COMPUTING; Geremia E, 2010, LECT NOTES COMPUT SC, V6361, P111; Ghose S, 2012, INT C PATT REC ICPR, P1; Ghose S, 2012, RANDOM FOREST BASED; Ghose S, 2012, COMPUT METH PROG BIO, V108, P262, DOI 10.1016/j.cmpb.2012.04.006; Kapur T, 2014, COLOR IN PRESS; Kirschner M, 2011, SPIE MED IMAGING IMA, V7962; Kirschner M, 2012, AUTOMATIC PROSTATE S; Klein S, 2008, MED PHYS, V35, P1407, DOI 10.1118/1.2842076; Kroon DJ, 2012, P SPIE MED IMAGING C, V8315; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Li W, 2011, LECT NOTES COMPUT SC, V6893, P570, DOI 10.1007/978-3-642-23626-6_70; Lindeberg T, 1996, PROC CVPR IEEE, P465, DOI 10.1109/CVPR.1996.517113; Litjens G, 2012, MED IMAGE COMPUTING; Maan B, 2012, MED IMAGE COMPUTING; Makni N, 2009, INT J COMPUT ASS RAD, V4, P181, DOI 10.1007/s11548-008-0281-y; Malmberg F, 2012, SMART PAINT NEW INTE; Martin S, 2008, INT J COMPUT ASS RAD, V3, P485, DOI 10.1007/s11548-008-0247-0; Medical Image Computing and Computer Assisted Intervention (MICCAI), 2012, GRAND CHALL PROST MR; Moschidis E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1727, DOI 10.1109/ISBI.2012.6235913; Ou Y, 2012, MULTIATLAS SEGMENTAI; Samiee M, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P203, DOI 10.1109/ISSPIT.2006.270797; Sampa MP, 2006, IEEE IMAGE PROC, P81, DOI 10.1109/ICIP.2006.312367; Strekalovskiy E, 2011, IEEE I CONF COMP VIS, P2619, DOI 10.1109/ICCV.2011.6126551; Toth R, 2012, DEFORMABLE LANDMARK; Veksler O, 2008, LECT NOTES COMPUT SC, V5304, P454, DOI 10.1007/978-3-540-88690-7_34; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Xin L, 2009, IEEE T MED IMAGING, V28, P906, DOI 10.1109/TMI.2009.2012888; Yin Y, 2012, SPIE MED IAMGING IMA, V8314; Yuan J., 2012, EFFICIENT CONVEX OPT; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zwiggelaar R, 2003, LECT NOTES COMPUT SC, V2652, P1108	51	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76645	10.1371/journal.pone.0076645	http://dx.doi.org/10.1371/journal.pone.0076645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146901	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400068
J	Singh, NK; Repsilber, D; Liebscher, V; Taher, L; Fuellen, G				Singh, Nitesh Kumar; Repsilber, Dirk; Liebscher, Volkmar; Taher, Leila; Fuellen, Georg			Identifying Genes Relevant to Specific Biological Conditions in Time Course Microarray Experiments	PLOS ONE			English	Article							EXPRESSION; CLASSIFICATION; ASSOCIATIONS; PREDICTION; SELECTION; NETWORKS; PROTEINS; DATABASE; MODEL	Microarrays have been useful in understanding various biological processes by allowing the simultaneous study of the expression of thousands of genes. However, the analysis of microarray data is a challenging task. One of the key problems in microarray analysis is the classification of unknown expression profiles. Specifically, the often large number of non-informative genes on the microarray adversely affects the performance and efficiency of classification algorithms. Furthermore, the skewed ratio of sample to variable poses a risk of overfitting. Thus, in this context, feature selection methods become crucial to select relevant genes and, hence, improve classification accuracy. In this study, we investigated feature selection methods based on gene expression profiles and protein interactions. We found that in our setup, the addition of protein interaction information did not contribute to any significant improvement of the classification results. Furthermore, we developed a novel feature selection method that relies exclusively on observed gene expression changes in microarray experiments, which we call "relative Signal-to-Noise ratio" (rSNR). More precisely, the rSNR ranks genes based on their specificity to an experimental condition, by comparing intrinsic variation, i.e. variation in gene expression within an experimental condition, with extrinsic variation, i.e. variation in gene expression across experimental conditions. Genes with low variation within an experimental condition of interest and high variation across experimental conditions are ranked higher, and help in improving classification accuracy. We compared different feature selection methods on two time-series microarray datasets and one static microarray dataset. We found that the rSNR performed generally better than the other methods.	[Singh, Nitesh Kumar; Taher, Leila; Fuellen, Georg] Univ Rostock, Dept Med, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Repsilber, Dirk] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Germany; [Liebscher, Volkmar] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, Greifswald, Germany	University of Rostock; Forschungsinstitut fur Nutztierbiologie (FBN); Ernst Moritz Arndt Universitat Greifswald	Taher, L (corresponding author), Univ Rostock, Dept Med, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany.	leila.taher@uni-rostock.de; fuellen@uni-rostock.de	Liebscher, Volkmar/R-6865-2019; Liebscher, Volkmar/P-3543-2018	Liebscher, Volkmar/0000-0003-1446-4423; Liebscher, Volkmar/0000-0003-1446-4423; Singh, Nitesh/0000-0002-4536-2318; Taher, Leila/0000-0002-2013-5426	German Research Foundation (DFG) [FUE 583/2-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	LT and GF are funded by the German Research Foundation (DFG, FUE 583/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Constantinides CD, 2005, MAGNETIC RESONANCE M, V38, P852, DOI DOI 10.1002/MRM.1910380524/ABSTRACT; Daly TM, 2005, J MOL DIAGN, V7, P404, DOI 10.1016/S1525-1578(10)60570-3; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Duval B, 2010, BRIEF BIOINFORM, V11, P127, DOI 10.1093/bib/bbp035; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engreitz JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-603; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goh L., 2004, P 2 C AS PAC BIOINF, P161; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hafemeister C, 2011, BIOINFORMATICS, V27, P946, DOI 10.1093/bioinformatics/btr037; Hayes KR, 2005, MOL PHARMACOL, V67, P1360, DOI 10.1124/mol.104.009175; Hengpraprohm S, 2009, INT J INNOVATIVE COM, V5; Huang CJ, 2003, PROC INT C TOOLS ART, P451, DOI 10.1109/TAI.2003.1250224; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Lakshmi K, 2006, THIRD INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: NEW GENERATIONS, PROCEEDINGS, P541, DOI 10.1109/ITNG.2006.30; Ma XT, 2007, BIOINFORMATICS, V23, P215, DOI 10.1093/bioinformatics/btl569; Mishra D., 2011, INT J SCI ENG RES, V2; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ryu J, 2002, IEEE IJCNN, P198, DOI 10.1109/IJCNN.2002.1005469; Scheubert L, 2011, DNA RES, V18, P233, DOI 10.1093/dnares/dsr016; Slonim D. K., 2000, RECOMB 2000. Proceedings of the Fourth Annual International Conference on Computational Molecular Biology, P263, DOI 10.1145/332306.332564; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Staiger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034796; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	46	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76561	10.1371/journal.pone.0076561	http://dx.doi.org/10.1371/journal.pone.0076561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146889	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400064
J	Hou, AH; Toh, LX; Gan, KH; Lee, KJR; Manser, E; Tong, L				Hou, Aihua; Toh, Li Xian; Gan, Kah Hui; Lee, Khee Jin Ryan; Manser, Edward; Tong, Louis			Rho GTPases and Regulation of Cell Migration and Polarization in Human Corneal Epithelial Cells	PLOS ONE			English	Article							BINDING PROTEIN-RHO; FAMILY GTPASES; CDC42 CONTROLS; INTEGRIN ALPHA-V-BETA-5; KINASE; EXPRESSION; ADHESION; CYTOSKELETON; ACTIVATION; LIMBAL	Purpose: Epithelial cell migration is required for regeneration of tissues and can be defective in a number of ocular surface diseases. This study aimed to determine the expression pattern of Rho family small G-proteins in human corneal epithelial cells to test their requirement in directional cell migration. Methods: Rho family small G-protein expression was assessed by reverse transcription-polymerase chain reaction. Dominant-inhibitory constructs encoding Rho proteins or Rho protein targeting small interfering RNA were transfected into human corneal epithelial large T antigen cells, and wound closure rate were evaluated by scratch wounding assay, and a complementary non-traumatic cell migration assay. Immunofluorescence staining was performed to study cell polarization and to assess Cdc42 downstream effector. Results: Cdc42, Chp, Rac1, RhoA, TC10 and TCL were expressed in human corneal epithelial cells. Among them, Cdc42 and TCL were found to significantly affect cell migration in monolayer scratch assays. These results were confirmed through the use of validated siRNAs directed to Cdc42 and TCL. Scramble siRNA transfected cells had high percentage of polarized cells than Cdc42 or TCL siRNA transfected cells at the wound edge. We showed that the Cdc42-specific effector p21-activated kinase 4 localized predominantly to cell-cell junctions in cell monolayers, but failed to translocate to the leading edge in Cdc42 siRNA transfected cells after monolayer wounding. Conclusion: Rho proteins expressed in cultured human corneal epithelial cells, and Cdc42, TCL facilitate two-dimensional cell migration in-vitro. Although silencing of Cdc42 and TCL did not noticeably affect the appearance of cell adhesions at the leading edge, the slower migration of these cells indicates both GTP-binding proteins play important roles in promoting cell movement of human corneal epithelial cells.	[Hou, Aihua; Gan, Kah Hui; Lee, Khee Jin Ryan; Tong, Louis] Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore, Singapore; [Toh, Li Xian; Manser, Edward] ASTAR, Inst Med Biol, RGS Grp, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore; [Tong, Louis] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	National University of Singapore; Singapore National Eye Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Singapore National Eye Center; National University of Singapore; National University of Singapore	Tong, L (corresponding author), Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore, Singapore.	Louis.tong.h.t@snec.com.sg	Manser, Edward/ABD-2301-2020	Tong, Louis/0000-0002-3986-6552	Singapore National Research Foundation [NMRC/1206/2009, NMRC/CSA/013/2009, NMRC/TCR/002-SERI/2008]	Singapore National Research Foundation(National Research Foundation, Singapore)	This research is supported by the Singapore National Research Foundation under its NMRC/1206/2009, NMRC/CSA/013/2009, NMRC/TCR/002-SERI/2008 and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Anderson SC, 2001, INVEST OPHTH VIS SCI, V42, P933; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Faure Sandrine, 2011, Small GTPases, V2, P310; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Inaki M, 2012, P NATL ACAD SCI USA, V109, P2027, DOI 10.1073/pnas.1115260109; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; KAUR S, 2011, CHARACTERISATION EXP; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kimura K, 2011, INVEST OPHTH VIS SCI, V52, P3181, DOI 10.1167/iovs.10-5684; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Li J, 2011, MOL VIS, V17, P2263; Li ZL, 2010, MOL BIOL CELL, V21, P3317, DOI 10.1091/mbc.E10-03-0245; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P941; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; POTHULA S, 2013, INVEST OPHTHALMOL VI; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Ridley AJ, 2012, METHODS MOL BIOL, V827, P3, DOI 10.1007/978-1-61779-442-1_1; Saito J, 2004, JPN J OPHTHALMOL, V48, P199, DOI 10.1007/s10384-003-0059-2; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Siak JJK, 2011, INVEST OPHTH VIS SCI, V52, P230, DOI 10.1167/iovs.10-5735; Streichan SJ, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045004; SundarRaj N, 1998, INVEST OPHTH VIS SCI, V39, P1266; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; Weber KSC, 1998, EUR J IMMUNOL, V28, P2245, DOI 10.1002/(SICI)1521-4141(199807)28:07<2245::AID-IMMU2245>3.0.CO;2-V; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Wherlock M, 2002, J CELL SCI, V115, P239; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; WU RL, 1994, DIFFERENTIATION, V55, P137, DOI 10.1046/j.1432-0436.1994.5520137.x; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yin J, 2008, INVEST OPHTH VIS SCI, V49, P900, DOI 10.1167/iovs.07-1122; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	66	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77107	10.1371/journal.pone.0077107	http://dx.doi.org/10.1371/journal.pone.0077107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130842	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200059
J	Tan, J; Buache, E; Alpy, F; Daguenet, E; Tomasetto, CL; Ren, GS; Rio, MC				Tan, J.; Buache, E.; Alpy, F.; Daguenet, E.; Tomasetto, C-L; Ren, G-S; Rio, M-C			Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development	ONCOGENE			English	Article						mammary gland postnatal development; breast cancer; epithelial-stromal cell crosstalk/interaction; MMP-11; collagen; paracrine function	BRANCHING MORPHOGENESIS; EXTRACELLULAR-MATRIX; DUCTAL MORPHOGENESIS; SIGNALING PATHWAYS; CANCER-CELLS; COLLAGEN-VI; C5 DOMAIN; IN-VIVO; END BUD; STROMELYSIN-3	MMP-11 is a bad prognosis paracrine factor in invasive breast cancers. However, its mammary physiological function remains largely unknown. In the present study we have investigated MMP-11 function during postnatal mammary gland development and function using MMP-11-deficient (MMP-11-/-) mice. Histological and immunohistochemical analyses as well as whole-mount mammary gland staining show alteration of the mammary gland in the absence of MMP-11, where ductal tree, alveolar structures and milk production are reduced. Moreover, a series of transplantation experiments allowed us to demonstrate that MMP-11 exerts an essential local paracrine function that favors mammary gland branching and epithelial cell outgrowth and invasion through adjacent connective tissues. Indeed, MMP-11-/- cleared fat pads are not permissive for wild-type epithelium development, whereasMMP-11-/- epithelium transplants grow normally when implanted in wild-type cleared fat pads. In addition, using primary mammary epithelial organoids, we show in vitro that this MMP-11 pro-branching effect is not direct, suggesting that MMP11 acts via production/release of stroma-associated soluble factor(s). Finally, the lack of MMP-11 leads to decreased periductal collagen content, suggesting that MMP-11 has a role in collagen homeostasis. Thus, local stromal MMP-11 might also regulate mammary epithelial cell behavior mechanically by promoting extracellular matrix stiffness. Collectively, the present data indicate that MMP-11 is a paracrine factor involved during postnatal mammary gland morphogenesis, and support the concept that the stroma strongly impact epithelial cell behavior. Interestingly, stromal MMP-11 has previously been reported to favor malignant epithelial cell survival and promote cancer aggressiveness. Thus, MMP-11 has a paracrine function during mammary gland development that might be harnessed to promote tumor progression, exposing a new link between development and malignancy.	[Tan, J.; Buache, E.; Alpy, F.; Daguenet, E.; Tomasetto, C-L; Rio, M-C] Univ Strasbourg, Inst Natl Sante & Rech Med U964, Ctr Natl Rech Sci UMR 7104, Inst Genet & Biol Mol & Cellulaire,Dept Funct Gen, Strasbourg, France; [Tan, J.; Ren, G-S] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Rio, M-C] Equipe Labellise Ligue Natl Canc, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Chongqing Medical University	Rio, MC (corresponding author), IGBMC, INSERM U964, CNRS UMR 7104, Inst Genet & Biol Mol & Cellulaire, 1 Rue L Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	rio@igbmc.fr	Daguenet, Elisabeth/N-4122-2019; Tomasetto, Catherine Laure/J-2783-2014; Alpy, Fabien/ABD-5893-2020; Daguenet, Elisabeth/K-5507-2015; Alpy, Fabien/H-8941-2016	Daguenet, Elisabeth/0000-0002-6101-1016; Tomasetto, Catherine Laure/0000-0002-1811-5848; Alpy, Fabien/0000-0002-0526-0720; Daguenet, Elisabeth/0000-0002-6101-1016; Alpy, Fabien/0000-0002-0526-0720	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise Contre le Cancer (LNCC; Comites du Haut-Rhin, Bas-Rhin et de la Haute-Savoie); Institut National du Cancer (INCA PL-BIO ADIPOK); Chinese fellowship of National Natural Science Foundation of China [81102008]; LNCC; INCA fellowships	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise Contre le Cancer (LNCC; Comites du Haut-Rhin, Bas-Rhin et de la Haute-Savoie); Institut National du Cancer (INCA PL-BIO ADIPOK)(Institut National du Cancer (INCA) France); Chinese fellowship of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); LNCC; INCA fellowships	We thank Susan Chan and Gerard Gradwohl for helpful discussion, and Corinne Wendling, Laure Nivlet and Olivia Wendling for technical assistance. This work was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Hopital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, the Ligue Nationale Francaise Contre le Cancer (LNCC; Comites du Haut-Rhin, Bas-Rhin et de la Haute-Savoie) and the Institut National du Cancer (INCA PL-BIO ADIPOK 2011-2013). JT was a recipient of a Chinese fellowship of National Natural Science Foundation of China (number: 81102008); EB was a recipient of LNCC and INCA fellowships.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Basset P, 1997, CRIT REV ONCOL HEMAT, V26, P43, DOI 10.1016/S1040-8428(97)00010-3; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cannata D, 2010, ENDOCRINOLOGY, V151, P5751, DOI 10.1210/en.2010-0792; Ching S, 2011, J CELL BIOCHEM, V112, P3393, DOI 10.1002/jcb.23273; Couldrey C, 2002, DEV DYNAM, V223, P459, DOI 10.1002/dvdy.10065; DEOME KB, 1959, CANCER RES, V19, P515; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Edwards PAW, 2000, ADV EXP MED BIOL, V480, P163; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; Ha HY, 2001, CANCER RES, V61, P984; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Holtz B, 1999, BIOCHEMISTRY-US, V38, P12174, DOI 10.1021/bi990876m; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Kannan R, 1999, PROTEIN EXPRES PURIF, V16, P76, DOI 10.1006/prep.1999.1068; KEELY PJ, 1995, DIFFERENTIATION, V59, P1, DOI 10.1046/j.1432-0436.1995.5910001.x; Khialeeva E, 2011, DEVELOPMENT, V138, P767, DOI 10.1242/dev.057588; Khokha R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004333; Kren L, 2006, Cesk Patol, V42, P16; Kurley SJ, 2012, DEVELOPMENT, V139, P1754, DOI 10.1242/dev.072769; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Lanigan F, 2007, CELL MOL LIFE SCI, V64, P3161, DOI 10.1007/s00018-007-7386-2; LEFEBVRE O, 1992, J CELL BIOL, V119, P997, DOI 10.1083/jcb.119.4.997; Lijnen HR, 2002, THROMB HAEMOSTASIS, V87, P530; Lo AT, 2012, J MAMMARY GLAND BIOL, V17, P103, DOI 10.1007/s10911-012-9251-7; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; McCave EJ, 2010, J MAMMARY GLAND BIOL, V15, P291, DOI 10.1007/s10911-010-9190-0; Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236; Motrescu ER, 2008, ONCOGENE, V27, P6347, DOI 10.1038/onc.2008.218; Motrescu ER, 2008, BIOL CHEM, V389, P1037, DOI 10.1515/BC.2008.110; Naylor MJ, 2002, DEV DYNAM, V225, P100, DOI 10.1002/dvdy.10133; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Noel A, 2000, ONCOGENE, V19, P1605, DOI 10.1038/sj.onc.1203465; Noel AC, 1996, J CLIN INVEST, V97, P1924, DOI 10.1172/JCI118624; Pavlovich AL, 2010, TISSUE ENG PT A, V16, P3719, DOI [10.1089/ten.tea.2009.0836, 10.1089/ten.TEA.2009.0836]; Pedersen G, 2009, CLIN EXP IMMUNOL, V155, P257, DOI 10.1111/j.1365-2249.2008.03836.x; Simian M, 2001, DEVELOPMENT, V128, P3117; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Wasenius VM, 2003, CLIN CANCER RES, V9, P68; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; WITTY EP, 1995, MOL BIOL CELL, V6, P1287, DOI 10.1091/mbc.6.10.1287; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Wu EX, 2001, J CELL BIOCHEM, V82, P549, DOI 10.1002/jcb.1181; Zhao ZS, 2010, HUM PATHOL, V41, P686, DOI 10.1016/j.humpath.2009.10.010	56	27	30	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4050	4059		10.1038/onc.2013.434	http://dx.doi.org/10.1038/onc.2013.434			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24141782	hybrid			2022-12-25	WOS:000340595300004
J	Hyde, AS; Thelen, AM; Barycki, JJ; Simpson, MA				Hyde, Annastasia S.; Thelen, Ashley M.; Barycki, Joseph J.; Simpson, Melanie A.			UDP-glucose Dehydrogenase Activity and Optimal Downstream Cellular Function Require Dynamic Reorganization at the Dimer-Dimer Subunit Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dehydrogenase; Enzyme Catalysis; Glycobiology; Hyaluronate; Prostate Cancer; Protein Conformation; Protein Dynamics; Cardiac Defects; Human UGDH; Hyaluronan	URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; SITES REACTIVITY; LIVER; MECHANISM; 6-DEHYDROGENASE; BINDING; HYALURONAN; EXPRESSION; STABILITY; RESIDUES	Background: UDP-glucose dehydrogenase (UGDH) mutants were engineered to perturb hexamer:dimer quaternary structure equilibrium. Results: Dimeric species of UGDH have reduced activity in vitro and in supporting hyaluronan production by cultured cells. Conclusion: Only dynamic UGDH hexamers support robust cellular function. Significance: Manipulation of UGDH activity by hexamer stabilization may offer new therapeutic options in cancer and other pathologies. UDP-glucose dehydrogenase (UGDH) provides precursors for steroid elimination, hyaluronan production, and glycosaminoglycan synthesis. The wild-type UGDH enzyme purifies in a hexamer-dimer equilibrium and transiently undergoes dynamic motion that exposes the dimer-dimer interface during catalysis. In the current study we created and characterized point mutations that yielded exclusively dimeric species (obligate dimer, T325D), dimeric species that could be induced to form hexamers in the ternary complex with substrate and cofactor (T325A), and a previously described exclusively hexameric species (UGDH132) to investigate the role of quaternary structure in regulation of the enzyme. Characterization of the purified enzymes revealed a significant decrease in the enzymatic activity of the obligate dimer and hexamer mutants. Kinetic analysis of wild-type UGDH and the inducible hexamer, T325A, showed that upon increasing enzyme concentration, which favors the hexameric species, activity was modestly decreased and exhibited cooperativity. In contrast, cooperative kinetic behavior was not observed in the obligate dimer, T325D. These observations suggest that the regulation of the quaternary assembly of the enzyme is essential for optimal activity and allosteric regulation. Comparison of kinetic and thermal stability parameters revealed structurally dependent properties consistent with a role for controlled assembly and disassembly of the hexamer in the regulation of UGDH. Finally, both T325A and T325D mutants were significantly less efficient in promoting downstream hyaluronan production by HEK293 cells. These data support a model that requires an operational dimer-hexamer equilibrium to function efficiently and preserve regulated activity in the cell.	[Hyde, Annastasia S.; Thelen, Ashley M.; Barycki, Joseph J.; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Barycki, JJ (corresponding author), Univ Nebraska, Dept Biochem, N114 Beadle Ctr, Lincoln, NE 68588 USA.	jbarycki2@unl.edu; msimpson2@unl.edu			NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL CANCER INSTITUTE [R01CA165574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311, P20GM103489, R01GM077289] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Chimera was supported by NIGMS, National Institutes of Health Grant P41-GM103311 (to the University of California at San Francisco).	Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; ECCLESTON ED, 1979, J BIOL CHEM, V254, P1399; Egger S, 2012, J BIOL CHEM, V287, P2119, DOI 10.1074/jbc.M111.313015; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; FRANZEN JS, 1983, BIOCHIM BIOPHYS ACTA, V746, P146, DOI 10.1016/0167-4838(83)90068-7; FRANZEN JS, 1973, BIOCHEM BIOPH RES CO, V50, P517, DOI 10.1016/0006-291X(73)90870-X; FRANZEN JS, 1980, BIOCHIM BIOPHYS ACTA, V614, P242, DOI 10.1016/0005-2744(80)90214-4; FRANZEN JS, 1980, BIOCHEMISTRY-US, V19, P6080, DOI 10.1021/bi00567a021; FRANZEN JS, 1976, BIOCHEMISTRY-US, V15, P5665, DOI 10.1021/bi00670a036; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Hyde AS, 2012, J BIOL CHEM, V287, P32708, DOI 10.1074/jbc.M112.395202; Kadirvelraj R, 2013, BIOCHEMISTRY-US, V52, P1456, DOI 10.1021/bi301593c; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Nelsestuen G L, 1971, J Biol Chem, V246, P3824; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prydz K, 2000, J CELL SCI, V113, P193; SCHILLER JG, 1972, CARBOHYD RES, V25, P403, DOI 10.1016/S0008-6215(00)81651-1; Sennett NC, 2012, BIOCHEMISTRY-US, V51, P9364, DOI 10.1021/bi301067w; Sennett NC, 2011, BIOCHEMISTRY-US, V50, P9651, DOI 10.1021/bi201381e; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Stewart DC, 1998, PLANT PHYSIOL, V116, P349, DOI 10.1104/pp.116.1.349; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Turner W, 2002, ARCH BIOCHEM BIOPHYS, V407, P209, DOI 10.1016/S0003-9861(02)00500-3; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wei Q, 2009, CANCER RES, V69, P2332, DOI 10.1158/0008-5472.CAN-08-3083	34	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35049	35057		10.1074/jbc.M113.519090	http://dx.doi.org/10.1074/jbc.M113.519090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145036	hybrid, Green Published			2022-12-25	WOS:000329867600007
J	Cook, KM; McNeil, HP; Hogg, PJ				Cook, Kristina M.; McNeil, H. Patrick; Hogg, Philip J.			Allosteric Control of beta 11-Tryptase by a Redox Active Disulfide Bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Disulfide; Mast Cell; Redox Regulation; Serine Protease	MAST-CELL TRYPTASE; HUMAN BETA-TRYPTASE; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; AIRWAY ACIDIFICATION; PROTEASE INHIBITORS; LAVAGE FLUID; INTERNAL-PH; THIOREDOXIN; TETRAMER	Background: The S1A serine proteases function in many biological processes and contain a conserved disulfide bond near the active site. Results: This disulfide in the S1A mast cell protease, II-tryptase, exists in oxidized and reduced states in the enzyme, which influences the specificity and efficiency of the enzyme. Conclusion: II-Tryptase is regulated by an allosteric disulfide bond. Significance: Other S1A proteases are likely similarly regulated. The S1A serine proteases function in many key biological processes such as development, immunity, and blood coagulation. S1A proteases contain a highly conserved disulfide bond (Cys(191)-Cys(220) in chymotrypsin numbering) that links two -loop structures that define the rim of the active site pocket. Mast cell II-tryptase is a S1A protease that is associated with pathological inflammation. In this study, we have found that the conserved disulfide bond (Cys(220)-Cys(248) in II-tryptase) exists in oxidized and reduced states in the enzyme stored and secreted by mast cells. The disulfide bond has a standard redox potential of -301 mV and is stoichiometrically reduced by the inflammatory mediator, thioredoxin, with a rate constant of 350 m(-1) s(-1). The oxidized and reduced enzymes have different substrate specificity and catalytic efficiency for hydrolysis of both small and macromolecular substrates. These observations indicate that II-tryptase activity is post-translationally regulated by an allosteric disulfide bond. It is likely that other S1A serine proteases are similarly regulated.	[Cook, Kristina M.; Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Cook, Kristina M.; Hogg, Philip J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [McNeil, H. Patrick] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Cook, Kristina/B-8012-2008	McNeil, Hugh Patrick/0000-0003-4336-2960; Cook, Kristina/0000-0002-0503-7166; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council; New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by grants from the National Health and Medical Research Council. Mass spectrometric analysis for this work was carried out at the Bioanalytical Mass Spectrometry Facility, University of New South Wales and was supported in part by infrastructure funding from the New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy.	ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; Buckley MG, 1997, CLIN SCI, V93, P363, DOI 10.1042/cs0930363; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Cairns JA, 2005, PULM PHARMACOL THER, V18, P55, DOI 10.1016/j.pupt.2004.09.032; CASTELLS M, 1988, J ALLERGY CLIN IMMUN, V82, P348, DOI 10.1016/0091-6749(88)90005-X; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Fajardo I, 2003, BIOCHEM J, V369, P603, DOI 10.1042/BJ20021418; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; Fiorucci L, 2004, CELL MOL LIFE SCI, V61, P1278, DOI 10.1007/s00018-004-3400-0; Fukuoka Y, 2004, BIOCHEMISTRY-US, V43, P10757, DOI 10.1021/bi049486c; Fukuoka Y, 2006, J IMMUNOL, V176, P3165, DOI 10.4049/jimmunol.176.5.3165; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; GEBOREK P, 1989, J RHEUMATOL, V16, P468; Hallgren J, 2005, J MOL BIOL, V345, P129, DOI 10.1016/j.jmb.2004.10.029; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; JARJOUR NN, 1991, AM REV RESPIR DIS, V144, P83, DOI 10.1164/ajrccm/144.1.83; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; JOHNSON RG, 1980, FEBS LETT, V120, P75, DOI 10.1016/0014-5793(80)81050-7; Kodric M, 2007, AM J RESP CRIT CARE, V175, P905, DOI 10.1164/rccm.200607-940OC; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; LAGUNOFF D, 1983, EXP CELL RES, V144, P353, DOI 10.1016/0014-4827(83)90414-7; Lemarechal H, 2006, CLIN CHIM ACTA, V367, P156, DOI 10.1016/j.cca.2005.12.006; Liang GY, 2012, BIOORG MED CHEM LETT, V22, P1606, DOI 10.1016/j.bmcl.2011.12.127; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MIYATA T, 1989, P NATL ACAD SCI USA, V86, P8319, DOI 10.1073/pnas.86.21.8319; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren S, 1997, J IMMUNOL, V159, P3540; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; Schwertassek U., 2007, SCI STKE, V2007, pl8; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Torchinski M., 1974, THIOL DISULFIDE GROU; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Varallyay V, 1997, BIOCHEM BIOPH RES CO, V230, P592, DOI 10.1006/bbrc.1996.6009; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamada Y, 2003, IMMUNOL LETT, V86, P199, DOI 10.1016/S0165-2478(03)00006-3; Yousef GM, 2004, BBA-PROTEINS PROTEOM, V1698, P77, DOI 10.1016/j.bbapap.2003.10.008	62	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34920	34929		10.1074/jbc.M113.523506	http://dx.doi.org/10.1074/jbc.M113.523506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142694	hybrid, Green Published			2022-12-25	WOS:000329812800058
J	Sembongi, H; Miranda, M; Han, GS; Fakas, S; Grimsey, N; Vendrell, J; Carman, GM; Siniossoglou, S				Sembongi, Hiroshi; Miranda, Merce; Han, Gil-Soo; Fakas, Stylianos; Grimsey, Neil; Vendrell, Joan; Carman, George M.; Siniossoglou, Symeon			Distinct Roles of the Phosphatidate Phosphatases Lipin 1 and 2 during Adipogenesis and Lipid Droplet Biogenesis in 3T3-L1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Lipids; Mouse; Phosphatase; Phosphatidate; Triacylglycerol; Lipin	ACTIVATED RECEPTOR-GAMMA; SUBCELLULAR-LOCALIZATION; EXPRESSION; PROTEIN; ACID; TRIACYLGLYCEROL; LIPODYSTROPHY; MAINTENANCE; ADIPOCYTES; ISOFORMS	Background: Lipins are phosphatidate phosphatases that generate diacylglycerol for lipid synthesis. Results: Lipin 1 or lipin 2 depletion has distinct effects on differentiating adipocytes. Cells depleted of both lipins after initiation of adipogenesis accumulate triacylglycerol but display lipid droplet fragmentation. Conclusion: Lipins have a role in lipid droplet biogenesis after initiation of adipogenesis. Significance: Lipins play multiple roles during adipocyte differentiation. Lipins are evolutionarily conserved Mg2+-dependent phosphatidate phosphatase (PAP) enzymes with essential roles in lipid biosynthesis. Mammals express three paralogues: lipins 1, 2, and 3. Loss of lipin 1 in mice inhibits adipogenesis at an early stage of differentiation and results in a lipodystrophic phenotype. The role of lipins at later stages of adipogenesis, when cells initiate the formation of lipid droplets, is less well characterized. We found that depletion of lipin 1, after the initiation of differentiation in 3T3-L1 cells but before the loading of lipid droplets with triacylglycerol, results in a reciprocal increase of lipin 2, but not lipin 3. We generated 3T3-L1 cells where total lipin protein and PAP activity levels are down-regulated by the combined depletion of lipins 1 and 2 at day 4 of differentiation. These cells still accumulated triacylglycerol but displayed a striking fragmentation of lipid droplets without significantly affecting their total volume per cell. This was due to the lack of the PAP activity of lipin 1 in adipocytes after day 4 of differentiation, whereas depletion of lipin 2 led to an increase of lipid droplet volume per cell. We propose that in addition to their roles during early adipogenesis, lipins also have a role in lipid droplet biogenesis.	[Sembongi, Hiroshi; Grimsey, Neil; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Miranda, Merce; Vendrell, Joan] Univ Rovira & Virgili, Hosp Univ Joan 23, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Inst Invest Pere Virgili, E-43007 Tarragona, Spain; [Han, Gil-Soo; Fakas, Stylianos; Carman, George M.] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Fakas, Stylianos; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Siniossoglou, S (corresponding author), Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	ss560@cam.ac.uk	Vendrell, Joan j/V-4034-2018; Grimsey, Neil/B-1634-2015; Fakas, Stylianos/AAQ-7594-2020; miranda, merce/H-7467-2017; Fakas, Stylianos/R-9908-2019; Grimsey, Neil/AAB-9153-2020	Vendrell, Joan j/0000-0002-6994-6115; Grimsey, Neil/0000-0002-0481-4920; Fakas, Stylianos/0000-0001-8692-1326; miranda, merce/0000-0001-6214-1042; Fakas, Stylianos/0000-0001-8692-1326; Grimsey, Neil/0000-0002-0481-4920	National Institutes of Health [GM-28140]; Medical Research Council [G0701446]; Instituto de Salud Carlos III; European Regional Development Fund [PI10/00967, CP11/00021, PI11/00085]; MRC [G0701446] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.). This work was also supported by Medical Research Council Grant G0701446 (to S. S.), funds from the Instituto de Salud Carlos III, and European Regional Development Fund Grants PI10/00967 and CP11/00021 (to M. M.) and PI11/00085 (to J. V.).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Haller JF, 2011, BBA-MOL BASIS DIS, V1812, P1393, DOI 10.1016/j.bbadis.2011.07.007; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Mylonis I, 2012, J CELL SCI, V125, P3485, DOI 10.1242/jcs.106682; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Stapleton CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018932; Swift S., 1999, CURRENT PROTOCOL S31; Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang HJ, 2011, FEBS LETT, V585, P1979, DOI 10.1016/j.febslet.2011.05.035; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681	40	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34502	34513		10.1074/jbc.M113.488445	http://dx.doi.org/10.1074/jbc.M113.488445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133206	Green Published, hybrid			2022-12-25	WOS:000329812800020
J	Shi, N; Chen, SY				Shi, Ning; Chen, Shi-You			Cell Division Cycle 7 Mediates Transforming Growth Factor-beta-induced Smooth Muscle Maturation through Activation of Myocardin Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Gene Regulation; Gene Transcription; Smooth Muscle; Transforming Growth Factor- (TGF-); Cell Division Cycle 7; Smooth Muscle Maturation	SERUM RESPONSE FACTOR; TGF-BETA; 10T1/2 CELLS; DIFFERENTIATION; EXPRESSION; REGULATOR; MARKER; PATHOGENESIS; SUFFICIENT; MODULATION	Background: Cell division cycle 7 (Cdc7) plays a role in cell fate determination in the early stage of smooth muscle (SM) differentiation. Results: Cdc7 activated myocardin gene transcription by interacting with Nkx2.5, leading to the induction of a mature SM marker smooth muscle myosin heavy chain (SMMHC). Conclusion: Cdc7 regulates SM maturation by activation of myocardin expression. Significance: Cdc7 regulates SM differentiation and maturation through different mechanisms. Smooth muscle (SM) development consists of several processes, including cell fate determination, differentiation, and maturation. The molecular mechanisms controlling SM early differentiation have been studied extensively. However, little is known about the mechanism underlying SM maturation. Cell division cycle 7 (Cdc7) has been shown to regulate cell fate determination in the initial phase of transforming growth factor- (TGF-)-induced SM differentiation. Our present study indicates that Cdc7 also regulates SM maturation. Knockdown of Cdc7 suppresses TGF--induced expression of SM myosin heavy chain, a late marker of SM differentiation. Cdc7 overexpression, on the other hand, enhances SM myosin heavy chain expression. Interestingly, Cdc7 activates the mRNA expression and promoter activity of myocardin (Myocd), a master regulator of SM differentiation, whose transcription is blocked in the initial phase of the differentiation because TGF- does not induce Myocd mRNA until after the early SM markers are induced. These data suggest that Cdc7 mediates TGF--induced SM maturation via activation of Myocd transcription. Mechanistically, Cdc7 physically and functionally interacts with Nkx2.5 to regulate Myocd promoter activity. Cdc7 appears to enhance Nkx2.5 binding to Myocd promoter, leading to Myocd activation. Taken together, our studies demonstrate that Cdc7 regulates the initial and late phase of SM differentiation through distinct mechanisms.	[Shi, Ning; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Shi, Ning/I-5631-2015		National Institutes of Health [HL093429, HL107526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093429, R01HL107526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093429 and HL107526 (to S.-Y.C.).	AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Ko YS, 1999, ARTERIOSCL THROM VAS, V19, P1669, DOI 10.1161/01.ATV.19.7.1669; KOCHER O, 1991, LAB INVEST, V65, P459; KOCHER O, 1986, HUM PATHOL, V17, P875, DOI 10.1016/S0046-8177(86)80637-2; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Raphel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044052; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yao YC, 2007, CARDIOVASC RES, V74, P279, DOI 10.1016/j.cardiores.2006.09.014; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	40	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34336	34342		10.1074/jbc.M113.498238	http://dx.doi.org/10.1074/jbc.M113.498238			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133205	Green Published, hybrid			2022-12-25	WOS:000329812800005
J	Khanna, V; Jain, M; Singh, V; Kanshana, JS; Prakash, P; Barthwal, MK; Murthy, PSR; Dikshit, M				Khanna, Vivek; Jain, Manish; Singh, Vishal; Kanshana, Jitendra S.; Prakash, Prem; Barthwal, Manoj K.; Murthy, Puvvada S. R.; Dikshit, Madhu			Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BALLOON INJURY; METALLOPROTEINASE ACTIVITY; MATRIX METALLOPROTEINASES; NEOINTIMAL FORMATION; PROGENITOR CELLS; VASCULAR INJURY; MIGRATION; MODELS; AORTA	Effect of long term cholesterol diet withdrawal on accelerated atherosclerosis in iliac artery of New Zealand White (NZW) rabbits has not been explored so far. Atherosclerosis was thus induced in rabbits by a combination of balloon injury and atherogenic diet (AD) (1% cholesterol and 6% peanut oil) feeding for 8 weeks (baseline) followed by chow diet (CD) feeding for 4, 8, 16, 32, 50 and 64 weeks. The plaque characterization was done using histology, real time RT-PCR and vasoreactivity studies. Significant elevation in plasma lipids with AD feeding was normalized following 16 weeks of CD feeding. However, baseline comparison showed advanced plaque features even after 8 weeks of CD period with significant elevation in intima/media thickness ratio and plaque area later showing reduction at 50 and 64 weeks CD periods. Lesion lipid accumulation and CD68 positivity was maintained till 16 weeks of CD feeding which significantly reduced from 32 to 64 weeks CD periods. Baseline comparison showed significant increase in ground substance, MMP-9 and significant decrease in alpha-actin and collagen content at 8 weeks CD period indicating features of unstable plaque. These features regressed up to 64 weeks of CD. Partial restoration of functional vasoconstriction and vasorelaxation was seen after 64 weeks of CD feeding. mRNA expression of MCP-1, VCAM-1, collagen type I and III, MMP-9, TIMP-1, IFN-gamma, TNF-alpha, IL-10 and eNOS supported the above findings. The study thus reveals insights into initial plaque instability and subsequent regression on AD withdrawal in this model. These results are suggestive of an appropriate window for drug intervention for plaque stability/regression and restenosis as well as improves understanding of plaque regression phenomenon in this model.	[Khanna, Vivek; Jain, Manish; Singh, Vishal; Kanshana, Jitendra S.; Prakash, Prem; Barthwal, Manoj K.; Dikshit, Madhu] CSIR Cent Drug Res Inst, Div Pharmacol, Lucknow, Uttar Pradesh, India; [Murthy, Puvvada S. R.] CSIR Cent Drug Res Inst, Div Toxicol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Dikshit, M (corresponding author), CSIR Cent Drug Res Inst, Div Pharmacol, BS 10-1,Sect 10, Lucknow, Uttar Pradesh, India.	madhu_dikshit@cdri.res.in	Jain, Manish/ABE-7652-2021; Kanshana, Jitendra/AEW-5567-2022; Singh, Vishal/N-1838-2019; Prakash, Prem/AAI-1672-2020	Jain, Manish/0000-0002-7263-9829; Prakash, Prem/0000-0001-9501-0065; Singh, Vishal/0000-0003-3577-1713	CSIR project THUNDER [BSC0102]; CSIR-Network project, India [BSC0103]; Council of Scientific and Industrial Research (CSIR), New Delhi, India; Indian Council of Medical Research, New Delhi, India	CSIR project THUNDER; CSIR-Network project, India; Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by a Financial grant to M. D. from the CSIR project THUNDER (BSC0102) and CSIR-Network project (BSC0103), India. The authors gratefully acknowledge the award of research fellowships by the Council of Scientific and Industrial Research (CSIR), New Delhi, India to V. K., V. S., J.S.K., P. P., and Indian Council of Medical Research, New Delhi, India to M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A CWM, 1967, VASCULAR HISTOCHEMIS; Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Al-Mallah MH, 2011, ATHEROSCLEROSIS, V219, P395, DOI 10.1016/j.atherosclerosis.2011.08.023; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; CANDIPAN RC, 1994, CIRCULATION, V89, P777, DOI 10.1161/01.CIR.89.2.777; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; COOKE JP, 1992, J CLIN INVEST, V90, P1168, DOI 10.1172/JCI115937; Dapson RW, 2011, BIOTECH HISTOCHEM, V86, P133, DOI 10.3109/10520295.2011.570277; Dollery CM, 1999, CIRCULATION, V99, P3199, DOI 10.1161/01.CIR.99.24.3199; Dong B, 2008, ARTERIOSCL THROM VAS, V28, P1270, DOI 10.1161/ATVBAHA.108.164715; Dornas WC, 2010, ARQ BRAS CARDIOL, V95, P272, DOI 10.1590/S0066-782X2010001200020; DOWELL FJ, 1995, ARTERIOSCL THROM VAS, V15, P1152, DOI 10.1161/01.ATV.15.8.1152; Feig JE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00286; Ferrer MD, 2010, RADIOLOGIA-MADRID, V52, P45, DOI 10.1016/j.rx.2009.09.011; Francis AA, 2011, EXP CLIN CARDIOL, V16, P77; FREIMAN PC, 1986, CIRC RES, V58, P783, DOI 10.1161/01.RES.58.6.783; FRIEDMAN M, 1963, AM J PATHOL, V43, P349; Fuster V, 2007, CIRCULATION, V116, P1966, DOI 10.1161/CIRCULATIONAHA.107.733444; Gomez-Garre D, 2009, BRIT J PHARMACOL, V156, P1218, DOI 10.1111/j.1476-5381.2008.00091.x; Haarer S. L., 1998, Basic Research in Cardiology, V93, P210, DOI 10.1007/s003950050089; Hagensen MK, 2012, CARDIOVASC RES, V93, P223, DOI 10.1093/cvr/cvr278; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Herrero-Beaumont G, 2008, BRIT J PHARMACOL, V154, P843, DOI 10.1038/bjp.2008.113; Khanna V, 2011, PHARMACOL RES, V64, P274, DOI 10.1016/j.phrs.2011.03.016; Krejcy K, 1996, ATHEROSCLEROSIS, V122, P59, DOI 10.1016/0021-9150(95)05747-1; Lee HM, 2008, J VASC RES, V45, P259, DOI 10.1159/000112941; Li CJ, 2007, J ENDOCRINOL, V193, P137, DOI 10.1677/JOE-06-0173; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Liu MW, 1996, ATHEROSCLEROSIS, V127, P221, DOI 10.1016/S0021-9150(96)05959-X; Loftus IM, 2002, BRIT J SURG, V89, P680, DOI 10.1046/j.1365-2168.2002.02099.x; MALINOW MR, 1980, CIRC RES, V46, P311, DOI 10.1161/01.RES.46.3.311; MALINOW MR, 1983, ATHEROSCLEROSIS, V48, P105, DOI 10.1016/0021-9150(83)90097-7; Meguro K, 2009, AM J PHYSIOL-HEART C, V296, pH211, DOI 10.1152/ajpheart.00960.2008; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; Moreno PR, 2009, J AM COLL CARDIOL, V53, P2315, DOI 10.1016/j.jacc.2009.02.057; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Nadkarni SK, 2009, LASER MED SCI, V24, P439, DOI 10.1007/s10103-007-0535-x; Nakazawa Gaku, 2008, Expert Rev Cardiovasc Ther, V6, P1379, DOI 10.1586/14779072.6.10.1379; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; Okabe T, 2011, INT J CARDIOL, V147, P271, DOI 10.1016/j.ijcard.2009.09.528; Orlandi A, 2000, ARTERIOSCL THROM VAS, V20, P1123, DOI 10.1161/01.ATV.20.4.1123; Pasterkamp G, 1998, ATHEROSCLEROSIS, V137, P205, DOI 10.1016/S0021-9150(97)00255-4; Phinikaridou A, 2009, J LIPID RES, V50, P787, DOI 10.1194/jlr.M800460-JLR200; Riedmuller K, 2010, ATHEROSCLEROSIS, V210, P407, DOI 10.1016/j.atherosclerosis.2010.01.009; Shinohara M, 2005, CARDIOVASC RES, V68, P249, DOI 10.1016/j.cardiores.2005.06.016; Singh V, 2009, CURR VASC PHARMACOL, V7, P75, DOI 10.2174/157016109787354097; Son DJ, 2008, PROSTAG LEUKOTR ESS, V78, P383, DOI 10.1016/j.plefa.2008.04.010; STCLAIR RW, 1983, PROG CARDIOVASC DIS, V26, P109; Tian JW, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/121867; Tzafriri AR, 2010, J CONTROL RELEASE, V142, P332, DOI 10.1016/j.jconrel.2009.11.007; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang BY, 1996, J AM COLL CARDIOL, V28, P1573, DOI 10.1016/S0735-1097(96)00337-3; Watanabe Noboru, 2004, Curr Atheroscler Rep, V6, P112, DOI 10.1007/s11883-004-0099-1; Wissler R W, 1988, J Clin Apher, V4, P52, DOI 10.1002/jca.2920040203; Zaltsman AB, 1999, ARTERIOSCL THROM VAS, V19, P1700, DOI 10.1161/01.ATV.19.7.1700	56	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77037	10.1371/journal.pone.0077037	http://dx.doi.org/10.1371/journal.pone.0077037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146955	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200030
J	Finnamore, H; Le Couteur, J; Hickson, M; Busbridge, M; Whelan, K; Shovlin, CL				Finnamore, Helen; Le Couteur, James; Hickson, Mary; Busbridge, Mark; Whelan, Kevin; Shovlin, Claire L.			Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; MENSTRUAL BLOOD-LOSS; ANEMIA; MANAGEMENT; EPISTAXIS; PREVALENCE; FREQUENCY; DIAGNOSIS; SEVERITY; CRITERIA	Background: Iron deficiency anemia remains a major global health problem. Higher iron demands provide the potential for a targeted preventative approach before anemia develops. The primary study objective was to develop and validate a metric that stratifies recommended dietary iron intake to compensate for patient-specific non-menstrual hemorrhagic losses. The secondary objective was to examine whether iron deficiency can be attributed to under-replacement of epistaxis (nosebleed) hemorrhagic iron losses in hereditary hemorrhagic telangiectasia (HHT). Methodology/Principal Findings: The hemorrhage adjusted iron requirement (HAIR) sums the recommended dietary allowance, and iron required to replace additional quantified hemorrhagic losses, based on the pre-menopausal increment to compensate for menstrual losses (formula provided). In a study population of 50 HHT patients completing concurrent dietary and nosebleed questionnaires, 43/50 (86%) met their recommended dietary allowance, but only 10/50 (20%) met their HAIR. Higher HAIR was a powerful predictor of lower hemoglobin (p = 0.009), lower mean corpuscular hemoglobin content (p<0.001), lower log-transformed serum iron (p = 0.009), and higher log-transformed red cell distribution width (p<0.001). There was no evidence of generalised abnormalities in iron handling Ferritin and ferritin(2) explained 60% of the hepcidin variance (p<0.001), and the mean hepcidinferritin ratio was similar to reported controls. Iron supplement use increased the proportion of individuals meeting their HAIR, and blunted associations between HAIR and hematinic indices. Once adjusted for supplement use however, reciprocal relationships between HAIR and hemoglobin/serum iron persisted. Of 568 individuals using iron tablets, most reported problems completing the course. For patients with hereditary hemorrhagic telangiectasia, persistent anemia was reported three-times more frequently if iron tablets caused diarrhea or needed to be stopped. Conclusions/significance: HAIR values, providing an indication of individuals' iron requirements, may be a useful tool in prevention, assessment and management of iron deficiency. Iron deficiency in HHT can be explained by under-replacement of nosebleed hemorrhagic iron losses.	[Finnamore, Helen; Shovlin, Claire L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Le Couteur, James; Hickson, Mary; Busbridge, Mark; Shovlin, Claire L.] Imperial Coll Healthcare NHS Trust, London, England; [Whelan, Kevin] Kings Coll London, Sch Med, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Finnamore, Helen] Univ Liverpool, Sch Med, Liverpool L69 3BX, Merseyside, England	Imperial College London; Imperial College London; University of London; King's College London; University of Liverpool	Shovlin, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	c.shovlin@imperial.ac.uk	Hickson, Mary/D-3672-2011; Whelan, Kevin/ABD-5350-2021; Whelan, Kevin/ABD-5154-2021	Hickson, Mary/0000-0001-7996-0095; Whelan, Kevin/0000-0001-5414-2950; Shovlin, Claire/0000-0001-9007-5775; Busbridge, Mark/0000-0002-5452-6986	Medical Research Council UK [G9502233, G0300128]; Cancer Research UK [C865/A2883]; National Institute of Health Research Biomedical Research Centre Funding Scheme (Imperial BRC); MRC [G0300128] Funding Source: UKRI; Medical Research Council [G0300128] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute of Health Research Biomedical Research Centre Funding Scheme (Imperial BRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study received support from donations by families and friends of British patients with hereditary haemorrhagic telangiectasia, and internal Bachelor of Science project funding (for HF). EPIC-Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). CLS and MH acknowledge support from the National Institute of Health Research Biomedical Research Centre Funding Scheme (Imperial BRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SM, 2011, BLOOD TRANSFUS-ITALY, V9, P167, DOI 10.2450/2010.0040-10; Alleyne M, 2008, AM J MED, V121, P943, DOI 10.1016/j.amjmed.2008.07.012; ANAND IS, 1995, J AM COLL CARDIOL, V25, P1402, DOI 10.1016/0735-1097(95)00007-Q; Androne AS, 2003, CIRCULATION, V107, P226, DOI 10.1161/01.CIR.0000052623.16194.80; ARONSTAM A, 1982, PHARMATHERAPEUTICA, V3, P263; Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Boulton F, 2008, TRANSFUSION MED, V18, P13, DOI 10.1111/j.1365-3148.2007.00818.x; BURDETT E, 2006, BR J HOSP MED LOND, V67, P200; Busbridge M, 2009, BRIT J BIOMED SCI, V66, P150, DOI 10.1080/09674845.2009.11730263; Buscarini E, 2011, DIGEST DIS SCI, V56, P2166, DOI 10.1007/s10620-011-1585-2; *CDCP, 2011, NUTR EV BAS IR IR DE; Centers for Disease Control and Prevention, 1998, MMWR RECOMM REP, V47, p1; *CTR DIS CONTR, 2002, MMWR WEEKLY, V51, P897; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department of Health, 1991, DIET REF VAL FOOD EN; Devlin HL, 2013, NEW ENGL J MED, V368, P876, DOI 10.1056/NEJMc1213554; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Franzini C, 2000, CLIN CHIM ACTA, V298, P181, DOI 10.1016/S0009-8981(00)00273-4; FRYKMAN E, 1994, J LAB CLIN MED, V123, P561; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hallberg L., 2000, Scandinavian Journal of Nutrition/Naringsforskning, V44, P150; Hallberg L, 2001, ANNU REV NUTR, V21, P1, DOI 10.1146/annurev.nutr.21.1.1; HALLBERG L, 1966, ACTA MED SCAND, VS, P3; HALLBERG L, 1966, ACTA MED SCAND, V180, P639; *HMSO, 2004, NAT DIET NUTR SURV A; Hoag JB, 2010, LARYNGOSCOPE, V120, P838, DOI 10.1002/lary.20818; *INT AG RES CANC W, 2010, EUR PROSP INV CANC N; KERR DNS, 1958, LANCET, V2, P489; Livesey JA, 2012, THORAX, V67, P328, DOI 10.1136/thoraxjnl-2011-201076; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Milman N, 2012, ANN HEMATOL, V91, P143, DOI 10.1007/s00277-011-1381-2; Nelson M, 2007, LOW INCOME DIET NUTR, V3, P38; *NICE, 2011, COL CANC COST REP IM; *NICE, CLIN KNOWL SUMM INT; Pasricha SR, 2012, PATHOLOGY, V44, P139, DOI 10.1097/PAT.0b013e32834e8291; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Pope LER, 2005, POSTGRAD MED J, V81, P309, DOI 10.1136/pgmj.2004.025007; Rhodes CJ, 2011, J AM COLL CARDIOL, V58, P300, DOI 10.1016/j.jacc.2011.02.057; Rimon E, 2005, AM J MED, V118, P1142, DOI 10.1016/j.amjmed.2005.01.065; Roked F, 2011, AM J RESP CRIT CARE, V183, P828, DOI 10.1164/ajrccm.183.6.828; *ROY COLL OBST GYN, 2009, PREV MAN POSTP HEM G, V52; *ROY PHARM SOC GRE, 2012, BRIT NATL FORM 63; *ROYAL PHARM SOC G, 2012, BRIT NAT FORM 63; Saban Y, 2012, ARCH FACIAL PLAST S, V14, P429, DOI 10.1001/archfacial.2012.202; SANTHIRAPALA V, 2013, HEMATOLOGY REPORTS, V5, P33; SHAW ST, 1972, CONTRACEPTION, V5, P497, DOI 10.1016/0010-7824(72)90015-7; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Silva BM, 2013, LARYNGOSCOPE, V123, P1092, DOI 10.1002/lary.23893; Smith TG, 2008, J PHYSIOL-LONDON, V586, P5999, DOI 10.1113/jphysiol.2008.160960; Spielmann M, 2012, EUR J CANCER, V48, P101, DOI 10.1016/j.ejca.2011.09.011; Swain DG, 2000, INJURY, V31, P7, DOI 10.1016/S0020-1383(99)00191-6; Tan TCH, 2012, LIVER INT, V32, P1391, DOI 10.1111/j.1478-3231.2012.02828.x; Tay HL, 1998, ANN OTO RHINOL LARYN, V107, P671, DOI 10.1177/000348949810700808; Thane CW, 2003, PUBLIC HEALTH NUTR, V6, P485, DOI 10.1079/PHN2002455; *UN CHILDR FDN, 2001, WHONHD013 UN CHILDR; VALBERG LS, 1980, CAN MED ASSOC J, V122, P1240; Welch AA, 2005, J HUM NUTR DIET, V18, P99, DOI 10.1111/j.1365-277X.2005.00593.x; WHYTE MKB, 1993, J APPL PHYSIOL, V75, P321, DOI 10.1152/jappl.1993.75.1.321; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zeidman A, 2004, ISR MED ASSOC J, V6, P16	65	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76516	10.1371/journal.pone.0076516	http://dx.doi.org/10.1371/journal.pone.0076516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146883	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400069
J	Kassa, A; Dey, AK; Sarkar, P; Labranche, C; Go, EP; Clark, DF; Sun, YD; Nandi, A; Hartog, K; Desaire, H; Montefiori, D; Carfi, A; Srivastava, IK; Barnett, SW				Kassa, Aemro; Dey, Antu K.; Sarkar, Pampi; Labranche, Celia; Go, Eden P.; Clark, Daniel F.; Sun, Yide; Nandi, Avishek; Hartog, Karin; Desaire, Heather; Montefiori, David; Carfi, Andrea; Srivastava, Indresh K.; Barnett, Susan W.			Stabilizing Exposure of Conserved Epitopes by Structure Guided Insertion of Disulfide Bond in HIV-1 Envelope Glycoprotein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 INNER DOMAIN; NEUTRALIZING ANTIBODIES; CD4; IMMUNOGENICITY; RECEPTOR; PURIFICATION; SPECIFICITY; EXPRESSION; COMPLEX	Entry of HIV-1 into target cells requires binding of the viral envelope glycoprotein (Env) to cellular receptors and subsequent conformational changes that culminates in fusion of viral and target cell membranes. Recent structural information has revealed that these conformational transitions are regulated by three conserved but potentially flexible layers stacked between the receptor-binding domain (gp120) and the fusion arm (gp41) of Env. We hypothesized that artificial insertion of a covalent bond will 'snap' Env into a conformation that is less mobile and stably expose conserved sites. Therefore, we analyzed the interface between these gp120 layers (layers 1, 2 and 3) and identified residues that may form disulfide bonds when substituted with cysteines. We subsequently probed the structures of the resultant mutant gp120 proteins by assaying their binding to a variety of ligands using Surface Plasmon Resonance (SPR) assay. We found that a single disulfide bond strategically inserted between the highly conserved layers 1 and 2 (C65-C115) is able to 'lock' gp120 in a CD4 receptor bound conformation (in the absence of CD4), as indicated by the lower dissociation constant (Kd) for the CD4-induced (CD4i) epitope binding 17b antibody. When disulfide-stabilized monomeric (gp120) and trimeric (gp140) Envs were used to immunize rabbits, they were found to elicit a higher proportion of antibodies directed against both CD4i and CD4 binding site epitopes than the wild-type proteins. These results demonstrate that structure-guided stabilization of inter-layer interactions within HIV-1 Env can be used to expose conserved epitopes and potentially overcome the sequence diversity of these molecules.	[Kassa, Aemro; Dey, Antu K.; Sarkar, Pampi; Nandi, Avishek; Carfi, Andrea; Srivastava, Indresh K.; Barnett, Susan W.] Novartis Vaccines & Diagnost Inc, Vaccines Res, Cambridge, MA USA; [Sun, Yide; Hartog, Karin] Novartis Vaccines & Diagnost Inc, Vaccines Res, Emeryville, CA USA; [Labranche, Celia; Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Go, Eden P.; Clark, Daniel F.; Desaire, Heather] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	Novartis; Novartis; Duke University; University of Kansas	Dey, AK (corresponding author), Novartis Vaccines & Diagnost Inc, Vaccines Res, Cambridge, MA USA.	antu.dey@novartis.com; susan.barnett@novartis.com		Dey, Antu/0000-0001-7438-9379	NIAID-NIH HIV Vaccine Research and Design (HIVRAD) grant [5P01 AI066287]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094797, P01AI066287] Funding Source: NIH RePORTER	NIAID-NIH HIV Vaccine Research and Design (HIVRAD) grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIAID-NIH HIV Vaccine Research and Design (HIVRAD) grant # 5P01 AI066287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; [Anonymous], 2010, GLOBAL REPORT UNAIDS; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Crooks Emma T., 2005, Human Antibodies, V14, P101; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005; Dey AK, 2012, USE POLYANIONI UNPUB; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Dey AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030233; Dey AK, 2012, VACCINE, V30, P2749, DOI 10.1016/j.vaccine.2012.02.027; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Go EP, 2011, J PROTEOME RES, V10, P578, DOI 10.1021/pr100764a; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Guan Y, 2012, P NATL ACAD IN PRESS; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jobes DV, 2006, AIDS RES HUM RETROV, V22, P1014, DOI 10.1089/aid.2006.22.1014; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Kovacs JM, 2012, P NATL ACAD IN PRESS; Kwong PD, 2005, NATURE, V433, P815, DOI 10.1038/433815a; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Martin G, 2011, J BIOL CHEM; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	54	15	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76139	10.1371/journal.pone.0076139	http://dx.doi.org/10.1371/journal.pone.0076139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146829	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400040
J	Huehnchen, P; Boehmerle, W; Endres, M				Huehnchen, Petra; Boehmerle, Wolfgang; Endres, Matthias			Assessment of Paclitaxel Induced Sensory Polyneuropathy with "Catwalk" Automated Gait Analysis in Mice	PLOS ONE			English	Article							CHANNEL ALPHA(2)DELTA-1 SUBUNIT; PAINFUL PERIPHERAL NEUROPATHY; SCIATIC-NERVE INJURY; MECHANICAL ALLODYNIA; UP-REGULATION; RAT; MODELS; GABAPENTIN; EXPRESSION; NOCICEPTION	Neuropathic pain as a symptom of sensory nerve damage is a frequent side effect of chemotherapy. The most common behavioral observation in animal models of chemotherapy induced polyneuropathy is the development of mechanical allodynia, which is quantified with von Frey filaments. The data from one study, however, cannot be easily compared with other studies owing to influences of environmental factors, inter-rater variability and differences in test paradigms. To overcome these limitations, automated quantitative gait analysis was proposed as an alternative, but its usefulness for assessing animals suffering from polyneuropathy has remained unclear. In the present study, we used a novel mouse model of paclitaxel induced polyneuropathy to compare results from electrophysiology and the von Frey method to gait alterations measured with the Catwalk test. To mimic recently improved clinical treatment strategies of gynecological malignancies, we established a mouse model of dose-dense paclitaxel therapy on the common C57Bl/6 background. In this model paclitaxel treated animals developed mechanical allodynia as well as reduced caudal sensory nerve action potential amplitudes indicative of a sensory polyneuropathy. Gait analysis with the Catwalk method detected distinct alterations of gait parameters in animals suffering from sensory neuropathy, revealing a minimized contact of the hind paws with the floor. Treatment of mechanical allodynia with gabapentin improved altered dynamic gait parameters. This study establishes a novel mouse model for investigating the side effects of dose-dense paclitaxel therapy and underlines the usefulness of automated gait analysis as an additional easy-to-use objective test for evaluating painful sensory polyneuropathy.	[Huehnchen, Petra; Boehmerle, Wolfgang; Endres, Matthias] Charite, Klin & Hsch Ambulanz Neurol, D-13353 Berlin, Germany; [Huehnchen, Petra; Boehmerle, Wolfgang; Endres, Matthias] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Endres, Matthias] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Boehmerle, W (corresponding author), Charite, Klin & Hsch Ambulanz Neurol, D-13353 Berlin, Germany.	wolfgang.boehmerle@charite.de	Huehnchen, Petra/ABA-5685-2020	Huehnchen, Petra/0000-0002-6825-7270; Endres, Matthias/0000-0001-6520-3720; Boehmerle, Wolfgang/0000-0001-7195-3894	federal ministry of education and research via the grant center for stroke research Berlin [01 EO 0801]; Volkswagen foundation; Deutsche Forschungsgemeinschaft DFG (NeuroCure)	federal ministry of education and research via the grant center for stroke research Berlin; Volkswagen foundation(Volkswagen); Deutsche Forschungsgemeinschaft DFG (NeuroCure)	The research leading to these results has received funding for the procurement of equipment and consumables from the federal ministry of education and research via the grant center for stroke research Berlin (01 EO 0801), the Volkswagen foundation (Lichtenberg program to Matthias Endres), and Deutsche Forschungsgemeinschaft DFG (NeuroCure). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmet A, 2006, INT J PEDIATR OTORHI, V70, P779, DOI 10.1016/j.ijporl.2005.11.011; Authier N, 2009, NEUROTHERAPEUTICS, V6, P620, DOI 10.1016/j.nurt.2009.07.003; Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; Cendelin J, 2010, BEHAV BRAIN RES, V210, P8, DOI 10.1016/j.bbr.2010.01.035; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Ferland CE, 2011, PHARMACOL BIOCHEM BE, V97, P603, DOI 10.1016/j.pbb.2010.11.003; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Gauchan P, 2009, BIOL PHARM BULL, V32, P732, DOI 10.1248/bpb.32.732; Hess V, 2003, ANN ONCOL, V14, P638, DOI 10.1093/annonc/mdg176; Katsumata N, 2011, ANN ONCOL S8, V22, pviii29; Kim KJ, 1997, EXP BRAIN RES, V113, P200, DOI 10.1007/BF02450318; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Leandri M, 2012, J NEUROSCI METH, V209, P403, DOI 10.1016/j.jneumeth.2012.07.005; Lindenlaub T, 2000, BRAIN RES, V866, P15, DOI 10.1016/S0006-8993(00)02190-9; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; Mo M, 2012, FASEB J; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; OCHOA JL, 1994, CURR OPIN NEUROL, V7, P407, DOI 10.1097/00019052-199410000-00008; Piesla MJ, 2009, BRAIN RES, V1295, P89, DOI 10.1016/j.brainres.2009.07.091; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sato J, 1999, NEUROSCI LETT, V266, P21, DOI 10.1016/S0304-3940(99)00260-8; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang MS, 2002, ANN NEUROL, V52, P442, DOI 10.1002/ana.10300; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044	39	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76772	10.1371/journal.pone.0076772	http://dx.doi.org/10.1371/journal.pone.0076772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143194	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100029
J	Jaouadi, NZ; Rekik, H; Badis, A; Trabelsi, S; Belhoul, M; Yahiaoui, AB; Ben Aicha, H; Toumi, A; Bejar, S; Jaouadi, B				Jaouadi, Nadia Zarai; Rekik, Hatem; Badis, Abdelmalek; Trabelsi, Sahar; Belhoul, Mouna; Yahiaoui, Amina Benkiar; Ben Aicha, Houda; Toumi, Abdessatar; Bejar, Samir; Jaouadi, Bassem			Biochemical and Molecular Characterization of a Serine Keratinase from Brevibacillus brevis US575 with Promising Keratin-Biodegradation and Hide-Dehairing Activities	PLOS ONE			English	Article							BACILLUS-PUMILUS CBS; ALKALINE PROTEASE; PURIFICATION; IDENTIFICATION; PROTEINASE; BACTERIUM	Dehairing is one of the highly polluting operations in the leather industry. The conventional lime-sulfide process used for dehairing produces large amounts of sulfide, which poses serious toxicity and disposal problems. This operation also involves hair destruction, a process that leads to increased chemical oxygen demand (COD), biological oxygen demand (BOD), and total suspended solid (TSS) loads in the effluent. With these concerns in mind, enzyme-assisted dehairing has often been proposed as an alternative method. The main enzyme preparations so far used involved keratinases. The present paper reports on the purification of an extracellular keratinase (KERUS) newly isolated from Brevibacillus brevis strain US575. Matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF/MS) analysis revealed that the purified enzyme was a monomer with a molecular mass of 29121.11 Da. The sequence of the 27 N-terminal residues of KERUS showed high homology with those of Bacillus keratinases. Optimal activity was achieved at pH 8 and 40 degrees C. Its thermoactivity and thermostability were upgraded in the presence of 5 mM Ca2+. The enzyme was completely inhibited by phenylmethanesulfonyl fluoride (PMSF) and diiodopropyl fluorophosphates (DFP), which suggests that it belongs to the serine protease family. KERUS displayed higher levels of hydrolysis, substrate specificity, and catalytic efficiency than NUE 12 MG and KOROPON (R) MK EG keratinases. The enzyme also exhibited powerful keratinolytic activity that made it able to accomplish the entire feather-biodegradation process on its own. The kerUS gene encoding KERUS was cloned, sequenced, and expressed in Escherichia coli. The biochemical properties of the extracellular purified recombinant enzyme (rKERUS) were similar to those of native KERUS. Overall, the findings provide strong support for the potential candidacy of this enzyme as an effective and eco-friendly alternative to the conventional chemicals used for the dehairing of rabbit, goat, sheep and bovine hides in the leather processing industry.	[Jaouadi, Nadia Zarai; Rekik, Hatem; Trabelsi, Sahar; Belhoul, Mouna; Bejar, Samir; Jaouadi, Bassem] Univ Sfax, CBS, LMB, Sfax, Tunisia; [Badis, Abdelmalek] Univ Saad Dahlab USD Blida, LNPCB, Blida, Algeria; [Badis, Abdelmalek; Yahiaoui, Amina Benkiar] Natl Ctr Res & Dev Fisheries & Aquaculture CNRDPA, Bousmail, W Tipaza, Algeria; [Ben Aicha, Houda; Toumi, Abdessatar] Natl Leather & Shoe Ctr CNCC, Megrine, Ben Arous, Tunisia	Centre de Biotechnologie de Sfax; Universite de Sfax	Jaouadi, B (corresponding author), Univ Sfax, CBS, LMB, Sfax, Tunisia.	bassem.jaouadi@yahoo.fr	JAOUADI, Bassem/AAN-8106-2021	Bassem, JAOUADI/0000-0002-5182-7353	Tunisian Ministry of Higher Education and Scientific Research; Algerian Ministry of Higher Education and Scientific Research and Technology "Project Tuniso-Algerian JAOUADI/BADIS" [TNDZ-MicrooZymes_2012-2015]; Tunisian Ministry of Higher Education and Scientific Research "Contract program LMB-CBS" [LR10CBS04]; Tunisian Ministry of Industry; Tunisian Ministry of Higher Education and Scientific Research "National Programme for the Promotion of Technological Innovation PNRI-ENZYMES"	Tunisian Ministry of Higher Education and Scientific Research; Algerian Ministry of Higher Education and Scientific Research and Technology "Project Tuniso-Algerian JAOUADI/BADIS"; Tunisian Ministry of Higher Education and Scientific Research "Contract program LMB-CBS"; Tunisian Ministry of Industry; Tunisian Ministry of Higher Education and Scientific Research "National Programme for the Promotion of Technological Innovation PNRI-ENZYMES"	This work was funded by The Tunisian Ministry of Higher Education and Scientific Research and the Algerian Ministry of Higher Education and Scientific Research and Technology "Project Tuniso-Algerian JAOUADI/BADIS grant no. TNDZ-MicrooZymes_2012-2015;" The Tunisian Ministry of Higher Education and Scientific Research "Contract program LMB-CBS, grant no. LR10CBS04;" The Tunisian Ministry of Industry and The Tunisian Ministry of Higher Education and Scientific Research "National Programme for the Promotion of Technological Innovation PNRI-ENZYMES 2012-2013." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Nissen J., 1986, ENZYMIC HYDROLYSIS F; Benkiar A, 2013, INT BIODETER BIODEGR, V83, P129, DOI 10.1016/j.ibiod.2013.05.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandelli A, 2010, APPL MICROBIOL BIOT, V85, P1735, DOI 10.1007/s00253-009-2398-5; Burtt E. H., 1999, US Patent, Patent No. 6214676; Cavello IA, 2013, PROCESS BIOCHEM, V48, P972, DOI 10.1016/j.procbio.2013.03.012; Chaudhari PN, 2013, PROCESS BIOCHEM, V48, P144, DOI 10.1016/j.procbio.2012.11.009; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dayanandan A, 2003, J CLEAN PROD, V11, P533, DOI 10.1016/S0959-6526(02)00056-2; El-Refai HA, 2005, PROCESS BIOCHEM, V40, P2325, DOI 10.1016/j.procbio.2004.09.006; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fakhfakh-Zouari N, 2010, APPL BIOCHEM BIOTECH, V162, P329, DOI 10.1007/s12010-009-8774-x; Grazziotin A, 2007, BIORESOURCE TECHNOL, V98, P3172, DOI 10.1016/j.biortech.2006.10.034; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058393; Huang Q, 2003, CURR MICROBIOL, V46, P169, DOI 10.1007/s00284-002-3850-2; Jaouadi B, 2008, BIOCHIMIE, V90, P1291, DOI 10.1016/j.biochi.2008.03.004; Jaouadi B, 2010, BIORESOURCE TECHNOL, V101, P8361, DOI 10.1016/j.biortech.2010.05.066; Jaouadi B, 2010, BIOCHIMIE, V92, P360, DOI 10.1016/j.biochi.2010.01.008; Jaouadi B, 2009, BIOTECHNOL BIOPROC E, V14, P503, DOI 10.1007/s12257-008-0244-8; Jaouadi NZ, 2012, BIORESOURCE TECHNOL, V105, P142, DOI 10.1016/j.biortech.2011.11.115; Kumar AG, 2008, J APPL MICROBIOL, V104, P411, DOI 10.1111/j.1365-2672.2007.03564.x; Kumar CG, 2002, LETT APPL MICROBIOL, V34, P13, DOI [10.1046/j.1472-765x.2002.01044.x, 10.1046/j.1472-765X.2002.01044.x]; Kumar CG, 1999, BIOTECHNOL ADV, V17, P561, DOI 10.1016/S0734-9750(99)00027-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miyaji T, 2006, LETT APPL MICROBIOL, V42, P242, DOI 10.1111/j.1472-765X.2005.01851.x; Pan J, 2004, CURR MICROBIOL, V49, P165, DOI 10.1007/s00284-004-4305-8; Pandeeti EVP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016742; Pillai P, 2008, APPL MICROBIOL BIOT, V78, P643, DOI 10.1007/s00253-008-1355-z; Pillai P, 2012, PROCESS BIOCHEM, V47, P2116, DOI 10.1016/j.procbio.2012.07.030; Rajput Rinky, 2010, Enzyme Res, V2010, P132148, DOI 10.4061/2010/132148; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Riffel A, 2002, J IND MICROBIOL BIOT, V29, P255, DOI 10.1038/sj.jim.7000307; Sambrook J., 1989, MOL CLONING LAB MANU, P23; Shih J. C. H., 1992, US Patent, Patent No. [US5171682, 5171682]; SHIH JCH, 1990, Patent No. 4908220; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Son HJ, 2008, BIOTECHNOL LETT, V30, P461, DOI 10.1007/s10529-007-9567-3; Vetter R, 2003, European Patent, Patent No. [EP0572992 B1, 0572992]; Wang HY, 2007, LETT APPL MICROBIOL, V44, P1, DOI 10.1111/j.1472-765X.2006.02039.x; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990	43	97	104	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76722	10.1371/journal.pone.0076722	http://dx.doi.org/10.1371/journal.pone.0076722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146914	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400076
J	Li, ZJ; Sohn, KC; Choi, DK; Shi, G; Hong, D; Lee, HE; Whang, KU; Lee, YH; Im, M; Lee, Y; Seo, YJ; Kim, CD; Lee, JH				Li, Zheng Jun; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Shi, Ge; Hong, Dongkyun; Lee, Han-Eul; Whang, Kyu Uang; Lee, Young Ho; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon			Roles of TLR7 in Activation of NF-kappa B Signaling of Keratinocytes by Imiquimod	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HUMAN EPIDERMAL-KERATINOCYTES; IMMUNE-RESPONSE MODIFIER; CYTOKINE GENE-EXPRESSION; ACID-SENSING TLRS; DENDRITIC CELLS; TOPICAL IMMUNOMODULATOR; AUTOIMMUNITY; PATHOGENESIS; RECOGNITION	Imiquimod is known to exert its effects through Toll-like receptor 7 (TLR7) and/or TLR8, resulting in expression of proinflammatory cytokines and chemokines. Keratinocytes have not been reported to constitutively express TLR7 and TLR8, and the action of imiquimod is thought to be mediated by the adenine receptor, not TLR7 or TLR8. In this study, we revealed the expression of TLR7 in keratinocytes after calcium-induced differentiation. After addition of calcium to cultured keratinocytes, the immunological responses induced by imiquimod, such as activation of NF-kappa B and induction of TNF-alpha and IL-8, were more rapid and stronger. In addition, imiquimod induced the expression TLR7, and acted synergistically with calcium to induce proinflammatory cytokines. We confirmed that the responses induced by imiquimod were significantly inhibited by microRNAs suppressing TLR7 expression. These results suggest that TLR7 expressed in keratinocytes play key roles in the activation of NF-kB signaling by imiquimod, and that their modulation in keratinocytes could provide therapeutic potential for many inflammatory skin diseases.	[Li, Zheng Jun; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Hong, Dongkyun; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea; [Li, Zheng Jun; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Hong, Dongkyun; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Shi, Ge] Guangdong Med Coll, Affiliated Hosp 1, Dept Dermatol, Zhanjiang, Peoples R China; [Lee, Han-Eul; Whang, Kyu Uang] Soonchunhyang Univ, Coll Med, Dept Dermatol, Cheonan, South Korea; [Lee, Young Ho] Chungnam Natl Univ, Sch Med, Dept Anat, Taejon, South Korea	Chungnam National University; Chungnam National University; Guangdong Medical University; Soonchunhyang University; Chungnam National University	Lee, JH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea.	jhoon@cnu.ac.kr		Lee, Young Ho/0000-0001-8238-2345; Kim, Chang Deok/0000-0001-9341-6491; Seo, Young-Joon/0000-0002-4955-590X; Lee, Young/0000-0001-9205-1785	Korea Ministry of Health and Welfare [2012RA1A2008920]	Korea Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Ministry of Health and Welfare (2012RA1A2008920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Bong AB, 2002, DERMATOLOGY, V205, P135, DOI 10.1159/000063904; De Pita O, 2011, INT J IMMUNOPATH PH, V24, P185, DOI 10.1177/039463201102400121; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Fujisawa H, 1996, J INTERF CYTOK RES, V16, P555, DOI 10.1089/jir.1996.16.555; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Geisse JK, 2002, J AM ACAD DERMATOL, V47, P390, DOI 10.1067/mjd.2002.126215; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; KONO T, 1994, LYMPHOKINE CYTOK RES, V13, P71; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee Y, 2010, EXP DERMATOL, V19, pE44, DOI 10.1111/j.1600-0625.2009.00963.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Marek LR, 2011, FRONT BIOSCI-LANDMRK, V16, P2060, DOI 10.2741/3839; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller LS, 2007, SEMIN IMMUNOPATHOL, V29, P15, DOI 10.1007/s00281-007-0061-8; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; Morizane S, 2012, J INVEST DERMATOL, V132, P135, DOI 10.1038/jid.2011.259; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Shi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054355; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wu Jason K, 2004, Australas J Dermatol, V45, P47, DOI 10.1111/j.1440-0960.2004.00030.x	31	45	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77159	10.1371/journal.pone.0077159	http://dx.doi.org/10.1371/journal.pone.0077159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146965	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400102
J	Xiang, YX; Chen, L; Liu, HQ; Liu, XQ; Wei, XB; Sun, BZ; Wang, T; Zhang, XM				Xiang, Yanxiao; Chen, Lin; Liu, Huiqing; Liu, Xiaoqian; Wei, Xinbing; Sun, Baozhu; Wang, Tian; Zhang, Xiumei			Inhibition of sPLA(2)-IIA Prevents LPS-Induced Neuroinflammation by Suppressing ERK1/2-cPLA(2)alpha Pathway in Mice Cerebral Cortex	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ARACHIDONIC-ACID RELEASE; CENTRAL-NERVOUS-SYSTEM; CPLA(2) PHOSPHORYLATION; CEREBROSPINAL-FLUID; PROSTAGLANDIN E-2; BRAIN; IIA; ASTROCYTES; LIPOPOLYSACCHARIDE	Neuroinflammation is involved in various central nervous system (CNS) disorders, including brain infections, ischemia, trauma, stroke, and degenerative CNS diseases. In the CNS inflammation, secretory phospholipase A(2)-IIA (sPLA(2)-IIA) acts as a mediator, resulting in the generation of the precursors of pro-inflammatory lipid mediators, such as prostaglandins (PGs) and leukotrienes (LTs). However, the role of sPLA(2)-IIA in neuroinflammation is more complicated and remains unclear yet. In the present study, we investigated the effect of sPLA(2)-IIA inhibition by specific inhibitor SC-215 on the inflammation in LPS-induced mice cerebral cortex and primary astrocytes. Our results showed that the inhibition of sPLA(2)-IIA alleviated the release of PGE(2) by suppressing the activation of ERK1/2, cPLA2 alpha, COX-2 and mPGES-1. These findings demonstrated that sPLA(2)-IIA showed the potential to regulate the neuroinflammation in vivo and in vitro, indicating that sPLA(2)-IIA might be a novel target for the treatment of acute neuroinflammation.	[Xiang, Yanxiao; Chen, Lin; Liu, Huiqing; Liu, Xiaoqian; Wei, Xinbing; Zhang, Xiumei] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Sun, Baozhu] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan 250100, Peoples R China; [Wang, Tian] Yantai Univ, Sch Pharm, Dept Pharmacol, Yantai, Shandong, Peoples R China	Shandong University; Shandong University; Yantai University	Zhang, XM (corresponding author), Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China.	zhangxm@sdu.edu.cn			Natural Science Foundation of Shandong Province, China [ZR2010HM132, ZR2010HM082]; Graduate Independent Innovation Foundation of Shandong University, GIIFSDU [21300072613091]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Graduate Independent Innovation Foundation of Shandong University, GIIFSDU	This work was supported by the Natural Science Foundation of Shandong Province, China (Nos. ZR2010HM132 and ZR2010HM082) and the Graduate Independent Innovation Foundation of Shandong University, GIIFSDU (No 21300072613091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; Blom M, 1998, BLOOD, V91, P3037; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bosetti F, 2003, J NEUROCHEM, V87, P1471, DOI 10.1046/j.1471-4159.2003.02118.x; Cannon TR, 1998, BRIT J PHARMACOL, V123, P637, DOI 10.1038/sj.bjp.0701650; CARASSO RL, 1977, J NEUROL NEUROSUR PS, V40, P967, DOI 10.1136/jnnp.40.10.967; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Chalbot S, 2009, CLIN CHEM, V55, P2171, DOI 10.1373/clinchem.2009.130286; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dieter P, 2002, CELL SIGNAL, V14, P199, DOI 10.1016/S0898-6568(01)00243-1; DiSanto E, 1996, BRAIN RES, V740, P239, DOI 10.1016/S0006-8993(96)00865-7; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fonteh AN, 2000, J IMMUNOL, V165, P2773, DOI 10.4049/jimmunol.165.5.2773; Gao W, 2009, J PHYSIOL PHARMACOL, V60, P145; Guo JT, 2002, J NEUROSCI, V22, P5900; Hansford KA, 2003, CHEMBIOCHEM, V4, P181, DOI 10.1002/cbic.200390029; Ibeas E, 2009, CARDIOVASC RES, V81, P54, DOI 10.1093/cvr/cvn234; Jaulmes A, 2005, ARTERIOSCL THROM VAS, V25, P1161, DOI 10.1161/01.ATV.0000164310.67356.a9; Johann S, 2008, J MOL NEUROSCI, V34, P177, DOI 10.1007/s12031-007-9028-4; Johnson RW, 1997, BRAIN RES, V752, P219, DOI 10.1016/S0006-8993(96)01454-0; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Kwiatkoski M, 2013, EXP NEUROL, V240, P88, DOI 10.1016/j.expneurol.2012.11.008; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Strokin M, 2007, J NEUROCHEM, V102, P1771, DOI 10.1111/j.1471-4159.2007.04663.x; TAKAKUWA T, 1994, RES COMMUN CHEM PATH, V84, P283; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Tian W, 2008, J BIOL CHEM, V283, P3960, DOI 10.1074/jbc.M707345200; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	46	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77909	10.1371/journal.pone.0077909	http://dx.doi.org/10.1371/journal.pone.0077909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130900	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900143
J	Monaco, G; Decrock, E; Nuyts, K; Wagner, LE; Luyten, T; Strelkov, SV; Missiaen, L; De Borggraeve, WM; Leybaert, L; Yule, DI; De Smedt, H; Parys, JB; Bultynck, G				Monaco, Giovanni; Decrock, Elke; Nuyts, Koen; Wagner, Larry E., II; Luyten, Tomas; Strelkov, Sergei V.; Missiaen, Ludwig; De Borggraeve, Wim M.; Leybaert, Luc; Yule, David I.; De Smedt, Humbert; Parys, Jan B.; Bultynck, Geert			Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP3 Receptor	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; ENDOPLASMIC-RETICULUM; BCL-2 FAMILY; BH4 DOMAIN; CALCIUM-RELEASE; BETA-SHEET; APOPTOSIS; BINDING	The anti-apoptotic Bcl-2 protein is the founding member and namesake of the Bcl-2-protein family. It has recently been demonstrated that Bcl-2, apart from its anti-apoptotic role at mitochondrial membranes, can also directly interact with the inositol 1,4,5-trisphosphate receptor (IP3R), the primary Ca2+-release channel in the endoplasmic reticulum (ER). Bcl-2 can thereby reduce pro-apoptotic IP3R-mediated Ca2+ release from the ER. Moreover, the Bcl-2 homology domain 4 (Bcl-2-BH4) has been identified as essential and sufficient for this IP3R-mediated anti-apoptotic activity. In the present study, we investigated whether the reported inhibitory effect of a Bcl-2-BH4 peptide on the IP (3)R1 was related to the distinctive alpha-helical conformation of the BH4 domain peptide. We therefore designed a peptide with two glycine "hinges" replacing residues I14 and V15, of the wild-type Bcl-2-BH4 domain (Bcl-2-BH4-IV/GG). By comparing the structural and functional properties of the Bcl-2-BH4-IV/GG peptide with its native counterpart, we found that the variant contained reduced alpha-helicity, neither bound nor inhibited the IP (3)R1 channel, and in turn lost its anti-apoptotic effect. Similar results were obtained with other substitutions in Bcl-2-BH4 that destabilized the alpha-helix with concomitant loss of IP3R inhibition. These results provide new insights for the further development of Bcl-2-BH4-derived peptides as specific inhibitors of the IP3R with significant pharmacological implications.	[Monaco, Giovanni; Luyten, Tomas; Missiaen, Ludwig; De Smedt, Humbert; Parys, Jan B.; Bultynck, Geert] Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium; [Decrock, Elke; Leybaert, Luc] Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Nuyts, Koen; De Borggraeve, Wim M.] Dept Chem, Sect Mol Design & Synth, Heverlee, Belgium; [Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Strelkov, Sergei V.] Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, Louvain, Belgium	Ghent University; University of Rochester	Monaco, G (corresponding author), Dept Cellular & Mol Med, Lab Mol & Cellular Signaling, Louvain, Belgium.	Giovanni.Monaco@med.kuleuven.be; Geert.Bultynck@med.kuleuven.be	Nuyts, Koen/L-9930-2017; Strelkov, Sergei V/G-7425-2014; Monaco, Giovanni/J-2957-2019; Leybaert, Luc/F-4079-2015; De Borggraeve, Wim/AGE-5612-2022	Nuyts, Koen/0000-0003-0387-9965; Strelkov, Sergei V/0000-0001-7189-4652; Monaco, Giovanni/0000-0001-5209-4326; Leybaert, Luc/0000-0001-6452-6982; De Borggraeve, Wim/0000-0001-7813-6192; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Council KU Leuven [OT/STRT1/10/044]; Research Foundation - Flanders (F.W.O.) [G.0788.11, G.0571.12, G.0819.13]; Interuniversity Attraction Poles Program (Belgian Science Policy) [IAP/P7]; Royal Flemish Academy of Belgium for Science and the Arts (Research Award from the Octaaf Dupont Foundation); Research Foundation - Flanders	Research Council KU Leuven(KU Leuven); Research Foundation - Flanders (F.W.O.)(FWO); Interuniversity Attraction Poles Program (Belgian Science Policy)(Belgian Federal Science Policy Office); Royal Flemish Academy of Belgium for Science and the Arts (Research Award from the Octaaf Dupont Foundation); Research Foundation - Flanders(FWO)	This work has been supported by grants from the Research Council KU Leuven (OT/STRT1/10/044 to GB) [http://www.kuleuven.be/research/funding/bof/]; Research Foundation - Flanders (F.W.O.; grant numbers G.0788.11 to GB and SS, G.0571.12 to GB and JBP and G.0819.13 to GB and HDS) [http://www.fwo.be/]; The Interuniversity Attraction Poles Program (Belgian Science Policy IAP/P7 to GB, HDS, JBP, LM) [http://www.belspo.be/belspo/iap/index_en.stm]; and The Royal Flemish Academy of Belgium for Science and the Arts (Research Award from the Octaaf Dupont Foundation 2010 to GB) [http://www.kvab.be]. GM and ED are supported by the Research Foundation - Flanders through a doctoral and postdoctoral fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; Bender T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011106; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; BOND SL, 1994, CELL GROWTH DIFFER, V5, P179; Cantara S, 2004, J VASC RES, V41, P202, DOI 10.1159/000077408; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; De Vuyst E, 2008, BIOPHYS J, V94, P469, DOI 10.1529/biophysj.107.109470; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DECROCK E, 2013, COLD SPRING IN PRESS; Dremina ES, 2012, BIOCHEM J, V444, P127, DOI 10.1042/BJ20111114; Dremina ES, 2004, BIOCHEM J, V383, P361, DOI 10.1042/BJ20040187; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Hunter JJ, 1996, MOL CELL BIOL, V16, P877; Jochim AL, 2009, MOL BIOSYST, V5, P924, DOI 10.1039/b903202a; JOHANNING GL, 2012, CHEMOTHERAPY, V1, P1, DOI DOI 10.4236/MC.2012.11001; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Kawamoto SA, 2012, J MED CHEM, V55, P1137, DOI 10.1021/jm201125d; Khemtemourian L, 2006, J PEPT SCI, V12, P58, DOI 10.1002/psc.686; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Lama D, 2010, BIOCHEMISTRY-US, V49, P2574, DOI 10.1021/bi100029k; Lee LC, 1996, J BIOL CHEM, V271, P23284, DOI 10.1074/jbc.271.38.23284; LYU PCC, 1991, J AM CHEM SOC, V113, P3568, DOI 10.1021/ja00009a052; McDunn JE, 2009, BIOCHEM BIOPH RES CO, V382, P657, DOI 10.1016/j.bbrc.2009.03.080; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Monaco G, 2013, CELL MOL LIFE SCI, V70, P1171, DOI 10.1007/s00018-012-1118-y; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Reed JC, 1996, ADV EXP MED BIOL, V406, P99; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sani MA, 2008, FEBS J, V275, P561, DOI 10.1111/j.1742-4658.2007.06222.x; Sani MA, 2007, J PEPT SCI, V13, P100, DOI 10.1002/psc.803; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Wang KR, 2008, PEPTIDES, V29, P963, DOI 10.1016/j.peptides.2008.01.015; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	54	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73386	10.1371/journal.pone.0073386	http://dx.doi.org/10.1371/journal.pone.0073386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24137498	Green Published, gold, Green Submitted			2022-12-25	WOS:000323880200074
J	Yu, T; Liu, K; Wu, Y; Fan, J; Chen, J; Li, C; Yang, Q; Wang, Z				Yu, T.; Liu, K.; Wu, Y.; Fan, J.; Chen, J.; Li, C.; Yang, Q.; Wang, Z.			MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/beta-catenin signaling pathway	ONCOGENE			English	Article						microRNA-9; CXC chemokine receptor 4; lentivirus; cell proliferation; oral squamous cell carcinoma; wnt/beta-catenin pathway	DOWN-REGULATION; CANCER; MIR-9; MIGRATION; TONGUE; IDENTIFICATION; INVASION; CADHERIN	Aberrant expression of microRNAs (miRNAs) has been involved in the development and progression of malignancy. MicroRNA-9 (miR-9) has been confirmed to be underexpressed in many types of cancers. However, the relationship between miR-9 and the Wnt/beta-catenin signaling pathway in oral squamous cell carcinoma (OSCC) remains largely unknown. Here we showed that the miR-9 was underexpressed in patients with OSCC and several OSCC cell lines. Lentivirus-mediated miR-9 overexpression in highly aggressive (Tca8113 and SCC-9) tumor cells significantly inhibited proliferation of the two cell lines in vitro and in vivo. Furthermore, we found that the CXC chemokine receptor 4 (CXCR4) gene was a direct target of miR-9. RNA interference silencing of CXCR4 proved that miR-9 underexpression led to constitutive activation of beta-catenin through activation of CXCR4 expression in OSCC cells. Finally, we also analyzed the possible relationship between miR-9 and the genes downstream of the Wnt/beta-catenin pathway in OSCC development and progression. These results provide new evidence of miR-9 as a promising tumor gene therapeutic target for OSCC patients.	[Yu, T.; Liu, K.; Fan, J.; Chen, J.; Li, C.; Yang, Q.; Wang, Z.] Sichuan Canc Hosp, Dept Head & Neck Oncol Surg, Chengdu 610041, Sichuan, Peoples R China; [Wu, Y.] Sichuan Univ, West China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	Sichuan University	Yu, T (corresponding author), Sichuan Canc Hosp, Dept Head & Neck Oncol Surg, 55 Sec 4,Renminnan Rd, Chengdu 610041, Sichuan, Peoples R China.	vince8181@163.com; zhaohuiwang512@163.com	YU, TAO/AAA-3089-2022					Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avissar M, 2009, CARCINOGENESIS, V30, P2059, DOI 10.1093/carcin/bgp277; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Choe Y, 2012, DEV NEUROSCI-BASEL, V34, P502, DOI 10.1159/000345353; Fracalossi ACC, 2010, EXP MOL PATHOL, V88, P176, DOI 10.1016/j.yexmp.2009.11.004; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Gao F, 2013, BIOCHEM BIOPH RES CO, V431, P610, DOI 10.1016/j.bbrc.2012.12.097; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058273; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jin Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-480; Jing LJ, 2011, NEUROREPORT, V22, P206, DOI 10.1097/WNR.0b013e328344a666; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kessler P, 2008, BRIT J ORAL MAX SURG, V46, P1, DOI 10.1016/j.bjoms.2007.08.006; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Leucci E, 2012, ONCOGENE, V31, P5081, DOI 10.1038/onc.2012.15; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Liu NN, 2012, ONCOL REP, V28, P961, DOI 10.3892/or.2012.1905; Liu SJ, 2012, J PATHOL, V226, P61, DOI 10.1002/path.2964; Lowy AM, 2003, ANN SURG ONCOL, V10, P284, DOI 10.1245/ASO.2003.05.003; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Rotkrua P, 2011, INT J CANCER, V129, P2611, DOI 10.1002/ijc.25923; Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sun Z, 2013, MOL ONCOL; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Wong TS, 2008, INT J CANCER, V123, P251, DOI 10.1002/ijc.23583; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64	47	99	103	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2014	33	42					5017	5027		10.1038/onc.2013.448	http://dx.doi.org/10.1038/onc.2013.448			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OB	24141785				2022-12-25	WOS:000343768000006
J	Banerjee, J; Mishra, R; Li, X; Jackson, RS; Sharma, A; Bhowmick, NA				Banerjee, J.; Mishra, R.; Li, X.; Jackson, R. S., II; Sharma, A.; Bhowmick, N. A.			A reciprocal role of prostate cancer on stromal DNA damage	ONCOGENE			English	Article						stromal coevolution; prostate cancer; TGF-beta; IL-6; DNA methylation	REACTIVE STROMA; TUMOR PROGRESSION; FIBROBLASTS; METHYLATION; GROWTH; TUMORIGENESIS; MECHANISMS; INDUCTION; PROMOTER; THERAPY	DNA damage found in prostate cancer-associated fibroblasts (CAF) promotes tumor progression. In the absence of somatic mutations in CAF, epigenetic changes dictate how stromal coevolution is mediated in tumors. Seventy percent of prostate cancer patients lose expression of transforming growth factor-beta type II receptor (TGFBR2) in the stromal compartment (n = 77, P-value = 0.0001), similar to the rate of glutathione S-transferase P1 (GSTP1) silencing. Xenografting of human prostate cancer epithelia, LNCaP, resulted in the epigenetic Tgfbr2 silencing of host mouse prostatic fibroblasts. Stromal Tgfbr2 promoter hypermethylation, initiated by LNCaP cells, was found to be dependent on interleukin 6 expression, based on neutralizing antibody studies. We further found that pharmacologic and transgenic knockout of TGF-beta responsiveness in prostatic fibroblasts induced Gstp1 promoter methylation. It is known that TGF-beta promotes DNA stability, however, the mechanism is not well understood. Both prostatic human CAF and mouse transgenic knockout of Tgbr2 had elevated DNA methyltransferase I (DNMT1) activity and histone H3 lysine 9 trimethylation (H3K9me3) to suggest greater promoter methylation. Interestingly, the conditional knockout of Tgfbr2 in mouse prostatic fibroblasts, in modeling epigenetic silencing of Tgfbr2, had greater epigenetic gene silencing of multiple DNA damage repair and oxidative stress response genes, based on promoter methylation array analysis. Homologous gene silencing was validated by reverse transcriptase (RT)-PCR in mouse and human prostatic CAF. Not surprisingly, DNA damage repair gene silencing in the prostatic stromal cells corresponded with the presence of DNA damage. Restoring the expression of the epigenetically silenced genes in wild-type fibroblasts with radiation-induced DNA damage reduced tumor progression. Tumor progression was inhibited even when epigenetic silencing was reversed in the Tgfbr2-knockout prostatic fibroblasts. Taken together, fibroblastic epigenetic changes causative of DNA damage, initiated by association with cancer epithelia, is a dominant mediator of tumor progression over TGF-beta responsiveness.	[Banerjee, J.; Li, X.; Jackson, R. S., II] Vanderbilt Univ, Dept Urol, Nashville, TN USA; [Mishra, R.; Bhowmick, N. A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Los Angeles, CA 90048 USA; [Jackson, R. S., II; Bhowmick, N. A.] Greater Los Angeles Vet Adm, Los Angeles, CA USA; [Sharma, A.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN USA	Vanderbilt University; Cedars Sinai Medical Center; University of Tennessee System; University of Tennessee Knoxville	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Mishra, Rajeev/AEX-2208-2022; Bhowmick, Neil/AAA-7302-2019; Mishra, Rajeev/T-4216-2017	Mishra, Rajeev/0000-0002-7411-4022; Bhowmick, Neil/0000-0001-8747-5989; , Xiaohong/0000-0001-5074-193X	National Cancer Institute [R01CA108646]; NATIONAL CANCER INSTITUTE [R01CA108646] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by R01CA108646 (to NAB) from the National Cancer Institute.	Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cunha G R, 1984, Prog Clin Biol Res, V145, P81; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Jackson RS, 2012, NEOPLASIA, V14, P656, DOI 10.1593/neo.12640; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2007, CANCER-AM CANCER SOC, V109, P1705, DOI 10.1002/cncr.22602; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Olumi AF, 1999, CANCER RES, V59, P5002; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Shen H, 2012, CELL STEM CELL, V10, P353, DOI 10.1016/j.stem.2012.03.012; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	39	34	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4924	4931		10.1038/onc.2013.431	http://dx.doi.org/10.1038/onc.2013.431			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24141771	Green Accepted			2022-12-25	WOS:000343767900005
J	Almenar-Queralt, A; Kim, SN; Benner, C; Herrera, CM; Kang, DE; Garcia-Bassets, I; Goldstein, LSB				Almenar-Queralt, Angels; Kim, Sonia N.; Benner, Christopher; Herrera, Cheryl M.; Kang, David E.; Garcia-Bassets, Ivan; Goldstein, Lawrence S. B.			Presenilins Regulate Neurotrypsin Gene Expression and Neurotrypsin-dependent Agrin Cleavage via Cyclic AMP Response Element-binding Protein (CREB) Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChIP); CREB; Presenilin; Promoters; Secretases; Drosophila Larval Brains; GSK3; MEFs; Tequila; Neurotrypsin	AMYLOID PRECURSOR PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL ACTIVITY; SYNAPTIC FUNCTION; STEM-CELLS; ACTIVATION; DROSOPHILA; MUTATIONS	Background: Presenilins regulate multiple cellular pathways by controlling transcription. Results: Presenilins repress neurotrypsin expression by preventing CREB recruitment to its promoter. Conclusion: A new strategy utilized by presenilins to regulate CREB signaling relies on preventing CREB recruitment to gene promoters. Significance: Learning how presenilins control CREB signaling will help understanding their physiological/pathological roles. Presenilins, the catalytic components of the -secretase complex, are upstream regulators of multiple cellular pathways via regulation of gene transcription. However, the underlying mechanisms and the genes regulated by these pathways are poorly characterized. In this study, we identify Tequila and its mammalian ortholog Prss12 as genes negatively regulated by presenilins in Drosophila larval brains and mouse embryonic fibroblasts, respectively. Prss12 encodes the serine protease neurotrypsin, which cleaves the heparan sulfate proteoglycan agrin. Altered neurotrypsin activity causes serious synaptic and cognitive defects; despite this, the molecular processes regulating neurotrypsin expression and activity are poorly understood. Using -secretase drug inhibitors and presenilin mutants in mouse embryonic fibroblasts, we found that a mature -secretase complex was required to repress neurotrypsin expression and agrin cleavage. We also determined that PSEN1 endoproteolysis or processing of well known -secretase substrates was not essential for this process. At the transcriptional level, PSEN1/2 removal induced cyclic AMP response element-binding protein (CREB)/CREB-binding protein binding, accumulation of activating histone marks at the neurotrypsin promoter, and neurotrypsin transcriptional and functional up-regulation that was dependent on GSK3 activity. Upon PSEN1/2 reintroduction, this active epigenetic state was replaced by a methyl CpG-binding protein 2 (MeCP2)-containing repressive state and reduced neurotrypsin expression. Genome-wide analysis revealed hundreds of other mouse promoters in which CREB binding is similarly modulated by the presence/absence of presenilins. Our study thus identifies Tequila and neurotrypsin as new genes repressed by presenilins and reveals a novel mechanism used by presenilins to modulate CREB signaling based on controlling CREB recruitment.	[Almenar-Queralt, Angels; Kim, Sonia N.; Herrera, Cheryl M.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kang, David E.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Garcia-Bassets, Ivan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Almenar-Queralt, Angels; Kim, Sonia N.; Herrera, Cheryl M.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Benner, Christopher] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Almenar-Queralt, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.	aalmenar@ucsd.edu; lgoldstein@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Kang, David E./E-5234-2012	Garcia-Bassets, Ivan/0000-0002-6941-9585; Kim, Sonia Nan/0000-0002-2998-2621; Benner, Christopher/0000-0002-4618-0719; Kang, David E./0000-0002-7132-821X	National Institutes of Health [1F32AG20039]; National Research Service Award from the NIA; NIA [5R01AG032180, 1R01AG033055]; Ovarian Cancer Research Fund; Estate of Agatha Fort (Liz Tilberis Scholar); NATIONAL INSTITUTE ON AGING [R01AG033055, R01AG032180, P50AG005131, F32AG020039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the NIA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ovarian Cancer Research Fund; Estate of Agatha Fort (Liz Tilberis Scholar); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F32AG20039, a National Research Service Award from the NIA (to A. A. Q.); 5R01AG032180 from the NIA (to L S. B. G.); and 1R01AG033055 (to D. E. K.) and by the Ovarian Cancer Research Fund and the Estate of Agatha Fort (Liz Tilberis Scholar) (to I. G. B.).	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boer U, 2008, NEUROPSYCHOPHARMACOL, V33, P2407, DOI 10.1038/sj.npp.1301640; Bogdanik LP, 2011, HUM MOL GENET, V20, P4617, DOI 10.1093/hmg/ddr396; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Boulianne GL, 1997, NEUROREPORT, V8, P1025, DOI 10.1097/00001756-199703030-00041; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen SZ, 2011, CANCER RES, V71, P6270, DOI 10.1158/0008-5472.CAN-11-0838; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Daniels MP, 2012, NEUROCHEM INT, V61, P848, DOI 10.1016/j.neuint.2012.02.028; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Francis YI, 2006, NEUROREPORT, V17, P917, DOI 10.1097/01.wnr.0000220137.06542.a0; Gadadhar A, 2011, J NEUROSCI, V31, P2615, DOI 10.1523/JNEUROSCI.4767-10.2011; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Garcia-Bassets I, 2012, CELL CYCLE, V11, P3199, DOI 10.4161/cc.21281; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gopisetty G, 2013, ONCOGENE, V32, P3119, DOI 10.1038/onc.2012.331; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Handler M, 2000, DEVELOPMENT, V127, P2593; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ho A, 2011, TRENDS MOL MED, V17, P617, DOI 10.1016/j.molmed.2011.06.002; Hong CS, 1997, NEUROREPORT, V8, P665, DOI 10.1097/00001756-199702100-00017; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Jayadev S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015743; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kawamura Y, 2001, EUR J BIOCHEM, V268, P3036, DOI 10.1046/j.1432-1327.2001.02197.x; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Li T, 2003, J NEUROSCI, V23, P3272; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; Raurell I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004080; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; St George-Hyslop P, 2012, J NEUROCHEM, V120, P84, DOI 10.1111/j.1471-4159.2011.07505.x; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tyson DR, 2002, ENDOCRINOLOGY, V143, P674, DOI 10.1210/en.143.2.674; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wen PH, 2004, NEUROSCI LETT, V371, P249, DOI 10.1016/j.neulet.2004.09.038; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wolfer DP, 2001, MOL CELL NEUROSCI, V18, P407, DOI 10.1006/mcne.2001.1029; Yang T, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-15; Yu G, 2000, J BIOL CHEM, V275, P27348; Zhong HB, 2009, MOL BIOSYST, V5, P1356, DOI 10.1039/b905752h; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	83	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35222	35236		10.1074/jbc.M113.513705	http://dx.doi.org/10.1074/jbc.M113.513705			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145027	Green Published, hybrid			2022-12-25	WOS:000329867600022
J	Dejima, K; Takemura, M; Nakato, E; Peterson, J; Hayashi, Y; Kinoshita-Toyoda, A; Toyoda, H; Nakato, H				Dejima, Katsufumi; Takemura, Masahiko; Nakato, Eriko; Peterson, Jesse; Hayashi, Yoshiki; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Nakato, Hiroshi			Analysis of Drosophila Glucuronyl C5-Epimerase IMPLICATIONS FOR DEVELOPMENTAL ROLES OF HEPARAN SULFATE SULFATION COMPENSATION AND 2-O-SULFATED GLUCURONIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Fibroblast Growth Factor (FGF); Genetics; Heparan Sulfate; Immunohistochemistry; C5-Epimerase; Gagosome; Sulfation Compensation	MORPHOGEN GRADIENT FORMATION; HEXURONIC ACID 2-O-SULFOTRANSFERASE; INTEGRAL MEMBRANE PROTEOGLYCAN; L-IDURONIC ACID; IN-VIVO; CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; NERVOUS-SYSTEM; CELL-SURFACE; GENE	Background: The physiological significance of C5-epimerization of glucuronic acid (GlcA) remains elusive. Results:Drosophila Hsepi mutants are viable and fertile with only minor morphological defects, but they have a short lifespan. Conclusion: Sulfation compensation and 2-O-sulfated GlcA contribute to the mild phenotypes of Hsepi mutants. Significance: The findings suggest novel developmental roles of 2-O-sulfated GlcA. During the biosynthesis of heparan sulfate (HS), glucuronyl C5-epimerase (Hsepi) catalyzes C5-epimerization of glucuronic acid (GlcA), converting it to iduronic acid (IdoA). Because HS 2-O-sulfotransferase (Hs2st) shows a strong substrate preference for IdoA over GlcA, C5-epimerization is required for normal HS sulfation. However, the physiological significance of C5-epimerization remains elusive. To understand the role of Hsepi in development, we isolated Drosophila Hsepi mutants. Homozygous mutants are viable and fertile with only minor morphological defects, including the formation of an ectopic crossvein in the wing, but they have a short lifespan. We propose that two mechanisms contribute to the mild phenotypes of Hsepi mutants: HS sulfation compensation and possible developmental roles of 2-O-sulfated GlcA (GlcA2S). HS disaccharide analysis showed that loss of Hsepi resulted in a significant impairment of 2-O-sulfation and induced compensatory increases in N- and 6-O-sulfation. Simultaneous block of Hsepi and HS 6-O-sulfotransferase (Hs6st) activity disrupted tracheoblast formation, a well established FGF-dependent process. This result suggests that the increase in 6-O-sulfation in Hsepi mutants is critical for the rescue of FGF signaling. We also found that the ectopic crossvein phenotype can be induced by expression of a mutant form of Hs2st with a strong substrate preference for GlcA-containing units, suggesting that this phenotype is associated with abnormal GlcA 2-O-sulfation. Finally, we show that Hsepi formed a complex with Hs2st and Hs6st in S2 cells, raising the possibility that this complex formation contributes to the close functional relationships between these enzymes.	[Dejima, Katsufumi; Takemura, Masahiko; Nakato, Eriko; Peterson, Jesse; Hayashi, Yoshiki; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Fac Pharmaceut Sci, Shiga 5258577, Japan	University of Minnesota System; University of Minnesota Twin Cities; Ritsumeikan University	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Hayashi, Yoshiki/0000-0002-8966-8730; Takemura, Masahiko/0000-0003-3984-4481	National Institutes of Health [R01 HD042769]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD042769 (to H. N.).	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Chen J, 2012, DEVELOPMENT, V139, P2170, DOI 10.1242/dev.073817; Dejima K, 2013, J BIOL CHEM, V288, P6574, DOI 10.1074/jbc.M112.404830; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Fujise M, 2001, DEV BIOL, V235, P433, DOI 10.1006/dbio.2001.0290; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Ghiselli G, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-19; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hayashi Y, 2012, DEVELOPMENT, V139, P4162, DOI 10.1242/dev.078055; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kleinschmit A, 2010, DEV BIOL, V345, P204, DOI 10.1016/j.ydbio.2010.07.006; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; Merry CLR, 2002, BIOCHEM SOC SYMP, V69, P47; Merry CLR, 2002, BBA-GEN SUBJECTS, V1573, P319, DOI 10.1016/S0304-4165(02)00399-9; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Smeds E, 2010, GLYCOBIOLOGY, V20, P1274, DOI 10.1093/glycob/cwq089; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Townley RA, 2011, J BIOL CHEM, V286, P16824, DOI 10.1074/jbc.M111.227926; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; White-Cooper H, 2004, METH MOL B, V247, P45; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200	47	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34384	34393		10.1074/jbc.M113.499269	http://dx.doi.org/10.1074/jbc.M113.499269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133213	Green Published, hybrid			2022-12-25	WOS:000329812800010
J	Hu, JX; Hu, K; Liu, T; Stern, MK; Mistry, R; Challiss, RAJ; Costanzi, S; Wess, J				Hu, Jianxin; Hu, Kelly; Liu, Tong; Stern, Matthew K.; Mistry, Rajendra; Challiss, R. A. John; Costanzi, Stefano; Wess, Juergen			Novel Structural and Functional Insights into M-3 Muscarinic Receptor Dimer/Oligomer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholinergic Receptor; G Protein-coupled Receptors (GPCR); Neurotransmitter Receptors; Receptor Structure-function; Site-directed Mutagenesis	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTORS; OPIOID RECEPTOR; NATIVE MEMBRANES; MOLECULAR-BASIS; DRUG DISCOVERY; RHODOPSIN; ACTIVATION; TRANSDUCIN	Background: G protein-coupled receptors (GPCRs) exist in dimeric/oligomeric arrays but the structural basis underling this phenomenon is not well understood. Results: The M-3 muscarinic receptor, a prototypic GPCR, can form multiple, structurally distinct dimeric species. Conclusion: GPCRs may exist in a dynamic equilibrium of multiple dimers or oligomers. Significance: Our findings may facilitate efforts to target GPCR dimers for therapeutic purposes. Class A G protein-coupled receptors (GPCRs) are able to form homodimers and/or oligomeric arrays. We recently proposed, based on bioluminescence resonance energy transfer studies with the M-3 muscarinic receptor (M3R), a prototypic class A GPCR, that the M3R is able to form multiple, structurally distinct dimers that are probably transient in nature (McMillin, S. M., Heusel, M., Liu, T., Costanzi, S., and Wess, J. (2011) J. Biol. Chem. 286, 28584-28598). To provide more direct experimental support for this concept, we employed a disulfide cross-linking strategy to trap various M3R dimeric species present in a native lipid environment (transfected COS-7 cells). Disulfide cross-linking studies were carried out with many mutant M3Rs containing single cysteine (Cys) substitutions within two distinct cytoplasmic M3R regions, the C-terminal portion of the second intracellular loop (i2) and helix H8 (H8). The pattern of cross-links that we obtained, in combination with molecular modeling studies, was consistent with the existence of two structurally distinct M3R dimer interfaces, one involving i2/i2 contacts (TM4-TM5-i2 interface) and the other one characterized by H8-H8 interactions (TM1-TM2-H8 interface). Specific H8-H8 disulfide cross-links led to significant impairments in M3R-mediated G protein activation, suggesting that changes in the structural orientation or mobility of H8 are critical for efficient receptor-G protein coupling. Our findings provide novel structural and functional insights into the mechanisms involved in M3R dimerization (oligomerization). Because the M3R shows a high degree of sequence similarity with many other class A GPCRs, our findings should be of considerable general interest.	[Hu, Jianxin; Hu, Kelly; Liu, Tong; Stern, Matthew K.; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Mistry, Rajendra; Challiss, R. A. John] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Costanzi, Stefano] Amer Univ, Dept Chem, Washington, DC 20016 USA; [Costanzi, Stefano] Amer Univ, Ctr Behav Neurosci, Washington, DC 20016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Leicester; American University; American University	Wess, J (corresponding author), Bldg 8A,Rm B1A-05,8 Ctr Dr MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov		Challiss, John/0000-0001-5506-2848; Costanzi, Stefano/0000-0003-3183-7332	National Institutes of Health, NIDDK; American University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIDDK, and the American University.	Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; [Anonymous], 2010, MOL OP ENV MOE VERS; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; GRIFFITH IP, 1972, BIOCHEM J, V126, P553, DOI 10.1042/bj1260553; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2010, REGUL PEPTIDES, V164, P113, DOI 10.1016/j.regpep.2010.06.001; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yang K, 1996, BIOCHEMISTRY-US, V35, P14040, DOI 10.1021/bi962113u; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 1999, J BIOL CHEM, V274, P16629, DOI 10.1074/jbc.274.23.16629	51	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34777	34790		10.1074/jbc.M113.503714	http://dx.doi.org/10.1074/jbc.M113.503714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133207	hybrid, Green Published			2022-12-25	WOS:000329812800046
J	Pham, TH; Gao, XF; Singh, G; Hardwidge, PR				Pham, Thanh H.; Gao, Xiaofei; Singh, Gyanendra; Hardwidge, Philip R.			Escherichia coli Virulence Protein NleH1 Interaction with the v-Crk Sarcoma Virus CT10 Oncogene-like Protein (CRKL) Governs NleH1 Inhibition of the Ribosomal Protein 53 (RPS3)/Nuclear Factor kappa B (NF-kappa B) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; Innate Immunity; NF-B; Type III Secretion System; Virulence factors; CRKL; IKK; NleH1	TYROSINE PHOSPHORYLATION; BACTERIAL EFFECTOR; SECRETION; APOPTOSIS; RECEPTOR; COMPLEX; LOCALIZATION; EXPRESSION; INFECTION; LIGATION	Background: Bacterial pathogens use virulence proteins to inhibit the host innate immune system. Results: The Escherichia coli O157:H7 NleH1 protein interacts with the host CRKL protein. Conclusion: CRKL may recruit NleH1 to a host kinase on which NleH1 performs its inhibitory function. Significance: These data clarify a mechanism by which E. coli inhibits innate immunity. Enterohemorrhagic Escherichia coli and other attaching/effacing bacterial pathogens cause diarrhea in humans. These pathogens use a type III secretion system to inject virulence proteins (effectors) into host cells, some of which inhibit the innate immune system. The enterohemorrhagic E. coli NleH1 effector prevents the nuclear translocation of RPS3 (ribosomal protein S3) to inhibit its participation as a nuclear specifier of NF-B binding to target gene promoters. NleH1 binds to RPS3 and inhibits its phosphorylation on Ser-209 by IB kinase- (IKK). However, the precise mechanism of this inhibition is unclear. NleH1 possesses a Ser/Thr protein kinase activity that is essential both for its ability to inhibit the RPS3/NF-B pathway and for full virulence of the attaching/effacing mouse pathogen Citrobacter rodentium. However, neither RPS3 nor IKK is a substrate of NleH1 kinase activity. We therefore screened approximate to 9,000 human proteins to identify NleH1 kinase substrates and identified CRKL (v-Crk sarcoma virus CT10 oncogene-like protein), a substrate of the BCR/ABL kinase. Knockdown of CRKL abundance prevented NleH1 from inhibiting RPS3 nuclear translocation and NF-B activity. CRKL residues Tyr-198 and Tyr-207 were required for interaction with NleH1. Lys-159, the kinase-active site of NleH1, was necessary for its interaction with CRKL. We also identified CRKL as an IKK interaction partner, mediated by CRKL Tyr-198. We propose that the CRKL interaction with IKK recruits NleH1 to the IKK complex, where NleH1 then inhibits the RPS3/NF-B pathway.	[Pham, Thanh H.; Singh, Gyanendra; Hardwidge, Philip R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Gao, Xiaofei] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Kansas State University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Hardwidge, PR (corresponding author), Kansas State Univ, Manhattan, KS 66506 USA.	hardwidg@gmail.com		PHAM, THANH/0000-0001-8959-7947	National Institutes of Health from NIAID [AI099002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099002, R56AI099002] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI099002 from NIAID.	Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gao XF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00137; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Koval AP, 1998, J BIOL CHEM, V273, P14780, DOI 10.1074/jbc.273.24.14780; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pham TH, 2012, INFECT IMMUN, V80, P2133, DOI 10.1128/IAI.06358-11; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Robinson KS, 2010, MICROBIOL-SGM, V156, P1815, DOI 10.1099/mic.0.037259-0; Ruchaud-Sparagano MH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002414; Sattler M, 1997, J BIOL CHEM, V272, P10248; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Sattler Martin, 1997, Cytokine and Growth Factor Reviews, V8, P63, DOI 10.1016/S1359-6101(96)00047-0; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231	36	20	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34567	34574		10.1074/jbc.M113.512376	http://dx.doi.org/10.1074/jbc.M113.512376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145029	hybrid, Green Published			2022-12-25	WOS:000329812800025
J	Edros, RZ; McDonnell, S; Al-Rubeai, M				Edros, Raihana Z.; McDonnell, Susan; Al-Rubeai, Mohamed			Using Molecular Markers to Characterize Productivity in Chinese Hamster Ovary Cell Lines	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; PROTEIN DISULFIDE-ISOMERASE; RECOMBINANT CHO-CELLS; MESSENGER-RNA LEVELS; BIOPHARMACEUTICAL BENCHMARKS; GENE AMPLIFICATION; SECRETION RATES; COPY NUMBERS; IMMUNOGLOBULIN; EXPRESSION	Selection of high producing cell lines to produce maximum product concentration is a challenging and time consuming task for the biopharmaceutical industry. The identification of early markers to predict high productivity will significantly reduce the time required for new cell line development. This study identifies candidate determinants of high productivity by profiling the molecular and morphological characteristics of a panel of six Chinese Hamster Ovary (CHO) stable cell lines with varying recombinant monoclonal antibody productivity levels ranging between 2 and 50 pg/cell/day. We examined the correlation between molecular parameters and specific productivity (q(p)) throughout the growth phase of batch cultures. Results were statistically analyzed using Pearson correlation coefficient. Our study revealed that, overall, heavy chain (HC) mRNA had the strongest association with q(p) followed by light chain (LC) mRNA, HC intracellular polypeptides, and intracellular antibodies. A significant correlation was also obtained between qp and the following molecular markers: growth rate, biomass, endoplasmic reticulum, and LC polypeptides. However, in these cases, the correlation was not observed at all-time points throughout the growth phase. The repeated sampling throughout culture duration had enabled more accurate predictions of productivity in comparison to performing a single-point measurement. Since the correlation varied from day to day during batch cultivation, single-point measurement was of limited use in making a reliable prediction.	[Al-Rubeai, Mohamed] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 2, Ireland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Al-Rubeai, M (corresponding author), Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 2, Ireland.	m.al-rubeai@ucd.ie		Edros, Raihana/0000-0001-9315-8605	University Malaysia Pahang	University Malaysia Pahang	RRZE is funded by University Malaysia Pahang. The fund is to cover registration and bench fees and maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	ALRUBEAI M, 1990, J BIOTECHNOL, V16, P67, DOI 10.1016/0168-1656(90)90066-K; Barnes LM, 2004, BIOTECHNOL BIOENG, V85, P115, DOI 10.1002/bit.10893; Barnes LM, 2006, BIOTECHNOL BIOENG, V94, P530, DOI 10.1002/bit.20856; Becker E, 2008, J BIOTECHNOL, V135, P217, DOI 10.1016/j.jbiotec.2008.03.008; Becker E, 2010, J BIOTECHNOL, V146, P198, DOI 10.1016/j.jbiotec.2009.11.018; BERGMAN LW, 1979, J BIOL CHEM, V254, P5690; BERGMAN LW, 1981, J BIOL CHEM, V256, P701; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Borth N, 1999, J BIOTECHNOL, V67, P57, DOI 10.1016/S0168-1656(98)00162-X; Cain K, 2013, BIOTECHNOLOGY PROGR; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Davis R, 2000, BIOTECHNOL PROGR, V16, P736, DOI 10.1021/bp000107q; Derouazi M, 2006, BIOCHEM BIOPH RES CO, V340, P1069, DOI 10.1016/j.bbrc.2005.12.111; Dorai H, 2006, HYBRIDOMA, V25, P1, DOI 10.1089/hyb.2006.25.1; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Fann CH, 1999, BIOTECHNOL BIOENG, V63, P464, DOI 10.1002/(SICI)1097-0290(19990520)63:4<464::AID-BIT10>3.0.CO;2-H; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Gomez N, 2012, BIOTECHNOL BIOENG, V109, P125, DOI 10.1002/bit.23288; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Gu MB, 1995, CYTOTECHNOLOGY, V18, P159, DOI 10.1007/BF00767763; HAYWARD BE, 1986, NUCLEIC ACIDS RES, V14, P999, DOI 10.1093/nar/14.2.999; Jun SC, 2006, BIOTECHNOL PROGR, V22, P770, DOI 10.1021/bp060004t; Kalwy S, 2006, MOL BIOTECHNOL, V34, P151, DOI 10.1385/MB:34:2:151; Khoo SHG, 2009, BIOTECHNOL BIOENG, V102, P188, DOI 10.1002/bit.22041; Kim NS, 2001, BIOTECHNOL PROGR, V17, P69, DOI 10.1021/bp000144h; Kim SJ, 1999, BIOTECHNOL BIOENG, V64, P741, DOI 10.1002/(SICI)1097-0290(19990920)64:6<741::AID-BIT14>3.0.CO;2-X; Kingston RE, 2001, AMPLIFICATION USING; Krampe B, 2011, BIOTECHNOL BIOENG, V108, P1603, DOI 10.1002/bit.23100; Ku SCY, 2010, BIOTECHNOL PROGR, V26, P517, DOI 10.1002/btpr.322; LASKOV R, 1971, J MOL BIOL, V56, P327, DOI 10.1016/0022-2836(71)90468-2; Lattenmayer C, 2007, J BIOTECHNOL, V128, P716, DOI 10.1016/j.jbiotec.2006.12.016; Lee CJ, 2009, BIOTECHNOL BIOENG, V102, P1107, DOI 10.1002/bit.22126; Lee MS, 2000, BIOTECHNOL BIOENG, V68, P260, DOI 10.1002/(SICI)1097-0290(20000505)68:3<260::AID-BIT4>3.0.CO;2-M; LENNY N, 1991, J BIOL CHEM, V266, P20532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd DR, 1999, CYTOTECHNOLOGY, V30, P49, DOI 10.1023/A:1008093404237; Lloyd DR, 2000, CYTOTECHNOLOGY, V34, P59, DOI 10.1023/A:1008103730027; McNeeley KM, 2005, CYTOTECHNOLOGY, V48, P15, DOI 10.1007/s10616-005-2926-9; Mohan C, 2007, BIOTECHNOL BIOENG, V98, P611, DOI 10.1002/bit.21453; O'Callaghan PM, 2010, BIOTECHNOL BIOENG, V106, P938, DOI 10.1002/bit.22769; Ohya T, 2008, BIOTECHNOL BIOENG, V100, P317, DOI 10.1002/bit.21758; Osterlehner A, 2011, BIOTECHNOL BIOENG, V108, P2670, DOI 10.1002/bit.23216; PENDSE GJ, 1992, BIOTECHNOL BIOENG, V40, P119, DOI 10.1002/bit.260400117; Peng RW, 2011, BIOTECHNOL BIOENG, V108, P611, DOI 10.1002/bit.22986; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P839, DOI 10.1002/bit.260360814; Reisinger H, 2008, APPL MICROBIOL BIOT, V81, P701, DOI 10.1007/s00253-008-1701-1; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Walsh G, 2003, NAT BIOTECHNOL, V21, P865, DOI 10.1038/nbt0803-865; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004	61	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75935	10.1371/journal.pone.0075935	http://dx.doi.org/10.1371/journal.pone.0075935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146795	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200005
J	Kovacs, E; Wirth, R; Maroti, G; Bagi, Z; Rakhely, G; Kovacs, KL				Kovacs, Etelka; Wirth, Roland; Maroti, Gergely; Bagi, Zoltan; Rakhely, Gabor; Kovacs, Kornel L.			Biogas Production from Protein-Rich Biomass: Fed-Batch Anaerobic Fermentation of Casein and of Pig Blood and Associated Changes in Microbial Community Composition	PLOS ONE			English	Article							WASTE-WATER TREATMENT; METHANOGENIC BACTERIA; CO-DIGESTION; BY-PRODUCTS; AMMONIA CONCENTRATIONS; METHANE FERMENTATION; REDUCING BACTERIUM; INDUSTRIAL-WASTE; GENOME SEQUENCE; CATTLE MANURE	It is generally accepted as a fact in the biogas technology that protein-rich biomass substrates should be avoided due to inevitable process inhibition. Substrate compositions with a low C/N ratio are considered difficult to handle and may lead to process failure, though protein-rich industrial waste products have outstanding biogas generation potential. This common belief has been challenged by using protein-rich substrates, i.e. casein and precipitated pig blood protein in laboratory scale continuously stirred mesophilic fed-batch biogas fermenters. Both substrates proved suitable for sustained biogas production (0.447 L CH4/g protein oDM, i.e. organic total solids) in high yield without any additives, following a period of adaptation of the microbial community. The apparent key limiting factors in the anaerobic degradation of these proteinaceous materials were the accumulation of ammonia and hydrogen sulfide. Changes in time in the composition of the microbiological community were determined by next-generation sequencing-based metagenomic analyses. Characteristic rearrangements of the biogas-producing community upon protein feeding and specific differences due to the individual protein substrates were recognized. The results clearly demonstrate that sustained biogas production is readily achievable, provided the system is well-characterized, understood and controlled. Biogas yields (0.45 L CH4/g oDM) significantly exceeding those of the commonly used agricultural substrates (0.25-0.28 L CH4/g oDM) were routinely obtained. The results amply reveal that these high-energy-content waste products can be converted to biogas, a renewable energy carrier with flexible uses that can replace fossil natural gas in its applications. Process control, with appropriate acclimation of the microbial community to the unusual substrate, is necessary. Metagenomic analysis of the microbial community by next-generation sequencing allows a precise determination of the alterations in the community composition in the course of the process.	[Kovacs, Etelka; Wirth, Roland; Bagi, Zoltan; Rakhely, Gabor; Kovacs, Kornel L.] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Maroti, Gergely] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Rakhely, Gabor; Kovacs, Kornel L.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Kovacs, KL (corresponding author), Univ Szeged, Dept Biotechnol, Szeged, Hungary.	kovacs.kornel@brc.mta.hu	Rakhely, Gabor/K-3696-2014; Dr. Wirth, Roland/L-8886-2018	Rakhely, Gabor/0000-0003-2557-3641; Dr. Wirth, Roland/0000-0002-2383-2323; Maroti, Gergely/0000-0002-3705-0461	EU [HUSRB/1002/214/041 IPA, HURO/1001/193/2.2.2. CBC, IEE/10/235 SI2.591589 GreenGasGrids];  [Baross_ALGOLABH OMFB-00356/2010];  [TAMOP 4.2.4.A/2-11-1-2012-0001];  [TAMOP-4.2.2/B-10/1-2010-0012]	EU(European Commission); ; ; 	This work was supported by EU projects HUSRB/1002/214/041 IPA, HURO/1001/193/2.2.2. CBC, and IEE/10/235 SI2.591589 GreenGasGrids. Funding from Baross_ALGOLABH OMFB-00356/2010, TAMOP 4.2.4.A/2-11-1-2012-0001 and TAMOP-4.2.2/B-10/1-2010-0012 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRING BK, 1994, WATER SCI TECHNOL, V30, P241, DOI 10.2166/wst.1994.0619; Andreesen J.R., 1989, INTRO PHYSL BIOCH GE; ANGELIDAKI I, 1993, APPL MICROBIOL BIOT, V38, P560; [Anonymous], 2013, International Patent, Patent No. [WO; 2013/038216 A1, 2013038216]; Banks CJ, 1999, WATER SCI TECHNOL, V40, P69, DOI 10.1016/S0273-1223(99)00365-0; Borja R, 1996, J ENVIRON SCI HEAL A, V31, P479, DOI 10.1080/10934529609376369; Braun R, 2003, APPL BIOCHEM BIOTECH, V109, P139, DOI 10.1385/ABAB:109:1-3:139; BRAUN R, 1981, BIOTECHNOL LETT, V3, P159; Caspari C., 2010, POULTRY EGG SECTORS; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Coates JD, 2005, APPL ENVIRON MICROB, V71, P4728, DOI 10.1128/AEM.71.8.4728-4735.2005; CONRAD R, 1989, FEMS MICROBIOL ECOL, V62, P285, DOI 10.1111/j.1574-6968.1989.tb03382.x; Danish Environmental Protection Agency, SURV WAST SPREAD LAN; DEBAERE LA, 1984, WATER RES, V18, P543, DOI 10.1016/0043-1354(84)90201-X; Demirel B, 2002, J CHEM TECHNOL BIOT, V77, P743, DOI 10.1002/jctb.630; Edstrom M, 2003, APPL BIOCHEM BIOTECH, V109, P127, DOI 10.1385/ABAB:109:1-3:127; Entcheva P, 2001, APPL ENVIRON MICROB, V67, P89, DOI 10.1128/AEM.67.1.89-99.2001; Fardeau ML, 2000, INT J SYST EVOL MICR, V50, P2141, DOI 10.1099/00207713-50-6-2141; Fisher E, 2008, ANN NY ACAD SCI, V1125, P230, DOI 10.1196/annals.1419.006; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; Gallert C, 1998, APPL MICROBIOL BIOT, V50, P495, DOI 10.1007/s002530051326; Gerardi M.H., 2003, MICROBIOLOGY ANAEROB; Grabkowsky B, 2009, WORLD POULT, V25; HAJARNIS SR, 1994, WORLD J MICROB BIOT, V10, P350, DOI 10.1007/BF00414879; Hansen H.K., 1996, WATER RES, V32, P5; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Hejnfelt A, 2009, BIOMASS BIOENERG, V33, P1046, DOI 10.1016/j.biombioe.2009.03.004; Hewitt C. J, 2010, COMPREHENSIVE BIOPRO, P295; Hill T., 2007, STAT METHODS APPL; Kaparaju P, 2002, WATER SCI TECHNOL, V45, P275, DOI 10.2166/wst.2002.0352; KAYHANIAN M, 1994, J CHEM TECHNOL BIOT, V59, P349, DOI 10.1002/jctb.280590406; KOSTER IW, 1988, BIOL WASTE, V25, P51, DOI 10.1016/0269-7483(88)90127-9; Kovacs KL, 2013, J BIOMED BIOTECHNOL, V2013, DOI [10.1155/2013/482653, DOI 10.1155/2013/482653.ACCESSED]; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; KROEKER EJ, 1979, J WATER POLLUT CON F, V51, P718; Kuratoriumfur Technik und Bauwesen in der Landwirtschaft, 2004, POS GAS LANDW BIOG; LAHRING B.K., 2003, ADV BIOCHEM ENG BIOT, V81; Luste S, 2010, BIORESOURCE TECHNOL, V101, P2657, DOI 10.1016/j.biortech.2009.10.071; Macias-Corral M, 2008, BIORESOURCE TECHNOL, V99, P8288, DOI 10.1016/j.biortech.2008.03.057; Magot M, 1997, INT J SYST BACTERIOL, V47, P818, DOI 10.1099/00207713-47-3-818; MCGHEE T J, 1968, Water and Sewage Works, V115, P162; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Minas K, 2011, FEMS MICROBIOL LETT, V325, P162, DOI 10.1111/j.1574-6968.2011.02424.x; Mitchell R, 2009, ENVIRON MICROBIOL; Nielsen HB, 2008, BIORESOURCE TECHNOL, V99, P7995, DOI 10.1016/j.biortech.2008.03.049; NISMAN B, 1954, BACTERIOL REV, V18, P16, DOI 10.1128/MMBR.18.1.16-42.1954; Acs N, 2013, BIORESOURCE TECHNOL, V131, P121, DOI 10.1016/j.biortech.2012.12.134; Nordmann W, 1977, UBERWACHTUNG SCHLAMM, V3, P77; Onyenwoke RU, 2007, INT J SYST EVOL MICR, V57, P2191, DOI 10.1099/ijs.0.65051-0; Parkin G.F., 1983, P 37 PURD IND WAST C; PARKIN GF, 1983, J WATER POLLUT CON F, V55, P44; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; PERLE M, 1995, WATER RES, V29, P1549, DOI 10.1016/0043-1354(94)00248-6; Pohland F G, 1971, Environ Lett, V1, P255; Rajeshwari KV, 2000, RENEW SUST ENERG REV, V4, P135, DOI 10.1016/S1364-0321(99)00014-3; Ramsay IR, 2001, BIODEGRADATION, V12, P247, DOI 10.1023/A:1013116728817; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Schnurer A, 2008, WATER SCI TECHNOL, V57, P735, DOI 10.2166/wst.2008.097; SPROTT GD, 1986, SYST APPL MICROBIOL, V7, P358; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Symons GE, 1933, J AM CHEM SOC, V55, P2028, DOI 10.1021/ja01332a039; Tafdrup S, 1995, BIOMASS BIOENERG, V9, P303, DOI 10.1016/0961-9534(95)00098-4; van Bodegom PM, 2004, FEMS MICROBIOL ECOL, V49, P261, DOI 10.1016/j.femsec.2004.03.017; VDI 4630, 2006, VEREIN DTSCH INGENIE; Vigneron V, 2007, 11 INT WAST MAN LAND; Westerholm M, 2012, BIORESOURCE TECHNOL, V114, P314, DOI 10.1016/j.biortech.2012.03.005; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004	70	64	64	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77265	10.1371/journal.pone.0077265	http://dx.doi.org/10.1371/journal.pone.0077265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146974	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000326019400098
J	Vega, RP; van Leeuwen, PM; Velez, ER; Lemij, HG; de Winter, JCF				Vega, Rocio Prado; van Leeuwen, Peter M.; Velez, Elizabeth Rendon; Lemij, Hans G.; de Winter, Joost C. F.			Obstacle Avoidance, Visual Detection Performance, and Eye-Scanning Behavior of Glaucoma Patients in a Driving Simulator: A Preliminary Study	PLOS ONE			English	Article							MOTOR-VEHICLE COLLISIONS; FIELD-OF-VIEW; ON-ROAD; OLDER DRIVERS; IMPAIRMENT; REAL; RISK; VIOLATIONS; DEFECTS; FITNESS	The objective of this study was to evaluate differences in driving performance, visual detection performance, and eye-scanning behavior between glaucoma patients and control participants without glaucoma. Glaucoma patients (n = 23) and control participants (n = 12) completed four 5-min driving sessions in a simulator. The participants were instructed to maintain the car in the right lane of a two-lane highway while their speed was automatically maintained at 100 km/h. Additional tasks per session were: Session 1: none, Session 2: verbalization of projected letters, Session 3: avoidance of static obstacles, and Session 4: combined letter verbalization and avoidance of static obstacles. Eye-scanning behavior was recorded with an eye-tracker. Results showed no statistically significant differences between patients and control participants for lane keeping, obstacle avoidance, and eye-scanning behavior. Steering activity, number of missed letters, and letter reaction time were significantly higher for glaucoma patients than for control participants. In conclusion, glaucoma patients were able to avoid objects and maintain a nominal lane keeping performance, but applied more steering input than control participants, and were more likely than control participants to miss peripherally projected stimuli. The eye-tracking results suggest that glaucoma patients did not use extra visual search to compensate for their visual field loss. Limitations of the study, such as small sample size, are discussed.	[Vega, Rocio Prado; van Leeuwen, Peter M.; Velez, Elizabeth Rendon; de Winter, Joost C. F.] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands; [Lemij, Hans G.] ROI, Rotterdam, Netherlands; [Lemij, Hans G.] REH, Rotterdam, Netherlands	Delft University of Technology	de Winter, JCF (corresponding author), Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands.	j.c.f.dewinter@tudelft.nl	de Winter, Joost/AAD-7043-2020	de Winter, Joost/0000-0002-1281-8200; Rendon-Velez, Elizabeth/0000-0001-6624-5930	Dutch Technology Foundation (Stichting voor de Technische Wetenschappen); Applied Science Division of the Netherlands Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); Technology Program of the Ministry of Economic Affairs	Dutch Technology Foundation (Stichting voor de Technische Wetenschappen); Applied Science Division of the Netherlands Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); Technology Program of the Ministry of Economic Affairs	The research of Joost de Winter was supported by the Dutch Technology Foundation (Stichting voor de Technische Wetenschappen), the Applied Science Division of the Netherlands Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek), and the Technology Program of the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinwuntan AE, 2003, ARCH PHYS MED REHAB, V84, P1792, DOI 10.1016/S0003-9993(03)00767-6; Baughan C, 2002, 529 TRL; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Brookhuis KA, 2003, ERGONOMICS, V46, P433, DOI 10.1080/001401302/1000039556; Coeckelbergh TRM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1509, DOI 10.1001/archopht.120.11.1509; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; de Winter JCF, 2013, ACCIDENT ANAL PREV, V52, P71, DOI 10.1016/j.aap.2012.12.018; de Winter JCF, 2008, IEEE T SYST MAN CY B, V38, P189, DOI 10.1109/TSMCB.2007.908860; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Dijksterhuis C, 2011, ACCIDENT ANAL PREV, V43, P1074, DOI 10.1016/j.aap.2010.12.014; Engstrom J, 2005, TRANSPORT RES F-TRAF, V8, P97, DOI 10.1016/j.trf.2005.04.012; Fiedler K, 2012, PERSPECT PSYCHOL SCI, V7, P661, DOI 10.1177/1745691612462587; Gallimore JJ, 1998, HUM FAC ERG SOC P, P6; Hart S.G., 2006, P HUM FACT ERG SOC A, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Horberry T, 2006, ACCIDENT ANAL PREV, V38, P185, DOI 10.1016/j.aap.2005.09.007; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; Hu PS, 1998, ACCIDENT ANAL PREV, V30, P569, DOI 10.1016/S0001-4575(98)00019-0; Hunt LA, 1997, ALZ DIS ASSOC DIS, V11, P13, DOI 10.1097/00002093-199706001-00004; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jagacinski R. J., 2011, CONTROL THEORY HUMAN; Kasper EF, 1997, P SOC PHOTO-OPT INS, V3058, P34, DOI 10.1117/12.276658; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; Lee HC, 2003, ACCIDENT ANAL PREV, V35, P797, DOI 10.1016/S0001-4575(02)00083-0; Lin JJW, 2002, P IEEE VIRT REAL ANN, P164, DOI 10.1109/VR.2002.996519; Lockhart J, 2009, 811062 DOT HS NAT HI; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; MCRUER DT, 1967, IEEE TRANS HUM FACT, VHFE8, P231, DOI 10.1109/THFE.1967.234304; Medeiros FA, 2012, J GLAUCOMA, V21, P221, DOI 10.1097/IJG.0b013e3182071832; Mudge JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032734; Owen VMF, 2008, INVEST OPHTH VIS SCI, V49, P2449, DOI 10.1167/iovs.07-0877; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Parrish R K 2nd, 1996, Trans Am Ophthalmol Soc, V94, P919; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; RIZZO M, 2002, GERONTECHNOLOGY, V1, P291; Rosen P, 2011, P INT DRIV S HUM FAC, P233; Saffarian M, 2012, ERGONOMICS, V55, P971, DOI 10.1080/00140139.2012.691993; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Santos J, 2005, TRANSPORT RES F-TRAF, V8, P135, DOI 10.1016/j.trf.2005.04.001; Saunders LJ, 2012, BRIT J OPHTHALMOL, V96, P1185, DOI 10.1136/bjophthalmol-2012-301827; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Szlyk JP, 2002, J REHABIL RES DEV, V39, P467; Szoboszlay Z, 1995, P SOC PHOTO-OPT INS, P142; Underwood G, 2011, TRANSPORT RES F-TRAF, V14, P435, DOI 10.1016/j.trf.2011.04.008	52	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77294	10.1371/journal.pone.0077294	http://dx.doi.org/10.1371/journal.pone.0077294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146975	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400099
J	Chou, TW; Feng, JH; Huang, CC; Cheng, YW; Chien, SC; Wang, SY; Shyur, LF				Chou, Tsui-Wei; Feng, Jia-Hua; Huang, Chi-Chang; Cheng, Ya-Wen; Chien, Shih-Chang; Wang, Sheng-Yang; Shyur, Lie-Fen			A Plant Kavalactone Desmethoxyyangonin Prevents Inflammation and Fulminant Hepatitis in Mice	PLOS ONE			English	Article							NF-KAPPA-B; ALPINIA-PRICEI HAYATA; SIGNAL-TRANSDUCTION; LIVER; LIPOPOLYSACCHARIDE; METABOLOMICS; CELL; ACID; ACTIVATION; FAILURE	Alpinia pricei Hayata is a Formosan plant which has been popularly used as nutraceutical or folk medicine for inflammation and various disorders. An active compound of the plant rhizomes, desmethoxyyangonin (DMY), was identified in this study for its novel effect against endotoxin lipopolysaccharide (LPS)-stimulated inflammation in murine macrophages and LPS/D-galactosamine (LPS/D-GalN)-induced fulminant hepatitis in mice. DMY was observed to significantly inhibit proliferation and activation of T cells ex vivo and the activity of several pro-inflammatory mediators in vitro. DMY also protected LPS/D-GalN-induced acute hepatic damages in mice through inhibiting aminotransferases activities and infiltrations of inflammatory macrophages, neutrophils and pathogenic T cells into the liver tissues. In addition, pretreatment with DMY significantly improved the survival rate of LPS/D-GalN -treated mice to 90% (9/10), compared to LPS/D-GalN-treated group (40%, 4/10). UPLC/MS platform-based comparative metabolomics approach was used to explore the serum metabolic profile in fulminant hepatic failure (FHF) mice with or without the DMY pretreatment. The results showed that LPS/D-GalN-induced hepatic damage is likely through perturbing amino acid metabolism, which leads to decreased pyruvate formation via catalysis of aminotransferases, and DMY treatment can prevent to a certain degree of these alterations in metabolic network in mouse caused by LPS/D-GalN. Mechanistic investigation demonstrated that DMY protects LPS or LPS/D-GalN -induced damages in cell or liver tissues mainly through de-regulating IKK/NF.B and Jak2/STAT3 signaling pathways. This report provides evidence-based knowledge to support the rationale for the use of A. pricei root extract in anti-inflammation and also its new function as hepatoprotetive agent against fulminant hepatitis.	[Chou, Tsui-Wei] Taoyuan Innovat Inst Technol, Dept Culinary Arts, Chungli, Taoyuan County, Taiwan; [Feng, Jia-Hua; Cheng, Ya-Wen; Shyur, Lie-Fen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Feng, Jia-Hua] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Huang, Chi-Chang] Natl Taiwan Sport Univ, Grad Inst Sports Sci, Guishan Township, Taoyuan County, Taiwan; [Chien, Shih-Chang] Natl Chung Hsing Univ, Expt Forest Management Off, Taichung 40227, Taiwan; [Wang, Sheng-Yang] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Shyur, Lie-Fen] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Chung Hsing University; National Chung Hsing University; Taipei Medical University	Wang, SY (corresponding author), Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan.	taiwanfir@dragon.nchu.edu.tw; lfshyur@ccvax.sinica.edu.tw	Wang, Sheng-Yang/M-9656-2019	Wang, Sheng-Yang/0000-0002-8579-3569; Huang, Chi-Chang/0000-0003-1446-6787	NSTP/AB; Academia Sinica, Taiwan, R.O.C	NSTP/AB; Academia Sinica, Taiwan, R.O.C(Academia Sinica - Taiwan)	This study was supported by a grant from the NSTP/AB and an institutional grant from Academia Sinica, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; Chang NW, 2010, FOOD CHEM TOXICOL, V48, P2350, DOI 10.1016/j.fct.2010.05.070; Chiang YM, 2005, BRIT J PHARMACOL, V146, P352, DOI 10.1038/sj.bjp.0706343; Chou YC, 2009, PHYTOTHER RES, V23, P558, DOI 10.1002/ptr.2691; Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429; Feng B, 2008, LIVER TRANSPLANT, V14, P1620, DOI 10.1002/lt.21578; Gao JJ, 1998, J IMMUNOL, V161, P4803; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GUAN KL, 1994, CELL SIGNAL, V6, P581, DOI 10.1016/0898-6568(94)90041-8; Hou CC, 2010, J NUTR BIOCHEM, V21, P1045, DOI 10.1016/j.jnutbio.2009.08.010; Hseu YC, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep142; Huang CC, 2013, J NUTR BIOCHEM, V24, P516, DOI 10.1016/j.jnutbio.2012.01.013; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kao ES, 2009, BIOSCI BIOTECH BIOCH, V73, P385, DOI 10.1271/bbb.80639; Katayama K, 2004, HEPATOL RES, V30, pS71, DOI 10.1016/j.hepres.2004.08.013; Kosai K, 1999, HEPATOLOGY, V30, P151, DOI 10.1002/hep.510300102; Kuo YF, 2010, FREE RADICAL BIO MED, V49, P214, DOI 10.1016/j.freeradbiomed.2010.04.005; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Manna SK, 2011, J PROTEOME RES, V10, P4120, DOI 10.1021/pr200310s; Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rockey DC, 1996, AM J PHYSIOL-GASTR L, V271, pG260, DOI 10.1152/ajpgi.1996.271.2.G260; Russo FP, 2011, CYTOTHERAPY, V13, P135, DOI 10.3109/14653249.2010.545386; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Shyur LF, 2008, CURR OPIN CHEM BIOL, V12, P66, DOI 10.1016/j.cbpa.2008.01.032; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Wang XY, 2011, METABOLOMICS, V7, P226, DOI 10.1007/s11306-010-0244-5; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Yang YX, 2007, MOL IMMUNOL, V44, P984, DOI 10.1016/j.molimm.2006.03.013; ZIMMERMANN C, 1989, HEPATOLOGY, V9, P594, DOI 10.1002/hep.1840090414	31	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77626	10.1371/journal.pone.0077626	http://dx.doi.org/10.1371/journal.pone.0077626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143247	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100085
J	Jin, XK; Guo, XN; Li, S; Wu, MH; Zhu, YT; Yu, AQ; Tan, SJ; Li, WW; Zhang, P; Wang, Q				Jin, Xing-Kun; Guo, Xiao-Nv; Li, Shuang; Wu, Min-Hao; Zhu, You-Ting; Yu, Ai-Qing; Tan, Shang-Jian; Li, Wei-Wei; Zhang, Ping; Wang, Qun			Association of a Hepatopancreas-Specific C-Type Lectin with the Antibacterial Response of Eriocheir sinensis	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; CARBOHYDRATE-RECOGNITION DOMAINS; CHINESE MITTEN CRAB; MANDUCA-SEXTA; CELLULAR ENCAPSULATION; INVERTEBRATE IMMUNITY; LITOPENAEUS-VANNAMEI; TOBACCO HORNWORM; GENE-EXPRESSION; ANIMAL LECTINS	Pattern recognition receptors (PPRs) are part of the initial step of a host defense against pathogens in detecting pathogen-associated molecular patterns. However, determinants of the specificity of this recognition by innate immune molecules of invertebrates remain largely unknown. In this study, we investigated the potential involvement of an invertebrate PRR C-type lectin in the antimicrobial response of the crustacean Eriocheir sinensis. Based on the initial expressed sequence tags (EST) of a hepatopancreatic cDNA library, the full-length EsLecF cDNA was cloned and determined to contain a 477-bp open reading frame encoding a putative 158-amino-acid protein. A comparison with other reported invertebrate and vertebrate C-type lectin superfamily sequences revealed the presence of a common carbohydrate recognition domain (CRD). EsLecF transcripts in E. sinensis were mainly detected in the hepatopancreas and were inducible by a lipopolysaccharide (LPS) injection. The recombinant EsLecF (rEsLecF) protein produced via a prokaryotic expression system and affinity chromatography was found to have a wide spectrum of binding activities towards various microorganisms, and its microbial-binding activity was calcium-independent. Moreover, the binding of rEsLecF induced the aggregation of microbial pathogens. Results of the microorganism growth inhibitory assay and antibacterial assay revealed capabilities of rEsLecF in suppressing microorganism growth and directly killing bacteria, respectively. Furthermore, rEsLecF could enhance cellular encapsulation in vitro. Collectively, the findings presented here demonstrated the successful isolation of a novel C-type lectin in a crustacean and highlighted its critical role in the innate immunity of an invertebrate.	[Jin, Xing-Kun; Guo, Xiao-Nv; Li, Shuang; Wu, Min-Hao; Zhu, You-Ting; Yu, Ai-Qing; Tan, Shang-Jian; Li, Wei-Wei; Zhang, Ping; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Zhang, P (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	pzhang@bio.ecnu.edu.cn; qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Jin, Xingkun/H-4366-2013; LI, WEIWEI/J-3538-2013	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; 	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]; Innovation Program of Shanghai Municipal Education Commission [13zz031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04), the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016) and the Innovation Program of Shanghai Municipal Education Commission (13zz031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Cheng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054053; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Guo HZ, 2011, FISH SHELLFISH IMMUN, V30, P515, DOI 10.1016/j.fsi.2010.11.027; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Jin XK, 2013, DEV COMP IMMUNOL, V41, P544, DOI 10.1016/j.dci.2013.07.016; Jin XK, 2012, FISH SHELLFISH IMMUN, V33, P1149, DOI 10.1016/j.fsi.2012.08.027; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Junkunlo K, 2012, DEV COMP IMMUNOL, V37, P334, DOI 10.1016/j.dci.2011.12.010; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Lin XH, 2011, BLOOD, V117, P6417, DOI 10.1182/blood-2010-11-320614; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Smith V.J., 1992, Fish & Shellfish Immunology, V2, P1, DOI 10.1016/S1050-4648(06)80024-0; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Soderhall K., 1986, P208; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Soderhall Kenneth, 1992, Annual Review of Fish Diseases, V2, P3, DOI 10.1016/0959-8030(92)90053-Z; Sun YD, 2008, MOL IMMUNOL, V45, P348, DOI 10.1016/j.molimm.2007.06.355; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; Tunkijjanukij S, 1998, DEV COMP IMMUNOL, V22, P139, DOI 10.1016/S0145-305X(98)00017-2; Wang LL, 2013, FISH SHELLFISH IMMUN, V34, P832, DOI 10.1016/j.fsi.2012.12.010; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Wang XW, 2009, FISH SHELLFISH IMMUN, V27, P556, DOI 10.1016/j.fsi.2009.07.011; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Xu WT, 2010, AMINO ACIDS, V39, P1227, DOI 10.1007/s00726-010-0558-7; Yu XQ, 2006, INSECT BIOCHEM MOLEC, V36, P505, DOI 10.1016/j.ibmb.2006.03.010; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang H, 2011, FISH SHELLFISH IMMUN, V31, P358, DOI 10.1016/j.fsi.2011.06.001; Zhang XW, 2009, MOL IMMUNOL, V46, P1626, DOI 10.1016/j.molimm.2009.02.029; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	51	31	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76132	10.1371/journal.pone.0076132	http://dx.doi.org/10.1371/journal.pone.0076132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146827	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400040
J	Li, WWY; Lam, WWT; Shun, SC; Lai, YH; Law, WL; Poon, J; Fielding, R				Li, Wylie Wai Yee; Lam, Wendy Wing Tak; Shun, Shiow-Ching; Lai, Yeur-Hur; Law, Wai-Lun; Poon, Jensen; Fielding, Richard			Psychometric Assessment of the Chinese Version of the Supportive Care Needs Survey Short-Form (SCNS-SF34-C) among Hong Kong and Taiwanese Chinese Colorectal Cancer Patients	PLOS ONE			English	Article							SATISFACTION QUESTIONNAIRE CHPSQ-9; CONFIRMATORY FACTOR-ANALYSIS; QUALITY-OF-LIFE; BREAST-CANCER; RECTAL-CANCER; LUNG-CANCER; VALIDATION; SCALE; INSTRUMENT; CARCINOMA	Background: Accurate assessment of unmet supportive care needs is essential for optimal cancer patient care. This study used confirmatory factor analysis (CFA) to test the known factor structures of the short form of Supportive Care Need Survey (SCNS-34) in Hong Kong and Taiwan Chinese patients diagnosed with colorectal cancer (CRC). Methods: 360 Hong Kong and 263 Taiwanese Chinese CRC patients completed the Chinese version of SCNS-SF34. Comparative measures (patient satisfaction, anxiety, depression, and symptom distress) tested convergent validity while known group differences were examined to test discriminant validity. Results: The original 5-factor and recent 4-factor models of the SCNS demonstrated poor data fit using CFA in both Hong Kong and Taiwan samples. Subsequently a modified five-factor model with correlated residuals demonstrated acceptable fit in both samples. Correlations demonstrated convergent and divergent validity and known group differences were observed. Conclusions: While the five-factor model demonstrated a better fit for data from Chinese colorectal cancer patients, some of the items within its domain overlapped, suggesting item redundancy. The five-factor model showed good psychometric properties in these samples but also suggests conceptualization of unmet supportive care needs are currently inadequate.	[Li, Wylie Wai Yee; Lam, Wendy Wing Tak; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Div Behav Hlth, Ctr Psychooncol Res & Training, Hong Kong, Hong Kong, Peoples R China; [Shun, Shiow-Ching; Lai, Yeur-Hur] Natl Taiwan Univ, Dept Nursing, Taipei 10764, Taiwan; [Poon, Jensen] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National Taiwan University; University of Hong Kong	Lam, WWT (corresponding author), Univ Hong Kong, Sch Publ Hlth, Div Behav Hlth, Ctr Psychooncol Res & Training, Hong Kong, Hong Kong, Peoples R China.	wwtlam@hku.hk	; Lam, Wendy Wing Tak/C-4319-2009	SHUN, SHIOW-CHING/0000-0002-9883-4446; LAI, YEUR-HUR/0000-0003-0313-2634; Lam, Wendy Wing Tak/0000-0003-2383-0149	Health Services Research Fund, Food and Health Bureau, The Government of Hong Kong, SAR [08090921]	Health Services Research Fund, Food and Health Bureau, The Government of Hong Kong, SAR	This work was supported by a grant from Health Services Research Fund (Grant No. 08090921), Food and Health Bureau, The Government of Hong Kong, SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge L, 2009, PSYCHOONCOLOGY S2, V18, pS117; Au A, 2011, PSYCHO-ONCOLOGY, V20, P1292, DOI 10.1002/pon.1851; Beesley V, 2008, PSYCHO-ONCOLOGY, V17, P392, DOI 10.1002/pon.1249; Black J.T, 1992, MULTIVARIATE DATA AN; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Boyes A, 2009, J EVAL CLIN PRACT, V15, P602, DOI 10.1111/j.1365-2753.2008.01057.x; Bredart A, 2012, EUR J CANCER CARE, V21, P450, DOI 10.1111/j.1365-2354.2012.01356.x; Butler LD, 1995, QUALITY PATIENTS PER; Byrne B. M., 2006, STRUCTURAL EQUATION, V2nd; Chan YF, 2010, QUAL LIFE RES, V19, P865, DOI 10.1007/s11136-010-9645-1; Chorost MI, 2000, AM J SURG, V179, P271, DOI 10.1016/S0002-9610(00)00327-5; Cossich T, 2004, QUAL LIFE RES, V13, P1225, DOI 10.1023/B:QURE.0000037496.94640.d9; Fielding R, 2004, CANCER-AM CANCER SOC, V100, P2500, DOI 10.1002/cncr.20303; Fielding R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065099; Girgis A, 2012, PSYCHO-ONCOLOGY, V21, P827, DOI 10.1002/pon.1973; Hong Kong Cancer Registry, 2009, LEAD CANC SIT HONG K; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jorgensen ML, 2012, SUPPORT CARE CANCER, V20, P1275, DOI 10.1007/s00520-011-1214-9; Kline R.B., 2011, PRINCIPLES PRACTICE; Lai YH., 1998, J NURS RES, V6, P279, DOI [10.7081/NR.199808.0279, DOI 10.7081/NR.199808.0279]; Lam WWT, 2011, BREAST CANCER RES TR, V130, P531, DOI 10.1007/s10549-011-1592-1; Larn WWT, 2008, J PAIN SYMPTOM MANAG, V36, P584, DOI 10.1016/j.jpainsymman.2007.12.008; Lehmann C, 2012, SUPPORT CARE CANCER, V20, P2415, DOI 10.1007/s00520-011-1351-1; Li WWY, 2012, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3068, DOI 10.1002/P0N.3068]; Liao MN, 2012, ONCOL NURS FORUM, V39, pE380, DOI 10.1188/12.ONF.E380-E389; McCorkle R, 1978, Cancer Nurs, V1, P373; McDowell ME, 2010, PSYCHO-ONCOLOGY, V19, P508, DOI 10.1002/pon.1604; Muthen L.K., 2009, MPLUS USERS GUIDE; Okuyama T, 2009, PSYCHO-ONCOL, V18, P1003, DOI 10.1002/pon.1482; Patel D, 2011, J AFFECT DISORDERS, V131, P412, DOI 10.1016/j.jad.2010.11.014; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Sanders SL, 2010, PSYCHO-ONCOLOGY, V19, P480, DOI 10.1002/pon.1577; Schofield P, 2012, PSYCHO-ONCOLOGY, V21, P1107, DOI 10.1002/pon.2016; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sharpe L, 2011, J PSYCHOSOM RES, V70, P395, DOI 10.1016/j.jpsychores.2010.11.003; SPRANGERS MAG, 1995, DIS COLON RECTUM, V38, P361, DOI 10.1007/BF02054222; Uchida M, 2011, JPN J CLIN ONCOL, V41, P530, DOI 10.1093/jjco/hyq230; Wang J.C., 2012, STRUCTURAL EQUATION, DOI [DOI 10.1002/9781118356258, DOI 10.1002/, 10.1002/9781118356258]; Ware J. E., 1997, MAP R WINDOWS MULTIT; Wilson TR, 2006, DIS COLON RECTUM, V49, P1692, DOI 10.1007/s10350-006-0709-9; Wong WS, 2008, PSYCHO-ONCOL, V17, P292, DOI 10.1002/pon.1247; Wong WS, 2009, VALUE HEALTH, V12, P597, DOI 10.1111/j.1524-4733.2008.00480.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	19	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75755	10.1371/journal.pone.0075755	http://dx.doi.org/10.1371/journal.pone.0075755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146774	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400018
J	Endo, H; Shiroki, T; Nakagawa, T; Yokoyama, M; Tamai, K; Yamanami, H; Fujiya, T; Sato, I; Yamaguchi, K; Tanaka, N; Iijima, K; Shimosegawa, T; Sugamura, K; Satoh, K				Endo, Hiroyuki; Shiroki, Takeharu; Nakagawa, Takayuki; Yokoyama, Misa; Tamai, Keiichi; Yamanami, Hideaki; Fujiya, Tsuneaki; Sato, Ikuro; Yamaguchi, Kazunori; Tanaka, Nobuyuki; Iijima, Katsunori; Shimosegawa, Tooru; Sugamura, Kazuo; Satoh, Kennichi			Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer	PLOS ONE			English	Article							CARCINOMA PROGRESSION; SURVIVAL; ELEMENTS; PROJECT	The long non-coding RNA HOTAIR has been reported to be a poor prognostic biomarker in a variety of malignant tumors. However, little is known about the association of HOTAIR with gastric cancer. We examined the expression of HOTAIR in 68 gastric cancer samples using quantitative real-time RT-PCR and analyzed its correlation with the clinical parameters. The functional role of HOTAIR was examined by generating human gastric cancer cell lines with increased or suppressed HOTAIR expression. The anchorage -independent growth was assessed by soft agar assay. The increased or suppressed HOTAIR expressing gastric cancer cells were injected into the tail vein or peritoneal cavity of immunodeficient mice to examine the effect of this molecule on metastasis and peritoneal dissemination. The expression of HOTAIR was significantly higher in cancer lesions than in adjacent non-cancerous tissues in human gastric cancers. In the diffuse type of gastric cancer, the High-HOTAIR group (HOTAIR/GAPDH > 1) showed significantly more venous invasion, frequent lymph node metastases and a lower overall survival rate compared to the Low-HOTAIR group (HOTAIR/GAPDH < 1). Colony formation on the soft agar was enhanced in a HOTAIR-dependent manner. HOTAIR-expressing MKN74 formed more liver metastasis compared to control when they were injected into the tail vein of mice. In addition, reduced expression of HOTAIR in KATO III suppressed peritoneal dissemination. These results suggest that HOTAIR plays a pivotal role in the development of gastric cancer.	[Endo, Hiroyuki; Shiroki, Takeharu; Nakagawa, Takayuki; Yokoyama, Misa; Satoh, Kennichi] Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, Natori, Miyagi 9811293, Japan; [Tamai, Keiichi; Yamaguchi, Kazunori; Tanaka, Nobuyuki; Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Yamanami, Hideaki; Fujiya, Tsuneaki] Miyagi Canc Ctr, Dept Surg, Natori, Miyagi 9811293, Japan; [Sato, Ikuro] Miyagi Canc Ctr, Dept Pathol, Natori, Miyagi 9811293, Japan; [Endo, Hiroyuki; Shiroki, Takeharu; Iijima, Katsunori; Shimosegawa, Tooru] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi 980, Japan	Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center; Miyagi Cancer Center; Tohoku University	Satoh, K (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Stem Cell, 47-1 Aza Nodayama, Natori, Miyagi 9811293, Japan.	ksatoh-gi@umin.ac.jp	Tamai, Keiichi/AAW-8261-2021	Tamai, Keiichi/0000-0003-0813-5885	JSPS KAKENHI [24791480, 24591022]; HIROMI Medical Research Foundation; Daiwa Securities Health Foundation; Grants-in-Aid for Scientific Research [23592521, 24591022, 25860572] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); HIROMI Medical Research Foundation; Daiwa Securities Health Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 24791480 and 24591022 (http://www.jsps.go.jp/j-grantsinaid/index.html), and grant-in-aid from HIROMI Medical Research Foundation (http://www.smtb.jp/personal/entrustment/management/public/example/pdf/natural-06a.pdf) and Daiwa Securities Health Foundation (http://www.daiwa-grp.jp/dsh/grant/outline.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boku N, 2013, GASTRIC CAN IN PRESS; Boku N, 2011, JPN J CLIN ONCOL, V41, P1315, DOI 10.1093/jjco/hyr129; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajjari M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0670-0; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; NAKATANI H, 1990, JPN J CANCER RES, V81, P707, DOI 10.1111/j.1349-7006.1990.tb02631.x; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Yagi K, 2012, DIAGN THER ENDOSC; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	20	210	225	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77070	10.1371/journal.pone.0077070	http://dx.doi.org/10.1371/journal.pone.0077070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130837	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200054
J	Flenniken, ML; Andino, R				Flenniken, Michelle L.; Andino, Raul			Non-Specific dsRNA-Mediated Antiviral Response in the Honey Bee	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; COLONY COLLAPSE DISORDER; DEFORMED WING VIRUS; COMPLETE GENOME SEQUENCE; ACUTE PARALYSIS VIRUS; PICORNA-LIKE VIRUS; QUEEN-CELL-VIRUS; APIS-MELLIFERA; IMMUNE-RESPONSES; GENE-EXPRESSION	Honey bees are essential pollinators of numerous agricultural crops. Since 2006, honey bee populations have suffered considerable annual losses that are partially attributed to Colony Collapse Disorder (CCD). CCD is an unexplained phenomenon that correlates with elevated incidence of pathogens, including RNA viruses. Honey bees are eusocial insects that live in colonies of genetically related individuals that work in concert to gather and store nutrients. Their social organization provides numerous benefits, but also facilitates pathogen transmission between individuals. To investigate honey bee antiviral defense mechanisms, we developed an RNA virus infection model and discovered that administration of dsRNA, regardless of sequence, reduced virus infection. Our results suggest that dsRNA, a viral pathogen associated molecular pattern (PAMP), triggers an antiviral response that controls virus infection in honey bees.	[Flenniken, Michelle L.; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Flenniken, Michelle L.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	University of California System; University of California San Francisco; Montana State University System; Montana State University Bozeman	Flenniken, ML (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	michelle.flenniken@montana.edu; raul.andino@ucsf.edu			A. P. Giannini Foundation; Honey Bee Biology Postdoctoral Fellowship; UC-Davis and Haagen Dazs; National Science Foundation EPSCoR Cooperative Agreement [EPS-110134]; Project Apis m.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040085] Funding Source: NIH RePORTER; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	A. P. Giannini Foundation; Honey Bee Biology Postdoctoral Fellowship; UC-Davis and Haagen Dazs; National Science Foundation EPSCoR Cooperative Agreement(National Science Foundation (NSF)); Project Apis m.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by postdoctoral fellowships awarded to Dr. Michelle L. Flenniken by the A. P. Giannini Foundation and by a Honey Bee Biology Postdoctoral Fellowship co-sponsored by UC-Davis and Haagen Dazs, and current support from the National Science Foundation EPSCoR Cooperative Agreement #EPS-110134 and Project Apis m. (projectapism.org), and funding support awarded to Dr. Raul Andino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; Asgari S, 2010, INSECT VIROLOGY, V1, P54; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attasart P, 2010, ARCH VIROL, V155, P825, DOI 10.1007/s00705-010-0649-5; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; Bartholomay LC, 2012, J INVERTEBR PATHOL, V110, P261, DOI 10.1016/j.jip.2012.03.002; Benjeddou M, 2002, J GEN VIROL, V83, P3139, DOI 10.1099/0022-1317-83-12-3139; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Cash AC, 2005, GENES BRAIN BEHAV, V4, P267, DOI 10.1111/j.1601-183X.2005.00131.x; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen Y, 2004, APIDOLOGIE; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Desai SD, 2012, INSECT MOL BIOL, V21, P446, DOI 10.1111/j.1365-2583.2012.01150.x; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2009, J APICULT RES, V48, P300, DOI 10.3896/IBRA.1.48.4.13; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Evans J, 2010, PARLIAMENT AFF, V63, P1, DOI 10.1093/pa/gsp042; Fischman BJ, 2011, P NATL ACAD SCI USA, V108, P10847, DOI 10.1073/pnas.1100301108; Flenniken ML, 2010, INSECT VIROLOGY, P367; Nunes FMF, 2009, INSECT BIOCHEM MOLEC, V39, P157, DOI 10.1016/j.ibmb.2008.10.011; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hirai M, 2004, INSECT MOL BIOL, V13, P399, DOI 10.1111/j.0962-1075.2004.00497.x; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Jefferson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054097; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Kingsolver MB, 2012, P NATL ACAD SCI USA, V109, P18639, DOI 10.1073/pnas.1216736109; Labreuche Y, 2010, DEV COMP IMMUNOL, V34, P1209, DOI 10.1016/j.dci.2010.06.017; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Lozano J, 2012, DEV GENES EVOL, V222, P229, DOI 10.1007/s00427-012-0404-x; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Naug D, 2007, P ROY SOC B-BIOL SCI, V274, P61, DOI 10.1098/rspb.2006.3695; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810; Nilsen KA, 2011, J EXP BIOL, V214, P1488, DOI 10.1242/jeb.050393; Nunes Francis M.F., 2013, Insects, V4, P90, DOI 10.3390/insects4010090; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Pitaluga AN, 2008, DEV COMP IMMUNOL, V32, P191, DOI 10.1016/j.dci.2007.06.008; Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Robalino J, 2004, J VIROL, V78, P10442, DOI 10.1128/JVI.78.19.10442-10448.2004; Robalino J, 2007, DEV COMP IMMUNOL, V31, P539, DOI 10.1016/j.dci.2006.08.011; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Sheffield JB, 2007, MICROSC MICROANAL, V13, P200, DOI 10.1017/S1431927607076611; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang Y, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000896, DOI 10.1371/J0URNAL.PGEN.1000896]; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhang Y, 2010, J INSECT PHYSIOL, V56, P1207, DOI 10.1016/j.jinsphys.2010.03.019	113	87	90	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77263	10.1371/journal.pone.0077263	http://dx.doi.org/10.1371/journal.pone.0077263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130869	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200076
J	Korrodi-Gregorio, L; Lopes, AM; Esteves, SLC; Afonso, S; de Matos, AL; Lissovsky, AA; Silva, OABDE; Silva, EFDE; Esteves, PJ; Fardilha, M				Korrodi-Gregorio, Luis; Lopes, Ana Margarida; Esteves, Sara L. C.; Afonso, Sandra; de Matos, Ana Lemos; Lissovsky, Andrey A.; da Cruz e Silva, Odete A. B.; da Cruz e Silva, Edgar F.; Esteves, Pedro Jose; Fardilha, Margarida			An Intriguing Shift Occurs in the Novel Protein Phosphatase 1 Binding Partner, TCTEX1D4: Evidence of Positive Selection in a Pika Model	PLOS ONE			English	Article							STRUCTURAL BASIS; CYTOPLASMIC DYNEIN; CATALYTIC SUBUNIT; DOCKING MOTIF; OCHOTONA; IDENTIFICATION; GLYCOSYLATION; GENE; PROTEIN-PHOSPHATASE-1; DIVERSIFICATION	T-complex testis expressed protein 1 domain containing 4 (TCTEX1D4) contains the canonical phosphoprotein phosphatase 1 (PPP1) binding motif, composed by the amino acid sequence RVSF. We identified and validated the binding of TCTEX1D4 to PPP1 and demonstrated that indeed this protein is a novel PPP1 interacting protein. Analyses of twenty-one mammalian species available in public databases and seven Lagomorpha sequences obtained in this work showed that the PPP1 binding motif 90RVSF93 is present in all of them and is flanked by a palindromic sequence, PLGS, except in three species of pikas (Ochotona princeps, O. dauurica and O. pusilla). Furthermore, for the Ochotona species an extra glycosylation site, motif 96NLS98, and the loss of the palindromic sequence were observed. Comparison with other lagomorphs suggests that this event happened before the Ochotona radiation. The d(N)/d(S) for the sequence region comprising the PPP1 binding motif and the flanking palindrome highly supports the hypothesis that for Ochotona species this region has been evolving under positive selection. In addition, mutational screening shows that the ability of pikas TCTEX1D4 to bind to PPP1 is maintained, although the PPP1 binding motif is disrupted, and the N- and C-terminal surrounding residues are also abrogated. These observations suggest pika as an ideal model to study novel PPP1 complexes regulatory mechanisms.	[Korrodi-Gregorio, Luis; Esteves, Sara L. C.; da Cruz e Silva, Edgar F.; Fardilha, Margarida] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Lab Signal Transduct, P-3800 Aveiro, Portugal; [Korrodi-Gregorio, Luis; Esteves, Sara L. C.; da Cruz e Silva, Odete A. B.; da Cruz e Silva, Edgar F.; Fardilha, Margarida] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Lopes, Ana Margarida; Afonso, Sandra; de Matos, Ana Lemos; Esteves, Pedro Jose] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, CIBIO UP,InBio, Vairao, Portugal; [Lopes, Ana Margarida] Univ Porto, Fac Ciencias, Dept Zool & Antropol, P-4100 Oporto, Portugal; [Lopes, Ana Margarida] Univ Nantes, INSERM, U892, Nantes, France; [de Matos, Ana Lemos] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Lissovsky, Andrey A.] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [da Cruz e Silva, Odete A. B.] Univ Aveiro, Dept Hlth Sci, Ctr Cell Biol, Neurosci Lab, P-3800 Aveiro, Portugal; [Esteves, Pedro Jose] Inst Invest & Formacao Avancada Ciencias & Tecnol, CESPU, Gandra Prd, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto; Universidade do Porto; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Loyola University Chicago; Lomonosov Moscow State University; Universidade de Aveiro	Esteves, PJ (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, CIBIO UP,InBio, Vairao, Portugal.	pjesteves@cibio.up.pt; mfardilha@ua.pt	Esteves, Pedro J/A-7537-2010; Lissovsky, Andrey A/B-1965-2012; afonso, sandra/M-5702-2013; da Cruz e Silva, Odete A B/F-4072-2010; Afonso, Sandra/AAV-9350-2021; Fardilha, Margarida/G-3182-2010; Korrodi-Gregório, Luís/N-6796-2013; Lopes, Ana/M-3285-2013; Esteves, Sara/L-9001-2013	Esteves, Pedro J/0000-0002-6055-8298; Lissovsky, Andrey A/0000-0003-0525-0327; afonso, sandra/0000-0001-7212-991X; da Cruz e Silva, Odete A B/0000-0003-3718-9874; Afonso, Sandra/0000-0001-7212-991X; Fardilha, Margarida/0000-0001-7459-9173; Korrodi-Gregório, Luís/0000-0002-2811-8081; Lopes, Ana/0000-0002-7176-0969; Esteves, Sara/0000-0002-1658-3816	FCT (Portuguese Foundation for Science and Technology) [SFRH/BD/41751/2007, SFRH/BD/78738/2011, SFRH/BD/42334/2007, SFRH/BD/48566/2008, SPRH/BPD/27021/2006]; FCT project [PTDC/BIABEC/103158/2008]; project "Genomics Applied to Genetic Resources"; North Portugal Regional Operational Programme under the National Strategic Reference Framework, through the European Regional Development Fund [ON.2-O Novo Norte]	FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); FCT project(Portuguese Foundation for Science and Technology); project "Genomics Applied to Genetic Resources"; North Portugal Regional Operational Programme under the National Strategic Reference Framework, through the European Regional Development Fund	FCT (Portuguese Foundation for Science and Technology) supported the doctoral fellowship of Luis Korrodi-Gregorio (SFRH/BD/41751/2007), Ana Margarida Lopes (SFRH/BD/78738/2011), Sara Luisa de Castro Esteves (SFRH/BD/42334/2007) and Ana Lemos de Matos (SFRH/BD/48566/2008) and post-doctoral fellowship of Pedro Jose Esteves (SPRH/BPD/27021/2006). This work was also supported by a FCT project (PTDC/BIABEC/103158/2008) and by the project "Genomics Applied to Genetic Resources," cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON.2-O Novo Norte), under the National Strategic Reference Framework, through the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2009, CONSERV GENET, P1; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Browne GJ, 2007, BIOCHEM J, V402, P187, DOI 10.1042/BJ20060600; Carmo CR, 2006, IMMUNOGENETICS, V58, P494, DOI 10.1007/s00251-006-0095-4; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chang JS, 2002, J BIOL CHEM, V277, P48002, DOI 10.1074/jbc.M208471200; Cohen PTW, 2002, J CELL SCI, V115, P241; Cohen PTW, 2003, METHOD ENZYMOL, V366, P135; Corbet G, 1983, ACTA ZOOL FENN, P1; Dawson M, 1981, P WORLD LAG C; de Matos AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-294; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Esteves PJ, 2005, IMMUNOGENETICS, V57, P874, DOI 10.1007/s00251-005-0022-0; Fardilha M, 2004, ANN NY ACAD SCI, V1030, P468, DOI 10.1196/annals.1329.059; Fardilha M, 2010, CURRENT MED CHEM, V17; Fardilha M, 2004, CHARACTERIZATION PP1; Fardilha M, 2011, BIOCHEM PHARMACOL, V82, P1403, DOI 10.1016/j.bcp.2011.02.018; Gibbons JA, 2005, J BIOL CHEM, V280, P15903, DOI 10.1074/jbc.M500871200; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoffman R, 2005, MAMMAL SPECIES WORLD, P185; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Korrodi-Gregorio L, 2013, BIOL OPEN; Lanier HC, 2009, MOL PHYLOGENET EVOL, V53, P1, DOI 10.1016/j.ympev.2009.05.035; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lissovsky AA, 2007, J MAMMAL, V88, P1195, DOI 10.1644/06-MAMM-A-363R.1; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Marques F, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-135; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; McKenna Malcolm C., 1997, pi; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Niu YD, 2004, FOLIA ZOOL, V53, P141; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Pinheiro A, 2013, IMMUNOGENETICS; Pinheiro A, 2011, IMMUNOGENETICS, V63, P397, DOI 10.1007/s00251-011-0533-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rose KD, 2008, P ROY SOC B-BIOL SCI, V275, P1203, DOI 10.1098/rspb.2007.1661; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; Takemiya A, 2009, PLANT PHYSIOL, V150, P144, DOI 10.1104/pp.109.135335; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; van der Loo W, 2009, J VIROL, V83, P2386, DOI 10.1128/JVI.01116-08; van der Loo W, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-72; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wakula P, 2006, BIOCHEM J, V400, P377, DOI 10.1042/BJ20060758; Wu WJ, 2007, J BIOL CHEM, V282, P26431, DOI 10.1074/jbc.M704969200; Yu N, 2000, MOL PHYLOGENET EVOL, V16, P85, DOI 10.1006/mpev.2000.0776; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	66	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77236	10.1371/journal.pone.0077236	http://dx.doi.org/10.1371/journal.pone.0077236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130861	Green Submitted, gold, Green Published			2022-12-25	WOS:000325814200071
J	Langhammer, PF; Lips, KR; Burrowes, PA; Tunstall, T; Palmer, CM; Collins, JP				Langhammer, Penny F.; Lips, Karen R.; Burrowes, Patricia A.; Tunstall, Tate; Palmer, Crystal M.; Collins, James P.			A Fungal Pathogen of Amphibians, Batrachochytrium dendrobatidis, Attenuates in Pathogenicity with In Vitro Passages	PLOS ONE			English	Article							POPULATION DECLINES; CHYTRIDIOMYCOSIS; DISEASE; HISTORY; TRANSMISSION; TEMPERATURE; EXTINCTION; DYNAMICS	Laboratory investigations into the amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), have accelerated recently, given the pathogen's role in causing the global decline and extinction of amphibians. Studies in which host animals were exposed to Bd have largely assumed that lab-maintained pathogen cultures retained the infective and pathogenic properties of wild isolates. Attenuated pathogenicity is common in artificially maintained cultures of other pathogenic fungi, but to date, it is unknown whether, and to what degree, Bd might change in culture. We compared zoospore production over time in two samples of a single Bd isolate having different passage histories: one maintained in artificial media for more than six years (JEL427-P39), and one recently thawed from cryopreserved stock (JEL427-P9). In a common garden experiment, we then exposed two different amphibian species, Eleutherodactylus coqui and Atelopus zeteki, to both cultures to test whether Bd attenuates in pathogenicity with in vitro passages. The culture with the shorter passage history, JEL427-P9, had significantly greater zoospore densities over time compared to JEL427-P39. This difference in zoospore production was associated with a difference in pathogenicity for a susceptible amphibian species, indicating that fecundity may be an important virulence factor for Bd. In the 130-day experiment, Atelopus zeteki frogs exposed to the JEL427-P9 culture experienced higher average infection intensity and 100% mortality, compared with 60% mortality for frogs exposed to JEL427-P39. This effect was not observed with Eleutherodactylus coqui, which was able to clear infection. We hypothesize that the differences in phenotypic performance observed with Atelopus zeteki are rooted in changes of the Bd genome. Future investigations enabled by this study will focus on the underlying mechanisms of Bd pathogenicity.	[Langhammer, Penny F.; Palmer, Crystal M.; Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Lips, Karen R.; Tunstall, Tate] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Burrowes, Patricia A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Langhammer, PF (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	penny.langhammer@asu.edu		Lips, Karen/0000-0002-2719-1551	EPA STAR Graduate Fellowship; P.E.O Scholar Award	EPA STAR Graduate Fellowship(United States Environmental Protection Agency); P.E.O Scholar Award	This study was funded by an EPA STAR Graduate Fellowship and a P.E.O Scholar Award to Penny Langhammer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bishop PJ, 2009, DIS AQUAT ORGAN, V84, P9, DOI 10.3354/dao02028; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Brem FMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061260; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Butt TM, 2006, ECOLOGICAL AND SOCIETAL APPROACH TO BIOLOGICAL CONTROL, P213; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Collins J.P., 2009, EXTINCTION OUR TIMES; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Greenspan SE, 2012, J WILDLIFE DIS, V48, P575, DOI 10.7589/0090-3558-48.3.575; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; IUCN, 2022, IUCN RED LIST THREAT; Joneson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002338; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longo AV, 2013, J WILDLIFE DIS, V49, P197, DOI 10.7589/2012-05-129; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; LORD JC, 1986, J INVERTEBR PATHOL, V48, P355, DOI 10.1016/0022-2011(86)90064-9; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Myers JM, 2012, J CHEM ECOL, V38, P958, DOI 10.1007/s10886-012-0170-2; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Core Development Team, 2008, R LANG ENV STAT COMP; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Safavi SA, 2012, BIOLOGIA, V67, P1062, DOI 10.2478/s11756-012-0120-z; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Voyles J, 2009, THESIS J COOK U; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Voyles J, 2011, FUNGAL ECOL, V4, P196, DOI [10.1016/j.funeco.2010.12.003, 10.1016/j.funeco.2010.12.00]; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	45	42	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77630	10.1371/journal.pone.0077630	http://dx.doi.org/10.1371/journal.pone.0077630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130895	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200092
J	Silambarasan, S; Abraham, J				Silambarasan, Sivagnanam; Abraham, Jayanthi			Mycoremediation of Endosulfan and Its Metabolites in Aqueous Medium and Soil by Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9	PLOS ONE			English	Article							TOXIC METABOLITE; BETA-ENDOSULFAN; ALPHA-ENDOSULFAN; VERATRYL ALCOHOL; DEGRADATION; BIODEGRADATION; ENRICHMENT; BIOREMEDIATION; INSECTICIDE; ASCOMYCETE	Microbial degradation offers an efficient and ecofriendly approach to remove toxicants from the contaminated environments. Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9 were capable of degrading endosulfan and their metabolites which were isolated through enrichment technique. Both the strains were able to withstand an exposure of 1300 mg/L and showed luxuriant growth at 1000 mg/L of endosulfan. The change in pH in the culture broth was from 6.8 to 3.4 and 3.8 during growth kinetic studies of JAS6 and JAS9 strains, respectively upon biological degradation of endosulfan. The degradation of endosulfan by JAS6 and JAS9 strains were examined by HPLC. The biodegradation rate constant (k) and the initial concentration were reduced by 50% (DT50) which was determined by first and pseudo first order kinetic models. In the present investigation it has been revealed that Botryosphaeria laricina JAS6 and Aspergillus tamarii JAS9 possessing endosulfan degrading capability are being reported for the first time. These findings confirm the degradation of endosulfan by JAS6 and JAS9 strains which were accompanied by significant reduction in the toxicity and could be used as remedial measure in contaminated environments.	[Silambarasan, Sivagnanam; Abraham, Jayanthi] VIT Univ, Microbial Biotechnol Lab, Sch Biosci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Abraham, J (corresponding author), VIT Univ, Microbial Biotechnol Lab, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	jayanthi.abraham@gmail.com	Abraham, Jayanthi/Q-6651-2018	Abraham, Jayanthi/0000-0001-5005-3088				Awasthi N, 2003, APPL MICROBIOL BIOT, V62, P279, DOI 10.1007/s00253-003-1241-7; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; Barbosa AM, 1996, LETT APPL MICROBIOL, V23, P93, DOI 10.1111/j.1472-765X.1996.tb00038.x; Bhalerao TS, 2007, INT BIODETER BIODEGR, V59, P315, DOI 10.1016/j.ibiod.2006.09.002; Dekker RFH, 2001, ENZYME MICROB TECH, V28, P81, DOI 10.1016/S0141-0229(00)00274-X; Frisvad JC, 2000, STUD MYCOL, P201; GOEBEL H, 1982, RESIDUE REV, V83, P1; Goswami S, 2009, BIODEGRADATION, V20, P199, DOI 10.1007/s10532-008-9213-3; Goto T, 1996, APPL ENVIRON MICROB, V62, P4036, DOI 10.1128/AEM.62.11.4036-4038.1996; Goveas SW, 2011, EURASIA J BIOSCI, V5, P48, DOI DOI 10.5053/EJ0BI0S.2011.5.0.6; Guerin T.F., 2005, INT J ENVIRON STUD, V62, P235, DOI 10.1080/0020723042000257745; Guha A., 2000, INDIAN J ENV HLTH, V42, P9; Horn BW, 1996, MYCOLOGIA, V88, P574, DOI 10.2307/3761151; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Hussain S, 2007, BIODEGRADATION, V18, P731, DOI 10.1007/s10532-007-9102-1; Hussain S, 2007, WORLD J MICROB BIOT, V23, P939, DOI 10.1007/s11274-006-9317-z; JANARDHANAN KK, 1984, CAN J MICROBIOL, V30, P247, DOI 10.1139/m84-036; KATAYAMA A, 1993, ENVIRON TOXICOL CHEM, V12, P1059, DOI 10.1002/etc.5620120612; Kullman SW, 1996, APPL ENVIRON MICROB, V62, P593, DOI 10.1128/AEM.62.2.593-600.1996; Kumar K, 2007, CHEMOSPHERE, V68, P317, DOI 10.1016/j.chemosphere.2006.12.076; Kwon GS, 2005, APPL MICROBIOL BIOT, V67, P845, DOI 10.1007/s00253-004-1879-9; Kwon GS, 2002, FEMS MICROBIOL LETT, V215, P255, DOI 10.1111/j.1574-6968.2002.tb11399.x; Li W, 2009, J HAZARD MATER, V167, P209, DOI 10.1016/j.jhazmat.2008.12.111; MARTENS R, 1976, APPL ENVIRON MICROB, V31, P853, DOI 10.1128/AEM.31.6.853-858.1976; Martin AR, 2007, INT BIODETER BIODEGR, V60, P35, DOI DOI 10.1016/J.IBI0D.2006.10.008; Mukherjee I, 2005, B ENVIRON CONTAM TOX, V75, P1034, DOI 10.1007/s00128-005-0853-2; Mukherjee I., 1994, TOXICOL ENVIRON CHEM, V46, P217, DOI DOI 10.1080/02772249409358115; Paul V, 1997, ENVIRON TOXICOL PHAR, V18, P571; Pino N, 2011, INT BIODETER BIODEGR, V65, P827, DOI 10.1016/j.ibiod.2011.06.001; Rivero A, 2012, J CHROMATOGR B, V907, P168, DOI 10.1016/j.jchromb.2012.09.010; Shetty PK, 2000, CURR SCI INDIA, V79, P1381; Shivaramaiah HM, 2005, J ENVIRON SCI HEAL B, V40, P711, DOI 10.1080/03601230500189311; Siddique T, 2003, J AGR FOOD CHEM, V51, P8015, DOI 10.1021/jf030503z; Siddique T, 2003, J ENVIRON QUAL, V32, P47, DOI 10.2134/jeq2003.0047; Silambarasan S, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1369-0; Singh NS, 2011, BIODEGRADATION, V22, P845, DOI 10.1007/s10532-010-9442-0; Sutherland TD, 2002, J APPL MICROBIOL, V92, P541, DOI 10.1046/j.1365-2672.2002.01559.x; Sutherland TD, 2000, APPL ENVIRON MICROB, V66, P2822, DOI 10.1128/AEM.66.7.2822-2828.2000; Wan MT, 2005, ENVIRON TOXICOL CHEM, V24, P1146, DOI 10.1897/04-300R1.1	39	17	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77170	10.1371/journal.pone.0077170	http://dx.doi.org/10.1371/journal.pone.0077170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130848	Green Published, gold, Green Submitted			2022-12-25	WOS:000325814200063
J	Zhao, BB; Zheng, SJ; Gong, LL; Wang, Y; Chen, CF; Jin, WJ; Zhang, D; Yuan, XH; Guo, J; Duan, ZP; He, YW				Zhao, Bin-Bin; Zheng, Su-Jun; Gong, Lu-Lu; Wang, Yu; Chen, Cai-Feng; Jin, Wen-Jing; Zhang, Ding; Yuan, Xiao-Hui; Guo, Jian; Duan, Zhong-Ping; He, You-Wen			T Lymphocytes from Chronic HCV-Infected Patients Are Primed for Activation-Induced Apoptosis and Express Unique Pro-Apoptotic Gene Signature	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; CELLS; LIVER; IL-9; DYSFUNCTION; RESPONSES; GAMMA; IMMUNOBIOLOGY; MECHANISMS; HISTORY	Although extensive studies have demonstrated the functional impairment of antigen-specific CD4(+) and CD8(+) T-cells during chronic hepatitis C virus (HCV) infection, the functional status of global CD4(+) and CD8(+) T-cells remains unclear. In this report, we recruited 42 long-term (similar to 20 years) treatment-naive chronic HCV (CHC) patients and 15 healthy donors (HDs) to investigate differences in global CD4(+) and CD8(+) T-cells function. We show that CD4(+) and CD8(+) T-cells from CHC patients underwent increased apoptosis after TCR stimulation. Furthermore, IFN-gamma, IL-9 and IP-10 were elevated in CHC patients' plasma and promoted activation-induced T-cells death. Global CD4(+) and CD8(+) T-cells also showed unique transcriptional profiles in the expression of apoptosis-related genes. We identified BCL2, PMAIP1, and CASP1 in CD4(+) T-cells and IER3 and BCL2A1 in CD8(+) T-cells from CHC patients as HCV-specific gene signatures. Importantly, the gene expression patterns of CD4(+) and CD8(+) T-cells from CHC patients differ from those in CD4(+) and CD8(+) T-cells from human immunodeficiency virus type 1 (HIV-1) or hepatitis B virus (HBV) infected individuals. Our results indicate that chronic HCV infection causes a systemic change in cytokine levels that primes T-cells for activation-induced apoptosis. Furthermore, HCV infection programs unique apoptosis-related gene expression profiles in CD4(+) and CD8(+) T-cells, leading to their enhanced activation-induced apoptosis. These results provide novel insights to the pathogenesis of chronic HCV infection.	[Zhao, Bin-Bin; Gong, Lu-Lu; Chen, Cai-Feng; Jin, Wen-Jing; Zhang, Ding; Yuan, Xiao-Hui; He, You-Wen] Chinese Acad Med Sci, Inst Pathogen Biol, Minist Hlth, Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhao, Bin-Bin; Gong, Lu-Lu; Chen, Cai-Feng; Jin, Wen-Jing; Zhang, Ding; Yuan, Xiao-Hui; He, You-Wen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zheng, Su-Jun; Duan, Zhong-Ping] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China; [Wang, Yu; Guo, Jian; He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Duke University	Duan, ZP (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China.	duan2517@163.com; youwen.he@duke.edu		Wang, Yu/0000-0001-7935-9902	Ministry of Health of China [2012ZX10002-006, 2013ZX10004-601, 2013ZX10002002-006, 2012ZX10002004-006]; Beijing Municipal Bureau of Health [2011-2018-04]; Institute of Pathogen Biology [2009IPB108]; Chinese Academy of Medical Science & Peking Union Medical College	Ministry of Health of China; Beijing Municipal Bureau of Health; Institute of Pathogen Biology; Chinese Academy of Medical Science & Peking Union Medical College	This study is supported by the National Grand Program on Key Infectious Diseases (No. 2012ZX10002-006, No. 2013ZX10004-601, No. 2013ZX10002002-006; No. 2012ZX10002004-006) from the Ministry of Health of China, the Capital Health Development Research Project (No. 2011-2018-04) from Beijing Municipal Bureau of Health and the Institute of Pathogen Biology (No. 2009IPB108), Chinese Academy of Medical Science & Peking Union Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; Chuang YT, 2008, J IMMUNOL, V180, P3238, DOI 10.4049/jimmunol.180.5.3238; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Dunkle A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.95; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Epperly MW, 2002, RADIAT RES, V157, P568, DOI 10.1667/0033-7587(2002)157[0568:MSDSIR]2.0.CO;2; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Guzman-Fulgencio M, 2012, J ANTIMICROB CHEMOTH, V67, P1238, DOI 10.1093/jac/dkr595; He YW, 1998, CRIT REV IMMUNOL, V18, P503, DOI 10.1615/CritRevImmunol.v18.i6.20; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jin WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033356; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Li HM, 2011, EUR J IMMUNOL, V41, P2197, DOI 10.1002/eji.201041125; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sidahmed AME, 2012, CYTOKINE, V59, P433, DOI 10.1016/j.cyto.2012.05.002; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; ZHANG ZN, 2013, CLIN CHEM	44	13	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77008	10.1371/journal.pone.0077008	http://dx.doi.org/10.1371/journal.pone.0077008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130824	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200047
J	Nadratowska-Wesolowska, B; Haugsten, EM; Zakrzewska, M; Jakimowicz, P; Zhen, Y; Pajdzik, D; Wesche, J; Wiedlocha, A				Nadratowska-Wesolowska, B.; Haugsten, E. M.; Zakrzewska, M.; Jakimowicz, P.; Zhen, Y.; Pajdzik, D.; Wesche, J.; Wiedlocha, A.			RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789	ONCOGENE			English	Article						FGF1; FGFR1; signaling; ERK1/2; RSK2; serine phosphorylation; endocytosis	GROWTH-FACTOR RECEPTOR; RIBOSOMAL S6 KINASE; EPITHELIAL-CELLS; CANCER; PROTEIN; SITE; UBIQUITINATION; ACTIVATION; INHIBITOR; MUTATIONS	FGFR1 (fibroblast growth factor receptor 1) regulates many key cellular responses including proliferation, migration and differentiation through activation of signaling pathways. Irregularities in FGFR1 signaling have been implicated in several pathological conditions, including human cancer. In order to discover novel regulators of FGFR1 signaling, we performed yeast two-hybrid screens and identified RSK2 (p90 ribosomal S6 kinase 2) as a potential FGFR1 interaction partner. RSK2 belongs to the family of serine/threonine kinases that are activated through the Ras-MAPK signal transduction pathway. Both in vitro and in vivo experiments confirmed the interaction and we show that phosphorylated RSK2 binds to and phosphorylates serine 789 in the C-terminal tail of FGFR1. Inhibition of RSK2 activity led to prolonged tyrosine transphosphorylation of FGFR1. Furthermore, prevention of FGFR1 phosphorylation by inhibition of RSK2 activity or mutation of serine 789 to alanine reduced FGFR1 endocytosis and ubiquitination explaining mechanistically the prolonged signaling activity. We propose a novel regulatory mechanism whereby activated RSK2 directly interacts with and phosphorylates FGFR1, thereby modulating receptor signaling through regulation of endocytosis.	[Nadratowska-Wesolowska, B.; Haugsten, E. M.; Zhen, Y.; Wesche, J.; Wiedlocha, A.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Nadratowska-Wesolowska, B.; Haugsten, E. M.; Zhen, Y.; Wesche, J.; Wiedlocha, A.] Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway; [Zakrzewska, M.] Univ Wroclaw, Fac Biotechnol, Dept Prot Engn, PL-50138 Wroclaw, Poland; [Jakimowicz, P.; Pajdzik, D.] Univ Wroclaw, Fac Biotechnol, Dept Prot Biotechnol, PL-50138 Wroclaw, Poland	University of Oslo; University of Oslo; University of Wroclaw; University of Wroclaw	Wiedlocha, A (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway.	Antoni.Wiedlocha@rr-research.no	Wesche, Jorgen/ABH-7524-2020; Nadratowska-Wesolowska, Beata/B-7613-2015	Wesche, Jorgen/0000-0002-9200-9162; Zakrzewska, Malgorzata/0000-0001-8214-1533; Haugsten, Ellen Margrethe/0000-0002-3111-5092	Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund [PNRF-87-AI-1/07]; Polish Ministry of Science and Higher Education [0627/IP1/2011/71]; South-Eastern Norway Regional Health Authority	Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); South-Eastern Norway Regional Health Authority	This work was supported by grant PNRF-87-AI-1/07 from Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund and by the Polish Ministry of Science and Higher Education (grant 0627/IP1/2011/71). The skilful technical assistance of Anne Gro Bergersen and Anne-Mari G. Pedersen is gratefully acknowledged. JW holds a senior scientist grant from South-Eastern Norway Regional Health Authority.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; GANDINO L, 1994, J BIOL CHEM, V269, P1815; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Haugsten EM, 2005, J CELL SCI, V118, P3869, DOI 10.1242/jcs.02509; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Pan ZZ, 2004, MOL BIOL CELL, V15, P3106, DOI 10.1091/mbc.E04-01-0043; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Smith JA, 2005, CANCER RES, V65, P1027; Sorensen V, 2008, MOL CELL BIOL, V28, P4129, DOI 10.1128/MCB.02117-07; Sun QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012819; THEROUX SJ, 1992, MOL ENDOCRINOL, V6, P1849, DOI 10.1210/me.6.11.1849; Tsang M., 2004, SCI STKE, V2004, pE17; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wong A, 2002, P NATL ACAD SCI USA, V99, P6684, DOI 10.1073/pnas.052138899; Xian W, 2009, CANCER RES, V69, P2244, DOI 10.1158/0008-5472.CAN-08-3398; Zakrzewska M, 2004, PROTEIN ENG DES SEL, V17, P603, DOI 10.1093/protein/gzh076; Zakrzewska M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003087	36	18	18	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4823	4836		10.1038/onc.2013.425	http://dx.doi.org/10.1038/onc.2013.425			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24141780				2022-12-25	WOS:000343240100004
J	Chen, X; Wu, Q; Tan, L; Porter, D; Jager, MJ; Emery, C; Bastian, BC				Chen, X.; Wu, Q.; Tan, L.; Porter, D.; Jager, M. J.; Emery, C.; Bastian, B. C.			Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations	ONCOGENE			English	Article						GNAQ/GNA11; MAPK signaling; protein kinase C; combined PKC and MEK inhibition; melanoma; PKC inhibitor	PROTEIN-KINASE-C; PROMOTING PHORBOL ESTERS; SIGNAL-REGULATED KINASE; PHASE-II; BRAF INHIBITION; ALPHA-SUBUNIT; LUNG-CANCER; PATHWAY; RESISTANCE; RAF	Uveal melanoma (UM) is a genetically and biologically distinct type of melanoma, and once metastatic there is no effective treatment currently available. Eighty percent of UMs harbor mutations in the G alpha(q) family members GNAQ and GNA11. Understanding the effector pathways downstream of these oncoproteins is important to identify opportunities for targeted therapy. We report consistent activation of the protein kinase C (PKC) and MAPK pathways as a consequence of GNAQ or GNA11 mutation. PKC inhibition with AEB071 or AHT956 suppressed PKC and MAPK signalling and induced G1 arrest selectively in melanoma cell lines carrying GNAQ or GNA11 mutations. In contrast, treatment with two different MEK inhibitors, PD0325901 and MEK162, inhibited the proliferation of melanoma cell lines irrespective of their mutation status, indicating that in the context of GNAQ or GNA11 mutation MAPK activation can be attributed to activated PKC. AEB071 significantly slowed the growth of tumors in an allograft model of GNAQ(Q209L)-transduced melanocytes, but did not induce tumor shrinkage. In vivo and in vitro studies showed that PKC inhibitors alone were unable to induce sustained suppression of MAP-kinase signaling. However, combinations of PKC and MEK inhibition, using either PD0325901or MEK162, led to sustained MAP-kinase pathway inhibition and showed a strong synergistic effect in halting proliferation and in inducing apoptosis in vitro. Furthermore, combining PKC and MEK inhibition was efficacious in vivo, causing marked tumor regression in a UM xenograft model. Our data identify PKC as a rational therapeutic target for melanoma patients with GNAQ or GNA11 mutations and demonstrate that combined MEK and PKC inhibition is synergistic, with superior efficacy compared to treatment with either approach alone.	[Chen, X.; Bastian, B. C.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Chen, X.; Wu, Q.; Bastian, B. C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Chen, X.; Wu, Q.; Bastian, B. C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Chen, X.; Wu, Q.; Bastian, B. C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Tan, L.; Porter, D.; Emery, C.] Novartis, Novartis Inst BioMed Res, Cambridge, MA USA; [Jager, M. J.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Novartis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Emery, C (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	caroline.emery@novartis.com; Boris.Bastian@ucsf.edu	Jager, Martine/AAR-3525-2020	Jager, Martine/0000-0003-2261-3820; Bastian, Boris/0000-0003-1836-6062; chen, xu/0000-0003-2524-4979	National Cancer Institute [CA142873]; Melanoma Research Alliance Team Science Award; NATIONAL CANCER INSTITUTE [R01CA142873] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance Team Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant CA142873 from the National Cancer Institute and a Melanoma Research Alliance Team Science Award.	ARITA Y, 1992, CANCER RES, V52, P4514; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Bosco R, 2011, MINI-REV MED CHEM, V11, P185, DOI 10.2174/138955711795049899; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Clement-Duchene C, 2012, LUNG CANCER, V78, P57, DOI 10.1016/j.lungcan.2012.06.003; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Friday BB, 2008, CANCER RES, V68, P6145, DOI 10.1158/0008-5472.CAN-08-1430; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; GRAGOUDAS ES, 1991, OPHTHALMOLOGY, V98, P383; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gronberg BH, 2012, LUNG CANCER, V78, P63, DOI 10.1016/j.lungcan.2012.07.007; HEEMSKERK FMJ, 1993, BIOCHEM BIOPH RES CO, V190, P236, DOI 10.1006/bbrc.1993.1036; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; McLean IW, 2004, CAN J OPHTHALMOL, V39, P343, DOI 10.1016/S0008-4182(04)80004-8; Millward MJ, 2006, BRIT J CANCER, V95, P829, DOI 10.1038/sj.bjc.6603331; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Wu XQ, 2012, MOL CANCER THER, V11, P1905, DOI 10.1158/1535-7163.MCT-12-0121; Wu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029622	49	124	128	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4724	4734		10.1038/onc.2013.418	http://dx.doi.org/10.1038/onc.2013.418			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24141786	Green Accepted			2022-12-25	WOS:000343239500003
J	Wong, LY; Hatfield, JK; Brown, MA				Wong, Larry Y.; Hatfield, Julianne K.; Brown, Melissa A.			Ikaros Sets the Potential for Th17 Lineage Gene Expression through Effects on Chromatin State in Early T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Immunology; T Cell; Transcription Factors; Transcription Regulation	ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; RETRACTED ARTICLE. SEE; TRANSCRIPTION FACTORS; T(H)17 DIFFERENTIATION; CUTTING EDGE; T-H-17 CELLS; HISTONE H3; ACTIVATION; CYTOKINE	Th17 cells are important effectors of immunity to extracellular pathogens, particularly at mucosal surfaces, but they can also contribute to pathologic tissue inflammation and autoimmunity. Defining the multitude of factors that influence their development is therefore of paramount importance. Our previous studies using Ikaros(-/-) CD4+ T cells implicated Ikaros in Th1 versus Th2 lineage decisions. Here we demonstrate that Ikaros also regulates Th17 differentiation through its ability to promote expression of multiple Th17 lineage-determining genes, including Ahr, Runx1, Rorc, Il17a, and Il22. Ikaros exerts its influence on the chromatin remodeling of these loci at two distinct stages in CD4+ T helper cell development. In naive cells, Ikaros is required to limit repressive chromatin modifications at these gene loci, thus maintaining the potential for expression of the Th17 gene program. Subsequently, Ikaros is essential for the acquisition of permissive histone marks in response to Th17 polarizing signals. Additionally, Ikaros represses the expression of genes that limit Th17 development, including Foxp3 and Tbx21. These data define new targets of the action of Ikaros and indicate that Ikaros plays a critical role in CD4+ T cell differentiation by integrating specific cytokine cues and directing epigenetic modifications that facilitate activation or repression of relevant genes that drive T cell lineage choice.	[Wong, Larry Y.; Hatfield, Julianne K.; Brown, Melissa A.] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Brown, MA (corresponding author), Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, 303 E Chicago Ave,Tarry 6-701, Chicago, IL 60611 USA.	m-brown12@northwestern.edu			National Institutes of Health [R21 NS047578, R56 AI082407]; MS Society grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MS Society grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS047578 and R56 AI082407 (to M. A. B.). This work was also supported by an MS Society grant.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koipally J, 2002, J BIOL CHEM, V277, P23143, DOI 10.1074/jbc.M202079200; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Koipally J, 1999, COLD SPRING HARB SYM, V64, P79, DOI 10.1101/sqb.1999.64.79; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; Nichogiannopoulou A, 1998, SEMIN IMMUNOL, V10, P119, DOI 10.1006/smim.1998.0113; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Umetsu SE, 2009, J IMMUNOL, V183, P5518, DOI 10.4049/jimmunol.0901284; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2010, CURR OPIN IMMUNOL, V22, P747, DOI 10.1016/j.coi.2010.09.001; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	68	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35170	35179		10.1074/jbc.M113.481440	http://dx.doi.org/10.1074/jbc.M113.481440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145030	Green Published, hybrid			2022-12-25	WOS:000329867600018
J	Jimenez-Lopez, JC; Rodriguez-Garcia, MI; Alche, JD				Jimenez-Lopez, Jose C.; Rodriguez-Garcia, Maria I.; Alche, Juan D.			Analysis of the Effects of Polymorphism on Pollen Profilin Structural Functionality and the Generation of Conformational, T- and B-Cell Epitopes	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; HIGH-LEVEL EXPRESSION; BET V 1; CROSS-REACTIVITY; MAJOR ALLERGEN; FOOD ALLERGENS; ANTIGENIC DETERMINANTS; ESCHERICHIA-COLI; PHOSPHOINOSITIDE 3-KINASE; PANALLERGEN PROFILIN	An extensive polymorphism analysis of pollen profilin, a fundamental regulator of the actin cytoskeleton dynamics, has been performed with a major focus in 3D-folding maintenance, changes in the 2-D structural elements, surface residues involved in ligands-profilin interactions and functionality, and the generation of conformational and lineal B-and T-cell epitopes variability. Our results revealed that while the general fold is conserved among profilins, substantial structural differences were found, particularly affecting the special distribution and length of different 2-D structural elements (i.e. cysteine residues), characteristic loops and coils, and numerous micro-heterogeneities present in fundamental residues directly involved in the interacting motifs, and to some extension these residues nearby to the ligand-interacting areas. Differential changes as result of polymorphism might contribute to generate functional variability among the plethora of profilin isoforms present in the olive pollen from different genetic background (olive cultivars), and between plant species, since biochemical interacting properties and binding affinities to natural ligands may be affected, particularly the interactions with different actin isoforms and phosphoinositides lipids species. Furthermore, conspicuous variability in lineal and conformational epitopes was found between profilins belonging to the same olive cultivar, and among different cultivars as direct implication of sequences polymorphism. The variability of the residues taking part of IgE-binding epitopes might be the final responsible of the differences in cross-reactivity among olive pollen cultivars, among pollen and plant-derived food allergens, as well as between distantly related pollen species, leading to a variable range of allergy reactions among atopic patients. Identification and analysis of commonly shared and specific epitopes in profilin isoforms is essential to gain knowledge about the interacting surface of these epitopes, and for a better understanding of immune responses, helping design and development of rational and effective immunotherapy strategies for the treatment of allergy diseases.	[Jimenez-Lopez, Jose C.; Rodriguez-Garcia, Maria I.; Alche, Juan D.] High Council Sci Res CSIC, EEZ, Dept Biochem Cell & Mol Biol plants, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Jimenez-Lopez, JC (corresponding author), High Council Sci Res CSIC, EEZ, Dept Biochem Cell & Mol Biol plants, Granada, Spain.	josecarlos.jimenez@eez.csic.es; juandedios.alche@eez.csic.es	Jimenez-Lopez, Jose C./H-5896-2011; Rodriguez-Garcia, Maria/K-5833-2014; De Dios Alche, Juan/K-6079-2014	Jimenez-Lopez, Jose C./0000-0002-1470-360X; Rodriguez-Garcia, Maria/0000-0002-7664-3235; De Dios Alche, Juan/0000-0002-7547-6025	MCINN BFU [2004-00601/BFI]; BFU [2008-00629]; CICE (Junta de Andalucia) [P2010-CVI15767, P2010-AGR6274, P2011-CVI-7487]; Spain/Germany MEC [HA2004-0094]; Spanish CSIC [I3P-BPD-CSIC]; European Marie Curie research program [PIOF-GA-2011-301550];  [BFU2011-22779]	MCINN BFU; BFU; CICE (Junta de Andalucia)(Junta de Andalucia); Spain/Germany MEC; Spanish CSIC; European Marie Curie research program; 	This study was supported by the following European Regional Development Fund co-financed grants: MCINN BFU 2004-00601/BFI, BFU 2008-00629, BFU2011-22779, CICE (Junta de Andalucia) P2010-CVI15767, P2010-AGR6274 and P2011-CVI-7487, and by the coordinated project Spain/Germany MEC HA2004-0094. JCJ-L thanks Spanish CSIC and the European Marie Curie research program for his I3P-BPD-CSIC, and PIOF-GA-2011-301550 grants, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x; Arcangeli C, 2008, J STRUCT BIOL, V164, P119, DOI 10.1016/j.jsb.2008.06.013; ARCHER SJ, 1993, BIOCHEMISTRY-US, V32, P6680, DOI 10.1021/bi00077a022; Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P427, DOI 10.1067/mai.2003.1611; Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1; Asturias JA, 1997, CLIN EXP ALLERGY, V27, P1307, DOI 10.1111/j.1365-2222.1997.tb01176.x; Asturias JA, 2002, INT IMMUNOL, V14, P993, DOI 10.1093/intimm/dxf070; Babich M, 2005, P W PHARMACOL SOC, V48, P39; Babich M, 1996, BIOCHEM BIOPH RES CO, V218, P125, DOI 10.1006/bbrc.1996.0022; Bannon GA, 2006, MOL NUTR FOOD RES, V50, P638, DOI 10.1002/mnfr.200500276; Behrendt H, 1997, INT ARCH ALLERGY IMM, V113, P69, DOI 10.1159/000237511; BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; BLASCO R, 1991, J VIROL, V65, P4598, DOI 10.1128/JVI.65.9.4598-4608.1991; BOND JF, 1991, J IMMUNOL, V146, P3380; BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x; Bufe A, 1998, INT ARCH ALLERGY IMM, V117, P215, DOI 10.1159/000024013; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; Carlos Jimenez-Lopez Jose, 2011, P245; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Czaplewski C, 2004, PROTEIN ENG DES SEL, V17, P29, DOI 10.1093/protein/gzh003; Deeks MJ, 2002, TRENDS PLANT SCI, V7, P492, DOI 10.1016/S1360-1385(02)02341-5; Fedorov AA, 1997, INT ARCH ALLERGY IMM, V113, P109, DOI 10.1159/000237520; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Fritsch R, 1998, J ALLERGY CLIN IMMUN, V102, P679, DOI 10.1016/S0091-6749(98)70287-8; Gao ZS, 2005, THEOR APPL GENET, V110, P479, DOI 10.1007/s00122-004-1856-9; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Gibbon BC, 1998, PLANT CELL, V10, P981, DOI 10.1105/tpc.10.6.981; Haikarainen T, 2009, ACTA CRYSTALLOGR D, V65, P303, DOI 10.1107/S0907444909000699; Hamman-Khalifa A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-10; Hauser M., 2008, OPEN IMMUNOL J, V1, P1, DOI DOI 10.2174/1874226200801010001; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Heiss S, 1996, J ALLERGY CLIN IMMUN, V98, P938, DOI 10.1016/S0091-6749(96)80010-8; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Jimenez-Lopez JC, 2012, CURRENT INSIGHTS POL, P71; Jimenez-Lopez JC, 2012, J MOL MODEL, V18, P4965, DOI 10.1007/s00894-012-1492-2; Jimenez-Lopez JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030878; Jimenez-Lopez JC, 2012, MOL BIOL REP, V39, P123, DOI 10.1007/s11033-011-0717-2; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Kaiser DA, 1999, J CELL SCI, V112, P3779; Kolaskar AS, 1999, VIROLOGY, V261, P31, DOI 10.1006/viro.1999.9859; Kovar DR, 2001, BIOCHEM J, V358, P49, DOI 10.1042/0264-6021:3580049; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Meno KH, 2011, ALLERGY, V66, P19, DOI 10.1111/j.1398-9995.2011.02625.x; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; MITTERMANN I, 1995, PLANT MOL BIOL, V27, P137, DOI 10.1007/BF00019185; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Pierce J.R., 1980, INTRO INFORM THEORY; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Psaradellis Telly, 2000, Allergology International, V49, P27, DOI 10.1046/j.1440-1592.2000.00155.x; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Rothkegel M, 1996, J CELL SCI, V109, P83; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schimek EM, 2005, J ALLERGY CLIN IMMUN, V116, P1327, DOI 10.1016/j.jaci.2005.09.007; Schluter K, 1998, J CELL SCI, V111, P3261; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; SILVANOVICH A, 1991, J BIOL CHEM, V266, P1204; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; STAIGER CJ, 1993, PLANT J, V4, P631, DOI 10.1046/j.1365-313X.1993.04040631.x; Tanabe S, 2004, J NUTR SCI VITAMINOL, V50, P367, DOI 10.3177/jnsv.50.367; Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; VALENTA R, 1994, BIOCHEM BIOPH RES CO, V199, P106, DOI 10.1006/bbrc.1994.1201; Valenta Rudolf, 1996, P269; VALLIER P, 1995, CLIN EXP ALLERGY, V25, P332, DOI 10.1111/j.1365-2222.1995.tb01051.x; Vieira T, 2012, ALLERGOL IMMUNOPATH, V40, P172, DOI 10.1016/j.aller.2011.03.013; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; VINSON VK, 1993, J CELL BIOL, V122, P1277, DOI 10.1083/jcb.122.6.1277; Vrtala S, 1996, BIOCHEM BIOPH RES CO, V226, P42, DOI 10.1006/bbrc.1996.1309; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Wilkies DE, 2003, J EUKARYOT MICROBIOL, V50, P252, DOI 10.1111/j.1550-7408.2003.tb00130.x; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; Wopfner N, 2002, BIOL CHEM, V383, P1779, DOI 10.1515/BC.2002.199; Wu ST, 2010, STRUCTURE, V18, P858, DOI 10.1016/j.str.2010.04.007; ZHU XJ, 1995, J IMMUNOL, V155, P5064; Zienkiewicz K, 2012, CURRENT INSIGHTS POL, P41	98	18	136	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76066	10.1371/journal.pone.0076066	http://dx.doi.org/10.1371/journal.pone.0076066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146818	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200009
J	Scheepens, JF; Frei, ES; Stocklin, J				Scheepens, J. F.; Frei, Eva S.; Stoecklin, Juerg			Glacial History Affected Phenotypic Differentiation in the Alpine Plant, Campanula thyrsoides	PLOS ONE			English	Article							LATITUDINAL POPULATION DIFFERENTIATION; GENETIC DIFFERENTIATION; F-ST; DIVERGENCE; GROWTH; Q(ST); CONSEQUENCES; DISPERSAL; PHENOLOGY; TIME	Numerous widespread Alpine plant species show molecular differentiation among populations from distinct regions. This has been explained as the result of genetic drift during glacial survival in isolated refugia along the border of the European Alps. Since genetic drift may affect molecular markers and phenotypic traits alike, we asked whether phenotypic differentiation mirrors molecular patterns among Alpine plant populations from different regions. Phenotypic traits can be under selection, so we additionally investigated whether part of the phenotypic differentiation can be explained by past selection and/or current adaptation. Using the monocarpic Campanula thyrsoides as our study species, a common garden experiment with plants from 21 populations from four phylogeographic groups located in regions across the Alps and the Jura Mountains was performed to test for differentiation in morphological and phenological traits. Past selection was investigated by comparing phenotypic differentiation among and within regions with molecular differentiation among and within regions. The common garden results indicated regional differentiation among populations for all investigated phenotypic traits, particularly in phenology. Delayed flowering in plants from the South-eastern Alps suggested adaptation to long sub-mediterranean summers and contrasted with earlier flowering of plants experiencing shorter growing seasons in regions with higher elevation to the West. Comparisons between molecular and phenotypic differentiation revealed diversifying selection among regions in height and biomass, which is consistent with adaptation to environmental conditions in glacial refugia. Within regions, past selection acted against strong diversification for most phenotypic traits, causing restricted postglacial adaptation. Evidence consistent with post-glacial adaptation was also given by negative correlation coefficients between several phenotypic traits and elevation of the population's origin. In conclusion, our study suggests that, irrespective of adaptation of plants to their current environment, glacial history can have a strong and long-lasting influence on the phenotypic evolution of Alpine plants.	[Scheepens, J. F.; Frei, Eva S.; Stoecklin, Juerg] Univ Basel, Inst Bot, Sect Plant Ecol, CH-4056 Basel, Switzerland	University of Basel	Scheepens, JF (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	jofrsc@utu.fi	Scheepens, J.F./AAF-7440-2021	Scheepens, J.F./0000-0003-1650-2008	Swiss National Science Foundation [3100AO-116785]; Freiwillige Akademische Gesellschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Freiwillige Akademische Gesellschaft	This study has been supported financially by the Swiss National Science Foundation (http://www.snf.ch), project no. 3100AO-116785 to J.S., and with a grant from the Freiwillige Akademische Gesellschaft (http://www.fag-basel.ch/) to J.F.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2007, FLORA, V202, P218, DOI 10.1016/j.flora.2006.06.003; AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; Aeschimann D., 2005, FLORA ALPINA; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Crawley MJ., 2007, R BOOK; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Frei ES, 2012, ALPINE BOT, V122, P23, DOI 10.1007/s00035-012-0103-2; Frei ES, 2012, PLANT ECOL, V213, P395, DOI 10.1007/s11258-011-9984-1; Frei ES, 2012, J ECOL, V100, P297, DOI 10.1111/j.1365-2745.2011.01909.x; GALEN C, 1991, EVOLUTION, V45, P1218, DOI 10.1111/j.1558-5646.1991.tb04388.x; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Goudet J, 2006, GENETICS, V172, P1337, DOI 10.1534/genetics.105.050583; Hautier Y, 2009, J PLANT ECOL, V2, P125, DOI 10.1093/jpe/rtp011; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jager EJ., 2000, BER BAYR BOT GES, V69, P93; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klekowski EJ, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P227; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Kuss P, 2011, PERSPECT PLANT ECOL, V13, P101, DOI 10.1016/j.ppees.2011.02.003; Kuss P, 2008, J ECOL, V96, P821, DOI 10.1111/j.1365-2745.2008.01374.x; Kuss P, 2007, PERSPECT PLANT ECOL, V9, P37, DOI 10.1016/j.ppees.2007.06.001; Lamy JB, 2012, MOL ECOL, V21, P5646, DOI 10.1111/mec.12017; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merxmuller H, 1954, JB VEREINS SCHUTZE A, V19, P97; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; OUBORG NJ, 1991, OECOLOGIA, V86, P359, DOI 10.1007/BF00317601; Ozenda P., 1988, VEGETATION ALPEN EUR; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; R Development Core Team, 2009, R FDN STAT COMP; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Sandring S, 2007, J EVOLUTION BIOL, V20, P558, DOI 10.1111/j.1420-9101.2006.01260.x; Scheepens JF, 2012, ANN BOT-LONDON, V110, P1479, DOI 10.1093/aob/mcs131; Scheepens JF, 2011, PLANT ECOL DIVERS, V4, P403, DOI 10.1080/17550874.2011.636077; Scheepens JF, 2011, ALPINE BOT, V121, P37, DOI 10.1007/s00035-011-0087-3; Scheepens JF, 2010, OECOLOGIA, V164, P141, DOI 10.1007/s00442-010-1650-0; SCHMID B, 1994, EVOLUTION, V48, P1525, DOI 10.1111/j.1558-5646.1994.tb02194.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Sokal RR, 1995, BIOMETRY; SPITZE K, 1993, GENETICS, V135, P367; Thiel-Egenter C, 2011, J BIOGEOGR, V38, P772, DOI 10.1111/j.1365-2699.2010.02441.x; Thiel-Egenter C, 2009, MOL ECOL, V18, P4495, DOI 10.1111/j.1365-294X.2009.04360.x; Vitasse Y, 2009, CAN J FOREST RES, V39, P1259, DOI 10.1139/X09-054; Volis S, 2005, HEREDITY, V95, P466, DOI 10.1038/sj.hdy.6800745; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344	53	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e73854	10.1371/journal.pone.0073854	http://dx.doi.org/10.1371/journal.pone.0073854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146742	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000326019400002
J	van Hoek, AJ; Andrews, N; Campbell, H; Amirthalingam, G; Edmunds, WJ; Miller, E				van Hoek, Albert Jan; Andrews, Nick; Campbell, Helen; Amirthalingam, Gayatri; Edmunds, W. John; Miller, Elizabeth			The Social Life of Infants in the Context of Infectious Disease Transmission; Social Contacts and Mixing Patterns of the Very Young	PLOS ONE			English	Article							SCHOOL-CHILDREN; PERTUSSIS; SPREAD; VACCINATION	Insight into how humans interact helps further understanding of the transmission of infectious diseases. For diseases such as pertussis, infants are at particular risk for severe outcomes. To understand the contact pattern of infants, especially those too young to be vaccinated, we sent contact diaries to a representative sample of 1000 mothers in the United Kingdom. We received 115 responses with a total of 758 recorded contacts. The average number of daily contacts for an infant was 6.68 overall and 5.7 for those aged <= 10 weeks. Of the latter, 2.1 (37%) contacts were with non-household members and were >15 minutes duration, suggesting that a cocooning programme may miss a substantial proportion of exposures leading to disease transmission. The least contact was between adolescents and infants. Thus the impact of adolescent (pertussis) vaccination on infants would likely be limited, unless it reduces transmission to other age groups whose contact with infants is greater.	[van Hoek, Albert Jan; Andrews, Nick; Campbell, Helen; Amirthalingam, Gayatri; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England; [Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine	van Hoek, AJ (corresponding author), Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England.	albertjan.vanhoek@phe.gov.uk			Public Health England	Public Health England	This study was funded by Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID VIR RASH PREGN; Bind R, 2012, CHILDCARE EARLY YEAR; Campbell H, 2012, EMERG INFECT DIS, V18, P38, DOI 10.3201/eid1801.110784; de Greeff SC, 2012, EPIDEMIOLOGY, V23, P852, DOI 10.1097/EDE.0b013e31826c2b9e; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Hallander Hans O, 2011, Expert Rev Clin Pharmacol, V4, P705, DOI 10.1586/ecp.11.55; Health Protection Agency, 2013, HLTH PROTECTION REPO, V7; Health Protection Agency, HPA NAT MEASL GUID L; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, 2010, CHAR BIRTH 2 TABL 5; Office for National Statistics, 2012, MID 2011 POP EST UK; Office for National Statistics, 2012, MID 2011 POP ES ENGL; R Development Core Team, 2009, R FDN STAT COMP; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X	24	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76180	10.1371/journal.pone.0076180	http://dx.doi.org/10.1371/journal.pone.0076180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146835	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400042
J	Vares, G; Cui, X; Wang, B; Nakajima, T; Nenoi, M				Vares, Guillaume; Cui, Xing; Wang, Bing; Nakajima, Tetsuo; Nenoi, Mitsuru			Generation of Breast Cancer Stem Cells by Steroid Hormones in Irradiated Human Mammary Cell Lines	PLOS ONE			English	Article							MEMBRANE PROGESTIN RECEPTORS; MESSENGER-RNA; RADIATION; ESTROGEN; EXPRESSION; APOPTOSIS; MICRORNAS; RADIOSENSITIVITY; IDENTIFICATION; PROGRESSION	Exposure to ionizing radiation was shown to result in an increased risk of breast cancer. There is strong evidence that steroid hormones influence radiosensitivity and breast cancer risk. Tumors may be initiated by a small subpopulation of cancer stem cells (CSCs). In order to assess whether the modulation of radiation-induced breast cancer risk by steroid hormones could involve CSCs, we measured by flow cytometry the proportion of CSCs in irradiated breast cancer cell lines after progesterone and estrogen treatment. Progesterone stimulated the expansion of the CSC compartment both in progesterone receptor (PR)-positive breast cancer cells and in PR-negative normal cells. In MCF10A normal epithelial PR-negative cells, progesterone-treatment and irradiation triggered cancer and stemness-associated microRNA regulations (such as the downregulation of miR-22 and miR-29c expression), which resulted in increased proportions of radiation-resistant tumor-initiating CSCs.	[Vares, Guillaume; Wang, Bing; Nakajima, Tetsuo; Nenoi, Mitsuru] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan; [Cui, Xing] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Vares, G (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan.	vares@nirs.go.jp	Vares, Guillaume/S-6530-2019; Vares, Guillaume/A-9257-2011	Vares, Guillaume/0000-0002-6191-9032; Vares, Guillaume/0000-0002-6191-9032	JSPS KAKENHI [24710066]; Grants-in-Aid for Scientific Research [24710066] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI Grant Number 24710066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andarawewa KL, 2011, INT J RADIAT ONCOL, V79, P1523, DOI 10.1016/j.ijrobp.2010.11.058; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Anderson E, 2002, BREAST CANCER RES, V4, P197, DOI 10.1186/bcr452; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Ashley RL, 2006, ENDOCRINOLOGY, V147, P4151, DOI 10.1210/en.2006-0002; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Axlund SD, 2012, MOL CELL ENDOCRINOL, V357, P71, DOI 10.1016/j.mce.2011.09.021; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Behera MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE1089, DOI 10.1152/ajpendo.00209.2009; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Boyle P, 2008, WORLD CANC REPORT 20; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clarke RB, 1997, CANCER RES, V57, P4987; Cui X, 2011, CANCER RES, V71, P3676, DOI 10.1158/0008-5472.CAN-10-2926; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DiRenzo J, 2002, CANCER RES, V62, P89; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gompel A, 2000, STEROIDS, V65, P593, DOI 10.1016/S0039-128X(00)00172-0; Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921; Hulka BS, 2008, MATURITAS, V61, P203, DOI 10.1016/j.maturitas.2008.11.016; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; John EM, 2007, INT J CANCER, V121, P386, DOI 10.1002/ijc.22668; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kramer EA, 2006, EUR J OBSTET GYN R B, V129, P77, DOI 10.1016/j.ejogrb.2005.12.004; Kramer EA, 2006, J STEROID BIOCHEM, V98, P174, DOI 10.1016/j.jsbmb.2005.11.002; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Oeffinger KC, 2009, JAMA-J AM MED ASSOC, V301, P404, DOI 10.1001/jama.2008.1039; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ricoul M, 1997, MUTAT RES-FUND MOL M, V374, P73, DOI 10.1016/S0027-5107(96)00220-5; RICOUL M, 1991, MUTAT RES, V250, P331, DOI 10.1016/0027-5107(91)90189-U; Sartorius CA, 2005, CANCER RES, V65, P9779, DOI 10.1158/0008-5472.CAN-05-0505; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; SOULE HD, 1990, CANCER RES, V50, P6075; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vares G, 2004, ONCOGENE, V23, P4603, DOI 10.1038/sj.onc.1207601; Wang S, 2011, GENES IMMUN, V12, P149, DOI 10.1038/gene.2010.53; WAZER DE, 1989, BRIT J RADIOL, V62, P1079, DOI 10.1259/0007-1285-62-744-1079; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	63	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77124	10.1371/journal.pone.0077124	http://dx.doi.org/10.1371/journal.pone.0077124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146960	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400094
J	Cowan, FM; Mtetwa, S; Davey, C; Fearon, E; Dirawo, J; Wong-Gruenwald, R; Ndikudze, T; Chidiya, S; Benedikt, C; Busza, J; Hargreaves, JR				Cowan, Frances M.; Mtetwa, Sibongile; Davey, Calum; Fearon, Elizabeth; Dirawo, Jeffrey; Wong-Gruenwald, Ramona; Ndikudze, Theresa; Chidiya, Samson; Benedikt, Clemens; Busza, Joanna; Hargreaves, James R.			Engagement with HIV Prevention Treatment and Care among Female Sex Workers in Zimbabwe: a Respondent Driven Sampling Survey	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CONDOM USE; BARRIERS; BEHAVIOR; WOMEN; RISK; INTERVENTIONS; INFECTIONS; PREVALENCE; PROSTITUTES	Objective(S): To determine the HIV prevalence and extent of engagement with HIV prevention and care among a representative sample of Zimbabwean sex workers working in Victoria Falls, Hwange and Mutare. Design: Respondent driven sampling (RDS) surveys conducted at each site. Methods: Sex workers were recruited using respondent driven sampling with each respondent limited to recruiting 2 peers. Participants completed an interviewer-administered questionnaire and provided a finger prick blood sample for HIV antibody testing. Statistical analysis took account of sampling method. Results: 870 women were recruited from the three sites. HIV prevalence was between 50 and 70%. Around half of those confirmed HIV positive were aware of their HIV status and of those 50-70% reported being enrolled in HIV care programmes. Overall only 25-35% of those with laboratory-confirmed HIV were accessing antiretroviral therapy. Among those reporting they were HIV negative, 21-28% reported having an HIV test in the last 6 months. Of those tested HIV negative, most (65-82%) were unaware of their status. Around two-thirds of sex workers reported consistent condom use with their clients. As in other settings, sex workers reported high rates of gender based violence and police harassment. Conclusions: This survey suggests that prevalence of HIV is high among sex workers in Zimbabwe and that their engagement with prevention, treatment and care is sub-optimal. Intensifying prevention and care interventions for sex workers has the potential to markedly reduce HIV and social risks for sex workers, their clients and the general population in Zimbabwe and elsewhere in the region.	[Cowan, Frances M.] UCL, London, England; [Cowan, Frances M.; Mtetwa, Sibongile; Dirawo, Jeffrey] Zimbabwe AIDS Prevent Project Trust, Harare, Zimbabwe; [Cowan, Frances M.; Mtetwa, Sibongile; Dirawo, Jeffrey] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabwe, Harare, Zimbabwe; [Davey, Calum; Fearon, Elizabeth; Busza, Joanna; Hargreaves, James R.] London Sch Hyg & Trop Med, London WC1, England; [Wong-Gruenwald, Ramona; Ndikudze, Theresa] Deutsch Gesell Int Zusammenarbeit GmbH, Bonn, Germany; [Chidiya, Samson; Benedikt, Clemens] United Nations Populat Fund UNFPA, Harare, Zimbabwe	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; United Nations Population Fund	Cowan, FM (corresponding author), UCL, London, England.	f.cowan@ucl.ac.uk		Fearon, Elizabeth/0000-0001-5574-251X; Cowan, Frances/0000-0003-3087-4422; Rutsito, Sibongile/0000-0002-9155-840X; Busza, Joanna/0000-0001-6334-0318; Hargreaves, James/0000-0002-3509-3572	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; German Federal Ministry for Economic Cooperation and Development (BMZ)	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; German Federal Ministry for Economic Cooperation and Development (BMZ)	The study was funded by Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ). Two members of GIZ's team acted as co-investigators. In addition, Stefan Weinmann and Sabine Flessenkamper commented on the manuscript.	Arnott J, 2009, RIGHTS NOT RESCUE RE; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; *COUNC NA, 2006, ZIMB NAT BEH CHANG S; Cowan FM, 2005, JAIDS-J ACQ IMM DEF, V38, P202, DOI 10.1097/00126334-200502010-00012; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; Cwikel JG, 2008, SEX HEALTH, V5, P9, DOI 10.1071/SH07024; Deering KN, 2009, AIDS PATIENT CARE ST, V23, P603, DOI 10.1089/apc.2009.0022; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Kachroo S, 2006, B WORLD HEALTH ORGAN, V84, P999, DOI 10.2471/BLT.06.032656; Kayembe PK, 2008, SEX TRANSM INFECT, V84, P202, DOI 10.1136/sti.2007.028324; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Kriitmaa K, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000386735.87177.2a; Langhaug L, 2012, TROP MED INT HEALTH, V17, P827, DOI 10.1111/j.1365-3156.2012.02999.x; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mavhu W, 2008, CULT HEALTH SEX, V10, P563, DOI 10.1080/13691050801948102; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; MUNOZ J, 2010, SAHARA J-J SOC ASP H, V7, P51, DOI DOI 10.1080/17290376.2010.9724969; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; *NAT AIDS COUNC MO, 2006, ZIMB NAT HIV AIDS ST, P2006; Pauw I, 2003, CULT HEALTH SEX, V5, P465, DOI 10.1080/136910501185198; PIOT P, 1988, SOZ PRAVENTIV MED, V33, P336, DOI 10.1007/BF02084300; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Scorgie F., 2011, I EXPECT BE ABUSED I; Szwarcwald CL, 2011, JAIDS-J ACQ IMM DEF, V57, pS129, DOI 10.1097/QAI.0b013e31821e9a36; UNAIDS, 2012, REP GLOB AIDS EP; *US NAT COMM CLIN, 1997, STAND BLOOD COLL FIL; Valdiserri RO, 2003, NAT MED, V9, P881, DOI 10.1038/nm0703-881; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; White RG, 2012, SEX TRANSM INFECT, V88, P397, DOI 10.1136/sextrans-2012-050703; WHO, 2011, PREV HIV SEX WORK SE; *WHO UNAIDS NSWP, 2012, PREV TREATM HIV OTH; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; *WORLD HLTH ORG DO, 2005, TOOLK TARG HIV AIDS; *ZIMB CENTR STAT A, 2011, ZIMB DEM HLTH SURV 2	46	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77080	10.1371/journal.pone.0077080	http://dx.doi.org/10.1371/journal.pone.0077080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237TP	24143203	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000325894100038
J	Parravicini, V; Micheli, F; Montefalcone, M; Morri, C; Villa, E; Castellano, M; Povero, P; Bianchi, CN				Parravicini, Valeriano; Micheli, Fiorenza; Montefalcone, Monica; Morri, Carla; Villa, Elisa; Castellano, Michela; Povero, Paolo; Bianchi, Carlo Nike			Conserving Biodiversity in a Human-Dominated World: Degradation of Marine Sessile Communities within a Protected Area with Conflicting Human Uses	PLOS ONE			English	Article							MASS-MORTALITY; FACILITATION; DISTURBANCE; HABITATS; CASCADES; IMPACTS; MEADOWS; REEF	Conservation research aims at understanding whether present protection schemes are adequate for the maintenance of ecosystems structure and function across time. We evaluated long-term variation in rocky reef communities by comparing sites surveyed in 1993 and again in 2008. This research took place in Tigullio Gulf, an emblematic case study where various conservation measures, including a marine protected area, have been implemented to manage multiple human uses. Contrary to our prediction that protection should have favored ecosystem stability, we found that communities subjected to conservation measures (especially within the marine protected area) exhibited the greatest variation toward architectural complexity loss. Between 1993 and 2008, chronic anthropogenic pressures (especially organic load) that had already altered unprotected sites in 1993 expanded their influence into protected areas. This expansion of human pressure likely explains our observed changes in the benthic communities. Our results suggest that adaptive ecosystem-based management (EBM), that is management taking into account human interactions, informed by continuous monitoring, is needed in order to attempt reversing the current trend towards less architecturally complex communities. Protected areas are not sufficient to stop ecosystem alteration by pressures coming from outside. Monitoring, and consequent management actions, should therefore extend to cover the relevant scales of those pressures.	[Parravicini, Valeriano] CESAB FRB, Aix En Provence, France; [Parravicini, Valeriano] IRD UR Coreus Lab Arago 227, Banyuls Sur Mer, France; [Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Montefalcone, Monica; Morri, Carla; Villa, Elisa; Castellano, Michela; Povero, Paolo; Bianchi, Carlo Nike] Univ Genoa, DiSTAV, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy	Institut de Recherche pour le Developpement (IRD); Stanford University; University of Genoa	Parravicini, V (corresponding author), CESAB FRB, Immeuble Henri Poincare Domaine Petit Arbois, Aix En Provence, France.	valeriano.parravicini@ird.fr	Parravicini, Valeriano/A-8539-2011	Castellano, Michela/0000-0001-6101-0112; Morri, Carla/0000-0003-4520-2741; Micheli, Fiorenza/0000-0002-6865-1438; Parravicini, Valeriano/0000-0002-3408-1625; Bianchi, Carlo Nike/0000-0003-1071-3285	Italian Ministry of the Environment; Pew Fellowship in Marine Conservation	Italian Ministry of the Environment; Pew Fellowship in Marine Conservation	The present work is done under the aegis of the project 'The impacts of biological invasions and climate change on the biodiversity of the Mediterranean Sea' (Italy-Israel co-operation) funded by the Italian Ministry of the Environment. FM was partly supported by a Pew Fellowship in Marine Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Alvarez-Filip L, 2011, CORAL REEFS, V30, P1051, DOI 10.1007/s00338-011-0795-6; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Asnaghi V, 2009, MAR ECOL-EVOL PERSP, V30, P505, DOI 10.1111/j.1439-0485.2009.00346.x; Bianchi C.N., 2004, BIOL MAR MEDITERR, V11, P185; Bianchi C. N., 1994, B MUS I BIOL U GEN, V58-59, P181; Bianchi C. N., 1994, BENTHOS GOLFO TIGULL; Bulleri F, 2008, MAR ECOL PROG SER, V364, P77, DOI 10.3354/meps07484; Bussotti S., 1996, Doriana, V6, P1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Danovaro R, 1997, ESTUAR COAST SHELF S, V44, P723, DOI 10.1006/ecss.1996.0135; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Duarte L, 2013, ACTA OECOL, V51, P1, DOI 10.1016/j.actao.2013.05.002; Fukami T, 2001, OIKOS, V92, P215, DOI 10.1034/j.1600-0706.2001.920203.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Greco S, 2004, AQUAT CONSERV, V14, pS119, DOI 10.1002/aqc.656; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Royo CLY, 2009, J ENVIRON MANAGE, V90, P1494, DOI 10.1016/j.jenvman.2008.10.007; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mardia K.V, 1980, MULTIVARIATE ANAL; Marti R, 2005, ESTUAR COAST SHELF S, V64, P613, DOI 10.1016/j.ecss.2005.04.009; McLeod KL, COMMUNICATION PARTNE; Melegari GE, 1973, PORTOFINO SUBGUIDA C; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; Misic C, 2008, CONT SHELF RES, V28, P2725, DOI 10.1016/j.csr.2008.09.006; Montefalcone M, 2010, AQUAT CONSERV, V20, P507, DOI 10.1002/aqc.1128; Montefalcone M, 2009, MAR POLLUT BULL, V58, P515, DOI 10.1016/j.marpolbul.2008.12.001; Morri C, 1988, B MUS I BIOL U GEN S, V52, P213; Nike Bianchi Carlo, 2003, Biogeographia, V24, P319; Olsson P, 2008, P NATL ACAD SCI USA, V105, P9489, DOI 10.1073/pnas.0706905105; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; Parravicini V, 2010, BIOL CONSERV, V143, P2435, DOI 10.1016/j.biocon.2010.06.006; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Pisano E., 1980, Memorie di Biologia Marina e di Oceanografia, V10, P269; Pisano E., 1982, ATT CONV UN OP AFF S, P93; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sano M, 2010, COAST MANAGE, V38, P76, DOI 10.1080/08920750903411734; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Thomsen MS, 2010, INTEGR COMP BIOL, V50, P158, DOI 10.1093/icb/icq042; Tortonese E., 1962, Pubblicazioni della Stazione Zoologica di Napoli, V32, P99; Tortonese E., 1961, Archivio di Oceanografia e Limnologia Roma, V12, P163; Tortonese E., 1958, Archivio di Oceanografia e Limnologia, V11, P167; Vietti RC, 2010, CHEM ECOL, V26, P319, DOI 10.1080/02757541003689845; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P264, DOI 10.1016/j.jembe.2011.02.017	58	52	52	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75767	10.1371/journal.pone.0075767	http://dx.doi.org/10.1371/journal.pone.0075767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143173	Green Published, gold			2022-12-25	WOS:000325894100008
J	Rousalova, I; Banerjee, S; Sangwan, V; Evenson, K; McCauley, JA; Kratzke, R; Vickers, SM; Saluja, A; D'Cunha, J				Rousalova, Ilona; Banerjee, Sulagna; Sangwan, Veena; Evenson, Kristen; McCauley, Joel A.; Kratzke, Robert; Vickers, Selwyn M.; Saluja, Ashok; D'Cunha, Jonathan			Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PANCREATIC-CANCER; RADIATION SENSITIZATION; PRECLINICAL MODELS; MET AMPLIFICATION; INDUCE APOPTOSIS; TRIPTOLIDE; EXPRESSION; ACTIVATION	Background: Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent. The precise mechanisms of its cytotoxic effects remain unclear. Methods: Cell viability was studied using CCK8 assay. Cell proliferation was measured real-time on cultured cells using Electric Cell Substrate Impedence Sensing (ECIS). Apoptosis was assayed by Caspase activity on cultured lung cancer cells and TUNEL staining on tissue sections. Expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA, APAF-1) was estimated by qRTPCR. Effect of Minnelide on proliferative cells in the tissue was estimated by Ki-67 staining of animal tissue sections. Results: In this study, we investigated in vitro and in vivo antitumor effects of triptolide/Minnelide in non-small cell lung carcinoma (NSCLC). Triptolide/Minnelide exhibited anti-proliferative effects and induced apoptosis in NSCLC cell lines and NSCLC mouse models. Triptolide/Minnelide significantly down-regulated the expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA) and up-regulated pro-apoptotic APAF-1 gene, in part, via attenuating the NF-kappa B signaling activity. Conclusion: In conclusion, our results provide supporting mechanistic evidence for Minnelide as a potential in NSCLC.	[Rousalova, Ilona; Banerjee, Sulagna; Sangwan, Veena; Evenson, Kristen; McCauley, Joel A.; Vickers, Selwyn M.; Saluja, Ashok] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Kratzke, Robert] Univ Minnesota, Minneapolis, MN 55455 USA; [D'Cunha, Jonathan] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saluja, A (corresponding author), Univ Minnesota, Dept Surg, Div Basic & Translat Res, Box 242 UMHC, Minneapolis, MN 55455 USA.	asaluja@umn.edu	Rousalova, Ilona/O-4425-2017	Rousalova, Ilona/0000-0002-6736-1287	Norgren/MacMillan Lung Cancer Research Fund; Herbert Schwieters Family Lung Cancer Research Fund; University of Minnesota, Department of Surgery; NIH [R01-CA170946, CA124723]; Proshek-Fulbright Fellowship; NATIONAL CANCER INSTITUTE [R01CA170946, R01CA124723] Funding Source: NIH RePORTER	Norgren/MacMillan Lung Cancer Research Fund; Herbert Schwieters Family Lung Cancer Research Fund; University of Minnesota, Department of Surgery(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Proshek-Fulbright Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Norgren/MacMillan Lung Cancer Research Fund, Herbert Schwieters Family Lung Cancer Research Fund, and intramural funding from the University of Minnesota, Department of Surgery. Part of the study was supported by NIH grants R01-CA170946 and CA124723 to AKS. IR was supported by Proshek-Fulbright Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; American Cancer Society, 2013, ANC FACTS FIG 2013; Antonoff MB, 2010, J SURG RES, V163, P72, DOI 10.1016/j.jss.2010.04.047; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Baby J, 2007, CANCER LETT, V255, P85, DOI 10.1016/j.canlet.2007.03.024; Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Batra S, 2011, ARCH IMMUNOL THER EX, V59, P335, DOI 10.1007/s00005-011-0136-z; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Borja-Cacho D, 2010, J GASTROINTEST SURG, V14, P252, DOI 10.1007/s11605-009-1065-6; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; Burikhanov R, 2013, CANCER RES, V73, P1011, DOI 10.1158/0008-5472.CAN-12-3212; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Chen YW, 2010, ANTI-CANCER DRUG, V21, P502, DOI 10.1097/CAD.0b013e328337337c; Chugh R, 2012, SCI TRANSL MED, V4; Corvaro M, 2007, CANCER BIOL THER, V6, P209, DOI 10.4161/cbt.6.2.3622; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fischer B, 2003, BIOCHEM BIOPH RES CO, V306, P516, DOI 10.1016/S0006-291X(03)01004-0; Frese S, 2003, ONCOGENE, V22, P5427, DOI 10.1038/sj.onc.1206842; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Gomyo Y, 2004, ONCOGENE, V23, P6779, DOI 10.1038/sj.onc.1207381; Hoffarth S, 2008, CELL DEATH DIFFER, V15, P161, DOI 10.1038/sj.cdd.4402256; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Hu YP, 2003, CLIN CANCER RES, V9, P2826; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jones DR, 2002, J THORAC CARDIOV SUR, V123, P310, DOI 10.1067/mtc.2002.118684; Jones DR, 2000, ANN THORAC SURG, V70, P930, DOI 10.1016/S0003-4975(00)01635-0; Kim SM, 2013, J BIOCHEM, V153, P93, DOI 10.1093/jb/mvs119; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krepela E, 2004, BIOL CHEM, V385, P153, DOI 10.1515/BC.2004.034; Krosch TCK, 2013, AM J SURG, V205, P387, DOI 10.1016/j.amjsurg.2013.01.008; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lee KY, 2002, EXP MOL MED, V34, P462, DOI 10.1038/emm.2002.64; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu JR, 2002, CANCER RES, V62, P924; Liu L, 2009, FEBS J, V276, P1459, DOI 10.1111/j.1742-4658.2009.06888.x; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mujumdar N, 2010, AUTOPHAGY, V6, P997, DOI 10.4161/auto.6.7.13334; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; MUKHOPADHYAY T, 1995, ONCOGENE, V11, P999; Nam HT, 2010, J BIOCHEM, V148, P573, DOI 10.1093/jb/mvq089; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Ries L, 2013, ANCER STAT REV 1975; Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Shinoura N, 2001, INT J CANCER, V93, P252, DOI 10.1002/ijc.1327; Shinoura N, 2001, JPN J CANCER RES, V92, P467, DOI 10.1111/j.1349-7006.2001.tb01117.x; Sun H, 2012, ANTI-CANCER DRUG, V23, P1039, DOI 10.1097/CAD.0b013e32835679b8; Sun LX, 2011, BIOCHEM BIOPH RES CO, V416, P99, DOI 10.1016/j.bbrc.2011.11.004; Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Tang XY, 2007, POSTGRAD MED J, V83, P338, DOI 10.1136/pgmj.2006.055426; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; WEI YS, 1991, ACTA PHARM SINIC, V12, P406; Westfall SD, 2008, CHEMOTHERAPY, V54, P67, DOI 10.1159/000112419; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; Xu B, 2010, CANCER LETT, V291, P200, DOI 10.1016/j.canlet.2009.10.013; Yang H, 2008, J INT MED RES, V36, P734, DOI 10.1177/147323000803600416; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Yang M, 2008, INT J MOL MED, V22, P489, DOI 10.3892/ijmm_00000047; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zhang ZF, 2006, ANN THORAC SURG, V82, P243, DOI 10.1016/j.athoracsur.2006.01.049; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	93	36	37	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77411	10.1371/journal.pone.0077411	http://dx.doi.org/10.1371/journal.pone.0077411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143232	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100069
J	Sokhi, UK; Bacolod, MD; Dasgupta, S; Emdad, L; Das, SK; Dumur, CI; Miles, MF; Sarkar, D; Fisher, PB				Sokhi, Upneet K.; Bacolod, Manny D.; Dasgupta, Santanu; Emdad, Luni; Das, Swadesh K.; Dumur, Catherine I.; Miles, Michael F.; Sarkar, Devanand; Fisher, Paul B.			Identification of Genes Potentially Regulated by Human Polynucleotide Phosphorylase (hPNPase(old-35)) Using Melanoma as a Model	PLOS ONE			English	Article							TERMINAL DIFFERENTIATION; INTERMEMBRANE SPACE; RNA DEGRADATION; DOWN-REGULATION; KI-67 PROTEIN; CENP-E; CELLS; GROWTH; PROGRESSION; EXPRESSION	Human Polynucleotide Phosphorylase (hPNPase(old)-35 or PNPT1) is an evolutionarily conserved 3'-> 5' exoribonuclease implicated in the regulation of numerous physiological processes including maintenance of mitochondrial homeostasis, mtRNA import and aging-associated inflammation. From an RNase perspective, little is known about the RNA or miRNA species it targets for degradation or whose expression it regulates; except for c-myc and miR-221. To further elucidate the functional implications of hPNPase(old-35) in cellular physiology, we knocked-down and overexpressed hPNPase(old-35) in human melanoma cells and performed gene expression analyses to identify differentially expressed transcripts. Ingenuity Pathway Analysis indicated that knockdown of hPNPase(old-35) resulted in significant gene expression changes associated with mitochondrial dysfunction and cholesterol biosynthesis; whereas overexpression of hPNPase(old-35) caused global changes in cell-cycle related functions. Additionally, comparative gene expression analyses between our hPNPase(old-35) knockdown and overexpression datasets allowed us to identify 77 potential "direct" and 61 potential "indirect" targets of hPNPaseo(ld-35) which formed correlated networks enriched for cell-cycle and wound healing functional association, respectively. These results provide a comprehensive database of genes responsive to hPNPase(old-35) expression levels; along with the identification new potential candidate genes offering fresh insight into cellular pathways regulated by PNPT1 and which may be used in the future for possible therapeutic intervention in mitochondrial-or inflammation-associated disease phenotypes.	[Sokhi, Upneet K.; Bacolod, Manny D.; Dasgupta, Santanu; Emdad, Luni; Das, Swadesh K.; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Bacolod, Manny D.; Dasgupta, Santanu; Emdad, Luni; Das, Swadesh K.; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA USA; [Emdad, Luni; Miles, Michael F.; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Richmond, VA USA; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	pbfisher@vcu.edu	Miculescu, Florin/A-4524-2011; Dumur, Catherine/AAH-9489-2020; Duta, Liviu Marian/AAF-9375-2019; Duta, Liviu Marian/G-3417-2011	Miculescu, Florin/0000-0001-6757-5616; Duta, Liviu Marian/0000-0002-6408-6056; Duta, Liviu Marian/0000-0002-6408-6056; SOKHI, UPNEET/0000-0001-5907-5646; Bacolod, Manny/0000-0002-2085-4877	National Institutes of Health [R01 CA097318]; Samuel Waxman Cancer Research Foundation; VCU Massey Cancer Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; VCU Massey Cancer Center	The present study was supported in part by National Institutes of Health, NCI grant R01 CA097318, the Samuel Waxman Cancer Research Foundation and the VCU Massey Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BALABAN G, 1984, CANCER GENET CYTOGEN, V11, P429, DOI 10.1016/0165-4608(84)90024-4; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Chan I, 2008, J CELL PHYSIOL, V215, P401, DOI 10.1002/jcp.21320; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Das SK, 2011, ONCOGENE, V30, P1733, DOI 10.1038/onc.2010.572; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; Deutscher MP, 2001, PROG NUCLEIC ACID RE, V66, P67; DEUTSCHER MP, 1993, J BIOL CHEM, V268, P13011; Dumur CI, 2009, LARYNGOSCOPE, V119, P91, DOI 10.1002/lary.20005; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; FISHER PB, 1985, J INTERFERON RES, V5, P11, DOI 10.1089/jir.1985.5.11; Gatta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015965; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; HERLYN M, 1985, CANCER RES, V45, P5670; HUBERMAN E, 1979, CANCER RES, V39, P2618; Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; JIANG HP, 1995, ONCOGENE, V10, P1855; Leszczyniecka M, 2003, GENE, V316, P143, DOI 10.1016/S0378-1119(03)00752-2; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Oliveros JC, 2007, VENNY INTERACTIVE TO; Rahmanzadeh R, 2007, CELL PROLIFERAT, V40, P422, DOI 10.1111/j.1365-2184.2007.00433.x; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Redmond LC, 2008, DEV DYNAM, V237, P436, DOI 10.1002/dvdy.21426; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; Sarkar D, 2004, CANCER RES, V64, P7473, DOI 10.1158/0008-5472.CAN-04-1772; Sarkar D, 2006, CELL DEATH DIFFER, V13, P1541, DOI 10.1038/sj.cdd.4401829; Sarkar D, 2003, J BIOL CHEM, V278, P24542, DOI 10.1074/jbc.M302421200; Sarkar D, 2007, CANCER RES, V67, P7948, DOI 10.1158/0008-5472.CAN-07-0872; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Sarkar D, 2006, CELL CYCLE, V5, P1080, DOI 10.4161/cc.5.10.2741; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Sokhi UK, 2013, ADV CANC RE IN PRESS, P119; Staudt MR, 2009, J CELL PHYSIOL, V218, P304, DOI 10.1002/jcp.21602; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Van Maerken T, 2009, J CELL PHYSIOL, V219, P707, DOI 10.1002/jcp.21719; Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001; Wang G., 2011, BIOCHIM BIOPHYS ACTA, V1819, P998; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077	58	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76284	10.1371/journal.pone.0076284	http://dx.doi.org/10.1371/journal.pone.0076284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143183	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100018
J	Togao, O; Kessinger, CW; Huang, G; Soesbe, TC; Sagiyama, K; Dimitrov, I; Sherry, AD; Gao, JM; Takahashi, M				Togao, Osamu; Kessinger, Chase W.; Huang, Gang; Soesbe, Todd C.; Sagiyama, Koji; Dimitrov, Ivan; Sherry, A. Dean; Gao, Jinming; Takahashi, Masaya			Characterization of Lung Cancer by Amide Proton Transfer (APT) Imaging: An In-Vivo Study in an Orthotopic Mouse Model	PLOS ONE			English	Article							HUMAN BRAIN-TUMORS; MAGNETIZATION-TRANSFER; SCREENING EXPERIENCE; COMPUTED-TOMOGRAPHY; PULMONARY NODULES; WATER SATURATION; CHEST CT; RESONANCE; EXCHANGE; MRI	Amide proton transfer (APT) imaging is one of the chemical exchange saturation transfer (CEST) imaging methods which images the exchange between protons of free tissue water and the amide groups (-NH) of endogenous mobile proteins and peptides. Previous work suggested the ability of APT imaging for characterization of the tumoral grade in the brain tumor. In this study, we tested the feasibility of in-vivo APT imaging of lung tumor and investigated whether the method could differentiate the tumoral types on orthotopic tumor xenografts from two malignant lung cancer cell lines. The results revealed that APT imaging is feasible to quantify lung tumors in the moving lung. The measured APT effect was higher in the tumor which exhibited more active proliferation than the other. The present study demonstrates that APT imaging has the potential to provide a characterization test to differentiate types or grade of lung cancer noninvasively, which may eventually reduce the need invasive needle biopsy or resection for lung cancer.	[Togao, Osamu; Soesbe, Todd C.; Sagiyama, Koji; Dimitrov, Ivan; Sherry, A. Dean; Takahashi, Masaya] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Adv Imaging Res Ctr, Dallas, TX 75235 USA; [Kessinger, Chase W.; Huang, Gang; Gao, Jinming] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, M (corresponding author), UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Adv Imaging Res Ctr, Dallas, TX 75235 USA.	masaya.takahashi@utsouthwestern.edu	Togao, Osamu/AAE-4702-2022; Sherry, Dean/P-2348-2018	Sagiyama, Koji/0000-0001-7253-0703; Sherry, Dean/0000-0001-7150-8301	Cancer Prevention & Research Institution of Texas [RP101243-P04]; National Institutes of Health [RO1CA129011]; NATIONAL CANCER INSTITUTE [R01CA129011, R01CA115531] Funding Source: NIH RePORTER	Cancer Prevention & Research Institution of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Cancer Prevention & Research Institution of Texas (RP101243-P04) and the National Institutes of Health (RO1CA129011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco E, 2010, CANCER RES, V70, P3896, DOI 10.1158/0008-5472.CAN-09-3995; Diederich S, 2000, CANCER, V89, P2483, DOI 10.1002/1097-0142(20001201)89:11+<2483::AID-CNCR27>3.0.CO;2-1; Dimitrov I., 2012, P 20 ANN M EXH INT S; Hansell DM, 1999, CLIN CHEST MED, V20, P739, DOI 10.1016/S0272-5231(05)70253-7; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Imbalzano KM, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-7; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Kangasniemi K, 2012, P 20 ANN M EXH INT S; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Kino A, 2007, EUR J RADIOL, V64, P397, DOI 10.1016/j.ejrad.2007.08.014; Kiryu S, 2006, MAGN RESON IMAGING, V24, P1325, DOI 10.1016/j.mri.2006.08.009; Kubo S, 2006, MAGN RESON MED, V56, P698, DOI 10.1002/mrm.21006; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Lindell RM, 2009, CHEST, V136, P1586, DOI 10.1378/chest.09-0915; Lindell RM, 2005, AM J ROENTGENOL, V185, P126, DOI 10.2214/ajr.185.1.01850126; Madero-Visbal RA, 2010, SURG ONCOL; Mani T, 2009, CONTRAST MEDIA MOL I, V4, P183, DOI 10.1002/cmmi.279; Matsuoka S, 2008, MAGN RESON IMAGING C, V16, P275, DOI 10.1016/j.mric.2008.03.006; Pastorino U, 2010, BRIT J CANCER, V102, P1681, DOI 10.1038/sj.bjc.6605660; Pekar J, 1996, MAGNET RESON MED, V35, P70, DOI 10.1002/mrm.1910350110; Ren JM, 2008, MAGN RESON MED, V60, P1047, DOI 10.1002/mrm.21722; Revel MP, 2004, RADIOLOGY, V231, P453, DOI 10.1148/radiol.2312030167; Salhotra A, 2008, NMR BIOMED, V21, P489, DOI 10.1002/nbm.1216; Scheidegger R, 2011, MAGN RESON MED, V66, P1275, DOI 10.1002/mrm.22912; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Soesbe TC, 2012, MAGN RESON MED, V68, P816, DOI 10.1002/mrm.23302; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Takahashi M, 2007, EUR J RADIOL, V64, P367, DOI 10.1016/j.ejrad.2007.08.011; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Togao O, 2010, MAGN RESON MED, V64, P1491, DOI 10.1002/mrm.22521; van Zijl PCM, 2003, MAGNET RESON MED, V49, P440, DOI 10.1002/mrm.10398; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; Varma G, 2012, MAGN RESON MED, V68, P1228, DOI 10.1002/mrm.23310; Zhao XN, 2013, MOL IMAGING BIOL, V15, P114, DOI 10.1007/s11307-012-0563-1; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	41	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77019	10.1371/journal.pone.0077019	http://dx.doi.org/10.1371/journal.pone.0077019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143199	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100034
J	Chen, JF; Marks, E; Lai, B; Zhang, ZJ; Duce, JA; Lam, LQ; Volitakis, I; Bush, AI; Hersch, S; Fox, JH				Chen, Jianfang; Marks, Eileen; Lai, Barry; Zhang, Zhaojie; Duce, James A.; Lam, Linh Q.; Volitakis, Irene; Bush, Ashley I.; Hersch, Steven; Fox, Jonathan H.			Iron Accumulates in Huntington's Disease Neurons: Protection by Deferoxamine	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; OXIDATIVE STRESS; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; IN-VIVO; BRAIN; MICROGLIA; FERRITIN; ALPHA; HOMEOSTASIS	Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a polyglutamine-encoding CAG expansion in the huntingtin gene. Iron accumulates in the brains of HD patients and mouse disease models. However, the cellular and subcellular sites of iron accumulation, as well as significance to disease progression are not well understood. We used independent approaches to investigate the location of brain iron accumulation. In R6/2 HD mouse brain, synchotron x-ray fluorescence analysis revealed iron accumulation as discrete puncta in the perinuclear cytoplasm of striatal neurons. Further, perfusion Turnbull's staining for ferrous iron (II) combined with transmission electron microscope ultra-structural analysis revealed increased staining in membrane bound perinuclear vesicles in R6/2 HD striatal neurons. Analysis of iron homeostatic proteins in R6/2 HD mice revealed decreased levels of the iron response proteins (IRPs 1 and 2) and accordingly decreased expression of iron uptake transferrin receptor (TfR) and increased levels of neuronal iron export protein ferroportin (FPN). Finally, we show that intra-ventricular delivery of the iron chelator deferoxamine results in an improvement of the motor phenotype in R6/2 HD mice. Our data supports accumulation of redox-active ferrous iron in the endocytic / lysosomal compartment in mouse HD neurons. Expression changes of IRPs, TfR and FPN are consistent with a compensatory response to an increased intra-neuronal labile iron pool leading to increased susceptibility to iron-associated oxidative stress. These findings, together with protection by deferoxamine, support a potentiating role of neuronal iron accumulation in HD.	[Chen, Jianfang; Marks, Eileen; Fox, Jonathan H.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Chen, Jianfang; Marks, Eileen; Fox, Jonathan H.] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Lai, Barry] Argonne Natl Lab, Lemont, IL USA; [Zhang, Zhaojie] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Duce, James A.; Lam, Linh Q.; Volitakis, Irene; Bush, Ashley I.] Mental Hlth Res Inst, Melbourne, Vic, Australia; [Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Hersch, Steven] MassGen Inst Neurodegenerat Dis, Charlestown, MA USA	University of Wyoming; University of Wyoming; United States Department of Energy (DOE); Argonne National Laboratory; University of Wyoming; University of Leeds	Fox, JH (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA.	jfox7@uwyo.edu	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Duce, James/0000-0002-8762-2245; Volitakis, Irene/0000-0003-0766-817X	National Institutes of Health; Huntington's Disease Society of America; National Center for Research Resources from the National Institutes of Health [5P30RR032128-02]; National Institute of General Medical Sciences from the National Institutes of Health [8 P30GM103398-02]; National Institute of Neurological Disorders and Stroke from the National Institutes of Health [RO1NS079450]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America; National Center for Research Resources from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Institute of Neurological Disorders and Stroke from the National Institutes of Health; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health and by the Huntington's Disease Society of America, the National Center for Research Resources (5P30RR032128-02), the National Institute of General Medical Sciences (8 P30GM103398-02) and National Institute of Neurological Disorders and Stroke (RO1NS079450) from the National Institutes of Health. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Ayton S, 2013, ANN NEUROL; BROWNE SE, 1994, BIOCHEM SOC T, V22, P1002, DOI 10.1042/bst0221002; Cherny RA, HUNTINGTONS DIS, V1, P211; Cheville N., 2009, ULTRASTRUCTURAL PATH; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dumas EM, 2012, NEUROIMAGE, V61, P558, DOI 10.1016/j.neuroimage.2012.03.056; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Grundy MA, 2004, J BIOCHEM BIOPH METH, V59, P195, DOI 10.1016/j.jbbm.2004.01.001; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040813; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kuehnel W., 2003, COLOR ATLAS CYTOLOGY; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lippard J.M.B.S.J., 1994, PRINCIPLES BIOINORGA; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; McColl G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032685; Meguro R, 2008, ARCH HISTOL CYTOL, V71, P205, DOI 10.1679/aohc.71.205; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Paunesku T, 2006, J CELL BIOCHEM, V99, P1489, DOI 10.1002/jcb.21047; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Rathore KI, 2012, GLIA, V60, P738, DOI 10.1002/glia.22303; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rosas HD, 2012, ARCH NEUROL-CHICAGO; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369	59	79	83	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77023	10.1371/journal.pone.0077023	http://dx.doi.org/10.1371/journal.pone.0077023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146952	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400095
J	Geiling, B; Vandal, G; Posner, AR; de Bruyns, A; Dutchak, KL; Garnett, S; Dankort, D				Geiling, Benjamin; Vandal, Guillaume; Posner, Ada R.; de Bruyns, Angeline; Dutchak, Kendall L.; Garnett, Samantha; Dankort, David			A Modular Lentiviral and Retroviral Construction System to Rapidly Generate Vectors for Gene Expression and Gene Knockdown In Vitro and In Vivo	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; RNA INTERFERENCE; TUMOR SUPPRESSION; MESSENGER-RNA; PROTEIN; CELLS; VIRUS; P53; DELIVERY; MOUSE	The ability to express exogenous cDNAs while suppressing endogenous genes via RNAi represents an extremely powerful research tool with the most efficient non-transient approach being accomplished through stable viral vector integration. Unfortunately, since traditional restriction enzyme based methods for constructing such vectors are sequence dependent, their construction is often difficult and not amenable to mass production. Here we describe a non-sequence dependent Gateway recombination cloning system for the rapid production of novel lentiviral (pLEG) and retroviral (pREG) vectors. Using this system to recombine 3 or 4 modular plasmid components it is possible to generate viral vectors expressing cDNAs with or without inhibitory RNAs (shRNAmirs). In addition, we demonstrate a method to rapidly produce and triage novel shRNAmirs for use with this system. Once strong candidate shRNAmirs have been identified they may be linked together in tandem to knockdown expression of multiple targets simultaneously or to improve the knockdown of a single target. Here we demonstrate that these recombinant vectors are able to express cDNA and effectively knockdown protein expression using both cell culture and animal model systems.	[Geiling, Benjamin; Vandal, Guillaume; Posner, Ada R.; de Bruyns, Angeline; Dutchak, Kendall L.; Garnett, Samantha; Dankort, David] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Dankort, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	david.dankort@mcgill.ca		Dankort, David/0000-0002-5862-6829	Canadian Institutes of Health Research [MOP-97925]; Melanoma Research Alliance; Canadian Cancer Society [CCSRI] [2011-700876]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Melanoma Research Alliance; Canadian Cancer Society [CCSRI]	This work was supported by the Canadian Institutes of Health Research [operating grant MOP-97925 to DD, Graduate scholarship to GV]; the Melanoma Research Alliance [New Investigator Award]; and the Canadian Cancer Society [CCSRI# 2011-700876]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Audouy S, 2001, MOL MEMBR BIOL, V18, P129, DOI 10.1080/713816122; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bitzer M, 2003, J GENE MED, V5, P543, DOI 10.1002/jgm.426; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Johnson LG, 2003, HUM GENE THER, V14, P729, DOI 10.1089/104303403765255138; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Kesireddy V, 2010, MOL BIOL REP, V37, P2863, DOI 10.1007/s11033-009-9840-8; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kovesdi I, 1997, CURR OPIN BIOTECH, V8, P583, DOI 10.1016/S0958-1669(97)80033-X; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NASH HA, 1980, COLD SPRING HARB SYM, V45, P417, DOI 10.1101/SQB.1981.045.01.056; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Rashtchian Ayoub, 1995, Current Opinion in Biotechnology, V6, P30, DOI 10.1016/0958-1669(95)80006-9; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; SHUMAN S, 1994, J BIOL CHEM, V269, P32678; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Stauffer Y, 1998, J MOL BIOL, V283, P529, DOI 10.1006/jmbi.1998.2113; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Wong SP, 2009, CURR OPIN MOL THER, V11, P433; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	86	13	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76279	10.1371/journal.pone.0076279	http://dx.doi.org/10.1371/journal.pone.0076279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146852	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400051
J	Pena, JM; Torres-Sanchez, J; de Castro, AI; Kelly, M; Lopez-Granados, F				Manuel Pena, Jose; Torres-Sanchez, Jorge; Isabel de Castro, Ana; Kelly, Maggi; Lopez-Granados, Francisca			Weed Mapping in Early-Season Maize Fields Using Object-Based Analysis of Unmanned Aerial Vehicle (UAV) Images	PLOS ONE			English	Article							PRECISION AGRICULTURE; DIGITAL IMAGES; MANAGEMENT; IDENTIFICATION; ACQUISITION; PATCHES; SYSTEM	The use of remote imagery captured by unmanned aerial vehicles (UAV) has tremendous potential for designing detailed site-specific weed control treatments in early post-emergence, which have not possible previously with conventional airborne or satellite images. A robust and entirely automatic object-based image analysis (OBIA) procedure was developed on a series of UAV images using a six-band multispectral camera (visible and near-infrared range) with the ultimate objective of generating a weed map in an experimental maize field in Spain. The OBIA procedure combines several contextual, hierarchical and object-based features and consists of three consecutive phases: 1) classification of crop rows by application of a dynamic and auto-adaptive classification approach, 2) discrimination of crops and weeds on the basis of their relative positions with reference to the crop rows, and 3) generation of a weed infestation map in a grid structure. The estimation of weed coverage from the image analysis yielded satisfactory results. The relationship of estimated versus observed weed densities had a coefficient of determination of r(2)=0.89 and a root mean square error of 0.02. A map of three categories of weed coverage was produced with 86% of overall accuracy. In the experimental field, the area free of weeds was 23%, and the area with low weed coverage (<5% weeds) was 47%, which indicated a high potential for reducing herbicide application or other weed operations. The OBIA procedure computes multiple data and statistics derived from the classification outputs, which permits calculation of herbicide requirements and estimation of the overall cost of weed management operations in advance.	[Manuel Pena, Jose; Torres-Sanchez, Jorge; Isabel de Castro, Ana; Lopez-Granados, Francisca] CSIC, IAS, Dept Crop Protect, Cordoba, Spain; [Kelly, Maggi] Univ Calif Berkeley, Environm Sci Policy & Management Dept, Berkeley, CA 94720 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); University of California System; University of California Berkeley	Pena, JM (corresponding author), CSIC, IAS, Dept Crop Protect, Cordoba, Spain.	jmpena@ias.csic.es	Peña, Jose M/K-4201-2014; Torres-Sánchez, Jorge/H-4714-2019; Lopez-Granados, Francisca/J-5617-2014; MA, Lei/I-4597-2014; De Castro Megías, Ana Isabel/K-7429-2017	Peña, Jose M/0000-0003-4592-3792; Torres-Sánchez, Jorge/0000-0003-1420-0145; Lopez-Granados, Francisca/0000-0001-9165-7558; De Castro Megías, Ana Isabel/0000-0002-6699-2204	European Union [245986]; Marie Curie Program [FP7-PEOPLE-2011-CIG-293991]; Spanish Ministry of Economy and Competition, FEDER Funds [AGL2011-30442-CO2-01]; JAEDoc Program; JAEPre Program; FPI Program; FEDER funds	European Union(European Commission); Marie Curie Program(European Commission); Spanish Ministry of Economy and Competition, FEDER Funds; JAEDoc Program; JAEPre Program; FPI Program; FEDER funds(European Commission)	This research was partly financed by the 7th Framework Programme of the European Union under the Grant Agreement No. 245986 (RHEA Project) and the Marie Curie Program (FP7-PEOPLE-2011-CIG-293991 project) and by the Spanish Ministry of Economy and Competition, FEDER Funds (AGL2011-30442-CO2-01 project). Research of Dr. Pena, Dr. de Castro and Mr. Torres-Sanchez was financed by JAEDoc, JAEPre and FPI Programs, respectively. The stay of Dr. Pena at the University of California, Berkeley (USA) was financed by FEDER funds approved by the Consejer a de Economia, Innovacion y Ciencia de la Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Burgos-Artizzu XP, 2009, COMPUT ELECTRON AGR, V65, P176, DOI 10.1016/j.compag.2008.09.001; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Donald WW, 2006, WEED SCI, V54, P373; Fridgen JJ, 2004, AGRON J, V96, P100, DOI 10.2134/agronj2004.0100; Gibson KD, 2004, WEED TECHNOL, V18, P742, DOI 10.1614/WT-03-170R1; Goktogan AH, 2010, J INTELL ROBOT SYST, V57, P467, DOI 10.1007/s10846-009-9371-5; Gomez-Candon D, 2012, PRECIS AGRIC, V13, P322, DOI 10.1007/s11119-011-9249-y; Gomez-Candon D, 2012, PRECIS AGRIC, V13, P337, DOI 10.1007/s11119-011-9250-5; Heijting S, 2007, WEED RES, V47, P381, DOI 10.1111/j.1365-3180.2007.00580.x; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; de Castro AI, 2012, PRECIS AGRIC, V13, P302, DOI 10.1007/s11119-011-9247-0; Koger CH, 2003, WEED TECHNOL, V17, P696, DOI 10.1614/WT02-122; Laliberte AS, 2010, PHOTOGRAMM ENG REM S, V76, P661, DOI 10.14358/PERS.76.6.661; Lopez-Granados F, 2011, WEED RES, V51, P1, DOI 10.1111/j.1365-3180.2010.00829.x; Pedersen SM, 2006, PRECIS AGRIC, V7, P295, DOI 10.1007/s11119-006-9014-9; Pena J.M., 2012, P 4 INT C GEOGR OBJ, P426; Pena-Barragan JM, 2007, WEED RES, V47, P164, DOI 10.1111/j.1365-3180.2007.00553.x; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Romeo J, 2013, EXPERT SYST APPL, V40, P2275, DOI 10.1016/j.eswa.2012.10.033; Rouse J.W., 1973, NASA GODDARD SPACE F, P303, DOI DOI 10.1021/JF60203A024; Shaw DR, 2005, WEED SCI, V53, P264, DOI 10.1614/WS-04-072R1; Srinavasan A., 2006, HDB PRECISION AGR PR, V1st ed., P3, DOI [10.1300/5627_01, DOI 10.1300/5627_01]; Stafford JV, 2000, J AGR ENG RES, V76, P267, DOI 10.1006/jaer.2000.0577; Strobl J., 2000, ANGEW GEOGRAPHISCHE, P12; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; Williams J. C., 2011, Aspects of Applied Biology, P269; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5	29	252	266	14	233	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77151	10.1371/journal.pone.0077151	http://dx.doi.org/10.1371/journal.pone.0077151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146963	Green Published, gold			2022-12-25	WOS:000325819400100
J	Yu, X; Bi, YC; Han, ZZ; Law, SP				Yu, Xi; Bi, Yanchao; Han, Zaizhu; Law, Sam-Po			An fMRI Study of Grammatical Morpheme Processing Associated with Nouns and Verbs in Chinese	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; SENTENCE COMPREHENSION; FRONTAL-CORTEX; NAMING ACTIONS; BROCAS AREA; BRAIN; LANGUAGE; REPRESENTATIONS; CLASSIFIERS; COMPLEXITY	This study examined whether the degree of complexity of a grammatical component in a language would impact on its representation in the brain through identifying the neural correlates of grammatical morpheme processing associated with nouns and verbs in Chinese. In particular, the processing of Chinese nominal classifiers and verbal aspect markers were investigated in a sentence completion task and a grammaticality judgment task to look for converging evidence. The Chinese language constitutes a special case because it has no inflectional morphology per se and a larger classifier than aspect marker inventory, contrary to the pattern of greater verbal than nominal paradigmatic complexity in most European languages. The functional imaging results showed BA47 and left supplementary motor area and superior medial frontal gyrus more strongly activated for classifier processing, and the left posterior middle temporal gyrus more responsive to aspect marker processing. We attributed the activation in the left prefrontal cortex to greater processing complexity during classifier selection, analogous to the accounts put forth for European languages, and the left posterior middle temporal gyrus to more demanding verb semantic processing. The overall findings significantly contribute to cross-linguistic observations of neural substrates underlying processing of grammatical morphemes from an analytic and a classifier language, and thereby deepen our understanding of neurobiology of human language.	[Yu, Xi; Law, Sam-Po] Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China; [Bi, Yanchao; Han, Zaizhu] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Hong Kong; Beijing Normal University	Law, SP (corresponding author), Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China.	splaw@hku.hk		Yu, Xi/0000-0003-0818-1451	Research Grant Council of Hong Kong [HKU 746608H]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	study was supported by a General Research Fund from the Research Grant Council of Hong Kong (HKU 746608H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN K, 1977, LANGUAGE, V53, P285, DOI 10.2307/413103; BADECKER W, 1987, BRAIN LANG, V32, P278, DOI 10.1016/0093-934X(87)90129-5; Berlingeri M, 2008, COGN NEUROPSYCHOL, V25, P528, DOI 10.1080/02643290701674943; Bi YC, 2010, COGNITION, V116, P101, DOI 10.1016/j.cognition.2010.04.004; Bick A, 2008, J COGNITIVE NEUROSCI, V20, P406, DOI 10.1162/jocn.2008.20.3.406; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bozic M, 2010, LANG LINGUIST COMPAS, V4, P1063, DOI 10.1111/j.1749-818x.2010.00254.x; Cappelletti M, 2008, J COGNITIVE NEUROSCI, V20, P707, DOI 10.1162/jocn.2008.20045; Chan AHD, 2008, ANN NY ACAD SCI, V1145, P30, DOI 10.1196/annals.1416.000; Chao Y.R., 1979, GRAMMAR SPOKEN CHINE; Chien YC, 2003, J EAST ASIAN LINGUIS, V12, P91, DOI 10.1023/A:1022401006521; Chou TL, 2006, HUM BRAIN MAPP, V27, P915, DOI 10.1002/hbm.20231; Chou TL, 2012, NEUROPSYCHOLOGIA, V50, P1408, DOI 10.1016/j.neuropsychologia.2012.02.025; Chou TL, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.027.2009; Chou TL, 2009, EXP BRAIN RES, V198, P465, DOI 10.1007/s00221-009-1942-y; Chou TL, 2006, NEUROIMAGE, V29, P1141, DOI 10.1016/j.neuroimage.2005.09.064; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Cooke A, 2002, HUM BRAIN MAPP, V15, P80, DOI 10.1002/hbm.10006; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; Davis MH, 2004, BRAIN LANG, V89, P439, DOI 10.1016/S0093-934X(03)00471-1; DEMB JB, 1995, J NEUROSCI, V15, P5870; Deng Y, 2008, NEUROPSYCHOLOGIA, V46, P1864, DOI 10.1016/j.neuropsychologia.2007.09.010; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gao MY, 2009, LANG COGNITIVE PROC, V24, P1124, DOI 10.1080/01690960802018323; Grindrod CM, 2008, BRAIN RES, V1229, P167, DOI 10.1016/j.brainres.2008.07.017; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Han ZH, 2010, SECOND LANG ACQUIS, P1; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Hong Z, 2007, J EAST ASIAN LINGUIS, V16, P43, DOI 10.1007/s10831-006-9006-9; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Killingley S.-Y., 1983, CANTONESE CLASSIFIER; Li CharlesN., 1981, MANDARIN CHINESE FUN; Li P, 2004, NEUROIMAGE, V21, P1533, DOI 10.1016/j.neuroimage.2003.10.044; Li P, 2010, J EAST ASIAN LINGUIS, V19, P207, DOI 10.1007/s10831-010-9060-1; Liljestrom M, 2008, NEUROIMAGE, V41, P1132, DOI 10.1016/j.neuroimage.2008.03.016; Liu CL, 2006, NEUROREPORT, V17, P1397, DOI 10.1097/01.wnr.0000233090.00463.35; Longe O, 2007, CEREB CORTEX, V17, P1812, DOI 10.1093/cercor/bhl099; Makuuchi M, 2009, P NATL ACAD SCI USA, V106, P8362, DOI 10.1073/pnas.0810928106; Marangolo P, 2006, CORTEX, V42, P1093, DOI 10.1016/S0010-9452(08)70221-1; Marslen-Wilson W, 1998, TRENDS COGN SCI, V2, P428, DOI 10.1016/S1364-6613(98)01239-X; Meinzer M, 2009, NEUROPSYCHOLOGIA, V47, P1964, DOI 10.1016/j.neuropsychologia.2009.03.008; MICELI G, 1988, BRAIN LANG, V35, P24, DOI 10.1016/0093-934X(88)90100-9; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palti D, 2007, HUM BRAIN MAPP, V28, P303, DOI 10.1002/hbm.20280; Righi G, 2010, J COGNITIVE NEUROSCI, V22, P213, DOI 10.1162/jocn.2009.21200; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Roskies AL, 2001, J COGNITIVE NEUROSCI, V13, P829, DOI 10.1162/08989290152541485; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Sahin NT, 2006, CORTEX, V42, P540, DOI 10.1016/S0010-9452(08)70394-0; Shapiro K, 2003, NEUROPSYCHOLOGIA, V41, P1189, DOI 10.1016/S0028-3932(03)00037-X; Shapiro K, 2000, COGNITIVE NEUROPSYCH, V17, P665, DOI 10.1080/026432900750038281; Shapiro KA, 2005, NEUROIMAGE, V24, P1058, DOI 10.1016/j.neuroimage.2004.10.015; Shapiro KA, 2006, P NATL ACAD SCI USA, V103, P1644, DOI 10.1073/pnas.0504142103; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Shapiro KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00026; Siri S, 2008, CEREB CORTEX, V18, P171, DOI 10.1093/cercor/bhm043; Slobin D. I., 1985, CROSSLINGUISTIC STUD, V2; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tranel D, 2005, BRAIN LANG, V92, P288, DOI 10.1016/j.bandl.2004.01.011; Tsapkini K, 2002, J NEUROLINGUIST, V15, P265, DOI 10.1016/S0911-6044(01)00039-2; Tyler LK, 2008, J COGNITIVE NEUROSCI, V20, P1381, DOI 10.1162/jocn.2008.20095; Tyler LK, 2008, PHILOS T R SOC B, V363, P1037, DOI 10.1098/rstb.2007.2158; TZENG OJL, 1991, BRAIN LANG, V41, P184, DOI 10.1016/0093-934X(91)90152-Q; Vannest J, 2005, COGN AFFECT BEHAV NE, V5, P67, DOI 10.3758/CABN.5.1.67; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; WANG WSY, 1973, SCI AM, V228, P50, DOI 10.1038/scientificamerican0273-50; Wilson SM, 2004, J COGNITIVE NEUROSCI, V16, P238, DOI 10.1162/089892904322984535; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Yang J, 2011, J NEUROLINGUIST, V24, P674, DOI 10.1016/j.jneuroling.2011.07.002; Yu X, 2012, BRAIN LANG, V122, P126, DOI 10.1016/j.bandl.2012.05.002; Yu X, 2011, NEUROIMAGE, V58, P912, DOI 10.1016/j.neuroimage.2011.06.039; Zhang JX, 2004, NEUROIMAGE, V23, P975, DOI 10.1016/j.neuroimage.2004.07.008; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	80	7	7	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e74952	10.1371/journal.pone.0074952	http://dx.doi.org/10.1371/journal.pone.0074952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	236SL	24146745	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400004
J	Elster, JD; McGuire, TF; Lu, J; Prochownik, EV				Elster, Jennifer D.; McGuire, Terence F.; Lu, Jie; Prochownik, Edward V.			Rapid In Vitro Derivation of Endothelium Directly From Human Cancer Cells	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; PROGENITOR CELLS; BREAST-CANCER; GROWTH-FACTOR; BEVACIZUMAB; EXPRESSION; MICROENVIRONMENT	The development of an independent blood supply by a tumor is essential for maintaining growth beyond a certain limited size and for providing a portal for metastatic dissemination. Host-derived endothelial cells (ECs) residing in and compromising the tumor vasculature originate via distinct processes known as sprouting angiogenesis and vasculogenesis. More recently ECs originating directly from the tumor cells themselves have been described although the basis for this phenomenon remains poorly understood. Here we describe in vitro conditions that allow lung and ovarian cancer cells to undergo a rapid and efficient transition into ECs that are indistinguishable from those obtained in vivo. A variety of methods were used to establish that the acquired phenotypes and behaviors of these tumor-derived ECs (TDECs) closely resemble those of authentic ECs. Xenografts arising from co-inoculated in vitro-derived TDECs and tumor cells were also more highly vascularized than control tumors; moreover, their blood vessels were on average larger and frequently contained admixtures of host-derived ECs and TDECs derived from the initial inoculum. These results demonstrate that cancer cells can be manipulated under well-defined in vitro conditions to initiate a tumor cell-to-EC transition that is largely cell-autonomous, highly efficient and closely mimics the in vivo process. These studies provide a suitable means by which to identify and perhaps modify the earliest steps in TDEC generation.	[Elster, Jennifer D.; McGuire, Terence F.; Lu, Jie; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA.	procev@chp.edu			NIH [RO1 CA140624]; St. Baldrick's post-doctoral fellowship award; NATIONAL CANCER INSTITUTE [R01CA140624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's post-doctoral fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant RO1 CA140624 to E.V.P. and by a St. Baldrick's post-doctoral fellowship award to J.D.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Amini A, 2012, CURR CANCER DRUG TAR, V12, P23, DOI 10.2174/156800912798888956; Beaudry P, 2008, MOL CANCER THER, V7, P418, DOI 10.1158/1535-7163.MCT-07-0568; Birner P, 2003, BRAIN PATHOL, V13, P133, DOI 10.1111/j.1750-3639.2003.tb00013.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Folkman J, 2003, CANCER BIOL THER, V2, pS127; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Le Bourhis X, 2010, BREAST CANCER RES TR, V120, P17, DOI 10.1007/s10549-009-0686-5; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Mackey JR, 2012, CANCER TREAT REV, V38, P673, DOI 10.1016/j.ctrv.2011.12.002; McGuire TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037138; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Naumov GN, 2009, CLIN EXP METASTAS, V26, P51, DOI 10.1007/s10585-008-9176-0; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rigolin GM, 2006, BLOOD, V107, P2531, DOI 10.1182/blood-2005-04-1768; Rini BI, 2004, CLIN CANCER RES, V10, P2584, DOI 10.1158/1078-0432.CCR-03-0605; Sajithlal GB, 2010, INT J CANCER, V127, P2268, DOI 10.1002/ijc.25251; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77675	10.1371/journal.pone.0077675	http://dx.doi.org/10.1371/journal.pone.0077675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130897	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900142
J	Phipps, WL; Wolter, K; Michael, MD; MacTavish, LM; Yarnell, RW				Phipps, W. Louis; Wolter, Kerri; Michael, Michael D.; MacTavish, Lynne M.; Yarnell, Richard W.			Do Power Lines and Protected Areas Present a Catch-22 Situation for Cape Vultures (Gyps coprotheres)?	PLOS ONE			English	Article							LAND-USE; RANGING BEHAVIOR; BREEDING STATUS; WIND-FARMS; MORTALITY; FULVUS; AFRICANUS; POPULATION; DECLINE	Cape vulture Gyps coprotheres populations have declined across their range due to multiple anthropogenic threats. Their susceptibility to fatal collisions with the expanding power line network and the prevalence of carcasses contaminated with illegal poisons and other threats outside protected areas are thought to be the primary drivers of declines in southern Africa. We used GPS-GSM units to track the movements and delineate the home ranges of five adult (mean +/- SD minimum convex polygon area = 121,655 +/- 90,845 km(2)) and four immature (mean +/- SD minimum convex polygon area = 492,300 +/- 259,427 km(2)) Cape vultures to investigate the influence of power lines and their use of protected areas. The vultures travelled more than 1,000 km from the capture site and collectively entered five different countries in southern Africa. Their movement patterns and core foraging ranges were closely associated with the spatial distribution of transmission power lines and we present evidence that the construction of power lines has allowed the species to extend its range to areas previously devoid of suitable perches. The distribution of locations of known Cape vulture mortalities caused by interactions with power lines corresponded to the core ranges of the tracked vultures. Although some of the vultures regularly roosted at breeding colonies located inside protected areas the majority of foraging activity took place on unprotected farmland. Their ability to travel vast distances very quickly and the high proportion of time they spend in the vicinity of power lines and outside protected areas make Cape vultures especially vulnerable to negative interactions with the expanding power line network and the full range of threats across the region. Co-ordinated cross-border conservation strategies beyond the protected area network will therefore be necessary to ensure the future survival of threatened vultures in Africa.	[Phipps, W. Louis; Yarnell, Richard W.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England; [Wolter, Kerri] VulPro, Rietfontein, North West Prov, South Africa; [Michael, Michael D.] Eskom Holdings Ltd, Res Testing & Dev, Johannesburg, Gauteng Provinc, South Africa; [MacTavish, Lynne M.] Mankwe Wildlife Reserve, Mogwase, North West Prov, South Africa	Nottingham Trent University	Phipps, WL (corresponding author), Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England.	louis.phipps@ntu.ac.uk	Yarnell, Richard W/C-3531-2014; Phipps, Louis/I-2935-2019	Phipps, Louis/0000-0003-0400-2014; Yarnell, Richard/0000-0001-6584-7374	Mazda Wildlife; Rand Merchant Bank and Computer Facilities; Eskom Holdings Ltd through VulPro; Mankwe Wildlife Reserve; Leverhulme Trust; WLP; Nottingham Trent University	Mazda Wildlife; Rand Merchant Bank and Computer Facilities; Eskom Holdings Ltd through VulPro; Mankwe Wildlife Reserve; Leverhulme Trust(Leverhulme Trust); WLP; Nottingham Trent University	The Mazda Wildlife Fund provided KW and VulPro with a research vehicle. Rand Merchant Bank and Computer Facilities provided additional funding to VulPro. Eskom Holdings Ltd funded the tracking units through VulPro. Mankwe Wildlife Reserve provided additional funding for fieldwork. The Leverhulme Trust funded fieldwork and WLP with a Study Abroad Studentship. WLP received a Vice Chancellor's bursary from Nottingham Trent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. D., 2008, VULTURE NEWS, V57, P45; Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; Bamford AJ, 2009, IBIS, V151, P51, DOI 10.1111/j.1474-919X.2008.00878.x; Barrientos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032569; Benson PC, 2004, OSTRICH, V75, P118, DOI 10.2989/00306520409485423; BENSON PC, 1990, OSTRICH, V61, P134, DOI 10.1080/00306525.1990.9634162; Beyer H. L, 2012, GEOSPATIAL MODELLING; BirdLife International, 2012, IUCN 2012 IUCN RED L; BirdLife International, 2008, IUCN RED LIST THREAT; Borello WD, 2002, BIRD CONSERV INT, V12, P79, DOI 10.1017/S0959270902002058; Bose M, 2007, ORYX, V41, P503, DOI 10.1017/S0030605307000312; Boshoff AF, 2011, BIRD CONSERV INT, V21, P311, DOI 10.1017/S095927091100013X; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Diekmann M., 2004, VULTURE NEWS, V51, P34; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Duriez O, 2012, BIRD STUDY, V59, P193, DOI 10.1080/00063657.2012.658640; Duriez Olivier, 2011, Ringing & Migration, V26, P24; Eskom-EWT, 2012, CENTR INC REG HELD C; ESRI, 2008, ARCMAP 8 3; Garcia-Fernandez AJ, 2005, ENVIRON TOXICOL, V20, P459, DOI 10.1002/tox.20132; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Guil F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028212; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Herremans M, 2000, BIOL CONSERV, V94, P31, DOI 10.1016/S0006-3207(99)00166-4; HOUSTON DC, 1974, J ZOOL, V172, P35; *IUCN, 2003, WORLD DAT PROT AR; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Janss GFE, 2000, BIOL CONSERV, V95, P353, DOI 10.1016/S0006-3207(00)00021-5; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Kendall CJ, 2012, J RAPTOR RES, V46, P135, DOI 10.3356/JRR-10-87.1; Kruger R, 2001, AVIAN INTERACTIONS U, P229; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2012, SCIENCE, V338, P192, DOI 10.1126/science.338.6104.192-a; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; MERETSKY VJ, 1992, CONDOR, V94, P313, DOI 10.2307/1369205; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Mundy P., 1992, VULTURES AFRICA; Mundy P.J., 1997, ATLAS SO AFRICAN BIR, V1, P158; Murn C, 2008, OSTRICH, V79, P191, DOI 10.2989/OSTRICH.2008.79.2.9.583; Naidoo V, 2011, J S AFR VET ASSOC, V82, P24; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Phipps WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052813; Rodgers A.R., 2007, HOME RANGE TOOLS HRT; Shaw JM, 2010, IBIS, V152, P590, DOI 10.1111/j.1474-919X.2010.01039.x; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Thiollay JM, 2006, BIRD CONSERV INT, V16, P353, DOI 10.1017/S0959270906000487; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Whittington-Jones C, 2011, VULTURE NEWS, V60, P6; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	62	20	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76794	10.1371/journal.pone.0076794	http://dx.doi.org/10.1371/journal.pone.0076794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24137496	gold, Green Published			2022-12-25	WOS:000325810900084
J	De, A; De, A; Papasian, C; Hentges, S; Banerjee, S; Haque, I; Banerjee, SK				De, Alok; De, Archana; Papasian, Chris; Hentges, Shane; Banerjee, Snigdha; Haque, Inamul; Banerjee, Sushanta K.			Emblica officinalis Extract Induces Autophagy and Inhibits Human Ovarian Cancer Cell Proliferation, Angiogenesis, Growth of Mouse Xenograft Tumors	PLOS ONE			English	Article							BETA-ENDORPHIN RELEASE; HYPOTHALAMIC NEURONS; UP-REGULATION; IN-VITRO; APOPTOSIS; HYPOXIA; EXPRESSION; INDUCTION; BCL-2; MODULATION	Patients with ovarian cancer (OC) may be treated with surgery, chemotherapy and/or radiation therapy, although none of these strategies are very effective. Several plant-based natural products/dietary supplements, including extracts from Emblica officinalis (Amla), have demonstrated potent anti-neoplastic properties. In this study we determined that Amla extract (AE) has anti-proliferative effects on OC cells under both in vitro and in vivo conditions. We also determined the anti-proliferative effects one of the components of AE, quercetin, on OC cells under in vitro conditions. AE did not induce apoptotic cell death, but did significantly increase the expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions. Quercetin also increased the expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions. AE also significantly reduced the expression of several angiogenic genes, including hypoxia-inducible factor 1 alpha (HIF-1 alpha) in OVCAR3 cells. AE acted synergistically with cisplatin to reduce cell proliferation and increase expression of the autophagic proteins beclin1 and LC3B-II under in vitro conditions. AE also had anti-proliferative effects and induced the expression of the autophagic proteins beclin1 and LC3B-II in mouse xenograft tumors. Additionally, AE reduced endothelial cell antigen - CD31 positive blood vessels and HIF-1 alpha expression in mouse xenograft tumors. Together, these studies indicate that AE inhibits OC cell growth both in vitro and in vivo possibly via inhibition of angiogenesis and activation of autophagy in OC. Thus AE may prove useful as an alternative or adjunct therapeutic approach in helping to fight OC.	[De, Alok] Univ Missouri, Sch Med, Dept OB GYN, Kansas City, MO 64108 USA; [De, Archana; Banerjee, Snigdha; Haque, Inamul; Banerjee, Sushanta K.] VA Med Ctr, Canc Res Unit, Kansas City, MO USA; [Papasian, Chris] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Hentges, Shane] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Banerjee, Snigdha; Haque, Inamul; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Med, Div Hematol & Oncol, Kansas City, KS 66103 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Colorado State University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	De, A (corresponding author), Univ Missouri, Sch Med, Dept OB GYN, Kansas City, MO 64108 USA.	dea@umkc.edu	Haque, Inamul/I-2482-2019; Hentges, Shane T/B-9747-2012	Haque, Inamul/0000-0002-1307-9446; Banerjee, Sushanta/0000-0002-7698-0717	UMKC; VA Merit Award Grant	UMKC; VA Merit Award Grant(US Department of Veterans Affairs)	This study was supported by a UMKC intramural fund and a VA Merit Award Grant (SKB, SB). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish or participation of the manuscript.	Baliga MS, 2011, EUR J CANCER PREV, V20, P225, DOI 10.1097/CEJ.0b013e32834473f4; Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; *BOARD, 2011, SURV RAT OV CANC; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chopra RN, 1958, INDIGENOUS DRUGS IND; Conte C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003078; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DE A, 1994, J BIOL CHEM, V269, P26697; De A, 2002, ALCOHOL CLIN EXP RES, V26, P1420, DOI 10.1097/01.ALC.0000030621.35354.E0; De A, 1999, ALCOHOL CLIN EXP RES, V23, P850, DOI 10.1097/00000374-199905000-00013; De A, 2002, J PHARMACOL EXP THER, V301, P119, DOI 10.1124/jpet.301.1.119; DE A, 1995, INT J ONCOL, V7, P643; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Folkman J, 1974, Adv Cancer Res, V19, P331, DOI 10.1016/S0065-230X(08)60058-5; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Haddad JJ, 2002, EUR CYTOKINE NETW, V13, P250; HAWKINS CJ, 1994, IMMUNOL REV, V142, P127, DOI 10.1111/j.1600-065X.1994.tb00886.x; Hirsch K, 2000, NUTR CANCER, V38, P245, DOI 10.1207/S15327914NC382_14; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Ishikawa K, 2010, INVEST OPHTH VIS SCI, V51, P4307, DOI 10.1167/iovs.09-4605; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jose JK, 2001, J ETHNOPHARMACOL, V75, P65, DOI 10.1016/S0378-8741(00)00378-0; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Liu WK, 2008, J NAT PROD, V71, P842, DOI 10.1021/np8001223; Lu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043934; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; NEWCOMB EW, 2009, HIF 1 REGULATION CHE; Ngamkitidechakul C, 2010, PHYTOTHER RES, V24, P1405, DOI 10.1002/ptr.3127; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Penolazzi L, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-59; PEVERALI FA, 1994, J CELL PHYSIOL, V161, P1, DOI 10.1002/jcp.1041610102; Plouzek CA, 1999, EUR J CANCER, V35, P1541, DOI 10.1016/S0959-8049(99)00180-X; Ricciardi A, 2008, MOL CANCER RES, V6, P175, DOI 10.1158/1541-7786.MCR-07-0391; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sen S, 2010, INT J PHARM SCI RES, V1, P32, DOI 10.13040/IJPSR.0975-8232.1(11).32-44; Shi YH, 2007, PATHOLOGY, V39, P396, DOI 10.1080/00313020701444549; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slager EH, 2006, BLOOD, V107, P4954, DOI 10.1182/blood-2005-09-3883; Tan ML, 2005, J ETHNOPHARMACOL, V96, P287, DOI 10.1016/j.jep.2004.09.025; TSUJIMOTO Y, 1989, ONCOGENE, V4, P1331; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang XM, 1997, J MED MICROBIOL, V46, P705, DOI 10.1099/00222615-46-8-705; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang Lan-zhen, 2003, Zhongguo Zhongyao Zazhi, V28, P940; Zhao Y, 1997, CANCER LETT, V121, P163, DOI 10.1016/S0304-3835(97)00348-0; Zhu YM, 2006, BRIT J CANCER, V94, P1936, DOI 10.1038/sj.bjc.6603177	58	50	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72748	10.1371/journal.pone.0072748	http://dx.doi.org/10.1371/journal.pone.0072748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24133573	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000112
J	Kim, HY; Yang, DH; Shin, SW; Kim, MY; Yoon, JH; Kim, S; Park, HC; Kang, DW; Min, D; Hur, MW; Choi, KY				Kim, Hyun-Yi; Yang, Dong-Hwa; Shin, Song-Weon; Kim, Mi-Yeon; Yoon, Jae-Hyun; Kim, Suhyun; Park, Hae-Chul; Kang, Dong Woo; Min, DoSik; Hur, Man-Wook; Choi, Kang-Yell			CXXC5 is a transcriptional activator of Flk-1 and mediates bone morphogenic protein-induced endothelial cell differentiation and vessel formation	FASEB JOURNAL			English	Article						HUVECs; mouse embryonic stem cells; caudal vein plex vessel formation	EMBRYONIC STEM-CELLS; SIGNAL-TRANSDUCTION; BINDING DOMAIN; VEGF; PATHWAY; ANGIOGENESIS; EXPRESSION; GENE; IDENTIFICATION; PROLIFERATION	CXXC5 is a member of a small subset of proteins containing CXXC-type zinc-finger domain. Here, we show that CXXC5 is a transcription factor activating Flk-1, a receptor for vascular endothelial growth factor. CXXC5 and Flk-1 were accmulated in nucli and membrane of mouse embryonic stem cells (mESCs), respectively, during their endothelial differentiation. CXXC5 overexpression induced Flk-1 transcription in both endothelium-differentiated mESCs and human umbilical vein endothelial cells (HUVECs). In vitro DNA binding assay showed direct interaction of CXXC5 on the Flk-1 promoter region, and mutation on its DNA-binding motif abolished transcriptional activity. We showed that bone morphorgeneic protein 4 (BMP4) induced CXXC5 transcription in the cells, and inhibitors of BMP signaling suppressed the CXXC5 induction and the consequent Flk-1 induction by BMP4 treatment. CXXC5 knockdown resulted in suppression of BMP4-induced stress fiber formation (56.8 +/- 1.3% decrease, P<0.05) and migration (54.6 +/- 1.9% decrease, P<0.05) in HUVECs. The in vivo roles of CXXC5 in BMP-signaling-specific vascular development and angiogenesis were shown by specific defect of caudal vein plex vessel formation (57.9 +/- 11.8% decrease, P<0.05) in cxxc5 morpholino-injected zebrafish embryos and by supression of BMP4-induced angigogensis in subcutaneously injected Matrigel plugs in CXXC5(-/-) mice. Overall, CXXC5 is a transcriptional activator for Flk-1, mediating BMP signaling for differentiation and migration of endothelial cell and vessel formation.Kim, H.-Y., Yang, D.-H., Shin, S.-W., Kim, M.-Y., Yoon, J.-H., Kim, S., Park, H.-C., Kang, D. W., Min, D., Hur, M.-W., Choi, K.-Y. CXXC5 is a transcriptional activator of Flk-1 and mediates bone morphogenic protein-induced endothelial cell differentiation and vessel formation.	[Kim, Hyun-Yi; Yang, Dong-Hwa; Shin, Song-Weon; Kim, Mi-Yeon; Kang, Dong Woo; Min, DoSik; Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Kim, Hyun-Yi; Yang, Dong-Hwa; Shin, Song-Weon; Kim, Mi-Yeon; Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Yoon, Jae-Hyun; Hur, Man-Wook] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 120749, South Korea; [Kim, Suhyun; Park, Hae-Chul] Korea Univ, Grad Sch Med, Ansan, South Korea; [Kang, Dong Woo; Min, DoSik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Pusan National University	Choi, KY (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea.	kychoi@yonsei.ac.kr		Kim, Suhyun/0000-0001-7425-1310; Hur, Man-Wook/0000-0002-3416-1334; Kim, Mi-Yeon/0000-0002-7929-865X	National Research Foundation (NRF); Ministry of Education, Science, and Technology (MEST) of Korea through the Translational Research Center for Protein Function Control [2010-00001919]; Midcareer Researcher Program [2012-010285]; Stem Cell Research Project [2010-0020235]; BK21 studentship from the NRF	National Research Foundation (NRF); Ministry of Education, Science, and Technology (MEST) of Korea through the Translational Research Center for Protein Function Control; Midcareer Researcher Program; Stem Cell Research Project; BK21 studentship from the NRF	This work was supported by grants from the National Research Foundation (NRF), funded by the Ministry of Education, Science, and Technology (MEST) of Korea through the Translational Research Center for Protein Function Control (2010-00001919), the Midcareer Researcher Program (2012-010285), and Stem Cell Research Project (2010-0020235); and S.W.S., H.Y.K., M.Y.K., and J.H.Y, were supported by a BK21 studentship from the NRF. The authors thank S. B. Lee for helpful discussions and for sharing unpublished work.	Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Bai H, 2010, J CELL BIOCHEM, V109, P363, DOI 10.1002/jcb.22410; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Chappell JC, 2011, SEMIN CELL DEV BIOL, V22, P1005, DOI 10.1016/j.semcdb.2011.10.006; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; He C, 2005, BIOCHEM BIOPH RES CO, V329, P324, DOI 10.1016/j.bbrc.2005.01.133; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Kim MS, 2010, J BIOL CHEM, V285, P14585, DOI 10.1074/jbc.M109.094334; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lee WJ, 2000, BIOCHEM J, V349, P821, DOI 10.1042/bj3490821; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moreno-Miralles I, 2009, CURR OPIN HEMATOL, V16, P195, DOI 10.1097/MOH.0b013e32832a07d6; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; PASSANITI A, 1992, LAB INVEST, V67, P519; Pendino F, 2009, BLOOD, V113, P3172, DOI 10.1182/blood-2008-07-170035; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yue W, 2010, STEM CELLS DEV, V19, P1937, DOI 10.1089/scd.2010.0096; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang M, 2009, SCI CHINA SER C, V52, P528, DOI 10.1007/s11427-009-0083-7	47	25	28	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					615	626		10.1096/fj.13-236216	http://dx.doi.org/10.1096/fj.13-236216			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24136587				2022-12-25	WOS:000331072200010
J	Matczuk, AK; Kunec, D; Veit, M				Matczuk, Anna Karolina; Kunec, Dusan; Veit, Michael			Co-translational Processing of Glycoprotein 3 from Equine Arteritis Virus N-GLYCOSYLATION ADJACENT TO THE SIGNAL PEPTIDE PREVENTS CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Glycosylation; Protein Translocation; Signal Peptidase; Virology; Arterivirus; Gp3; N-Glycosylation; Signal Peptide Cleavage	ENDOPLASMIC-RETICULUM; GP(3); COMPLEXES; SEQUENCE; ENCODES; CELLS; GP(4); YEAST; SITE	Signal peptide cleavage and N-glycosylation of proteins are co-translational processes, but little is known about their interplay if they compete for adjacent sites. Here we report two unique findings for processing of glycoprotein 3 of equine arteritis virus. Glycoprotein 3 (Gp3) contains an N-terminal signal peptide, which is not removed, although bioinformatics predicts cleavage with high probability. There is an overlapping sequon, NNTT, adjacent to the signal peptide that we show to be glycosylated at both asparagines. Exchanging the overlapping sequon and blocking glycosylation allows signal peptide cleavage, indicating that carbohydrate attachment inhibits processing of a potentially cleavable signal peptide. Bioinformatics analyses suggest that a similar processing scheme may exist for some cellular proteins. Membrane fractionation and secretion experiments revealed that the signal peptide of Gp3 does not act as a membrane anchor, indicating that it is completely translocated into the lumen of the endoplasmic reticulum. Membrane attachment is caused by the hydrophobic C terminus of Gp3, which, however, does not span the membrane but rather attaches the protein peripherally to endoplasmic reticulum membranes.	[Matczuk, Anna Karolina; Kunec, Dusan; Veit, Michael] Free Univ Berlin, Inst Virol, D-14163 Berlin, Germany	Free University of Berlin	Veit, M (corresponding author), Free Univ Berlin, Zentrum Infekt Med Robert von Ostertag Haus, Inst Virol, Fachbereich Vet Med, D-14163 Berlin, Germany.	mveit@zedat.fu-berlin.de		Veit, Michael/0000-0002-7638-1829; Matczuk, Anna/0000-0002-7282-6560; Kunec, Dusan/0000-0001-6697-7621	European Union (FP7, Initial Training network "Virus entry"); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER	European Union (FP7, Initial Training network "Virus entry"); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Union (FP7, Initial Training network "Virus entry").	Balasuriya U. B., 2013, VET MICROBIOL, DOI 10.1016/j.vetmic.2013.06.015; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; DEVRIES AAF, 1995, J VIROL, V69, P3441, DOI 10.1128/JVI.69.6.3441-3448.1995; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ernst AM, 2013, FEBS LETT, V587, P1411, DOI 10.1016/j.febslet.2013.03.019; Faaberg KS, 1997, VIROLOGY, V227, P245, DOI 10.1006/viro.1996.8310; GAROFF H, 1990, J CELL BIOL, V111, P867, DOI 10.1083/jcb.111.3.867; Hedges JF, 1999, VIROLOGY, V264, P92, DOI 10.1006/viro.1999.9982; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Karamyshev AL, 2005, J BIOL CHEM, V280, P40489, DOI 10.1074/jbc.M509168200; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Mardassi H, 1998, J VIROL, V72, P6298, DOI 10.1128/JVI.72.8.6298-6306.1998; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nitschke M, 2008, VIROLOGY, V377, P248, DOI 10.1016/j.virol.2008.04.041; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reddy A, 1999, GLYCOBIOLOGY, V9, P547, DOI 10.1093/glycob/9.6.547; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Thaa B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065548; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Veit Michael, 2008, V446, P163, DOI 10.1007/978-1-60327-084-7_12; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wieringa R, 2004, J VIROL, V78, P13019, DOI 10.1128/JVI.78.23.13019-13027.2004; Wieringa R, 2003, J VIROL, V77, P6216, DOI 10.1128/JVI.77.11.6216-6226.2003; Wieringa R, 2002, J VIROL, V76, P10829, DOI 10.1128/JVI.76.21.10829-10840.2002; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200	35	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35396	35405		10.1074/jbc.M113.505420	http://dx.doi.org/10.1074/jbc.M113.505420			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142700	Green Published, hybrid			2022-12-25	WOS:000329867600036
J	Watanabe, Y; Katayama, N; Takeuchi, K; Togano, T; Itoh, R; Sato, M; Yamazaki, M; Abe, M; Sato, T; Oda, K; Yokoyama, M; Takao, K; Fukaya, M; Miyakawa, T; Watanabe, M; Sakimura, K; Manabe, T; Igarashi, M				Watanabe, Yumi; Katayama, Norikazu; Takeuchi, Kosei; Togano, Tetsuya; Itoh, Rieko; Sato, Michiko; Yamazaki, Maya; Abe, Manabu; Sato, Toshiya; Oda, Kanako; Yokoyama, Minesuke; Takao, Keizo; Fukaya, Masahiro; Miyakawa, Tsuyoshi; Watanabe, Masahiko; Sakimura, Kenji; Manabe, Toshiya; Igarashi, Michihiro			Point Mutation in Syntaxin-1A Causes Abnormal Vesicle Recycling, Behaviors, and Short Term Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calmodulin-dependent Protein Kinase (CaMK); Exocytosis; SNARE Proteins; Synaptic Plasticity; Synaptosomes	PROTEIN-KINASE-II; GENETICALLY-ENGINEERED MICE; NEUROPSYCHIATRIC DISORDERS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC PLASTICITY; CONFORMATIONAL SWITCH; CA1 REGION; SYNAPSIN-I; EXOCYTOSIS; COMPLEXIN	Background: Roles of the syntaxin-1ACaMKII interaction are not physiologically understood in vivo.Results: A point mutation in syntaxin-1A caused abnormal plasticity, recycling, and behaviors in mice. Conclusion: The CaMKII/syntaxin-1A interaction is essential for maintenance of neuronal plasticity. Significance: Syntaxin-1A is involved in regulatory pathways in higher brain functions. Syntaxin-1A is a t-SNARE that is involved in vesicle docking and vesicle fusion; it is important in presynaptic exocytosis in neurons because it interacts with many regulatory proteins. Previously, we found the following: 1) that autophosphorylated Ca2+/calmodulin-dependent protein kinase II (CaMKII), an important modulator of neural plasticity, interacts with syntaxin-1A to regulate exocytosis, and 2) that a syntaxin missense mutation (R151G) attenuated this interaction. To determine more precisely the physiological importance of this interaction between CaMKII and syntaxin, we generated mice with a knock-in (KI) syntaxin-1A (R151G) mutation. Complexin is a molecular clamp involved in exocytosis, and in the KI mice, recruitment of complexin to the SNARE complex was reduced because of an abnormal CaMKII/syntaxin interaction. Nevertheless, SNARE complex formation was not inhibited, and consequently, basal neurotransmission was normal. However, the KI mice did exhibit more enhanced presynaptic plasticity than wild-type littermates; this enhanced plasticity could be associated with synaptic response than did wild-type littermates; this pronounced response included several behavioral abnormalities. Notably, the R151G phenotypes were generally similar to previously reported CaMKII mutant phenotypes. Additionally, synaptic recycling in these KI mice was delayed, and the density of synaptic vesicles was reduced. Taken together, our results indicated that this single point mutation in syntaxin-1A causes abnormal regulation of neuronal plasticity and vesicle recycling and that the affected syntaxin-1A/CaMKII interaction is essential for normal brain and synaptic functions in vivo.	[Watanabe, Yumi; Takeuchi, Kosei; Togano, Tetsuya; Itoh, Rieko; Sato, Michiko; Igarashi, Michihiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Neurochem & Mol Cell Biol, Niigata 9518510, Japan; [Togano, Tetsuya] Niigata Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Niigata 9518510, Japan; [Watanabe, Yumi; Takeuchi, Kosei; Igarashi, Michihiro] Niigata Univ, Transdisciplinary Res Program, Niigata 9518510, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata 9518510, Japan; [Sato, Toshiya; Oda, Kanako; Yokoyama, Minesuke] Niigata Univ, Dept Expt Anim Resource, Brain Res Inst, Niigata 9518510, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 4448585, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi 4701192, Japan; [Katayama, Norikazu; Manabe, Toshiya] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo 1088639, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2520374, Japan; Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Watanabe, Yumi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Niigata University; Niigata University; Niigata University; Niigata University; Niigata University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; University of Tokyo; Kitasato University; Hokkaido University; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST)	Igarashi, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Cellular Biol, Chuo Ku, 1-757 Asahimachi, Niigata 9518510, Japan.	tarokaja@med.niigata-u.ac.jp	Yamazaki, Maya/C-6952-2012; Watanabe, Masahiko/S-3614-2019; Miyakawa, Tsuyoshi/A-7741-2008; Takeuchi, Kosei/AAV-3577-2021; Takao, Keizo/B-9527-2008	Watanabe, Masahiko/0000-0001-5037-7138; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Takeuchi, Kosei/0000-0001-6397-2243; Takao, Keizo/0000-0002-4734-3583; Togano, Tetsuya/0000-0003-2853-1308; Sato, Toshiya/0000-0001-7844-9930	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Sciences KAKENHI [17023019, 22040040, 24111515, 11J40157, 23220008, 25116505, 25640005]; Comprehensive Center of Education and Research for Chemical Biology of Diseases (Global COE Program); Strategic Research Program for Brain Sciences from the MEXT; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24111515, 23220008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Sciences KAKENHI; Comprehensive Center of Education and Research for Chemical Biology of Diseases (Global COE Program); Strategic Research Program for Brain Sciences from the MEXT; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Sciences KAKENHI 17023019, 22040040, and 24111515 (to M.I.), 11J40157 (to Y.W.), 23220008, 25116505, and 25640005 (to T. Manabe), the Comprehensive Center of Education and Research for Chemical Biology of Diseases (Global COE Program) (to T. Manabe), the Strategic Research Program for Brain Sciences from the MEXT (to T. Manabe), and a grant from the Uehara Memorial Foundation (to T. Manabe).	BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Igarashi M, 2007, NEUROSCI RES, V58, P226, DOI 10.1016/j.neures.2007.03.005; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kitayama K, 2001, BIOCHEM BIOPH RES CO, V281, P1134, DOI 10.1006/bbrc.2001.4492; Krishnakumar SS, 2011, NAT STRUCT MOL BIOL, V18, P934, DOI 10.1038/nsmb.2103; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Nomura K, 2003, J NEUROSCI RES, V72, P198, DOI 10.1002/jnr.10563; Ohyama A, 2002, J NEUROSCI, V22, P3342; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Takao K, 2009, J TOXICOL SCI, V34, pSP293, DOI 10.2131/jts.34.SP293; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Weninger KR, 2011, NAT STRUCT MOL BIOL, V18, P861, DOI 10.1038/nsmb.2118; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342	35	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34906	34919		10.1074/jbc.M113.504050	http://dx.doi.org/10.1074/jbc.M113.504050			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24136198	hybrid, Green Published			2022-12-25	WOS:000329812800057
J	Binder, ZA; Siu, IM; Eberhart, CG; ap Rhys, C; Bai, RY; Staedtke, V; Zhang, H; Smoll, NR; Piantadosi, S; Piccirillo, SG; DiMeco, F; Weingart, JD; Vescovi, A; Olivi, A; Riggins, GJ; Gallia, GL				Binder, Zev A.; Siu, I-Mei; Eberhart, Charles G.; ap Rhys, Colette; Bai, Ren-Yuan; Staedtke, Verena; Zhang, Hao; Smoll, Nicolas R.; Piantadosi, Steven; Piccirillo, Sara G.; DiMeco, Francesco; Weingart, Jon D.; Vescovi, Angelo; Olivi, Alessandro; Riggins, Gregory J.; Gallia, Gary L.			Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome	PLOS ONE			English	Article							GENE-EXPRESSION; EMBRYONAL CARCINOMA; MAJOR SIALOPROTEIN; PROSTATE-CANCER; SELF-RENEWAL; MOUSE-BRAIN; IDENTIFICATION; TUMORS; BREAST; MARKER	Glioblastoma multiforme (GBM) is the most common primary malignant adult brain tumor and is associated with poor survival. Recently, stem-like cell populations have been identified in numerous malignancies including GBM. To identify genes whose expression is changed with differentiation, we compared transcript profiles from a GBM oncosphere line before and after differentiation. Bioinformatic analysis of the gene expression profiles identified podocalyxin-like protein (PODXL), a protein highly expressed in human embryonic stem cells, as a potential marker of undifferentiated GBM stem-like cells. The loss of PODXL expression upon differentiation of GBM stem-like cell lines was confirmed by quantitative real-time PCR and flow cytometry. Analytical flow cytometry of numerous GBM oncosphere lines demonstrated PODXL expression in all lines examined. Knockdown studies and flow cytometric cell sorting experiments demonstrated that PODXL is involved in GBM stem-like cell proliferation and oncosphere formation. Compared to PODXL-negative cells, PODXL-positive cells had increased expression of the progenitor/stem cell markers Musashi1, SOX2, and BMI1. Finally, PODXL expression directly correlated with increasing glioma grade and was a marker for poor outcome in patients with GBM. In summary, we have demonstrated that PODXL is expressed in GBM stem-like cells and is involved in cell proliferation and oncosphere formation. Moreover, high PODXL expression correlates with increasing glioma grade and decreased overall survival in patients with GBM.	[Binder, Zev A.; Siu, I-Mei; ap Rhys, Colette; Bai, Ren-Yuan; DiMeco, Francesco; Weingart, Jon D.; Olivi, Alessandro; Riggins, Gregory J.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Binder, Zev A.] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Binder, Zev A.] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Staedtke, Verena] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Zhang, Hao] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Smoll, Nicolas R.] Monash Univ, Gippsland Med Sch, Churchill, Vic, Australia; [Piantadosi, Steven] Johns Hopkins Univ, Sch Med, Dept Oncol Biostat, Baltimore, MD USA; [Piccirillo, Sara G.] StemGen, Milan, Italy; [DiMeco, Francesco] Ist Nazl Neurol Carlo Besta, Dept Neurosurg, Milan, Italy; [Weingart, Jon D.; Olivi, Alessandro; Riggins, Gregory J.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Vescovi, Angelo] Univ Milano Biocca, Dept Biotechnol & Biosci, Milan, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Federation University Australia; Monash University; Johns Hopkins University; IRCCS Istituto Neurologico Besta; Johns Hopkins University; University of Milano-Bicocca	Gallia, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	ggallia1@jhmi.edu	Vescovi, Angelo Luigi/A-4919-2015; Olivi, Alessandro/K-6531-2016; DiMeco, Francesco/Z-5431-2019; DiMeco, Francesco/Q-3785-2016; Smoll, Nicolas/D-3322-2013	Vescovi, Angelo Luigi/0000-0002-1742-4112; Olivi, Alessandro/0000-0002-4489-7564; DiMeco, Francesco/0000-0001-6213-5793; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992; Smoll, Nicolas/0000-0002-6923-9701	Brain Tumor Funding Collaborative; Virginia and D.K. Ludwig Fund for Cancer Research; National Institutes of Health [T32CA130840]; NATIONAL CANCER INSTITUTE [T32CA130840] Funding Source: NIH RePORTER	Brain Tumor Funding Collaborative; Virginia and D.K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Brain Tumor Funding Collaborative (GJR), the Virginia and D.K. Ludwig Fund for Cancer Research (GJR), and the Postdoctoral Training Program in Nanotechnology for Cancer Medicine supported by National Institutes of Health grant T32CA130840 (ZAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Cai JL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-26; Cancer Genome Anatomy Project, 2002, SAGE GEN; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Cerutti JM, 2004, J CLIN INVEST, V113, P1234, DOI 10.1172/JCI200419617; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V374, P394, DOI 10.1016/j.bbrc.2008.07.049; He JT, 2010, J PROTEOME RES, V9, P2565, DOI 10.1021/pr100012p; Heukamp LC, 2006, HISTOPATHOLOGY, V49, P242, DOI 10.1111/j.1365-2559.2006.02489.x; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kelley TW, 2005, AM J CLIN PATHOL, V124, P134, DOI 10.1309/7BHLAHHU0N4MHT7Q; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerosuo L, 2004, BRIT J HAEMATOL, V124, P809, DOI 10.1111/j.1365-2141.2004.04840.x; Koch LK, 2008, HUM PATHOL, V39, P1597, DOI 10.1016/j.humpath.2008.03.008; Larrucea S, 2007, CELL MOL LIFE SCI, V64, P2965, DOI 10.1007/s00018-007-7374-6; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Loilome W, 2009, J NEURO-ONCOL, V94, P359, DOI 10.1007/s11060-009-9885-5; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Ney JT, 2007, HUM PATHOL, V38, P359, DOI 10.1016/j.humpath.2006.08.025; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Nowakowski A, 2010, MOL CELL NEUROSCI, V43, P90, DOI 10.1016/j.mcn.2009.09.011; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Platet N, 2007, FEBS LETT, V581, P1435, DOI 10.1016/j.febslet.2007.02.071; Porter DA, 2001, CANCER RES, V61, P5697; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Shen G, 2008, IN VITRO CELL DEV-AN, V44, P280, DOI 10.1007/s11626-008-9115-z; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siu IM, 2010, J NEUROSURG-PEDIATR, V6, P92, DOI 10.3171/2010.3.PEDS09366; Siu IM, 1997, AM J PATHOL, V150, P1805; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Stanhope-Baker P, 2004, J BIOL CHEM, V279, P33575, DOI 10.1074/jbc.M404787200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vitureira N, 2005, GENE EXPR PATTERNS, V5, P349, DOI 10.1016/j.modgep.2004.10.002; Vitureira N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012003; Wu H, 2013, EXP THER MED, V5, P1025, DOI 10.3892/etm.2013.957; Yasuoka H, 2008, J CLIN PATHOL, V61, P1228, DOI 10.1136/jcp.2008.059956; Yasuoka H, 2012, J CLIN PATHOL, V65, P399, DOI 10.1136/jclinpath-2011-200359; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269	68	32	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75945	10.1371/journal.pone.0075945	http://dx.doi.org/10.1371/journal.pone.0075945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146797	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400026
J	Craje, C; Santello, M; Gordon, AM				Craje, Celine; Santello, Marco; Gordon, Andrew M.			Effects of Visual Cues of Object Density on Perception and Anticipatory Control of Dexterous Manipulation	PLOS ONE			English	Article							CENTER-OF-MASS; UNDERLYING MOTOR COMMANDS; SENSORIMOTOR MEMORY; PRECISION GRIP; FORCE CONTROL; WEIGHT; SIZE; REPRESENTATIONS; INFORMATION; INDEPENDENCE	Anticipatory force planning during grasping is based on visual cues about the object's physical properties and sensorimotor memories of previous actions with grasped objects. Vision can be used to estimate object mass based on the object size to identify and recall sensorimotor memories of previously manipulated objects. It is not known whether subjects can use density cues to identify the object's center of mass (CM) and create compensatory moments in an anticipatory fashion during initial object lifts to prevent tilt. We asked subjects (n = 8) to estimate CM location of visually symmetric objects of uniform densities (plastic or brass, symmetric CM) and non-uniform densities (mixture of plastic and brass, asymmetric CM). We then asked whether subjects can use density cues to scale fingertip forces when lifting the visually symmetric objects of uniform and non-uniform densities. Subjects were able to accurately estimate an object's center of mass based on visual density cues. When the mass distribution was uniform, subjects could scale their fingertip forces in an anticipatory fashion based on the estimation. However, despite their ability to explicitly estimate CM location when object density was non-uniform, subjects were unable to scale their fingertip forces to create a compensatory moment and prevent tilt on initial lifts. Hefting object parts in the hand before the experiment did not affect this ability. This suggests a dichotomy between the ability to accurately identify the object's CM location for objects with non-uniform density cues and the ability to utilize this information to correctly scale their fingertip forces. These results are discussed in the context of possible neural mechanisms underlying sensorimotor integration linking visual cues and anticipatory control of grasping.	[Craje, Celine; Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Columbia University; Columbia University Teachers College; Arizona State University; Arizona State University-Tempe	Gordon, AM (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	ag275@columbia.edu		Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS 1152916, BCS-1153034]; Direct For Social, Behav & Economic Scie [1153034, 1152916] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by a Collaborative Research Grant BCS 1152916 (AG) and BCS-1153034 (MS) from the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Ahmed AA, 2008, CURR BIOL, V18, P763, DOI 10.1016/j.cub.2008.04.061; Albert F, 2009, NEUROSCI LETT, V463, P188, DOI 10.1016/j.neulet.2009.07.080; Baud-Bovy G, 2001, J EXP PSYCHOL HUMAN, V27, P692, DOI 10.1037//0096-1523.27.3.692; Baugh LA, 2012, J NEUROPHYSIOL, V108, P1262, DOI 10.1152/jn.00263.2012; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P617, DOI 10.3758/BF03211785; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P633, DOI 10.3758/BF03211786; Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Carey DP, 2001, TRENDS COGN SCI, V5, P109, DOI 10.1016/S1364-6613(00)01592-8; Chang EC, 2008, EXP BRAIN RES, V185, P319, DOI 10.1007/s00221-007-1156-0; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Chouinard PA, 2009, NEUROIMAGE, V44, P200, DOI 10.1016/j.neuroimage.2008.08.023; Cole KJ, 2008, EXP BRAIN RES, V188, P551, DOI 10.1007/s00221-008-1392-y; DAVI M, 1992, PERCEPT PSYCHOPHYS, V52, P151, DOI 10.3758/BF03206768; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Fu QS, 2012, J NEUROSCI, V32, P15086, DOI 10.1523/JNEUROSCI.2468-12.2012; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gordon AM, 2004, P ANN INT IEEE EMBS, V26, P4641; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Liby BW, 2010, PERCEPT MOTOR SKILL, V110, P195, DOI 10.2466/PMS.110.1.195-212; Loh MN, 2010, J NEUROSCI, V30, P6984, DOI 10.1523/JNEUROSCI.6207-09.2010; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Mon-Williams M, 2000, EXP BRAIN RES, V135, P405, DOI 10.1007/s002210000538; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Seashore CE, 1899, U IOWA STUDIES PSYCH, V2, P36; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76855	10.1371/journal.pone.0076855	http://dx.doi.org/10.1371/journal.pone.0076855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146935	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400090
J	Cucinotta, FA; Kim, MHY; Chappell, LJ; Huff, JL				Cucinotta, Francis A.; Kim, Myung-Hee Y.; Chappell, Lori J.; Huff, Janice L.			How Safe Is Safe Enough? Radiation Risk for a Human Mission to Mars	PLOS ONE			English	Article							CIRCULATORY DISEASE; IONIZING-RADIATION; SPACE RADIATION; EXPOSURE; IRRADIATION; CANCER; DEPENDENCE; MORTALITY; RAYS	Astronauts on a mission to Mars would be exposed for up to 3 years to galactic cosmic rays (GCR) - made up of high-energy protons and high charge (Z) and energy (E) (HZE) nuclei. GCR exposure rate increases about three times as spacecraft venture out of Earth orbit into deep space where protection of the Earth's magnetosphere and solid body are lost. NASA's radiation standard limits astronaut exposures to a 3% risk of exposure induced death (REID) at the upper 95% confidence interval (CI) of the risk estimate. Fatal cancer risk has been considered the dominant risk for GCR, however recent epidemiological analysis of radiation risks for circulatory diseases allow for predictions of REID for circulatory diseases to be included with cancer risk predictions for space missions. Using NASA's models of risks and uncertainties, we predicted that central estimates for radiation induced mortality and morbidity could exceed 5% and 10% with upper 95% CI near 10% and 20%, respectively for a Mars mission. Additional risks to the central nervous system (CNS) and qualitative differences in the biological effects of GCR compared to terrestrial radiation may significantly increase these estimates, and will require new knowledge to evaluate.	[Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA; [Cucinotta, Francis A.] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA; [Kim, Myung-Hee Y.; Chappell, Lori J.; Huff, Janice L.] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Universities Space Research Association (USRA)	Cucinotta, FA (corresponding author), NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA.	francis.cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020	Huff, Janice/0000-0003-4236-7698; Kim, Myung-Hee/0000-0001-5575-6858	NASA Space Radiation Risk Project; University of Nevada Las Vegas	NASA Space Radiation Risk Project; University of Nevada Las Vegas	This work was supported by the NASA Space Radiation Risk Project, and the University of Nevada Las Vegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerospace Safety Advisory Panel, 2010, ANN REP 2010; Alpen E.L., 1993, RADIAT RES, V88, P132, DOI DOI 10.2307/3575758; Alwood JS, 2010, BONE, V47, P248, DOI 10.1016/j.bone.2010.05.004; [Anonymous], 2009, 2009502 NASA SP; Badhwar GD, 2000, RADIAT RES, V153, P1, DOI 10.1667/0033-7587(2000)153[0001:ACODDO]2.0.CO;2; Badhwar GD, 1992, RADIAT MEAS, V20, P403; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Chylack LT, 2012, RADIAT RES, V178, P25, DOI 10.1667/RR2876.1; Committee for Evaluation of Space Radiation Cancer Risk Model National Research Council, 2012, TECHN EV NASA MOD CA; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2013, 2013217375 NASA TP; Cucinotta FA, 2008, RADIAT RES, V170, P127, DOI 10.1667/RR1330.1; Cucinotta FA, 2007, RADIAT ENVIRON BIOPH, V46, P101, DOI 10.1007/s00411-007-0099-y; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Datta K, 2013, PLOS ONE, V8; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Durante M, 2011, REV MOD PHYS, V83, P1245, DOI 10.1103/RevModPhys.83.1245; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; GRAHN D, 1992, RADIAT RES, V129, P19, DOI 10.2307/3577899; Haley GE, 2013, RADIAT RES, V179, P590, DOI 10.1667/RR2946.1; International Commission on Radiation Protection, 2003, ICRP PUBL, V103; JOSEPH JA, 1992, RADIAT RES, V130, P88, DOI 10.2307/3578484; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Kim MHY, 2009, ADV SPACE RES, V44, P1428, DOI 10.1016/j.asr.2009.07.028; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; *NAT RES COUNC, 1996, RAD HAZ CREWS INT MI; National Academy of Sciences Committee on the Biological Effects of Radiation, 2006, HLTH RISKS EXP LOW L; National Aeronautics and Space Administration, 2013, ASTR FACT BOOK; National Aeronautics and Space Administration, 2007, STD3001 NASA; National Council on Radiation Protection and Measurements, 2000, 132 NCRP; National Council on Radiation Protection and Measurements, 1997, 126 NCRP; National Council on Radiation Protection and Measurements, 2011, 167 NCRP; National Council on Radiation Protection and Measurements, 2006, 153 NAT COUNC RAD PR; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Rola R, 2008, RADIAT RES, V169, P626, DOI 10.1667/RR1263.1; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, UNSCEAR 2008 REP GEN; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1; WILSON JW, 1994, ADV SPACE RES, V14, P841, DOI 10.1016/0273-1177(94)90549-5; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	45	113	117	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e74988	10.1371/journal.pone.0074988	http://dx.doi.org/10.1371/journal.pone.0074988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146746	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400003
J	Ridenhour, BJ; Campitelli, MA; Kwong, JC; Rosella, LC; Armstrong, BG; Mangtani, P; Calzavara, AJ; Shay, DK				Ridenhour, Benjamin J.; Campitelli, Michael A.; Kwong, Jeffrey C.; Rosella, Laura C.; Armstrong, Ben G.; Mangtani, Punam; Calzavara, Andrew J.; Shay, David K.			Effectiveness of Inactivated Influenza Vaccines in Preventing Influenza-Associated Deaths and Hospitalizations among Ontario Residents Aged >= 65 Years: Estimates with Generalized Linear Models Accounting for Healthy Vaccinee Effects	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS; ALL-CAUSE MORTALITY; ELDERLY-PEOPLE; HERD-IMMUNITY; VACCINATION; IMPACT; BIAS; IMMUNIZATION; EFFICACY	Background: Estimates of the effectiveness of influenza vaccines in older adults may be biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications. Methods: We conducted a retrospective cohort study among Ontario residents aged >= 65 years from September 1993 through September 2008. We linked weekly vaccination, hospitalization, and death records for 1.4 million community-dwelling persons aged >= 65 years. Vaccine effectiveness was estimated by comparing ratios of outcome rates during weeks of high versus low influenza activity (defined by viral surveillance data) among vaccinated and unvaccinated subjects by using log-linear regression models that accounted for temperature and time trends with natural spline functions. Effectiveness was estimated for three influenza-associated outcomes: all-cause deaths, deaths occurring within 30 days of pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations. Results: During weeks when 5% of respiratory specimens tested positive for influenza A, vaccine effectiveness among persons aged >= 65 years was 22% (95% confidence interval [CI], -6%-42%) for all influenza-associated deaths, 25% (95% CI, 13%-37%) for deaths occurring within 30 days after an influenza-associated pneumonia/influenza hospitalization, and 19% (95% CI, 4%-31%) for influenza-associated pneumonia/influenza hospitalizations. Because small proportions of deaths, deaths after pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations were associated with influenza virus circulation, we estimated that vaccination prevented 1.6%, 4.8%, and 4.1% of these outcomes, respectively. Conclusions: By using confounding-reducing techniques with 15 years of provincial-level data including vaccination and health outcomes, we estimated that influenza vaccination prevented similar to 4% of influenza-associated hospitalizations and deaths occurring after hospitalizations among older adults in Ontario.	[Ridenhour, Benjamin J.; Shay, David K.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Ridenhour, Benjamin J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, South Bend, IN USA; [Campitelli, Michael A.; Kwong, Jeffrey C.; Calzavara, Andrew J.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.; Rosella, Laura C.] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Kwong, Jeffrey C.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Armstrong, Ben G.; Mangtani, Punam] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Calzavara, Andrew J.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	Centers for Disease Control & Prevention - USA; University of Notre Dame; University of Toronto; University of Toronto; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ridenhour, BJ (corresponding author), US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.	ridenhour.1@nd.edu		Mangtani, Punam/0000-0001-7074-2999; Ridenhour, Benjamin/0000-0001-8271-4629; armstrong, benedict/0000-0003-4407-0409; Shay, David/0000-0001-9619-4820				ANDERSON RM, 1987, EPIDEMIOL INFECT, V99, P65, DOI 10.1017/S0950268800066875; Armstrong BG, 2004, BMJ-BRIT MED J, V329, P660, DOI 10.1136/bmj.38198.594109.AE; Baxter R, 2010, VACCINE, V28, P7267, DOI 10.1016/j.vaccine.2010.08.088; Campitelli MA, 2010, VACCINE, V29, P240, DOI 10.1016/j.vaccine.2010.10.049; Chan B, 1999, Hosp Q, V3, P17; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Falagas ME, 2009, CAN MED ASSOC J, V181, P484, DOI 10.1503/cmaj.090694; Ferdinands JM, 2013, EPIDEMIOLOGY, V24, P530, DOI 10.1097/EDE.0b013e3182953065; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; GOVAERT TME, 1994, VACCINE, V12, P1185, DOI 10.1016/0264-410X(94)90241-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Iron K, 2008, LIVING DYING ONTARIO; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Keitel WA, 2009, VACCINE, V28, P379, DOI 10.1016/j.vaccine.2009.10.037; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Kwong JC, 2007, VACCINE, V25, P1270, DOI 10.1016/j.vaccine.2006.10.004; Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mangtani P, 2006, CLIN INFECT DIS, V42, P640, DOI 10.1086/499810; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; MARTEL L, 2007, PORTRAIT CANADIAN PO; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Naylor D, 1999, CARDIOVASCULAR HLTH; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Talbot HK, 2009, VACCINE, V27, P1923, DOI 10.1016/j.vaccine.2009.01.108; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517	41	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76318	10.1371/journal.pone.0076318	http://dx.doi.org/10.1371/journal.pone.0076318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146855	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326019400053
J	Wang, J; Song, SJ; Shi, L; Zhu, Q; Ma, CC; Tan, XQ; Ding, Y; Niu, ZY				Wang, Jing; Song, Shujun; Shi, Liang; Zhu, Qiang; Ma, Chuanchuan; Tan, Xiaoqing; Ding, Yin; Niu, Zhongying			Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; ER-ALPHA; GENE-EXPRESSION; OSTEOBLASTS; PROTEIN; BETA; MNAR; ACTIVATION; RESISTANCE	Background: Osteogenic induction and bone formation are heavily affected by environmental factors, including estrogen, estrogen receptors, and coregulatory proteins, such as the recently reported proline-, glutamic acid-, and leucine-rich protein 1(Pelp1). Objective: To investigate Pelp1 expression in rat bone mesenchymal stem cells (rBMSCs) during cell proliferation and osteogenic differentiation. Methods: rBMSCs were cultured in routine and osteogenic differentiation media. Cell proliferation was assessed at days 1, 3, 5, 7, 9, 11, 14, and 21. Pelp1 protein expression in the nucleus and cytoplasm were detected by immunocytochemical analysis. Real-time RT-PCR and western blot were used to detect mRNA and protein expressions of Pelp1, osteocalcin (OCN), and alkaline phosphatase (ALP). Results: Over 21 days, rBMSCs in routine culture exhibited a 1-2 day lag phase and exponential growth from day 3 to 9, plateauing at day 9, and correlated with temporal mRNA expression of Pelp1, which almost reached baseline levels at day 21. In osteogenic induction cultures, Pelp1 mRNA levels rose at day 9 and steadily increased until day 21, reaching 6.8-fold greater value compared with day 1. Interestingly, Pelp1 mRNA expression in osteogenic cultures exhibited a trend similar to that of OCN expression. Pelp1 knockdown by siRNA transfection inhibited undifferentiated rBMSC proliferation, and bone markers OCN and ALP expressions in rBMSCs cultured in routine and osteogenic differentiation media. Conclusions: Pelp1 may be a key player in BMSCs proliferation and osteogenic differentiation, meriting further consideration as a target for development of therapies for pathological bone loss conditions, such as menopausal bone loss.	[Wang, Jing; Ding, Yin] Forth Mil Med Univ, Coll Stomatol, Dept Orthodont, Xian, Peoples R China; [Song, Shujun; Tan, Xiaoqing] 306 Hosp PLA, Dept Pathol & Expt Med, Beijing, Peoples R China; [Shi, Liang; Ma, Chuanchuan; Niu, Zhongying] 306 Hosp PLA, Dept Stomatol, Beijing, Peoples R China; [Zhu, Qiang] Gen Hosp Peoples Liberat Army, Dept Urol, Beijing, Peoples R China	Air Force Military Medical University	Ding, Y (corresponding author), Forth Mil Med Univ, Coll Stomatol, Dept Orthodont, Xian, Peoples R China.	dingyin.fmmu@gmail.com; zhongying.niu@gmail.com		Shi, Liang/0000-0002-4325-2879	306th Hospital of the People's Liberation Army (PLA)	306th Hospital of the People's Liberation Army (PLA)	The authors gratefully acknowledge the support of the 306th Hospital of the People's Liberation Army (PLA). We thank the staff in the Center of Pathology and Experimental Medicine of the 306th Hospital of PLA for their skills, knowledge, and advice.	Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Bennani-Baiti IM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3249; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Bowring C E, 2011, Menopause Int, V17, P63, DOI 10.1258/mi.2011.011012; Brann DW, 2008, MOL CELL ENDOCRINOL, V290, P2, DOI 10.1016/j.mce.2008.04.019; Brennan O, 2012, HORM METAB RES, V44, P47, DOI 10.1055/s-0031-1291358; Centrella M, 2012, STEROIDS, V77, P174, DOI 10.1016/j.steroids.2011.10.016; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Chimutengwende-Gordon M, 2012, CURR STEM CELL RES T, V7, P122, DOI 10.2174/157488812799219036; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Grivas PD, 2009, CELL ONCOL, V31, P235, DOI 10.3233/CLO-2009-0467; Hongo Hiromi, 2011, Clin Calcium, V21, P63, DOI CliCa111116471654; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Mishra SK, 2004, GENE, V330, P115, DOI 10.1016/j.gene.2004.01.011; Pawlak J, 2005, CELL TISSUE RES, V320, P545, DOI 10.1007/s00441-005-1090-z; Shi H, 2010, ANAL CHEM, V82, P2213, DOI 10.1021/ac902417s; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P59, DOI 10.1016/j.mce.2008.07.020; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Toran-Allerand CD, 2004, EXP GERONTOL, V39, P1579, DOI 10.1016/j.exger.2004.05.006; Vadlamudi RK, 2005, HUM PATHOL, V36, P670, DOI 10.1016/j.humpath.2005.03.016; Vadlamudi RK, 2007, NUCL RECEPT SIGNAL, V5; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Xiao Y, 2010, INT J ORAL SCI, V2, P127, DOI 10.4248/IJOS10045; Yildirim M, 2011, BRAIN RES, V1379, P98, DOI 10.1016/j.brainres.2010.07.053; Zilli M, 2009, BBA-REV CANCER, V1795, P62, DOI 10.1016/j.bbcan.2008.08.003	29	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75477	10.1371/journal.pone.0075477	http://dx.doi.org/10.1371/journal.pone.0075477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146754	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400007
J	Crawford, TQ; Hecht, FM; Pilcher, CD; Ndhlovu, LC; Barbour, JD				Crawford, Timothy Q.; Hecht, Fredrick M.; Pilcher, Christopher D.; Ndhlovu, Lishomwa C.; Barbour, Jason D.			Activation Associated ERK1/2 Signaling Impairments in CD8(+) T Cells Co-Localize with Blunted Polyclonal and HIV-1 Specific Effector Functions in Early Untreated HIV-1 Infection	PLOS ONE			English	Article							MAP-KINASE; IMMUNE ACTIVATION; PERFORIN EXPRESSION; MEMORY; RESPONSES; PHOSPHORYLATION; PROLIFERATION; AP-1; TRANSCRIPTION; EXHAUSTION	We recently observed that a large proportion of activated (CD38(+)HLA-DR+) CD8(+) T cells from recently HIV-1-infected adults are refractory to phosphorylation of ERK1/2 kinases (p-ERK1/2-refractory). Given that the ERK1/2 pathway mediates intracellular signaling critical for multiple T cell functions, including key effector functions, the loss of ERK1/2 responsiveness may have broad consequences for CD8(+) T cell function. In the current study, we hypothesized that the p-ERK1/2-refractory population, localized largely within the activated CD38(+)HLA-DR+ CD8(+) T cell population, would display impairments in CD8(+) T cell effector functions, such as cytokine production and degranulation, compared to CD8(+) p-ERK1/2-responsive cells. We further hypothesized that the p-ERK1/2-refractory phenotype is persistent over time during untreated infection, and would correlate with poorer virologic control, in a manner independent of CD8(+) T cell activation level. We performed single-cell resolution, flow cytometric assays of phospho-kinase responses paired to intracellular cytokine staining in one assay to examine IFN-gamma, perforin and CD107 alpha responses in CD8(+) T cells by ERK1/2 signaling profile. On a per cell basis, p-ERK1/2-refractory cells, which fall predominantly within the activated CD8(+) T cell compartment, produced less IFN-gamma in response to polyclonal or HIV-1 antigen-specific stimulation, and expressed lower levels of perforin and CD107 alpha. The p-ERK1/2 refractory cell population displayed minimal overlap with the PD-1 and Tim-3 inhibitory exhaustion markers and predicted high viral load independent of activation, suggesting that ERK1/2 may be a unique marker and point of intervention for improving CD8(+) T cell function. Blunted effector functions, secondary to ERK1/2 signaling deficits concentrated within activated CD8(+) T cells, may contribute to immunodeficiency and underlie the predictive capacity of CD8(+) T cell activation on HIV-1 disease progression. (270/300).	[Crawford, Timothy Q.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Univ Hawaii Manoa, Hawaii Ctr HIV AIDS, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Hecht, Fredrick M.; Pilcher, Christopher D.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA USA	University of Hawaii System; University of Hawaii Manoa; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Barbour, JD (corresponding author), Univ Hawaii Manoa, Hawaii Ctr HIV AIDS, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	jbarbour@hawaii.edu	n, l/AAX-3992-2020	Ndhlovu, Lishomwa/0000-0001-5427-4187; Hecht, Frederick/0000-0002-5782-1171	National Institutes of Health [R21 AI076014, R56 AI083112, P01 AI071713, K24 AT007827]; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P01AI071713, R56AI083112, R21AI076014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was supported by the following grants from the National Institutes of Health: R21 AI076014 (Barbour), R56 AI083112 (Ndhlovu), P01 AI071713 (Hecht) and K24 AT007827 (Hecht). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Betts MR, 2001, IMMUNOL LETT, V79, P117, DOI 10.1016/S0165-2478(01)00273-5; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Card CM, 2012, JAIDS-J ACQ IMM DEF, V59, P427, DOI 10.1097/QAI.0b013e3182454fcd; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Crawford TQ, 2011, J VIROL, V85, P12343, DOI 10.1128/JVI.05682-11; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Egerton M, 1998, INT IMMUNOL, V10, P223, DOI 10.1093/intimm/10.2.223; Egerton M, 1996, EUR J IMMUNOL, V26, P2279, DOI 10.1002/eji.1830261002; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Freer G., 2013, METHODS; Furler RL, 2010, IMMUNOL RES; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2012, CURR HIV AIDS REP; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Ndongala ML, 2009, CLIN IMMUNOL, V131, P277, DOI 10.1016/j.clim.2008.11.006; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Park WR, 2004, INT IMMUNOL, V16, P295, DOI 10.1093/intimm/dxh034; Pasquinelli V, 2013, J INFECT DIS, V207, P340, DOI 10.1093/infdis/jis672; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Samten B, 2008, J IMMUNOL, V181, P2056, DOI 10.4049/jimmunol.181.3.2056; Schulz Kenneth R, 2012, Curr Protoc Immunol, VChapter 8, DOI 10.1002/0471142735.im0817s96; Sharma A, 2012, J IMMUNOL, V188, P3859, DOI 10.4049/jimmunol.1103729; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Teixeiro E, 2010, FEBS J, V277, P30, DOI 10.1111/j.1742-4658.2009.07368.x; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tzelepis F, 2013, J IMMUNOL, V190, P1066, DOI 10.4049/jimmunol.1200639; van Baarle D, 2005, IMMUNOL LETT, V97, P19, DOI 10.1016/j.imlet.2004.10.003; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	64	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77412	10.1371/journal.pone.0077412	http://dx.doi.org/10.1371/journal.pone.0077412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143233	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100070
J	Henner, A; Ventura, PB; Jiang, Y; Zong, H				Henner, Astra; Ventura, P. Britten; Jiang, Ying; Zong, Hui			MADM-ML, a Mouse Genetic Mosaic System with Increased Clonal Efficiency	PLOS ONE			English	Article							DOUBLE MARKERS; CELL; MEDULLOBLASTOMA; MICE; ORIGIN	Mosaic Analysis with Double Markers (MADM) is a mouse genetic system that allows simultaneous gene knockout and fluorescent labeling of sparse, clonally-related cells within an otherwise normal mouse, thereby circumventing embryonic lethality problems and providing single-cell resolution for phenotypic analysis in vivo. The clonal efficiency of MADM is intrinsically low because it relies on Cre/loxP-mediated mitotic recombination between two homologous chromosomes rather than within the same chromosome, as in the case of conditional knockout (CKO). Although sparse labeling enhances in vivo resolution, the original MADM labels too few or even no cells when a low-expressing Cre transgene is used or a small population of cells is studied. Recently, we described the usage of a new system, MADM-ML, which contains three mutually exclusive, self-recognizing loxP variant sites as opposed to a single loxP site present in the original MADM system (referred to as MADM-SL in this paper). Here we carefully compared the recombination efficiency between MADM-SL and MADM-ML using the same Cre transgene, and found that the new system labels significantly more cells than the original system does. When we established mouse medulloblastoma models with both the original and the new MADM systems, we found that, while the MADM-SL model suffered from varied tumor progression and incomplete penetrance, the MADM-ML model had consistent tumor progression and full penetrance of tumor formation. Therefore MADM-ML, with its higher recombination efficiency, will broaden the applicability of MADM for studying many biological questions including normal development and disease modeling at cellular resolution in vivo.	[Henner, Astra; Ventura, P. Britten; Jiang, Ying; Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Zong, H (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Ctr Cell Signaling, Ctr Brain Immunol & Glia, Charlottesville, VA 22903 USA.	hz9s@virginia.edu			NIH/NCI [R01-CA136495]; NIH/NINDS [7F31NS076313]; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R01CA136495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076313] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is partially supported by NIH/NCI grant (R01-CA136495). P Britten Ventura is supported by NIH/NINDS pre-doctoral fellowship (7F31NS076313). Hui Zong is a Pew Scholar in Biomedical Sciences, supported by the Pew Charitable Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; EVANS DGR, 1991, BRIT J CANCER, V64, P959, DOI 10.1038/bjc.1991.435; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hippenmeyer S, 2013, CELL REP, V3, P960, DOI 10.1016/j.celrep.2013.02.002; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Kim HS, 2013, CELL, V152, P387, DOI 10.1016/j.cell.2013.01.027; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Lo Muzio L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-32; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Tasic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033332; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wetmore C, 2001, CANCER RES, V61, P513; Yang SB, 2012, J PHYSIOL-LONDON, V590, P2645, DOI 10.1113/jphysiol.2012.228486; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	28	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77672	10.1371/journal.pone.0077672	http://dx.doi.org/10.1371/journal.pone.0077672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143253	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100092
J	Burtnick, MN; Brett, PJ				Burtnick, Mary N.; Brett, Paul J.			Burkholderia mallei and Burkholderia pseudomallei Cluster 1 Type VI Secretion System Gene Expression Is Negatively Regulated by Iron and Zinc	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GLANDERS; VIRULENCE; PROTEIN; IDENTIFICATION; MUTAGENESIS; REQUIRES; MELIOIDOSIS; INFECTION; PHOSPHATE	Burkholderia mallei is a facultative intracellular pathogen that causes glanders in humans and animals. Previous studies have demonstrated that the cluster 1 type VI secretion system (T6SS-1) expressed by this organism is essential for virulence in hamsters and is positively regulated by the VirAG two-component system. Recently, we have shown that T6SS-1 gene expression is up-regulated following internalization of this pathogen into phagocytic cells and that this system promotes multinucleated giant cell formation in infected tissue culture monolayers. In the present study, we further investigated the complex regulation of this important virulence factor. To assess T6SS-1 expression, B. mallei strains were cultured in various media conditions and Hcp1 production was analyzed by Western immunoblotting. Transcript levels of several VirAG-regulated genes (bimA, tssA, hcp1 and tssM) were also determined using quantitative real time PCR. Consistent with previous observations, T6SS-1 was not expressed during growth of B. mallei in rich media. Curiously, growth of the organism in minimal media (M9G) or minimal media plus casamino acids (M9CG) facilitated robust expression of T6SS-1 genes whereas growth in minimal media plus tryptone (M9TG) did not. Investigation of this phenomenon confirmed a regulatory role for VirAG in this process. Additionally, T6SS-1 gene expression was significantly down-regulated by the addition of iron and zinc to M9CG. Other genes under the control of VirAG did not appear to be as tightly regulated by these divalent metals. Similar results were observed for B. pseudomallei, but not for B. thailandensis. Collectively, our findings indicate that in addition to being positively regulated by VirAG, B. mallei and B. pseudomallei T6SS-1 gene expression is negatively regulated by iron and zinc.	[Burtnick, Mary N.; Brett, Paul J.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama	Burtnick, MN (corresponding author), Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	mburtnick@southalabama.edu			National Institute of Allergy and Infectious Diseases [AI065359, AI091783]; University of South Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091783, U54AI065359] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of South Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award numbers AI065359 and AI091783 from the National Institute of Allergy and Infectious Diseases, and lab start-up funds from the University of South Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Brett PJ, 2008, CELL MICROBIOL, V10, P487, DOI 10.1111/j.1462-5822.2007.01063.x; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chakraborty S, 2010, J BIOL CHEM, V285, P38876, DOI 10.1074/jbc.M110.179150; Chen YH, 2011, INFECT IMMUN, V79, P3064, DOI 10.1128/IAI.05148-11; Cotter P, 2011, NATURE, V475, P301, DOI 10.1038/475301a; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Elschner MC, 2009, EQUINE VET EDUC, V21, P147, DOI 10.2746/095777309X401071; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Khaki P, 2012, IRAN J MICROBIOL, V4, P3; Khan I, 2013, TRANSBOUND EMERG DIS, V60, P204, DOI 10.1111/j.1865-1682.2012.01342.x; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leung KY, 2010, CURR OPIN MICROBIOL, V14, P1; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Loprasert S, 2000, GENE, V254, P129, DOI 10.1016/S0378-1119(00)00279-1; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Malik P, 2012, VET ITAL, V48, P167; MILLER WR, 1948, J BACTERIOL, V55, P127, DOI 10.1128/JB.55.1.127-135.1948; Miyata ST, 2013, J MED MICROBIOL, V62, P663, DOI 10.1099/jmm.0.053983-0; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Neubauer H, 2005, J VET MED B, V52, P201, DOI 10.1111/j.1439-0450.2005.00855.x; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; REDFEARN MS, 1966, J GEN MICROBIOL, V43, P293, DOI 10.1099/00221287-43-2-293; Ribot WJ, 2006, INFECT IMMUN, V74, P4349, DOI 10.1128/IAI.01939-05; Rogge ML, 2011, APPL ENVIRON MICROB, V77, P4293, DOI 10.1128/AEM.00195-11; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Sun GW, 2010, MOL MICROBIOL, V76, P677, DOI 10.1111/j.1365-2958.2010.07124.x; Ulrich RL, 2006, DIAGN MICR INFEC DIS, V55, P37, DOI 10.1016/j.diagmicrobio.2005.11.007; Urich RL, 2004, INFECT IMMUN, V72, P1150, DOI 10.1128/IAI.72.2.1150-1154.2004; Voskuhl Gene W, 2003, J Okla State Med Assoc, V96, P214; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; Wernery U, 2011, EMERG INFECT DIS, V17, P1277, DOI 10.3201/eid1707.110222; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	75	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76767	10.1371/journal.pone.0076767	http://dx.doi.org/10.1371/journal.pone.0076767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146925	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400081
J	Kochhan, E; Lenard, A; Ellertsdottir, E; Herwig, L; Affolter, M; Belting, HG; Siekmann, AF				Kochhan, Eva; Lenard, Anna; Ellertsdottir, Elin; Herwig, Lukas; Affolter, Markus; Belting, Heinz-Georg; Siekmann, Arndt F.			Blood Flow Changes Coincide with Cellular Rearrangements during Blood Vessel Pruning in Zebrafish Embryos	PLOS ONE			English	Article							PROGRAMMED CAPILLARY REGRESSION; IN-VIVO; TRANSGENIC ZEBRAFISH; APOPTOSIS; ANGIOGENESIS; LYMPHANGIOGENESIS; MACROPHAGES; NETWORK; PATHWAY; DEATH	After the initial formation of a highly branched vascular plexus, blood vessel pruning generates a hierarchically structured network with improved flow characteristics. We report here on the cellular events that occur during the pruning of a defined blood vessel in the eye of developing zebrafish embryos. Time-lapse imaging reveals that the connection of a new blood vessel sprout with a previously perfused multicellular endothelial tube leads to the formation of a branched, Y-shaped structure. Subsequently, endothelial cells in parts of the previously perfused branch rearrange from a multicellular into a unicellular tube, followed by blood vessel detachment. This process is accompanied by endothelial cell death. Finally, we show that differences in blood flow between neighboring vessels are important for the completion of the pruning process. Our data suggest that flow induced changes in tubular architecture ensure proper blood vessel pruning.	[Kochhan, Eva; Siekmann, Arndt F.] Max Planck Inst Mol Biomed, Lab Cardiovasc Patterning, Munster, Germany; [Lenard, Anna; Ellertsdottir, Elin; Herwig, Lukas; Affolter, Markus; Belting, Heinz-Georg] Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland	Max Planck Society; University of Basel	Siekmann, AF (corresponding author), Max Planck Inst Mol Biomed, Lab Cardiovasc Patterning, Munster, Germany.	arndt.siekmann@mpi-muenster.mpg.de	Siekmann, Arndt/AAE-4769-2021	Affolter, Markus/0000-0002-5171-0016; Siekmann, Arndt/0000-0001-6972-2173; Belting, Heinz-Georg/0000-0002-1538-4364	Max Planck Society; Deutsche Forschungsgemeinschaft [DFG SI-1374/3-1]; European Research Council [260794-ZebrafishAngio]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was funded by the Max Planck Society (www.mpg.de; AFS), the Deutsche Forschungsgemeinschaft (DFG SI-1374/3-1; www.dfg.de; AFS) and an European Research Council starting grant (260794-ZebrafishAngio; erc.europa.eu; AFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Baluk P, 2004, AM J PATHOL, V165, P1071, DOI 10.1016/S0002-9440(10)63369-X; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Fujita M, 2011, DEVELOPMENT, V138, P1705, DOI 10.1242/dev.058776; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LANG R, 1994, DEVELOPMENT, V120, P3395; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lobov IB, 2011, BLOOD, V117, P6728, DOI 10.1182/blood-2010-08-302067; Meeson A, 1996, DEVELOPMENT, V122, P3929; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Taniguchi H, 1999, ANN ANAT, V181, P555, DOI 10.1016/S0940-9602(99)80061-2; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Westerfield M, 1993, ZEBRAFISH BOOK; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Zanella C, 2010, IEEE T IMAGE PROCESS, V19, P770, DOI 10.1109/TIP.2009.2033629	36	77	77	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75060	10.1371/journal.pone.0075060	http://dx.doi.org/10.1371/journal.pone.0075060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146748	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400006
J	Rix, U; Colinge, J; Blatt, K; Gridling, M; Rix, LLR; Parapatics, K; Cerny-Reiterer, S; Burkard, TR; Jager, U; Melo, JV; Bennett, KL; Valent, P; Superti-Furga, G				Rix, Uwe; Colinge, Jacques; Blatt, Katharina; Gridling, Manuela; Rix, Lily L. Remsing; Parapatics, Katja; Cerny-Reiterer, Sabine; Burkard, Thomas R.; Jaeger, Ulrich; Melo, Junia V.; Bennett, Keiryn L.; Valent, Peter; Superti-Furga, Giulio			A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph plus ALL	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; TYROSINE KINASE INHIBITORS; B-CELL RECEPTOR; CHEMICAL PROTEOMICS; DOMAIN MUTATIONS; SMALL MOLECULES; CHRONIC-PHASE; IMATINIB	Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is in part driven by the tyrosine kinase bcr-abl, but imatinib does not produce long-term remission. Therefore, second-generation ABL inhibitors are currently in clinical investigation. Considering different target specificities and the pronounced genetic heterogeneity of Ph+ ALL, which contributes to the aggressiveness of the disease, drug candidates should be evaluated with regard to their effects on the entire Ph+ ALL-specific signaling network. Here, we applied an integrated experimental and computational approach that allowed us to estimate the differential impact of the bcr-abl inhibitors nilotinib, dasatinib, Bosutinib and Bafetinib. First, we determined drug-protein interactions in Ph+ ALL cell lines by chemical proteomics. We then mapped those interactions along with known genetic lesions onto public protein-protein interactions. Computation of global scores through correlation of target affinity, network topology, and distance to disease-relevant nodes assigned the highest impact to dasatinib, which was subsequently confirmed by proliferation assays. In future, combination of patient-specific genomic information with detailed drug target knowledge and network-based computational analysis should allow for an accurate and individualized prediction of therapy.	[Rix, Uwe; Colinge, Jacques; Gridling, Manuela; Rix, Lily L. Remsing; Parapatics, Katja; Burkard, Thomas R.; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr, A-1010 Vienna, Austria; [Blatt, Katharina; Cerny-Reiterer, Sabine; Jaeger, Ulrich; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Cerny-Reiterer, Sabine; Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Melo, Junia V.] Ctr Canc Biol, Dept Haematol, Adelaide, SA, Australia; [Melo, Junia V.] Univ London Imperial Coll Sci Technol & Med, London, England	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Ludwig Boltzmann Institute; Centre for Cancer Biology; Imperial College London	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr, A-1010 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Test, Test/Y-7921-2019; Test, PV/U-9451-2019; Colinge, Jacques/D-1578-2017; Colinge, Jacques/Z-2613-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Bennett, Keiryn L./0000-0001-9356-7708; Burkard, Thomas/0000-0002-0884-2929	Austrian federal ministry for science and research bmwf under the GEN-AU program project PLACEBO [GZ BMWF-70.081/0018-II/1a/2008]; Austrian federal ministry for science and research bmwf under the GEN-AU program project BIN III [GZ BMWF-70.081/0018-II/1a/2008]; Austrian federal ministry for science and research bmwf (FFG) [820961, 820962]; Austrian Science Fund (FWF) [P18737-B11]; NIHR Biomedical Research Centre Funding Scheme, UK; Austrian Academy of Sciences (OAW)	Austrian federal ministry for science and research bmwf under the GEN-AU program project PLACEBO; Austrian federal ministry for science and research bmwf under the GEN-AU program project BIN III; Austrian federal ministry for science and research bmwf (FFG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIHR Biomedical Research Centre Funding Scheme, UK; Austrian Academy of Sciences (OAW)	This study was supported by the Austrian federal ministry for science and research bmwf under the GEN-AU program projects PLACEBO and BIN III (GZ BMWF-70.081/0018-II/1a/2008, FFG project numbers 820961 and 820962), the Austrian Science Fund (FWF; P18737-B11) and the NIHR Biomedical Research Centre Funding Scheme, UK. CeMM is supported by the Austrian Academy of Sciences (OAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Berger SI, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000723; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; BREHME M, 2009, P NATL ACAD SCI USA, P80743; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Colinge J, 2010, LECT NOTES OPER RES, V13, P305; Colinge J, 2012, PROTEOM CLIN APPL, V6, P102, DOI 10.1002/prca.201100077; Daub H, 2005, BBA-PROTEINS PROTEOM, V1754, P183, DOI 10.1016/j.bbapap.2005.07.028; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2006, NEW ENGL J MED, V354, P2594, DOI 10.1056/NEJMe068073; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Fernbach NV, 2009, J PROTEOME RES, V8, P4753, DOI 10.1021/pr900455x; Fullmer A, 2011, LEUKEMIA LYMPHOMA, V52, P81, DOI 10.3109/10428194.2010.546917; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Gruber F, 2009, BRIT J HAEMATOL, V145, P581, DOI 10.1111/j.1365-2141.2009.07666.x; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Horio T, 2007, BIOORG MED CHEM LETT, V17, P2712, DOI 10.1016/j.bmcl.2007.03.002; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian H, 2010, CANCER-AM CANCER SOC, V116, P2665, DOI 10.1002/cncr.25079; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ottmann O, 2007, BLOOD, V110, P2309, DOI 10.1182/blood-2007-02-073528; Pfeifer H, 2007, BLOOD, V110, P727, DOI 10.1182/blood-2006-11-052373; Piccaluga PP, 2007, CANCER-AM CANCER SOC, V110, P1178, DOI 10.1002/cncr.22881; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wetzler M, 2004, BRIT J HAEMATOL, V124, P275, DOI 10.1046/j.1365-2141.2003.04736.x	52	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77155	10.1371/journal.pone.0077155	http://dx.doi.org/10.1371/journal.pone.0077155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130846	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200062
J	Chen, WT; Zhu, GY; Pfaffenbach, K; Kanel, G; Stiles, B; Lee, AS				Chen, Wan-Ting; Zhu, Genyuan; Pfaffenbach, Kyle; Kanel, Gary; Stiles, Bangyan; Lee, Amy S.			GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN	CANCER RESEARCH			English	Meeting Abstract									[Chen, Wan-Ting; Zhu, Genyuan; Kanel, Gary; Lee, Amy S.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Pfaffenbach, Kyle] Eastern Oregon Univ, La Grande, OR USA; [Stiles, Bangyan] Univ So Calif, Sch Pharm, Los Angeles, CA USA	University of Southern California; Eastern Oregon University; University of Southern California			chen, want/GRX-0662-2022		NCI NIH HHS [R01 CA154986, R01 CA027607, P30 CA014089] Funding Source: Medline; NIA NIH HHS [P01 AG034906] Funding Source: Medline; NIDDK NIH HHS [R21 DK075928, P30 DK048522, R01 DK084241, P30DK048522] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	8	8	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2013	73			19		C61				10.1158/1538-7445.FBCR13-C61	http://dx.doi.org/10.1158/1538-7445.FBCR13-C61			2	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	V40RV	24141775				2022-12-25	WOS:000209496600151
J	Driemel, C; Kremling, H; Schumacher, S; Will, D; Wolters, J; Lindenlauf, N; Mack, B; Baldus, SA; Hoya, V; Pietsch, JM; Panagiotidou, P; Raba, K; Vay, C; Vallbohmer, D; Harreus, U; Knoefel, WT; Stoecklein, NH; Gires, O				Driemel, C.; Kremling, H.; Schumacher, S.; Will, D.; Wolters, J.; Lindenlauf, N.; Mack, B.; Baldus, S. A.; Hoya, V.; Pietsch, J. M.; Panagiotidou, P.; Raba, K.; Vay, C.; Vallboehmer, D.; Harreus, U.; Knoefel, W. T.; Stoecklein, N. H.; Gires, O.			Context-dependent adaption of EpCAM expression in early systemic esophageal cancer	ONCOGENE			English	Article						EpCAM; esophageal cancers; disseminated tumor cells	CELL ADHESION MOLECULE; DISSEMINATED TUMOR-CELLS; EP-CAM; CARCINOMA; MAINTENANCE; PHENOTYPE; HALLMARKS; TARGET; CD326	The role of the epithelial cell adhesion molecule EpCAM in cancer progression remains largely unclear. High expression of EpCAM in primary tumors is often associated with more aggressive phenotypes and EpCAM is the prime epithelial antigen in use to isolate circulating tumor cells (CTCs) and characterize disseminated tumor cells (DTCs). However, reduced expression of EpCAM was associated with epithelial-to-mesenchymal transition (EMT) and reports on a lack of EpCAM on CTCs emerged. These contradictory observations might reflect a context-dependent adaption of EpCAM expression during metastatic progression. To test this, EpCAM expression was monitored in esophageal cancer at different sites of early systemic disease. Although most of the primary esophageal tumors expressed high levels of EpCAM, the majority of DTCs in bone marrow lacked EpCAM. In vitro, downregulation of EpCAM expression at the plasma membrane was observed in migrating and invading cells, and was associated with a partial loss of the epithelial phenotype and with significantly decreased proliferation. Accordingly, induction of EMT through the action of TGF beta resulted in substantial loss of EpCAM cell surface expression on esophageal cancer cells. Knock-down or natural loss of EpCAM recapitulated these effects as it reduced proliferation while enhancing migration and invasion of cancer cells. Importantly, expression of EpCAM on DTCs was significantly associated with the occurrence of lymph node metastases and with significantly decreased overall survival of esophageal cancer patients. We validated this observation by showing that high expression of EpCAM promoted tumor outgrowth after xenotransplantation of esophageal carcinoma cells. The present data disclose a dynamic expression of EpCAM throughout tumor progression, where EpCAM(high) phenotypes correlate with proliferative stages, whereas EpCAM(low/negative) phenotypes associated with migration, invasion and dissemination. Thus, differing expression levels of EpCAM must be taken into consideration for therapeutic approaches and during clinical retrieval of disseminated tumor cells.	[Driemel, C.; Schumacher, S.; Wolters, J.; Lindenlauf, N.; Hoya, V.; Pietsch, J. M.; Panagiotidou, P.; Vay, C.; Vallboehmer, D.; Knoefel, W. T.; Stoecklein, N. H.] Univ Hosp, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany; [Driemel, C.; Schumacher, S.; Wolters, J.; Lindenlauf, N.; Baldus, S. A.; Hoya, V.; Pietsch, J. M.; Panagiotidou, P.; Raba, K.; Vay, C.; Vallboehmer, D.; Knoefel, W. T.; Stoecklein, N. H.] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Kremling, H.; Will, D.; Mack, B.; Harreus, U.; Gires, O.] Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-81377 Munich, Bavaria, Germany; [Baldus, S. A.] Univ Hosp, Inst Pathol, Dusseldorf, Germany; [Raba, K.] Univ Hosp, Inst Transplantat Diagnost & Cellular Therapy, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Munich	Gires, O (corresponding author), Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Bavaria, Germany.	Olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017; Raba, Katharina/B-8697-2017	Gires, Olivier/0000-0002-2292-7064; Raba, Katharina/0000-0001-8818-4219; Driemel, Christiane/0000-0001-9595-3768	Wilhelm-Sander-Stiftung [2009.083.1]; Deutsche Forschungsgemeinschaft (DFG) [STO464/2-2]; Rudolf-Bartling Stiftung [II/89]	Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rudolf-Bartling Stiftung	This project was funded by The Wilhelm-Sander-Stiftung (2009.083.1), in part by the Deutsche Forschungsgemeinschaft (DFG STO464/2-2), the Rudolf-Bartling Stiftung (II/89). We thank Christof Seifarth for excellent technical support.	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Floor SL, 2012, TRENDS MOL MED, V18, P509, DOI 10.1016/j.molmed.2012.06.005; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kimura H, 2007, INT J ONCOL, V30, P171; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Rao CG, 2005, INT J ONCOL, V27, P49; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Stoecklein NH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-165; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vannier C, 2013, J BIOL CHEM, V288, P18643, DOI 10.1074/jbc.M113.467787; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Winter MJ, 2007, MOL CELL BIOCHEM, V302, P19, DOI 10.1007/s11010-007-9420-y	36	61	65	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4904	4915		10.1038/onc.2013.441	http://dx.doi.org/10.1038/onc.2013.441			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24141784				2022-12-25	WOS:000343767900003
J	Park, JY; Singh, TR; Nassar, N; Zhang, F; Freund, M; Hanenberg, H; Meetei, AR; Andreassen, PR				Park, J-Y; Singh, T. R.; Nassar, N.; Zhang, F.; Freund, M.; Hanenberg, H.; Meetei, A. R.; Andreassen, P. R.			Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair	ONCOGENE			English	Article						PALB2; RAD51C; BRCA2; homologous recombination; BRCA genes; DNA repair	HOMOLOGOUS RECOMBINATION REPAIR; CAUSE FANCONI-ANEMIA; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; CHROMOSOMAL BREAKS; PROTEIN COMPLEX; PATHWAY; XRCC3; IDENTIFICATION; DEFICIENCY	Heterozygous carriers of germ-line mutations in the BRCA2/FANCD1, PALB2/FANCN and RAD51C/FANCO DNA repair genes have an increased lifetime risk of developing breast, ovarian and other cancers; bi-allelic mutations in these genes clinically manifest as Fanconi anemia (FA). Here, we demonstrate that RAD51C is part of a novel protein complex that contains PALB2 and BRCA2. Further, the PALB2 WD40 domain can directly and independently bind RAD51C and BRCA2. To understand the role of these homologous recombination (HR) proteins in DNA repair, we functionally characterize effects of missense mutants of the PALB2 WD40 domain that have been reported in breast cancer patients. In contrast to large truncations of PALB2, which display a complete loss of interaction, the L939W, T1030I and L1143P missense mutants/variants of the PALB2 WD40 domain are associated with altered patterns of direct binding to the RAD51C, RAD51 and BRCA2 HR proteins in biochemical assays. Further, the T1030I missense mutant is unstable, whereas the L939W and L1143P proteins are stable but partially disrupt the PALB2-RAD51C-BRCA2 complex in cells. Functionally, the L939W and L1143P mutants display a decreased capacity for DNA double-strand break-induced HR and an increased cellular sensitivity to ionizing radiation. As further evidence for the functional importance of the HR complex, RAD51C mutants that are associated with cancer susceptibility and FA also display decreased complex formation with PALB2. Together, our results suggest that three different cancer susceptibility and FA proteins function in a DNA repair pathway based upon the PALB2 WD40 domain binding to RAD51C and BRCA2.	[Park, J-Y; Singh, T. R.; Nassar, N.; Zhang, F.; Meetei, A. R.; Andreassen, P. R.] Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Nassar, N.; Meetei, A. R.; Andreassen, P. R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Freund, M.; Hanenberg, H.] Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, Sch Med, Dusseldorf, Germany; [Hanenberg, H.] Indiana Univ Sch Med, Riley Hosp, Dept Pediat, Unit Pediat Hematol Oncol,Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Hanenberg, H.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University Bloomington	Meetei, AR (corresponding author), Cincinnati Childrens Res Fdn, 3333 Burnet Ave ML S7-203, Cincinnati, OH 45229 USA.	Ruhikanta.Meetei@cchmc.org; Paul.Andreassen@cchmc.org	Nassar, Natasha/K-3918-2019	singh, thiyam/0000-0002-0441-6818	BMBF; NIH [R01 CA138237, CA155294, R01 HL084082, R01 HL085587]; NATIONAL CANCER INSTITUTE [R01CA138237, R01CA155294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084082, R01HL085587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	BMBF(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr Hans Joenje (Vrije Universiteit Medical Center), Dr Youngho Kim (Wonkwang University), Dr James Lessard (Cincinnati Children's Research Foundation), Dr Yoshihiro Nakatani (Dana-Farber Cancer Institute) and Drs Maria Jasin and Koji Nakanishi (Memorial Sloan-Kettering Cancer Center) for EUFA1341 fibroblasts, the human RAD51 cDNA, anti-actin antibodies, pOZ vectors, and U2OS-DR cells and pCBASce, respectively. This work was supported by the BMBF networks of 'Inherited bone marrow failure syndromes' and 'Foamyvirus-mediated genetic therapy for FNACA (FoneFA) and NIH R01 CA138237 and CA155294 (HH), NIH R01 HL084082 (ARM) and NIH R01 HL085587 (PRA).	Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Adank MA, 2011, BREAST CANCER RES TR, V127, P357, DOI 10.1007/s10549-010-1001-1; Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Andreassen PR, 2009, CURR CANCER DRUG TAR, V9, P101, DOI 10.2174/156800909787314011; Balia C, 2010, FAM CANCER, V9, P531, DOI 10.1007/s10689-010-9382-1; Bogdanova N, 2011, BREAST CANCER RES TR, V126, P545, DOI 10.1007/s10549-010-1290-4; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Catucci I, 2012, FAM CANCER, V11, P483, DOI 10.1007/s10689-012-9540-8; Chun J, 2013, MOL CELL BIOL, V33, P387, DOI 10.1128/MCB.00465-12; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Ding YC, 2011, BREAST CANCER RES TR, V126, P227, DOI 10.1007/s10549-010-1271-7; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Hayakawa T, 2010, J CELL SCI, V123, P1124, DOI 10.1242/jcs.060178; Hellebrand H, 2011, HUM MUTAT, V32, pE2176, DOI 10.1002/humu.21478; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Miller KA, 2004, NUCLEIC ACIDS RES, V32, P169, DOI 10.1093/nar/gkg925; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Oliver AW, 2009, EMBO REP, V10, P990, DOI 10.1038/embor.2009.126; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Somyajit K, 2012, J BIOL CHEM, V287, P3366, DOI 10.1074/jbc.M111.311241; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zheng YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/cncr.26388	56	84	91	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4803	4812		10.1038/onc.2013.421	http://dx.doi.org/10.1038/onc.2013.421			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24141787	Green Accepted, Green Submitted			2022-12-25	WOS:000343240100002
J	Krauson, AJ; Rued, AC; Carattino, MD				Krauson, Aram J.; Rued, Anna C.; Carattino, Marcelo D.			Independent Contribution of Extracellular Proton Binding Sites to ASIC1a Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid Sensing Ion Channels (ASIC); Enac; Gating; Ion Channels; Site-directed Mutagenesis	SENSING ION CHANNELS; SENSORY NEURONS; SODIUM-CHANNEL; SELECTIVITY; PLASTICITY; SENSATION; ISCHEMIA; DOMAIN; PAIN; 1A	Background: Protons activate ASIC1a by an unknown mechanism. Results: E79K and D345K mutants showed shifted biphasic proton activation curves. The introduction of Lys residues at both of these sites restrained to a large extent proton gating. Conclusion: Two independent proton binding sites in the extracellular region of each subunit contribute to ASIC1a activation. Significance: These findings are relevant to understand the process of activation of ASIC1a. Acid-sensing ion channels (ASICs) are a group of trimeric cation permeable channels gated by extracellular protons that are mainly expressed in the nervous system. Despite the structural information available for ASIC1, there is limited understanding of the molecular mechanism that allows these channels to sense and respond to drops in extracellular pH. In this report, we employed the substituted cysteine accessibility method and site-directed mutagenesis to examine the mechanism of activation of ASIC1a by extracellular protons. We found that the modification of E238C and D345C channels by MTSET reduced proton apparent affinity for activation. Furthermore, the introduction of positively charged residues at position 345 rendered shifted biphasic proton activation curves. Likewise, channels bearing mutations at positions 79 and 416 in the palm domain of the channel showed reduced proton apparent affinity and biphasic proton activation curves. Of significance, the effect of the mutations at positions 79 and 345 on channel activation was additive. E79K-D345K required a change to a pH lower than 2 for maximal activation. In summary, this study provides direct evidence for the presence of two distinct proton coordination sites in the extracellular region of ASIC1a, which jointly facilitate pore opening in response to extracellular acidification.	[Krauson, Aram J.; Rued, Anna C.; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu	Krauson, Aram/ABH-1593-2021; Krauson, Aram J/M-4866-2013	Krauson, Aram/0000-0001-7948-5730; Krauson, Aram J/0000-0001-7948-5730	National Institutes of Health [R01 DK084060, T32 DK061296, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060, P30DK079307, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health R01 DK084060 (to M. D. C.), T32 DK061296, and P30 DK079307.	Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Carattino MD, 2012, J BIOL CHEM, V287, P12927, DOI 10.1074/jbc.M111.329284; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Duan B, 2011, J NEUROSCI, V31, P2101, DOI 10.1523/JNEUROSCI.4351-10.2011; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	26	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34375	34383		10.1074/jbc.M113.504324	http://dx.doi.org/10.1074/jbc.M113.504324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142696	hybrid, Green Published			2022-12-25	WOS:000329812800009
J	Tsanev, R; Vanatalu, K; Jarvet, J; Tanner, R; Laur, K; Tiigimagi, P; Kragelund, BB; Osterlund, T; Kogerman, P				Tsanev, Robert; Vanatalu, Kalju; Jarvet, Jueri; Tanner, Risto; Laur, Kristi; Tiigimaegi, Piret; Kragelund, Birthe B.; Osterlund, Torben; Kogerman, Priit			The Transcriptional Repressor Domain of Gli3 Is Intrinsically Disordered	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN; SUPPRESSOR; BINDING; LONG	The transcription factor Gli3 is acting mainly as a transcriptional repressor in the Sonic hedgehog signal transduction pathway. Gli3 contains a repressor domain in its N-terminus from residue G106 to E236. In this study we have characterized the intracellular structure of the Gli3 repressor domain using a combined bioinformatics and experimental approach. According to our findings the Gli3 repressor domain while being intrinsically disordered contains predicted anchor sites for partner interactions. The obvious interaction partners to test were Ski and DNA; however, with both of these the structure of Gli3 repressor domain remained disordered. To locate residues important for the repressor function we mutated several residues within the Gli3 repressor domain. Two of these, H141A and H157N, targeting predicted helical regions, significantly decreased transcriptional repression and thus identify important functional parts of the domain.	[Tsanev, Robert; Vanatalu, Kalju; Laur, Kristi; Tiigimaegi, Piret; Kogerman, Priit] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Jarvet, Jueri; Tanner, Risto] NICPB, Tallinn, Estonia; [Kragelund, Birthe B.] Univ Copenhagen, Struct Biol & Nucl Magnet Resonance Lab, Copenhagen, Denmark; [Osterlund, Torben] Zealand Pharma AS, Mol Pharmacol, Glostrup, Denmark	Tallinn University of Technology; National Institute of Chemical Physics & Biophysics (NICPB); University of Copenhagen; Zealand Pharma A/S	Tsanev, R (corresponding author), Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia.	robert.tsanev@ttu.ee	Jarvet, Jüri/A-7330-2008; Kragelund, Birthe/M-3927-2014	Jarvet, Jüri/0000-0002-7863-1887; Kragelund, Birthe/0000-0002-7454-1761; Tanner, Risto/0000-0001-6926-2752; Osterlund, Torben/0000-0002-2047-767X	Wellcome Trust; Estonian Science Foundation [8116, 7279, 6847]; Estonian Ministry of Education and Research Targeted Financing Theme [SF0690034s09]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Science Foundation; Estonian Ministry of Education and Research Targeted Financing Theme	This study was supported by the Wellcome Trust and Estonian Science Foundation (grant 8116 to P. K., 7279 to T.O., and 6847 to K. V.) and Estonian Ministry of Education and Research Targeted Financing Theme SF0690034s09 to J.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batey S, 2008, J MOL BIOL, V378, P297, DOI 10.1016/j.jmb.2008.02.032; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Crowley PB, 2011, CHEMBIOCHEM, V12, P1043, DOI 10.1002/cbic.201100063; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Johansen D, 2011, BIOPHYS J, V100, P1120, DOI 10.1016/j.bpj.2011.01.020; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Polyanichko AM, 2006, BIOPOLYMERS, V83, P182, DOI 10.1002/bip.20544; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; SUZUKI M, 1990, NATURE, V344, P562, DOI 10.1038/344562a0; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Tsanev R, 2009, FEBS LETT, V583, P224, DOI 10.1016/j.febslet.2008.12.010; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; ZHANG YZ, 1995, PROTEIN SCI, V4, P804	37	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76972	10.1371/journal.pone.0076972	http://dx.doi.org/10.1371/journal.pone.0076972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146948	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200028
J	Delye, C; Deulvot, C; Chauvel, B				Delye, Christophe; Deulvot, Chrystel; Chauvel, Bruno			DNA Analysis of Herbarium Specimens of the Grass Weed Alopecurus myosuroides Reveals Herbicide Resistance Pre-Dated Herbicides	PLOS ONE			English	Article							A CARBOXYLASE INHIBITORS; ACETYL-COA CARBOXYLASE; COENZYME; EVOLUTION; AMPLIFICATION; MUTATIONS; FITNESS; COSTS	Acetyl-CoA carboxylase (ACCase) alleles carrying one point mutation that confers resistance to herbicides have been identified in arable grass weed populations where resistance has evolved under the selective pressure of herbicides. In an effort to determine whether herbicide resistance evolves from newly arisen mutations or from standing genetic variation in weed populations, we used herbarium specimens of the grass weed Alopecurus myosuroides to seek mutant ACCase alleles carrying an isoleucine-to-leucine substitution at codon 1781 that endows herbicide resistance. These specimens had been collected between 1788 and 1975, i.e., prior to the commercial release of herbicides inhibiting ACCase. Among the 734 specimens investigated, 685 yielded DNA suitable for PCR. Genotyping the ACCase locus using the derived Cleaved Amplified Polymorphic Sequence (dCAPS) technique identified one heterozygous mutant specimen that had been collected in 1888. Occurrence of a mutant codon encoding a leucine residue at codon 1781 at the heterozygous state was confirmed in this specimen by sequencing, clearly demonstrating that resistance to herbicides can pre-date herbicides in weeds. We conclude that point mutations endowing resistance to herbicides without having associated deleterious pleiotropic effects can be present in weed populations as part of their standing genetic variation, in frequencies higher than the mutation frequency, thereby facilitating their subsequent selection by herbicide applications.	[Delye, Christophe; Deulvot, Chrystel; Chauvel, Bruno] INRA, Agroecol UMR1347, F-21034 Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Delye, C (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	delye@dijon.inra.fr			Bayer CropScience SA (Lyon, France)	Bayer CropScience SA (Lyon, France)	The authors are grateful to Bayer CropScience SA (Lyon, France) for supporting this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Chauvel B, 2012, CROP PROT, V42, P320, DOI 10.1016/j.cropro.2012.07.011; Cozzolino S, 2007, CONSERV GENET, V8, P629, DOI 10.1007/s10592-006-9209-7; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Delye C, 2007, WEED RES, V47, P95, DOI 10.1111/j.1365-3180.2007.00544.x; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, WEED RES, V45, P323, DOI 10.1111/j.1365-3180.2005.00467.x; Delye C, 2004, MOL BIOL EVOL, V21, P884, DOI 10.1093/molbev/msh095; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; DELYE C, 2013, TRENDS GENET, DOI DOI 10.1016/J.TIG.2013.06.001.PUBMED:23830583; Delye C, 2010, BASIC APPL ECOL, V11, P504, DOI 10.1016/j.baae.2010.06.008; Delye C, 2013, ANN BOT-LONDON, V111, P681, DOI 10.1093/aob/mct018; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; Delye C, 2010, NEW PHYTOL, V186, P1005, DOI 10.1111/j.1469-8137.2010.03233.x; Ffrench-Constant RH, 2007, TRENDS GENET, V23, P1, DOI 10.1016/j.tig.2006.11.006; Gressel J, 2006, P NATL ACAD SCI USA, V103, P12215, DOI 10.1073/pnas.0603666103; Gugerli F, 2005, NEW PHYTOL, V166, P409, DOI 10.1111/j.1469-8137.2005.01360.x; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Jasieniuk M, 1996, WEED SCI, V44, P176, DOI 10.1017/S0043174500093747; Johnsson H, 1944, HEREDITAS, V30, P469; Menchari Y, 2008, J APPL ECOL, V45, P939, DOI 10.1111/j.1365-2664.2008.01462.x; Moss SR, 2007, WEED TECHNOL, V21, P300, DOI 10.1614/WT-06-087.1; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; RENDINA AR, 1988, PLANT PHYSIOL, V86, P983, DOI 10.1104/pp.86.4.983; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Sundar D.R, 2009, BINOM BINOMIAL CONFI; Telle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003584; VANHIMME M, 1975, P EUR WEED RES SOC S, P23; Vila-Aiub MM, 2011, HEREDITY, V107, P386, DOI 10.1038/hdy.2011.29; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Wang T, 2010, HEREDITY, V105, P394, DOI 10.1038/hdy.2009.183	35	27	30	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75117	10.1371/journal.pone.0075117	http://dx.doi.org/10.1371/journal.pone.0075117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146749	Green Published, gold			2022-12-25	WOS:000326019400004
J	Gazi, M; Caro-Gomez, E; Goez, Y; Cespedes, MA; Hidalgo, M; Correa, P; Valbuena, G				Gazi, Michal; Caro-Gomez, Erika; Goez, Yenny; Cespedes, Maria A.; Hidalgo, Marylin; Correa, Paula; Valbuena, Gustavo			Discovery of a Protective Rickettsia prowazekii Antigen Recognized by CD8(+) T Cells, RP884, Using an In Vivo Screening Platform	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; EPIDEMIC TYPHUS; SPOTTED-FEVER; GAMMA-INTERFERON; VACCINIA VIRUS; RESPONSES; IMMUNITY; CONORII; PROTEIN; IMMUNIZATION	Rickettsia prowazekii has been tested for biological warfare due to the high mortality that it produces after aerosol transmission of very low numbers of rickettsiae. Epidemic typhus, the infection caused by these obligately intracellular bacteria, continues to be a threat because it is difficult to diagnose due to initial non-specific symptoms and the lack of commercial diagnostic tests that are sensitive and specific during the initial clinical presentation. A vaccine to prevent epidemic typhus would constitute an effective deterrent to the weaponization of R. prowazekii; however, an effective and safe vaccine is not currently available. Due to the cytoplasmic niche of Rickettsia, CD8(+) T-cells are critical effectors of immunity; however, the identification of antigens recognized by these cells has not been systematically addressed. To help close this gap, we designed an antigen discovery strategy that uses cell-based vaccination with antigen presenting cells expressing microbe's proteins targeted to the MHC class I presentation pathway. We report the use of this method to discover a protective T-cell rickettsial antigen, RP884, among a test subset of rickettsial proteins.	[Gazi, Michal; Caro-Gomez, Erika; Goez, Yenny; Cespedes, Maria A.; Valbuena, Gustavo] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Hidalgo, Marylin] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Bogota, Colombia; [Correa, Paula] Univ Antioquia, Grp Inmunomodulac, Fac Med, Medellin, Colombia; [Valbuena, Gustavo] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis,Inst Translat Sc, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Pontificia Universidad Javeriana; Universidad de Antioquia; University of Texas System; University of Texas Medical Branch Galveston	Valbuena, G (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	gvalbuen@utmb.edu	Hidalgo, Marylin/AAF-5736-2019	Correa, Paula/0000-0002-0941-9700; Caro, Erika/0000-0002-5960-1295; Hidalgo, Marylin/0000-0001-8960-0616	NIAID/NIH [5U54AI057156-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number 5U54AI057156-09 from NIAID/NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bechah Y, 2008, LANCET INFECT DIS, V8, P417, DOI 10.1016/S1473-3099(08)70150-6; CHURILLA A, 1990, ANN NY ACAD SCI, V590, P215, DOI 10.1111/j.1749-6632.1990.tb42222.x; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Farhang Azad A., 1988, P51; Feng HM, 1997, J IMMUNOL, V158, P5314; Feng HM, 2003, VACCINE, V21, P3901, DOI 10.1016/S0264-410X(03)00301-3; FENG HM, 1994, INFECT IMMUN, V62, P1952, DOI 10.1128/IAI.62.5.1952-1960.1994; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Hailing-Brown M, 2008, TRENDS IMMUNOL, V29, P374, DOI 10.1016/j.it.2008.06.001; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Jing L, 2008, J VIROL, V82, P7120, DOI 10.1128/JVI.00453-08; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; LI H, 1987, INFECT IMMUN, V55, P1252, DOI 10.1128/IAI.55.5.1252-1255.1987; Li Z, 2003, INFECT IMMUN, V71, P3920, DOI 10.1128/IAI.71.7.3920-3926.2003; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MASON RA, 1976, J BIOL STAND, V4, P217, DOI 10.1016/S0092-1157(76)80006-6; MOE JB, 1980, MIL MED, V145, P780; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; Riedl P, 2009, J IMMUNOL, V183, P370, DOI 10.4049/jimmunol.0900505; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Stemke-Hale K, 2005, VACCINE, V23, P3016, DOI 10.1016/j.vaccine.2004.12.013; Stuehler C, 2011, BLOOD, V117, P5881, DOI 10.1182/blood-2010-12-325084; SUMNER JW, 1995, VACCINE, V13, P29, DOI 10.1016/0264-410X(95)80007-Z; Sykes K, 2008, EXPERT REV VACCINES, V7, P1395, DOI 10.1586/14760584.7.9.1395; Valbuena G, 2004, J INFECT DIS, V190, P1221, DOI 10.1086/423819; Walker DH, 2009, VACCINE, V27, pD52, DOI 10.1016/j.vaccine.2009.07.045; Walker DH, 2000, LAB INVEST, V80, P1361, DOI 10.1038/labinvest.3780144; Walker DH, 2001, INFECT IMMUN, V69, P1841, DOI 10.1128/IAI.69.3.1841-1846.2001; WALKER DH, 1980, LAB INVEST, V43, P388; WOODWARD TE, 1986, S AFR MED J, P73; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zinsser H, 1933, NEW ENGL J MED, V209, P815, DOI 10.1056/NEJM193310262091701	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76253	10.1371/journal.pone.0076253	http://dx.doi.org/10.1371/journal.pone.0076253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146844	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400046
J	Lupatini, M; Suleiman, AKA; Jacques, RJS; Antoniolli, ZI; Kuramae, EE; Camargo, FAD; Roesch, LFW				Lupatini, Manoeli; Ahmad Suleiman, Afnan Khalil; Seminoti Jacques, Rodrigo Josemar; Antoniolli, Zaida Ines; Kuramae, Eiko Eurya; de Oliveira Camargo, Flavio Anastacio; Wuerdig Roesch, Luiz Fernando			Soil-Borne Bacterial Structure and Diversity Does Not Reflect Community Activity in Pampa Biome	PLOS ONE			English	Article							LAND-USE; MICROBIAL COMMUNITIES; FUNGAL COMMUNITIES; ENZYME-ACTIVITIES; PSEUDOREPLICATION; PH	The Pampa biome is considered one of the main hotspots of the world's biodiversity and it is estimated that half of its original vegetation was removed and converted to agricultural land and tree plantations. Although an increasing amount of knowledge is being assembled regarding the response of soil bacterial communities to land use change, to the associated plant community and to soil properties, our understanding about how these interactions affect the microbial community from the Brazilian Pampa is still poor and incomplete. In this study, we hypothesized that the same soil type from the same geographic region but under distinct land use present dissimilar soil bacterial communities. To test this hypothesis, we assessed the soil bacterial communities from four land-uses within the same soil type by 454-pyrosequencing of 16S rRNA gene and by soil microbial activity analyzes. We found that the same soil type under different land uses harbor similar (but not equal) bacterial communities and the differences were controlled by many microbial taxa. No differences regarding diversity and richness between natural areas and areas under anthropogenic disturbance were detected. However, the measures of microbial activity did not converge with the 16S rRNA data supporting the idea that the coupling between functioning and composition of bacterial communities is not necessarily correlated.	[Lupatini, Manoeli; Ahmad Suleiman, Afnan Khalil; Seminoti Jacques, Rodrigo Josemar; Antoniolli, Zaida Ines] Univ Fed Santa Maria, Dept Solos, BR-97119900 Santa Maria, RS, Brazil; [Kuramae, Eiko Eurya] Netherlands Inst Ecol NIOO KANW, Dept Microbial Ecol, Wageningen, Netherlands; [de Oliveira Camargo, Flavio Anastacio] Univ Fed Rio Grande do Sul, Dept Solos, Porto Alegre, RS, Brazil; [Wuerdig Roesch, Luiz Fernando] Univ Fed PAMPA, Sao Gabriel, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidade Federal do Rio Grande do Sul; Universidade Federal do Pampa	Roesch, LFW (corresponding author), Univ Fed PAMPA, Campus Sao Gabriel, Sao Gabriel, RS, Brazil.	luizroesch@unipampa.edu.br	Kuramae, Eiko Eurya/F-4738-2012; Roesch, Luiz/GRS-4638-2022; Jacques, Rodrigo/AAX-1211-2021; Roesch, Luiz F W/D-2838-2009; Camargo, Flavio A O/J-6914-2013; KNAW, NIOO-KNAW/A-4320-2012	Kuramae, Eiko Eurya/0000-0001-6701-8668; Roesch, Luiz F W/0000-0003-1450-8828; KNAW, NIOO-KNAW/0000-0002-3835-159X; camargo, flavio/0000-0003-1080-0549; Suleiman, Afnan/0000-0002-1388-9190; Josemar Seminoti Jacques, Rodrigo/0000-0002-8240-5145	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [479133/2012-3, 476121/2010-8]; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - grant numbers 479133/2012-3 and 476121/2010-8). RJS Jacques, ZI Antoniolli, FAO Camargo and LFW Roesch receive research fellowships from the CNPq. M Lupatini and AKA Suleiman receive research fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Suleiman AKA, 2013, SYST APPL MICROBIOL, V36, P137, DOI 10.1016/j.syapm.2012.10.007; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Baker KL, 2009, SOIL BIOL BIOCHEM, V41, P2292, DOI 10.1016/j.soilbio.2009.08.010; Brazilian Institute of Geography and Statistics-IBGE, 2004, MAP VEG BRAZ MAP BIO; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faoro H, 2010, APPL ENVIRON MICROB, V76, P4744, DOI 10.1128/AEM.03025-09; Felske A, 1998, MICROB ECOL, V36, P31, DOI 10.1007/s002489900090; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HARGROVE WW, 1992, LANDSCAPE ECOL, V6, P251, DOI 10.1007/BF00129703; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kindt R., 2005, WORLD; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Kuramae E, 2011, FEMS MICROBIOL ECOL, V77, P285, DOI 10.1111/j.1574-6941.2011.01110.x; Kuramae EE, 2012, FEMS MICROBIOL ECOL, V79, P12, DOI 10.1111/j.1574-6941.2011.01192.x; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lombard N, 2011, FEMS MICROBIOL ECOL, V78, P31, DOI 10.1111/j.1574-6941.2011.01140.x; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Marshall CB, 2011, SOIL BIOL BIOCHEM, V43, P78, DOI 10.1016/j.soilbio.2010.09.016; Ministry of the Environment-MMA, 2007, BRAZ BIOD PRIOR AR C; MMA (Ministerio do Meio Ambiente), 2002, BRAZILIAN BIODIVERSI; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Osborne CA, 2011, FEMS MICROBIOL ECOL, V78, P70, DOI 10.1111/j.1574-6941.2011.01105.x; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Pillar VP, 2009, SO FIELDS CONSERVATI; R Development Core Team, 2012, R LANG ENV STAT COMP; Roesch L. F. W., 2009, Diversity, V1, P182; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schank JC, 2009, J COMP PSYCHOL, V123, P421, DOI 10.1037/a0013579; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva FC, 2009, HDB CHEM ANAL SOILS; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Stotzky G., 1965, METHODS SOIL ANAL 2, V9, P1550; Suzuki C, 2009, SOIL SCI PLANT NUTR, V55, P80, DOI 10.1111/j.1747-0765.2008.00344.x; Thomson BC, 2010, MICROB ECOL, V59, P335, DOI 10.1007/s00248-009-9575-z; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Upchurch R, 2008, SOIL BIOL BIOCHEM, V40, P1294, DOI 10.1016/j.soilbio.2007.06.027; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Wallenius K, 2011, SOIL BIOL BIOCHEM, V43, P1464, DOI 10.1016/j.soilbio.2011.03.018; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williams MA, 2013, SOIL BIOL BIOCHEM, V57, P749, DOI 10.1016/j.soilbio.2012.08.023; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003	64	37	37	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76465	10.1371/journal.pone.0076465	http://dx.doi.org/10.1371/journal.pone.0076465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146873	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400061
J	Smrz, J; Kovac, L; Mikes, J; Lukesova, A				Smrz, Jaroslav; Kovac, Lubomir; Mikes, Jaromir; Lukesova, Alena			Microwhip Scorpions (Palpigradi) Feed on Heterotrophic Cyanobacteria in Slovak Caves - A Curiosity among Arachnida	PLOS ONE			English	Article							FINE-STRUCTURE; ACARI; HEMOCYTES	To date, only morphological and anatomical descriptions of microwhip scorpions (Arachnida: Palpigradi) have been published. This very rare group is enigmatic not only in its relationships to other arachnids, but especially due to the fact that these animals dwell only underground (in caves, soil, and interstitial spaces). We observed the curious feeding habit of the microwhip scorpion Eukoenenia spelaea over the course of one year in Ardovska Cave, located in Slovakia's Karst region. We chose histology as our methodology in studying 17 specimens and based it upon Masson's triple staining, fluorescent light and confocal microscopy. Single-celled cyanobacteria (blue-green algae) were conspicuously predominant in the gut of all studied palpigrades. Digestibility of the consumed cyanobacteria was supported by the presence of guanine crystals, glycogen deposits and haemocytes inside the palpigrade body. Cyanobacteria, the oldest cellular organisms on Earth, are very resistant to severe conditions in caves, including even darkness. Therefore, the cyanobacteria are able to survive in dark caves as nearly heterotrophic organisms and are consumed by cave palpigrades. Such feeding habit is extraordinary within the almost wholly predacious orders of the class Arachnida, and particularly so due to the type of food observed.	[Smrz, Jaroslav] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Kovac, Lubomir; Mikes, Jaromir] Safarik Univ, Inst Biol & Ecol, Fac Sci, Kosice, Slovakia; [Lukesova, Alena] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	Charles University Prague; University of Pavol Jozef Safarik Kosice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Smrz, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	smrz@cesnet.cz	Kováč, Ľubomír/J-5954-2015; Lukešová, Alena/G-1451-2014; Mikes, Jaromir/X-3588-2019	Kováč, Ľubomír/0000-0001-8194-2128; Mikes, Jaromir/0000-0002-9941-7855	Slovak Research and Development Agency [VVCE-0001-07]; NEXO (Network of Excellence in Oncology) [007/20092.1/OPVaV]; Ministry of Education of the Czech Republic [MSM 0021620828]	Slovak Research and Development Agency(Slovak Research and Development Agency); NEXO (Network of Excellence in Oncology); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	The study was supported by the Slovak Research and Development Agency under contract no. VVCE-0001-07 and the NEXO (Network of Excellence in Oncology) under contract no. 007/20092.1/OPVaV and by grant MSM 0021620828 from the Ministry of Education of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullin SR, 2009, RUSS J ECOL+, V40, P301, DOI 10.1134/S1067413609040122; ALBERTI G, 1979, ZOOMORPHOLOGIE, V94, P111, DOI 10.1007/BF00994060; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; BRINTON LP, 1971, J PARASITOL, V57, P1110, DOI 10.2307/3277874; Bronn, 1943, KLASSEN ORDNUNGEN TI, V5, P1; CASTENHOLZ RW, 1992, J PHYCOL, V28, P737, DOI 10.1111/j.0022-3646.1992.00737.x; Christian Erhard, 1998, Senckenbergiana Biologica, V77, P241; FAY P, 1965, J GEN MICROBIOL, V39, P11, DOI 10.1099/00221287-39-1-11; Flechtner V. R., 1999, ENIGMATIC MICROORGAN, P231; Hammen L. van der, 1969, Zoologische Mededeelingen Leiden, V44, P41; Imms AD, 1973, GEN TXB ENTOMOLOGY; Kalina T., 2005, CYANOBACTERIA ALGAE; Kova L., 2002, STUDIES SOIL FAUNA C, P93; Kovac L'ubomir, 1999, P157; Krantz G., 2009, MANUAL ACAROLOGY; Lamprinou V, 2009, FOTTEA, V9, P155, DOI 10.5507/fot.2009.014; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; Martinez A, 2010, J CAVE KARST STUD, V72, P11, DOI 10.4311/jcks2009lsc0082; Millot J., 1943, REV FRANC ENT, V9, P127; Millot J., 1942, REV FRANC ENT, V9, P33; Monniot F., 1966, Rev Ecol Biol Sci, V3, P41; Novakova A, 2005, CONTRIBUTIONS SOIL Z, P107; Roewer CF, 1943, BRONNS KLASSEN ORDNU, V5, P640; ROWLAND JM, 1980, J ARACHNOL, V8, P69; Ruckeb Augusta, 1903, Zoologische Jahrbuecher (Systematik), Vxviii, P401; SMRZ J, 1989, J MORPHOL, V200, P215, DOI 10.1002/jmor.1052000210; Smrz J, 2000, PEDOBIOLOGIA, V44, P175, DOI 10.1078/S0031-4056(04)70036-0; Smrz J, 2002, EUR J SOIL BIOL, V38, P35, DOI 10.1016/S1164-5563(01)01120-7; Smrz J, 2006, EUR J ENTOMOL, V103, P679, DOI 10.14411/eje.2006.088; Sustr V, 2005, EUR J SOIL BIOL, V41, P69, DOI 10.1016/j.ejsobi.2005.09.008; Symonova R, 2009, J CRUSTACEAN BIOL, V29, P18, DOI 10.1651/08-3003.1; Taylor T.N., 1996, PALYNOLOGY PRINCIPLE, P427; van der Hammen L., 1982, ZOOL VERH, V196, P1; Vandel A., 1965, BIOSPELEOLOGY BIOL C; Vinogradova ON, 2000, ALGAE, V2, P41	35	17	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75989	10.1371/journal.pone.0075989	http://dx.doi.org/10.1371/journal.pone.0075989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146804	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400028
J	Alqudah, MAY; Agarwal, S; Al-Keilani, MS; Sibenaller, ZA; Ryken, TC; Assem, M				Alqudah, Mohammad A. Y.; Agarwal, Supreet; Al-Keilani, Maha S.; Sibenaller, Zita A.; Ryken, Timothy C.; Assem, Mahfoud			NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN D1; GLIOBLASTOMA; PATHWAY; GROWTH; CANCER; PROGRESSION; INHIBITION; RECEPTOR	Using a GWA analysis of a comprehensive glioma specimen population, we identified whole gain of chromosome 19 as one of the major chromosomal aberrations that correlates to patients' outcomes. Our analysis of significant loci revealed for the first time NOTCH3 as one of the most significant amplification. NOTCH3 amplification is associated with worse outcome compared to tumors with non-amplified locus. NOTCH receptors (NOTCH1-4) are key positive regulators of cell-cell interactions, angiogenesis, cell adhesion and stem cell niche development which have been shown to play critical roles in several human cancers. Our objective is to determine the molecular roles of NOTCH3 in glioma pathogenesis and aggressiveness. Here we show for the first time that NOTCH3 plays a major role in glioma cell proliferation, cell migration, invasion and apoptosis. Therefore, our study uncovers the prognostic value and the oncogenic function of NOTCH3 in gliomagenesis and supports NOTCH3 as a promising target of therapy in high grade glioma. Our studies allowed the identification of a subset of population that may benefit from GSI- or anti-NOTCH3- based therapies. This may lead to the design of novel strategies to improve therapeutic outcome of patients with glioma by establishing medical and scientific basis for personalized chemotherapies.	[Alqudah, Mohammad A. Y.; Agarwal, Supreet; Al-Keilani, Maha S.; Assem, Mahfoud] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Sibenaller, Zita A.; Ryken, Timothy C.] Univ Iowa, Dept Neurosurg & Radiat Oncol, Iowa City, IA 52242 USA; [Ryken, Timothy C.] Iowa Spine & Brain Inst, Dept Neurosurg, Waterloo, IA USA	University of Iowa; University of Iowa	Assem, M (corresponding author), Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA.	mahfoud-assem@uiowa.edu	agarwal, supreet/AAI-7296-2021	Alqudah, Mohammad/0000-0001-7210-7964	Institute of Clinical and Translational Science at the University of Iowa; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) [UL1RR024979]; American Cancer Society [IRG-77-004-34]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER	Institute of Clinical and Translational Science at the University of Iowa; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Institute of Clinical and Translational Science at the University of Iowa award. This publication was made possible by Grant Number UL1RR024979 from the National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CTSA or NIH. This research was also supported through the Institutional Research Grant Number IRG-77-004-34 from the American Cancer Society, administered through The Holden Comprehensive Cancer Center at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062852; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Assem M, 2012, OMICS, V16, P113, DOI 10.1089/omi.2011.0031; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bellavia D, 2007, CELL CYCLE, V6, P2730, DOI 10.4161/cc.6.22.4894; Burton EC, 2002, CANCER RES, V62, P6205; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Dang L, 2006, DEV NEUROSCI-BASEL, V28, P58, DOI 10.1159/000090753; Dang TP, 2012, ADV EXP MED BIOL, V727, P199, DOI 10.1007/978-1-4614-0899-4_15; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fassl A, 2012, ONCOGENE, V31, P4698, DOI 10.1038/onc.2011.615; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Huhn SL, 1999, CLIN CANCER RES, V5, P1435; Lin J, 2010, ARCH MED RES, V41, P519, DOI 10.1016/j.arcmed.2010.10.006; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Opferman JT, 2006, CELL DEATH DIFFER, V13, P1260, DOI 10.1038/sj.cdd.4401978; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Reardon DA, 2012, BRIT J CANCER, V107, P1481, DOI 10.1038/bjc.2012.415; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Tchorz JS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.65; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Xiang J, 2012, CL LYMPH MYELOM LEUK, V12, P59, DOI 10.1016/j.clml.2011.07.005; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yao J, 2010, MED ONCOL, V27, P1017, DOI 10.1007/s12032-009-9326-5; Zhang XH, 2012, CANCER SCI, V103, P181, DOI 10.1111/j.1349-7006.2011.02154.x	38	36	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77299	10.1371/journal.pone.0077299	http://dx.doi.org/10.1371/journal.pone.0077299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143218	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100055
J	Ikotun, OF; Marquez, BV; Huang, CF; Masuko, K; Daiji, M; Masuko, T; McConathy, J; Lapi, SE				Ikotun, Oluwatayo F.; Marquez, Bernadette V.; Huang, Chaofeng; Masuko, Kazue; Daiji, Miyamoto; Masuko, Takashi; McConathy, Jonathan; Lapi, Suzanne E.			Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MONOCLONAL-ANTIBODIES; HEAVY-CHAIN; IN-VIVO; PET; EXPRESSION; CANCER; TUMORS; F-18-FDG; PROTEIN	The L-type amino acid transporter-1 (LAT1, SLC7A5) is upregulated in a wide range of human cancers, positively correlated with the biological aggressiveness of tumors, and a promising target for both imaging and therapy. Radiolabeled amino acids such as O-(2-[F-18]fluoroethyl)-L-tyrosine (FET) that are transport substrates for system L amino acid transporters including LAT1 have met limited success for oncologic imaging outside of the brain, and thus new strategies are needed for imaging LAT1 in systemic cancers. Here, we describe the development and biological evaluation of a novel zirconium-89 labeled antibody, [Zr-89]DFO-Ab2, targeting the extracellular domain of LAT1 in a preclinical model of colorectal cancer. This tracer demonstrated specificity for LAT1 in vitro and in vivo with excellent tumor imaging properties in mice with xenograft tumors. PET imaging studies showed high tumor uptake, with optimal tumor-to-non target contrast achieved at 7 days post administration. Biodistribution studies demonstrated tumor uptake of 10.5 +/- 1.8 percent injected dose per gram (%ID/g) at 7 days with a tumor to muscle ratio of 13 to 1. In contrast, the peak tumor uptake of the radiolabeled amino acid [F-18]FET was 4.4 +/- 0.5 % ID/g at 30 min after injection with a tumor to muscle ratio of 1.4 to 1. Blocking studies with unlabeled anti-LAT1 antibody demonstrated a 55% reduction of [Zr-89] DFO-Ab2 accumulation in the tumor at 7 days. These results are the first report of direct PET imaging of LAT1 and demonstrate the potential of immunoPET agents for imaging specific amino acid transporters.	[Ikotun, Oluwatayo F.; Marquez, Bernadette V.; Huang, Chaofeng; McConathy, Jonathan; Lapi, Suzanne E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Masuko, Kazue; Daiji, Miyamoto; Masuko, Takashi] Kinki Univ, Sch Pharm, Cell Biol Lab, Dept Pharmaceut Sci, Osaka, Japan	Washington University (WUSTL); Kindai University (Kinki University)	Lapi, SE (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	lapis@mir.wustl.edu		marquez-nostra, bernadette/0000-0001-9024-0750	American Cancer Society [PFTED-10-208-01-SIED]; National Cancer Institute [K08CA154790]; Mallinckrodt Institute of Radiology; NATIONAL CANCER INSTITUTE [P30CA091842, K08CA154790] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mallinckrodt Institute of Radiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	O. F. Ikotun is supported by the American Cancer Society (PFTED-10-208-01-SIED). Dr. McConathy is supported by the National Cancer Institute (K08CA154790) and the Mallinckrodt Institute of Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou DS, 2011, NUCL MED BIOL, V38, P675, DOI 10.1016/j.nucmedbio.2010.12.011; Boado RJ, 2007, BIOTECHNOL BIOENG, V97, P1376, DOI 10.1002/bit.21369; Chang AJ, 2013, MOL IMAGING, V12, P1, DOI 10.2310/7290.2012.00016; Chen W, 2006, J NUCL MED, V47, P904; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Dijkers ECF, 2009, J NUCL MED, V50, P974, DOI 10.2967/jnumed.108.060392; Fan XT, 2010, BIOCHEM PHARMACOL, V80, P811, DOI 10.1016/j.bcp.2010.05.021; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Grosu AL, 2011, INT J RADIAT ONCOL, V81, P1049, DOI 10.1016/j.ijrobp.2010.07.002; Haase C, 2007, J NUCL MED, V48, P2063, DOI 10.2967/jnumed.107.043620; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Jager PL, 2001, J NUCL MED, V42, P432; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kaira K, 2009, CANCER SCI, V100, P249, DOI 10.1111/j.1349-7006.2008.01029.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Lahoutte T, 2004, J NUCL MED, V45, P1591; Lee TS, 2009, NUCL MED BIOL, V36, P681, DOI 10.1016/j.nucmedbio.2009.03.009; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Masuko T, 2011, CANCER SCI, V102, P25, DOI 10.1111/j.1349-7006.2010.01741.x; Mishra V, 2006, J DRUG TARGET, V14, P45, DOI 10.1080/10611860600612953; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Nayak TK, 2012, J NUCL MED, V53, P113, DOI 10.2967/jnumed.111.094169; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ohkawa M, 2011, BIOCHEM BIOPH RES CO, V406, P649, DOI 10.1016/j.bbrc.2011.02.135; Ohno Y, 2008, CANCER SCI, V99, P1000, DOI 10.1111/j.1349-7006.2008.00770.x; Pauleit D, 2004, J NUCL MED, V45, P374; Pauleit D, 2009, NUCL MED BIOL, V36, P779, DOI 10.1016/j.nucmedbio.2009.05.005; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Sai KKS, 2013, J NUCL MED, V54, P1120, DOI 10.2967/jnumed.112.113217; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Spaeth N, 2004, J NUCL MED, V45, P1931; TEIXEIRA S, 1987, J BIOL CHEM, V262, P9574; Vosjan MJWD, 2010, NAT PROTOC, V5, P739, DOI 10.1038/nprot.2010.13; Watanabe H, 2000, EUR J NUCL MED, V27, P1509, DOI 10.1007/s002590000344; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Youland RS, 2013, J NEURO-ONCOL, V111, P11, DOI 10.1007/s11060-012-0986-1; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zuhayra M, 2009, BIOORGAN MED CHEM, V17, P7441, DOI 10.1016/j.bmc.2009.09.029	41	29	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77476	10.1371/journal.pone.0077476	http://dx.doi.org/10.1371/journal.pone.0077476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143237	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100074
J	Izikki, M; Mercier, O; Lecerf, F; Guin, LL; Hoang, E; Dorfmuller, P; Perros, F; Humbert, M; Simonneau, G; Dartevelle, P; Fadel, E; Eddahibi, S				Izikki, Mohamed; Mercier, Olaf; Lecerf, Florence; Guin, Lauriane Lubert; Hoang, Eric; Dorfmueller, Peter; Perros, Frederic; Humbert, Marc; Simonneau, Gerald; Dartevelle, Philippe; Fadel, Elie; Eddahibi, Saadia			The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats	PLOS ONE			English	Article							MUSCLE-CELL APOPTOSIS; GROWTH-FACTOR; ORGAN-CULTURE; DNA-SYNTHESIS; INHIBITION; PROLIFERATION; CARCINOMA; ARTERIES; BINDING	Background: Pulmonary hypertension (PH) is a progressive disorder characterized by an increase in pulmonary artery pressure and structural changes in the pulmonary vasculature. Several observations indicate that growth factors play a key role in PH by modulating pulmonary artery smooth muscle cell (PA-SMC) function. In rats, established monocrotaline-induced PH (MCT-PH) can be reversed by blocking platelet-derived growth factor receptors (PDGF-R), epidermal growth factor receptors (EGF-R), or fibroblast growth factor receptors (FGF-R). All these receptors belong to the receptor tyrosine kinase (RTK) family. Methods and Results: We evaluated whether RTK blockade by the nonspecific growth factor inhibitor, suramin, reversed advanced MCT-PH in rats via its effects on growth-factor signaling pathways. We found that suramin inhibited RTK and ERK1/2 phosphorylation in cultured human PA-SMCs. Suramin inhibited PA-SMC proliferation induced by serum, PDGF, FGF2, or EGF in vitro and ex vivo. Treatment with suramin from day 1 to day 21 after monocrotaline injection attenuated PH development, as shown by lower values for pulmonary artery pressure, right ventricular hypertrophy, and distal vessel muscularization on day 21 compared to control rats. Treatment with suramin from day 21 to day 42 after monocrotaline injection reversed established PH, thereby normalizing the pulmonary artery pressure values and vessel structure. Suramin treatment suppressed PA-SMC proliferation and attenuated both the inflammatory response and the deposition of collagen. Conclusions: RTK blockade by suramin can prevent MCT-PH and reverse established MCT-PH in rats. This study suggests that an anti-RTK strategy that targets multiple RTKs could be useful in the treatment of pulmonary hypertension.	[Izikki, Mohamed; Lecerf, Florence; Guin, Lauriane Lubert; Hoang, Eric; Dorfmueller, Peter; Perros, Frederic; Humbert, Marc; Simonneau, Gerald; Fadel, Elie; Eddahibi, Saadia] INSERM, U999, Le Plessis Robinson, France; [Mercier, Olaf; Lecerf, Florence; Dorfmueller, Peter; Dartevelle, Philippe; Fadel, Elie; Eddahibi, Saadia] Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue	Eddahibi, S (corresponding author), INSERM, U999, Le Plessis Robinson, France.	saadia.eddahibi@inserm.fr	Humbert, Marc/ABD-5112-2021; Perros, Frédéric/N-6921-2017; Simonneau, Gerald/ABE-6614-2020; Humbert, Marc/AAC-8459-2019	Perros, Frédéric/0000-0001-7730-2427; Humbert, Marc/0000-0003-0703-2892; Mercier, Olaf/0000-0002-4760-6267; Dorfmuller, Peter/0000-0003-2499-6829	INSERM; Agence National de la Recherche [ANR-08-GENOPAT-004]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR))	This study was supported by grants from the INSERM, and the Agence National de la Recherche (ANR-08-GENOPAT-004 to S. E., A. L-V and M. H.). This article reflects only the authors' views and under no circumstances is the European Community liable for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan YS, 2003, J APPL PHYSIOL, V95, P771, DOI 10.1152/japplphysiol.00915.2002; Cowan KN, 1999, CIRC RES, V84, P1223, DOI 10.1161/01.RES.84.10.1223; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Ghofrani HA, 2010, AM J RESP CRIT CARE, V182, P1171, DOI 10.1164/rccm.201001-0123OC; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Karam Gholamreza Asadi, 2005, Pak J Pharm Sci, V18, P46; LESCHEY KH, 1991, INVEST OPHTH VIS SCI, V32, P1770; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Mekontso-Dessap A, 2006, J THORAC CARDIOV SUR, V131, P651, DOI 10.1016/j.jtcvs.2005.08.048; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; MOTZER RJ, 1992, CANCER RES, V52, P5775; MYERS C, 1992, J CLIN ONCOL, V10, P881, DOI 10.1200/JCO.1992.10.6.881; RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818, DOI 10.1152/ajpheart.1979.236.6.H818; Raj P A, 1998, Angiogenesis, V2, P183, DOI 10.1023/A:1009244623717; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Shi WB, 1997, J APPL PHYSIOL, V83, P1476, DOI 10.1152/jappl.1997.83.5.1476; SJOLUND M, 1989, CELL TISSUE RES, V256, P35; Souza R, 2006, THORAX, V61, P736, DOI 10.1136/thx.2006.064097; TAKANO S, 1994, CANCER RES, V54, P2654; WALTHER MM, 1994, J UROLOGY, V152, P1599, DOI 10.1016/S0022-5347(17)32486-2; WILLIAMS LT, 1984, J BIOL CHEM, V259, P5287; Zanghi JA, 2000, BIOTECHNOL PROGR, V16, P319, DOI 10.1021/bp0000353; Zhang YL, 2001, J PHARMACOL EXP THER, V299, P426	27	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77073	10.1371/journal.pone.0077073	http://dx.doi.org/10.1371/journal.pone.0077073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143201	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100036
J	Kolanowska, M				Kolanowska, Marta			Niche Conservatism and the Future Potential Range of Epipactis helleborine (Orchidaceae)	PLOS ONE			English	Article							DISTRIBUTIONS; MODELS	The aim of the present study was to evaluate the current distribution of suitable niches for the invasive orchid species, Epipactis helleborine, and to estimate the possibility of its further expansion. Moreover, niche modeling tools were used to explain its rapid expansion in North America and to test the niche conservatism of the species. The maximum entropy method was used to create models of the suitable niche distribution. A database of E. helleborine localities was prepared based on the examination of herbarium specimens, information from electronic databases as well as data gathered during field works. The differences between the niches occupied by native and invasive populations were evaluated using the niche overlap and niche identity test indexes. Moreover, the coverage of the most suitable habitats for the species was measured for three future scenarios as well as for the present time model. Populations of E. helleborine occupy North American west coast habitats very similar to those preferred by native, Eurasian populations, while the expansion in the east coast is related to the niche shift. The created models of suitable niche distribution indicate that the species does not realize its potential niche in the native range. The total surface of the habitats potentially available for E. helleborine will decrease in all climate change scenarios created for 2080.	Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk	Kolanowska, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020	Kolanowska, Marta/0000-0001-5347-5403				Ackerman J., 2007, LANKESTERIANA, V7, P19, DOI [10.15517/lank.v7i1-2.18386, DOI 10.15517/LANK.V7I1-2.18386]; Adamowski Wojciech, 1995, Wiadomosci Botaniczne, V39, P105; Brenan J. P. M., 1983, WATSONIA, V14, P237; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Defrieri RL, 2011, J SOIL SCI PLANT NUT, V11, P111, DOI 10.4067/S0718-95162011000300009; Delforge P, 2005, GUIDE ORCHIDEES EURO; Dickson J. H., 1990, URBAN ECOL, P245; Dorn R. D., 1984, VASCULAR PLANTS MONT; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 1999, GENET RESOUR CROP EV, V46, P291, DOI 10.1023/A:1008628005016; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Kolanowska M, 2013, PLANT BIOSY IN PRESS; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P47, DOI 10.1111/j.1472-4642.2011.00849.x; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Palaoro AV, 2013, FRESHWATER BIOL, V58, P1379, DOI 10.1111/fwb.12134; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prochazka F, 1983, ORCHIDEJE NASI PRIRO; Ramirez J, 2008, HIGH RESOLUTION STAT; Rebele F, 1998, LANDSCHAFT STADT, V20, P49; Recart W, 2013, BIOL INVASIONS, V15, P283, DOI 10.1007/s10530-012-0283-0; Rodriguez-Robles JA, 2010, MOL ECOL, V19, P1860, DOI 10.1111/j.1365-294X.2010.04616.x; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Squirrell J, 2001, AM J BOT, V88, P1409, DOI 10.2307/3558447; Swiercz A, 2004, PRZEGLAD PRZYRODNICZ, V15, P117; Thiers B., INDEX HERBARIORUM GL; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weber W. A., 1996, COLORADO FLORA E SLO; Zenkert CA, 1949, HOBBIES, V29, P93; [No title captured]	45	33	36	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77352	10.1371/journal.pone.0077352	http://dx.doi.org/10.1371/journal.pone.0077352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143222	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100059
J	Mohr, AM; Bailey, JM; Lewallen, ME; Liu, X; Radhakrishnan, P; Yu, F; Tapprich, W; Hollingsworth, MA				Mohr, Ashley M.; Bailey, Jennifer M.; Lewallen, Michelle E.; Liu, Xiang; Radhakrishnan, Prakash; Yu, Fang; Tapprich, William; Hollingsworth, Michael A.			MUC1 Regulates Expression of Multiple microRNAs Involved in Pancreatic Tumor Progression, Including the miR-200c/141 Cluster	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; BETA-CATENIN; E-CADHERIN; DOWN-REGULATION; TARGETING ZEB1; C-SRC; TRANSCRIPTION; GROWTH; CARCINOMA	MUC1 is a transmembrane glycoprotein that modulates transcription via its cytoplasmic domain. We evaluated the capacity of MUC1 to regulate the global transcription of microRNAs in pancreatic cancer cells expressing MUC1. Results indicated that MUC1 regulated expression of at least 103 microRNAs. We evaluated further regulation of the microRNA transcript cluster miR-200c/141, which was among the most highly regulated microRNAs. We found that MUC1 directly interacted with ZEB1, a known transcriptional repressor of the miR-200c/141 cluster, at the promoter of miR-200c/141, and further reduced transcript production. These data indicate that signaling through MUC1 influences cancer progression by regulating transcription of microRNAs that are associated with the process of metastasis.	[Mohr, Ashley M.; Liu, Xiang; Radhakrishnan, Prakash; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Bailey, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Surg, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Lewallen, Michelle E.] Stowers Inst Med Res, Kansas City, MO USA; [Yu, Fang] Univ Nebraska Med Ctr, Coll Publ Hlth Biostat, Omaha, NE USA; [Tapprich, William] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; Johns Hopkins University; Stowers Institute for Medical Research; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	mahollin@unmc.edu		Bailey-Lundberg, Jennifer/0000-0002-4750-106X	NIH [R01CA57362, P50 CA127297-02, U01 CA111294, U54 CA163120]; NCI Cancer Center [P30 CA036727-2452]; Alliance of Glycobiologists for Detection of Cancer and Cancer Risk [NIH U01 CA128437]; Tumor Microenvironment Network; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA057362, P50CA127297, U01CA111294, U54CA163120, U01CA128437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alliance of Glycobiologists for Detection of Cancer and Cancer Risk; Tumor Microenvironment Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH R01CA57362, NIH P50 CA127297-02, NCI Cancer Center Support Grant P30 CA036727-2452, NIH U01 CA111294 Early Detection Research Network, NIH U01 CA128437 Alliance of Glycobiologists for Detection of Cancer and Cancer Risk, NIH U54 CA163120 Tumor Microenvironment Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Mohr AM, 2012, P 103 ANN M AM ASS C; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Rajabi H, 2013, ONCOGENE; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Tian Z, 2012, BLOOD; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Yang L, 2007, CANCER RES, V67, P5587, DOI 10.1158/0008-5472.CAN-06-2287; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zhao JL, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-23	37	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e73306	10.1371/journal.pone.0073306	http://dx.doi.org/10.1371/journal.pone.0073306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143167	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100002
J	Stelter, M; Acajjaoui, S; McSweeney, S; Timmins, J				Stelter, Meike; Acajjaoui, Samira; McSweeney, Sean; Timmins, Joanna			Structural and Mechanistic Insight into DNA Unwinding by Deinococcus radiodurans UvrD	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; E. COLI UVRD; ESCHERICHIA-COLI; PCRA HELICASE; REP HELICASE; CRYSTAL-STRUCTURES; PROTEIN; PURIFICATION; REPLICATION; GENE	DNA helicases are responsible for unwinding the duplex DNA, a key step in many biological processes. UvrD is a DNA helicase involved in several DNA repair pathways. We report here crystal structures of Deinococcus radiodurans UvrD (drUvrD) in complex with DNA in different nucleotide-free and bound states. These structures provide us with three distinct snapshots of drUvrD in action and for the first time trap a DNA helicase undergoing a large-scale spiral movement around duplexed DNA. Our structural data also improve our understanding of the molecular mechanisms that regulate DNA unwinding by Superfamily 1A (SF1A) helicases. Our biochemical data reveal that drUvrD is a DNA-stimulated ATPase, can translocate along ssDNA in the 3'-5' direction and shows ATP-dependent 3'-5', and surprisingly also, 5'-3' helicase activity. Interestingly, we find that these translocase and helicase activities of drUvrD are modulated by the ssDNA binding protein. Analysis of drUvrD mutants indicate that the conserved beta-hairpin structure of drUvrD that functions as a separation pin is critical for both drUvrD's 3'-5' and 5'-3' helicase activities, whereas the GIG motif of drUvrD involved in binding to the DNA duplex is essential for the 5'-3' helicase activity only. These special features of drUvrD may reflect its involvement in a wide range of DNA repair processes in vivo.	[Stelter, Meike; Acajjaoui, Samira; McSweeney, Sean; Timmins, Joanna] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Stelter, Meike; Timmins, Joanna] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Stelter, Meike; Timmins, Joanna] CNRS, Inst Biol Struct, Grenoble, France; [Stelter, Meike; Timmins, Joanna] Commissariat Energie Atom & Energies Alternat, Dept Sci Vivant, Inst Biol Struct, Grenoble, France	European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Timmins, J (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, BP 220, F-38043 Grenoble, France.	joanna.timmins@ibs.fr	TIMMINS, Joanna/P-5486-2019	TIMMINS, Joanna/0000-0002-9066-9095	ESRF; CNRS via an ATIP-AVENIR; Ligue contre le Cancer	ESRF; CNRS via an ATIP-AVENIR; Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was funded by the inhouse research program of the ESRF. MS and JT are funded by the CNRS via an ATIP-AVENIR grant and by the Ligue contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine P. V., 2005, CCP4 NEWSLETTER, P42; AMARATUNGA M, 1993, BIOCHEMISTRY-US, V32, P6815, DOI 10.1021/bi00078a003; An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Anand SP, 2004, NUCLEIC ACIDS RES, V32, P3190, DOI 10.1093/nar/gkh641; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Cao Z, 2009, DNA REPAIR, V8, P612, DOI 10.1016/j.dnarep.2008.12.011; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Chang TL, 2002, J BIOL CHEM, V277, P45880, DOI 10.1074/jbc.M207383200; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Collins R, 2003, EXTREMOPHILES, V7, P35, DOI 10.1007/s00792-002-0293-4; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kumar S, 2001, IBM J RES DEV, V45, P499, DOI 10.1147/rd.453.0499; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1987, J BIOL CHEM, V262, P2066; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris PD, 2001, METHODS, V23, P149, DOI 10.1006/meth.2000.1116; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naqvi A, 2003, J BACTERIOL, V185, P6633, DOI 10.1128/JB.185.22.6633-6639.2003; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; PANUSKA JR, 1980, J BIOL CHEM, V255, P5208; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sabarinathan R, 2011, J BIOSCIENCES, V36, P253, DOI 10.1007/s12038-011-9067-4; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Suhasini AN, 2010, CELL CYCLE, V9, P2317, DOI 10.4161/cc.9.12.11902; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Sun B, 2008, EMBO J, V27, P3279, DOI 10.1038/emboj.2008.240; Tomko EJ, 2012, J MOL BIOL, V418, P32, DOI 10.1016/j.jmb.2012.02.013; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Unciuleac MC, 2010, J BIOL CHEM, V285, P34319, DOI 10.1074/jbc.M110.162925; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu YL, 2010, METHODS, V51, P303, DOI 10.1016/j.ymeth.2010.02.021; Yang W, 2010, ANNU REV BIOPHYS, V39, P367, DOI 10.1146/annurev.biophys.093008.131415; Yokota H, 2013, BIOPHYS J, V104, P924, DOI 10.1016/j.bpj.2013.01.014; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998; Zhang WK, 2007, J MOL BIOL, V371, P336, DOI 10.1016/j.jmb.2007.05.050	60	19	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77364	10.1371/journal.pone.0077364	http://dx.doi.org/10.1371/journal.pone.0077364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143224	Green Published, gold			2022-12-25	WOS:000325894100061
J	Zabetakis, D; Anderson, GP; Bayya, N; Goldman, ER				Zabetakis, Dan; Anderson, George P.; Bayya, Nikhil; Goldman, Ellen R.			Contributions of the Complementarity Determining Regions to the Thermal Stability of a Single-Domain Antibody	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; AFFINITY TRANSFER; ANTIGEN RECEPTOR; ENTEROTOXIN-B; FRAGMENTS; IDENTIFICATION; FRAMEWORK; SCAFFOLD; PROTEIN; SHARKS	Single domain antibodies (sdAbs) are the recombinantly-expressed variable domain from camelid (or shark) heavy chain only antibodies and provide rugged recognition elements. Many sdAbs possess excellent affinity and specificity; most refold and are able to bind antigen after thermal denaturation. The sdAb A3, specific for the toxin Staphylococcal enterotoxin B (SEB), shows both sub-nanomolar affinity for its cognate antigen (0.14 nM) and an unusually high melting point of 85 degrees C. Understanding the source of sdAb A3' s high melting temperature could provide a route for engineering improved melting temperatures into other sdAbs. The goal of this work was to determine how much of sdAb A3' s stability is derived from its complementarity determining regions (CDRs) versus its framework. Towards answering this question we constructed a series of CDR swap mutants in which the CDRs from unrelated sdAbs were integrated into A3' s framework and where A3' s CDRs were integrated into the framework of the other sdAbs. All three CDRs from A3 were moved to the frameworks of sdAb D1 (a ricin binder that melts at 50 C) and the anti-ricin sdAb C8 (melting point of 60 degrees C). Similarly, the CDRs from sdAb D1 and sdAb C8 were moved to the sdAb A3 framework. In addition individual CDRs of sdAb A3 and sdAb D1 were swapped. Melting temperature and binding ability were assessed for each of the CDR-exchange mutants. This work showed that CDR2 plays a critical role in sdAb A3' s binding and stability. Overall, results from the CDR swaps indicate CDR interactions play a major role in the protein stability.	[Zabetakis, Dan; Anderson, George P.; Goldman, Ellen R.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA; [Bayya, Nikhil] Amer Soc Engn Educ, Sci & Engn Apprenticeship Program, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Goldman, ER (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA.	ellen.goldman@nrl.navy.mil	Anderson, George P/D-2461-2011	Anderson, George P/0000-0001-7545-9893	Defense Threat Reduction Agency (DTRA) [CBCALL12-LS6-2-0036]; Naval Research Laboratory base 6.1 funds	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Naval Research Laboratory base 6.1 funds	This work was supported by Defense Threat Reduction Agency (DTRA) project number CBCALL12-LS6-2-0036, and Naval Research Laboratory base 6.1 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; Anderson GP, 2008, ANAL CHEM, V80, P9604, DOI 10.1021/ac8019398; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Glaven RH, 2012, BIOSENSORS-BASEL, V2, P43, DOI 10.3390/bios2010043; Goldman ER, 2011, TOXINS, V3, P1405, DOI 10.3390/toxins3111405; Graef RR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-86; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Inoue H, 2011, PROTEIN SCI, V20, P1971, DOI 10.1002/pro.734; McConnell AD, 2013, PROTEIN ENG DES SEL, V26, P151, DOI 10.1093/protein/gzs090; Nicaise M, 2004, PROTEIN SCI, V13, P1882, DOI 10.1110/ps.03540504; Nuttall SD, 2001, MOL IMMUNOL, V38, P313, DOI 10.1016/S0161-5890(01)00057-8; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Walper SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032801	24	28	42	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77678	10.1371/journal.pone.0077678	http://dx.doi.org/10.1371/journal.pone.0077678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143255	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100094
J	Conidi, A; van den Berghe, V; Leslie, K; Stryjewska, A; Xue, H; Chen, YG; Seuntjens, E; Huylebroeck, D				Conidi, Andrea; van den Berghe, Veronique; Leslie, Kris; Stryjewska, Agata; Xue, Hua; Chen, Ye-Guang; Seuntjens, Eve; Huylebroeck, Danny			Four Amino Acids within a Tandem QxVx Repeat in a Predicted Extended alpha-Helix of the Smad-Binding Domain of Sip1 Are Necessary for Binding to Activated Smad Proteins	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REGULATES E-CADHERIN; GROWTH-FACTOR-BETA; TGF-BETA; INTERACTING PROTEIN-1; HIRSCHSPRUNG-DISEASE; SIGNAL-TRANSDUCTION; STEM-CELLS; CANCER PROGRESSION; MENTAL-RETARDATION	The zinc finger transcription factor Smad-interacting protein-1 (Sip1; Zeb2, Zfhx1b) plays an important role during vertebrate embryogenesis in various tissues and differentiating cell types, and during tumorigenesis. Previous biochemical analysis suggests that interactions with several partner proteins, including TGF beta family receptor-activated Smads, regulate the activities of Sip1 in the nucleus both as a DNA-binding transcriptional repressor and activator. Using a peptide aptamer approach we mapped in Sip1 its Smad-binding domain (SBD), initially defined as a segment of 51 amino acids, to a shorter stretch of 14 amino acids within this SBD. Modelling suggests that this short SBD stretch is part of an extended a-helix that may fit the binding to a hydrophobic corridor within the MH2 domain of activated Smads. Four amino acids (two polar Q residues and two non-polar V residues) that form the tandem repeat (QxVx)(2) in this 14-residue stretch were found to be crucial for binding to both TGF beta/Nodal/Activin-Smads and BMP-Smads. A full-length Sip1 with collective mutation of these Q and V residues (to A) no longer binds to Smads, while it retains its binding activity to its cognate bipartite target DNA sequence. This missense mutant Sip1(AxAx)(2) provides a new molecular tool to identify SBD (in) dependent target genes in Sip1-controlled TGF beta and/or BMP (de) regulated cellular, developmental and pathological processes.	[Conidi, Andrea; van den Berghe, Veronique; Stryjewska, Agata; Seuntjens, Eve; Huylebroeck, Danny] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Mol Biol Celgen, Louvain, Belgium; [Conidi, Andrea; Leslie, Kris; Huylebroeck, Danny] Erasmus Univ, Dept Cell Biol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Xue, Hua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Beijing Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	KU Leuven; Erasmus University Rotterdam; Erasmus MC; Tsinghua University	Huylebroeck, D (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Mol Biol Celgen, Louvain, Belgium.	danny.huylebroeck@med.kuleuven.be	Seuntjens, Eve/AAM-2478-2021; Chen, Ye-Guang/L-6998-2019	Huylebroeck, Danny/0000-0003-4862-1079; van den Berghe, Veronique/0000-0001-8787-4365; Seuntjens, Eve/0000-0002-0126-461X	Research Council of KU Leuven [GOA-11/012, BIL08/10]; Fund of Scientific Research-Flanders FWO-V [G.0954.11N]; Belgian Science Policy Office in the Interuniversity Attraction Poles program [IAP-VII/07]; Agency for Innovation by Science and Technology (IWT)	Research Council of KU Leuven(KU Leuven); Fund of Scientific Research-Flanders FWO-V(FWO); Belgian Science Policy Office in the Interuniversity Attraction Poles program; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was funded by the Research Council of KU Leuven (grant GOA-11/012 to D.H.; grant BIL08/10 (to D.H. and Y.-G.C.) within the framework agreements between KU Leuven and Tsinghua University; https://admin.kuleuven.be/raden/en/research-council), by the Fund of Scientific Research-Flanders FWO-V (G.0954.11N, to D.H. and E.S.; http://www.fwo.be/), and by the Belgian Science Policy Office in the Interuniversity Attraction Poles program (IAP-VII/07 funding to D.H.; http://www.belspo.be/IAP/). V.v.d.B. was supported by the Agency for Innovation by Science and Technology (IWT; http://www.iwt.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Chong PA, 2004, J BIOL CHEM, V279, P40707, DOI 10.1074/jbc.M404375200; Colas P, 2000, CURR OPIN CHEM BIOL, V4, P54, DOI 10.1016/S1367-5931(99)00051-4; Colas Pierre, 2008, Curr Drug Discov Technol, V5, P190, DOI 10.2174/157016308785739875; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conidi A, 2011, CYTOKINE GROWTH F R, V22, P287, DOI 10.1016/j.cytogfr.2011.11.006; Cui QQ, 2005, ONCOGENE, V24, P3864, DOI 10.1038/sj.onc.1208556; Dang LTH, 2012, STEM CELLS DEV, V21, P2838, DOI 10.1089/scd.2011.0593; Dang LTH, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-13; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Evans E, 2012, AM J MED GENET A, V158A, P358, DOI 10.1002/ajmg.a.34405; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jeub M, 2011, PAIN, V152, P2384, DOI 10.1016/j.pain.2011.07.006; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI [10.1007/s11689-009-9035-6, 10.1007/s11689-009-9040-9]; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peterson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036548; Polleux F, 2002, SCI STKE, V136, P19; Pradier B, 2013, EUR J PAIN; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Schiro MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025021; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seuntjens E, CYTOKINE GROWTH FACT, V20, P449; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; van Grunsven LA, 2000, MECH DEVELOP, V94, P189, DOI 10.1016/S0925-4773(00)00318-X; van Grunsven LA, 2007, DEV BIOL, V306, P34, DOI 10.1016/j.ydbio.2007.02.045; Van Grunsven LA, 2006, DEV DYNAM, V235, P1491, DOI 10.1002/dvdy.20727; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Verstappen G, 2008, HUM MOL GENET, V17, P1175, DOI 10.1093/hmg/ddn007; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Weng QJ, 2012, NEURON, V73, P713, DOI 10.1016/j.neuron.2011.12.021; Zakin L, 2010, CURR BIOL, V20, pR89, DOI 10.1016/j.cub.2009.11.021; Zhao BM, 2006, MOL BIOL CELL, V17, P3819, DOI 10.1091/mbc.e05-10-0990	69	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76733	10.1371/journal.pone.0076733	http://dx.doi.org/10.1371/journal.pone.0076733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146916	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400078
J	O'Shea, OR; Braccini, M; McAuley, R; Speed, CW; Meekan, MG				O'Shea, Owen R.; Braccini, Matias; McAuley, Rory; Speed, Conrad W.; Meekan, Mark G.			Growth of Tropical dasyatid Rays Estimated Using a Multi-Analytical Approach	PLOS ONE			English	Article							AGE-DETERMINATION; NEOTRYGON-KUHLII; COMMON STINGRAY; VALIDATION; REPRODUCTION; PARAMETERS; PASTINACA; PRECISION; SELECTION; MATURITY	We studied the age and growth of four sympatric stingrays: reticulate whipray, Himanutra uarnak (n=19); blue mask, Neotrygon kuhlii (n=34); cowtail, Pastinachus atrus (n=32) and blue-spotted fantail, Taeniura lymma (n=40) rays at Ningaloo Reef, a fringing coral reef on the north-western coast of western Australia. Age estimates derived from band counts within sectioned vertebrae ranged between 1 and 27 years (H. uarnak, 1 - 25 yrs.; N. kuhlii, 1.5 - 13 yrs.; P. atrus, 1 - 27 yrs. and T. lymma, 1 -11 yrs.). Due to limitations of sample sizes, we combined several analytical methods for estimating growth parameters. First, we used nonlinear least squares (NLS) to identify the growth model that best fitted the data. We then used this model, prior information and the data within a Bayesian framework to approximate the posterior distribution of the growth parameters. For all species the two-parameter von Bertalanffy growth model provided the best fit to size-at-age datasets. Based on this model, the Bayesian approach allowed the estimation of median values of W-D infinity (cm) and k (yr(-1)) for the four species (H. uarnak: 149 and 0.12; N. kuhlii: 42 and 0.38; P. atrus 156 and 0.16, and T. lymma 33 and 0.24, respectively). Our approach highlights the value of combining different analytical methods and prior knowledge for estimating growth parameters when data quality and quantity are limited.	[O'Shea, Owen R.; Speed, Conrad W.; Meekan, Mark G.] Australian Inst Marine Sci, Crawley, WA, Australia; [O'Shea, Owen R.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Braccini, Matias; McAuley, Rory] WA Fisheries & Marine Res Labs, Shark & Ray Sustainabil Grp, Hillarys Boat Harbour, WA, Australia	Australian Institute of Marine Science; Murdoch University	O'Shea, OR (corresponding author), Australian Inst Marine Sci, Crawley, WA, Australia.	oshea@ceibahamas.org	Speed, Conrad W/F-2913-2015	Speed, Conrad W/0000-0003-3186-8710; Meekan, Mark/0000-0002-3067-9427	Australian Institute of Marine Science	Australian Institute of Marine Science	This study was funded by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Beverton RJ, 1993, DYNAMICS EXPLOITED F; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Cowley PD, 1997, S AFR J MARINE SCI, V18, P31; Dale JJ, 2012, MAR FRESHWATER RES, V63, P475, DOI 10.1071/MF11231; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; DAVENPORT S, 1988, AUST J MAR FRESH RES, V39, P417; Dell Q, 2009, FISHERIES MANAG ECOL, V16, P191, DOI 10.1111/j.1365-2400.2009.00655.x; Dulvy NK, 2010, CRC MAR BIOL SER, P639; EDWARDS RRC, 1980, AUST J MAR FRESH RES, V31, P459; FABENS AJ, 1965, GROWTH, V29, P265; FORD E., 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V19, P305; Gelman A., 2003, BAYESIAN DATA ANAL; Goldman K.J., 2005, FAO FISH TECH PAP, P76; Hale LF, 2008, J FISH BIOL, V73, P510, DOI 10.1111/j.1095-8649.2008.01940.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Ismen A, 2003, FISH RES, V60, P169, DOI 10.1016/S0165-7836(02)00058-9; Jacobsen IP, 2011, J FISH BIOL, V78, P1249, DOI 10.1111/j.1095-8649.2011.02933.x; Jacobsen IP, 2010, J FISH BIOL, V77, P2405, DOI 10.1111/j.1095-8649.2010.02829.x; McAuley RB, 2006, ENVIRON BIOL FISH, V77, P385, DOI 10.1007/s10641-006-9126-0; Musick JA, 1999, LIF SLOW LAN EC CONS; O'Shea OR, 2013, P AUSTR NZ COUNC CAR; Pierce SJ, 2009, J FISH BIOL, V75, P2490, DOI 10.1111/j.1095-8649.2009.02435.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RICKER W E, 1975, P382; Ridewood WG, 1921, PHILOS T R SOC LON B, V210, P311, DOI 10.1098/rstb.1921.0008; Siegfried KI, 2006, ENVIRON BIOL FISH, V77, P301, DOI 10.1007/s10641-006-9112-6; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Smart JJ, 2013, AQUAT CONSERV, V23, P124, DOI 10.1002/aqc.2274; Smith WD, 2007, MAR FRESHWATER RES, V58, P54, DOI 10.1071/MF06083; Thorson JT, 2009, FISH RES, V98, P75, DOI 10.1016/j.fishres.2009.03.016; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; WALFORD LA, 1946, BIOL BULL, V90, P141, DOI 10.2307/1538217; White W.T., 2006, EC IMPORTANT SHARKS; White WT, 2002, MAR BIOL, V140, P699, DOI 10.1007/s00227-001-0756-7; White WT, 2001, MAR BIOL, V138, P135, DOI 10.1007/s002270000436; Yigin CC, 2012, MAR BIOL RES, V8, P644, DOI 10.1080/17451000.2012.659667; Zhu LX, 2009, CHIN J OCEANOL LIMN, V27, P457, DOI 10.1007/s00343-009-9236-6	44	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77194	10.1371/journal.pone.0077194	http://dx.doi.org/10.1371/journal.pone.0077194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146968	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400104
J	Wang, CJ; Funk, CC; Eddy, JA; Price, ND				Wang, Chunjing; Funk, Cory C.; Eddy, James A.; Price, Nathan D.			Transcriptional Analysis of Aggressiveness and Heterogeneity across Grades of Astrocytomas	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; PILOCYTIC ASTROCYTOMAS; MALIGNANT GLIOMAS; FACTOR RECEPTOR; GLIOBLASTOMA; CELLS; CLASSIFICATION; TARGET; MITOCHONDRIA	Astrocytoma is the most common glioma, accounting for half of all primary brain and spinal cord tumors. Late detection and the aggressive nature of high-grade astrocytomas contribute to high mortality rates. Though many studies identify candidate biomarkers using high-throughput transcriptomic profiling to stratify grades and subtypes, few have resulted in clinically actionable results. This shortcoming can be attributed, in part, to pronounced lab effects that reduce signature robustness and varied individual gene expression among patients with the same tumor. We addressed these issues by uniformly preprocessing publicly available transcriptomic data, comprising 306 tumor samples from three astrocytoma grades (Grade 2, 3, and 4) and 30 non-tumor samples (normal brain as control tissues). Utilizing Differential Rank Conservation (DIRAC), a network-based classification approach, we examined the global and individual patterns of network regulation across tumor grades. Additionally, we applied gene-based approaches to identify genes whose expression changed consistently with increasing tumor grade and evaluated their robustness across multiple studies using statistical sampling. Applying DIRAC, we observed a global trend of greater network dysregulation with increasing tumor aggressiveness. Individual networks displaying greater differences in regulation between adjacent grades play well-known roles in calcium/PKC, EGF, and transcription signaling. Interestingly, many of the 90 individual genes found to monotonically increase or decrease with astrocytoma grade are implicated in cancer-affected processes such as calcium signaling, mitochondrial metabolism, and apoptosis. The fact that specific genes monotonically increase or decrease with increasing astrocytoma grade may reflect shared oncogenic mechanisms among phenotypically similar tumors. This work presents statistically significant results that enable better characterization of different human astrocytoma grades and hopefully can contribute towards improvements in diagnosis and therapy choices. Our results also identify a number of testable hypotheses relating to astrocytoma etiology that may prove helpful in developing much-needed biomarkers for earlier disease detection.	[Wang, Chunjing; Funk, Cory C.; Eddy, James A.; Price, Nathan D.] Inst Syst Biol, Seattle, WA USA; [Wang, Chunjing; Price, Nathan D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Eddy, James A.; Price, Nathan D.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	Institute for Systems Biology (ISB); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA USA.	Nathan.Price@systemsbiology.org		Price, Nathan/0000-0002-4157-0267	National Institute of Health Howard Temin Pathway [4R00CA126184]; Grand Duchy of Luxembourg-Institute for Systems Biology Consortium; Roy J. Carver Foundation Young Investigator Grant, an NIH Center for Systems Biology [P50 GM076547]; Camille Dreyfus Teacher-Scholar program; NATIONAL CANCER INSTITUTE [R00CA126184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	National Institute of Health Howard Temin Pathway(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Duchy of Luxembourg-Institute for Systems Biology Consortium; Roy J. Carver Foundation Young Investigator Grant, an NIH Center for Systems Biology; Camille Dreyfus Teacher-Scholar program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of Health Howard Temin Pathway to Independence Award (4R00CA126184), the Grand Duchy of Luxembourg-Institute for Systems Biology Consortium, a Roy J. Carver Foundation Young Investigator Grant, an NIH Center for Systems Biology (P50 GM076547), and the Camille Dreyfus Teacher-Scholar program (NDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cheng Y, 2000, HISTOPATHOLOGY, V37, P437, DOI 10.1046/j.1365-2559.2000.01005.x; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Eddy JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000792; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Frey H, 2013, FEBS J; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Godard S, 2003, CANCER RES, V63, P6613; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Grzmil M, 2010, BBA-PROTEINS PROTEOM, V1804, P476, DOI 10.1016/j.bbapap.2009.10.018; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holand K, 2011, CURR CANCER DRUG TAR, V11, P894, DOI 10.2174/156800911797264743; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kim W, 2012, NEUROSURG CLIN N AM, V23, P471, DOI 10.1016/j.nec.2012.04.009; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; LEENSTRA S, 1992, CANCER RES, V52, P1568; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liu ZH, 2011, J NEUROSCI, V31, P2052, DOI 10.1523/JNEUROSCI.3278-10.2011; Llaguno SRA, 2009, CLIN CANCER RES, V15, P7124, DOI 10.1158/1078-0432.CCR-09-0433; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Shannon P, 2005, AM J PATHOL, V167, P859, DOI 10.1016/S0002-9440(10)62057-3; Shirahata M, 2007, CLIN CANCER RES, V13, P7341, DOI 10.1158/1078-0432.CCR-06-2789; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sung J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003148; Turkheimer FE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-526; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Wong KK, 2005, CANCER RES, V65, P76; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wypych D, 2013, ADV EXP MED BIOL, V986, P61, DOI 10.1007/978-94-007-4719-7_4; Zhu J, 2012, J MOL NEUROSCI	63	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76694	10.1371/journal.pone.0076694	http://dx.doi.org/10.1371/journal.pone.0076694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146911	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400073
J	Thu, HNT; Tien, SFH; Loh, SL; Yan, JSB; Korzh, V				Hang Nguyen Thi Thu; Tien, Steven Fong Haw; Loh, Siau Lin; Yan, Jimmy So Bok; Korzh, Vladimir			tbx2a Is Required for Specification of Endodermal Pouches during Development of the Pharyngeal Arches	PLOS ONE			English	Article							T-BOX GENES; TRANSCRIPTION FACTOR TBX2; NEURAL CREST; CRANIOFACIAL DEVELOPMENT; THYROID-HORMONE; EXPRESSION; ZEBRAFISH; HEART; EVOLUTION; IDENTIFICATION	Tbx2 is a member of the T-box family of transcription factors essential for embryo-and organogenesis. A deficiency in the zebrafish paralogue tbx2a causes abnormalities of the pharyngeal arches in a p53-independent manner. The pharyngeal arches are formed by derivatives of all three embryonic germ layers: endodermal pouches, mesenchymal condensations and neural crest cells. While tbx2a expression is restricted to the endodermal pouches, its function is required for the normal morphogenesis of the entire pharyngeal arches. Given the similar function of Tbx1 in craniofacial development, we explored the possibility of an interaction between Tbx1 and Tbx2a. The use of bimolecular fluorescence complementation revealed the interaction between Tbx2a and Tbx1, thus providing support for the idea that functional interaction between different, co-expressed Tbx proteins could be a common theme across developmental processes in cell lineages and tissues. Together, this work provides mechanistic insight into the role of TBX2 in human disorders affecting the face and neck.	[Hang Nguyen Thi Thu; Tien, Steven Fong Haw; Loh, Siau Lin; Korzh, Vladimir] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Hang Nguyen Thi Thu; Korzh, Vladimir] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Hang Nguyen Thi Thu; Yan, Jimmy So Bok] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National University of Singapore	Korzh, V (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	vlad@imcb.a-star.edu.sg	Korzh, Vladimir P/H-1596-2011	Korzh, Vladimir P/0000-0002-6580-7986; So, Jimmy, Bok-Yan/0000-0002-9772-7905	Agency for Science, Technology and Resaerch of Singapore	Agency for Science, Technology and Resaerch of Singapore	Agency for Science, Technology and Resaerch of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Ballif BC, 2010, AM J HUM GENET, V86, P454, DOI 10.1016/j.ajhg.2010.01.038; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005; Borke JL, 2003, ANN PLAS SURG, V51, P499, DOI 10.1097/01.SAP.0000067964.14122.3E; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cheah FSH, 2010, MECH DEVELOP, V127, P329, DOI 10.1016/j.mod.2010.04.003; Chen JR, 2004, CALCIFIED TISSUE INT, V74, P561, DOI 10.1007/s00223-003-0106-5; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; COULY GF, 1993, DEVELOPMENT, V117, P409; Dheen T, 1999, DEVELOPMENT, V126, P2703; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Gibson-Brown JJ, 1998, MECH DEVELOP, V74, P165, DOI 10.1016/S0925-4773(98)00056-2; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; GonzalezManchon C, 1997, DNA CELL BIOL, V16, P533, DOI 10.1089/dna.1997.16.533; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Graham A, 2005, J ANAT, V207, P479, DOI 10.1111/j.1469-7580.2005.00472.x; Graham A, 2001, J ANAT, V199, P133, DOI 10.1017/S0021878201008159; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hatcher CJ, 2001, NAT MED, V7, P1185, DOI 10.1038/nm1101-1185; Hayata T, 1999, DEV GENES EVOL, V209, P625, DOI 10.1007/s004270050297; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; KARDONG K, 2002, VERTEBRATES COMP ANA, P762; Khattab M, 2011, AM J MED GENET A, V155A, P3082, DOI 10.1002/ajmg.a.34307; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; King M, 2006, AM J MED GENET A, V140A, P1407, DOI 10.1002/ajmg.a.31250; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Kusch T, 2002, GENE DEV, V16, P518, DOI 10.1101/gad.213002; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee KH, 1996, DEV BIOL, V180, P722, DOI 10.1006/dbio.1996.0341; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mesbah K, 2012, HUM MOL GENET, V21, P1217, DOI 10.1093/hmg/ddr553; Minguillon Carolina, 2003, Briefings in Functional Genomics & Proteomics, V2, P224, DOI 10.1093/bfgp/2.3.224; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Paxton C, 2002, GENE, V283, P117, DOI 10.1016/S0378-1119(01)00878-2; Peyrieras N, 1998, CURR BIOL, V8, P783, DOI 10.1016/S0960-9822(98)70303-3; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Prince VE, 1998, DEVELOPMENT, V125, P393; Quinlan R, 2004, DEVELOPMENT, V131, P593, DOI 10.1242/dev.00950; Radio FC, 2010, AM J MED GENET A, V152A, P2061, DOI 10.1002/ajmg.a.33506; Renucci A, 1996, DEVELOPMENT, V122, P3735; Ribeiro I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000398; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schoenwolf GC., 2009, LARSENS HUMAN EMBRYO; Showell C, 2006, DEV DYNAM, V235, P1623, DOI 10.1002/dvdy.20714; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; Vaccari E, 2010, DEV BIOL, V343, P94, DOI 10.1016/j.ydbio.2010.04.016; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402	72	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77171	10.1371/journal.pone.0077171	http://dx.doi.org/10.1371/journal.pone.0077171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130849	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200064
J	Lind, U; Rosenblad, MA; Wrange, AL; Sundell, KS; Jonsson, PR; Andre, C; Havenhand, J; Blomberg, A				Lind, Ulrika; Rosenblad, Magnus Alm; Wrange, Anna-Lisa; Sundell, Kristina S.; Jonsson, Per R.; Andre, Carl; Havenhand, Jonathan; Blomberg, Anders			Molecular Characterization of the alpha-Subunit of Na+/K+ ATPase from the Euryhaline Barnacle Balanus improvisus Reveals Multiple Genes and Differential Expression of Alternative Splice Variants	PLOS ONE			English	Article							TROPONIN-T GENE; H+-ATPASE; SALINITY TOLERANCE; NA++K+-ATPASE; GILLS; NA,K-ATPASE; CRAB; OSMOREGULATION; NA+,K+-ATPASE; MEMBRANE	The euryhaline bay barnacle Balanus improvisus has one of the broadest salinity tolerances of any barnacle species. It is able to complete its life cycle in salinities close to freshwater (3 PSU) up to fully marine conditions (35 PSU) and is regarded as one of few truly brackish-water species. Na+/K+ ATPase (NAK) has been shown to be important for osmoregulation when marine organisms are challenged by changing salinities, and we therefore cloned and examined the expression of different NAKs from B. improvisus. We found two main gene variants, NAK1 and NAK2, which were approximately 70% identical at the protein level. The NAK1 mRNA existed in a long and short variant with the encoded proteins differing only by 27 N-terminal amino acids. This N-terminal stretch was coded for by a separate exon, and the two variants of NAK1 mRNAs appeared to be created by alternative splicing. We furthermore showed that the two NAK1 isoforms were differentially expressed in different life stages and in various tissues of adult barnacle, i.e the long isoform was predominant in cyprids and in adult cirri. In barnacle cyprid larvae that were exposed to a combination of different salinities and pCO(2) levels, the expression of the long NAK1 mRNA increased relative to the short in low salinities. We suggest that the alternatively spliced long variant of the Nak1 protein might be of importance for osmoregulation in B. improvisus in low salinity conditions.	[Lind, Ulrika; Rosenblad, Magnus Alm; Blomberg, Anders] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Wrange, Anna-Lisa; Sundell, Kristina S.; Jonsson, Per R.; Andre, Carl; Havenhand, Jonathan] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Blomberg, A (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	anders.blomberg@cmb.gu.se	Sundell, Kristina/F-8884-2016; Andre, Carl/B-4237-2010; Havenhand, Jon N/F-5435-2013; Sundell, Kristina/E-5606-2014; Jonsson, Per R/E-6707-2013	Sundell, Kristina/0000-0002-7643-2083; Andre, Carl/0000-0003-4404-7292; Havenhand, Jon N/0000-0003-0253-3428; Jonsson, Per/0000-0002-1793-5473; Havenhand, Jonathan/0000-0001-6721-7763; Blomberg, Anders/0000-0002-1260-3920	Swedish Research Councils, VR; FORMAS; BILS	Swedish Research Councils, VR(Swedish Research Council); FORMAS(Swedish Research Council Formas); BILS	This work was performed within Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se) which is supported by a Linnaeus-grant from the Swedish Research Councils, VR (www.vr.se) and FORMAS (www.formas.se). MAR was partly funded by BILS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AUSTIN AP, 1958, Q J MICROSC SCI, V99, P497; Babakov AV, 2000, PLANTA, V211, P446, DOI 10.1007/s004250000347; BAXTERLOWE LA, 1989, FEBS LETT, V257, P181, DOI 10.1016/0014-5793(89)81816-2; Benoist P, 1998, J BIOL CHEM, V273, P7538, DOI 10.1074/jbc.273.13.7538; Berntsson KM, 2000, J EXP MAR BIOL ECOL, V251, P59, DOI 10.1016/S0022-0981(00)00210-0; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boxshall Geoff A., 2009, Arthropod Systematics & Phylogeny, V67, P229; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Chan PM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005157; CHARMANTIER G, 1988, BIOL BULL-US, V175, P102, DOI 10.2307/1541897; Charmantier G, 2001, J EXP BIOL, V204, P967; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Cieluch U, 2007, MAR ECOL PROG SER, V329, P169, DOI 10.3354/meps329169; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; DAVENPORT J, 1976, J MAR BIOL ASSOC UK, V56, P889, DOI 10.1017/S0025315400020932; De Gregoris TB, 2011, BIOFOULING, V27, P367, DOI 10.1080/08927014.2011.577211; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DINEEN JF, 1992, J EXP MAR BIOL ECOL, V156, P239, DOI 10.1016/0022-0981(92)90249-A; Efendiev R, 2005, J BIOL CHEM, V280, P16272, DOI 10.1074/jbc.M500486200; Fehsenfeld S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-488; FOSTER BA, 1970, PHILOS T ROY SOC B, V256, P377, DOI 10.1098/rstb.1970.0001; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; FYHN HJ, 1976, COMP BIOCHEM PHYS A, V53, P19, DOI 10.1016/S0300-9629(76)80004-7; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Gohad NV, 2009, J EXP MAR BIOL ECOL, V380, P88, DOI 10.1016/j.jembe.2009.09.008; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; Havird JC, 2013, COMP BIOCHEM PHYS D, V8, P131, DOI 10.1016/j.cbd.2013.01.003; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; IPCC, 2007, CLIM CHANG PHYS SCI; Jayasundara N, 2007, J EXP BIOL, V210, P2070, DOI 10.1242/jeb.004309; Jimenez T, 2010, REPRODUCTION, V139, P835, DOI 10.1530/REP-09-0495; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Jorgensen PL, 2008, J MEMBRANE BIOL, V221, P39, DOI 10.1007/s00232-007-9083-3; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaeodee M, 2011, COMP BIOCHEM PHYS B, V159, P244, DOI 10.1016/j.cbpb.2011.05.004; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kerkeb L, 2002, PHYSIOL PLANTARUM, V116, P37, DOI 10.1034/j.1399-3054.2002.1160105.x; Kultz D, 2001, J EXP BIOL, V204, P2975; Lind U, 2010, MOL PHARMACOL, V78, P237, DOI 10.1124/mol.110.063594; Lucu C, 2003, COMP BIOCHEM PHYS A, V135, P195; Lucu C, 2000, J EXP MAR BIOL ECOL, V246, P163, DOI 10.1016/S0022-0981(99)00179-3; MACIAS MT, 1991, GENE, V105, P197, DOI 10.1016/0378-1119(91)90151-Z; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Magee JA, 2003, CAN J FISH AQUAT SCI, V60, P214, DOI 10.1139/F03-015; Marden JH, 2001, J EXP BIOL, V204, P3457; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; McCormick SD, 2009, J EXP BIOL, V212, P3994, DOI 10.1242/jeb.037275; NASROLAHI A, 2012, THESIS KIEL; Nasrolahi A, 2012, MAR BIOL, V159, P331, DOI 10.1007/s00227-011-1811-7; Nilsen TO, 2007, J EXP BIOL, V210, P2885, DOI 10.1242/jeb.002873; Nongthomba U, 2007, GENETICS, V177, P295, DOI 10.1534/genetics.106.056812; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Perry SF, 2006, RESP PHYSIOL NEUROBI, V154, P199, DOI 10.1016/j.resp.2006.04.010; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pham D, 2012, AQUACULTURE, V362, P10, DOI 10.1016/j.aquaculture.2012.07.026; PRESSLEY TA, 1992, AM J PHYSIOL, V262, pC743, DOI 10.1152/ajpcell.1992.262.3.C743; Price NT, 2010, J BIOL CHEM, V285, P7857, DOI 10.1074/jbc.M109.072892; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; Richards JG, 2003, J EXP BIOL, V206, P4475, DOI 10.1242/jeb.00701; Saez AG, 2009, GENETICA, V136, P479, DOI 10.1007/s10709-009-9356-0; Segall L, 2002, J BIOL CHEM, V277, P35202, DOI 10.1074/jbc.M206115200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; TAKEYASU K, 1990, AM J PHYSIOL, V259, pC619, DOI 10.1152/ajpcell.1990.259.4.C619; Towle DW, 2001, J EXP BIOL, V204, P4005; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Turpayeva YP, 1961, T I OCEANOL, V49, P205; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WALLEY LJ, 1969, PHILOS T ROY SOC B, V256, P237, DOI 10.1098/rstb.1969.0042; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhen Y, 2012, SCIENCE, V337, P1634, DOI 10.1126/science.1226630	78	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77069	10.1371/journal.pone.0077069	http://dx.doi.org/10.1371/journal.pone.0077069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130836	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900121
J	Rasmussen, G; Monecke, S; Ehricht, R; Soderquist, B				Rasmussen, Gunlog; Monecke, Stefan; Ehricht, Ralf; Soderquist, Bo			Prevalence of Clonal Complexes and Virulence Genes among Commensal and Invasive Staphylococcus aureus Isolates in Sweden	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; METHICILLIN-RESISTANT; EXPERIMENTAL ENDOCARDITIS; CAPSULAR POLYSACCHARIDES; INFECTIVE ENDOCARDITIS; BIOFILM FORMATION; CLUMPING FACTOR; STRAINS; EXPRESSION; ADHERENCE	Staphylococcus aureus encodes a remarkable number of virulence factors which may contribute to its pathogenicity and ability to cause invasive disease. The main objective of this study was to evaluate the association between S. aureus invasiveness and bacterial genotype, in terms of the presence of virulence genes and affiliation to clonal complexes. Also, the significance of different virulence genes, mainly adhesins, for the development of infective endocarditis was investigated. DNA microarray technology was used to analyze 134 S. aureus isolates, all methicillin-susceptible, derived from three groups of clinically well-characterized patients: nasal carriers (n=46), bacteremia (n=55), and bacteremia with infective endocarditis (n=33). Invasive isolates were dominant in four of the major clonal complexes: 5, 8, 15, and 25. Of the 170 virulence genes examined, those encoding accessory gene regulator group II (agr II), capsule polysaccharide serotype 5 (cap5), and adhesins such as S. aureus surface protein G (sasG) and fibronectin-binding protein B (fnbB) were found to be associated with invasive disease. The same was shown for the leukocidin genes lukD/lukE, as well as the genes encoding serine protease A and B (splA/splB), staphylococcal complement inhibitor (scn) and the staphylococcal exotoxin-like protein (setC or selX). In addition, there was a trend of higher prevalence of certain genes or gene clusters (sasG, agr II, cap5) among isolates causing infective endocarditis compared to other invasive isolates. In most cases, the presence of virulence genes was linked to clonal complex affiliation. In conclusion, certain S. aureus clonal lineages harboring specific sets of virulence genes seem to be more successful in causing invasive disease.	[Rasmussen, Gunlog; Soderquist, Bo] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Soderquist, Bo] Orebro Univ Hosp Sweden, Orebro, Sweden; [Rasmussen, Gunlog; Soderquist, Bo] Univ Orebro, Fac Med & Hlth, Orebro, Sweden	Orebro University; Alere; Technische Universitat Dresden; Orebro University	Rasmussen, G (corresponding author), Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden.	gunlog.rasmussen@orebroll.se		Soderquist, Bo/0000-0001-5939-2932	Research Comitte of the County Council of Orebro University Hospital	Research Comitte of the County Council of Orebro University Hospital	Funding for this study was provided by grants from the Research Comitte of the County Council of Orebro University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Chi Chia-Yu, 2010, J Clin Microbiol, V48, P292, DOI 10.1128/JCM.01788-09; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Ferry Tristan, 2005, Curr Infect Dis Rep, V7, P420, DOI 10.1007/s11908-005-0043-8; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Gillaspy AF, 1998, INFECT IMMUN, V66, P3170, DOI 10.1128/IAI.66.7.3170-3178.1998; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Hogevik H, 1998, APMIS, V106, P901, DOI 10.1111/j.1699-0463.1998.tb00237.x; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Que YA, 2001, INFECT IMMUN, V69, P6296, DOI 10.1128/IAI.69.10.6296-6302.2001; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Soderquist Bo, 1998, Clin Microbiol Infect, V4, P366, DOI 10.1111/j.1469-0691.1998.tb00080.x; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279; Werbick C, 2007, J INFECT DIS, V195, P1678, DOI 10.1086/517517; Xiong YQ, 2009, J INFECT DIS, V199, P201, DOI 10.1086/595738	37	59	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77477	10.1371/journal.pone.0077477	http://dx.doi.org/10.1371/journal.pone.0077477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130888	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900138
J	Yoneda, Y; Ito, S; Kunisada, T; Morimoto, Y; Kanzaki, H; Yoshida, A; Shimizu, K; Ozaki, T; Ouchida, M				Yoneda, Yasushi; Ito, Sachio; Kunisada, Toshiyuki; Morimoto, Yuki; Kanzaki, Hirotaka; Yoshida, Aki; Shimizu, Kenji; Ozaki, Toshifumi; Ouchida, Mamoru			Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein	PLOS ONE			English	Article							ONCOPROTEIN SYT-SSX1; NUCLEAR-LOCALIZATION; SYT INTERACTS; GENE; EXPRESSION; TRANSLOCATION; COMPLEXES; POLYCOMB; GROWTH; IDENTIFICATION	Synovial sarcoma is a relatively rare high-grade soft tissue sarcoma that often develops in the limbs of young people and induces the lung and the lymph node metastasis resulting in poor prognosis. In patients with synovial sarcoma, specific chromosomal translocation of t(X; 18) (p11.2; q11.2) is observed, and SS18-SSX fusion protein expressed by this translocation is reported to be associated with pathogenesis. However, role of the fusion protein in the pathogenesis of synovial sarcoma has not yet been completely clarified. In this study, we focused on the localization patterns of SS18-SSX fusion protein. We constructed expression plasmids coding for the full length SS18-SSX, the truncated SS18 moiety (tSS18) and the truncated SSX moiety (tSSX) of SS18-SSX, tagged with fluorescent proteins. These plasmids were transfected in synovial sarcoma SYO-1 cells and we observed the expression of these proteins using a fluorescence microscope. The SS18-SSX fusion protein showed a characteristic speckle pattern in the nucleus. However, when SS18-SSX was co-expressed with tSSX, localization of SS18-SSX changed from speckle patterns to the diffused pattern similar to the localization pattern of tSSX and SSX. Furthermore, cell proliferation and colony formation of synovial sarcoma SYO-1 and YaFuSS cells were suppressed by exogenous tSSX expression. Our results suggest that the characteristic speckle localization pattern of SS18-SSX is strongly involved in the tumorigenesis through the SSX moiety of the SS18-SSX fusion protein. These findings could be applied to further understand the pathogenic mechanisms, and towards the development of molecular targeting approach for synovial sarcoma.	[Yoneda, Yasushi; Morimoto, Yuki; Yoshida, Aki; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthoped Surg, Okayama 7008530, Japan; [Yoneda, Yasushi; Ito, Sachio; Kanzaki, Hirotaka; Shimizu, Kenji; Ouchida, Mamoru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan; [Kunisada, Toshiyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Mat Musculoskeletal Reconstruct, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Ouchida, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama 7008530, Japan.	ouchidam@md.okayama-u.ac.jp						Al-Hussaini H., 2011, Sarcoma, V2011, P231789, DOI 10.1155/2011/231789; Barco R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005060; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; de Bruijn DRH, 2007, GENE CHROMOSOME CANC, V46, P107, DOI 10.1002/gcc.20399; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; de Bruijn DRH, 2001, ONCOGENE, V20, P3281, DOI 10.1038/sj.onc.1204419; dos Santos NR, 2000, EXP CELL RES, V256, P192, DOI 10.1006/excr.2000.4813; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Fernebro J, 2006, INT J CANCER, V118, P1165, DOI 10.1002/ijc.21475; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Gure AO, 1997, INT J CANCER, V72, P965, DOI 10.1002/(SICI)1097-0215(19970917)72:6<965::AID-IJC8>3.0.CO;2-N; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Horvai AE, 2006, ARCH PATHOL LAB MED, V130, P792; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ishida M, 2004, GENES CELLS, V9, P419, DOI 10.1111/j.1356-9597.2004.00737.x; Ishida M, 2007, MOL CELL BIOL, V27, P1348, DOI 10.1128/MCB.00658-06; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Ito T, 2004, LAB INVEST, V84, P1484, DOI 10.1038/labinvest.3700174; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawai A, 2004, CANCER LETT, V204, P105, DOI 10.1016/j.canlet.2003.09.031; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Morimoto Y, 2003, CANCER LETT, V199, P35, DOI 10.1016/S0304-3835(03)00314-8; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Naka N, 2005, J MOL DIAGN, V7, P187, DOI 10.1016/S1525-1578(10)60545-4; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Palmerini E, 2009, CANCER, V115, P2988, DOI 10.1002/cncr.24370; Paulino AC, 2004, AM J CLIN ONCOL-CANC, V27, P122, DOI 10.1097/01.coc.0000047130.91699.DC; Perani M, 2003, ONCOGENE, V22, P8156, DOI 10.1038/sj.onc.1207031; Przybyl Joanna, 2012, Sarcoma, V2012, P249219, DOI 10.1155/2012/249219; Saito T, 2006, CANCER RES, V66, P6919, DOI 10.1158/0008-5472.CAN-05-3697; Shi WY, 2013, AM J CLIN ONCOL-CANC, V36, P83, DOI 10.1097/COC.0b013e31823fe450; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; Smith HA, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/150591; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Sun Y, 2006, ONCOGENE, V25, P1042, DOI 10.1038/sj.onc.1209143; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tornkvist M, 2008, BIOCHEM BIOPH RES CO, V368, P793, DOI 10.1016/j.bbrc.2008.01.162; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P93, DOI 10.1016/0165-4608(86)90153-6; Tureci O, 1996, CANCER RES, V56, P4766; Tureci O, 1998, INT J CANCER, V77, P19, DOI 10.1002/(SICI)1097-0215(19980703)77:1<19::AID-IJC4>3.0.CO;2-2; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xie YT, 2003, ONCOGENE, V22, P7628, DOI 10.1038/sj.onc.1207153	53	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77564	10.1371/journal.pone.0077564	http://dx.doi.org/10.1371/journal.pone.0077564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130893	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900141
J	Yazawa, K; Furusawa, H; Okahata, Y				Yazawa, Kenjiro; Furusawa, Hiroyuki; Okahata, Yoshio			Real-time Monitoring of Intermediates Reveals the Reaction Pathway in the Thiol-Disulfide Exchange between Disulfide Bond Formation Protein A (DsbA) and B (DsbB) on a Membrane-immobilized Quartz Crystal Microbalance (QCM) System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Kinetics; Membrane Lipids; Membrane Proteins; Protein Chemistry; Disulfide Bond Formation Protein; Quartz Crystal Microbalance; Supported Lipid Bilayer; Transient Kinetic Analysis	ESCHERICHIA-COLI; KINETIC MEASUREMENTS; REDOX PROPERTIES; CATALYST DSBB; ENZYME DSBB; MECHANISM; GENERATION; HYDROLYZES; CELLS	Background: A device of QCM can be used in the transient kinetics of oxidation of a pair of cysteine residues in DsbA by DsbB. Results: The obtained kinetic parameters indicate that the two pairs of cysteine residues in DsbB are important. Conclusion: The reaction pathway of almost all DsbA oxidation processes would proceed through the stable intermediate. Significance: The transient kinetics of the reaction intermediate is important. Disulfide bond formation protein B (DsbB(S-S,S-S)) is an inner membrane protein in Escherichia coli that has two disulfide bonds (S-S, S-S) that play a role in oxidization of a pair of cysteine residues (SH, SH) in disulfide bond formation protein A (DsbA(SH,SH)). The oxidized DsbA(S-S), with one disulfide bond (S-S), can oxidize proteins with SH groups for maturation of a folding preprotein. Here, we have described the transient kinetics of the oxidation reaction between DsbA(SH,SH) and DsbB(S-S,S-S). We immobilized DsbB(S-S,S-S) embedded in lipid bilayers on the surface of a 27-MHz quartz crystal microbalance (QCM) device to detect both formation and degradation of the reaction intermediate (DsbA-DsbB), formed via intermolecular disulfide bonds, as a mass change in real time. The obtained kinetic parameters (intermediate formation, reverse, and oxidation rate constants (k(f), k(r), and k(cat), respectively) indicated that the two pairs of cysteine residues in DsbB(S-S,S-S) were more important for the stability of the DsbA-DsbB intermediate than ubiquinone, an electron acceptor for DsbB(S-S,S-S). Our data suggested that the reaction pathway of almost all DsbA(SH,SH) oxidation processes would proceed through this stable intermediate, avoiding the requirement for ubiquinone.	Yamagata Univ, Innovat Flex Course Frontier Organ Mat Syst iFron, Yonezawa, Yamagata 9928510, Japan; Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan	Yamagata University; Tokyo Institute of Technology	Okahata, Y (corresponding author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	yokahata@yz.yamagata-u.ac.jp	Yazawa, Kenjiro/C-7423-2017	Yazawa, Kenjiro/0000-0001-7268-5983	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22225005] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science.	Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Becker B, 2011, J MOL RECOGNIT, V24, P754, DOI 10.1002/jmr.1117; BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006; Furusawa H, 2008, ANAL CHEM, V80, P1005, DOI 10.1021/ac702290z; Furusawa H, 2008, ORG BIOMOL CHEM, V6, P727, DOI 10.1039/b717171d; Furusawa H, 2009, ANAL CHEM, V81, P1841, DOI 10.1021/ac8022229; Furusawa H, 2009, ANAL CHEM, V81, P2268, DOI 10.1021/ac802412t; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P4004, DOI 10.1002/1521-3773(20001117)39:22<4004::AID-ANIE4004>3.0.CO;2-2; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i; Matsuno H, 2004, CHEM-EUR J, V10, P6172, DOI 10.1002/chem.200400030; Niikura K, 1998, J AM CHEM SOC, V120, P8537, DOI 10.1021/ja980967r; Okahata Y, 1998, ANAL CHEM, V70, P1288, DOI 10.1021/ac970584w; Okahata Y, 2000, ANAL SCI, V16, P1113, DOI 10.2116/analsci.16.1113; Ozeki T, 2007, ANAL CHEM, V79, P79, DOI 10.1021/ac060873x; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Takahashi S, 2007, ANAL BIOCHEM, V361, P210, DOI 10.1016/j.ab.2006.11.030; Tang M, 2011, J AM CHEM SOC, V133, P4359, DOI 10.1021/ja107775w; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Watson J.D., 2014, MOL BIOL GENE, V5, P657; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Yazawa K, 2013, CHEM LETT, V42, P241, DOI 10.1246/cl.2013.241; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	34	7	7	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35969	35981		10.1074/jbc.M113.519876	http://dx.doi.org/10.1074/jbc.M113.519876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24145032	Green Published, hybrid			2022-12-25	WOS:000329814700033
J	Niu, LL; Qian, M; Yang, W; Meng, L; Xiao, Y; Wong, KKL; Abbott, D; Liu, X; Zheng, HR				Niu, Lili; Qian, Ming; Yang, Wei; Meng, Long; Xiao, Yang; Wong, Kelvin K. L.; Abbott, Derek; Liu, Xin; Zheng, Hairong			Surface Roughness Detection of Arteries via Texture Analysis of Ultrasound Images for Early Diagnosis of Atherosclerosis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CAROTID-ARTERY; B-MODE; CLASSIFICATION; RISK; PROGRESSION; FEATURES; PLAQUES; SIGNAL; ASSOCIATION	There is a strong research interest in identifying the surface roughness of the carotid arterial inner wall via texture analysis for early diagnosis of atherosclerosis. The purpose of this study is to assess the efficacy of texture analysis methods for identifying arterial roughness in the early stage of atherosclerosis. Ultrasound images of common carotid arteries of 15 normal mice fed a normal diet and 28 apoE(-/-) mice fed a high-fat diet were recorded by a high-frequency ultrasound system (Vevo 2100, frequency: 40 MHz). Six different texture feature sets were extracted based on the following methods: first-order statistics, fractal dimension texture analysis, spatial gray level dependence matrix, gray level difference statistics, the neighborhood gray tone difference matrix, and the statistical feature matrix. Statistical analysis indicates that 11 of 19 texture features can be used to distinguish between normal and abnormal groups (p<0.05). When the 11 optimal features were used as inputs to a support vector machine classifier, we achieved over 89% accuracy, 87% sensitivity and 93% specificity. The accuracy, sensitivity and specificity for the k-nearest neighbor classifier were 73%, 75% and 70%, respectively. The results show that it is feasible to identify arterial surface roughness based on texture features extracted from ultrasound images of the carotid arterial wall. This method is shown to be useful for early detection and diagnosis of atherosclerosis.	[Niu, Lili; Qian, Ming; Yang, Wei; Meng, Long; Xiao, Yang; Liu, Xin; Zheng, Hairong] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Adelaide; University of Adelaide	Qian, M (corresponding author), Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	ming.qian@siat.ac.cn; hr.zheng@siat.ac.cn	XIAO, YANG/GPW-5529-2022; Abbott, Derek/E-8352-2011; Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Abbott, Derek/0000-0002-0945-2674; Wong, Kelvin Kian Loong/0000-0002-8600-1105; 	National Research Program (973 Grant) from Ministry of Science and Technology, China [2011CB707903, 2013CB733800]; National Science Foundation Grants (NSFC) [11302239, 11304341, 81027006, 61020106008, 11002152, 11272329, 61002001]	National Research Program (973 Grant) from Ministry of Science and Technology, China; National Science Foundation Grants (NSFC)	The work was supported by National Research Program (973 Grant Nos. 2011CB707903 and 2013CB733800) from Ministry of Science and Technology, China, and National Science Foundation Grants (NSFC Grant Nos. 11302239, 11304341, 81027006, 61020106008, 11002152, 11272329, and 61002001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Asvestas P, 2002, ULTRASOUND MED BIOL, V28, P1129, DOI 10.1016/S0301-5629(02)00550-1; Bellman R., 1957, DYNAMIC PROGRAMMING; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Ciccone MM, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-32; Cinthio M, 2011, IEEE T ULTRASON FERR, V58, P853, DOI 10.1109/TUFFC.2011.1879; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Dogan S, 2009, J AM SOC ECHOCARDIOG, V22, P1137, DOI 10.1016/j.echo.2009.07.008; Engler O, 2010, INTRODUCTION TO TEXTURE ANALYSIS: MACROTEXTURE, MICROTEXTURE, AND ORIENTATION MAPPING, 2ND EDITION, P1; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gunarathne GPP, 2001, IEEE T INSTRUM MEAS, V50, P1144, DOI 10.1109/19.963174; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Kadah YM, 1996, IEEE T MED IMAGING, V15, P466, DOI 10.1109/42.511750; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Lefebvre F, 2000, ULTRASOUND MED BIOL, V26, P1421, DOI 10.1016/S0301-5629(00)00302-1; Li R, 2008, ADV SPACE RES, V42, P1469, DOI 10.1016/j.asr.2007.12.015; Loizou CP, 2005, IEEE T ULTRASON FERR, V52, P1653, DOI 10.1109/TUFFC.2005.1561621; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; McCrindle BW, 2007, CIRCULATION, V115, P1948, DOI 10.1161/CIRCULATIONAHA.107.181946; Nicolaides AN, 2010, J VASC SURG, V52, P1486, DOI 10.1016/j.jvs.2010.07.021; Niu LL, 2011, ULTRASOUND MED BIOL, V37, P1280, DOI 10.1016/j.ultrasmedbio.2011.05.006; Osowski S, 2004, IEEE T BIO-MED ENG, V51, P582, DOI 10.1109/TBME.2004.824138; Platt J., 1998, SEQUENTIAL MINIMAL O; Polak JF, 1998, RADIOLOGY, V208, P649, DOI 10.1148/radiology.208.3.9722841; Rakebrandt F, 2000, ULTRASOUND MED BIOL, V26, P1393, DOI 10.1016/S0301-5629(00)00314-8; Romero MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055340; Rubba P, 2001, STROKE, V32, P1953, DOI 10.1161/hs0901.095601; Schmidt-Trucksass A, 2003, ATHEROSCLEROSIS, V166, P57, DOI 10.1016/S0021-9150(02)00245-9; Tou J. T., 1974, PATTERN RECOGN; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Vapnik V., 1998, STAT LEARNING THEORY; Vince DG, 2000, COMPUT MED IMAG GRAP, V24, P221, DOI 10.1016/S0895-6111(00)00011-2; WESZKA JS, 1976, IEEE T SYST MAN CYB, V6, P269, DOI 10.1109/TSMC.1976.5408777; Wilhjelm JE, 2001, IEEE T ULTRASON FERR, V48, P511, DOI 10.1109/58.911734; Wilhjelm JE, 1998, IEEE T MED IMAGING, V17, P910, DOI 10.1109/42.746624; Willekes C, 1999, ULTRASOUND MED BIOL, V25, P57, DOI 10.1016/S0301-5629(98)00138-0; WU CM, 1992, IEEE T MED IMAGING, V11, P141, DOI 10.1109/42.141636; Xie J, 2005, IEEE T MED IMAGING, V24, P45, DOI 10.1109/TMI.2004.837792; Zhang H., 2006, 2006 IEEE COMP SOC C, V2, P2126, DOI [DOI 10.1109/CVPR.2006.301, 10.1109/CVPR.2006.301]; Zhang WY, 2004, ULTRASOUND MED BIOL, V30, P1461, DOI 10.1016/j.ultrasmedbio.2004.08.020; ZWEIG MH, 1993, CLIN CHEM, V39, P561	47	32	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76880	10.1371/journal.pone.0076880	http://dx.doi.org/10.1371/journal.pone.0076880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146940	Green Published, gold			2022-12-25	WOS:000326022200023
J	Buonanno, M; Randers-Pehrson, G; Bigelow, AW; Trivedi, S; Lowy, FD; Spotnitz, HM; Hammer, SM; Brenner, DJ				Buonanno, Manuela; Randers-Pehrson, Gerhard; Bigelow, Alan W.; Trivedi, Sheetal; Lowy, Franklin D.; Spotnitz, Henry M.; Hammer, Scott M.; Brenner, David J.			207-nm UV Light - A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. I: In Vitro Studies	PLOS ONE			English	Article							ULTRAVIOLET GERMICIDAL IRRADIATION; RESISTANT STAPHYLOCOCCUS-AUREUS; CARE-ASSOCIATED INFECTIONS; MAMMALIAN-CELLS; LASER-RADIATION; VACUUM ULTRAVIOLET; AIR DISINFECTION; SKIN-CANCER; DNA-DAMAGE; NM	Background: 0.5% to 10% of clean surgeries result in surgical-site infections, and attempts to reduce this rate have had limited success. Germicidal UV lamps, with a broad wavelength spectrum from 200 to 400 nm are an effective bactericidal option against drug-resistant and drug-sensitive bacteria, but represent a health hazard to patient and staff. By contrast, because of its limited penetration, similar to 200 nm far-UVC light is predicted to be effective in killing bacteria, but without the human health hazards to skin and eyes associated with conventional germicidal UV exposure. Aims: The aim of this work was to test the biophysically-based hypothesis that,200 nm UV light is significantly cytotoxic to bacteria, but minimally cytotoxic or mutagenic to human cells either isolated or within tissues. Methods: A Kr-Br excimer lamp was used, which produces 207-nm UV light, with a filter to remove higher-wavelength components. Comparisons were made with results from a conventional broad spectrum 254-nm UV germicidal lamp. First, cell inactivation vs. UV fluence data were generated for methicillin-resistant S. aureus (MRSA) bacteria and also for normal human fibroblasts. Second, yields of the main UV-associated pre-mutagenic DNA lesions (cyclobutane pyrimidine dimers and 6-4 photoproducts) were measured, for both UV radiations incident on 3-D human skin tissue. Results: We found that 207-nm UV light kills MRSA efficiently but, unlike conventional germicidal UV lamps, produces little cell killing in human cells. In a 3-D human skin model, 207-nm UV light produced almost no pre-mutagenic UV-associated DNA lesions, in contrast to significant yields induced by a conventional germicidal UV lamp. Conclusions: As predicted based on biophysical considerations, 207-nm light kills bacteria efficiently but does not appear to be significantly cytotoxic or mutagenic to human cells. Used appropriately, 207-nm light may have the potential for safely and inexpensively reducing surgical-site infection rates, including those of drug-resistant origin.	[Buonanno, Manuela; Randers-Pehrson, Gerhard; Bigelow, Alan W.; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Trivedi, Sheetal; Lowy, Franklin D.; Hammer, Scott M.] Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA; [Spotnitz, Henry M.] Columbia Univ, Dept Med, Dept Surg, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Brenner, DJ (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	djb3@columbia.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	Columbia University Medical Center	Columbia University Medical Center	This was funded through internal funding at Columbia University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; Avdeev SM, 2008, LIGHT ENG, V16, P32; BASFORD JR, 1986, ARCH PHYS MED REHAB, V67, P151, DOI 10.1016/0003-9993(86)90053-5; BERG M, 1991, J BONE JOINT SURG BR, V73, P811, DOI 10.1302/0301-620X.73B5.1894672; Broex ECJ, 2009, J HOSP INFECT, V72, P193, DOI 10.1016/j.jhin.2009.03.020; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; COOHILL TP, 1986, PHOTOCHEM PHOTOBIOL, V44, P359, DOI 10.1111/j.1751-1097.1986.tb04676.x; Crolla RMPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044599; Dai TH, 2012, EXPERT REV ANTI-INFE, V10, P185, DOI [10.1586/eri.11.166, 10.1586/ERI.11.166]; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Frei E, 2011, VASC ENDOVASC SURG, V45, P688, DOI 10.1177/1538574411419528; Fry DE, 2011, SURG INFECT, V12, P191, DOI 10.1089/sur.2011.068; GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; GREEN H, 1987, CANCER RES, V47, P410; Haley VB, 2012, INFECT CONT HOSP EP, V33, P565, DOI 10.1086/665710; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hitzschke L, 2001, P 9 INT S SCI TECHN, P411; JOSE JG, 1985, EXP EYE RES, V41, P545, DOI 10.1016/S0014-4835(85)80011-7; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; KOCHEVAR IE, 1991, CANCER RES, V51, P288; KOCHEVAR IE, 1990, RADIAT RES, V122, P142, DOI 10.2307/3577598; Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165; Kreusch S, 2003, ANAL BIOCHEM, V313, P208, DOI 10.1016/S0003-2697(02)00460-8; Kubilus J, 2004, ATLA-ALTERN LAB ANIM, V32, P75, DOI 10.1177/026119290403201s12; Lessa FC, 2012, CLIN INFECT DIS, V55, P232, DOI 10.1093/cid/cis408; LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5; LORIAN V, 1985, DIAGN MICR INFEC DIS, V3, P433, DOI 10.1016/0732-8893(85)90082-3; Matafonova GG, 2008, LETT APPL MICROBIOL, V47, P508, DOI 10.1111/j.1472-765X.2008.02461.x; McDonald RS, 2013, EUR CELLS MATER, V25, P204, DOI 10.22203/eCM.v025a15; Metzler DE., 2001, BIOCH CHEM REACTIONS; Miller J, 2011, APPL OPTICS, V50, P876, DOI 10.1364/AO.50.000876; MITCHELL DL, 1988, PHOTODERMATOLOGY, V5, P61; Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; PREISS JW, 1956, J CHEM PHYS, V25, P138, DOI 10.1063/1.1742806; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; QIN XS, 1994, CANCER LETT, V83, P291, DOI 10.1016/0304-3835(94)90332-8; QUICKENDEN TI, 1980, J CHEM PHYS, V72, P4416, DOI 10.1063/1.439733; Rao BK, 2011, OSTOMY WOUND MANAG, V57, P46; Reed NG, 2010, PUBLIC HEALTH REP, V125, P15, DOI 10.1177/003335491012500105; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Russell LM, 2008, EUR J PHARM BIOPHARM, V69, P861, DOI 10.1016/j.ejpb.2008.02.002; Salvermoser M, 2003, APPL PHYS LETT, V83, P1932, DOI 10.1063/1.1605798; Scott RD, 2009, DIRECT MED COSTS HEA; Sliney D, 2013, PHOTOCHEM PHOTOBIOL, V89, P770, DOI 10.1111/php.12093; SODERBERG PG, 1988, ACTA OPHTHALMOL, V66, P141; Sommer R, 1996, APPL ENVIRON MICROB, V62, P1977, DOI 10.1128/AEM.62.6.1977-1983.1996; Sosnin EA, 2005, INSTRUM EXP TECH+, V48, P663, DOI 10.1007/s10786-005-0118-7; Sosnin EA, 2006, J PHOTOCH PHOTOBIO C, V7, P145, DOI 10.1016/j.jphotochemrev.2006.12.002; Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001; Stolper G, 2011, 651 MATTEK CORP; TAYLOR GJS, 1995, J HOSP INFECT, V30, P85, DOI 10.1016/0195-6701(95)90148-5; Tscherteu G, 2012, KPN TOWER ROTTERDAM; Volkova G. A., 1984, Journal of Applied Spectroscopy, V41, P1194, DOI 10.1007/BF00659516; Vollkommer F., 1998, Proceedings of 8th International Symposium on the Science and Technology of Light Sources (LS-8), P51; Wang D, 2010, PHOTOCHEM PHOTOBIOL, V86, P176, DOI 10.1111/j.1751-1097.2009.00640.x; Wengraitis S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1480, DOI 10.1111/j.1751-1097.2012.01193.x; ZOLZER F, 1984, PHOTOCHEM PHOTOBIOL, V40, P49, DOI 10.1111/j.1751-1097.1984.tb04552.x	66	78	82	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76968	10.1371/journal.pone.0076968	http://dx.doi.org/10.1371/journal.pone.0076968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146947	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400091
J	Christley, RM; Mort, M; Wynne, B; Wastling, JM; Heathwaite, AL; Pickup, R; Austin, Z; Latham, SM				Christley, Robert M.; Mort, Maggie; Wynne, Brian; Wastling, Jonathan M.; Heathwaite, A. Louise; Pickup, Roger; Austin, Zoe; Latham, Sophia M.			"Wrong, but Useful": Negotiating Uncertainty in Infectious Disease Modelling	PLOS ONE			English	Article							2001 UK FOOT; MOUTH EPIDEMIC; VACCINATION STRATEGIES; SCIENCE; POLICY; OUTBREAK	For infectious disease dynamical models to inform policy for containment of infectious diseases the models must be able to predict; however, it is well recognised that such prediction will never be perfect. Nevertheless, the consensus is that although models are uncertain, some may yet inform effective action. This assumes that the quality of a model can be ascertained in order to evaluate sufficiently model uncertainties, and to decide whether or not, or in what ways or under what conditions, the model should be 'used'. We examined uncertainty in modelling, utilising a range of data: interviews with scientists, policy-makers and advisors, and analysis of policy documents, scientific publications and reports of major inquiries into key livestock epidemics. We show that the discourse of uncertainty in infectious disease models is multi-layered, flexible, contingent, embedded in context and plays a critical role in negotiating model credibility. We argue that usability and stability of a model is an outcome of the negotiation that occurs within the networks and discourses surrounding it. This negotiation employs a range of discursive devices that renders uncertainty in infectious disease modelling a plastic quality that is amenable to 'interpretive flexibility'. The utility of models in the face of uncertainty is a function of this flexibility, the negotiation this allows, and the contexts in which model outputs are framed and interpreted in the decision making process. We contend that rather than being based predominantly on beliefs about quality, the usefulness and authority of a model may at times be primarily based on its functional status within the broad social and political environment in which it acts.	[Christley, Robert M.; Wastling, Jonathan M.; Latham, Sophia M.] Univ Liverpool, Inst Infect & Global Hlth, Neston, Cheshire, England; [Christley, Robert M.; Latham, Sophia M.] Natl Consortium Zoonosis Res, Neston, Cheshire, England; [Mort, Maggie] Univ Lancaster, Dept Sociol, Lancaster, England; [Mort, Maggie] Univ Lancaster, Sch Med, Lancaster, England; [Wynne, Brian] Univ Lancaster, Ctr Econ & Social Aspects Genom, Lancaster, England; [Heathwaite, A. Louise; Austin, Zoe] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Pickup, Roger] Univ Lancaster, Biomed & Life Sci Div, Lancaster, England	University of Liverpool; Lancaster University; Lancaster University; Lancaster University; Lancaster University; Lancaster University	Christley, RM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Neston, Cheshire, England.	robc@liverpool.ac.uk	Heathwaite, Ann Louise/F-7002-2014	Heathwaite, Ann Louise/0000-0001-8791-0039; Mort, Margaret Mary Elizabeth/0000-0003-0188-324X; Christley, Robert/0000-0001-9250-3032; Pickup, Roger William/0000-0002-9469-1724	UK Research Councils' Rural Economy and Land Use (RELU) programme [RES-229-25-0015]; Economic and Social Research Council; Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Department for Environment, Food and Rural Affairs (Defra); Scottish Government; Natural Environment Research Council [ceh010010] Funding Source: researchfish	UK Research Councils' Rural Economy and Land Use (RELU) programme; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this project has come from the UK Research Councils' Rural Economy and Land Use (RELU) programme grant number RES-229-25-0015. RELU is funded jointly by the Economic and Social Research Council, the Biotechnology and Biological Sciences Research Council and the Natural Environment Research Council, with additional funding from the Department for Environment, Food and Rural Affairs (Defra) and the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, VET REC, V168, P578, DOI 10.1136/vr.d3377; [Anonymous], 1984, OPENING PANDORAS BOX; [Anonymous], 2001, MINUTES EVIDENCE ENV; Barnes B., 1996, SCI KNOWLEDGE SOCIOL; Beven K., 2009, ENV MODELLING UNCERT; Box GEP, 1979, ROB STAT P WORKSH; Campbell D, 2003, SOC LEGAL STUD, V12, P425, DOI 10.1177/0964663903012004002; Defra, 2011, DEFR CONT PLAN EX NO; Department of Health, 2007, PAND FLU NAT FRAM RE; Environment Food and Rural Affairs Committee, 2002, IMP FOOT MOUTH DIS; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2010, SAC MOD MODELLING UN; Fish R, 2011, PHILOS T R SOC B, V366, P2023, DOI 10.1098/rstb.2010.0400; Guitian J, 2006, VET J, V172, P393, DOI 10.1016/j.tvjl.2006.03.001; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Jewell CP, 2009, PREV VET MED, V91, P19, DOI 10.1016/j.prevetmed.2009.05.019; Keeling M, 2006, STAT OF SCI REV PRED; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; KEEPIN B, 1984, NATURE, V312, P691, DOI 10.1038/312691a0; Kitching RP, 2006, REV SCI TECH OIE, V25, P293, DOI 10.20506/rst.25.1.1665; Lahsen M, 2005, SOC STUD SCI, V35, P895, DOI 10.1177/0306312705053049; Leach M, 2013, SOC SCI MED, V88, P10, DOI 10.1016/j.socscimed.2013.03.017; MacKenzie Donald, 1990, INVENTING ACCURACY H; Mansley LM, 2011, REV SCI TECH OIE, V30, P483; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; National Audit Office, 2002, 2001 OUTBR FOOT MOUT; Peiso OO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022066; Pinch T, 1992, SHAPING TECHNOLOGY B; Shackley S, 1996, SCI TECHNOL HUM VAL, V21, P275, DOI 10.1177/016224399602100302; Shackley S, 1996, FUTURES, V28, P201, DOI 10.1016/0016-3287(96)00002-X; Shackley S, 1994, WEATHER, V49, P110; Singleton V., 1998, DIFFERENCES MED UNRA, P86; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Stirling A, 2010, NATURE, V468, P1029, DOI 10.1038/4681029a; The Royal Society, 2002, INFECT DIS LIVESTOCK; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Vynnycky E, 2010, INTR INF DIS MOD; WOOLHOUSE M, 2011, GUIDE GOOD PRACTICE; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387; Woolhouse MEJ, 2003, J APPL MICROBIOL, V94, p126S; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; WYNNE B, 1992, GLOBAL ENVIRON CHANG, V2, P111, DOI 10.1016/0959-3780(92)90017-2; Wynne B, 1997, SCI PUBL POLICY, P95	48	29	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76277	10.1371/journal.pone.0076277	http://dx.doi.org/10.1371/journal.pone.0076277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146851	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400051
J	Larrasoana, JC; Roberts, AP; Rohling, EJ				Larrasoana, Juan C.; Roberts, Andrew P.; Rohling, Eelco J.			Dynamics of Green Sahara Periods and Their Role in Hominin Evolution	PLOS ONE			English	Article							DAKHLA OASIS REGION; WESTERN DESERT; NORTH-AFRICA; MONSOON VARIABILITY; LATE QUATERNARY; PLUVIAL EPISODES; HUMAN DISPERSAL; WATER-BALANCE; PAST CLIMATE; FAZZAN BASIN	Astronomically forced insolation changes have driven monsoon dynamics and recurrent humid episodes in North Africa, resulting in green Sahara Periods (GSPs) with savannah expansion throughout most of the desert. Despite their potential for expanding the area of prime hominin habitats and favouring out-of-Africa dispersals, GSPs have not been incorporated into the narrative of hominin evolution due to poor knowledge of their timing, dynamics and landscape composition at evolutionary timescales. We present a compilation of continental and marine paleoenvironmental records from within and around North Africa, which enables identification of over 230 GSPs within the last 8 million years. By combining the main climatological determinants of woody cover in tropical Africa with paleoenvironmental and paleoclimatic data for representative (Holocene and Eemian) GSPs, we estimate precipitation regimes and habitat distributions during GSPs. Their chronology is consistent with the ages of Saharan archeological and fossil hominin sites. Each GSP took 2-3 kyr to develop, peaked over 4-8 kyr, biogeographically connected the African tropics to African and Eurasian mid latitudes, and ended within 2-3 kyr, which resulted in rapid habitat fragmentation. We argue that the well-dated succession of GSPs presented here may have played an important role in migration and evolution of hominins.	[Larrasoana, Juan C.] Inst Geol & Minero Espana, Zaragoza, Spain; [Larrasoana, Juan C.; Roberts, Andrew P.; Rohling, Eelco J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Rohling, Eelco J.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton, Hants, England	Australian National University; NERC National Oceanography Centre; University of Southampton	Larrasoana, JC (corresponding author), Inst Geol & Minero Espana, Zaragoza, Spain.	jc.larra@igme.es	Roberts, Andrew P/E-6422-2010; Rohling, Eelco J/B-9736-2008; Larrasoana, Juan C./O-1350-2013	Roberts, Andrew P/0000-0003-0566-8117; Rohling, Eelco J/0000-0001-5349-2158; Larrasoana, Juan Cruz/0000-0003-4568-631X	UK Natural Environment Research Council [NE/E01531X/1]; Spanish Ministry of Education [PR2011-0480]; AQUIFER: Hidrologia Subterranea (E72) of the Aragon Government; NERC [NE/E01531X/1, NE/H004424/1, NE/I009906/1] Funding Source: UKRI; Natural Environment Research Council [NE/I009906/1, NE/H004424/1, NE/E01531X/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Spanish Ministry of Education(Spanish Government); AQUIFER: Hidrologia Subterranea (E72) of the Aragon Government; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by projects NE/E01531X/1 (RESET) of the UK Natural Environment Research Council, PR2011-0480 of the Spanish Ministry of Education, and AQUIFER: Hidrologia Subterranea (E72) of the Aragon Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, QUATERNARY SCI REV, V30, P1338, DOI 10.1016/j.quascirev.2010.04.012; Armitage SJ, 2007, QUAT GEOCHRONOL, V2, P181, DOI 10.1016/j.quageo.2006.05.019; Arz HW, 2003, SCIENCE, V300, P118, DOI 10.1126/science.1080325; Ashley GM, 2010, QUATERNARY RES, V74, P333, DOI 10.1016/j.yqres.2010.08.006; Bailey GN, 2011, J HUM EVOL, V60, P257, DOI 10.1016/j.jhevol.2010.01.004; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Bergner AGN, 2003, GLOBAL PLANET CHANGE, V36, P117, DOI 10.1016/S0921-8181(02)00178-9; Blackwell BAB, 2012, QUAT GEOCHRONOL, V10, P430, DOI 10.1016/j.quageo.2012.01.005; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; BROOKES IA, 1993, QUATERNARY SCI REV, V12, P529, DOI 10.1016/0277-3791(93)90068-W; Brookes IA, 2010, QUATERNARY RES, V74, P252, DOI 10.1016/j.yqres.2010.05.001; Brown FH, 2012, J HUM EVOL, V63, P577, DOI 10.1016/j.jhevol.2012.05.014; Caley T, 2011, QUATERNARY SCI REV, V30, P3705, DOI 10.1016/j.quascirev.2011.09.015; Carrion JS, 2011, QUATERNARY SCI REV, V30, P1281, DOI 10.1016/j.quascirev.2011.04.003; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; CAUSSE C, 1988, CR ACAD SCI II, V306, P1459; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Crombie MK, 1997, PALAEOGEOGR PALAEOCL, V130, P337, DOI 10.1016/S0031-0182(96)00134-4; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Derricourt R, 2005, J WORLD PREHIST, V19, P119, DOI 10.1007/s10963-006-9002-z; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Drake NA, 2013, QUATERN INT, V300, P48, DOI 10.1016/j.quaint.2012.12.018; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Elton S, 2008, J ANAT, V212, P377, DOI 10.1111/j.1469-7580.2008.00872.x; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P371, DOI 10.1016/S0031-0182(00)00059-6; Feibel CS, 2011, NATURE, V476, P39, DOI 10.1038/476039a; Fernandes CA, 2006, J BIOGEOGR, V33, P961, DOI 10.1111/j.1365-2699.2006.01478.x; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Geraads D, 2010, QUATERN INT, V212, P159, DOI 10.1016/j.quaint.2009.06.002; Geyh MA, 2008, PALAEOGEOGR PALAEOCL, V257, P1, DOI 10.1016/j.palaeo.2007.07.001; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Griffin DL, 2002, PALAEOGEOGR PALAEOCL, V182, P65, DOI 10.1016/S0031-0182(01)00453-9; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Hamdan M.A.E., 2000, SEDIMENTOLOGY EGYPT, V8, P49; Hilgen FJ, 1995, EARTH PLANET SC LETT, V136, P495, DOI 10.1016/0012-821X(95)00207-S; Hoelzmann P, 2000, GLOBAL PLANET CHANGE, V26, P105, DOI 10.1016/S0921-8181(00)00038-2; Hooghiemstra H, 2006, QUATERN INT, V148, P29, DOI 10.1016/j.quaint.2005.11.005; Husing SK, 2009, EARTH PLANET SC LETT, V282, P140, DOI 10.1016/j.epsl.2009.03.010; Issawi B., 1992, FOLLOWERS HORUS, P1; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kieniewicz JM, 2009, GEOL SOC AM BULL, V121, P1154, DOI 10.1130/B26301.1; Kleindienst M.R., 2008, OASIS PAPERS 2 P 2 D, P25; KOWALSKI K, 1989, QUATERNARY RES, V32, P335, DOI 10.1016/0033-5894(89)90099-9; Krinner G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050992; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; KUTZBACH JE, 1980, QUATERNARY RES, V14, P210, DOI 10.1016/0033-5894(80)90049-6; Lahr MM, 2010, VERTEBR PALEOBIOL PA, P27, DOI 10.1007/978-90-481-9036-2_3; Larrasoana JC, 2003, CLIM DYNAM, V21, P689, DOI 10.1007/s00382-003-0355-z; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lebamba J, 2010, CLIM PAST DISCUSS, V6, P2703; Lebatard AE, 2010, EARTH PLANET SC LETT, V297, P57, DOI 10.1016/j.epsl.2010.06.003; LEZINE AM, 1991, GEOLOGY, V19, P307, DOI 10.1130/0091-7613(1991)019<0307:COACRD>2.3.CO;2; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; Macgregor DS, 2012, PETROL GEOSCI, V18, P417, DOI 10.1144/petgeo2011-074; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1175, DOI 10.1073/pnas.1209405109; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; MCHUGH WP, 1988, J FIELD ARCHAEOL, V15, P361, DOI 10.1179/jfa.1988.15.4.361; MEES F, 1991, Journal of Paleolimnology, V5, P227; Negri A, 2003, PALAEOGEOGR PALAEOCL, V190, P243, DOI 10.1016/S0031-0182(02)00608-9; Nicoll K, 2004, QUATERNARY SCI REV, V23, P561, DOI 10.1016/j.quascirev.2003.10.004; O'Regan HJ, 2011, QUATERNARY SCI REV, V30, P1343, DOI 10.1016/j.quascirev.2009.11.028; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Osinski GR, 2007, EARTH PLANET SC LETT, V253, P378, DOI 10.1016/j.epsl.2006.10.039; Osmond JK, 2004, QUATERNARY RES, V61, P85, DOI 10.1016/j.yqres.2003.09.004; Ouda B, 1998, CR ACAD SCI II A, V326, P855, DOI 10.1016/S1251-8050(98)80024-4; Pachur HJ, 2000, J AFR EARTH SCI, V30, P929, DOI 10.1016/S0899-5362(00)00061-0; Paillou P, 2012, CR GEOSCI, V344, P406, DOI 10.1016/j.crte.2012.07.002; Petit Maire N, 1994, CR HEBD ACAD SCI, V319, P805; Petit-Maire N, 1997, EPISODES, V20, P232, DOI 10.18814/epiiugs/1997/v20i4/004; PETITMAIRE N, 1986, EPISODES, V9, P7; PRELL WL, 1987, J GEOPHYS RES-ATMOS, V92, P8411, DOI 10.1029/JD092iD07p08411; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Ritchie J.C., 1994, HOLOCENE, V4, P9, DOI DOI 10.1177/095968369400400102; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rohling EJ, 2004, MAR MICROPALEONTOL, V50, P89, DOI 10.1016/S0377-8398(03)00068-9; Rohling EJ, 2002, EARTH PLANET SC LETT, V202, P61, DOI 10.1016/S0012-821X(02)00775-6; Rohling EJ, 2002, CLIM DYNAM, V18, P587, DOI 10.1007/s00382-001-0194-8; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Schenau SJ, 1999, MAR GEOL, V153, P117, DOI 10.1016/S0025-3227(98)00086-3; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; Smith JR, 2007, J HUM EVOL, V52, P690, DOI 10.1016/j.jhevol.2007.01.004; Smith JR, 2004, GEOARCHAEOLOGY, V19, P407, DOI 10.1002/gea.20004; Smits JM, 2012, MIND AND METHOD OF THE LEGAL ACADEMIC, P35; Sultan M, 1997, QUATERNARY RES, V48, P29, DOI 10.1006/qres.1997.1907; SZABO BJ, 1995, PALAEOGEOGR PALAEOCL, V113, P227, DOI 10.1016/0031-0182(95)00052-N; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Vaks A, 2007, GEOLOGY, V35, P831, DOI 10.1130/G23794A.1; van der Laan E, 2012, PALAEOGEOGR PALAEOCL, V313, P107, DOI 10.1016/j.palaeo.2011.10.013; van der Made J, 2011, QUATERNARY SCI REV, V30, P1353, DOI 10.1016/j.quascirev.2010.02.028; Watrin J, 2009, CR GEOSCI, V341, P656, DOI 10.1016/j.crte.2009.06.007; Wehausen R, 2000, PALAEOGEOGR PALAEOCL, V158, P325, DOI 10.1016/S0031-0182(00)00057-2; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; WENDORF F, 1993, EGYPT LAST INTERGLAC, P552; Wendorf F, 1994, LATE QUATERNARY CHRO, P147; White F., 1983, VEGETATION AFRICA DE; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; Zhao YL, 2012, QUATERNARY SCI REV, V57, P58, DOI 10.1016/j.quascirev.2012.10.009	106	156	156	6	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76514	10.1371/journal.pone.0076514	http://dx.doi.org/10.1371/journal.pone.0076514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239JR	24146882	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400068
J	von Stechow, L; Ruiz-Aracama, A; van de Water, B; Peijnenburg, A; Danen, E; Lommen, A				von Stechow, Louise; Ruiz-Aracama, Ainhoa; van de Water, Bob; Peijnenburg, Ad; Danen, Erik; Lommen, Arjen			Identification of Cisplatin-Regulated Metabolic Pathways in Pluripotent Stem Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PROFILING REVEALS; CANCER; GENE; RESISTANCE; PROLINE; NUCLEOSIDES; MECHANISMS; APOPTOSIS; METSCAPE	The chemotherapeutic compound, cisplatin causes various kinds of DNA lesions but also triggers other pertubations, such as ER and oxidative stress. We and others have shown that treatment of pluripotent stem cells with cisplatin causes a plethora of transcriptional and post-translational alterations that, to a major extent, point to DNA damage response (DDR) signaling. The orchestrated DDR signaling network is important to arrest the cell cycle and repair the lesions or, in case of damage beyond repair, eliminate affected cells. Failure to properly balance the various aspects of the DDR in stem cells contributes to ageing and cancer. Here, we performed metabolic profiling by mass spectrometry of embryonic stem (ES) cells treated for different time periods with cisplatin. We then integrated metabolomics with transcriptomics analyses and connected cisplatin-regulated metabolites with regulated metabolic enzymes to identify enriched metabolic pathways. These included nucleotide metabolism, urea cycle and arginine and proline metabolism. Silencing of identified proline metabolic and catabolic enzymes indicated that altered proline metabolism serves as an adaptive, rather than a toxic response. A group of enriched metabolic pathways clustered around the metabolite S-adenosylmethionine, which is a hub for methylation and transsulfuration reactions and polyamine metabolism. Enzymes and metabolites with pro-or antioxidant functions were also enriched but enhanced levels of reactive oxygen species were not measured in cisplatin-treated ES cells. Lastly, a number of the differentially regulated metabolic enzymes were identified as target genes of the transcription factor p53, pointing to p53-mediated alterations in metabolism in response to genotoxic stress. Altogether, our findings reveal interconnecting metabolic pathways that are responsive to cisplatin and may serve as signaling modules in the DDR in pluripotent stem cells.	[von Stechow, Louise; van de Water, Bob; Danen, Erik] Leiden Univ, Dept Toxicol, LACDR, Leiden, Netherlands; [Ruiz-Aracama, Ainhoa; Peijnenburg, Ad; Lommen, Arjen] RIKILT Inst Food Safety, Wageningen, Netherlands; [von Stechow, Louise; Ruiz-Aracama, Ainhoa] Netherlands Toxicogen Ctr, Maastricht, Netherlands	Leiden University; Leiden University - Excl LUMC; Wageningen University & Research	Danen, E (corresponding author), Leiden Univ, Dept Toxicol, LACDR, Leiden, Netherlands.	e.danen@lacdr.leidenuniv.nl; arjen.lommen@wur.nl	Aracama, Ainhoa Ruiz/S-2836-2019; Ruiz, Ainhoa/G-1842-2015	Ruiz, Ainhoa/0000-0002-2004-425X; danen, erik/0000-0002-0491-6345	Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO) [050-060-510]	Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO): nr 050-060-510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cano KE, 2010, J PROTEOME RES, V9, P5382, DOI 10.1021/pr100614a; Cavill R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001113; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Christensen KE, 2008, VITAM HORM, V79, P393, DOI 10.1016/S0083-6729(08)00414-7; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Duarte IF, 2010, J PROTEOME RES, V9, P5877, DOI 10.1021/pr100635n; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048; GEHRKE CW, 1979, CANCER RES, V39, P1150; Hector S, 2004, MOL CANCER THER, V3, P813; Hsu WY, 2009, CLIN CHIM ACTA, V402, P31, DOI 10.1016/j.cca.2008.12.009; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jansen BAJ, 2002, J INORG BIOCHEM, V89, P197, DOI 10.1016/S0162-0134(02)00381-1; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Lommen A, 2011, METABOLOMICS, V7, P15, DOI 10.1007/s11306-010-0230-y; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Morris SM, 2004, J NUTR, V134, p2765S, DOI 10.1093/jn/134.10.2765S; Morris SM, 2004, J NUTR, V134, p2743S, DOI 10.1093/jn/134.10.2743S; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pederzolli CD, 2009, METAB BRAIN DIS, V24, P283, DOI 10.1007/s11011-009-9137-6; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Pines A, 2011, MOL CELL BIOL, V31, P4964, DOI 10.1128/MCB.05258-11; Puigvert JC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003208; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Tichy ED, 2011, EXP BIOL MED, V236, P987, DOI 10.1258/ebm.2011.011107; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XY, 2007, ANTI-CANCER AGENT ME, V7, P19, DOI 10.2174/187152007779314062; Welin M, 2010, BIOCHEM BIOPH RES CO, V396, P157, DOI 10.1016/j.bbrc.2010.04.054; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Yan XD, 2007, J PROTEOME RES, V6, P772, DOI 10.1021/pr060402r; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405	53	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76476	10.1371/journal.pone.0076476	http://dx.doi.org/10.1371/journal.pone.0076476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146875	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400063
J	Felmy, B; Songhet, P; Slack, EMC; Muller, AJ; Kremer, M; Van Maele, L; Cayet, D; Heikenwalder, M; Sirard, JC; Hardt, WD				Felmy, Boas; Songhet, Pascal; Slack, Emma Marie Caroline; Mueller, Andreas J.; Kremer, Marcus; Van Maele, Laurye; Cayet, Delphine; Heikenwalder, Mathias; Sirard, Jean-Claude; Hardt, Wolf-Dietrich			NADPH Oxidase Deficient Mice Develop Colitis and Bacteremia upon Infection with Normally Avirulent, TTSS-1-and TTSS-2-Deficient Salmonella Typhimurium	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ENTERICA SEROVAR TYPHIMURIUM; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; HOST-DEFENSE; DENDRITIC CELLS; REACTIVE OXYGEN; PATHOGENICITY ISLAND-2; PHAGOCYTE OXIDASE; MOUSE MODEL	Infections, microbe sampling and occasional leakage of commensal microbiota and their products across the intestinal epithelial cell layer represent a permanent challenge to the intestinal immune system. The production of reactive oxygen species by NADPH oxidase is thought to be a key element of defense. Patients suffering from chronic granulomatous disease are deficient in one of the subunits of NADPH oxidase. They display a high incidence of Crohn's disease-like intestinal inflammation and are hyper-susceptible to infection with fungi and bacteria, including a 10-fold increased risk of Salmonellosis. It is not completely understood which steps of the infection process are affected by the NADPH oxidase deficiency. We employed a mouse model for Salmonella diarrhea to study how NADPH oxidase deficiency (Cybb(-/-)) affects microbe handling by the large intestinal mucosa. In this animal model, wild type S. Typhimurium causes pronounced enteropathy in wild type mice. In contrast, an avirulent S. Typhimurium mutant (S.Tm-avir; invGsseD), which lacks virulence factors boosting trans-epithelial penetration and growth in the lamina propria, cannot cause enteropathy in wild type mice. We found that Cybb(-/-) mice are efficiently infected by S.Tm-avir and develop enteropathy by day 4 post infection. Cell depletion experiments and infections in Cybb(-/-) Myd88(-/-) mice indicated that the S.Tm-avir-inflicted disease in Cybb(-/-) mice hinges on CD11c(+)CX(3)CR1(+) monocytic phagocytes mediating colonization of the cecal lamina propria and on Myd88-dependent proinflammatory immune responses. Interestingly, in mixed bone marrow chimeras a partial reconstitution of Cybb-proficiency in the bone marrow derived compartment was sufficient to ameliorate disease severity. Our data indicate that NADPH oxidase expression is of key importance for restricting the growth of S.Tm-avir in the mucosal lamina propria. This provides important insights into microbe handling by the large intestinal mucosa and the role of NADPH oxidase in maintaining microbe-host mutualism at this exposed body surface.	[Felmy, Boas; Songhet, Pascal; Slack, Emma Marie Caroline; Mueller, Andreas J.; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, D BIOL, CH-8092 Zurich, Switzerland; [Kremer, Marcus] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, D-80290 Munich, Germany; [Van Maele, Laurye; Cayet, Delphine; Sirard, Jean-Claude] Univ Lille Nord France, Inst Natl Sante & Rech Med, Ctr Infect & Immun Lille, Inst Pasteur Lille,CNRS,UMR 8204, Lille, France; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, D-80290 Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hardt, WD (corresponding author), ETH, Inst Microbiol, D BIOL, CH-8092 Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Van Maele, Laurye/ABD-3375-2020; Slack, Emma/AAD-5837-2019; Sirard, Jean-Claude/B-5932-2011; Van Maele, Laurye/P-2882-2017; Slack, Emma/B-1612-2016; Heikenwalder, Mathias/AAA-2269-2020	Van Maele, Laurye/0000-0001-9495-5403; Slack, Emma/0000-0002-2473-1145; Sirard, Jean-Claude/0000-0001-9854-4652; Van Maele, Laurye/0000-0001-9495-5403; Slack, Emma/0000-0002-2473-1145; Muller, Andreas/0000-0002-0281-6383; Hardt, Wolf-Dietrich/0000-0002-9892-6420; CAYET, Delphine/0000-0003-1720-0845	Swiss National Science Foundation [310000-113623/1, 310030-132997/1]; European Union [SavinMucoPath INCO-CT-2006-032296]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported by grants to WDH from the Swiss National Science Foundation (310000-113623/1 and 310030-132997/1) and from the European Union (SavinMucoPath INCO-CT-2006-032296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alam MS, 2008, MICROBIOL IMMUNOL, V52, P197, DOI 10.1111/j.1348-0421.2008.00030.x; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Bjorgvinsdottir H, 1997, BLOOD, V89, P41, DOI 10.1182/blood.V89.1.41.41_41_48; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; Elsen S, 2004, J CELL SCI, V117, P2215, DOI 10.1242/jcs.01085; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Grez M, 2011, MOL THER, V19, P28, DOI 10.1038/mt.2010.232; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kappeli R, 2011, INT J MED MICROBIOL, V301, P117, DOI 10.1016/j.ijmm.2010.08.017; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Mutunga M, 2004, VACCINE, V22, P4124, DOI 10.1016/j.vaccine.2003.10.053; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; OHNO Y, 1985, J BIOL CHEM, V260, P8438; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; REX JH, 1990, J INFECT DIS, V162, P523, DOI 10.1093/infdis/162.2.523; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Silva-Herzog E, 2008, CELL MICROBIOL, V10, P2151, DOI 10.1111/j.1462-5822.2008.01192.x; Simonsen J, 2009, STAT MED, V28, P1882, DOI 10.1002/sim.3592; Soler-Palacin P, 2007, ALLERGOL IMMUNOPATH, V35, P83, DOI 10.1157/13106774; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; Talbot S, 2009, IMMUNOLOGY, V128, P472, DOI 10.1111/j.1365-2567.2009.03146.x; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vallance BA, 2002, INFECT IMMUN, V70, P6424, DOI 10.1128/IAI.70.11.6424-6435.2002; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546	66	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77204	10.1371/journal.pone.0077204	http://dx.doi.org/10.1371/journal.pone.0077204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143212	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100047
J	Vincent-Salomon, A; Benhamo, V; Gravier, E; Rigaill, G; Gruel, N; Robin, S; de Rycke, Y; Mariani, O; Pierron, G; Gentien, D; Reyal, F; Cottu, P; Fourquet, A; Rouzier, R; Sastre-Garau, X; Delattre, O				Vincent-Salomon, Anne; Benhamo, Vanessa; Gravier, Eleonore; Rigaill, Guillem; Gruel, Nadege; Robin, Stephane; de Rycke, Yann; Mariani, Odette; Pierron, Gaelle; Gentien, David; Reyal, Fabien; Cottu, Paul; Fourquet, Alain; Rouzier, Roman; Sastre-Garau, Xavier; Delattre, Olivier			Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; ADJUVANT CHEMOTHERAPY; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; RECURRENCE SCORE; CANCER; SURVIVAL; SIGNATURE; HYBRIDIZATION; EXPERIENCE	Background: The accurate prognosis definition to tailor treatment for early luminal invasive breast carcinoma patients remains challenging. Materials and Methods: Two hundred fourteen early luminal breast carcinomas were genotyped with single nucleotide polymorphisms (SNPs) array to determine the number of chromosomal breakpoints as a marker of genomic instability. Proliferation was assessed by KI67 (immunohistochemistry) and genomic grade index (transcriptomic analysis). IHC3 (IHC4 score for HER2 negative tumors) was also determined. Results: In the training set (109 cases), the optimal cut-off was 34 breakpoints with a specificity of 0.94 and a sensitivity of 0.57 (Area under the curve (AUC): 0.81[0.71; 0.91]). In the validation set (105 cases), the outcome of patients with > 34 breakpoints (11 events / 22 patients) was poorer (logrank test p < 0.001; Relative Risk (RR): 3.7 [1.73; 7.92]), than that of patients with < 34 breakpoints (19 events / 83 patients). Whereas genomic grade and KI67 had a significant prognostic value in univariate analysis in contrast to IHC3 that failed to have a statistical significant prognostic value in this series, the number of breakpoints remained the only significant parameter predictive of outcome (RR: 3.47, Confidence Interval (CI [1.29; 9.31], p = 0.014)) in multivariate analysis. Conclusion: Genomic instability, defined herein as a high number of chromosomal breakpoints, in early stage luminal breast carcinoma is a stronger prognostic marker than proliferation.	[Vincent-Salomon, Anne; Mariani, Odette; Pierron, Gaelle; Sastre-Garau, Xavier] Inst Curie, Dept Tumor Biol, Paris, France; [Vincent-Salomon, Anne; Benhamo, Vanessa; Gruel, Nadege; Delattre, Olivier] Inst Curie, INSERM, U830, Paris, France; [Benhamo, Vanessa; Gravier, Eleonore; Rigaill, Guillem; Gruel, Nadege; Gentien, David] Inst Curie, Dept Translat Res, Paris, France; [Gravier, Eleonore; de Rycke, Yann] Inst Curie, Dept Biostat, Paris, France; [Gravier, Eleonore] Inst Curie, INSERM, U900, Paris, France; [Gravier, Eleonore] Ecole Mines Paris, Paris, France; [Rigaill, Guillem; Robin, Stephane] AgroParisTech, UMR518, Paris, France; [Reyal, Fabien; Rouzier, Roman] Inst Curie, Dept Surg, Paris, France; [Cottu, Paul] Inst Curie, Dept Med Oncol, Paris, France; [Fourquet, Alain] Inst Curie, Dept Radiat Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Vincent-Salomon, A (corresponding author), Inst Curie, Dept Tumor Biol, Paris, France.	anne.salomon@curie.net	Gentien, David/O-9356-2019; Cottu, Paul/ABC-8595-2020; Gentien, David/L-7757-2017; Rouzier, Roman/G-2953-2018	Gentien, David/0000-0001-8317-5188; Sastre-Garau, Xavier/0000-0001-5992-2083; Rigaill, Guillem/0000-0002-7176-7511; delattre, olivier/0000-0002-8730-2276; Rouzier, Roman/0000-0002-8167-6808				Arnedos M, 2012, EUR J CANCER, V48, P2293, DOI 10.1016/j.ejca.2012.06.014; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Bedard PL, 2011, NAT REV CLIN ONCOL, V8, P272, DOI 10.1038/nrclinonc.2011.19; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Blamey RW, 2010, EUR J CANCER, V46, P56, DOI 10.1016/j.ejca.2009.09.009; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gravier E, 2010, GENE CHROMOSOME CANC, V49, P1125, DOI 10.1002/gcc.20820; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Ignatiadis M, 2012, NAT REV CLIN ONCOL, V9, P12, DOI 10.1038/nrclinonc.2011.188; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krijgsman O, 2012, GENE CHROMOSOME CANC, V51, P344, DOI 10.1002/gcc.21920; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Picard F, 2011, BIOSTATISTICS, V12, P413, DOI 10.1093/biostatistics/kxq076; Piccart-Gebhart MJ, 2007, ANN ONCOL, V18, P2, DOI 10.1093/annonc/mdm532; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Reyal F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035184; RIGAILL G, 2010, ARXIV10040887V1, P40887; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Smid M, 2011, BREAST CANCER RES TR, V128, P23, DOI 10.1007/s10549-010-1026-5; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Zhang NR, 2007, BIOMETRICS, V63, P22, DOI 10.1111/j.1541-0420.2006.00662.x	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76496	10.1371/journal.pone.0076496	http://dx.doi.org/10.1371/journal.pone.0076496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143191	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100026
J	Wu, T; Tang, Q; Gao, ZC; Yu, ZP; Song, HZ; Zheng, XD; Chen, W				Wu, Tao; Tang, Qiong; Gao, Zichun; Yu, Zhuoping; Song, Haizhao; Zheng, Xiaodong; Chen, Wei			Blueberry and Mulberry Juice Prevent Obesity Development in C57BL/6 Mice	PLOS ONE			English	Article							BERRY ANTHOCYANINS; INSULIN-RESISTANCE; WHOLE BERRIES; WEIGHT; ANTIOXIDANT; PARAMETERS; LEPTIN; MODEL	Objectives: To establish whether blueberry (Vaccinium ashei) and mulberry (Morus australis Poir) juice, anthocyanin rich fruit juice, may help counteract obesity. Design: And Methods: Four-week-old C57BL/6 mice were fed a high-fat diet (HFD) with or without blueberry and mulberry juice for 12 weeks. Body weight, serum and hepatic lipids, liver and adipose tissues morphology, insulin and leptin were assessed. Results: Mice fed HFD exhibited increased body weight, insulin resistance, serum and hepatic lipids. In comparison, blueberry and mulberry juice inhibited body weight gain, decreased the serum cholesterol, reduced the resistance to insulin, attenuated lipid accumulation and decreased the leptin secretin. Conclusion: These results indicate that blueberry and mulberry juice may help counteract obesity.	[Wu, Tao; Tang, Qiong; Gao, Zichun; Yu, Zhuoping; Song, Haizhao; Zheng, Xiaodong; Chen, Wei] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Tao; Zheng, Xiaodong; Chen, Wei] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, XD (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xdzheng@zju.edu.cn; zjuchenwei@zju.edu.cn	Wu, Tao/E-7769-2011	Wu, Tao/0000-0002-0629-8421	National Key Technology R&D Program of China [2012BAD33B08]; National Natural Science Foundation of China [31000775]; Zhejiang Innovation Program for Graduates [YK2011008]; Fundamental Research Funds for the Central Universities [2013QNA6012]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Innovation Program for Graduates; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Key Technology R&D Program of China (Grant No. 2012BAD33B08), the National Natural Science Foundation of China (Grant No. 31000775), Zhejiang Innovation Program for Graduates (Grant No. YK2011008) and the Fundamental Research Funds for the Central Universities (2013QNA6012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003; Arcari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158; Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Dennison BA, 1999, J AM COLL NUTR, V18, P346, DOI 10.1080/07315724.1999.10718874; Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Finer N, 2013, ENCY HUMAN NUTR, P404; FOLCH J, 1957, J BIOL CHEM, V226, P497; GILBERT CA, 2013, ANNU REV MED, V64, P1, DOI DOI 10.1146/ANNUREV-MED-121211-091605.PUBMED:23020876; Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Kaume L, 2012, J FUNCT FOODS, V4, P480, DOI 10.1016/j.jff.2012.02.008; Kim KH, 2011, ANNU REV FOOD SCI T, V2, P237, DOI 10.1146/annurev-food-022510-133656; LIST EO, 2012, INT J OBESITY, V11, P1; Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697; Maratos-Flier E, 2008, NAT MED, V14, P604, DOI 10.1038/nm0608-604; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nicklas TA, 2008, ARCH PEDIAT ADOL MED, V162, P557, DOI 10.1001/archpedi.162.6.557; Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498; Prior RL, 2008, J AGR FOOD CHEM, V56, P647, DOI 10.1021/jf071993o; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862; SAMUELWU YH, 2013, J FUNCT FOODS, V5, P923, DOI DOI 10.1016/J.JFF.2013.02.002; Siegrist M, 2013, NUTRITION, V29, P851, DOI 10.1016/j.nut.2012.12.011; Sancho RAS, 2012, FOOD RES INT, V46, P378, DOI 10.1016/j.foodres.2011.11.021; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Titta L, 2010, INT J OBESITY, V34, P578, DOI 10.1038/ijo.2009.266; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	36	81	86	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77585	10.1371/journal.pone.0077585	http://dx.doi.org/10.1371/journal.pone.0077585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143244	Green Published, gold			2022-12-25	WOS:000325894100082
J	Masquelier, T; Deco, G				Masquelier, Timothee; Deco, Gustavo			Network Bursting Dynamics in Excitatory Cortical Neuron Cultures Results from the Combination of Different Adaptive Mechanism	PLOS ONE			English	Article							AVALANCHES; SYNCHRONIZATION; TRANSMISSION; PLASTICITY; MEMORY; TIME	In the brain, synchronization among cells of an assembly is a common phenomenon, and thought to be functionally relevant. Here we used an in vitro experimental model of cell assemblies, cortical cultures, combined with numerical simulations of a spiking neural network (SNN) to investigate how and why spontaneous synchronization occurs. In order to deal with excitation only, we pharmacologically blocked GABA(A)ergic transmission using bicuculline. Synchronous events in cortical cultures tend to involve almost every cell and to display relatively constant durations. We have thus named these "network spikes'' (NS). The inter-NS-intervals (INSIs) proved to be a more interesting phenomenon. In most cortical cultures NSs typically come in series or bursts ("bursts of NSs'', BNS), with short (similar to 1 s) INSIs and separated by long silent intervals (tens of s), which leads to bimodal INSI distributions. This suggests that a facilitating mechanism is at work, presumably short-term synaptic facilitation, as well as two fatigue mechanisms: one with a short timescale, presumably short-term synaptic depression, and another one with a longer timescale, presumably cellular adaptation. We thus incorporated these three mechanisms into the SNN, which, indeed, produced realistic BNSs. Next, we systematically varied the recurrent excitation for various adaptation timescales. Strong excitability led to frequent, quasi-periodic BNSs (CV similar to 0), and weak excitability led to rare BNSs, approaching a Poisson process (CV similar to 1). Experimental cultures appear to operate within an intermediate weakly-synchronized regime (CV similar to 0.5), with an adaptation timescale in the 2-8 s range, and well described by a Poisson-with-refractory-period model. Taken together, our results demonstrate that the INSI statistics are indeed informative: they allowed us to infer the mechanisms at work, and many parameters that we cannot access experimentally.	[Masquelier, Timothee; Deco, Gustavo] Univ Pompeu Fabra, Dept Informat & Commun Technol, Unit Brain & Cognit, Barcelona, Spain; [Masquelier, Timothee] CNRS, Lab Neurobiol Adapt Proc, UMR 7102, Paris, France; [Masquelier, Timothee] Univ Paris 06, Paris, France; [Deco, Gustavo] Univ Pompeu Fabra, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; ICREA; Pompeu Fabra University	Masquelier, T (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Unit Brain & Cognit, Barcelona, Spain.	timothee.masquelier@alum.mit.edu	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Masquelier, Timothee/F-1159-2010; DECO, GUSTAVO/A-6341-2008	Masquelier, Timothee/0000-0001-8629-9506; DECO, GUSTAVO/0000-0002-8995-7583	European Union [269459]; ERC [295129]; Spanish Research Project [SAF2010-16085]; CONSOLIDER-INGENIO Program [CSD2007-00012]; ICREA Funding Source: Custom	European Union(European Commission); ERC(European Research Council (ERC)European Commission); Spanish Research Project(Spanish Government); CONSOLIDER-INGENIO Program(Spanish Government); ICREA(ICREA)	This work was funded by the European Union Seventh Framework Program (FP7/2007-2013) under grant agreements no. 269459 (Coronet). GD was also supported by the ERC Advanced Grant: DYSTRUCTURE (n. 295129), by the Spanish Research Project SAF2010-16085, and by the CONSOLIDER-INGENIO 2010 Program CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Baltz T, 2011, J NEUROPHYSIOL, V106, P1500, DOI 10.1152/jn.00889.2010; Beggs JM, 2003, J NEUROSCI, V23, P11167; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Corner MA, 2002, NEUROSCI BIOBEHAV R, V26, P127, DOI 10.1016/S0149-7634(01)00062-8; Eytan D, 2003, J NEUROSCI, V23, P9349; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; FRERE RC, 1982, BRAIN RES, V244, P145, DOI 10.1016/0006-8993(82)90912-X; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gerstner W., 2002, SPIKING NEURON MODEL; Gigante G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.148101; Gilson M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002231; Giugliano M, 2004, J NEUROPHYSIOL, V92, P977, DOI 10.1152/jn.00067.2004; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Gritsun T, 2011, BIOL CYBERN, V105, P197, DOI 10.1007/s00422-011-0457-3; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nakanishi K, 1998, BRAIN RES, V795, P137, DOI 10.1016/S0006-8993(98)00283-2; Park I, 2006, IEEE IJCNN, P581; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Thivierge JP, 2008, J NEUROSCI, V28, P7968, DOI 10.1523/JNEUROSCI.0870-08.2008; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Tsodyks M, 2000, J NEUROSCI, V20; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wiedemann UA, 2003, J NEUROPHYSIOL, V90, P3902, DOI 10.1152/jn.00284.2003; Zrenner C, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00173; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	49	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75824	10.1371/journal.pone.0075824	http://dx.doi.org/10.1371/journal.pone.0075824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146781	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400022
J	Wang, L; Jiang, Q; Chu, J; Lin, L; Li, XG; Chai, GS; Wang, Q; Wang, JZ; Tian, Q				Wang, Lu; Jiang, Qian; Chu, Jiang; Lin, Li; Li, Xiao-Guang; Chai, Gao-Shang; Wang, Qun; Wang, Jian-Zhi; Tian, Qing			Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; PAIRED HELICAL FILAMENTS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PROTEIN-TAU; PHOSPHORYLATED-TAU; TRANSGENIC MICE; NEUROFIBRILLARY PATHOLOGY; CEREBRAL-CORTEX	Accumulation of microtubule-associated protein tau has been observed in the brain of aging and tauopathies. Tau was observed in microglia, but its role is not illustrated. By immunofluorescence staining and the fractal dimension value assay in the present study, we observed that microglia were activated in the brains of rats and mice during aging, simultaneously, the immunoreactivities of total tau and the phosphorylated tau were significantly enhanced in the activated microglia. Furtherly by transient transfection of tau40 (human 2N/4R tau) into the cultured rat microglia, we demonstrated that expression of tau40 increased the level of Iba1, indicating activation of microglia. Moreover, expression of tau40 significantly enhanced the membranous localization of the phosphorylated tau at Ser396 in microglia possibly by a mechanism involving protein phosphatase 2A, extracellular signal-regulated kinase and glycogen synthase kinase-3 beta. It was also found that expression of tau40 promoted microglial migration and phagocytosis, but not proliferation. And we observed increased secretion of several cytokines, including interleukin (IL)-1 beta, IL-6, IL-10, tumor necrosis factor-a and nitric oxide after the expression of tau40. These data suggest a novel role of human 2N/4R tau in microglial activation.	[Wang, Lu; Jiang, Qian; Chu, Jiang; Lin, Li; Li, Xiao-Guang; Chai, Gao-Shang; Wang, Qun; Wang, Jian-Zhi; Tian, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Dis, Dept Pathophysiol,Key Lab, Wuhan 430074, Peoples R China; [Wang, Lu] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Peoples R China	Huazhong University of Science & Technology; Xinxiang Medical University	Wang, JZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Dis, Dept Pathophysiol,Key Lab, Wuhan 430074, Peoples R China.	wangjz@mails.tjmu.edu.cn; tianq@hust.edu.cn			Natural Science Foundation of China [30971204, 81271404]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the Natural Science Foundation of China (grant number: 30971204, 81271404)(http://www.nsfc.gov.cn/Portal0/default152.htm). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arrasate M, 2000, NEUROCHEM RES, V25, P43, DOI 10.1023/A:1007583214722; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bashir A, 2011, EUR REV MED PHARMACO, V15, P1282; Becher B, 2000, GLIA, V29, P293; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Cakman I, 1996, MECH AGEING DEV, V87, P197, DOI 10.1016/0047-6374(96)01708-3; Carlson NG, 1999, J IMMUNOL, V163, P3963; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Chung HS, 2013, NEUROCHEM RES; Crespo-Biel N, 2007, NEUROCHEM INT, V50, P435, DOI 10.1016/j.neuint.2006.10.002; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; GOEDERT M, 1995, NEUROBIOL AGING, V16, P325, DOI 10.1016/0197-4580(95)00017-9; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Iseki E, 2006, NEUROSCI LETT, V405, P29, DOI 10.1016/j.neulet.2006.06.036; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P172837, DOI 10.1155/2012/172837; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mitchell TW, 2002, ANN NEUROL, V51, P182, DOI 10.1002/ana.10086; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; ODAWARA T, 1995, NEUROSCI LETT, V192, P145, DOI 10.1016/0304-3940(95)11595-N; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; SHIN RW, 1989, AM J PATHOL, V134, P1365; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Sjogren M, 2001, CLIN CHEM, V47, P1776; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Sloane JA, 1999, NEUROBIOL AGING, V20, P395, DOI 10.1016/S0197-4580(99)00066-4; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tapiola T, 1997, NEUROREPORT, V8, P3961, DOI 10.1097/00001756-199712220-00022; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; TODARO GJ, 1965, J CELL COMPAR PHYSL, V66, P325, DOI 10.1002/jcp.1030660310; Uchihara T, 2000, NEUROSCI LETT, V286, P99, DOI 10.1016/S0304-3940(00)01103-4; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; Weindruch R, 2002, MECH AGEING DEV, V123, P177, DOI 10.1016/S0047-6374(01)00344-X; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4	91	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76057	10.1371/journal.pone.0076057	http://dx.doi.org/10.1371/journal.pone.0076057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146816	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400037
J	Wang, YX; Xu, L; Zhang, XH; You, QS; Zhao, L; Jonas, JB				Wang, Ya Xing; Xu, Liang; Zhang, Xiao Hui; You, Qi Sheng; Zhao, Liang; Jonas, Jost B.			Five-Year Change in Intraocular Pressure Associated with Changes in Arterial Blood Pressure and Body Mass Index. The Beijing Eye Study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; CENTRAL CORNEAL THICKNESS; SYSTEMIC FACTORS; GLAUCOMA; ANGLE; POPULATION; ADULTS; AGE	Purpose: To examine a potential association between longitudinal changes in intraocular pressure (IOP), arterial blood pressure and body mass index (BMI) in a population-based setting. Methods: The longitudinal population-based Beijing Eye Study included 2355 subjects with an age of 45+ years who were examined in 2006 and in 2011. The participants underwent a detailed ophthalmic examination including tonometry and measurement of arterial blood pressure and BMI. Results: Data on IOP, arterial blood pressure and BMI measured in 2006 and in 2011 were available for 2257 (95.8%) subjects with a mean age of 59.5 +/- 9.7 years. The mean change in IOP was -1.25 +/- 2.26 mm Hg, mean change in mean blood pressure -7.4 +/- 12.1 mmHg, and mean change in BMI was 0.01 +/- 2.04 kg/m(2). In multivariate analysis, the 5-year change in IOP was significantly associated with a higher change in mean blood pressure (P<0.001; standardized regression coefficient Beta: 0.11; regression coefficient B:0.02; 95% confidence interval (CI): 0.01,0.03) after adjusting for younger age (P<0.001; Beta: -0.18; B: -0.04; 95% CI: -0.05,-0.03), shorter body stature (P = 0.002; Beta: -0.06; B: -0.06; 95% CI: -0.03,-0.01), thicker central corneal thickness (P<0.001; Beta: 0.19; B: 0.02; 95% CI: 0.01,0.02), deeper anterior chamber depth (P = 0.01; Beta: 0.05; B: 0.33; 95% CI: 0.07,0.60), and lower intraocular pressure at baseline (P<0.001; Beta: -0.56; B: -0.42; 95% CI: -0.45,-0.39). If the analysis included only longitudinal parameters, the change in IOP was significantly associated with a higher change in mean arterial blood pressure (P<0.001; Beta: 0.10; B: 0.02; 95% CI: 0.01,0.03) and a higher change in body mass index (P<0.04; Beta:0.04; B: 0.04; 95% CI: 0.01,0.09). Conclusions: In the 5-year follow-up of our population-based sample, a change in IOP was associated with a corresponding change in arterial blood pressure and with a corresponding change in body mass index. These longitudinal data support the notion of a physiological relationship between arterial blood pressure, intraocular pressure and body mass index. These findings may be of interest for the discussion of the pathogenesis of glaucomatous optic neuropathy.	[Wang, Ya Xing; Xu, Liang; Zhang, Xiao Hui; You, Qi Sheng; Zhao, Liang; Jonas, Jost B.] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com; Jost.Jonas@augen.ma.uni-heidelberg.de	You, Qisheng/A-3619-2014; You, Qisheng/AAG-7153-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81770890]; Beijing NOVA Program [2011058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China 81770890; Beijing NOVA Program 2011058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Czarnik T, 2009, INJURY, V40, P33, DOI 10.1016/j.injury.2008.10.010; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; Gasser P, 1999, J GLAUCOMA, V8, P8; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE233, DOI 10.1111/j.1442-9071.2011.02625.x; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P5028, DOI 10.1167/iovs.13-11971; Klein BEK, 2005, BRIT J OPHTHALMOL, V89, P284, DOI 10.1136/bjo.2004.048710; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; MCLEOD SD, 1990, INVEST OPHTH VIS SCI, V31, P2361; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nangia V, 2013, PLOS ONE; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wong TT, 2009, INVEST OPHTH VIS SCI, V50, P4097, DOI 10.1167/iovs.08-2822; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030104; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	31	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77180	10.1371/journal.pone.0077180	http://dx.doi.org/10.1371/journal.pone.0077180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146967	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400103
J	Ager-Wick, E; Dirks, RP; Burgerhout, E; Nourizadeh-Lillabadi, R; de Wijze, DL; Spaink, HP; van den Thillart, GEEJM; Tsukamoto, K; Dufour, S; Weltzien, FA; Henkel, CV				Ager-Wick, Eirill; Dirks, Ron P.; Burgerhout, Erik; Nourizadeh-Lillabadi, Rasoul; de Wijze, Danielle L.; Spaink, Herman P.; van den Thillart, Guido E. E. J. M.; Tsukamoto, Katsumi; Dufour, Sylvie; Weltzien, Finn-Arne; Henkel, Christiaan V.			The Pituitary Gland of the European Eel Reveals Massive Expression of Genes Involved in the Melanocortin System	PLOS ONE			English	Article							GONADOTROPIN-BETA-SUBUNIT; FRESH-WATER EELS; ANGUILLA-ANGUILLA; CARBOXYPEPTIDASE-E; SECRETOGRANIN-II; DIFFERENTIAL EXPRESSION; SORTING RECEPTOR; JAPANESE EEL; PROOPIOMELANOCORTIN; SEQUENCE	Hormones secreted from the pituitary gland regulate important processes such as development, growth and metabolism, reproduction, water balance, and body pigmentation. Synthesis and secretion of pituitary hormones are regulated by different factors from the hypothalamus, but also through feedback mechanisms from peripheral organs, and from the pituitary itself. In the European eel extensive attention has been directed towards understanding the different components of the brain-pituitary-gonad axis, but little is known about the regulation of upstream processes in the pituitary gland. In order to gain a broader mechanistic understanding of the eel pituitary gland, we have performed RNA-seq transcriptome profiling of the pituitary of prepubertal female silver eels. RNA-seq reads generated on the Illumina platform were mapped to the recently assembled European eel genome. The most abundant transcript in the eel pituitary codes for pro-opiomelanocortin, the precursor for hormones of the melanocortin system. Several genes putatively involved in downstream processing of pro-opiomelanocortin were manually annotated, and were found to be highly expressed, both by RNA-seq and by qPCR. The melanocortin system, which affects skin color, energy homeostasis and in other teleosts interacts with the reproductive system, has so far received limited attention in eels. However, since up to one third of the silver eel pituitary's mRNA pool encodes pro-opiomelanocortin, our results indicate that control of the melanocortin system is a major function of the eel pituitary.	[Ager-Wick, Eirill; Nourizadeh-Lillabadi, Rasoul; Weltzien, Finn-Arne; Henkel, Christiaan V.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Dirks, Ron P.; Burgerhout, Erik; de Wijze, Danielle L.; van den Thillart, Guido E. E. J. M.; Henkel, Christiaan V.] ZF Screens BV, Leiden, Netherlands; [Burgerhout, Erik; de Wijze, Danielle L.; Spaink, Herman P.; van den Thillart, Guido E. E. J. M.; Henkel, Christiaan V.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Dufour, Sylvie] Museum Natl Hist Nat, Res Unit BOREA, CNRS 7208, F-75231 Paris, France	Norwegian University of Life Sciences; Leiden University; Leiden University - Excl LUMC; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Henkel, CV (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	c.v.henkel@biology.leidenuniv.nl	Burgerhout, Erik/AAI-4527-2020; Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Ager-Wick, Eirill/0000-0001-8368-2008; Henkel, Christiaan/0000-0001-9838-8215; weltzien, finn-arne/0000-0002-5111-1558	Norwegian School of Veterinary Science; Research Council of Norway [184851]; Centre National de la Recherche Scientifique; L'Agence Nationale de la Recherche [08-BLAN-0173]	Norwegian School of Veterinary Science; Research Council of Norway(Research Council of Norway); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); L'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Norwegian School of Veterinary Science and the Research Council of Norway (184851), by Centre National de la Recherche Scientifique and L'Agence Nationale de la Recherche (08-BLAN-0173), and by private resources from ZF-screens B.V., Leiden University and The University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrubaian J, 2003, GEN COMP ENDOCR, V132, P384, DOI 10.1016/S0016-6480(03)00119-9; Anders S, 2012, HTSEQ VERSION 0 5 3P; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Aroua S, 2007, GEN COMP ENDOCR, V153, P333, DOI 10.1016/j.ygcen.2007.02.027; ARVAN P, 1991, J BIOL CHEM, V266, P14171; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burgerhout E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-16; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coll AP, 2009, MOL CELL ENDOCRINOL, V300, P147, DOI 10.1016/j.mce.2008.09.007; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cool DR, 1998, MOL CELL ENDOCRINOL, V139, P7, DOI 10.1016/S0303-7207(98)00081-1; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; DUFOUR S, 1988, GEN COMP ENDOCR, V70, P20, DOI 10.1016/0016-6480(88)90090-1; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; Freyhof J., 2010, IUCN RED LIST THREAT; Han YS, 2003, AQUACULTURE, V219, P783, DOI 10.1016/S0044-8486(02)00578-1; Heinsbroek LTN, 2007, AQUACULTURE, V267, P175, DOI 10.1016/j.aquaculture.2007.03.028; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Holthuis JCM, 1996, J NEUROCHEM, V66, P2248; Holthuis JCM, 1996, J BIOL CHEM, V271, P17755, DOI 10.1074/jbc.271.30.17755; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Huang YS, 1999, ENDOCRINOLOGY, V140, P1228, DOI 10.1210/en.140.3.1228; Kanda S, 2011, GEN COMP ENDOCR, V173, P253, DOI 10.1016/j.ygcen.2011.05.015; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Lee J, 1999, PEPTIDES, V20, P1391, DOI 10.1016/S0196-9781(99)00148-5; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Metz JR, 2006, GEN COMP ENDOCR, V148, P150, DOI 10.1016/j.ygcen.2006.03.001; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Mizusawa K, 2011, GEN COMP ENDOCR, V171, P75, DOI 10.1016/j.ygcen.2010.12.008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; NOZAKI M, 1990, GEN COMP ENDOCR, V77, P348, DOI 10.1016/0016-6480(90)90224-A; Palstra Arjan, 2009, V30, P229; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; PANKHURST NW, 1984, CAN J ZOOL, V62, P1143, DOI 10.1139/z84-165; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Rousseau Karine, 2009, V30, P39; Sbaihi M, 2001, J FISH BIOL, V59, P302, DOI 10.1006/jfbi.2001.1642; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Takahashi A, 2006, GEN COMP ENDOCR, V148, P85, DOI 10.1016/j.ygcen.2005.09.020; Tanaka S, 2003, ZOOL SCI, V20, P1183, DOI 10.2108/zsj.20.1183; Tesch F-W., 2003, EEL; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Van Ginneken V, 2007, ANIM BIOL, V57, P63, DOI 10.1163/157075607780002014; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Weltzien FA, 2005, GEN COMP ENDOCR, V142, P134, DOI 10.1016/j.ygcen.2004.12.019; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Weltzien FA, 2003, GEN COMP ENDOCR, V131, P87, DOI 10.1016/S0016-6480(02)00606-8; Yada T, 2002, GEN COMP ENDOCR, V128, P36, DOI 10.1016/S0016-6480(02)00047-3; Yasuda A, 2011, PEPTIDES, V32, P2127, DOI 10.1016/j.peptides.2011.08.016; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014; Zhao E, 2006, NEUROPEPTIDES, V40, P275, DOI 10.1016/j.npep.2006.05.002	67	11	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77396	10.1371/journal.pone.0077396	http://dx.doi.org/10.1371/journal.pone.0077396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130881	gold, Green Published			2022-12-25	WOS:000325814200085
J	Kabyemela, E; Goncalves, BP; Prevots, DR; Morrison, R; Harrington, W; Gwamaka, M; Kurtis, JD; Fried, M; Duffy, PE				Kabyemela, Edward; Goncalves, Bronner P.; Prevots, D. Rebecca; Morrison, Robert; Harrington, Whitney; Gwamaka, Moses; Kurtis, Jonathan D.; Fried, Michal; Duffy, Patrick E.			Cytokine Profiles at Birth Predict Malaria Severity during Infancy	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM-FALCIPARUM MALARIA; FACTOR-ALPHA; GAMMA-INTERFERON; IMMUNE-RESPONSES; IN-VITRO; CHILDREN; ANEMIA; RISK; SUSCEPTIBILITY	Background: Severe malaria risk varies between individuals, and most of this variation remains unexplained. Here, we examined the hypothesis that cytokine profiles at birth reflect inter-individual differences that persist and influence malaria parasite density and disease severity throughout early childhood. Methods and Findings: Cytokine levels (TNF-alpha, IFN-gamma, IL-1 beta, IL-4, IL-5, IL-6 and IL-10) were measured at birth (cord blood; N=783) and during subsequent routine follow-up visits (peripheral blood) for children enrolled between 2002 and 2006 into a birth cohort in Muheza, Tanzania. Children underwent blood smear and clinical assessments every 2-4 weeks, and at the time of any illness. Cord blood levels of all cytokines were positively correlated with each other (Spearman's rank correlation). Cord levels of IL-1 beta and TNF-alpha (but not other cytokines) correlated with levels of the same cytokine measured at routine visits during early life (P < 0.05). Higher cord levels of IL-1 beta but not TNF-alpha were associated with lower parasite densities during infancy (P=0.003; Generalized Estimating Equation (GEE) method), with an average similar to 40% reduction versus children with low cord IL-1 beta levels, and with decreased risk of severe malaria during follow-up (Cox regression): adjusted hazard ratio (95% CI) 0.60 (0.39-0.92), P = 0.02. Conclusion: IL-1 beta levels at birth are related to future IL-1 beta levels as well as the risk of severe malaria in early life. The effect on severe malaria risk may be due in part to the effect of inflammatory cytokines to control parasite density.	[Kabyemela, Edward; Morrison, Robert; Gwamaka, Moses; Fried, Michal; Duffy, Patrick E.] Seattle Biomed Res Inst, MOMS Project, Seattle, WA 98109 USA; [Kabyemela, Edward; Morrison, Robert; Gwamaka, Moses; Fried, Michal; Duffy, Patrick E.] Muheza Designated Dist Hosp, Muheza, Tanzania; [Goncalves, Bronner P.; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Goncalves, Bronner P.; Prevots, D. Rebecca] NIAID, Lab Clin Infect Dis, Epidemiol Unit, NIH, Bethesda, MD 20892 USA; [Harrington, Whitney] Seattle Childrens Hosp, Seattle, WA USA; [Harrington, Whitney] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Kurtis, Jonathan D.] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [Kurtis, Jonathan D.] Brown Univ, Sch Med, Dept Pathol & Lab Med, Providence, RI 02912 USA	Center for Infectious Disease Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Duffy, PE (corresponding author), Seattle Biomed Res Inst, MOMS Project, 4 Nickerson St, Seattle, WA 98109 USA.	patrick.duffy@nih.gov		Prevots, D Rebecca/0000-0003-0339-9873	Division of Intramural Research (DIR) of NIAID, NIH; NIAID, NIH [R01AI52059]; Bill & Melinda Gates Foundation [29202]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative [1364]; US National Institutes of Health Fogarty International Center (FIC) [D43 TW005509]; FOGARTY INTERNATIONAL CENTER [D43TW005509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001153, R01AI052059, ZIAAI001178] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of NIAID, NIH; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research (DIR) and the extramural program (grant R01AI52059) of NIAID, NIH; the Bill & Melinda Gates Foundation (grant 29202); the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (grant 1364); the US National Institutes of Health Fogarty International Center (FIC) (grant D43 TW005509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taiar A, 2009, T ROY SOC TROP MED H, V103, P72, DOI 10.1016/j.trstmh.2008.09.010; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Chong SS, 2000, BLOOD, V95, P360; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; CURFS JHAJ, 1990, J EXP MED, V172, P1287, DOI 10.1084/jem.172.5.1287; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Fievet N, 1996, PARASITE IMMUNOL, V18, P483, DOI 10.1046/j.1365-3024.1996.d01-19.x; Fortin A, 2002, HUM MOL GENET, V11, P2469, DOI 10.1093/hmg/11.20.2469; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Hensmann M, 2001, INFECT IMMUN, V69, P2364, DOI 10.1128/IAI.69.4.2364-2371.2001; Hugosson E, 2004, PARASITE IMMUNOL, V26, P111, DOI 10.1111/j.0141-9838.2004.00678.x; Jacobs P, 1996, INFECT IMMUN, V64, P44, DOI 10.1128/IAI.64.1.44-49.1996; Kabyemela ER, 2008, INFECT IMMUN, V76, P1527, DOI 10.1128/IAI.00964-07; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; King CL, 2002, J IMMUNOL, V168, P356, DOI 10.4049/jimmunol.168.1.356; KREMSNER PG, 1995, AM J TROP MED HYG, V53, P532, DOI 10.4269/ajtmh.1995.53.532; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Ly NP, 2007, PEDIATRICS, V119, pE171, DOI 10.1542/peds.2006-0524; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Ouma C, 2008, J INFECT DIS, V198, P1219, DOI 10.1086/592055; PIED S, 1992, J IMMUNOL, V148, P197; Ramharter M, 2004, EUR CYTOKINE NETW, V15, P189; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; ROCKETT KA, 1991, INFECT IMMUN, V59, P3280, DOI 10.1128/IAI.59.9.3280-3283.1991; ROCKETT KA, 1992, INFECT IMMUN, V60, P3725, DOI 10.1128/IAI.60.9.3725-3730.1992; ROCKETT KA, 1994, AM J TROP MED HYG, V50, P735, DOI 10.4269/ajtmh.1994.50.735; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Thuma PE, 2011, J INFECT DIS, V203, P211, DOI 10.1093/infdis/jiq041; WENISCH C, 1995, CLIN IMMUNOL IMMUNOP, V74, P115, DOI 10.1006/clin.1995.1017; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	43	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77214	10.1371/journal.pone.0077214	http://dx.doi.org/10.1371/journal.pone.0077214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130857	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200069
J	Balachandran, YL; Girija, S; Selvakumar, R; Tongpim, S; Gutleb, AC; Suriyanarayanan, S				Balachandran, Yekkuni L.; Girija, Shanmugam; Selvakumar, Rajendran; Tongpim, Saowanit; Gutleb, Arno C.; Suriyanarayanan, Sarvajeyakesavalu			Differently Environment Stable Bio-Silver Nanoparticles: Study on Their Optical Enhancing and Antibacterial Properties	PLOS ONE			English	Article							SURFACE-CHARGE; ESCHERICHIA-COLI; GREEN SYNTHESIS; OUTER-MEMBRANE; TOXICITY; STABILITY; RAMAN; SIZE; AGGREGATION; CHEMISTRY	Generally, limited research is extended in studying stability and applicational properties of silver nanoparticles (Ag NPs) synthesized by adopting 'green chemistry' protocol. In this work, we report on the synthesis of stable Ag NPs using plant-derived materials such as leaf extract of Neem (Azadirachta indica) and biopolymer pectin from apple peel. In addition, the applicational properties of Ag NPs such as surface-enhanced Raman scattering (SERS) and antibacterial efficiencies were also investigated. As-synthesized nanoparticles (NPs) were characterized using various instrumentation techniques. Both the plant materials (leaf extract and biopolymer) favored the synthesis of well-defined NPs capped with biomaterials. The NPs were spherical in shape with an average particle size between 14-27 nm. These bio-NPs exhibited colloidal stability in most of the suspended solutions such as water, electrolyte solutions (NaCl; NaNO3), biological solution (bovine serum albumin), and in different pH solutions (pH 7; 9) for a reasonable time period of 120 hrs. Both the bio-NPs were observed to be SERS active through displaying intrinsic SERS signals of the Raman probe molecule (Nile blue A). The NPs were effective against the Escherichia coli bacterium when tested in nutrient broth and agar medium. Scanning and high-resolution transmission electron microscopy (SEM and HRTEM) images confirmed cellular membrane damage of nanoparticle treated E. coli cells. These environmental friendly template Ag NPs can be used as an antimicrobial agent and also for SERS based analytical applications.	[Balachandran, Yekkuni L.; Girija, Shanmugam] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Selvakumar, Rajendran] PSG Inst Adv Studies, Dept Nanobiotechnolgy, Coimbatore, Tamil Nadu, India; [Tongpim, Saowanit] Khon Kaen Univ, Dept Microbiol, Khon Kaen, Thailand; [Gutleb, Arno C.] Ctr Rech Publ Gabriel Lippmann, Dept Environm & Agrobiotechnol, Belvaux, Luxembourg; [Suriyanarayanan, Sarvajeyakesavalu] JSS Univ, Dept Water & Hlth, Mysore, Karnataka, India	Bharathiar University; Khon Kaen University; Luxembourg Institute of Science & Technology; JSS Academy of Higher Education & Research	Suriyanarayanan, S (corresponding author), JSS Univ, Dept Water & Hlth, Mysore, Karnataka, India.	sunsjk@jssuni.edu.in	Gutleb, Arno C./AAK-9182-2021; Sarvajayakesavalu, Suriyanarayanan/W-3608-2019; sarvajayakesavalu, suriyanarayanan/GPF-9996-2022; Yekkuni, Balachandran L/L-3461-2013	Gutleb, Arno C./0000-0001-9725-9112; Sarvajayakesavalu, Suriyanarayanan/0000-0003-3607-8304; Yekkuni, Balachandran L/0000-0003-0050-0999				Alvarez-Puebla RA, 2005, J PHYS CHEM B, V109, P3787, DOI 10.1021/jp045015o; Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x; Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002; Chen KL, 2006, LANGMUIR, V22, P10994, DOI 10.1021/la062072v; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; dos Santos DS, 2005, J MATER CHEM, V15, P3045, DOI 10.1039/b506218g; Doty RC, 2005, CHEM MATER, V17, P4630, DOI 10.1021/cm0508017; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P9004, DOI 10.1021/es901706j; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jacob JA, 2008, LANGMUIR, V24, P528, DOI 10.1021/la702073r; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p; Kong JM, 2008, SYNTH REACT INORG M, V38, P186, DOI 10.1080/15533170801926218; Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023; LAWLESS MK, 1992, J CHEM PHYS, V96, P8037, DOI 10.1063/1.462355; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314; MacCuspie RI, 2011, J ENVIRON MONITOR, V13, P1212, DOI 10.1039/c1em10024f; MAY CD, 1990, CARBOHYD POLYM, V12, P79, DOI 10.1016/0144-8617(90)90105-2; Mukhiddinov ZK, 2000, TALANTA, V53, P171, DOI 10.1016/S0039-9140(00)00456-2; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Parashar UK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415104; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Selvakumar R, 2014, J EXP NANOSCI, V9, P1075, DOI 10.1080/17458080.2013.778425; Shukla R, 2008, SMALL, V4, P1425, DOI 10.1002/smll.200800525; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sriamornsak P., 2003, SILPAKORN U SCI INT, V3, P206, DOI DOI 10.5458/JAG.54.211; Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374; Sutton A, 2009, J POLYM SCI POL CHEM, V47, P4482, DOI 10.1002/pola.23501; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Tielemans M, 2006, PROG ORG COAT, V55, P128, DOI 10.1016/j.porgcoat.2005.08.010; Verwey E.J., 1948, THEORY STABILITY LYO; Zamiri R, 2012, B MATER SCI, V35, P727, DOI 10.1007/s12034-012-0360-0; Zhang W, 2011, ENVIRON SCI TECHNOL, V45, P4422, DOI 10.1021/es104205a	41	35	36	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77043	10.1371/journal.pone.0077043	http://dx.doi.org/10.1371/journal.pone.0077043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130832	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900119
J	Lemak, A; Yee, A; Wu, H; Yap, D; Zeng, H; Dombrovski, L; Houliston, S; Aparicio, S; Arrowsmith, CH				Lemak, Alexander; Yee, Adelinda; Wu, Hong; Yap, Damian; Zeng, Hong; Dombrovski, Ludmila; Houliston, Scott; Aparicio, Samuel; Arrowsmith, Cheryl H.			Solution NMR Structure and Histone Binding of the PHD Domain of Human MLL5	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; LINEAGE LEUKEMIA 5; AUTOIMMUNE REGULATOR; PROTEIN STRUCTURES; GENE-EXPRESSION; FINGER; METHYLATION; RECOGNITION; CONTRIBUTES; HOMOLOG	Mixed Lineage Leukemia 5 (MLL5) is a histone methyltransferase that plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. In addition to its catalytic domain, MLL5 contains a PHD finger domain, a protein module that is often involved in binding to the N-terminus of histone H3. Here we report the NMR solution structure of the MLL5 PHD domain showing a variant of the canonical PHD fold that combines conserved H3 binding features from several classes of other PHD domains (including an aromatic cage) along with a novel C-terminal alpha-helix, not previously seen. We further demonstrate that the PHD domain binds with similar affinity to histone H3 tail peptides di- and tri-methylated at lysine 4 (H3K4me2 and H3K4me3), the former being the putative product of the MLL5 catalytic reaction. This work establishes the PHD domain of MLL5 as a bone fide 'reader' domain of H3K4 methyl marks suggesting that it may guide the spreading or further methylation of this site on chromatin.	[Lemak, Alexander; Yee, Adelinda; Houliston, Scott] Northeast Struct Genom Consortium, Toronto, ON, Canada; [Lemak, Alexander; Yee, Adelinda; Houliston, Scott] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Wu, Hong; Zeng, Hong; Dombrovski, Ludmila] Univ Toronto, Struct Genom Consortium, Toronto, ON M5S 1A1, Canada; [Yap, Damian; Aparicio, Samuel] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Inst Canc, Toronto, ON M5S 1A1, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Structural Genomics Consortium; British Columbia Cancer Agency; University of Toronto; University of Toronto		carrow@uhnres.utoronto.ca		Yap, Damian/0000-0002-5370-4592; Aparicio, Samuel/0000-0002-0487-9599; Arrowsmith, Cheryl/0000-0002-4971-3250	National Institutes of Health through Northeast Structural Genomics Consortium [U54 GM094597]; Natural Sciences and Engineering Research Council of Canada; Structural Genomics Consortium which is a registered charity [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research (CIHR); Genome Canada through the Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health through Northeast Structural Genomics Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Structural Genomics Consortium which is a registered charity; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health through Northeast Structural Genomics Consortium (U54 GM094597), the Natural Sciences and Engineering Research Council of Canada, and the Structural Genomics Consortium which is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, Canada Foundation for Innovation, the Canadian Institutes for Health Research (CIHR), Genome Canada through the Ontario Genomics Institute [OGI-055], GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Cheng F, 2011, ONCOGENE, V30, P3599, DOI 10.1038/onc.2011.71; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; GODDARD TD, 2003, SPARKY NMR ASSIGNMEN; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu J, 2012, J CELL SCI, V125, P4676, DOI 10.1242/jcs.110411; Liu J, 2010, J BIOL CHEM, V285, P20904, DOI 10.1074/jbc.M109.098558; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	47	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77020	10.1371/journal.pone.0077020	http://dx.doi.org/10.1371/journal.pone.0077020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130829	gold, Green Published, Green Submitted			2022-12-25	WOS:000325810900117
J	Fogarty, FM; O'Keeffe, J; Zhadanov, A; Papkovsky, D; Ayllon, V; O'Connor, R				Fogarty, F. M.; O'Keeffe, J.; Zhadanov, A.; Papkovsky, D.; Ayllon, V.; O'Connor, R.			HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H+ ATPase	ONCOGENE			English	Article						V-ATPase; HRG-1; glucose metabolism; pH; IGF-1	PROTON PUMPS; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMA-MEMBRANE; CYTOSOLIC PH; A3 ISOFORM; V-ATPASES; SUBUNIT; TRANSLOCATION; EXPRESSION; TRANSPORTERS	Haeme-responsive gene (HRG)-1 encodes a 16-kDa transmembrane protein that is induced by insulin-like growth factor-1 (IGF-1) and associates with the vacuolar-(H+) ATPase (V-ATPase). We previously reported that HRG-1 is essential for V-ATPase activity in endosomal acidification and receptor trafficking. Here, we show that in highly invasive and migratory cancer cell lines, HRG-1 and the V-ATPase are co-expressed at the plasma membrane, whereas in less invasive cell lines and non-transformed cells HRG-1 overexpression remains confined to intracellular compartments. Stable suppression of HRG-1 in invasive breast cancer MDA-MB-231 cells decreases extracellular pH, cell growth, migration and invasion. Ectopic expression of HRG-1 in non-invasive MCF-7 cells enhances V-ATPase activity, lowers the extracellular pH and increases the pH-dependent activity of MMP2 and MMP9 matrix metalloproteinases. HRG-1 enhances trafficking of the glucose transporter-1 (GLUT-1) with a concomitant increase in glucose uptake and lactate production. HRG-1 also promotes trafficking of the insulin-like growth factor I receptor (IGF-1R), beta 1-integrin and IGF-1 signalling. Taken together, our findings indicate that HRG-1 expression at the plasma membrane enhances V-ATPase activity, drives glycolytic flux and facilitates cancer cell growth, migration and invasion. Thus, HRG-1 may represent a novel target for selectively disrupting V-ATPase activity and the metastatic potential of cancer cells.	[Fogarty, F. M.; O'Keeffe, J.; Ayllon, V.; O'Connor, R.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cell Biol Lab, Cork, Ireland; [Zhadanov, A.; Papkovsky, D.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Lab Biophys & Bioanal, Cork, Ireland	University College Cork; University College Cork	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Lab Biophys & Bioanal, Coll Rd, Cork, Ireland.	r.oconnor@ucc.ie	O'Connor, Rosemary/B-7902-2014; Ayllon, Veronica/L-7069-2014	O'Connor, Rosemary/0000-0002-0687-3422; Ayllon, Veronica/0000-0002-7322-9282; Papkovsky, Dmitri/0000-0003-1556-1145	Health Research Board (PhD Scholars Programme in Cancer Biology(FF)); Science Foundation Ireland (PI) [06/INI/B107]	Health Research Board (PhD Scholars Programme in Cancer Biology(FF)); Science Foundation Ireland (PI)(Science Foundation Ireland)	We are grateful to our colleagues in the Cell Biology Laboratory and Dr Kellie Dean for helpful discussions, and to Kurt Tidmore for preparing illustrations. This work was supported by the Health Research Board (PhD Scholars Programme in Cancer Biology (FF)) and Science Foundation Ireland (PI Award: 06/INI/B107).	Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chiche J, 2012, INT J CANCER, V130, P1511, DOI 10.1002/ijc.26125; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernandez A, 2012, CURR PHARM DESIGN, V18, P1383, DOI 10.2174/138161212799504821; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Kubota S, 2000, BIOCHEM BIOPH RES CO, V278, P390, DOI 10.1006/bbrc.2000.3802; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu X, 2005, CANCER RES, V65, P6843; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Ohta T, 1998, J PATHOL, V185, P324, DOI 10.1002/(SICI)1096-9896(199807)185:3<324::AID-PATH72>3.0.CO;2-9; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Perez-Sayans M, 2012, BRAZ J BIOL, V72, P189, DOI 10.1590/S1519-69842012000100023; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Samih N, 2000, ENDOCRINOLOGY, V141, P4146, DOI 10.1210/en.141.11.4146; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2012, CURR PROTEIN PEPT SC, V13, P152; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Spugnini EP, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-44; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Thomsen P, 1999, BBA-MOL CELL RES, V1452, P285, DOI 10.1016/S0167-4889(99)00132-9; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; Zhdanov AV, 2013, BBA-GEN SUBJECTS, V1830, P3553, DOI 10.1016/j.bbagen.2013.02.016	39	23	25	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4653	4663		10.1038/onc.2013.403	http://dx.doi.org/10.1038/onc.2013.403			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24141772				2022-12-25	WOS:000342007200004
J	Butail, S; Bartolini, T; Porfiri, M				Butail, Sachit; Bartolini, Tiziana; Porfiri, Maurizio			Collective Response of Zebrafish Shoals to a Free-Swimming Robotic Fish	PLOS ONE			English	Article							DANIO-RERIO RESPONDS; TAIL BEAT FREQUENCY; BEHAVIORAL-RESPONSES; MODEL; PREFERENCES; MECHANISMS; ALCOHOL; MOTION; SCHOOL; SIZE	In this work, we explore the feasibility of regulating the collective behavior of zebrafish with a free-swimming robotic fish. The visual cues elicited by the robot are inspired by salient features of attraction in zebrafish and include enhanced coloration, aspect ratio of a fertile female, and carangiform/subcarangiform locomotion. The robot is autonomously controlled with an online multi-target tracking system and swims in circular trajectories in the presence of groups of zebrafish. We investigate the collective response of zebrafish to changes in robot speed, achieved by varying its tail-beat frequency. Our results show that the speed of the robot is a determinant of group cohesion, quantified through zebrafish nearest-neighbor distance, which increases with the speed of the robot until it reaches 3cm/s. We also find that the presence of the robot causes a significant decrease in the group speed, which is not accompanied by an increase in the freezing response of the subjects. Findings of this study are expected to inform the design of experimental protocols that leverage the use of robots to study the zebrafish animal model.	[Butail, Sachit; Bartolini, Tiziana; Porfiri, Maurizio] NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA.	mporfiri@poly.edu	Butail, Sachit/O-2928-2013	Butail, Sachit/0000-0001-9785-7374; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [CMMI-0745753, CMMI-1129820]; Mitsui USA Foundation; Div Of Civil, Mechanical, & Manufact Inn [0745753] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Mitsui USA Foundation; Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation under Grant nos. CMMI-0745753 and CMMI-1129820 and the Mitsui USA Foundation through a fellowship to Tiziana Bartolini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Bode NWF, 2010, P ROY SOC B-BIOL SCI, V277, P3065, DOI 10.1098/rspb.2010.0855; BREDER CM, 1946, PHYSIOL ZOOL, V19, P154, DOI 10.1086/physzool.19.2.30151891; Buske C, 2011, PROG NEURO-PSYCHOPH, V35, P1409, DOI 10.1016/j.pnpbp.2010.09.003; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Cianca V, 2013, PLOS ONE IN PRESS; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; de Margerie E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/034001; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandez-Juricic E, 2011, BEHAV ECOL, V22, P1304, DOI 10.1093/beheco/arr132; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Kolpas A, 2008, MATH BIOSCI, V214, P49, DOI 10.1016/j.mbs.2008.06.003; Kopman V, 2013, IEEE-ASME T MECH, V18, P471, DOI 10.1109/TMECH.2012.2222431; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Miklosi A, 2006, ZEBRAFISH, V3, P227, DOI 10.1089/zeb.2006.3.227; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Miller N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048865; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Patricelli GL, 2006, ANIM BEHAV, V71, P49, DOI 10.1016/j.anbehav.2005.03.029; Plaut I, 2000, J EXP BIOL, V203, P813; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Polverino G, 2013, BIOINSPIRAT IN PRESS; Polverino G, 2013, BEHAV BRAIN RES, V250, P133, DOI 10.1016/j.bbr.2013.05.008; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Rosenthal GG, 2005, ANIM BEHAV, V70, P1063, DOI 10.1016/j.anbehav.2005.02.005; Rossi C, 2012, SWIMMING PHYSL FISH, P407; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spinello C, 2013, ALCOHOL, V47, P391, DOI 10.1016/j.alcohol.2013.04.003; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swain DT, 2012, P IEEE, V100, P150, DOI 10.1109/JPROC.2011.2165449; Thomas JK, 2011, AQUAT TOXICOL, V102, P79, DOI 10.1016/j.aquatox.2010.12.020; Tien JH, 2004, EVOL ECOL RES, V6, P555; Todd DJ, 1993, ROBOT BIOL SYST NEW, V102, P193; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Webb B, 2000, ANIM BEHAV, V60, P545, DOI 10.1006/anbe.2000.1514; Webster MM, 2007, BEHAV ECOL SOCIOBIOL, V62, P273, DOI 10.1007/s00265-007-0462-7; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023	56	80	80	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76123	10.1371/journal.pone.0076123	http://dx.doi.org/10.1371/journal.pone.0076123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146825	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400039
J	Costa, A; Candeo, A; Fieramonti, L; Valentini, G; Bassi, A				Costa, Alex; Candeo, Alessia; Fieramonti, Luca; Valentini, Gianluca; Bassi, Andrea			Calcium Dynamics in Root Cells of Arabidopsis thaliana Visualized with Selective Plane Illumination Microscopy	PLOS ONE			English	Article							CA2+ DYNAMICS; REVEALS; OSCILLATIONS; RESOLUTION; CAMELEON; GROWTH; INFORMATION; SIGNATURES; SIGNALS; RANGE	Selective Plane Illumination Microscopy (SPIM) is an imaging technique particularly suited for long term in-vivo analysis of transparent specimens, able to visualize small organs or entire organisms, at cellular and eventually even subcellular resolution. Here we report the application of SPIM in Calcium imaging based on Forster Resonance Energy Transfer (FRET). Transgenic Arabidopsis plants expressing the genetically encoded-FRET-based Ca2+ probe Cameleon, in the cytosol or nucleus, were used to demonstrate that SPIM enables ratiometric fluorescence imaging at high spatial and temporal resolution, both at tissue and single cell level. The SPIM-FRET technique enabled us to follow nuclear and cytosolic Ca2+ dynamics in Arabidopsis root tip cells, deep inside the organ, in response to different stimuli. A relevant physiological phenomenon, namely Ca2+ signal percolation, predicted in previous studies, has been directly visualized.	[Costa, Alex] Univ Milan, Dipartimento Biosci, Milan, Italy; [Candeo, Alessia; Fieramonti, Luca; Valentini, Gianluca; Bassi, Andrea] Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy	University of Milan; Polytechnic University of Milan	Costa, A (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	alex.costa@unimi.it	Candeo, Alessia/AAC-7138-2021; Costa, Alex/I-5172-2015; Bassi, Andrea/I-4542-2012; Valentini, Gianluca/G-4594-2011	Candeo, Alessia/0000-0001-9597-3056; Costa, Alex/0000-0002-2628-1176; Bassi, Andrea/0000-0002-5017-0775; Valentini, Gianluca/0000-0002-6340-3021	Futuro in Ricerca [2010 RBFR10S1LJ_001]	Futuro in Ricerca	This work was partially supported by Futuro in Ricerca 2010 RBFR10S1LJ_001 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Behera S, 2013, COLD SPRING HARB PRO, V1, P2013; Costa A, 2010, PLANT J, V62, P760, DOI 10.1111/j.1365-313X.2010.04190.x; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Grossmann G, 2011, PLANT CELL, V23, P4234, DOI 10.1105/tpc.111.092577; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Krebs M, 2012, PLANT J, V69, P181, DOI 10.1111/j.1365-313X.2011.04780.x; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Loro G, 2013, J MICROSC-OXFORD, V249, P8, DOI 10.1111/j.1365-2818.2012.03683.x; Loro G, 2012, PLANT J, V71, P1, DOI 10.1111/j.1365-313X.2012.04968.x; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Maizel A, 2011, PLANT J, V68, P377, DOI 10.1111/j.1365-313X.2011.04692.x; Mazars C, 2011, BIOCHIMIE, V93, P2068, DOI 10.1016/j.biochi.2011.05.039; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Plieth C, 2010, PLANT SIGNAL BEHAV, V5, P379, DOI 10.4161/psb.5.4.10717; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Rincon-Zachary M, 2010, PLANT PHYSIOL, V152, P1442, DOI 10.1104/pp.109.147256; Sena G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021303; Short EF, 2012, PLANT J, V71, P948, DOI 10.1111/j.1365-313X.2012.05043.x; Sieberer BJ, 2009, PLANT PHYSIOL, V151, P1197, DOI 10.1104/pp.109.142851; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; Swoger J, 2007, OPT EXPRESS, V15, P8029, DOI 10.1364/OE.15.008029; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Whalley HJ, 2013, NEW PHYTOL, V197, P690, DOI 10.1111/nph.12087; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhu XH, 2013, MOL PLANT, V6, P444, DOI 10.1093/mp/sst013	42	55	56	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75646	10.1371/journal.pone.0075646	http://dx.doi.org/10.1371/journal.pone.0075646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146766	Green Published, gold			2022-12-25	WOS:000326019400012
J	Houssaye, A; Lindgren, J; Pellegrini, R; Lee, AH; Germain, D; Polcyn, MJ				Houssaye, Alexandra; Lindgren, Johan; Pellegrini, Rodrigo; Lee, Andrew H.; Germain, Damien; Polcyn, Michael J.			Microanatomical and Histological Features in the Long Bones of Mosasaurine Mosasaurs (Reptilia, Squamata) - Implications for Aquatic Adaptation and Growth Rates	PLOS ONE			English	Article							LIFE-STYLE; VERTEBRAL MICROANATOMY; MARINE REPTILES; AMNIOTES; PHYLOGENY; EVOLUTION; SKELETOCHRONOLOGY; MASS	Background: During their evolution in the Late Cretaceous, mosasauroids attained a worldwide distribution, accompanied by a marked increase in body size and open ocean adaptations. This transition from land-dwellers to highly marine-adapted forms is readily apparent not only at the gross anatomic level but also in their inner bone architecture, which underwent profound modifications. Methodology/Principal Findings: The present contribution describes, both qualitatively and quantitatively, the internal organization (microanatomy) and tissue types and characteristics (histology) of propodial and epipodial bones in one lineage of mosasauroids; i.e., the subfamily Mosasaurinae. By using microanatomical and histological data from limb bones in combination with recently acquired knowledge on the inner structure of ribs and vertebrae, and through comparisons with extant squamates and semi-aquatic to fully marine amniotes, we infer possible implications on mosasaurine evolution, aquatic adaptation, growth rates, and basal metabolic rates. Notably, we observe the occurrence of an unusual type of parallel-fibered bone, with large and randomly shaped osteocyte lacunae (otherwise typical of fibrous bone) and particular microanatomical features in Dallasaurus, which displays, rather than a spongious inner organization, bone mass increase in its humeri and a tubular organization in its femora and ribs. Conclusions/Significance: The dominance of an unusual type of parallel-fibered bone suggests growth rates and, by extension, basal metabolic rates intermediate between that of the extant leatherback turtle, Dermochelys, and those suggested for plesiosaur and ichthyosaur reptiles. Moreover, the microanatomical features of the relatively primitive genus Dallasaurus differ from those of more derived mosasaurines, indicating an intermediate stage of adaptation for a marine existence. The more complete image of the various microanatomical trends observed in mosasaurine skeletal elements supports the evolutionary convergence between this lineage of secondarily aquatically adapted squamates and cetaceans in the ecological transition from a coastal to a pelagic lifestyle.	[Houssaye, Alexandra] Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany; [Lindgren, Johan] Lund Univ, Dept Geol, Lund, Sweden; [Pellegrini, Rodrigo] New Jersey State Museum, Trenton, NJ USA; [Lee, Andrew H.] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Germain, Damien] UPMC, MNHN, CNRS, UMR7207,Dept Hist Terre, Paris, France; [Polcyn, Michael J.] So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA	University of Bonn; Lund University; Midwestern University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Southern Methodist University	Houssaye, A (corresponding author), Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany.	houssaye@uni-bonn.de	Houssaye, Alexandra/J-5631-2015; Pellegrini, Rodrigo/GSI-5160-2022	Pellegrini, Rodrigo/0000-0003-2163-8524; Germain, Damien/0000-0002-7608-2212; Lee, Andrew/0000-0001-7829-334X	A. v. Humboldt Foundation; Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences; Institute for the Study of Earth and Man at Southern Methodist University; Projecto PaleoAngola	A. v. Humboldt Foundation(Alexander von Humboldt Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences; Institute for the Study of Earth and Man at Southern Methodist University; Projecto PaleoAngola	A.H. acknowledges financial support from the A. v. Humboldt Foundation and J.L. from the Swedish Research Council, the Crafoord Foundation and the Royal Swedish Academy of Sciences. M.J. Polcyn acknowledges financial support from Institute for the Study of Earth and Man at Southern Methodist University, and Projecto PaleoAngola. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amprino R., 1947, ARCH BIOL SCI, V58, P315; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bell Gorden L. Jr, 1997, P293, DOI 10.1016/B978-012155210-7/50017-X; Bell Jr GL, 1986, J ALA ACAD SCI, V57, P2; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Caldwell MW, 2007, J VERTEBR PALEONTOL, V27, P863, DOI 10.1671/0272-4634(2007)27[863:ANBMFT]2.0.CO;2; Caldwell MW, 1996, ZOOL J LINN SOC-LOND, V116, P407, DOI 10.1006/zjls.1996.0027; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Carroll Robert L., 1997, P467, DOI 10.1016/B978-012155210-7/50025-9; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; CURREY JD, 1985, J ZOOL, V206, P453; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Enlow D. H., 1969, pUnpaginated; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Francillon-Vieillot H., 1990, P471; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Houssaye A, 2008, P 2 MOSASAUR M FORT, P81; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2013, BIOL REV, V88, P117, DOI 10.1111/j.1469-185X.2012.00243.x; Houssaye A, 2012, J VERTEBR PALEONTOL, V32, P1042, DOI 10.1080/02724634.2012.680999; Houssaye A, 2012, LETHAIA, V45, P200, DOI 10.1111/j.1502-3931.2011.00273.x; Houssaye A, 2010, J ANAT, V217, P715, DOI 10.1111/j.1469-7580.2010.01307.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Laurin M, 2004, PALEOBIOLOGY, V30, P589, DOI 10.1666/0094-8373(2004)030<0589:TEOLBM>2.0.CO;2; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; Lindgren J, 2004, ACTA PALAEONTOL POL, V49, P219; Lindgren J, 2011, PALEOBIOLOGY, V37, P445, DOI 10.1666/09023.1; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; LINGHAMSOLIAR T, 1995, PHILOS T ROY SOC B, V347, P155, DOI 10.1098/rstb.1995.0019; Lopuchowycz Victoria B., 2002, Paludicola, V3, P139; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; Motani R, 2002, PALEOBIOLOGY, V28, P251, DOI 10.1666/0094-8373(2002)028<0251:SSEOEM>2.0.CO;2; Motani R, 1998, J PALEONTOL, V72, P133, DOI 10.1017/S0022336000024069; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Nopcia F., 1934, Acta Zoologica Stockholm, V15, P431; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Pellegrini Rodrigo, 2007, Transactions of the Kansas Academy of Science, V110, P83, DOI 10.1660/0022-8443(2007)110[83:SOTLEO]2.0.CO;2; Polcyn MJ, 2008, P 2 MOSASAUR M FORT, P137; Polcyn MJ, PALAEOGEOGR IN PRESS; Quemeneur S, 2013, BIOL J LINN SOC, V109, P644, DOI 10.1111/bij.12066; R Development Core Team, 2011, R LANG ENV STAT COMP; Reid R.E.H., 1987, Modern Geology, V11, P133; Robbins J.A., 2008, P 2 MOS M FORT HAYS, V3, P123; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Salgado L, 2007, AMEGHINIANA, V44, P513; Scheyer TM, 2010, SEMIN CELL DEV BIOL, V21, P462, DOI 10.1016/j.semcdb.2009.11.005; Sheldon A, 1998, PALUDICOLA, V2, P190; Sheldon A, 1997, ANCIENT MARINE REPTI, P293; Sheldon A, 1995, THESIS U ROCHESTER N; Sheldon Amy, 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P369; TAYLOR MA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P151; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453	62	38	39	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76741	10.1371/journal.pone.0076741	http://dx.doi.org/10.1371/journal.pone.0076741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146919	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400084
J	Robin, MH; Colbach, N; Lucas, P; Montfort, F; Cholez, C; Debaeke, P; Aubertot, JN				Robin, Marie-Helene; Colbach, Nathalie; Lucas, Philippe; Montfort, Francoise; Cholez, Celia; Debaeke, Philippe; Aubertot, Jean-Noel			Injury Profile SIMulator, a Qualitative Aggregative Modelling Framework to Predict Injury Profile as a Function of Cropping Practices, and Abiotic and Biotic Environment. II. Proof of Concept: Design of IPSIM-Wheat-Eyespot	PLOS ONE			English	Article							WINTER-WHEAT; PSEUDOCERCOSPORELLA-HERPOTRICHOIDES; OCULIMACULA-YALLUNDAE; MULTIATTRIBUTE MODEL; DISEASE DEVELOPMENT; TAPESIA ACUFORMIS; CAUSAL AGENT; SOIL TILLAGE; YIELD LOSS; SYSTEMS	IPSIM (Injury Profile SIMulator) is a generic modelling framework presented in a companion paper. It aims at predicting a crop injury profile as a function of cropping practices and abiotic and biotic environment. IPSIM's modelling approach consists of designing a model with an aggregative hierarchical tree of attributes. In order to provide a proof of concept, a model, named IPSIM-Wheat-Eyespot, has been developed with the software DEXi according to the conceptual framework of IPSIM to represent final incidence of eyespot on wheat. This paper briefly presents the pathosystem, the method used to develop IPSIM-Wheat-Eyespot using IPSIM's modelling framework, simulation examples, an evaluation of the predictive quality of the model with a large dataset (526 observed site-years) and a discussion on the benefits and limitations of the approach. IPSIM-Wheat-Eyespot proved to successfully represent the annual variability of the disease, as well as the effects of cropping practices (Efficiency = 0.51, Root Mean Square Error of Prediction = 24%; bias = 5.0%). IPSIM-Wheat-Eyespot does not aim to precisely predict the incidence of eyespot on wheat. It rather aims to rank cropping systems with regard to the risk of eyespot on wheat in a given production situation through ex ante evaluations. IPSIM-Wheat-Eyespot can also help perform diagnoses of commercial fields. Its structure is simple and permits to combine available knowledge in the scientific literature (data, models) and expertise. IPSIM-Wheat-Eyespot is now available to help design cropping systems with a low risk of eyespot on wheat in a wide range of production situations, and can help perform diagnoses of commercial fields. In addition, it provides a proof of concept with regard to the modelling approach of IPSIM. IPSIM-Wheat-Eyespot will be a sub-model of IPSIM-Wheat, a model that will predict injury profile on wheat as a function of cropping practices and the production situation.	[Robin, Marie-Helene; Cholez, Celia; Debaeke, Philippe; Aubertot, Jean-Noel] INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France; [Robin, Marie-Helene; Cholez, Celia] Univ Toulouse, Inst Natl Polytech Toulouse, Ecole Ingn Purpan, Toulouse, France; [Colbach, Nathalie] INRA, Unite Mixte Rech Agroecol 1347, F-21034 Dijon, France; [Debaeke, Philippe; Aubertot, Jean-Noel] Univ Toulouse, Inst Natl Polytech Toulouse, Unite Mixte Rech Agrosyst & Agri Gest Ressources, Castanet Tolosan, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Aubertot, JN (corresponding author), INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France.	Jean-Noel.Aubertot@toulouse.inra.fr	Colbach, Nathalie/C-6677-2014	Colbach, Nathalie/0000-0002-3791-037X; ROBIN, Marie-Helene/0000-0002-3108-3908	INRA; INPT EI Purpan; project MICMAC design [ANR-09-STRA-06]; French National Agency for Research; Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB")	INRA; INPT EI Purpan; project MICMAC design; French National Agency for Research(French National Research Agency (ANR)); Programme "Assessing and reducing environmental risks from plant protection products (pesticides)"; French Ministry in charge of Ecology and Sustainable Development (project "ASPIB")	This study was carried out within a PhD project co-funded by INRA and INPT EI Purpan, by the project MICMAC design (ANR-09-STRA-06) supported by the French National Agency for Research, and by the Programme "Assessing and reducing environmental risks from plant protection products (pesticides)", funded by the French Ministry in charge of Ecology and Sustainable Development (project "ASPIB"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Anken T, 2004, SOIL TILL RES, V78, P171, DOI 10.1016/j.still.2004.02.005; Aubertot J. N., 2005, P 9 INT WORKSH PLANT; Aubertot JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073202; Bailey KL, 2001, CAN J PLANT SCI, V81, P789, DOI 10.4141/P00-152; Bell EM, 2006, J AGRIC SAF HEALTH, V12, P101, DOI 10.13031/2013.20385; Bergez JE, 2010, EUR J AGRON, V32, P3, DOI 10.1016/j.eja.2009.06.001; Birch ANE, 2011, J EXP BOT, V62, P3251, DOI 10.1093/jxb/err064; Bohanec M, 2003, SPRING INT SER ENG C, V745, P23; Bohanec M, 2009, DEXI PROGRAM MULTIAT; Bohanec M, 2008, ECOL MODEL, V215, P247, DOI 10.1016/j.ecolmodel.2008.02.016; Bohanec M, 2007, PEDOBIOLOGIA, V51, P239, DOI 10.1016/j.pedobi.2007.03.006; BREMAN H, 1983, SCIENCE, V221, P1341, DOI 10.1126/science.221.4618.1341; Burnett F.J., 2004, DEV RISK ASSESSMENT; Cavelier A., 1998, Brighton Crop Protection Conference: Pests & Diseases - 1998: Volume 3: Proceedings of an International Conference, Brighton, UK, 16-19 November 1998., P1023; CLARKSON JDS, 1981, PLANT PATHOL, V30, P125, DOI 10.1111/j.1365-3059.1981.tb01243.x; CLARKSON JP, 1993, PLANT PATHOL, V42, P543, DOI 10.1111/j.1365-3059.1993.tb01534.x; COLBACH N, 1994, AGRONOMIE, V14, P525, DOI 10.1051/agro:19940805; COLBACH N, 1995, EUR J AGRON, V4, P217, DOI 10.1016/S1161-0301(14)80048-8; Colbach N, 1998, EUR J PLANT PATHOL, V104, P37, DOI 10.1023/A:1008673925979; Colbach N, 1999, CROP PROT, V18, P451, DOI 10.1016/S0261-2194(99)00044-7; COLBACH N, 1995, EUR J PLANT PATHOL, V101, P601, DOI 10.1007/BF01874864; Colbach N, 1995, MODELISATION INFLUEN; COX JUDITH, 1962, PLANT PATHOL, V11, P65, DOI 10.1111/j.1365-3059.1962.tb00168.x; Crous PW, 2003, EUR J PLANT PATHOL, V109, P841, DOI 10.1023/A:1026111030426; Datnoff LE., 2007, MINERAL NUTR PLANT D; Delos M., 1995, Phytoma, P26; Dore T, 2008, AGRON SUSTAIN DEV, V28, P151, DOI 10.1051/agro:2007031; DOUSSINAULT G, 1983, NATURE, V303, P698, DOI 10.1038/303698a0; Dyer PS, 1996, MYCOL RES, V100, P1219, DOI 10.1016/S0953-7562(96)80184-5; Epstein L, 2003, ANNU REV PHYTOPATHOL, V41, P351, DOI 10.1146/annurev.phyto.41.052002.095612; FITT BDL, 1988, PLANT PATHOL, V37, P311, DOI 10.1111/j.1365-3059.1988.tb02081.x; FITT BDL, 1990, ANN APPL BIOL, V117, P473, DOI 10.1111/j.1744-7348.1990.tb04235.x; Griffiths BS, 2010, APPL SOIL ECOL, V46, P43, DOI 10.1016/j.apsoil.2010.06.012; HERRMAN T, 1985, PLANT DIS, V69, P948; Jalaluddin M, 1996, PLANT PATHOL, V45, P1052, DOI 10.1046/j.1365-3059.1996.d01-194.x; Jenkyn JF, 2010, ANN APPL BIOL, V156, P387, DOI 10.1111/j.1744-7348.2010.00396.x; Jenkyn JF, 2001, J AGR SCI, V136, P1, DOI 10.1017/S0021859600008558; Kropff MJ, 1995, AGR SYST, V49, P413, DOI 10.1016/0308-521X(95)00034-3; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Leroux P., 2006, 8eme Conference Internationale sur les Maladies des Plantes, Tours, France,  5 et 6 Decembre, 2006, P574; Leroux P, 1997, PESTIC SCI, V51, P321, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;321::AID-PS639&gt;3.0.CO;2-U; Loyce C, 2008, CROP PROT, V27, P1131, DOI 10.1016/j.cropro.2008.02.001; Lucas JA, 2000, ADV BOT RES, V33, P225, DOI 10.1016/S0065-2296(00)33044-0; Matusinsky P, 2009, J PLANT PATHOL, V91, P93; Meynard JM, 2003, CR BIOL, V326, P37, DOI 10.1016/S1631-0691(03)00006-4; Montanari A, 2006, J PLANT PATHOL, V88, P149; MUNDT CC, 1995, CROP PROT, V14, P509, DOI 10.1016/0261-2194(95)00035-K; MURRAY TD, 1994, PLANT BREEDING, V113, P281, DOI 10.1111/j.1439-0523.1994.tb00737.x; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; Paillotin G, 2008, ECOPHYTO2018 CHANTIE; Parnell S, 2008, PLANT PATHOL, V57, P509, DOI 10.1111/j.1365-3059.2007.01786.x; Payen D, 1979, CR HEBD ACAD SCI, V7, P473; Pelzer E, 2012, ECOL INDIC, V18, P171, DOI 10.1016/j.ecolind.2011.11.019; PREW RD, 1995, J AGR SCI, V124, P173, DOI 10.1017/S0021859600072853; Ray RV, 2006, J EXP BOT, V57, P2249, DOI 10.1093/jxb/erj192; Ray RV, 2004, CROP PROT, V23, P1199, DOI 10.1016/j.cropro.2004.05.003; Russell PE, 2005, J AGR SCI-CAMBRIDGE, V143, P11, DOI 10.1017/S0021859605004971; Sadok W, 2009, AGRON SUSTAIN DEV, V29, P447, DOI 10.1051/agro/2009006; Saur L, 1997, AGRONOMIE, V17, P113, DOI 10.1051/agro:19970204; Savary S, 2000, PLANT DIS, V84, P341, DOI 10.1094/PDIS.2000.84.3.341; Savary S, 2006, EUR J PLANT PATHOL, V115, P123, DOI 10.1007/s10658-005-0651-z; SCOTT PR, 1974, ANN APPL BIOL, V78, P269, DOI 10.1111/j.1744-7348.1974.tb01506.x; Smiley RW, 1996, PLANT DIS, V80, P813, DOI 10.1094/PD-80-0813; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Toderi G., 2000, ATTI GIORNATE FITOPA, V2, P241; Vanova M, 2011, PLANT SOIL ENVIRON, V57, P245, DOI 10.17221/334/2010-PSE; VILICHMELLER V, 1992, BIOL AGRIC HORTIC, V8, P299, DOI 10.1080/01448765.1992.9754607; Wallach D., 2006, WORKING DYNAMIC CROP, Vfirst; Wei L, 2011, J PHYTOPATHOL, V159, P457, DOI 10.1111/j.1439-0434.2011.01795.x; Wiese M.V., 1987, COMPENDIUM WHEAT DIS; Willocquet L, 2008, FIELD CROP RES, V107, P12, DOI 10.1016/j.fcr.2007.12.013; Zhang XY, 2006, CROP PROT, V25, P1013, DOI 10.1016/j.cropro.2006.01.013	73	8	8	6	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75829	10.1371/journal.pone.0075829	http://dx.doi.org/10.1371/journal.pone.0075829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146783	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400020
J	Girerd, N; Scridon, A; Bessiere, F; Chauveau, S; Geloen, A; Boussel, L; Morel, E; Chevalier, P				Girerd, Nicolas; Scridon, Alina; Bessiere, Francis; Chauveau, Samuel; Geloen, Alain; Boussel, Loic; Morel, Elodie; Chevalier, Philippe			Periatrial Epicardial Fat Is Associated with Markers of Endothelial Dysfunction in Patients with Atrial Fibrillation	PLOS ONE			English	Article							WILLEBRAND-FACTOR LEVELS; ADIPOSE-TISSUE; PERICARDIAL FAT; RISK-FACTOR; FOLLOW-UP; OBESITY; PREDICTORS; EXPRESSION; RHYTHM	Background: Epicardial adipose tissue (EAT) is associated to atrial fibrillation (AF) burden and outcome after AF ablation. We intended to determine whether global or local EAT is associated with systemic and/or left atrial (LA) inflammation and markers of endothelial dysfunction in AF patients. Methods and Results: Total, atrial, and ventricular EAT volume (EATtotal, EATatrial, EATventricular) were measured by multislice cardiac CT in 49 patients with paroxysmal (PAF, n=25) or persistent AF (PeF, n=24). Periatrial epicardial fat thickness at the esophagus (LA-ESO) and thoracic aorta (LA-ThA) were also measured. Vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), soluble intercellular adhesion molecule 1 (sICAM-1), transforming growth factor-beta 1 (TGF-beta 1), and von Willebrand Factor (vWF) levels were measured in peripheral and LA blood samples obtained during catheterization during AF ablation. Patients with PeF had higher EATatrial (P<0.05) and LA-ESO (P=0.04) than patients with PAF. VEGF, IL-8, and TGF-beta 1 were not associated with EAT. In contrast, after adjusting for LA volume and body mass index, higher LA-ThA was significantly associated with higher sICAM-1 and vWF levels, both in peripheral blood (P<0.05) and in LA (P<0.05). Similar results were found with LA-ESO. Body mass index, EATtotal and EATventricular were not associated with sICAM-1 and vWF. Conclusions: Periatrial epicardial fat showed a significant positive association with increased levels of sICAM-1 and vWF, which are biomarkers of endothelial dysfunction. No such associations were found when considering body mass index or EATtotal. These results suggest that local EAT rather than regional or total adiposity may modulate endothelial dysfunction in patients with AF.	[Girerd, Nicolas; Bessiere, Francis; Chauveau, Samuel; Chevalier, Philippe] Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Dept, Bron, France; [Scridon, Alina] Univ Med & Pharm Targu Mures, Dept Physiol, Targu Mures, Romania; [Geloen, Alain] INSA, INSERM, U870, INRA 1235, Villeurbanne, France; [Boussel, Loic] Hosp Civils Lyon, Croix Rousse Hosp, Dept Radiol, Lyon, France; [Morel, Elodie; Chevalier, Philippe] Louis Pradel Cardiovasc Hosp, Lyon Reference Ctr Inherited Arrhythmias, Lyon, France	CHU Lyon; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU Lyon; CHU Lyon	Chevalier, P (corresponding author), Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Dept, Bron, France.	philippe.chevalier@chu-lyon.fr	Boussel, Loic/H-7184-2014; GIRERD, Nicolas/D-5493-2011	Girerd, Nicolas/0000-0002-3278-2057; Scridon, Alina/0000-0002-9763-4266; GELOEN, Alain/0000-0001-7921-1254				Acevedo M, 2012, J THROMB THROMBOLYS, V33, P383, DOI 10.1007/s11239-012-0690-1; Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Aydin H, 2010, METAB SYNDR RELAT D, V8, P229, DOI 10.1089/met.2009.0080; Batal O, 2010, CIRC-ARRHYTHMIA ELEC, V3, P230, DOI 10.1161/CIRCEP.110.957241; Bosanska L, 2010, PHYSIOL RES, V59, P79, DOI 10.33549/physiolres.931705; Chen PS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P618, DOI 10.1161/CIRCEP.112.974956; Chevalier P, 2005, HEART RHYTHM, V2, P518, DOI 10.1016/j.hrthm.2005.01.022; Hanzu FA, 2011, J THROMB HAEMOST, V9, P1236, DOI 10.1111/j.1538-7836.2011.04285.x; Kamiyama N, 1998, JPN CIRC J, V62, P837, DOI 10.1253/jcj.62.837; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lin YK, 2013, INT J CARDIOL, V167, P1979, DOI 10.1016/j.ijcard.2012.05.009; Lin YK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0293-1; Lin YK, 2010, MED HYPOTHESES, V74, P1026, DOI 10.1016/j.mehy.2010.01.004; Lip GYH, 2006, STROKE, V37, P2294, DOI 10.1161/01.STR.0000236840.00467.84; Liu T, 2011, J AM COLL CARDIOL, V57, P1249, DOI 10.1016/j.jacc.2010.09.068; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mizia-Stec Katarzyna, 2006, Pharmacol Rep, V58 Suppl, P21; Nagashima K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P676, DOI 10.1161/CIRCEP.112.971200; Nagashima K, 2011, CIRC J, V75, P2559, DOI 10.1253/circj.CJ-11-0554; Parikh NI, 2009, OBESITY, V17, P2054, DOI 10.1038/oby.2009.60; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pinto A, 2009, CLIN SCI, V116, P781, DOI 10.1042/CS20080372; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; Scridon A, 2012, EUROPACE, V14, P948, DOI 10.1093/europace/eur418; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P376, DOI 10.1111/j.1540-8167.2010.01919.x; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Thijssen DHJ, 2006, AM J PHYSIOL-HEART C, V291, pH3122, DOI 10.1152/ajpheart.00240.2006; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	34	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77167	10.1371/journal.pone.0077167	http://dx.doi.org/10.1371/journal.pone.0077167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143210	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100045
J	Gunawardana, M; Mullen, M; Moss, JA; Pyles, RB; Nusbaum, RJ; Patel, J; Vincent, KL; Wang, C; Guo, C; Yuan, YC; Warden, CD; Baum, MM				Gunawardana, Manjula; Mullen, Madeline; Moss, John A.; Pyles, Richard B.; Nusbaum, Rebecca J.; Patel, Jignesh; Vincent, Kathleen L.; Wang, Charles; Guo, Chao; Yuan, Yate-Ching; Warden, Charles D.; Baum, Marc M.			Global Expression of Molecular Transporters in the Human Vaginal Tract: Implications for HIV Chemoprophylaxis	PLOS ONE			English	Article							PROTEASE INHIBITOR SAQUINAVIR; ANTIRETROVIRAL PROPHYLAXIS; DRUG-INTERACTIONS; ANTIVIRAL AGENTS; GENE-EXPRESSION; PREVENTION; PHARMACOKINETICS; INFECTION; TENOFOVIR; REPRODUCIBILITY	Background: Pre-exposure chemoprophylaxis (PrECP) using antiretroviral agents is a promising strategy for the prevention of sexual HIV transmission in women. Molecular transporters in the human vaginal tract (VT) may play a pivotal role in determining drug disposition and, consequently, pharmacodynamic outcomes in these efforts. Little is known, however, on the expression of these transporters in vaginal tissues, representing a critical knowledge gap. Methodology/Principal Findings: Our study analyzed the genome-wide transcriptome in 44 vaginal tissue samples from 6 reproductive-age women undergoing gynecologic surgeries. The analysis revealed that, unexpectedly, a large number (43%) of gene isoforms corresponding to membrane transporters were over-expressed (above the median expression level) in all samples. A subset of 12 highly expressed membrane transporters was identified and contained 10 members (83%) of the solute carrier superfamily. The largest difference in membrane transporter gene expression was observed across subjects, but more subtle differential expression also was found along the anterior-posterior axis of the VT. Cross-validation of the microarray analyses with measurements RT-qPCR demonstrated high concordance between these data sets. Immunofluorescence labeling of membrane transporter proteins in vaginal tissues was highly dependent on tissue/cell types. Conclusions/Significance: Antiretroviral PrECP drugs currently under evaluation are substrates for molecular transporters that were commonly expressed, but fell into both over-or under-expressed categories in all samples, suggesting a complex role for carrier-mediated processes in determining the disposition of these xenobiotics in vaginal tissues. These findings hold important implications for the successful development of products, either oral or intravaginal, for female-controlled HIV PrECP.	[Gunawardana, Manjula; Mullen, Madeline; Moss, John A.; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Pasadena, CA USA; [Pyles, Richard B.; Patel, Jignesh] UTMB, Dept Pediat, Galveston, TX USA; [Pyles, Richard B.; Patel, Jignesh] UTMB, Dept Microbiol & Immunol, Galveston, TX USA; [Nusbaum, Rebecca J.] UTMB, Human Pathophysiol & Translat Med Grad Program, Galveston, TX USA; [Vincent, Kathleen L.] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Wang, Charles; Guo, Chao] City Hope Comprehens Canc Ctr, Beckman Res Inst, Funct Genom Core, Duarte, CA USA; [Yuan, Yate-Ching; Warden, Charles D.] City Hope Natl Med Ctr, Dept Mol Med, Bioinformat Core, Duarte, CA 91010 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Baum, MM (corresponding author), Oak Crest Inst Sci, Dept Chem, Pasadena, CA USA.	m.baum@oak-crest.org	Guo, Chao/B-2647-2010	Guo, Chao/0000-0002-6673-0933; Warden, Charles/0000-0002-1827-4486; Moss, John/0000-0001-8091-3245; Nusbaum, Rebecca/0000-0002-8378-8037; Baum, Marc/0000-0003-1558-5649; Vincent, Kathleen/0000-0003-3051-9551	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI100744]; National Center for Research Resources, National Institutes of Health [1UL1RR029876-01]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100744] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI100744. Funding support under Award Number 1UL1RR029876-01 from the National Center for Research Resources, National Institutes of Health, also is acknowledged. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand BS, 2004, CURR EYE RES, V29, P153, DOI 10.1080/02713680490504614; Anand BS, 2003, INVEST OPHTH VIS SCI, V44, P2529, DOI 10.1167/iovs.02-1251; Anderle P, 2004, EUR J PHARM SCI, V21, P17, DOI 10.1016/S0928-0987(03)00169-6; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown KC, 2009, CLIN PHARMACOKINET, V48, P211, DOI 10.2165/00003088-200948040-00001; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2012, AIDS, V26, P1585, DOI 10.1097/QAD.0b013e3283543e83; Dickinson L, 2010, ANTIVIR RES, V85, P176, DOI 10.1016/j.antiviral.2009.07.017; Ford J, 2004, J ANTIMICROB CHEMOTH, V54, P982, DOI 10.1093/jac/dkh487; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Jain R, 2005, INT J PHARMACEUT, V303, P8, DOI 10.1016/j.ijpharm.2005.06.017; Janoria KG, 2010, J OCUL PHARMACOL TH, V26, P265, DOI 10.1089/jop.2009.0123; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kim Richard B, 2003, Top HIV Med, V11, P136; Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001; Kuchiiwa T, 2011, HISTOCHEM CELL BIOL, V135, P351, DOI 10.1007/s00418-011-0794-2; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Maffeo A, 2004, MICROBIOLOGICA, V27, P119; Mao Shihong, 2009, Journal of Bioinformatics and Computational Biology, V7, P157, DOI 10.1142/S0219720009004011; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Shattock RJ, 2011, SCIENCE, V333, P42, DOI 10.1126/science.1206399; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; [No title captured]; [No title captured]	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77340	10.1371/journal.pone.0077340	http://dx.doi.org/10.1371/journal.pone.0077340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143220	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100057
J	Inoue, K; Wada, J; Eguchi, J; Nakatsuka, A; Teshigawara, S; Murakami, K; Ogawa, D; Terami, T; Katayama, A; Tone, A; Iseda, I; Hida, K; Yamada, M; Ogawa, T; Makino, H				Inoue, Kentaro; Wada, Jun; Eguchi, Jun; Nakatsuka, Atsuko; Teshigawara, Sanae; Murakami, Kazutoshi; Ogawa, Daisuke; Terami, Takahiro; Katayama, Akihiro; Tone, Atsuhito; Iseda, Izumi; Hida, Kazuyuki; Yamada, Masao; Ogawa, Tomohisa; Makino, Hirofumi			Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray	PLOS ONE			English	Article							OROSOMUCOID EXCRETION; KIDNEY; ALBUMINURIA; DISEASE; ALPHA(1)-MICROGLOBULIN; GLYCOSYLATION; ADIPONECTIN; BIOMARKERS; PROTEOMICS; MORTALITY	We analyzed the urine samples of patients with type 2 diabetes at various stages of diabetic nephropathy by lectin microarray to identify a biomarker to predict the progression of diabetic nephropathy. Japanese patients with type 2 diabetes at various stages of nephropathy were enrolled and we performed lectin microarray analyses (n = 17) and measured urinary excretion of fetuin-A (n = 85). The increased signals of urine samples were observed in Sia alpha 2-6Gal/GalNAc-binding lectins (SNA, SSA, TJA-I) during the progression of diabetic nephropathy. We next isolated sialylated glycoproteins by using SSA-lectin affinity chromatography and identified fetuin-A by liquid chromatography-tandem mass spectrometer. Urinary excretion of fetuin-A significantly increased during the progression of albuminuria (A1, 0.40 +/- 0.43; A2, 0.60 +/- 0.53; A3 1.57 +/- 1.13 ng/gCr; p = 7.29x10(-8)) and of GFR stages (G1, 0.39 +/- 0.39; G2, 0.49 +/- 0.45; G3, 1.25 +/- 1.18; G4, 1.34 +/- 0.80 ng/gCr; p = 3.89x10(-4)). Multivariate logistic regression analysis was employed to assess fetuin-A as a risk for diabetic nephropathy with microalbuminuria or GFR<60 mL/min. Fetuin-A is demonstrated as a risk factor for both microalbuminuria and reduction of GFR in diabetic nephropathy with the odds ratio of 4.721 (1.881-11.844) and 3.739 (1.785-7.841), respectively. Collectively, the glycan profiling analysis is useful method to identify the urine biomarkers and fetuin-A is a candidate to predict the progression of diabetic nephropathy.	[Inoue, Kentaro; Wada, Jun; Eguchi, Jun; Nakatsuka, Atsuko; Teshigawara, Sanae; Murakami, Kazutoshi; Ogawa, Daisuke; Terami, Takahiro; Katayama, Akihiro; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008530, Japan; [Nakatsuka, Atsuko; Ogawa, Daisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Kita Ku, Okayama 7008530, Japan; [Murakami, Kazutoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008530, Japan; [Tone, Atsuhito; Iseda, Izumi; Hida, Kazuyuki] Natl Hosp Org, Okayama Med Ctr, Dept Diabet & Metab, Kita Ku, Okayama, Japan; [Yamada, Masao] GlycoTechnica Ltd, Aoba Ku, Yokohama, Kanagawa, Japan; [Ogawa, Tomohisa] GP BioSci Co Ltd, Aoba Ku, Yokohama, Kanagawa, Japan	Okayama University; Okayama University; Okayama University	Wada, J (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008530, Japan.	junwada@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011; Nakatsuka, Atsuko/L-2765-2017; Murakami, Kazutoshi/AAV-1940-2020	WADA, Jun/0000-0003-1468-5170; Murakami, Kazutoshi/0000-0002-6042-8960; Ogawa, Tomohisa/0000-0001-8700-6330	JSPS [23390241, 25126716]; Health Labor Sciences Research Grant, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grant, Japan	This work was supported by JSPS Grant-in-Aid for Scientific Research, Grant numbers (23390241, 25126716) and Health Labor Sciences Research Grant, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2010, PROTEOM CLIN APPL, V4, P644, DOI 10.1002/prca.200900196; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; BIERHUIZEN MFA, 1988, EUR J BIOCHEM, V175, P387, DOI 10.1111/j.1432-1033.1988.tb14208.x; BRATT T, 1993, BIOCHIM BIOPHYS ACTA, V1157, P147, DOI 10.1016/0304-4165(93)90058-G; Christiansen MS, 2010, DIABETES RES CLIN PR, V89, P16, DOI 10.1016/j.diabres.2010.03.018; Christiansen MS, 2009, SCAND J CLIN LAB INV, V69, P272, DOI 10.1080/00365510802531100; Christiansen MS, 2002, DIABETOLOGIA, V45, P115, DOI 10.1007/s125-002-8251-3; Emoto M, 2010, METABOLISM, V59, P873, DOI 10.1016/j.metabol.2009.10.005; Epaso LH, 2010, DIABETES CARE, V33, P408, DOI 10.2337/dc09-1541; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Galanti LM, 1996, DIABETES METAB, V22, P324; Gu W, 2008, PROTEOM CLIN APPL, V2, P744, DOI 10.1002/prca.200780083; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hong CY, 2003, DIABETES CARE, V26, P338, DOI 10.2337/diacare.26.2.338; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; ITO S, 1989, ACTA ENDOCRINOL-COP, V120, P584, DOI 10.1530/acta.0.1200584; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jiang HJ, 2009, NEPHROLOGY, V14, P332, DOI 10.1111/j.1440-1797.2008.01053.x; Jung CH, 2013, DIAB VASC DIS RES; KIDO T, 1985, TOXICOL LETT, V24, P195; Koluman BU, 2013, CLIN NEPHROL, V80, P9, DOI 10.5414/CN107920; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; Matsui I, 2013, AM J PHYSIOL-RENAL, V304, pF751, DOI 10.1152/ajprenal.00329.2012; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Narita T, 2004, DIABETES CARE, V27, P1176, DOI 10.2337/diacare.27.5.1176; Nedic O, 2012, J CHROMATOGR B, V904, P93, DOI 10.1016/j.jchromb.2012.07.028; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Pal D., 2012, NAT MED; Penders J, 2004, CLIN CHIM ACTA, V346, P107, DOI 10.1016/j.cccn.2004.03.037; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; PFLEIDERER S, 1993, CLIN INVESTIGATOR, V71, P972; Raimondo F, 2013, MOL BIOSYST, V9, P1139, DOI 10.1039/c2mb25396h; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; Roos M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-48; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Saroha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046374; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Thanabalasingham G, 2013, DIABETES, V62, P1329, DOI 10.2337/db12-0880; WATERS PJ, 1995, DIABETIC MED, V12, P670, DOI 10.1111/j.1464-5491.1995.tb00567.x; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874; Zurbig P, 2012, DIABETES, V61, P3304, DOI 10.2337/db12-0348	45	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77118	10.1371/journal.pone.0077118	http://dx.doi.org/10.1371/journal.pone.0077118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143207	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100042
J	Caillon, L; Killian, JA; Lequin, O; Khemtemourian, L				Caillon, Lucie; Killian, J. Antoinette; Lequin, Olivier; Khemtemourian, Lucie			Biophysical Investigation of the Membrane-Disrupting Mechanism of the Antimicrobial and Amyloid-Like Peptide Dermaseptin S9	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; BIOLOGICAL-MEMBRANES; MAGNETIC-RESONANCE; LIPID INTERACTIONS; NMR-SPECTROSCOPY; MODEL MEMBRANES; BILAYERS; POLYPEPTIDE; BINDING; PHOSPHOLIPIDS	Dermaseptin S9 (Drs S9) is an atypical cationic antimicrobial peptide with a long hydrophobic core and with a propensity to form amyloid-like fibrils. Here we investigated its membrane interaction using a variety of biophysical techniques. Rather surprisingly, we found that Drs S9 induces efficient permeabilisation in zwitterionic phosphatidylcholine (PC) vesicles, but not in anionic phosphatidylglycerol (PG) vesicles. We also found that the peptide inserts more efficiently in PC than in PG monolayers. Therefore, electrostatic interactions between the cationic Drs S9 and anionic membranes cannot explain the selectivity of the peptide towards bacterial membranes. CD spectroscopy, electron microscopy and ThT fluorescence experiments showed that the peptide adopts slightly more beta-sheet and has a higher tendency to form amyloid-like fibrils in the presence of PC membranes as compared to PG membranes. Thus, induction of leakage may be related to peptide aggregation. The use of a pre-incorporation protocol to reduce peptide/peptide interactions characteristic of aggregates in solution resulted in more alpha-helix formation and a more pronounced effect on the cooperativity of the gel-fluid lipid phase transition in all lipid systems tested. Calorimetric data together with H-2-and P-31-NMR experiments indicated that the peptide has a significant impact on the dynamic organization of lipid bilayers, albeit slightly less for zwitterionic than for anionic membranes. Taken together, our data suggest that in particular in membranes of zwitterionic lipids the peptide binds in an aggregated state resulting in membrane leakage. We propose that also the antimicrobial activity of Drs S9 may be a result of binding of the peptide in an aggregated state, but that specific binding and aggregation to bacterial membranes is regulated not by anionic lipids but by as yet unknown factors.	[Caillon, Lucie; Lequin, Olivier; Khemtemourian, Lucie] Univ Paris 06, UMR CNRS UPMC ENS 7203, Lab Biomol, Paris, France; [Killian, J. Antoinette] Univ Utrecht, Bijvoet Ctr, Res Grp Membrane Biochem & Biophys, NL-3508 TB Utrecht, Netherlands; [Killian, J. Antoinette] Univ Utrecht, Inst Biomembranes, Utrecht, Netherlands	UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Utrecht University	Lequin, O (corresponding author), Univ Paris 06, UMR CNRS UPMC ENS 7203, Lab Biomol, Paris, France.	olivier.lequin@upmc.fr; lucie.khemtemourian@upmc.fr	Killian, J. Antoinette/I-3001-2016	Killian, J. Antoinette/0000-0001-8010-3816; LEQUIN, Olivier/0000-0001-5307-3068; khemtemourian, lucie/0000-0001-6754-5724	TGIR-RMN-THC [Fr3050]	TGIR-RMN-THC	Financial support from the TGIR-RMN-THC Fr3050 for conducting the NMR experiments is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; Ambroggio EE, 2004, BBA-BIOMEMBRANES, V1664, P31, DOI 10.1016/j.bbamem.2004.03.013; Auvynet C, 2008, FEBS J, V275, P4134, DOI 10.1111/j.1742-4658.2008.06554.x; BLOOM M, 1981, CHEM PHYS LETT, V80, P198, DOI 10.1016/0009-2614(81)80089-9; Bonev B, 2001, PHYS CHEM CHEM PHYS, V3, P2904, DOI 10.1039/b103352m; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Buchoux S, 2008, BIOPHYS J, V95, P3840, DOI 10.1529/biophysj.107.128322; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Byrne C, 2012, STEROIDS, V77, P979, DOI 10.1016/j.steroids.2012.02.022; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Castano S, 2000, BBA-BIOMEMBRANES, V1463, P65, DOI 10.1016/S0005-2736(99)00175-3; Castano S, 1999, BBA-BIOMEMBRANES, V1416, P176, DOI 10.1016/S0005-2736(98)00220-X; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; DUFOURC EJ, 1990, EUR J BIOCHEM, V187, P581, DOI 10.1111/j.1432-1033.1990.tb15340.x; DUFOURC EJ, 1986, BIOCHEMISTRY-US, V25, P6448, DOI 10.1021/bi00369a016; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fernandez DI, 2011, AUST J CHEM, V64, P798, DOI 10.1071/CH11062; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Heimburg T, 1996, BIOPHYS J, V70, P84, DOI 10.1016/S0006-3495(96)79551-6; Ivanova VP, 2003, BIOPHYS J, V84, P2427, DOI 10.1016/S0006-3495(03)75047-4; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Joanne P, 2009, BBA-BIOMEMBRANES, V1788, P1772, DOI 10.1016/j.bbamem.2009.05.001; Khemtemourian L, 2007, EUR BIOPHYS J BIOPHY, V36, P107, DOI 10.1007/s00249-006-0111-5; Khemtemourian L, 2011, J AM CHEM SOC, V133, P15598, DOI 10.1021/ja205007j; Khemtemourian L, 2010, BBA-BIOMEMBRANES, V1798, P1805, DOI 10.1016/j.bbamem.2010.05.022; Khemtemourian L, 2010, EUR BIOPHYS J BIOPHY, V39, P1359, DOI 10.1007/s00249-009-0572-4; Khemtemourian L, 2009, BIOCHEMISTRY-US, V48, P10918, DOI 10.1021/bi901076d; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Lee DK, 2013, BIOCHEMISTRY; Lequin O, 2006, BIOCHEMISTRY-US, V45, P468, DOI 10.1021/bi051711i; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; Mason AJ, 2007, BIOCHEMISTRY-US, V46, P15175, DOI 10.1021/bi701344m; Mason AJ, 2006, MOL MEMBR BIOL, V23, P185, DOI 10.1080/09687860500485303; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ramamoorthy A, 2006, BBA-BIOMEMBRANES, V1758, P154, DOI 10.1016/j.bbamem.2006.02.014; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Salnikov ES, 2009, BIOCHIMIE, V91, P734, DOI 10.1016/j.biochi.2009.01.002; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Sood R, 2007, J FLUORESC, V17, P223, DOI 10.1007/S10895-007-0161-9; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; Walrant A, 2011, BBA-BIOMEMBRANES, V1808, P382, DOI 10.1016/j.bbamem.2010.09.009; Zhao H, 2006, BBA-BIOMEMBRANES, V1758, P1461, DOI 10.1016/j.bbamem.2006.03.037; Zhao HX, 2005, BIOCHEMISTRY-US, V44, P2857, DOI 10.1021/bi048510j	56	36	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75528	10.1371/journal.pone.0075528	http://dx.doi.org/10.1371/journal.pone.0075528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146759	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400010
J	Lin, M; Lai, DY; Pang, CY; Fan, SL; Song, MZ; Yu, SX				Lin, Min; Lai, Deyong; Pang, Chaoyou; Fan, Shuli; Song, Meizhen; Yu, Shuxun			Generation and Analysis of a Large-Scale Expressed Sequence Tag Database from a Full-Length Enriched cDNA Library of Developing Leaves of Gossypium hirsutum L.	PLOS ONE			English	Article							LEAF SENESCENCE; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; SIGNALING PATHWAYS; MOLECULAR MARKERS; ARABIDOPSIS; IDENTIFICATION; REVEALS; ANNOTATION; BLAST2GO	Background: Cotton (Gossypium hirsutum L.) is one of the world's most economically-important crops. However, its entire genome has not been sequenced, and limited resources are available in GenBank for understanding the molecular mechanisms underlying leaf development and senescence. Methodology/Principal Findings: In this study, 9,874 high-quality ESTs were generated from a normalized, full-length cDNA library derived from pooled RNA isolated from throughout leaf development during the plant blooming stage. After clustering and assembly of these ESTs, 5,191 unique sequences, representative 1,652 contigs and 3,539 singletons, were obtained. The average unique sequence length was 682 bp. Annotation of these unique sequences revealed that 84.4% showed significant homology to sequences in the NCBI non-redundant protein database, and 57.3% had significant hits to known proteins in the Swiss-Prot database. Comparative analysis indicated that our library added 2,400 ESTs and 991 unique sequences to those known for cotton. The unigenes were functionally characterized by gene ontology annotation. We identified 1,339 and 200 unigenes as potential leaf senescence-related genes and transcription factors, respectively. Moreover, nine genes related to leaf senescence and eleven MYB transcription factors were randomly selected for quantitative real-time PCR (qRT-PCR), which revealed that these genes were regulated differentially during senescence. The qRT-PCR for three GhYLSs revealed that these genes express express preferentially in senescent leaves. Conclusions/Significance: These EST resources will provide valuable sequence information for gene expression profiling analyses and functional genomics studies to elucidate their roles, as well as for studying the mechanisms of leaf development and senescence in cotton and discovering candidate genes related to important agronomic traits of cotton. These data will also facilitate future whole-genome sequence assembly and annotation in G. hirsutum and comparative genomics among Gossypium species.	[Lin, Min; Lai, Deyong; Pang, Chaoyou; Fan, Shuli; Song, Meizhen; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn	Lin, Min/HDN-8028-2022	Lin, Min/0000-0001-9242-115X	National Basic Research Program of China [2010CB126006]; China Agriculture Research System [CARS-18]	National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	This work was supported by the National Basic Research Program of China (No. 2010CB126006) and the earmarked fund for the China Agriculture Research System (CARS-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brautigam M, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-18; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Bremer B, 2003, BOT J LINN SOC, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chu ZH, 2003, CHINESE SCI BULL, V48, P229, DOI 10.1360/03tb9047; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hung KT, 2004, J PLANT PHYSIOL, V161, P1347, DOI 10.1016/j.jplph.2004.05.011; Hung KT, 2003, J PLANT PHYSIOL, V160, P871, DOI 10.1078/0176-1617-01118; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2003, TRENDS PLANT SCI, V8, P272, DOI 10.1016/S1360-1385(03)00103-1; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lindqvist C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-16; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; Liu XC, 2011, NUCLEIC ACIDS RES, V39, pD1103, DOI 10.1093/nar/gkq1169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sekhon RS, 2012, PLANT PHYSIOL, V159, P1730, DOI 10.1104/pp.112.199224; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shuxun Y, 2010, INT COTT IN GEN ICGI, P2; Taliercio E, 2006, GENOME, V49, P306, DOI 10.1139/G05-115; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson J, 2000, BIOCHEM SOC T, V28, P775, DOI 10.1042/BST0280775; Thompson JE, 1998, PROG LIPID RES, V37, P119, DOI 10.1016/S0163-7827(98)00006-X; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yoshida S, 2001, PLANT CELL PHYSIOL, V42, P170, DOI 10.1093/pcp/pce021; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104; Zhang X, 2011, PLANT CELL PHYSIOL, V52, P138, DOI 10.1093/pcp/pcq180; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2	62	8	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76443	10.1371/journal.pone.0076443	http://dx.doi.org/10.1371/journal.pone.0076443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146870	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400058
J	Tay, EL; Grant, K; Kirk, M; Mounts, A; Kelly, H				Tay, Ee Laine; Grant, Kristina; Kirk, Martyn; Mounts, Anthony; Kelly, Heath			Exploring a Proposed WHO Method to Determine Thresholds for Seasonal Influenza Surveillance	PLOS ONE			English	Article							DISEASE SURVEILLANCE; INFECTIOUS-DISEASE; AUSTRALIA; VICTORIA; EPIDEMICS; OUTBREAKS; VACCINE	Introduction: Health authorities find thresholds useful to gauge the start and severity of influenza seasons. We explored a method for deriving thresholds proposed in an influenza surveillance manual published by the World Health Organization (WHO). Methods: For 2002-2011, we analysed two routine influenza-like-illness (ILI) datasets, general practice sentinel surveillance and a locum medical service sentinel surveillance, plus laboratory data and hospital admissions for influenza. For each sentinel dataset, we created two composite variables from the product of weekly ILI data and the relevant laboratory data, indicating the proportion of tested specimens that were positive. For all datasets, including the composite datasets, we aligned data on the median week of peak influenza or ILI activity and assigned three threshold levels: seasonal threshold, determined by inspection; and two intensity thresholds termed average and alert thresholds, determined by calculations of means, medians, confidence intervals (CI) and percentiles. From the thresholds, we compared the seasonal onset, end and intensity across all datasets from 2002-2011. Correlation between datasets was assessed using the mean correlation coefficient. Results: The median week of peak activity was week 34 for all datasets, except hospital data (week 35). Means and medians were comparable and the 90% upper CIs were similar to the 95th percentiles. Comparison of thresholds revealed variations in defining the start of a season but good agreement in describing the end and intensity of influenza seasons, except in hospital admissions data after the pandemic year of 2009. The composite variables improved the agreements between the ILI and other datasets. Datasets were well correlated, with mean correlation coefficients of >0.75 for a range of combinations. Conclusions: Thresholds for influenza surveillance are easily derived from historical surveillance and laboratory data using the approach proposed by WHO. Use of composite variables is helpful for describing influenza season characteristics.	[Tay, Ee Laine; Grant, Kristina; Kelly, Heath] Victoria Infect Dis Reference Lab, Melbourne, Vic, Australia; [Tay, Ee Laine; Kirk, Martyn; Kelly, Heath] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Mounts, Anthony] WHO, Global Influenza Programme, CH-1211 Geneva, Switzerland	Victorian Infectious Diseases Reference Laboratory; Australian National University; World Health Organization	Tay, EL (corresponding author), Victoria Infect Dis Reference Lab, Melbourne, Vic, Australia.	eelaine.tay@mh.org.au		Kirk, Martyn/0000-0001-5432-5984	Master of Philosophy in Applied Epidemiology Scholarship; Victorian Infectious Diseases Reference Laboratory; Victorian Department of Health; Victorian Government Department of Health	Master of Philosophy in Applied Epidemiology Scholarship; Victorian Infectious Diseases Reference Laboratory; Victorian Department of Health; Victorian Government Department of Health	The General Practitioner Sentinel Surveillance system is funded by the Victorian Government Department of Health. Ee Laine Tay was supported by a Master of Philosophy in Applied Epidemiology Scholarship funded by the Victorian Infectious Diseases Reference Laboratory and the Victorian Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso TV, 2004, INT CONGR SER, V1263, P281, DOI 10.1016/j.ics.2004.02.121; Atlanta, 2013, PREV CFDCA; Atlanta, 2012, PREV CFDCA; Clothier HJ, 2006, COMMUN DIS INTELL, V30, P345; Cooper DL, 2009, J PUBLIC HEALTH-UK, V31, P17, DOI 10.1093/pubmed/fdm068; Coory M, 2009, EUROSURVEILLANCE, V14, P1; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Dedman DJ, 1997, PHLS MICROBIOL DIGES, V14, P206; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; European Centre for Disease Prevention and Control, 2013, WEEKL INFL SURV OV; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Goldstein E, 2012, EPIDEMIOLOGY; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hashimoto S, 2000, INT J EPIDEMIOL, V29, P905, DOI 10.1093/ije/29.5.905; Kelly H, 2000, Commun Dis Intell, V24, P379; Kelly HA, 2012, INFLUENZA OTHER RESP; Kelly H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005079; Kelly H, 2009, INFLUENZA OTHER RESP, V3, P183, DOI 10.1111/j.1750-2659.2009.00088.x; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Kuang J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-418; Lambert SB, 2010, MED J AUSTRALIA, V193, P43, DOI 10.5694/j.1326-5377.2010.tb03741.x; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2008, VACCINE, V26, pD45, DOI 10.1016/j.vaccine.2008.07.066; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OBrien SJ, 1997, PUBLIC HEALTH, V111, P255, DOI 10.1016/S0033-3506(97)00044-9; Parantharnan K, 2008, EMERG INFECT DIS, V14, P520, DOI 10.3201/eid1403.071275; Public Health Surveillance New; Zealand, 2013, RES IOESA; Quigley C, 2004, BRIT MED J, V329, P1239, DOI 10.1136/bmj.329.7476.1239; Sentinel Influenza Surveillance, 2013, CURR INFL SURV REP; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Steiner SH, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-37; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Turner J, 2005, Euro Surveill, V10, P96; Vega T, 2012, INFLUENZA OTHER RESP; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; World Health Organization, 2009, INFL SEAS FACTSH; World Health Organization, 2012, WHO GLOB SURV STAND	38	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77244	10.1371/journal.pone.0077244	http://dx.doi.org/10.1371/journal.pone.0077244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146973	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400108
J	Khongkow, P; Karunarathna, U; Khongkow, M; Gong, C; Gomes, AR; Yague, E; Monteiro, LJ; Kongsema, M; Zona, S; Man, EPS; Tsang, JWH; Coombes, RC; Wu, KJ; Khoo, US; Medema, RH; Freire, R; Lam, EWF				Khongkow, P.; Karunarathna, U.; Khongkow, M.; Gong, C.; Gomes, A. R.; Yague, E.; Monteiro, L. J.; Kongsema, M.; Zona, S.; Man, E. P. S.; Tsang, J. W-H; Coombes, R. C.; Wu, K-J; Khoo, U-S; Medema, R. H.; Freire, R.; Lam, E. W-F			FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance	ONCOGENE			English	Article						FOXM1; senescence; DNA damage; NBS1; epirubicin; resistance; breast cancer	STRAND BREAK REPAIR; ATR-DEPENDENT PHOSPHORYLATION; CANCER; ACTIVATION; EXPRESSION; LINKAGE; CELLS; P53	FOXM1 is implicated in genotoxic drug resistance but its mechanism of action remains elusive. We show here that FOXM1-depletion can sensitize breast cancer cells and mouse embryonic fibroblasts (MEFs) into entering epirubicin-induced senescence, with the loss of long-term cell proliferation ability, the accumulation of gamma H2AX foci, and the induction of senescence-associated beta-galactosidase activity and cell morphology. Conversely, reconstitution of FOXM1 in FOXM1-deficient MEFs alleviates the accumulation of senescence-associated gamma H2AX foci. We also demonstrate that FOXM1 regulates NBS1 at the transcriptional level through an forkhead response element on its promoter. Like FOXM1, NBS1 is overexpressed in the epirubicin-resistant MCF-7Epi(R) cells and its expression level is low but inducible by epirubicin in MCF-7 cells. Consistently, overexpression of FOXM1 augmented and FOXM1 depletion reduced NBS1 expression and epirubicin-induced ataxia-telangiectasia mutated (ATM)phosphorylation in breast cancer cells. Together these findings suggest that FOXM1 increases NBS1 expression and ATM phosphorylation, possibly through increasing the levels of the MRN(MRE11/RAD50/NBS1) complex. Consistent with this idea, the loss of P-ATM induction by epirubicin in the NBS1-deficient NBS1-LBI fibroblasts can be rescued by NBS1 reconstitution. Resembling FOXM1, NBS1 depletion also rendered MCF-7 and MCF-7Epi(R) cells more sensitive to epirubicin-induced cellular senescence. In agreement, the DNA repair-defective and senescence phenotypes in FOXM1-deficent cells can be effectively rescued by overexpression of NBS1. Moreover, overexpression of NBS1 and FOXM1 similarly enhanced and their depletion downregulated homologous recombination (HR) DNA repair activity. Crucially, overexpression of FOXM1 failed to augment HR activity in the background of NBS1 depletion, demonstrating that NBS1 is indispensable for the HR function of FOXM1. The physiological relevance of the regulation of NBS1 expression by FOXM1 is further underscored by the strong and significant correlation between nuclear FOXM1 and total NBS1 expression in breast cancer patient samples, further suggesting that NBS1 as a key FOXM1 target gene involved in DNA damage response, genotoxic drug resistance and DNA damage-induced senescence.	[Khongkow, P.; Karunarathna, U.; Khongkow, M.; Gong, C.; Gomes, A. R.; Yague, E.; Monteiro, L. J.; Kongsema, M.; Zona, S.; Coombes, R. C.; Lam, E. W-F] Imperial Coll London, Dept Surg & Canc, London W12 0NN, England; [Gong, C.; Man, E. P. S.; Khoo, U-S] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsang, J. W-H] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Wu, K-J] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Medema, R. H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Freire, R.] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, San Cristobal la Laguna, Spain	Imperial College London; University of Hong Kong; University of Hong Kong; National Yang Ming Chiao Tung University; Netherlands Cancer Institute; Universidad de la Laguna	Lam, EWF (corresponding author), Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Cane Rd, London W12 0NN, England.	eric.lam@imperial.ac.uk	Kongsema, Mesayamas/H-3063-2017; Khoo, Ui Soon/C-4293-2009; Freire, Raimundo/Q-7660-2019; Khoo, Ui Soon/C-1345-2014; Monteiro, Lara J/AAU-8518-2020; Wu, Kou-Juey/P-4654-2015; Khoo, Ui Soon/K-2041-2019; Lam, Eric W-F/AAW-8566-2020	Khoo, Ui Soon/0000-0003-2200-7505; Freire, Raimundo/0000-0003-4473-8894; Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; Khongkow, Pasarat/0000-0003-3068-2412; Kongsema, Mesayamas/0000-0001-7146-9349; Khongkow, Mattaka/0000-0002-4424-8898; Medema, Rene/0000-0002-6754-0381; Coombes, Raoul Charles/0000-0002-4811-1100	Cancer Research UK; Breast Cancer Campaign; Fundacao para a Ciencia e a Tecnologia; Royal Thai Government Scholarships; Biotechnology and Biological Sciences Research Council [1243234] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Breast Cancer Campaign [2012NovPhD016, 2012MayPR070] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Royal Thai Government Scholarships; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Breast Cancer Campaign	EW-F Lam, AR Gomes, RC Coombes were supported by grants from Cancer Research UK, EW-F Lam and S Zona by grants from Breast Cancer Campaign, LJ Monteiro grants from Fundacao para a Ciencia e a Tecnologia, and P Khongkow, M Khongkow and M Kongsema from the Royal Thai Government Scholarships. We also thank Julie Millour for initiating the study and help with this work.	Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; de Olano N, 2012, MOL CANCER RES, V10, P1189, DOI 10.1158/1541-7786.MCR-11-0559; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kuo LJ, 2008, IN VIVO, V22, P305; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Monteiro LJ, 2013, ONCOGENE, V32, P4634, DOI 10.1038/onc.2012.491; NERI B, 1989, INT J CLIN PHARM TH, V27, P388; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Seviour EG, 2010, AGING-US, V2, P900, DOI 10.18632/aging.100248; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Stearns V, 2004, PHARMACOGENOMICS J, V4, P143, DOI 10.1038/sj.tpj.6500242; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2	36	85	85	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4144	4155		10.1038/onc.2013.457	http://dx.doi.org/10.1038/onc.2013.457			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24141789	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000340595700005
J	Cheng, SW; Cao, DF; Hottman, DA; Yuan, LL; Bergo, MO; Li, L				Cheng, Shaowu; Cao, Dongfeng; Hottman, David A.; Yuan, LiLian; Bergo, Martin O.; Li, Ling			Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimers Disease; Amyloid; Isoprenoid; Neuroinflammation; Transgenic Mice; Learning and Memory; Protein Prenylation	AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; A-BETA; REDUCTASE INHIBITORS; NEURONAL PLASTICITY; GAMMA-SECRETASE; H-RAS; ISOPRENOIDS; DEFICITS; GERANYLGERANYLATION	Background: Protein prenylation may play an important role in Alzheimer disease. Results: Haplodeficiency in farnesyltransferase and geranylgeranyltransferase-1 attenuates neuropathology, but only reduction of farnesyltransferase rescues cognitive function in Alzheimer mice. Conclusion: Protein farnesylation and geranylgeranylation differentially affect the course of Alzheimer disease. Significance: Specific inhibition of protein farnesylation might be a potential strategy for effectively treating Alzheimer disease. Isoprenoids and prenylated proteins have been implicated in the pathophysiology of Alzheimer disease (AD), including amyloid- precursor protein metabolism, Tau phosphorylation, synaptic plasticity, and neuroinflammation. However, little is known about the relative importance of the two protein prenyltransferases, farnesyltransferase (FT) and geranylgeranyltransferase-1 (GGT), in the pathogenesis of AD. In this study, we defined the impact of deleting one copy of FT or GGT on the development of amyloid- (A)-associated neuropathology and learning/memory impairments in APPPS1 double transgenic mice, a well established model of AD. Heterozygous deletion of FT reduced A deposition and neuroinflammation and rescued spatial learning and memory function in APPPS1 mice. Heterozygous deletion of GGT reduced the levels of A and neuroinflammation but had no impact on learning and memory. These results document that farnesylation and geranylgeranylation play differential roles in AD pathogenesis and suggest that specific inhibition of protein farnesylation could be a potential strategy for effectively treating AD.	[Cheng, Shaowu; Cao, Dongfeng; Hottman, David A.; Li, Ling] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Yuan, LiLian] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Bergo, Martin O.] Univ Gothenburg, Inst Med, Sahlgrenska Canc Ctr, S-41390 Gothenburg, Sweden	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Gothenburg	Li, L (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, 2001 6th St SE,MTRF 4-208, Minneapolis, MN 55455 USA.	lil@umn.edu		Li, Ling/0000-0002-9245-7387; cheng, shaowu/0000-0001-9059-4727	National Institutes of Health [AG031846]; Alzheimer's Association [IIRG-09-131791]; American Health Assistance Foundation/Bright Focus Foundation [A2010328]; Academic Health Center of the University of Minnesota; NATIONAL INSTITUTE ON AGING [R01AG031846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation/Bright Focus Foundation(BrightFocus Foundation); Academic Health Center of the University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG031846. This work was also supported by Alzheimer's Association Grant IIRG-09-131791, American Health Assistance Foundation/Bright Focus Foundation Grant A2010328, and the Academic Health Center of the University of Minnesota (to L. L.).	Bi XN, 2004, J BIOL CHEM, V279, P48238, DOI 10.1074/jbc.M405442200; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boo JH, 2008, BIOCHEM BIOPH RES CO, V372, P913, DOI 10.1016/j.bbrc.2008.05.153; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cespedes-Rubio A, 2010, J NEUROSCI RES, V88, P3621, DOI 10.1002/jnr.22511; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Cole SL, 2006, NEUROBIOL DIS, V22, P209, DOI 10.1016/j.nbd.2005.11.007; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Eckert GP, 2009, NEUROBIOL DIS, V35, P251, DOI 10.1016/j.nbd.2009.05.005; Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004; Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020; Holstein SA, 2002, BIOCHEMISTRY-US, V41, P13698, DOI 10.1021/bi026251x; Holtzman D.M., 2012, COLD SPRING HARB PER, V2; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lee M, 2002, BIOCHEM J, V366, P937, DOI 10.1042/BJ20020453; Leuchtenberger S, 2006, J NEUROCHEM, V96, P355, DOI 10.1111/j.1471-4159.2005.03553.x; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Li L, 2012, MOL NEUROBIOL, V46, P64, DOI 10.1007/s12035-012-8253-1; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Liu M, 2010, P NATL ACAD SCI USA, V107, P6471, DOI 10.1073/pnas.0908396107; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Manabe T, 2000, J NEUROSCI, V20, P2504; Mans RA, 2012, NEUROSCIENCE, V202, P1, DOI 10.1016/j.neuroscience.2011.12.007; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Wang PL, 2009, J NEUROSCI RES, V87, P2105, DOI 10.1002/jnr.22039; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Ye XJ, 2010, NEURON, V68, P340, DOI 10.1016/j.neuron.2010.09.013; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com	48	33	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35952	35960		10.1074/jbc.M113.503904	http://dx.doi.org/10.1074/jbc.M113.503904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24136196	Green Published, hybrid			2022-12-25	WOS:000329814700031
J	Kim, H; Falet, H; Hoffmeister, KM; Hartwig, JH				Kim, Hugh; Falet, Herve; Hoffmeister, Karin M.; Hartwig, John H.			Wiskott-Aldrich Syndrome Protein (WASp) Controls the Delivery of Platelet Transforming Growth Factor-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Extracellular Matrix; Platelets; Signal Transduction; Signaling	FILAMENT BARBED ENDS; GROWTH-FACTOR-BETA; COLLAGEN RECEPTOR; MEMBRANE SKELETON; ACTIVATION; SECRETION; DOWNSTREAM; GELSOLIN; BINDING; CDC42	Background: The mechanisms that regulate cytokine secretion from platelets are undefined. Results: Inhibiting the expression or function of the Wiskott-Aldrich syndrome protein (WASp) increases TGF-1 release from platelets. Conclusion: WASp curtails the secretion of TGF-1 from human and mouse platelets. Significance: Identifying the biochemical mechanisms of cytokine secretion will improve our understanding of platelets vis-a-vis the host immune response. Platelets are immunologically competent cells containing cytokines such as TGF-1 that regulate cell-mediated immunity. However, the mechanisms underlying cytokine secretion from platelets are undefined. The Wiskott-Aldrich syndrome protein (WASp) regulates actin polymerization in nucleated hematopoietic cells but has other role(s) in platelets. WASp-null (WASp(-/-)) platelets stimulated with a PAR-4 receptor agonist had increased TGF-1 release compared with WT platelets; inhibiting WASp function with wiskostatin augmented TRAP-induced TGF-1 release in human platelets. TGF-1 release is dissociated from -granule secretion (P-selectin up-regulation) and occurs more gradually, with approximate to 10-15% released after 30-60 min. Blockade of Src family kinase-mediated WASp Tyr-291/Tyr-293 phosphorylation increased TGF-1 release, with no additive effect in WASp(-/-) platelets, signifying that phosphorylation is critical for WASp-limited TGF-1 secretion. Inhibiting F-actin assembly with cytochalasin D enhanced secretion in WT platelets and further increased TGF-1 release in WASp(-/-) platelets, indicating that WASp and actin assembly independently regulate TGF-1 release. A permeabilized platelet model was used to test the role of upstream small GTPases in TGF-1 release. N17Cdc42, but not Rac1 mutants, increased TGF-1 secretion and abrogated WASp phosphorylation. We conclude that WASp function restricts TGF-1 secretion in a Cdc42- and Src family kinase-dependent manner and independently of actin assembly.	[Kim, Hugh] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kim, H (corresponding author), Brigham & Womens Hosp, Div Translat Med, 1 Blackfan Circle,Karp 6, Boston, MA 02115 USA.	hkim28@rics.bwh.harvard.edu		Falet, Herve/0000-0003-0788-9204	National Institutes of Health [HL059561-11, HL107146]; Canadian Institutes of Health Research Clinician-Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561, P01HL107146, R01HL104145, R01HL089224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Clinician-Scientist Award(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL059561-11 (to J. H. H. and H. F.) and HL107146 (to K. M. H.). This work was also supported by a Canadian Institutes of Health Research Clinician-Scientist Award (to H. K.).	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Calaminus SDJ, 2007, J THROMB HAEMOST, V5, P535, DOI 10.1111/j.1538-7836.2007.02377.x; Catucci M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00209; Cleland SY, 2011, FEBS LETT, V585, P3710, DOI 10.1016/j.febslet.2011.10.031; Derry JM, 1994, CELL, V79, P922; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Falet H, 2000, BLOOD, V96, P3786, DOI 10.1182/blood.V96.12.3786.h8003786_3786_3792; Falet H, 2005, AM J PHYSIOL-CELL PH, V289, pC819, DOI 10.1152/ajpcell.00587.2004; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; Falet H, 2002, BLOOD, V100, P2113, DOI 10.1182/blood.V100.6.2113.h81802002113_2113_2122; Falet H, 2009, BLOOD, V114, P4729, DOI 10.1182/blood-2009-02-202721; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Feng SJ, 2003, BLOOD, V102, P2122, DOI 10.1182/blood-2002-12-3805; Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392; Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48; Gerdes N, 2011, THROMB HAEMOSTASIS, V106, P353, DOI 10.1160/TH11-01-0020; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Gross BS, 1999, BLOOD, V94, P4166, DOI 10.1182/blood.V94.12.4166.424k36_4166_4176; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kim S, 2011, J BIOL CHEM, V286, P24170, DOI 10.1074/jbc.M110.212274; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lutskiy MI, 2007, BRIT J HAEMATOL, V139, P98, DOI 10.1111/j.1365-2141.2007.06745.x; Oda A, 2000, BLOOD, V95, P1663; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Rutledge Tara W, 2004, Methods Mol Biol, V272, P109; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; VOSTAL JG, 1993, BIOCHEM J, V294, P675, DOI 10.1042/bj2940675; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	53	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34352	34363		10.1074/jbc.M113.459750	http://dx.doi.org/10.1074/jbc.M113.459750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133214	Green Published, hybrid			2022-12-25	WOS:000329812800007
J	Shiryaev, SA; Remacle, AG; Chernov, AV; Golubkov, VS; Motamedchaboki, K; Muranaka, N; Dambacher, CM; Capek, P; Kukreja, M; Kozlov, IA; Perucho, M; Cieplak, P; Strongin, AY				Shiryaev, Sergey A.; Remacle, Albert G.; Chernov, Andrei V.; Golubkov, Vladislav S.; Motamedchaboki, Khatereh; Muranaka, Norihito; Dambacher, Corey M.; Capek, Petr; Kukreja, Muskan; Kozlov, Igor A.; Perucho, Manuel; Cieplak, Piotr; Strongin, Alex Y.			Substrate Cleavage Profiling Suggests a Distinct Function of Bacteroides fragilis Metalloproteinases (Fragilysin and Metalloproteinase II) at the Microbiome-Inflammation-Cancer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Enzymes; Metalloprotease; Microbial Pathogenesis; Toxins; Bacteroides; Fragilysin	IN-VITRO SELECTION; PATHOGENICITY ISLAND; KAPPA-B; HUMAN COMMENSAL; ENTEROTOXIN; PROTEIN; TOXIN; INHIBITORS; GENE; COLITIS	Background: Two distinct metalloproteinase types (fragilysin and metalloproteinase II/MPII) are encoded by the Bacteroides fragilis pathogenicity island. Results: Our assays determined substrate cleavage characteristics of fragilysin and MPII. Conclusion: MPII is the first zinc metalloproteinase with the dibasic cleavage preferences. Significance: Our results are important for understanding B. fragilis virulence and fundamental roles of the microbiome in human health and disease. Enterotoxigenic anaerobic Bacteroides fragilis is a significant source of inflammatory diarrheal disease and a risk factor for colorectal cancer. Two distinct metalloproteinase types (the homologous 1, 2, and 3 isoforms of fragilysin (FRA1, FRA2, and FRA3, respectively) and metalloproteinase II (MPII)) are encoded by the B. fragilis pathogenicity island. FRA was demonstrated to be important to pathogenesis, whereas MPII, also a potential virulence protein, remained completely uncharacterized. Here, we, for the first time, extensively characterized MPII in comparison with FRA3, a representative of the FRA isoforms. We employed a series of multiplexed peptide cleavage assays to determine substrate specificity and proteolytic characteristics of MPII and FRA. These results enabled implementation of an efficient assay of MPII activity using a fluorescence-quenched peptide and contributed to structural evidence for the distinct substrate cleavage preferences of MPII and FRA. Our data imply that MPII specificity mimics the dibasic ArgArg cleavage motif of furin-like proprotein convertases, whereas the cleavage motif of FRA (Pro-X-X-Leu-(Arg/Ala/Leu)) resembles that of human matrix metalloproteinases. To the best of our knowledge, MPII is the first zinc metalloproteinase with the dibasic cleavage preferences, suggesting a high level of versatility of metalloproteinase proteolysis. Based on these data, we now suggest that the combined (rather than individual) activity of MPII and FRA is required for the overall B. fragilis virulence in vivo.	[Shiryaev, Sergey A.; Remacle, Albert G.; Chernov, Andrei V.; Golubkov, Vladislav S.; Motamedchaboki, Khatereh; Perucho, Manuel; Cieplak, Piotr; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Muranaka, Norihito; Dambacher, Corey M.; Capek, Petr; Kukreja, Muskan; Kozlov, Igor A.] Prognosys Biosci Inc, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Chernov, Andrei/I-1623-2019; Golubkov, Vladislav/L-6828-2017; Capek, Petr/G-1303-2012; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016; Perucho, Manuel/0000-0002-2169-2662	National Institutes of Health [R01CA83017, R01CA157328, R01DE022757, R44GM085884, R01GM098835]; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM085884, R01GM098835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA83017, R01CA157328, and R01DE022757 (to A.Y.S) R44GM085884 (to I.A.K.), and R01GM098835 (to P. Cieplak).	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER 12; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Claros MC, 2006, ANAEROBE, V12, P17, DOI 10.1016/j.anaerobe.2005.06.005; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/fmb.13.17, 10.2217/FMB.13.17]; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Foulon I, 2003, J CLIN MICROBIOL, V41, P4428, DOI 10.1128/JCM.41.9.4428-4430.2003; Franco AA, 1999, J BACTERIOL, V181, P6623, DOI 10.1128/JB.181.21.6623-6633.1999; Franco AA, 2004, J BACTERIOL, V186, P6077, DOI 10.1128/jb.186.18.6077-6092.2004; GALARDY RE, 1994, ANN NY ACAD SCI, V732, P315, DOI 10.1111/j.1749-6632.1994.tb24746.x; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Holton John, 2008, Curr Infect Dis Rep, V10, P99, DOI 10.1007/s11908-008-0018-7; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kling JJ, 1997, FEMS MICROBIOL LETT, V146, P279, DOI 10.1016/S0378-1097(96)00488-0; Kozlov IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037441; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Levy DE, 1998, J MED CHEM, V41, P199, DOI 10.1021/jm970494j; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; Noto Jennifer M, 2012, Methods Mol Biol, V921, P7; Obiso RJ, 1997, INFECT IMMUN, V65, P1431, DOI 10.1128/IAI.65.4.1431-1439.1997; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Remacle AG, 2013, J BIOL CHEM, V288, P20568, DOI 10.1074/jbc.M113.471508; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Riegler M, 1999, GUT, V44, P504, DOI 10.1136/gut.44.4.504; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Saidi RF, 1997, CELL MOTIL CYTOSKEL, V37, P159, DOI 10.1002/(SICI)1097-0169(1997)37:2<159::AID-CM8>3.3.CO;2-N; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sanchez E, 2012, APPL ENVIRON MICROB, V78, P6507, DOI 10.1128/AEM.00563-12; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Sears CL, 2006, INFECT IMMUN, V74, P5595, DOI 10.1128/IAI.00135-06; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shalinsky DR, 1999, ANN NY ACAD SCI, V878, P236, DOI 10.1111/j.1749-6632.1999.tb07689.x; Shiryaev SA, 2012, PLOS ONE, V7; Shiryaev SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054290; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Trinchieri G., 2011, F1000 MED REP, V3, P11; VANTASSELL RL, 1992, INFECT IMMUN, V60, P1343, DOI 10.1128/IAI.60.4.1343-1350.1992; Vines RR, 2000, VACCINE, V19, P655, DOI 10.1016/S0264-410X(00)00254-1; Wells CL, 1996, GASTROENTEROLOGY, V110, P1429, DOI 10.1053/gast.1996.v110.pm8613048; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb; Woessner JF, 1999, ANN NY ACAD SCI, V878, P388, DOI 10.1111/j.1749-6632.1999.tb07697.x; Wu SG, 2004, INFECT IMMUN, V72, P5832, DOI 10.1128/IAI.72.10.5832-5839.2004; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001; Yoon YM, 2010, INFECT IMMUN, V78, P2024, DOI 10.1128/IAI.00118-10	73	19	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34956	34967		10.1074/jbc.M113.516153	http://dx.doi.org/10.1074/jbc.M113.516153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145028	Green Published, hybrid			2022-12-25	WOS:000329812800061
J	Ullah, S; Ahmed, F; Badshah, A; Altaf, AA; Raza, R; Lal, B; Hussain, R				Ullah, Shafiq; Ahmed, Fiaz; Badshah, Amin; Altaf, Ataf Ali; Raza, Ramsha; Lal, Bhajan; Hussain, Rizwan			Solvothermal Preparation of ZnO Nanorods as Anode Material for Improved Cycle Life Zn/AgO Batteries	PLOS ONE			English	Article							ZINC ELECTRODES; SILVER-ZINC; NANOSTRUCTURES; MICROPARTICLES; ADDITIVES; POWDER; OXIDE	Nano materials with high surface area increase the kinetics and extent of the redox reactions, thus resulting in high power and energy densities. In this study high surface area zinc oxide nanorods have been synthesized by surfactant free ethylene glycol assisted solvothermal method. The nanorods thus prepared have diameters in the submicron range (300 similar to 500 nm) with high aspect ratio. They have uniform geometry and well aligned direction. These nanorods are characterized by XRD, SEM, Specific Surface Area Analysis, solubility in alkaline medium, EDX analysis and galvanostatic charge/discharge studies in Zn/AgO batteries. The prepared zinc oxide nanorods have low solubility in alkaline medium with higher structural stability, which imparts the improved cycle life stability to Zn/AgO cells.	[Ullah, Shafiq; Badshah, Amin; Lal, Bhajan] Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan; [Ahmed, Fiaz; Raza, Ramsha; Hussain, Rizwan] Natl Engn & Sci Commiss, Islamabad, Pakistan; [Altaf, Ataf Ali] Bahauddin Zakariya Univ, Dept Chem, Sahiwal, Pakistan	Quaid I Azam University; National Engineering & Scientific Commission - Pakistan; Bahauddin Zakariya University	Badshah, A (corresponding author), Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan.	aminbadshah@yahoo.com	Badshah, Amin/H-9397-2015; Altaf, Ataf Ali/A-5258-2013	Altaf, Ataf Ali/0000-0001-8018-5890	Quaid-i-Azam University	Quaid-i-Azam University	Funding from Quaid-i-Azam University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, J MATER CHEM, V21, P7723, DOI 10.1039/c1jm10720h; Baruah S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/013001; Braam KT, 2012, J POWER SOURCES, V199, P367, DOI 10.1016/j.jpowsour.2011.09.076; Cao Z, 2011, APPL SURF SCI, V257, P4151, DOI 10.1016/j.apsusc.2010.11.188; Coleman VA, 2006, ZINC OXIDE BULK, THIN FILMS AND NANOSTRUCTURES: PROCESSING, PROPERTIES AND APPLICATIONS, P1, DOI 10.1016/B978-008044722-3/50001-4; El Abedin SZ, 2012, AUST J CHEM, V65, P1529, DOI 10.1071/CH12330; Jothi N. S. N., 2012, ARCH APPL SCI RES, V4, P1698; Kalpana R., 2012, ARCH APPL SCI RES, V4, P1996; Karpinski AP, 1999, J POWER SOURCES, V80, P53, DOI 10.1016/S0378-7753(99)00164-0; Kiani MA, 2011, INT J ELECTROCHEM SC, V6, P2581; Kong JZ, 2010, J SOLID STATE CHEM, V183, P1359, DOI 10.1016/j.jssc.2010.04.005; Lee JH, 2011, APPL PHYS A-MATER, V102, P545, DOI 10.1007/s00339-010-6097-y; Lewis H, 2001, J POWER SOURCES, V96, P128, DOI 10.1016/S0378-7753(01)00489-X; Linden D., 2002, HDB BATTERIES, P18; Liu JP, 2009, J PHYS CHEM C, V113, P5336, DOI 10.1021/jp900427c; Park I, 2011, ORG ELECTRON, V12, P424, DOI 10.1016/j.orgel.2010.12.002; Ramimoghadam D, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-71; Salkind AJ, 1996, ELECTROCHEM SOC P, V95, P101; Shivkumar R, 1998, J POWER SOURCES, V75, P90, DOI 10.1016/S0378-7753(98)00096-2; SHIVKUMAR R, 1995, J POWER SOURCES, V55, P53, DOI 10.1016/0378-7753(94)02170-8; Skelton J, 1997, J POWER SOURCES, V80, P53; Smith DF, 1999, J POWER SOURCES, V80, P66, DOI 10.1016/S0378-7753(98)00251-1; Suryakala K, 2006, INT J ELECTROCHEM SC, V1, P372; Takahashi S, 2008, MATER LETT, V62, P3407, DOI 10.1016/j.matlet.2008.03.018; Ullah S, 2011, INT J ELECTROCHEM SC, V6, P3801; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Xiang Q, 2010, SENSOR ACTUAT B-CHEM, V143, P635, DOI 10.1016/j.snb.2009.10.007; Zhang H, 2009, J RARE EARTH, V27, P980, DOI 10.1016/S1002-0721(08)60374-9; Zhu LQ, 2009, J PHYS CHEM SOLIDS, V70, P45, DOI 10.1016/j.jpcs.2008.09.005	29	12	12	6	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75999	10.1371/journal.pone.0075999	http://dx.doi.org/10.1371/journal.pone.0075999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146807	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200007
J	Shultz, S; Maslin, M				Shultz, Susanne; Maslin, Mark			Early Human Speciation, Brain Expansion and Dispersal Influenced by African Climate Pulses	PLOS ONE			English	Article							TURKANA BASIN; HUMAN-EVOLUTION; KOOBI-FORA; VARIABILITY; PATTERNS; HISTORY; RIFT; COMPETITION; DIVERSITY; HABITATS	Early human evolution is characterised by pulsed speciation and dispersal events that cannot be explained fully by global or continental paleoclimate records. We propose that the collated record of ephemeral East African Rift System (EARS) lakes could be a proxy for the regional paleoclimate conditions experienced by early hominins. Here we show that the presence of these lakes is associated with low levels of dust deposition in both West African and Mediterranean records, but is not associated with long-term global cooling and aridification of East Africa. Hominin expansion and diversification seem to be associated with climate pulses characterized by the precession-forced appearance and disappearance of deep EARS lakes. The most profound period for hominin evolution occurs at about 1.9 Ma; with the highest recorded diversity of hominin species, the appearance of Homo (sensu stricto) and major dispersal events out of East Africa into Eurasia. During this period, ephemeral deep-freshwater lakes appeared along the whole length of the EARS, fundamentally changing the local environment. The relationship between the local environment and hominin brain expansion is less clear. The major step-wise expansion in brain size around 1.9 Ma when Homo appeared was coeval with the occurrence of ephemeral deep lakes. Subsequent incremental increases in brain size are associated with dry periods with few if any lakes. Plio-Pleistocene East African climate pulses as evinced by the paleo-lake records seem, therefore, fundamental to hominin speciation, encephalisation and migration.	[Shultz, Susanne] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Maslin, Mark] UCL, Dept Geog, London, England	University of Manchester; University of London; University College London	Maslin, M (corresponding author), UCL, Dept Geog, London, England.	m.maslin@ucl.ac.uk		Shultz, Susanne/0000-0002-7135-4880; Maslin, Mark/0000-0001-9957-3463	Royal Society	Royal Society(Royal Society of London)	This research was supported by a Royal Society Wolfson Research Merit award for work on early human evolution (MM) and a Royal Society Dorothy Hodgkin Fellowship (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, QUATERNARY SCI REV, V30, P1338, DOI 10.1016/j.quascirev.2010.04.012; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Deino AL, 2006, EARTH PLANET SC LETT, V247, P41, DOI 10.1016/j.epsl.2006.04.009; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; Dunkley PN, 1993, 185 NERC; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Feibel CS, 2011, EVOL ANTHROPOL, V20, P206, DOI 10.1002/evan.20331; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Grove M, 2012, J ARCHAEOL SCI, V39, P3085, DOI 10.1016/j.jas.2012.04.023; Grove M, 2011, J ARCHAEOL SCI, V38, P3038, DOI 10.1016/j.jas.2011.07.002; Grove M, 2011, J HUM EVOL, V61, P306, DOI 10.1016/j.jhevol.2011.04.005; HOPF FA, 1993, EVOL ECOL, V7, P142, DOI 10.1007/BF01239385; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kingston JD, 2007, J HUM EVOL, V53, P487, DOI 10.1016/j.jhevol.2006.12.007; KLEIN RG, 1989, HUMAN CAREER; Larrasoana JC, 2003, CLIM DYNAM, V21, P689, DOI 10.1007/s00382-003-0355-z; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lepre CJ, 2007, J HUM EVOL, V53, P504, DOI 10.1016/j.jhevol.2007.01.015; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1167, DOI 10.1073/pnas.1206276110; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Reed KE, 2009, VERTEBRATE PALEOBIOL, P159; Roach NT, 2013, NATURE, V498, P483, DOI 10.1038/nature12267; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shultz S, 2012, PHILOS T R SOC B, V367, P2130, DOI 10.1098/rstb.2012.0115; Shultz S, 2010, J COMP PSYCHOL, V124, P252, DOI 10.1037/a0018894; STRECKER MR, 1990, GEOLOGY, V18, P299, DOI 10.1130/0091-7613(1990)018<0299:ROEDIT>2.3.CO;2; Tiercelin JJ, 2002, ADV GLOB CHANGE RES, V12, P3; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2010, QUATERNARY SCI REV, V29, P2981, DOI 10.1016/j.quascirev.2010.07.007; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Venables W., 2002, MODERN APPL STAT S, VFourth; Vrba E.S., 1988, P405; Wells JCK, 2007, YEARB PHYS ANTHROPOL, V50, P191, DOI 10.1002/ajpa.20735; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317	50	53	54	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76750	10.1371/journal.pone.0076750	http://dx.doi.org/10.1371/journal.pone.0076750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146922	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400086
J	Lopez-Martinez, R; Ramirez-Salinas, GL; Correa-Basurto, J; Barron, BL				Lopez-Martinez, Rogelio; Lizbeth Ramirez-Salinas, G.; Correa-Basurto, Jose; Barron, Blanca L.			Inhibition of Influenza A Virus Infection In Vitro by Peptides Designed In Silico	PLOS ONE			English	Article							FUSION PEPTIDE; HERPES-SIMPLEX; PANDEMIC INFLUENZA; STEM REGION; HEMAGGLUTININ; PREDICTION; OSELTAMIVIR; RESIDUES; IDENTIFICATION; REPLICATION	Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causing severe human respiratory infections. Currently, only two types of drugs are used to treat influenza A infections, the M2 H+ ion channel blockers (amantadine and rimantadine) and the neuraminidase inhibitors (NAI) (oseltamivir and zanamivir). Moreover, the emergence of drug-resistant influenza A virus strains has emphasized the need to develop new antiviral agents to complement or replace the existing drugs. Influenza A virus has on the surface a glycoprotein named hemagglutinin (HA) which due to its important role in the initial stage of infection: receptor binding and fusion activities of viral and endosomal membranes, is a potential target for new antiviral drugs. In this work we designed nine peptides using several bioinformatics tools. These peptides were derived from the HA1 and HA2 subunits of influenza A HA with the aim to inhibit influenza A virus infection. The peptides were synthetized and their antiviral activity was tested in vitro against several influenza A viral strains: Puerto Rico/916/34 (H1N1), (H1N1)pdm09, swine (H1N1) and avian (H5N2). We found these peptides were able to inhibit the influenza A viral strains tested, without showing any cytotoxic effect. By docking studies we found evidence that all the peptides were capable to bind to the viral HA, principally to important regions on the viral HA stalk, thus could prevent the HA conformational changes required to carry out its membranes fusion activity.	[Lopez-Martinez, Rogelio; Barron, Blanca L.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Virol, Mexico City, DF, Mexico; [Lizbeth Ramirez-Salinas, G.; Correa-Basurto, Jose] Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Bioinform, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Barron, BL (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Virol, Carpio & Plan Ayala S-N, Mexico City, DF, Mexico.	bbarron@ipn.mx		RODRIGUEZ-CORTES, OCTAVIO/0000-0002-7380-5665	CONACYT [CB-99164]; ICyT-DF [2009/225]; Secretaria de Investigacion y Posgrado del IPN	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyT-DF; Secretaria de Investigacion y Posgrado del IPN	This work is funded by CONACYT CB-99164, ICyT-DF 2009/225, and Secretaria de Investigacion y Posgrado del IPN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Beaufays J, 2012, J PEPT SCI, V18, P17, DOI 10.1002/psc.1410; Betancur-Galvis LA, 2002, MEM I OSWALDO CRUZ, V97, P541, DOI 10.1590/S0074-02762002000400017; Burke J D, 2009, Curr Mol Pharmacol, V2, P32; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; Chang DK, 2006, BIOCHEM J, V396, P557, DOI 10.1042/BJ20051920; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; Cohen FS, 2001, NAT STRUCT BIOL, V8, P653, DOI 10.1038/90341; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Costin JM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000721; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Delcroix M, 2010, PHARMACEUTICALS, V3, P448, DOI 10.3390/ph3030448; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Eckert DM, 2010, P NATL ACAD SCI USA, V107, P13563, DOI 10.1073/pnas.1008672107; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110; HAYES PJ, 1994, J MED VIROL, V42, P323, DOI 10.1002/jmv.1890420402; Janies DA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-13; Jesus T, 2012, BIOINFORMATION, V8, P870, DOI 10.6026/97320630008870; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; LIU S, 2009, PLOS ONE, V4, DOI DOI 10.1371/J0URNAL.P0NE.0005022.PUBMED:19325912; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Luo M, 2012, ADV EXP MED BIOL, V726, P201, DOI 10.1007/978-1-4614-0980-9_9; Mahy BWJ, 1996, VIROLOGY METHODS MAN; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Mullan Lisa J, 2002, Brief Bioinform, V3, P92, DOI 10.1093/bib/3.1.92; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rajik M, 2009, INT J BIOL SCI, V5, P543; Rajik M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-74; Real E, 2004, J VIROL, V78, P7410, DOI 10.1128/JVI.78.14.7410-7417.2004; Russell CJ, 2011, NEW ENGL J MED, V365, P1541, DOI 10.1056/NEJMcibr1109447; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Su CTT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S21; SUDO K, 1994, J VIROL METHODS, V49, P169, DOI 10.1016/0166-0934(94)90041-8; Suzuki Y, 2002, MOL BIOL EVOL, V19, P501, DOI 10.1093/oxfordjournals.molbev.a004105; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wilkins MR, 1999, METH MOL B, V112, P531; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Xu YT, 2012, PROTEINS, V80, P2154, DOI 10.1002/prot.24105; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	68	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76876	10.1371/journal.pone.0076876	http://dx.doi.org/10.1371/journal.pone.0076876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146939	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400089
J	Mukolo, A; Blevins, M; Victor, B; Vaz, LME; Sidat, M; Vergara, A				Mukolo, Abraham; Blevins, Meridith; Victor, Bart; Vaz, Lara M. E.; Sidat, Mohsin; Vergara, Alfredo			Correlates of Social Exclusion and Negative Labeling and Devaluation of People Living with HIV/AIDS in Rural Settings: Evidence from a General Household Survey in Zambezia Province, Mozambique	PLOS ONE			English	Article							HIV-RELATED STIGMA; SOUTH-AFRICAN WOMEN; DISCRIMINATORY ATTITUDES; AIDS STIGMA; CARE; SERVICES; INTERVENTIONS; PREVALENCE; PREDICTORS; KNOWLEDGE	Background: Increased HIV/AIDS knowledge and access to antiretroviral treatment (ART) have been hypothesized to decrease HIV stigma. However, stigma persists as a barrier to HIV services uptake. We studied the relationship between stigma, knowledge and attitudes towards HIV and its treatment, and confidence in the legal system (legal rights certitude). Methods: We analyzed data from a household survey of 3749 randomly sampled female heads of households in 259 enumeration areas across 14 districts of Zambezia Province, Mozambique. The questionnaire included questions about beliefs, attitudes and behavior towards PLWHA, HIV transmission knowledge, treatment-related beliefs, and legal rights certitude. Factor analysis distinguished two stigma constructs: Negative labeling and devaluation (NLD) and social exclusion (SoE). Multivariable linear regression was used to determine the association between stigma, knowledge of HIV/AIDS, treatment-related beliefs, and legal rights certitude, while controlling for variance in socio-demographics. Results: A 4-point increase in knowledge about HIV transmission was associated with more than a 3 unit decrease in NLD and SoE stigma scores (p<0.001). Given HIV transmission knowledge, a 25-point increase in legal rights certitude was associated with a 4.62 unit drop in NLD stigma (p<0.001); we did not detect an association between legal rights certitude and SoE stigma. Knowing at least one HIV positive person was associated with lower SoE (-3.17, 95% CI: -5.78, -0.56); no association with NLD (p = 0.1) was detected. ART efficacy belief was associated with higher NLD and lower SoE (2.90 increase and 6.94 decrease, respectively; p <= 0.001). Conclusion: Increasing knowledge about HIV transmission and access to ART are likely to reduce stigma, but neither of the two is a panacea. Raising community awareness of the legal rights of PLWHA might improve the efficacy of stigma reduction efforts. Strategies that focus on specific domains of stigma might be more effective than generic stigma reduction strategies.	[Mukolo, Abraham; Blevins, Meridith; Vaz, Lara M. E.; Vergara, Alfredo] Vanderbilt Univ Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Mukolo, Abraham; Vaz, Lara M. E.; Vergara, Alfredo] Vanderbilt Univ Sch Med, Dept Prevent Med, Nashville, TN USA; [Blevins, Meridith] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA; [Vaz, Lara M. E.] Friends Global Hlth, Maputo, Mozambique; [Sidat, Mohsin] Univ Eduardo Mondlane, Sch Med, Maputo, Mozambique; [Victor, Bart] Vanderbilt Univ, Owen Grad Sch Management, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Eduardo Mondlane University; Vanderbilt University	Mukolo, A (corresponding author), Vanderbilt Univ Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN USA.	abraham.mukolo@vanderbilt.edu		Blevins, Meridith/0000-0002-3861-9859; Sidat, Mohsin/0000-0002-8378-2014	United States Agency for International Development (USAID)-Mozambique through World Vision, Inc. [656-A-00-09-00141-00]; Vanderbilt University through the endowment of the Amos Christie Chair in Global Health	United States Agency for International Development (USAID)-Mozambique through World Vision, Inc.(United States Agency for International Development (USAID)); Vanderbilt University through the endowment of the Amos Christie Chair in Global Health	The Ogumaniha-SCIP baseline survey was supported by the United States Agency for International Development (USAID)-Mozambique (Award No. 656-A-00-09-00141-00) through a sub-grant from World Vision, Inc. Funding support for the secondary data analysis is from Vanderbilt University through the endowment of the Amos Christie Chair in Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2004, SCHIZOPHRENIA BULL, V30, P1049, DOI 10.1093/oxfordjournals.schbul.a007120; [Anonymous], 2008, HORIZONS OR TOOLKIT; [Anonymous], 1990, HUMAN DEV REPORT; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Campbell C, 2007, J HEALTH PSYCHOL, V12, P403, DOI 10.1177/1359105307076229; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; de Wit JBF, 2008, HIV MED, V9, P20, DOI 10.1111/j.1468-1293.2008.00586.x; Dlamini PS, 2007, PUBLIC HEALTH NURS, V24, P389, DOI 10.1111/j.1525-1446.2007.00649.x; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Ekstrand ML, 2012, AIDS BEHAV, V16, P700, DOI 10.1007/s10461-011-9888-z; Esses VM, 2004, PREJUDICE DISCRIMINA, P101; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Goffman E., 1963, BEHAV PUBLIC PLACES; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harrell FE, 2001, REGRESSION MODELING; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Holzemer W L, 2004, SAHARA J, V1, P165; Instituto Nacional de Saude (INS), 2009, MOZ NAT SURV PREV BE; Jorm AF, 2009, AUST NZ J PSYCHIAT, V43, P183, DOI 10.1080/00048670802653349; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kalofonos IA, 2010, MED ANTHROPOL Q, V24, P363, DOI 10.1111/j.1548-1387.2010.01109.x; Kohi TW, 2010, J ASSOC NURSE AIDS C, V21, P134, DOI 10.1016/j.jana.2009.09.004; Kohi TW, 2006, NURS ETHICS, V13, P404, DOI 10.1191/0969733006ne865oa; Kuppin S, 2006, AM J PUBLIC HEALTH, V96, P1766, DOI 10.2105/AJPH.2004.060855; Lau J, 2003, DISABIL REHABIL, V25, P1354, DOI 10.1080/09638280310001616349; Lau JTF, 2005, SEX TRANSM INFECT, V81, P113, DOI 10.1136/sti.2004.011767; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Little R. J. A., 1987, STAT ANAL MISSING DA; Luseno WK, 2010, AIDS PATIENT CARE ST, V24, P257, DOI 10.1089/apc.2009.0213; Luseno WK, 2009, AIDS CARE, V21, P178, DOI 10.1080/09540120802017594; MacPherson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026814; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Mall S, 2013, AIDS CARE, V25, P194, DOI 10.1080/09540121.2012.689810; Maman S, 2009, SOC SCI MED, V68, P2271, DOI 10.1016/j.socscimed.2009.04.002; Maughan-Brown B, 2010, SOC SCI MED, V70, P368, DOI 10.1016/j.socscimed.2009.09.041; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Mukolo A, 2013, AIDS BEHAV, V17, P5, DOI 10.1007/s10461-011-0097-6; Mukolo A, 2010, J AM ACAD CHILD PSY, V49, P92, DOI 10.1016/j.jaac.2009.12.003; MULDER M, 1973, J PERS SOC PSYCHOL, V26, P151, DOI 10.1037/h0034468; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nthomang K, 2009, HEALTH CARE WOMEN IN, V30, P233, DOI 10.1080/07399330802662077; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Pearson CR, 2009, AIDS BEHAV, V13, P1189, DOI 10.1007/s10461-009-9596-0; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P619, DOI 10.1176/appi.ps.58.5.619; Petros G, 2006, CULT HEALTH SEX, V8, P67, DOI 10.1080/13691050500391489; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Pulerwitz J, 2008, AIDS CARE, V20, P764, DOI 10.1080/09540120701506796; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P272, DOI 10.1177/003335491012500218; Riessman CK, 2009, SOCIOL HEALTH ILL, V31, P300, DOI 10.1111/j.1467-9566.2008.1154_1.x; Roura M, 2009, SEX TRANSM INFECT, V85, P308, DOI 10.1136/sti.2008.033183; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Smith RA, 2012, AIDS BEHAV, V16, P525, DOI 10.1007/s10461-012-0154-9; Surkan PJ, 2010, AIDS CARE, V22, P803, DOI 10.1080/09540120903443392; Tee Y, 2009, SAHARA J-J SOC ASP H, V6, P179, DOI 10.1080/17290376.2009.9724946; Turan JM, 2010, AIDS BEHAV; UNAIDS/RST-ESA, 2012, MOZ KEY EL NAT RESP; UNAIDS/RST-ESA, 2008, HUM RIGHTS STIGM DIS; Uys L, 2009, AIDS PATIENT CARE ST, V23, P1059, DOI 10.1089/apc.2009.0085; Vergara AE, 2011, BASELINE SURVEY REPO; Visser MJ, 2009, AIDS CARE, V21, P197, DOI 10.1080/09540120801932157; Zuch M, 2012, AIDS BEHAV, V16, P564, DOI 10.1007/s10461-011-0089-6	72	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75744	10.1371/journal.pone.0075744	http://dx.doi.org/10.1371/journal.pone.0075744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146771	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400016
J	Olsen, HG; Skovgaard, K; Nielsen, OL; Leifsson, PS; Jensen, HE; Iburg, T; Heegaard, PMH				Olsen, Helle G.; Skovgaard, Kerstin; Nielsen, Ole L.; Leifsson, Pall S.; Jensen, Henrik E.; Iburg, Tine; Heegaard, Peter M. H.			Organization and Biology of the Porcine Serum Amyloid A (SAA) Gene Cluster: Isoform Specific Responses to Bacterial Infection	PLOS ONE			English	Article							A PROTEIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; STAPHYLOCOCCUS-AUREUS; SYNOVIAL-FLUID; MESSENGER-RNAS; EXPRESSION; PIGS; FAMILY; PATHOGENESIS; EVOLUTION	Serum amyloid A (SAA) is a prominent acute phase protein. Although its biological functions are debated, the wide species distribution of highly homologous SAA proteins and their uniform behavior in response to injury or inflammation in itself suggests a significant role for this protein. The pig is increasingly being used as a model for the study of inflammatory reactions, yet only little is known about how specific SAA genes are regulated in the pig during acute phase responses and other responses induced by pro-inflammatory host mediators. We designed SAA gene specific primers and quantified the gene expression of porcine SAA1, SAA2, SAA3, and SAA4 by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) in liver, spleen, and lung tissue from pigs experimentally infected with the Gram-negative swine specific bacterium Actinobacillus pleuropneumoniae, as well as from pigs experimentally infected with the Gram-positive bacterium Staphylococcus aureus. Our results show that: 1) SAA1 may be a pseudogene in pigs; 2) we were able to detect two previously uncharacterized SAA transcripts, namely SAA2 and SAA4, of which the SAA2 transcript is primarily induced in the liver during acute infection and presumably contributes to circulating SAA in pigs; 3) Porcine SAA3 transcription is induced both hepatically and extrahepatically during acute infection, and may be correlated to local organ affection; 4) Hepatic transcription of SAA4 is markedly induced in pigs infected with A. pleuropneumoniae, but only weakly in pigs infected with S. aureus. These results for the first time establish the infection response patterns of the four porcine SAA genes which will be of importance for the use of the pig as a model for human inflammatory responses, e. g. within sepsis, cancer, and obesity research.	[Olsen, Helle G.; Nielsen, Ole L.; Leifsson, Pall S.; Jensen, Henrik E.; Iburg, Tine] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Skovgaard, Kerstin; Heegaard, Peter M. H.] Tech Univ Denmark, Innate Immunol Grp, Natl Vet Inst, Frederiksberg, Denmark	University of Copenhagen; Technical University of Denmark	Heegaard, PMH (corresponding author), Tech Univ Denmark, Innate Immunol Grp, Natl Vet Inst, Frederiksberg, Denmark.	pmhh@vet.dtu.dk	Heegaard, Peter/E-9794-2015	Heegaard, Peter/0000-0003-4506-4932; Nielsen, Ole Lerberg/0000-0003-2678-6622; Jensen, Henrik Elvang/0000-0001-7277-7829; skovgaard, kerstin/0000-0001-5663-4879; Iburg, Tine Moesgaard/0000-0003-0246-5146; Leifsson, Pall S/0000-0003-1539-9491	Danish Medical Research Council [271-07-0417]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was financed by grant no. 271-07-0417 from the Danish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Butler A, 1996, IMMUNOGENETICS, V44, P468, DOI 10.1007/BF02602809; Chang WC, 2007, ASIAN AUSTRAL J ANIM, V20, P768, DOI 10.5713/ajas.2007.768; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; deBeer MC, 1996, GENOMICS, V34, P139, DOI 10.1006/geno.1996.0253; DEBEER MC, 1994, J BIOL CHEM, V269, P4661; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Heegaard PMH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-50; HUSBY G, 1994, AMYLOID, V1, P119, DOI 10.3109/13506129409148635; Jacobsen S, 2006, VET IMMUNOL IMMUNOP, V110, P325, DOI 10.1016/j.vetimm.2005.10.012; Jacobsen S, 2005, VET IMMUNOL IMMUNOP, V104, P21, DOI 10.1016/j.vetimm.2004.09.031; Jensen HE, 2010, IN VIVO, V24, P257; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kjelgaard-Hansen M, 2007, VET IMMUNOL IMMUNOP, V117, P296, DOI 10.1016/j.vetimm.2007.03.008; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kushner, 1982, ANN NY ACAD SCI, V389, P39; Leifsson PS, 2010, FEMS MICROBIOL LETT, V309, P208, DOI 10.1111/j.1574-6968.2010.02042.x; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Liljegren CH, 2003, APMIS, V111, P531, DOI 10.1034/j.1600-0463.2003.1110501.x; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; McDonald TL, 2001, VET IMMUNOL IMMUNOP, V83, P203, DOI 10.1016/S0165-2427(01)00380-4; MCDONALD TL, 1991, J IMMUNOL METHODS, V144, P149, DOI 10.1016/0022-1759(91)90081-P; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1989, P NATL ACAD SCI USA, V86, P1890, DOI 10.1073/pnas.86.6.1890; MITCHELL TI, 1991, J CLIN INVEST, V87, P1177, DOI 10.1172/JCI115116; MORROW JF, 1981, P NATL ACAD SCI-BIOL, V78, P4718, DOI 10.1073/pnas.78.8.4718; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RAMADORI G, 1985, J IMMUNOL, V135, P3645; Rodriguez BD, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-4; SELLAR GC, 1994, GENOMICS, V23, P492, DOI 10.1006/geno.1994.1530; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Skovgaard K, 2007, VET IMMUNOL IMMUNOP, V118, P140, DOI 10.1016/j.vetimm.2007.04.010; Skovgaard K, 2010, INNATE IMMUN-LONDON, V16, P343, DOI 10.1177/1753425909342730; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Soerensen KE, 2013, J COMP PATH IN PRESS; Soler L, 2013, J THEOR BIOL, V317, P119, DOI 10.1016/j.jtbi.2012.10.011; Soler L, 2011, VET IMMUNOL IMMUNOP, V141, P109, DOI 10.1016/j.vetimm.2011.02.019; Sorensen NS, 2006, VET IMMUNOL IMMUNOP, V113, P157, DOI 10.1016/j.vetimm.2006.04.008; Souvorov A., 2010, GNOMON NCBI EUKARYOT; Steel DM, 1996, SCAND J IMMUNOL, V44, P493, DOI 10.1046/j.1365-3083.1996.d01-341.x; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Sung HJ, 2012, J PROTEOMICS, V75, P2170, DOI 10.1016/j.jprot.2012.01.018; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; WEBB CF, 1989, BIOCHEMISTRY-US, V28, P4785, DOI 10.1021/bi00437a040; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; Yamada T, 1997, J CLIN LAB ANAL, V11, P363; YAMADA T, 1994, AMYLOID, V1, P114, DOI 10.3109/13506129409148634	54	23	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76695	10.1371/journal.pone.0076695	http://dx.doi.org/10.1371/journal.pone.0076695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146912	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400074
J	Torres-Espin, A; Hernandez, J; Navarro, X				Torres-Espin, Abel; Hernandez, Joaquim; Navarro, Xavier			Gene Expression Changes in the Injured Spinal Cord Following Transplantation of Mesenchymal Stem Cells or Olfactory Ensheathing Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL RECOVERY; DELAYED TRANSPLANTATION; LAMINA-PROPRIA; NITRIC-OXIDE; AXON GROWTH; RAT; PROMOTES; GLIA	Transplantation of bone marrow derived mesenchymal stromal cells (MSC) or olfactory ensheathing cells (OEC) have demonstrated beneficial effects after spinal cord injury (SCI), providing tissue protection and improving the functional recovery. However, the changes induced by these cells after their transplantation into the injured spinal cord remain largely unknown. We analyzed the changes in the spinal cord transcriptome after a contusion injury and MSC or OEC transplantation. The cells were injected immediately or 7 days after the injury. The mRNA of the spinal cord injured segment was extracted and analyzed by microarray at 2 and 7 days after cell grafting. The gene profiles were analyzed by clustering and functional enrichment analysis based on the Gene Ontology database. We found that both MSC and OEC transplanted acutely after injury induce an early up-regulation of genes related to tissue protection and regeneration. In contrast, cells transplanted at 7 days after injury down-regulate genes related to tissue regeneration. The most important change after MSC or OEC transplant was a marked increase in expression of genes associated with foreign body response and adaptive immune response. These data suggest a regulatory effect of MSC and OEC transplantation after SCI regarding tissue repair processes, but a fast rejection response to the grafted cells. Our results provide an initial step to determine the mechanisms of action and to optimize cell therapy for SCI.	[Navarro, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Grp Neuroplast & Regenerat, Bellaterra, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain	Autonomous University of Barcelona; CIBERNED	Navarro, X (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Grp Neuroplast & Regenerat, Bellaterra, Spain.	xavier.navarro@uab.cat	Navarro, Xavier/C-9577-2011; Torres-Espin, Abel/ABD-1354-2020; Torres Espin, Abel/HGA-5068-2022; Hernandez, Joaquim/E-1298-2011	Navarro, Xavier/0000-0001-9849-902X; Torres-Espin, Abel/0000-0002-9787-8738; Hernandez, Joaquim/0000-0003-1409-5568	Ministerio de Ciencia e Innovacion [SAF2009-12495]; CIBERNED; Red de Terapia Celular (TERCEL); Instituto de Salud Carlos III of Spain; FEDER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Red de Terapia Celular (TERCEL); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (grant SAF2009-12495), and funds from CIBERNED and Red de Terapia Celular (TERCEL), Instituto de Salud Carlos III of Spain, and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Bieback K, 2012, J MOL MED, V90, P773, DOI 10.1007/s00109-012-0915-y; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012; Cole DK, 2012, IMMUNOLOGY, V137, P139, DOI 10.1111/j.1365-2567.2012.03625.x; Collazos-Castro JE, 2005, J NEUROSURG-SPINE, V3, P308, DOI 10.3171/spi.2005.3.4.0308; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dressel R, 2001, IMMUNOL REV, V184, P82, DOI 10.1034/j.1600-065x.2001.1840108.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Gunther E, 2001, IMMUNOGENETICS, V53, P520, DOI 10.1007/s002510100361; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024; Jeon YK, 2010, WOUND REPAIR REGEN, V18, P655, DOI 10.1111/j.1524-475X.2010.00636.x; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2012, J BIOL CHEM, V287, P38716, DOI 10.1074/jbc.M112.373159; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Li Y, 1998, J NEUROSCI, V18, P10514; Lopez-Vales R, 2006, SPINE, V31, P1100; Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lopez-Vales R, 2007, GLIA, V55, P303, DOI 10.1002/glia.20457; Lozito TP, 2009, J CELL BIOCHEM, V107, P706, DOI 10.1002/jcb.22166; Lu DY, 2009, J CELL PHYSIOL, V220, P163, DOI 10.1002/jcp.21746; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Okada M, 2007, NEUROSCI RES, V58, P371, DOI 10.1016/j.neures.2007.04.009; Oo YH, 2010, DIGEST DIS, V28, P31, DOI 10.1159/000282062; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Ronsyn MW, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-90; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Ruitenberg MJ, 2002, GENE THER, V9, P135, DOI 10.1038/sj.gt.3301626; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002; Steward O, 2006, EXP NEUROL, V198, P483, DOI 10.1016/j.expneurol.2005.12.034; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594; Takami T, 2002, J NEUROSCI, V22, P6670; Teller P, 2009, SURG CLIN N AM, V89, P599, DOI 10.1016/j.suc.2009.03.006; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Verdu E, 2003, GLIA, V42, P275, DOI 10.1002/glia.10217; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19	89	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76141	10.1371/journal.pone.0076141	http://dx.doi.org/10.1371/journal.pone.0076141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146830	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400042
J	Weiser, K; Barton, M; Gershoony, D; DasGupta, R; Cardozo, T				Weiser, Keren; Barton, Meredith; Gershoony, Dafna; DasGupta, Ramanuj; Cardozo, Timothy			HIV's Nef Interacts with beta-Catenin of the Wnt Signaling Pathway in HEK293 Cells	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; CD4(+) T-CELLS; CLATHRIN-COATED VESICLES; CRYSTAL-STRUCTURE; DOWN-REGULATION; STRUCTURE PREDICTION; DILEUCINE MOTIF; SURFACE CD4; SUBUNIT-H; V-ATPASE	The Wnt signaling pathway is implicated in major physiologic cellular functions, such as proliferation, migration, cell fate specification, maintenance of pluripotency and induction of tumorigenicity. Proliferation and migration are important responses of T-cells, which are major cellular targets of HIV infection. Using an informatics screen, we identified a previously unsuspected interaction between HIV's Nef protein and beta-catenin, a key component of the Wnt pathway. A segment in Nef contains identical amino acids at key positions and structurally mimics the beta-catenin binding sites on endogenous beta-catenin ligands. The interaction between Nef and beta-catenin was confirmed in vitro and in a co-immunoprecipitation from HEK293 cells. Moreover, the introduction of Nef into HEK293 cells specifically inhibited a Wnt pathway reporter.	[Weiser, Keren; Barton, Meredith; Gershoony, Dafna; DasGupta, Ramanuj; Cardozo, Timothy] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA	New York University	Cardozo, T (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	Timothy.Cardozo@nyumc.org		Dasgupta, Ramanuj/0000-0001-9015-3729	National Institutes of Health [DP2 OD004631, P30AI027742]; NATIONAL CANCER INSTITUTE [R01CA155125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027742] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by: National Institutes of Health (http://www.nih.gov), Grant numbers: DP2 OD004631 and P30AI027742 (CFAR Developmental Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R, 1997, COMP SIM BIOMOL SYST, V3, P32; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P731, DOI 10.1007/s11481-012-9411-y; Allers K, 2010, J VIROL, V84, P3259, DOI 10.1128/JVI.01715-09; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Bucher P, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P53; Carroll-Anzinger D, 2007, J VIROL, V81, P5864, DOI 10.1128/JVI.02234-06; Churchill MJ, 2006, J VIROL, V80, P1047, DOI 10.1128/JVI.80.2.1047-1052.2006; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Djordjevic JT, 2004, AIDS RES HUM RETROV, V20, P547, DOI 10.1089/088922204323087804; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; Gail R, 2005, J BIOL CHEM, V280, P7107, DOI 10.1074/jbc.M410215200; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Henderson LJ, 2012, J NEUROSCI, V32, P16306, DOI 10.1523/JNEUROSCI.3145-12.2012; Hossain MZ, 2008, INT IMMUNOL, V20, P925, DOI 10.1093/intimm/dxn051; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; KOHLEISEN B, 1992, AIDS, V6, P1427, DOI 10.1097/00002030-199212000-00002; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Mandic R, 2001, MOL BIOL CELL, V12, P463, DOI 10.1091/mbc.12.2.463; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; MARIANI R, 1993, P NATL ACAD SCI USA, V90, P5549, DOI 10.1073/pnas.90.12.5549; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; OVOD V, 1992, AIDS, V6, P25, DOI 10.1097/00002030-199201000-00003; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sawai ET, 2000, J VIROL, V74, P2038, DOI 10.1128/JVI.74.4.2038-2045.2000; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; Sreenath K, 2010, VIROLOGY, V400, P76, DOI 10.1016/j.virol.2010.01.017; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun J, 2011, J MOL BIOL, V405, P519, DOI 10.1016/j.jmb.2010.11.010; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Williams M, 2002, J VIROL, V76, P12173, DOI 10.1128/JVI.76.23.12173-12184.2002; Wortman B, 2002, J VIROL, V76, P11159, DOI 10.1128/JVI.76.21.11159-11165.2002; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108; Zsak L, 2001, J VIROL, V75, P3066, DOI 10.1128/JVI.75.7.3066-3076.2001	87	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77865	10.1371/journal.pone.0077865	http://dx.doi.org/10.1371/journal.pone.0077865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130899	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200095
J	Yang, J; Liu, DM; Jing, WX; Dahms, HU; Wang, L				Yang, Jian; Liu, Dongmei; Jing, Weixin; Dahms, Hans-Uwe; Wang, Lan			Effects of Cadmium on Lipid Storage and Metabolism in the Freshwater Crab Sinopotamon henanense	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; YANGTZE-RIVER; HEAVY-METALS; YELLOW-RIVER; ACCUMULATION; TOXICITY; METALLOTHIONEIN; HEPATOPANCREAS; PEROXIDATION; HEPATOCYTES	Since environmental effects of molecular traits are often questioned we analyze here the molecular effects of cadmium (Cd) on lipid pathways and their effects on tissues development. Lipids are an important energy source for the developing embryo, and accumulate in the ovary and hepatopancreas of decapod crustaceans. The extend of Cd affecting lipid storage and metabolism, is studied here with the freshwater crabs Sinopotamon henanense. Crabs were exposed to water-born Cd at 1.45, 2.9, 5.8 mg/l for 10, 15, and 20 days. With significantly increased Cd accumulation in exposed crabs, lipid content in hepatopancreas and ovary showed a time-dependent and concentration-dependent reduction, being at least one of the reasons for a lower ovarian index (OI) and hepatopancreatic index (HI). After 10-day exposure increased triglyceride (TG) level in hemolymph and up-regulation of pancreatic lipase (PL) activity in the hepatopancreas suggested an increased nutritional lipid uptake. However, two processes led to lower lipid levels upon Cd exposure: an increased utilization of lipids and a down-regulated lipoprotein lipase (LPL) led to insufficient lipid transport. 10-day Cd exposure also triggered the production of beta-nicotinamide adenine dinucleotide 2'-phosphate reduced tetrasodium salt hydrate (NADPH), as well as to the synthesis of adenosine triphosphate (ATP) and fatty acids. With increasing exposure time, the crabs at 15 and 20-day exposure contained less lipid and TG, suggesting that more energy was consumed during the exposure time. Meanwhile, the level of NADPH, ATP and the activity of PL, LPL, fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC) activity was down-regulated suggesting an impairment of the crab metabolism by Cd in addition to causing a lower lipid level.	[Yang, Jian; Liu, Dongmei; Jing, Weixin; Wang, Lan] Shanxi Univ, Sch Life Sci, Lab Bioeffect & Mol Mech Class Environm Pollutant, Taiyuan, Shanxi Province, Peoples R China; [Dahms, Hans-Uwe] Sangmyung Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea	Shanxi University; Sang Myung University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Lab Bioeffect & Mol Mech Class Environm Pollutant, Taiyuan, Shanxi Province, Peoples R China.	lanwang@sxu.edu.cn			National Science Foundation of China [30870267, 30970361]; Shanxi Province Nature Science Foundation [2008011069]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Province Nature Science Foundation	This research was supported by a grant from the National Science Foundation of China (30870267 and 30970361) and Shanxi Province Nature Science Foundation (2008011069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAVA VR, 1993, NIPPON SUICAN GAKKAI, V59, P345, DOI DOI 10.2331/SUISAN.59.345; ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Andre JM, 2007, COMP BIOCHEM PHYS A, V148, P899, DOI 10.1016/j.cbpa.2007.09.006; ANGER K, 1986, MAR BIOL, V90, P261, DOI 10.1007/BF00569137; Bai JH, 2012, J HYDROL, V450, P244, DOI 10.1016/j.jhydrol.2012.05.006; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calhoa CF, 2012, ECOTOXICOLOGY, V21, P48, DOI 10.1007/s10646-011-0762-6; CAREY C, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432406; Chen Yao-wu, 2007, Journal of China University of Petroleum, V31, P74; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; CHINNI S, 2004, J APPL AQUACULT, V14, P47, DOI DOI 10.1300/J028V14N03_; Corticeiro SC, 2006, ENZYME MICROB TECH, V40, P132, DOI 10.1016/j.enzmictec.2005.10.053; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; ENGEL DW, 1979, ENVIRON HEALTH PERSP, V28, P81, DOI 10.2307/3428908; Feng JL, 2010, SCI CHINA CHEM, V53, P1217, DOI 10.1007/s11426-010-0089-9; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Firat O, 2010, FISH PHYSIOL BIOCHEM, V36, P647, DOI 10.1007/s10695-009-9337-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Goldberg IJ, 1996, J LIPID RES, V37, P693; Han Tuo, 2008, Sichuan Journal of Zoology, V27, P804; HAVEL RJ, 1987, AM J PHYSIOL, V253, pE1, DOI 10.1152/ajpendo.1987.253.1.E1; KANG X, 2012, TOXIC DRUGS TEST, V4, P221; Larregle EV, 2008, FOOD CHEM TOXICOL, V46, P1786, DOI 10.1016/j.fct.2008.01.018; LAUTIER J, 1988, BIOCHEM SYST ECOL, V16, P203, DOI 10.1016/0305-1978(88)90098-1; Li Yong-Quan, 2008, Acta Hydrobiologica Sinica, V32, P373; Lin S, 2002, CHEM GEOL, V182, P377, DOI 10.1016/S0009-2541(01)00331-X; Liu DM, 2011, AQUAT TOXICOL, V105, P394, DOI 10.1016/j.aquatox.2011.07.013; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Lubzens E, 1995, ISR J AQUACULT-BAMID, V47, P185; Lucia M, 2010, ECOTOXICOLOGY, V19, P163, DOI 10.1007/s10646-009-0401-7; MA W, 2007, ENVIRON TOXICOL, V23, P393; Mendez L, 2001, MAR BIOL, V138, P687, DOI 10.1007/s002270000508; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; MOURENTE G, 1994, MAR BIOL, V121, P187, DOI 10.1007/BF00349488; Pacyna JM, 2009, ATMOS ENVIRON, V43, P117, DOI 10.1016/j.atmosenv.2008.09.066; Pan LQ, 2006, COMP BIOCHEM PHYS C, V144, P67, DOI 10.1016/j.cbpc.2006.06.001; Pierron F, 2007, AQUAT TOXICOL, V81, P304, DOI 10.1016/j.aquatox.2006.12.014; Pirrone N., 2010, ATMOSPHERIC CHEM PHY, V10, P4719, DOI DOI 10.5194/ACPD-10-4719-2010; Revathi P, 2011, ECOTOX ENVIRON SAFE, V74, P623, DOI 10.1016/j.ecoenv.2010.08.027; ROMERO MJM, 1991, TOXICOL APPL PHARM, V111, P485, DOI 10.1016/0041-008X(91)90252-A; SAMYAL A, 2011, J FOOD SCI TECHNOL, V3, P160; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; TESHIMA S, 1983, B JPN SOC SCI FISH, V49, P957; TORREBLANCA A, 1991, B ENVIRON CONTAM TOX, V47, P933, DOI 10.1007/BF01689526; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Venugopal NBRK, 1997, B ENVIRON CONTAM TOX, V59, P132, DOI 10.1007/s001289900455; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WANG J, 2007, BIOCHEMISTRY; Wang L, 2008, CHEMOSPHERE, V74, P51, DOI 10.1016/j.chemosphere.2008.09.025; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024405; Weinstock PH, 1997, P NATL ACAD SCI USA, V94, P10261, DOI 10.1073/pnas.94.19.10261; Wen XB, 2001, COMP BIOCHEM PHYS B, V130, P95, DOI 10.1016/S1096-4959(01)00411-0; Winzer K, 2001, J HISTOCHEM CYTOCHEM, V49, P1025, DOI 10.1177/002215540104900810; WRIGHT DA, 1977, J EXP BIOL, V67, P163; Wu JP, 2005, COMP BIOCHEM PHYS C, V140, P383, DOI 10.1016/j.cca.2005.03.006; XUAN R, 2013, GUANGDONG AGR SCI, V7, P123; Xuan RJ, 2011, COMP BIOCHEM PHYS C, V154, P268, DOI 10.1016/j.cbpc.2011.06.005; Xue L.Z., 1987, J E CHINA NORMAL U N, V3, P88; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701; Zhao S, 2012, MAR POLLUT BULL, V64, P1163, DOI 10.1016/j.marpolbul.2012.03.023; Zhou LB, 2012, APPL MECH MATER, V209-211, P1116, DOI 10.4028/www.scientific.net/AMM.209-211.1116	64	32	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77569	10.1371/journal.pone.0077569	http://dx.doi.org/10.1371/journal.pone.0077569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130894	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200091
J	Binici, J; Hartmann, J; Herrmann, J; Schreiber, C; Beyer, S; Guler, G; Vogel, V; Tumulka, F; Abele, R; Mantele, W; Koch, J				Binici, Janina; Hartmann, Jessica; Herrmann, Julia; Schreiber, Christine; Beyer, Steffen; Gueler, Guennur; Vogel, Vitali; Tumulka, Franz; Abele, Rupert; Maentele, Werner; Koch, Joachim			A Soluble Fragment of the Tumor Antigen BCL2-associated Athanogene 6 (BAG-6) Is Essential and Sufficient for Inhibition of NKp30 Receptor-dependent Cytotoxicity of Natural Killer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Immunosuppression; Innate Immunity; Natural Killer (NK) Cell; Tumor Immunology; Tumor Marker; BAG-6; BAT3; NKp30; Natural Killer Cell Receptors (NCR); Tumor Immune Escape	B-ASSOCIATED TRANSCRIPT-3; ACUTE MYELOID-LEUKEMIA; NKG2D LIGANDS; EXPRESSION; BINDING; BAT3; APOPTOSIS; SCYTHE; RECOGNITION; MECHANISMS	Background: Cellular ligands of the activating natural killer (NK) cell receptor NKp30 are poorly characterized. Results: The identified domain of the cellular ligand BCL2-associated athanogene 6 (BAG-6) is essential and sufficient to bind NKp30 and inhibits NK cell function. Conclusion: The BAG-6 domain from amino acid 686 to 936 is an important element of BAG-6-dependent tumor immune escape. Significance: This study gives the first molecular insights into BAG-6-mediated inhibition of NKp30-dependent NK cell cytotoxicity. Immunosurveillance of tumor cells depends on NKp30, a major activating receptor of human natural killer (NK) cells. The human BCL2-associated athanogene 6 (BAG-6, also known as BAT3; 1126 amino acids) is a cellular ligand of NKp30. To date, little is known about the molecular details of this receptor ligand system. Within the current study, we have located the binding site of NKp30 to a sequence stretch of 250 amino acids in the C-terminal region of BAG-6 (BAG-6(686-936)). BAG-6(686-936) forms a noncovalent dimer of 57-59 kDa, which is sufficient for high affinity interaction with NKp30 (K-D < 100 nm). As our most important finding, BAG-6(686-936) inhibits NKp30-dependent signaling, interferon- release, and degranulation of NK cells in the presence of malignantly transformed target cells. Based on these data, we show for the first time that BAG-6(686-936) comprises a subdomain of BAG-6, which is sufficient for receptor docking and inhibition of NKp30-dependent NK cell cytotoxicity as part of a tumor immune escape mechanism. These molecular insights provide an access point to restore tumor immunosurveillance by NK cells and to increase the efficacy of cellular therapies.	[Binici, Janina; Hartmann, Jessica; Herrmann, Julia; Schreiber, Christine; Beyer, Steffen; Koch, Joachim] Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Germany; [Gueler, Guennur; Vogel, Vitali; Maentele, Werner] Goethe Univ Frankfurt, Inst Biophys, Bioctr, D-60438 Frankfurt, Germany; [Tumulka, Franz; Abele, Rupert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany	Octapharma; Goethe University Frankfurt; Goethe University Frankfurt	Koch, J (corresponding author), Georg Speyer Haus, Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	joachim.koch@em.uni-frankfurt.de	Vogel, Vitali R/I-4767-2013; Vogel, Vitali/F-9126-2011; Güler, Günnur/GLQ-7527-2022; Hartmann, Jessica/AAL-8849-2021	Hartmann, Jessica/0000-0001-9372-8954; Guler, Gunnur/0000-0002-8485-7372	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK)	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK)	We thank Carsten Watzl (Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany) for critical review of the manuscript and helpful discussions and Elke Pogge von Strandmann (Medical School University of Cologne, Germany) for helpful discussions and technical advice. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK).	Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Cerwenka A, 2003, TISSUE ANTIGENS, V61, P335, DOI 10.1034/j.1399-0039.2003.00070.x; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; Funke J, 2011, AIDS REV, V13, P67; Hammond T, 2010, CELL IMMUNOL, V264, P150, DOI 10.1016/j.cellimm.2010.06.001; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; Reiners KS, 2013, BLOOD, V121, P3658, DOI 10.1182/blood-2013-01-476606; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wu W, 2012, J CELL SCI, V125, P4219, DOI 10.1242/jcs.086553; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	34	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34295	34303		10.1074/jbc.M113.483602	http://dx.doi.org/10.1074/jbc.M113.483602			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133212	hybrid, Green Published			2022-12-25	WOS:000329812800002
J	Li, L; Carter, CW				Li, Li; Carter, Charles W., Jr.			Full Implementation of the Genetic Code by Tryptophanyl-tRNA Synthetase Requires Intermodular Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthesis; Aminoacyl tRNA Synthetase; Cooperativity; Enzyme Kinetics; Protein Evolution; Protein Synthesis; Antidocon-binding Domain; Connecting Peptide 1; Factorial Design; Urzymes	CLASS-I; MG2+-ASSISTED CATALYSIS; DOMAIN; TRPRS; AMINOACYLATION; EVOLUTION; BINDING	Background: Aminoacyl-tRNA synthetases evolved from Urzymes with reduced amino acid specificity. Results: Independent restoration of either the catalytic insertion domain or the anticodon-binding domain greatly reduces both amino acid specificity and tRNA aminoacylation. Conclusion: Amino acid selectivity and tRNA acylation require interdomain cooperativity. Significance: Independent recruitment of either module would have significantly reduced evolutionary fitness as Class I aaRS evolved. Tryptophanyl-tRNA Synthetase (TrpRS) Urzyme (fragments A and C), a 130-residue construct containing only secondary structures positioning the HIGH and KMSKS active site signatures and the specificity helix, accelerates tRNA(Trp) aminoacylation with approximate to 10-fold specificity toward tryptophan, relative to structurally related tyrosine. We proposed that including the 76-residue connecting peptide 1 insertion (Fragment B) might enhance tryptophan affinity and hence amino acid specificity, because that subdomain constrains the orientation of the specificity helix. We test that hypothesis by characterizing two new constructs: the catalytic domain (fragments A-C) and the Urzyme supplemented with the anticodon-binding domain (fragments A, C, and D). The three constructs, together with the full-length enzyme (fragments A-D), comprise a factorial experiment from which we deduce individual and combined contributions of the two modules to the steady-state kinetics parameters for tryptophan-dependent (PPi)-P-32 exchange, specificity for tryptophan versus tyrosine, and aminoacylation of tRNA(Trp). Factorial design directly measures the energetic coupling between the two more recent modules in the contemporary enzyme and demonstrates its functionality. Combining the TrpRS Urzyme individually in cis with each module affords an analysis of long term evolution of amino acid specificity and tRNA aminoacylation, both essential for expanding the genetic code. Either module significantly enhances tryptophan activation but unexpectedly eliminates amino acid specificity for tryptophan, relative to tyrosine, and significantly reduces tRNA aminoacylation. Exclusive dependence of both enhanced functionalities of full-length TrpRS on interdomain coupling energies between the two new modules argues that independent recruitment of connecting peptide 1 and the anticodon-binding domain during evolutionary development of Urzymes would have entailed significant losses of fitness.	[Li, Li; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7270, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			National Institutes of Health [NIGMS 78227, NIGMS 40906]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227, R01GM090406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIGMS 78227 and NIGMS 40906.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER C W JR, 1990, Methods (Orlando), V1, P12, DOI 10.1016/S1046-2023(05)80142-2; Chopra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2421; Cleland W. W, 1970, ENZYMES, V2, P1; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Corigliano EM, 2009, BIOCHEMISTRY-US, V48, P676, DOI 10.1021/bi801552y; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Ilyin VA, 2000, PROTEIN SCI, V9, P218; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; Johnson JM, 2013, BIOCHEMISTRY-US, V52, P4399, DOI 10.1021/bi400079h; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; SAS, 2004, JMP STAT GRAPH GUID; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Weimer KME, 2009, J BIOL CHEM, V284, P10088, DOI 10.1074/jbc.M807361200; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200	35	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34736	34745		10.1074/jbc.M113.510958	http://dx.doi.org/10.1074/jbc.M113.510958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142809	hybrid, Green Published			2022-12-25	WOS:000329812800040
J	Huo, Q; Zhang, N; Wang, XL; Jiang, LY; Ma, TT; Yang, QF				Huo, Qiang; Zhang, Ning; Wang, Xiaolong; Jiang, Liyu; Ma, Tingting; Yang, Qifeng			Effects of Ambient Particulate Matter on Human Breast Cancer: Is Xenogenesis Responsible?	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AIR-POLLUTION; NEOADJUVANT CHEMOTHERAPY; RECEPTOR STATUS; LIFE-STYLE; RISK; EXPOSURE; METABOLISM; MORTALITY; DIET	Background: Recently, evidence from several studies has revealed that air pollution is associated with the increased morbidity and mortality of breast cancer patients. However, to date, the underlying mechanism remains largely unclear. Considering the high prevalence of air pollution and breast cancer in China, it is necessary to understand how air pollution may affect breast cancer. Methods: We analyzed 1,832 female patients who had resided in the same cities for at least 10 years prior to their diagnosis. Variables including demographic data as well as clinical and tumor characteristics, including the patient's age at menarche, family history of breast cancer, tumor histopathological type, tumor size, lymph node metastasis, distant metastasis, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status and human epidermal growth factor receptor 2 (HER-2) status at the time of diagnosis were analyzed. Results: Compared to patients residing in low-pollution areas, patients living in high-pollution areas demonstrated a younger age at menarche (p < 0.001), a greater family history of breast cancer (p = 0.034) and more invasive cancers (p = 0.028) with higher tumor grades (p = 0.028) and estrogen receptor (ER)-positive status (p = 0.022). Differences in tumor grade were only found in ER-positive cases. Conclusions: Our findings and clinical data indicate that long-term air pollution exposure may contribute to the development of breast cancer by playing the role of a xenoestrogen, and also provides new insight into the association between air pollution and the morbidity and mortality of breast cancer patients. Furthermore, it is urgently necessary to study the association between air pollution and breast cancer to improve the living quality and health of females, and applicable public health strategies may need to be established or modified as soon as possible.	[Huo, Qiang; Zhang, Ning; Wang, Xiaolong; Jiang, Liyu; Ma, Tingting; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China; [Huo, Qiang] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China.	qifengy@gmail.com	Zhang, Ning/GNP-1966-2022; yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [30772133, 81072150, 81172529, 81272903]; Shandong Science and Technology Development Plan [2012GZC22115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan	This work was supported by the National Natural Science Foundation of China (No. 30772133; No. 81072150; No. 81172529; No. 81272903) and the Shandong Science and Technology Development Plan (No. 2012GZC22115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Bonner MR, 2005, CANCER EPIDEM BIOMAR, V14, P53; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2627, DOI 10.1002/cncr.22656; Chameides William L., 2010, Reviews on Environmental Health, V25, P17; Chen ST, 2013, J ENVIRON SCI HEAL A, V48, P173, DOI 10.1080/10934529.2012.717809; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; Crouse DL, 2010, ENVIRON HEALTH PERSP, V118, P1578, DOI 10.1289/ehp.1002221; Hu H, 2013, BREAST CANCER RES TR, V139, P217, DOI 10.1007/s10549-013-2527-9; Ibarluzea JM, 2004, CANCER CAUSE CONTROL, V15, P591, DOI 10.1023/B:CACO.0000036167.51236.86; Li DH, 1996, CANCER RES, V56, P287; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; MANE SS, 1990, ENVIRON MOL MUTAGEN, V15, P78, DOI 10.1002/em.2850150204; MOORE CJ, 1986, CANCER RES, V46, P4946; Nie J, 2007, CANCER CAUSE CONTROL, V18, P947, DOI 10.1007/s10552-007-9036-2; Parl FF, 2009, CANCER INFORM, V7, P109; Pieta B, 2009, EUR J GYNAECOL ONCOL, V30, P186; Rana A, 2010, FUTURE ONCOL, V6, P1369, DOI 10.2217/fon.10.112; Redden MH, 2013, SURG CLIN N AM, V93, P493, DOI 10.1016/j.suc.2013.01.006; Sagiv SK, 2009, ENVIRON RES, V109, P287, DOI 10.1016/j.envres.2008.11.005; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Sprague BL, 2010, BREAST CANCER RES TR, V124, P487, DOI 10.1007/s10549-010-0869-0; Stoll BA, 1998, BREAST CANCER RES TR, V49, P187, DOI 10.1023/A:1006003110909; Yanagi Y, 2012, CAD SAUDE PUBLICA, V28, P1737, DOI 10.1590/S0102-311X2012000900012; Zhang N, 2011, CANCER INVEST, V29, P594, DOI 10.3109/07357907.2011.621913	24	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76609	10.1371/journal.pone.0076609	http://dx.doi.org/10.1371/journal.pone.0076609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146897	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400076
J	Kimball, BA; Yamazaki, K; Kohler, D; Bowen, RA; Muth, JP; Opiekun, M; Beauchamp, GK				Kimball, Bruce A.; Yamazaki, Kunio; Kohler, Dennis; Bowen, Richard A.; Muth, Jack P.; Opiekun, Maryanne; Beauchamp, Gary K.			Avian Influenza Infection Alters Fecal Odor in Mallards	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; PARASITIZED MALES; VIRUS-INFECTION; RECOGNITION; AVOIDANCE; SCENT; ODORTYPES; RESPONSES	Changes in body odor are known to be a consequence of many diseases. Much of the published work on disease-related and body odor changes has involved parasites and certain cancers. Much less studied have been viral diseases, possibly due to an absence of good animal model systems. Here we studied possible alteration of fecal odors in animals infected with avian influenza viruses (AIV). In a behavioral study, inbred C57BL/6 mice were trained in a standard Y-maze to discriminate odors emanating from feces collected from mallard ducks (Anas platyrhynchos) infected with low-pathogenic avian influenza virus compared to fecal odors from non-infected controls. Mice could discriminate odors from non-infected compared to infected individual ducks on the basis of fecal odors when feces from post-infection periods were paired with feces from pre-infection periods. Prompted by this indication of odor change, fecal samples were subjected to dynamic headspace and solvent extraction analyses employing gas chromatography/mass spectrometry to identify chemical markers indicative of AIV infection. Chemical analyses indicated that AIV infection was associated with a marked increase of acetoin (3-hydroxy-2-butanone) in feces. These experiments demonstrate that information regarding viral infection exists via volatile metabolites present in feces. Further, they suggest that odor changes following virus infection could play a role in regulating behavior of conspecifics exposed to infected individuals.	[Kimball, Bruce A.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Philadelphia, PA USA; [Yamazaki, Kunio; Opiekun, Maryanne; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Kohler, Dennis] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Muth, Jack P.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Monell Chemical Senses Center; United States Department of Agriculture (USDA); Colorado State University; Colorado State University	Kimball, BA (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Philadelphia, PA USA.	bruce.a.kimball@aphis.usda.gov			United States Department of Agriculture- Animal and Plant Health Inspection Service (USDA-APHIS)-National Wildlife Disease Program	United States Department of Agriculture- Animal and Plant Health Inspection Service (USDA-APHIS)-National Wildlife Disease Program	Funding was provided to Monell by the United States Department of Agriculture- Animal and Plant Health Inspection Service (USDA-APHIS)-National Wildlife Disease Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albone ES, 1984, MAMALIAN SEMIOCHEMIS; Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; BEAUCHAMP GK, 1994, IMMUNOGENETICS, V39, P109, DOI 10.1007/BF00188613; BEAUCHAMP GK, 1995, P NATL ACAD SCI USA, V92, P2617, DOI 10.1073/pnas.92.7.2617; Carriere KC, 2001, COMMUN STAT-SIMUL C, V30, P327, DOI 10.1081/SAC-100002370; DISTELHEIM I H, 1973, International Journal of Dermatology, V12, P241, DOI 10.1111/j.1365-4362.1973.tb00043.x; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Kavaliers M, 2005, ANIM BEHAV, V70, P693, DOI 10.1016/j.anbehav.2004.12.016; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; KAVALIERS M, 1995, ANIM BEHAV, V50, P1161, DOI 10.1016/0003-3472(95)80032-8; Kavaliers M, 2003, ANIM BEHAV, V65, P59, DOI 10.1006/anbe.2002.2043; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; LIDDELL K, 1976, POSTGRAD MED J, V52, P136, DOI 10.1136/pgmj.52.605.136; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; Moser E, 2010, J VET BEHAV, V5, P145, DOI 10.1016/j.jveb.2010.01.002; Murphy J, 2005, J APPL MICROBIOL, V99, P301, DOI 10.1111/j.1365-2672.2005.02590.x; Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308; Penn D, 1998, ETHOLOGY, V104, P685, DOI 10.1111/j.1439-0310.1998.tb00102.x; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Rajchard J, 2008, VET MED-CZECH, V53, P412, DOI 10.17221/1926-VETMED; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; SPIZIZEN J, 1957, BIOCHIM BIOPHYS ACTA, V23, P333, DOI 10.1016/0006-3002(57)90336-0; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Xiao ZJ, 2010, AFR J MICROBIOL RES, V4, P1997; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099	31	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75411	10.1371/journal.pone.0075411	http://dx.doi.org/10.1371/journal.pone.0075411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146753	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400006
J	Koblin, BA; Egan, JE; Rundle, A; Quinn, J; Tieu, HV; Cerda, M; Ompad, DC; Greene, E; Hoover, DR; Frye, V				Koblin, Beryl A.; Egan, James E.; Rundle, Andrew; Quinn, James; Hong-Van Tieu; Cerda, Magdalena; Ompad, Danielle C.; Greene, Emily; Hoover, Donald R.; Frye, Victoria			Methods to Measure the Impact of Home, Social, and Sexual Neighborhoods of Urban Gay, Bisexual, and Other Men Who Have Sex with Men	PLOS ONE			English	Article							DISPARITIES GEOCODING PROJECT; COLLECTIVE EFFICACY; UNITED-STATES; TRANSMITTED INFECTIONS; SOCIOECONOMIC MEASURES; BUILT ENVIRONMENT; HEALTH OUTCOMES; RISK BEHAVIOR; HIV; PREVENTION	Men who have sex with men (MSM) accounted for 61% of new HIV diagnoses in the United States in 2010. Recent analyses indicate that socio-structural factors are important correlates of HIV infection. NYCM2M was a cross-sectional study designed to identify neighborhood-level characteristics within the urban environment that influence sexual risk behaviors, substance use and depression among MSM living in New York City. The sample was recruited using a modified venue-based time-space sampling methodology and through select websites and mobile applications. This paper describes novel methodological approaches used to improve the quality of data collected for analysis of the impact of neighborhoods on MSM health. Previous research has focused predominately on residential neighborhoods and used pre-determined administrative boundaries (e. g., census tracts) that often do not reflect authentic and meaningful neighborhoods. This study included the definition and assessment of multiple neighborhoods of influence including where men live (home neighborhood), socialize (social neighborhood) and have sex (sexual neighborhood). Furthermore, making use of technological advances in mapping, we collected geo-points of reference for each type of neighborhood and identified and constructed self-identified neighborhood boundary definitions. Finally, this study collected both perceived neighborhood characteristics and objective neighborhood conditions to create a comprehensive, flexible and rich neighborhood-level set of covariates. This research revealed that men perceived their home, social and sexual neighborhoods in different ways. Few men (15%) had the same home, social and sexual neighborhoods; for 31%, none of the neighborhoods was the same. Of the three types of neighborhoods, the number of unique social neighborhoods was the lowest; the size of sexual neighborhoods was the smallest. The resultant dataset offers the opportunity to conduct analyses that will yield context-specific and nuanced understandings of the relations among neighborhood space, and the well-being and health of urban MSM.	[Koblin, Beryl A.; Hong-Van Tieu] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Egan, James E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Rundle, Andrew; Quinn, James; Cerda, Magdalena; Greene, Emily] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Hong-Van Tieu] Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Ompad, Danielle C.] NYU, CHIBPS, New York, NY USA; [Ompad, Danielle C.] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Nutr Food Studies & Publ Hlth, New York, NY USA; [Greene, Emily; Frye, Victoria] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Social & Behav Sci, New York, NY 10021 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Frye, Victoria] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA	New York Blood Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University; New York University; New York University; New York Blood Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University	Koblin, BA (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA.	bkoblin@nybloodcenter.org	Rundle, Andrew G/A-5282-2009; Ompad, Danielle/F-3163-2013	Rundle, Andrew G/0000-0003-0211-7707; Ompad, Danielle/0000-0003-0240-0393; Greene, Emily/0000-0001-6321-7088; Frye, Victoria/0000-0003-3239-7201; Egan, James Erin/0000-0003-3888-7148; Cerda, Magdalena/0000-0001-8441-7046	National Institute of Child Health and Human Development (NICHD) [R01 HD059729]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035, K01DA030449, T32DA031099] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by a grant from National Institute of Child Health and Human Development (NICHD) R01 HD059729 http://www.nichd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2009, DRUG ALCOHOL DEPEN, V100, P138, DOI 10.1016/j.drugalcdep.2008.09.012; Bolton SL, 2011, CAN J PSYCHIAT, V56, P35, DOI 10.1177/070674371105600107; Browning CR, 2004, DEMOGRAPHY, V41, P697, DOI 10.1353/dem.2004.0029; Browning CR, 2003, J MARRIAGE FAM, V65, P730, DOI 10.1111/j.1741-3737.2003.00730.x; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Buttram ME, 2013, AM J MENS HEALTH, V7, P110, DOI 10.1177/1557988312458793; Cameron JE, 2004, SELF IDENTITY, V3, P239, DOI 10.1080/13576500444000047; Carpiano RM, 2011, J HEALTH SOC BEHAV, V52, P74, DOI 10.1177/0022146510395026; Centers for Disease Control and Prevention (CDC), 2012, HIV SURV REP, V22; Choi KH, 2002, AIDS EDUC PREV, V14, P472, DOI 10.1521/aeap.14.8.472.24114; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Cohen D, 2000, AM J PUBLIC HEALTH, V90, P230, DOI 10.2105/AJPH.90.2.230; Drabble L, 2005, J STUD ALCOHOL, V66, P111, DOI 10.15288/jsa.2005.66.111; Egan JE, 2011, AIDS BEHAV, V15, pS35, DOI 10.1007/s10461-011-9902-5; Egan JE, 2011, 139 ANN M AM PUBL HL; Frye V, 2006, J URBAN HEALTH, V83, P308, DOI 10.1007/s11524-006-9033-x; Frye V, 2011, 139 ANN M AM PUBL HL; Frye V, 2008, AM J PUBLIC HEALTH, V98, P1473, DOI 10.2105/AJPH.2007.112813; Frye V, 2010, AIDS BEHAV, V14, P974, DOI 10.1007/s10461-008-9438-5; Galea S, 2005, SOC SCI MED, V60, P1017, DOI 10.1016/j.socscimed.2004.06.036; Gates G., 2011, US CENSUS SNAPSHOT 2; Google Inc, 2009, GOOGL EARTH VERS 5 1; Jones K. T., 2012, 19 INT AIDS C WASH D; KELLY JA, 1992, J CONSULT CLIN PSYCH, V60, P576, DOI 10.1037/0022-006X.60.4.576; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kelly JA, 2004, AIDS CARE, V16, P139, DOI 10.1080/09540120410001640986; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2003, PUBLIC HEALTH REP, V118, P240, DOI 10.1093/phr/118.3.240; Krieger Nancy, 2003, American Journal of Public Health, V93, P1655, DOI 10.2105/AJPH.93.10.1655; LALLI M, 1992, J ENVIRON PSYCHOL, V12, P285, DOI 10.1016/S0272-4944(05)80078-7; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mills TC, 2004, AM J PSYCHIAT, V161, P278, DOI 10.1176/appi.ajp.161.2.278; Mills TC, 2001, AM J PUBLIC HEALTH, V91, P980, DOI 10.2105/AJPH.91.6.980; New York City Department of Planning, 2010, BYT BIG APPL; New York City Mayor's Office of Operations, 2013, MAYORS MAN REP; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Perkins D, 1990, AM J COMMUN PSYCHOL, V19, P83; Purciel M, 2009, J ENVIRON PSYCHOL, V29, P457, DOI 10.1016/j.jenvp.2009.03.004; Root ED, 2012, ANN ASSOC AM GEOGR, V102, P986, DOI 10.1080/00045608.2012.659621; Ross CE, 1999, URBAN AFF REV, V34, P412, DOI 10.1177/107808749903400304; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ, 1997, NEIGHBORHOOD POVERTY, V2, P1; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P473; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P3, DOI DOI 10.1016/S0065-2601(05)37005-5; Tarrant M, 2001, J ADOLESCENCE, V24, P597, DOI 10.1006/jado.2000.0392; U. S. Census Bureau, 2011, NEW YORK CIT HOUS VA; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; WRIGHT D, 2002, DHHS PUBLICATION; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022	60	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75878	10.1371/journal.pone.0075878	http://dx.doi.org/10.1371/journal.pone.0075878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146785	Green Published, gold			2022-12-25	WOS:000326019400021
J	Ku, KM; Choi, JH; Kim, HS; Kushad, MM; Jeffery, EH; Juvik, JA				Ku, Kang Mo; Choi, Jeong Hee; Kim, Hyoung Seok; Kushad, Mosbah M.; Jeffery, Elizabeth H.; Juvik, John A.			Methyl Jasmonate and 1-Methylcyclopropene Treatment Effects on Quinone Reductase Inducing Activity and Post-Harvest Quality of Broccoli	PLOS ONE			English	Article							CHLOROPHYLL DEGRADING GENES; CELL-CYCLE ARREST; COLON-CANCER; GLUCOSINOLATE PROFILES; MYROSINASE ACTIVITY; MOLECULAR-CLONING; ETHYLENE-RESPONSE; ARABIDOPSIS; EXPRESSION; ISOTHIOCYANATES	Effect of pre-harvest methyl jasmonate (MeJA) and post-harvest 1-methylcyclopropene (1-MCP) treatments on broccoli floret glucosinolate (GS) concentrations and quinone reductase (QR, an in vitro anti-cancer biomarker) inducing activity were evaluated two days prior to harvest, at harvest and at 10, 20, and 30 days of post-harvest storage at 4 C. MeJA treatments four days prior to harvest of broccoli heads was observed to significantly increase floret ethylene biosynthesis resulting in chlorophyll catabolism during post-harvest storage and reduced product quality. Post-harvest treatment with 1-methylcyclopropene (1-MCP), which competitively binds to protein ethylene receptors, maintained post-harvest floret chlorophyll concentrations and product visual quality in both control and MeJA-treated broccoli. Transcript abundance of BoPPH, a gene which is responsible for the synthesis of pheophytinase, the primary enzyme associated with chlorophyll catabolism in broccoli, was reduced by 1-MCP treatment and showed a significant, negative correlation with floret chlorophyll concentrations. The GS, glucobrassicin, neoglucobrassicin, and gluconasturtiin were significantly increased by MeJA treatments. The products of some of the GS from endogenous myrosinase hydrolysis [sulforaphane (SF), neoascorbigen (NeoASG), N-methoxyindole-3-carbinol (NI3C), and phenethyl isothiocyanate (PEITC)] were also quantified and found to be significantly correlated with QR. Sulforaphane, the isothiocyanate hydrolysis product of the GS glucoraphanin, was found to be the most potent QR induction agent. Increased sulforaphane formation from the hydrolysis of glucoraphanin was associated with up-regulated gene expression of myrosinase (BoMyo) and the myrosinase enzyme co-factor gene, epithiospecifier modifier1 (BoESM1). This study demonstrates the combined treatment of MeJA and 1-MCP increased QR activity without post-harvest quality loss.	[Ku, Kang Mo; Choi, Jeong Hee; Kim, Hyoung Seok; Kushad, Mosbah M.; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Jeffery, Elizabeth H.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Choi, Jeong Hee] Korea Food Res Inst, Distribut Syst Res Grp, Gyeonggi Do, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Korea Food Research Institute (KFRI)	Juvik, JA (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	juvik@illinois.edu		Jeffery, Elizabeth/0000-0002-8827-9469; Ku, Kang Mo/0000-0002-8588-1163	Department of Crop Sciences at the University of Illinois at Urbana-Champaign	Department of Crop Sciences at the University of Illinois at Urbana-Champaign	The first author was supported financially by the Boerner Fellowship in the Department of Crop Sciences at the University of Illinois at Urbana-Champaign. AgroFresh, a division of Rohm & Hass Inc., provided 1-MCP and equipment for its application. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bak S, 1998, PLANT MOL BIOL, V38, P725, DOI 10.1023/A:1006064202774; Baskar V, 2012, APPL BIOCHEM BIOTECH, V168, P1694, DOI 10.1007/s12010-012-9890-6; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bergmeyer HU, 1974, ETHODS ENZYMATIC ANA; BODNARYK RP, 1994, PHYTOCHEMISTRY, V35, P301, DOI 10.1016/S0031-9422(00)94752-6; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Brown AF, 2002, J AM SOC HORTIC SCI, V127, P807, DOI 10.21273/JASHS.127.5.807; Buchert AM, 2011, J PLANT PHYSIOL, V168, P337, DOI 10.1016/j.jplph.2010.07.011; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cuendet M, 2006, J NAT PROD, V69, P460, DOI 10.1021/np050362q; Dixon G. R., 2007, VEGETABLE BRASSICAS; DROBNICA L, 1967, APPL MICROBIOL, V15, P701; Gomez-Lobato ME, 2012, SCI HORTIC-AMSTERDAM, V144, P208, DOI 10.1016/j.scienta.2012.07.017; Gaofeng Yuan, 2010, Food Chemistry, V118, P774; Gomez-Lobato ME, 2012, J SCI FOOD AGR, V92, P151, DOI 10.1002/jsfa.4555; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Hasperue JH, 2013, POSTHARVEST BIOL TEC, V82, P22, DOI 10.1016/j.postharvbio.2013.02.021; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hwang ES, 2003, FOOD CHEM TOXICOL, V41, P1817, DOI 10.1016/S0278-6915(03)00235-7; Jump SM, 2008, BIOCHEM PHARMACOL, V75, P713, DOI 10.1016/j.bcp.2007.09.024; Jun BK, 2011, GENES GENOM, V33, P299, DOI 10.1007/s13258-011-0031-3; Jung S, 2004, PLANT PHYSIOL BIOCH, V42, P225, DOI 10.1016/j.plaphy.2004.01.001; Kai K, 2011, PLANT BIOTECHNOL-NAR, V28, P379, DOI 10.5511/plantbiotechnology.11.0704b; Kim DJ, 2003, MUTAT RES-FUND MOL M, V523, P99, DOI 10.1016/S0027-5107(02)00325-1; Kim H. S., 2011, THESIS U ILLINOIS UR; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kronbak R, 2010, J AGR FOOD CHEM, V58, P8453, DOI 10.1021/jf101806t; Ku KM, 2012, HORTSCIENCE, V47, pS311; Ku KM, 2013, PLANT FOOD HUM NUTR, V68, P113, DOI 10.1007/s11130-013-0356-y; Ku VVV, 1999, POSTHARVEST BIOL TEC, V17, P127, DOI 10.1016/S0925-5214(99)00042-3; Li X, 2004, J AGR FOOD CHEM, V52, P6950, DOI 10.1021/jf0401827; Ma G, 2010, POSTHARVEST BIOL TEC, V58, P121, DOI 10.1016/j.postharvbio.2010.05.011; Ma G, 2009, PLANT GROWTH REGUL, V57, P223, DOI 10.1007/s10725-008-9339-7; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Neave AS, 2005, TOXICOL SCI, V83, P126, DOI 10.1093/toxsci/kfi008; Paliyath G., 2008, POSTHARVEST BIOL TEC, P195; Pang QY, 2009, PHYSIOL PLANTARUM, V136, P1, DOI 10.1111/j.1399-3054.2009.01211.x; Penas E, 2011, J AGR FOOD CHEM, V59, P3772, DOI 10.1021/jf200356m; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Rodrigues AS, 1999, J SCI FOOD AGR, V79, P1028, DOI [10.1002/(SICI)1097-0010(19990515)79:7<1028::AID-JSFA322>3.0.CO;2-I, 10.1002/(SICI)1097-0010(19990515)79:7&lt;1028::AID-JSFA322&gt;3.0.CO;2-I]; Sellam A, 2006, FEMS MICROBIOL LETT, V258, P241, DOI 10.1111/j.1574-6968.2006.00223.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; van Poppel G, 1999, ADV EXP MED BIOL, V472, P159; Wallig MA, 1998, FOOD CHEM TOXICOL, V36, P365, DOI 10.1016/S0278-6915(97)00156-7; Watanabe K, 2000, J JPN SOC HORTIC SCI, V69, P605, DOI 10.2503/jjshs.69.605; Wilson EA, 2011, CHROMATOGRAPHIA, V73, pS137, DOI 10.1007/s10337-010-1878-1; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	56	48	48	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77127	10.1371/journal.pone.0077127	http://dx.doi.org/10.1371/journal.pone.0077127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146962	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400095
J	Szopek, M; Schmickl, T; Thenius, R; Radspieler, G; Crailsheim, K				Szopek, Martina; Schmickl, Thomas; Thenius, Ronald; Radspieler, Gerald; Crailsheim, Karl			Dynamics of Collective Decision Making of Honeybees in Complex Temperature Fields	PLOS ONE			English	Article							DECENTRALIZED CONTROL; PUPAL DEVELOPMENT; HEAT-PRODUCTION; BEE; THERMOREGULATION; COLONIES; CLUSTERS; INSECTS; BEHAVIOR; AGE	Endothermic heat production is a crucial evolutionary adaptation that is, amongst others, responsible for the great success of honeybees. Endothermy ensures the survival of the colonies in harsh environments and is involved in the maintenance of the brood nest temperature, which is fundamental for the breeding and further development of healthy individuals and thus the foraging and reproduction success of this species. Freshly emerged honeybees are not yet able to produce heat endothermically and thus developed behavioural patterns that result in the location of these young bees within the warm brood nest where they further develop and perform tasks for the colony. Previous studies showed that groups of young ectothermic honeybees exposed to a temperature gradient collectively aggregate at the optimal place with their preferred temperature of 36 degrees C but most single bees do not locate themselves at the optimum. In this work we further investigate the behavioural patterns that lead to this collective thermotaxis. We tested single and groups of young bees concerning their ability to discriminate a local from a global temperature optimum and, for groups of bees, analysed the speed of the decision making process as well as density dependent effects by varying group sizes. We found that the majority of tested single bees do not locate themselves at the optimum whereas sufficiently large groups of bees are able to collectively discriminate a suboptimal temperature spot and aggregate at 36 degrees C. Larger groups decide faster than smaller ones, but in larger groups a higher percentage of bees may switch to the sub-optimum due to crowding effects. We show that the collective thermotaxis is a simple but well evolved, scalable and robust social behaviour that enables the collective of bees to perform complex tasks despite the limited abilities of each individual.	[Szopek, Martina; Schmickl, Thomas; Thenius, Ronald; Radspieler, Gerald; Crailsheim, Karl] Karl Franzens Univ Graz, Artificial Life Lab, Dept Zool, Graz, Austria	University of Graz	Szopek, M (corresponding author), Karl Franzens Univ Graz, Artificial Life Lab, Dept Zool, Graz, Austria.	martina.szopek@uni-graz.at		Schmickl, Thomas/0000-0001-8598-7462	Austrian Science Fund [P19478-B16, P23943-N13]; European Union [270382, 601074]; Austrian Science Fund (FWF) [P 23943] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund research grants P19478-B16 and P23943-N13 (http://www.fwf.ac.at/en/index.asp) and European Union-Information and Communication Technologies projects 'CoCoRo', no. 270382 and 'ASSISI_bf', no. 601074 (http://cordis.europa.eu/fp7/ict/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, LECT NOTES COMPUT SC, V4095, P713; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; Bodi M, 2011, ADV ARTIFICIAL LIFE, P367; Bodi M, 2012, MATH COMP MODEL DYN, V18, P87, DOI 10.1080/13873954.2011.601420; Bonabeau E, 2001, HARVARD BUS REV, V79, P106; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Deal J, 1941, J ANIM ECOL, V10, P323, DOI 10.2307/1316; Deneubourg J, 2007, PEDESTRIAN EVACUATIO, V2005, P455; Dixon AFG, 2009, FUNCT ECOL, V23, P257, DOI 10.1111/j.1365-2435.2008.01489.x; FAHRENHOLZ L, 1989, J COMP PHYSIOL B, V159, P551, DOI 10.1007/BF00694379; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Free JB, 1955, BEHAVIOUR, V7, P304; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Hallman G. J., 1998, TEMPERATURE SENSITIV; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HARRISON JM, 1987, J EXP BIOL, V129, P53; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Heran H, 1952, J COMP PHYSIOL A, V34, P179; Himmer A., 1927, J COMP PHYSIOL A, V5, P375; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Karsai I, 1999, ARTIF LIFE, V5, P117, DOI 10.1162/106454699568719; Kernbach S, 2009, ADAPT BEHAV, V17, P237, DOI 10.1177/1059712309104966; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Kovac H, 2009, APIDOLOGIE, V40, P82, DOI 10.1051/apido/2008069; Langton C. G., 1994, ARTIF LIFE, P417; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Lecomte J, 1950, J COMP PHYSIOL A, V32, P499; Menzel R, 1977, VERH DTSCH ZOOL GES, P26; Moussaid M, 2009, TOP COGN SCI, V1, P469, DOI 10.1111/j.1756-8765.2009.01028.x; MYERSCOUGH MR, 1993, J THEOR BIOL, V162, P381, DOI 10.1006/jtbi.1993.1094; NIESCHULZ OTTO, 1933, ZOOL AM, V103, P21; OHTANI T, 1992, HUM NATURE, V1, P11; Pratt SC, 1998, BEHAV ECOL SOCIOBIOL, V42, P193, DOI 10.1007/s002650050431; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V54, P511, DOI 10.1007/s00265-003-0664-6; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SOUTHWICK EE, 1985, J COMP PHYSIOL B, V156, P143, DOI 10.1007/BF00692937; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Sumpter DJT, 2000, J THEOR BIOL, V204, P1, DOI 10.1006/jtbi.1999.1063; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; von Frisch Karl, 1965, TANZSPRACHE ORIENTIE; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; WATMOUGH J, 1995, J THEOR BIOL, V176, P391, DOI 10.1006/jtbi.1995.0207; WILSON EO, 1988, TRENDS ECOL EVOL, V3, P65, DOI 10.1016/0169-5347(88)90018-3	50	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76250	10.1371/journal.pone.0076250	http://dx.doi.org/10.1371/journal.pone.0076250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146843	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400045
J	Chen, MY; Zhang, XM; Liu, JN; Storey, KB				Chen, Muyan; Zhang, Xiumei; Liu, Jianning; Storey, Kenneth B.			High-Throughput Sequencing Reveals Differential Expression of miRNAs in Intestine from Sea Cucumber during Aestivation	PLOS ONE			English	Article							APOSTICHOPUS-JAPONICUS SELENKA; MICRORNA REGULATION; WATER TEMPERATURE; EMERGING ROLES; BIOGENESIS; RESPONSES; CLUSTER; GROWTH; GENE	The regulatory role of miRNA in gene expression is an emerging hot new topic in the control of hypometabolism. Sea cucumber aestivation is a complicated physiological process that includes obvious hypometabolism as evidenced by a decrease in the rates of oxygen consumption and ammonia nitrogen excretion, as well as a serious degeneration of the intestine into a very tiny filament. To determine whether miRNAs play regulatory roles in this process, the present study analyzed profiles of miRNA expression in the intestine of the sea cucumber (Apostichopus japonicus), using Solexa deep sequencing technology. We identified 308 sea cucumber miRNAs, including 18 novel miRNAs specific to sea cucumber. Animals sampled during deep aestivation (DA) after at least 15 days of continuous torpor, were compared with animals from a non-aestivation (NA) state (animals that had passed through aestivation and returned to the active state). We identified 42 differentially expressed miRNAs [RPM (reads per million)> 10, |FC| (|fold change|) >= 1, FDR (false discoveryrate) <0.01] during aestivation, which were validated by two other miRNA profiling methods: miRNA microarray and real-time PCR. Among the most prominent miRNA species, miR-200-3p, miR-2004, miR-2010, miR-22, miR-252a, miR-252a-3p and miR92 were significantly over-expressed during deep aestivation compared with non-aestivation animals. Preliminary analyses of their putative target genes and GO analysis suggest that these miRNAs could play important roles in global transcriptional depression and cell differentiation during aestivation. High-throughput sequencing data and microarray data have been submitted to GEO database.	[Chen, Muyan; Zhang, Xiumei] Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China; [Liu, Jianning] LC BIO CO LTD, Hangzhou, Zhejiang, Peoples R China; [Storey, Kenneth B.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	Ocean University of China; Carleton University	Chen, MY (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Peoples R China.	chenmuyan@gmail.com	Liu, Jian Ning/GZA-6919-2022	Liu, Jian Ning/0000-0002-8932-054X	National Natural Science Foundation [31201972]; Research Fund of young scholars for the Doctoral Program of Higher Education of China [20120132120009]; Research fund for talented scholars Ocean University of China [1400841212003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund of young scholars for the Doctoral Program of Higher Education of China; Research fund for talented scholars Ocean University of China	This work was supported by the National Natural Science Foundation (No. 31201972), Research Fund of young scholars for the Doctoral Program of Higher Education of China (No. 20120132120009) and Research fund for talented scholars Ocean University of China (No. 1400841212003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnous K, 2008, BBA-GEN SUBJECTS, V1780, P185, DOI 10.1016/j.bbagen.2007.10.009; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biggar Kyle K., 2012, Genomics Proteomics & Bioinformatics, V10, P302, DOI 10.1016/j.gpb.2012.09.002; Biggar KK, 2012, CELL CYCLE, V11, P1705, DOI 10.4161/cc.19790; Biggar KK, 2011, J MOL CELL BIOL, V3, P167, DOI 10.1093/jmcb/mjq045; Biggar KK, 2009, CRYOBIOLOGY, V59, P317, DOI 10.1016/j.cryobiol.2009.08.009; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Du HX, 2011, PLOS ONE, V7; Friedman LM, 2009, MAMM GENOME, V20, P581, DOI 10.1007/s00335-009-9230-5; Gao F, 2009, CHIN J OCEANOL LIMN, V27, P714, DOI 10.1007/s00343-009-9202-3; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Huang YC, 2013, DEVELOPMENT, V140, P897, DOI 10.1242/dev.080192; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li F., 1996, FISH CHINA, V3, P49, DOI DOI 10.1152/AJPCELL.1998.275.1.C1; Liu LH, 2010, TOXICOL IN VITRO, V24, P1168, DOI 10.1016/j.tiv.2010.02.016; Liu YT, 2010, PHYSIOL GENOMICS, V42A, P39, DOI 10.1152/physiolgenomics.00054.2010; Loomis SH, 2010, PROG MOL SUBCELL BIO, V49, P231, DOI 10.1007/978-3-642-02421-4_11; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morin PJ, 2008, BBA-GENE REGUL MECH, V1779, P628, DOI 10.1016/j.bbagrm.2008.07.011; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Storey KB, 2007, J EXP BIOL, V210, P1700, DOI 10.1242/jeb.02716; Storey KB, 2012, J EXP BIOL, V215, P1425, DOI 10.1242/jeb.054403; Tazawa H, 2011, EXPERT OPIN BIOL TH, V11, P145, DOI 10.1517/14712598.2011.542749; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Withers PC, 2010, MOL PHYSL ASPECTS; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiong J, 2012, CURR MOL MED, V12, P247, DOI 10.2174/156652412799218886; Yang HS, 2006, J EXP MAR BIOL ECOL, V330, P505, DOI 10.1016/j.jembe.2005.09.010; Yang HS, 2005, AQUAC RES, V36, P1085, DOI 10.1111/j.1365-2109.2005.01325.x	39	50	53	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76120	10.1371/journal.pone.0076120	http://dx.doi.org/10.1371/journal.pone.0076120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143179	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100014
J	Chen, YT; Chen, FYT; Vijmasi, T; Stephens, DN; Gallup, M; McNamara, NA				Chen, Ying Ting; Chen, Feeling Y. T.; Vijmasi, Trinka; Stephens, Denise N.; Gallup, Marianne; McNamara, Nancy A.			Pax6 Downregulation Mediates Abnormal Lineage Commitment of the Ocular Surface Epithelium in Aqueous-Deficient Dry Eye Disease	PLOS ONE			English	Article							SQUAMOUS METAPLASIA; SJOGRENS-SYNDROME; STEM-CELLS; CORNEAL EPITHELIUM; EXPRESSION; PROTEIN; TRANSDIFFERENTIATION; DIFFERENTIATION; MOUSE; GENE	Keratinizing squamous metaplasia (SQM) of the ocular surface is a blinding consequence of systemic autoimmune disease and there is no cure. Ocular SQM is traditionally viewed as an adaptive tissue response during chronic keratoconjunctivitis sicca (KCS) that provokes pathological keratinization of the corneal epithelium and fibrosis of the corneal stroma. Recently, we established the autoimmune regulator-knockout (Aire KO) mouse as a model of autoimmune KCS and identified an essential role for autoreactive CD4+ T cells in SQM pathogenesis. In subsequent studies, we noted the down-regulation of paired box gene 6 (Pax6) in both human patients with chronic KCS associated with Sjgren's syndrome and Aire KO mice. Pax6 encodes a pleiotropic transcription factor guiding eye morphogenesis during development. While the postnatal function of Pax6 is largely unknown, we hypothesized that its role in maintaining ocular surface homeostasis was disrupted in the inflamed eye and that loss of Pax6 played a functional role in the initiation and progression of SQM. Adoptive transfer of autoreactive T cells from Aire KO mice to immunodeficient recipients confirmed CD4+ T cells as the principal downstream effectors promoting Pax6 downregulation in Aire KO mice. CD4+ T cells required local signaling via Interleukin-1 receptor (IL-1R1) to provoke Pax6 loss, which prompted a switch from corneal-specific cytokeratin, CK12, to epidermal-specific CK10. The functional role of Pax6 loss in SQM pathogenesis was indicated by the reversal of SQM and restoration of ocular surface homeostasis following forced expression of Pax6 in corneal epithelial cells using adenovirus. Thus, tissue-restricted restoration of Pax6 prevented aberrant epidermal-lineage commitment suggesting adjuvant Pax6 gene therapy may represent a novel therapeutic approach to prevent SQM in patients with chronic inflammatory diseases of the ocular surface.	[Chen, Ying Ting; Chen, Feeling Y. T.; Vijmasi, Trinka; Stephens, Denise N.; Gallup, Marianne; McNamara, Nancy A.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [McNamara, Nancy A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [McNamara, Nancy A.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [McNamara, Nancy A.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [McNamara, Nancy A.] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McNamara, NA (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.	nancy.mcnamara@ucsf.edu		Chen, Ying-Ting/0000-0002-8606-2418	NEI [EY016203, EY02162]; NATIONAL EYE INSTITUTE [P30EY002162, R01EY016203] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NEI EY016203 (NAM) and EY02162 (UCSF Ophthalmology Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bian F, 2010, STEM CELLS, V28, P2172, DOI 10.1002/stem.539; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Chen YT, 2009, MOL VIS, V15, P563; Chen YT, 2012, LAB INVEST J TECH ME; Chin-Chance CVT, 2006, J INVEST MED, V54, P132, DOI 10.2310/6650.2006.05035; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; COOPER KD, 1985, J INVEST DERMATOL, V85, P546, DOI 10.1111/1523-1747.ep12277391; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; DeVoss JJ, 2010, J IMMUNOL, V184, P4236, DOI 10.4049/jimmunol.0902434; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li W, 2008, INVEST OPHTH VIS SCI, V49, P154, DOI 10.1167/iovs.07-0883; MOLL R, 1983, DIFFERENTIATION, V23, P256; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; TSENG SCG, 1985, OPHTHALMOLOGY, V92, P728; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Zhou DL, 2012, AM J PATHOL, V181, P753, DOI 10.1016/j.ajpath.2012.05.014	34	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77286	10.1371/journal.pone.0077286	http://dx.doi.org/10.1371/journal.pone.0077286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143217	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100054
J	Garg, M; Potter, JA; Abrahams, VM				Garg, Manish; Potter, Julie A.; Abrahams, Vikki M.			Identification of microRNAs That Regulate TLR2-Mediated Trophoblast Apoptosis and Inhibition of IL-6 mRNA	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED REGULATION; HTR-8/SVNEO CELLS; HUMAN PLACENTAS; EXPRESSION; ACTIVATION; RECEPTOR; LET-7; PREGNANCY; TOLL-LIKE-RECEPTOR-2	While infection-induced placental inflammation is a common mechanism of adverse pregnancy outcome, some pathogens can also trigger placental apoptosis, and Toll-like receptors (TLRs) mediate this response. Treatment of human first trimester trophoblast cells with bacterial peptidoglycan (PDG) reduces their constitutive secretion of IL-6 protein and induces apoptosis. This apoptotic response is dependent upon the cell's expression of TLR1, TLR2 and TLR10, and their lack of TLR6, such that ectopic expression of TLR6 prevents PDG-induced apoptosis and restores IL-6 production. In this current study we have identified three microRNAs (miRs) that regulate TLR2-mediated responses in the human trophoblast. Herein we report that miR-329 plays a pivotal role in mediating PDG-induced trophoblast apoptosis and inhibition of IL-6 mRNA expression by targeting the NF-kappa B subunit, p65. TLR2 activation by PDG upregulates miR-329 expression and inhibits NF-kappa B p65 and IL-6 mRNA, and this is reversed by the presence of TLR6. Moreover, inhibition of miR-329 prevents PDG-induced inhibition of NF-kappa B p65 and IL-6 mRNA expression, and restores cell survival. In addition, we have found miR-23a and let-7c to directly regulate PDG-mediated inhibition of IL-6 mRNA. TLR2 activation by PDG upregulates miR23a and let-7c expression and this is reversed by the presence of TLR6. Furthermore, inhibition of both miR23a and let-7c prevents PDG-inhibition of trophoblast IL-6 mRNA expression. Together, our findings suggest that multiple miRs are involved in the molecular regulation of TLR2-mediated responses in the trophoblast towards gram-positive bacterial components.	[Abrahams, Vikki M.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Div Maternal Fetal Med, New Haven, CT USA	Yale University; Yale University	Abrahams, VM (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, New Haven, CT 06520 USA.	vikki.abrahams@yale.edu			NICHD, NIH [HD049446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049446] Funding Source: NIH RePORTER	NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant HD049446 from the NICHD, NIH (to VMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, J IMMUNOL, V180, P6035, DOI 10.4049/jimmunol.180.9.6035; Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Aravalli RN, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-11; Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Balkundi DR, 2003, BIOL REPROD, V69, P718, DOI 10.1095/biolreprod.102.013102; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellas RE, 1997, AM J PATHOL, V151, P891; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Equils O, 2006, J IMMUNOL, V177, P1257, DOI 10.4049/jimmunol.177.2.1257; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Herschkowitz JI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002182; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Keane MM, 2000, BREAST CANCER RES TR, V64, P211, DOI 10.1023/A:1006458407515; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Ma Y, 2007, PLACENTA, V28, P1024, DOI 10.1016/j.placenta.2007.05.003; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Montenegro D, 2009, J PATHOL, V217, P113, DOI 10.1002/path.2463; Morales-Prieto DM, 2011, AM J REPROD IMMUNOL, V66, P57, DOI 10.1111/j.1600-0897.2011.01037.x; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Mulla MJ, 2013, AM J REPROD IMMUNOL, V69, P449, DOI 10.1111/aji.12065; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	56	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77249	10.1371/journal.pone.0077249	http://dx.doi.org/10.1371/journal.pone.0077249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143215	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100051
J	Gehre, F; Antonio, M; Faihun, F; Odoun, M; Uwizeye, C; de Rijk, P; de Jong, BC; Affolabi, D				Gehre, Florian; Antonio, Martin; Faihun, Frank; Odoun, Mathieu; Uwizeye, Cecile; de Rijk, Pim; de Jong, Bouke C.; Affolabi, Dissou			The First Phylogeographic Population Structure and Analysis of Transmission Dynamics of M. africanum West African 1-Combining Molecular Data from Benin, Nigeria and Sierra Leone	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; GENETIC DIVERSITY; MIRU-VNTRPLUS; STRAINS; IDENTIFICATION; EPIDEMIOLOGY; BACTERIA; CAMEROON; LINEAGE; BACILLI	Mycobacterium africanum is an important cause of tuberculosis (TB) in West Africa. So far, two lineages called M. africanum West African 1 (MAF1) and M. africanum West African 2 (MAF2) have been defined. Although several molecular studies on MAF2 have been conducted to date, little is known about MAF1. As MAF1 is mainly present in countries around the Gulf of Guinea we aimed to estimate its prevalence in Cotonou, the biggest city in Benin. Between 2005-06 we collected strains in Cotonou/Benin and genotyped them using spoligo- and 12-loci-MIRU-VNTR-typing. Analyzing 194 isolates, we found that 31% and 6% were MAF1 and MAF2, respectively. Therefore Benin is one of the countries with the highest prevalence (37%) of M. africanum in general and MAF1 in particular. Moreover, we combined our data from Benin with publicly available genotyping information from Nigeria and Sierra Leone, and determined the phylogeographic population structure and genotypic clustering of MAF1. Within the MAF1 lineage, we identified an unexpected great genetic variability with the presence of at least 10 sub-lineages. Interestingly, 8 out of 10 of the discovered sub-lineages not only clustered genetically but also geographically. Besides showing a remarkable local restriction to certain regions in Benin and Nigeria, the sub-lineages differed dramatically in their capacity to transmit within the human host population. While identifying Benin as one of the countries with the highest overall prevalence of M. africanum, this study also contains the first detailed description of the transmission dynamics and phylogenetic composition of the MAF1 lineage.	[Gehre, Florian; Antonio, Martin; de Jong, Bouke C.] MRC Unit, Fajara, Gambia; [Gehre, Florian; Uwizeye, Cecile; de Rijk, Pim; de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium; [de Jong, Bouke C.] NYU, New York, NY USA; [Faihun, Frank; Odoun, Mathieu; Affolabi, Dissou] Lab Reference Mycobacteries, Cotonou, Benin	University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); New York University	Gehre, F (corresponding author), MRC Unit, Fajara, Gambia.	fgehre@mrc.gm	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675	Belgian Directorate-Generale for Development Co-orporation (DGDC) as part of the "Strategic Network TB 3.14"; project "Study on M. africanum population structure in Benin and The Gambia"; European Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council [MC_U190071468, MC_UP_A900_1122] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI	Belgian Directorate-Generale for Development Co-orporation (DGDC) as part of the "Strategic Network TB 3.14"; project "Study on M. africanum population structure in Benin and The Gambia"; European Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by a grant from the Belgian Directorate-Generale for Development Co-orporation (DGDC) as part of the "Strategic Network TB 3.14" and the project "Study on M. africanum population structure in Benin and The Gambia" as well as by the European Developing Countries Clinical Trials Partnership (EDCTP) - funded "West African Node of Excellence for Tuberculosis and Malaria" (WANETAM-plus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2005, AIDS, V19, P1714, DOI 10.1097/01.aids.0000185991.54595.41; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; HUET M, 1971, Revue de Tuberculose et de Pneumologie, V35, P413; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lawson L, 2012, PLOS ONE, V7; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	23	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77000	10.1371/journal.pone.0077000	http://dx.doi.org/10.1371/journal.pone.0077000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143198	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100033
J	Low, SK; Takahashi, A; Ashikawa, K; Inazawa, J; Miki, Y; Kubo, M; Nakamura, Y; Katagiri, T				Low, Siew-Kee; Takahashi, Atsushi; Ashikawa, Kyota; Inazawa, Johji; Miki, Yoshio; Kubo, Michiaki; Nakamura, Yusuke; Katagiri, Toyomasa			Genome-Wide Association Study of Breast Cancer in the Japanese Population	PLOS ONE			English	Article							ORAL-CONTRACEPTIVE USE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; CONFER SUSCEPTIBILITY; MAMMOGRAPHIC DENSITY; RISK; GENE; ESTROGEN; WOMEN; MUTATIONS	Breast cancer is the most common malignancy among women in worldwide including Japan. Several studies have identified common genetic variants to be associated with the risk of breast cancer. Due to the complex linkage disequilibrium structure and various environmental exposures in different populations, it is essential to identify variants associated with breast cancer in each population, which subsequently facilitate the better understanding of mammary carcinogenesis. In this study, we conducted a genome-wide association study (GWAS) as well as whole-genome imputation with 2,642 cases and 2,099 unaffected female controls. We further examined 13 suggestive loci (P<1.0x10(-5)) using an independent sample set of 2,885 cases and 3,395 controls and successfully validated two previously-reported loci, rs2981578 (combined P-value of 1.31610 212, OR = 1.23; 95% CI = 1.16-.30) on chromosome 10q26 (FGFR2), rs3803662 (combined P-value of 2.79610 211, OR = 1.21; 95% CI = 1.15-. 28) and rs12922061 (combined P-value of 3.97610 210, OR = 1.23; 95% CI = 1.15-. 31) on chromosome 16q12 (TOX3-LOC643714). Weighted genetic risk score on the basis of three significantly associated variants and two previously reported breast cancer associated loci in East Asian population revealed that individuals who carry the most risk alleles in category 5 have 2.2 times higher risk of developing breast cancer in the Japanese population than those who carry the least risk alleles in reference category 1. Although we could not identify additional loci associated with breast cancer, our study utilized one of the largest sample sizes reported to date, and provided genetic status that represent the Japanese population. Further local and international collaborative study is essential to identify additional genetic variants that could lead to a better, accurate prediction for breast cancer.	[Low, Siew-Kee; Takahashi, Atsushi] Inst Phys & Chem Res RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Low, Siew-Kee; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Ashikawa, Kyota; Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Lab Genotyping Dev, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Miki, Yoshio] Japanese Fdn Canc Res, Inst Canc, Dept Genet Iagnosis, Tokyo 170, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med & Surg, Chicago, IL 60637 USA; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima, Japan	RIKEN; University of Tokyo; RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japanese Foundation for Cancer Research; University of Chicago; Tokushima University	Low, SK (corresponding author), Inst Phys & Chem Res RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.	amanda.sklow@src.riken.jp	Kubo, Michiaki/N-7947-2015	Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Sciences and Technology; Japanese Government	Ministry of Education, Culture, Sports, Sciences and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government	This work was conducted as a part of Biobank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bates CM, 2007, PEDIATR NEPHROL, V22, P343, DOI 10.1007/s00467-006-0239-7; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; COLES C, 1992, CANCER RES, V52, P5291; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elgazzar S, 2012, J HUM GENET, V57, P766, DOI 10.1038/jhg.2012.108; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iodice S, 2010, EUR J CANCER, V46, P2275, DOI 10.1016/j.ejca.2010.04.018; Islam T, 2012, EUR J CANC PREV; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Liang J, 2008, CARCINOGENESIS, V29, P2341, DOI 10.1093/carcin/bgn235; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; McTiernan A, 2003, ONCOLOGIST, V8, P326, DOI 10.1634/theoncologist.8-4-326; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Phipps AI, 2011, JNCI-J NATL CANCER I, V103, P470, DOI 10.1093/jnci/djr030; Raskin L, 2008, CANCER EPIDEM BIOMAR, V17, P1060, DOI 10.1158/1055-9965.EPI-08-0018; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhu XG, 2009, MOL ENDOCRINOL, V23, P1397, DOI 10.1210/me.2009-0071	45	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76463	10.1371/journal.pone.0076463	http://dx.doi.org/10.1371/journal.pone.0076463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143190	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100025
J	Gerka-Stuyt, J; Au, A; Peachey, NS; Alagramam, KN				Gerka-Stuyt, John; Au, Adrian; Peachey, Neal S.; Alagramam, Kumar N.			Transient Receptor Potential Melastatin 1: A Hair Cell Transduction Channel Candidate	PLOS ONE			English	Article							MOUSE INNER-EAR; BIPOLAR CELLS; MECHANOTRANSDUCTION; TRPM1; GENE; TRPA1; STEREOCILIA; EXPRESSION; CLARIN-1; DOMINANT	Sound and head movements are perceived through sensory hair cells in the inner ear. Mounting evidence indicates that this process is initiated by the opening of mechanically sensitive calcium-permeable channels, also referred to as the mechanoelectrical transducer (MET) channels, reported to be around the tips of all but the tallest stereocilia. However, the identity of MET channel remains elusive. Literature suggests that the MET channel is a non-selective cation channel with a high Ca2+ permeability and similar to 100 picosiemens conductance. These characteristics make members of the transient receptor potential (TRP) superfamily likely candidates for this role. One of these candidates is the transient receptor potential melastatin 1 protein (TRPM1), which is expressed in various cells types within the cochlea of the mouse including the hair cells. Recent studies demonstrate that mutations in the TRPM1 gene underlie the inherited retinal disease complete congenital stationary night blindness in humans and depolarizing bipolar cell dysfunction in the mouse retina, but auditory function was not assessed. Here we investigate the role of Trpm1 in hearing and as a possible hair cell MET channel using mice homozygous for the null allele of Trpm1 (Trpm1(-/-)) or a missense mutation in the pore domain of TRPM1 (Trpm1(tvrm27/tvrm27)). Hearing thresholds were evaluated in adult (4-5 months old) mice with auditory-evoked brain stem responses. Our data shows no statistically significant difference in hearing thresholds in Trpm1(-/-) or Trpm1(tvrm27/tvrm27) mutants compared to littermate controls. Further, none of the mutant mice showed any sign of balance disorder, such as head bobbing or circling. These data suggest that TRPM1 is not essential for development of hearing or balance and it is unlikely that TRPM1 is a component of the hair cell MET channel.	[Gerka-Stuyt, John; Au, Adrian; Alagramam, Kumar N.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Res Serv, Cleveland, OH USA; [Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Alagramam, KN (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	kna3@case.edu	Peachey, Neal/G-5533-2010; Au, Adrian/AAE-9654-2019	Peachey, Neal/0000-0002-4419-7226; Au, Adrian/0000-0001-8110-9988	Maniglia Endowed Chair, University Hospitals Case Medical Center; Department of Veterans Affairs(NP); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010816] Funding Source: NIH RePORTER	Maniglia Endowed Chair, University Hospitals Case Medical Center; Department of Veterans Affairs(NP); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by funds from the Maniglia Endowed Chair, University Hospitals Case Medical Center (to KA) and from the Department of Veterans Affairs(NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Devi S, 2013, PIGM CELL MELANOMA R, V26, P348, DOI 10.1111/pcmr.12083; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Selvakumar D, 2013, J BIOL CHEM, V288, P7215, DOI 10.1074/jbc.M112.443226; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1050, DOI 10.1080/00016480802570545; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384	32	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77213	10.1371/journal.pone.0077213	http://dx.doi.org/10.1371/journal.pone.0077213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146970	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400105
J	Gomes, H; Romeiro, NC; Braz, GRC; de Oliveira, EAG; Rodrigues, C; da Fonseca, RN; Githaka, N; Isezaki, M; Konnai, S; Ohashi, K; Vaz, ID; Logullo, C; Moraes, J				Gomes, Helga; Romeiro, Nelilma C.; Braz, Gloria R. C.; Gamosa de Oliveira, Eduardo Alves; Rodrigues, Camilla; da Fonseca, Rodrigo Nunes; Githaka, Naftaly; Isezaki, Masayoshi; Konnai, Satoru; Ohashi, Kazuhiko; Vaz, Itabajara da Silva, Jr.; Logullo, Carlos; Moraes, Jorge			Identification and Structural-Functional Analysis of Cyclin-Dependent Kinases of the Cattle Tick Rhipicephalus (Boophilus) microplus	PLOS ONE			English	Article							BOVINE OOCYTES; CRYSTAL-STRUCTURE; CDK INHIBITORS; ROSCOVITINE; APOPTOSIS; MATURATION; NUCLEAR; PRETREATMENT; REPLICATION; ACTIVATION	Cyclin-dependent kinases (CDKs) are a family of serine/threonine kinases essential for cell cycle progression. Herein, we describe the participation of CDKs in the physiology of Rhipicephalus microplus, the southern cattle tick and an important disease vector. Firstly, amino acid sequences homologous with CDKs of other organisms were identified from a R. microplus transcriptome database in silico. The analysis of the deduced amino acid sequences of CDK1 and CDK10 from R. microplus showed that both have caspase-3/7 cleavage motifs despite their differences in motif position and length of encoded proteins. CDK1 has two motifs (DKRGD and SAKDA) located opposite to the ATP binding site while CDK10 has only one motif (SLLDN) for caspase 3-7 near the ATP binding site. Roscovitine (Rosco), a purine derivative that inhibits CDK/cyclin complexes by binding to the catalytic domain of the CDK molecule at the ATP binding site, which prevents the transfer of ATP's cphosphoryl group to the substrate. To determine the effect of Rosco on tick CDKs, BME26 cells derived from R. microplus embryo cells were utilized in vitro inhibition assays. Cell viability decreased in the Rosco-treated groups after 24 hours of incubation in a concentration-dependent manner and this was observed up to 48 hours following incubation. To our knowledge, this is the first report on characterization of a cell cycle protein in arachnids, and the sensitivity of BME26 tick cell line to Rosco treatment suggests that CDKs are potential targets for novel drug design to control tick infestation.	[Gomes, Helga; Rodrigues, Camilla; da Fonseca, Rodrigo Nunes; Moraes, Jorge] NUPEM UFRJ, Lab Integrado Bioquim Hatisaburo Masuda, Macae, RJ, Brazil; [Gomes, Helga; Moraes, Jorge] Univ Fed Rio de Janeiro, Inst Bioquim Med, CCS, Bloco H,Cidade Univ,Ilha Fundao, Rio De Janeiro, RJ, Brazil; [Braz, Gloria R. C.; da Fonseca, Rodrigo Nunes; Vaz, Itabajara da Silva, Jr.; Logullo, Carlos; Moraes, Jorge] Inst Nacl Ciencia Tecnologia Entomol Mol, Rio De Janeiro, RJ, Brazil; [Braz, Gloria R. C.] IQ UFRJ, Inst Quim, Dept Bioquim, Rio De Janeiro, RJ, Brazil; [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Fac Vet, Porto Alegre, RS, Brazil; [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil; [Logullo, Carlos] Univ Estadual N Fluminen, CBB, Unidade Expt Anim, Lab Quim Funcao Prot & Peptideos, Campos dos Goytacazes, RJ, Brazil; [Romeiro, Nelilma C.; Gamosa de Oliveira, Eduardo Alves] NUPEM UFRJ, Lab Integrado Comp Cient, Macae, RJ, Brazil; [Githaka, Naftaly; Isezaki, Masayoshi; Konnai, Satoru; Ohashi, Kazuhiko] Hokkaido Univ, Infect Dis Lab, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido, Japan	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Hokkaido University	Moraes, J (corresponding author), NUPEM UFRJ, Lab Integrado Bioquim Hatisaburo Masuda, Campus Macae,Ave Sao Jose Barreto, Macae, RJ, Brazil.	jorgemoraes@bioqmed.ufrj.br	da Fonseca, Rodrigo Nunes/S-3964-2018; Fernandes Gomes, Helga/AFV-5696-2022; Silva Vaz Jr., Itabajara/A-5943-2009; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; vaz, itabajara/F-5244-2014	da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Silva Vaz Jr., Itabajara/0000-0003-0309-9328; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; vaz, itabajara/0000-0003-0309-9328; Githaka, Dr Naftaly/0000-0003-4530-7164; Satoru, Konnai/0000-0002-3230-7109	CNPq-Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (Brazil); FINEP (Brazil); CAPES (Brazil); CNPq (Brazil); FAPERJ (Brazil); FUNEMAC (Brazil); FAPERGS (Brazil); Japanese Ministry of Health, Labor and Welfare; Japan Society for the Promotion of Science (JSPS) (Japan); Grants-in-Aid for Scientific Research [25257415] Funding Source: KAKEN	CNPq-Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (Brazil); FINEP (Brazil)(Financiadora de Inovacao e Pesquisa (Finep)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FUNEMAC (Brazil); FAPERGS (Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS) (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from CNPq-Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, FINEP, CAPES, CNPq, FAPERJ, FUNEMAC and FAPERGS (Brazil), grants-in-Aid for research on emerging and reemerging infectious diseases from the Japanese Ministry of Health, Labor and Welfare, and Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin JL, 2005, THERIOGENOLOGY, V64, P1740, DOI 10.1016/j.theriogenology.2005.04.018; Alberts B, 2002, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews MJI, 2006, CHEMBIOCHEM, V7, P1909, DOI 10.1002/cbic.200600189; Arisan ED, 2012, AMINO ACIDS, V42, P655, DOI 10.1007/s00726-011-1040-x; Barretto LSS, 2007, ANIM REPROD SCI, V99, P202, DOI 10.1016/j.anireprosci.2006.06.001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; CAFRUNE MM, 1995, RES VET SCI, V58, P284, DOI 10.1016/0034-5288(95)90119-1; Chiu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033742; Coley HM, 2007, ANTICANCER RES, V27, P273; Coy P, 2005, REPRODUCTION, V129, P19, DOI 10.1530/rep.1.00299; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Di Talia S, 2012, DEV CELL, V22, P763, DOI 10.1016/j.devcel.2012.01.019; Ellefson ML, 2011, J CELL BIOL, V193, P1229, DOI 10.1083/jcb.201104008; Esposito L, 2013, CURR PHARM DES, V4; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Farrell JA, 2012, GENE DEV, V26, P714, DOI 10.1101/gad.186429.111; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Gladwin MT, 2012, J CLIN INVEST, V122, P1205, DOI 10.1172/JCI62972; Gould KL, 2000, FR MOLEC B, V29, P277; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hoogendijk AJ, 2012, SHOCK, V38, P375, DOI 10.1097/SHK.0b013e3182656e7b; Icreverzi A, 2012, CELL CYCLE, V11, P554, DOI 10.4161/cc.11.3.19062; Jonsson NN, 2000, VET PARASITOL, V88, P79, DOI 10.1016/S0304-4017(99)00189-2; Kaedei Y, 2010, J ANIM VET ADV, V9, P2848, DOI 10.3923/javaa.2010.2848.2853; Kim EH, 2004, ONCOGENE, V23, P446, DOI 10.1038/sj.onc.1207025; KOVAL TM, 1977, GENETICS, V87, P512; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lodish H, 1995, MOL CELL BIOL; Maity AK, 2011, FEBS LETT, V585, P2635, DOI 10.1016/j.febslet.2011.06.017; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Meijer L, 2000, DRUG RESIST UPDATE, V3, P83, DOI 10.1054/drup.2000.0129; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Pietack N, 2010, J MOL MICROB BIOTECH, V18, P129, DOI 10.1159/000308512; Pohl PC, 2012, PARASITOL RES, V111, P2345, DOI 10.1007/s00436-012-3089-1; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor SL, 2004, J VIROL, V78, P2853, DOI 10.1128/JVI.78.6.2853-2862.2004; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van den Heuvel S., 2005, WORMBOOK, DOI [10.1895/wormbook.1.28.1, DOI 10.1895/W0RMB00K.1.28.1]; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vigneron C, 2003, MOL REPROD DEV, V65, P114, DOI 10.1002/mrd.10265; Weingrill E, 2007, HAEMATOLOGICA, V92, P1286, DOI 10.3324/haematol.10680; Wu PC, 2008, J OCUL PHARMACOL TH, V24, P25, DOI 10.1089/jop.2007.0044	53	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76128	10.1371/journal.pone.0076128	http://dx.doi.org/10.1371/journal.pone.0076128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146826	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400039
J	Karsa, M; Dalla Pozza, L; Venn, NC; Law, T; Shi, R; Giles, JE; Bahar, AY; Cross, S; Catchpoole, D; Haber, M; Marshall, GM; Norris, MD; Sutton, R				Karsa, Mawar; Dalla Pozza, Luciano; Venn, Nicola C.; Law, Tamara; Shi, Rachael; Giles, Jodie E.; Bahar, Anita Y.; Cross, Shamira; Catchpoole, Daniel; Haber, Michelle; Marshall, Glenn M.; Norris, Murray D.; Sutton, Rosemary			Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease	PLOS ONE			English	Article							AIEOP-BFM; T-CELL; GENE REARRANGEMENTS; MOLECULAR RESPONSE; FLOW-CYTOMETRY; THERAPY; IMMUNOGLOBULIN; CHILDREN	The stratification of patients with acute lymphoblastic leukemia (ALL) into treatment risk groups based on quantification of minimal residual disease (MRD) after induction therapy is now well accepted but the relapse rate of about 20% in intermediate risk patients remains a challenge. The purpose of this study was to further improve stratification by MRD measurement at an earlier stage. MRD was measured in stored day 15 bone marrow samples for pediatric patients enrolled on ANZCHOG ALL8 using Real-time Quantitative PCR to detect immunoglobulin and T-cell receptor gene rearrangements with the same assays used at day 33 and day 79 in the original MRD stratification. MRD levels in bone marrow at day 15 and 33 were highly predictive of outcome in 223 precursor B-ALL patients (log rank Mantel-Cox tests both P<0.001) and identified patients with poor, intermediate and very good outcomes. The combined use of MRD at day 15 (>= 1x10(-2)) and day 33 (>= 5x1(-5)) identified a subgroup of medium risk precursor B-ALL patients as poor MRD responders with 5 year relapse-free survival of 55% compared to 84% for other medium risk patients (log rank Mantel-Cox test, P = 0.0005). Risk stratification of precursor B-ALL but not T-ALL could be improved by using MRD measurement at day 15 and day 33 instead of day 33 and day 79 in similar BFM-based protocols for children with this disease.	[Karsa, Mawar; Venn, Nicola C.; Law, Tamara; Shi, Rachael; Giles, Jodie E.; Bahar, Anita Y.; Haber, Michelle; Marshall, Glenn M.; Norris, Murray D.; Sutton, Rosemary] Univ NSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Dalla Pozza, Luciano; Cross, Shamira; Catchpoole, Daniel] Childrens Hosp Westmead, Oncol Unit, Westmead, NSW, Australia; [Marshall, Glenn M.] Sydneys Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Randwick, NSW, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; University of Sydney	Sutton, R (corresponding author), Univ NSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia.	rsutton@ccia.unsw.edu.au	Sutton, Rosemary/J-3784-2014	Sutton, Rosemary/0000-0002-0188-6005; Norris, Murray/0000-0002-0632-4589; Haber, Michelle/0000-0003-2036-8817; Karsa, Mawar/0000-0001-9682-1118	National Health and Medical Research Council [209599, 350886]; Cancer Council NSW; Leukaemia Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Leukaemia Foundation	This study was funded by project grants 209599 and 350886 from the National Health and Medical Research Council www.nhmrc.gov.au; a 2006 program grant from The Cancer Council NSW www.cancercouncil.com.au and a 2004 grant-in-aid from the Leukaemia Foundation www.leukaemia.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso G, 2009, J CLIN ONCOL, V27, P5168, DOI 10.1200/JCO.2008.20.8934; Bruggemann M, 2010, LEUKEMIA, V24, P521, DOI 10.1038/leu.2009.268; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Coustan-Smith E, 2002, BLOOD, V100, P52, DOI 10.1182/blood-2002-01-0006; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Gaynon PS, 1997, CANCER-AM CANCER SOC, V80, P1717, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B; Lauten M, 2012, HAEMATOL-HEMATOL J, V97, P1048, DOI 10.3324/haematol.2011.047613; Marshall GM, 2003, J CLIN ONCOL, V21, P704, DOI 10.1200/JCO.2003.10.080; Marshall GM, 2013, LEUKEMIA, DOI [10.1038/leu.2013.1044, DOI 10.1038/LEU.2013.1044]; Panzer-Grumayer ER, 2000, BLOOD, V95, P790, DOI 10.1182/blood.V95.3.790.003k48_790_794; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Ratei R, 2009, LEUKEMIA, V23, P528, DOI 10.1038/leu.2008.324; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Sutton R, 2008, LEUKEMIA, V22, P2265, DOI 10.1038/leu.2008.121; Sutton R, 2009, BRIT J HAEMATOL, V146, P292, DOI 10.1111/j.1365-2141.2009.07744.x; van der Velden VHJ, 2007, LEUKEMIA, V21, P604, DOI 10.1038/sj.leu.2404586; Volejnikova J, 2013, PEDIATR BLOOD CANCER, V60, P420, DOI 10.1002/pbc.24299; ZWEIG MH, 1993, CLIN CHEM, V39, P561	18	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76455	10.1371/journal.pone.0076455	http://dx.doi.org/10.1371/journal.pone.0076455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146872	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400060
J	Liu, ZF; Ye, FH; Zhang, HY; Gao, Y; Tan, AH; Zhang, SJ; Xiao, Q; Zhang, B; Huang, LL; Ye, BB; Qin, X; Wu, CL; Lu, Z; Zhang, YJ; Liao, M; Yang, XB; Mo, ZN				Liu, Zhenfang; Ye, Fanghui; Zhang, Haiying; Gao, Yong; Tan, Aihua; Zhang, Shijun; Xiao, Qiang; Zhang, Bing; Huang, Lulu; Ye, Bingbing; Qin, Xue; Wu, Chunlei; Lu, Zheng; Zhang, Youjie; Liao, Ming; Yang, Xiaobo; Mo, Zengnan			The Association between the Levels of Serum Ferritin and Sex Hormones in a Large Scale of Chinese Male Population	PLOS ONE			English	Article							TESTOSTERONE LEVELS; RISK-FACTORS; TRANSCRIPTIONAL REGULATION; RESPONSIVE ELEMENT; METABOLIC SYNDROME; PROSTATE-CANCER; IRON-DEFICIENCY; MEN; ANDROGEN; HEPCIDIN	Background: The ferritin is an important participant of iron-storage but its regulation and related factors were not well defined. The present objective was to explore the potential association between serum ferritin levels and sex hormones. Methods: 1999 Chinese men in the Fangchenggang Area Male Health and Examination Survey (FAMHES) were recruited in this cross-sectional study. Levels of serum ferritin, total testosterone (free testosterone was calculated from the total one), estradiol and sex hormone-binding protein were detected in venous blood samples. The effects of age, BMI, smoking as well as alcohol consumption were analyzed on ferritin levels, respectively, and then the Pearson's correlation analysis was used to evaluate the association between ferritin levels and sex hormones adjusting for the above factors. Results: The age, BMI and alcohol consumption significantly affected serum ferritin levels, but there was no significant difference between smokers and nonsmokers. Ferritin levels were significantly and negatively associated with total testosterone (R = -0.205, P<0.001), sex hormone-binding protein (R = -0.161, P<0.001) and free testosterone (R = -0.097, P<0.001). After age and alcohol consumption were adjusted, the above associations were still significant (R = -0.200, -0.181 and -0.083, respectively, all P<0.001). However, there was only borderline negative association between ferritin levels and estradiol (adjusted R = -0.039, P = 0.083). Conclusion: The large scale of epidemic results showed the significantly negative associations between serum ferritin levels and sex hormones, which may provide more clues to explore the potential regulation and biological mechanism of ferritin.	[Liu, Zhenfang] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Guangxi, Peoples R China; [Ye, Fanghui; Zhang, Haiying; Gao, Yong; Tan, Aihua; Zhang, Shijun; Xiao, Qiang; Zhang, Bing; Huang, Lulu; Ye, Bingbing; Wu, Chunlei; Lu, Zheng; Zhang, Youjie; Liao, Ming; Yang, Xiaobo; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Zhang, Haiying; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Wu, Chunlei; Lu, Zheng; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Yang, XB (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China.	yxbo21021@163.com; zengnanmo@hotmail.com	Zhang, Youjie/F-7346-2016; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138	Guangxi Science Fund for Distinguished Young Scholars [2012jjFA40011]; National Key Basic Research Program grant 973 [2012CB518300, 2012CB518303]; National Natural Science Foundation of China [81160072, 81060234]; Guangxi Natural Science Foundation [2010GXNSFB013064]	Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Key Basic Research Program grant 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	The study was supported by grants from the Guangxi Science Fund for Distinguished Young Scholars (2012jjFA40011), National Key Basic Research Program grant 973 (2012CB518300 and 2012CB518303), National Natural Science Foundation of China (81160072, 81060234), and Guangxi Natural Science Foundation (2010GXNSFB013064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051379; Assia N, 2010, MOL VIS, V16, P2487; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; BERGE LN, 1994, ARTERIOSCLER THROMB, V14, P857, DOI 10.1161/01.ATV.14.6.857; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BEVILACQUA MA, 1994, GENE, V141, P287, DOI 10.1016/0378-1119(94)90587-8; Brockenbrough AT, 2006, AM J KIDNEY DIS, V47, P251, DOI 10.1053/j.ajkd.2005.10.022; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052255; Chen JX, 2012, BBA-GEN SUBJECTS, V1820, P256, DOI 10.1016/j.bbagen.2011.07.015; Choi Hyoung Soo, 2012, Korean J Hematol, V47, P286, DOI 10.5045/kjh.2012.47.4.286; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Eguchi A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/239476; Enea C, 2008, STEROIDS, V73, P1203, DOI 10.1016/j.steroids.2008.06.009; Garcia-Cruz E, 2012, BJU INT, V110, pE199, DOI 10.1111/j.1464-410X.2011.10876.x; Garcia-Cruz E, 2012, BJU INT, V110, pE541, DOI 10.1111/j.1464-410X.2012.11232.x; Gautier A, 2011, EUR J ENDOCRINOL, V165, P339, DOI 10.1530/EJE-11-0215; Gonzales GF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1319, DOI 10.1152/ajpendo.90940.2008; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Hong D, 2013, MATURITAS, V74, P148, DOI 10.1016/j.maturitas.2012.10.016; Huhtaniemi IT, 2010, J CLIN ENDOCR METAB, V95, P1898, DOI 10.1210/jc.2009-2071; INTRAGUMTORNCHAI T, 1988, AM J CLIN NUTR, V48, P641, DOI 10.1093/ajcn/48.3.641; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; JONES BM, 1980, CLIN CHIM ACTA, V106, P203, DOI 10.1016/0009-8981(80)90173-4; Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kuvibidila SR, 2004, J NATL MED ASSOC, V96, P641; Laaksonen DE, 2003, EUR J ENDOCRINOL, V149, P601, DOI 10.1530/eje.0.1490601; Leedman PJ, 1996, J BIOL CHEM, V271, P12017, DOI 10.1074/jbc.271.20.12017; Li S, 2011, CLIN BIOCHEM, V44, P1325, DOI 10.1016/j.clinbiochem.2011.08.1137; Liao MZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034085, 10.1371/journal.pone.0039234]; Mohr BA, 2006, EUR J ENDOCRINOL, V155, P443, DOI 10.1530/eje.1.02241; Moilanen AM, 2007, CARCINOGENESIS, V28, P916, DOI 10.1093/carcin/bgl222; Przybyszewska J, 2013, POL ARCH MED WEWN, V123, P105, DOI 10.20452/pamw.1623; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Rushton DH, 2010, CRIT REV ONCOL HEMAT, V73, P1, DOI 10.1016/j.critrevonc.2009.03.010; SANTAMBROGIO P, 1987, BRIT J HAEMATOL, V65, P235, DOI 10.1111/j.1365-2141.1987.tb02271.x; Shahani S, 2009, J ENDOCRINOL INVEST, V32, P704, DOI 10.1007/BF03345745; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Tan TCH, 2012, LIVER INT, V32, P1391, DOI 10.1111/j.1478-3231.2012.02828.x; Tivesten A, 2009, J CLIN ENDOCR METAB, V94, P2482, DOI 10.1210/jc.2008-2650; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vaarala MH, 2008, INT J CANCER, V122, P2511, DOI 10.1002/ijc.23425; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.23537; WORWOOD M, 1975, CLIN SCI MOL MED, V48, P441, DOI 10.1042/cs0480441; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Wu IC, 2010, MATURITAS, V67, P348, DOI 10.1016/j.maturitas.2010.07.010; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; YOKOMORI N, 1991, ENDOCRINOLOGY, V128, P1474, DOI 10.1210/endo-128-3-1474; Yoo KD, 2012, CLIN ENDOCRINOL, V77, P233, DOI 10.1111/j.1365-2265.2011.04248.x; Zandman-Goddard G, 2008, ISR MED ASSOC J, V10, P83	54	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75908	10.1371/journal.pone.0075908	http://dx.doi.org/10.1371/journal.pone.0075908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146788	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400025
J	Pakpour, N; Camp, L; Smithers, HM; Wang, B; Tu, ZJ; Nadler, SA; Luckhart, S				Pakpour, Nazzy; Camp, Lauren; Smithers, Hannah M.; Wang, Bo; Tu, Zhijian; Nadler, Steven A.; Luckhart, Shirley			Protein Kinase C-Dependent Signaling Controls the Midgut Epithelial Barrier to Malaria Parasite Infection in Anopheline Mosquitoes	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; PLASMODIUM-FALCIPARUM; PKC ISOFORMS; REAL-TIME; PHOSPHORYLATION; SOTRASTAURIN; ACTIVATION; OOKINETE; OCCLUDIN	Anopheline mosquitoes are the primary vectors of parasites in the genus Plasmodium, the causative agents of malaria. Malaria parasites undergo a series of complex transformations upon ingestion by the mosquito host. During this process, the physical barrier of the midgut epithelium, along with innate immune defenses, functionally restrict parasite development. Although these defenses have been studied for some time, the regulatory factors that control them are poorly understood. The protein kinase C (PKC) gene family consists of serine/threonine kinases that serve as central signaling molecules and regulators of a broad spectrum of cellular processes including epithelial barrier function and immunity. Indeed, PKCs are highly conserved, ranging from 7 isoforms in Drosophila to 16 isoforms in mammals, yet none have been identified in mosquitoes. Despite conservation of the PKC gene family and their potential as targets for transmission-blocking strategies for malaria, no direct connections between PKCs, the mosquito immune response or epithelial barrier integrity are known. Here, we identify and characterize six PKC gene family members -PKC delta, PKC epsilon, PKC zeta, PKD, PKN, and an indeterminate conventional PKC - in Anopheles gambiae and Anopheles stephensi. Sequence and phylogenetic analyses of the anopheline PKCs support most subfamily assignments. All six PKCs are expressed in the midgut epithelia of A. gambiae and A. stephensi post-blood feeding, indicating availability for signaling in a tissue that is critical for malaria parasite development. Although inhibition of PKC enzymatic activity decreased NF-kappa B-regulated anti-microbial peptide expression in mosquito cells in vitro, PKC inhibition had no effect on expression of a panel of immune genes in the midgut epithelium in vivo. PKC inhibition did, however, significantly increase midgut barrier integrity and decrease development of P. falciparum oocysts in A. stephensi, suggesting that PKC-dependent signaling is a negative regulator of epithelial barrier function and a potential new target for transmission-blocking strategies.	[Pakpour, Nazzy; Smithers, Hannah M.; Wang, Bo; Luckhart, Shirley] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Camp, Lauren; Nadler, Steven A.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	University of California System; University of California Davis; University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Pakpour, N (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	npakpour@ucdavis.edu			NIH NIAID [R01 AI080799, R01 AI073745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080799, R01AI073745] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for these studies was provided by NIH NIAID R01 AI080799 and R01 AI073745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Avila A, 2002, MOL CELL BIOL, V22, P8787, DOI 10.1128/MCB.22.24.8787-8795.2002; Bahia D, 2006, BIOCHEM BIOPH RES CO, V345, P1138, DOI 10.1016/j.bbrc.2006.05.025; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Beyenbach KW, 2012, ANN NY ACAD SCI, V1258, P166, DOI 10.1111/j.1749-6632.2012.06527.x; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; CANNING EU, 1973, PARASITOLOGY, V67, P29, DOI 10.1017/S0031182000046266; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Clerk A, 2001, CIRC RES, V89, P847, DOI 10.1161/res.89.10.847; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fallon A. M., 1987, Advances in Cell Culture, V5, P97; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friman S, 2011, AM J TRANSPLANT, V11, P1444, DOI 10.1111/j.1600-6143.2011.03538.x; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hauck ES, 2013, MICROBES INFECT; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Jain S, 2011, BIOCHEM J, V437, P289, DOI 10.1042/BJ20110587; Kofler K, 2002, GENOME BIOL, V3; Kovarik JM, 2011, TRANSPL INT, V24, P276, DOI 10.1111/j.1432-2277.2010.01196.x; Koyanagi M, 1998, FEBS LETT, V439, P66, DOI 10.1016/S0014-5793(98)01339-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luckhart S, 1999, GENE, V232, P25, DOI 10.1016/S0378-1119(99)00121-3; Maier D, 2006, GENE EXPR PATTERNS, V6, P849, DOI 10.1016/j.modgep.2006.03.007; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Miller MA, 2010, CREATING CIPRES SCI; Millholland MG, 2013, CELL HOST MICROBE, V13, P15, DOI 10.1016/j.chom.2012.12.001; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Shieh BH, 2002, J BIOCHEM, V132, P523, DOI 10.1093/oxfordjournals.jbchem.a003252; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Valledor AF, 2000, J IMMUNOL, V164, P29, DOI 10.4049/jimmunol.164.1.29; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yamashita K, 2012, TRANSPLANTATION, V93, P146, DOI 10.1097/TP.0b013e31823d4b1f; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	88	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76535	10.1371/journal.pone.0076535	http://dx.doi.org/10.1371/journal.pone.0076535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146884	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400063
J	Tibiletti, M; Galbusera, F; Ciavarro, C; Brayda-Bruno, M				Tibiletti, Marta; Galbusera, Fabio; Ciavarro, Cristina; Brayda-Bruno, Marco			Is the Transport of a Gadolinium-Based Contrast Agent Decreased in a Degenerated or Aged Disc? A Post Contrast MRI Study	PLOS ONE			English	Article							ISSLS PRIZE WINNER; HUMAN LUMBAR DISCS; INTERVERTEBRAL DISC; END-PLATE; IN-VIVO; SOLUTE TRANSPORT; CELL VIABILITY; DIFFUSION; ENHANCEMENT; CLASSIFICATION	A post contrast magnetic resonance imaging study has been performed in a wide population of low back pain patients to investigate which radiological and phenotypic characteristics influence the penetration of the contrast agent in lumbar discs in vivo. 37 patients affected by different pathologies (disc herniation, spondylolisthesis, foraminal stenosis, central canal stenosis) were enrolled in the study. The selected population included 26 male and 11 female subjects, with a mean age of 42.4 +/- 9.3 years (range 18-60). Magnetic resonance images of the lumbar spine were obtained with a 1.5 T scanner (Avanto, Siemens, Erlangen, Germany) with a phased-array back coil. A paramagnetic non-ionic contrast agent was injected with a dose of 0.4 ml/kg. T1-weighted magnetic resonance images were subsequently acquired at 5 time points, 5 and 10 minutes, 2, 4 and 6 hours after injection. Endplates presented clear enhancement already 5 minutes after injection, and showed an increase in the next 2 hours followed by a decrease. At 5 and 10 minutes, virtually no contrast medium was present inside the intervertebral disc; afterwards, enhancement significantly increased. Highly degenerated discs showed higher enhancement in comparison with low and medium degenerated discs. Discs classified as Pfirrmann 5 showed a statistically significant higher enhancement than Pfirrmann 1, 2 and 3 at all time points but the first one, possibly due to vascularization. Disc height collapse and Modic changes significantly increased enhancement. Presence of endplate defects did not show any significant influence on post contrast enhancement, but the lack of a clear classification of endplate defects as seen on magnetic resonance scans may be shadowing some effects. In conclusion, disc height, high level of degeneration and presence of Modic changes are factors which increase post contrast enhancement in the intervertebral disc. The effect of age could not be demonstrated.	[Tibiletti, Marta; Galbusera, Fabio; Ciavarro, Cristina] IRCCS Galeazzi Orthopaed Inst, Lab Biol Struct Mech, Milan, Italy; [Tibiletti, Marta] Univ Ulm, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Brayda-Bruno, Marco] IRCCS Galeazzi Orthopaed Inst, Dept Spine Surg 3, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; Ulm University; IRCCS Istituto Ortopedico Galeazzi	Galbusera, F (corresponding author), IRCCS Galeazzi Orthopaed Inst, Lab Biol Struct Mech, Milan, Italy.	fabio.galbusera@grupposandonato.it	Galbusera, Fabio/J-8618-2016; Brayda-Bruno, Marco/B-8639-2017	Galbusera, Fabio/0000-0003-1826-9190; Brayda-Bruno, Marco/0000-0002-8608-0114	EU FP7 project GENODISC [HEALTH-F2-2008-201626]	EU FP7 project GENODISC	This work is funded by the EU FP7 project GENODISC (HEALTH-F2-2008-201626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun R, 2009, SPINE, V34, P2324, DOI 10.1097/BRS.0b013e3181b4df92; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; BERNICK S, 1982, SPINE, V7, P97, DOI 10.1097/00007632-198203000-00002; BOOS N, 1994, MAGN RESON IMAGING, V12, P577, DOI 10.1016/0730-725X(94)92452-X; Galbusera F, 2013, COMPUT METHOD BIOMEC, V16, P328, DOI 10.1080/10255842.2011.619184; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130; Holme S, 2008, TRANSFUSION, V48, P910, DOI 10.1111/j.1537-2995.2007.01619.x; IBRAHIM MA, 1995, AM J NEURORADIOL, V16, P1307; IBRAHIM MA, 1994, AM J NEURORADIOL, V15, P419; IBRAHIM MA, 1994, AM J NEURORADIOL, V15, P1907; Idee JM, 2006, FUND CLIN PHARMACOL, V20, P563, DOI 10.1111/j.1472-8206.2006.00447.x; Junghanns, 1971, HUMAN SPINE HLTH DIS; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Niemelainen R, 2008, CLIN RADIOL, V63, P252, DOI 10.1016/j.crad.2007.08.012; Nunimaki J, 2009, MAGMA, V22, P101; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rajasekaran S, 2008, EUR SPINE J, V17, P626, DOI 10.1007/s00586-008-0645-6; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Rajasekaran S, 2010, SPINE, V35, P1930, DOI 10.1097/BRS.0b013e3181e9a156; Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3; ROBERTS S, 1993, J ORTHOP RES, V11, P747, DOI 10.1002/jor.1100110517; Rodriguez AG, 2011, SPINE, V36, P512, DOI 10.1097/BRS.0b013e3181f72b94; Shirazi-Adl A, 2010, J BIOMECH, V43, P1330, DOI 10.1016/j.jbiomech.2010.01.023; URBAN JPG, 1982, CLIN ORTHOP RELAT R, P296; Urban MR, 2001, SPINE, V26, P984, DOI 10.1097/00007632-200104150-00028; van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018; Videman T, 2008, SPINE, V33, P2781, DOI 10.1097/BRS.0b013e31817e1d11; Wang Y, 2012, SPINE, V37, P1432, DOI 10.1097/BRS.0b013e31824dd20a; White A.A., 1990, CLIN BIOMECH	32	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76697	10.1371/journal.pone.0076697	http://dx.doi.org/10.1371/journal.pone.0076697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146913	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400075
J	Tu, LH; Hu, TX; Zhang, J; Huang, LH; Xiao, YL; Chen, G; Hu, HL; Liu, L; Zheng, JK; Xu, ZF; Chen, LH				Tu, Li-hua; Hu, Ting-xing; Zhang, Jian; Huang, Li-hua; Xiao, Yin-long; Chen, Gang; Hu, Hong-ling; Liu, Li; Zheng, Jiang-kun; Xu, Zhen-feng; Chen, Liang-hua			Nitrogen Distribution and Cycling through Water Flows in a Subtropical Bamboo Forest under High Level of Atmospheric Deposition	PLOS ONE			English	Article							PLEIOBLASTUS-AMARUS PLANTATION; ORGANIC NITROGEN; RAINY AREA; SOIL RESPIRATION; N DEPOSITION; THROUGHFALL; STEMFLOW; PRECIPITATION; RAINFALL; SULFUR	Background: The hydrological cycle is an important way of transportation and reallocation of reactive nitrogen (N) in forest ecosystems. However, under a high level of atmospheric N deposition, the N distribution and cycling through water flows in forest ecosystems especially in bamboo ecosystems are not well understood. Methodology/Principal Findings: In order to investigate N fluxes through water flows in a Pleioblastus amarus bamboo forest, event rainfall/snowfall (precipitation, PP), throughfall (TF), stemflow (SF), surface runoff (SR), forest floor leachate (FFL), soil water at the depth of 40 cm (SW1) and 100 cm (SW2) were collected and measured through the whole year of 2009. Nitrogen distribution in different pools in this ecosystem was also measured. Mean N pools in vegetation and soil (0-1 m) were 351.7 and 7752.8 kg ha(-1). Open field nitrogen deposition at the study site was 113.8 kg N ha(-1) yr(-1), which was one of the highest in the world. N-NH4+, N-NO3- and dissolved organic N (DON) accounted for 54%, 22% and 24% of total wet N deposition. Net canopy accumulated of N occurred with N-NO3- and DON but not N-NH4+. The flux of total dissolved N (TDN) to the forest floor was greater than that in open field precipitation by 17.7 kg N ha(-1) yr(-1), due to capture of dry and cloudwater deposition net of canopy uptake. There were significant negative exponential relationships between monthly water flow depths and monthly mean TDN concentrations in PP, TF, SR, FFL and SW1. Conclusions/Significance: The open field nitrogen deposition through precipitation is very high over the world, which is the main way of reactive N input in this bamboo ecosystem. The water exchange and N consume mainly occurred in the litter floor layer and topsoil layer, where most of fine roots of bamboo distributed.	[Tu, Li-hua; Hu, Ting-xing; Zhang, Jian; Huang, Li-hua; Xiao, Yin-long; Chen, Gang; Hu, Hong-ling; Zheng, Jiang-kun] Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China; [Zhang, Jian; Xu, Zhen-feng; Chen, Liang-hua] Sichuan Agr Univ, Coll Forestry, Inst Ecol Forestry, Chengdu, Peoples R China; [Liu, Li] Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China; [Liu, Li] Sichuan Agr Univ, Personnel Dept, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Hu, TX (corresponding author), Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China.	hutx001@163.com			Specialized Research Fund for the Doctoral Program of Higher Education of China [20125103120018]; Scientific Research Fund of Sichuan Provincial Education Department [12ZA118]; National Key Technology R&D Program of China [2011BAC09B05]; Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Fund of Sichuan Provincial Education Department; National Key Technology R&D Program of China(National Key Technology R&D Program); Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	This study was funded by Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20125103120018), Scientific Research Fund of Sichuan Provincial Education Department (No. 12ZA118), National Key Technology R&D Program of China (No. 2011BAC09B05), and Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Aber JD, 1995, WATER AIR SOIL POLL, V85, P1665, DOI 10.1007/BF00477219; AGREN GI, 1988, ENVIRON POLLUT, V54, P185, DOI 10.1016/0269-7491(88)90111-X; Boyce RL, 1996, CAN J FOREST RES, V26, P1539, DOI 10.1139/x26-173; Brookshire ENJ, 2007, ECOSYSTEMS, V10, P252, DOI 10.1007/s10021-007-9019-x; BUTLER TJ, 1995, ATMOS ENVIRON, V29, P1253, DOI 10.1016/1352-2310(94)00339-M; Chaves J, 2009, ECOSYSTEMS, V12, P961, DOI 10.1007/s10021-009-9270-4; Chen XY, 2007, SCI TOTAL ENVIRON, V378, P317, DOI 10.1016/j.scitotenv.2007.02.028; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Chuyong GB, 2004, BIOGEOCHEMISTRY, V67, P73, DOI 10.1023/B:BIOG.0000015316.90198.cf; Cornell SE, 2011, ENVIRON POLLUT, V159, P2214, DOI 10.1016/j.envpol.2010.11.014; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Dezi S, 2010, GLOBAL CHANGE BIOL, V16, P1470, DOI 10.1111/j.1365-2486.2009.02102.x; Dezzeo N, 2006, FOREST ECOL MANAG, V234, P218, DOI 10.1016/j.foreco.2006.07.003; Draaijers GPJ, 1995, WATER AIR SOIL POLL, V85, P2253, DOI 10.1007/BF01186169; Draaijers GPJ, 1996, ATMOS ENVIRON, V30, P3349, DOI 10.1016/1352-2310(96)00030-1; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; Fang YT, 2009, ECOSYSTEMS, V12, P33, DOI 10.1007/s10021-008-9203-7; FAO, 2010, GLOBAL FOREST RESOUR; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; GALLOWAY JN, 1982, J GEOPHYS RES-OCEANS, V87, P8771, DOI 10.1029/JC087iC11p08771; Goller R, 2006, BIOGEOCHEMISTRY, V77, P57, DOI 10.1007/s10533-005-1061-1; Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Hagedorn F, 2000, BIOGEOCHEMISTRY, V50, P137, DOI 10.1023/A:1006398105953; Hogberg P, 2007, NATURE, V447, P781, DOI 10.1038/447781a; Hu ZY, 2007, PEDOSPHERE, V17, P360, DOI 10.1016/S1002-0160(07)60043-5; Jia GD, 2010, ATMOS ENVIRON, V44, P2309, DOI 10.1016/j.atmosenv.2010.03.041; JORDAN CF, 1978, OIKOS, V31, P257, DOI 10.2307/3543571; KRUG FJ, 1979, ANALYST, V104, P47, DOI 10.1039/an9790400047; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lehmann CMB, 2005, ENVIRON POLLUT, V135, P347, DOI 10.1016/j.envpol.2004.11.016; Lin XinChun, 2004, Journal of Zhejiang Forestry College, V21, P168; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; LLOYD CR, 1988, AGR FOREST METEOROL, V42, P63, DOI 10.1016/0168-1923(88)90067-6; Mitchell MJ, 2001, HYDROL PROCESS, V15, P3305, DOI 10.1002/hyp.503; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; Onozawa Y, 2009, J FOREST RES-JPN, V14, P111, DOI 10.1007/s10310-008-0108-2; SCHULZE ED, 1989, SCIENCE, V244, P776, DOI 10.1126/science.244.4906.776; SFAPRC, 2010, STAT FOR RES CHIN 20; Sleutel S, 2009, BIOGEOSCIENCES, V6, P2743, DOI 10.5194/bg-6-2743-2009; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Tu LH, 2011, PEDOSPHERE, V21, P685, DOI 10.1016/S1002-0160(11)60171-9; Tu Li-Hua, 2011, Chinese Journal of Plant Ecology, V35, P125, DOI 10.3724/SP.J.1258.2011.00125; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; Tu Li-hua, 2010, Yingyong Shengtai Xuebao, V21, P2472; Tu Li-hua, 2009, Yingyong Shengtai Xuebao, V20, P2943; van Leeuwen EP, 1995, 722108006 RIVM; Violaki K, 2010, MAR CHEM, V120, P179, DOI 10.1016/j.marchem.2009.08.004; Vries W. de, 2009, Forest Ecology and Management, V258, P1814, DOI 10.1016/j.foreco.2009.02.034; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Zhang Y, 2008, ATMOS ENVIRON, V42, P1436, DOI 10.1016/j.atmosenv.2007.11.002; Zhang Y, 2012, ATMOS ENVIRON, V46, P195, DOI 10.1016/j.atmosenv.2011.09.080; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; ZHU PF, 1989, FOREST SOIL SICHUAN; Zhuang Ping, 2002, Shengwu Duoyangxing, V10, P339	58	10	16	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75862	10.1371/journal.pone.0075862	http://dx.doi.org/10.1371/journal.pone.0075862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146784	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400023
J	Shukla, KK; Kwon, WS; Rahman, MS; Park, YJ; You, YA; Pang, MG				Shukla, Kamla Kant; Kwon, Woo-Sung; Rahman, Md Saidur; Park, Yoo-Jin; You, Young-Ah; Pang, Myung-Geol			Nutlin-3a Decreases Male Fertility via UQCRC2	PLOS ONE			English	Article							HUMAN SPERM FUNCTION; TYROSINE PHOSPHORYLATION; MOUSE SPERM; HUMAN-SPERMATOZOA; IN-VITRO; PROTEIN; P53; CAPACITATION; MDM2; DEGRADATION	Ubiquinol-cytochrome-c reductase core protein 2 (UQCRC2) is a component of ubiquinol-cytochrome c reductase complex that is known to correlate with male fertility via spermatogenesis. Simultaneously, nutlin-3a is a small molecule antagonist of mouse double minute 2 repressor (MDM2), activate p53 and induce apoptosis responsible for spermatogenesis. To date, however there are no known effects of nutlin-3a on reproduction. Therefore, present study was designed to investigate the effect of nutlin-3a on male fertility via UQCRC2. In this in vitro trial with mice spermatozoa, we utilized CASA, CTC staining, ATP assay, western blotting, and IVF to measure the main study outcome. The short-term exposure of spermatozoa in nutlin-3a decreases sperm motion kinematics, intracellular ATP production, capacitation, the acrosome reaction, UQCRC2, and tyrosine phosphorylation (TYP) of sperm proteins in a dose-dependent manner. Notably, the decreased UQCRC2 and TYP were associated with reduced sperm kinematics, ATP production, and capacitation, which ultimately led to adverse effects on male fertility such as poor fertilization rates and embryo development. Thus, nutlin-3a may be considered as a potential male contraceptive agent due to its ability to decrease fertility secondary to changes in overall sperm physiology and embryonic development. However, the results of this preliminary study have to be confirmed by additional independent trial.	[Shukla, Kamla Kant; Kwon, Woo-Sung; Rahman, Md Saidur; Park, Yoo-Jin; You, Young-Ah; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Rahman, Md Saidur/AAT-2972-2020; Rahman, Saidur/J-7855-2012; Pang, Myung-Geol/AAV-2014-2021; Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Shukla, Kamla Kant/AAO-1256-2020; Rahman, Mohammad Sohelur/AAJ-7376-2020	Rahman, Saidur/0000-0003-4583-8731; Pang, Myung-Geol/0000-0003-2019-3789; Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Mohammad Sohelur/0000-0002-4489-2202; You, Younag-Ah/0000-0001-6714-7144; Shukla, Kamla Kant/0000-0001-6086-2938	Rural Development Administration, Republic of Korea [PJ008415]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by the Rural Development Administration, Republic of Korea, through a project entitled the "Cooperative Research Program for Agriculture Science & Technology Development" (Project No. PJ008415), which is currently being implemented in the Department of Animal Science and Technology, Chung-Ang University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1995, J CELL SCI, V108, P2017; Edwards SE, 2007, REPROD SCI, V14, P655, DOI 10.1177/1933719107306227; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hong S, 2011, CURR PHARM DESIGN, V17, P560, DOI [10.2174/138161211795222603, DOI 10.2174/138161211795222603.PUBMED:21391906]; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Kwon WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054192; Kwon WS, 2013, FERTIL STERIL, V99, P354, DOI 10.1016/j.fertnstert.2012.09.021; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Marin-Briggiler CI, 2003, FERTIL STERIL, V79, P1396, DOI 10.1016/S0015-0282(03)00267-X; Marty MS, 1999, MUTAT RES-FUND MOL M, V427, P39, DOI 10.1016/S0027-5107(99)00083-4; Maxwell WMC, 1999, THERIOGENOLOGY, V52, P1353, DOI 10.1016/S0093-691X(99)00222-8; Megumi T, 2009, J RADIAT RES, V50, P11, DOI [10.1269/jrr.08099, DOI 10.1269/JRR.08099.PUBMED:19218778]; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Park YJ, 2012, J PROTEOME RES, V11, P4162, DOI 10.1021/pr300248s; Perez LJ, 1996, THERIOGENOLOGY, V45, P1037, DOI 10.1016/0093-691X(96)00031-3; QUINN P, 1982, J REPROD FERTIL, V66, P161; Seligman J, 2004, BIOL REPROD, V71, P1009, DOI 10.1095/biolreprod.104.028035; Shukla KK, 2012, J ANDROL, V33, P777, DOI 10.2164/jandrol.111.015552; Shukla KK, 2011, REPROD BIOMED ONLINE, V22, P421, DOI 10.1016/j.rbmo.2011.01.010; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Suryawanshi AR, 2011, J ANDROL, V32, P240, DOI 10.2164/jandrol.110.010967; Sutovsky P, 2004, HUM REPROD, V19, P628, DOI 10.1093/humrep/deh131; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WISHART GJ, 1986, BRIT POULTRY SCI, V27, P97, DOI 10.1080/00071668608416859	31	26	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76959	10.1371/journal.pone.0076959	http://dx.doi.org/10.1371/journal.pone.0076959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130818	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900111
J	Yuan, YM; Li, MY; Hong, N; Hong, YH				Yuan, Yongming; Li, Mingyou; Hong, Ni; Hong, Yunhan			Correlative light and electron microscopic analyses of mitochondrial distribution in blastomeres of early fish embryos	FASEB JOURNAL			English	Article						medaka; Tom20; localization; fluorescent protein; out membrane	STEM-CELLS; DRUG SELECTION; IN-VITRO; MEDAKA; ESTABLISHMENT; PRESERVATION; FLUORESCENCE; ZEBRAFISH; PROTEINS; IMPORT	Early embryos of vertebrates undergo remarkable dynamic molecular events, such as embryonic gradient, cellular polarity, and asymmetry necessary for cell fate decisions. Correlative light and electron microscopy (CLEM) is a powerful tool to investigate rare or dynamic molecular events and has been developed for relatively small cells in culture and tissues but is not yet available for large cells of early development stage embryos. Here we report the capability of CLEM in blastomeres of medaka fish by using the mitochondria detection system. A short N-terminal signal peptide of the mitochondrial protein Tom20 was linked to green fluorescent protein (GFP), resulting in a fusion protein termed Tom20:GFP. The subcellular location of Tom20:GFP in medaka blastomeres reveals the lack of mitochondrial distribution in pseudopodia as well as inconspicuous redistribution during divisions. Blastomeres, after sample preparation procedures including high-pressure freezing and freeze substitution, are able to preserve fluorescence, antigenicity, and fine structures, which allows for precise correlation between the Tom20:GFP fluorescence and mitochondria on merged light and electron micrographs. Furthermore, nanogold immunostaining for Tom20:GFP and endogenous Tom20 revealed their specific localization on the mitochondrial outer membrane. Our results extend the CLEM approach to early development stage embryos of a vertebrate.Yuan, Y., Li, M., Hong, N., Hong, Y. Correlative light and electron microscopic analyses of mitochondrial distribution in blastomeres of early fish embryos.	[Yuan, Yongming; Li, Mingyou; Hong, Ni; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Li, Mingyou; Hong, Yunhan] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	National University of Singapore; Shanghai Ocean University	Hong, YH (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbshyh@nus.edu.sg	Hong, Ni/Y-6114-2018; Yuan, Yongming/H-7240-2016; Hong, Yunhan/D-4197-2009	Hong, Ni/0000-0002-9404-3110; Yuan, Yongming/0000-0002-2057-2204; Li, Mingyou/0000-0002-8729-7964	National Research Foundation Singapore [NRF-CRP7-2010-03]	National Research Foundation Singapore(National Research Foundation, Singapore)	The authors thank J. R. Deng for fish breeding and C. M. Foong for laboratory management. This work was supported by the National Research Foundation Singapore (NRF-CRP7-2010-03). Author contributions: Y.Y. and Y.H. designed the experiment and prepared the manuscript; Y.Y., M.L., and N.H. performed the research work. The authors declare no conflicts of interest.	Arismendi-Morillo G, 2012, ULTRASTRUCT PATHOL, V36, P409, DOI 10.3109/01913123.2012.694582; Brown E, 2009, SEMIN CELL DEV BIOL, V20, P910, DOI 10.1016/j.semcdb.2009.07.006; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; GARRIS DR, 1984, GYNECOL OBSTET INVES, V17, P10, DOI 10.1159/000299116; Giepmans BNG, 2008, HISTOCHEM CELL BIOL, V130, P211, DOI 10.1007/s00418-008-0460-5; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Hong N, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0144; Hong N, 2012, STEM CELLS DEV, V21, P2333, DOI 10.1089/scd.2011.0630; Hong N, 2010, CELL MOL LIFE SCI, V67, P1189, DOI 10.1007/s00018-009-0247-4; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 2004, TRANSGENIC RES, V13, P41, DOI 10.1023/B:TRAG.0000017172.71391.fa; Hong YH, 1996, MOL MAR BIOL BIOTECH, V5, P93; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Li MY, 2009, MECH DEVELOP, V126, P366, DOI 10.1016/j.mod.2009.02.004; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; MCDONALD K, 1993, MICROSC RES TECHNIQ, V24, P465, DOI 10.1002/jemt.1070240603; Muller-Reichert T, 2007, METHOD CELL BIOL, V79, P101, DOI 10.1016/S0091-679X(06)79004-5; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yamano K, 2011, NAT CELL BIOL, V13, P1026, DOI 10.1038/ncb2334; Yi MS, 2010, NAT PROTOC, V5, P1418, DOI 10.1038/nprot.2010.104; Yi MS, 2010, SCI CHINA LIFE SCI, V53, P426, DOI 10.1007/s11427-010-0079-3; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Zhao HB, 2012, ANAL CHEM, V84, P987, DOI 10.1021/ac202541t	35	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					577	585		10.1096/fj.13-233635	http://dx.doi.org/10.1096/fj.13-233635			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24136588				2022-12-25	WOS:000331072200006
J	Turnbull, J; Tiberia, E; Pereira, S; Zhao, XC; Pencea, N; Wheeler, AL; Yu, WQ; Ivovic, A; Naranian, T; Israelian, N; Draginov, A; Piliguian, M; Frankland, PW; Wang, PX; Ackerley, CA; Giacca, A; Minassian, BA				Turnbull, Julie; Tiberia, Erica; Pereira, Sandra; Zhao, Xiaochu; Pencea, Nela; Wheeler, Anne L.; Yu, Wen Qin; Ivovic, Alexander; Naranian, Taline; Israelian, Nyrie; Draginov, Arman; Piliguian, Mark; Frankland, Paul W.; Wang, Peixiang; Ackerley, Cameron A.; Giacca, Adria; Minassian, Berge A.			Deficiency of a Glycogen Synthase-associated Protein, Epm2aip1, Causes Decreased Glycogen Synthesis and Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Diabetes; Glycogen Synthase; Mouse Genetics; Obesity; Lafora Disease; Mouse Model; Glycogen Metabolism	PROGRESSIVE MYOCLONUS EPILEPSY; DEPENDENT DIABETES-MELLITUS; MUSCLE GLYCOGEN; SKELETAL-MUSCLE; GLUCOSE-TOLERANCE; LAFORA DISEASE; METABOLISM; MICE; LIVER; IDENTIFICATION	Background: Impaired activation of glycogen synthesis is a major component of insulin resistance. Results: We identified a protein, Epm2aip1, that associates with glycogen synthase (GS) and whose absence impairs allosteric activation of GS and causes hepatic insulin resistance. Conclusion: Epm2aip1 is a modulator of GS activity under insulin control. Significance: This study uncovers a novel component of glycogen regulation and hepatic insulin resistance. Glycogen synthesis is a major component of the insulin response, and defective glycogen synthesis is a major portion of insulin resistance. Insulin regulates glycogen synthase (GS) through incompletely defined pathways that activate the enzyme through dephosphorylation and, more potently, allosteric activation. We identify Epm2aip1 as a GS-associated protein. We show that the absence of Epm2aip1 in mice impairs allosteric activation of GS by glucose 6-phosphate, decreases hepatic glycogen synthesis, increases liver fat, causes hepatic insulin resistance, and protects against age-related obesity. Our work identifies a novel GS-associated GS activity-modulating component of insulin resistance.	[Turnbull, Julie; Tiberia, Erica; Zhao, Xiaochu; Pencea, Nela; Naranian, Taline; Israelian, Nyrie; Draginov, Arman; Piliguian, Mark; Wang, Peixiang; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Pencea, Nela; Ackerley, Cameron A.] Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; [Wheeler, Anne L.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Turnbull, Julie] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Pereira, Sandra; Ivovic, Alexander; Giacca, Adria] Univ Toronto, Dept Physiol & Med, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Minassian, BA (corresponding author), Univ Toronto, 100 Coll St, Toronto, ON M5S 1A1, Canada.	berge.minassian@sickkids.ca	Wheeler, Anne/V-1215-2019	Wheeler, Anne/0000-0002-1103-0526	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	ACHESON KJ, 1988, AM J CLIN NUTR, V48, P240, DOI 10.1093/ajcn/48.2.240; Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Bouskila M, 2010, CELL METAB, V12, P456, DOI 10.1016/j.cmet.2010.10.006; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruno C, 2004, NEUROLOGY, V63, P1053, DOI 10.1212/01.WNL.0000138429.11433.0D; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CHEN CB, 1993, AM J PHYSIOL, V265, pE743, DOI 10.1152/ajpendo.1993.265.5.E743; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Daniele N, 1999, J BIOL CHEM, V274, P3597, DOI 10.1074/jbc.274.6.3597; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Duez H, 2009, ENDOCRINOLOGY, V150, P56, DOI 10.1210/en.2008-1137; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; Golay A, 2002, METABOLISM, V51, P549, DOI 10.1053/meta.2002.31972; Henry RR, 1996, J CLIN INVEST, V98, P1231, DOI 10.1172/JCI118906; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; Ianzano L, 2003, GENOMICS, V81, P579, DOI 10.1016/S0888-7543(03)00094-6; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jensen Jorgen, 2009, Archives of Physiology and Biochemistry, V115, P13, DOI 10.1080/13813450902778171; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kadotani A, 2007, ARCH BIOCHEM BIOPHYS, V466, P283, DOI 10.1016/j.abb.2007.08.006; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; NEWGARD CB, 1984, DIABETES, V33, P192, DOI 10.2337/diabetes.33.2.192; Niederwanger A, 2005, J CHROMATOGR B, V820, P143, DOI 10.1016/j.jchromb.2005.02.019; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Skurat A. V., 2004, DIABETES MELLITUS FU; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Taylor R., 2011, HDB PHYSL ENDOCRINE, P787; THORBURN AW, 1991, J CLIN INVEST, V87, P489, DOI 10.1172/JCI115022; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; Tourlakis ME, 2012, GASTROENTEROLOGY, V143, P481, DOI 10.1053/j.gastro.2012.04.012; Turnbull J, 2012, BRAIN, V135, P2684, DOI 10.1093/brain/aws205; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998	52	12	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34627	34637		10.1074/jbc.M113.483198	http://dx.doi.org/10.1074/jbc.M113.483198			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142699	Green Published, hybrid			2022-12-25	WOS:000329812800030
J	Li, ML; Reynolds, CM; Sloboda, DM; Gray, C; Vickers, MH				Li, Minglan; Reynolds, Clare M.; Sloboda, Deborah M.; Gray, Clint; Vickers, Mark H.			Effects of Taurine Supplementation on Hepatic Markers of Inflammation and Lipid Metabolism in Mothers and Offspring in the Setting of Maternal Obesity	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LOW-PROTEIN DIET; NEONATAL LEPTIN TREATMENT; BETA-CELL FUNCTION; INSULIN-RESISTANCE; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; OLIGONUCLEOTIDE MICROARRAY; DIABETES-MELLITUS; N-ACETYLCYSTEINE	Maternal obesity is associated with obesity and metabolic disorders in offspring. However, intervention strategies to reverse or ameliorate the effects of maternal obesity on offspring health are limited. Following maternal undernutrition, taurine supplementation can improve outcomes in offspring, possibly via effects on glucose homeostasis and insulin secretion. The effects of taurine in mediating inflammatory processes as a protective mechanism has not been investigated. Further, the efficacy of taurine supplementation in the setting of maternal obesity is not known. Using a model of maternal obesity, we examined the effects of maternal taurine supplementation on outcomes related to inflammation and lipid metabolism in mothers and neonates. Time-mated Wistar rats were randomised to either: 1) control : control diet during pregnancy and lactation (CON); 2) CON supplemented with 1.5% taurine in drinking water (CT); 3) maternal obesogenic diet (high fat, high fructose) during pregnancy and lactation (MO); or 4) MO supplemented with taurine (MOT). Maternal and neonatal weights, plasma cytokines and hepatic gene expression were analysed. A MO diet resulted in maternal hyperinsulinemia and hyperleptinemia and increased plasma glucose, glutamate and TNF-alpha concentrations. Taurine normalised maternal plasma TNF-alpha and glutamate concentrations in MOT animals. Both MO and MOT mothers displayed evidence of fatty liver accompanied by alterations in key markers of hepatic lipid metabolism. MO neonates displayed a pro-inflammatory hepatic profile which was partially rescued in MOT offspring. Conversely, a pro-inflammatory phenotype was observed in MOT mothers suggesting a possible maternal trade-off to protect the neonate. Despite protective effects of taurine in MOT offspring, neonatal mortality was increased in CT neonates, indicating possible adverse effects of taurine in the setting of normal pregnancy. These data suggest that maternal taurine supplementation may ameliorate the adverse effects observed in offspring following a maternal obesogenic diet but these effects are dependent upon prior maternal nutritional background.	[Li, Minglan; Reynolds, Clare M.; Sloboda, Deborah M.; Gray, Clint; Vickers, Mark H.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Li, Minglan; Reynolds, Clare M.; Sloboda, Deborah M.; Gray, Clint; Vickers, Mark H.] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand; [Sloboda, Deborah M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Auckland; University of Auckland; McMaster University	Vickers, MH (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	m.vickers@auckland.ac.nz		Vickers, Mark/0000-0003-4876-9356; Reynolds, Clare/0000-0001-5782-6303; Li, Minglan/0000-0002-3095-7490	Gravida: National Centre for Growth and Development [3607214]; Kelliher Trust [3700171]	Gravida: National Centre for Growth and Development; Kelliher Trust	This work was supported by funding from Gravida: National Centre for Growth and Development (www.gravida.org.nz, Project 3607214) and the Kelliher Trust (kellihercharitabletrust.org.nz, Project 3700171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Anuradha CV, 1999, CAN J PHYSIOL PHARM, V77, P749, DOI 10.1139/cjpp-77-10-749; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Carneiro EA, 2009, J NUTR BIOCHEM, V20, P503, DOI 10.1016/j.jnutbio.2008.05.008; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chang YY, 2011, J AGR FOOD CHEM, V59, P450, DOI 10.1021/jf103167u; Chen SW, 2006, DIGEST DIS SCI, V51, P2225, DOI 10.1007/s10620-006-9359-y; Cherif H, 1998, J ENDOCRINOL, V159, P341, DOI 10.1677/joe.0.1590341; Chiappini F, 2006, LAB INVEST, V86, P154, DOI 10.1038/labinvest.3700374; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Davalli AM, 2012, ACTA DIABETOL, V49, P167, DOI 10.1007/s00592-011-0364-z; Elshorbagy AK, 2013, METABOLISM, V62, P509, DOI 10.1016/j.metabol.2012.10.005; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Franconi F, 2004, NEUROCHEM RES, V29, P143, DOI 10.1023/B:NERE.0000010443.05899.2f; Gentile CL, 2011, AM J PHYSIOL-REG I, V301, pR1710, DOI 10.1152/ajpregu.00677.2010; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053505; Haber CA, 2003, AM J PHYSIOL-ENDOC M, V285, pE744, DOI 10.1152/ajpendo.00355.2002; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hermanowski-Vosatka A, 2000, BIOCHEM BIOPH RES CO, V279, P330, DOI 10.1006/bbrc.2000.3966; Hermanussen M, 2006, EUR J CLIN NUTR, V60, P25, DOI 10.1038/sj.ejcn.1602263; Hillemeier MM, 2011, J WOMENS HEALTH, V20, P703, DOI 10.1089/jwh.2010.2397; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; IENTILE R, 1992, ITAL J BIOCHEM, V41, P183; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Kaaja R, 1999, METABOLISM, V48, P892, DOI 10.1016/S0026-0495(99)90225-1; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Lin S, 2013, MOL NUTR FOOD RES; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manco M, 2007, AM J CLIN PATHOL, V127, P954, DOI 10.1309/6VJ4DWGYDU0XYJ8Q; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McArthur MJ, 1999, J LIPID RES, V40, P1371; Merezak S, 2004, DIABETOLOGIA, V47, P669, DOI 10.1007/s00125-004-1357-z; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Mikami N, 2012, J FOOD SCI, V77, pH114, DOI 10.1111/j.1750-3841.2012.02687.x; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nandhini ATA, 2005, DIABETES METAB, V31, P337; Nodine PM, 2012, MCN-AM J MATERN-CHIL, V37, P110, DOI 10.1097/NMC.0b013e3182430296; OLNEY JW, 1970, NATURE, V227, P609, DOI 10.1038/227609b0; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Shivananjappa MM, 2012, REPROD BIOMED ONLINE, V24, P558, DOI 10.1016/j.rbmo.2012.01.016; STEINEGER HH, 1994, EUR J BIOCHEM, V225, P967, DOI 10.1111/j.1432-1033.1994.0967b.x; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Tang C, 2013, REPRODUCTION, V145, P609, DOI 10.1530/REP-12-0388; Tiikkainen M, 2002, OBES RES, V10, P859, DOI 10.1038/oby.2002.118; Valladolid-Acebes I, 2012, AM J PHYSIOL-ENDOC M, V302, pE396, DOI 10.1152/ajpendo.00343.2011; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; WORDEN JA, 1985, COMP BIOCHEM PHYS B, V82, P233, DOI 10.1016/0305-0491(85)90232-9; Yu TX, 1997, BRAIN RES, V747, P195, DOI 10.1016/S0006-8993(96)01181-X; Yu XP, 2008, NEUROCHEM RES, V33, P500, DOI 10.1007/s11064-007-9465-z; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	70	47	49	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76961	10.1371/journal.pone.0076961	http://dx.doi.org/10.1371/journal.pone.0076961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146946	gold, Green Submitted, Green Published			2022-12-25	WOS:000326022200027
J	Salinero-Fort, MA; San Andres-Rebollo, FJ; de Burgos-Lunar, C; Arrieta-Blanco, FJ; Gomez-Campelo, P				Salinero-Fort, Miguel A.; Javier San Andres-Rebollo, Francisco; de Burgos-Lunar, Carmen; Jesus Arrieta-Blanco, Francisco; Gomez-Campelo, Paloma		MADIABETES Grp	Four-Year Incidence of Diabetic Retinopathy in a Spanish Cohort: The MADIABETES Study	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; FOLLOW-UP; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS RISK; PRIMARY PREVENTION; VISUAL IMPAIRMENT; 9-YEAR INCIDENCE; 5-YEAR INCIDENCE; PLASMA-GLUCOSE	Objective: To evaluate the incidence of diabetic retinopathy in patients with Type 2 Diabetes Mellitus, to identify the risk factors associated with the incidence of retinopathy and to develop a risk table to predict four-year retinopathy risk stratification for clinical use, from a four-year cohort study. Design: The MADIABETES Study is a prospective cohort study of 3,443 outpatients with Type 2 Diabetes Mellitus, sampled from 56 primary health care centers (131 general practitioners) in Madrid (Spain). Results: The cumulative incidence of retinopathy at four-year follow-up was 8.07% (95% CI = 7.04-9.22) and the incidence density was 2.03 (95% CI = 1.75-2.33) cases per 1000 patient-months or 2.43 (95% CI = 2.10-2.80) cases per 100 patient-years. The highest adjusted hazard ratios of associated risk factors for incidence of diabetic retinopathy were LDL-C >190 mg/dl (HR = 7.91; 95% CI = 3.39-18.47), duration of diabetes longer than 22 years (HR = 2.00; 95% CI = 1.18-3.39), HbA1c>8% (HR = 1.90; 95% CI = 1.30-2.77), and aspirin use (HR = 1.65; 95% CI = 1.22-2.24). Microalbuminuria (HR = 1.17; 95% CI = 0.75-1.82) and being female (HR = 1.12; 95% CI = 0.84-1.49) showed a non-significant increase of diabetic retinopathy. The greatest risk is observed in females who had diabetes for more than 22 years, with microalbuminuria, HbA1c>8%, hypertension, LDL-Cholesterol >190 mg/dl and aspirin use. Conclusions: After a four-year follow-up, the cumulative incidence of retinopathy was relatively low in comparison with other studies. Higher baseline HbA1c, aspirin use, higher LDL-Cholesterol levels, and longer duration of diabetes were the only statistically significant risk factors found for diabetic retinopathy incidence. This is the first study to demonstrate an association between aspirin use and diabetic retinopathy risk in a well-defined cohort of patients with Type 2 Diabetes Mellitus at low risk of cardiovascular events. However, further studies with patients at high cardiovascular and metabolic risk are needed to clarify this issue.	[Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma] Hosp Carlos III, Serv Madrileno Salud, Fdn Invest Biomed, Madrid, Spain; [Javier San Andres-Rebollo, Francisco] Ctr Salud Las Calesas, Serv Madrileno Salud, Madrid, Spain; [de Burgos-Lunar, Carmen] Hosp Carlos III, Unidad Epidemiol Clin, Serv Madrileno Salud, Madrid, Spain; [Jesus Arrieta-Blanco, Francisco] Hosp Ramon & Cajal, Serv Endocrinol & Nutr, Unidad Nutr Obesidad & Metab, CIBER Obesidad & Nutr,IRYCIS,Serv Madrileno Salud, E-28034 Madrid, Spain	Hospital Carlos III; Hospital Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Universitario Ramon y Cajal	Salinero-Fort, MA (corresponding author), Hosp Carlos III, Serv Madrileno Salud, Fdn Invest Biomed, Madrid, Spain.	miguel.salinero@salud.madrid.org	SALINERO-FORT, MIGUEL A./GOP-2536-2022; de Santa Pau, Enrique Carrillo/AAV-7544-2021; ALVAREZ EMBARBA, BEATRIZ/AHE-8612-2022	SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; ALVAREZ EMBARBA, BEATRIZ/0000-0002-2084-3051; Vich Perez, Pilar/0000-0002-6702-909X; Serrano Serrano, Maria Encarnacion/0000-0003-3150-2348; Gomez Campelo, Paloma/0000-0003-2299-1741	Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III [PI05/0681, PI10/02796, PI12/01806]	Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III	This study has been funded by the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III(PI05/0681, PI10/02796, PI12/01806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajoy MVK, 2011, INDIAN J OPHTHALMOL, V59, P207, DOI 10.4103/0301-4738.81029; American Diabetes Association, 2011, DIABETES CARE S1, V35, pS11; [Anonymous], 1991, Ophthalmology, V98, P786; Benarous R, 2011, INVEST OPHTH VIS SCI, V52, P7464, DOI 10.1167/iovs.11-7598; Bergerhoff K, 2002, ENDOCRIN METAB CLIN, V31, P779, DOI 10.1016/S0889-8529(02)00017-8; Bosomworth NJ, 2011, CAN FAM PHYSICIAN, V57, P417; Brown JB, 2003, DIABETES CARE, V26, P2637, DOI 10.2337/diacare.26.9.2637; Bruno G, 1996, DIABETES CARE, V19, P43, DOI 10.2337/diacare.19.1.43; CHEN MS, 1995, INT J EPIDEMIOL, V24, P787, DOI 10.1093/ije/24.4.787; Chen YH, 2012, DIABETES CARE, V35, P803, DOI 10.2337/dc11-1955; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; CIGNARELLI M, 1992, DIABETES CARE, V15, P1002, DOI 10.2337/diacare.15.8.1002; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; Davies, 2012, DIABETES, P1, DOI DOI 10.1002/9781118405550.CH1; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Domenech JM, 2008, ANALISIS SUPERVIVENC; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Estacio RO, 2000, DIABETES CARE, V23, pB54; GALL MA, 1991, DIABETOLOGIA, V34, P655, DOI 10.1007/BF00400995; Gimeno-Orna JA, 2003, J DIABETES COMPLICAT, V17, P78, DOI 10.1016/S1056-8727(02)00197-6; Guven D, 1996, OPHTHALMOLOGY, V103, P1245; Hirsch IB, 2010, JAMA-J AM MED ASSOC, V303, P2291, DOI 10.1001/jama.2010.785; Hosseini SM, 2009, J RES MED SCI, V14, P105; Juutilainen A, 2007, DIABETES CARE, V30, P292, DOI 10.2337/dc06-1747; Kim HK, 1998, DIABETES CARE, V21, P134, DOI 10.2337/diacare.21.1.134; Klein BEK, 2012, JAMA-J AM MED ASSOC, V308, P2469, DOI 10.1001/jama.2012.65406; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; KLEIN R, 1992, OPHTHALMOLOGY, V99, P58; KLEIN R, 1993, DIABETES CARE, V16, P1325, DOI 10.2337/diacare.16.10.1325; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Klein R, 2008, CONTEMP DIABETES, P67, DOI 10.1007/978-1-59745-563-3_3; KNOWLER WC, 1980, NEW ENGL J MED, V302, P645, DOI 10.1056/NEJM198003203021201; Kohner EM, 2008, DIABETIC MED, V25, P20, DOI 10.1111/j.1464-5491.2008.02505.x; Leske MC, 2006, ARCH OPHTHALMOL-CHIC, V124, P250, DOI 10.1001/archopht.124.2.250; Leske MC, 2005, OPHTHALMOLOGY, V112, P799, DOI 10.1016/j.ophtha.2004.11.054; Leske MC, 2003, OPHTHALMOLOGY, V110, P941, DOI 10.1016/S0161-6420(03)00086-1; Liu DP, 2002, DIABETES RES CLIN PR, V56, P125, DOI 10.1016/S0168-8227(01)00349-7; LIU QZ, 1993, DIABETOLOGIA, V36, P428, DOI 10.1007/BF00402279; Looker HC, 2003, DIABETES CARE, V26, P320, DOI 10.2337/diacare.26.2.320; López Gálvez MI, 2004, Arch Soc Esp Oftalmol, V79, P149; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Manaviat MR, 2008, EUR J OPHTHALMOL, V18, P572, DOI 10.1177/112067210801800412; Manaviat Masoud R, 2004, BMC Ophthalmol, V4, P9, DOI 10.1186/1471-2415-4-9; Marrugat J, 2003, REV ESP CARDIOL, V56, P253, DOI 10.1157/13043951; McCarty DJ, 2003, CLIN EXP OPHTHALMOL, V31, P397, DOI 10.1046/j.1442-9071.2003.00685.x; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Newman D J, 2005, Health Technol Assess, V9, piii; Perol J, 2012, DIABETES METAB, V38, P225, DOI 10.1016/j.diabet.2012.01.001; Pignone M, 2010, NAT REV ENDOCRINOL, V6, P619, DOI 10.1038/nrendo.2010.169; Potisat Somkiat, 2008, Journal of the Medical Association of Thailand, V91, P846; Pugliese G, 2012, DIABETES RES CLIN PR, V25; Raman R, 2012, CURR EYE RES, V37, P513, DOI 10.3109/02713683.2012.669005; Rani PK, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-9; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Romero-Aroca P, 2012, J DIABETES COMPLICAT, V26, P506, DOI 10.1016/j.jdiacomp.2012.06.010; Santos-Bueso E, 2007, ARCH SOC ESPANOLA OF, V82; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; Simpson SH, 2011, J GEN INTERN MED, V26, P1336, DOI 10.1007/s11606-011-1757-y; Singh S K, 2001, J Assoc Physicians India, V49, P439; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tam T. K. W., 2005, Hong Kong Medical Journal, V11, P438; Tam VHK, 2009, J DIABETES COMPLICAT, V23, P185, DOI 10.1016/j.jdiacomp.2008.03.001; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; Targher G, 2008, DIABETIC MED, V25, P45, DOI 10.1111/j.1464-5491.2007.02327.x; Teruel Maicas C, 2005, ARCH SOC ESP OFTALMO, V80; Thomas RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e874; Thompson JW, 1998, HEALTH AFFAIR, V17, P152, DOI 10.1377/hlthaff.17.1.152; Tong PCY, 2007, DIABETIC MED, V24, P741, DOI 10.1111/j.1464-5491.2007.02145.x; Tudor SM, 1998, DIABETES CARE, V21, P53, DOI 10.2337/diacare.21.1.53; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unnikrishnan R, 2007, DIABETES CARE, V30, P2019, DOI 10.2337/dc06-2554; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; Varma R, 2010, AM J OPHTHALMOL, V149, P752, DOI 10.1016/j.ajo.2009.11.014; VIGSTRUP J, 1985, ACTA OPHTHALMOL, V63, P530; Voutilainen-Kaunisto RM, 2001, J DIABETES COMPLICAT, V15, P24, DOI 10.1016/S1056-8727(00)00126-4; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026871; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wirta OR, 1995, J DIABETES COMPLICAT, V9, P177, DOI 10.1016/1056-8727(94)00034-L; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; Zhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058821	90	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76417	10.1371/journal.pone.0076417	http://dx.doi.org/10.1371/journal.pone.0076417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146865	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200013
J	Wu, DY; Jospin, G; Eisen, JA				Wu, Dongying; Jospin, Guillaume; Eisen, Jonathan A.			Systematic Identification of Gene Families for Use as "Markers" for Phylogenetic and Phylogeny-Driven Ecological Studies of Bacteria and Archaea and Their Major Subgroups	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; GENOME; EVOLUTION; ALIGNMENT; DATABASE; PROTEIN; TREES; DIVERSITY; IMPACT; CORE	With the astonishing rate that genomic and metagenomic sequence data sets are accumulating, there are many reasons to constrain the data analyses. One approach to such constrained analyses is to focus on select subsets of gene families that are particularly well suited for the tasks at hand. Such gene families have generally been referred to as "marker" genes. We are particularly interested in identifying and using such marker genes for phylogenetic and phylogeny-driven ecological studies of microbes and their communities (e. g., construction of species trees, phylogenetic based assignment of metagenomic sequence reads to taxonomic groups, phylogeny-based assessment of alpha-and beta-diversity of microbial communities from metagenomic data). We therefore refer to these as PhyEco (for phylogenetic and phylogenetic ecology) markers. The dual use of these PhyEco markers means that we needed to develop and apply a set of somewhat novel criteria for identification of the best candidates for such markers. The criteria we focused on included universality across the taxa of interest, ability to be used to produce robust phylogenetic trees that reflect as much as possible the evolution of the species from which the genes come, and low variation in copy number across taxa. We describe here an automated protocol for identifying potential PhyEco markers from a set of complete genome sequences. The protocol combines rapid searching, clustering and phylogenetic tree building algorithms to generate protein families that meet the criteria listed above. We report here the identification of PhyEco markers for different taxonomic levels including 40 for "all bacteria and archaea", 114 for "all bacteria (greatly expanding on the similar to 30 commonly used), and 100 s to 1000 s for some of the individual phyla of bacteria. This new list of PhyEco markers should allow much more detailed automated phylogenetic and phylogenetic ecology analyses of these groups than possible previously.	[Wu, Dongying; Jospin, Guillaume; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Dept Med Microbiol & Immunol, Dept Evolut & Ecol, Davis, CA 95616 USA; [Wu, Dongying] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Wu, DY (corresponding author), Univ Calif Davis, Genome Ctr, Dept Med Microbiol & Immunol, Dept Evolut & Ecol, Davis, CA 95616 USA.	dygwu@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Jospin, Guillaume/0000-0002-8746-2632	Gordon and Betty Moore Foundation [1660, 3300]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding for this work was provided by the Gordon and Betty Moore Foundation (grant #1660 and #3300, website: http://www.moore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-324; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALCH WE, 1977, J MOL EVOL, V9, P305, DOI 10.1007/BF01796092; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeWall MT, 2011, BRIEF FUNCT GENOMICS, V10, P312, DOI 10.1093/bfgp/elr030; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 1995, J MOL EVOL, V41, P1105; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; HASEGAWA M, 1993, NATURE, V361, P23, DOI 10.1038/361023b0; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; LLOYD AT, 1993, J MOL EVOL, V37, P399; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Oxelman B, 2004, MOL PHYLOGENET EVOL, V32, P462, DOI 10.1016/j.ympev.2004.01.014; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Sandler SJ, 1999, J BACTERIOL, V181, P907, DOI 10.1128/JB.181.3.907-915.1999; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shannon CE, 1997, M D COMPUT, V14, P306; Sharpton TJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-264; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Z, 2013, MOL BIOL EVOL; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yang SX, 2001, J MOL BIOL, V312, P999, DOI 10.1006/jmbi.2001.5025; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	54	106	106	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77033	10.1371/journal.pone.0077033	http://dx.doi.org/10.1371/journal.pone.0077033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146954	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200029
J	Hirasawa, R; Matoba, S; Inoue, K; Ogura, A				Hirasawa, Ryutaro; Matoba, Shogo; Inoue, Kimiko; Ogura, Atsuo			Somatic Donor Cell Type Correlates with Embryonic, but Not Extra-Embryonic, Gene Expression in Postimplantation Cloned Embryos	PLOS ONE			English	Article							NUCLEAR TRANSFER; STEM-CELLS; MOUSE EMBRYO; TROPHOBLAST DEVELOPMENT; PLACENTAL DEVELOPMENT; BLASTOCYST STAGE; CLONING; MICE; DIFFERENTIATION; PLURIPOTENCY	The great majority of embryos generated by somatic cell nuclear transfer (SCNT) display defined abnormal phenotypes after implantation, such as an increased likelihood of death and abnormal placentation. To gain better insight into the underlying mechanisms, we analyzed genome-wide gene expression profiles of day 6.5 postimplantation mouse embryos cloned from three different cell types (cumulus cells, neonatal Sertoli cells and fibroblasts). The embryos retrieved from the uteri were separated into embryonic (epiblast) and extraembryonic (extraembryonic ectoderm and ectoplacental cone) tissues and were subjected to gene microarray analysis. Genotype- and sex-matched embryos produced by in vitro fertilization were used as controls. Principal component analysis revealed that whereas the gene expression patterns in the embryonic tissues varied according to the donor cell type, those in extraembryonic tissues were relatively consistent across all groups. Within each group, the embryonic tissues had more differentially expressed genes (DEGs) (>2-fold vs. controls) than did the extraembryonic tissues (P<1.0x10(-26)). In the embryonic tissues, one of the common abnormalities was upregulation of Dlk1, a paternally imprinted gene. This might be a potential cause of the occasional placenta-only conceptuses seen in SCNT-generated mouse embryos (1-5% per embryos transferred in our laboratory), because dysregulation of the same gene is known to cause developmental failure of embryos derived from induced pluripotent stem cells. There were also some DEGs in the extraembryonic tissues, which might explain the poor development of SCNT-derived placentas at early stages. These findings suggest that SCNT affects the embryonic and extraembryonic development differentially and might cause further deterioration in the embryonic lineage in a donor cell-specific manner. This could explain donor cell-dependent variations in cloning efficiency using SCNT.	[Hirasawa, Ryutaro; Matoba, Shogo; Inoue, Kimiko; Ogura, Atsuo] RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan; [Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan	RIKEN; University of Tsukuba; University of Tokyo	Ogura, A (corresponding author), RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; MATOBA, Shogo/D-9995-2016	Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu JH, 2010, DEV BIOL, V342, P63, DOI 10.1016/j.ydbio.2010.03.009; Couldrey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055153; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; Hogan B, 1994, MANIPULATING MOUSE E, P220; Inoue K, 2003, BIOL REPROD, V69, P1394, DOI 10.1095/biolreprod.103.017731; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Niemann H, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02121.x; Ogura A, 2000, MOL REPROD DEV, V57, P55, DOI 10.1002/1098-2795(200009)57:1&lt;55::AID-MRD8&gt;3.0.CO;2-W; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Rogers ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036483; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Sato S, 2011, GENOMICS, V98, P120, DOI 10.1016/j.ygeno.2011.05.003; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Singh U, 2005, DEV DYNAM, V234, P1034, DOI 10.1002/dvdy.20597; Singh U, 2004, DEV DYNAM, V230, P149, DOI 10.1002/dvdy.20024; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama T, 1999, SEMIN CELL DEV BIOL, V10, P253, DOI 10.1006/scdb.1998.0267; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wakisaka N, 2008, PLACENTA, V29, P753, DOI 10.1016/j.placenta.2008.05.008; Wakisaka-Saito N, 2006, BIOCHEM BIOPH RES CO, V349, P106, DOI 10.1016/j.bbrc.2006.08.057; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	49	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76422	10.1371/journal.pone.0076422	http://dx.doi.org/10.1371/journal.pone.0076422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146866	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400059
J	Li, RX; Yu, CG; Jiang, F; Gao, L; Li, JY; Wang, YM; Beckwith, N; Yao, LB; Zhang, J; Wu, GJ				Li, Ruixiao; Yu, Chuigong; Jiang, Feng; Gao, Lei; Li, Jianying; Wang, Yingmei; Beckwith, Noor; Yao, Libo; Zhang, Jing; Wu, Guojun			Overexpression of N-Myc Downstream-Regulated Gene 2 (NDRG2) Regulates the Proliferation and Invasion of Bladder Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							EXPRESSION; SUPPRESSION; TUMORS; LIVER	N-Myc downstream-regulated gene 2 (NDRG2) is a candidate tumor suppressor gene, which plays an important role in controlling tumor growth. The aim of this study was to investigate the expression of NDRG2 gene in bladder cancer (BC) tissues and several bladder cancer cell lines, and to seek its clinical and pathological significance. Ninety-seven bladder carcinoma and 15 normal bladder tissue sections were analyzed retrospectively with immunohistochemistry. The human bladder cancer cell line T24 was infected with LEN-NDRG2 or LEN-LacZ. The effects of NDRG2 overexpression on T24 cells and T24 nude mouse xenografts were measured via cell growth curves, tumor growth curves, flow cytometric analysis, western blot and Transwell assay. NDRG2 was highly expressed in normal bladder tissue, but absent or rarely expressed in cacinomatous tissues (chi(2)=8.761, p<0.01). The NDRG2 level was negatively correlated with tumor grade and pathologic stage(r=-0.248, p<0.05), as well as increased c-myc level (r=-0.454, p<0.001). The expression of NDRG2 was low in the three BC cell lines. T24 cells infected with LEN-NDRG2 showed inhibition of proliferation both in vitro and in vivo, and NDRG2 overexpression can inhibit tumor growth and invasion in vitro.	[Li, Ruixiao; Li, Jianying; Yao, Libo; Zhang, Jing] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Li, Ruixiao; Yu, Chuigong; Gao, Lei; Wu, Guojun] Fourth Mil Med Univ, Dept Urol, Xijing Hosp, Xian 710032, Peoples R China; [Jiang, Feng] Fourth Mil Med Univ, Dept Obstet & Gynaecol, Tangdu Hosp, Xian 710032, Peoples R China; [Wang, Yingmei] Fourth Mil Med Univ, Dept Pathol, Xian 710032, Peoples R China; [Beckwith, Noor] Harvard Univ, Sch Med, Boston, MA USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Harvard University; Harvard Medical School	Zhang, J (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China.	zhangjing.99@163.com; gunwu@sina.com		Beckwith, Noor/0000-0001-6025-8642	National Natural Science Foundation of China [31070681]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was financially supported by National Natural Science Foundation of China (31070681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle H, 2011, CURR OPIN UROL, V21, P409, DOI 10.1097/MOU.0b013e3283495758; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Foletta VC, 2009, J PHYSIOL-LONDON, V587, P1619, DOI 10.1113/jphysiol.2008.167882; Gao L, 2011, CANCER LETT, V310, P94, DOI 10.1016/j.canlet.2011.06.015; Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032368; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Mansoor M, 2011, JCPSP-J COLL PHYSICI, V21, P157, DOI 03.2011/JCPSP.157160; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Szarvas T, 2011, NAT REV UROL, V8, P241, DOI 10.1038/nrurol.2011.44; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Yu CG, 2011, CANCER BIOL THER, V12, P304, DOI 10.4161/cbt.12.4.16382; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zhao HL, 2008, J ADV MECH DES SYST, V2, P303, DOI 10.1299/jamdsm.2.303; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	23	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76689	10.1371/journal.pone.0076689	http://dx.doi.org/10.1371/journal.pone.0076689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146910	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400082
J	Nichols, E; Uriarte, M; Peres, CA; Louzada, J; Braga, RF; Schiffler, G; Endo, W; Spector, SH				Nichols, Elizabeth; Uriarte, Maria; Peres, Carlos A.; Louzada, Julio; Braga, Rodrigo Fagundes; Schiffler, Gustavo; Endo, Whaldener; Spector, Sacha H.			Human-Induced Trophic Cascades along the Fecal Detritus Pathway	PLOS ONE			English	Article							DUNG BEETLE COMMUNITIES; POPULATION-DENSITIES; INTERACTION STRENGTH; ASSEMBLAGE STRUCTURE; ECOSYSTEM FUNCTION; TROPICAL FORESTS; SEED DISPERSAL; TOP-DOWN; DIVERSITY; MAMMALS	Human presence and activity in tropical forest is thought to exert top-down regulation over the various 'green-world' pathways of plant-based foodwebs. However, these effects have never been explored for the 'brown-world' pathways of fecal-detritus webs. The strong effects of humans on tropical game mammals are likely to indirectly influence fecal detritivores (including Scarabaeine dung beetles), with subsequent indirect impacts on detrivore-mediated and plant-facilitating detrital processes. Across a 380-km gradient of human influence in the western Brazilian Amazon, we conducted the first landscape-level assessment of human-induced cascade effects on the fecal detritus pathway, by coupling data on human impact, game mammal and detritivore community structure, and rate measurements of a key detritus process (i.e. dung beetle-mediated secondary seed dispersal). We found evidence that human impact indirectly influences both the diversity and biomass of fecal detritivores, but not detritivore-mediated processes. Cascade strength varied across detritivore groups defined by species' traits. We found smaller-bodied dung beetles were at higher risk of local decline in areas of human presence, and that body size was a better predictor of cascade structure than fecal resource manipulation strategy. Cascade strength was also stronger in upland, unflooded forests, than in seasonally flooded forests. Our results suggest that the impact of human activity in tropical forest on fecal-detritus food web structure is mediated by both species' traits and habitat type. Further research will be required to determine the conditions under which these cascade effects influence fecal-detritus web function.	[Nichols, Elizabeth; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Nichols, Elizabeth] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Louzada, Julio; Braga, Rodrigo Fagundes] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Louzada, Julio] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Schiffler, Gustavo] Univ Estadual Campinas, Dept Biol, Sao Paulo, Brazil; [Endo, Whaldener] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Spector, Sacha H.] Scen Hudson, Dept Conservat Sci, Poughkeepsie, NY USA	Columbia University; American Museum of Natural History (AMNH); University of East Anglia; Universidade Federal de Lavras; Lancaster University; Universidade Estadual de Campinas; Norwegian University of Life Sciences	Nichols, E (corresponding author), Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil.	lizsnichols@gmail.com	Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020; Endo, Whaldener/D-1726-2012; Louzada, Julio/F-1265-2010; Uriarte, Maria/L-8944-2013; Nichols, Elizabeth/L-7484-2013; Peres, Carlos A./B-1276-2013	Peres, Carlos A./0000-0002-1588-8765; Endo, Whaldener/0000-0002-7305-4398; Louzada, Julio/0000-0002-1481-3112; Nichols, Elizabeth/0000-0002-4960-6842; Peres, Carlos A./0000-0002-1588-8765	Brazilian Conselho Nacional Desenvolvimento Cientifico e Tecnologico [CNPq - 480645/2008-6]; United States National Science Foundation Research Coordination Network (NSF) [DEB-0043443]; DEFRA/UK Darwin Initiative grant [16-001]; Department of Ecology, Evolution and Environmental Biology at Columbia University; Columbia University Faculty Fellowship; Yeh Family Foundation; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Brazilian Conselho Nacional Desenvolvimento Cientifico e Tecnologico; United States National Science Foundation Research Coordination Network (NSF); DEFRA/UK Darwin Initiative grant; Department of Ecology, Evolution and Environmental Biology at Columbia University; Columbia University Faculty Fellowship; Yeh Family Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support for this study came from a Brazilian Conselho Nacional Desenvolvimento Cientifico e Tecnologico grant to EN, SS and JL (CNPq - 480645/2008-6; http://www.cnpq.br/), a United States National Science Foundation Research Coordination Network grant to SS (NSF Grant No. DEB-0043443; http://www.nsf.gov/), a DEFRA/UK Darwin Initiative grant to CAP (Ref. 16-001;http://www.defra.gov.uk/) and a pre-dissertation travel award from the Department of Ecology, Evolution and Environmental Biology at Columbia University to EN. EN also acknowledges funding from a Columbia University Faculty Fellowship and the Yeh Family Foundation. No individuals employed or contracted by any of these funders other than the named authors played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen E, 2007, BIOTROPICA, V39, P141, DOI 10.1111/j.1744-7429.2006.00239.x; Andresen Ellen, 2005, P331, DOI 10.1079/9780851998060.0331; [Anonymous], 2002, CAUSE CORRELATION BI; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bates D. M., 2010, IME4 MIXED EFFECTS M; Bayley PB, 1989, CAN SPEC PUBL FISH A, V106, P385; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Braga RF, 2012, ECOSYSTEMS, V15, P1173, DOI 10.1007/s10021-012-9576-5; BURGER BV, 1991, Z NATURFORSCH C, V46, P1073; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Chame M, 2003, MEM I OSWALDO CRUZ, V98, P71, DOI 10.1590/S0074-02762003000900014; Clayton L, 1997, ECOL APPL, V7, P642, DOI 10.1890/1051-0761(1997)007[0642:BHTBAS]2.0.CO;2; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; Derickx J, 1992, NO CORACAO AMAZONA J; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Esterci Neide, 2010, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V5, P59; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Halffter G., 1982, NESTING BEHAV DUNG B; Haugaasen T, 2005, AM J PRIMATOL, V67, P243, DOI 10.1002/ajp.20180; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Hawes JE, 2012, FOREST ECOL MANAG, V281, P163, DOI 10.1016/j.foreco.2012.06.023; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Horgan FG, 2005, FOREST ECOL MANAG, V216, P117, DOI 10.1016/j.foreco.2005.05.049; HOWDEN H F, 1975, Biotropica, V7, P77, DOI 10.2307/2989750; [Instituto Brasileiro de Geografia e Estatstica (IBGE) The Brazilian Institute of Geography and Statistics], 2010, CENS POP 2010; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Maron JL, 2011, ECOL LETT, V14, P661, DOI 10.1111/j.1461-0248.2011.01633.x; Martin-Piera F., 1996, Miscellania Zoologica (Barcelona), V19, P13; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; MEB, 2003, MOV ED BAS DEP CAR M; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Naranjo EJ, 2007, BIOL CONSERV, V138, P412, DOI 10.1016/j.biocon.2007.05.010; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1106, DOI 10.1046/j.1523-1739.2003.02045.x; Newton P, 2012, ENVIRON CONSERV, V39, P97, DOI 10.1017/S0376892911000580; Newton P, 2012, GLOBAL ENVIRON CHANG, V22, P127, DOI 10.1016/j.gloenvcha.2011.10.006; Newton P, 2011, FOREST ECOL MANAG, V261, P255, DOI 10.1016/j.foreco.2010.10.014; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Nichols E, 2011, DUNG BEETLE ECOLOGY; Nichols E, 2013, ECOLOGY, V94, P180, DOI 10.1890/12-0251.1; Otto SB, 2008, ECOLOGY, V89, P134, DOI 10.1890/07-0066.1; Palacois E, 2005, FOLIA PRIMATOL, V76, P135, DOI 10.1159/000084376; Parry L, 2009, BIOL CONSERV, V142, P1777, DOI 10.1016/j.biocon.2009.03.018; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2000, BIOL RESOURCE MANAGE, P31; Peres CA, 1997, FOLIA PRIMATOL, V68, P199, DOI 10.1159/000157247; PERES CA, 1999, MAMMALS NEOTROPICS C, P564; Peres CA, 2011, CENSO MONITORAMENTO; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Persson L, 1999, OIKOS, V85, P385, DOI 10.2307/3546688; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Poulsen JR, 2011, ECOL APPL, V21, P1819, DOI 10.1890/10-1083.1; Puertas PE, 2004, PEOPLE NATURE WILDLI, P122; R Core Team, 2016, R FDN STAT COMP; Refisch J, 2005, BIOTROPICA, V37, P136, DOI 10.1111/j.1744-7429.2005.03174.x; Rist J, 2008, BIOL CONSERV, V141, P2086, DOI 10.1016/j.biocon.2008.06.005; ROBINSON JG, 1986, OECOLOGIA, V68, P516, DOI 10.1007/BF00378765; Roslin T, 2001, OECOLOGIA, V127, P69, DOI 10.1007/s004420000565; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Silvius KM, 2002, J TROP ECOL, V18, P707, DOI 10.1017/S0266467402002468; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J., 2010, TROPHIC CASCADES PRE; Terborgh J., 2006, EMERGING THREATS TRO, P241; Tribe G.D., 2011, P87; Urquiza-Haas T, 2011, ANIM CONSERV, V14, P271, DOI 10.1111/j.1469-1795.2010.00426.x; Vaz-de-Mello FZ, 2011, ZOOTAXA, P1; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Wardle DA, 2004, FRONT ECOL ENVIRON, V2, P145, DOI 10.1890/1540-9295(2004)002[0145:HCILHM]2.0.CO;2; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Wu XW, 2011, ECOL MONOGR, V81, P313, DOI 10.1890/10-0808.1; Zhao C, 2013, J ANIM ECOL, V82, P749, DOI 10.1111/1365-2656.12058	96	25	25	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75819	10.1371/journal.pone.0075819	http://dx.doi.org/10.1371/journal.pone.0075819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146780	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400019
J	Rumah, KR; Linden, J; Fischetti, VA; Vartanian, T				Rumah, Kareem Rashid; Linden, Jennifer; Fischetti, Vincent A.; Vartanian, Timothy			Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease	PLOS ONE			English	Article							MICROCYSTIC MACULAR EDEMA; HIGH-AFFINITY BINDING; INNER NUCLEAR LAYER; D EPSILON-TOXIN; FAROE-ISLANDS; INTESTINAL INFECTIONS; SHEEP; PATHOLOGY; BRAIN; MICE	We have isolated Clostridium perfringens type B, an epsilon toxin-secreting bacillus, from a young woman at clinical presentation of Multiple Sclerosis (MS) with actively enhancing lesions on brain MRI. This finding represents the first time that C. perfringens type B has been detected in a human. Epsilon toxin's tropism for the blood-brain barrier (BBB) and binding to oligodendrocytes/myelin makes it a provocative candidate for nascent lesion formation in MS. We examined a well-characterized population of MS patients and healthy controls for carriage of C. perfringens toxinotypes in the gastrointestinal tract. The human commensal Clostridium perfringens type A was present in approximately 50% of healthy human controls compared to only 23% in MS patients. We examined sera and CSF obtained from two tissue banks and found that immunoreactivity to ETX is 10 times more prevalent in people with MS than in healthy controls, indicating prior exposure to ETX in the MS population. C. perfringens epsilon toxin fits mechanistically with nascent MS lesion formation since these lesions are characterized by BBB permeability and oligodendrocyte cell death in the absence of an adaptive immune infiltrate.	[Rumah, Kareem Rashid] Rockefeller Univ, Tri Inst MD PhD Program, Weill Cornell Med Coll, New York, NY 10021 USA; [Rumah, Kareem Rashid] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Rumah, Kareem Rashid; Linden, Jennifer; Vartanian, Timothy] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA; [Rumah, Kareem Rashid; Linden, Jennifer; Vartanian, Timothy] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA	Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Rockefeller University	Vartanian, T (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA.	tiv2002@med.cornell.edu		Vartanian, Timothy/0000-0001-9471-1855	Laurence Tisch Family Research Fund; Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research; Widgeon Point Charitable Foundation; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Laurence Tisch Family Research Fund; Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research; Widgeon Point Charitable Foundation; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported in part by The Laurence Tisch Family Research Fund, The Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research, The Widgeon Point Charitable Foundation, and the Rockefeller University Funds to the Laboratory of Bacterial Pathogenesis and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1952, AM J MED, V12, P510, DOI 10.1016/0002-9343(52)90234-9; Alqurashi Abdelrahman Mohammad, 2013, J Egypt Soc Parasitol, V43, P147; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Balali-Mood M, 2013, TOXICON, V69, P131, DOI 10.1016/j.toxicon.2013.01.005; Barkhof F, 2003, ANN NEUROL, V53, P718, DOI 10.1002/ana.10551; BARNES D, 1991, BRAIN, V114, P1271, DOI 10.1093/brain/114.3.1271; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Barnett MH, 2009, ANN NEUROL, V65, P32, DOI 10.1002/ana.21524; Basilio D, 2011, J GEN PHYSIOL, V137, P343, DOI 10.1085/jgp.201010578; BLACKWELL TE, 1983, CAN J COMP MED, V47, P127; Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; Bossi P, 2006, CELL MOL LIFE SCI, V63, P2196, DOI 10.1007/s00018-006-6308-z; Carman RJ, 2008, ANAEROBE, V14, P102, DOI 10.1016/j.anaerobe.2008.01.003; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Christensen KA, 2005, BIOCHEMISTRY-US, V44, P1047, DOI 10.1021/bi047791s; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Doganay Mehmet, 2010, J Infect Public Health, V3, P98, DOI 10.1016/j.jiph.2010.07.004; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; ENGELL T, 1986, ACTA OPHTHALMOL, V64, P583; ERICKSON JE, 1978, APPL ENVIRON MICROB, V36, P567, DOI 10.1128/AEM.36.4.567-571.1978; FINNIE JW, 1984, J COMP PATHOL, V94, P445, DOI 10.1016/0021-9975(84)90031-8; FINNIE JW, 1992, AUST VET J, V69, P261, DOI 10.1111/j.1751-0813.1992.tb09878.x; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; Garcia JP, 2013, INFECT IMMUN, V81, P2405, DOI 10.1128/IAI.00238-13; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Ghabriel MN, 2000, ACTA NEUROCHIR SUPPL, V76, P231; GLEESONWHITE MH, 1955, LANCET, V1, P384; Goldstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007065; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; HAVARD HL, 1992, FEMS MICROBIOL LETT, V97, P77, DOI 10.1111/j.1574-6968.1992.tb05443.x; HOROWITZ AL, 1989, AM J NEURORADIOL, V10, P303; ITODO AE, 1986, VET MICROBIOL, V12, P93, DOI 10.1016/0378-1135(86)90045-3; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; Kundi M, 2007, CIENC SAUDE COLETIVA, V12, P419, DOI 10.1590/S1413-81232007000200018; KURTZKE JF, 1979, ANN NEUROL, V5, P6, DOI 10.1002/ana.410050104; KURTZKE JF, 1986, NEUROLOGY, V36, P307, DOI 10.1212/WNL.36.3.307; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Kurtzke JF, 2001, J CLIN EPIDEMIOL, V54, P1, DOI 10.1016/S0895-4356(00)00268-7; KURTZKE JF, 1982, NEUROLOGY, V32, P143, DOI 10.1212/WNL.32.2.143; KURTZKE JF, 1988, NEUROEPIDEMIOLOGY, V7, P190, DOI 10.1159/000110154; KURTZKE JF, 1995, ACTA NEUROL SCAND, V91, P321, DOI 10.1111/j.1600-0404.1995.tb07015.x; Li JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002429; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Meer RR, 1997, AM J VET RES, V58, P702; Miyakawa MEF, 2003, ANAEROBE, V9, P145, DOI 10.1016/S1075-9964(03)00069-6; Miyakawa MEF, 2003, VET RES COMMUN, V27, P231, DOI 10.1023/A:1023348708599; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; MORABIA A, 1991, EPIDEMIOLOGY, V2, P367, DOI 10.1097/00001648-199109000-00010; MURRELL TGC, 1986, MED HYPOTHESES, V19, P27, DOI 10.1016/0306-9877(86)90134-9; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Robertson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022053; RUCKER CW, 1972, MAYO CLIN PROC, V47, P335; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Souza AM, 2010, GENET MOL RES, V9, P266, DOI 10.4238/vol9-1gmr711; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; Uzal FA, 2008, J VET DIAGN INVEST, V20, P253, DOI 10.1177/104063870802000301; VINEIS P, 1991, THEOR MED, V12, P171, DOI 10.1007/BF00489797; Wioland L, 2013, TOXICON, V75, P122, DOI 10.1016/j.toxicon.2013.04.003; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	74	125	129	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76359	10.1371/journal.pone.0076359	http://dx.doi.org/10.1371/journal.pone.0076359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146858	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400055
J	Wolfram, L; Fischbeck, A; Frey-Wagner, I; Wojtal, KA; Lang, S; Fried, M; Vavricka, SR; Hausmann, M; Rogler, G				Wolfram, Lutz; Fischbeck, Anne; Frey-Wagner, Isabelle; Wojtal, Kacper A.; Lang, Silvia; Fried, Michael; Vavricka, Stephan R.; Hausmann, Martin; Rogler, Gerhard			Regulation of the Expression of Chaperone gp96 in Macrophages and Dendritic Cells	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; MOLECULAR CHAPERONES; PHYLOGENETIC CONSERVATION; SCAVENGER RECEPTOR; ER STRESS; DIFFERENTIATION; INFLAMMATION; INDUCTION; MONOCYTE	The chaperone function of the ER-residing heat shock protein gp96 plays an important role in protein physiology and has additionally important immunological functions due to its peptide-binding capacity. Low amounts of gp96 stimulate immunity; high quantities induce tolerance by mechanisms not fully understood. A lack of gp96 protein in intestinal macrophages (IMACs) from Crohns disease (CD) patients correlates with loss of tolerance against the host gut flora, leading to chronic inflammation. Since gp96 shows dose-dependent direction of immunological reactions, we studied primary IMACs and developed cell models to understand the regulation of gp96 expression. Induction of gp96-expression was higher in in vitro differentiated dendritic cells (i.v.DCs) than in in vitro differentiated macrophages (i.v.MACs), whereas monocytes (MOs) expressed only low gp96 levels. The highest levels of expression were found in IMACs. Lipopolysaccharide (LPS), muramyl dipeptide (MDP), tumour necrosis factor (TNF), and Interleukin (IL)-4 induced gp96-expression, while IL12, IL-17, IL-23 and interferon (IFN)-gamma were not effective indicating that Th1 and Th17 cells are probably not involved in the induction of gp96. Furthermore, gp96 was able to induce its own expression. The ER-stress inducer tunicamycin increased gp96-expression in a concentration-and time-dependent manner. Both ulcerative colitis (UC) and CD patients showed significantly elevated gp96 mRNA levels in intestinal biopsies which correlated positively with the degree of inflammation of the tissue. Since gp96 is highly expressed on the one hand upon stress induction as during inflammation and on the other hand possibly mediating tolerance, these results will help to understand the whether gp96 plays a role in the pathophysiology of inflammatory bowel disease (IBD).	[Wolfram, Lutz; Fischbeck, Anne; Frey-Wagner, Isabelle; Wojtal, Kacper A.; Lang, Silvia; Fried, Michael; Vavricka, Stephan R.; Hausmann, Martin; Rogler, Gerhard] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Rogler, G (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	gerhard.rogler@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Hausmann, Martin/0000-0002-0696-0251	Swiss National Science Foundation [310030-120312, 320000-114009/3, 32473B_135694/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by a research grant from the Swiss National Science Foundation (http://www.snf.ch; Grant No. 310030-120312 to GR and Grant No. 320000-114009/3 and 32473B_135694/1 to SRV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee PP, 2002, J IMMUNOL, V169, P3507, DOI 10.4049/jimmunol.169.7.3507; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Berwin B, 2004, J BIOL CHEM, V279, P51250, DOI 10.1074/jbc.M406202200; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Berwin B, 2001, TRAFFIC, V2, P690, DOI 10.1034/j.1600-0854.2001.21003.x; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Chen YG, 2003, CELL STRESS CHAPERON, V8, P242, DOI 10.1379/1466-1268(2003)008<0242:IOHSPG>2.0.CO;2; Davies EL, 2006, CLIN EXP IMMUNOL, V145, P183, DOI 10.1111/j.1365-2249.2006.03109.x; Han J, 2010, PLOS ONE, V5, P1; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2010, CURR OPIN GASTROENTE, V3; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Lammert E, 1997, EUR J IMMUNOL, V27, P923, DOI 10.1002/eji.1830270418; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21, DOI 10.1097/00054725-200002000-00004; Maloy KJ, 2008, J INTERN MED, V263, P584, DOI 10.1111/j.1365-2796.2008.01950.x; Mao C, 2010, PLOS ONE, V5, P1; Matsutake Toyoshi, 2010, Cancer Immun, V10, P7; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Pockley A, 2007, METHODS, V43; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Robert J, 2001, EUR J IMMUNOL, V31, P186, DOI 10.1002/1521-4141(200101)31:1<186::AID-IMMU186>3.0.CO;2-D; Robert J, 2008, J IMMUNOL, V180, P3176, DOI 10.4049/jimmunol.180.5.3176; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Schild H, 2000, NAT IMMUNOL, V1, P100, DOI 10.1038/77770; Schreiter K, 2005, GUT, V54, P935, DOI 10.1136/gut.2004.053116; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Singh-Jasuja H, 2000, CELL STRESS CHAPERON, V5, P462, DOI 10.1379/1466-1268(2000)005<0462:THSPGA>2.0.CO;2; Spoettl T, 2007, WORLD J GASTROENTERO, V13, P1032, DOI 10.3748/wjg.v13.i7.1032; Spottl T, 2001, J LEUKOCYTE BIOL, V70, P241; Stoilova D, 2000, CELL STRESS CHAPERON, V5, P395; Suriano R, 2009, GLYCOBIOLOGY, V19, P1427, DOI 10.1093/glycob/cwp096; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzuki S, 2010, BIOCHEM BIOPH RES CO, V398, P525, DOI 10.1016/j.bbrc.2010.06.112; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wang XH, 2005, CANCER IMMUNOL IMMUN, V54, P971, DOI 10.1007/s00262-005-0662-9; Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367	52	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76350	10.1371/journal.pone.0076350	http://dx.doi.org/10.1371/journal.pone.0076350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146856	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326019400054
J	Ha, B; Lv, ZY; Bian, Z; Zhang, XG; Mishra, A; Liu, Y				Ha, Binh; Lv, Zhiyuan; Bian, Zhen; Zhang, Xiugen; Mishra, Aarti; Liu, Yuan			'Clustering' SIRP alpha into the Plasma Membrane Lipid Microdomains Is Required for Activated Monocytes and Macrophages to Mediate Effective Cell Surface Interactions with CD47	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL-REGULATORY PROTEIN; NEUTROPHIL TRANSMIGRATION; COMPLEX-FORMATION; GROWTH-FACTOR; SHP-2; SUBSTRATE-1; RECEPTOR; SHPS-1; RAFTS	SIRP alpha, an ITIMs-containing signaling receptor, negatively regulates leukocyte responses through extracellular interactions with CD47. However, the dynamics of SIRP alpha-CD47 interactions on the cell surface and the governing mechanisms remain unclear. Here we report that while the purified SIRPa binds to CD47 and that SIRPa is expressed on monocytes and monocytic THP-1 or U937, these SIRPa are ineffective to mediate cell binding to immobilized CD47. However, cell binding to CD47 is significantly enhanced when monocytes transmigrating across endothelia, or being differentiated into macrophages. Cell surface labeling reveals SIRP alpha to be diffused on naive monocytes but highly clustered on transmigrated monocytes and macrophages. Protein crosslink and equilibrium centrifugation confirm that SIRP alpha in the latter cells forms oligomerized complexes resulting in increased avidity for CD47 binding. Furthermore, formation of SIRPa complexes/clusters requires the plasma membrane 'lipid rafts' and the activity of Src family kinase during macrophage differentiation. These results together suggest that 'clustering' SIRP alpha into plasma membrane microdomains is essential for activated monocytes and macrophages to effectively interact with CD47 and initiate intracellular signaling.	[Ha, Binh; Lv, Zhiyuan; Bian, Zhen; Zhang, Xiugen; Mishra, Aarti; Liu, Yuan] Georgia State Univ, Program Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Lv, Zhiyuan; Bian, Zhen] Nanjing Univ, Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China	University System of Georgia; Georgia State University; Nanjing University	Liu, Y (corresponding author), Georgia State Univ, Program Cellular Biol & Immunol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	yliu@gsu.edu	Mishra, Aarti/AAI-4038-2021	Mishra, Aarti/0000-0002-7845-6759	American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106839] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Research Scholar Grant from the American Cancer Society (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ikeda H, 2006, J IMMUNOL, V177, P3123, DOI 10.4049/jimmunol.177.5.3123; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kinchen JM, 2008, CURR BIOL, V18, pR521, DOI 10.1016/j.cub.2008.04.058; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; Mamtani M, 2007, MED HYPOTHESES, V68, P1065, DOI 10.1016/j.mehy.2006.09.044; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Ochi F, 1997, BIOCHEM BIOPH RES CO, V239, P483, DOI 10.1006/bbrc.1997.7489; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Okajo J, 2007, J IMMUNOL, V178, P6164, DOI 10.4049/jimmunol.178.10.6164; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Olsson M, 2007, BIOCHEM BIOPH RES CO, V352, P193, DOI 10.1016/j.bbrc.2006.11.002; Patschan S, 2006, AM J PHYSIOL-HEART C, V290, pH2210, DOI 10.1152/ajpheart.01112.2005; Riff JD, 2005, INFECT IMMUN, V73, P7113, DOI 10.1128/IAI.73.11.7113-7125.2005; ROUSSEL MF, 1989, P NATL ACAD SCI USA, V86, P7924, DOI 10.1073/pnas.86.20.7924; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Takada T, 1998, J BIOL CHEM, V273, P9234, DOI 10.1074/jbc.273.15.9234; Takizawa H, 2007, NAT IMMUNOL, V8, P1287, DOI 10.1038/ni1207-1287; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109	40	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77615	10.1371/journal.pone.0077615	http://dx.doi.org/10.1371/journal.pone.0077615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143245	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100083
J	Xu, DM; Liu, G; Cheng, L; Lu, XH; Chen, WQ; Deng, ZX				Xu, Dongmei; Liu, Guang; Cheng, Lin; Lu, Xinhua; Chen, Wenqing; Deng, Zixin			Identification of Mur34 as the Novel Negative Regulator Responsible for the Biosynthesis of Muraymycin in Streptomyces sp NRRL30471	PLOS ONE			English	Article							AUTOREGULATOR RECEPTOR PROTEIN; PHOR-PHOP SYSTEM; PEPTIDOGLYCAN BIOSYNTHESIS; SECONDARY METABOLISM; LAVENDULAE FRI-5; GENE-CLUSTER; TRANSCRIPTIONAL REGULATOR; 2-COMPONENT SYSTEM; FARA ACTS; A-FACTOR	Background: Muraymycin, a potent translocase I (MraY) inhibitor, is produced by Streptomyces sp. NRRL30471. The muraymycin gene cluster (mur) was recently cloned, and bioinformatic analysis of mur34 revealed its encoding product exhibits high homology to a large family of proteins, including KanI and RacI in individual biosynthetic pathway of kanamycin and ribostamycin. However, the precise role of these proteins remains unknown. Principal Findings: Here we report the identification of Mur34 as the novel negative regulator involved in muraymycin biosynthesis. Independent disruption of mur34 on chromosome and cosmid directly resulted in significant improvement of muraymycin production by at least 10 folds, thereof confirming the negative function of Mur34 during muraymycin biosynthesis and realizing the engineered production of muraymycin in heterologous host. Gene expression analysis indicated that the transcription level of the mur genes in mur34 mutant (DM-5) was dramatically enhanced by ca. 30 folds. Electrophoretic mobility shift assay (EMSA) showed that Mur34 specifically bound to the promoter region of mur33. Further experiments showed that a 28-bp region downstream of the transcription start point (TSP) was protected by His(6)Mur34, and the 210 region is essential for the activity of mur33 promoter. Conclusions: Mur34 plays an unambiguously negative role in muraymycin biosynthesis via binding to the upstream of mur33. More importantly, Mur34 represents a novel family of regulators acting in negative manner to regulate the secondary metabolites biosynthesis in bacteria.	[Xu, Dongmei; Liu, Guang; Chen, Wenqing; Deng, Zixin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Dongmei; Liu, Guang; Chen, Wenqing; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Cheng, Lin; Chen, Wenqing; Deng, Zixin] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan 430072, Peoples R China; [Cheng, Lin; Chen, Wenqing; Deng, Zixin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430072, Peoples R China; [Xu, Dongmei; Lu, Xinhua] NCPC New Drug Res & Dev Co Ltd, North China Pharmaceut Grp Corp, Shijiazhuang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wuhan University; Wuhan University	Chen, WQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	wenqingchen2010@gmail.com; zxdeng@sjtu.edu.cn		Chen, Wenqing/0000-0003-2557-8960	Ministry of Science and Technology [973, 863]; National Science Foundation of China,; Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry; Ministry of Education, the Science and Technology Commission of Shanghai Municipality; Shanghai Leading Academic Discipline [B203]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China,(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry; Ministry of Education, the Science and Technology Commission of Shanghai Municipality; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project)	This work was supported by Grants 973 and 863 from the Ministry of Science and Technology, the National Science Foundation of China, Open Fund of State Key Laboratory of Bio-organic and Natural Products Chemistry, the Ministry of Education, the Science and Technology Commission of Shanghai Municipality, and Shanghai Leading Academic Discipline Project B203. (http://www.most.gov.cn/; http://www.nsfc.gov.cn/Portal0/default152.htm; http://211.166.12.38/V1/Program1/Default. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TB, 2001, MOL MICROBIOL, V39, P553, DOI 10.1046/j.1365-2958.2001.02240.x; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; HORINOUCHI S, 1992, ANNU REV MICROBIOL, V46, P377, DOI 10.1146/annurev.micro.46.1.377; INGRAM C, 1989, J BACTERIOL, V171, P6617, DOI 10.1128/jb.171.12.6617-6624.1989; Kang JG, 1997, NUCLEIC ACIDS RES, V25, P2566, DOI 10.1093/nar/25.13.2566; Kato JY, 2004, J BACTERIOL, V186, P2206, DOI 10.1128/JB.186.7.2206-2211.2004; Kaysser L, 2011, CHEMBIOCHEM, V12, P477, DOI 10.1002/cbic.201000460; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kimura K, 1998, J ANTIBIOT, V51, P1099, DOI 10.7164/antibiotics.51.1099; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kitani S, 1999, J BACTERIOL, V181, P5081, DOI 10.1128/JB.181.16.5081-5084.1999; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Li Q, 2013, J BACTERIOL; Lin YI, 2002, BIOORG MED CHEM LETT, V12, P2341, DOI 10.1016/S0960-894X(02)00469-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDonald LA, 2003, ANAL CHEM, V75, P2730, DOI 10.1021/ac0264731; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Paradkar A, 2003, CRIT REV BIOTECHNOL, V23, P1, DOI 10.1080/713609296; Rodriguez-Garcia A, 2009, NUCLEIC ACIDS RES, V37, P3230, DOI 10.1093/nar/gkp162; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SALATREP.JM, 1971, EUR J BIOCHEM, V20, P400, DOI 10.1111/j.1432-1033.1971.tb01406.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sheeler NL, 2005, J BACTERIOL, V187, P687, DOI 10.1128/JB.187.2.687-696.2005; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Tanino T, 2011, J MED CHEM, V54, P8421, DOI 10.1021/jm200906r; Tanino T, 2010, J ORG CHEM, V75, P1366, DOI 10.1021/jo9027193; Yamashita A, 2003, BIOORG MED CHEM LETT, V13, P3345, DOI 10.1016/S0960-894X(03)00671-1; Zhang WJ, 2010, P NATL ACAD SCI USA, V107, P16828, DOI 10.1073/pnas.1011557107; ZUKOWSKI MM, 1983, P NATL ACAD SCI-BIOL, V80, P1101, DOI 10.1073/pnas.80.4.1101	43	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76068	10.1371/journal.pone.0076068	http://dx.doi.org/10.1371/journal.pone.0076068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143177	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100012
J	Blasco, R; Rosell, J; Cuartero, F; Peris, JF; Gopher, A; Barkai, R				Blasco, Ruth; Rosell, Jordi; Cuartero, Felipe; Fernandez Peris, Josep; Gopher, Avi; Barkai, Ran			Using Bones to Shape Stones: MIS 9 Bone Retouchers at Both Edges of the Mediterranean Sea	PLOS ONE			English	Article							BOLOMOR CAVE VALENCIA; QESEM CAVE; SITE; ATAPUERCA; CUTMARKS; REMAINS; BURGOS; SIERRA	A significant challenge in Prehistory is to understand the mechanisms involved in the behavioural evolution of human groups. The degree of technological and cultural development of prehistoric groups is assessed mainly through stone tools. However, other elements can provide valuable information as well. This paper presents two bone retouchers dated to the Middle Pleistocene MIS 9 used for the shaping of lithic artefacts. Originating from Bolomor Cave (Spain) and Qesem Cave (Israel), these two bone retouchers are among the earliest of the Old World. Although the emergence of such tools might be found in the latest phases of the Acheulean, their widespread use seems to coincide with independently emergent post-Acheulean cultural complexes at both ends of the Mediterranean Sea: the post-Acheulean/pre-Mousterian of Western Europe and the Acheulo Yabrudian Cultural Complex of the Levant. Both entities seem to reflect convergent processes that may be viewed in a wider cultural context as reflecting new technology-related behavioural patterns as well as new perceptions in stone tool manufacturing.	[Rosell, Jordi] URV, Area Prehist, Tarragona, Spain; [Rosell, Jordi] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Cuartero, Felipe] Univ Autonoma Madrid, Dept Prehist & Arqueol, Madrid, Spain; [Fernandez Peris, Josep] Museo Prehist, SIP, Valencia, Spain; [Gopher, Avi; Barkai, Ran] Tel Aviv Univ, Inst Archaeol, IL-69978 Tel Aviv, Israel	Universitat Rovira i Virgili; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Autonomous University of Madrid; Tel Aviv University		rblascolopez@gmail.com	Barkai, Ran/L-6495-2019; Blasco, Ruth/AAG-8200-2019; Rosell, Jordi/G-8705-2015; CUARTERO MONTEAGUDO, FELIPE/S-8690-2016	Blasco, Ruth/0000-0001-9804-739X; Rosell, Jordi/0000-0002-6758-6291; CUARTERO MONTEAGUDO, FELIPE/0000-0002-9024-2980; BARKAI, RAN/0000-0002-8125-8788	Spanish Ministry of Science and Innovation [CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717]; Generalitat de Catalunya [2009 SGR 188]; Israel Science Foundation; CARE Archaeological Foundation; Leakey Foundation; Wenner-Gren Foundation; Thyssen Foundation; European Union	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Israel Science Foundation(Israel Science Foundation); CARE Archaeological Foundation; Leakey Foundation; Wenner-Gren Foundation; Thyssen Foundation; European Union(European Commission)	The Bolomor excavation is part of the program of archaeological excavations conducted by the SIP (Prehistoric Investigation Service) of the Prehistory Museum of Valencia under the authority of the Provincial Council of Valencia, Spain. The research is supported with funding from the Spanish Ministry of Science and Innovation, project nos. CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717 and from Generalitat de Catalunya, 2009 SGR 188. The Qesem Cave excavation project is supported by the Israel Science Foundation, CARE Archaeological Foundation, Leakey Foundation, Wenner-Gren Foundation, and Thyssen Foundation. R. Blasco is a Beatriu de Pinos-A post-doctoral scholarship recipient from Generalitat de Catalunya and co-financed by the European Union through Marie Curie Actions, FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimene M., 1998, ACT 18 RENC INT ARCH, P193; and D., 1998, EC PREHISTORIQUE COM; Anzidei A.P., 2001, WORLD ELEPHANTS, P415; Auguste P., 2002, RETOUCHOIRS COMPRESS, P39; Barkai R., 2009, HUM EVOL, V24, P57; Barkai R., 2005, EURASIAN PREHISTORY, V3, P39; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Ben-Dor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028689; Biddittu I, 2001, WORLD ELEPHANTS, P91; Blasco R, 2013, QUATERNARY SCI REV, V70, P124, DOI 10.1016/j.quascirev.2013.03.008; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; d'Errico F, 2009, J ARCHAEOL SCI, V36, P1764, DOI 10.1016/j.jas.2009.04.005; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; de Gruchy S, 2002, J FORENSIC SCI, V47, P933; Dobosi, 2001, WORLD ELEPHANTS, P429; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046414; Fernandez Peris J., 2007, SERIE TRABAJOS VARIO, V108; Peris JF, 2012, QUATERN INT, V247, P267, DOI 10.1016/j.quaint.2010.10.014; Fumanal M.P., 1993, CUADERNOS GEOGRAFIA, V54, P223; Gaudzinski S, 2005, QUATERN INT, V126, P179, DOI 10.1016/j.quaint.2004.04.022; Giacobini G., 1998, ATT 13 C UISPP, P167; Gopher A, 2010, QUAT GEOCHRONOL, V5, P644, DOI 10.1016/j.quageo.2010.03.003; Guillem P., 1995, CUATERNARIO PAIS VAL, P227; Hershkovitz I, 2011, AM J PHYS ANTHROPOL, V144, P575, DOI 10.1002/ajpa.21446; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Langlois A, 2004, SUJET CHEVAL MICOQUE, V1; Arsuaga JL, 2012, J HUM EVOL, V62, P629, DOI 10.1016/j.jhevol.2012.02.002; Mallye JB, 2012, J ARCHAEOL SCI, V39, P1131, DOI 10.1016/j.jas.2011.12.018; Mania D., 2005, INDIVIDUAL HOMINID C, P98; Martinez Valle R., 1995, FAUNA CUATERNARIA PA, P235; Mercier N, 2013, J ARCHAEOL SCI, V40, P3011, DOI 10.1016/j.jas.2013.03.002; Moncel MH, 2012, J HUM EVOL, V63, P653, DOI 10.1016/j.jhevol.2012.08.001; Holgueras MM, 2009, TRABAJOS PREHIST, V66, P27, DOI 10.3989/tp.2009.09011; Passemard E, 1922, REV ARCHEOLOGIQUE, V15, P1; Patou-Mathis M., 2002, RETOUCHOIRS COMPRESS; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Rabinovich R, 2012, QUATERN INT, V276, P183, DOI 10.1016/j.quaint.2012.05.009; Roberts M, 1999, ENGLISH HERITAGE MON, V17; Rosell J, 2011, J HUM EVOL, V61, P125, DOI 10.1016/j.jhevol.2011.02.001; Sacca D, 2012, QUATERN INT, V276, P27, DOI 10.1016/j.quaint.2012.03.055; Serra AS, 2008, COMPLUTUM, V19, P25; SEGRE A, 1984, CURR ANTHROPOL, V25, P230, DOI 10.1086/203117; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Smith GM, 2013, J ARCHAEOL SCI, V40, P3754, DOI 10.1016/j.jas.2013.05.002; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; Tartar E, 2009, OUTIL CARACTERISATIO; Tartar E, 2002, ETUDE FONCTIONNELLE; Tixier J., 1982, STUDIA PRAEHISTORICA, V2, P13; Verna C, 2011, J HUM EVOL, V60, P145, DOI 10.1016/j.jhevol.2010.07.027; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Wenban-Smith FF., 1999, BOXGROVE MIDDLE PLEI, P384	58	69	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76780	10.1371/journal.pone.0076780	http://dx.doi.org/10.1371/journal.pone.0076780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146928	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400083
J	Devi, L; Ohno, M				Devi, Latha; Ohno, Masuo			Deletion of the eIF2 alpha Kinase GCN2 Fails to Rescue the Memory Decline Associated with Alzheimer's Disease	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; BETA-SECRETASE; GENE-EXPRESSION; TRANSGENIC MICE; MOUSE MODELS; NEURON LOSS; PHOSPHORYLATION; DEFICITS	Emerging evidence suggests that dysregulated translation through phosphorylation of eukaryotic initiation factor-alpha a (eIF alpha a) may contribute to Alzheimer's disease (AD) and related memory impairments. However, the underlying mechanisms remain unclear. Here, we crossed knockout mice for an eIF2 alpha kinase (GCN2: general control nonderepressible-2 kinase) with 5XFAD transgenic mice, and investigated whether GCN2 deletion affects AD-like traits in this model. As observed in AD brains, 5XFAD mice recapitulated significant elevations in the beta-secretase enzyme BACE1 and the CREB repressor ATF4 concomitant with a dramatic increase of eIF2a phosphorylation. Contrary to expectation, we found that GCN2(-/-) and GCN2(+/-) deficiencies aggravate rather than suppress hippocampal BACE1 and ATF4 elevations in 5XFAD mice, failing to rescue memory deficits as tested by the contextual fear conditioning. The facilitation of these deleterious events resulted in exacerbated b-amyloid accumulation, plaque pathology and CREB dysfunction in 5XFAD mice with GCN2 mutations. Notably, GCN2 deletion caused overactivation of the PKR-endoplasmic reticulum-related kinase (PERK)-dependent eIF2a phosphorylation pathway in 5XFAD mice in the absence of changes in the PKR pathway. Moreover, PERK activation in response to GCN2 deficiency was specific to 5XFAD mice, since phosphorylated PERK levels were equivalent between GCN2(+/-) and wild-type control mice. Our findings suggest that GCN2 may be an important eIF2a kinase under the physiological condition, whereas blocking the GCN2 pathway under exposure to significant beta-amyloidosis rather aggravates eIF2 alpha phosphorylation leading to BACE1 and ATF4 elevations in AD.	[Devi, Latha; Ohno, Masuo] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA; [Ohno, Masuo] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Ohno, M (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA.	mohno@nki.rfmh.org			American Health Assistance Foundation [A2011311]; National Institutes of Health [AG044703]	American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Health Assistance Foundation grant (A2011311 to MO) and the National Institutes of Health grant (AG044703 to MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Devi L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-34; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; Donnelly N, 2013, CELL MOL LI IN PRESS; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Jawhar S., 2012, NEUROBIOL AGING, V33, pe129, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.027, DOI 10.1016/j.neurobiolaging.2010.05.027]; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kim HS, 2007, J NEUROSCI RES, V85, P1528, DOI 10.1002/jnr.21267; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010489; Leroy K, 2012, AM J PATHOL, V181, P1928, DOI 10.1016/j.ajpath.2012.08.012; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	41	43	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77335	10.1371/journal.pone.0077335	http://dx.doi.org/10.1371/journal.pone.0077335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146979	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400109
J	Donini, LM; Poggiogalle, E; Mosca, V; Pinto, A; Brunani, A; Capodaglio, P				Donini, Lorenzo Maria; Poggiogalle, Eleonora; Mosca, Veronica; Pinto, Alessandro; Brunani, Amelia; Capodaglio, Paolo			Disability Affects the 6-Minute Walking Distance in Obese Subjects (BMI > 40 kg/m(2))	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; REFERENCE EQUATIONS; REFERENCE VALUES; ELDERLY ADULTS; EXERCISE; WORK; INDIVIDUALS; COPD	ntroduction: In obese subjects, the relative reduction of the skeletal muscle strength, the reduced cardio-pulmonary capacity and tolerance to effort, the higher metabolic costs and, therefore, the increased inefficiency of gait together with the increased prevalence of co-morbid conditions might interfere with walking. Performance tests, such as the six-minute walking test (6MWT), can unveil the limitations in cardio-respiratory and motor functions underlying the obesity-related disability. Therefore the aims of the present study were: to explore the determinants of the 6-minute walking distance (6MWD) and to investigate the predictors of interruption of the walk test in obese subjects. Methods: Obese patients [body mass index (BMI)>40 kg/m(2)] were recruited from January 2009 to December 2011. Anthropometry, body composition, specific questionnaire for Obesity-related Disabilities (TSD-OC test), fitness status and 6MWT data were evaluated. The correlation between the 6MWD and the potential independent variables (anthropometric parameters, body composition, muscle strength, flexibility and disability) were analysed. The variables which were singularly correlated with the response variable were included in a multivariated regression model. Finally, the correlation between nutritional and functional parameters and test interruption was investigated. Results: 354 subjects (87 males, mean age 48.5 +/- 14 years, 267 females, mean age 49.8 +/- 15 years) were enrolled in the study. Age, weight, height, BMI, fat mass and fat free mass indexes, handgrip strength and disability were significantly correlated with the 6MWD and considered in the multivariate analysis. The determination coefficient of the regression analysis ranged from 0.21 to 0.47 for the different models. Body weight, BMI, waist circumference, TSD-OC test score and flexibility were found to be predictors of the 6MWT interruption. Discussion: The present study demonstrated the impact of disability in obese subjects, together with age, anthropometric data, body composition and strength, on the 6-minute walking distance.	[Donini, Lorenzo Maria; Poggiogalle, Eleonora; Mosca, Veronica; Pinto, Alessandro] Univ Roma La Sapienza, Food Sci & Endocrinol Sect, Dept Expt Med Med Physiopathol, I-00185 Rome, Italy; [Brunani, Amelia; Capodaglio, Paolo] Ist Auxol Italiano IRCCS, Rehabil Unit, Oggebbio, Verbania, Italy; [Brunani, Amelia; Capodaglio, Paolo] Ist Auxol Italiano IRCCS, Res Lab Biomech & Rehabil, Oggebbio, Verbania, Italy	Sapienza University Rome; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Donini, LM (corresponding author), Univ Roma La Sapienza, Food Sci & Endocrinol Sect, Dept Expt Med Med Physiopathol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	lorenzomaria.donini@uniroma1.it	Paolo, Capodaglio/AAB-7795-2019; Poggiogalle, Eleonora/AAB-9338-2019; Donini, Lorenzo/AAS-3873-2020	Paolo, Capodaglio/0000-0003-3719-8789; Donini, Lorenzo/0000-0003-4692-4754; Amelia, Brunani/0000-0003-3059-544X; Poggiogalle, Eleonora/0000-0003-0862-5892; Pinto, Alessandro/0000-0002-4864-2294				Alameri H, 2009, RESP MED, V103, P1041, DOI 10.1016/j.rmed.2009.01.012; Andrews AW, 1996, PHYS THER, V76, P248, DOI 10.1093/ptj/76.3.248; Beriault K, 2009, INT J SPORTS MED, V30, P725, DOI 10.1055/s-0029-1231043; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Capodaglio P, 2013, J ENDOCRINOL INVEST, V19; Capodaglio P, 2013, DISABIL REHABIL, V35, P1199, DOI 10.3109/09638288.2012.726313; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-47; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Donini LM, 2011, DISABIL REHABIL, V33, P2509, DOI 10.3109/09638288.2011.575529; Dourado Victor Zuniga, 2011, Arq. Bras. Cardiol., V96, pe128; Dourado VZ, 2006, CHEST, V129, P551, DOI 10.1378/chest.129.3.551; Enright Paul L, 2003, Respir Care, V48, P783; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206; Jenkins Sue, 2009, Physiotherapy Theory and Practice, V25, P516, DOI [10.1080/09593980802664711, 10.3109/09593980802664711]; KUSHNER RF, 1992, J AM COLL NUTR, V11, P199; Larsson UE, 2008, PHYSIOTHER RES INT, V13, P84, DOI 10.1002/pri.398; Launois C, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-61; Li AM, 2007, AM J RESP CRIT CARE, V176, P174, DOI 10.1164/rccm.200607-883OC; Lohman TG, 1988, ANTHROPOMETRIC STAND, P183; Malatesta D, 2009, MED SCI SPORT EXER, V41, P426, DOI 10.1249/MSS.0b013e31818606e7; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Poh H, 2006, RESPIROLOGY, V11, P211, DOI 10.1111/j.1440-1843.2006.00820.x; Precilios H, 2013, J ENDOCRINOL INVEST, V36, P72, DOI 10.3275/8240; Saad HB, 2009, RESP MED, V103, P74, DOI 10.1016/j.rmed.2008.07.023; Salvadori A, 1999, RESPIRATION, V66, P25, DOI 10.1159/000029333; SALVADORI A, 1992, CHEST, V101, P674, DOI 10.1378/chest.101.3.674; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Wearing SC, 2006, OBES REV, V7, P239, DOI 10.1111/j.1467-789X.2006.00251.x; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x	38	28	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75491	10.1371/journal.pone.0075491	http://dx.doi.org/10.1371/journal.pone.0075491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146756	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400008
J	Sainio, A; Nyman, M; Lund, R; Vuorikoski, S; Bostrom, P; Laato, M; Bostrom, PJ; Jarvelainen, H				Sainio, Annele; Nyman, Marie; Lund, Riikka; Vuorikoski, Sanna; Bostrom, Pia; Laato, Matti; Bostrom, Peter J.; Jarvelainen, Hannu			Lack of Decorin Expression by Human Bladder Cancer Cells Offers New Tools in the Therapy of Urothelial Malignancies	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; BREAST-CANCER; EXTRACELLULAR-MATRIX; GENE; BIGLYCAN; PROTEIN; CARCINOMA; ORGANIZATION; MODULATION; TISSUES	Decorin, a multifunctional small leucine-rich extracellular matrix proteoglycan, has been shown to possess potent antitumour activity. However, there is some uncertainty whether different cancer cells express decorin in addition to nonmalignant stromal cells. In this study we clarified decorin expression by human bladder cancer cells both in vivo and in vitro. In addition, the effect of adenovirus-mediated decorin expression on human bladder cancer cells in vitro was examined. We first demonstrated using the publicly available GeneSapiens databank that decorin gene expression is present in both normal and malignant human bladder tissues. However, when we applied in situ hybridization with digoxigenin-labeled RNA probes for decorin on human bladder carcinoma tissue samples derived from a large radical cystectomy patient cohort (n = 199), we unambiguously demonstrated that invasive and non-invasive bladder carcinoma cells completely lack decorin mRNA. The cancer cells were also negative for decorin immunoreactivity. Instead, decorin expression was localized solely to original non-malignant stromal areas of bladder tissue. In accordance with the aforementioned results, human bladder cancer cells in vitro were also negative for decorin expression as shown by RT-qPCR analyses. The lack of decorin expression by bladder cancer cells was shown not to be due to the methylation of the proximal promoter region of the decorin gene. When bladder cancer cells were transfected with a decorin adenoviral vector, their proliferation was significantly decreased. In conclusion, we have shown that human bladder cancer cells are totally devoid of decorin expression. We have also shown that adenovirus-mediated decorin gene transduction of human bladder cancer cell lines markedly inhibits their proliferation. Thus, decorin gene delivery offers new potential therapeutic tools in urothelial malignancies.	[Sainio, Annele; Nyman, Marie; Jarvelainen, Hannu] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Lund, Riikka; Vuorikoski, Sanna] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Lund, Riikka; Vuorikoski, Sanna] Abo Akad Univ, Turku, Finland; [Bostrom, Pia] Univ Turku, Dept Pathol, Turku, Finland; [Jarvelainen, Hannu] Turku Univ Hosp, Dept Endocrinol, Div Med, FIN-20520 Turku, Finland; [Laato, Matti; Bostrom, Peter J.] Turku Univ Hosp, Dept Urol, Div Digest Surg & Urol, FIN-20520 Turku, Finland	University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Jarvelainen, H (corresponding author), Univ Turku, Dept Med Biochem & Genet, Turku, Finland.	hanjar@utu.fi	Sainio, Annele/R-3140-2019; Lund, Riikka/AAW-7853-2020; Lund, Riikka/K-2441-2019	Sainio, Annele/0000-0002-6284-5696; Lund, Riikka/0000-0002-1068-5918; Bostrom, Peter/0000-0003-3647-0015	Medical Research Fund (EVO) of Turku University Hospital; Cancer Foundations of South-Western Finland; Foundation of Ida Montin; Oskar Oflunds Stiftelse; Finnish Cultural Foundation/Varsinais-Suomi Regional Fund, Biocenter Finland; Academy of Finland; University of Turku	Medical Research Fund (EVO) of Turku University Hospital; Cancer Foundations of South-Western Finland; Foundation of Ida Montin; Oskar Oflunds Stiftelse; Finnish Cultural Foundation/Varsinais-Suomi Regional Fund, Biocenter Finland; Academy of Finland(Academy of Finland); University of Turku	Financially this study was supported by Medical Research Fund (EVO) of Turku University Hospital, Cancer Foundations of South-Western Finland, Foundation of Ida Montin, Oskar Oflunds Stiftelse, The Finnish Cultural Foundation/Varsinais-Suomi Regional Fund, Biocenter Finland, Academy of Finland, and University of Turku. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANY R, 1990, J BIOL CHEM, V265, P11389; Augoff K, 2008, MED SCI MONITOR, V14, pCR530; Banerjee Abhijit G, 2003, Mol Cancer, V2, P34, DOI 10.1186/1476-4598-2-34; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bostrom P, 2013, HISTOCHEM CELL BIOL, V139, P161, DOI 10.1007/s00418-012-1026-0; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Lu J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-33; Maclejewski CC, 2012, J UROLOGY, V188, P1543, DOI 10.1016/j.juro.2012.03.045; Morrione A, 2013, FEBS J, V280, P2138, DOI 10.1111/febs.12149; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Pucci-Minafra I, 2008, CONNECT TISSUE RES, V49, P30, DOI 10.1080/03008200701820443; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Salomaki HH, 2008, J HISTOCHEM CYTOCHEM, V56, P639, DOI 10.1369/jhc.2008.950287; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Shridhar V, 2001, CANCER RES, V61, P5895; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Troup S, 2003, CLIN CANCER RES, V9, P207; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	38	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76190	10.1371/journal.pone.0076190	http://dx.doi.org/10.1371/journal.pone.0076190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146840	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400047
J	Lin, KT; Shann, YJ; Chau, GY; Hsu, CN; Huang, CYF				Lin, K-T; Shann, Y-J; Chau, G-Y; Hsu, C-N; Huang, C-Y F.			Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing	ONCOGENE			English	Article						hepatocellular carcinoma; DUNQU1; FGFR2; alternative splicing; RNA-Seq	ALTERNATIVE EXON USE; ADAM15 GENE; EXPRESSION; CANCER; QUANTIFICATION; PATHWAYS	There is an urgent need to identify biomarkers for hepatocellular carcinoma due to limited treatment options and the poor prognosis of this common lethal disease. Whole-transcriptome shotgun sequencing (RNA-Seq) provides new possibilities for biomarker identification. We sequenced similar to 250 million pair-end reads from a pair of adjacent normal and tumor liver samples. With the aid of bioinformatics tools, we determined the transcriptome landscape and sought novel biomarkers by further empirical validations in 55 pairs of adjacent normal and tumor liver samples with various viral statuses such as HBV(+), HCV(+) and HBV(-) HCV(-). We identified a novel gene with coding regions, termed DUNQU1, which has a tissue-specific expression pattern in tumor liver samples of HCV(+) and HBV(-) HCV(-) hepatocellular carcinomas. Overexpression of DUNQU1 in Huh7 cell lines enhances the ability to form colonies in soft agar. Also, we identified three novel differentially-expressed protein-coding genes (ALG1L, SERPINA11 and TMEM82) that lack documented expression profiles in liver cancer and showed that the level of SREPINA11 is correlated with pathology stages. Moreover, we showed that the alternative splicing event of FGFR2 is associated with virus infection, tumor size, cirrhosis and tumor recurrence. The findings indicate that these new markers of hepatocellular carcinoma may be of value in improving prognosis and could have potential as new targets for developing new treatment options.	[Lin, K-T; Huang, C-Y F.] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Shann, Y-J; Huang, C-Y F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Chau, G-Y] Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hsu, C-N] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Hsu, C-N] USC Informat Sci Inst, Marina Del Rey, CA USA; [Hsu, C-N] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA; [Huang, C-Y F.] Natl Yang Ming Univ, Canc Res Ctr, Taipei 112, Taiwan; [Huang, C-Y F.] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; University of Southern California; University of California System; University of California San Diego; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, 155,Li Non St,Sec 2, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937	National Science Council [NSC94-3112-B-182-002, NSC97-3112-B-182-004, NSC101-2627-B-010-001-, NSC102-2627-B-010-001-, NSC 100-2917-I-010-001]; National Health Research Institutes, Taiwan; Taipei Veterans General Hospital [V102E2-006]; National Health Research Institutes [NHRI-EX102-10029BI]; Ministry of Economic Affairs [101-EC-17-A-17-S1-152]; Ministry of Education, Aim for the Top University Plan (National Yang-Ming University)	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Economic Affairs; Ministry of Education, Aim for the Top University Plan (National Yang-Ming University)	We thank the Taiwan Liver Cancer Network for providing the liver tumor tissue samples and related clinical data (all are anonymous) for this work. This network currently includes five major medical centers in Taiwan (National Taiwan University Hospital, Chang-Gung Memorial Hospital-Linko, Veteran General Hospital-Taichung, Chang-Gung Memorial Hospital-Kaohsiung and Veteran General Hospital-Kaohsiung). Taiwan Liver Cancer Network is supported by grants from the National Science Council (NSC94-3112-B-182-002, NSC97-3112-B-182-004) and National Health Research Institutes, Taiwan. We also want to thank National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan, NSC102-2319-B-010-002), National Research Program for Biopharmaceuticals (NRPB, NSC10102325-B-492-001) and National Center for High-performance Computing of National Applied Research Laboratories (NCHC, NARLabs) for providing computing and storage resources. Finally, we want to thank Professor Adrian R Krainer for his valuable comments on the manuscript and hosting at Cold Spring Harbor Laboratory.; This research was supported by grants from the National Science Council (NSC101-2627-B-010-001- and NSC102-2627-B-010-001-), Taipei Veterans General Hospital (V102E2-006), the National Health Research Institutes (NHRI-EX102-10029BI), Ministry of Economic Affairs (101-EC-17-A-17-S1-152) and the Ministry of Education, Aim for the Top University Plan (National Yang-Ming University) to C-YF. Huang. This research was also supported by the research aboard grant from the National Science Council (NSC 100-2917-I-010-001) to K-T. Lin.	Amann T, 2010, AM J PATHOL, V176, P1433, DOI 10.2353/ajpath.2010.090356; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Cheng Y, 2007, BRIT J CANCER, V97, P1441, DOI 10.1038/sj.bjc.6604013; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Eichler EE, 2008, NEW ENGL J MED, V358, P737, DOI 10.1056/NEJMe0708756; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Huang QC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026168; Huijts PEA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2917; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kleino I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-90; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ortiz RM, 2004, GENE CHROMOSOME CANC, V41, P366, DOI 10.1002/gcc.20102; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Somarelli JA, 2013, RNA, V19, P116, DOI 10.1261/rna.035097.112; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wu J, 2011, BIOINFORMATICS, V27, P3010, DOI 10.1093/bioinformatics/btr508; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	42	33	37	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4786	4794		10.1038/onc.2013.424	http://dx.doi.org/10.1038/onc.2013.424			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24141781				2022-12-25	WOS:000343239500009
J	Dmitriev, P; Stankevicins, L; Ansseau, E; Petrov, A; Barat, A; Dessen, P; Robert, T; Turki, A; Lazar, V; Labourer, E; Belayew, A; Carnac, G; Laoudj-Chenivesse, D; Lipinski, M; Vassetzky, YS				Dmitriev, Petr; Stankevicins, Luiza; Ansseau, Eugenie; Petrov, Andrei; Barat, Ana; Dessen, Philippe; Robert, Thomas; Turki, Ahmed; Lazar, Vladimir; Labourer, Emmanuel; Belayew, Alexandra; Carnac, Gilles; Laoudj-Chenivesse, Dalila; Lipinski, Marc; Vassetzky, Yegor S.			Defective Regulation of MicroRNA Target Genes in Myoblasts from Facioscapulohumeral Dystrophy Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Diseases; MicroRNA; Muscular Dystrophy; Transcription; Transcription Regulation; Facioscapulohumeral Dystrophy	LONG NONCODING RNA; MUSCULAR-DYSTROPHY; DNA REARRANGEMENTS; MYOGENIC FACTORS; FSHD MYOBLASTS; CANDIDATE GENE; 4Q35 REGION; EXPRESSION; MUSCLE; DIFFERENTIATION	Background: FSHD is characterized by the overexpression of double homeobox genes DUX4 and DUX4c. Results: We found 29 miRNAs differentially expressed between FSHD and normal myoblasts. Twelve of these miRNAs were up-regulated in myoblasts ectopically expressing DUX4c. Conclusion:DUX4c is linked to the abnormal miRNA expression profile observed in FSHD. Significance: We observe a defective gene regulation by miRNAs in FSHD. Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant hereditary neuromuscular disorder linked to the deletion of an integral number of 3.3-kb-long macrosatellite repeats (D4Z4) within the subtelomeric region of chromosome 4q. Most genes identified in this region are overexpressed in FSHD myoblasts, including the double homeobox genes DUX4 and DUX4c. We have carried out a simultaneous miRNome/transcriptome analysis of FSHD and control primary myoblasts. Of 365 microRNAs (miRNAs) analyzed in this study, 29 were found to be differentially expressed between FSHD and normal myoblasts. Twenty-one microRNAs (miR-1, miR-7, miR-15a, miR-22, miR-30e, miR-32, miR-107, miR-133a, miR-133b, miR-139, miR-152, miR-206, miR-223, miR-302b, miR-331, miR-362, miR-365, miR-382, miR-496, miR-532, miR-654, and miR-660) were up-regulated, and eight were down-regulated (miR-15b, miR-20b, miR-21, miR-25, miR-100, miR-155, miR-345, and miR-594). Twelve of the miRNAs up-regulated in FHSD were also up-regulated in the cells ectopically expressing DUX4c, suggesting that this gene could regulate miRNA gene transcription. The myogenic miRNAs miR-1, miR-133a, miR-133b, and miR-206 were highly expressed in FSHD myoblasts, which nonetheless did not prematurely enter myogenic differentiation. This could be accounted for by the fact that in FSHD myoblasts, functionally important target genes, including cell cycle, DNA damage, and ubiquitination-related genes, escape myogenic microRNA-induced repression.	[Dmitriev, Petr; Stankevicins, Luiza; Barat, Ana; Lipinski, Marc; Vassetzky, Yegor S.] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR 8126, F-94805 Villejuif, France; [Dmitriev, Petr; Turki, Ahmed; Carnac, Gilles; Laoudj-Chenivesse, Dalila] INSERM, U1046, F-34295 Montpellier, France; [Dessen, Philippe; Robert, Thomas; Lazar, Vladimir] Inst Cancerol Gustave Roussy, Funct Genom Unit, F-94805 Villejuif, France; [Labourer, Emmanuel] Ambion Inc, Austin, TX 78744 USA; [Petrov, Andrei] IBC Generium, Volginsky 601125, Russia; [Ansseau, Eugenie; Belayew, Alexandra] Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Gustave Roussy; University of Mons	Vassetzky, YS (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR 8126, F-94805 Villejuif, France.	vassetzky@igr.fr	Lazar, Vladimir/AAQ-2086-2020; BELAYEW, Alexandra/D-5205-2013; Stankevicins, Luiza/K-1858-2014; Vassetzky, Yegor S/C-6447-2008; Lazar, Vladimir/AAV-2087-2020; Vassetzky, Yegor/M-3383-2019; Carnac, Gilles/N-6744-2018; Laoudj-Chenivesse, dalila/N-7097-2018	BELAYEW, Alexandra/0000-0001-5115-2424; Vassetzky, Yegor S/0000-0003-3101-7043; Vassetzky, Yegor/0000-0003-3101-7043; Turki, Ahmed/0000-0003-4559-3105; Carnac, Gilles/0000-0002-3518-8774; Laoudj-Chenivesse, dalila/0000-0003-4356-9187	Association Francaise contre les Myopathies; Association de Recherche Contre le Cancer; Association Amis FSH; University of Montpellier I; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior - Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) felllowship	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association de Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Amis FSH; University of Montpellier I; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior - Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) felllowship	This work was supported by grants from the Association Francaise contre les Myopathies (to Y. S. V. and D. L).; Supported by the Association de Recherche Contre le Cancer, the Association Amis FSH, and the University of Montpellier I.; Recipient of a Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior - Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) felllowship.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Block GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035532; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Deak KL, 2007, NEUROLOGY, V68, P578, DOI 10.1212/01.wnl.0000254991.21818.f3; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2011, J BIOL CHEM, V286, P44620, DOI 10.1074/jbc.M111.254052; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harafuji N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-55; HITI AL, 1989, MOL CELL BIOL, V9, P4722, DOI 10.1128/MCB.9.11.4722; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A., 2003, Genetika, V39, P202; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharma V., 2013, PLOS ONE, V8; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Vizoso M, 2012, CELL RES, V22, P1413, DOI 10.1038/cr.2012.93; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	66	49	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					34989	35002		10.1074/jbc.M113.504522	http://dx.doi.org/10.1074/jbc.M113.504522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145033	Green Published, hybrid			2022-12-25	WOS:000329867600002
J	Finley, R; Glass-Kaastra, SK; Hutchinson, J; Patrick, DM; Weiss, K; Conly, J				Finley, Rita; Glass-Kaastra, Shiona K.; Hutchinson, Jim; Patrick, David M.; Weiss, Karl; Conly, John			Declines in Outpatient Antimicrobial Use in Canada (1995-2010)	PLOS ONE			English	Article							ANTIBIOTIC USE; RESISTANCE; SURVEILLANCE; IMPACT	Background: With rising reports of antimicrobial resistance in outpatient communities, surveillance of antimicrobial use is imperative for supporting stewardship programs. The primary objective of this article is to assess the levels of antimicrobial use in Canada over time. Methods: Canadian antimicrobial use data from 1995 to 2010 were acquired and assessed by four metrics: population-adjusted prescriptions, Defined Daily Doses, spending on antimicrobials (inflation-adjusted), and average Defined Daily Doses per prescription. Linear mixed models were built to assess significant differences among years and antimicrobial groups, and to account for repeated measurements over time. Measures were also compared to published reports from European countries. Results: Temporal trends in antimicrobial use in Canada vary by metric and antimicrobial grouping. Overall reductions were seen for inflation-adjusted spending, population-adjusted prescription rates and Defined Daily Doses, and increases were observed for the average number of Defined Daily Doses per prescription. The population-adjusted prescription and Defined Daily Doses values for 2009 were comparable to those reported by many European countries, while the average Defined Daily Dose per prescription for Canada ranked high. A significant reduction in the use of broad spectrum penicillins occurred between 1995 and 2004, coupled with increases in macrolide and quinolone use, suggesting that replacement of antimicrobial drugs may occur as new products arrive on the market. Conclusions: There have been modest decreases of antimicrobial use in Canada over the past 15 years. However, continued surveillance of antimicrobial use coupled with data detailing antimicrobial resistance within bacterial pathogens affecting human populations is critical for targeting interventions and maintaining the effectiveness of these products for future generations.	[Finley, Rita; Glass-Kaastra, Shiona K.] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Hutchinson, Jim] Univ British Columbia, Isl Med Program, Div Med Microbiol, Victoria, BC, Canada; [Patrick, David M.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Conly, John] Univ Montreal, Dept Infect Dis & Microbiol, Hop Maisonneuve Rosemont, Montreal, PQ, Canada; [Conly, John] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Conly, John] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Synder Inst Chron Dis, Calgary, AB, Canada	Public Health Agency of Canada; University of British Columbia; University of British Columbia; Universite de Montreal; University of Calgary; University of Calgary; University of Calgary	Finley, R (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada.	Rita.Finley@phac-aspc.gc.ca			Abbott; Bayer; Gilead; Merck; Pfizer; Optimer Pharma; Roche; Vertex; Alberta Heritage Foundation for Medical Research; Canadian Institutes for Health Research; PHAC; NCCID; Alberta Advanced Education and Technology	Abbott(Abbott Laboratories); Bayer(Bayer AG); Gilead(Gilead Sciences); Merck(Merck & Company); Pfizer(Pfizer); Optimer Pharma; Roche(Roche Holding); Vertex(Vertex Pharmaceuticals); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); PHAC; NCCID; Alberta Advanced Education and Technology	KW has received research funds and/or has been on the advisory board from Abbott, Bayer, Gilead, Merck, Pfizer, Optimer Pharma, Roche, Vertex. JC has received honoraria from the Canadian Agency for Drugs and Technologies in Health for work as an expert reviewer and clinical expert, respectively, for projects on the role of rapid PCR testing for MRSA in hospitalized patients and the use of vancomycin or metronidazole for treatment of Clostridium difficile colitis within the last three years. He has also received speaker's honoraria related to new anti-bacterial agents from Janssen-Ortho and Pfizer within the past three years. He has received financial support for research activities from the Alberta Heritage Foundation for Medical Research, the Canadian Institutes for Health Research, PHAC, NCCID, Alberta Advanced Education and Technology, and Pfizer. RF, SGK, DP and JH do not have any competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data or materials.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Bader MS, 2010, POSTGRAD MED, V122, P7, DOI 10.3810/pgm.2010.11.2217; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Canada Health, 2007, CAN COMM DIS REP S7, V23, P1; Conly J, 2002, CAN MED ASSOC J, V167, P885; Fishman N, 2006, AM J MED, V119, pS53, DOI 10.1016/j.amjmed.2006.04.003; Government of Canada, 2011, CAN INT PROGR ANT RE; IMS Health Canada, 2007, UNL VAL HLTH INF CAN; Koningstein M, 2011, CLIN INFECT DIS, V53, P644, DOI 10.1093/cid/cir504; National Collaborating Centre for Infectious Diseases, 2010, COMM ACQ ANT RES CON; Owens RC, 2008, DIAGN MICR INFEC DIS, V61, P110, DOI 10.1016/j.diagmicrobio.2008.02.012; Richter SS, 2005, CLIN INFECT DIS, V40, P225, DOI 10.1086/426817; Statistics Canada, 2012, TABL 051 0001 EST PO; The Canadian Committee on Antibiotic Resistance, 2009, PANC STAK CONS ANT R; Vernaz N, 2011, J ANTIMICROB CHEMOTH, V66, P928, DOI 10.1093/jac/dkq525; Versporten A, 2011, 21 EUR C CLIN MICR I; Webster PC, 2010, CAN MED ASSOC J, V182, pE737, DOI 10.1503/cmaj.109-3696; Webster PC, 2010, CAN MED ASSOC J, V182, pE141, DOI 10.1503/cmaj.109-3109; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; WHO Collaborating Centre for Drug Statistics Methodology, 2012, ATC DDD IND; Zervos MJ, 2003, CLIN INFECT DIS, V37, P1643, DOI 10.1086/379709	21	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76398	10.1371/journal.pone.0076398	http://dx.doi.org/10.1371/journal.pone.0076398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146863	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400058
J	Luger, D; Yang, YA; Raviv, A; Weinberg, D; Banerjee, S; Lee, MJ; Trepel, J; Yang, L; Wakefield, LM				Luger, Dror; Yang, Yu-an; Raviv, Asaf; Weinberg, Douglas; Banerjee, Subhadra; Lee, Min-Jung; Trepel, Jane; Yang, Li; Wakefield, Lalage M.			Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects	PLOS ONE			English	Article							SUPPRESSOR-CELLS; IG-ALPHA; BONE-MARROW; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; CANCER-PATIENTS; ACUTE-LEUKEMIA; BEARING HOST; BETA; LINEAGE	The role of myeloid derived suppressor cells (MDSCs) in promoting tumorigenesis is well-established, and significant effort is being made to further characterize surface markers on MDSCs both for better diagnosis and as potential targets for therapy. Here we show that the B cell receptor adaptor molecule CD79a is unexpectedly expressed on immature bone marrow myeloid cells, and is upregulated on MDSCs generated in multiple different mouse models of metastatic but not nonmetastatic cancer. CD79a on MDSCs is upregulated and activated in response to soluble factors secreted by tumor cells. Activation of CD79a on mouse MDSCs, by crosslinking with a specific antibody, maintained their immature phenotype (CD11b+Gr1+), enhanced their migration, increased their suppressive effect on T cell proliferation, and increased secretion of pro-tumorigenic cytokines such as IL-6 and CCL22. Furthermore, crosslinking CD79a on myeloid cells activated signaling through Syk, BLNK, ERK and STAT3 phosphorylation. In vivo, CD79+ myeloid cells showed enhanced ability to promote primary tumor growth and metastasis. Finally we demonstrate that CD79a is upregulated on circulating myeloid cells from lung cancer patients, and that CD79a+ myeloid cells infiltrate human breast tumors. We propose that CD79a plays a functional role in the tumor promoting effects of myeloid cells, and may represent a novel target for cancer therapy.	[Luger, Dror; Yang, Yu-an; Raviv, Asaf; Weinberg, Douglas; Banerjee, Subhadra; Yang, Li; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Lee, Min-Jung; Trepel, Jane] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luger, D (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	lugerd@mail.nih.gov; lw34g@nih.gov	Wakefield, Lalage M/M-1963-2017	Wakefield, Lalage M/0000-0003-4124-5250	National Institutes of Health (NIH), NCI, Center for Cancer Research, Intramural Research Program [ZIA BC 010881]; NATIONAL CANCER INSTITUTE [ZIABC011163, ZIABC010881] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI, Center for Cancer Research, Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (NIH), NCI, Center for Cancer Research, Intramural Research Program (Grant# ZIA BC 010881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram Clare L, 2007, Sci STKE, V2007, pre2, DOI 10.1126/stke.3772007re2; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Arber DA, 1996, AM J PATHOL, V149, P1105; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benlagha K, 1999, J BIOL CHEM, V274, P19389, DOI 10.1074/jbc.274.27.19389; Bhargava P, 2007, AM J CLIN PATHOL, V128, P306, DOI 10.1309/UXCDG9PWN7G89Y54; Chiang MY, 2001, J IMMUNOL, V166, P6091, DOI 10.4049/jimmunol.166.10.6091; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Dworzak MN, 1998, BLOOD, V92, P3203, DOI 10.1182/blood.V92.9.3203.421k34_3203_3209; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Faget J, 2011, CANCER RES, V71, P6143, DOI 10.1158/0008-5472.CAN-11-0573; Figueroa JD, 2009, BREAST CANC RES TREA; Frater JL, 2003, ARCH PATHOL LAB MED, V127, P356; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Fuentes-Panana EM, 2006, J IMMUNOL, V177, P7913, DOI 10.4049/jimmunol.177.11.7913; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hamerman Jessica A, 2006, Sci STKE, V2006, pre1, DOI 10.1126/stke.3202006re1; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamoto H, 2010, INT IMMUNOL, V22, P65, DOI 10.1093/intimm/dxp125; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Kozlov I, 2005, CANCER GENET CYTOGEN, V163, P62, DOI 10.1016/j.cancergencyto.2005.06.002; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; LEDUC I, 1992, CLIN EXP IMMUNOL, V90, P141; MATSUO T, 1993, J IMMUNOL, V150, P3766; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Paredes-Aguilera R, 2001, AM J HEMATOL, V68, P69, DOI 10.1002/ajh.1155; Parish CR, 2009, CURR PROTOC IMMUNOL; Park SR, 2013, CANCER CHEMOTH PHARM, V71, P981, DOI 10.1007/s00280-013-2091-3; Patterson HC, 2011, J IMMUNOL, V187, P2853, DOI 10.4049/jimmunol.1101143; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Pike KA, 2004, J IMMUNOL, V172, P2210, DOI 10.4049/jimmunol.172.4.2210; Reichlin A, 2004, J EXP MED, V199, P855, DOI 10.1084/jem.20031140; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sims R, 2012, MOL BIOL REP, V39, P3185, DOI 10.1007/s11033-011-1085-7; Sumida K, 2012, EUR J IMMUNOL, V42, P2060, DOI 10.1002/eji.201142335; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Zumsteg A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006494	63	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76115	10.1371/journal.pone.0076115	http://dx.doi.org/10.1371/journal.pone.0076115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146823	Green Submitted, Green Published, gold			2022-12-25	WOS:000326019400038
J	Odd, D; Evans, D; Emond, A				Odd, David; Evans, David; Emond, Alan			Preterm Birth, Age at School Entry and Educational Performance	PLOS ONE			English	Article							CHILDREN BORN; ATTAINMENT; OUTCOMES; INFANTS	Objective: To investigate if the lack of gestational age correction may explain some of the school failure seen in ex-preterm infants. Design: A cohort study based on the Avon Longitudinal Study of Parents and Children (ALSPAC). The primary outcome was a low Key Stage 1 score (KS1) score at age 7 or having special educational needs (SEN). Exposure groups were defined as preterm (<37 weeks gestation, n = 722) or term (37-42 weeks, n = 11,268). Conditional regression models were derived, matching preterm to term infants on date of birth (DOB), expected date of delivery (EDD) or expected date of delivery and year of school entry. Multiple imputation was used to account for missing covariate data. Results: When matching for DOB, infants born preterm had an increased odds of a low KS1 score (OR 1.73 (1.45-2.06)) and this association persisted after adjusting for potential confounders (OR 1.57 (1.25-1.97)). The association persisted in the analysis matching for EDD (fully adjusted OR 1.53 (1.21-1.94)) but attenuated substantially after additionally restricting to those infants who entered school at the same time as the control infants (fully adjusted OR 1.25 (0.98-1.60)). A compatible reduction in the population attributable risk fraction was seen from 4.60% to 2.12%, and year of school entry appeared to modify the association between gestational age and the risk of a poor KS1 score (p = 0.029). Conclusions: This study provides evidence that the school year placement and assessment of ex-preterm infants based on their actual birthday (rather than their EDD) may increase their risk of learning difficulties with corresponding school failure.	[Odd, David; Evans, David] North Bristol NHS Trust, Neonatal Unit, Bristol, Avon, England; [Emond, Alan] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England	North Bristol NHS Trust; University of Bristol	Odd, D (corresponding author), North Bristol NHS Trust, Neonatal Unit, Bristol, Avon, England.	david.odd@nbt.nhs.uk	Odd, David/G-8418-2016	Odd, David/0000-0002-6416-4966	Medical Research Council [G9815508] Funding Source: Medline; Wellcome Trust [092731] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; GUZZETTA F, 1986, PEDIATRICS, V78, P995; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2009, J PEDIATR-US, V155, P488, DOI 10.1016/j.jpeds.2009.04.013; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Odd DE, 2012, DEV MED CHILD NEUROL, V54, P704, DOI 10.1111/j.1469-8749.2012.04315.x; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V1-3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V2; Peacock PJ, 2012, ARCH DIS CHILD, V97, P118, DOI 10.1136/adc.2011.300925; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; Wolke D, 2008, J PEDIATR, V152, P256, DOI 10.1016/j.jpeds.2007.06.043; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	16	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76615	10.1371/journal.pone.0076615	http://dx.doi.org/10.1371/journal.pone.0076615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146899	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400077
J	Zhan, YY; Wang, L; Liu, J; Ma, KL; Liu, CP; Zhang, Y; Zou, W				Zhan, Yaoyao; Wang, Liang; Liu, Jing; Ma, Keli; Liu, Cuiping; Zhang, Yuan; Zou, Wei			Choline Plasmalogens Isolated from Swine Liver Inhibit Hepatoma Cell Proliferation Associated with Caveolin-1/Akt Signaling	PLOS ONE			English	Article							PI3K/AKT/MTOR PATHWAY; EXPRESSION; CHOLESTEROL; PURIFICATION; INVOLVEMENT; DEFICIENCY; CAVEOLAE; HEALTH; BCL-2; PEMT2	Plasmalogens play multiple roles in the structures of biological membranes, cell membrane lipid homeostasis and human diseases. We report the isolation and identification of choline plasmalogens (ChoPlas) from swine liver by high performance thin layer chromatography (HPTLC) and high performance liquid chromatography (HPLC)/MS. The growth and viability of hepatoma cells (CBRH7919, HepG2 and SMMC7721) was determined following ChoPlas treatment comparing with that of human normal immortal cell lines (HL7702). Result indicated that ChoPlas inhibited hepatoma cell proliferation with an optimal concentration and time of 25 mu mol/L and 24 h. To better understand the mechanism of the ChoPlas-induced inhibition of hepatoma cell proliferation, Caveolin-1 and PI3K/Akt pathway signals, including total Akt, phospho-Akt(pAkt) and Bcl-2 expression in CBRH7919 cells, were determined by western blot. ChoPlas treatment increased Caveolin-1 expression and reduced the expression of phospho-Akt (pAkt) and Bcl-2, downstream targets of the PI3K/Akt pathway. Further cell cycle analysis showed that ChoPlas treatment induced G1 and G1/S phase transition cell cycle arrest. The expression of essential cell cycle regulatory proteins involved in the G1 and G1/S phase transitions, cyclin D, CDK4, cyclin E and CDK2, were also analyzed by western blot. ChoPlas reduced CDK4, cyclin E and CDK2 expression. Taken together, the results indicate that swine liver-derived natural ChoPlas inhibits hepatoma cell proliferation associated with Caveolin-1 and PI3K/Akt signals.	[Zhan, Yaoyao; Wang, Liang; Liu, Cuiping; Zhang, Yuan; Zou, Wei] Liaoning Normal Univ, Coll Life Sci, Dalian, Liaoning, Peoples R China; [Liu, Jing] Dalian Med Univ, Affiliated Hosp 1, Regenerat Med Ctr, Dalian, Liaoning, Peoples R China; [Zhan, Yaoyao] Dalian Ocean Univ, Coll Fisheries & Life Sci, Dalian, Liaoning, Peoples R China; [Ma, Keli] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Liaoning, Peoples R China; [Zhang, Yuan] Jilin Univ, Key Lab Mol Enzymol, Ministrat Educ, Changchun 130023, Jilin, Peoples R China	Liaoning Normal University; Dalian Medical University; Dalian Ocean University; Dalian Medical University; Jilin University	Zou, W (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian, Liaoning, Peoples R China.	weizou60@hotmail.com	Wang, Liang/O-8394-2019	Wang, Liang/0000-0003-1952-3525	key laboratory project of Department of Education of Liaoning Province [LS2010095]; National Natural Science Foundation of China [30570225, 30970353]; International S&T Coorperation Project of the Ministry of ST China [2010DFR30850]	key laboratory project of Department of Education of Liaoning Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Coorperation Project of the Ministry of ST China	This work was supported by the key laboratory project of Department of Education of Liaoning Province (LS2010095), National Natural Science Foundation of China (numbers 30570225, 30970353), International S&T Coorperation Project of the Ministry of S&T China (number 2010DFR30850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Braverman NE, 2012, BIOCHIM BIOPHYS ACTA, V1822, P1422; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Chen Wong L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P575, DOI 10.2174/156801105774574649; CUI Z, 1993, J BIOL CHEM, V268, P16655; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Eymin B, 2010, CELL ADHES MIGR, V4, P114, DOI 10.4161/cam.4.1.10977; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Farooqui AA, 1997, NEUROCHEM RES, V22, P523, DOI 10.1023/A:1027380331807; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frank PG, 2007, CELL CYCLE, V6, P115, DOI 10.4161/cc.6.2.3722; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Ghayad SE, 2010, RECENT PAT ANTI-CANC, V5, P29, DOI 10.2174/157489210789702208; Guruswamy S, 2009, INT J ONCOL, V35, P1037, DOI 10.3892/ijo_00000418; HEYMANS HSA, 1983, NATURE, V306, P69, DOI 10.1038/306069a0; Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P299, DOI 10.1007/BF00710270; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Li YL, 2009, IUBMB LIFE, V61, P846, DOI 10.1002/iub.222; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu J, 2001, AM J PHYSIOL-CELL PH, V280, pC823, DOI 10.1152/ajpcell.2001.280.4.C823; Liu PS, 1999, NAT CELL BIOL, V1, P369, DOI 10.1038/14067; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Mandel H, 1998, BIOCHEM BIOPH RES CO, V250, P369, DOI 10.1006/bbrc.1998.9321; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Nadler Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1998; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; RAPPORT MM, 1984, J LIPID RES, V25, P1522; Ren Gang, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P379; SCHAEFER EJ, 1995, J LIPID RES, V36, P1427; Schedin S, 1997, J BIOL CHEM, V272, P6245, DOI 10.1074/jbc.272.10.6245; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Straten PT, 2010, ONCOTARGET, V1, P239; VANCE JE, 1990, BIOCHIM BIOPHYS ACTA, V1045, P128, DOI 10.1016/0005-2760(90)90141-J; Liang W, 2006, CHIN J CHROMATOGR, V24, P271; Wang X, 2011, MOL BIOL REP, V38, P761, DOI 10.1007/s11033-010-0164-5; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-182; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-214; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001; Zou W, 2002, BBA-MOL CELL BIOL L, V1581, P49, DOI 10.1016/S1388-1981(02)00120-8; Zundel W, 2000, MOL CELL BIOL, V20, P1507, DOI 10.1128/MCB.20.5.1507-1514.2000	55	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77387	10.1371/journal.pone.0077387	http://dx.doi.org/10.1371/journal.pone.0077387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143228	Green Submitted, gold, Green Published			2022-12-25	WOS:000325894100065
J	Buchberger, E; El Harchi, M; Payrhuber, D; Zommer, A; Schauer, D; Simonitsch-Klupp, I; Bilban, M; Brostjan, C				Buchberger, Elisabeth; El Harchi, Miriam; Payrhuber, Dietmar; Zommer, Anna; Schauer, Dominic; Simonitsch-Klupp, Ingrid; Bilban, Martin; Brostjan, Christine			Overexpression of the Transcriptional Repressor Complex BCL-6/BCoR Leads to Nuclear Aggregates Distinct from Classical Aggresomes	PLOS ONE			English	Article							HISTONE DEACETYLASES; MOLECULAR CHAPERONE; PROTEIN; SUPPRESSION; PROTEASOME; HUNTINGTIN; INCLUSIONS; DISEASE; BODIES; FAMILY	Nuclear inclusions of aggregated proteins have primarily been characterized for molecules with aberrant polyglutamine repeats and for mutated or structurally altered proteins. They were termed "nuclear aggresomes" and misfolding was shown to promote association with molecular chaperones and proteasomes. Here, we report that two components of a transcriptional repressor complex (BCL-6 and BCoR) of wildtype amino acid sequence can independently or jointly induce the formation of nuclear aggregates when overexpressed. The observation that the majority of cells rapidly downregulate BCL-6/BCoR levels, supports the notion that expression of these proteins is under tight control. The inclusions occur when BCL-6/BCoR expression exceeds 150-fold of endogenous levels. They preferentially develop in the nucleus by a gradual increase in aggregate size to form large, spheroid structures which are not associated with heat shock proteins or marked by ubiquitin. In contrast, we find the close association of BCL-6/BCoR inclusions with PML bodies and a reduction in aggregation upon the concomitant overexpression of histone deacetylases or heat shock protein 70. In summary, our data offer a perspective on nuclear aggregates distinct from classical "nuclear aggresomes": Large complexes of spheroid structure can evolve in the nucleus without being marked by the cellular machinery for protein refolding and degradation. However, nuclear proteostasis can be restored by balancing the levels of chaperones.	[Buchberger, Elisabeth; El Harchi, Miriam; Payrhuber, Dietmar; Zommer, Anna; Schauer, Dominic; Brostjan, Christine] Med Univ Vienna, Vienna Gen Hosp, Dept Surg, Vienna, Austria; [Simonitsch-Klupp, Ingrid] Med Univ Vienna, Vienna Gen Hosp, Clin Inst Pathol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Vienna Gen Hosp, Core Facil Genom, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Brostjan, C (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Surg, Vienna, Austria.	christine.brostjan@meduniwien.ac.at		Brostjan, Christine/0000-0003-1462-5397; Bilban, Martin/0000-0001-7043-7142	Anniversary Fund of the Oesterreichische Nationalbank [12678]	Anniversary Fund of the Oesterreichische Nationalbank	This work was supported by the Anniversary Fund of the Oesterreichische Nationalbank (http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp), project number: 12678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albagli O, 2000, MOL CELL BIOL, V20, P8560, DOI 10.1128/MCB.20.22.8560-8570.2000; Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 1999, J NEUROSCI, V19, P10338; Chen TLL, 2001, EXP CELL RES, V263, P224, DOI 10.1006/excr.2000.5093; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Fusco C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040440; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; HUTT DM, 2013, COLD SPRING HARB PER, V5, P86914; Huynh KD, 2000, GENE DEV, V14, P1810; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kon M, 2010, FEBS LETT, V584, P1399, DOI 10.1016/j.febslet.2009.12.025; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Marquard L, 2009, HISTOPATHOLOGY, V54, P688, DOI 10.1111/j.1365-2559.2009.03290.x; Miranker AD, 2005, NATURE, V437, P197, DOI 10.1038/437197a; Moran DM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-32; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Puvion-Dutilleul F, 2003, MICROSC RES TECHNIQ, V61, P389, DOI 10.1002/jemt.10363; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Stead MA, 2008, ACTA CRYSTALLOGR F, V64, P1101, DOI 10.1107/S1744309108036063; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang XY, 2006, INVEST OPHTH VIS SCI, V47, P700, DOI 10.1167/iovs.05-0697; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76845	10.1371/journal.pone.0076845	http://dx.doi.org/10.1371/journal.pone.0076845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146931	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400085
J	Naggara, O; Raymond, J; Ayllon, MD; Al-Shareef, F; Touze, E; Chenoufi, M; Gerber, S; Mellerio, C; Zuber, M; Meder, JF; Mas, JL; Oppenheim, C				Naggara, Olivier; Raymond, Jean; Ayllon, Montserrat Domingo; Al-Shareef, Fawaz; Touze, Emmanuel; Chenoufi, Meriem; Gerber, Sophie; Mellerio, Charles; Zuber, Matthieu; Meder, Jean Francois; Mas, Jean-Louis; Oppenheim, Catherine			T2*"Susceptibility Vessel Sign" Demonstrates Clot Location and Length in Acute Ischemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTERNAL CAROTID-ARTERY; INTRAVENOUS THROMBOLYSIS; SUSCEPTIBILITY SIGN; OCCLUSION; RECANALIZATION; BURDEN; SCORE; ANGIOGRAPHY; HEMORRHAGE	Objectives: The aim of our study was to evaluate, in acute ischemic stroke patients, the diagnostic accuracy of the MRI susceptibility vessel sign (SVS) against catheter angiography (DSA) for the detection of the clot and its value in predicting clot location and length. Materials and Methods: We identified consecutive patients (2006-2012) admitted to our center, where 1.5 T MRI is systematically implemented as first-line diagnostic work-up, with: (1) pre-treatment 6-mm-thick multislice 2D T2* sequence; (2) delay from MRI-to-DSA <3 hrs; (3) no fibrinolysis between MRI and DSA. The location and length of SVS on T2* was independently assessed by three readers, and compared per patient, per artery and per segment, to DSA findings, obtained by two different readers. Clot length measured on T2* and DSA were compared using intra-class correlation coefficient (ICC), Bland & Altman test and Passing & Bablok regression analysis. Results: On DSA, a clot was present in 85 patients, in 126 of 1190 (10.6%) arteries and 175 of 1870 (9.4%) segments. Sensitivity of the SVS, as sensed by the used protocol at 1.5 T, was 81.1% (69 of 85 patients) and was higher in anterior (55 of 63, 87.3%), than in posterior circulation stroke (14 of 22, 63.6%, p=0.02). Sensitivity/ specificity was 69.8/99.6% (per artery) and 76.6/99.7% (per segment). Positive (PPV) and negative predictive value (NPV) and accuracy were all >94%. Inter-and intra-observer ICC was excellent for clot length as measured on T2* (kappa >= 0.97) and as measured on DSA (kappa >= 0.94). Correlation between T2* and DSA for clot length was excellent (ICC: ;0.88, 95%CI: 0.81-0.92; Bland & Altman: mean bias of 1.6% [95%CI: -4.7 to 7.8%], Passing & Bablok: 0.91). Conclusions: SVS is a specific marker of clot location in the anterior and posterior circulation. Clot length greater than 6 mm can be reliably measured on T2*.	[Naggara, Olivier; Ayllon, Montserrat Domingo; Al-Shareef, Fawaz; Chenoufi, Meriem; Mellerio, Charles; Meder, Jean Francois; Oppenheim, Catherine] Univ Paris 05, INSERM, Ctr Hosp St Anne, Dept Neuroradiol,UMR 894, Paris, Ile De France, France; [Touze, Emmanuel; Mas, Jean-Louis] Univ Paris 05, INSERM, Ctr Hosp St Anne, Dept Neurol,UMR 894, Paris, Ile De France, France; [Gerber, Sophie] St Joseph Hosp, Dept Radiol, Paris, France; [Zuber, Matthieu] St Joseph Hosp, Dept Neurol, Paris, Ile De France, France; [Raymond, Jean] Univ Montreal, Notre Dame Hosp, Intervent Neuroradiol Res Unit, Dept Radiol,Int Consortium Neuroendovasc Ctr, Montreal, PQ H3C 3J7, Canada	GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	Naggara, O (corresponding author), Univ Paris 05, INSERM, Ctr Hosp St Anne, Dept Neuroradiol,UMR 894, Paris, Ile De France, France.	o.naggara@ch-sainte-anne.fr	Domingo, Montse/ABH-6596-2020; Oppenheim, Catherine/N-1635-2018; Naggara, Olivier/R-3939-2017	Oppenheim, Catherine/0000-0003-3410-0862; MELLERIO, Charles/0000-0002-9987-9101; Touze, Emmanuel/0000-0002-7254-2162; Naggara, Olivier/0000-0002-9544-379X; Meder, Jean-Francois/0000-0002-0898-0133				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Assouline E, 2005, CEREBROVASC DIS, V20, P6, DOI 10.1159/000086120; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Barreto AD, 2008, STROKE, V39, P3231, DOI 10.1161/STROKEAHA.108.521054; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BLINC A, 1992, HAEMOSTASIS, V22, P195; CLARK RA, 1990, RADIOLOGY, V175, P201, DOI 10.1148/radiology.175.1.2315481; Deistung A, 2009, J MAGN RESON IMAGING, V29, P1478, DOI 10.1002/jmri.21673; Derex L, 2002, CEREBROVASC DIS, V13, P225, DOI 10.1159/000057847; Flacke S, 2000, RADIOLOGY, V215, P476, DOI 10.1148/radiology.215.2.r00ma09476; Gralla J, 2008, AM J NEURORADIOL, V29, P247, DOI 10.3174/ajnr.A0790; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; JANSEN O, 1995, AM J NEURORADIOL, V16, P1977; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Lee KY, 2007, STROKE, V38, P192, DOI 10.1161/01.STR.0000251788.03914.00; Legrand L, 2013, STROKE, V2013; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Liebeskind DS, 2009, STROKE, V40, pE30, DOI 10.1161/STROKEAHA.108.541441; Linfante I, 2002, STROKE, V33, P2066, DOI 10.1161/01.STR.0000021001.18101.A5; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Molina CA, 2005, STROKE, V36, P2333, DOI 10.1161/01.STR.0000185933.44619.1b; Naggara O, 2011, AM J NEURORADIOL, V32, P869, DOI 10.3174/ajnr.A2553; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Rovira A, 2004, RADIOLOGY, V232, P466, DOI 10.1148/radiol.2322030273; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Shinohara Y, 2012, NEURORADIOLOGY, V54, P427, DOI 10.1007/s00234-011-0895-6; Soman S, 2013, AJNR AM J NEURORADIO; Taber KH, 1996, JMRI-J MAGN RESON IM, V6, P878, DOI 10.1002/jmri.1880060607; Tisserand M, 2011, NEUROLOGY, V76, P1288, DOI 10.1212/WNL.0b013e3182152855; Turc G, 2013, STROKE, V44, P1323, DOI 10.1161/STROKEAHA.111.000127; Wang S, 2013, STROKE, V44, P2315, DOI 10.1161/STROKEAHA.113.001638	39	50	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76727	10.1371/journal.pone.0076727	http://dx.doi.org/10.1371/journal.pone.0076727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146915	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400077
J	Wakai, T; Yamamoto, N				Wakai, Taketo; Yamamoto, Naoyuki			A Novel Branched Chain Amino Acids Responsive Transcriptional Regulator, BCARR, Negatively Acts on the Proteolytic System in Lactobacillus helveticus	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; ANTIHYPERTENSIVE PEPTIDES; BINDING DOMAIN; FERMENTED MILK; CBS DOMAIN; SOUR MILK; CODY; PROTEINS	Transcriptional negative regulation of the proteolytic system of Lactobacillus helveticus CM4 in response to amino acids seems to be very important for the control of antihypertensive peptide production; however, it remains poorly understood. A 26-kDa protein with N-terminal cystathionine beta-synthase domains (CBS domain protein), which seems to be involved in the regulatory system, was purified by using a DNA-sepharose bound 300-bp DNA fragment corresponding to the upstream regions of the six proteolytic genes that are down-regulated by amino acids. The CBS domain protein bound to a DNA fragment corresponding to the region upstream of the pepV gene in response to branched chain amino acids (BCAAs). The expression of the pepV gene in Escherichia coli grown in BCAA-enriched medium was repressed when the CBS domain protein was co-expressed. These results reveal that the CBS domain protein acts as a novel type of BCAA-responsive transcriptional regulator (BCARR) in L. helveticus. From comparative analysis of the promoter regions of the six proteolysis genes, a palindromic AT-rich motif, 5'-AAAAANNCTWTTATT-3', was predicted as the consensus DNA motif for the BCARR protein binding. Footprint analysis using the pepV promotor region and gel shift analyses with the corresponding short DNA fragments strongly suggested that the BCARR protein binds adjacent to the pepV promoter region and affects the transcription level of the pepV gene in the presence of BCAAs. Homology search analysis of the C-terminal region of the BCARR protein suggested the existence of a unique beta alpha beta beta alpha beta fold structure that has been reported in a variety of ACT (aspartate kinase-chorismate mutase-tyrA) domain proteins for sensing amino acids. These results also suggest that the sensing of BCAAs by the ACT domain might promote the binding of the BCARR to DNA sequences upstream of proteolysis genes, which affects the gene expression of the proteolytic system in L. helveticus.	[Wakai, Taketo] Calpis Co Ltd, Microbiol & Fermentat Lab, Sagamihara, Kanagawa, Japan; [Yamamoto, Naoyuki] Calpis Co Ltd, Res & Dev Planning Dept, Sagamihara, Kanagawa, Japan		Yamamoto, N (corresponding author), Calpis Co Ltd, Res & Dev Planning Dept, Sagamihara, Kanagawa, Japan.	naoyuki.yamamoto@calpis.co.jp						Aguado-Llera D, 2010, FEBS LETT, V584, P4485, DOI 10.1016/j.febslet.2010.10.006; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bailey TL, 1994, FITTING MIXTURE MODE; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2011, J BACTERIOL, V193, P473, DOI 10.1128/JB.01151-10; Blagova EV, 2003, ACTA CRYSTALLOGR D, V59, P155, DOI 10.1107/S0907444902018358; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; De Man J., 1972, J APPL BACTERIOL, V23, P130, DOI DOI 10.1111/J.1365-2672.1960.TB00188.X; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; den Hengst CD, 2005, J BACTERIOL, V187, P512, DOI 10.1128/JB.187.2.512-521.2005; Ettema TJG, 2002, J BIOL CHEM, V277, P37464, DOI 10.1074/jbc.M206063200; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Gatti M, 2004, APPL ENVIRON MICROB, V70, P182, DOI 10.1128/AEM.70.1.182-190.2004; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Joseph P, 2005, J BACTERIOL, V187, P4127, DOI 10.1128/JB.187.12.4127-4139.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEENHOUTS KJ, 1990, APPL ENVIRON MICROB, V56, P2726, DOI 10.1128/AEM.56.9.2726-2735.1990; Lemos JA, 2008, J BACTERIOL, V190, P5291, DOI 10.1128/JB.00288-08; Liu F, 2009, FEMS MICROBIOL LETT, V297, P164, DOI 10.1111/j.1574-6968.2009.01672.x; Liu ST, 1998, ANAL BIOCHEM, V255, P158, DOI 10.1006/abio.1997.2457; NAKAMURA Y, 1995, J DAIRY SCI, V78, P1253, DOI 10.3168/jds.S0022-0302(95)76745-5; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004; Petranovic D, 2004, MOL MICROBIOL, V53, P613, DOI 10.1111/j.1365-2958.2004.04136.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Ritt JF, 2009, J APPL MICROBIOL, V106, P801, DOI 10.1111/j.1365-2672.2008.04032.x; Sadat-Mekmene L, 2011, INT J FOOD MICROBIOL, V146, P1, DOI 10.1016/j.ijfoodmicro.2011.01.039; Sambrook J., 1989, MOL CLONING; Slattery L, 2010, J DAIRY SCI, V93, P4435, DOI 10.3168/jds.2010-3327; Sneath PHA, 1986, BERGEYS MANUAL SYSTE, V2; Wakai T, 2013, J BIOSCI BIOENG, V115, P246, DOI 10.1016/j.jbiosc.2012.09.020; Wakai T, 2012, J BIOSCI BIOENG, V114, P133, DOI 10.1016/j.jbiosc.2012.03.015; YAMAMOTO N, 1994, BIOSCI BIOTECH BIOCH, V58, P776, DOI 10.1271/bbb.58.776; YAMAMOTO N, 1995, APPL ENVIRON MICROB, V61, P698, DOI 10.1128/AEM.61.2.698-701.1995; Yamamoto N, 2011, LACTIC ACID BACTERIA AND BIFIDOBACTERIA: CURRENT PROGRESS IN ADVANCED RESEARCH, P223; Yin J, 2011, ACTA CRYSTALLOGR F, V67, P933, DOI 10.1107/S1744309111021105	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75976	10.1371/journal.pone.0075976	http://dx.doi.org/10.1371/journal.pone.0075976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146802	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400032
J	Yeh, FC; Tseng, WYI				Yeh, Fang-Cheng; Tseng, Wen-Yih Isaac			Sparse Solution of Fiber Orientation Distribution Function by Diffusion Decomposition	PLOS ONE			English	Article							SPHERICAL DECONVOLUTION; CROSSING FIBERS; LEAST ANGLE; MRI; REGRESSION; TRACTOGRAPHY; RESOLUTION	Fiber orientation is the key information in diffusion tractography. Several deconvolution methods have been proposed to obtain fiber orientations by estimating a fiber orientation distribution function (ODF). However, the L-2 regularization used in deconvolution often leads to false fibers that compromise the specificity of the results. To address this problem, we propose a method called diffusion decomposition, which obtains a sparse solution of fiber ODF by decomposing the diffusion ODF obtained from q-ball imaging (QBI), diffusion spectrum imaging (DSI), or generalized q-sampling imaging (GQI). A simulation study, a phantom study, and an in-vivo study were conducted to examine the performance of diffusion decomposition. The simulation study showed that diffusion decomposition was more accurate than both constrained spherical deconvolution and ball-and-sticks model. The phantom study showed that the angular error of diffusion decomposition was significantly lower than those of constrained spherical deconvolution at 30 degrees crossing and ball-and-sticks model at 60 degrees crossing. The in-vivo study showed that diffusion decomposition can be applied to QBI, DSI, or GQI, and the resolved fiber orientations were consistent regardless of the diffusion sampling schemes and diffusion reconstruction methods. The performance of diffusion decomposition was further demonstrated by resolving crossing fibers on a 30-direction QBI dataset and a 40-direction DSI dataset. In conclusion, diffusion decomposition can improve angular resolution and resolve crossing fibers in datasets with low SNR and substantially reduced number of diffusion encoding directions. These advantages may be valuable for human connectome studies and clinical research.	[Yeh, Fang-Cheng] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Coll Med, Ctr Optoelectron Med, Taipei, Taiwan; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	Carnegie Mellon University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tseng, WYI (corresponding author), Natl Taiwan Univ Coll Med, Ctr Optoelectron Med, Taipei, Taiwan.	wytseng@ntu.edu.tw	Yeh, Fang-Cheng/E-9698-2012	Yeh, Fang-Cheng/0000-0002-7946-2173; Tseng, Wen-Yih Isaac/0000-0002-2314-6868	National Science Council, Taiwan [NSC100-3112-B-002-016, NSC100-2321-B-002-015]; National Health Research Institute, Taiwan [NHRI-EX101-10145NI]; National Institutes of Health/National Institute of Mental Health, USA [U01MH093765]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health/National Institute of Mental Health, USA	This work was supported in part by the National Science Council, Taiwan (NSC100-3112-B-002-016, NSC100-2321-B-002-015), National Health Research Institute, Taiwan (NHRI-EX101-10145NI) and National Institutes of Health/National Institute of Mental Health, USA (U01MH093765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil H, 2011, SCIENCE, V331, P708, DOI 10.1126/science.1199305; Alexander DC, 2005, LECT NOTES COMPUT SC, V3565, P76; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Dell'Acqua F, 2010, NEUROIMAGE, V49, P1446, DOI 10.1016/j.neuroimage.2009.09.033; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hastie T, 2007, ELECTRON J STAT, V1, P1, DOI 10.1214/07-EJS004; Hesterberg T, 2008, STAT SURV, V2, P61, DOI 10.1214/08-SS035; Jeurissen B, 2012, HUM BRAIN MAPP; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaden E, 2012, MED IMAGE ANAL, V16, P876, DOI 10.1016/j.media.2012.01.004; Kezele I, 2010, MED IMAGE ANAL, V14, P332, DOI 10.1016/j.media.2010.01.002; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Landman BA, 2012, NEUROIMAGE, V59, P2175, DOI 10.1016/j.neuroimage.2011.10.011; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Patel V, 2010, NEUROIMAGE, V51, P1071, DOI 10.1016/j.neuroimage.2010.02.060; Ramirez-Manzanares A, 2007, IEEE T MED IMAGING, V26, P1091, DOI 10.1109/TMI.2007.900461; Schultz T, 2010, LECT NOTES COMPUT SC, V6361, P674; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Yeh FC, 2011, NEUROIMAGE, V55, P1054, DOI 10.1016/j.neuroimage.2010.11.087; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126	31	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75747	10.1371/journal.pone.0075747	http://dx.doi.org/10.1371/journal.pone.0075747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146772	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400017
J	Slater, J; Tierney, A; Kraus, N				Slater, Jessica; Tierney, Adam; Kraus, Nina			At-Risk Elementary School Children with One Year of Classroom Music Instruction Are Better at Keeping a Beat	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; DEVELOPMENTAL DYSLEXIA; COGNITIVE-DEVELOPMENT; RHYTHM PERCEPTION; TEMPORAL CONTROL; LIFE-SPAN; SKILLS; BRAIN; ENTRAINMENT; METER	Temporal processing underlies both music and language skills. There is increasing evidence that rhythm abilities track with reading performance and that language disorders such as dyslexia are associated with poor rhythm abilities. However, little is known about how basic time-keeping skills can be shaped by musical training, particularly during critical literacy development years. This study was carried out in collaboration with Harmony Project, a non-profit organization providing free music education to children in the gang reduction zones of Los Angeles. Our findings reveal that elementary school children with just one year of classroom music instruction perform more accurately in a basic finger-tapping task than their untrained peers, providing important evidence that fundamental time-keeping skills may be strengthened by short-term music training. This sets the stage for further examination of how music programs may be used to support the development of basic skills underlying learning and literacy, particularly in at-risk populations which may benefit the most.	[Slater, Jessica; Tierney, Adam; Kraus, Nina] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Slater, Jessica; Tierney, Adam; Kraus, Nina] Northwestern Univ, Dept Commun Sci, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.	nkraus@northwestern.edu	Slater, Jessica/AAS-4515-2020	Slater, Jessica/0000-0001-7281-5231; Tierney, Adam/0000-0002-7624-6918	Knowles Hearing Center, NIH [T32 DC009399-02]; National Association of Music Merchants; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009399] Funding Source: NIH RePORTER	Knowles Hearing Center, NIH; National Association of Music Merchants; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Knowles Hearing Center, NIH T32 DC009399-02, and the National Association of Music Merchants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Ben-Pazi H, 2003, DEV MED CHILD NEUROL, V45, P743, DOI 10.1017/S0012162203001385; Ben-Pazi H, 2007, J CHILD NEUROL, V22, P543, DOI 10.1177/0883073807302610; Bugaj K, 2011, B COUN RES MUSIC ED, P89; Buzsaki G., 2009, RHYTHMS BRAIN, DOI [10.1093/acprof:oso/9780195301069.001.0001, DOI 10.1093/ACPROF:OSO/9780195301069.001.0001]; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; DAUER RM, 1983, J PHONETICS, V11, P51, DOI 10.1016/S0095-4470(19)30776-4; Dellatolas G, 2009, ARCH CLIN NEUROPSYCH, V24, P555, DOI 10.1093/arclin/acp044; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Drewing K, 2006, INT J BEHAV DEV, V30, P280, DOI 10.1177/0165025406066764; Ellis RJ, 2013, NEUROIMAGE, V75, P97, DOI 10.1016/j.neuroimage.2013.02.045; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gooding L., 2011, UPDATE APPL RES MUSI, V30, P32, DOI [DOI 10.1177/8755123311418481, 10.1177/8755123311418481]; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grieshaber K., 1987, B COUNCIL RES MUSIC, V90, P73; Gromko JE, 2005, J RES MUSIC EDUC, V53, P199, DOI 10.2307/3598679; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, COGNITIVE PSYCHOL, V50, P354, DOI 10.1016/j.cogpsych.2004.09.003; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Levitin DJ., 2009, MUSIC MED, V1, P9, DOI [10.1177/1943862109338604, DOI 10.1177/1943862109338604]; Lipscomb S. D., 2008, 2008 INT C MUS PERC; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Reifinger J, 2006, UPDATE U S C DEP MUS, V25, P15; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2007, MUSIC PERCEPT, V24, P367, DOI 10.1525/MP.2007.24.4.367; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2010, HUM MOVEMENT SCI, V29, P200, DOI 10.1016/j.humov.2009.08.002; Schlaug G, 2005, ANN NY ACAD SCI, V1060, P219, DOI 10.1196/annals.1360.015; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Skoe E, 2012, J NEUROSCI, V32, P11507, DOI 10.1523/JNEUROSCI.1949-12.2012; Standley JM, 2008, UPDATE APPL RES MUS, V27, P17, DOI DOI 10.1177/8755123308322270; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Tierney A, 2013, J NEUROSCI; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; Trainor LJ, 2009, ANN NY ACAD SCI, V1169, P133, DOI 10.1111/j.1749-6632.2009.04589.x; Woerner C, 1999, WECHSLER ABBREVIATED	54	34	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77250	10.1371/journal.pone.0077250	http://dx.doi.org/10.1371/journal.pone.0077250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236QM	24130865	Green Published, gold, Green Accepted			2022-12-25	WOS:000325814200074
J	Chan, LH; Wang, W; Yeung, W; Deng, Y; Yuan, P; Mak, KK				Chan, L. H.; Wang, W.; Yeung, W.; Deng, Y.; Yuan, P.; Mak, K. K.			Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression	ONCOGENE			English	Article						osteosarcoma; yes-associated protein1; long non-coding RNA H19	YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; NONCODING RNA; CANDIDATE ONCOGENE; CTCF-BINDING; CELL-CYCLE; EXPRESSION; BONE; CANCER; PATHWAY	Osteosarcoma is one of the most common bone tumors. However, the genetic basis for its pathogenesis remains elusive. Here, we investigated the roles of Hedgehog (Hh) signaling in osteosarcoma development. Genetically-engineered mice with ubiquitous upregulated Hh signaling specifically in mature osteoblasts develop focal bone overgrowth, which greatly resembles the early stage of osteosarcoma. However, these mice die within three months, which prohibits further analysis of tumor progression. We therefore generated a mouse model with partial upregulated Hh signaling in mature osteoblasts and crossed it into a p53 heterozygous background to potentiate tumor development. We found that these mutant mice developed malignant osteosarcoma with high penetrance. Isolated primary tumor cells were mainly osteoblastic and highly proliferative with many characteristics of human osteosarcomas. Allograft transplantation into immunocompromised mice displayed high tumorigenic potential. More importantly, both human and mouse tumor tissues express high level of yes-associated protein 1 (Yap1), a potent oncogene that is amplified in various cancers. We show that inhibition of Hh signaling reduces Yap1 expression and knockdown of Yap1 significantly inhibits tumor progression. Moreover, long non-coding RNA H19 is aberrantly expressed and induced by upregulated Hh signaling and Yap1 overexpression. Our results demonstrate that aberrant Hh signaling in mature osteoblasts is responsible for the pathogenesis of osteoblastic osteosarcoma through Yap1 and H19 overexpression.	[Chan, L. H.; Wang, W.; Yeung, W.; Deng, Y.; Mak, K. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Key Labs Regenerat Med,Minist Educ, Shatin, Hong Kong, Peoples R China; [Yuan, P.] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Mak, K. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Program, Shatin, Hong Kong, Peoples R China; [Mak, K. K.] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Mak, KK (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Program, Shatin, Hong Kong, Peoples R China.	kmak@cuhk.edu.hk		Yuan, Ping/0000-0001-7243-3487; Mak, Kingston King-Lun/0000-0002-4733-9146; Deng, Youping/0000-0002-5951-8213	School of Biomedical Sciences, The Chinese University of Hong Kong [4620504]; Research Grant Council of the Hong Kong Special Administrative Region [CUHK479012]; United College, The Chinese University of Hong Kong [CA11189];  [CUHK2041745]	School of Biomedical Sciences, The Chinese University of Hong Kong; Research Grant Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); United College, The Chinese University of Hong Kong(Chinese University of Hong Kong); 	We thank Drs. Tin-lap Lee and David John Wilmshurst for critical comments on the manuscript. This work is supported by the Seed Fund of the School of Biomedical Sciences, The Chinese University of Hong Kong (4620504), Early Career Scheme of the Research Grant Council of the Hong Kong Special Administrative Region (CUHK479012), Direct Grant for research (CUHK2041745) and the Endowment Fund Research Grant of the United College, The Chinese University of Hong Kong (CA11189).	Andela VB, 2005, J CLIN PATHOL, V58, P328, DOI 10.1136/jcp.2004.017640; Arima T, 1997, CANCER GENET CYTOGEN, V93, P39, DOI 10.1016/S0165-4608(96)00221-X; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fults Daniel W, 2005, Neurosurg Focus, V19, pE7, DOI 10.3171/foc.2005.19.5.8; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Hibi K, 1996, CANCER RES, V56, P480; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Li N, 2009, CANCER-AM CANCER SOC, V115, P4795, DOI 10.1002/cncr.24519; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Mutsaers AJ, 2013, BONE, V55, P166, DOI 10.1016/j.bone.2013.02.016; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Raffel C, 1997, CANCER RES, V57, P842; Reifenberger J, 1998, CANCER RES, V58, P1798; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; SWEETNAM R, 1982, BRIT J HOSP MED, V28, P112; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Tanos V, 2004, INT J GYNECOL CANCER, V14, P521, DOI 10.1111/j.1048-891x.2004.014314.x; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Ulaner GA, 2003, ENDOCRINOLOGY, V144, P4420, DOI 10.1210/en.2003-0681; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Venkatachalam S, 2001, TOXICOL PATHOL, V29, P147, DOI 10.1080/019262301753178555; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Warzecha J, 2007, J CHEMOTHERAPY, V19, P554, DOI 10.1179/joc.2007.19.5.554; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; Won KY, 2009, TUMORI J, V95, P311; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8	54	117	121	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 2	2014	33	40					4857	4866		10.1038/onc.2013.433	http://dx.doi.org/10.1038/onc.2013.433			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0EH	24141783				2022-12-25	WOS:000343240100007
J	Zhang, L; Wang, N; Shen, Q; Cheng, W; Qian, GJ				Zhang, Lei; Wang, Neng; Shen, Qiang; Cheng, Wen; Qian, Guo-Jun			Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma	PLOS ONE			English	Article							COAGULATION THERAPY; THERMAL ABLATION; LIVER-TUMORS; MANAGEMENT; MODEL	The aim of this study was to investigate the therapeutic efficacy of percutaneous radiofrequency (RF) ablation versus microwave (MW) ablation for hepatocellular carcinoma (HCC) measuring <= 5 cm in greatest diameter. From January 2006 to December 2006, 78 patients had undergone RF ablation whereas 77 had undergone MW ablation. Complete ablation (CA), local tumour progression (LTP) and distant recurrence (DR) were compared. The overall survival curves were calculated with the Kaplan-Meier technique and compared with the log-rank test. The CA rate was 83.4% (78/93) for RF ablation and 86.7%(91/105 for MW ablation. The LTP rate was 11.8% (11/93) for RF ablation and 10.5% (11/105) for MW ablation. DR was found in 51 (65.4%) in the RF ablation and 62 (80.5%) in the MW ablation. There was no significant difference in the 1-, 3-, and 5-year overall survival rates (P=0.780) and the 1-, 3-, and 5-year disease-free survival rates (P=0.123) between RF and MW ablation. At subgroup analyses, for patients with tumors <= 3.0 cm, there was no significant difference in the 1-, 3-, and 5-year overall survival rates (P=0.067) and the corresponding disease-free survival rates(P=0.849). For patients with tumor diameters of 3.1-5.0 cm, the 1-, 3-, and 5-year overall survival rates were 87.1%, 61.3%, and 40.1% for RF ablation and 85.4%, 36.6%, and 22% for MW ablation, with no significant difference (P=0.068). The corresponding disease-free survival rates were 74.2%, 54.8%, and 45.2% for the RF ablation group and 53.3%, 26.8%, and 17.1% for the MW ablation group. The disease-free survival curve for the RF ablation group was significantly better than that for the MW ablation group (P=0.018). RF ablation and MW ablation are both effective methods in treating hepatocellular carcinomas, with no significant differences in CA, LTP, DR, and overall survival.	[Zhang, Lei; Cheng, Wen] Harbin Med Univ Canc Hosp, Dept Ultrasound, Harbin, Peoples R China; [Zhang, Lei; Wang, Neng; Shen, Qiang; Qian, Guo-Jun] Second Mil Med Univ Eastern Hepatobiliary Surg Ho, Dept Minimal Invas, Ward 1, Shanghai, Peoples R China	Naval Medical University	Cheng, W (corresponding author), Harbin Med Univ Canc Hosp, Dept Ultrasound, Harbin, Peoples R China.	chengwen69@yahoo.com; qgjs@sina.com						Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Buscarini L, 2001, EUR RADIOL, V11, P914, DOI 10.1007/s003300000659; Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Cherqui D, 2009, ANN SURG, V250, P738, DOI 10.1097/SLA.0b013e3181bd582b; Dong Bao-wei, 2006, Zhonghua Yi Xue Za Zhi, V86, P797; Dong BW, 2003, AM J ROENTGENOL, V180, P1547, DOI 10.2214/ajr.180.6.1801547; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Goldberg SN, 2002, J CLIN GASTROENTEROL, V35, pS115, DOI 10.1097/00004836-200211002-00008; Itoh S, 2011, ANN SURG ONCOL, V18, P3650, DOI 10.1245/s10434-011-1831-z; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Liang P, 2003, AM J ROENTGENOL, V181, P1319, DOI 10.2214/ajr.181.5.1811319; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; Livraghi T, 2012, CARDIOVASC INTER RAD, V35, P868, DOI 10.1007/s00270-011-0241-8; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng ZW, 2008, EJSO-EUR J SURG ONC, V34, P166, DOI 10.1016/j.ejso.2007.08.004; Peng ZW, 2012, RADIOLOGY, V262, P689, DOI 10.1148/radiol.11110637; Qian GJ, 2012, EUR RADIOL, V22, P1983, DOI 10.1007/s00330-012-2442-1; Shibata T, 2002, RADIOLOGY, V223, P331, DOI 10.1148/radiol.2232010775; Shimada K, 2005, CANCER-AM CANCER SOC, V104, P1939, DOI 10.1002/cncr.21461; Sun YY, 2012, EUR J RADIOL, V81, P553, DOI 10.1016/j.ejrad.2011.02.013; Wright AS, 2005, RADIOLOGY, V236, P132, DOI 10.1148/radiol.2361031249; Xu HX, 2004, CLIN RADIOL, V59, P53, DOI 10.1016/j.crad.2003.09.006; Yamashiki N, 2003, AM J GASTROENTEROL, V98, P2052, DOI 10.1016/S0002-9270(03)00553-7	25	70	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76119	10.1371/journal.pone.0076119	http://dx.doi.org/10.1371/journal.pone.0076119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146824	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200010
J	Shakya, M; Gottel, N; Castro, H; Yang, ZMK; Gunter, L; Labbe, J; Muchero, W; Bonito, G; Vilgalys, R; Tuskan, G; Podar, M; Schadt, CW				Shakya, Migun; Gottel, Neil; Castro, Hector; Yang, Zamin K.; Gunter, Lee; Labbe, Jessy; Muchero, Wellington; Bonito, Gregory; Vilgalys, Rytas; Tuskan, Gerald; Podar, Mircea; Schadt, Christopher W.			A Multifactor Analysis of Fungal and Bacterial Community Structure in the Root Microbiome of Mature Populus deltoides Trees	PLOS ONE			English	Article							MYCORRHIZAL FUNGI; BLACK COTTONWOOD; ECOLOGICAL DATA; RHIZOSPHERE; DIVERSITY; POPLAR; ENDOPHYTES; PLANTS; GROWTH; COEXISTENCE	Bacterial and fungal communities associated with plant roots are central to the host health, survival and growth. However, a robust understanding of the root-microbiome and the factors that drive host associated microbial community structure have remained elusive, especially in mature perennial plants from natural settings. Here, we investigated relationships of bacterial and fungal communities in the rhizosphere and root endosphere of the riparian tree species Populus deltoides, and the influence of soil parameters, environmental properties (host phenotype and aboveground environmental settings), host plant genotype (Simple Sequence Repeat (SSR) markers), season (Spring vs. Fall) and geographic setting (at scales from regional watersheds to local riparian zones) on microbial community structure. Each of the trees sampled displayed unique aspects to its associated community structure with high numbers of Operational Taxonomic Units (OTUs) specific to an individual trees (bacteria >90%, fungi >60%). Over the diverse conditions surveyed only a small number of OTUs were common to all samples within rhizosphere (35 bacterial and 4 fungal) and endosphere (1 bacterial and 1 fungal) microbiomes. As expected, Proteobacteria and Ascomycota were dominant in root communities (>50%) while other higher-level phylogenetic groups (Chytridiomycota, Acidobacteria) displayed greatly reduced abundance in endosphere compared to the rhizosphere. Variance partitioning partially explained differences in microbiome composition between all sampled roots on the basis of seasonal and soil properties (4% to 23%). While most variation remains unattributed, we observed significant differences in the microbiota between watersheds (Tennessee vs. North Carolina) and seasons (Spring vs. Fall). SSR markers clearly delineated two host populations associated with the samples taken in TN vs. NC, but overall host genotypic distances did not have a significant effect on corresponding communities that could be separated from other measured effects.	[Shakya, Migun; Gottel, Neil; Castro, Hector; Yang, Zamin K.; Gunter, Lee; Labbe, Jessy; Muchero, Wellington; Tuskan, Gerald; Podar, Mircea; Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Shakya, Migun; Podar, Mircea; Schadt, Christopher W.] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN USA; [Castro, Hector; Podar, Mircea; Schadt, Christopher W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Bonito, Gregory; Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Duke University	Schadt, CW (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	schadtcw@ornl.gov	Labbe, Jessy/G-9532-2011; Schadt, Christopher W./B-7143-2008; Gunter, Lee E/L-3480-2016; Schadt, Christopher/M-8746-2019; Podar, Mircea/B-7299-2012; Tuskan, Gerald/A-6225-2011	Labbe, Jessy/0000-0003-0368-2054; Schadt, Christopher W./0000-0001-8759-2448; Gunter, Lee E/0000-0003-1211-7532; Schadt, Christopher/0000-0001-8759-2448; Podar, Mircea/0000-0003-2776-0205; Tuskan, Gerald/0000-0003-0106-1289; muchero, wellington/0000-0002-0200-9856; Shakya, Migun/0000-0003-3876-691X; Castro, Hector/0000-0001-7323-1123; Vilgalys, Rytas/0000-0001-8299-3605	Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area; U.S. Department of Energy [DE-AC05-00OR22725]	Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was sponsored by the Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov). Oak Ridge National Laboratory is managed by UT-Battelle LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2010, SOIL BIOL BIOCHEM, V42, P2276, DOI 10.1016/j.soilbio.2010.08.029; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doty SL, 2009, SYMBIOSIS, V47, P23, DOI 10.1007/BF03179967; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Graff A, 2005, FEMS MICROBIOL ECOL, V53, P401, DOI 10.1016/j.femsec.2005.01.009; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Kai M, 2008, PLANT SIGNAL BEHAV, V3, P482, DOI 10.4161/psb.3.7.5681; Khan AL, 2012, BIOL FERT SOILS, V48, P519, DOI 10.1007/s00374-011-0649-y; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Lottmann Jana, 2010, Environmental Biosafety Research, V9, DOI 10.1051/ebr/2010007; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; LU XH, 1994, NEW PHYTOL, V128, P211, DOI 10.1111/j.1469-8137.1994.tb04004.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Marschner P, 2005, J PLANT NUTR SOIL SC, V168, P343, DOI 10.1002/jpln.200424101; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; MENDES R, 2013, FEMS MICROBIOL REV; Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Roesti D, 2005, APPL ENVIRON MICROB, V71, P6673, DOI 10.1128/AEM.71.11.6673-6679.2005; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; Singh BK, 2008, ENVIRON MICROBIOL, V10, P534, DOI 10.1111/j.1462-2920.2007.01474.x; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; Vestergard M, 2008, FEMS MICROBIOL ECOL, V64, P78, DOI 10.1111/j.1574-6941.2008.00447.x; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weston DJ, 2012, MOL PLANT MICROBE IN, V25, P765, DOI 10.1094/MPMI-09-11-0253	63	184	195	5	209	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76382	10.1371/journal.pone.0076382	http://dx.doi.org/10.1371/journal.pone.0076382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146861	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400057
J	Bourne, Y; Renault, L; Essono, S; Mondielli, G; Lamourette, P; Boquet, D; Grassi, J; Marchot, P				Bourne, Yves; Renault, Ludovic; Essono, Sosthene; Mondielli, Gregoire; Lamourette, Patricia; Boquet, Didier; Grassi, Jacques; Marchot, Pascale			Molecular Characterization of Monoclonal Antibodies that Inhibit Acetylcholinesterase by Targeting the Peripheral Site and Backdoor Region	PLOS ONE			English	Article							TORPEDO-CALIFORNICA; CONFORMATIONAL FLEXIBILITY; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; VARIABLE REGIONS; ATOMIC-STRUCTURE; SUBSTRATE; BINDING; FASCICULIN; GORGE	The inhibition properties and target sites of monoclonal antibodies (mAbs) Elec403, Elec408 and Elec410, generated against Electrophorus electricus acetylcholinesterase (AChE), have been defined previously using biochemical and mutagenesis approaches. Elec403 and Elec410, which bind competitively with each other and with the peptidic toxin inhibitor fasciculin, are directed toward distinctive albeit overlapping epitopes located at the AChE peripheral anionic site, which surrounds the entrance of the active site gorge. Elec408, which is not competitive with the other two mAbs nor fasciculin, targets a second epitope located in the backdoor region, distant from the gorge entrance. To characterize the molecular determinants dictating their binding site specificity, we cloned and sequenced the mAbs; generated antigen-binding fragments (Fab) retaining the parental inhibition properties; and explored their structure-function relationships using complementary x-ray crystallography, homology modeling and flexible docking approaches. Hypermutation of one Elec403 complementarity-determining region suggests occurrence of antigen-driven selection towards recognition of the AChE peripheral site. Comparative analysis of the 1.9A-resolution structure of Fab408 and of theoretical models of its Fab403 and Fab410 congeners evidences distinctive surface topographies and anisotropic repartitions of charges, consistent with their respective target sites and inhibition properties. Finally, a validated, data-driven docking model of the Fab403-AChE complex suggests a mode of binding at the PAS that fully correlates with the functional data. This comprehensive study documents the molecular peculiarities of Fab403 and Fab410, as the largest peptidic inhibitors directed towards the peripheral site, and those of Fab408, as the first inhibitor directed toward the backdoor region of an AChE and a unique template for the design of new, specific modulators of AChE catalysis.	[Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, CNRS, Marseille, France; [Renault, Ludovic; Marchot, Pascale] Aix Marseille Univ, CNRS, Fac Med, Sect Nord, Marseille, France; [Essono, Sosthene; Lamourette, Patricia; Grassi, Jacques] CEA, iBiTecS, SPI, LERI, Gif Sur Yvette, France; [Mondielli, Gregoire; Marchot, Pascale] Aix Marseille Univ, CNRS, Fac Med, CRN2M,Sect Nord, Marseille, France; [Boquet, Didier] CEA, iBiTecS, SPI, LIAS, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Marchot, P (corresponding author), Aix Marseille Univ, CNRS, Campus Luminy, Marseille, France.	pascale.marchot@univ-amu.fr	Bourne, Yves/AAC-4635-2022; MARCHOT, Pascale/AAC-4752-2022	Bourne, Yves/0000-0003-3850-0548; MARCHOT, Pascale/0000-0003-0630-0541; Mondielli, Gregoire/0000-0001-9608-7961; BOQUET, Didier/0000-0002-4048-7867; Renault, Ludovic/0000-0001-6464-8808	Association Francaise contre les Myopathies (AFM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (AFM, http://www.afm-telethon.fr/) to LR (PhD grant) and PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN L, 1953, BIOCHEM J, V54, P695, DOI 10.1042/bj0540695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Brazzolotto X, 2012, FEBS J, V279, P2905, DOI 10.1111/j.1742-4658.2012.08672.x; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; Chardes T, 1999, FEBS LETT, V452, P386, DOI 10.1016/S0014-5793(99)00649-3; Chitlaru T, 1998, BIOCHEM J, V336, P647, DOI 10.1042/bj3360647; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Colletier JP, 2006, J AM CHEM SOC, V128, P4526, DOI 10.1021/ja058683b; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essono S, 2003, J IMMUNOL METHODS, V279, P251, DOI 10.1016/S0022-1759(03)00242-4; Felder CE, 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI 10.1107/S0907444902011642; Felder CE, 1997, J MOL GRAPH MODEL, V15, P318, DOI 10.1016/S1093-3263(98)00005-9; Frobert Y, 1997, BBA-PROTEIN STRUCT M, V1339, P253, DOI 10.1016/S0167-4838(97)00009-5; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Jackson RM, 1999, PROTEIN SCI, V8, P603; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kryger G, 1999, STRUCTURE, V7, P297, DOI 10.1016/S0969-2126(99)80040-9; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; Mallender WD, 2000, BIOCHEMISTRY-US, V39, P7753, DOI 10.1021/bi000210o; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachon F, 2008, FEBS J, V275, P2659, DOI 10.1111/j.1742-4658.2008.06413.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PyMOL, 2010, PYMOL MOL GRAPH SYST; RADIC Z, 1994, J BIOL CHEM, V269, P11233; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; REMY MH, 1995, EUR J BIOCHEM, V231, P651, DOI 10.1111/j.1432-1033.1995.tb20744.x; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Taylor P, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.1_Suppl_1.S30; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; VANDENBORN HKL, 1995, PROTEIN SCI, V4, P703; Xu YC, 2010, BIOPHYS J, V99, P4003, DOI 10.1016/j.bpj.2010.10.047	66	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77226	10.1371/journal.pone.0077226	http://dx.doi.org/10.1371/journal.pone.0077226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146971	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400106
J	Martinez-Bakker, ME; Sell, SK; Swanson, BJ; Kelly, BP; Tallmon, DA				Martinez-Bakker, Micaela E.; Sell, Stephanie K.; Swanson, Bradley J.; Kelly, Brendan P.; Tallmon, David A.			Combined Genetic and Telemetry Data Reveal High Rates of Gene Flow, Migration, and Long-Distance Dispersal Potential in Arctic Ringed Seals (Pusa hispida)	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; PHOCA-HISPIDA; MICROSATELLITE VARIATION; HALICHOERUS-GRYPUS; POPULATION SIZES; CLIMATE-CHANGE; LAKE SAIMAA; GREY SEALS; DIVERSITY; ALGORITHM	Ringed seals (Pusa hispida) are broadly distributed in seasonally ice covered seas, and their survival and reproductive success is intricately linked to sea ice and snow. Climatic warming is diminishing Arctic snow and sea ice and threatens to endanger ringed seals in the foreseeable future. We investigated the population structure and connectedness within and among three subspecies: Arctic (P. hispida hispida), Baltic (P. hispida botnica), and Lake Saimaa (P. hispida saimensis) ringed seals to assess their capacity to respond to rapid environmental changes. We consider (a) the geographical scale of migration, (b) use of sea ice, and (c) the amount of gene flow between subspecies. Seasonal movements and use of sea ice were determined for 27 seals tracked via satellite telemetry. Additionally, population genetic analyses were conducted using 354 seals representative of each subspecies and 11 breeding sites. Genetic analyses included sequences from two mitochondrial regions and genotypes of 9 microsatellite loci. We found that ringed seals disperse on a pan-Arctic scale and both males and females may migrate long distances during the summer months when sea ice extent is minimal. Gene flow among Arctic breeding sites and between the Arctic and the Baltic Sea subspecies was high; these two subspecies are interconnected as are breeding sites within the Arctic subspecies.	[Martinez-Bakker, Micaela E.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Martinez-Bakker, Micaela E.; Tallmon, David A.] Univ Alaska Southeast, Biol & Marine Biol Program, Juneau, AK USA; [Sell, Stephanie K.; Swanson, Bradley J.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Kelly, Brendan P.] Natl Sci Fdn, Arctic Sci Sect, Arlington, VA 22230 USA	University of Michigan System; University of Michigan; University of Alaska System; University of Alaska Southeastern; Central Michigan University; National Science Foundation (NSF)	Martinez-Bakker, ME (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	bakkerma@umich.edu	Martinez-Bakker, Micaela/J-3721-2013	Martinez-Bakker, Micaela/0000-0002-9248-9450; Swanson, Bradley/0000-0002-0360-3590	North Pacific Research Board [0515, 0631]; Cooperative Institute for Arctic Research [CIPY-23]; National Oceanic and Atmospheric Administration [NA17RJ1224]; University of Alaska; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0852111] Funding Source: National Science Foundation	North Pacific Research Board; Cooperative Institute for Arctic Research; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Alaska; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	North Pacific Research Board, Grant No. 0515, funded from May 1, 2005 - Dec 31, 2007, budget: $203,644.00, Project Title: Ice Seal movements. Website: < http://project.nprb.org/view.jsp?id = 5478c509-e849-4ccf-924b-2f8626758ab2 >. North Pacific Research Board, Grant No. 0631, funded from Sept 1, 2006 - Apr 30, 2009, budget: $223,658.00, Project Title: Population structure of ringed seals. Website: < http://project.nprb.org/view.jsp?id = de34ea6c-f2dc-4283-ae07-8a4334fb45ca >. This publication is the result in part of research sponsored by the Cooperative Institute for Arctic Research (Project CIPY-23) with funds from the National Oceanic and Atmospheric Administration under cooperative agreement NA17RJ1224 with the University of Alaska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2006, MAR ECOL PROG SER, V309, P117, DOI 10.3354/meps309117; Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Amano M, 2002, J MAMMAL, V83, P370, DOI 10.1644/1545-1542(2002)083<0370:GVITSO>2.0.CO;2; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli Peter, 2009, V17, P42; Berta A, 2012, MAMMAL REV, V42, P207, DOI 10.1111/j.1365-2907.2011.00193.x; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Davis CS, 2008, MOL ECOL, V17, P3078, DOI 10.1111/j.1365-294X.2008.03819.x; Davis CS, 2002, MOL ECOL NOTES, V2, P203, DOI 10.1046/j.1471-8286.2002.00187.x; *DEP COMM, 1992, FED REGISTER, V57, P60162; *DEP COMM, 2012, FED REGISTER, V77, P76706; DRUMMOND A, 2011, GENEIOUS V4 7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; FETTERER F, 2009, SEA ICE INDEX; Freeland J., 2005, MOL ECOLOGY; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Furgal CM, 2002, POLAR RES, V21, P1, DOI 10.1111/j.1751-8369.2002.tb00063.x; GJERTZ I, 1986, Polar Research, V4, P53, DOI 10.1111/j.1751-8369.1986.tb00518.x; Gjertz I, 2000, POLAR BIOL, V23, P651, DOI 10.1007/s003000000143; Goodman SJ, 1997, ANIM GENET, V28, P310; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harding KC, 1999, AMBIO, V28, P619; Harkonen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002006; Harwood LA, 2012, ARCTIC, V65, P35; Hezel PJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052794; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kelly BP, 2001, FINGERPRINTS OF CLIMATE CHANGE, P43; KELLY BP, 1990, CAN J ZOOL, V68, P2503, DOI 10.1139/z90-350; Kelly BP, 2010, STATUS REV RINGED SE; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; Kokko H, 1999, ANN ZOOL FENN, V36, P65; LOWRY LF, 1980, CAN J FISH AQUAT SCI, V37, P2254, DOI 10.1139/f80-270; MCLAREN IA, 1958, FISHERIES RES BOARD, V118; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Monnett C, 2006, POLAR BIOL, V29, P681, DOI 10.1007/s00300-005-0105-2; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Palo JU, 2003, CONSERV GENET, V4, P117, DOI 10.1023/A:1023303109701; Palo JU, 2001, HEREDITY, V86, P609, DOI 10.1046/j.1365-2540.2001.00859.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rozen S, 2000, Methods Mol Biol, V132, P365; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMITH TG, 1976, CAN J ZOOL, V54, P1610, DOI 10.1139/z76-188; SMITH TG, 1991, ARCTIC, V44, P124; SMITH TG, 1981, CAN J ZOOL, V59, P966, DOI 10.1139/z81-135; SMITH TG, 1975, CAN J ZOOL, V53, P1297, DOI 10.1139/z75-155; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; Swanson BJ, 2006, MOL ECOL NOTES, V6, P1006, DOI 10.1111/j.1471-8286.2006.01473.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *US FISH WILDL SER, 2008, END THREAT WILDL PLA; Valtonen M, 2012, CONSERV GENET, V13, P1231, DOI 10.1007/s10592-012-0367-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS., 1996, GENETIC DATA ANAL; WRIGHT S., 1938, Science (Washington), V87, P430; 1993, FED REG, V58, P40538	59	24	24	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77125	10.1371/journal.pone.0077125	http://dx.doi.org/10.1371/journal.pone.0077125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130843	gold, Green Published			2022-12-25	WOS:000325814200060
J	Singh, M; Singh, S; Randhawa, H; Singh, J				Singh, Manjit; Singh, Surinder; Randhawa, Harpinder; Singh, Jaswinder			Polymorphic Homoeolog of Key Gene of RdDM Pathway, ARGONAUTE4_9 class Is Associated with Pre-Harvest Sprouting in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							WHITE SPRING WHEAT; EPIGENETIC CHROMATIN MODIFIERS; SEED DORMANCY; DNA METHYLATION; ARABIDOPSIS-THALIANA; ABA SENSITIVITY; EXPRESSION; BARLEY; GERMINATION; MUTANT	Resistance to pre-harvest sprouting (PHS) is an important objective for the genetic improvement of many cereal crops, including wheat. Resistance, or susceptibility, to PHS is mainly influenced by seed dormancy, a complex trait. Reduced seed dormancy is the most important aspect of seed germination on a spike prior to harvesting, but it is influenced by various environmental factors including light, temperature and abiotic stresses. The basic genetic framework of seed dormancy depends on the antagonistic action of abscisic acid (ABA) and gibberellic acid (GA) to promote dormancy and germination. Recent studies have revealed a role for epigenetic changes, predominantly histone modifications, in controlling seed dormancy. To investigate the role of DNA methylation in seed dormancy, we explored the role of ARGONAUTE4_9 class genes in seed development and dormancy in wheat. Our results indicate that the two wheat AGO4_9 class genes i.e. AGO802 and AGO804 map to chromosomes 3S and 1S are preferentially expressed in the embryos of developing seeds. Differential expressions of AGO802-B in the embryos of PHS resistant and susceptible varieties also relates with DNA polymorphism in various wheat varieties due to an insertion of a SINE-like element into this gene. DNA methylation patterns of the embryonic tissue from six PHS resistant and susceptible varieties demonstrate a correlation with this polymorphism. These results suggest a possible role for AGO802-B in seed dormancy and PHS resistance through the modulation of DNA methylation.	[Singh, Manjit; Singh, Surinder; Singh, Jaswinder] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Randhawa, Harpinder] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	McGill University; Agriculture & Agri Food Canada	Singh, J (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	Jaswinder.Singh@mcgill.ca	Singh, Manjit/GWM-3934-2022; Randhawa, Harpinder/AAQ-7207-2021	Singh, Manjit/0000-0002-5451-3659; 	Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1993, CROP SCI, V33, P453, DOI 10.2135/cropsci1993.0011183X003300030008x; Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Demetriou K, 2009, PHYSIOL PLANTARUM, V136, P358, DOI 10.1111/j.1399-3054.2009.01236.x; DePauw RM, 2009, EUPHYTICA, V168, P347, DOI 10.1007/s10681-009-9933-4; DePauw RM, 1998, CAN J PLANT SCI, V78, P617, DOI 10.4141/P97-150; DEPAUW RM, 1992, CROP SCI, V32, P838, DOI 10.2135/cropsci1992.0011183X003200030069x; Fang J, 2008, PLANT SIGNAL BEHAV, V3, P1046, DOI 10.4161/psb.3.12.6606; Faris J. D., 2002, Current Genomics, V3, P577, DOI 10.2174/1389202023350219; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; HUGHES GR, 1993, CAN J PLANT SCI, V73, P193, DOI 10.4141/cjps93-032; Humphreys DG, 2007, CAN J PLANT SCI, V87, P301, DOI 10.4141/P06-139; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Kapazoglou A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-73; Knox RE, 1995, CAN J PLANT SCI, V75, P899, DOI 10.4141/cjps95-150; Lamb-Palmer ND, 2013, MOL BIOTECHNOL, V54, P685, DOI 10.1007/s12033-012-9610-z; Lan XiuJin, 2012, African Journal of Agricultural Research, V7, P6191; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Molina-Cano JL, 1999, THEOR APPL GENET, V98, P347, DOI 10.1007/s001220051079; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Ng DWK, 2006, PLANT CELL, V18, P119, DOI 10.1105/tpc.105.037010; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Patel M, 2008, J EXP BOT, V59, P1625, DOI 10.1093/jxb/erm368; Pauw RMD, 1983, CAN J PLANT SCI, V63, P581; Peng JR, 2002, CURR OPIN PLANT BIOL, V5, P376, DOI 10.1016/S1369-5266(02)00279-0; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; Sadasivaiah RS, 2009, CAN J PLANT SCI, V89, P1099, DOI 10.4141/CJPS09010; Sadasivaiah RS, 2004, CROP SCI, V44, P696, DOI [10.2135/cropsci2004.0697, 10.2135/cropsci2004.0696]; Schramm EC, 2013, THEOR APPL GENET, V126, P791, DOI 10.1007/s00122-012-2018-0; Schramm EC, 2012, EUPHYTICA, V188, P35, DOI 10.1007/s10681-012-0669-1; Scutt CP, 2003, PLANT PHYSIOL, V132, P653, DOI 10.1104/pp.102.017798; Singh J, 2001, J CEREAL SCI, V34, P85, DOI 10.1006/jcrs.2001.0380; Singh M, 2012, EUPHYTICA, V188, P123, DOI 10.1007/s10681-012-0624-1; Singh M, 2011, PLANT CELL, V23, P443, DOI 10.1105/tpc.110.079020; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Sunkar R, 2012, ROLE MIRNAS SEED DEV, P109; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Vaillant I, 2007, PLANT CELL PHYSIOL, V48, P745, DOI 10.1093/pcp/pcm043; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zheng J, 2012, NEW PHYTOL, V193, P605, DOI 10.1111/j.1469-8137.2011.03969.x; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	49	20	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77009	10.1371/journal.pone.0077009	http://dx.doi.org/10.1371/journal.pone.0077009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130825	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900116
J	Liao, JM; Zhou, X; Gatignol, A; Lu, H				Liao, J-M; Zhou, X.; Gatignol, A.; Lu, H.			Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex	ONCOGENE			English	Article						c-Myc; TRBP2; microRNA; RPL11; RPL5; ribosomal stress	EMBRYONIC STEM-CELLS; P53 ACTIVATION; NEOPLASTIC PHENOTYPE; COLORECTAL-CANCER; MDM2; INHIBITION; STRESS; BIOGENESIS; PROLIFERATION; DEGRADATION	Oncogene MYC is highly expressed in many human cancers and functions as a global regulator of ribosome biogenesis. Previously, we reported that ribosomal protein (RP) L11 binds to c-Myc and inhibits its transcriptional activity in response to ribosomal stress. Here, we show that RPL5, co-operatively with RPL11, guides the RNA-induced silencing complex (RISC) to c-Myc mRNA and mediates the degradation of the mRNA, consequently leading to inhibition of c-Myc activity. Knocking down of RPL5 induced c-Myc expression at both mRNA and protein levels, whereas overexpression of RPL5 suppressed c-Myc expression and activity. Immunoprecipitation revealed that RPL5 binds to 3'UTR of c-Myc mRNA and two subunits of RISC, TRBP (HIV-1 TAR RNA-binding protein) and Ago2, mediating the targeting of c-Myc mRNA by miRNAs. Interestingly, RPL5 and RPL11 co-resided on c-Myc mRNA and suppressed c-Myc expression co-operatively. These findings uncover a mechanism by which these two RPs can co-operatively suppress c-Myc expression, allowing a tightly controlled ribosome biogenesis in cells.	[Liao, J-M; Zhou, X.; Lu, H.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Liao, J-M; Zhou, X.; Lu, H.] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Gatignol, A.] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Montreal, PQ, Canada	Tulane University; Tulane University; Lady Davis Institute; McGill University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Gatignol, Anne/AAA-6501-2020; Zhou, Xiang/J-5046-2017	Gatignol, Anne/0000-0002-4553-0836; Zhou, Xiang/0000-0002-1172-7948	National Institutes of Health (NIH)-National Cancer Institute (NCI) [CA095441, CA079721, CA129828, CA172468]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA079721, R01CA172468, R01CA129828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Karen Vousden for providing us with the RPL11 mutant plasmid, Mu-shui Dai for offering some reagents and Shelya X Zeng as well as other members of the Lu laboratory for advices and active discussion. This work was supported in part by National Institutes of Health (NIH)-National Cancer Institute (NCI) grants CA095441, CA079721, CA129828 and CA172468 to H. L.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Golomb L, 2012, MOL CELL, V45, P222, DOI 10.1016/j.molcel.2011.11.022; GOURSE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2722, DOI 10.1073/pnas.78.5.2722; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu H, 2011, NAT MED, V17, P930, DOI 10.1038/nm.2434; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; PFEIFEROHLSSON S, 1984, CELL, V38, P585, DOI 10.1016/0092-8674(84)90513-0; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2011, J BIOL CHEM, V286, P22730, DOI 10.1074/jbc.M111.223651; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang Q, 2011, J BIOL CHEM, V286, P38264, DOI 10.1074/jbc.M111.277012; Zhang X, 2013, ONCOGENE, V32, P2782, DOI 10.1038/onc.2012.289; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	57	55	55	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4916	4923		10.1038/onc.2013.430	http://dx.doi.org/10.1038/onc.2013.430			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24141778	Green Accepted			2022-12-25	WOS:000343767900004
J	Giese, M; Unternaehrer, E; Brand, S; Calabrese, P; Holsboer-Trachsler, E; Eckert, A				Giese, Maria; Unternaehrer, Eva; Brand, Serge; Calabrese, Pasquale; Holsboer-Trachsler, Edith; Eckert, Anne			The Interplay of Stress and Sleep Impacts BDNF Level	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; GENE-EXPRESSION; MESSENGER-RNA; RAT-BRAIN; SERUM; DEPRESSION; RECEPTORS; HIPPOCAMPUS; GLUCOCORTICOIDS; DISORDERS	Background: Sleep plays a pivotal role in normal biological functions. Sleep loss results in higher stress vulnerability and is often found in mental disorders. There is evidence that brain-derived neurotrophic factor (BDNF) could be a central player in this relationship. Recently, we could demonstrate that subjects suffering from current symptoms of insomnia exhibited significantly decreased serum BDNF levels compared with sleep-healthy controls. In accordance with the paradigm indicating a link between sleep and BDNF, we aimed to investigate if the stress system influences the association between sleep and BDNF. Methodology/Principal Findings: Participants with current symptoms of insomnia plus a former diagnosis of Restless Legs Syndrome (RLS) and/or Periodic Limb Movement (PLM) and sleep healthy controls were included in the study. They completed questionnaires on sleep (ISI, Insomnia Severity Index) and stress (PSS, Perceived Stress Scale) and provided a blood sample for determination of serum BDNF. We found a significant interaction between stress and insomnia with an impact on serum BDNF levels. Moreover, insomnia severity groups and score on the PSS each revealed a significant main effect on serum BDNF levels. Insomnia severity was associated with increased stress experience affecting serum BDNF levels. Of note, the association between stress and BDNF was only observed in subjects without insomnia. Using a mediation model, sleep was revealed as a mediator of the association between stress experience and serum BDNF levels. Conclusions: This is the first study to show that the interplay between stress and sleep impacts BDNF levels, suggesting an important role of this relationship in the pathogenesis of stress-associated mental disorders. Hence, we suggest sleep as a key mediator at the connection between stress and BDNF. Whether sleep is maintained or disturbed might explain why some individuals are able to handle a certain stress load while others develop a mental disorder.	[Giese, Maria; Eckert, Anne] Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland; [Unternaehrer, Eva; Brand, Serge; Calabrese, Pasquale] Univ Basel, Div Mol & Cognit Neurosci, Basel, Switzerland; [Unternaehrer, Eva] Univ Basel, Dept Clin Psychol & Epidemiol, Basel, Switzerland; [Brand, Serge; Holsboer-Trachsler, Edith] Univ Basel, Depress & Sleep Res Unit, Psychiat Univ Clin, Basel, Switzerland; [Giese, Maria; Calabrese, Pasquale; Eckert, Anne] Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Eckert, A (corresponding author), Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland.	anne.eckert@upkbs.ch	Calabrese, Pasquale/AAL-5291-2020; Brand, Serge/H-7159-2019	Brand, Serge/0000-0003-2175-2765; Unternaehrer, Eva/0000-0002-3507-1883; Eckert, Anne/0000-0002-9341-3669				American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, Vxii; Aydemir O, 2009, TURK PSIKIYATR DERG, V20, P385; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Boulle F, 2012, MOL PSYCHIATR, V17, P584, DOI 10.1038/mp.2011.107; Brand S, 2010, INT J STRESS MANAGE, V17, P114, DOI 10.1037/a0019090; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Czubak A, 2009, PHARMACOL REP, V61, P1017, DOI 10.1016/S1734-1140(09)70163-X; Diniz BS, 2010, WORLD J BIOL PSYCHIA, V11, P550, DOI 10.3109/15622970903544620; Duman RS, 2002, EUR PSYCHIAT, V17, p306S; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Giese M, 2013, MOL PSYCHIAT; Haghighi M, 2013, J PSYCHIATR RES, V47, P908, DOI 10.1016/j.jpsychires.2013.03.006; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Janak PH, 2006, ALCOHOL CLIN EXP RES, V30, P214, DOI 10.1111/j.1530-0277.2006.00026.x; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Masi G, 2011, CNS DRUGS, V25, P913, DOI 10.2165/11595900-000000000-00000; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mori T, 2003, PRIMATES, V44, P167, DOI 10.1007/s10329-002-0015-7; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pae CU, 2012, NEUROPSYCHOBIOLOGY, V65, P1, DOI 10.1159/000327605; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Sartorius A, 2009, PHARMACOPSYCHIATRY, V42, P270, DOI 10.1055/s-0029-1224162; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; Schulte-Herbruggen O, 2006, PSYCHONEUROENDOCRINO, V31, P1266, DOI 10.1016/j.psyneuen.2006.09.008; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shimizu M, 2003, GEN COMP ENDOCR, V132, P103, DOI 10.1016/S0016-6480(03)00052-2; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Steiger A, 2007, J PSYCHIATR RES, V41, P537, DOI 10.1016/j.jpsychires.2006.04.007; Stein MB, 2008, PSYCHOSOM MED, V70, P913, DOI 10.1097/PSY.0b013e3181871405; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2003, J SLEEP RES, V12, P181, DOI 10.1046/j.1365-2869.2003.00357.x; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wolf I, 1998, EFFEKTE STRESS SOZIA; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	49	55	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76050	10.1371/journal.pone.0076050	http://dx.doi.org/10.1371/journal.pone.0076050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146812	gold, Green Submitted, Green Published			2022-12-25	WOS:000326019400032
J	Liu, JH; Mao, KZ; Liu, ZS; Wang, XM; Cui, FZ; Guo, WG; Mao, KY; Yang, SY				Liu, Jianheng; Mao, Kezheng; Liu, Zhengsheng; Wang, Xiumei; Cui, Fuzhai; Guo, Wenguang; Mao, Keya; Yang, Shuying			Injectable Biocomposites for Bone Healing in Rabbit Femoral Condyle Defects	PLOS ONE			English	Article							CALCIUM-SULFATE HEMIHYDRATE; MORPHOGENETIC PROTEINS; MINERALIZED COLLAGEN; POLYMERIC SCAFFOLDS; IN-VIVO; PHOSPHATE; RHBMP-2; REPAIR; REGENERATION; MODEL	A novel biomimetic bone scaffold was successfully prepared in this study, which was composed of calcium sulfate hemihydrate (CSH), collagen and nano-hydroxyapatite (nHAC). CSH/nHAC was prepared and observed with scanning electron microscope and rhBMP-2 was introduced into CSH/nHAC. The released protein content from the scaffold was detected using high performance liquid chromatography at predetermined time interval. In vivo bone formation capacity was investigated by means of implanting the scaffolds with rhBMP-2 or without rhBMP-2 respectively into a critical size defect model in the femoral condyle of rabbit. The releasing character of rhBMP-2 was that an initial burst release (37.5%) was observed in the first day, followed by a sustained release and reached 100% at the end of day 20. The CSH/nHAC showed a gradual decrease in degradation with the content of nHAC increase. The results of X-rays, Micro CT and histological observation indicated that more new bone was formed in rhBMP-2 group. The results implied that this new injectable bone scaffold should be very promising for bone repair and has a great potential in bone tissue engineering.	[Liu, Jianheng; Mao, Kezheng; Liu, Zhengsheng; Mao, Keya] Gen Hosp Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China; [Wang, Xiumei; Cui, Fuzhai] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China; [Guo, Wenguang] Beijing Olymp Fine Pharmaceut Technol Co Ltd, Beijing, Peoples R China; [Yang, Shuying] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA	Tsinghua University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mao, KY (corresponding author), Gen Hosp Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China.	maokeya@sina.com; sy47@buffalo.edu			National Nature Science Foundation of China [NO50830102]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055678] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is supported by the National Nature Science Foundation of China, Grant NO50830102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p; Chen ZG, 2011, J BIOMED MATER RES A, V99A, P554, DOI 10.1002/jbm.a.33212; Dodde R, 2000, J CRANIOFAC SURG, V11, P346, DOI 10.1097/00001665-200011040-00013; Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U; El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1.87; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; Furlan JC, 2007, J NEUROSURG-SPINE, V7, P486, DOI 10.3171/SPI-07/09/486; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; GERHART TN, 1993, CLIN ORTHOP RELAT R, P317; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Hao B, 2002, SHENG WU YI XUE GONG, V19, P171; Hao Baoqing, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P140; Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002; Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439; Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011; Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035; Liu HY, 2010, TISSUE ENG PT A, V16, P2075, DOI [10.1089/ten.tea.2009.0669, 10.1089/ten.TEA.2009.0669]; Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e; Liu X, 2010, J BIOMED MATER RES B, V94B, P72, DOI 10.1002/jbm.b.31625; Liu YC, 2006, J ORTHOP RES, V24, P1454, DOI 10.1002/jor.20148; McAuliffe John A, 2003, J Hand Ther, V16, P180; Mino-Farina N, 2009, VET J, V179, P264, DOI 10.1016/j.tvjl.2007.09.011; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.0.CO;2-U; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Ohura K, 2000, KEY ENG MAT, V192-1, P833; Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6; Parsons J R, 1988, Ann N Y Acad Sci, V523, P190, DOI 10.1111/j.1749-6632.1988.tb38512.x; Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001; Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Schlegel KA, 2006, ORAL SURG ORAL MED O, V102, P7, DOI 10.1016/j.tripleo.2005.09.011; SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4; Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239; Stubbs D, 2004, BIOMATERIALS, V25, P5037, DOI 10.1016/j.biomaterials.2004.02.014; Tas AC, 2000, BIOMATERIALS, V21, P1429; Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035; Wang Y, 2008, J BIOMED MATER RES B, V86B, P29, DOI 10.1002/jbm.b.30984; Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001; YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005; Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0; Yuan ZT, 2008, CHINESE J INORG CHEM, V24, P1062; Zhang SM, 2003, J MATER SCI-MATER M, V14, P641, DOI 10.1023/A:1024083309982; Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g	58	5	9	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75668	10.1371/journal.pone.0075668	http://dx.doi.org/10.1371/journal.pone.0075668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146770	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400015
J	Mazur, A; Westerman, R; Mueller, U				Mazur, Allan; Westerman, Ronny; Mueller, Ulrich			Is Rising Obesity Causing a Secular (Age-Independent) Decline in Testosterone among American Men?	PLOS ONE			English	Article							LIFE-STYLE FACTORS; Y GASTRIC BYPASS; OLDER MEN; SURGERY; HEALTH	The testosterone of men in industrial societies peaks in their twenties and tends to decline with increasing age. Apart from this individual-level decline, there have been reports of a secular (age-independent population-level) decline in testosterone among American and Scandinavian men during the past few decades, possibly an indication of declining male reproductive health. It has been suggested that both declines in testosterone (individual-level and population-level) are due to increasing male obesity because men in industrial society tend to add body fat as they age, and overall rates of obesity are increasing. Using an unusually large and lengthy longitudinal dataset (991 US Air Force veterans examined in six cycles over 20 years), we investigate the relationship of obesity to individual and population-level declines in testosterone. Over twenty years of study, longitudinal decline in mean testosterone was at least twice what would be expected from cross-sectional estimates of the aging decline. Men who put on weight intensified their testosterone decline, some greatly so, but even among those who held their weight constant or lost weight during the study, mean testosterone declined 117 ng/dl (19%) over 20 years. We have not identified the reason for secular decline in testosterone, but we exclude increasing obesity as a sufficient or primary explanation, and we deny the supposition that men who avoid excessive weight will maintain their youthful levels of testosterone.	[Mazur, Allan] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA; [Westerman, Ronny; Mueller, Ulrich] Univ Marburg, Inst Med Sociol & Social Med, Marburg, Germany	Syracuse University; Philipps University Marburg	Mazur, A (corresponding author), Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA.	amazur@syr.edu						Air Force Health Study, 2005, AFRLHEBRSR20050003 E; Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P44, DOI 10.1210/jc.2006-2438; Botella-Carretero JI, 2013, J ENDOCRINOL INVEST, V36, P227, DOI 10.3275/8469; Buffler PA, 2011, ANN EPIDEMIOL, V21, P673, DOI 10.1016/j.annepidem.2011.02.001; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Campbell B, 2006, AM J HUM BIOL, V18, P71, DOI 10.1002/ajhb.20468; Centers for Disease Control, 2010, HLTH PEOPL 2010 FIN; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Hammoud A, 2009, J CLIN ENDOCR METAB, V94, P1329, DOI 10.1210/jc.2008-1598; Kim YS, 2012, CLIN ENDOCRINOL, V77, P296, DOI 10.1111/j.1365-2265.2012.04375.x; Mazur A, 1998, SOC FORCES, V77, P315, DOI 10.2307/3006019; Mazur A, 2009, AGING MALE, V12, P66, DOI 10.1080/13685530903071802; Michalek JE, 2008, J OCCUP ENVIRON MED, V50, P330, DOI 10.1097/JOM.0b013e31815f889b; Perheentupa A, 2013, EUR J ENDOCRINOL, V168, P227, DOI 10.1530/EJE-12-0288; Ponholzer A, 2005, Aging Male, V8, P190, DOI 10.1080/13685530500298154; Rosenblatt A, 2012, SURG OBES RELAT DIS; Shi Z, 2013, J CLIN ENDOCRIN META; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Trimpou P, 2012, EUR J ENDOCRINOL, V166, P887, DOI 10.1530/EJE-11-0808; Vermeulen A., 1999, Journal of Endocrinological Investigation, V22, P110; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P762, DOI 10.1002/ajhb.20927; Woodard G, 2012, BRIT J SURG, V99, P693, DOI 10.1002/bjs.8693; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76178	10.1371/journal.pone.0076178	http://dx.doi.org/10.1371/journal.pone.0076178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146834	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400041
J	Schreuder, AB; Vanikova, J; Vitek, L; Havinga, R; Ahlfors, CE; Hulzebos, CV; Verkade, HJ				Schreuder, Andrea B.; Vanikova, Jana; Vitek, Libor; Havinga, Rick; Ahlfors, Charles E.; Hulzebos, Christian V.; Verkade, Henkjan J.			Optimizing Exchange Transfusion for Severe Unconjugated Hyperbilirubinemia: Studies in the Gunn Rat	PLOS ONE			English	Article							GLUCURONYL TRANSFERASE; BILIRUBIN; KERNICTERUS; ALBUMIN; MANAGEMENT; MORBIDITY; MORTALITY; FREQUENCY; THERAPY; MODEL	Background: Severe unconjugated hyperbilirubinemia carries the risk of neurotoxicity. Phototherapy (PT) and exchange transfusion (ET) are cornerstones in the treatment of unconjugated hyperbilirubinemia. Studies to improve ET efficacy have been hampered by the low application of ET in humans and by the lack of an in vivo model. The absence of an appropriate animal model has also prevented to determine the efficacy of adjunct or alternative treatment options such as albumin (Alb) administration. Aim: To establish an in vivo model for ET and to determine the most effective treatment (combination) of ET, PT and Alb administration. Methods: Gunn rats received either PT, PT+Alb, ET, ET+PT, ET+PT+Alb or sham operation (each n = 7). ET was performed via the right jugular vein in similar to 20 min. PT (18 mu W/cm(2)/nm) was started after ET or at T-0. Albumin i.p. injections (2.5 g/kg) were given after ET or before starting PT. Plasma unconjugated bilirubin (UCB), plasma free bilirubin (Bf), and brain bilirubin concentrations were determined. Results: We performed ET in 21 Gunn rats with 100% survival. At T-1, ET was profoundly more effective in decreasing both UCB -44%, p<0.01) and Bf -81%, p<0.05) than either PT or PT+Alb. After 48 h, the combination of ET+PT+Alb showed the strongest hypobilirubinemic effect (-54% compared to ET). Conclusions: We optimized ET for severe unconjugated hyperbilirubinemia in the Gunn rat model. Our data indicate that ET is the most effective treatment option, in the acute as well as the follow-up situation.	[Schreuder, Andrea B.; Havinga, Rick; Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Liver Digest & Metab Dis,Dept Pediat, Groningen, Netherlands; [Vanikova, Jana; Vitek, Libor] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague 2, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague 2, Czech Republic; [Ahlfors, Charles E.] Stanford Univ, Sch Med, Stanford, CA USA; [Hulzebos, Christian V.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, NL-9713 AV Groningen, Netherlands	University of Groningen; Charles University Prague; Charles University Prague; Stanford University; University of Groningen	Verkade, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Liver Digest & Metab Dis,Dept Pediat, Groningen, Netherlands.	h.j.verkade@umcg.nl	Hulzebos, Christian Victor/AAY-6803-2021; Vitek, Libor/A-2645-2008; Jasprova, Jana/H-7839-2017	Hulzebos, Christian Victor/0000-0002-8159-7501; Vitek, Libor/0000-0002-5318-0151; Jasprova, Jana/0000-0002-0579-0895; Verkade, Henkjan J/0000-0002-7034-2861				AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Ahlfors CE, 2006, CLIN CHIM ACTA, V365, P78, DOI 10.1016/j.cca.2005.07.030; Ahlfors CE, 2009, J PERINATOL; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; CHAN G, 1976, J PEDIATR-US, V88, P609, DOI 10.1016/S0022-3476(76)80020-0; Cuperus FJC, 2013, J HEPATOL, V58, P134, DOI 10.1016/j.jhep.2012.08.011; Dennery PA, 2001, NEW ENGL J MED, V344, P581, DOI 10.1056/NEJM200102223440807; DIAMOND I, 1966, J CLIN INVEST, V45, P678, DOI 10.1172/JCI105383; Eguchi S, 1998, ARTIF ORGANS, V22, P847, DOI 10.1046/j.1525-1594.1998.06166.x; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Gourley GR, 1993, PEDIAT GASTROINTESTI, P88; HENRY CA, 1991, NUCL MED BIOL, V18, P565, DOI 10.1016/0883-2897(91)90120-A; HODGES GR, 1984, ANTIMICROB AGENTS CH, V26, P903, DOI 10.1128/AAC.26.6.903; Jackson JC, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e7; JOHNSON L, 1959, AMA J DIS CHILD, V97, P591, DOI 10.1001/archpedi.1959.02070010593009; JOHNSON L, 1961, AM J DIS CHILD, V101, P322, DOI 10.1001/archpedi.1961.04020040050007; KEENAN WJ, 1985, PEDIATRICS, V75, P417; KURANTSINMILLS J, 1987, MICROVASC RES, V34, P152, DOI 10.1016/0026-2862(87)90050-1; LAUER BA, 1982, PEDIATRICS, V70, P43; LIVADITIS A, 1974, ACTA PAEDIATR SCAND, V63, P277, DOI 10.1111/j.1651-2227.1974.tb04796.x; Maisels M J, 2001, J Perinatol, V21 Suppl 1, pS93, DOI 10.1038/sj.jp.7210642; ODELL GB, 1962, PEDIATRICS, V30, P613; OSTROW JD, 1971, J CLIN INVEST, V50, P707, DOI 10.1172/JCI106541; Patra K, 2004, J PEDIATR-US, V144, P626, DOI 10.1016/j.jpeds.2004.01.054; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Steiner LA, 2007, PEDIATRICS, V120, P27, DOI 10.1542/peds.2006-2910; STREBEL L, 1971, PEDIATR RES, V5, P548, DOI 10.1203/00006450-197110000-00007; TAKEDA K, 1989, TOHOKU J EXP MED, V157, P31, DOI 10.1620/tjem.157.31; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	31	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77179	10.1371/journal.pone.0077179	http://dx.doi.org/10.1371/journal.pone.0077179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143211	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100046
J	Stoner, KA; Eitzer, BD				Stoner, Kimberly A.; Eitzer, Brian D.			Using a Hazard Quotient to Evaluate Pesticide Residues Detected in Pollen Trapped from Honey Bees (Apis mellifera) in Connecticut	PLOS ONE			English	Article							RISK-ASSESSMENT; SYSTEMIC INSECTICIDES; COLONY LOSSES; TOXICITY; HYMENOPTERA; EXPOSURE; APIDAE; USA	Analysis of pollen trapped from honey bees as they return to their hives provides a method of monitoring fluctuations in one route of pesticide exposure over location and time. We collected pollen from apiaries in five locations in Connecticut, including urban, rural, and mixed agricultural sites, for periods from two to five years. Pollen was analyzed for pesticide residues using a standard extraction method widely used for pesticides (QuEChERS) and liquid chromatography/mass spectrometric analysis. Sixty pesticides or metabolites were detected. Because the dose lethal to 50% of adult worker honey bees (LD50) is the only toxicity parameter available for a wide range of pesticides, and among our pesticides there were contact LD50 values ranging from 0.006 to > 1000 mu g per bee (range 166,000X), and even among insecticides LD50 values ranged from 0.006 to 59.8 mu g/bee (10,000X); therefore we propose that in studies of honey bee exposure to pesticides that concentrations be reported as Hazard Quotients as well as in standard concentrations such as parts per billion. We used both contact and oral LD50 values to calculate Pollen Hazard Quotients (PHQ = concentration in ppb divided by LD50 as mu g/bee) when both were available. In this study, pesticide Pollen Hazard Quotients ranged from over 75,000 to 0.01. The pesticides with the greatest Pollen Hazard Quotients at the maximum concentrations found in our study were (in descending order): phosmet, Imidacloprid, indoxacarb, chlorpyrifos, fipronil, thiamethoxam, azinphos-methyl, and fenthion, all with at least one Pollen Hazard Quotient (using contact or oral LD50) over 500. At the maximum rate of pollen consumption by nurse bees, a Pollen Hazard Quotient of 500 would be approximately equivalent to consuming 0.5% of the LD50 per day. We also present an example of a Nectar Hazard Quotient and the percentage of LD50 per day at the maximum nectar consumption rate.	[Stoner, Kimberly A.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Eitzer, Brian D.] Connecticut Agr Expt Stn, Dept Analyt Chem, New Haven, CT 06504 USA	Connecticut Agricultural Experiment Station; Connecticut Agricultural Experiment Station	Stoner, KA (corresponding author), Connecticut Agr Expt Stn, Dept Entomol, POB 1106, New Haven, CT 06504 USA.	Kimberly.Stoner@ct.gov	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Stoner, Kimberly/0000-0003-1248-7082	US Department of Agriculture Hatch Funds [CONH00384, CONH00392]; Hatch Multistate [NC1173]	US Department of Agriculture Hatch Funds(United States Department of Agriculture (USDA)); Hatch Multistate	This research was funded over a period of five years by US Department of Agriculture Hatch Funds CONH00384, CONH00392, and the Hatch Multistate project NC1173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Alix A, 2007, PEST MANAG SCI, V63, P1069, DOI 10.1002/ps.1463; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Dahlgren L, 2012, J ECON ENTOMOL, V105, P1895, DOI 10.1603/EC12175; Detroy BF, 1976, 163 AGR RES SERV; Fischer D., 2011, PEST RISK ASS POLL S; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Lehotay SJ, 2005, METH BIOTEC, V19, P239; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Nepi M, 2001, INT J PLANT SCI, V162, P353, DOI 10.1086/319581; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328	19	125	131	7	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77550	10.1371/journal.pone.0077550	http://dx.doi.org/10.1371/journal.pone.0077550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143241	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100079
J	Banerjee, A; Abdelmegeed, MA; Jang, S; Song, BJ				Banerjee, Atrayee; Abdelmegeed, Mohamed A.; Jang, Sehwan; Song, Byoung-Joon			Zidovudine (AZT) and Hepatic Lipid Accumulation: Implication of Inflammation, Oxidative and Endoplasmic Reticulum Stress Mediators	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVATED PROTEIN-KINASE; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MITOCHONDRIAL PROTEINS; LACTIC-ACIDOSIS; FATTY LIVER; STEATOSIS; DYSFUNCTION; MECHANISM	The clinical effectiveness of Zidovudine (AZT) is constrained due to its side-effects including hepatic steatosis and toxicity. However, the mechanism(s) of hepatic lipid accumulation in AZT-treated individuals is unknown. We hypothesized that AZT-mediated oxidative and endoplasmic reticulum (ER) stress may play a role in the AZT-induced hepatic lipid accumulation. AZT treatment of C57BL/6J female mice (400 mg/day/kg body weight, i.p.) for 10 consecutive days significantly increased hepatic triglyceride levels and inflammation. Markers of oxidative stress such as protein oxidation, nitration, glycation and lipid peroxidation were significantly higher in the AZT-treated mice compared to vehicle controls. Further, the levels of ER stress marker proteins like GRP78, p-PERK, and p-eIF2 alpha were significantly elevated in AZT-treated mice. The level of nuclear SREBP-1c, a transcription factor involved in fat synthesis, was increased while significantly decreased protein levels of phospho-acetyl-CoA carboxylase, phospho-AMP kinase and PPAR alpha as well as inactivation of 3-keto-acyl-CoA thiolase in the mitochondrial fatty acid beta-oxidation pathway were observed in AZT-exposed mice compared to those in control animals. Collectively, these data suggest that elevated oxidative and ER stress plays a key role, at least partially, in lipid accumulation, inflammation and hepatotoxicity in AZT-treated mice.	[Banerjee, Atrayee; Abdelmegeed, Mohamed A.; Jang, Sehwan; Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Song, BJ (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD USA.	bj.song@nih.gov			Intramural Program of National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	Intramural Program of National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The research was supported by the Intramural Program of National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMEGEED MA, 2013, FREE RADIC BIOL MED; Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Acosta BS, 1999, SOUTHERN MED J, V92, P421, DOI 10.1097/00007611-199904000-00015; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035; Calvaruso V, 2009, J VIRAL HEPATITIS, V16, P529, DOI 10.1111/j.1365-2893.2009.01150.x; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Corcuera T, 1996, PATHOL RES PRACT, V192, P182, DOI 10.1016/S0344-0338(96)80218-4; de la Asuncion JG, 1999, HEPATOLOGY, V29, P985; de la Asuncion JG, 1998, J CLIN INVEST, V102, P4, DOI 10.1172/JCI1418; Desai VG, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/317695; FREIMAN JP, 1993, AIDS, V7, P379, DOI 10.1097/00002030-199303000-00012; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gao RY, 2011, MOL MED REP, V4, P151, DOI 10.3892/mmr.2010.390; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Gentile CL, 2011, BIOFACTORS, V37, P8, DOI 10.1002/biof.135; Georges B, 2003, BIOCHEM PHARMACOL, V65, P1483, DOI 10.1016/S0006-2952(03)00110-2; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Hansen L, 2013, J BIOMECH, V46, P1540, DOI 10.1016/j.jbiomech.2013.03.021; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kim BJ, 2006, PROTEOMICS, V6, P1250, DOI 10.1002/pmic.200500447; Kimzey AL, 2003, BIOCHEMISTRY-US, V42, P12691, DOI 10.1021/bi0349975; Lapadula Giuseppe, 2007, J Med Case Rep, V1, P19, DOI 10.1186/1752-1947-1-19; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; MILLER TL, 1993, AM J CLIN NUTR, V57, P588, DOI 10.1093/ajcn/57.4.588; Moon KH, 2008, PROTEOMICS, V8, P3906, DOI 10.1002/pmic.200800215; Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Omar RF, 1996, TOXICOL APPL PHARM, V139, P324, DOI 10.1006/taap.1996.0172; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Puoti Massimo, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P30, DOI 10.1177/1545109708330906; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Shah I, 2006, J TROP PEDIATRICS, V52, P244, DOI 10.1093/tropej/fmi086; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Sutinen J, 2002, AIDS, V16, P2183, DOI 10.1097/00002030-200211080-00011; Szabados E, 1999, FREE RADICAL BIO MED, V26, P309, DOI 10.1016/S0891-5849(98)00199-3; Wu DF, 2012, FREE RADICAL BIO MED, V53, P1346, DOI 10.1016/j.freeradbiomed.2012.07.005; Wu J, 2010, ACTA PHARMACOL SIN, V31, P1367, DOI 10.1038/aps.2010.110; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898	59	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76850	10.1371/journal.pone.0076850	http://dx.doi.org/10.1371/journal.pone.0076850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146933	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400086
J	Brand, LH; Henneges, C; Schussler, A; Kolukisaoglu, HU; Koch, G; Wallmeroth, N; Hecker, A; Thurow, K; Zell, A; Harter, K; Wanke, D				Brand, Luise H.; Henneges, Carsten; Schuessler, Axel; Kolukisaoglu, H. Uener; Koch, Grit; Wallmeroth, Niklas; Hecker, Andreas; Thurow, Kerstin; Zell, Andreas; Harter, Klaus; Wanke, Dierk			Screening for Protein-DNA Interactions by Automatable DNA-Protein Interaction ELISA	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR; BINDING MICROARRAYS; LAC-REPRESSOR; SEQUENCE SPECIFICITIES; NONRADIOACTIVE ASSAY; NUCLEIC-ACID; GATA FAMILY; ARABIDOPSIS; EFFECTOR; BZIP	DNA-binding proteins (DBPs), such as transcription factors, constitute about 10% of the protein-coding genes in eukaryotic genomes and play pivotal roles in the regulation of chromatin structure and gene expression by binding to short stretches of DNA. Despite their number and importance, only for a minor portion of DBPs the binding sequence had been disclosed. Methods that allow the de novo identification of DNA-binding motifs of known DBPs, such as protein binding microarray technology or SELEX, are not yet suited for high-throughput and automation. To close this gap, we report an automatable DNA-protein-interaction (DPI)-ELISA screen of an optimized double-stranded DNA (dsDNA) probe library that allows the high-throughput identification of hexanucleotide DNA-binding motifs. In contrast to other methods, this DPI-ELISA screen can be performed manually or with standard laboratory automation. Furthermore, output evaluation does not require extensive computational analysis to derive a binding consensus. We could show that the DPI-ELISA screen disclosed the full spectrum of binding preferences for a given DBP. As an example, AtWRKY11 was used to demonstrate that the automated DPI-ELISA screen revealed the entire range of in vitro binding preferences. In addition, protein extracts of AtbZIP63 and the DNA-binding domain of AtWRKY33 were analyzed, which led to a refinement of their known DNA-binding consensi. Finally, we performed a DPI-ELISA screen to disclose the DNA-binding consensus of a yet uncharacterized putative DBP, AtTIFY1. A palindromic TGATCA-consensus was uncovered and we could show that the GATC-core is compulsory for AtTIFY1 binding. This specific interaction between AtTIFY1 and its DNA-binding motif was confirmed by in vivo plant one-hybrid assays in protoplasts. Thus, the value and applicability of the DPI-ELISA screen for de novo binding site identification of DBPs, also under automatized conditions, is a promising approach for a deeper understanding of gene regulation in any organism of choice.	[Brand, Luise H.; Kolukisaoglu, H. Uener; Wallmeroth, Niklas; Hecker, Andreas; Harter, Klaus; Wanke, Dierk] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany; [Henneges, Carsten; Schuessler, Axel; Zell, Andreas] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany; [Kolukisaoglu, H. Uener; Koch, Grit; Thurow, Kerstin] Ctr Life Sci Automat, Rostock, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Wanke, D (corresponding author), Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany.	dierk.wanke@uni-tuebingen.de	Wanke, Dierk/AAA-8529-2019; Kolukisaoglu, Üner/J-8831-2014; Thurow, Kerstin/AAY-4709-2020	Kolukisaoglu, Üner/0000-0002-8656-5963; 	Landesgraduiertenforderung des Landes Baden-Wurttemberg; German Science Foundation [HA2146/8-2]	Landesgraduiertenforderung des Landes Baden-Wurttemberg; German Science Foundation(German Research Foundation (DFG))	This research was supported by a scholarship of the Landesgraduiertenforderung des Landes Baden-Wurttemberg to LHB. Funding for open access charge: German Science Foundation project grant HA2146/8-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER K, 1972, NATURE, V237, P322, DOI 10.1038/237322a0; Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Benotmane AM, 1997, ANAL BIOCHEM, V250, P181, DOI 10.1006/abio.1997.2231; Berendzen KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-522; Berendzen KW, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-125; Berendzen Kenneth W., 2009, V479, P311, DOI 10.1007/978-1-59745-289-2_20; Berendzen KW, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-25; Berger Michael F., 2006, V338, P245; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Biswas D, 2004, MOL CELL BIOL, V24, P8312, DOI 10.1128/MCB.24.18.8312-8321.2004; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brand LH, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-25; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bulyk ML, 2006, METHOD ENZYMOL, V410, P279, DOI 10.1016/S0076-6879(06)10013-0; Bulyk ML, 2007, ADV BIOCHEM ENG BIOT, V104, P65, DOI 10.1007/10_025; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chai CL, 2011, METHODS MOL BIOL, V754, P249, DOI 10.1007/978-1-61779-154-3_14; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Coats JE, 2013, NUCLEIC ACIDS RES, V41, P1372, DOI 10.1093/nar/gks1208; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Czapla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056548; Dey B, 2012, MOL CELL BIOCHEM, V365, P279, DOI 10.1007/s11010-012-1269-z; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Djordjevic M, 2010, METHODS MOL BIOL, V674, P195, DOI 10.1007/978-1-60761-854-6_12; Dong FM, 1999, J MOL BIOL, V290, P653, DOI 10.1006/jmbi.1999.2902; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Ghirlando R, 2003, J BIOL CHEM, V278, P45620, DOI 10.1074/jbc.M306410200; Godoy M, 2011, PLANT J, V66, P700, DOI 10.1111/j.1365-313X.2011.04519.x; Gross J., 2003, HDB GRAPH THEORY; GUBLER ML, 1995, BIOTECHNIQUES, V18, P1008; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Helwa R, 2010, ANAL BIOANAL CHEM, V398, P2551, DOI 10.1007/s00216-010-4096-7; HIBMA MH, 1994, NUCLEIC ACIDS RES, V22, P3806, DOI 10.1093/nar/22.18.3806; Hudson ME, 2006, BIOTECHNIQUES, V41, P673, DOI 10.2144/000112322; Jagelska E, 2002, J IMMUNOL METHODS, V267, P227, DOI 10.1016/S0022-1759(02)00182-5; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kang SG, 2010, MOL PLANT, V3, P361, DOI 10.1093/mp/ssp115; Kerschgens J, 2009, TRENDS MOL MED, V15, P352, DOI 10.1016/j.molmed.2009.06.004; Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023; Kolukisaoglu U, 2010, PLANT SCI, V178, P476, DOI 10.1016/j.plantsci.2010.03.006; Labazi M, 2009, NUCLEIC ACIDS RES, V37, P7581, DOI 10.1093/nar/gkp649; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; LEHMING N, 1988, P NATL ACAD SCI USA, V85, P7947, DOI 10.1073/pnas.85.21.7947; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Maienschein-Cline M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks771; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Massie CE, 2008, EMBO REP, V9, P337, DOI 10.1038/embor.2008.44; Matiolli CC, 2011, PLANT PHYSIOL, V157, P692, DOI 10.1104/pp.111.181743; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Merkle T, 1996, PLANT J, V10, P1177, DOI 10.1046/j.1365-313X.1996.10061177.x; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ogawa N, 2012, METHODS MOL BIOL, V786, P51, DOI 10.1007/978-1-61779-292-2_3; Opper K, SIGMA ALDRICH BIOTEC; Pazos E, 2011, CHEMBIOCHEM, V12, P1958, DOI 10.1002/cbic.201100247; Pearson Joseph C, 2013, Bioinformatics, V29, P1690, DOI 10.1093/bioinformatics/btt264; Pfreundt U, 2010, NUCLEIC ACIDS RES, V38, pD443, DOI 10.1093/nar/gkp910; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reece-Hoyes JS, 2012, METHODS, V57, P441, DOI 10.1016/j.ymeth.2012.07.027; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SARTORIUS J, 1991, J MOL BIOL, V218, P313, DOI 10.1016/0022-2836(91)90714-H; Schroder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013876; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Skiena S. S., 2008, ALGORITHM DESIGN MAN; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Sprenger-Haussels M, 2000, PLANT J, V22, P1, DOI 10.1046/j.1365-313x.2000.00687.x; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; Wanke Dierk, 2009, V479, P291, DOI 10.1007/978-1-59745-289-2_19; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yamasaki K, 2013, TRENDS PLANT SCI, V18, P267, DOI 10.1016/j.tplants.2012.09.001; Zheng YM, 2011, METHODS MOL BIOL, V754, P277, DOI 10.1007/978-1-61779-154-3_16; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	101	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75177	10.1371/journal.pone.0075177	http://dx.doi.org/10.1371/journal.pone.0075177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146751	gold, Green Published			2022-12-25	WOS:000325819400007
J	Li, Q; Canosa, S; Flynn, K; Michaud, M; Krauthammer, M; Madri, JA				Li, Qi; Canosa, Sandra; Flynn, Kelly; Michaud, Michael; Krauthammer, Michael; Madri, Joseph A.			Modeling the Neurovascular Niche: Unbiased Transcriptome Analysis of the Murine Subventricular Zone in Response to Hypoxic Insult	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NEURAL STEM-CELLS; ENDOTHELIAL-CELLS; YOUNG ADULTHOOD; MORTALITY; OUTCOMES; OLIG2	Premature infants often experience chronic hypoxia, resulting in cognitive & motor neurodevelopmental handicaps. These sometimes devastating handicaps are thought to be caused by compromised neural precursor cell (NPC) repair/recovery resulting in variable central nervous system (CNS) repair/recovery. We have identified differential responses of two mouse strains (C57BL/6 & CD1) to chronic hypoxia that span the range of responsiveness noted in the premature human population. We previously correlated several CNS tissue and cellular behaviors with the different behavioral parameters manifested by these two strains. In this report, we use unbiased array technology to interrogate the transcriptome of the subventricular zone (SVZ) in these strains. Our results illustrate differences in mRNA expression in the SVZ of both C57BL/6 and CD1 mice following hypoxia as well as differences between C57BL/6 and CD1 SVZ under both normoxic and hypoxic conditions. Differences in expression were found in gene sets associated with Sox10-mediated neural functions that explain, in part, the differential cognitive and motor responsiveness to hypoxic insult. This may shed additional light on our understanding of the variable responses noted in the human premature infant population and facilitate early intervention approaches. Further interrogation of the differentially expressed gene sets will provide a more complete understanding of the differential responses to, and recovery from, hypoxic insult allowing for more informed modeling of the ranges of disease severity observed in the very premature human population.	[Li, Qi; Canosa, Sandra; Flynn, Kelly; Michaud, Michael; Krauthammer, Michael; Madri, Joseph A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Madri, JA (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	JOSEPH.MADRI@YALE.EDU		Michaud, Michael/0000-0001-7332-4987; Krauthammer, Michael/0000-0002-4808-1845	Yale University Clinical and Translational Science award [BUL1TR000142]; USPHS [RO1-HL51018, PO1-NS00344738]; Connecticut Stem Cell Grant; Reed Foundation Fellowship;  [T32-DK07556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007556] Funding Source: NIH RePORTER	Yale University Clinical and Translational Science award; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Stem Cell Grant; Reed Foundation Fellowship; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by a Yale University Clinical and Translational Science award BUL1TR000142 to MK, USPHS grants RO1-HL51018 and PO1-NS00344738 to JAM and a Connecticut Stem Cell Grant to QL. KR was supported by T32-DK07556 and a Reed Foundation Fellowship to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Bassan H, 2006, PEDIATR NEUROL, V35, P85, DOI 10.1016/j.pediatrneurol.2006.03.005; Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF293, DOI 10.1136/adc.2005.080192; Curristin SM, 2002, P NATL ACAD SCI USA, V99, P15729, DOI 10.1073/pnas.232568799; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Gaber ZB, 2011, NEURON, V69, P833, DOI 10.1016/j.neuron.2011.02.037; Gonzalez-Perez O, 2011, BRAIN RES REV, V67, P147, DOI 10.1016/j.brainresrev.2011.01.001; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lee KE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-408; Li Q, 2008, J NEUROSCI RES, V86, P1227, DOI 10.1002/jnr.21597; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Li Q, 2011, ANGIOGENESIS, V14, P173, DOI 10.1007/s10456-011-9201-9; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Ment LR, 2007, NAT CLIN PRAC NEUROL, V3; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Paul David A, 2006, BMC Pediatr, V6, P2, DOI 10.1186/1471-2431-6-2; Pozniak CD, 2010, P NATL ACAD SCI USA, V107, P21795, DOI 10.1073/pnas.1016485107; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schafer RJ, 2009, BRAIN PATHOL; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Srinivasan R, 2012, NUCLEIC ACIDS RES, V40, P6449, DOI 10.1093/nar/gks313; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2011, NEURON, V69, P906, DOI 10.1016/j.neuron.2011.02.005; Tyson JE, 2005, JAMA-J AM MED ASSOC, V294, P371, DOI 10.1001/jama.294.3.371; Ward NL, 2007, J APPL PHYSIOL, V102, P1927, DOI 10.1152/japplphysiol.00909.2006; Wegner M, GENES DEV, V25, P2423; Weider M, 2013, BIOL CHEM, V394, P1583, DOI 10.1515/hsz-2013-0146; Williams C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053208; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Yalcin B, 2011, NATURE, P477; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zwemer CF, 2007, J APPL PHYSIOL, V102, P286, DOI 10.1152/japplphysiol.00536.2006	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76265	10.1371/journal.pone.0076265	http://dx.doi.org/10.1371/journal.pone.0076265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146847	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400050
J	Manchia, M; Cullis, J; Turecki, G; Rouleau, GA; Uher, R; Alda, M				Manchia, Mirko; Cullis, Jeffrey; Turecki, Gustavo; Rouleau, Guy A.; Uher, Rudolf; Alda, Martin			The Impact of Phenotypic and Genetic Heterogeneity on Results of Genome Wide Association Studies of Complex Diseases	PLOS ONE			English	Article							BIPOLAR DISORDER; SAMPLE-SIZE; MISCLASSIFICATION; LINKAGE; METAANALYSIS; POWER; REPLICATION; SUPPORTS; ERRORS; RISK	Phenotypic misclassification (between cases) has been shown to reduce the power to detect association in genetic studies. However, it is conceivable that complex traits are heterogeneous with respect to individual genetic susceptibility and disease pathophysiology, and that the effect of heterogeneity has a larger magnitude than the effect of phenotyping errors. Although an intuitively clear concept, the effect of heterogeneity on genetic studies of common diseases has received little attention. Here we investigate the impact of phenotypic and genetic heterogeneity on the statistical power of genome wide association studies (GWAS). We first performed a study of simulated genotypic and phenotypic data. Next, we analyzed the Wellcome Trust Case-Control Consortium (WTCCC) data for diabetes mellitus (DM) type 1 (T1D) and type 2 (T2D), using varying proportions of each type of diabetes in order to examine the impact of heterogeneity on the strength and statistical significance of association previously found in the WTCCC data. In both simulated and real data, heterogeneity (presence of "non-cases") reduced the statistical power to detect genetic association and greatly decreased the estimates of risk attributed to genetic variation. This finding was also supported by the analysis of loci validated in subsequent large-scale meta-analyses. For example, heterogeneity of 50% increases the required sample size by approximately three times. These results suggest that accurate phenotype delineation may be more important for detecting true genetic associations than increase in sample size.	[Manchia, Mirko; Cullis, Jeffrey; Uher, Rudolf; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	Dalhousie University; McGill University; McGill University	Alda, M (corresponding author), Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada.	malda@dal.ca	Uher, Rudolf/A-5477-2008; Alda, Martin/F-5812-2010; Turecki, Gustavo/K-5100-2015; Manchia, Mirko/A-2907-2010	Uher, Rudolf/0000-0002-2998-0546; Alda, Martin/0000-0001-9544-3944; Manchia, Mirko/0000-0003-4175-6413; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research (CIHR) [64410]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was in part funded by grant 64410 from Canadian Institute of Health Research (CIHR) to MA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2005, PROG NEURO-PSYCHOPH, V29, P1038, DOI 10.1016/j.pnpbp.2005.03.021; Angst J, 2007, WORLD PSYCHIATRY, V6, P30; Barral S, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-24; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buyske S, 2009, HUM HERED, V67, P287, DOI 10.1159/000194981; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Corvin A, 2010, PSYCHOL MED, V40, P1063, DOI 10.1017/S0033291709991723; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; DAVIES P, 1986, NEUROBIOL AGING, V7, P459, DOI 10.1016/0197-4580(86)90071-0; de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Evangelou E, 2011, AM J EPIDEMIOL, V173, P1336, DOI 10.1093/aje/kwr024; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Goes FS, 2007, AM J PSYCHIAT, V164, P236, DOI 10.1176/appi.ajp.164.2.236; GORDON D, 2004, STAT APPL GENET MOL, V3; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; Himswort HP, 1940, BMJ-BRIT MED J, V1940, P719, DOI 10.1136/bmj.1.4139.719; Himsworth HP, 2011, DIABETIC MED, V28, P1440, DOI 10.1111/j.1464-5491.2011.3508.x; Ji F, 2005, STAT APPL GENET MOL, V4; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu HQ, 2010, HUM MOL GENET, V19, P2534, DOI 10.1093/hmg/ddq133; RISCH N, 1990, AM J HUM GENET, V46, P222; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; Vassos E, 2012, BIOL PSYCHIAT, V72, P645, DOI 10.1016/j.biopsych.2012.02.040; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257	40	128	129	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76295	10.1371/journal.pone.0076295	http://dx.doi.org/10.1371/journal.pone.0076295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146854	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400052
J	Schoepf, V; Grottoli, AG; Warner, ME; Cai, WJ; Melman, TF; Hoadley, KD; Pettay, DT; Hu, XP; Li, Q; Xu, H; Wang, YC; Matsui, Y; Baumann, JH				Schoepf, Verena; Grottoli, Andrea G.; Warner, Mark E.; Cai, Wei-Jun; Melman, Todd F.; Hoadley, Kenneth D.; Pettay, D. Tye; Hu, Xinping; Li, Qian; Xu, Hui; Wang, Yongchen; Matsui, Yohei; Baumann, Justin H.			Coral Energy Reserves and Calcification in a High-CO2 World at Two Temperatures	PLOS ONE			English	Article							CO2 PARTIAL-PRESSURE; CO2-INDUCED OCEAN ACIDIFICATION; POCILLOPORA-DAMICORNIS LINNAEUS; SCLERACTINIAN CORAL; CLIMATE-CHANGE; REEF CORAL; SKELETAL GROWTH; CARBON-DIOXIDE; SEAWATER ACIDIFICATION; STYLOPHORA-PISTILLATA	Rising atmospheric CO2 concentrations threaten coral reefs globally by causing ocean acidification (OA) and warming. Yet, the combined effects of elevated pCO(2) and temperature on coral physiology and resilience remain poorly understood. While coral calcification and energy reserves are important health indicators, no studies to date have measured energy reserve pools (i.e., lipid, protein, and carbohydrate) together with calcification under OA conditions under different temperature scenarios. Four coral species, Acropora millepora, Montipora monasteriata, Pocillopora damicornis, Turbinaria reniformis, were reared under a total of six conditions for 3.5 weeks, representing three pCO(2) levels (382, 607, 741 mu atm), and two temperature regimes (26.5, 29.0 degrees C) within each pCO(2) level. After one month under experimental conditions, only A. millepora decreased calcification (-53%) in response to seawater pCO(2) expected by the end of this century, whereas the other three species maintained calcification rates even when both pCO(2) and temperature were elevated. Coral energy reserves showed mixed responses to elevated pCO(2) and temperature, and were either unaffected or displayed nonlinear responses with both the lowest and highest concentrations often observed at the mid-pCO(2) level of 607 matm. Biweekly feeding may have helped corals maintain calcification rates and energy reserves under these conditions. Temperature often modulated the response of many aspects of coral physiology to OA, and both mitigated and worsened pCO(2) effects. This demonstrates for the first time that coral energy reserves are generally not metabolized to sustain calcification under OA, which has important implications for coral health and bleaching resilience in a high-CO2 world. Overall, these findings suggest that some corals could be more resistant to simultaneously warming and acidifying oceans than previously expected.	[Schoepf, Verena; Grottoli, Andrea G.; Matsui, Yohei; Baumann, Justin H.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Warner, Mark E.; Hoadley, Kenneth D.; Pettay, D. Tye] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Cai, Wei-Jun; Hu, Xinping; Li, Qian; Xu, Hui; Wang, Yongchen] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Melman, Todd F.] Reef Syst Coral Farm, New Albany, OH USA	University System of Ohio; Ohio State University; University of Delaware; University System of Georgia; University of Georgia	Schoepf, V (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	schoepf.4@osu.edu	Warner, Mark E/J-6241-2013; Cai, Wei-Jun/C-1361-2013; Schoepf, Verena/H-5786-2014; Hu, Xinping/F-6282-2011	Cai, Wei-Jun/0000-0003-3606-8325; Schoepf, Verena/0000-0002-9467-1088; Hu, Xinping/0000-0002-0613-6545; Warner, Mark/0000-0003-1015-9413; Baumann, Justin/0000-0003-0113-0491; Hoadley, Kenneth/0000-0002-9287-181X	National Science Foundation [NSF-EF-1041124, 1040940, 1041070]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (grants NSF-EF-1041124, 1040940, 1041070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2002, LIMNOL OCEANOGR, V47, P1417, DOI 10.4319/lo.2002.47.5.1417; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Cai WJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005482; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Clausen C.D., 1971, EXPT COELENTERATE BI, P246; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, MAR BIOL, V160, P1127, DOI 10.1007/s00227-012-2165-5; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Drenkard EJ, 2013, CORAL REEFS, DOI [10.1007/s00338-00013-01021-00335, DOI 10.1007/S00338-00013-01021-00335]; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edmunds PJ, 2012, MAR BIOL, V159, P2149, DOI 10.1007/s00227-012-2001-y; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Edmunds PJ, 2011, LIMNOL OCEANOGR, V56, P2402, DOI 10.4319/lo.2011.56.6.2402; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; Godinot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025024; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Grottoli AG, 2002, GEOCHIM COSMOCHIM AC, V66, P1955, DOI 10.1016/S0016-7037(01)00901-2; Harvey BP, 2013, ECOLOGY EVOLUTION, DOI [10.1002/ece1003.1516, DOI 10.1002/ECE1003.1516]; Herfort L, 2008, J PHYCOL, V44, P91, DOI 10.1111/j.1529-8817.2007.00445.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holcomb M, 2012, BIOGEOSCIENCES, V9, P29, DOI 10.5194/bg-9-29-2012; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2012, CORAL REEFS, V31, P101, DOI 10.1007/s00338-011-0819-2; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IPCC, 2007, CONTRIBUTION WORKING; Johannes RE, 1970, LIMNOL OCEANOGR, V21, P540; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Levas S., 2012, THESIS OHIO STATE U; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Lewis E., 1998, ORNLCDIAC105 US DEP; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Muehllehner N, 2008, FT LAUD FLOR 7 11 JU, P57; Muller-Parker G., 1994, Pacific Science, V48, P273; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Reynaud-Vaganay S, 2001, PALAEOGEOGR PALAEOCL, V175, P393, DOI 10.1016/S0031-0182(01)00382-0; Ries JB, 2011, GEOCHIM COSMOCHIM AC, V75, P4053, DOI 10.1016/j.gca.2011.04.025; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STAMBLER N, 1991, Pacific Science, V45, P299; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; TAKABAYASHI M, 1995, MAR BIOL, V123, P705, DOI 10.1007/BF00349113; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; Tolosa I, 2011, CORAL REEFS, V30, P763, DOI 10.1007/s00338-011-0753-3; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wang ZHA, 2004, LIMNOL OCEANOGR, V49, P341, DOI 10.4319/lo.2004.49.2.0341; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Warren CR, 2008, J PLANT NUTR, V31, P1321, DOI 10.1080/01904160802135092; WEISS RF, 1985, NATURE, V314, P608, DOI 10.1038/314608a0; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Winer BJ, 1971, STAT PRINCIPLES EXPT	111	113	114	1	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75049	10.1371/journal.pone.0075049	http://dx.doi.org/10.1371/journal.pone.0075049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146747	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400005
J	Allen-Sharpley, MR; Tjia, M; Cramer, KS				Allen-Sharpley, Michelle R.; Tjia, Michelle; Cramer, Karina S.			Differential Roles for EphA and EphB Signaling in Segregation and Patterning of Central Vestibulocochlear Nerve Projections	PLOS ONE			English	Article							AXON GUIDANCE; EXPRESSION; REGENERATION; RECEPTORS; GANGLION; NEURONS; SYSTEM; GROWTH; CELLS; MORPHOGENESIS	Auditory and vestibular afferents enter the brainstem through the VIIIth cranial nerve and find targets in distinct brain regions. We previously reported that the axon guidance molecules EphA4 and EphB2 have largely complementary expression patterns in the developing avian VIIIth nerve. Here, we tested whether inhibition of Eph signaling alters central targeting of VIIIth nerve axons. We first identified the central compartments through which auditory and vestibular axons travel. We then manipulated Eph-ephrin signaling using pharmacological inhibition of Eph receptors and in ovo electroporation to misexpress EphA4 and EphB2. Anterograde labeling of auditory afferents showed that inhibition of Eph signaling did not misroute axons to non-auditory target regions. Similarly, we did not find vestibular axons within auditory projection regions. However, we found that pharmacologic inhibition of Eph receptors reduced the volume of the vestibular projection compartment. Inhibition of EphB signaling alone did not affect auditory or vestibular central projection volumes, but it significantly increased the area of the auditory sensory epithelium. Misexpression of EphA4 and EphB2 in VIIIth nerve axons resulted in a significant shift of dorsoventral spacing between the axon tracts, suggesting a cell-autonomous role for the partitioning of projection areas along this axis. Cochlear ganglion volumes did not differ among treatment groups, indicating the changes seen were not due to a gain or loss of cochlear ganglion cells. These results suggest that Eph-ephrin signaling does not specify auditory versus vestibular targets but rather contributes to formation of boundaries for patterning of inner ear projections in the hindbrain.	[Allen-Sharpley, Michelle R.; Tjia, Michelle; Cramer, Karina S.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92623 USA	University of California System; University of California Irvine	Cramer, KS (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92623 USA.	cramerk@uci.edu		Tjia, Michelle/0000-0003-1210-8775; Cramer, Karina/0000-0003-3793-4862	NIH [R01 DC010796, T32 DC010775]; DOE GAANN [P200A120165]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010796, T32DC010775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE GAANN(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by: NIH R01 DC010796, NIH T32 DC010775, DOE GAANN P200A120165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Sharpley MR, 2013, JOVE-J VIS EXP, DOI 10.3791/50305; Allen-Sharpley MR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-29; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Bianchi LM, 2002, EUR J NEUROSCI, V16, P1499, DOI 10.1046/j.1460-9568.2002.02248.x; Bianchi LM, 1999, ANAT REC, V254, P127; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Bulankina AV, 2012, PHYSIOLOGY, V27, P100, DOI 10.1152/physiol.00036.2011; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Cho J, 2009, MOL NEUROBIOL, V39, P1, DOI 10.1007/s12035-008-8047-7; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Cramer KS, 2006, DEV BIOL, V295, P76, DOI 10.1016/j.ydbio.2006.03.010; Cramer KS, 2004, DEV BIOL, V269, P26, DOI 10.1016/j.ydbio.2004.01.002; Cramer KS, 2000, J COMP NEUROL, V426, P270; Davidovics NS, 2013, JARO-J ASSOC RES OTO, V14, P233, DOI 10.1007/s10162-013-0370-7; Defourny J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2445; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Huffman KJ, 2007, DEV NEUROBIOL, V67, P1655, DOI 10.1002/dneu.20535; Jeon EJ, 2011, NEUROSCIENCE, V177, P321, DOI 10.1016/j.neuroscience.2011.01.014; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; Merfeld DM, 2012, CURR OPIN OTOLARYNGO, V20, P386, DOI 10.1097/MOO.0b013e328357630f; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Molea D, 2003, J COMP NEUROL, V466, P577, DOI 10.1002/cne.10896; Niederlander C, 1996, DEVELOPMENT, V122, P2367; PARKS TN, 1978, J COMP NEUROL, V180, P439, DOI 10.1002/cne.901800303; Perde-Schrepler M, 2012, J OTOLARYNGOL-HEAD N, V41, P227, DOI 10.2310/7070.2012.00027; Person AL, 2004, J NEUROBIOL, V60, P28, DOI 10.1002/neu.10330; Pickles JO, 2003, HEARING RES, V178, P44, DOI 10.1016/S0378-5955(03)00029-7; Pickles JO, 1997, DEV NEUROSCI-BASEL, V19, P476, DOI 10.1159/000111245; Ren ZW, 2012, REV NEUROSCIENCE, V23, P135, DOI 10.1515/revneuro-2011-0069; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Saeger BM, 2011, DEV DYNAM, V240, P1578, DOI 10.1002/dvdy.22632; Siddiqui SA, 2005, J COMP NEUROL, V482, P309, DOI 10.1002/cne.20396; Simmons D, 2011, DEV INNER EAR EFFERE; Simmons DD, 2002, J NEUROBIOL, V53, P228, DOI 10.1002/neu.10130; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Thompson LA, 2012, J VESTIBUL RES-EQUIL, V22, P11, DOI 10.3233/VES-2012-0442; Torii M, 2013, CEREB CORTEX, V23, P775, DOI 10.1093/cercor/bhs066; Zhou CQ, 2011, LARYNGOSCOPE, V121, P1541, DOI 10.1002/lary.21861	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e78658	10.1371/journal.pone.0078658	http://dx.doi.org/10.1371/journal.pone.0078658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130906	gold, Green Published			2022-12-25	WOS:000325814200100
J	Gillory, LA; Megison, ML; Stewart, JE; Mroczek-Musulman, E; Nabers, HC; Waters, AM; Kelly, V; Coleman, JM; Markert, JM; Gillespie, GY; Friedman, GK; Beierle, EA				Gillory, Lauren A.; Megison, Michael L.; Stewart, Jerry E.; Mroczek-Musulman, Elizabeth; Nabers, Hugh C.; Waters, Alicia M.; Kelly, Virginia; Coleman, Jennifer M.; Markert, James M.; Gillespie, G. Yancey; Friedman, Gregory K.; Beierle, Elizabeth A.			Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma	PLOS ONE			English	Article							IONIZING-RADIATION; N-MYC; CELL-LINES; BRAIN-TUMORS; STEM-CELLS; THERAPY; CANCER; REPLICATION; VIROTHERAPY; EXPRESSION	Despite intensive research efforts and therapeutic advances over the last few decades, the pediatric neural crest tumor, neuroblastoma, continues to be responsible for over 15% of pediatric cancer deaths. Novel therapeutic options are needed for this tumor. Recently, investigators have shown that mice with syngeneic murine gliomas treated with an engineered, neuroattenuated oncolytic herpes simplex virus-1 (oHSV), M002, had a significant increase in survival. M002 has deletions in both copies of the gamma,134.5 gene, enabling replication in tumor cells but precluding infection of normal neural cells. We hypothesized that M002 would also be effective in the neural crest tumor, neuroblastoma. We showed that M002 infected, replicated, and decreased survival in neuroblastoma cell lines. In addition, we showed that in murine xenografts, treatment with M002 significantly decreased tumor growth, and that this effect was augmented with the addition of ionizing radiation. Importantly, survival could be increased by subsequent doses of radiation without re-dosing of the virus. Finally, these studies showed that the primary entry protein for oHSV, CD111 was expressed by numerous neuroblastoma cell lines and was also present in human neuroblastoma specimens. We concluded that M002 effectively targeted neuroblastoma and that this oHSV may have potential for use in children with unresponsive or relapsed neuroblastoma.	[Gillory, Lauren A.; Megison, Michael L.; Stewart, Jerry E.; Nabers, Hugh C.; Waters, Alicia M.; Beierle, Elizabeth A.] Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA; [Mroczek-Musulman, Elizabeth] Childrens Alabama, Dept Pathol, Birmingham, AL USA; [Kelly, Virginia; Friedman, Gregory K.] Univ Alabama Birmingham, Div Hematol Oncol, Dept Pediat, Birmingham, AL 35294 USA; [Coleman, Jennifer M.; Markert, James M.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beierle, EA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA.	elizabeth.beierle@childrensal.org		Beierle, Elizabeth/0000-0002-4613-0527; Friedman, Gregory/0000-0002-6653-7420; Gillespie, George/0000-0001-6436-9542	National Cancer Institute [T32CA091078, K08CA118178, P01 CA071933]; St. Baldrick's Foundation; Kaul Pediatric Research Institute; NATIONAL CANCER INSTITUTE [P01CA071933, T32CA091078, K08CA118178] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; Kaul Pediatric Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are supported in part by grants from the National Cancer Institute, Grant Number T32CA091078 (LAG, MLM), K08CA118178 (EAB) and, P01 CA071933 (GYG, JMM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. GFK is supported by funding from St. Baldrick's Foundation(http://www.stbaldricks.org/) and Kaul Pediatric Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2007, ANN SURG ONCOL, V14, P258, DOI 10.1245/s10434-006-9127-4; Adusumilli PS, 2005, ANN THORAC SURG, V80, P409, DOI 10.1016/j.athoracsur.2005.01.048; Advani SJ, 2011, GENE THER, V18, P1098, DOI 10.1038/gt.2011.61; Advani SJ, 1998, GENE THER, V5, P160, DOI 10.1038/sj.gt.3300546; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Blank SV, 2002, HUM GENE THER, V13, P627, DOI 10.1089/10430340252837224; Brodeur G. M., 2006, PRINCIPLES PRACTICE, P933; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chung RY, 1999, J VIROL, V73, P7556, DOI 10.1128/JVI.73.9.7556-7564.1999; Chung SM, 2002, GENE THER, V9, P75, DOI 10.1038/sj.gt.3301620; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cotterill SJ, 2001, MED PEDIATR ONCOL, V36, P231, DOI 10.1002/1096-911X(20010101)36:1<231::AID-MPO1056>3.0.CO;2-U; Dai MH, 2010, BRIT J SURG, V97, P1385, DOI 10.1002/bjs.7124; Davidoff AM, 1999, J PEDIATR SURG, V34, P902, DOI 10.1016/S0022-3468(99)90395-0; EVANS AE, 1980, CANCER, V45, P1799, DOI 10.1002/cncr.1980.45.s7.1799; Friedman GK, 2012, PEDIATR RES, V71, P500, DOI 10.1038/pr.2011.58; Friedman GK, 2009, J NEURO-ONCOL, V95, P199, DOI 10.1007/s11060-009-9926-0; Friedman GK, 2009, MOL THER, V17, P1125, DOI 10.1038/mt.2009.73; Fukuhara H, 2005, CANCER RES, V65, P10663, DOI 10.1158/0008-5472.CAN-05-2534; Garcia-Castro J, 2010, CANCER GENE THER, V17, P476, DOI 10.1038/cgt.2010.4; Gil M, 2011, BRIT J CANCER, V105, P1512, DOI 10.1038/bjc.2011.429; Guffey MB, 2007, CANCER GENE THER, V14, P45, DOI 10.1038/sj.cgt.7700978; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Mahller YY, 2008, CANCER GENE THER, V15, P733, DOI 10.1038/cgt.2008.40; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Mezhir JJ, 2005, CANCER RES, V65, P9479, DOI 10.1158/0008-5472.CAN-05-1927; Moroz V, 2011, EUR J CANCER, V47, P561, DOI 10.1016/j.ejca.2010.10.022; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; Nguyen T, 2003, BIOCHEM BIOPH RES CO, V302, P462, DOI 10.1016/S0006-291X(03)00177-3; Parikh NS, 2005, PEDIATR BLOOD CANCER, V44, P469, DOI 10.1002/pbc.20268; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Pesonen S, 2010, ACTA ONCOL, V49, P120, DOI 10.3109/02841860903071369; Ramirez M, 2010, DISCOV MED, V10, P387; Redlinger RE, 2003, J PEDIATR SURG, V38, P199, DOI 10.1053/jpsu.2003.50043; SCHWEIGERER L, 1990, CANCER RES, V50, P4411; Siapati KE, 2003, BRIT J CANCER, V88, P1641, DOI 10.1038/sj.bjc.6600928; Todo T, 2001, P NATL ACAD SCI USA, V98, P6396, DOI 10.1073/pnas.101136398; Toyoda H, 2007, CANCER RES, V67, P2857, DOI 10.1158/0008-5472.CAN-06-3713; UCAR K, 1995, CANCER GENE THER, V2, P171	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77753	10.1371/journal.pone.0077753	http://dx.doi.org/10.1371/journal.pone.0077753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130898	Green Submitted, gold, Green Published			2022-12-25	WOS:000325814200094
J	Mou, HQ; Lu, J; Zhu, SF; Lin, CL; Tian, GZ; Xu, X; Zhao, WJ				Mou, Hai-Qing; Lu, Jie; Zhu, Shui-Fang; Lin, Cai-Li; Tian, Guo-Zhong; Xu, Xia; Zhao, Wen-Jun			Transcriptomic Analysis of Paulownia Infected by Paulownia Witches'-Broom Phytoplasma	PLOS ONE			English	Article							ABSCISIC-ACID; GENE-EXPRESSION; BIOSYNTHESIS; ARABIDOPSIS; PLANTS; TOOL; PROLIFERATION; PERIWINKLE; CONVERSION; GROWTH	Phytoplasmas are plant pathogenic bacteria that have no cell wall and are responsible for major crop losses throughout the world. Phytoplasma-infected plants show a variety of symptoms and the mechanisms they use to physiologically alter the host plants are of considerable interest, but poorly understood. In this study we undertook a detailed analysis of Paulownia infected by Paulownia witches'-broom (PaWB) Phytoplasma using high-throughput mRNA sequencing (RNA-Seq) and digital gene expression (DGE). RNA-Seq analysis identified 74,831 unigenes, which were subsequently used as reference sequences for DGE analysis of diseased and healthy Paulownia in field grown and tissue cultured plants. Our study revealed that dramatic changes occurred in the gene expression profile of Paulownia after PaWB Phytoplasma infection. Genes encoding key enzymes in cytokinin biosynthesis, such as isopentenyl diphosphate isomerase and isopentenyltransferase, were significantly induced in the infected Paulownia. Genes involved in cell wall biosynthesis and degradation were largely up-regulated and genes related to photosynthesis were down-regulated after PaWB Phytoplasma infection. Our systematic analysis provides comprehensive transcriptomic data about plants infected by Phytoplasma. This information will help further our understanding of the detailed interaction mechanisms between plants and Phytoplasma.	[Mou, Hai-Qing; Lu, Jie; Zhu, Shui-Fang; Xu, Xia; Zhao, Wen-Jun] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China; [Lin, Cai-Li; Tian, Guo-Zhong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Chinese Academy of Inspection & Quarantine; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Zhao, WJ (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China.	wenjunzhao@188.com			National Science and technology support program [2012BAK11B02]	National Science and technology support program	This work was supported by the National Science and technology support program (2012BAK11B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS U, 1992, PHYTOPATHOLOGY, V82, P828, DOI 10.1094/Phyto-82-828; Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNEY SE, 1969, NEW PHYTOL, V68, P1001, DOI 10.1111/j.1469-8137.1969.tb06500.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; BRAUN EJ, 1978, PHYTOPATHOLOGY, V68, P1733, DOI 10.1094/Phyto-68-1733; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Cline M, 1997, PLANT CELL PHYSIOL, V38, P659, DOI 10.1093/oxfordjournals.pcp.a029218; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Curkovic Perica M, 2008, J APPL MICROBIOL, V105, P1826, DOI 10.1111/j.1365-2672.2008.03946.x; De Luca V, 2011, MOL BIOL REP, V38, P2993, DOI 10.1007/s11033-010-9964-x; Doi M, 1967, ANN PHYTOPATHOL SOC, V33, P259, DOI DOI 10.3186/JJPHYT0PATH.33.259; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Guthrie JN, 2001, PHYSIOL MOL PLANT P, V58, P23, DOI 10.1006/pmpp.2000.0311; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Himeno M, 2011, PLANT J, V67, P971, DOI 10.1111/j.1365-313X.2011.04650.x; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Junqueira A, 2004, PHYSIOL MOL PLANT P, V65, P181, DOI 10.1016/j.pmpp.2005.01.005; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kamada-Nobusada T, 2009, PHYTOCHEMISTRY, V70, P444, DOI 10.1016/j.phytochem.2009.02.007; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Karnchanatat A, 2007, FEMS MICROBIOL LETT, V270, P162, DOI 10.1111/j.1574-6968.2007.00662.x; KARTTE S, 1991, J PHYTOPATHOL, V131, P149, DOI 10.1111/j.1439-0434.1991.tb04740.x; KAUFMAN PB, 1974, PHYSIOL PLANTARUM, V31, P39, DOI 10.1111/j.1399-3054.1974.tb03674.x; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lepka P, 1999, PHYSIOL MOL PLANT P, V55, P59, DOI 10.1006/pmpp.1999.0202; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Luccioni LG, 2002, PLANT PHYSIOL, V128, P173, DOI 10.1104/pp.010668; Maust BE, 2003, PHYTOPATHOLOGY, V93, P976, DOI 10.1094/PHYTO.2003.93.8.976; McCoy RE, 1983, U FLORIDA AGR EXP ST, V834; MEDFORD JI, 1989, PLANT CELL, V1, P403, DOI 10.1105/tpc.1.4.403; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Namba S., 2002, Journal of General Plant Pathology, V68, P257, DOI 10.1007/PL00013086; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Roach M, 2012, PLANT J, V70, P967, DOI 10.1111/j.1365-313X.2012.04929.x; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sanchez JP, 2001, PLANT CELL, V13, P1143, DOI 10.1105/tpc.13.5.1143; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI DOI 10.1016/S1360-1385(01)02187-2; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Tian G.Z., 1996, FOREST TREES PALMS D, P227; Weintraub PG, 2010, PHYTOPLASMAS: GENOMES, PLANT HOSTS AND VECTORS, P233, DOI 10.1079/9781845935306.0233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao Y, 2009, INT J SYST EVOL MICR, V59, P2582, DOI 10.1099/ijs.0.010249-0; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	54	54	59	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77217	10.1371/journal.pone.0077217	http://dx.doi.org/10.1371/journal.pone.0077217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130859	Green Submitted, Green Published, gold			2022-12-25	WOS:000325814200070
J	Dong, Y; Richards, JAE; Gupta, R; Aung, PP; Emley, A; Kluger, Y; Dogra, SK; Mahalingam, M; Wajapeyee, N				Dong, Y.; Richards, J-A E.; Gupta, R.; Aung, P. P.; Emley, A.; Kluger, Y.; Dogra, S. K.; Mahalingam, M.; Wajapeyee, N.			PTEN functions as a melanoma tumor suppressor by promoting host immune response	ONCOGENE			English	Article						tumor suppressor; melanoma; immune evasion	NF-KAPPA-B; BRAF MUTATIONS; EXPRESSION; CANCER; STAT3; CYTOKINES; PATHWAY; PHOSPHORYLATION; SENESCENCE; FAMILY	Cancer cells acquire several traits that allow for their survival and progression, including the ability to evade the host immune response. However, the mechanisms by which cancer cells evade host immune responses remain largely elusive. Here we study the phenomena of immune evasion in malignant melanoma cells. We find that the tumor suppressor phosphatase and tensin homolog (PTEN) is an important regulator of the host immune response against melanoma cells. Mechanistically, PTEN represses the expression of immunosuppressive cytokines by blocking the phosphatidylinositide 3-kinase (PI3K) pathway. In melanoma cells lacking PTEN, signal transducer and activator of transcription 3 activates the transcription of immunosuppressive cytokines in a PI3K-dependent manner. Furthermore, conditioned media from PTEN-deficient, patient-derived short-term melanoma cultures and established melanoma cell lines blocked the production of the interleukin-12 (IL-12) in human monocyte-derived dendritic cells. Inhibition of IL-12 production was rescued by restoring PTEN or using neutralizing antibodies against the immunosuppressive cytokines. Furthermore, we report that PTEN, as an alternative mechanism to promote the host immune response against cancer cells, represses the expression of programmed cell death 1 ligand, a known repressor of the host immune response. Finally, to establish the clinical significance of our results, we analyzed malignant melanoma patient samples with or without brisk host responses. These analyses confirmed that PTEN loss is associated with a higher percentage of malignant melanoma samples with non-brisk host responses compared with samples with brisk host responses. Collectively, these results establish that PTEN functions as a melanoma tumor suppressor in part by regulating the host immune response against melanoma cells and highlight the importance of assessing PTEN status before recruiting melanoma patients for immunotherapies.	[Dong, Y.; Gupta, R.; Kluger, Y.; Wajapeyee, N.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Dong, Y.] Hebei Med Univ, Coll Stomatol, Dept Oral & Maxillofacial Surg, Shijiazhuang, Peoples R China; [Richards, J-A E.; Aung, P. P.; Emley, A.; Mahalingam, M.] Boston Univ, Sch Med, Dept Dermatol, Dermatopathol Sect, Boston, MA 02118 USA; [Dogra, S. K.] ASTAR, Brenner Ctr Mol Med, Singapore Inst Clin Sci, Singapore, Singapore	Yale University; Hebei Medical University; Boston University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Wajapeyee, N (corresponding author), Yale Univ, Sch Med, Dept Pathol, LH-214A,310 Cedar St, New Haven, CT 06510 USA.	mmahalin@bu.edu; Narendra.Wajapeyee@yale.edu	Dogra, Shaillay Kumar/K-7073-2015	Aung, Phyu/0000-0002-3398-0573	Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [R33CA106709] Funding Source: NIH RePORTER	Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NW is a Sidney Kimmel Scholar for translational Cancer research and is supported by a team science award from Melanoma Research Alliance and a Career Development Award from Melanoma Research Foundation. NW and YK are members of the Yale Cancer Center.	Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Brandl C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010800; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Cozar Jose Manuel, 2008, J Med Case Rep, V2, P111, DOI 10.1186/1752-1947-2-111; Dadzie OE, 2009, BRIT J DERMATOL, V160, P368, DOI 10.1111/j.1365-2133.2008.08887.x; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Donia M, 2012, ONCOIMMUNOLOGY, V1, P1476, DOI 10.4161/onci.21940; Greene VR, 2009, J INVEST DERMATOL, V129, P1483, DOI 10.1038/jid.2008.374; Hart JR, 2011, P NATL ACAD SCI USA, V108, P13247, DOI 10.1073/pnas.1110486108; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Lengagne R, 2008, J IMMUNOL, V180, P130, DOI 10.4049/jimmunol.180.1.130; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lund TC, 1999, CELL SIGNAL, V11, P789, DOI 10.1016/S0898-6568(99)00045-5; Mihm MC, 1996, LAB INVEST, V74, P43; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013940; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rosso Ritchie, 2009, J Invest Dermatol, V129, P1318, DOI 10.1038/jid.2009.107; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tsao H, 2003, J AM ACAD DERMATOL, V49, P865, DOI 10.1016/S0190-9622(03)02473-3; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Witten IH, 2011, MOR KAUF D, P1; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	40	64	66	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4632	4642		10.1038/onc.2013.409	http://dx.doi.org/10.1038/onc.2013.409			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24141770				2022-12-25	WOS:000342007200002
J	Patel, N; Barrientos, A; Landgraf, R				Patel, Nirav; Barrientos, Antoni; Landgraf, Ralf			The Growth Factor Receptor ERBB2 Regulates Mitochondria! Activity on a Signaling Time Scale	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucose Metabolism; Mitochondria; Receptor Tyrosine Kinase; Signal Transduction; Uncoupling Proteins	UNCOUPLING PROTEIN-2; PROTON TRANSPORT; OXYGEN-CONSUMPTION; OXIDATIVE STRESS; UCP2; EXPRESSION; METABOLISM; MEMBRANE; KINASE; GENE	Background: Overexpressed UCP2 and ERBB2 are oncogenic, but their functions at low expression are unclear. Results: ERBB2 regulates UCP2 levels at low and overexpression settings. The rapid regulation of mitochondria by ERBB2 requires UCP2, but not its transporter activity. Conclusion: At low levels, UCP2 integrates mitochondria into the acute (2 h) signaling response. Significance: This study links growth factor signaling, mitochondrial adaptability, and oncogenic deregulation. Overexpression of the ERBB2 receptor tyrosine kinase and the mitochondrial inner membrane protein UCP2 occurs frequently in aggressive cancers with dysfunctional mitochondria. Overexpressed ERBB2 signals constitutively and elevated UCP2 can uncouple mitochondria and alleviate oxidative stress. However, the physiological contributions of UCP2 and ERBB2 at the low expression levels that are typical of most tissues, as well as the path to oncogenic deregulation, are poorly understood. We now show that ERBB2 directly controls UCP2 levels, both at low physiological levels and oncogenic overexpression. At low levels of receptor and UCP2, ligand stimulation creates a distinct temporal response pattern driven by the opposing forces of translational suppression of the exceptionally short lived UCP2 protein and a time delayed transcriptional up-regulation. The latter becomes dominant through constitutive signaling by overexpressed ERBB2, resulting in high levels of UCP2 that contribute mitochondrial uncoupling. By contrast, ligand stimulation of non-overexpressed ERBB2 transiently removes UCP2 and paradoxically reduces the mitochondrial membrane potential, oxygen consumption, and OXPHOS on a signaling time scale. However, neither the transporter activity nor down-regulation of already low UCP2 levels drive this reduction in mitochondrial activity. Instead, UCP2 is required to establish mitochondria that are capable of responding to ligand. UCP2 knockdown impairs proliferation at high glucose but its absence specifically impairs ligand-induced growth when glucose levels fluctuate. These findings demonstrate the ability of growth factor signaling to control oxidative phosphorylation on a signaling time scale and point toward a non-transporter role for low levels of UCP2 in establishing dynamic response capability.	[Patel, Nirav; Barrientos, Antoni; Landgraf, Ralf] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Landgraf, Ralf] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33101 USA	University of Miami; University of Miami; University of Miami	Landgraf, R (corresponding author), Box 016129 R-629, Miami, FL 33101 USA.	rlandgraf@med.miami.edu			National Institutes of Health [R01-CA98881]; NCI; Braman Family Breast Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA098881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Braman Family Breast Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA98881 (to R. L.) from the NCI and the Braman Family Breast Cancer Institute (to R. L.).	Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Azzu V, 2008, BBA-BIOENERGETICS, V1777, P1378, DOI 10.1016/j.bbabio.2008.07.001; Ball WB, 2011, J IMMUNOL, V187, P1322, DOI 10.4049/jimmunol.1004237; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bugger H, 2011, CANCER CHEMOTH PHARM, V67, P1381, DOI 10.1007/s00280-010-1441-7; Criscuolo F, 2006, BBA-BIOENERGETICS, V1757, P1284, DOI 10.1016/j.bbabio.2006.06.002; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Dalgaard LT, 2011, J OBES, V2011, DOI 10.1155/2011/340241; Dalgaard LT, 2012, BIOCHEM BIOPH RES CO, V417, P495, DOI 10.1016/j.bbrc.2011.11.148; Dhamrait SS, 2004, EUR HEART J, V25, P468, DOI 10.1016/j.ehj.2004.01.007; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Ewer MS, 1999, SEMIN ONCOL, V26, P96; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; KORTENJANN M, 1995, ONCOGENE, V11, P2105; Landgraf R, 1998, BIOCHEMISTRY-US, V37, P3220, DOI 10.1021/bi972326z; Landgraf R, 2000, BIOCHEMISTRY-US, V39, P8503, DOI 10.1021/bi000953+; Lemmens K, 2011, AM J PHYSIOL-HEART C, V300, pH931, DOI 10.1152/ajpheart.00385.2010; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Pegram MD, 1997, ONCOGENE, V15, P537, DOI 10.1038/sj.onc.1201222; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Suarez E, 2001, J BIOL CHEM, V276, P18257, DOI 10.1074/jbc.M008100200; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Warren CM, 2006, J BIOL CHEM, V281, P27306, DOI 10.1074/jbc.M512887200; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Yang J, 2012, J CLIN INVEST, V122, P600, DOI 10.1172/JCI58780; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou H, 2009, ARCH BIOCHEM BIOPHYS, V486, P88, DOI 10.1016/j.abb.2009.02.017	54	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35253	35265		10.1074/jbc.M113.478271	http://dx.doi.org/10.1074/jbc.M113.478271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142693	Green Published, hybrid			2022-12-25	WOS:000329867600024
J	Rajagopal, S; Bassoni, DL; Campbell, JJ; Gerard, NP; Gerard, C; Wehrman, TS				Rajagopal, Sudarshan; Bassoni, Daniel L.; Campbell, James J.; Gerard, Norma P.; Gerard, Craig; Wehrman, Tom S.			Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Chemokines; G Protein-coupled Receptors (GPCR); G Proteins; Signaling; Biased Agonism	I RECEPTOR; PROTEIN; LIGAND; CXCR3; ASSAY; COMPLEMENTATION; RECRUITMENT; ACTIVATION; TRV120027; HEART	Background: Chemokines have been thought to act in a redundant fashion through their shared receptors. Results: Chemokines can display different efficacies for G proteins and -arrestins, resulting in different chemotactic profiles. Conclusion: Chemokines can behave as biased agonists at their receptors, leading to functionally distinct, not redundant, responses. Significance: Biased agonism plays an important role in biological signaling. Chemokines display considerable promiscuity with multiple ligands and receptors shared in common, a phenomenon that is thought to underlie their biochemical redundancy. Their receptors are part of a larger seven-transmembrane receptor superfamily, commonly referred to as G protein-coupled receptors, which have been demonstrated to be able to signal with different efficacies to their multiple downstream signaling pathways, a phenomenon referred to as biased agonism. Biased agonism has been primarily reported as a phenomenon of synthetic ligands, and the biologic prevalence and importance of such signaling are unclear. Here, to assess the presence of biased agonism that may underlie differential signaling by chemokines targeting the same receptor, we performed a detailed pharmacologic analysis of a set of chemokine receptors with multiple endogenous ligands using assays for G protein signaling, -arrestin recruitment, and receptor internalization. We found that chemokines targeting the same receptor can display marked differences in their efficacies for G protein- or -arrestin-mediated signaling or receptor internalization. This ligand bias correlates with changes in leukocyte migration, consistent with different mechanisms underlying the signaling downstream of these receptors induced by their ligands. These findings demonstrate that biased agonism is a common and likely evolutionarily conserved biological mechanism for generating qualitatively distinct patterns of signaling via the same receptor in response to different endogenous ligands.	[Rajagopal, Sudarshan] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Bassoni, Daniel L.; Wehrman, Tom S.] DiscoveRx Corp, Fremont, CA 94538 USA; [Campbell, James J.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Gerard, Norma P.; Gerard, Craig] Childrens Hosp, Dept Pediat, Div Resp Dis, Boston, MA 02115 USA	Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Rajagopal, S (corresponding author), Duke Univ, Med Ctr, 2301 Erwin Rd,DUMC 3845, Durham, NC 27710 USA.	sudarshan.rajagopal@dm.duke.edu	Rajagopal, Sudarshan/G-8975-2013	Rajagopal, Sudarshan/0000-0002-3443-5040; Campbell, James/0000-0003-4252-5182	National Institutes of Health [HL07101-34]; T32 training grant [R21A1092388, R21A1097468, R01A1039795-14, 5R01HL51366-15]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051366, T32HL007101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097468, R21AI092388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL07101-34, a T32 training grant (to S. R.); R21A1092388 and R21A1097468 (to J. C.); and R01A1039795-14 and 5R01HL51366-15 (to C. G.). D. B. and T. W. are employees of DiscoveRx Corporation, which commercializes the PathHunter technology.	Bassoni Daniel L, 2012, Methods Mol Biol, V897, P171, DOI 10.1007/978-1-61779-909-9_8; Bassoni Daniel L, 2012, Methods Mol Biol, V897, P181, DOI 10.1007/978-1-61779-909-9_9; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Bradley J, 2009, METHODS MOL BIOL, V552, P171, DOI 10.1007/978-1-60327-317-6_12; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Eglen RM, 2002, ASSAY DRUG DEV TECHN, V1, P97, DOI 10.1089/154065802761001356; Ehlert FJ, 2008, N-S ARCH PHARMACOL, V377, P549, DOI 10.1007/s00210-008-0260-4; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Furchgott RF., 1966, ADV DRUG RES, V3, P21; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; GURWITZ D, 1994, EUR J PHARM-MOLEC PH, V267, P21, DOI 10.1016/0922-4106(94)90220-8; Hammer MM, 2007, FASEB J, V21, P3827, DOI 10.1096/fj.07-8777com; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Power CA, 2003, J IMMUNOL METHODS, V273, P73, DOI 10.1016/S0022-1759(02)00419-2; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Watts AO, 2012, BIOCHEM BIOPH RES CO, V419, P412, DOI 10.1016/j.bbrc.2012.02.036; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	35	90	90	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35039	35048		10.1074/jbc.M113.479113	http://dx.doi.org/10.1074/jbc.M113.479113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145037	Green Published, hybrid			2022-12-25	WOS:000329867600006
J	Belugin, S; Diogenes, AR; Patil, MJ; Ginsburg, E; Henry, MA; Akopian, AN				Belugin, Sergei; Diogenes, Anibal R.; Patil, Mayur J.; Ginsburg, Erika; Henry, Michael A.; Akopian, Armen N.			Mechanisms of Transient Signaling via Short and Long Prolactin Receptor Isoforms in Female and Male Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neuroendocrinology; Pain; PI3-kinase (PI3K); Prolactin; Protein Kinase C (PKC)	PROTEIN-KINASE-C; DELTA-OPIOID-RECEPTOR; MESSENGER-RNA; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY HYPERALGESIA; TRIGEMINAL NOCICEPTORS; FUNCTIONAL COMPETENCE; INHIBITORY-ACTION; TRP CHANNELS; SHORT-FORM	Background: Prolactin regulates the activity of nociceptors in pain conditions. Results: Prolactin regulation of sensory neurons is acute and mediated via PI3K and PKCE following activation of prolactin receptor short isoform. Prolactin receptor short isoform actions are inhibited by the long isoform. Conclusion: Prolactin receptor short isoform mediates transient sensitization of nociceptors. Significance: The proposed mechanism could underlie prolactin involvement in hyperalgesia/pain. Prolactin (PRL) regulates activity of nociceptors and causes hyperalgesia in pain conditions. PRL enhances nociceptive responses by rapidly modulating channels in nociceptors. The molecular mechanisms underlying PRL-induced transient signaling in neurons are not well understood. Here we use a variety of cell biology and pharmacological approaches to show that PRL transiently enhanced capsaicin-evoked responses involve protein kinase C E (PKCE) or phosphatidylinositol 3-kinase (PI3K) pathways in female rat trigeminal (TG) neurons. We next reconstituted PRL-induced signaling in a heterologous expression system and TG neurons from PRL receptor (PRLR)-null mutant mice by expressing rat PRLR-long isoform (PRLR-L), PRLR-short isoform (PRLR-S), or a mix of both. Results show that PRLR-S, but not PRLR-L, is capable of mediating PRL-induced transient enhancement of capsaicin responses in both male and female TG neurons. However, co-expression of PRLR-L with PRLR-S (1:1 ratio) leads to the inhibition of the transient PRL actions. Co-expression of PRLR-L deletion mutants with PRLR-S indicated that the cytoplasmic site adjacent to the trans-membrane domain of PRLR-L was responsible for inhibitory effects of PRLR-L. Furthermore, in situ hybridization and immunohistochemistry data indicate that in normal conditions, PRLR-L is expressed mainly in glia with little expression in rat sensory neurons (3-5%) and human nerves. The predominant PRLR form in TG neurons/nerves from rats and humans is PRLR-S. Altogether, PRL-induced transient signaling in sensory neurons is governed by PI3K or PKCE, mediated via the PRLR-S isoform, and transient effects mediated by PRLR-S are inhibited by presence of PRLR-L in these cells.	[Belugin, Sergei; Diogenes, Anibal R.; Henry, Michael A.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Patil, Mayur J.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Ginsburg, Erika] NCI, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	akopian@uthscsa.edu	Belugin, Sergei/L-5005-2013	Belugin, Sergei/0000-0001-9006-7732	National Institutes of Health [DE017696]; Intramural Research Program of the NCI/National Institutes of Health; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DE017696 (to A.N.A.) and by the Intramural Research Program of the NCI/National Institutes of Health (to E.G.).	Ahonen TJ, 2002, ENDOCRINOLOGY, V143, P228, DOI 10.1210/en.143.1.228; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; Bakowska JC, 2003, MOL BRAIN RES, V116, P50, DOI 10.1016/S0169-328X(03)00213-4; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; BRIDGES RS, 1990, P NATL ACAD SCI USA, V87, P8003, DOI 10.1073/pnas.87.20.8003; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brown RSE, 2012, ENDOCRINOLOGY, V153, P2375, DOI 10.1210/en.2011-2005; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Clevenger CV, 2001, LUPUS, V10, P706, DOI 10.1191/096120301717164949; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; DUDLEY CA, 1982, ENDOCRINOLOGY, V110, P677, DOI 10.1210/endo-110-2-677; FUKAZAWA H, 1994, FEBS LETT, V340, P155, DOI 10.1016/0014-5793(94)80127-4; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Ginsburg E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-678; Goffin V, 1996, CLIN ENDOCRINOL, V45, P247, DOI 10.1046/j.1365-2265.1996.00799.x; Gorski E, 1999, MOL UROL, V3, P17; Goupille O, 1997, MOL CELL ENDOCRINOL, V127, P155, DOI 10.1016/S0303-7207(97)04005-7; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Gutzman JH, 2004, MOL ENDOCRINOL, V18, P3064, DOI 10.1210/me.2004-0187; Henry MA, 2006, PAIN, V124, P222, DOI 10.1016/j.pain.2006.05.028; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; Kumar A, 1997, INT J IMMUNOPHARMACO, V19, P129, DOI 10.1016/S0192-0561(97)00022-2; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Lyons DJ, 2012, J NEUROSCI, V32, P8074, DOI 10.1523/JNEUROSCI.0129-12.2012; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mena F, 2013, NEUROSCIENCE, V248, P552, DOI 10.1016/j.neuroscience.2013.06.052; NOEL MB, 1993, PHYSIOL BEHAV, V54, P151, DOI 10.1016/0031-9384(93)90057-M; Ochoa-Amaya JE, 2011, NEUROIMMUNOMODULAT, V18, P245, DOI 10.1159/000323774; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Patil MJ, 2013, NEUROSCIENCE, V253, P132, DOI 10.1016/j.neuroscience.2013.08.035; Patil M. J., 2013, AM J PHYSL IN PRESS; Patil M, 2011, NEUROPHARMACOLOGY, V61, P778, DOI 10.1016/j.neuropharm.2011.05.024; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; Patwardhan AM, 2006, PAIN, V125, P114, DOI 10.1016/j.pain.2006.05.007; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; Pi XJ, 1999, J MOL ENDOCRINOL, V23, P13, DOI 10.1677/jme.0.0230013; Pi XJ, 2002, J NEUROSCI RES, V67, P551, DOI 10.1002/jnr.10147; Qazi AM, 2006, MOL ENDOCRINOL, V20, P1912, DOI 10.1210/me.2005-0291; REINER Z, 1987, ACTA OTO-LARYNGOL, V103, P665; Scotland PE, 2011, EUR J NEUROSCI, V34, P745, DOI 10.1111/j.1460-9568.2011.07788.x; Sobhia ME, 2013, EXPERT OPIN THER PAT, V23, P1297, DOI 10.1517/13543776.2013.805205; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Xie YL, 2009, MOL CELL BIOL, V29, P2546, DOI 10.1128/MCB.01716-08; Yardeni Israel Z, 2007, Int J Surg, V5, P239, DOI 10.1016/j.ijsu.2006.09.008; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	63	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34943	34955		10.1074/jbc.M113.486571	http://dx.doi.org/10.1074/jbc.M113.486571			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142695	hybrid, Green Published			2022-12-25	WOS:000329812800060
J	Liang, WX; Deutscher, MP				Liang, Wenxing; Deutscher, Murray P.			Ribosomes Regulate the Stability and Action of the Exoribonuclease RNase R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; Protein Stability; Ribonuclease; Ribosomes; RNA Metabolism	ESCHERICHIA-COLI; MESSENGER-RNA; STABLE RNA; NUCLEASE DOMAIN; STRUCTURED RNA; 10SA RNA; DEGRADATION; TMRNA; BACTERIA; STRESS	Background: Cells require mechanisms to regulate the potentially destructive action of RNases. Results: RNase R is largely bound to ribosomes in growing cells dependent on tmRNA-SmpB and nonstop mRNA. Conclusion: Ribosome binding stabilizes RNase R and sequesters it away from action on many functional RNAs. Significance: This work defines a previously unknown mechanism by which ribosomes regulate a deleterious enzyme. Ribonucleases play an important role in RNA metabolism. Yet, they are also potentially destructive enzymes whose activity must be controlled. Here we describe a novel regulatory mechanism affecting RNase R, a 3 to 5 exoribonuclease able to act on essentially all RNAs including those with extensive secondary structure. Most RNase R is sequestered on ribosomes in growing cells where it is stable and participates in trans-translation. In contrast, the free form of the enzyme, which is deleterious to cells, is extremely unstable, turning over with a half-life of 2 min. RNase R binding to ribosomes is dependent on transfer-messenger RNA (tmRNA)-SmpB, nonstop mRNA, and the modified form of ribosomal protein S12. Degradation of the free form of RNase R also requires tmRNA-SmpB, but this process is independent of ribosomes, indicating two distinct roles for tmRNA-SmpB. Inhibition of RNase R binding to ribosomes leads to slower growth and a massive increase in RNA degradation. These studies indicate a previously unknown role for ribosomes in cellular homeostasis.	[Liang, Wenxing; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA.	mdeutsch@med.miami.edu			National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; COHEN L, 1977, J BACTERIOL, V129, P651, DOI 10.1128/JB.129.2.651-657.1977; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Komine Y, 1996, J BIOCHEM-TOKYO, V119, P463; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Liang WX, 2006, ARCH VIROL, V151, P2311, DOI 10.1007/s00705-006-0780-5; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Strader MB, 2013, J PROTEOME RES, V12, P1289, DOI 10.1021/pr3009435; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Sundermeier TR, 2007, J BIOL CHEM, V282, P34779, DOI 10.1074/jbc.M707256200; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	36	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34791	34798		10.1074/jbc.M113.519553	http://dx.doi.org/10.1074/jbc.M113.519553			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133211	Green Published, hybrid			2022-12-25	WOS:000329812800047
J	Braff, WA; Willner, D; Hugenholtz, P; Rabaey, K; Buie, CR				Braff, William A.; Willner, Dana; Hugenholtz, Philip; Rabaey, Korneel; Buie, Cullen R.			Dielectrophoresis-Based Discrimination of Bacteria at the Strain Level Based on Their Surface Properties	PLOS ONE			English	Article							INSULATOR-BASED DIELECTROPHORESIS; MUCOID PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-MITIS; ANTIBIOTIC-RESISTANCE; BINDING; ADHESION; PROTEINS; DEVICES	Insulator-based dielectrophoresis can be used to manipulate biological particles, but has thus far found limited practical applications due to low sensitivity. We present linear sweep three-dimensional insulator-based dielectrophoresis as a considerably more sensitive approach for strain-level discrimination bacteria. In this work, linear sweep three-dimensional insulator-based dielectrophoresis was performed on Pseudomonas aeruginosa PA14 along with six isogenic mutants as well as Streptococcus mitis SF100 and PS344. Strain-level discrimination was achieved between these clinically important pathogens with applied electric fields below 10 V/mm. This low voltage, high sensitivity technique has potential applications in clinical diagnostics as well as microbial physiology research.	[Braff, William A.; Buie, Cullen R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Willner, Dana; Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Rabaey, Korneel] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Rabaey, Korneel] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium	Massachusetts Institute of Technology (MIT); University of Queensland; University of Queensland; Ghent University	Buie, CR (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	crb@mit.edu	Hugenholtz, Philip/AAD-9138-2019	Hugenholtz, Philip/0000-0001-5386-7925; Rabaey, Korneel/0000-0001-8738-7778	National Science Foundation [1150615]; MIT International Science and Technology Initiatives; European Research Council	National Science Foundation(National Science Foundation (NSF)); MIT International Science and Technology Initiatives; European Research Council(European Research Council (ERC)European Commission)	This work was partially supported by the National Science Foundation (Award #1150615), the MIT International Science and Technology Initiatives Seed Fund, and a Starter Grant from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail LI, 2007, ENVIRON SCI TECHNOL, V41, P8031, DOI 10.1021/es071047o; Alos JI, 2005, CLIN MICROBIOL INFEC, V11, P199, DOI 10.1111/j.1469-0691.2004.01057.x; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Braff WA, 2012, LAB CHIP, V12, P1327, DOI 10.1039/c2lc21212a; Brown L, 2006, LAB CHIP, V6, P66, DOI 10.1039/b512179e; Bruinsma GM, 2001, J MICROBIOL METH, V45, P95, DOI 10.1016/S0167-7012(01)00238-X; Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5; Cummings EB, 2003, ANAL CHEM, V75, P4724, DOI 10.1021/ac0340612; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; LAM J, 1980, INFECT IMMUN, V28, P546; Lapizco-Encinas BH, 2004, ELECTROPHORESIS, V25, P1695, DOI 10.1002/elps.200405899; Masuda T., 2011, 2011 IEEE 11th International Conference on Nanotechnology (IEEE-NANO), P241, DOI 10.1109/NANO.2011.6144622; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Persat A, 2007, CHIPS TIPS LAB CHIP, P1; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Samuelson P, 2002, J BIOTECHNOL, V96, P129, DOI 10.1016/S0168-1656(02)00043-3; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Srivastava SK, 2011, ANAL BIOANAL CHEM, V399, P301, DOI 10.1007/s00216-010-4222-6; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Zellner P, 2012, ELECTROPHORESIS, V33, P2498, DOI 10.1002/elps.201100661; Zhu K, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3435336	29	41	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76751	10.1371/journal.pone.0076751	http://dx.doi.org/10.1371/journal.pone.0076751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146923	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400087
J	Kolb, AW; Ane, C; Brandt, CR				Kolb, Aaron W.; Ane, Cecile; Brandt, Curtis R.			Using HSV-1 Genome Phylogenetics to Track Past Human Migrations	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SEQUENCE VARIABILITY; NATURAL-RESISTANCE; APOLIPOPROTEIN-E; MIXED INFECTION; NERVOUS-SYSTEM; TYPE-1; RECOMBINATION; STRAINS; GENETICS	We compared 31 complete and nearly complete globally derived HSV-1 genomic sequences using HSV-2 HG52 as an outgroup to investigate their phylogenetic relationships and look for evidence of recombination. The sequences were retrieved from NCBI and were then aligned using Clustal W. The generation of a maximum likelihood tree resulted in a six clade structure that corresponded with the timing and routes of past human migration. The East African derived viruses contained the greatest amount of genetic diversity and formed four of the six clades. The East Asian and European/North American derived viruses formed separate clades. HSV-1 strains E07, E22 and E03 were highly divergent and may each represent an individual clade. Possible recombination was analyzed by partitioning the alignment into 5 kb segments, performing individual phylogenetic analysis on each partition and generating a. phylogenetic network from the results. However most evidence for recombination spread at the base of the tree suggesting that recombination did not significantly disrupt the clade structure. Examination of previous estimates of HSV-1 mutation rates in conjunction with the phylogenetic data presented here, suggests that the substitution rate for HSV-1 is approximately 1.38x10(-7) subs/site/year. In conclusion, this study expands the previously described HSV-1 three clade phylogenetic structures to a minimum of six and shows that the clade structure also mirrors global human migrations. Given that HSV-1 has co-evolved with its host, sequencing HSV-1 isolated from various populations could serve as a surrogate biomarker to study human population structure and migration patterns.	[Kolb, Aaron W.; Brandt, Curtis R.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Ane, Cecile] Univ Wisconsin, Dept Bot, Madison, WI USA; [Ane, Cecile] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Brandt, Curtis R.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brandt, Curtis R.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Brandt, CR (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	crbrandt@wisc.edu		Ane, Cecile/0000-0002-4702-8217	NIH [R01EY07336, R01EY018597]; Core Grant for Vision Research [P30EY016665]; Research to Prevent Blindness, Inc. (RPB); RPB, Inc.; NATIONAL EYE INSTITUTE [R01EY018597, P30EY016665, R01EY023292, R01EY007336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; Research to Prevent Blindness, Inc. (RPB)(Research to Prevent Blindness (RPB)); RPB, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were supported by grants from the NIH (R01EY07336 and R01EY018597) to CRB, a Core Grant for Vision Research (P30EY016665), a Research to Prevent Blindness Senior Scientist Award to CRB from Research to Prevent Blindness, Inc. (RPB), and an unrestricted grant to the Department of Ophthalmology and Visual Sciences from RPB, Inc.	Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bhattacharjee PS, 2008, EXP EYE RES, V87, P122, DOI 10.1016/j.exer.2008.05.007; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; Brandt CR, 2005, EXP EYE RES, V80, P607, DOI 10.1016/j.exer.2004.09.007; Brandt CR, 2004, CURR EYE RES, V29, P103, DOI 10.1080/02713680490504533; BRANDT CR, 1991, J VIROL METHODS, V35, P127, DOI 10.1016/0166-0934(91)90128-M; BRANDT CR, 1990, INVEST OPHTH VIS SCI, V31, P2214; BROWN SM, 1992, J GEN VIROL, V73, P293, DOI 10.1099/0022-1317-73-2-293; Burgos JS, 2006, J VIROL, V80, P5383, DOI 10.1128/JVI.00006-06; CAMPADELLIFIUME G, 1990, J VIROL, V64, P6070, DOI 10.1128/JVI.64.12.6070-6079.1990; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; DOYMAZ MZ, 1992, CURR TOP MICROBIOL, V179, P121; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; KASTRUKOFF LF, 1986, J GEN VIROL, V67, P613, DOI 10.1099/0022-1317-67-4-613; KINTNER RL, 1995, ARCH VIROL, V140, P231, DOI 10.1007/BF01309859; KINTNER RL, 1995, CURR EYE RES, V14, P145, DOI 10.3109/02713689508999926; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P9061, DOI 10.1167/iovs.11-7812; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P4630, DOI 10.1167/iovs.10-7032; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; LOPEZ C, 1975, NATURE, V258, P152, DOI 10.1038/258152a0; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; Mador N, 2002, J NEUROVIROL, V8, P97, DOI 10.1080/13550280290167920; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; NISHIYAMA Y, 1991, J VIROL, V65, P4520, DOI 10.1128/JVI.65.8.4520-4524.1991; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Pavesi A, 2005, J GEN VIROL, V86, P1315, DOI 10.1099/vir.0.80650-0; Pavesi A, 2004, J MOL EVOL, V58, P304, DOI 10.1007/s00239-003-2552-0; Pollara G, 2004, CURR OPIN INFECT DIS, V17, P199, DOI 10.1097/00001432-200406000-00005; SAKAOKA H, 1994, J GEN VIROL, V75, P513, DOI 10.1099/0022-1317-75-3-513; SEDARATI F, 1988, J VIROL, V62, P3037, DOI 10.1128/JVI.62.8.3037-3039.1988; Shackelton LA, 2006, J VIROL, V80, P9928, DOI 10.1128/JVI.00441-06; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; STULTING RD, 1985, INVEST OPHTH VIS SCI, V26, P1360; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; UMENE K, 1985, J GEN VIROL, V66, P2659, DOI 10.1099/0022-1317-66-12-2659; Whitley RJ, 1996, FIELDS VIROLOGY, P2297; YIRRELL DL, 1992, ARCH VIROL, V125, P227, DOI 10.1007/BF01309640; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	64	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76267	10.1371/journal.pone.0076267	http://dx.doi.org/10.1371/journal.pone.0076267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146849	Green Published, gold			2022-12-25	WOS:000326019400049
J	Lozano, M; Subira, ME; Aparicio, J; Lorenzo, C; Gomez-Merino, G				Lozano, Marina; Eulalia Subira, Maria; Aparicio, Jose; Lorenzo, Carlos; Gomez-Merino, Gala			Toothpicking and Periodontal Disease in a Neanderthal Specimen from Cova Forada Site (Valencia, Spain)	PLOS ONE			English	Article							DENTAL-CARIES; TASK ACTIVITY; TEETH; WEAR; GROOVES; POPULATIONS; DENTITIONS; ATAPUERCA; INDIANS; SAMPLE	We present a Neanderthal maxilla (CF-1) from Cova Forada site (Oliva, Valencia, Spain) with periodontal disease and evidence of attempts to alleviate pain with the use of a toothpick. Two interproximal grooves have been found on the distal surfaces of the upper left Pm-3 and M-1 of CF-1 maxilla. The location, morphology and size of the grooves coincide with other interproximal grooves found on the teeth of other fossil specimens. Heavy dental wear and periodontal disease would have caused the Cova Forada Neanderthal specimen pain and discomfort, which the individual attempted to mitigate using some kind of dental probe.	[Lozano, Marina; Lorenzo, Carlos; Gomez-Merino, Gala] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Lozano, Marina; Lorenzo, Carlos; Gomez-Merino, Gala] Univ Rovira & Virgili URV Tarragona, Area Prehist, Tarragona, Spain; [Eulalia Subira, Maria] Univ Autonoma Barcelona, Fac Biociencies, Unitat Antropol Biol GRAPAC, E-08193 Barcelona, Spain; [Eulalia Subira, Maria] MINOA Arqueol & Serv SL I D, Bellaterra, Spain; [Aparicio, Jose] Diputac Prov Valencia, Seccio Estudis Arqueol Valencians, Valencia, Spain	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Autonomous University of Barcelona	Lozano, M (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain.	mlozano@iphes.cat	Lozano, Marina/G-7293-2015; Lorenzo, Carlos/E-4290-2015; Gomez-Merino, Gala/AAB-3189-2019	Lozano, Marina/0000-0002-6304-7848; Lorenzo, Carlos/0000-0001-5706-293X; Gomez Merino, Gala/0000-0002-3906-3856	Direccion General de Investigacion of M.E.C. [CGL2012-38434-C03-01, CGL2012-38434-C03-03]; Generalitat of Catalunya [AGAUR 2009 SGR-324, SGR-566]	Direccion General de Investigacion of M.E.C.(German Research Foundation (DFG)); Generalitat of Catalunya(Generalitat de Catalunya)	This work is funded by the Direccion General de Investigacion of M.E.C., projects number CGL2012-38434-C03-01 and CGL2012-38434-C03-03. This research has been supported by AGAUR 2009 SGR-324 and SGR-566 projects of the Generalitat of Catalunya. Field work at the Cova Forada site is supported by Diputacion de Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger WA, 2004, CURR ANTHROPOL, V45, P403, DOI 10.1086/420905; BERRYMAN HE, 1979, AM J PHYS ANTHROPOL, V50, P209, DOI 10.1002/ajpa.1330500209; Bonfiglioli B, 2004, INT J OSTEOARCHAEOL, V14, P448, DOI 10.1002/oa.726; Brothwell D.R., 1981, DIGGING BONES EXCAVA; BROWN T, 1990, AM J PHYS ANTHROPOL, V81, P545, DOI 10.1002/ajpa.1330810410; Campillo D, 2002, CYPSELA, V14, P143; Chimenos E., 2002, ANTROPOLOGIA PALEONT, P293; de Castro J M, 1986, Paleopathol Newsl, P5; de Lumley M.A., 1973, ANTENEANDERTALIENS N; DECASTRO JMB, 1983, ANTHROPOLOGIE, V87, P521; DeCastro JMB, 1997, AM J PHYS ANTHROPOL, V102, P369, DOI 10.1002/(SICI)1096-8644(199703)102:3<369::AID-AJPA6>3.0.CO;2-Q; DeWitte SN, 2010, AM J PHYS ANTHROPOL, V142, P341, DOI 10.1002/ajpa.21228; Eckhardt R.B., 1988, CURR ANTHR, V29, P668; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; FORMICOLA V, 1991, AM J PHYS ANTHROPOL, V86, P85, DOI 10.1002/ajpa.1330860108; FORMICOLA V, 1988, CURR ANTHROPOL, V29, P663, DOI 10.1086/203686; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; FRAYER DW, 1987, AM J PHYS ANTHROPOL, V74, P393, DOI 10.1002/ajpa.1330740311; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Hillson S, 2001, INT J OSTEOARCHAEOL, V11, P249; Hlusko LJ, 2003, CURR ANTHROPOL, V44, P738, DOI 10.1086/379263; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Langley MC, 2008, CAMB ARCHAEOL J, V18, P289, DOI 10.1017/S0959774308000371; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Molnar P, 2008, AM J PHYS ANTHROPOL, V136, P423, DOI 10.1002/ajpa.20824; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Perez P J, 1982, Paleopathol Newsl, V39, P11; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; ROSE JJ, 1983, AM J PHYS ANTHROPOL, V62, P255, DOI 10.1002/ajpa.1330620305; SCHULZ PD, 1977, AM J PHYS ANTHROPOL, V46, P87, DOI 10.1002/ajpa.1330460112; Siffre A, 1923, REV ANTHR, V33, P291; Skinner M, 1997, J ARCHAEOL SCI, V24, P677, DOI 10.1006/jasc.1996.0151; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Subira ME, NEANDERTHAL RE UNPUB; UBELAKER DH, 1969, AM J PHYS ANTHROPOL, V30, P145, DOI 10.1002/ajpa.1330300118; Ungar PS, 2001, ARCH ORAL BIOL, V46, P285, DOI 10.1016/S0003-9969(00)00128-X; Urbanowski M, 2010, NATURWISSENSCHAFTEN, V97, P411, DOI 10.1007/s00114-010-0646-2; Zero DT, 2009, J AM DENT ASSOC, V140, p25S, DOI 10.14219/jada.archive.2009.0355	39	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76852	10.1371/journal.pone.0076852	http://dx.doi.org/10.1371/journal.pone.0076852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146934	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400089
J	Oulton, LJ; Haviland, V; Brown, C				Oulton, Lois Jane; Haviland, Vivian; Brown, Culum			Predator Recognition in Rainbowfish, Melanotaenia duboulayi, Embryos	PLOS ONE			English	Article							ANTIPREDATOR RESPONSES; SALAMANDER EGGS; AVOIDANCE; EXPOSURE; SALMON; NAIVE; CUES	Exposure to olfactory cues during embryonic development can have long term impacts on birds and amphibians behaviour. Despite the vast literature on predator recognition and responses in fishes, few researchers have determined how fish embryos respond to predator cues. Here we exposed four-day-old rainbowfish (Melanotaenia duboulayi) embryos to cues emanating from a novel predator, a native predator and injured conspecifics. Their response was assessed by monitoring heart rate and hatch time. Results showed that embryos have an innate capacity to differentiate between cues as illustrated by faster heart rates relative to controls. The greatest increase in heart rate occurred in response to native predator odour. While we found no significant change in the time taken for eggs to hatch, all treatments experienced slight delays as expected if embryos are attempting to reduce exposure to larval predators.	[Oulton, Lois Jane; Haviland, Vivian; Brown, Culum] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Brown, C (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	Culum.Brown@mq.edu.au	Brown, Culum/S-9826-2017	Brown, Culum/0000-0002-0210-1820	Environmental Trust Grant from The New South Wales Department of Environment and Heritage	Environmental Trust Grant from The New South Wales Department of Environment and Heritage	This project was funded by an Environmental Trust Grant from The New South Wales Department of Environment and Heritage www.environment.nsw.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; BARRY MJ, 1995, AQUAT TOXICOL, V32, P115, DOI 10.1016/0166-445X(94)00084-4; Brown C, 1997, BEHAV ECOL SOCIOBIOL, V41, P61, DOI 10.1007/s002650050364; Brown C, 1999, ETHOLOGY, V105, P491, DOI 10.1046/j.1439-0310.1999.00442.x; Brown C, 2011, FISH COGNITION BEHAV, Vsecond, P240, DOI DOI 10.1002/9781444342536.CH11; Brown GE, 1997, BEHAVIOUR, V134, P1123, DOI 10.1163/156853997X00098; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Brown GE, 2009, BEHAV ECOL SOCIOBIOL, V63, P699, DOI 10.1007/s00265-008-0703-4; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Dittman AH, 1996, J EXP BIOL, V199, P83; Dupuch A, 2004, CAN J ZOOL, V82, P407, DOI 10.1139/Z04-003; Eriksen MS, 2006, J FISH BIOL, V69, P114, DOI 10.1111/j.1095-8649.2006.01071.x; Gibson AK, 2006, J FISH BIOL, V69, P224, DOI 10.1111/j.1095-8649.2006.01102.x; GROOT EP, 1985, CAN J ZOOL, V63, P552, DOI 10.1139/z85-082; Hawkins LA, 2004, BEHAVIOUR, V141, P1249, DOI 10.1163/1568539042729694; Kelley Jennifer L., 2011, P174; Kydd E, 2009, J FISH BIOL, V74, P2187, DOI 10.1111/j.1095-8649.2009.02240.x; Marking LL, 1973, INVESTIGATIVE FISH C; Mathis A, 2008, P ROY SOC B-BIOL SCI, V275, P2603, DOI 10.1098/rspb.2008.0754; Moore RD, 1996, OIKOS, V77, P331, DOI 10.2307/3546073; Scheurer JA, 2007, J FISH BIOL, V70, P1057, DOI 10.1111/j.1095-8649.2007.01367.x; SIH A, 1993, AM NAT, V142, P947, DOI 10.1086/285583; Sneddon H, 1998, PHYSIOL BEHAV, V64, P133, DOI 10.1016/S0031-9384(98)00037-7; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	24	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76061	10.1371/journal.pone.0076061	http://dx.doi.org/10.1371/journal.pone.0076061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146817	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400034
J	Tribelli, PM; Hay, AG; Lopez, NI				Tribelli, Paula M.; Hay, Anthony G.; Lopez, Nancy I.			The Global Anaerobic Regulator Anr, Is Involved in Cell Attachment and Aggregation Influencing the First Stages of Biofilm Development in Pseudomonas extremaustralis	PLOS ONE			English	Article							TWITCHING MOTILITY; GENE-EXPRESSION; AERUGINOSA; STRESS; POLY(3-HYDROXYBUTYRATE); RESPIRATION; INFECTIONS; SECRETION; FLAGELLAR; SYSTEM	Pseudomonas extremaustralis is a versatile Antarctic bacterium, able to grow under microaerobic and anaerobic conditions and is related to several non-pathogenic Pseudomonads. Here we report on the role of the global anaerobic regulator Anr, in the early steps of P. extremaustralis biofilm development. We found that the anr mutant was reduced in its ability to attach, to form aggregates and to display twitching motility but presented higher swimming motility than the wild type. In addition, microscopy revealed that the wild type biofilm contained more biomass and was thicker, but were less rough than that of the anr mutant. In silico analysis of the P. extremaustralis genome for Anr-like binding sites led to the identification of two biofilm-related genes as potential targets of this regulator. When measured using Quantitative Real Time PCR, we found that the anr mutant expressed lower levels of pilG, which encodes a component of Type IV pili and has been previously implicated in cellular adhesion. Levels of morA, involved in signal transduction and flagella development, were also lower in the mutant. Our data suggest that under low oxygen conditions, such as those encountered in biofilms, Anr differentially regulates aggregation and motility thus affecting the first stages of biofilm formation.	[Tribelli, Paula M.; Lopez, Nancy I.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina; [Tribelli, Paula M.; Lopez, Nancy I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dpto Quim Biol, Buenos Aires, DF, Argentina; [Hay, Anthony G.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Cornell University	Lopez, NI (corresponding author), Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar		Lopez, Nancy/0000-0002-2966-3014; Tribelli, Paula Maria/0000-0001-9558-6275; Hay, Anthony/0000-0002-9427-148X	University of Buenos Aires-UBACyT [20020100100854]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)-PIP [0338]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 0639]; CONICET; International Union of Biochemistry and Molecular Biology	University of Buenos Aires-UBACyT(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)-PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); International Union of Biochemistry and Molecular Biology	This work was supported by grants from University of Buenos Aires-UBACyT 2011-2014 Proyecto No 20020100100854, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)-PIP (2011) 0338, and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)-Programacion 2007, PICT 0639. N.I.L. is a career investigator from CONICET. P.M.T. received a post-graduate student fellowship from CONICET and a Wood-Wheland fellowship for short term research stays from the International Union of Biochemistry and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub ND, 2004, CURR MICROBIOL, V49, P170, DOI 10.1007/s00284-004-4254-2; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; HUISMAN GW, 1991, J BIOL CHEM, V266, P2191; Jackson AA, 2013, J BACTERIOL, V195, P3093, DOI 10.1128/JB.02169-12; Junker LM, 2006, MICROBIOL-SGM, V152, P2233, DOI 10.1099/mic.0.28767-0; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klebensberger J, 2009, ENVIRON MICROBIOL, V11, P3073, DOI 10.1111/j.1462-2920.2009.02012.x; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Newell PD, 2011, J BACTERIOL, V193, P4685, DOI 10.1128/JB.05483-11; O'Callaghan J, 2012, MICROBIOL-SGM, V158, P1057, DOI 10.1099/mic.0.056127-0; O'Callaghan J, 2011, MICROBIOL-SGM, V157, P3417, DOI 10.1099/mic.0.052050-0; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Romeo T, 2006, J BACTERIOL, V188, P7325, DOI 10.1128/JB.01317-06; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Thompson LS, 2003, FEMS MICROBIOL LETT, V220, P187, DOI 10.1016/S0378-1097(03)00097-1; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Tribelli PM, 2013, MICROBIOL-SGM, V159, P259, DOI 10.1099/mic.0.061085-0; Tribelli PM, 2012, BIODEGRADATION, V23, P645, DOI 10.1007/s10532-012-9540-2; Tribelli PM, 2012, J BACTERIOL, V194, P2381, DOI 10.1128/JB.00172-12; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; Tribelli PM, 2010, J MOL MICROB BIOTECH, V19, P180, DOI 10.1159/000320261; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Ugidos A, 2008, ENVIRON MICROBIOL, V10, P1690, DOI 10.1111/j.1462-2920.2008.01586.x; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	49	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76685	10.1371/journal.pone.0076685	http://dx.doi.org/10.1371/journal.pone.0076685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146909	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400081
J	Ulvskov, P; Paiva, DS; Domozych, D; Harholt, J				Ulvskov, Peter; Paiva, Dionisio Soares; Domozych, David; Harholt, Jesper			Classification, Naming and Evolutionary History of Glycosyltransferases from Sequenced Green and Red Algal Genomes	PLOS ONE			English	Article							SYNTHASE CESA GENES; CELL-WALL SYNTHESIS; HYDROXYPROLINE-ARABINOSIDES; CYANIDIOSCHYZON-MEROLAE; CARBOHYDRATE-METABOLISM; BIOINFORMATICS APPROACH; FLAGELLAR REGENERATION; GALDIERIA-SULPHURARIA; CELLULOSE SYNTHESIS; ANCHORED PROTEINS	The Archaeplastida consists of three lineages, Rhodophyta, Virideplantae and Glaucophyta. The extracellular matrix of most members of the Rhodophyta and Viridiplantae consists of carbohydrate-based or a highly glycosylated protein-based cell wall while the Glaucophyte covering is poorly resolved. In order to elucidate possible evolutionary links between the three advanced lineages in Archaeplastida, a genomic analysis was initiated. Fully sequenced genomes from the Rhodophyta and Virideplantae and the well-defined CAZy database on glycosyltransferases were included in the analysis. The number of glycosyltransferases found in the Rhodophyta and Chlorophyta are generally much lower then in land plants (Embryophyta). Three specific features exhibited by land plants increase the number of glycosyltransferases in their genomes: (1) cell wall biosynthesis, the more complex land plant cell walls require a larger number of glycosyltransferases for biosynthesis, (2) a richer set of protein glycosylation, and (3) glycosylation of secondary metabolites, demonstrated by a large proportion of family GT1 being involved in secondary metabolite biosynthesis. In a comparative analysis of polysaccharide biosynthesis amongst the taxa of this study, clear distinctions or similarities were observed in (1) N-linked protein glycosylation, i.e., Chlorophyta has different mannosylation and glucosylation patterns, (2) GPI anchor biosynthesis, which is apparently missing in the Rhodophyta and truncated in the Chlorophyta, (3) cell wall biosynthesis, where the land plants have unique cell wall related polymers not found in green and red algae, and (4) O-linked glycosylation where comprehensive orthology was observed in glycosylation between the Chlorophyta and land plants but not between the target proteins.	[Ulvskov, Peter; Paiva, Dionisio Soares; Harholt, Jesper] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Domozych, David] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Domozych, David] Skidmore Coll, Skidmore Microscopy Imaging Ctr, Saratoga Springs, NY 12866 USA	University of Copenhagen; Skidmore College; Skidmore College	Harholt, J (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark.	jesh@life.ku.dk	Harholt, Jesper/F-6865-2014; Ulvskov, Peter/I-1228-2014	Harholt, Jesper/0000-0002-7984-0066; Ulvskov, Peter/0000-0003-3776-818X	Villum-Kann Rasmussen grant; Danish Research Council [FTP-09-066624]; Villum Foundation; National Science Foundation (USA) [0919925]; Villum Fonden [00007173] Funding Source: researchfish	Villum-Kann Rasmussen grant; Danish Research Council(Det Frie Forskningsrad (DFF)); Villum Foundation(Villum Fonden); National Science Foundation (USA)(National Science Foundation (NSF)); Villum Fonden(Villum Fonden)	This work was supported by a Villum-Kann Rasmussen grant to the Pro-Active Plant Centre (www.proactiveplants.life.ku.dk), by the Danish Research Council (FTP-09-066624 to PU) and by the Villum Foundation's Young Investigator Programme to JH; National Science Foundation (USA) Molecular and Cell Biology Program grant 0919925 to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Bai M. S., 2000, Journal of Phycology, V36, P3; BAILEY RW, 1968, J GEN MICROBIOL, V54, P269, DOI 10.1099/00221287-54-2-269; Bakker H, 2001, FEBS LETT, V507, P307, DOI 10.1016/S0014-5793(01)02999-4; BALSHUSEMANN D, 1990, EUR J BIOCHEM, V192, P231, DOI 10.1111/j.1432-1033.1990.tb19220.x; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Campargue C, 1998, ANAL BIOCHEM, V257, P20, DOI 10.1006/abio.1997.2526; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Delwiche CF, 2011, CURR BIOL, V21, pR417, DOI 10.1016/j.cub.2011.04.021; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Doblin MS, 2001, PLANT PHYSIOL, V125, P2040, DOI 10.1104/pp.125.4.2040; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Domozych DS, 2009, ANN BOT-LONDON, V104, P1045, DOI 10.1093/aob/mcp193; Domozych DS, 2009, J EUKARYOT MICROBIOL, V56, P314, DOI 10.1111/j.1550-7408.2009.00392.x; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; Egelund J, 2010, ANN PLANT REV, P213; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Estevez JM, 2009, GLYCOBIOLOGY, V19, P212, DOI 10.1093/glycob/cwn101; Fernandez PV, 2010, J PHYCOL, V46, P456, DOI 10.1111/j.1529-8817.2010.00821.x; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; FRY SC, 1982, BIOCHEM J, V204, P449, DOI 10.1042/bj2040449; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Gillmor CS, 2005, PLANT CELL, V17, P1128, DOI 10.1105/tpc.105.031815; Godel S, 2000, PROTIST, V151, P147, DOI 10.1078/1434-4610-00015; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Hansen SF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00059; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; Harholt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035846; HELMCHEN TA, 1995, J MOL EVOL, V41, P203; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; HILLER RG, 1968, PLANTA, V78, P49; Hong ZL, 2001, PLANT CELL, V13, P769, DOI 10.1105/tpc.13.4.769; Izumi Y, 2003, PLANT CELL PHYSIOL, V44, P183, DOI 10.1093/pcp/pcg028; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; KLEIN U, 1987, PLANT PHYSIOL, V85, P892, DOI 10.1104/pp.85.4.892; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Leliaert F, 2011, BIOESSAYS, V33, P683, DOI 10.1002/bies.201100035; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Mackie W., 1974, ALGAL PHYSL BIOCH, V10, P40; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MCCONVILLE MJ, 1993, J BIOL CHEM, V268, P15595; MCFADDEN GI, 1985, PROTOPLASMA, V128, P31, DOI 10.1007/BF01273232; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MILLER DH, 1972, PLANT PHYSIOL, V49, P3; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; MULLER T, 1984, EUR J BIOCHEM, V138, P153, DOI 10.1111/j.1432-1033.1984.tb07894.x; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Nosjean O, 1997, BBA-REV BIOMEMBRANES, V1331, P153, DOI 10.1016/S0304-4157(97)00005-1; Oesterhelt C, 2008, PLANTA, V227, P353, DOI 10.1007/s00425-007-0622-z; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Orfila C, 2005, PLANTA, V222, P613, DOI 10.1007/s00425-005-0008-z; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Ostergaard L, 2002, PLANT MOL BIOL, V49, P559, DOI 10.1023/A:1015558231400; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Palmer JD, 2004, AM J BOT, V91, P1437, DOI 10.3732/ajb.91.10.1437; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Raven J. A., 1990, BIOL RED ALGAE, P171; REIZE IB, 1987, HELGOLANDER MEERESUN, V41, P149, DOI 10.1007/BF02364697; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roberts AW, 2004, ABSTR PAP AM CHEM S, V227, pU289; Roberts AW, 2002, EUKARYOT CELL, V1, P847, DOI 10.1128/EC.1.6.847-855.2002; Roberts E, 2009, J PHYCOL, V45, P203, DOI 10.1111/j.1529-8817.2008.00626.x; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Takano H, 2010, BBA-GEN SUBJECTS, V1800, P144, DOI 10.1016/j.bbagen.2009.07.020; Tounou Eiichirou, 2002, Cytologia (Tokyo), V67, P429, DOI 10.1508/cytologia.67.429; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Yoon HS, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-78; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x	121	25	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76511	10.1371/journal.pone.0076511	http://dx.doi.org/10.1371/journal.pone.0076511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146880	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400066
J	Zhou, C; Lei, H; Chen, YX; Liu, Q; Li, LC; Moorhead, JF; Varghese, Z; Ruan, XZ				Zhou, Chao; Lei, Han; Chen, Yaxi; Liu, Qing; Li, Lung-Chih; Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.			Enhanced SCAP Glycosylation by Inflammation Induces Macrophage Foam Cell Formation	PLOS ONE			English	Article							ACCELERATED ATHEROSCLEROSIS; CHOLESTEROL; MECHANISMS; RECEPTOR; INFECTION; PROLIFERATION; DYSREGULATION; EXPRESSION; RESISTANCE; SIROLIMUS	Inflammatory stress promotes foam cell formation by disrupting LDL receptor feedback regulation in macrophages. Sterol Regulatory Element Binding Proteins (SREBPs) Cleavage-Activating Protein (SCAP) glycosylation plays crucial roles in regulating LDL receptor and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCoAR) feedback regulation. The present study was to investigate if inflammatory stress disrupts LDL receptor and HMGCoAR feedback regulation by affecting SCAP glycosylation in THP-1 macrophages. Intracellular cholesterol content was assessed by Oil Red O staining and quantitative assay. The expression of molecules controlling cholesterol homeostasis was examined using real-time quantitative RT-PCR and Western blotting. The translocation of SCAP from the endoplasmic reticulum (ER) to the Golgi was detected by confocal microscopy. We demonstrated that exposure to inflammatory cytokines increased lipid accumulation in THP-1 macrophages, accompanying with an increased SCAP expression even in the presence of a high concentration of LDL. These inflammatory cytokines also prolonged the half-life of SCAP by enhancing glycosylation of SCAP due to the elevated expression of the Golgi mannosidase II. This may enhance translocation and recycling of SCAP between the ER and the Golgi, escorting more SREBP2 from the ER to the Golgi for activation by proteolytic cleavages as evidenced by an increased N-terminal of SREBP2 (active form). As a consequence, the LDL receptor and HMGCoAR expression were up-regulated. Interestingly, these effects could be blocked by inhibitors of Golgi mannosidases. Our results indicated that inflammation increased native LDL uptake and endogenous cholesterol de novo synthesis, thereby causing foam cell formation via increasing transcription and protein glycosylation of SCAP in macrophages. These data imply that inhibitors of Golgi processing enzymes might have a potential vascular-protective role in prevention of atherosclerotic foam cell formation.	[Zhou, Chao; Lei, Han; Chen, Yaxi; Ruan, Xiong Z.] Chongqing Med Univ, Ctr Lipid Res, Key Lab Metab Lipid & Glucose, Chongqing, Peoples R China; [Zhou, Chao; Lei, Han] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China; [Liu, Qing] Chongqing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Chongqing, Peoples R China; [Zhou, Chao; Li, Lung-Chih; Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.] UCL, Sch Med, Ctr Nephrol, John Moorhead Res Lab, London W1N 8AA, England; [Li, Lung-Chih] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Li, Lung-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of London; University College London; UCL Medical School; Chang Gung Memorial Hospital; Chang Gung University	Lei, H (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Key Lab Metab Lipid & Glucose, Chongqing, Peoples R China.	xiaoban@cqmu.edu.cn; x.ruan@ucl.ac.uk	Ruan, Xiong Zhong/GZA-5963-2022; Moorhead, John/M-7404-2014	Ruan, Xiong Zhong/0000-0001-5199-4971; 	Major State Basic Research Development Program of China (973 Program) [2012CB517700, 2012CB517500]; National Natural Science Foundation of China [81070631, 81070317, 81030008, 81270493, 81270789, 81200567]; Moorhead Trust; Royal Free Hospital Special Trustees Grant [115]; Kidney Research UK [RP37/2008]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Moorhead Trust; Royal Free Hospital Special Trustees Grant; Kidney Research UK(Kidney Research UK (KRUK))	This study was supported by Major State Basic Research Development Program of China (973 Program, NO. 2012CB517700 & 2012CB517500), the National Natural Science Foundation of China (81070631, 81070317, and Key Program, No. 81030008,81270493, 81270789, 81200567), the Moorhead Trust, the Royal Free Hospital Special Trustees Grant-115 through Dr. Zac Varghese, and Kidney Research UK (RP37/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NHLBI MORB MORT CHAR, DOI Bethesda, MD; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Cooke CL, 2009, GASTROENTEROLOGY, V137, P1061, DOI 10.1053/j.gastro.2009.04.014; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Li LC, 2013, AM J PHYSIOL-HEART C, V304, pH874, DOI 10.1152/ajpheart.00096.2012; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Linden S, 2010, HELICOBACTER, V15, P251, DOI 10.1111/j.1523-5378.2010.00765.x; Liuzzo G, 1999, J AM COLL CARDIOL, V34, P1696, DOI 10.1016/S0735-1097(99)00432-5; Ma KL, 2007, AM J PHYSIOL-HEART C, V292, pH2721, DOI 10.1152/ajpheart.01174.2006; Ma KL, 2010, AM J PHYSIOL-HEART C, V298, pH1646, DOI 10.1152/ajpheart.00492.2009; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruan XZ, 2006, ARTERIOSCL THROM VAS, V26, P1150, DOI 10.1161/01.ATV.0000217957.93135.c2; Ruan XZ, 2003, NEPHROL DIAL TRANSPL, V18, P27, DOI 10.1093/ndt/18.1.27; Ruan XZ, 2001, KIDNEY INT, V60, P1716, DOI 10.1046/j.1523-1755.2001.00025.x; Skaggs BJ, 2012, NAT REV RHEUMATOL, V8, P214, DOI 10.1038/nrrheum.2012.14; Swaminathan S, 2011, KIDNEY INT, V80, P453, DOI 10.1038/ki.2011.178; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Ye Q, 2009, INFLAMM RES, V58, P809, DOI 10.1007/s00011-009-0052-4; Yuan Y, 2011, AM J PHYSIOL-RENAL, V301, pF236, DOI 10.1152/ajprenal.00646.2010	34	16	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75650	10.1371/journal.pone.0075650	http://dx.doi.org/10.1371/journal.pone.0075650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146768	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400013
J	Deng, SF; Wang, M; Yan, ZC; Tian, Z; Chen, HR; Yang, XJ; Zhuo, YH				Deng, Shuifeng; Wang, Mei; Yan, Zhichao; Tian, Zhen; Chen, Hongrui; Yang, Xuejiao; Zhuo, Yehong			Autophagy in Retinal Ganglion Cells in a Rhesus Monkey Chronic Hypertensive Glaucoma Model	PLOS ONE			English	Article							NEURONAL AUTOPHAGY; CEREBRAL-ISCHEMIA; PRIMATE GLAUCOMA; MECHANISMS; BECLIN-1; DEATH; LC3; MACROAUTOPHAGY; DEGENERATION; ACTIVATION	Primary open angle glaucoma (POAG) is a neurodegenerative disease characterized by physiological intraocular hypertension that causes damage to the retinal ganglion cells (RGCs). In the past, RGC damage in POAG was suggested to have been attributed to RGC apoptosis. However, in the present study, we applied a model closer to human POAG through the use of a chronic hypertensive glaucoma model in rhesus monkeys to investigate whether another mode of progressive cell death, autophagy, was activated in the glaucomatous retinas. First, in the glaucomatous retinas, the levels of LC3B-II, LC3B-II/LC3B-I and Beclin 1 increased as demonstrated by Western blot analyses, whereas early or initial autophagic vacuoles (AVi) and late or degraded autophagic vacuoles (AVd) accumulated in the ganglion cell layer (GCL) and in the inner plexiform layer (IPL) as determined by transmission electron microscopy (TEM) analysis. Second, lysosome activity and autophagosome-lysosomal fusion increased in the RGCs of the glaucomatous retinas, as demonstrated by Western blotting against lysosome associated membrane protein-1 (LAMP1) and double labeling against LC3B and LAMP1. Third, apoptosis was activated in the glaucomatous eyes with increased levels of caspase-3 and cleaved caspase-3 and an increased number of TUNEL-positive RGCs. Our results suggested that autophagy was activated in RGCs in the chronic hypertensive glaucoma model of rhesus monkeys and that autophagy may have potential as a new target for intervention in glaucoma treatment.	[Deng, Shuifeng; Yan, Zhichao; Tian, Zhen; Chen, Hongrui; Yang, Xuejiao; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn	Yan, Zhichao/P-7671-2014; Yang, Xuejiao/GPG-4151-2022	Yan, Zhichao/0000-0003-1442-3015; Yang, Xuejiao/0000-0002-5347-1071	Key Project of the Natural Science Foundation of Guangdong Province [10251008901000028]; National Natural Science Foundation of China [81270992]; Natural Science Foundation of Guangdong Province [10451008901004759, s2011010006058]	Key Project of the Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Key Project of the Natural Science Foundation of Guangdong Province (No. 10251008901000028), the National Natural Science Foundation of China (No. 81270992)), and the Natural Science Foundation of Guangdong Province (Nos. 10451008901004759 and s2011010006058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Jindal V, 2013, MOL NEUROBIOL, V48, P186, DOI 10.1007/s12035-013-8416-8; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim SH, 2008, J NEUROSCI RES, V86, P2943, DOI 10.1002/jnr.21738; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lalezary M, 2006, AM J OPHTHALMOL, V142, P576, DOI 10.1016/j.ajo.2006.05.004; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; McLeland CB, 2011, METHODS MOL BIOL, V697, P199, DOI 10.1007/978-1-60327-198-1_21; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrison JC, 2011, EXP EYE RES, V93, P156, DOI 10.1016/j.exer.2010.08.005; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; PEDERSON JE, 1984, ARCH OPHTHALMOL-CHIC, V102, P1689, DOI 10.1001/archopht.1984.01040031373030; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rasmussen CA, 2005, J GLAUCOMA, V14, P311, DOI 10.1097/01.ijg.0000169409.01635.bc; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; You Y, 2013, REV NEUROSCIENCE, V24, P301, DOI 10.1515/revneuro-2013-0003; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602	48	61	64	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77100	10.1371/journal.pone.0077100	http://dx.doi.org/10.1371/journal.pone.0077100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143204	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100039
J	Gomez-Carballa, A; Pardo-Seco, J; Fachal, L; Vega, A; Cebey, M; Martinon-Torres, N; Martinon-Torres, F; Salas, A				Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Fachal, Laura; Vega, Ana; Cebey, Miriam; Martinon-Torres, Nazareth; Martinon-Torres, Federico; Salas, Antonio			Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; VLAX ROMA; GENETIC DIVERSITY; MTDNA VARIATION; POPULATIONS; HISTORY; ASSOCIATION; HAPLOGROUPS; ADMIXTURE; ANCESTRY	In agreement with historical documentation, several genetic studies have revealed ancestral links between the European Romani and India. The entire mitochondrial DNA (mtDNA) of 27 Spanish Romani was sequenced in order to shed further light on the origins of this population. The data were analyzed together with a large published dataset (mainly hypervariable region I [HVS-I] haplotypes) of Romani (N = 1,353) and non-Romani worldwide populations (N. 150,000). Analysis of mitogenomes allowed the characterization of various Romani-specific clades. M5a1b1a1 is the most distinctive European Romani haplogroup; it is present in all Romani groups at variable frequencies (with only sporadic findings in non-Romani) and represents 18% of their mtDNA pool. Its phylogeographic features indicate that M5a1b1a1 originated 1.5 thousand years ago (kya; 95% CI: 1.3-1.8) in a proto-Romani population living in Northwest India. U3 represents the most characteristic Romani haplogroup of European/Near Eastern origin (12.4%); it appears at dissimilar frequencies across the continent (Iberia: similar to 31%; Eastern/Central Europe:,13%). All U3 mitogenomes of our Iberian Romani sample fall within a new sub-clade, U3b1c, which can be dated to 0.5 kya (95% CI: 0.3-0.7); therefore, signaling a lower bound for the founder event that followed admixture in Europe/Near East. Other minor European/Near Eastern haplogroups (e.g. H24, H88a) were also assimilated into the Romani by introgression with neighboring populations during their diaspora into Europe; yet some show a differentiation from the phylogenetically closest non-Romani counterpart. The phylogeny of Romani mitogenomes shows clear signatures of low effective population sizes and founder effects. Overall, these results are in good agreement with historical documentation, suggesting that cultural identity and relative isolation have allowed the Romani to preserve a distinctive mtDNA heritage, with some features linking them unequivocally to their ancestral Indian homeland.	[Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Grp Med Xen GMX, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Fachal, Laura; Vega, Ana; Cebey, Miriam; Martinon-Torres, Nazareth; Martinon-Torres, Federico; Salas, Antonio] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Fachal, Laura; Vega, Ana; Cebey, Miriam; Martinon-Torres, Nazareth; Martinon-Torres, Federico; Salas, Antonio] Univ Santiago de Compostela USC, Galicia, Spain; [Fachal, Laura; Vega, Ana; Martinon-Torres, Federico] IDIS, Grp Med Xen USC, Fdn Publ Galega Med Xen SERGAS, Santiago De Compostela, Galicia, Spain; [Martinon-Torres, Nazareth] Hosp Clin Univ Santiago, Dept Pediat, Pediat Emergency & Crit Care Div, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain.	antonio.salas@usc.es	Vega, Ana/R-4758-2019; Martinon-Torres, Federico/E-4982-2016; Gómez-Carballa, Alberto/I-4610-2014; Pardo-Seco, Jacobo J/G-3752-2016; Salas, Antonio/U-2029-2019; Cebey, Miriam/K-9347-2014; Salas, Antonio/E-3977-2012; Fachal, Laura/N-5560-2014	Martinon-Torres, Federico/0000-0002-9023-581X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Salas, Antonio/0000-0002-2336-702X; Cebey, Miriam/0000-0003-0599-7519; Salas, Antonio/0000-0002-2336-702X; Fachal, Laura/0000-0002-7256-9752	Ministerio de Ciencia e Innovacion [SAF2008-02971]; Plan Galego IDT; Xunta de Galicia [EM 2012/045]; Conselleria de Sanidade/Xunta de Galicia; Instituto Carlos III; Fondo de Investigacion Sanitaria [FIS, PI070069, PI1000540]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Conselleria de Sanidade/Xunta de Galicia(Xunta de Galicia); Instituto Carlos III(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	The research leading to these results has received funding from the "Ministerio de Ciencia e Innovacion'' (SAF2008-02971) and from the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (A.S.) and Conselleria de Sanidade/Xunta de Galicia (RHI07/2- intensificacion actividad investigadora and 10PXIB918184PR), Instituto Carlos III (Intensificacio ' n de la actividad investigadora) and Fondo de Investigacion Sanitaria (FIS; PI070069 and PI1000540) del plan nacional de I+ D+ I and 'fondos FEDER' (F.M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt H-J, 2012, INT J LEGAL IN PRESS; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Chaix R, 2004, EUR J HUM GENET, V12, P285, DOI 10.1038/sj.ejhg.5201126; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Correa-Teiseira R, 2007, HIST CIGANOS BRASIL; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Deason ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-24; Dubut V, 2009, ANN HUM GENET, V73, P314, DOI 10.1111/j.1469-1809.2009.00519.x; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Fernandez O, 2008, TISSUE ANTIGENS, V71, P426, DOI 10.1111/j.1399-0039.2008.01016.x; Fraser, 1995, GYPSIES; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Iovita RP, 2004, AM ANTHROPOL, V106, P267, DOI 10.1525/aa.2004.106.2.267; Irwin J, 2007, INT J LEGAL MED, V121, P377, DOI 10.1007/s00414-006-0128-4; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lee WC, 2003, ANN HUM GENET, V67, P618, DOI 10.1046/j.1529-8817.2003.00063.x; Liegois JP, 2007, ROMS EUROPE EDITIONS; Malyarchuk BA, 2006, ANN HUM GENET, V70, P195, DOI 10.1111/j.1529-8817.2005.00222.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Klaric IM, 2009, AM J PHYS ANTHROPOL, V138, P333, DOI 10.1002/ajpa.20933; Mendizabal I, 2012, CURR BIOL, V22, P2342, DOI 10.1016/j.cub.2012.10.039; Mendizabal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015988; Moorjani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058633; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Non AL, 2011, AM J PHYS ANTHROPOL, V144, P1, DOI 10.1002/ajpa.21360; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Rai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048477; Regueiro M, 2012, GENE, V504, P296, DOI 10.1016/j.gene.2012.04.093; Repiska V, 2010, MOL BIOL+, V44, P870, DOI 10.1134/S0026893310060038; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Salihovic MP, 2011, AM J PHYS ANTHROPOL, V146, P262, DOI 10.1002/ajpa.21566; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stefflova K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007842; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Thomas-Sinclair A, 1917, AM GYPSIES; Trovoada MJ, 2004, ANN HUM GENET, V68, P40, DOI 10.1046/j.1529-8817.2003.00070.x; Turner RL, 1984, POSITION ROMANI INDO; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023	55	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75397	10.1371/journal.pone.0075397	http://dx.doi.org/10.1371/journal.pone.0075397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143169	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100004
J	Mu, DL; Li, LH; Wang, DX; Li, N; Shan, GJ; Li, J; Yu, QJ; Shi, CX				Mu, Dong-Liang; Li, Li-Huan; Wang, Dong-Xin; Li, Nan; Shan, Guo-Jin; Li, Jun; Yu, Qin-Jun; Shi, Chun-Xia			High Postoperative Serum Cortisol Level Is Associated with Increased Risk of Cognitive Dysfunction Early after Coronary Artery Bypass Graft Surgery: A Prospective Cohort Study	PLOS ONE			English	Article							CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; IMPAIRMENT; STRESS; ANESTHESIA; IMPACT; BRAIN; MEN	Context: Stress response induced by surgery is proposed to play an important role in the pathogenesis of postoperative cognitive dysfunction. Objective: To investigate the association between postoperative serum cortisol level and occurrence of cognitive dysfunction early after coronary artery bypass graft surgery. Design: Prospective cohort study. Setting: Two teaching hospitals. Patients: One hundred and sixth-six adult patients who were referred to elective coronary artery bypass graft surgery from March 2008 to December 2009. Intervention: None. Main Outcome Measures: Neuropsychological tests were completed one day before and seven days after surgery. Cognitive dysfunction was defined using the same definition as used in the ISPOCD1-study. Blood samples were obtained in the first postoperative morning for measurement of serum cortisol concentration. Multivariate Logistic regression analyses were performed to assess the relationship between serum cortisol level and occurrence of postoperative cognitive dysfunction. Results: Cognitive dysfunction occurred in 39.8% (66 of 166) of patients seven days after surgery. Multivariate Logistic regression analysis showed that high serum cortisol level was significantly associated with the occurrence of postoperative cognitive dysfunction (odds ratio [OR] 2.603, 95% confidence interval [CI] 1.371-4.944, P = 0.003). Other independent predictors of early postoperative cognitive dysfunction included high preoperative New York Heart Association functional class (OR 0.402, 95% CI 0.207-0.782, P = 0.007), poor preoperative Grooved Pegboard test score of nondominant hand (OR 1.022, 95% CI 1.003-1.040, P = 0.020), use of penehyclidine as premedication (OR 2.565, 95% CI 1.109-5.933, P = 0.028), and occurrence of complications within seven days after surgery (OR 2.677, 95% CI 1.201-5.963, P = 0.016). Conclusions: High serum cortisol level in the first postoperative morning was associated with increased risk of cognitive dysfunction seven days after coronary artery bypass graft surgery.	[Mu, Dong-Liang; Wang, Dong-Xin; Li, Nan; Shan, Guo-Jin; Li, Jun] Peking Univ, Hosp 1, Dept Anesthesiol & Surg Intens Care, Beijing 100871, Peoples R China; [Li, Li-Huan; Yu, Qin-Jun; Shi, Chun-Xia] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Anesthesiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Li-Huan; Yu, Qin-Jun; Shi, Chun-Xia] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, DX (corresponding author), Peking Univ, Hosp 1, Dept Anesthesiol & Surg Intens Care, Beijing 100871, Peoples R China.	wangdongxin@vip.sina.com			Peking University First Hospital, Beijing, China	Peking University First Hospital, Beijing, China	This study was supported by a fund for scientific research from Peking University First Hospital, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Belanoff JK, 2001, J PSYCHIATR RES, V35, P127, DOI 10.1016/S0022-3956(01)00018-8; BORNSTEIN RA, 1995, ACTA NEUROL SCAND, V91, P260, DOI 10.1111/j.1600-0404.1995.tb07001.x; Bottiggi KA, 2006, AM J GERIAT PSYCHIAT, V14, P980, DOI 10.1097/01.JGP.0000224619.87681.71; Canet J, 2003, ACTA ANAESTH SCAND, V47, P1204, DOI 10.1046/j.1399-6576.2003.00238.x; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Ferrari E, 2001, EUR J ENDOCRINOL, V144, P319, DOI 10.1530/eje.0.1440319; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Ghoneim MM, 2012, EUR J ANAESTH, V29, P409, DOI 10.1097/EJA.0b013e328356bd6e; Grigore AM, 2009, ANESTH ANALG, V109, P1741, DOI 10.1213/ANE.0b013e3181c04fea; Hamad MAS, 2007, ACTA ANAESTH BELG, V58, P37; Hamad MAS, 2008, ANN THORAC SURG, V85, P488, DOI 10.1016/j.athoracsur.2007.09.010; Han XY, 2005, BIOORG MED CHEM LETT, V15, P1979, DOI 10.1016/j.bmcl.2005.02.071; Hartholt KA, 2012, Z GERONTOL GERIATR, V45, P411, DOI 10.1007/s00391-012-0326-2; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Hoda MR, 2006, ANN THORAC SURG, V82, P2179, DOI 10.1016/j.athoracsur.2006.06.087; Hogue CW, 2006, ANESTH ANALG, V102, P1602, DOI 10.1213/01.ANE.0000219591.10826.17; Hoth KF, 2008, COGN BEHAV NEUROL, V21, P65, DOI 10.1097/WNN.0b013e3181799dc8; Hudetz JA, 2012, EUR J ANAESTH, V29, P320, DOI 10.1097/EJA.0b013e328354223d; Hwang HY, 2012, ANN THORAC SURG, V94, P1157, DOI 10.1016/j.athoracsur.2012.04.118; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; JI MH, 2013, J ANESTH, DOI DOI 10.1007/S00540-013-1633-5.PUBMED:23666452; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Liu YH, 2009, ANESTH ANALG, V109, P1013, DOI 10.1213/ane.0b013e3181aed2bb; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Mu Dong-liang, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P242; Mu DL, 2010, CRIT CARE, V14, DOI 10.1186/cc9393; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; Rasmussen LS, 1998, EUR J ANAESTH, V15, P761, DOI 10.1097/00003643-199811000-00026; Rasmussen LS, 2005, ACTA ANAESTH SCAND, V49, P1225, DOI 10.1111/j.1399-6576.2005.00791.x; RothIsigkeit AK, 1997, STEROIDS, V62, P695, DOI 10.1016/S0039-128X(97)00069-X; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Siepe M, 2011, EUR J CARDIO-THORAC, V40, P200, DOI 10.1016/j.ejcts.2010.11.024; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P431, DOI 10.1097/00000542-200703000-00006; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Song SW, 2008, CIRC J, V72, P1966, DOI 10.1253/circj.CJ-08-0291; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354; YAN M, 2006, LIN CHUANG MA ZUI XU, V22, P827	50	26	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77637	10.1371/journal.pone.0077637	http://dx.doi.org/10.1371/journal.pone.0077637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143249	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100087
J	Zamzow, JP; Siebeck, UE; Eckes, MJ; Grutter, AS				Zamzow, Jill P.; Siebeck, Ulrike E.; Eckes, Maxi J.; Grutter, Alexandra S.			Ultraviolet-B Wavelengths Regulate Changes in UV Absorption of Cleaner Fish Labroides dimidiatus Mucus	PLOS ONE			English	Article							AMINO-ACIDS MAAS; GREAT-BARRIER-REEF; INDUCED DNA-DAMAGE; ABSORBING COMPOUNDS; EPIDERMAL MUCUS; SEA-URCHIN; SOLAR-RADIATION; DIET; PROTECTION; ABSORBENCY	High-energy wavelengths in the ultraviolet-B (UVB, 280-315 nm) and the UVA (315-400-nm) portion of the spectrum are harmful to terrestrial and aquatic organisms. Interestingly, UVA is also involved in the repair of UV induced damage. Organisms living in shallow coral reef environments possess UV absorbing compounds, such as mycosporine-like amino acids, to protect them from UV radiation. While it has been demonstrated that exposure to UV (280-400 nm) affects the UV absorbance of fish mucus, whether the effects of UV exposure vary between UVB and UVA wavelengths is not known. Therefore, we investigated whether the UVB, UVA, or photosynthetically active radiation (PAR, 400-700 nm) portions of the spectrum affected the UV absorbance of epithelial mucus and Fulton's body condition index of the cleaner fish Labroides dimidiatus. We also compared field-measured UV absorbance with laboratory based high-performance liquid chromatography measurements of mycosporine-like amino acid concentrations. After 1 week, we found that the UV absorbance of epithelial mucus was higher in the UVB+UVA+PAR treatment compared with the UVA+PAR and PAR only treatments; after 2 and 3 weeks, however, differences between treatments were not detected. After 3 weeks, Fulton's body condition index was lower for fish in the UVB+UVA+PAR compared with PAR and UVA+PAR treatments; furthermore, all experimentally treated fish had a lower Fulton's body condition index than did freshly caught fish. Finally, we found a decrease with depth in the UV absorbance of mucus of wild-caught fish. This study suggests that the increase in UV absorbance of fish mucus in response to increased overall UV levels is a function of the UVB portion of the spectrum. This has important implications for the ability of cleaner fish and other fishes to adjust their mucus UV protection in response to variations in environmental UV exposure.	[Zamzow, Jill P.; Eckes, Maxi J.; Grutter, Alexandra S.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Siebeck, Ulrike E.; Eckes, Maxi J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Siebeck, UE (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	u.siebeck@uq.edu.au	Grutter, Alexandra S/J-2737-2013; Siebeck, Ulrike E/J-6190-2014	Grutter, Alexandra S/0000-0003-1688-2821; Siebeck, Ulrike E/0000-0003-2024-1568	American Australian Association; University of Queensland Foundation	American Australian Association; University of Queensland Foundation(University of Queensland)	This work was supported by the American Australian Association, The University of Queensland Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED FE, 1993, CANCER RES, V53, P2249; Arbeloa EM, 2010, FOOD CHEM, V119, P586, DOI 10.1016/j.foodchem.2009.06.061; BAKER KS, 1982, LIMNOL OCEANOGR, V27, P500, DOI 10.4319/lo.1982.27.3.0500; Banaszak AT, 2009, PHOTOCH PHOTOBIO SCI, V8, P1276, DOI 10.1039/b902763g; Banaszak AT, 1998, B MAR SCI, V63, P617; Bandaranayake WM, 1999, MAR BIOL, V133, P163, DOI 10.1007/s002270050455; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Carefoot TH, 1998, MAR BIOL, V130, P389, DOI 10.1007/s002270050259; Carreto JI, 2011, MAR DRUGS, V9, P387, DOI 10.3390/md9030387; Carroll AK, 1996, MAR BIOL, V124, P561, DOI 10.1007/BF00351037; CHIOCCARA F, 1980, B SOC CHIM BELG, V89, P1101; Chong K, 2005, AQUACULTURE, V249, P469, DOI 10.1016/j.aquaculture.2005.02.045; Dong Q, 2007, J PHOTOCH PHOTOBIO B, V88, P137, DOI 10.1016/j.jphotobiol.2007.07.002; DUNLAP WC, 1989, COMP BIOCHEM PHYS B, V93, P601, DOI 10.1016/0305-0491(89)90383-0; DUNLAP WC, 1986, J EXP MAR BIOL ECOL, V104, P239, DOI 10.1016/0022-0981(86)90108-5; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Dunlap WC, 2000, FREE RADICALS CHEM B, P200; Ebran N, 1999, COMP BIOCHEM PHYS A, V122, P181, DOI 10.1016/S1095-6433(98)10165-4; Eckes MJ, 2008, MAR ECOL PROG SER, V353, P203, DOI 10.3354/meps07210; Eckes MJ, 2009, THESIS U QUEENSLAND; Frank TM, 1996, MAR FRESHW BEHAV PHY, V27, P189, DOI 10.1080/10236249609378964; FREDERICK JE, 1989, PHOTOCHEM PHOTOBIOL, V50, P443, DOI 10.1111/j.1751-1097.1989.tb05548.x; Fulton CJ, 2001, MAR BIOL, V139, P25; Gravem SA, 2012, MAR BIOL, V159, P2839, DOI 10.1007/s00227-012-2045-z; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2004, ANIM BEHAV, V68, P583, DOI 10.1016/j.anbehav.2003.11.014; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Jeffrey SW, 1999, MAR ECOL PROG SER, V189, P35, DOI 10.3354/meps189035; Jerlov N. G., 1976, MARINE OPTICS; KARENTZ D, 1991, MAR BIOL, V108, P157, DOI 10.1007/BF01313484; Karentz D, 1997, MAR BIOL, V129, P343, DOI 10.1007/s002270050174; Karsten U, 1998, BOT MAR, V41, P443, DOI 10.1515/botm.1998.41.1-6.443; KLIGMAN LH, 1985, J INVEST DERMATOL, V84, P272, DOI 10.1111/1523-1747.ep12265353; Krabs G, 2004, PHOTOCHEM PHOTOBIOL, V79, P515, DOI 10.1562/2003-12-14-RA.1; Kuwamura T, 2002, ETHOLOGY, V108, P443, DOI 10.1046/j.1439-0310.2002.00791.x; Lesser MP, 2001, J EXP BIOL, V204, P157; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; Markkula SE, 2006, FISH SHELLFISH IMMUN, V21, P70, DOI 10.1016/j.fsi.2005.10.007; Masiri I, 2008, INT J REMOTE SENS, V29, P4443, DOI 10.1080/01431160801930255; Mason DS, 1998, COMP BIOCHEM PHYS A, V120, P587, DOI 10.1016/S1095-6433(98)10069-7; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Oyamada C, 2008, MAR BIOTECHNOL, V10, P141, DOI 10.1007/s10126-007-9043-z; PLACK PA, 1981, BIOCHEM J, V199, P741, DOI 10.1042/bj1990741; Portwich A, 2000, PHOTOCHEM PHOTOBIOL, V71, P493, DOI 10.1562/0031-8655(2000)071<0493:ANPUPI>2.0.CO;2; RICKER W E, 1975, P382; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; Salo HM, 2000, J PHOTOCH PHOTOBIO B, V56, P154, DOI 10.1016/S1011-1344(00)00072-5; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; SHICK JM, 1992, MAR ECOL PROG SER, V90, P139, DOI 10.3354/meps090139; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Siebeck UE, 2001, VISION RES, V41, P133, DOI 10.1016/S0042-6989(00)00240-6; Subramanian S, 2008, COMP BIOCHEM PHYS B, V150, P85, DOI 10.1016/j.cbpb.2008.01.011; Sweet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041989; WESSLER E, 1957, ACTA CHEM SCAND, V11, P1240, DOI 10.3891/acta.chem.scand.11-1240; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Zamzow JP, 2006, J FISH BIOL, V69, P1583, DOI 10.1111/j.1095-8649.2006.01219.x; Zamzow JP, 2008, AM SCI, V96, P482, DOI 10.1511/2008.75.482; Zamzow JP, 2007, MAR ECOL PROG SER, V343, P263, DOI 10.3354/meps06890; Zamzow JP, 2002, ENVIRON BIOL FISH, V63, P41, DOI 10.1023/A:1013846816869; Zamzow JP, 2004, MAR BIOL, V144, P1057, DOI 10.1007/s00227-003-1286-2; Zamzow JP, 2003, MAR ECOL PROG SER, V263, P169, DOI 10.3354/meps263169	64	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78527	10.1371/journal.pone.0078527	http://dx.doi.org/10.1371/journal.pone.0078527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143264	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100103
J	Zhang, WQ; Shan, BQ; Zhang, H; Tang, WZ				Zhang, Wenqiang; Shan, Baoqing; Zhang, Hong; Tang, Wenzhong			Assessment of Preparation Methods for Organic Phosphorus Analysis in Phosphorus-Polluted Fe/Al-Rich Haihe River Sediments Using Solution P-31-NMR	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NAOH-EDTA EXTRACTION; NMR-SPECTROSCOPY; LAKE-SEDIMENTS; SOIL-PHOSPHORUS; NEW-ZEALAND; CHINA; TRANSFORMATIONS; BIOAVAILABILITY; IDENTIFICATION	Fe/Al-rich river sediments that were highly polluted with phosphorus (P) were used in tests to determine the optimum preparation techniques for measuring organic P (Po) using solution P-31 nuclear magnetic resonance spectroscopy (P-31-NMR). The optimum pre-treatment, extraction time, sediment to solution ratio and sodium hydroxide-ethylenediamine-tetraacetic acid (NaOH-EDTA) extractant solution composition were determined. The total P and Po recovery rates were higher from freeze-and air-dried samples than from fresh samples. An extraction time of 16 h was adequate for extracting Po, and a shorter or longer extraction time led to lower recoveries of total P and Po, or led to the degradation of Po. An ideal P recovery rate and good-quality NMR spectra were obtained at a sediment: solution ratio of 1: 10, showing that this ratio is ideal for extracting Po. An extractant solution of 0.25 M NaOH and 50 mM EDTA was found to be more appropriate than either NaOH on its own, or a more concentrated NaOH-EDTA mixture for P-31-NMR analysis, as this combination minimized interference from paramagnetic ions and was appropriate for the detected range of Po concentrations. The most appropriate preparation method for Po analysis, therefore, was to extract the freeze-dried and ground sediment sample with a 0.25 M NaOH and 50 mM EDTA solution at a sediment: solution ratio of 1:10, for 16 h, by shaking. As lyophilization of the NaOH-EDTA extracts proved to be an optimal pre-concentration method for Po analysis in the river sediment, the extract was lyophilized as soon as possible, and analyzed by P-31-NMR.	[Zhang, Wenqiang; Shan, Baoqing; Zhang, Hong; Tang, Wenzhong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing, Peoples R China; [Zhang, Wenqiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shan, BQ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, POB 934, Beijing, Peoples R China.	bqshan@rcees.ac.cn	Tang, Wenzhong/AAM-6971-2020	Tang, Wenzhong/0000-0001-8347-8592	National Natural Science Foundation of China [20907067, 21107126]; National Water Pollution Control and Management Technology Major Projects of China [2012ZX07203-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Pollution Control and Management Technology Major Projects of China	This work was supported by the National Natural Science Foundation of China (Grant No. 20907067 and 21107126; http://www.nsfc.gov.cn/Portal0/default152.htm) and the National Water Pollution Control and Management Technology Major Projects of China (2012ZX07203-006; http://nwpcp.mep.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren J, 2006, LIMNOL OCEANOGR, V51, P2341, DOI 10.4319/lo.2006.51.5.2341; ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; Bjorkman KM, 2003, LIMNOL OCEANOGR, V48, P1049; BOWMAN RA, 1993, SOIL SCI SOC AM J, V57, P1516, DOI 10.2136/sssaj1993.03615995005700060020x; Cade-Menun BJ, 2006, ENVIRON SCI TECHNOL, V40, P7874, DOI 10.1021/es061843e; Cade-Menun BJ, 2005, TALANTA, V66, P359, DOI 10.1016/j.talanta.2004.12.024; Cade-Menun BJ, 1996, SOIL SCI, V161, P770, DOI 10.1097/00010694-199611000-00006; Cade-Menun BJ, 2005, MAR CHEM, V97, P293, DOI 10.1016/j.marchem.2005.05.005; Cheesman AW, 2010, ENVIRON SCI TECHNOL, V44, P9265, DOI 10.1021/es102460h; Condron LM, 1996, BIOL FERT SOILS, V21, P37, DOI 10.1007/BF00335991; Ding SM, 2010, J ENVIRON QUAL, V39, P1668, DOI 10.2134/jeq2009.0396; Dong LM, 2012, ENVIRON MONIT ASSESS, V184, P5829, DOI 10.1007/s10661-012-2550-z; EMSLEY J, 1983, PHOSPHORUS SULFUR, V16, P303, DOI 10.1080/03086648308080484; Gressel N, 1996, BIOGEOCHEMISTRY, V33, P97, DOI 10.1007/BF02181034; Hill JE, 2009, J ENVIRON QUAL, V38, P130, DOI 10.2134/jeq2007.0587; Hupfer M, 2004, LIMNOL OCEANOGR, V49, P1, DOI 10.4319/lo.2004.49.1.0001; HUPFER M, 1995, LIMNOL OCEANOGR, V40, P610, DOI 10.4319/lo.1995.40.3.0610; JENSEN HS, 1992, HYDROBIOLOGIA, V235, P731, DOI 10.1007/BF00026261; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P8784, DOI 10.1021/es050916b; Liu JY, 2009, ENVIRON POLLUT, V157, P49, DOI 10.1016/j.envpol.2008.07.031; Makarov MI, 2002, BIOL FERT SOILS, V35, P136, DOI 10.1007/s00374-002-0454-8; McDowell RW, 2009, MAR FRESHWATER RES, V60, P619, DOI 10.1071/MF08047; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]; NEWMAN RH, 1980, COMMUN SOIL SCI PLAN, V11, P835, DOI 10.1080/00103628009367083; Pant HK, 1999, COMMUN SOIL SCI PLAN, V30, P757, DOI 10.1080/00103629909370244; Pernet-Coudrier B, 2012, ENVIRON SCI TECHNOL, V46, P5294, DOI 10.1021/es3004415; Qu HJ, 2010, SCI TOTAL ENVIRON, V408, P2075, DOI 10.1016/j.scitotenv.2009.12.015; Reitzel K, 2007, BIOGEOCHEMISTRY, V82, P15, DOI 10.1007/s10533-006-9049-z; Reitzel K, 2006, CAN J FISH AQUAT SCI, V63, P1686, DOI 10.1139/F06-070; Sumann M, 1998, SOIL SCI SOC AM J, V62, P1580, DOI 10.2136/sssaj1998.03615995006200060015x; Sundareshwar PV, 2001, LIMNOL OCEANOGR, V46, P1570, DOI 10.4319/lo.2001.46.6.1570; Turner BL, 2008, EUR J SOIL SCI, V59, P453, DOI 10.1111/j.1365-2389.2007.00994.x; Turner BL, 2007, ECOSYSTEMS, V10, P1166, DOI 10.1007/s10021-007-9086-z; Turner BL, 2006, ENVIRON SCI TECHNOL, V40, P727, DOI 10.1021/es0516256; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Turner BL, 2003, SOIL SCI SOC AM J, V67, P1168, DOI 10.2136/sssaj2003.1168; Turner BL, 2003, ORG GEOCHEM, V34, P1199, DOI 10.1016/S0146-6380(03)00061-5; Wang JY, 2010, ENVIRON MONIT ASSESS, V171, P309, DOI 10.1007/s10661-009-1280-3; Wang SR, 2007, CHIN AGR SCI B, V23, P355; Xu D, 2012, J SOIL SEDIMENT, V12, P909, DOI 10.1007/s11368-012-0510-4; Zhang RY, 2009, J ENVIRON QUAL, V38, P353, DOI 10.2134/jeq2007.0616; [周毅 Zhou Yi], 2002, [海洋环境科学, Marine environmental science], V21, P60	44	18	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76525	10.1371/journal.pone.0076525	http://dx.doi.org/10.1371/journal.pone.0076525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143192	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100027
J	Fieni, F; Stone, M; Ma, ZM; Dutra, J; Fritts, L; Miller, CJ				Fieni, Francis; Stone, Mars; Ma, Zhong-Min; Dutra, Joseph; Fritts, Linda; Miller, Christopher J.			Viral RNA Levels and env Variants in Semen and Tissues of Mature Male Rhesus Macaques Infected with SIV by Penile Inoculation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MALE GENITAL-TRACT; INTRAVAGINAL INOCULATION; SEXUAL TRANSMISSION; HIV-INFECTION; COMPARTMENTALIZATION; BLOOD; POPULATIONS; SEQUENCES; ALIGNMENT	HIV is shed in semen but the anatomic site of virus entry into the genital secretions is unknown. We determined viral RNA (vRNA) levels and the envelope gene sequence in the SIVmac 251 viral populations in the genital tract and semen of 5 adult male rhesus monkeys (Macaca mulatta) that were infected after experimental penile SIV infection. Paired blood and semen samples were collected from 1-9 weeks after infection and the monkeys were necropsied eleven weeks after infection. The axillary lymph nodes, testes, epididymis, prostate, and seminal vesicles were collected and vRNA levels and single-genome analysis of the SIVmac251 env variants was performed. At the time of semen collection, blood vRNA levels were between 3.09 and 7.85 log10 vRNA copies/ml plasma. SIV RNA was found in the axillary lymph nodes of all five monkeys and in 3 of 5 monkeys, all tissues examined were vRNA positive. In these 3 monkeys, vRNA levels (log10 SIVgag copies/ug of total tissue RNA) in the axillary lymph node (6.48 +/- 0.50) were significantly higher than in the genital tract tissues: testis (3.67 +/- 2.16; p<0.05), epididymis (3.08 +/- 1.19; p<0.0001), prostate (3.36 +/- 1.30; p<0.01), and seminal vesicle (2.67 +/- 1.50; p<0.0001). Comparison of the SIVmac251 env viral populations in blood plasma, systemic lymph node, and genital tract tissues was performed in two of the macaques. Visual inspection of the Neighbor-Joining phylograms revealed that in both animals, all the sequences were generally distributed evenly among all tissue compartments. Importantly, viral populations in the genital tissues were not distinct from those in the systemic tissues. Our findings demonstrate striking similarity in the viral populations in the blood and male genital tract tissues within 3 months of penile SIV transmission.	[Fieni, Francis; Stone, Mars; Ma, Zhong-Min; Dutra, Joseph; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Fieni, Francis; Stone, Mars; Ma, Zhong-Min; Dutra, Joseph; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Med, Div Infect Dis, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Miller, CJ (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu			Public Health Service from grant National Center for Research Resources [P51RR00169]; Public Health Service from grant National Institute of Allergy and Infectious Disease [R01 AI066314]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Public Health Service from grant National Center for Research Resources; Public Health Service from grant National Institute of Allergy and Infectious Disease; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Public Health Service grants P51RR00169 from the National Center for Research Resources, R01 AI066314 (to CJM) from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coombs RW, 2006, JAIDS-J ACQ IMM DEF, V41, P430, DOI 10.1097/01.qai.0000209895.82255.08; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Curran R, 2002, J MED VIROL, V67, P9, DOI 10.1002/jmv.2186; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Haigwood NL, 2009, EUR J IMMUNOL, V39, P1994, DOI 10.1002/eji.200939576; Haigwood NL, 2004, AIDS REV, V6, P187; Kaizu M, 2006, J INFECT DIS, V194, P912, DOI 10.1086/507308; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Ma ZM, 2011, AIDS RES HUM RETROV, V27, P1259, DOI 10.1089/aid.2011.0090; Miller C J, 1994, Curr Top Microbiol Immunol, V188, P107; MILLER CJ, 1994, LAB INVEST, V70, P255; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Qureshi H, 2011, J VIROL; Ritola K, 2004, J VIROL, V78, P11208, DOI 10.1128/JVI.78.20.11208-11218.2004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SARASON RL, 1991, J MED PRIMATOL, V20, P122; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Stone M, 2009, VIROLOGY, V392, P260, DOI 10.1016/j.virol.2009.06.052; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weiler AM, 2008, J VIROL, V82, P4154, DOI 10.1128/JVI.01947-07; Whitney JB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001293	33	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76367	10.1371/journal.pone.0076367	http://dx.doi.org/10.1371/journal.pone.0076367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146859	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400054
J	Koshy, S; Wu, DL; Hu, XY; Tajhya, RB; Huq, R; Khan, FS; Pennington, MW; Wulff, H; Yotnda, P; Beeton, C				Koshy, Shyny; Wu, Danli; Hu, Xueyou; Tajhya, Rajeev B.; Huq, Redwan; Khan, Fatima S.; Pennington, Michael W.; Wulff, Heike; Yotnda, Patricia; Beeton, Christine			Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes	PLOS ONE			English	Article							MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GATED K+ CHANNELS; POTASSIUM CHANNELS; KV1.3 CHANNEL; NK CELLS; ADAPTIVE IMMUNITY; PERIPHERAL-BLOOD; NOD/SCID MICE; ION CHANNELS	Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.	[Koshy, Shyny; Hu, Xueyou; Tajhya, Rajeev B.; Huq, Redwan; Khan, Fatima S.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wu, Danli; Yotnda, Patricia] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Tajhya, Rajeev B.; Huq, Redwan] Baylor Coll Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Pennington, Michael W.] Peptides Int, Louisville, KY USA; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Davis	Beeton, C (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	beeton@bcm.edu	wulff, Heike/Z-2056-2019; Tajhya, Rajeev/C-7321-2016	Beeton, Christine/0000-0002-2500-5874; pennington, michael/0000-0001-5446-3447; Tajhya, Rajeev/0000-0002-5363-2293	Department of Defense Breast Cancer Research Program [BC096018]; American Heart Association [0665009Y]; NIH [GM076063, NS073712, RR024574, AI036211, CA125123]; American Lung Association [RT-197120-N]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073712] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Department of Defense Breast Cancer Research Program grant BC096018 (CB), American Heart Association grant 0665009Y (CB), NIH GM076063 (HW) and NS073712 (CB), and fellowship RT-197120-N from the American Lung Association (SK). The Cytometry and Cell Sorting Facility at Baylor College of Medicine is funded in part by the NIH (RR024574, AI036211, CA125123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C., 2007, JOVE-J VIS EXP, V8, pe326, DOI DOI 10.3791/3326; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Castriconi R, 2007, CANCER IMMUNOL IMMUN, V56, P1733, DOI 10.1007/s00262-007-0317-0; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chang SC, 2012, TOXICON, V60, P840, DOI 10.1016/j.toxicon.2012.05.017; Chang YH, 2013, CANCER RES, V73, P1777, DOI 10.1158/0008-5472.CAN-12-3558; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Harada H, 2005, EUR J IMMUNOL, V35, P3599, DOI 10.1002/eji.200535125; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hu XY, 2012, J BIOL CHEM, V287, P4014, DOI 10.1074/jbc.M111.312264; Marcenaro E, 2011, ADV EXP MED BIOL, V780, P45, DOI 10.1007/978-1-4419-5632-3_5; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matsushita N, 2007, IMMUNOPHARM IMMUNOT, V29, P31, DOI 10.1080/08923970701277791; MELDER RJ, 1990, J LEUKOCYTE BIOL, V48, P163, DOI 10.1002/jlb.48.2.163; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Quast SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039290; Rangaraju S, 2010, J BIOL CHEM, V285, P9124, DOI 10.1074/jbc.M109.071266; Ruggieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047825; SCHLICHTER L, 1986, P NATL ACAD SCI USA, V83, P451, DOI 10.1073/pnas.83.2.451; SCHLICHTER LC, 1989, EXP CELL RES, V184, P99, DOI 10.1016/0014-4827(89)90368-6; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; SIDELL N, 1986, J IMMUNOL, V137, P1650; Stabile H, 2010, BLOOD, V115, P2818, DOI 10.1182/blood-2009-07-235804; Strobaek D, 2012, BRIT J PHARMACOL, P1476; Sun R, 2003, J IMMUNOL METHODS, V279, P79, DOI 10.1016/S0022-1759(03)00245-X; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Weisman Z, 1997, NAT IMMUN, V15, P269; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11	49	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76740	10.1371/journal.pone.0076740	http://dx.doi.org/10.1371/journal.pone.0076740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146918	Green Published, gold			2022-12-25	WOS:000325819400079
J	Shuvaev, VV; Han, JY; Tliba, S; Arguiri, E; Christofidou-Solomidou, M; Ramirez, SH; Dykstra, H; Persidsky, Y; Atochin, DN; Huang, PL; Muzykantov, VR				Shuvaev, Vladimir V.; Han, Jingyan; Tliba, Samira; Arguiri, Evguenia; Christofidou-Solomidou, Melpo; Ramirez, Servio H.; Dykstra, Holly; Persidsky, Yuri; Atochin, Dmitriy N.; Huang, Paul L.; Muzykantov, Vladimir R.			Anti-Inflammatory Effect of Targeted Delivery of SOD to Endothelium: Mechanism, Synergism with NO Donors and Protective Effects In Vitro and In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ALLEVIATES OXIDATIVE STRESS; CELL-ADHESION MOLECULE-1; OXIDASE-DERIVED ROS; SUPEROXIDE-DISMUTASE; NITRIC-OXIDE; INDUCED APOPTOSIS; CATALASE; ACTIVATION	Pro-inflammatory activation of vascular endothelium is implicated in pathogenesis of severe conditions including stroke, infarction and sepsis. We have recently reported that superoxide dismutase (SOD) conjugated with antibodies (Ab/SOD) that provide targeted delivery into endothelial endosomes mitigates inflammatory endothelial activation by cytokines and agonists of Toll-like receptors (TLR). The goal of this study was to appraise potential utility and define the mechanism of this effect. Ab/SOD, but not non-targeted SOD injected in mice alleviated endotoxin-induced leukocyte adhesion in the cerebral vasculature and protected brain from ischemia-reperfusion injury. Transfection of endothelial cells with SOD, but not catalase inhibited NF kappa B signaling and expression of Vascular Cell Adhesion Molecule-1 induced by both cytokines and TLR agonists. These results affirmed that Ab/SOD-quenched superoxide anion produced by endothelial cells in response to proinflammatory agents mediates NF kappa B activation. Furthermore, Ab/SOD potentiates anti-inflammatory effect of NO donors in endothelial cells in vitro, as well as in the endotoxin-challenged mice. These results demonstrate the central role of intracellular superoxide as a mediator of pro-inflammatory activation of endothelium and support the notion of utility of targeted interception of this signaling pathway for management of acute vascular inflammation.	[Shuvaev, Vladimir V.; Han, Jingyan; Tliba, Samira; Muzykantov, Vladimir R.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Han, Jingyan; Tliba, Samira; Muzykantov, Vladimir R.] Univ Penn, Inst Translat Med & Therapeut, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA; [Arguiri, Evguenia; Christofidou-Solomidou, Melpo] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Ramirez, Servio H.; Dykstra, Holly; Persidsky, Yuri] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Atochin, Dmitriy N.; Huang, Paul L.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Atochin, Dmitriy N.; Huang, Paul L.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Atochin, Dmitriy N.; Huang, Paul L.] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Muzykantov, VR (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	Shuvaev, Vladimir/O-1719-2014; Atochin, Dmitriy/Q-3150-2016; Ramirez, Servio/F-8277-2014; Atochin, Dmitriy/AAH-8843-2020	Huang, Paul/0000-0002-5436-8658; Atochin, Dmitriy/0000-0002-2405-2070; ramirez, servio/0000-0002-4609-5653	National Institutes of Health [RO1 HL073940]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [Grant RO1 HL073940] (to V.R.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 1998, BIOCHEM J, V331, P853, DOI 10.1042/bj3310853; Atochin DN, 2004, STROKE, V35, P2177, DOI 10.1161/01.STR.0000137412.35700.0e; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Atochina EN, 1998, AM J PHYSIOL-LUNG C, V275, pL806, DOI 10.1152/ajplung.1998.275.4.L806; Bai JX, 2000, J BIOL CHEM, V275, P19241, DOI 10.1074/jbc.M000438200; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Cabrales P, 2010, FREE RADICAL BIO MED, V49, P530, DOI 10.1016/j.freeradbiomed.2010.04.034; Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; D'Alessio A, 2010, J BIOL CHEM, V285, P23868, DOI 10.1074/jbc.M110.122853; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Frazziano G, 2012, AM J PHYSIOL-HEART C, V302, pH2166, DOI 10.1152/ajpheart.00780.2011; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Giedt RJ, 2012, FREE RADICAL BIO MED, V52, P348, DOI [10.1016/j.freeradbiomed.2011.10.491, 10.1007/s10439-012-0568-6]; Han JY, 2012, THER DELIV, V3, P263, DOI 10.4155/TDE.11.151; Han JY, 2011, J PHARMACOL EXP THER, V338, P82, DOI 10.1124/jpet.111.180620; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Hernandez-Saavedra D, 2005, BIOMED PHARMACOTHER, V59, P204, DOI 10.1016/j.biopha.2005.03.001; Huang J, 2007, J ETHNOPHARMACOL, V114, P180, DOI 10.1016/j.jep.2007.07.036; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Laskin DL, 2010, ANN NY ACAD SCI, V1203, P60, DOI 10.1111/j.1749-6632.2010.05607.x; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Melendez JA, 1996, J BIOL CHEM, V271, P18898, DOI 10.1074/jbc.271.31.18898; Muro S, 2005, BLOOD, V105, P650, DOI 10.1182/blood-2004-05-1714; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Nacharaju P, 2012, NITRIC OXIDE-BIOL CH, V27, P150, DOI 10.1016/j.niox.2012.06.003; Nowak K, 2007, AM J PHYSIOL-LUNG C, V293, pL162, DOI 10.1152/ajplung.00001.2007; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Preissler G, 2011, TRANSPLANTATION, V92, P380, DOI 10.1097/TP.0b013e318226bc6b; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rosenbaugh EG, 2010, BIOMATERIALS, V31, P5218, DOI 10.1016/j.biomaterials.2010.03.026; Scherpereel A, 2002, J PHARMACOL EXP THER, V300, P777, DOI 10.1124/jpet.300.3.777; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Shuvaev VV, 2007, J PHARMACOL EXP THER, V323, P450, DOI 10.1124/jpet.107.127126; Shuvaev VV, 2011, ACS NANO, V5, P6991, DOI 10.1021/nn2015453; Shuvaev VV, 2011, J CONTROL RELEASE, V153, P56, DOI 10.1016/j.jconrel.2011.03.022; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Shuvaev VV, 2009, J PHARMACOL EXP THER, V331, P404, DOI 10.1124/jpet.109.156877; SUZUKI YJ, 1995, BIOCHEM BIOPH RES CO, V210, P537, DOI 10.1006/bbrc.1995.1693; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Waldow T, 2006, NITRIC OXIDE-BIOL CH, V15, P103, DOI 10.1016/j.niox.2005.12.005; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Yeh LH, 2001, J VASC RES, V38, P551, DOI 10.1159/000051091; Zimmerman MC, 2011, CURR OPIN PHARMACOL, V11, P138, DOI 10.1016/j.coph.2011.01.001	58	42	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77002	10.1371/journal.pone.0077002	http://dx.doi.org/10.1371/journal.pone.0077002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146950	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400093
J	Wagstaff, JL; Masterton, RJ; Povey, JF; Smales, CM; Howard, MJ				Wagstaff, Jane L.; Masterton, Rosalyn J.; Povey, Jane F.; Smales, C. Mark; Howard, Mark J.			H-1 NMR Spectroscopy Profiling of Metabolic Reprogramming of Chinese Hamster Ovary Cells upon a Temperature Shift during Culture	PLOS ONE			English	Article							MAMMALIAN-CELLS; ANTIBODY-PRODUCTION; COLD-SHOCK; CHO-CELLS; HYPOTHERMIA; EXPRESSION; LACTATE	We report an NMR based approach to determine the metabolic reprogramming of Chinese hamster ovary cells upon a temperature shift during culture by investigating the extracellular cell culture media and intracellular metabolome of CHOK1 and CHO-S cells during culture and in response to cold-shock and subsequent recovery from hypothermic culturing. A total of 24 components were identified for CHOK1 and 29 components identified for CHO-S cell systems including the observation that CHO-S media contains 5.6 times the level of glucose of CHOK1 media at time zero. We confirm that an NMR metabolic approach provides quantitative analysis of components such as glucose and alanine with both cell lines responding in a similar manner and comparable to previously reported data. However, analysis of lactate confirms a differentiation between CHOK1 and CHO-S and that reprogramming of metabolism in response to temperature was cell line specific. The significance of our results is presented using principal component analysis (PCA) that confirms changes in metabolite profile in response to temperature and recovery. Ultimately, our approach demonstrates the capability of NMR providing real-time analysis to detect reprogramming of metabolism upon cellular perception of cold-shock/sub-physiological temperatures. This has the potential to allow manipulation of metabolites in culture supernatant to improve growth or productivity.	[Smales, C. Mark] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; Univ Kent, Sch Biosci, Canterbury, Kent, England	University of Kent; University of Kent	Smales, CM (corresponding author), Univ Kent, Ctr Mol Proc, Canterbury, Kent, England.	c.m.smales@kent.ac.uk; m.j.howard@kent.ac.uk		Smales, Christopher Mark/0000-0002-2762-4724; Povey, Jane/0000-0003-4522-3630; Howard, Mark/0000-0002-0762-2887	University of Kent, Faculty of Sciences Strategic Development Fund; BBSRC [BB/I020055/1, BB/D009375/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009375/1, BB/I020055/1, BB/C006569/1] Funding Source: researchfish	University of Kent, Faculty of Sciences Strategic Development Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported through The University of Kent, Faculty of Sciences Strategic Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Aranibar N, 2011, J BIOMOL NMR, V49, P195, DOI 10.1007/s10858-011-9490-8; Barba I, 2008, LIVER INT, V28, P1141, DOI 10.1111/j.1478-3231.2008.01801.x; Bradley SA, 2010, J AM CHEM SOC, V132, P9531, DOI 10.1021/ja101962c; Chong WPK, 2009, RAPID COMMUN MASS SP, V23, P3763, DOI 10.1002/rcm.4328; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dietmair S, 2012, BIOTECHNOL BIOENG, V109, P1404, DOI 10.1002/bit.24496; Li JC, 2012, BIOTECHNOL BIOENG, V109, P1173, DOI 10.1002/bit.24389; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; Mead EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047422; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Sellick CA, 2011, BIOTECHNOL BIOENG, V108, P3025, DOI 10.1002/bit.23269; Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Suk Ahn W, 2012, METAB ENG; Underhill MF, 2006, MOL BIOTECHNOL, V34, P141, DOI 10.1385/MB:34:2:141; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	23	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77195	10.1371/journal.pone.0077195	http://dx.doi.org/10.1371/journal.pone.0077195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130854	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200068
J	Walker, T; Adamson, A; Jackson, DA				Walker, Thomas; Adamson, Antony; Jackson, Dean A.			BCL-3 Attenuation of TNFA Expression Involves an Incoherent Feed-Forward Loop Regulated by Chromatin Structure	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; P50; TRANSCRIPTION; RECRUITMENT; INDUCTION; MECHANISM; PROMOTER; ENCODES; BINDING	Induction of genes is rarely an isolated event; more typically occurring as part of a web of parallel interactions, or motifs, which act to refine and control gene expression. Here, we define an Incoherent Feed-forward Loop motif in which TNF alpha-induced NF-kappa B signalling activates expression of the TNFA gene itself and also controls synthesis of the negative regulator BCL-3. While sharing a common inductive signal, the two genes have distinct temporal expression profiles. Notably, while the TNFA gene promoter is primed to respond immediately to activated NF-kappa B in the nucleus, induction of BCL3 expression only occurs after a time delay of about 1h. We show that this time delay is defined by remodelling of the BCL3 gene promoter, which is required to activate gene expression, and characterise the chromatin delayed induction of BCL3 expression using mathematical models. The models show how a delay in inhibitor production effectively uncouples the rate of response to inflammatory cues from the final magnitude of inhibition. Hence, within this regulatory motif, a delayed (incoherent) feed-forward loop together with differential rates of TNFA (fast) and BCL3 (slow) mRNA turnover provide robust, pulsatile expression of TNF alpha. We propose that the structure of the BCL-3-dependent regulatory motif has a beneficial role in modulating	[Walker, Thomas; Adamson, Antony; Jackson, Dean A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Jackson, DA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	dean.jackson@manchester.ac.uk		Adamson, Antony/0000-0002-5408-0013	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [EPSRC/BBSRC]; BBSRC [BB/F00561X/1-DAJ]; BBSRC [BB/F005938/2, BB/F00561X/1, BB/F005938/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00561X/1, BB/F005938/1, BB/F005938/2] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council [EPSRC/BBSRC](UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Engineering and Physical Sciences Research Council and the Biotechnology and Biological Sciences Research Council [EPSRC/BBSRC funded University of Manchester Doctoral training Centre in Systems Biology - T.W. and BBSRC Grant BB/F00561X/1-DAJ, AA]. Funding for open access charge: Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Buetti-Dinh A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.61; Carey MF, 2009, COLD SPRING HARBOR P, V2009; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Keutgens A, 2010, MOL CELL BIOL, V30, P4006, DOI 10.1128/MCB.01600-09; Larson DR, 2011, CURR OPIN GENET DEV, V21, P591, DOI 10.1016/j.gde.2011.07.010; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Natoli G, 2012, IMMUNOL REV, V246, P183, DOI 10.1111/j.1600-065X.2012.01103.x; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Paszek P, 2010, CURR OPIN GENET DEV, V20, P670, DOI 10.1016/j.gde.2010.08.004; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77015	10.1371/journal.pone.0077015	http://dx.doi.org/10.1371/journal.pone.0077015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130828	Green Submitted, gold, Green Published			2022-12-25	WOS:000325814200050
J	de Groot, REA; Farin, HF; Macurkova, M; van Es, JH; Clevers, HC; Korswagen, HC				de Groot, Reinoud E. A.; Farin, Henner F.; Macurkova, Marie; van Es, Johan H.; Clevers, Hans C.; Korswagen, Hendrik C.			Retromer Dependent Recycling of the Wnt Secretion Factor Wls Is Dispensable for Stem Cell Maintenance in the Mammalian Intestinal Epithelium	PLOS ONE			English	Article							REQUIRES RETROMER; PROTEIN; WNTLESS; LGR5; IDENTIFICATION; COMPLEX	In C. elegans and Drosophila, retromer mediated retrograde transport of Wntless (Wls) from endosomes to the trans-Golgi network (TGN) is required for Wnt secretion. When this retrograde transport pathway is blocked, Wls is missorted to lysosomes and degraded, resulting in reduced Wnt secretion and various Wnt related phenotypes. In the mammalian intestine, Wnt signaling is essential to maintain stem cells. This prompted us to ask if retromer mediated Wls recycling is also important for Wnt signaling and stem cell maintenance in this system. To answer this question, we generated a conditional Vps35(fl) allele. As Vps35 is an essential subunit of the retromer complex, this genetic tool allowed us to inducibly interfere with retromer function in the intestinal epithelium. Using a pan-intestinal epithelial Cre line (Villin-CreERT2), we did not observe defects in crypt or villus morphology after deletion of Vps35 from the intestinal epithelium. Wnt secreted from the mesenchyme of the intestine may compensate for a reduction in epithelial Wnt secretion. To exclude the effect of the mesenchyme, we generated intestinal organoid cultures. Loss of Vps35 in intestinal organoids did not affect the overall morphology of the organoids. We were able to culture Vps35(Delta/Delta) organoids for many passages without Wnt supplementation in the growth medium. However, Wls protein levels were reduced and we observed a subtle growth defect in the Vps35(Delta/Delta) organoids. These results confirm the role of retromer in the retrograde trafficking of Wls in the intestine, but show that retromer mediated Wls recycling is not essential to maintain Wnt signaling or stem cell proliferation in the intestinal epithelium.	[de Groot, Reinoud E. A.; Farin, Henner F.; van Es, Johan H.; Clevers, Hans C.; Korswagen, Hendrik C.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [de Groot, Reinoud E. A.; Farin, Henner F.; van Es, Johan H.; Clevers, Hans C.; Korswagen, Hendrik C.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Macurkova, Marie] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Charles University Prague	Korswagen, HC (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	r.korswagen@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Macurkova, Marie/B-4424-2014; Korswagen, Hendrik/I-8782-2012; Farin, Henner/AAC-2574-2021	Farin, Henner/0000-0003-1558-5366; Macurkova, Marie/0000-0002-7082-0093; de Groot, Reinoud/0000-0002-1905-6501	Dutch Cancer Society [HUBR 2008-4114]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was funded by the Dutch Cancer Society (HUBR 2008-4114) (to HCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gasnereau I, 2011, J BIOL CHEM, V286, P43324, DOI 10.1074/jbc.M111.307231; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; RADICE G, 1991, DEVELOPMENT, V111, P801; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	31	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e76971	10.1371/journal.pone.0076971	http://dx.doi.org/10.1371/journal.pone.0076971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130821	Green Published, Green Submitted, gold			2022-12-25	WOS:000325810900113
J	Collins, DW; Gudiseva, HV; Trachtman, BT; Jerrehian, M; Gorry, T; Merritt, WT; Rhodes, AL; Sankar, PS; Regina, M; Miller-Ellis, E; O'Brien, JM				Collins, David W.; Gudiseva, Harini V.; Trachtman, Benjamin T.; Jerrehian, Matthew; Gorry, Thomasine; Merritt, William T., III; Rhodes, Allison L.; Sankar, Prithvi S.; Regina, Meredith; Miller-Ellis, Eydie; O'Brien, Joan M.			Mitochondrial Sequence Variation in African-American Primary Open-Angle Glaucoma Patients	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; DNA SEQUENCES; EYE; DYSFUNCTION; PREVALENCE; MUTATIONS; LINEAGES; CELLS; BIAS; TREE	Primary open-angle glaucoma (POAG) is a major cause of blindness and results from irreversible retinal ganglion cell damage and optic nerve degeneration. In the United States, POAG is most prevalent in African-Americans. Mitochondrial genetics and dysfunction have been implicated in POAG, and potentially pathogenic sequence variations, in particular novel transversional base substitutions, are reportedly common in mitochondrial genomes (mtDNA) from POAG patient blood. The purpose of this study was to ascertain the spectrum of sequence variation in mtDNA from African-American POAG patients and determine whether novel nonsynonymous, transversional or other potentially pathogenic sequence variations are observed more commonly in POAG cases than controls. mtDNA from African-American POAG cases (n = 22) and age-matched controls (n = 22) was analyzed by deep sequencing of a single 16,487 base pair PCR amplicon by Ion Torrent, and candidate novel variants were validated by Sanger sequencing. Sequence variants were classified and interpreted using the MITOMAP compendium of polymorphisms. 99.8% of the observed variations had been previously reported. The ratio of novel variants to POAG cases was 7-fold lower than a prior estimate. Novel mtDNA variants were present in 3 of 22 cases, novel nonsynonymous changes in 1 of 22 cases and novel transversions in 0 of 22 cases; these proportions are significantly lower (p<.0005, p<.0004, p<.0001) than estimated previously for POAG, and did not differ significantly from controls. Although it is possible that mitochondrial genetics play a role in African-Americans' high susceptibility to POAG, it is unlikely that any mitochondrial respiratory dysfunction is due to an abnormally high incidence of novel mutations that can be detected in mtDNA from peripheral blood.	[Collins, David W.; Gudiseva, Harini V.; Trachtman, Benjamin T.; Jerrehian, Matthew; Gorry, Thomasine; Merritt, William T., III; Rhodes, Allison L.; Sankar, Prithvi S.; Regina, Meredith; Miller-Ellis, Eydie; O'Brien, Joan M.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Collins, DW (corresponding author), Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA.	davcol@mail.med.upenn.edu			Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; F.M. Kirby Foundation; Research to Prevent Blindness; Paul & Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM [HHSN260220700001C, HHSN263201200001C]; NATIONAL EYE INSTITUTE [R01EY023557] Funding Source: NIH RePORTER	Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; F.M. Kirby Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Paul & Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA and with funds from the F.M. Kirby Foundation (http://foundationcenter.org/grantmaker/kirby/index.html), Research to Prevent Blindness (https://www.rpbusa.org/rpb/), The Paul & Evanina Bell Mackall Foundation Trust and the National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM (http://www.nei.nih.gov/resources/eyegene.asp) contract Nos. HHSN260220700001C and HHSN263201200001C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Abu-Amero KK, 2012, MOL VIS, V18, P1955; Abu-Amero KK, 2011, MOL VIS, V17, P1468; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews R, 2006, BRIT J OPHTHALMOL, V90, P488, DOI 10.1136/bjo.2005.084335; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Calandrella N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.40; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Inagaki Y, 2006, JPN J OPHTHALMOL, V50, P128, DOI 10.1007/s10384-005-0290-0; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Mitchell P, 2002, OPHTHAL EPIDEMIOL, V9, P333, DOI 10.1076/opep.9.5.333.10335; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varma R, 2004, OPHTHALMOLOGY, V111, P1121, DOI 10.1016/j.ophtha.2004.02.001; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yu-Wai-Man P, 2012, INVEST OPHTH VIS SCI, V53, P2438, DOI 10.1167/iovs.12-9815	34	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76627	10.1371/journal.pone.0076627	http://dx.doi.org/10.1371/journal.pone.0076627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24146900	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100081
J	Pagnotta, SM; Laudanna, C; Pancione, M; Sabatino, L; Votino, C; Remo, A; Cerulo, L; Zoppoli, P; Manfrin, E; Colantuoni, V; Ceccarelli, M				Pagnotta, Stefano Maria; Laudanna, Carmelo; Pancione, Massimo; Sabatino, Lina; Votino, Carolina; Remo, Andrea; Cerulo, Luigi; Zoppoli, Pietro; Manfrin, Erminia; Colantuoni, Vittorio; Ceccarelli, Michele			Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPAR gamma and TNF alpha Signaling	PLOS ONE			English	Article							INDUCED APOPTOSIS; BETA-CATENIN; F-SPONDIN; EXPRESSION; ECTO-5'-NUCLEOTIDASE; SUPPRESSOR; CARCINOMA; CD73	We describe a novel bioinformatic and translational pathology approach, gene Signature Finder Algorithm (gSFA) to identify biomarkers associated with Colorectal Cancer (CRC) survival. Here a robust set of CRC markers is selected by an ensemble method. By using a dataset of 232 gene expression profiles, gSFA discovers 16 highly significant small gene signatures. Analysis of dichotomies generated by the signatures results in a set of 133 samples stably classified in good prognosis group and 56 samples in poor prognosis group, whereas 43 remain unreliably classified. AKAP12, DCBLD2, NT5E and SPON1 are particularly represented in the signatures and selected for validation in vivo on two independent patients cohorts comprising 140 tumor tissues and 60 matched normal tissues. Their expression and regulatory programs are investigated in vitro. We show that the coupled expression of NT5E and DCBLD2 robustly stratifies our patients in two groups (one of which with 100% survival at five years). We show that NT5E is a target of the TNF-alpha signaling in vitro; the tumor suppressor PPAR gamma acts as a novel NT5E antagonist that positively and concomitantly regulates DCBLD2 in a cancer cell context-dependent manner.	[Pagnotta, Stefano Maria; Laudanna, Carmelo; Pancione, Massimo; Sabatino, Lina; Votino, Carolina; Cerulo, Luigi; Colantuoni, Vittorio; Ceccarelli, Michele] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Cerulo, Luigi; Ceccarelli, Michele] BIOGEM Scrl, Bioinformat Lab, Ariano Irpino, Italy; [Remo, Andrea] Hosp Mater Salutis, Dept Pathol, Legnano, Italy; [Zoppoli, Pietro] Columbia Univ, Inst Canc Genet, New York, NY USA; [Manfrin, Erminia] Univ Verona, Dept Surg & Oncol, I-37100 Verona, Italy	University of Sannio; Columbia University; University of Verona	Colantuoni, V (corresponding author), Univ Sannio, Dept Sci & Technol, Benevento, Italy.	vittorio.colantuoni@unisannio.it; michele.ceccarelli@unisannio.it	manfrin, erminia/P-2645-2016; Ceccarelli, Michele/AGP-1739-2022; Zoppoli, Pietro/J-9954-2018; Remo, Andrea/Q-7746-2016; Pancione, Massimo/AAF-2109-2019	manfrin, erminia/0000-0002-5706-0018; Zoppoli, Pietro/0000-0002-7860-9655; Remo, Andrea/0000-0002-2564-2988; PAGNOTTA, Stefano Maria/0000-0002-8298-9777; Sabatino, Lina/0000-0001-5341-7430; Ceccarelli, Michele/0000-0002-4702-6617; LAUDANNA, Carmelo/0000-0002-0397-6020; PANCIONE, Massimo/0000-0003-1728-8816	Ministero dell'Universita e della Ricerca [PRIN2008-20085CH22F]; Associazione italiana per la lotta ai linfomi e leucemie	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Associazione italiana per la lotta ai linfomi e leucemie(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero dell'Universita e della Ricerca under grant (PRIN2008-20085CH22F) and by Associazione italiana per la lotta ai linfomi e leucemie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Badiola I, 2012, GUT, V61, P1465, DOI 10.1136/gutjnl-2011-300810; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; Choi MC, 2004, ONCOGENE, V23, P7095, DOI 10.1038/sj.onc.1207932; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Guo XJ, 2009, J BIOL CHEM, V284, P29376, DOI 10.1074/jbc.M109.049684; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hayashi M, 2012, J SURG ONCOL, V105, P381, DOI 10.1002/jso.22135; Kim M, 2008, MOL CANCER RES, V6, P222, DOI 10.1158/1541-7786.MCR-07-0142; Liu WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024015; Liu WW, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.12.010; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Pancione M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014229; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Pyle-Chenault RA, 2005, TUMOR BIOL, V26, P245, DOI 10.1159/000087379; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Simmer F, 2012, EPIGENETICS-US, V7, P1355, DOI 10.4161/epi.22562; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Spychala J, 2004, EXP CELL RES, V296, P99, DOI 10.1016/j.yexcr.2003.11.001; Stagg J, 2012, CANCER RES, V72, P2190, DOI 10.1158/0008-5472.CAN-12-0420; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Wang J, 2011, BIOMED ENVIRON SCI, V24, P391, DOI 10.3967/0895-3988.2011.04.010; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068	39	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72638	10.1371/journal.pone.0072638	http://dx.doi.org/10.1371/journal.pone.0072638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	24133572	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700184
J	Gangula, NR; Maddika, S				Gangula, Narmadha Reddy; Maddika, Subbareddy			WD Repeat Protein WDR48 in Complex with Deubiquitinase USP12 Suppresses Akt-dependent Cell Survival Signaling by Stabilizing PH Domain Leucine-rich Repeat Protein Phosphatase 1 (PHLPP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; Protein Stability; Tumor Suppressor Gene; Ubiquitin; PHLPP; USP12; WDR48	TUMOR-SUPPRESSOR; CANCER	Background: PHLPP1 is a tumor suppressor phosphatase. Results: WDR48 in complex with USP12 controls cell survival signaling by deubiquitinating PHLPP1. Conclusion: WDR48 acts as a potential tumor suppressor by positively regulating PHLPP1 stability. Significance: WDR48 was identified as novel PHLPP1 regulator, which is critical in understanding its role as tumor suppressor in human cancers. PHLPP1 (PH domain leucine-rich repeat protein phosphatase 1) is a protein-serine/threonine phosphatase and a negative regulator of the PI3-kinase/Akt pathway. Although its function as a suppressor of tumor cell growth has been established, the mechanism of its regulation is not completely understood. In this study, by utilizing the tandem affinity purification approach we have identified WDR48 and USP12 as novel PHLPP1-associated proteins. The WDR48USP12 complex deubiquitinates PHLPP1 and thereby enhances its protein stability. Similar to PHLPP1 function, WDR48 and USP12 negatively regulate Akt activation and thus promote cellular apoptosis. Functionally, we show that WDR48 and USP12 suppress proliferation of tumor cells. Importantly, we found a WDR48 somatic mutation (L580F) that is defective in stabilizing PHLPP1 in colorectal cancers, supporting a WDR48 role in tumor suppression. Together, our results reveal WDR48 and USP12 as novel PHLPP1 regulators and potential suppressors of tumor cell survival.	[Gangula, Narmadha Reddy; Maddika, Subbareddy] CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Maddika, S (corresponding author), CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India.	humsreddy@cdfd.org.inu			Wellcome Trust/DBT India Alliance Intermediate Fellowship [500230/Z/11/Z]	Wellcome Trust/DBT India Alliance Intermediate Fellowship	This work was supported by Wellcome Trust/DBT India Alliance Intermediate Fellowship Grant 500230/Z/11/Z (to S. M.).	Andreozzi F, 2011, DIABETOLOGIA, V54, P1879, DOI 10.1007/s00125-011-2116-6; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Gao GL, 2013, MOL BIOL REP, V40, P2947, DOI 10.1007/s11033-012-2363-8; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel A, 2003, CANCER RES, V63, P1608; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Li X, 2013, ONCOGENE, V32, P471, DOI 10.1038/onc.2012.66; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Moretti J, 2012, J BIOL CHEM, V287, P29429, DOI 10.1074/jbc.M112.366807; Patael-Karasik Y, 2000, CANCER GENET CYTOGEN, V121, P26, DOI 10.1016/S0165-4608(00)00224-7; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Shimizu K, 2010, MOL BIOSYST, V6, P38, DOI 10.1039/b911410f; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Torring N, 2007, BRIT J CANCER, V96, P499, DOI 10.1038/sj.bjc.6603476; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zhang ZQ, 2012, J CANCER RES CLIN, V138, P1231, DOI 10.1007/s00432-012-1193-3	26	48	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34545	34554		10.1074/jbc.M113.503383	http://dx.doi.org/10.1074/jbc.M113.503383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145035	Green Published, hybrid			2022-12-25	WOS:000329812800023
J	Stefan, CP; Cunningham, KW				Stefan, Christopher P.; Cunningham, Kyle W.			Kch1 Family Proteins Mediate Essential Responses to Endoplasmic Reticulum Stresses in the Yeasts Saccharomyces cerevisiae and Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Channels; Cell Death; ER Stress; Potassium Transport; Antifungals	PLASMA-MEMBRANE PROTEIN; SODIUM LEAK CHANNELS; CA2+ INFLUX; CALCINEURIN INHIBITORS; TRANSCRIPTION FACTOR; NONAPOPTOTIC DEATH; SECRETORY PATHWAY; CALCIUM-CHANNELS; ER STRESS; GENE	Background: Fungal cells require Ca2+ influx and signaling to survive some antifungal assaults. Results: High affinity Ca2+ influx systems in yeasts required the Kch1 K+ transporters for full activation in response to ER stressors but not clinical antifungals. Conclusion: Kch1 family proteins regulate Ca2+ influx in many yeast species. Significance: Targeting fungal K+ transporters or Ca2+ channels may improve efficacy of existing antifungals in narrow situations. The activation of a high affinity Ca2+ influx system (HACS) in the plasma membrane is required for survival of yeast cells exposed to natural or synthetic inhibitors of essential processes (secretory protein folding or sterol biosynthesis) in the endoplasmic reticulum (ER). The mechanisms linking ER stress to HACS activation are not known. Here we show that Kch1, a recently identified low affinity K+ transporter in the plasma membrane of Saccharomyces cerevisiae, is up-regulated in response to several ER stressors and necessary for HACS activation. The activation of HACS required extracellular K+ and was also dependent on the high affinity K+ transporters Trk1 and Trk2. However, a paralog of Kch1 termed Kch2 was not expressed and not necessary for HACS activation in these conditions. The pathogenic yeast Candida albicans carries only one homolog of Kch1/Kch2, and homozygous knock-out mutants were similarly deficient in the activation of HACS during the responses to tunicamycin. However, the Kch1 homolog was not necessary for HACS activation or cell survival in response to several clinical antifungals (azoles, allylamines, echinocandins) that target the ER or cell wall. Thus, Kch1 family proteins represent a conserved linkage between HACS and only certain classes of ER stress in these yeasts.	[Stefan, Christopher P.; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	kwc@jhu.edu	Stefan, Christopher/V-5970-2019	Stefan, Christopher/0000-0003-4891-447X	National Institutes of Health [NS057023, NS074072]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074072, R21NS057023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Awards NS057023 and NS074072 (to K.W.C.).	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Bonilla Myriam, 2002, Sci STKE, V2002, ppe17; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; GABER RF, 1988, MOL CELL BIOL, V8, P2848, DOI 10.1128/MCB.8.7.2848; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haro R, 2002, BBA-BIOMEMBRANES, V1564, P114, DOI 10.1016/S0005-2736(02)00408-X; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1990, J BIOL CHEM, V265, P13391; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kim H, 2012, J BIOL CHEM, V287, P19029, DOI 10.1074/jbc.M112.363390; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; KO CH, 1990, GENETICS, V125, P305; Kusio-Kobialka M, 2012, CELL CYCLE, V11, P4069, DOI 10.4161/cc.22387; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Macario AJL, 2002, AGEING RES REV, V1, P295, DOI 10.1016/S1568-1637(01)00005-8; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2932, DOI 10.1128/AAC.44.11.2932-2938.2000; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Morrison Vicki A, 2006, Expert Rev Anti Infect Ther, V4, P325, DOI 10.1586/14787210.4.2.325; Moser NJ, 1996, MOL CELL BIOL, V16, P4824; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; Muller EM, 2001, GENETICS, V159, P1527; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Pallet N, 2010, PHARMACOGENOMICS, V11, P1491, DOI 10.2217/PGS.10.137; Pena A, 2010, J BIOENERG BIOMEMBR, V42, P419, DOI 10.1007/s10863-010-9311-x; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Sherman F., 1986, METHODS YEAST GENETI; SLAYMAN CL, 1973, J MEMBRANE BIOL, V14, P305, DOI 10.1007/BF01868083; SLAYMAN CL, 1965, J GEN PHYSIOL, V49, P69, DOI 10.1085/jgp.49.1.69; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	70	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34861	34870		10.1074/jbc.M113.508705	http://dx.doi.org/10.1074/jbc.M113.508705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142703	hybrid, Green Published			2022-12-25	WOS:000329812800053
J	Girard, YK; Wang, CY; Ravi, S; Howell, MC; Mallela, J; Alibrahim, M; Green, R; Hellermann, G; Mohapatra, SS; Mohapatra, S				Girard, Yvonne K.; Wang, Chunyan; Ravi, Sowndharya; Howell, Mark C.; Mallela, Jaya; Alibrahim, Mahmoud; Green, Ryan; Hellermann, Gary; Mohapatra, Shyam S.; Mohapatra, Subhra			A 3D Fibrous Scaffold Inducing Tumoroids: A Platform for Anticancer Drug Development	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MULTICELLULAR RESISTANCE; ELECTROSPUN MATRICES; SUSTAINED DELIVERY; SPHEROID FORMATION; ALKYLATING-AGENTS; CANCER SPHEROIDS; CULTURE; MODELS; TRANSITION	The development of a suitable three dimensional (3D) culture system for anticancer drug development remains an unmet need. Despite progress, a simple, rapid, scalable and inexpensive 3D-tumor model that recapitulates in vivo tumorigenesis is lacking. Herein, we report on the development and characterization of a 3D nanofibrous scaffold produced by electrospinning a mixture of poly(lactic-co-glycolic acid) (PLGA) and a block copolymer of polylactic acid (PLA) and monomethoxypolyethylene glycol (mPEG) designated as 3P. Cancer cells cultured on the 3P scaffold formed tight irregular aggregates similar to in vivo tumors, referred to as tumoroids that depended on the topography and net charge of the scaffold. 3P scaffolds induced tumor cells to undergo the epithelial-to-mesenchymal transition (EMT) as demonstrated by up-regulation of vimentin and loss of E-cadherin expression. 3P tumoroids showed higher resistance to anticancer drugs than the same tumor cells grown as monolayers. Inhibition of ERK and PI3K signal pathways prevented EMT and reduced tumoroid formation, diameter and number. Fine needle aspirates, collected from tumor cells implanted in mice when cultured on 3P scaffolds formed tumoroids, but showed decreased sensitivity to anticancer drugs, compared to tumoroids formed by direct seeding. These results show that 3P scaffolds provide an excellent platform for producing tumoroids from tumor cell lines and from biopsies and that the platform can be used to culture patient biopsies, test for anticancer compounds and tailor a personalized cancer treatment.	[Girard, Yvonne K.; Wang, Chunyan; Ravi, Sowndharya; Howell, Mark C.; Mallela, Jaya; Green, Ryan; Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA; [Girard, Yvonne K.; Wang, Chunyan; Ravi, Sowndharya; Howell, Mark C.; Mallela, Jaya; Green, Ryan; Hellermann, Gary; Mohapatra, Shyam S.; Mohapatra, Subhra] Univ S Florida, Morsani Coll Med, USF Nanomed Res Ctr, Tampa, FL USA; [Alibrahim, Mahmoud] Univ S Florida, Chem & Biomed Engn Dept, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mohapatra, S (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.	smohapa2@health.usf.edu	Mohapatra, Shyam/C-2500-2012; Mallela, Jaya/AAJ-9875-2021; Mohapatra, Subhra/A-1381-2012; Howell, Mark/ABA-6352-2021		Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work is supported by grants from the Office of Naval Research to SM and SSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Garcia PA, 2011, NEOPLASIA, V13, P831, DOI 10.1593/neo.11612; Ballangrud AM, 1999, CLIN CANCER RES, V5, p3171S; Bongio M, 2011, Eur Cell Mater, V22, P359; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Caicedo-Carvajal Carlos E, 2011, J Tissue Eng, V2011, P362326, DOI 10.4061/2011/362326; Castaneda F, 2000, J CANCER RES CLIN, V126, P305, DOI 10.1007/s004320050348; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Davis Y, 2011, TECHNOL INNOV, V13, P51, DOI 10.3727/194982411X13003853540036; Desoize B, 1998, Bull Cancer, V85, P785; Dnace A, 2012, SCIENTIST; do Amaral JB, 2011, TISSUE ENG PART C-ME, V17, P1097, DOI 10.1089/ten.tec.2011.0260; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; ERLANSON M, 1992, CANCER CHEMOTH PHARM, V29, P343, DOI 10.1007/BF00686002; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Gonen-Wadmany M, 2011, BIOMATERIALS, V32, P6025, DOI 10.1016/j.biomaterials.2011.04.055; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Guo LX, 2011, AM J PATHOL, V178, P2357, DOI 10.1016/j.ajpath.2011.01.047; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hedlund TE, 1999, PROSTATE, V41, P154; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WJ, 2010, CANCER SCI, V101, P2637, DOI 10.1111/j.1349-7006.2010.01723.x; Ivascu A, 2007, INT J ONCOL, V31, P1403; Johnson J, 2009, TISSUE ENG PART C-ME, V15, P531, DOI [10.1089/ten.tec.2008.0486, 10.1089/ten.TEC.2008.0486]; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Ma HL, 2012, MOL IMAGING, V11, P487, DOI 10.2310/7290.2012.00012; Mallela J, 2013, STEM CELLS; Masuda S., 2012, NAT REV CLIN ONCOL, V10, P79, DOI [10.1038/nrclinonc.2012.127-c1, DOI 10.1038/NRCLINONC.2012.127-C1]; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; OLIVE PL, 1991, INT J RADIAT BIOL, V60, P453, DOI 10.1080/09553009114552311; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peart TM, 2012, CLIN EXP METASTAS, V29, P293, DOI 10.1007/s10585-011-9451-3; Piskin E, 2007, NANOMEDICINE-UK, V2, P441, DOI 10.2217/17435889.2.4.441; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Samavedi S, 2012, BIOMATERIALS, V33, P7727, DOI 10.1016/j.biomaterials.2012.07.008; Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la034753l; Shin JY, 2012, BIOTECHNOL LETT, V34, P795, DOI 10.1007/s10529-011-0836-9; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Song H, 2004, TISSUE ENG, V10, P1266, DOI 10.1089/1076327041887673; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; StCroix B, 1996, NAT MED, V2, P1204; Sundaramurthi D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045005; Takagi A, 2007, ANTICANCER RES, V27, P45; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Timmins NE, 2005, CELL TISSUE RES, V320, P207, DOI 10.1007/s00441-004-1064-6; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Xie JW, 2008, J BIOMED MATER RES A, V85A, P897, DOI 10.1002/jbm.a.31499; Xie JW, 2006, PHARM RES-DORDR, V23, P1817, DOI 10.1007/s11095-006-9036-z; Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042; Yamashita N, 2013, J CANCER RES CLIN, V139, P739, DOI 10.1007/s00432-013-1376-6; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Yu DG, 2012, CARBOHYD POLYM, V90, P1016, DOI 10.1016/j.carbpol.2012.06.036; Zanatta G, 2012, BRAZ J MED BIOL RES, V45, P125, DOI 10.1590/S0100-879X2011007500163; Zanatta G, 2012, J BIOMED NANOTECHNOL, V8, P211, DOI 10.1166/jbn.2012.1382; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031	77	94	101	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75345	10.1371/journal.pone.0075345	http://dx.doi.org/10.1371/journal.pone.0075345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146752	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400005
J	Qu, Q; Qu, J; Zhan, M; Wu, LX; Zhang, YW; Lou, XY; Fu, LJ; Zhou, HH				Qu, Qiang; Qu, Jian; Zhan, Min; Wu, Lan-Xiang; Zhang, Yi-Wen; Lou, Xiao-Ya; Fu, Li-Juan; Zhou, Hong-Hao			Different Involvement of Promoter Methylation in the Expression of Organic Cation/Carnitine Transporter 2 (OCTN2) in Cancer Cell Lines	PLOS ONE			English	Article							DNA METHYLATION; CATION TRANSPORTER-2; CARNITINE DEFICIENCY; GENE-EXPRESSION; DOWN-REGULATION; CROHN-DISEASE; UP-REGULATION; SLC22A5; ASSOCIATION; IDENTIFICATION	Organic cation/carnitine transporter 2 (OCTN2) is responsible for the cellular uptake of the antineoplastic agent, oxaliplatin. Epigenetic modification is a possible mechanism of altered drug-transporter expression in cancers, leading to altered efficacy of chemotherapeutic drugs. However, the mechanisms governing OCTN2 regulation are not completely understood. In this study, the low levels of OCTN2 in HepG2 and LS174T cells were elevated by the demethylating reagent, decitabine (DCA). To further reveal the epigenetic mechanism of down-regulation of OCTN2, we found that Region-1 within the OCTN2 promoter (spanning -354 to +85) was a determinant of OCTN2 expression in a luciferase reporter assay. Moreover, methylation-specific PCR (MSP) and bisulfite genomic sequencing showed that the degree of individual methylated CpG sites within this region was inversely correlated with the levels of OCTN2 in different cancer cells. Application of DCA to HepG2 and LS174T cells reversed the hypermethylation status of the OCTN2 promoter and increased OCTN2 expression, enhancing cellular uptake of oxaliplatin. Thus, we identified that promoter methylation is responsible for epigenetic down-regulation of OCTN2 in HepG2 and LS174T cells. Given the essential role of OCTN2 in cancer cell uptake of chemotherapeutics, and thus treatment efficacy, pretreatment with a demethylating reagent is a possible strategy for optimizing pharmacotherapies against cancers.	[Qu, Qiang; Qu, Jian; Zhan, Min; Zhang, Yi-Wen; Lou, Xiao-Ya; Zhou, Hong-Hao] Cent S Univ, Xiangya Sch Med, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha 410083, Hunan, Peoples R China; [Wu, Lan-Xiang; Fu, Li-Juan] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China	Central South University; Chongqing Medical University	Zhou, HH (corresponding author), Cent S Univ, Xiangya Sch Med, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha 410083, Hunan, Peoples R China.	hhzhou2003@163.com			China Scholarship Council [201206370103]; National Scientific Foundation of China [81273595, 81072706]; Scientific Foundation of Hunan [11K073, 10JJ4020]; "863" Project [2012AA02A518]; Research Innovation Foundation of Graduate Student in Hunan province, P.R.C [CX2011B056];  [NCET-10-0843]	China Scholarship Council(China Scholarship Council); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Hunan; "863" Project(National High Technology Research and Development Program of China); Research Innovation Foundation of Graduate Student in Hunan province, P.R.C; 	This work was supported by the State Scholarship Fund from China Scholarship Council (File No. 201206370103), the National Scientific Foundation of China (No. 81273595, 81072706), the Scientific Foundation of Hunan (No. 11K073, 10JJ4020), the "863" Project (No. 2012AA02A518), NCET-10-0843 and Research Innovation Foundation of Graduate Student in Hunan province, P.R.C (CX2011B056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini S, 2012, PHARM RES, V68, P1; Aoki M, 2008, AM J PHYSIOL-RENAL, V295, pF165, DOI 10.1152/ajprenal.90257.2008; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Chu SH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-156; D'Argenio G, 2010, J BIOL CHEM, V285, P27078, DOI 10.1074/jbc.M110.109678; Fisher SA, 2006, HUM MUTAT, V27, P778, DOI 10.1002/humu.20358; Grigat S, 2009, DRUG METAB DISPOS, V37, P330, DOI 10.1124/dmd.108.023929; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Imai S, 2009, MOL PHARMACOL, V75, P568, DOI 10.1124/mol.108.052589; Jong NN, 2011, J PHARMACOL EXP THER, V338, P537, DOI 10.1124/jpet.111.181297; Kano T, 2009, DRUG METAB DISPOS, V37, P1009, DOI 10.1124/dmd.108.025015; Kato S, 2009, BIOPHARM DRUG DISPOS, V30, P495, DOI 10.1002/bdd.681; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Kurimoto M, 2013, LEUKEMIA, V27, P233, DOI 10.1038/leu.2012.178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040475; Martin V, 2013, BRIT J CANCER, V108, P2005, DOI 10.1038/bjc.2013.188; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Scalise M, 2012, CELL BIOCHEM FUNCT, V30, P419, DOI 10.1002/cbf.2816; Schaeffeler E, 2011, GENOME MED, V3, DOI 10.1186/gm298; Sheikhnejad G, 1999, J MOL BIOL, V285, P2021, DOI 10.1006/jmbi.1998.2426; Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tang NLS, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9053; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Yamazaki K, 2004, J HUM GENET, V49, P664, DOI 10.1007/s10038-004-0204-x; Yoon YA, 2012, ANN CLIN LAB SCI, V42, P424	32	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76474	10.1371/journal.pone.0076474	http://dx.doi.org/10.1371/journal.pone.0076474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146874	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400062
J	Cheung, SCK; Long, XH; Liu, LZ; Liu, QQ; Lan, LL; Tong, PCY; Sun, SSM				Cheung, Stanley C. K.; Long, Xiaohang; Liu, Lizhong; Liu, Qiaoquan; Lan, Linlin; Tong, Peter C. Y.; Sun, Samuel S. M.			Inhibition of Human MCF-7 Breast Cancer Cells and HT-29 Colon Cancer Cells by Rice-Produced Recombinant Human Insulin-Like Growth Binding Protein-3 (rhIGFBP-3)	PLOS ONE			English	Article							RETICULUM-RETENTION SIGNAL; SYNONYMOUS CODON CHOICE; MONOCLONAL-ANTIBODY; ENDOPLASMIC-RETICULUM; IN-VIVO; RESPECTIVE CODONS; ESCHERICHIA-COLI; TRANSGENIC RICE; RETINOIC ACID; TRANSFER-RNAS	Background: Insulin-like growth factor binding protein-3 (IGFBP-3) is a multifunctional molecule which is closely related to cell growth, apoptosis, angiogenesis, metabolism and senescence. It combines with insulin-like growth factor-I (IGF-I) to form a complex (IGF-I/IGFBP-3) that can treat growth hormone insensitivity syndrome (GHIS) and reduce insulin requirement in patients with diabetes. IGFBP-3 alone has been shown to have anti-proliferation effect on numerous cancer cells. Methodology/Principal Findings: We reported here an expression method to produce functional recombinant human IGFBP-3 (rhIGFBP-3) in transgenic rice grains. Protein sorting sequences, signal peptide and endoplasmic reticulum retention tetrapeptide (KDEL) were included in constructs for enhancing rhIGFBP-3 expression. Western blot analysis showed that only the constructs with signal peptide were successfully expressed in transgenic rice grains. Both rhIGFBP-3 proteins, with or without KDEL sorting sequence inhibited the growth of MCF-7 human breast cancer cells (65.76 +/- 1.72% vs 45.00 +/- 0.86%, p < 0.05; 50.84 +/- 1.97% vs 45.00 +/- 0.86%, p < 0.01 respectively) and HT-29 colon cancer cells (65.14 +/- 3.84% vs 18.01 +/- 13.81%, p < 0.05 and 54.7 +/- 9.44% vs 18.01 +/- 13.81%, p < 0.05 respectively) when compared with wild type rice. Conclusion/Significance: These findings demonstrated the feasibility of producing biological active rhIGFBP-3 in rice using a transgenic approach, which will definitely encourage more research on the therapeutic use of hIGFBP-3 in future.	[Cheung, Stanley C. K.; Long, Xiaohang; Sun, Samuel S. M.] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Cheung, Stanley C. K.; Liu, Lizhong; Lan, Linlin; Tong, Peter C. Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Liu, Qiaoquan] Yangzhou Univ, Coll Agr, Minist Educ, Key Lab Plant Funct Genom, Yangzhou, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Yangzhou University	Sun, SSM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China.	ssun@cuhk.edu.hk	Cheung, Stanley Chun Kai/A-9302-2015		ITC ITF [1907030]; Hong Kong SAR, the Ministry of Science and Technology [2012AA10A302-7, 2011ZX08001-006]; Jiangsu Natural Science Foundation of China [BK2012010]	ITC ITF; Hong Kong SAR, the Ministry of Science and Technology; Jiangsu Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province)	This research was supported by ITC ITF support to the Partner State Key Laboratories in Hong Kong, CUHK Focused Investment Scheme (2nd phase) (Project No. 1907030) Hong Kong SAR, the Ministry of Science and Technology (Project No. 2012AA10A302-7 and 2011ZX08001-006), and the Jiangsu Natural Science Foundation of China (Project No. BK2012010). The funders conceived and designed the experiments, contributed reagents/materials/ analysis tools and made a decision to publish the manuscript.	Alami N, 2008, GROWTH HORM IGF RES, V18, P487, DOI 10.1016/j.ghir.2008.04.002; Ali O, 2003, HORM METAB RES, V35, P726; Barrieu F, 1999, PLANT PHYSIOL, V120, P961, DOI 10.1104/pp.120.4.961; Baxter RC, 2013, J CELL COMMUN SIGNAL; Brosseau C, 2013, INT J CELL BIOL, V2013, P9; Cai H, 2004, BRIT J CANCER, V91, P1364, DOI 10.1038/sj.bjc.6602124; Chang YS, 2006, CANCER BIOL THER, V5, P586, DOI 10.4161/cbt.5.6.2658; Cheung SCK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-37; Cheung SCK, 2009, TRANSGENIC RES, V18, P943, DOI 10.1007/s11248-009-9286-8; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Colston KW, 1998, J MOL ENDOCRINOL, V20, P157, DOI 10.1677/jme.0.0200157; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1999, J ENDOCRINOL, V160, P379, DOI 10.1677/joe.0.1600379; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Forbes K, 2010, ENDOCRINOLOGY, V151, P1723, DOI 10.1210/en.2009-0896; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Greenham Trevor, 2013, Methods Mol Biol, V956, P311, DOI 10.1007/978-1-62703-194-3_22; Gucev ZS, 1996, CANCER RES, V56, P1545; Henderson AJ, 2012, ADV NUTR, V3, P643, DOI 10.3945/an.112.002303; Hood EE, 2002, CURR OPIN BIOTECH, V13, P630, DOI 10.1016/S0958-1669(02)00351-8; Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163; Huynh H, 1996, J BIOL CHEM, V271, P1016, DOI 10.1074/jbc.271.2.1016; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jain MG, 1999, NUTR CANCER, V34, P173, DOI 10.1207/S15327914NC3402_8; Kajiura H, 2013, MOL BIOTECHNOL, V54, P784, DOI 10.1007/s12033-012-9626-4; Kannan A, 2008, J AGR FOOD CHEM, V56, P11643, DOI 10.1021/jf802558v; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Kirman I, 2004, SURGERY, V136, P205, DOI 10.1016/j.surg.2004.04.020; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Kong CKL, 2009, BIOCHEM PHARMACOL, V77, P1487, DOI 10.1016/j.bcp.2009.02.008; Larrick JW, 2001, BIOMOL ENG, V18, P87, DOI 10.1016/S1389-0344(01)00102-2; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Liu Qiao-Quan, 2005, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V31, P247; Liu Qiao-Quan, 2004, Acta Genetica Sinica, V31, P518; Liu QQ, 2003, TRANSGENIC RES, V12, P71, DOI 10.1023/A:1022148824018; Manson MM, 2003, TRENDS MOL MED, V9, P11, DOI 10.1016/S1471-4914(02)00002-3; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Nicodemus KK, 2001, CANCER CAUSE CONTROL, V12, P917, DOI 10.1023/A:1013746719385; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Schouten A, 1996, PLANT MOL BIOL, V30, P781, DOI 10.1007/BF00019011; SMIGEL K, 1992, J NATL CANCER I, V84, P80, DOI 10.1093/jnci/84.2.80; Spok A, 2008, TRENDS BIOTECHNOL, V26, P506, DOI 10.1016/j.tibtech.2008.05.007; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; Stoger E, 2000, PLANT MOL BIOL, V42, P583, DOI 10.1023/A:1006301519427; Sun WG, 2009, J NUTR BIOCHEM, V20, P276, DOI 10.1016/j.jnutbio.2008.03.003; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; Triguero A, 2005, PLANT BIOTECHNOL J, V3, P449, DOI 10.1111/j.1467-7652.2005.00137.x; Triguero A, 2011, PLANT BIOTECHNOL J, V9, P1120, DOI 10.1111/j.1467-7652.2011.00638.x; Verschoyle RD, 2007, BRIT J CANCER, V96, P248, DOI 10.1038/sj.bjc.6603539; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yang LJ, 2006, FEBS LETT, V580, P3315, DOI 10.1016/j.febslet.2006.04.092; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	62	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77516	10.1371/journal.pone.0077516	http://dx.doi.org/10.1371/journal.pone.0077516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143239	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100077
J	Lawton, RJ; Mata, L; de Nys, R; Paul, NA				Lawton, Rebecca J.; Mata, Leonardo; de Nys, Rocky; Paul, Nicholas A.			Algal Bioremediation of Waste Waters from Land-Based Aquaculture Using Ulva: Selecting Target Species and Strains	PLOS ONE			English	Article							MULTI-TROPHIC AQUACULTURE; DISSOLVED INORGANIC NITROGEN; TEMPERATE ATLANTIC SEAWEEDS; GREEN TIDE ALGAE; LOCAL ADAPTATION; ECOTYPIC DIFFERENTIATION; RECIPROCAL TRANSPLANTS; MOLECULAR PHYLOGENY; NUCLEAR RDNA; CHLOROPHYTA	The optimised reduction of dissolved nutrient loads in aquaculture effluents through bioremediation requires selection of appropriate algal species and strains. The objective of the current study was to identify target species and strains from the macroalgal genus Ulva for bioremediation of land-based aquaculture facilities in Eastern Australia. We surveyed land-based aquaculture facilities and natural coastal environments across three geographic locations in Eastern Australia to determine which species of Ulva occur naturally in this region and conducted growth trials at three temperature treatments on a subset of samples from each location to determine whether local strains had superior performance under local environmental conditions. DNA barcoding using the markers ITS and tufA identified six species of Ulva, with U. ohnoi being the most common blade species and U. sp. 3 the most common filamentous species. Both species occurred at multiple land-based aquaculture facilities in Townsville and Brisbane and multiple strains of each species grew well in culture. Specific growth rates of U. ohnoi and U. sp. 3 were high (over 9% and 15% day(-1) respectively) across temperature treatments. Within species, strains of U. ohnoi had higher growth in temperatures corresponding to local conditions, suggesting that strains may be locally adapted. However, across all temperature treatments Townsville strains had the highest growth rates (11.2-20.4% day(-1)) and Sydney strains had the lowest growth rates (2.5-8.3% day(-1)). We also found significant differences in growth between strains of U. ohnoi collected from the same geographic location, highlighting the potential to isolate and cultivate fast growing strains. In contrast, there was no clearly identifiable competitive strain of filamentous Ulva, with multiple species and strains having variable performance. The fast growth rates and broad geographical distribution of U. ohnoi make this an ideal species to target for bioremediation activities at land-based aquaculture facilities in Eastern Australia.	[Lawton, Rebecca J.; Mata, Leonardo; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Lawton, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	rebecca.lawton@jcu.edu.au	Lawton, Rebecca/A-6149-2012; Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014; de Nys, Rocky/D-6741-2012; Mata, Leonardo/D-6733-2012	Lawton, Rebecca/0000-0001-6296-6415; de Nys, Rocky/0000-0003-3869-4928; Mata, Leonardo/0000-0002-5962-2483; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC) through the Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC) through the Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MH, 2011, AQUACULTURE, V312, P77, DOI 10.1016/j.aquaculture.2010.12.036; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Angell A, J PHYCOLOGY IN PRESS; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; Barrington K., 2009, INTEGR MARIC GLOB RE, V529, P7; Bergstrom L, 2006, J PHYCOL, V42, P36, DOI 10.1111/j.1529-8817.2006.00173.x; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Blanchette CA, 2002, MAR ECOL PROG SER, V239, P69, DOI 10.3354/meps239069; Bolton JJ, 2009, J APPL PHYCOL, V21, P575, DOI 10.1007/s10811-008-9385-6; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Chopin T, 2012, REV AQUACULT, V4, P209, DOI 10.1111/j.1753-5131.2012.01074.x; Copertino MD, 2009, J APPL PHYCOL, V21, P31, DOI 10.1007/s10811-008-9357-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DELRIO MJ, 1996, 15 INT SEAW S SPRING, V327, P61; DENNISON WC, 1986, J EXP MAR BIOL ECOL, V98, P265, DOI 10.1016/0022-0981(86)90217-0; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Fowler-Walker MJ, 2006, MAR BIOL, V148, P755, DOI 10.1007/s00227-005-0125-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harper JT, 2001, CAH BIOL MAR, V42, P25; Hayden HS, 2004, PHYCOLOGIA, V43, P364, DOI 10.2216/i0031-8884-43-4-364.1; Hays CG, 2007, ECOLOGY, V88, P149, DOI 10.1890/0012-9658(2007)88[149:APDATI]2.0.CO;2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2004.tb00311.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim JK, 2007, J APPL PHYCOL, V19, P431, DOI 10.1007/s10811-006-9150-7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Kraft LGK, 2010, J PHYCOL, V46, P1257, DOI 10.1111/j.1529-8817.2010.00909.x; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; Msuya FE, 2006, AQUACULTURE, V254, P284, DOI 10.1016/j.aquaculture.2005.10.044; Naylor R, 2005, ANNU REV ENV RESOUR, V30, P185, DOI 10.1146/annurev.energy.30.081804.121034; Neori A, 2003, J APPL PHYCOL, V15, P543, DOI 10.1023/B:JAPH.0000004382.89142.2d; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Neori A, 1991, GROWTH RATE YIELD C, V483; Nobre AM, 2010, AQUACULTURE, V306, P116, DOI 10.1016/j.aquaculture.2010.06.002; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; O' Kelly CJ, 2004, J PHYCOL, V40, P789, DOI 10.1111/j.1529-8817.2004.03204.x; Pakker H, 1996, EUR J PHYCOL, V31, P133, DOI 10.1080/09670269600651301; Pakker H, 1996, EUR J PHYCOL, V31, P123, DOI 10.1080/09670269600651291; Paul NA, 2008, AQUACULTURE, V281, P49, DOI 10.1016/j.aquaculture.2008.05.024; Pedersen A, 2004, J EXP MAR BIOL ECOL, V312, P235, DOI 10.1016/j.jembe.2004.05.021; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Ridler N., 2007, Aquaculture Economics and Management, V11, P99, DOI 10.1080/13657300701202767; Robinson N, 2013, J APPL PHYCOL, V25, P703, DOI 10.1007/s10811-012-9950-x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Silva PHD, 2012, AQUACULT ENV INTERAC, V2, P253, DOI 10.3354/aei00043; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; SUBANDAR A, 1993, J APPL PHYCOL, V5, P455, DOI 10.1007/BF02182738; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MW, 1999, J PHYCOL, V35, P740, DOI 10.1046/j.1529-8817.1999.3540740.x; Taylor R, 2001, BOT MAR, V44, P327, DOI 10.1515/BOT.2001.042; THOMPSON JD, 1991, NEW PHYTOL, V117, P129, DOI 10.1111/j.1469-8137.1991.tb00952.x; Troell M., 2009, FAO Fisheries and Aquaculture Technical Paper, P47; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Voskoboinikov GM, 1996, BOT MAR, V39, P341, DOI 10.1515/botm.1996.39.1-6.341; Woolcott GW, 1999, AUST SYST BOT, V12, P709, DOI 10.1071/SB97034; Yabe T, 2009, LIMNOLOGY, V10, P239, DOI 10.1007/s10201-009-0278-4; Yokoyama H, 2010, AQUACULTURE, V310, P74, DOI 10.1016/j.aquaculture.2010.10.018; Zhou Y, 2006, AQUACULTURE, V252, P264, DOI 10.1016/j.aquaculture.2005.06.046	65	90	92	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77344	10.1371/journal.pone.0077344	http://dx.doi.org/10.1371/journal.pone.0077344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143221	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000325894100058
J	Turk, EM; Das, V; Seibert, RD; Andrulis, ED				Turk, Edward M.; Das, Vaijayanti; Seibert, Ryan D.; Andrulis, Erik D.			The Mitochondrial RNA Landscape of Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST EXOSOME CORE; TRANSCRIPTION INITIATION; NUCLEOTIDE-SEQUENCE; DNA-REPLICATION; RIBOSOMAL-RNA; PROMOTER SEQUENCE; MESSENGER-RNAS; I-TASSER; 3' END; GENOME	Mitochondria are essential organelles that harbor a reduced genome, and expression of that genome requires regulated metabolism of its transcriptome by nuclear-encoded proteins. Despite extensive investigation, a comprehensive map of the yeast mitochondrial transcriptome has not been developed and all of the RNA-metabolizing proteins have not been identified, both of which are prerequisites to elucidating the basic RNA biology of mitochondria. Here, we present a mitochondrial transcriptome map of the yeast S288C reference strain. Using RNAseq and bioinformatics, we show the expression level of all transcripts, revise all promoter, origin of replication, and tRNA annotations, and demonstrate for the first time the existence of alternative splicing, mirror RNAs, and a novel RNA processing site in yeast mitochondria. The transcriptome map has revealed new aspects of mitochondrial RNA biology and we expect it will serve as a valuable resource. As a complement to the map, we present our compilation of all known yeast nuclear-encoded ribonucleases (RNases), and a screen of this dataset for those that are imported into mitochondria. We sought to identify RNases that are refractory to recovery in traditional mitochondrial screens due to an essential function or eclipsed accumulation in another cellular compartment. Using this in silico approach, the essential RNase of the nuclear and cytoplasmic exosome, Dis3p, emerges as a strong candidate. Bioinformatics and in vivo analyses show that Dis3p has a conserved and functional mitochondrial-targeting signal (MTS). A clean and marker-less chromosomal deletion of the Dis3p MTS results in a defect in the decay of intron and mirror RNAs, thus revealing a role for Dis3p in mitochondrial RNA decay.	[Turk, Edward M.; Das, Vaijayanti; Andrulis, Erik D.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Turk, Edward M.; Seibert, Ryan D.] Gilmour Acad, Dept Sci, Gates Mills, OH USA	Case Western Reserve University	Andrulis, ED (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	exa32@case.edu			National Institutes of Health [T32HD007104]; National Institutes of General Medical Sciences [R01 GM0272820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a developmental biology training grant from the National Institutes of Health (T32HD007104) to E.M.T. and the National Institutes of General Medical Sciences (R01 GM0272820) to E.D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1997, NATURE, V387, P5; BALDACCI G, 1982, EMBO J, V1, P987, DOI 10.1002/j.1460-2075.1982.tb01282.x; BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bernardi G, 2005, GENE, V354, P189, DOI 10.1016/j.gene.2005.03.024; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P9693, DOI 10.1021/bi982804l; BISWAS TK, 1990, P NATL ACAD SCI USA, V87, P9338, DOI 10.1073/pnas.87.23.9338; Biswas TK, 1996, GENE, V170, P23, DOI 10.1016/0378-1119(95)00874-8; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; Biswas TK, 1998, GENE, V212, P305, DOI 10.1016/S0378-1119(98)00133-4; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; BORDONNE R, 1987, NUCLEIC ACIDS RES, V15, P7381; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Brachmann CB, 1998, YEAST, V14, P115; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; CHRISTIANSON T, 1983, J BIOL CHEM, V258, P4025; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; Daoud R, 2012, NUCLEIC ACIDS RES, V40, P1728, DOI 10.1093/nar/gkr941; Deshpande AP, 2012, BBA-GENE REGUL MECH, V1819, P930, DOI 10.1016/j.bbagrm.2012.02.003; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Ephrussi B., 1949, UNITES BIOL DOUEES C, P165; FAUGERONFONTY G, 1984, GENE, V32, P459, DOI 10.1016/0378-1119(84)90020-9; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; FOLLEY LS, 1991, GENETICS, V129, P659; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Graham AC, 2009, TRAFFIC, V10, P499, DOI 10.1111/j.1600-0854.2009.00888.x; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; Hagemann R, 2010, MOL GENET GENOMICS, V283, P199, DOI 10.1007/s00438-010-0521-z; Hardwick SW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120028; HENSGENS LAM, 1983, CELL, V32, P379, DOI 10.1016/0092-8674(83)90457-9; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; HOFMANN TJ, 1993, YEAST, V9, P1319, DOI 10.1002/yea.320091205; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; HUDSPETH MES, 1982, CELL, V30, P617, DOI 10.1016/0092-8674(82)90258-6; KINOSHITA N, 1991, MOL CELL BIOL, V11, P5839, DOI 10.1128/MCB.11.12.5839; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Krause K, 2004, NUCLEIC ACIDS RES, V32, P6276, DOI 10.1093/nar/gkh966; KREIKE J, 1986, CURR GENET, V11, P185, DOI 10.1007/BF00420605; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Litvinchuk AV, 2013, EUR J CELL BIOL, V92, P169, DOI 10.1016/j.ejcb.2013.02.001; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mamolen M, 2010, NUCLEIC ACIDS RES, V38, P5507, DOI 10.1093/nar/gkq295; Mamolen M, 2009, BIOCHEM BIOPH RES CO, V390, P529, DOI 10.1016/j.bbrc.2009.09.132; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MORTIMER RK, 1986, GENETICS, V113, P35; MUELLER DM, 1986, J BIOL CHEM, V261, P1816; MUELLER DM, 1986, J BIOL CHEM, V261, P1756; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P7993, DOI 10.1093/nar/10.24.7993; OSINGA KA, 1982, NUCLEIC ACIDS RES, V10, P3617, DOI 10.1093/nar/10.12.3617; OSINGA KA, 1984, EMBO J, V3, P829, DOI 10.1002/j.1460-2075.1984.tb01892.x; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009; Szczesny RJ, 2012, BBA-GENE REGUL MECH, V1819, P1027, DOI 10.1016/j.bbagrm.2011.11.010; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; TRACY RL, 1995, CURR GENET, V28, P205, DOI 10.1007/BF00309779; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; VANOMMEN GJB, 1979, CELL, V18, P511, DOI 10.1016/0092-8674(79)90068-0; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLF K, 1973, MOL GEN GENET, V125, P53, DOI 10.1007/BF00292983; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZHU H, 1989, MOL CELL BIOL, V9, P1507, DOI 10.1128/MCB.9.4.1507; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	110	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78105	10.1371/journal.pone.0078105	http://dx.doi.org/10.1371/journal.pone.0078105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143261	Green Submitted, gold, Green Published			2022-12-25	WOS:000325894100100
J	Johnson, S; Chen, YJ; Phillips, R				Johnson, Stephanie; Chen, Yi-Ju; Phillips, Rob			Poly(dA:dT)-Rich DNAs Are Highly Flexible in the Context of DNA Looping	PLOS ONE			English	Article							TETHERED PARTICLE MOTION; SEQUENCE DEPENDENCE; STRUCTURAL FEATURES; PROMOTER ELEMENTS; ESCHERICHIA-COLI; REPRESSOR; TRANSCRIPTION; FLEXIBILITY; POLY(DA-DT); BINDING	Large-scale DNA deformation is ubiquitous in transcriptional regulation in prokaryotes and eukaryotes alike. Though much is known about how transcription factors and constellations of binding sites dictate where and how gene regulation will occur, less is known about the role played by the intervening DNA. In this work we explore the effect of sequence flexibility on transcription factor-mediated DNA looping, by drawing on sequences identified in nucleosome formation and ligase-mediated cyclization assays as being especially favorable for or resistant to large deformations. We examine a poly(dA:dT)-rich, nucleosome-repelling sequence that is often thought to belong to a class of highly inflexible DNAs; two strong nucleosome positioning sequences that share a set of particular sequence features common to nucleosome-preferring DNAs; and a CG-rich sequence representative of high G+C-content genomic regions that correlate with high nucleosome occupancy in vivo. To measure the flexibility of these sequences in the context of DNA looping, we combine the in vitro single-molecule tethered particle motion assay, a canonical looping protein, and a statistical mechanical model that allows us to quantitatively relate the looping probability to the looping free energy. We show that, in contrast to the case of nucleosome occupancy, G+C content does not positively correlate with looping probability, and that despite sharing sequence features that are thought to determine nucleosome affinity, the two strong nucleosome positioning sequences behave markedly dissimilarly in the context of looping. Most surprisingly, the poly(dA: dT)-rich DNA that is often characterized as highly inflexible in fact exhibits one of the highest propensities for looping that we have measured. These results argue for a need to revisit our understanding of the mechanical properties of DNA in a way that will provide a basis for understanding DNA deformation over the entire range of biologically relevant scenarios that are impacted by DNA deformability.	[Johnson, Stephanie] CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Chen, Yi-Ju] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Johnson, Stephanie] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; University of California System; University of California San Francisco	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu			National Institutes of Health [Northwestern PSOC center] [DP1 OD000217A, R01 GM085286, R01 GM085286-01S1, 1 U54 CA143869]; National Science Foundation; Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	National Institutes of Health [Northwestern PSOC center](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge the support of the National Institutes of Health (www.nih.gov, grant numbers DP1 OD000217A [Director's Pioneer Award], R01 GM085286, R01 GM085286-01S1, and 1 U54 CA143869 [Northwestern PSOC center]). SJ gratefully acknowledges the support of a graduate fellowship from the National Science Foundation (www.nsf.gov), and RP the support of the Fondation Pierre Gilles de Gennes (http://www.fondation-pgg.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Balasubramanian S, 2009, BIOPHYS J, V96, P2245, DOI 10.1016/j.bpj.2008.11.040; Bzymek M, 2001, GENETICS, V158, P527; Cheema AK, 1999, J BACTERIOL, V181, P5296, DOI 10.1128/JB.181.17.5296-5302.1999; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; Forties RA, 2009, NUCLEIC ACIDS RES, V37, P4580, DOI 10.1093/nar/gkp442; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Geggier S, 2011, NUCLEIC ACIDS RES, V39, P1419, DOI 10.1093/nar/gkq932; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; Haeusler AR, 2012, NUCLEIC ACIDS RES, V40, P4432, DOI 10.1093/nar/gks019; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; HOGAN M, 1983, NATURE, V304, P752, DOI 10.1038/304752a0; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Iyer VR, 2012, TRENDS CELL BIOL, V22, P250, DOI 10.1016/j.tcb.2012.02.004; JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547; Johnson S, 2012, NUCLEIC ACIDS RES, V40, P7728, DOI 10.1093/nar/gks473; KUNKEL GR, 1981, NUCLEIC ACIDS RES, V9, P6869, DOI 10.1093/nar/9.24.6869; Kuznetsov SV, 2006, P NATL ACAD SCI USA, V103, P18515, DOI 10.1073/pnas.0608394103; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lilja AE, 2004, J MOL BIOL, V342, P467, DOI 10.1016/j.jmb.2004.07.057; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Manzo C, 2012, BIOPHYS J, V103, P1753, DOI 10.1016/j.bpj.2012.09.006; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; Morgan MA, 2005, BIOPHYS J, V89, P2588, DOI 10.1529/biophysj.105.067728; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; Nishida H, 2013, CURR ISSUES MOL BIOL, V15, P19; Normanno D, 2008, NUCLEIC ACIDS RES, V36, P2505, DOI 10.1093/nar/gkn071; Olson WK, 2011, CURR OPIN STRUC BIOL, V21, P348, DOI 10.1016/j.sbi.2011.03.006; Olson WK, 2004, PHILOS T R SOC A, V362, P1403, DOI 10.1098/rsta.2004.1380; PECK LJ, 1981, NATURE, V292, P375, DOI 10.1038/292375a0; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; PRUNELL A, 1982, EMBO J, V1, P173, DOI 10.1002/j.1460-2075.1982.tb01143.x; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; RHODES D, 1979, NUCLEIC ACIDS RES, V6, P1805, DOI 10.1093/nar/6.5.1805; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Rutkauskas D, 2009, P NATL ACAD SCI USA, V106, P16627, DOI 10.1073/pnas.0904617106; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schulz A, 2000, J MOL BIOL, V300, P709, DOI 10.1006/jmbi.2000.3921; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SERRANO M, 1991, J MOL BIOL, V219, P403, DOI 10.1016/0022-2836(91)90182-6; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; SHRADER TE, 1990, J MOL BIOL, V216, P69, DOI 10.1016/S0022-2836(05)80061-0; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; STRAUSS F, 1981, EUR J BIOCHEM, V118, P215; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2003, P NATL ACAD SCI USA, V100; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136	77	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75799	10.1371/journal.pone.0075799	http://dx.doi.org/10.1371/journal.pone.0075799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146776	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400019
J	Mikalsen, LTG; Dhakal, HP; Bruland, OS; Naume, B; Borgen, E; Nesland, JM; Olsen, DR				Mikalsen, Lars Tore Gyland; Dhakal, Hari Prasad; Bruland, Oyvind S.; Naume, Bjorn; Borgen, Elin; Nesland, Jahn M.; Olsen, Dag Rune			The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients	PLOS ONE			English	Article							ISOLATED TUMOR-CELLS; ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW ANGIOGENESIS; TERM-FOLLOW-UP; MICROVESSEL DENSITY; CANCER-PATIENTS; PROGNOSTIC-FACTORS; CHALKLEY COUNT; IMAGE-ANALYSIS; CLINICOPATHOLOGICAL CORRELATIONS	Angiogenesis quantification, through vessel counting or area estimation in the most vascular part of the tumour, has been found to be of prognostic value across a range of carcinomas, breast cancer included. We have applied computer image analysis to quantify vascular properties pertaining to size, shape and spatial distributions in photographed fields of CD34 stained sections. Aided by a pilot (98 cases), seven parameters were selected and validated on a separate set from 293 breast cancer patients. Two new prognostic markers were identified through continuous Cox regression with endpoints Breast Cancer Specific Survival and Distant Disease Free Survival: The average size of the vessels as measured by their perimeter (p = 0.003 and 0.004, respectively), and the average complexity of the vessel shapes measured by their solidity (p = 0.004 and 0.004). The Hazard ratios for the corresponding median-dichotomized markers were 2.28 (p = 0.005) and 1.89 (p = 0.016) for the mean perimeter and 1.80 (p = 0.041) and 1.55 (p = 0.095) for the shape complexity. The markers were associated with poor histologic type, high grade, necrosis, HR negativity, inflammation, and p53 expression (vessel size only). Both markers were found to strongly influence the prognostic properties of vascular invasion (VI) and disseminated tumour cells in the bone marrow. The latter being prognostic only in cases with large vessels (p = 0.004 and 0.043) or low complexity (p = 0.018 and 0.024), but not in the small or complex vessel groups (p > 0.47). VI was significant in all groups, but showed greater hazard ratios for small and low complexity vessels (6.54-11.2) versus large and high complexity vessels (2.64-3.06). We find that not only the overall amount of produced vasculature in angiogenic hot-spots is of prognostic significance, but also the morphological appearance of the generated vessels, i.e. the size and shape of vessels in the studied hot spots.	[Mikalsen, Lars Tore Gyland] Univ Oslo, Dept Phys, Oslo, Norway; [Dhakal, Hari Prasad; Borgen, Elin; Nesland, Jahn M.] Oslo Univ Hosp HF, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Bruland, Oyvind S.; Naume, Bjorn] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Bruland, Oyvind S.; Naume, Bjorn; Nesland, Jahn M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Olsen, Dag Rune] Univ Bergen, Fac Math & Nat Sci, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen	Mikalsen, LTG (corresponding author), Univ Oslo, Dept Phys, Oslo, Norway.	l.t.g.mikalsen@fys.uio.no		Bruland, Oyvind Sverre/0000-0003-1631-3733	European Union [222741 - METOXIA]	European Union(European Commission)	The financial support from the European Union 7th Framework Programme (grant 222741 - METOXIA) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Belien JAM, 1999, J PATHOL, V189, P309; Braun S, 2005, J CLIN ONCOL, V23, P1623, DOI 10.1200/JCO.2005.10.073; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chlenski A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-138; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; Dhakal HP, 2008, CLIN CANCER RES, V14, P2341, DOI 10.1158/1078-0432.CCR-07-4214; Dhakal HP, 2012, HISTOPATHOLOGY, V61, P350, DOI 10.1111/j.1365-2559.2012.04223.x; Dhakal HP, 2009, HISTOL HISTOPATHOL, V24, P1049, DOI 10.14670/HH-24.1049; Ebrahirnsade S, 2007, PATHOL RES PRACT, V203, P695, DOI 10.1016/j.prp.2007.05.009; Ellis IO, 2003, TUMOURS BREAST FEMAL, P9; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farinha P, 2010, HAEMATOL-HEMATOL J, V95, P2157, DOI 10.3324/haematol.2009.021766; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fox SB, 2004, APMIS, V112, P413, DOI 10.1111/j.1600-0463.2004.apm11207-0803.x; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fox SB, 1997, JNCI-J NATL CANCER I, V89, P1044, DOI 10.1093/jnci/89.14.1044; Gasparini G, 2001, CRIT REV ONCOL HEMAT, V37, P97, DOI 10.1016/S1040-8428(00)00105-0; Hansen S, 2004, HISTOPATHOLOGY, V44, P428, DOI 10.1111/j.1365-2559.2004.01848.x; Hansen S, 2000, CLIN CANCER RES, V6, P139; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jacquemier JD, 1998, J PATHOL, V184, P130; Kato T, 2001, BREAST CANCER RES TR, V65, P203, DOI 10.1023/A:1010668616265; Konerding MA, 1999, BRIT J CANCER, V80, P724, DOI 10.1038/sj.bjc.6690416; Korkolopoulou P, 2005, LEUKEMIA, V19, P894, DOI 10.1038/sj.leu.2403690; Korkolopoulou P, 2003, BRIT J HAEMATOL, V122, P900, DOI 10.1046/j.1365-2141.2003.04527.x; Korkolopoulou P, 2003, LEUKEMIA, V17, P89, DOI 10.1038/sj.leu.2402769; Korkolopoulou P, 2001, LEUKEMIA, V15, P1369, DOI 10.1038/sj.leu.2402220; Korkolopoulou P, 2001, VIRCHOWS ARCH, V438, P603, DOI 10.1007/s004280100400; Laitakari J, 2004, J CLIN PATHOL, V57, P394, DOI 10.1136/jcp.2002.004978; LIOTTA LA, 1976, CANCER RES, V36, P889; Luukkaa H, 2009, J ORAL PATHOL MED, V38, P695, DOI 10.1111/j.1600-0714.2009.00810.x; Luukkaa H, 2007, ACTA OTO-LARYNGOL, V127, P869, DOI 10.1080/00016480601053099; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; McDonnell CO, 2000, EUR J SURG ONCOL, V26, P105, DOI 10.1053/ejso.1999.0753; Mikalsen LTG, 2011, ANTICANCER RES, V31, P4053; Mohammed RAA, 2011, J PATHOL, V223, P358, DOI 10.1002/path.2810; Mucci LA, 2009, J CLIN ONCOL, V27, P5627, DOI 10.1200/JCO.2008.20.8876; Naume B, 2004, CLIN CANCER RES, V10, P3091, DOI 10.1158/1078-0432.CCR-03-0373; Naume B, 2001, CLIN CANCER RES, V7, P4122; Nieto Y, 2007, BRIT J CANCER, V97, P391, DOI 10.1038/sj.bjc.6603875; Offersen BV, 2003, EUR J CANCER, V39, P881, DOI 10.1016/S0959-8049(02)00663-9; Offersen BV, 2002, ACTA ONCOL, V41, P695, DOI 10.1080/028418602321028337; Safali M, 2010, PATHOL RES PRACT, V206, P93, DOI 10.1016/j.prp.2009.10.004; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Taverna G, 2009, PATHOL RES PRACT, V205, P438, DOI 10.1016/j.prp.2008.12.019; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Weidner N, 1999, J PATHOL, V189, P297; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weidner N, 2008, METHOD ENZYMOL, V444, P305, DOI 10.1016/S0076-6879(08)02814-0; West CML, 2001, CANCER RES, V61, P2907; Weyn B, 2004, CLIN ONCOL-UK, V16, P307, DOI 10.1016/j.clon.2004.01.013; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	64	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75954	10.1371/journal.pone.0075954	http://dx.doi.org/10.1371/journal.pone.0075954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146798	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400029
J	Rakus, D; Gizak, A; Kasprzak, AA; Zarzycki, M; Maciaszczyk-Dziubinska, E; Dzugaj, A				Rakus, Dariusz; Gizak, Agnieszka; Kasprzak, Andrzej A.; Zarzycki, Marek; Maciaszczyk-Dziubinska, Ewa; Dzugaj, Andrzej			The Mechanism of Calcium-Induced Inhibition of Muscle Fructose 1,6-bisphosphatase and Destabilization of Glyconeogenic Complex	PLOS ONE			English	Article							GLYCEROL-PHOSPHATE-DEHYDROGENASE; GLYCOLYTIC-ENZYMES; LIVER FRUCTOSE-1,6-BISPHOSPHATASE; SKELETAL-MUSCLE; TERMINAL REGION; AMP INHIBITION; DYNAMIC LOOP; ALDOLASE; FBPASE; LOCALIZATION	The mechanism by which calcium inhibits the activity of muscle fructose 1,6-bisphosphatase (FBPase) and destabilizes its interaction with aldolase, regulating glycogen synthesis from non-carbohydrates in skeletal muscle is poorly understood. In the current paper, we demonstrate evidence that Ca2+ affects conformation of the catalytic loop 52-72 of muscle FBPase and inhibits its activity by competing with activatory divalent cations, e.g. Mg2+ and Zn2+. We also propose the molecular mechanism of Ca2+-induced destabilization of the aldolase-FBPase interaction, showing that aldolase associates with FBPase in its active form, i.e. with loop 52-72 in the engaged conformation, while Ca2+ stabilizes the disengaged-like form of the loop.	[Rakus, Dariusz; Gizak, Agnieszka] Univ Wroclaw, Dept Anim Mol Physiol, PL-50138 Wroclaw, Poland; [Kasprzak, Andrzej A.] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Zarzycki, Marek; Dzugaj, Andrzej] Univ Wroclaw, Depatment Genet, PL-50138 Wroclaw, Poland; [Maciaszczyk-Dziubinska, Ewa] Univ Wroclaw, Dept Genet & Cell Physiol, PL-50138 Wroclaw, Poland	University of Wroclaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Wroclaw; University of Wroclaw	Rakus, D (corresponding author), Univ Wroclaw, Dept Anim Mol Physiol, PL-50138 Wroclaw, Poland.	drakus@biol.uni.wroc.pl	Kasprzak, Andrzej A. A/R-4476-2016; Rakus, Dariusz/AAU-8496-2021	Kasprzak, Andrzej A. A/0000-0002-3602-5379; Rakus, Dariusz/0000-0002-3823-3163; Gizak, Agnieszka/0000-0001-9367-0270; Maciaszczyk-Dziubinska, Ewa/0000-0003-4681-7190; Rakus, Dariusz/0000-0002-3511-0459	Polish Ministry of Science and Higher Education Grant [N N301 069139]; Experimental Biology Institute of Wroclaw University Research Grant	Polish Ministry of Science and Higher Education Grant(Ministry of Science and Higher Education, Poland); Experimental Biology Institute of Wroclaw University Research Grant	This work was partially supported by Polish Ministry of Science and Higher Education Grant [no N N301 069139] and by Experimental Biology Institute of Wroclaw University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Robaiy S, 1999, BIOL CHEM, V380, P1079, DOI 10.1515/BC.1999.134; CASAZZA JP, 1979, J BIOL CHEM, V254, P4661; CHENZION M, 1993, BIOCHEM MED METAB B, V49, P173, DOI 10.1006/bmmb.1993.1020; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; Cornish-Bowden A, 2002, FUNDAMENTALS ENZYME, P95; Dzugaj A, 2006, ADV ENZYME REGUL, V46, P51, DOI 10.1016/j.advenzreg.2006.01.021; Fournier PA, 2002, COMP BIOCHEM PHYS A, V133, P755, DOI 10.1016/S1095-6433(02)00254-4; Gizak A, 2004, FEBS LETT, V576, P445, DOI 10.1016/j.febslet.2004.09.050; Gizak A, 2008, PROTEINS, V72, P209, DOI 10.1002/prot.21909; Gizak A, 2013, BBA-MOL CELL RES, V1833, P622, DOI 10.1016/j.bbamcr.2012.11.028; GODING JW, 1976, J IMMUNOL METHODS, V13, P215, DOI 10.1016/0022-1759(76)90068-5; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; KE HM, 1991, P NATL ACAD SCI USA, V88, P2989, DOI 10.1073/pnas.88.8.2989; Kowalski W, 2012, J CELL PHYSIOL, V227, P2613, DOI 10.1002/jcp.22998; Kowalski W, 2009, FEBS LETT, V583, P1841, DOI 10.1016/j.febslet.2009.05.004; Kraft T, 2000, J MUSCLE RES CELL M, V21, P691, DOI 10.1023/A:1005623002979; Mamczur P, 2005, FEBS LETT, V579, P1607, DOI 10.1016/j.febslet.2005.01.071; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; Rakus D, 2000, BIOCHEM BIOPH RES CO, V275, P611, DOI 10.1006/bbrc.2000.3308; Rakus D, 2004, BIOCHEMISTRY-US, V43, P14948, DOI 10.1021/bi048886x; Rakus D, 2003, FEBS LETT, V547, P11, DOI 10.1016/S0014-5793(03)00661-6; Rakus D, 2003, BIOL CHEM, V384, P51, DOI 10.1515/BC.2003.006; Rakus D, 2000, COMP BIOCHEM PHYS B, V127, P123, DOI 10.1016/S0305-0491(00)00245-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; VERTESSY B, 1987, EUR J BIOCHEM, V164, P655, DOI 10.1111/j.1432-1033.1987.tb11176.x; VERTESSY BG, 1991, BIOCHIM BIOPHYS ACTA, V1078, P236, DOI 10.1016/0167-4838(91)90564-G; Vertessy BG, 1997, J BIOL CHEM, V272, P25542, DOI 10.1074/jbc.272.41.25542; Zarzycki M, 2007, FEBS LETT, V581, P1347, DOI 10.1016/j.febslet.2007.02.051; Zhang RL, 1996, BIOCHEMISTRY-US, V35, P3038, DOI 10.1021/bi952188i; ZHANG YP, 1994, J MOL BIOL, V244, P609, DOI 10.1006/jmbi.1994.1755	35	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76669	10.1371/journal.pone.0076669	http://dx.doi.org/10.1371/journal.pone.0076669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146906	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400072
J	Forster, A; Kerl, HU; Wenz, H; Brockmann, MA; Nolte, I; Groden, C				Foerster, Alex; Kerl, Hans Ulrich; Wenz, Holger; Brockmann, Marc A.; Noelte, Ingo; Groden, Christoph			Diffusion- and Perfusion-Weighted Imaging in Acute Lacunar Infarction: Is There a Mismatch?	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PROGRESSIVE MOTOR DEFICITS; INTRAVENOUS THROMBOLYSIS; PROGNOSIS; CLASSIFICATION; PATHOLOGY; SOFTWARE; SUBTYPES; BRAIN	Purpose: Characterization of lacunar infarction (LI) by use of multimodal MRI including diffusion-and perfusion-weighted imaging (DWI, PWI) is difficult because of the small lesion size. Only a few studies evaluated PWI in LI and the results are inconsistent. Methods: In 16 LI patients who underwent initial MRI within 6 hours after symptom onset and follow-up MRI within 1 week demographics, clinical presentation, and MRI findings were analyzed with special emphasis on DWI and PWI findings. Time to peak maps were classified as showing a normal perfusion pattern or areas of hypoperfusion which were further categorized in mismatch (PWI>DWI), inverse mismatch (PWI<DWI), and match (PWI=DWI). Quantitative perfusion maps were generated and analyzed by use of Signal Processing in NMR-Software (SPIN). Results: Of the 16 patients (mean age 65.5 +/- 12.9 years), 14 (87.5%) were male. Clinical symptoms comprised dysarthria (50%), hemiparesis (81.3%), and hemihypaesthesia (18.8%). Intravenous thrombolysis was performed in 7 (43.8%) patients. Clinical improvement was observed in 12 patients (75 %), while 2 (12.5%) patients showed a deterioration and another 2 (12.5%) a stable course. Acute ischemic lesions (mean volume of 0.46 +/- 0.29 cm(3)) were located in the thalamus (n=8, 50%), internal capsule (n=4, 25%), corona Radiata (n=3, 18.8%) and the mesencephalon (n=1, 6.3%). Circumscribed hypoperfusion (mean volume 0.61 +/- 0.48 cm(3)) was evident in 10 (62.5%) patients. Of these, 3 patients demonstrated a match, 4 an inverse mismatch, and 3 a mismatch between DWI and PWI lesion. Mean CBF and CBV ratios were 0.65 +/- 0.28 and 0.84 +/- 0.41 respectively. Growth of DWI lesions was observed in 7 (43.8%) and reversal of DWI lesions in 3 (18.8%) patients. Conclusions: MRI allows identification of different DWI and PWI patterns in LI, including growth and reversal of ischemic lesions. Consequently, it may serve for a better characterization of this stroke subtype and support treatment decisions in daily clinical practice.	[Foerster, Alex; Kerl, Hans Ulrich; Wenz, Holger; Brockmann, Marc A.; Noelte, Ingo; Groden, Christoph] Heidelberg Univ, Dept Neuroradiol, Univ Med Mannheim, Heidelberg, Germany; [Brockmann, Marc A.] Rhein Westfal TH Aachen, Univ Hosp, Dept Diagnost & Intervent Neuroradiol, D-52062 Aachen, Germany	Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital	Forster, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Univ Med Mannheim, Heidelberg, Germany.	Alex.Foerster@umm.de						ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arnold M, 2004, STROKE, V35, P1135, DOI 10.1161/01.STR.0000125862.55804.29; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Caplan LR, 1997, NEW ENGL J MED, V337, P1309; Chalela JA, 2003, J NEUROIMAGING, V13, P152, DOI 10.1177/1051228403251260; Doege CA, 2003, AM J NEURORADIOL, V24, P1355; Fiebach JB, 2010, EUR RADIOL, V20, P2983, DOI 10.1007/s00330-010-1858-8; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Forster A, 2010, CEREBROVASC DIS, V29, P389, DOI 10.1159/000286341; Fuentes B, 2012, EUR J NEUROL, V19, P1568, DOI 10.1111/j.1468-1331.2012.03790.x; Galinovic I, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-16; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Huck S, 2012, CLIN NEURORADIOL, V22, P29, DOI 10.1007/s00062-011-0126-x; Lahoti SA, 2012, INT J STROKE; Lammie GA, 2000, BRIT MED BULL, V56, P296, DOI 10.1258/0007142001903229; Lee SJ, 2010, STROKE, V41, P2587, DOI 10.1161/STROKEAHA.110.586248; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mustanoja S, 2011, STROKE, V42, P102, DOI 10.1161/STROKEAHA.110.597534; Nakamura K, 1999, NEUROLOGY, V52, P29, DOI 10.1212/WNL.52.1.29; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Poppe AY, 2009, CEREBROVASC DIS, V28, P151, DOI 10.1159/000225908; Restrepo L, 2005, J NEUROIMAGING, V15, P254, DOI 10.1177/1051228405275199; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sacco S, 2006, NEUROLOGY, V66, P1335, DOI 10.1212/01.wnl.0000210457.89798.0e; Shobha N, 2012, INT J STROKE; Steinke W, 2002, STROKE, V33, P1510, DOI 10.1161/01.STR.0000016326.78014.FE; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; Weidauer S, 2004, EUR RADIOL, V14, P1615, DOI 10.1007/s00330-004-2303-7; Weimar C, 2007, NERVENARZT, V78, P957, DOI 10.1007/s00115-007-2268-2; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687	31	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77428	10.1371/journal.pone.0077428	http://dx.doi.org/10.1371/journal.pone.0077428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130885	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200087
J	Lips, KS; Kauschke, V; Hartmann, S; Thormann, U; Ray, S; Kampschulte, M; Langheinrich, A; Schumacher, M; Gelinsky, M; Heinemann, S; Hanke, T; Kautz, AR; Schnabelrauch, M; Schnettler, R; Heiss, C; Alt, V; Kilian, O				Lips, Katrin Susanne; Kauschke, Vivien; Hartmann, Sonja; Thormann, Ulrich; Ray, Seemun; Kampschulte, Marian; Langheinrich, Alexander; Schumacher, Matthias; Gelinsky, Michael; Heinemann, Sascha; Hanke, Thomas; Kautz, Armin R.; Schnabelrauch, Matthias; Schnettler, Reinhard; Heiss, Christian; Alt, Volker; Kilian, Olaf			Podoplanin Immunopositive Lymphatic Vessels at the Implant Interface in a Rat Model of Osteoporotic Fractures	PLOS ONE			English	Article							CALCIUM-PHOSPHATE PHASES; PLATELET-AGGREGATION; EPIDERMAL-KERATINOCYTES; MECHANICAL-PROPERTIES; MEMBRANE-PROTEIN; BONE; CELLS; EXPRESSION; DIFFERENTIATION; CLONING	Insertion of bone substitution materials accelerates healing of osteoporotic fractures. Biodegradable materials are preferred for application in osteoporotic patients to avoid a second surgery for implant replacement. Degraded implant fragments are often absorbed by macrophages that are removed from the fracture side via passage through veins or lymphatic vessels. We investigated if lymphatic vessels occur in osteoporotic bone defects and whether they are regulated by the use of different materials. To address this issue osteoporosis was induced in rats using the classical method of bilateral ovariectomy and additional calcium and vitamin deficient diet. In addition, wedge-shaped defects of 3, 4, or 5 mm were generated in the distal metaphyseal area of femur via osteotomy. The 4 mm defects were subsequently used for implantation studies where bone substitution materials of calcium phosphate cement, composites of collagen and silica, and iron foams with interconnecting pores were inserted. Different materials were partly additionally functionalized by strontium or bisphosphonate whose positive effects in osteoporosis treatment are well known. The lymphatic vessels were identified by immunohistochemistry using an antibody against podoplanin. Podoplanin immunopositive lymphatic vessels were detected in the granulation tissue filling the fracture gap, surrounding the implant and growing into the iron foam through its interconnected pores. Significant more lymphatic capillaries were counted at the implant interface of composite, strontium and bisphosphonate functionalized iron foam. A significant increase was also observed in the number of lymphatics situated in the pores of strontium coated iron foam. In conclusion, our results indicate the occurrence of lymphatic vessels in osteoporotic bone. Our results show that lymphatic vessels are localized at the implant interface and in the fracture gap where they might be involved in the removal of lymphocytes, macrophages, debris and the implants degradation products. Therefore the lymphatic vessels are involved in implant integration and fracture healing.	[Lips, Katrin Susanne; Kauschke, Vivien; Hartmann, Sonja; Ray, Seemun; Schnettler, Reinhard; Kilian, Olaf] Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany; [Thormann, Ulrich; Schnettler, Reinhard; Heiss, Christian; Alt, Volker] Univ Giessen, Univ Hosp Giessen, Dept Trauma Surg Giessen, D-35390 Giessen, Germany; [Kampschulte, Marian] Univ Giessen, Dept Radiol, D-35390 Giessen, Germany; [Langheinrich, Alexander] BG Trauma Hosp, Dept Diagnost & Intervent Radiol, Frankfurt, Germany; [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Fac Med, D-01062 Dresden, Germany; [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Univ Hosp, D-01062 Dresden, Germany; [Heinemann, Sascha; Hanke, Thomas] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany; [Heinemann, Sascha; Hanke, Thomas] Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany; [Kautz, Armin R.; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany; [Kilian, Olaf] Zentralklin, Dept Orthoped & Trauma, Bad Berka, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; Justus Liebig University Giessen; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Zentralklinik Bad Berka	Lips, KS (corresponding author), Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany.	Katrin.S.Lips@chiru.med.uni-giessen.de	Schumacher, Matthias/I-1530-2013; Gelinsky, Michael/A-9680-2012	Schumacher, Matthias/0000-0001-7207-7355; Gelinsky, Michael/0000-0001-9075-5121	Deutsche Forschungsgesellschaft DFG [SFB/TRR 79]	Deutsche Forschungsgesellschaft DFG(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgesellschaft DFG (SFB/TRR 79 projects B7, T1, T2 M2, M3 and Z3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024; Bellini C, 2012, LYMPHOLOGY, V45, P34; Boivin G., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P538; BOS I, 1990, PATHOL RES PRACT, V186, P707, DOI 10.1016/S0344-0338(11)80260-8; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Cheriyan T, 2013, ACTA BIOMATER, V9, P5751, DOI 10.1016/j.actbio.2012.11.010; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Edwards J, 2008, ACTA ORTHOP, V79, P289, DOI 10.1080/17453670710015175; Edwards JR, 2008, HUM PATHOL, V39, P49, DOI 10.1016/j.humpath.2007.04.022; Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7; Ekwall AKH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3274; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Gehlert S, 2010, LYMPHAT RES BIOL, V8, P165, DOI 10.1089/lrb.2009.0035; Goldhahn J, 2008, BONE, V43, P343, DOI 10.1016/j.bone.2008.04.017; Govindarajan P, 2013, MED SCI MONIT BASIC, V19, P76, DOI 10.12659/MSMBR.883815; Guo ML, 2010, ACTA CRYSTALLOGR E, V67, pm19; Heinemann S, 2013, ACTA BIOMATER, V9, P4878, DOI 10.1016/j.actbio.2012.10.010; Heinemann S, 2011, ACS APPL MATER INTER, V3, P4323, DOI 10.1021/am200993q; Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029; Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Kaji C, 2012, J ANAT, V220, P435, DOI 10.1111/j.1469-7580.2012.01484.x; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kashima TG, 2011, SPINE, V36, P899, DOI 10.1097/BRS.0b013e3182050284; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Kilian O, 2008, BIOMATERIALS, V29, P3429, DOI 10.1016/j.biomaterials.2008.05.003; Kotani M, 2002, J NEUROSCI RES, V67, P595, DOI 10.1002/jnr.10150; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Liang P, 2005, ANTICANCER RES, V25, P2705; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Mkonyi LE, 2012, J DENT RES, V91, P71, DOI 10.1177/0022034511424747; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; PENG Z, 1994, BONE, V15, P523, DOI 10.1016/8756-3282(94)90276-3; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Sabokbar A, 1996, ACTA ORTHOP SCAND, V67, P593, DOI 10.3109/17453679608997763; Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414; Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009; Scholl FG, 2000, LAB INVEST, V80, P1749, DOI 10.1038/labinvest.3780185; Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014; Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; Vanderbilt JN, 1998, AM J RESP CELL MOL, V19, P662, DOI 10.1165/ajrcmb.19.4.3121; WATANABE M, 1990, CANCER RES, V50, P6657; Wessel JM, 2012, INVEST OPHTH VIS SCI, V53, P3717, DOI 10.1167/iovs.12-9507; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; WRONSKI TJ, 1985, CALCIFIED TISSUE INT, V37, P324, DOI 10.1007/BF02554882; Xu YJ, 2011, ONCOL REP, V25, P599, DOI 10.3892/or.2011.1141; Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus	57	2	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77259	10.1371/journal.pone.0077259	http://dx.doi.org/10.1371/journal.pone.0077259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130867	Green Submitted, Green Published, gold			2022-12-25	WOS:000325810900131
J	Moreno, R; Jover, L; Diez, C; Sarda, F; Sanpera, C				Moreno, Rocio; Jover, Lluis; Diez, Carmen; Sarda, Francesc; Sanpera, Carola			Ten Years after the Prestige Oil Spill: Seabird Trophic Ecology as Indicator of Long-Term Effects on the Coastal Marine Ecosystem	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; FOOD-WEB; NATURAL VARIABILITY; CATHARACTA-SKUA; EUROPEAN SHAGS; NORTH-SEA; RECRUITMENT; FISHERIES; ATLANTIC; POSITION	Major oil spills can have long-term impacts since oil pollution does not only result in acute mortality of marine organisms, but also affects productivity levels, predator-prey dynamics, and damages habitats that support marine communities. However, despite the conservation implications of oil accidents, the monitoring and assessment of its lasting impacts still remains a difficult and daunting task. Here, we used European shags to evaluate the overall, lasting effects of the Prestige oil spill (2002) on the affected marine ecosystem. Using delta N-15 and Hg analysis, we trace temporal changes in feeding ecology potentially related to alterations of the food web due to the spill. Using climatic and oceanic data, we also investigate the influence of North Atlantic Oscillation (NAO) index, the sea surface temperature (SST) and the chlorophyll a (Chl a) on the observed changes. Analysis of delta N-15 and Hg concentrations revealed that after the Prestige oil spill, shag chicks abruptly switched their trophic level from a diet based on a high percentage of demersal-benthic fish to a higher proportion of pelagic/semi-pelagic species. There was no evidence that Chl a, SST and NAO reflected any particular changes or severity in environmental conditions for any year or season that may explain the sudden change observed in trophic level. Thus, this study highlighted an impact on the marine food web for at least three years. Our results provide the best evidence to date of the long-term consequences of the Prestige oil spill. They also show how, regardless of wider oceanographic variability, lasting impacts on predator-prey dynamics can be assessed using biochemical markers. This is particularly useful if larger scale and longer term monitoring of all trophic levels is unfeasible due to limited funding or high ecosystem complexity.	[Moreno, Rocio; Sanpera, Carola] Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain; [Jover, Lluis] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona 7, Spain; [Diez, Carmen] Univ Vigo, Dept Ecol & Biol Anim, Fac Ciencias, Galicia, Spain; [Sarda, Francesc] ICO, Museu Zool, Barcelona, Spain; [Sarda, Francesc] CTFC, Area Biodiversitat, Solsona, Spain	University of Barcelona; University of Barcelona; Universidade de Vigo; Centre Tecnologic Forestal de Catalunya (CTFC)	Moreno, R (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain.	rocio@rociomoreno.com	Jover, Lluís/D-2192-2011; sanpera, carolina/B-5461-2013	Jover, Lluís/0000-0003-0631-1398; sanpera, carolina/0000-0002-5198-6514; Sarda-Palomera, Francesc/0000-0002-3121-9182	FPU grant ("Ministerio de Educacion y Ciencia", Spain); Spanish "Ministerio de Educacion y Ciencia" [VEM2004-08524]; Spanish "Ministerio de Ciencia e Innovacion" [CGL2008-05448-C02-C01, CGL2008-05448-C02-C02]	FPU grant ("Ministerio de Educacion y Ciencia", Spain)(German Research Foundation (DFG)); Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	R. Moreno was supported by an FPU grant ("Ministerio de Educacion y Ciencia", Spain). Funding for this work was provided by project VEM2004-08524 from the Spanish "Ministerio de Educacion y Ciencia" and CGL2008-05448-C02-C01 and CGL2008-05448-C02-C02 from the Spanish "Ministerio de Ciencia e Innovacion". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott SA, 2002, MAR ECOL PROG SER, V238, P199, DOI 10.3354/meps238199; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Azeiteiro UM, 2006, ESTUAR COAST SHELF S, V69, P554, DOI 10.1016/j.ecss.2006.05.023; Baker JM, 1999, PURE APPL CHEM, V71, P135, DOI 10.1351/pac199971010135; BARRETT RT, 1991, SARSIA, V76, P153, DOI 10.1080/00364827.1991.10413470; Barrett RT, 2002, MAR ECOL PROG SER, V230, P275, DOI 10.3354/meps230275; BARRETT RT, 1990, MAR ECOL PROG SER, V66, P205, DOI 10.3354/meps066205; Bearhop S, 2000, MAR POLLUT BULL, V40, P181, DOI 10.1016/S0025-326X(99)00205-2; Becker PH, 2002, MAR ECOL PROG SER, V243, P261, DOI 10.3354/meps243261; BOTAS JA, 1990, ESTUAR COAST SHELF S, V30, P185, DOI 10.1016/0272-7714(90)90063-W; Burnham K. P., 1998, MODEL SELECTION INFE; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Figueiras FG, 2002, HYDROBIOLOGIA, V484, P121, DOI 10.1023/A:1021309222459; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox CJ, 2000, J SEA RES, V44, P159, DOI 10.1016/S1385-1101(00)00039-3; Fraga F., 1981, COASTAL UPWELLING, P176, DOI [10.1029/co001p0176, DOI 10.1029/C0001P0176, DOI 10.1029/CO001P0176]; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Garshelis DL, 2001, J APPL ECOL, V38, P19, DOI 10.1046/j.1365-2664.2001.00563.x; Golet GH, 2002, MAR ECOL PROG SER, V241, P287, DOI 10.3354/meps241287; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P1530, DOI 10.1016/j.icesjms.2006.05.009; Guterman L, 2009, SCIENCE, V323, P1558, DOI 10.1126/science.323.5921.1558; Hebert CE, 2008, ECOLOGY, V89, P891, DOI 10.1890/07-1603.1; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5618, DOI 10.1021/es0520619; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5624, DOI 10.1021/es0520621; Hebert CE, 2009, OECOLOGIA, V160, P15, DOI 10.1007/s00442-009-1285-1; Henderson PA, 1998, J SEA RES, V40, P131, DOI 10.1016/S1385-1101(98)00020-3; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Kerr R, 2010, SCIENCE, V328, P674, DOI 10.1126/science.328.5979.674; Lens S, 1986, B I ESP OCEANOGR, V3, P5; Martinez-Abrain A, 2006, MAR ECOL PROG SER, V318, P271, DOI 10.3354/meps318271; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Michener R.H., 1994, P138; Miller AK, 2004, MAR ECOL PROG SER, V281, P207, DOI 10.3354/meps281207; Montevecchi WA, 2007, MAR ECOL PROG SER, V352, P213, DOI 10.3354/meps07075; Moore J, 2006, LONG TERM ECOLOGICAL; Moreno R, 2011, MAR ECOL PROG SER, V442, P229, DOI 10.3354/meps09420; Moreno R, 2011, ENVIRON POLLUT, V159, P2454, DOI 10.1016/j.envpol.2011.06.033; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Parker KR, 2005, ECOL APPL, V15, P2037, DOI 10.1890/04-1723; Penela-Arenaz M, 2009, ADV MAR BIOL, V56, P1, DOI [10.1016/S0065-2881(09)56001-4, DOI 10.1016/S0065-2881(09)56001-4.PUBMED:19895974]; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Punzon A, 2005, ICES COUNC M; Sanchez F, 2003, 14 IEO, P8; Sanpera C, 2008, SCI TOTAL ENVIRON, V407, P242, DOI 10.1016/j.scitotenv.2008.07.052; Serrano A, 2006, MAR POLLUT BULL, V53, P315, DOI 10.1016/j.marpolbul.2005.09.030; Sheppard C, 2006, MAR POLLUT B, V52, P238; Signa G, 2008, CONT SHELF RES, V28, P2659, DOI 10.1016/j.csr.2008.08.008; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Thompson DR, 1998, SCI TOTAL ENVIRON, V213, P299, DOI 10.1016/S0048-9697(98)00103-X; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Varela M, 2006, MAR POLLUT BULL, V53, P272, DOI 10.1016/j.marpolbul.2005.10.005; Velando A, 2005, MAR ECOL PROG SER, V302, P263, DOI 10.3354/meps302263; Velando A, 2005, J ORNITHOL, V146, P116, DOI 10.1007/s10336-004-0068-z; Vieites DR, 2004, NATURWISSENSCHAFTEN, V91, P535, DOI 10.1007/s00114-004-0572-2; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x	61	39	40	1	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77360	10.1371/journal.pone.0077360	http://dx.doi.org/10.1371/journal.pone.0077360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130877	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900133
J	Gellert, M; Venz, S; Mitlohner, J; Cott, C; Hanschmann, EM; Lillig, CH				Gellert, Manuela; Venz, Simone; Mitloehner, Jessica; Cott, Catherine; Hanschmann, Eva-Maria; Lillig, Christopher Horst			Identification of a Dithiol-disulfide Switch in Collapsin Response Mediator Protein 2 (CRMP2) That Is Toggled in a Model of Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Neurodifferentiation; Redox Regulation; Redox Signaling; Thiol; CRMP2; Glutaredoxin; Neuronal Differentiation; Redox Switch	HUMAN GLUTAREDOXIN-2; EXPRESSION PATTERN; SIGNALING PATHWAYS; AXON GUIDANCE; THIOREDOXIN; MITOCHONDRIAL; MECHANISMS; THIOLTRANSFERASE; PHOSPHORYLATION; INVOLVEMENT	Background: Cytosolic glutaredoxin 2 (Grx2) is essential for neuronal development in zebrafish; collapsin response mediator protein 2 (CRMP2) was identified as Grx2 substrate. Results: Oxidation of CRMP2 by hydrogen peroxide induces an intermolecular disulfide, changes in -helical content, and hydrophobicity. Conclusion: The dithiol-disulfide redox switch defines two conformations of CRMP2. Significance: This switch may be functional during axonal outgrowth. Vertebrate-specific glutaredoxin 2 (Grx2) is expressed in at least two isoforms, mitochondrial Grx2a and cytosolic Grx2c. We have previously shown that cytosolic Grx2 is essential for embryonic development of the brain. In particular, we identified collapsin response mediator protein 2 (CRMP2/DPYSL2), a mediator of the semaphorin-plexin signaling pathway, as redox-regulated target of Grx2c and demonstrated that this regulation is required for normal axonal outgrowth. In this study, we demonstrate the molecular mechanism of this regulation, a specific and reversible intermolecular Cys-504-Cys-504 dithiol-disulfide switch in homotetrameric CRMP2. This switch determines two conformations of the quaternary CRMP2 complex that controls axonal outgrowth and thus neuronal development.	[Gellert, Manuela; Venz, Simone; Mitloehner, Jessica; Hanschmann, Eva-Maria; Lillig, Christopher Horst] Ernst Moritz Arndt Univ Greifswald, Univ Med, Inst Med Biochem & Mol Biol, D-17475 Greifswald, Germany; [Cott, Catherine] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Freiburg	Lillig, CH (corresponding author), Univ Med Greifswald, Inst Med Biochem & Mol Biol, J03 33 Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.	horst@lillig.de	Lillig, Christopher Horst/AAD-7098-2019; Hanschmann, Eva-Maria/AAS-9261-2021	Lillig, Christopher Horst/0000-0003-2509-5117; Gellert, Manuela/0000-0002-2545-7125	Deutsche Forschungsgemeinschaft [DFG SFB593-N01]; Science Networks (Forschungsverbunde) Neuroscience and Molecular Medicine, University Medicine Greifswald	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science Networks (Forschungsverbunde) Neuroscience and Molecular Medicine, University Medicine Greifswald	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SFB593-N01) and start-up funding by the Science Networks (Forschungsverbunde) Neuroscience and Molecular Medicine, University Medicine Greifswald.	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Beydoun A, 2009, EXPERT REV NEUROTHER, V9, P33, DOI 10.1586/14737175.9.1.33; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Hudemann C, 2009, ANTIOXID REDOX SIGN, V11, P1, DOI 10.1089/ars.2008.2068; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Nadella M, 2005, P NATL ACAD SCI USA, V102, P16830, DOI 10.1073/pnas.0504838102; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Patrakitkomjorn S, 2008, J BIOL CHEM, V283, P9399, DOI 10.1074/jbc.M708206200; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Schutte LD, 2013, BBA-GEN SUBJECTS, V1830, P4999, DOI 10.1016/j.bbagen.2013.07.009; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uchida Y, 2009, J BIOL CHEM, V284, P27393, DOI 10.1074/jbc.M109.000240; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang LH, 1997, J NEUROCHEM, V69, P2261	48	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35117	35125		10.1074/jbc.M113.521443	http://dx.doi.org/10.1074/jbc.M113.521443			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133216	hybrid, Green Published			2022-12-25	WOS:000329867600013
J	Tukey, DS; Ziff, EB				Tukey, David S.; Ziff, Edward B.			Ca2+-permeable AMPA (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Receptors and Dopamine D1 Receptors Regulate GluA1 Trafficking in Striatal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine; Glutamate; Glutamate Receptors; Neurons; Synaptic Plasticity; Dopamine; AMPA Receptor; Striatum; Nucleus Accumbens; GluA1; Medium Spiny Neurons; cGKII; cGMP	LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; MEDIUM SPINY NEURONS; D-ASPARTATE RECEPTOR; RECORDED IN-VIVO; SYNAPTIC PLASTICITY; ADENYLYL-CYCLASE; GUANYLYL CYCLASE; MEMBRANE EXCITABILITY; STIMULATION INCREASES	Regulation of striatal medium spiny neuron synapses underlies forms of motivated behavior and pathological drug seeking. A primary mechanism for increasing synaptic strength is the trafficking of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) into the postsynapse, a process mediated by GluA1 AMPAR subunit phosphorylation. We have examined the role of converging glutamate and dopamine inputs in regulating biochemical cascades upstream of GluA1 phosphorylation. We focused on the role of Ca2+-permeable AMPARs (CPARs), which lack the GluA2 AMPAR subunit. Under conditions that prevented depolarization, stimulation of CPARs activated neuronal nitric oxide synthase and production of cGMP. CPAR-dependent cGMP production was sufficient to induce synaptic insertion of GluA1, detected by confocal microscopy, through a mechanism dependent on GluA1 Ser-845 phosphorylation. Dopamine D1 receptors, in contrast, stimulate GluA1 extra synaptic insertion. Simultaneous activation of dopamine D1 receptors and CPARs induced additive increases in GluA1 membrane insertion, but only CPAR stimulation augmented CPAR-dependent GluA1 synaptic insertion. This incorporation into the synapse proceeded through a sequential two-step mechanism; that is, cGMP-dependent protein kinase II facilitated membrane insertion and/or retention, and protein kinase C activity was necessary for synaptic insertion. These data suggest a feed-forward mechanism for synaptic priming whereby an initial stimulus acting independently of voltage-gated conductance increases striatal neuron excitability, facilitating greater neuronal excitation by a subsequent stimulus.	[Tukey, David S.; Ziff, Edward B.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Ziff, EB (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave, New York, NY 10016 USA.	edward.ziff@nyumc.org		Ziff, Edward/0000-0001-7389-8649	National Institutes of Health [R01NS06192, R01MH67229]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229, F31MH076617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS06192 (CPAR studies) and R01MH67229 (cGKII studies) (to E. B. Z.)	Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P651, DOI 10.1152/jn.1990.63.4.651; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Carra KD, 2010, NEUROSCIENCE, V165, P1074, DOI 10.1016/j.neuroscience.2009.11.015; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Cooper DMF, 1998, J BIOL CHEM, V273, P27703, DOI 10.1074/jbc.273.42.27703; Corona JC, 2007, NEUROPHARMACOLOGY, V52, P1219, DOI 10.1016/j.neuropharm.2006.12.008; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kheirbek MA, 2008, J NEUROSCI, V28, P11401, DOI 10.1523/JNEUROSCI.4115-08.2008; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mahajan SS, 2007, MOL CELL NEUROSCI, V35, P470, DOI 10.1016/j.mcn.2007.04.006; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Marcoli M, 2006, NEUROCHEM INT, V49, P683, DOI 10.1016/j.neuint.2006.06.009; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; Sammut S, 2006, NEUROPSYCHOPHARMACOL, V31, P493, DOI 10.1038/sj.npp.1300826; Sammut S, 2010, NEUROPHARMACOLOGY, V58, P624, DOI 10.1016/j.neuropharm.2009.11.011; Schotanus SM, 2008, EUR J NEUROSCI, V27, P1957, DOI 10.1111/j.1460-9568.2008.06173.x; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Serulle Y, 2008, CHANNELS, V2, P230, DOI 10.4161/chan.2.4.6391; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Tukey DS, 2013, J NEUROSCI, V33, P6123, DOI 10.1523/JNEUROSCI.4806-12.2013; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; West AR, 2004, J NEUROSCI, V24, P1924, DOI 10.1523/JNEUROSCI.4470-03.2004; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	64	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35297	35306		10.1074/jbc.M113.516690	http://dx.doi.org/10.1074/jbc.M113.516690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133208	hybrid, Green Published			2022-12-25	WOS:000329867600028
J	Hermey, G; Mahlke, C; Gutzmann, JJ; Schreiber, J; Bluthgen, N; Kuhl, D				Hermey, Guido; Mahlke, Claudia; Gutzmann, Jakob J.; Schreiber, Joerg; Bluethgen, Nils; Kuhl, Dietmar			Genome-Wide Profiling of the Activity-Dependent Hippocampal Transcriptome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; SYNAPTIC PLASTICITY; NERVOUS-SYSTEM; KAINIC ACID; NEURONAL-ACTIVITY; TARGET GENES; EXPRESSION; PROTEIN; SEIZURE	Activity-dependent gene expression is central for sculpting neuronal connectivity in the brain. Despite the importance for synaptic plasticity, a comprehensive analysis of the temporal changes in the transcriptomic response to neuronal activity is lacking. In a genome wide survey we identified genes that were induced at 1, 4, 8, or 24 hours following neuronal activity in the hippocampus. According to their distinct expression kinetics we assigned these genes to five clusters, each containing approximately 200 genes. Using in situ hybridizations the regulated expression of 24 genes was validated. Apart from known activity-dependent genes our study reveals a large number of unknown induced genes with distinct expression kinetics. Among these we identified several genes with complex temporal expression patterns. Furthermore, our study provides examples for activity-induced exon switching in the coding region of genes and activity-induced alternative splicing of the 3'-UTR. One example is Zwint. In contrast to the constitutively expressed variant, the induced Zwint transcript harbors multiple regulatory elements in the 3'-UTR. Taken together, our study provides a comprehensive analysis of the transcriptomic response to neuronal activity and sheds new light on expression kinetics and alternative splicing events.	[Hermey, Guido; Mahlke, Claudia; Gutzmann, Jakob J.; Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, Inst Mol & Cellular Cognit, Hamburg, Germany; [Schreiber, Joerg] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Bluethgen, Nils] Charite, Inst Theoret Biol, D-13353 Berlin, Germany; [Bluethgen, Nils] Charite, Inst Pathol, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hermey, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, Inst Mol & Cellular Cognit, Hamburg, Germany.	hermey@zmnh.uni-hamburg.de; kuhl@zmnh.uni-hamburg.de	Kuhl, Dietmar/A-4689-2009; Bluthgen, Nils/A-1711-2011; Hermey, Guido/AAC-5565-2020	Kuhl, Dietmar/0000-0002-4772-6701; Bluthgen, Nils/0000-0002-0171-7447; Hermey, Guido/0000-0003-4762-5262	German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase I; German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase II; FORSYS-Partner program	German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase I; German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase II; FORSYS-Partner program	This work was supported by the German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase I (DK) and phase II (NB) and by the FORSYS-Partner program (NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; Barnes G, 2003, HIPPOCAMPUS, V13, P1, DOI 10.1002/hipo.10041; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chen CY, 1995, TRENDS BIOCHEM SCI, V11, P465, DOI DOI 10.1016/S0968-0004(00)89102-1.PUBMED:8578590; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Duman RS, 2002, MOL PSYCHIATR, V7, pS29, DOI 10.1038/sj.mp.4001016; Elam C, 2005, CANCER RES, V65, P3117, DOI 10.1158/0008-5472.CAN-04-0749; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Jacobs GH, 2006, NUCLEIC ACIDS RES, V34, pD37, DOI 10.1093/nar/gkj159; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW275, DOI 10.1093/nar/gkq438; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee HK, 2002, J NEUROCHEM, V81, P1338, DOI 10.1046/j.1471-4159.2002.00937.x; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Sala C, 2003, J NEUROSCI, V23, P6327; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; van Vlijmen T, 2008, FEBS LETT, V582, P2838, DOI 10.1016/j.febslet.2008.07.012; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zucman-Rossi J, 1996, GENOMICS, V38, P247, DOI 10.1006/geno.1996.0625	47	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76903	10.1371/journal.pone.0076903	http://dx.doi.org/10.1371/journal.pone.0076903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146943	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200026
J	Takada, S; Sato, T; Ito, Y; Yamashita, S; Kato, T; Kawasumi, M; Kanai-Azuma, M; Igarashi, A; Kato, T; Tamano, M; Asahara, H				Takada, Shuji; Sato, Tempei; Ito, Yoshiaki; Yamashita, Satoshi; Kato, Tomoko; Kawasumi, Miyuri; Kanai-Azuma, Masami; Igarashi, Arisa; Kato, Tomomi; Tamano, Moe; Asahara, Hiroshi			Targeted Gene Deletion of miRNAs in Mice by TALEN System	PLOS ONE			English	Article							DNA-RECOGNITION; DISRUPTION; EFFECTORS; CLEAVAGE	Mice are among the most valuable model animal species with an enormous amount of heritage in genetic modification studies. However, targeting genes in mice is sometimes difficult, especially for small genes, such as microRNAs (miRNAs) and targeting genes in repeat sequences. Here we optimized the application of TALEN system for mice and successfully obtained gene targeting technique in mice for intergenic region and series of microRNAs. Microinjection of synthesized RNA of TALEN targeting each gene in one cell stage of embryo was carried out and injected oocytes were transferred into pseudopregnant ICR female mice, producing a high success rate of the targeted deletion of miRNA genes. In our condition, TALEN RNA without poly(A) tail worked better than that of with poly(A) tail. This mutated allele in miRNA was transmitted to the next generation, suggesting the successful germ line transmission of this targeting method. Consistent with our notion of miRNAs maturation mechanism, in homozygous mutant mice of miR-10a, the non-mutated strand of miRNAs expression was completely diminished. This method will lead us to expand and accelerate our genetic research using mice in a high throughput way.	[Takada, Shuji; Yamashita, Satoshi; Kato, Tomoko; Igarashi, Arisa; Tamano, Moe; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan; [Sato, Tempei; Ito, Yoshiaki; Kato, Tomomi; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst BioMed, Grad Sch Med & Dent Sci, Tokyo, Japan; [Kawasumi, Miyuri; Kanai-Azuma, Masami] Tokyo Med & Dent Univ, Ctr Expt Anim, Tokyo, Japan; [Asahara, Hiroshi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Asahara, Hiroshi] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Scripps Research Institute	Takada, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Tokyo, Japan.	takada-s@ncchd.go.jp; asahara.syst@tmd.ac.jp		Takada, Shuji/0000-0002-9406-4683; Igarashi, Arisa/0000-0001-7206-3105; Sato, Tempei/0000-0002-8966-3374	National Institutes of Health [AR050631]; Health and Labour Sciences Research Grants; National Center for Child Heatlth and Development; MEXT; JST, CREST; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050631, R56AR050631] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23249071] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); National Center for Child Heatlth and Development; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by National Institutes of Health AR050631, Health and Labour Sciences Research Grants, The Grant of National Center for Child Heatlth and Development, Grants-in Aid for Scientific Research (MEXT) and JST, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Qiu ZW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt258; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940	19	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76004	10.1371/journal.pone.0076004	http://dx.doi.org/10.1371/journal.pone.0076004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146809	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400031
J	Zhang, JL; Wei, LJ; Kelly, P; Freeman, M; Jaegerson, K; Gong, JS; Xu, B; Pan, ZM; Xu, CL; Wang, CM				Zhang, Jilei; Wei, Lanjing; Kelly, Patrick; Freeman, Mark; Jaegerson, Kirsten; Gong, Jiansen; Xu, Bu; Pan, Zhiming; Xu, Chuanling; Wang, Chengming			Detection of Salmonella spp. Using a Generic and Differential FRET-PCR	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; FLORIDA ANIMAL SHELTER; ENTERICA SEROVAR TYPHI; NORMAL FECES; PARATYPHI-A; TYPHIMURIUM; FOOD; INFECTIONS; DIARRHEA	To facilitate the detection of Salmonella and to be able to rapidly and conveniently determine the species/subspecies present, we developed and tested a generic and differential FRET-PCR targeting their tetrathionate reductase response regulator gene. The differential pan-Salmonella FRET-PCR we developed successfully detected seven plasmids that contained partial sequences of S. bongori and the six S. enterica subspecies. The detection limit varied from similar to 5 copies of target gene/per PCR reaction for S. enterica enterica to similar to 200 for S. bongori. Melting curve analysis demonstrated a T-m of similar to 68 degrees C for S. enterica enterica, similar to 62.5 degrees C for S. enterica houtenae and S. enterica diarizonae, similar to 57 degrees C for S. enterica indica, and similar to 54 degrees C for S. bongori, S. enterica salamae and S. enterica arizonae. The differential pan-Salmonella FRET-PCR also detected and determined the subspecies of 4 reference strains and 47 Salmonella isolated from clinically ill birds or pigs. Finally, we found it could directly detect and differentiate Salmonella in feline (5/50 positive; 10%; one S. enterica salamae and 4 S. enterica enterica) and canine feces (15/114 positive; 13.2%; all S. enterica enterica). The differential pan-Salmonella FRET-PCR failed to react with 96 non-Salmonella bacterial strains. Our experiments show the differential pan-Salmonella FRET-PCR we developed is a rapid, sensitive and specific method to detect and differentiate Salmonella.	[Zhang, Jilei; Wei, Lanjing; Xu, Chuanling; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhang, Jilei; Wei, Lanjing; Gong, Jiansen; Xu, Bu; Pan, Zhiming; Xu, Chuanling; Wang, Chengming] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Kelly, Patrick; Jaegerson, Kirsten] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Freeman, Mark] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Gong, Jiansen; Xu, Bu] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China; [Pan, Zhiming] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Virginia Polytechnic Institute & State University; Chinese Academy of Agricultural Sciences; Yangzhou University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.	wangcm@yzu.edu.cn	Zhang, Jilei/L-8672-2019	Zhang, Jilei/0000-0002-9589-1162	Ross University School of Veterinary Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD); Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses	Ross University School of Veterinary Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD); Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses	This study was funded by the Ross University School of Veterinary Medicine, the Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD) and by Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2012, EMERG INFECT DIS, V18, P637, DOI 10.3201/eid1804.111386; Agarwal A, 2002, MOL CELL PROBE, V16, P243, DOI 10.1006/mcpr.2002.0418; Bopp CA, 2003, MANUAL CLIN MICROBIO, P654; Chart H, 2007, J MED MICROBIOL, V56, P1161, DOI 10.1099/jmm.0.47197-0; Chaudhry R, 2005, AM J MED, V118, P799, DOI 10.1016/j.amjmed.2004.12.030; Chen S, 1997, INT J FOOD MICROBIOL, V35, P239, DOI 10.1016/S0168-1605(97)01241-5; Ellingson JLE, 2004, MOL CELL PROBE, V18, P51, DOI 10.1016/j.mcp.2003.09.007; Gado I., 2000, Acta Microbiologica et Immunologica Hungarica, V47, P445; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Giammanco GM, 2002, J CLIN MICROBIOL, V40, P3502, DOI 10.1128/JCM.40.9.3502-3505.2002; Gong JS, 2013, AVIAN PATHOL, V42, P290, DOI 10.1080/03079457.2013.788129; Hein I, 2006, J MICROBIOL METH, V66, P538, DOI 10.1016/j.mimet.2006.02.008; Josefsen MH, 2007, APPL ENVIRON MICROB, V73, P3040, DOI 10.1128/AEM.02823-06; Josefsen MH, 2011, MOLECULAR DETECTION OF HUMAN BACTERIAL PATHOGENS, P1023; Kelly PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053450; Lee K, 2009, J APPL MICROBIOL, V107, P805, DOI 10.1111/j.1365-2672.2009.04263.x; Ma Jui-Shan, 2003, Journal of Microbiology Immunology and Infection, V36, P282; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Malorny B, 2007, INT J FOOD MICROBIOL, V117, P211, DOI 10.1016/j.ijfoodmicro.2007.04.004; McCarthy N, 2009, J FOOD PROTECT, V72, P2350, DOI 10.4315/0362-028X-72.11.2350; Pedersen K, 2009, ZOONOSES PUBLIC HLTH, V56, P238, DOI 10.1111/j.1863-2378.2008.01196.x; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Sabshin SJ, 2012, JAVMA-J AM VET MED A, V241, P331, DOI 10.2460/javma.241.3.331; Tupler T, 2012, JAVMA-J AM VET MED A, V241, P338, DOI 10.2460/javma.241.3.338; Zhou LQ, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-14	25	9	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76053	10.1371/journal.pone.0076053	http://dx.doi.org/10.1371/journal.pone.0076053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146814	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400033
J	Blower, MD; Jambhekar, A; Schwarz, DS; Toombs, JA				Blower, Michael D.; Jambhekar, Ashwini; Schwarz, Dianne S.; Toombs, James A.			Combining Different mRNA Capture Methods to Analyze the Transcriptome: Analysis of the Xenopus laevis Transcriptome	PLOS ONE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; TRANSLATIONAL CONTROL; REVEALS; LENGTH; EXPRESSION; OOGENESIS; LINCRNAS; REGIONS; EMBRYOS; GENOME	mRNA sequencing (mRNA-seq) is a commonly used technique to survey gene expression from organisms with fully sequenced genomes. Successful mRNA-seq requires purification of mRNA away from the much more abundant ribosomal RNA, which is typically accomplished by oligo-dT selection. However, mRNAs with short poly-A tails are captured poorly by oligo-dT based methods. We demonstrate that combining mRNA capture via oligo-dT with mRNA capture by the 5' 7-methyl guanosine cap provides a more complete view of the transcriptome and can be used to assay changes in mRNA poly-A tail length on a genome-wide scale. We also show that using mRNA-seq reads from both capture methods as input for de novo assemblers provides a more complete reconstruction of the transcriptome than either method used alone. We apply these methods of mRNA capture and de novo assembly to the transcriptome of Xenopus laevis, a well-studied frog that currently lacks a finished sequenced genome, to discover transcript sequences for thousands of mRNAs that are currently absent from public databases. The methods we describe here will be broadly applicable to many organisms and will provide insight into the transcriptomes of organisms with sequenced and unsequenced genomes.	[Blower, Michael D.; Jambhekar, Ashwini; Schwarz, Dianne S.; Toombs, James A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Blower, Michael D.; Jambhekar, Ashwini; Schwarz, Dianne S.; Toombs, James A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blower, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	blower@molbio.mgh.harvard.edu		Jambhekar, Ashwini/0000-0003-1078-6601; Blower, Michael/0000-0002-5037-1972; Toombs, James/0000-0002-1601-5675				Bajak Edyta Z., 2008, V419, P147, DOI 10.1007/978-1-59745-033-1_10; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CABADA MO, 1977, DEV BIOL, V57, P427, DOI 10.1016/0012-1606(77)90227-5; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Desai A, 1999, METHOD CELL BIOL, V61, P385; DWORKIN MB, 1985, DEV BIOL, V112, P451, DOI 10.1016/0012-1606(85)90417-8; Gilchrist MJ, 2012, GENESIS, V50, P143, DOI 10.1002/dvg.22008; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Guigo R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s2; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Morin RD, 2006, GENOME RES, V16, P796, DOI 10.1101/gr.4871006; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; Raz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019287; RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schoenberg DR, 2009, TRENDS BIOCHEM SCI, V34, P435, DOI 10.1016/j.tibs.2009.05.003; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; TASSAN JP, 1993, MOL CELL BIOL, V13, P2815, DOI 10.1128/MCB.13.5.2815; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9	44	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77700	10.1371/journal.pone.0077700	http://dx.doi.org/10.1371/journal.pone.0077700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143257	Green Submitted, Green Published, gold			2022-12-25	WOS:000325894100096
J	Crowe, J; Aubareda, A; McNamee, K; Przybycien, PM; Lu, X; Williams, RO; Bou-Gharios, G; Saklatvala, J; Dean, JLE				Crowe, Jonathan; Aubareda, Anna; McNamee, Kay; Przybycien, Paulina M.; Lu, Xin; Williams, Richard O.; Bou-Gharios, George; Saklatvala, Jeremy; Dean, Jonathan L. E.			Heat Shock Protein B1-Deficient Mice Display Impaired Wound Healing	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; MAPKAP KINASE-2; HUMAN HSP27; IN-VIVO; PHOSPHORYLATION; HEAT-SHOCK-PROTEIN-27; STRESS; RESISTANCE; TRISTETRAPROLIN	There is large literature describing in vitro experiments on heat shock protein (hsp)B1 but understanding of its function in vivo is limited to studies in mice overexpressing human hspB1 protein. Experiments in cells have shown that hspB1 has chaperone activity, a cytoprotective role, regulates inflammatory gene expression, and drives cell proliferation. To investigate the function of the protein in vivo we generated hspB1-deficient mice. HspB1-deficient fibroblasts display increased expression of the pro-inflammatory cytokine, interleukin-6, compared to wild-type cells, but reduced proliferation. HspB1-deficient fibroblasts exhibit reduced entry into S phase and increased expression of cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1). The expression of hspB1 protein and mRNA is also controlled by the cell cycle. To investigate the physiological function of hspB1 in regulating inflammation and cell proliferation we used an excisional cutaneous wound healing model. There was a significant impairment in the rate of healing of wounds in hspB1-deficient mice, characterised by reduced re-epithelialisation and collagen deposition but also increased inflammation. HspB1 deficiency augments neutrophil infiltration in wounds, driven by increased chemokine (C-X-C motif) ligand 1 expression. This appears to be a general mechanism as similar results were obtained in the air-pouch and peritonitis models of acute inflammation.	[Aubareda, Anna; McNamee, Kay; Przybycien, Paulina M.; Williams, Richard O.; Bou-Gharios, George; Saklatvala, Jeremy; Dean, Jonathan L. E.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Crowe, Jonathan] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Lu, Xin] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford, England	University of Oxford; Imperial College London; Ludwig Institute for Cancer Research; University of Oxford	Dean, JLE (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	jonathan.dean@kennedy.ox.ac.uk		Przybycien-Gaweda, Paulina M./0000-0002-6521-1031; Dean, Jonathan/0000-0002-0703-2756	Arthritis Research UK; Kennedy Institute of Rheumatology Trust	Arthritis Research UK(Versus Arthritis); Kennedy Institute of Rheumatology Trust	Arthritis Research UK and the Kennedy Institute of Rheumatology Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCH CELL BIO; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Chen SWC, 2009, TRANSPLANTATION, V87, P1478, DOI 10.1097/TP.0b013e3181a3c691; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Garrido C, 1997, CANCER RES, V57, P2661; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hayashi N, 2012, CELL DEATH DIFFER, V19, P990, DOI 10.1038/cdd.2011.184; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Huot J, 1996, CANCER RES, V56, P273; Jog NR, 2007, J IMMUNOL, V178, P2421, DOI 10.4049/jimmunol.178.4.2421; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KAUR P, 1989, FEBS LETT, V258, P269, DOI 10.1016/0014-5793(89)81671-0; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; MEHLEN P, 1995, J CELL BIOCHEM, V58, P248, DOI 10.1002/jcb.240580213; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; Sur R, 2008, J INVEST DERMATOL, V128, P1116, DOI 10.1038/sj.jid.5701157; Tessier PA, 1997, J IMMUNOL, V159, P3595; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wu Y, 2008, CELL SIGNAL	45	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77383	10.1371/journal.pone.0077383	http://dx.doi.org/10.1371/journal.pone.0077383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143227	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100064
J	Hattab, T; Lasram, FB; Albouy, C; Sammari, C; Romdhane, MS; Cury, P; Leprieur, F; Le Loc'h, F				Hattab, Tarek; Lasram, Frida Ben Rais; Albouy, Camille; Sammari, Cherif; Romdhane, Mohamed Salah; Cury, Philippe; Leprieur, Fabien; Le Loc'h, Francois			The Use of a Predictive Habitat Model and a Fuzzy Logic Approach for Marine Management and Planning	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; FISH ASSEMBLAGES; SPATIAL-DISTRIBUTION; PSEUDO-ABSENCES; CLIMATE-CHANGE; DISTRIBUTIONS; SUITABILITY; PERFORMANCE; CLASSIFICATION; COMMUNITY	Bottom trawl survey data are commonly used as a sampling technique to assess the spatial distribution of commercial species. However, this sampling technique does not always correctly detect a species even when it is present, and this can create significant limitations when fitting species distribution models. In this study, we aim to test the relevance of a mixed methodological approach that combines presence-only and presence-absence distribution models. We illustrate this approach using bottom trawl survey data to model the spatial distributions of 27 commercially targeted marine species. We use an environmentally-and geographically-weighted method to simulate pseudo-absence data. The species distributions are modelled using regression kriging, a technique that explicitly incorporates spatial dependence into predictions. Model outputs are then used to identify areas that met the conservation targets for the deployment of artificial anti-trawling reefs. To achieve this, we propose the use of a fuzzy logic framework that accounts for the uncertainty associated with different model predictions. For each species, the predictive accuracy of the model is classified as 'high'. A better result is observed when a large number of occurrences are used to develop the model. The map resulting from the fuzzy overlay shows that three main areas have a high level of agreement with the conservation criteria. These results align with expert opinion, confirming the relevance of the proposed methodology in this study.	[Hattab, Tarek; Lasram, Frida Ben Rais; Romdhane, Mohamed Salah] INAT, UR Ecosyst & Ressources Aquat 03AGRO1, Tunis, Tunisia; [Hattab, Tarek; Cury, Philippe; Le Loc'h, Francois] IRD, UMR Ecosyst Marins Exploites 212, Sete, France; [Albouy, Camille] UQAR, Dept Biol Chim & Geog, Quebec City, PQ, Canada; [Sammari, Cherif] INSTM, Lab Milieu Marin, Salammbo, Tunisia; [Leprieur, Fabien] UM2, UMR 5119, Lab Ecol Syst Marins Cotiers, Montpellier, France	Universite de Carthage; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Quebec; Universite du Quebec a Rimouski; Institut National des Sciences et Technologies de la Mer; Universite de Montpellier	Hattab, T (corresponding author), INAT, UR Ecosyst & Ressources Aquat 03AGRO1, Tunis, Tunisia.	hattab.tarek@gmail.com	Leprieur, Fabien/C-4430-2008; Hattab, Tarek/K-2992-2014; Le Loc'h, François/A-5038-2008; albouy, camille/ABD-2206-2021; albouy, camille/H-9317-2012; Leprieur, Fabien/ABA-4433-2020; Romdhane, Mohamed Salah/GTB-5864-2022	Hattab, Tarek/0000-0002-1420-5758; Le Loc'h, François/0000-0002-3372-6997; albouy, camille/0000-0003-1629-2389; albouy, camille/0000-0003-1629-2389; Romdhane, Mohamed Salah/0000-0002-3343-7554; Ben Rais Lasram, Frida/0000-0003-3327-908X; Cury, philippe/0000-0002-4622-4208	Institut de Recherche pour le Developpement; Fondation pour la Recherche sur la Biodiversite	Institut de Recherche pour le Developpement; Fondation pour la Recherche sur la Biodiversite	This work was partly funded by the Institut de Recherche pour le Developpement (http://www.ird.fr/) and by the 'Fondation pour la Recherche sur la Biodiversite' (http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2012, GLOBAL CHANGE BIOL, V18, P2995, DOI 10.1111/j.1365-2486.2012.02772.x; Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; [Anonymous], 1999, B I NAT SCI TECH MER; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Batisse M., 1995, GLOBAL REPRESENTATIV, VI, P77; Ben Mustapha K., 2007, MEDSUDMED TECHNICAL, P32; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chambers J. M., 1991, STAT MODELS S; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Degraer S, 2008, CONT SHELF RES, V28, P369, DOI 10.1016/j.csr.2007.09.001; Direction Generale de la Peche et de l'Aquaculture (DGPA), 2010, ANN STAT PECH TUN; Dixon PM, 2005, ECOLOGY, V86, P1114, DOI 10.1890/04-0601; El Lakhrach H, 2012, MEDITERR MAR SCI, V13, P12, DOI 10.12681/mms.19; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044486; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Hattour A., 1991, CHALUTAGE EAUX TUNIS; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Hengl T, 2009, ECOL MODEL, V220, P3499, DOI 10.1016/j.ecolmodel.2009.06.038; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hoffman JC, 2009, MAR COAST FISH, V1, P255, DOI 10.1577/C08-048.1; Jensen AC, 2000, ARTIFICIAL REEFS EUR; Jimenez-Valverde A, 2008, ANN ZOOL FENN, V45, P200, DOI 10.5735/086.045.0305; Johnson AF, 2013, FISH FISH, V14, P256, DOI 10.1111/j.1467-2979.2012.00466.x; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Katsanevakis S, 2009, FISHERIES SCI, V75, P13, DOI 10.1007/s12562-008-0033-5; KING G, 2001, POLITICAL ANAL, V0009; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; McCullagh P, 1989, GEN LINEAR MODELS; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; Monk J, 2014, FISH FISH, V15, P352, DOI 10.1111/faf.12039; Monk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034558; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Montero J, 2009, STUD FUZZ SOFT COMP, V243, P67; Montgomery DC., 2007, DESIGN ANAL EXPT; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Munoz-Perez JJ, 2000, B MAR SCI, V67, P761; Najar B, 2010, EVOLUTION PROFILS DE, V39; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Palialexis A, 2011, HYDROBIOLOGIA, V670, P241, DOI 10.1007/s10750-011-0673-9; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Teh LCL, 2011, ENVIRON MANAGE, V47, P536, DOI 10.1007/s00267-011-9645-0; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136; WILLIAMS AK, 2003, THESIS VIRGINIA POLY; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Yackulic CB, 2012, METHODS ECOLOGY EVOL, P236, DOI [10.1111/2041-210x12004, DOI 10.1111/2041-210X12004]; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zarnetske PL, 2007, ECOL APPL, V17, P1714, DOI 10.1890/06-1312.1; Zheng BY, 2000, STAT MED, V19, P1771, DOI 10.1002/1097-0258(20000715)19:13<1771::AID-SIM485>3.3.CO;2-G	76	40	40	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76430	10.1371/journal.pone.0076430	http://dx.doi.org/10.1371/journal.pone.0076430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146867	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400057
J	Stronen, AV; Jedrzejewska, B; Pertoldi, C; Demontis, D; Randi, E; Niedzialkowska, M; Pilot, M; Sidorovich, VE; Dykyy, I; Kusak, J; Tsingarska, E; Kojola, I; Karamanlidis, AA; Ornicans, A; Lobkov, VA; Dumenko, V; Czarnomska, SD				Stronen, Astrid V.; Jedrzejewska, Bogumila; Pertoldi, Cino; Demontis, Ditte; Randi, Ettore; Niedzialkowska, Magdalena; Pilot, Malgorzata; Sidorovich, Vadim E.; Dykyy, Ihor; Kusak, Josip; Tsingarska, Elena; Kojola, Ilpo; Karamanlidis, Alexandros A.; Ornicans, Aivars; Lobkov, Vladimir A.; Dumenko, Vitalii; Czarnomska, Sylwia D.			North-South Differentiation and a Region of High Diversity in European Wolves (Canis lupus)	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION-STRUCTURE; WOLF POPULATIONS; MITOCHONDRIAL; DIET; VARIABILITY; DISPERSAL; HISTORY; SIZE; CONSEQUENCES	European wolves (Canis lupus) show population genetic structure in the absence of geographic barriers, and across relatively short distances for this highly mobile species. Additional information on the location of and divergence between population clusters is required, particularly because wolves are currently recolonizing parts of Europe. We evaluated genetic structure in 177 wolves from 11 countries using over 67K single nucleotide polymorphism (SNP) loci. The results supported previous findings of an isolated Italian population with lower genetic diversity than that observed across other areas of Europe. Wolves from the remaining countries were primarily structured in a north-south axis, with Croatia, Bulgaria, and Greece (Dinaric-Balkan) differentiated from northcentral wolves that included individuals from Finland, Latvia, Belarus, Poland and Russia. Carpathian Mountain wolves in central Europe had genotypes intermediate between those identified in northcentral Europe and the Dinaric-Balkan cluster. Overall, individual genotypes from northcentral Europe suggested high levels of admixture. We observed high diversity within Belarus, with wolves from western and northern Belarus representing the two most differentiated groups within northcentral Europe. Our results support the presence of at least three major clusters (Italy, Carpathians, Dinaric-Balkan) in southern and central Europe. Individuals from Croatia also appeared differentiated from wolves in Greece and Bulgaria. Expansion from glacial refugia, adaptation to local environments, and human-related factors such as landscape fragmentation and frequent killing of wolves in some areas may have contributed to the observed patterns. Our findings can help inform conservation management of these apex predators and the ecosystems of which they are part.	[Stronen, Astrid V.; Jedrzejewska, Bogumila; Niedzialkowska, Magdalena; Czarnomska, Sylwia D.] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Pertoldi, Cino] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Pertoldi, Cino; Randi, Ettore] Aalborg Univ, Sect Environm Engn, Dept 18, Aalborg, Denmark; [Pertoldi, Cino] Aalborg Zoo, Aalborg, Denmark; [Demontis, Ditte] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Randi, Ettore] Ist Super Protez & Ric Ambientale, Genet Lab, Ozzano Dell Emilia, BO, Italy; [Pilot, Malgorzata] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Sidorovich, Vadim E.] Natl Acad Sci, Inst Zool, Minsk, BELARUS; [Dykyy, Ihor] Ivan Franko Natl Univ Lviv, Dept Zool, Fac Biol, Lvov, Ukraine; [Kusak, Josip] Univ Zagreb, Fac Vet Med, Dept Biol, Zagreb 41000, Croatia; [Tsingarska, Elena] BALKANI Wildlife Soc, Sofia, Bulgaria; [Kojola, Ilpo] Finnish Game & Fisheries Res Inst, Oulu, Finland; [Karamanlidis, Alexandros A.] Civil Soc Protect & Management Wildlife & Nat Env, ARCTUROS, Thessaloniki, Greece; [Karamanlidis, Alexandros A.] Norwegian Univ Life Sci, Dept Ecol & Nat Resources Management, As, Norway; [Ornicans, Aivars] Latvian State Forest Res Inst Silava, Salaspils, Latvia; [Lobkov, Vladimir A.] Natl II Mechnikov Univ, Zool Museum Odessa, Odessa, Ukraine; [Dumenko, Vitalii] Biosphere Reserve Askania Nova, Chaplynka Dist, Kherson Region, Ukraine	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Aarhus University; Aalborg University; Aarhus University; Italian Institute for Environmental Protection & Research (ISPRA); Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv; University of Zagreb; Natural Resources Institute Finland (Luke); Norwegian University of Life Sciences; Latvian State Forest Research Institute "Silava"; Ministry of Education & Science of Ukraine; Odesa I. I. Mechnikov National University	Stronen, AV (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	astrid.stronen@gmail.com	Kusak, Josip/T-8344-2019; Demontis, Ditte/M-4515-2013; Karamanlidis, Alexandros/S-8239-2017; Stronen, Astrid Vik/AFJ-8208-2022; Pertoldi, Cino/I-1746-2012; Dietz, Rune/F-9154-2015	Karamanlidis, Alexandros/0000-0003-0943-1619; Stronen, Astrid Vik/0000-0002-5169-6736; Pertoldi, Cino/0000-0002-4644-8981; Dietz, Rune/0000-0001-9652-317X; Dykyy, Ihor/0000-0003-3625-8567; Demontis, Ditte/0000-0001-9124-2766; Niedzialkowska, Magdalena/0000-0002-7746-4116; Pilot, Malgorzata/0000-0002-6057-5768; Kusak, Josip/0000-0002-5544-6486; Czarnomska, Sylwia/0000-0002-8081-0956	BIOCONSUS [245737]; BIOGEAST [247652]; Mammal Research Institute at the Polish Academy of Sciences; Polish Ministry of Science and Higher Education [6P04F 09421, NN 303 418437]; EURONATUR (Germany); Marie Curie Transfer of Knowledge Fellowships [MTKD-CT-2005-029957]; Danish Natural Science Research Council [11-103926, 09-065999, 95095995]; Carlsberg Foundation [2011-01-0059]; ISPRA (Instituto Superiore per la Protezione e la Ricerca Ambientale); Italian Ministry of Environment	BIOCONSUS; BIOGEAST; Mammal Research Institute at the Polish Academy of Sciences; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EURONATUR (Germany); Marie Curie Transfer of Knowledge Fellowships; Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); ISPRA (Instituto Superiore per la Protezione e la Ricerca Ambientale); Italian Ministry of Environment	This study was funded by BIOCONSUS (Research Potential in Conservation and Sustainable Management of Biodiversity, 7th Framework Programme contract no. 245737), BIOGEAST (Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme contract no. 247652), The Mammal Research Institute at the Polish Academy of Sciences, the Polish Ministry of Science and Higher Education (grants no. 6P04F 09421 and NN 303 418437), EURONATUR (Germany), Marie Curie Transfer of Knowledge Fellowships to CP and JK (project BIORESC in the 6th Framework Programme, contract no. MTKD-CT-2005-029957), grants to CP from the Danish Natural Science Research Council (grant number: #11-103926, #09-065999 and 95095995) and the Carlsberg Foundation (grant number 2011-01-0059), ISPRA (Instituto Superiore per la Protezione e la Ricerca Ambientale) and the Italian Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2012, MAMMAL REV, V42, P1, DOI 10.1111/j.1365-2907.2011.00185.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Brandstrom M, 2008, GENOME RES, V18, P881, DOI 10.1101/gr.075242.107; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; DUMENKO VP, 2001, T ZOOLOGICAL MUSEUM, V4, P170; DUMENKO VP, 2005, NEWS BIOSPHERE RESER, V7, P102; DUMENKO VP, 2004, NEWS BIOSPHERE RESER, V6, P83; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Gomercic T, 2010, ZOOL STUD, V49, P816; GURSKII I G, 1975, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V80, P131; Gursky I.G., 1985, P487; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; Hofreiter M, 2007, CURR BIOL, V17, pR609, DOI 10.1016/j.cub.2007.06.031; Huck M, 2011, ACTA THERIOL, V56, P91, DOI 10.1007/s13364-010-0006-9; *ILL INC, 2010, GENOMESTUDIO GEN MOD, P18815; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewska B, 1996, MAMMAL REV, V26, P103; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Jedrzejewski Wlodzimierz, 2010, P207; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kahlke R-D., 1999, HIST ORIGIN EVOLUTIO; Knowles JC, 2010, THESIS U ALBERTA EDM; Kojola I, 2004, J ZOOL, V263, P229, DOI 10.1017/S0952836904005084; Kusak J, 2005, EUR J WILDLIFE RES, V51, P254, DOI 10.1007/s10344-005-0111-2; KUSAK J, 2009, 2009 NOVEMBER 20 22, P51; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LINNELL J, 2008, GUIDELINES POPULATIO, P70501; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; Milenkovic M, 2010, J MAMMAL, V91, P376, DOI 10.1644/09-MAMM-A-265.1; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Nosil P, 2005, EVOLUTION, V59, P705; Nowak S, 2011, MAMM BIOL, V76, P709, DOI 10.1016/j.mambio.2011.06.007; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PAPAGEORGIOU N, 1994, ACTA THERIOL, V39, P411, DOI 10.4098/AT.arch.94-48; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039341; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2012, R LANG ENV STAT COMP; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rice AM, 2011, ECOL LETT, V14, P9, DOI 10.1111/j.1461-0248.2010.01546.x; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Sacks BN, 2005, MOL ECOL, V14, P1241, DOI 10.1111/j.1365-294X.2005.02473.x; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Schede J.-U., 2010, WOLFE BRANDENBURG SP; Sidorovich VE, 2007, CAN J ZOOL, V85, P295, DOI 10.1139/Z07-001; Sidorovich VE, 2003, WILDLIFE BIOL, V9, P103, DOI 10.2981/wlb.2003.032; Straka M, 2012, CONSERV GENET, V13, P153, DOI 10.1007/s10592-011-0271-4; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Weckworth BV, 2005, MOL ECOL, V14, P917, DOI 10.1111/j.1365-294X.2005.02461.x	70	49	50	0	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76454	10.1371/journal.pone.0076454	http://dx.doi.org/10.1371/journal.pone.0076454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146871	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400059
J	Vernon, LT; Demko, CA; Babineau, DC; Wang, XL; Toossi, Z; Weinberg, A; Rodriguez, B				Vernon, Lance T.; Demko, Catherine A.; Babineau, Denise C.; Wang, Xuelei; Toossi, Zahra; Weinberg, Aaron; Rodriguez, Benigno			Effect of Nadir CD4+T Cell Count on Clinical Measures of Periodontal Disease in HIV plus Adults before and during Immune Reconstitution on HAART	PLOS ONE			English	Article							ORAL-HEALTH-CARE; PEOPLE; IMMUNODEFICIENCY; INDIVIDUALS; PREVALENCE	Background: The contribution of HIV-infection to periodontal disease (PD) is poorly understood. We proposed that immunological markers would be associated with improved clinical measures of PD. Methods: We performed a longitudinal cohort study of HIV-infected adults who had started highly active antiretroviral therapy (HAART) <2 years. PD was characterized clinically as the percent of teeth with >= 1 site with periodontal probing depth (PPD) >= 5.0mm, recession (REC) >0mm, clinical attachment level (CAL) >= 4.0mm, and bleeding on probing (BOP) at >= 4 sites/tooth and microbiologically as specific periodontopathogen concentration. Linear mixed-effects models were used to assess the associations between immune function and PD. Results: Forty (40) subjects with median 2.7 months on HAART and median nadir CD4+ T-cell count of 212 cells/mu l completed a median 3 visits. Over 24 months, CD4+ T-cell count increased by a mean 173 cells/mu l (p<0.001) and HIV RNA decreased by 0.5 log(10) copies/ml (p<0.001); concurrently, PPD, CAL and BOP decreased by a mean 11.7%, 12.1%, and 14.7% respectively (all p<0.001). Lower nadir CD4+ T-cell count was associated with worse baseline REC (-6.72%; p=0.04) and CAL (9.06%; p<0.001). Further, lower nadir CD4+ T-cell count was associated with a greater relative longitudinal improvement in PPD in subjects with higher baseline levels of Porphyromonas gingivalis (p=0.027), and BOP in subjects with higher baseline levels of Porphyromonas gingivalis or Treponema denticola (p=0.001 and p=0.006 respectively). Longitudinal changes from baseline in CD4+ T-cell count and level of HIV RNA were not independently associated with longitudinal changes in any clinical markers of PD. Conclusion: Degree of immunosuppression was associated with baseline gingival recession. After HAART initiation, measures of active PD improved most in those with lower nadir CD4+ T-cell counts and higher baseline levels of specific periodontopathogens. Nadir CD4+ T-cell count differentially influences periodontal disease both before and after HAART in HIV-infected adults.	[Vernon, Lance T.; Weinberg, Aaron] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Demko, Catherine A.] Case Western Reserve Univ, Sch Dent Med, Dept Community Dent, Cleveland, OH 44106 USA; [Babineau, Denise C.; Wang, Xuelei] Case Western Reserve Univ, Ctr Clin Invest, Cleveland, OH 44106 USA; [Toossi, Zahra] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Rodriguez, Benigno] Case Western Reserve Univ, Univ Hosp Cleveland, Ctr AIDS Res, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Vernon, LT (corresponding author), Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA.	ltv1@case.edu	Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; Weinberg, Aaron/0000-0002-9960-7181	National Institute of Dental and Craniofacial Research [K23 DE15746-01A1, R21 DE21376-01]; Center for AIDS Research (CFAR) [AI36219]; William T. Dahms, M.D. Clinical Research Unit (Dahms CRU) of the Clinical and Translational Science Center [UL1 RR024989]; NIH [M01 RR000080]; CWRU Department of Biological Sciences [OPR892515]; Case Western Reserve University/Cleveland Clinic CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health [UL1 RR024989]; NIH roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE015746, R21DE021376] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Center for AIDS Research (CFAR); William T. Dahms, M.D. Clinical Research Unit (Dahms CRU) of the Clinical and Translational Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CWRU Department of Biological Sciences; Case Western Reserve University/Cleveland Clinic CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was from National Institute of Dental and Craniofacial Research, Grants K23 DE15746-01A1 and R21 DE21376-01, The Center for AIDS Research (CFAR), AI36219, the William T. Dahms, M.D. Clinical Research Unit (Dahms CRU) of the Clinical and Translational Science Center, UL1 RR024989, NIH, M01 RR000080, the CWRU Department of Biological Sciences, OPR892515, and the Case Western Reserve University/Cleveland Clinic CTSA Grant, UL1 RR024989 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health and NIH roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2006, J PERIODONTOL, V77, P773, DOI 10.1902/jop.2006.P04039; Beck James D, 2002, Ann Periodontol, V7, P79, DOI 10.1902/annals.2002.7.1.79; Beck JD, 2005, CIRCULATION, V112, P19, DOI 10.1161/CIRCULATIONAHA.104.511998; Benjamin RM, 2012, PUBLIC HEALTH REP, V127, P1; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; DRINKARD CR, 1991, COMMUNITY DENT ORAL, V19, P281, DOI 10.1111/j.1600-0528.1991.tb00168.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; FLEISS JL, 1987, COMMUNITY DENT ORAL, V15, P221, DOI 10.1111/j.1600-0528.1987.tb00525.x; FRIEDMAN RB, 1991, J PERIODONTOL, V62, P623, DOI 10.1902/jop.1991.62.10.623; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hsue P, 2003, INCREASED ATHEROSCLE; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Jeanty Y, 2012, PUBLIC HEALTH REP, V127, P17, DOI 10.1177/00333549121270S204; Kinane DF, 2006, PERIODONTOL 2000, V40, P107, DOI 10.1111/j.1600-0757.2005.00136.x; Lekakis J, 2008, CLIN SCI, V115, P189, DOI 10.1042/CS20070353; Mangili A, 2007, CLIN INFECT DIS, V44, P1368, DOI 10.1086/516616; McKaig RG, 1998, J PUBLIC HEALTH DENT, V58, P294, DOI 10.1111/j.1752-7325.1998.tb03012.x; Morillo JM, 2004, J CLIN PERIODONTOL, V31, P1054, DOI [10.1111/j.1600-051x.2004.00608.x, 10.1111/j.1600-051X.2004.00608.x]; Mulligan R, 2004, COMMUNITY DENT ORAL, V32, P86, DOI 10.1111/j.0301-5661.2004.00128.x; Ndiaye CF, 1997, J PERIODONTOL, V68, P827, DOI 10.1902/jop.1997.68.9.827; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Rajabiun S, 2012, PUBLIC HEALTH REP, V127, P73, DOI 10.1177/00333549121270S210; Robinson P G, 1996, Oral Dis, V2, P45; Robinson PC, 2002, ORAL DIS, V8, P144, DOI 10.1034/j.1601-0825.8.s2.5.x; RYDER MI, 1988, J ACQ IMMUN DEF SYND, V1, P346; Scheutz F, 1997, J CLIN PERIODONTOL, V24, P580, DOI 10.1111/j.1600-051X.1997.tb00232.x; Seymour RA, 2003, BRIT DENT J, V194, P649, DOI 10.1038/sj.bdj.4810352; Singer R, 2012, PUBLIC HEALTH REP, V127, P36, DOI 10.1177/00333549121270S206; Tobias CR, 2012, PUBLIC HEALTH REP, V127, P45, DOI 10.1177/00333549121270S207; Toossi Z, 2005, CLIN EXP IMMUNOL, V142, P327, DOI 10.1111/j.1365-2249.2005.02913.x; Vernon LT, 2011, AIDS RES HUM RETROV, V27, P1157, DOI [10.1089/aid.2010.0320, 10.1089/AID.2010.0320]; Vernon LT, 2009, COMMUNITY DENT ORAL, V37, P427, DOI 10.1111/j.1600-0528.2009.00485.x; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Winkler J R, 1987, CDA J, V15, P20; WINKLER JR, 1989, J AM DENT ASSOC, pS25	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76986	10.1371/journal.pone.0076986	http://dx.doi.org/10.1371/journal.pone.0076986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146949	Green Published, gold, Green Submitted			2022-12-25	WOS:000325819400092
J	Wang, HJ; Zhang, GQ; Qi, HN				Wang, Hang-jun; Zhang, Guang-qun; Qi, Heng-nian			Wood Recognition Using Image Texture Features	PLOS ONE			English	Article							AUTOCORRELATIONS	Inspired by theories of higher local order autocorrelation (HLAC), this paper presents a simple, novel, yet very powerful approach for wood recognition. The method is suitable for wood database applications, which are of great importance in wood related industries and administrations. At the feature extraction stage, a set of features is extracted from Mask Matching Image (MMI). The MMI features preserve the mask matching information gathered from the HLAC methods. The texture information in the image can then be accurately extracted from the statistical and geometrical features. In particular, richer information and enhanced discriminative power is achieved through the length histogram, a new histogram that embodies the width and height histograms. The performance of the proposed approach is compared to the state-of-the-art HLAC approaches using the wood stereogram dataset ZAFU WS 24. By conducting extensive experiments on ZAFU WS 24, we show that our approach significantly improves the classification accuracy.	[Wang, Hang-jun] Zhejiang A&F Univ, Coll Tianmu, Linan, Peoples R China; [Wang, Hang-jun] Chinese Acad Sci, Hefei Inst Intelligent Machines, Hefei, Peoples R China; [Wang, Hang-jun] Univ Sci & Technol China, Dept Automat, Hefei 230026, Peoples R China; [Zhang, Guang-qun; Qi, Heng-nian] Zhejiang A&F Univ, Sch Informat & Technol, Linan, Peoples R China	Zhejiang A&F University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang A&F University	Wang, HJ (corresponding author), Zhejiang A&F Univ, Coll Tianmu, Linan, Peoples R China.	hangjunw@mail.ustc.edu.cn			National Science Foundation of China [60970082]; Talent Start-up Foundation of Zhejiang AF University [2013FR051]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Start-up Foundation of Zhejiang AF University	This work is supported by the grants of the National Science Foundation of China, No. 60970082, and the Talent Start-up Foundation of Zhejiang A&F University under grant No. 2013FR051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaho S, 1993, B ELECTROTECHNICAL L, V57, P973; [Anonymous], 1989, IAWA BULL, V10, P219; Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Bremananth R, 2009, INT J INTELL SYST TE, V4, P54; Canadian Wood Council, 2012, DES WOOD SUST; CHEN YQ, 1995, PATTERN RECOGN, V28, P537, DOI 10.1016/0031-3203(94)00116-4; Csurka G., 2004, WORKSH STAT LEARN CO, V1, P1, DOI DOI 10.1234/12345678; Dalal N, 2005, P IEEE COMPUTER SOC, P20; Douglas JG, 2004, WOOD SCI; Francisco-Fernandez M, 2012, CHEMOMETR INTELL LAB, V118, P159, DOI 10.1016/j.chemolab.2012.07.003; Galasso Fabio, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2342, DOI 10.1109/CVPRW.2009.5206591; Goudail F, 1996, IEEE T PATTERN ANAL, V18, P1024, DOI 10.1109/34.541411; Hang-jun Wang, 2010, 2010 International Conference on Computer Application and System Modeling (ICCASM 2010), P477, DOI 10.1109/ICCASM.2010.5620573; Kobayashi T, 2008, LECT NOTES COMPUT SC, V5302, P346, DOI 10.1007/978-3-540-88682-2_27; Kreutz M, 1996, PATTERN RECOGN, V29, P19, DOI 10.1016/0031-3203(95)00078-X; Kurita T., 1998, P AS C COMP VIS, P89; Lajevardi S, 2010, SIGNAL IMAGE VIDEO P, V4, P113; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mallik A, 2011, CHEMOMETR INTELL LAB, V107, P351, DOI 10.1016/j.chemolab.2011.05.005; Matsukawa T, 2010, VISAPP 2010: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 2, P325; Matsukawa T, 2010, LECT NOTES COMPUT SC, V5996, P384; McGraw-Hill Editors, 2002, MCGRAW HILL ENC SCI, P600; MCLAUGHLIN JA, 1968, INFORM CONTROL, V12, P121, DOI 10.1016/S0019-9958(68)90241-6; Nadaraj M, 2008, INT J SIMULATION SYS, V9, P9; Nomotoy N, 2005, P IAPR C MACH VIS AP, P265; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Otsu N., 1988, Proceedings of IAPR Workshop on Computer Vision: Special Hardware and Industrial Applications, P431; Pan S., 2012, TRANS MACH LEARN DAT, V5, P45; Pan S, 2011, COMPUT ELECTRON AGR, V75, P250, DOI 10.1016/j.compag.2010.11.010; Piuri V, 2010, IEEE T SYST MAN CY C, V40, P358, DOI 10.1109/TSMCC.2009.2039479; Rojas JAM, 2011, APPL ACOUST, V72, P934, DOI 10.1016/j.apacoust.2011.05.016; Schoch W, PREPARATION WOOD MIC; Tanaka Y, 2010, IEEE T IMAGE PROCESS, V19, P934, DOI 10.1109/TIP.2009.2038820; Tarrio-Saavedra J, 2011, J THERM ANAL CALORIM, V104, P87, DOI 10.1007/s10973-010-1157-2; Toyoda T., 2005, 4 INT WORKSH TEXT AN, V12, P131; Toyoda T, 2007, PATTERN RECOGN, V40, P1466, DOI 10.1016/j.patcog.2006.10.006; Wang XF, 2010, PATTERN RECOGN, V43, P603, DOI 10.1016/j.patcog.2009.08.002; WWF, 2011, LIV PLAN REP 2010; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yusof R, 2010, 2010 12TH INTERNATIONAL CONFERENCE ON COMPUTER MODELLING AND SIMULATION (UKSIM), P289, DOI 10.1109/UKSIM.2010.61	41	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76101	10.1371/journal.pone.0076101	http://dx.doi.org/10.1371/journal.pone.0076101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146821	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400038
J	Zhao, XJ; Yun, KM; Seese, RR; Wang, ZY				Zhao, Xiaojie; Yun, Keming; Seese, Ronald R.; Wang, Zhenyuan			Galnon Facilitates Extinction of Morphine-Conditioned Place Preference but Also Potentiates the Consolidation Process	PLOS ONE			English	Article							RECOGNITION MEMORY; NEUROPEPTIDE GALANIN; DRUG MEMORIES; RECONSOLIDATION; REINFORCEMENT; MECHANISMS; ADDICTION; RECEPTORS; NICOTINE; CONTEXT	Learning and memory systems are intimately involved in drug addiction. Previous studies suggest that galanin, a neuropeptide that binds G-protein coupled receptors, plays essential roles in the encoding of memory. In the present study, we tested the function of galnon, a galanin receptor 1 and 2 agonist, in reward-associated memory, using conditioned place preference (CPP), a widely used paradigm in drug-associated memory. Either before or following CPP-inducing morphine administration, galnon was injected at four different time points to test the effects of galanin activation on different reward-associated memory processes: 15 min before CPP training (acquisition), immediately after CPP training (consolidation), 15 min before the post-conditioning test (retrieval), and multiple injection after post-tests (reconsolidation and extinction). Galnon enhanced consolidation and extinction processes of morphine-induced CPP memory, but the compound had no effect on acquisition, retrieval, or reconsolidation processes. Our findings demonstrate that a galanin receptor 1 and 2 agonist, galnon, may be used as a viable compound to treat drug addiction by facilitating memory extinction process.	[Zhao, Xiaojie; Wang, Zhenyuan] Xi An Jiao Tong Univ, Coll Med, Dept Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Zhao, Xiaojie] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Yun, Keming] Shanxi Med Univ, Sch Forens Med, Taiyuan, Shanxi, Peoples R China; [Seese, Ronald R.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA	Xi'an Jiaotong University; Nanjing Medical University; Shanxi Medical University; University of California System; University of California Irvine	Wang, ZY (corresponding author), Xi An Jiao Tong Univ, Coll Med, Dept Forens Sci, Xian 710049, Shaanxi, Peoples R China.	wzy218@mail.xjtu.edu.cn	wang, zhenyuan/AAB-4874-2021		National Sciences Foundation of China (NSFC) [81072509, 81273335]	National Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Sciences Foundation of China (NSFC, No. 81072509 & 81273335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abramov U, 2004, NEUROPEPTIDES, V38, P55, DOI 10.1016/j.npep.2004.01.001; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Crawley JN, 1996, LIFE SCI, V58, P2185, DOI 10.1016/0024-3205(96)00093-8; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Diergaarde L, 2008, EUR J PHARMACOL, V585, P453, DOI 10.1016/j.ejphar.2008.03.010; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Farahmandfar M, 2010, BEHAV BRAIN RES, V211, P156, DOI 10.1016/j.bbr.2010.03.013; Fricks-Gleason AN, 2008, LEARN MEMORY, V15, P643, DOI 10.1101/lm.1054608; Hawes JJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1864, DOI 10.1038/sj.npp.1301579; Heinrichs SC, 2010, BEHAV BRAIN RES, V207, P353, DOI 10.1016/j.bbr.2009.10.013; Hyman SE, 2007, FOCUS, V5, P220; Jackson KJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2339, DOI 10.1038/npp.2011.123; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; LAND T, 1991, INT J PEPT PROT RES, V38, P267; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lu XY, 2005, NEUROPEPTIDES, V39, P143, DOI 10.1016/j.npep.2004.12.012; Lu XY, 2005, P NATL ACAD SCI USA, V102, P874, DOI 10.1073/pnas.0408891102; Ma MX, 2007, NEUROSCIENCE, V147, P1059, DOI 10.1016/j.neuroscience.2007.05.020; Mariani RK, 2011, PSYCHOPHARMACOLOGY, V215, P483, DOI 10.1007/s00213-011-2215-6; Massey PV, 2003, NEUROPHARMACOLOGY, V44, P40, DOI 10.1016/S0028-3908(02)00297-6; Mazarati A, 2001, NEUROSCIENTIST, V7, P506, DOI 10.1177/107385840100700607; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Milton AL, 2012, NEUROSCI BIOBEHAV R, V36, P1119, DOI 10.1016/j.neubiorev.2012.01.002; Mitrovic SM, 2011, EUR REV MED PHARMACO, V15, P524; Mitrovic SM, 2011, PSYCHIAT DANUB, V23, P53; Narasimhaiah R, 2009, PSYCHOPHARMACOLOGY, V204, P95, DOI 10.1007/s00213-008-1438-7; Neugebauer NM, 2011, PHARMACOL BIOCHEM BE, V98, P87, DOI 10.1016/j.pbb.2010.12.015; Ogren SO, 1999, BRAIN RES, V848, P174, DOI 10.1016/S0006-8993(99)01973-3; Palmatier MI, 2007, PSYCHOPHARMACOLOGY, V195, P235, DOI 10.1007/s00213-007-0897-6; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Picciotto MR, 2010, EXPERIENTIA SUPPL, V102, P195, DOI 10.1007/978-3-0346-0228-0_14; Picciotto MR, 2010, BRAIN RES, V1314, P206, DOI 10.1016/j.brainres.2009.08.033; Picciotto MR, 2005, NEUROPEPTIDES, V39, P313, DOI 10.1016/j.npep.2004.12.001; Rajarao SJR, 2007, NEUROPEPTIDES, V41, P307, DOI 10.1016/j.npep.2007.05.001; Robinson MJF, 2007, BEHAV BRAIN RES, V178, P146, DOI 10.1016/j.bbr.2006.12.013; Robinson MJF, 2010, BEHAV BRAIN RES, V216, P281; Saar K, 2002, P NATL ACAD SCI USA, V99, P7136, DOI 10.1073/pnas.102163499; Sadler R, 2007, BEHAV PHARMACOL, V18, P699, DOI 10.1097/FBP.0b013e3282effb81; Sorg BA, 2012, NEUROSCI BIOBEHAV R, V36, P1400, DOI 10.1016/j.neubiorev.2012.02.004; Steiner RA, 2001, P NATL ACAD SCI USA, V98, P4184, DOI 10.1073/pnas.061445598; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Wang XY, 2008, J NEUROSCI, V28, P5602, DOI 10.1523/JNEUROSCI.0750-08.2008; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P9028, DOI 10.1073/pnas.1533224100; Zhai HF, 2008, BEHAV PHARMACOL, V19, P211, DOI 10.1097/FBP.0b013e3282fe88a0; Zhao XJ, 2011, NEUROSCI LETT, V501, P50, DOI 10.1016/j.neulet.2011.06.050	48	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76395	10.1371/journal.pone.0076395	http://dx.doi.org/10.1371/journal.pone.0076395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146862	gold, Green Published			2022-12-25	WOS:000325819400055
J	Ding, GX; Feng, CC; Jiang, HW; Ding, Q; Zhang, LM; Na, R; Xu, H; Liu, J				Ding, Guanxiong; Feng, Chenchen; Jiang, Haowen; Ding, Qiang; Zhang, Limin; Na, Rong; Xu, Hua; Liu, Jun			Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; MESENCHYMAL TRANSITION; GENE-EXPRESSION; CELLS; CARCINOMA; PATHWAYS; TRANSFORMATION; STATISTICS; RESISTANCE	Though prostate cancer (PCa) has slow progression, the hormone refractory (HRCP) and metastatic entities are substantially lethal and lack effective treatments. Transcription factor Slug is critical in regulating metastases of various tumors including PCa. Here we studied targeted therapy against Slug using combination of 3 drugs targeting 3 pathways respectively converging via Slug and further regulating PCa metastasis. Using in vitro assays we confirmed that Slug up-regulation incurred inhibition of E-cadherin that was anti-metastatic, and inhibited Bim-regulated cell apoptosis in PCa. Upstream PTEN/Akt, mTOR, Erk, and AR/Hsp90 pathways were responsible for Slug up-regulation and each of these could be targeted by rapamycin, CI-1040, and 17-AAG respectively. In 4 PCa cell lines with different traits in terms of PTEN loss and androgen sensitivity we tested the efficacy of mono-and combined therapy with the drugs. We found that metastatic capacity of the cells was maximally inhibited only when all 3 drugs were combined, due to the crosstalk between the pathways. 17-AAG decreases Slug expression via blockade of HSP90-dependent AR stability. Combination of rapamycin and CI-1040 diminishes invasiveness more potently in PCa cells that are androgen insensitive and with PTEN loss. Slug inhibited Bim-mediated apoptosis that could be rescued by mTOR/Erk/HSP90 inhibitors. Using mouse models for circulating PCa DNA quantification, we found that combination of mTOR/Erk/HSP90 inhibitors reduced circulating PCa cells in vivo significantly more potently than combination of 2 or monotherapy. Conclusively, combination of mTOR/Erk/Hsp90 inhibits metastatic capacity of prostate cancer via Slug inhibition.	[Ding, Guanxiong; Feng, Chenchen; Jiang, Haowen; Ding, Qiang; Zhang, Limin; Na, Rong; Xu, Hua; Liu, Jun] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Liu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	drliujun@126.com	Xu, Hua/AAH-2453-2019; Na, Rong/AAN-8655-2021	Na, Rong/0000-0001-7470-5108; Feng, Chenchen/0000-0002-1854-356X	Fudan University [144]; National Natural Science Foundation of China [NSFC-81202002]	Fudan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by Youth Elites Scientific Funding of Fudan University (No. 144) and Youth Scientific Funding of National Natural Science Foundation of China (NSFC-81202002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; He SQ, 2013, INT J ONCOL, V42, P35, DOI 10.3892/ijo.2012.1698; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Liu J, 2010, PROSTATE, V70, P1768, DOI 10.1002/pros.21213; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Waltering KK, 2012, MOL CELL ENDOCRINOL, V360, P38, DOI 10.1016/j.mce.2011.12.019; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149	28	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77400	10.1371/journal.pone.0077400	http://dx.doi.org/10.1371/journal.pone.0077400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130883	gold, Green Submitted, Green Published			2022-12-25	WOS:000325814200086
J	Helm, F; Kammertoens, T; Lehmann, FM; Wilke, A; Bruns, H; Mautner, J; Bornkamm, GW; Gerbitz, A				Helm, Florian; Kammertoens, Thomas; Lehmann, Frank M.; Wilke, Andrea; Bruns, Heiko; Mautner, Josef; Bornkamm, Georg W.; Gerbitz, Armin			Targeting c-MYC with T-Cells	PLOS ONE			English	Article							ONCOGENE INACTIVATION; TISSUE MICROARRAYS; BURKITTS-LYMPHOMA; DENDRITIC CELLS; CANCER; ANTIGEN; IMMUNOTHERAPY; DIFFERENTIATION; MUTATIONS; TUMORS	Over-expression of the proto-oncogene c-MYC is frequently observed in a variety of tumors and is a hallmark of Burkitt's lymphoma. The fact that many tumors are oncogene-addicted to c-MYC, renders c-MYC a powerful target for anti-tumor therapy. Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype. We identified an MHC class II-restricted CD4(+) T-cell epitope and therein an MHC class I-restricted CD8(+) T-cell epitope (SSPQGSPEPL) that, after prime/boost immunization, protected up to 25% of mice against a lethal lymphoma challenge. Lymphoma-rejecting animals contained MHC multimer-binding CD8(+) cell within the peripheral blood and displayed in vivo cytolytic activity with specificity for SSPQGSPEPL. Taken together these data suggest that oncogenic c-MYC can be targeted with specific T-cells.	[Helm, Florian; Kammertoens, Thomas; Wilke, Andrea] Charite, Dept Immunol, Berlin, Germany; [Lehmann, Frank M.; Bornkamm, Georg W.] Helmholtz Ctr, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Mautner, Josef] Tech Univ TU Munich, Dept Pediat, Munich, Germany; [Mautner, Josef] Tech Univ Munich, Clin Cooperat Grp Pediat Tumor Immunol, Munich, Germany; [Mautner, Josef] Helmholtz Ctr, Munich, Germany; [Bruns, Heiko; Gerbitz, Armin] Univ Erlangen Nurnberg, Dept Hematol, D-91054 Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg	Gerbitz, A (corresponding author), Univ Erlangen Nurnberg, Dept Hematol, D-91054 Erlangen, Germany.	armin.gerbitz@uk-erlangen.de		Lehmann, Frank Michael/0000-0002-0381-9033; Kammertoens, Thomas/0000-0003-3309-5141	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB TR36 (TPB4)]; Wilhelm-Sander Stiftung	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Wilhelm-Sander Stiftung	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) SFB TR36 (TPB4) and by the Wilhelm-Sander Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT T, 1994, ONCOGENE, V9, P759; Anders K, 2011, CANCER CELL, V20, P755, DOI 10.1016/j.ccr.2011.10.019; BARTH RJ, 1990, J IMMUNOL, V144, P1531; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Bubendorf L, 1999, CANCER RES, V59, P803; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gerbitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034552; Gold JS, 2003, J IMMUNOL, V170, P5188, DOI 10.4049/jimmunol.170.10.5188; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; KLEIN G, 1983, CELL, V32, P311, DOI 10.1016/0092-8674(83)90449-X; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lehmann FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042021; Leisegang M, 2010, J CLIN INVEST, V120, P3869, DOI 10.1172/JCI43437; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Malynn BA, 2000, GENE DEV, V14, P1390; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Schuler T, 2002, J MOL MED-JMM, V80, P533, DOI 10.1007/s00109-002-0360-4; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shanker A, 2007, J IMMUNOL, V179, P6651, DOI 10.4049/jimmunol.179.10.6651; Sodir NM, 2011, ONCOTARGET, V2, P1307; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Xue S, 2004, BLOOD CELL MOL DIS, V33, P288, DOI 10.1016/j.bcmd.2004.08.018; Yan XL, 2011, CANCER IMMUNOL IMMUN, V60, P1763, DOI 10.1007/s00262-011-1076-5; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77375	10.1371/journal.pone.0077375	http://dx.doi.org/10.1371/journal.pone.0077375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130880	gold, Green Published			2022-12-25	WOS:000325814200084
J	Zanatta, AP; Zanatta, L; Goncalves, R; Zamoner, A; Silva, FRMB				Zanatta, Ana Paula; Zanatta, Leila; Goncalves, Renata; Zamoner, Ariane; Mena Barreto Silva, Fatima Regina			Rapid Responses to Reverse T-3 Hormone in Immature Rat Sertoli Cells: Calcium Uptake and Exocytosis Mediated by Integrin	PLOS ONE			English	Article							AMINO-ACID ACCUMULATION; GENOMIC-INDEPENDENT ACTION; ALVEOLAR EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; MALE REPRODUCTIVE-SYSTEM; K-ATPASE ACTIVITY; THYROID-HORMONE; PLASMA-MEMBRANE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; IODOTHYRONINE DEIODINASES	There is increasing experimental evidence of the nongenomic action of thyroid hormones mediated by receptors located in the plasma membrane or inside cells. The aim of this work was to characterize the reverse T-3 (rT(3)) action on calcium uptake and its involvement in immature rat Sertoli cell secretion. The results presented herein show that very low concentrations of rT(3) are able to increase calcium uptake after 1 min of exposure. The implication of T-type voltage-dependent calcium channels and chloride channels in the effect of rT(3) was evidenced using flunarizine and 9-anthracene, respectively. Also, the rT(3)-induced calcium uptake was blocked in the presence of the RGD peptide (an inhibitor of integrin-ligand interactions). Therefore, our findings suggest that calcium uptake stimulated by rT(3) may be mediated by integrin alpha(v)beta(3). In addition, it was demonstrated that calcium uptake stimulated by rT(3) is PKC and ERK-dependent. Furthermore, the outcomes indicate that rT(3) also stimulates cellular secretion since the cells manifested a loss of fluorescence after 4 min incubation, indicating an exocytic quinacrine release that seems to be mediated by the integrin receptor. These findings indicate that rT(3) modulates the calcium entry and cellular secretion, which might play a role in the regulation of a plethora of intracellular processes involved in male reproductive physiology.	[Zanatta, Ana Paula; Goncalves, Renata; Zamoner, Ariane; Mena Barreto Silva, Fatima Regina] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Zanatta, Leila] Univ Comunitaria Regiao Chapeco, Chapeco, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Comunitaria Regional de Chapeco	Silva, FRMB (corresponding author), Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil.	mena.barreto@ufsc.br	Zamoner, A./D-9525-2012; Silva, Fátima Regina Mena Barreto/S-7939-2019; Zanatta, Leila/C-3505-2019	Zamoner, A./0000-0003-2844-8563; Zanatta, Leila/0000-0003-0935-4190	MCT; CNPq [471594/2010-5]; CAPES/COFECUB [554/07]; FAPESC-SC [FCTP1518/000]; CAPES/PPG-Pharmacy	MCT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESC-SC; CAPES/PPG-Pharmacy	This work was supported by grants from: MCT and CNPq (no 471594/2010-5)- www.cnpq.br, CAPES/COFECUB no 554/07 - www.capes.gov.br, FAPESC-SC (no FCTP1518/000) - www.fapesc.sc.gov.br and CAPES/PPG-Pharmacy - www.pgfar.ufsc.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano B, 2008, ENDOCRINOLOGY, V149, P4209, DOI 10.1210/en.2007-1679; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bates JM, 1999, ENDOCRINOLOGY, V140, P844, DOI 10.1210/en.140.2.844; BATRA S, 1983, LIFE SCI, V32, P315, DOI 10.1016/0024-3205(83)90076-0; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Costa RR, 2011, CELL CALCIUM, V49, P191, DOI 10.1016/j.ceca.2011.02.003; Davis PJ, 2005, TRENDS ENDOCRIN MET, V16, P429, DOI 10.1016/j.tem.2005.09.007; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Farwell AP, 2006, ENDOCRINOLOGY, V147, P2567, DOI 10.1210/en.2005-1272; Farwell AP, 2005, CURR OPIN ENDOCRINOL, V12, P17, DOI [DOI 10.1097/01.MED.0000152036.70617.1E, 10.1097/01.med.0000152036.70617.1, DOI 10.1097/01.MED.0000152036.70617.1]; Fujisawa M, 2001, UROL RES, V29, P144, DOI 10.1007/s002400100179; GALDIERI M, 1981, J ANDROL, V2, P249; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gorczynska-Fjalling Eleonora, 2004, Reprod Biol, V4, P219; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Iftinca M C, 2011, J Med Life, V4, P126; Jannini EA, 1999, J ENDOCRINOL INVEST, V22, P843, DOI 10.1007/BF03343656; Kavok NS, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-5; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; Lalevee N, 1997, BIOL REPROD, V56, P680, DOI 10.1095/biolreprod56.3.680; Lalevee N, 1999, J MEMBRANE BIOL, V169, P167, DOI 10.1007/s002329900528; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lee JH, 2010, ASIAN J ANDROL, V12, P807, DOI 10.1038/aja.2010.51; Lei J, 2008, AM J PHYSIOL-LUNG C, V294, pL749, DOI 10.1152/ajplung.00335.2007; Lei JX, 2003, AM J PHYSIOL-LUNG C, V285, pL762, DOI 10.1152/ajplung.00376.2002; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Linnertz R, 2011, NEUROSCIENCE, V188, P23, DOI 10.1016/j.neuroscience.2011.04.058; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahapatra S, 2012, CELL CALCIUM, V51, P321, DOI 10.1016/j.ceca.2012.01.005; Menegaz D, 2006, MOL CELL ENDOCRINOL, V246, P128, DOI 10.1016/j.mce.2005.11.019; Menegaz D, 2010, J STEROID BIOCHEM, V74, P264; Menegaz D, 2010, INT J BIOCHEM CELL B, V42, P1046, DOI 10.1016/j.biocel.2010.03.015; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rosso A, 2012, BIOCHIMIE, V94, P146, DOI 10.1016/j.biochi.2011.10.001; Russell L. D., 1993, SERTOLI CELL; Scapin S, 2010, STEROIDS, V75, P576, DOI 10.1016/j.steroids.2009.10.013; Scapin S, 2009, AM J PHYSIOL-CELL PH, V296, pC4, DOI 10.1152/ajpcell.90604.2007; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Silva FRMB, 2001, LIFE SCI, V69, P977, DOI 10.1016/S0024-3205(01)01186-9; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Taranta A, 1997, MOL CELL ENDOCRINOL, V126, P117, DOI 10.1016/S0303-7207(96)03973-1; Tsou R, 2001, MOL CELL BIOCHEM, V224, P81, DOI 10.1023/A:1011947301849; Van der Geyten S, 2002, GEN COMP ENDOCR, V128, P65, DOI 10.1016/S0016-6480(02)00065-5; VINATIER D, 1995, EUR J OBSTET GYN R B, V59, P71, DOI 10.1016/0028-2243(94)01987-I; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Volpato KC, 2004, LIFE SCI, V74, P1277, DOI 10.1016/j.lfs.2003.08.005; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zamoner A, 2005, LIFE SCI, V77, P3321, DOI 10.1016/j.lfs.2005.05.042; Zamoner A, 2006, LIFE SCI, V80, P51, DOI 10.1016/j.lfs.2006.08.020; Zamoner A, 2008, STEROIDS, V73, P1400, DOI 10.1016/j.steroids.2008.07.002; Zamoner A, 2007, NEUROSCI RES, V57, P98, DOI 10.1016/j.neures.2006.09.012; Zamoner A, 2011, LIFE SCI, V89, P507, DOI 10.1016/j.lfs.2011.04.006; Zanatta AP, 2013, BBA-GEN SUBJECTS, V1830, P2629, DOI 10.1016/j.bbagen.2012.10.022; Zanatta L, 2012, BBA-MOL CELL RES, V1823, P1708, DOI 10.1016/j.bbamcr.2012.06.023; Zanatta L, 2011, BIOCHEMISTRY-US, V50, P10284, DOI 10.1021/bi201113n; Zanatta L, 2011, ARCH BIOCHEM BIOPHYS, V515, P46, DOI 10.1016/j.abb.2011.09.001; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	64	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77176	10.1371/journal.pone.0077176	http://dx.doi.org/10.1371/journal.pone.0077176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130850	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200065
J	Zhong, H; Sanchez, C; Spitrzer, D; Plambeck-Suess, S; Gibbs, J; Hawkins, WG; Denardo, D; Gao, F; Pufahl, RA; Lockhart, AC; Xu, M; Linehan, D; Weber, J; Wang-Gillam, A				Zhong, Hua; Sanchez, Cesar; Spitrzer, Dirk; Plambeck-Suess, Stacy; Gibbs, Jesse; Hawkins, Williams G.; Denardo, David; Gao, Feng; Pufahl, Robert A.; Lockhart, Albert C.; Xu, Mai; Linehan, David; Weber, Jason; Wang-Gillam, Andrea			Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models	PLOS ONE			English	Article							PHASE-III TRIAL; AZD6244 ARRY-142886; BREAST-CANCER; INHIBITOR GDC-0941; ANTITUMOR-ACTIVITY; PLASMA-MEMBRANE; IN-VIVO; RAS; ACTIVATION; KINASE	Patients with pancreatic cancer have dismal prognoses, and novel therapies are urgently needed. Mutations of the KRAS oncogene occur frequently in pancreatic cancer and represent an attractive target. Direct targeting of the predominant KRAS pathways have been challenging and research into therapeutic strategies have been now refocused on pathways downstream of KRAS, phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK [MEK]). We hypothesized that concurrent inhibition of the PI3K and MEK pathways would result in synergistic antitumor activity, as it would circumvent the compensatory feedback loop between the two pathways. We investigated the combined effect of the PI3K inhibitor, GDC0941, and the MEK inhibitor, AZD6244, on cell viability, apoptosis and cell signaling in a panel of pancreatic cancer cell lines. An in vivo analysis was conducted on pancreatic cancer xenografts. While BxPC-3 (KRAS wild type) and MIA PaCa-2 (KRAS mutated) cell lines were sensitive to GDC0941 and AZD6244 as single agents, synergistic inhibition of tumor cell growth and induction of apoptosis were observed in both cell lines when the two drugs were combined. Interestingly, phosphorylation of the cap-dependent translational components, 4E-binding protein (p-4E-BP1) and S6 was found to be closely associated with sensitivity to GDC0941 and AZD6244. In BxPC-3 cell xenografts, survival differences were observed between the control and the AZD6244, GDC0941, and combination groups. Our study provides the rationale for concurrent targeting of the PI3K and MEK pathways, regardless of KRAS status, and suggests that phosphorylation of 4E-BP1and S6 can serve as a predictive biomarker for response to treatment.	[Zhong, Hua; Denardo, David; Pufahl, Robert A.; Lockhart, Albert C.; Xu, Mai; Weber, Jason; Wang-Gillam, Andrea] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA; [Sanchez, Cesar] Pontificia Univ Catolica Chile, Dept Hematol Oncol, Sch Med, Santiago, Chile; [Spitrzer, Dirk; Plambeck-Suess, Stacy; Gibbs, Jesse; Hawkins, Williams G.; Linehan, David] Washington Univ, Dept Surg, St Louis, MO USA; [Hawkins, Williams G.; Gao, Feng; Lockhart, Albert C.; Linehan, David; Wang-Gillam, Andrea] Washington Univ, Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Pontificia Universidad Catolica de Chile; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Wang-Gillam, A (corresponding author), Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA.	awang@dom.wustl.edu		Sanchez Rojel, cesar/0000-0001-7512-6474; DeNardo, David/0000-0002-3655-5783; Gao, Feng/0000-0002-1425-1623; Weber, Jason/0000-0002-1069-6983	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (MCATS) [UL1TR000448];  [KL2TR000450]; NATIONAL CANCER INSTITUTE [R21CA182701, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (MCATS); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The publication was supported by the Washington University Institute of Clinical and Translational Sciences Grant UL1TR000448 from the National Center for Advancing Translational Sciences (MCATS) and KL2TR000450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Benavente S, 2009, INT J RADIAT ONCOL, V75, P1316, DOI 10.1016/j.ijrobp.2009.01.004; Bennouna J, 2011, INVEST NEW DRUG, V29, P1021, DOI 10.1007/s10637-010-9392-8; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chang Q, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-515; Chao YK, 2012, J SURG ONCOL, V105, P288, DOI 10.1002/jso.22097; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Darb-Esfahani S, 2009, J CANCER RES CLIN, V135, P933, DOI 10.1007/s00432-008-0529-5; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hainsworth JD, 2010, J THORAC ONCOL, V5, P1630, DOI 10.1097/JTO.0b013e3181e8b3a3; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Korkolopoulou P, 2012, HISTOPATHOLOGY, V61, P293, DOI 10.1111/j.1365-2559.2012.04236.x; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Serra V, 2013, J CLIN INVEST, V123, P2551, DOI 10.1172/JCI66343; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Williams TM, 2012, MOL CANCER THER, V11, P1193, DOI 10.1158/1535-7163.MCT-12-0098; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343	37	26	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77243	10.1371/journal.pone.0077243	http://dx.doi.org/10.1371/journal.pone.0077243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130864	gold, Green Submitted, Green Published			2022-12-25	WOS:000325810900129
J	Haque, S; Yan, XJ; Rosen, L; McCormick, S; Chiorazzi, N; Mongini, PKA				Haque, Shabirul; Yan, Xiao Jie; Rosen, Lisa; McCormick, Steven; Chiorazzi, Nicholas; Mongini, Patricia K. A.			Effects of prostaglandin E-2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion	FASEB JOURNAL			English	Article						B lymphocyte; TP53; eicosanoid; inflammation; lymphoma	NF-KAPPA-B; SINGLE-STRANDED-DNA; PROTEIN-KINASE; SOMATIC HYPERMUTATION; GENE HYPERMUTATION; SJOGRENS-SYNDROME; POLYMERASE-ETA; A-T; MUTATIONS; ACTIVATION	Within T-cell-dependent germinal centers, p53 gene transcription is repressed by Bcl-6 and is thus less vulnerable to mutation. Malignant lymphomas within inflamed extranodal sites exhibit a relatively high incidence of p53 mutations. The latter might originate from normal B-cell clones manifesting activation-induced cytosine deaminase (AID) and up-regulated p53 following T-cell-independent (TI) stimulation. We here examine p53 gene transcription in such TI clones, with a focus on modulatory effects of prostaglandin E-2 (PGE(2)), and evaluate progeny for p53 mutations. Resting IgM(+)IgD(+)CD27(-) B cells from human tonsils were labeled with CFSE and stimulated in vitro with complement-coated antigen surrogate, IL-4, and BAFF +/- exogenous PGE(2) (50 nM) or an analog specific for the EP2 PGE(2) receptor. We use flow cytometry to measure p53 and AID protein within variably divided blasts, qRT-PCR of p53 mRNA from cultures with or without actinomycin D to monitor mRNA transcription/stability, and single-cell p53 RT-PCR/sequencing to assess progeny for p53 mutations. We report that EP2 signaling triggers increased p53 gene transcriptional activity in AID(+) cycling blasts (P<0.01). Progeny exhibit p53 mutations at a frequency (8.5x10(-4)) greater than the baseline error rate (<0.8x10(-4)). We conclude that, devoid of the repressive influences of Bcl-6, dividing B lymphoblasts in inflamed tissues should display heightened p53 transcription and increased risk of p53 mutagenesis.Haque, S., Yan, X. J., Rosen, L., McCormick, S., Chiorazzi, N., Mongini, P. K. A. Effects of prostaglandin E-2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.	[Haque, Shabirul; Yan, Xiao Jie; Rosen, Lisa; Chiorazzi, Nicholas; Mongini, Patricia K. A.] Feinstein Inst Med Res, North Shore Long Isl Jewish LIJ Hlth Syst, Manhasset, NY 11030 USA; [McCormick, Steven] New York Eye & Ear Infirm, Dept Pathol, New York, NY 10003 USA; [Chiorazzi, Nicholas; Mongini, Patricia K. A.] Hofstra North Shore LIJ, Sch Med, Dept Mol Med, Hempstead, NY USA	Northwell Health; New York Eye & Ear Infirmary of Mount Sinai; Hofstra University	Mongini, PKA (corresponding author), Feinstein Inst Med Res, Karches Ctr CLL Res, Lab Cell Biol B, 350 Community Dr, Manhasset, NY 11030 USA.	pmongini@nshs.edu	haque, shabirul/AAB-9136-2022	haque, shabirul/0000-0002-6721-0630	Karches Foundation; Prince Family Foundation; Marks Foundation; U.S. National Institutes of Health (NIH) [R21 AR061653, NIH M01]; General Clinical Research Center [RR01853]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR061653] Funding Source: NIH RePORTER	Karches Foundation; Prince Family Foundation; Marks Foundation; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by funds from The Karches Foundation, The Prince Family Foundation, and The Marks Foundation; U.S. National Institutes of Health (NIH) grant R21 AR061653 (to P.K.A.M.), and NIH M01 General Clinical Research Center grant RR01853. The authors thank Hyunjoo Lee and Jennifer Nieto for their skilled technical assistance; Herb Borrero for cell sorting; and Dr. Carlo Callissano for early help with single-cell RT-PCR. The authors also thank Dr. Betty Diamond and Dr. Michael Brunda for reviewing the manuscript and Dr. Thomas MacCarthy for helping to implement the web- based SHMTool (http://scb.aecom.yu.edu/shmtool). The authors declare no conflicts of interest.	Abbas T, 2004, J BIOL CHEM, V279, P9970, DOI 10.1074/jbc.M306979200; Abdouh M, 2001, J BIOL CHEM, V276, P4382, DOI 10.1074/jbc.M004559200; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; BALDINI L, 1994, BLOOD, V84, P270; BASICZANINOVIC T, 1995, MOL CARCINOGEN, V14, P214, DOI 10.1002/mc.2940140311; Bende RJ, 2009, HAEMATOL-HEMATOL J, V94, P1109, DOI 10.3324/haematol.2009.005983; Benoit V, 2006, ONCOGENE, V25, P5708, DOI 10.1038/sj.onc.1209579; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Berger M, 2001, J BIOL CHEM, V276, P3785, DOI 10.1074/jbc.M008879200; BHATIA KG, 1992, CANCER RES, V52, P4273; Bhattacharya P, 2008, EUR J IMMUNOL, V38, P227, DOI 10.1002/eji.200737664; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Casabonne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052808; Cerutti A, 2012, EUR J IMMUNOL, V42, P1956, DOI 10.1002/eji.201242594; Chahwan R, 2012, SEMIN IMMUNOL, V24, P293, DOI 10.1016/j.smim.2012.05.005; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Choi EM, 2009, BBA-MOL CELL RES, V1793, P1354, DOI 10.1016/j.bbamcr.2009.05.006; Das P, 2007, CANCER-AM CANCER SOC, V109, P2323, DOI 10.1002/cncr.22680; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Dorner T, 1998, EUR J IMMUNOL, V28, P3384; DU MQ, 1995, BLOOD, V86, P4587, DOI 10.1182/blood.V86.12.4587.bloodjournal86124587; Dumais N, 2002, J IMMUNOL, V168, P274, DOI 10.4049/jimmunol.168.1.274; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; FEIG DI, 1994, P NATL ACAD SCI USA, V91, P6609, DOI 10.1073/pnas.91.14.6609; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Gao N, 2010, J BIOL CHEM, V285, P28097, DOI 10.1074/jbc.M110.116566; Gostissa M, 2013, P NATL ACAD SCI USA, V110, P2934, DOI 10.1073/pnas.1222570110; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gudkov Andrei V, 2011, Genes Cancer, V2, P503, DOI 10.1177/1947601911409747; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hsu MC, 2006, P NATL ACAD SCI USA, V103, P5905, DOI 10.1073/pnas.0601502103; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Iwahashi H, 2000, J IMMUNOL, V164, P5403, DOI 10.4049/jimmunol.164.10.5403; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Klein RD, 2005, CANCER RES, V65, P1808, DOI 10.1158/0008-5472.CAN-04-3567; KOCIALKOWSKI S, 1995, BRIT J HAEMATOL, V89, P55, DOI 10.1111/j.1365-2141.1995.tb08911.x; Kramata P, 2005, CANCER RES, V65, P3577, DOI 10.1158/0008-5472.CAN-04-4537; Landgren O, 2007, BLOOD, V109, P2198, DOI 10.1182/blood-2006-08-044008; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee H, 2012, J IMMUNOL, V188, P6093, DOI 10.4049/jimmunol.1103037; Lee H, 2010, J IMMUNOL, V185, P5300, DOI 10.4049/jimmunol.1000574; Lens D, 1997, BLOOD, V89, P2015, DOI 10.1182/blood.V89.6.2015; Li SY, 2013, MOL IMMUNOL, V53, P214, DOI 10.1016/j.molimm.2012.08.009; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu XH, 2005, J BIOL CHEM, V280, P3817, DOI 10.1074/jbc.M406577200; MacCarthy T, 2009, P NATL ACAD SCI USA, V106, P8629, DOI 10.1073/pnas.0903803106; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Martomo SA, 2005, P NATL ACAD SCI USA, V102, P8656, DOI 10.1073/pnas.0501852102; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Mongini PKA, 2006, J IMMUNOL, V176, P6736, DOI 10.4049/jimmunol.176.11.6736; Mongini PKA, 2005, J IMMUNOL, V175, P6143, DOI 10.4049/jimmunol.175.9.6143; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Naderi EH, 2011, NEOPLASIA, V13, P653, DOI 10.1593/neo.11542; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Park SW, 2012, AM J PHYSIOL-GASTR L, V303, pG657, DOI 10.1152/ajpgi.00529.2011; Peng HZ, 1996, AM J PATHOL, V148, P643; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Rowh MAW, 2011, ONCOGENE, V30, P4757, DOI 10.1038/onc.2011.191; Royer B, 1997, BLOOD, V90, P766, DOI 10.1182/blood.V90.2.766; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Saldana-Meyer R, 2011, EPIGENETICS-US, V6, P1068, DOI 10.4161/epi.6.9.16683; Saxena A, 2004, J CLIN PATHOL, V57, P1258, DOI 10.1136/jcp.2004.018416; Schmidt NW, 2006, J LEUKOCYTE BIOL, V79, P852, DOI 10.1189/jlb.0705402; Schonhoff CM, 2008, HEPATOLOGY, V47, P1309, DOI 10.1002/hep.22162; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Shick L, 1997, CELL GROWTH DIFFER, V8, P121; Shim M, 2010, J BIOL CHEM, V285, P16206, DOI 10.1074/jbc.M109.078576; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; SMELAND EB, 1988, EUR J IMMUNOL, V18, P1847, DOI 10.1002/eji.1830181131; Steinert D, 2009, AM J PHYSIOL-CELL PH, V296, pC75, DOI 10.1152/ajpcell.00024.2008; Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; TAE HJ, 1995, J BIOL CHEM, V270, P21487, DOI 10.1074/jbc.270.37.21487; Takahashi P, 2011, APOPTOSIS, V16, P950, DOI 10.1007/s10495-011-0623-z; Takakuwa T, 2000, JPN J CANCER RES, V91, P280, DOI 10.1111/j.1349-7006.2000.tb00942.x; Tapinos NI, 1999, ARTHRITIS RHEUM-US, V42, P1466, DOI 10.1002/1529-0131(199907)42:7<1466::AID-ANR21>3.0.CO;2-L; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Ward JM, 1999, LAB INVEST, V79, P3; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Wright BE, 2011, CARCINOGENESIS, V32, P1559, DOI 10.1093/carcin/bgr177; WU HY, 1994, J BIOL CHEM, V269, P20067; Wu XS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015549; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Yamanishi Y, 2002, AM J PATHOL, V160, P123, DOI 10.1016/S0002-9440(10)64356-8; Young KH, 2008, BLOOD, V112, P3088, DOI 10.1182/blood-2008-01-129783; Zainuddin N, 2011, LEUKEMIA RES, V35, P272, DOI 10.1016/j.leukres.2010.08.023; Zhang SZ, 2011, FASEB J, V25, P2387, DOI 10.1096/fj.10-175299; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	116	6	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					627	643		10.1096/fj.13-237792	http://dx.doi.org/10.1096/fj.13-237792			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24145719	Green Published			2022-12-25	WOS:000331072200011
J	Tadokoro, H; Umezu, T; Ohyashiki, K; Hirano, T; Ohyashiki, JH				Tadokoro, Hiroko; Umezu, Tomohiro; Ohyashiki, Kazuma; Hirano, Toshihiko; Ohyashiki, Junko H.			Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cell-cell Interaction; Exosomes; Hypoxia; MicroRNA	MICROENVIRONMENTAL REGULATION; CANCER; ANGIOGENESIS; MICRORNAS; MICROVESICLES; MECHANISMS; PROTEINS; TARGET; VEGF	Background: We recently showed communication between leukemia and endothelial cells and induction of angiogenesis via exosomes. Results: Hypoxic leukemia cells secrete exosomal miRNA, which enhances tube formation in endothelial cells. Conclusion: Exosomal miRNA from a tumor itself helps modulate the microenvironment of the tumor. Significance: This study provides novel insight into the role of exosomes in cancer development. Hypoxia plays an important role during the evolution of cancer cells and their microenvironment. Emerging evidence suggests communication between cancer cells and their microenvironment occurs via exosomes. This study aimed to clarify whether hypoxia affects angiogenic function through exosomes secreted from leukemia cells. We used the human leukemia cell line K562 for exosome-generating cells and human umbilical vein endothelial cells (HUVECs) for exosome target cells. Exosomes derived from K562 cells cultured under normoxic (20%) or hypoxic (1%) conditions for 24 h were isolated and quantitated by nanoparticle tracking analysis. These exosomes were then cocultured with HUVECs to evaluate angiogenic activity. The exosomes secreted from K562 cells in hypoxic conditions significantly enhanced tube formation by HUVECs compared with exosomes produced in normoxic conditions. Using a TaqMan low-density miRNA array, we found a subset of miRNAs, including miR-210, were significantly increased in exosomes secreted from hypoxic K562 cells. We demonstrated that cancer cells and their exosomes have altered miRNA profiles under hypoxic conditions. Although exosomes contain various molecular constituents such as proteins and mRNAs, altered exosomal compartments under hypoxic conditions, including miR-210, affected the behavior of endothelial cells. Our results suggest that exosomal miRNA derived from cancer cells under hypoxic conditions may partly affect angiogenic activity in endothelial cells.	[Tadokoro, Hiroko; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Tokyo 1920392, Japan; [Umezu, Tomohiro; Ohyashiki, Kazuma] Tokyo Med Univ, Dept Mol Sci, Tokyo 1600023, Japan; [Ohyashiki, Kazuma] Tokyo Med Univ, Dept Internal Med 1, Tokyo 1600023, Japan; [Tadokoro, Hiroko; Umezu, Tomohiro; Ohyashiki, Junko H.] Tokyo Med Univ, Inst Med Sci, Tokyo 1600023, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Ohyashiki, JH (corresponding author), Tokyo Med Univ, Inst Med Sci, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	junko@hh.iij4u.or.jp	Umezu, Tomohiro/AAK-9711-2020	Umezu, Tomohiro/0000-0002-0123-8921	Private University Strategic Research Based Support Project Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) (Tokyo, Japan)	Private University Strategic Research Based Support Project Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) (Tokyo, Japan)	This work was supported by the Private University Strategic Research Based Support Project Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) (Tokyo, Japan).	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Camussi G, 2011, AM J CANCER RES, V1, P98; Corrado C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042310; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kvasnicka HM, 2004, BLOOD, V103, P3549, DOI 10.1182/blood-2003-08-2734; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Taverna S, 2012, INT J CANCER, V130, P2033, DOI 10.1002/ijc.26217; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722	36	263	281	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34343	34351		10.1074/jbc.M113.480822	http://dx.doi.org/10.1074/jbc.M113.480822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133215	hybrid, Green Published			2022-12-25	WOS:000329812800006
J	Bassett, E; Moore, S				Bassett, Emma; Moore, Spencer			Gender Differences in the Social Pathways Linking Neighborhood Disadvantage to Depressive Symptoms in Adults	PLOS ONE			English	Article							SOCIOECONOMIC DISADVANTAGE; MAJOR DEPRESSION; PHYSICAL HEALTH; DISORDER; OLDER; ASSOCIATIONS	Depression debilitates the lives of millions and is projected to be the second leading disease burden worldwide by 2020. At the population level, the causes of depression are found in the everyday social and physical environments in which people live. Research has shown that men and women often experience neighbourhood environments differently and that these variations are often reflected in health outcomes. The current study examines whether social and environmental correlates of depression are similar in men and women. This study examines whether (i) there are gender differences in the association between neighbourhood disadvantage and depressive symptoms, and (ii) dimensions of social capital and cohesion mediate these associations. Data come from the Montreal Neighbourhood Networks and Healthy Aging Study, which consists of a cluster stratified sample of Montreal census tracts (n(ct) = 300) and individuals within those tracts (n(i) = 2707). Depressive symptoms and social capital were measured with a questionnaire. Neighbourhood disadvantage was measured at the census tract level using data from the 2006 Canada Census. Multilevel logistic regression stratified by gender and a three-step mediation analysis procedure were used. Final sample size for these analyses was 2574 adults. Depressive symptoms had a prevalence of 17.3% in the overall sample. Disadvantage was associated with depressive symptoms in women only (OR = 1.25, 95% CI = 1.01-1.55). Perceived neighbourhood cohesion was shown to mediate the association of disadvantage and depressive symptoms in women (ab = 0.02; 95% CI = 0.003-0.04, p<0.05). Other socio-relational variables, specifically generalized trust and trust in neighbours were associated with depression in women but did not act as mediating variables. Health promotion initiatives meant to combat depression may wish to consider gender differences in the design and implementation of neighbourhood or peer-based programs.	[Bassett, Emma; Moore, Spencer] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Moore, Spencer] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Moore, S (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	mooresp@queensu.ca	Moore, Spencer/AAJ-5022-2020	Moore, Spencer/0000-0002-1229-9578	Canadian Institutes of Health Research - Institute of Aging (MOP) [84584]	Canadian Institutes of Health Research - Institute of Aging (MOP)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research - Institute of Aging (MOP #84584) (www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S, 2008, J HEALTH PSYCHOL, V13, P874, DOI 10.1177/1359105308095060; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Caughy MO, 2003, SOC SCI MED, V57, P227, DOI 10.1016/S0277-9536(02)00342-8; Echeverria S, 2008, HEALTH PLACE, V14, P853, DOI 10.1016/j.healthplace.2008.01.004; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Haines VA, 2011, J HEALTH SOC BEHAV, V52, P58, DOI 10.1177/0022146510394951; Hybels CF, 2006, AM J GERIAT PSYCHIAT, V14, P498, DOI 10.1097/01.JGP.0000194649.49784.29; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Karriker-Jaffe KJ, 2009, AM J COMMUN PSYCHOL, V43, P189, DOI 10.1007/s10464-009-9236-x; Kenny DA, 2008, ORGAN RES METHODS, V11, P353, DOI 10.1177/1094428107308978; Kruger DJ, 2007, AM J COMMUN PSYCHOL, V40, P261, DOI 10.1007/s10464-007-9139-7; Krull JL, 1999, EVALUATION REV, V23, P418, DOI 10.1177/0193841X9902300404; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Moore S, 2011, HEALTH PLACE, V17, P536, DOI 10.1016/j.healthplace.2010.12.010; Mulvaney C, 2005, SOC PSYCH PSYCH EPID, V40, P202, DOI 10.1007/s00127-005-0859-4; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rajaratnam JK, 2008, INT J MENT HEALTH AD, V6, P464, DOI DOI 10.1007/S11469-007-9115-3; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304; Schneiders J, 2003, J EPIDEMIOL COMMUN H, V57, P699, DOI 10.1136/jech.57.9.699; Silver E, 2002, SOC SCI MED, V55, P1457, DOI 10.1016/S0277-9536(01)00266-0; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Uddin M, 2010, DEPRESS ANXIETY, V27, P658, DOI 10.1002/da.20692; Walters K, 2004, AM J PUBLIC HEALTH, V94, P1768, DOI 10.2105/AJPH.94.10.1768; Webber M, 2011, J AFFECT DISORDERS, V129, P149, DOI 10.1016/j.jad.2010.08.005	35	37	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76554	10.1371/journal.pone.0076554	http://dx.doi.org/10.1371/journal.pone.0076554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239KL	24146888	Green Published, Green Submitted, gold			2022-12-25	WOS:000326022200017
J	Cai, YL; Stromme, M; Welch, K				Cai, Yanling; Stromme, Maria; Welch, Ken			Photocatalytic Antibacterial Effects Are Maintained on Resin-Based TiO2 Nanocomposites after Cessation of UV Irradiation	PLOS ONE			English	Article							NANOPARTICLES; EXPRESSION	Photocatalysis induced by TiO2 and UV light constitutes a decontamination and antibacterial strategy utilized in many applications including self-cleaning environmental surfaces, water and air treatment. The present work reveals that antibacterial effects induced by photocatalysis can be maintained even after the cessation of UV irradiation. We show that resin-based composites containing 20% TiO2 nanoparticles continue to provide a pronounced antibacterial effect against the pathogens Escherichia coli, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus mutans and Enterococcus faecalis for up to two hours post UV. For biomaterials or implant coatings, where direct UV illumination is not feasible, a prolonged antibacterial effect after the cessation of the illumination would offer new unexplored treatment possibilities.	[Cai, Yanling; Stromme, Maria; Welch, Ken] Uppsala Univ, Dept Engn Sci, Div Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden	Uppsala University	Cai, YL (corresponding author), Uppsala Univ, Dept Engn Sci, Div Nanotechnol & Funct Mat, Angstrom Lab, Uppsala, Sweden.	yanling.cai@angstrom.uu.se; ken.welch@angstrom.uu.se			Carl Tryggers Foundation [CTS 08:402]; Goran Gustafsson Foundation [0969]	Carl Tryggers Foundation; Goran Gustafsson Foundation	The authors greatly acknowledge The Carl Tryggers Foundation (grant number CTS 08:402, http://www.carltryggersstiftelse.se/) and The Goran Gustafsson Foundation (grant number 0969, http://www.gustafssonsstiftelse.se/) for the financially supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahloul W, 2012, MATER CHEM PHYS, V134, P399, DOI 10.1016/j.matchemphys.2012.03.008; Beydoun D, 1999, J NANOPART RES, V1, P439, DOI 10.1023/A:1010044830871; Brioukhanov AL, 2004, BIOCHEMISTRY-MOSCOW+, V69, P949, DOI 10.1023/B:BIRY.0000043537.04115.d9; Chae YK, 2009, THIN SOLID FILMS, V517, P4260, DOI 10.1016/j.tsf.2009.02.040; Charpentier PA, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/42/425606; Chiu CW, 2011, J POLYM RES, V18, P367, DOI 10.1007/s10965-010-9426-0; Dalrymple OK, 2010, APPL CATAL B-ENVIRON, V98, P27, DOI 10.1016/j.apcatb.2010.05.001; Dunlop PSM, 2010, J PHOTOCH PHOTOBIO A, V216, P303, DOI 10.1016/j.jphotochem.2010.07.004; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Gamage J., 2010, INT J PHOTOENERGY; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Hirakawa K, 2004, FREE RADICAL RES, V38, P439, DOI 10.1080/1071576042000206487; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jensen H, 2006, J EXP NANOSCI, V1, P355, DOI 10.1080/17458080600752482; Kiwi J, 2004, J PHYS CHEM B, V108, P17675, DOI 10.1021/jp048281a; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kwak SY, 2001, ENVIRON SCI TECHNOL, V35, P2388, DOI 10.1021/es0017099; Lilja M, 2012, BIOTECHNOL LETT, V34, P2299, DOI 10.1007/s10529-012-1040-2; Lilja M, 2012, J BIOMED MATER RES B, V100B, P1078, DOI 10.1002/jbm.b.32674; Lin HX, 2008, J BIOMED MATER RES B, V87B, P425, DOI 10.1002/jbm.b.31120; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a; Patel JD, 2012, J BIOMED MATER RES A, V100A, P2863, DOI 10.1002/jbm.a.34221; Podbielska A, 2011, CENT EUR J IMMUNOL, V36, P56; Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3; Vatanpour V, 2012, DESALINATION, V292, P19, DOI 10.1016/j.desal.2012.02.006; Wang ZB, 2005, J MATER SCI, V40, P6433, DOI 10.1007/s10853-005-1713-5; Welch K, 2012, J FUNCT BIOMATER, V3, DOI 10.3390/jfb3020418; Welch K, 2010, DENT MATER, V26, P491, DOI 10.1016/j.dental.2010.01.008; Yang YN, 2007, J MEMBRANE SCI, V288, P231, DOI 10.1016/j.memsci.2006.11.019; Zhang LF, 2003, SEP PURIF TECHNOL, V31, P105, DOI 10.1016/S1383-5866(02)00157-0; Zhao J, 2003, BUILD ENVIRON, V38, P645, DOI 10.1016/S0360-1323(02)00212-3; Zhou JP, 2006, J APPL POLYM SCI, V101, P3600, DOI 10.1002/app.22650; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	36	31	31	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75929	10.1371/journal.pone.0075929	http://dx.doi.org/10.1371/journal.pone.0075929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146793	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200004
J	Philp, A; MacKenzie, MG; Belew, MY; Towler, MC; Corstorphine, A; Papalamprou, A; Hardie, DG; Baar, K				Philp, Andrew; MacKenzie, Matthew G.; Belew, Micah Y.; Towler, Mhairi C.; Corstorphine, Alan; Papalamprou, Angela; Hardie, D. Grahame; Baar, Keith			Glycogen Content Regulates Peroxisome Proliferator Activated Receptor-partial derivative (PPAR-partial derivative) Activity in Rat Skeletal Muscle	PLOS ONE			English	Article							PGC-1-ALPHA PROTEIN EXPRESSION; MESSENGER-RNA EXPRESSION; ENDURANCE EXERCISE; MITOCHONDRIAL BIOGENESIS; NUCLEAR ABUNDANCE; FATTY-ACIDS; DELTA; INCREASES; GAMMA; METABOLISM	Performing exercise in a glycogen depleted state increases skeletal muscle lipid utilization and the transcription of genes regulating mitochondrial beta-oxidation. Potential candidates for glycogen-mediated metabolic adaptation are the peroxisome proliferator activated receptor (PPAR) coactivator-1 alpha (PGC-1 alpha) and the transcription factor/nuclear receptor PPAR-partial derivative. It was therefore the aim of the present study to examine whether acute exercise with or without glycogen manipulation affects PGC-1 alpha and PPAR-partial derivative function in rodent skeletal muscle. Twenty female Wistar rats were randomly assigned to 5 experimental groups (n = 4): control [CON]; normal glycogen control [NG-C]; normal glycogen exercise [NG-E]; low glycogen control [LG-C]; and low glycogen exercise [LG-E]). Gastrocnemius (GTN) muscles were collected immediately following exercise and analyzed for glycogen content, PPAR-partial derivative activity via chromatin immunoprecipitation (ChIP) assays, AMPK alpha 1/alpha 2 kinase activity, and the localization of AMPK and PGC-1 alpha. Exercise reduced muscle glycogen by 47 and 75% relative to CON in the NG-E and LG-E groups, respectively. Exercise that started with low glycogen (LG-E) finished with higher AMPK-alpha 2 activity (147%, p<0.05), nuclear AMPK-alpha 2 and PGC-1 alpha, but no difference in AMPK-alpha 1 activity compared to CON. In addition, PPAR-partial derivative binding to the CPT1 promoter was significantly increased only in the LG-E group. Finally, cell reporter studies in contracting C2C12 myotubes indicated that PPAR-partial derivative activity following contraction is sensitive to glucose availability, providing mechanistic insight into the association between PPAR-partial derivative and glycogen content/substrate availability. The present study is the first to examine PPAR-partial derivative activity in skeletal muscle in response to an acute bout of endurance exercise. Our data would suggest that a factor associated with muscle contraction and/or glycogen depletion activates PPAR-partial derivative and initiates AMPK translocation in skeletal muscle in response to exercise.	[Philp, Andrew] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Philp, Andrew; Belew, Micah Y.; Papalamprou, Angela; Baar, Keith] Univ Calif Davis, Davis, CA 95616 USA; [Philp, Andrew; MacKenzie, Matthew G.; Towler, Mhairi C.; Corstorphine, Alan; Hardie, D. Grahame; Baar, Keith] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland; [MacKenzie, Matthew G.] Univ Dundee, Jacqui Wood Canc Ctr, Dundee, Scotland; [Towler, Mhairi C.] Vivomotion, Dundee, Scotland	University of Birmingham; University of California System; University of California Davis; University of Dundee; University of Dundee	Baar, K (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	kbaar@ucdavis.edu	Hardie, David/Z-1979-2019	Baar, Keith/0000-0001-9337-6186; Hardie, Grahame/0000-0002-8373-7379; Philp, Andrew/0000-0003-3860-4136	E. Baar Memorial Research Trust	E. Baar Memorial Research Trust	The work was supported by the E. Baar Memorial Research Trust (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Hansen AK, 2005, J APPL PHYSIOL, V98, P93, DOI 10.1152/japplphysiol.00163.2004; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Hulston CJ, 2010, MED SCI SPORT EXER, V42, P2046, DOI 10.1249/MSS.0b013e3181dd5070; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; Philp A, 2011, AM J PHYSIOL-REG I, V301, pR864, DOI 10.1152/ajpregu.00232.2011; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pilegaard H, 2002, J PHYSIOL-LONDON, V541, P261, DOI 10.1113/jphysiol.2002.016832; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Terada S, 2005, ACTA PHYSIOL SCAND, V184, P59, DOI 10.1111/j.1365-201X.2005.01423.x; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Yeo WK, 2008, J APPL PHYSIOL, V105, P1462, DOI 10.1152/japplphysiol.90882.2008	44	35	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77200	10.1371/journal.pone.0077200	http://dx.doi.org/10.1371/journal.pone.0077200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146969	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200032
J	Anderwald, CH; Tura, A; Gessl, A; Luger, A; Pacini, G; Krebs, M				Anderwald, Christian-Heinz; Tura, Andrea; Gessl, Alois; Luger, Anton; Pacini, Giovanni; Krebs, Michael			Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; BETA-CELL FUNCTION; C-PEPTIDE; SUBCLINICAL CUSHINGS; DIABETES-MELLITUS; SENSITIVITY; DEXAMETHASONE; METABOLISM; ENDOCRINE; 1ST-PHASE	Background: Insulin-resistance is commonly found in adrenal incidentaloma (AI) patients. However, little is known about beta-cell secretion in AI, because comparisons are difficult, since beta-cell-function varies with altered insulin-sensitivity. Objectives: To retrospectively analyze beta-cell function in non-diabetic AI, compared to healthy controls (CON). Methods: AI (n=217, 34% males, 57 +/- 1years, body-mass-index: 27.7 +/- 0.3kg/m(2)) and CON [n=25, 32% males, 56 +/- 1years, 26.7 +/- 0.8kg/m(2)] with comparable anthropometry (p >= 0.31) underwent oral-glucose-tolerance-tests (OGTTs) with glucose, insulin, and C-peptide measurements. 1mg-dexamethasone-suppression-tests were performed in AI. AI were divided according to post-dexamethasone-suppression-test cortisol-thresholds of 1.8 and 5 mu g/dL into 3subgroups: pDexa<1.8 mu g/dL, pDexa1.8-5 mu g/dL and pDexa>5 mu g/dL. Using mathematical modeling, whole-body insulin-sensitivity [Clamp-like-Index (CLIX)], insulinogenic Index, Disposition Index, Adaptation Index, and hepatic insulin extraction were calculated. Results: CLIX was lower in AI combined (4.9 +/- 0.2mg . kg(-1) . min(-1)), pDexa<1.8 mu g/dL (4.9 +/- 0.3) and pDexa1.8-5 mu g/dL (4.7 +/- 0.3, p<0.04 vs. CON:6.7 +/- 0.4). Insulinogenic and Disposition Indexes were 35%-97% higher in AI and each subgroup (p<0.008 vs. CON), whereas C-peptide-derived Adaptation Index, compensating for insulin-resistance, was comparable between AI, subgroups, and CON. Mathematical estimation of insulin-derived (insulinogenic and Disposition) Indexes from associations to insulin-sensitivity in CON revealed that AI-subgroups had similar to 19%-32% higher insulin-secretion than expectable. These insulin-secretion-index differences negatively (r=-0.45, p<0.001) correlated with hepatic insulin extraction, which was 13-16% lower in AI and subgroups (p<0.003 vs.CON). Conclusions: AI-patients show insulin-resistance, but adequately adapted insulin secretion with higher insulin concentrations during an OGTT, because of decreased hepatic insulin extraction; this finding affects all AI-patients, regardless of dexamethasone-suppression-test outcome.	[Anderwald, Christian-Heinz; Gessl, Alois; Luger, Anton; Krebs, Michael] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Anderwald, Christian-Heinz; Tura, Andrea; Pacini, Giovanni] Natl Res Council ISIB CNR, Metab Unit, Inst Biomed Engn, Padua, Italy; [Anderwald, Christian-Heinz] Mariahilf Community Pharm, Arnoldstein, Austria; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, Micheldorf, Austria	Medical University of Vienna	Anderwald, CH (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria.	christian-heinz.anderwald@meduniwien.ac.at	Anderwald, Christian Heinz/AAG-2271-2021	Anderwald, Christian Heinz/0000-0001-7485-0815; Krebs, Michael/0000-0002-9265-7274				Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Anderwald C, 2007, EUR J CLIN INVEST, V37, P774, DOI 10.1111/j.1365-2362.2007.01858.x; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Anderwald C, 2007, DIABETES CARE, V30, P2374, DOI 10.2337/dc07-0422; Anderwald C, 2011, DIABETES CARE, V34, P1475, DOI 10.2337/dc10-2266; Anderwald C, 2011, DIABETES CARE, V34, P437, DOI 10.2337/dc10-1137; Anderwald C, 2011, J CLIN ENDOCR METAB, V96, P515, DOI 10.1210/jc.2010-1398; Anderwald C, 2009, ENDOCRINOLOGIST, V19, P302, DOI 10.1097/TEN.0b013e3181c0479d; Anderwald CH, 2012, DIABETES CARE, V35, P2580, DOI 10.2337/dc12-0197; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Bonadonna RC, 2003, DIABETES, V52, P470, DOI 10.2337/diabetes.52.2.470; Cerutti F, 1998, ACTA PAEDIATR, V87, P1045, DOI 10.1080/080352598750031356; CHAP Z, 1986, J CLIN INVEST, V78, P1355, DOI 10.1172/JCI112722; Chiodini I, 2011, J CLIN ENDOCR METAB, V96, P1223, DOI 10.1210/jc.2010-2722; Chiodini I, 2010, J CLIN ENDOCR METAB, V95, P2736, DOI 10.1210/jc.2009-2387; Chiodini L, 2005, EUR J ENDOCRINOL, V153, P837, DOI 10.1530/eje.1.02045; Elbein SC, 2000, DIABETES CARE, V23, P221, DOI 10.2337/diacare.23.2.221; Faerch K, 2010, J PHYSIOL-LONDON, V588, P759, DOI 10.1113/jphysiol.2009.184028; Fernandez-Real JM, 1998, CLIN ENDOCRINOL, V49, P53, DOI 10.1046/j.1365-2265.1998.00437.x; Garrapa GGM, 2001, J CLIN ENDOCR METAB, V86, P5301, DOI 10.1210/jc.86.11.5301; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; ISLES CG, 1983, CLIN ENDOCRINOL, V18, P37, DOI 10.1111/j.1365-2265.1983.tb03184.x; Ivovic M, 2013, METABOLISM, V62, P786, DOI 10.1016/j.metabol.2012.12.006; KautzkyWiller A, 1996, METABOLISM, V45, P486, DOI 10.1016/S0026-0495(96)90224-3; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muscogiuri G, 2011, CLIN ENDOCRINOL, V74, P300, DOI 10.1111/j.1365-2265.2010.03928.x; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Stadler M, 2006, DIABETES CARE, V29, P1031, DOI 10.2337/dc05-1247; Stadler M, 2009, DIABETOLOGIA, V52, P2435, DOI 10.1007/s00125-009-1520-7; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P4872, DOI 10.1210/jc.2001-011766; Terzolo M, 2002, J CLIN ENDOCR METAB, V87, P998, DOI 10.1210/jc.87.3.998; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Tura A, 2011, AM J PHYSIOL-REG I, V300, pR941, DOI 10.1152/ajpregu.00650.2010; Vila G, 2010, EUR J ENDOCRINOL, V163, P225, DOI 10.1530/EJE-10-0282; Wiesner TD, 2003, J CLIN ENDOCR METAB, V88, P3632, DOI 10.1210/jc.2003-030000; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77326	10.1371/journal.pone.0077326	http://dx.doi.org/10.1371/journal.pone.0077326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146977	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400101
J	Liu, H; Li, Y; Wei, Q; Liu, CX; Bolund, L; Vajta, G; Dou, HW; Yang, WX; Xu, Y; Luan, J; Wang, J; Yang, HM; Staunstrup, NH; Du, YT				Liu, Huan; Li, Yong; Wei, Qiang; Liu, Chunxin; Bolund, Lars; Vajta, Gabor; Dou, Hongwei; Yang, Wenxian; Xu, Ying; Luan, Jing; Wang, Jun; Yang, Huanming; Staunstrup, Nicklas Heine; Du, Yutao			Development of Transgenic Minipigs with Expression of Antimorphic Human Cryptochrome 1	PLOS ONE			English	Article							PERIPHERAL CIRCADIAN CLOCKS; GENE-EXPRESSION; BODY-TEMPERATURE; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; METABOLIC SYNDROME; HANDMADE CLONING; SOMATIC-CELLS; CLONED PIGS; MICE	Minipigs have become important biomedical models for human ailments due to similarities in organ anatomy, physiology, and circadian rhythms relative to humans. The homeostasis of circadian rhythms in both central and peripheral tissues is pivotal for numerous biological processes. Hence, biological rhythm disorders may contribute to the onset of cancers and metabolic disorders including obesity and type II diabetes, amongst others. A tight regulation of circadian clock effectors ensures a rhythmic expression profile of output genes which, depending on cell type, constitute about 3-20% of the transcribed mammalian genome. Central to this system is the negative regulator protein Cryptochrome 1 (CRY1) of which the dysfunction or absence has been linked to the pathogenesis of rhythm disorders. In this study, we generated transgenic Bama-minipigs featuring expression of the Cys414-Ala antimorphic human Cryptochrome 1 mutant (hCRY1(AP)). Using transgenic donor fibroblasts as nuclear donors, the method of handmade cloning (HMC) was used to produce reconstructed embryos, subsequently transferred to surrogate sows. A total of 23 viable piglets were delivered. All were transgenic and seemingly healthy. However, two pigs with high transgene expression succumbed during the first two months. Molecular analyzes in epidermal fibroblasts demonstrated disturbances to the expression profile of core circadian clock genes and elevated expression of the proinflammatory cytokines IL-6 and TNF-alpha, known to be risk factors in cancer and metabolic disorders.	[Liu, Huan; Li, Yong; Wei, Qiang; Liu, Chunxin; Bolund, Lars; Vajta, Gabor; Wang, Jun; Yang, Huanming; Du, Yutao] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Dou, Hongwei; Yang, Wenxian; Xu, Ying; Luan, Jing; Staunstrup, Nicklas Heine; Du, Yutao] BGI Shenzhen, BGI Ark Biotechnol, Shenzhen, Guangdong, Peoples R China; [Liu, Huan; Li, Yong; Wei, Qiang; Liu, Chunxin; Dou, Hongwei; Yang, Wenxian; Xu, Ying; Luan, Jing; Du, Yutao] BGI Shenzhen, ShenZhen Engn Lab Genom Assisted Anim Breeding, Shenzhen, Guangdong, Peoples R China; [Bolund, Lars; Staunstrup, Nicklas Heine] Univ Aarhus, Dept Biomed, Aarhus C, Denmark; [Vajta, Gabor] Cent Queensland Univ, Rockhampton, Qld 4702, Australia; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Aarhus University; Central Queensland University; University of Copenhagen; King Abdulaziz University	Staunstrup, NH (corresponding author), BGI Shenzhen, BGI Ark Biotechnol, Shenzhen, Guangdong, Peoples R China.	nhs@hum-gen.au.dk; duyt@genomics.cn	Wang, Jun/A-7261-2013; Vajta, Gabor/I-3672-2016; Staunstrup, Nicklas Heine/D-4870-2017; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Staunstrup, Nicklas Heine/0000-0002-5989-9298; Liu, Huan/0000-0003-3909-0931; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding in Shenzhen, China; National Basic Research Program of China (973 Program) [2011CB944201]	ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding in Shenzhen, China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by research grants from ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding in Shenzhen, China and the National Basic Research Program of China (973 Program 2011CB944201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bollinger T, 2010, GERONTOLOGY, V56, P574, DOI 10.1159/000281827; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Forster R, 2010, J PHARMACOL TOX MET, V62, P227, DOI 10.1016/j.vascn.2010.05.007; Glossop NRJ, 2002, J CELL SCI, V115, P3369; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hasan S, 2012, FASEB J, V26, P2414, DOI 10.1096/fj.11-201699; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Nagashima K, 2005, AM J PHYSIOL-REG I, V288, pR329, DOI 10.1152/ajpregu.00395.2004; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Okano S, 2010, EUR J CLIN INVEST, V40, P1011, DOI 10.1111/j.1365-2362.2010.02359.x; Okano S, 2009, NEUROSCI LETT, V451, P246, DOI 10.1016/j.neulet.2009.01.014; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; OXENHANDLER RW, 1979, AM J PATHOL, V96, P707; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Schmidt M, 2010, THERIOGENOLOGY, V74, P1233, DOI 10.1016/j.theriogenology.2010.05.026; Schonig K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-77; Sei H, 2001, NEUROREPORT, V12, P1461, DOI 10.1097/00001756-200105250-00033; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Staunstrup NH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036658; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Vandermeulen G, 2009, VACCINE, V27, P4272, DOI 10.1016/j.vaccine.2009.05.022; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Xi SM, 2004, INT J EXP PATHOL, V85, P223, DOI 10.1111/j.0959-9673.2004.00394.x; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Zhang P, 2012, CELL REPROGRAM, V14, P258, DOI 10.1089/cell.2011.0073; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	61	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76098	10.1371/journal.pone.0076098	http://dx.doi.org/10.1371/journal.pone.0076098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146819	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400035
J	Lonnstedt, OM; McCormick, MI				Loennstedt, Oona M.; McCormick, Mark I.			Ultimate Predators: Lionfish Have Evolved to Circumvent Prey Risk Assessment Abilities	PLOS ONE			English	Article							INVASIVE LIONFISH; PTEROIS-VOLITANS; ECOLOGY; BEHAVIOR; PACIFIC; PATTERNS; NAIVETE; HISTORY	Invasive species cause catastrophic alterations to communities worldwide by changing the trophic balance within ecosystems. Ever since their introduction in the mid 1980's common red lionfish, Pterois volitans, are having dramatic impacts on the Caribbean ecosystem by displacing native species and disrupting food webs. Introduced lionfish capture prey at extraordinary rates, altering the composition of benthic communities. Here we demonstrate that the extraordinary success of the introduced lionfish lies in its capacity to circumvent prey risk assessment abilities as it is virtually undetectable by prey species in its native range. While experienced prey damselfish, Chromis viridis, respond with typical antipredator behaviours when exposed to a common predatory rock cod (Cephalopholis microprion) they fail to visibly react to either the scent or visual presentation of the red lionfish, and responded only to the scent (not the visual cue) of a lionfish of a different genus, Dendrochirus zebra. Experienced prey also had much higher survival when exposed to the two non-invasive predators compared to P. volitans. The cryptic nature of the red lionfish has enabled it to be destructive as a predator and a highly successful invasive species.	[Loennstedt, Oona M.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Lonnstedt, OM (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	oona.lonnstedt1@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	ARC Centre of Excellence; Australian Museum	ARC Centre of Excellence(Australian Research Council); Australian Museum	Funding support was provided by the ARC Centre of Excellence and the Australian Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, CHEMOECOLOGY, V14, P165, DOI 10.1007/s00049-004-0274-4; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Bosiger YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034535; CALEY MJ, 1993, MAR BIOL, V117, P33, DOI 10.1007/BF00346423; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Colin SP, 2012, P NATL ACAD SCI USA, V107, P17223; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942; Diamond J, 1986, COMMUNITY ECOLOGY, P65; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; FISHLYN DA, 1980, BIOL BULL, V158, P34, DOI 10.2307/1540756; Green SJ, 2010, PLOS ONE, V7; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; Layman CA, 2012, MAR ECOL PROG SER, V448, P131, DOI 10.3354/meps09511; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2013, ECOL EVOL, V3, P38, DOI 10.1002/ece3.388; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Lonnstedt OM, 2011, ANIM BEHAV, V82, P213, DOI 10.1016/j.anbehav.2011.04.015; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Munoz RC, 2011, MAR ECOL PROG SER, V432, P181, DOI 10.3354/meps09154; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Ruttenberg BI, 2012, B MAR SCI, V88, P1051, DOI 10.5343/bms.2011.1108; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806	37	35	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75781	10.1371/journal.pone.0075781	http://dx.doi.org/10.1371/journal.pone.0075781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146775	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400017
J	van Marle, G; Sharkey, KA; Gill, MJ; Church, DL				van Marle, Guido; Sharkey, Keith A.; Gill, M. John; Church, Deirdre L.			Gastrointestinal Viral Load and Enteroendocrine Cell Number Are Associated with Altered Survival in HIV-1 Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; ENTEROCHROMAFFIN CELL; IMMUNE ACTIVATION; GENETIC DIVERSITY; TYPE-1 INFECTION; HIV-1 INFECTION; LYMPHOID-TISSUE; GUT; DISEASE	Human immunodeficiency virus type 1 (HIV-1) infects and destroys cells of the immune system leading to an overt immune deficiency known as HIV acquired immunodeficiency syndrome (HIV/AIDS). The gut associated lymphoid tissue is one of the major lymphoid tissues targeted by HIV-1, and is considered a reservoir for HIV-1 replication and of major importance in CD4+ T-cell depletion. In addition to immunodeficiency, HIV-1 infection also directly causes gastrointestinal (GI) dysfunction, also known as HIV enteropathy. This enteropathy can manifest itself as many pathological changes in the GI tract. The objective of this study was to determine the association of gut HIV-1 infection markers with long-term survival in a cohort of men who have sex with men (MSM) enrolled pre-HAART (Highly Active Antiretroviral Therapy). We examined survival over 15-years in a cohort of 42 HIV-infected cases: In addition to CD4+ T cell counts and HIV-1 plasma viral load, multiple gut compartment (duodenum and colon) biopsies were taken by endoscopy every 6 months during the initial 3-year period. HIV-1 was cultured from tissues and phenotyped and viral loads in the gut tissues were determined. Moreover, the tissues were subjected to an extensive assessment of enteroendocrine cell distribution and pathology. The collected data was used for survival analyses, which showed that patients with higher gut tissue viral load levels had a significantly worse survival prognosis. Moreover, lower numbers of serotonin (duodenum) and somatostatin (duodenum and colon) immunoreactive cell counts in the gut tissues of patients was associated with significant lower survival prognosis. Our study, suggested that HIV-1 pathogenesis and survival prognosis is associated with altered enteroendocrine cell numbers, which could point to a potential role for enteroendocrine function in HIV infection and pathogenesis.	[van Marle, Guido; Sharkey, Keith A.; Gill, M. John; Church, Deirdre L.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [van Marle, Guido; Gill, M. John; Church, Deirdre L.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Sharkey, Keith A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Church, Deirdre L.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Church, Deirdre L.] Calgary Lab Serv, Div Microbiol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	van Marle, G (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada.	vanmarle@ucalgary.ca	Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Gill, Michael John/0000-0002-8546-8790; Sharkey, Keith/0000-0001-9560-1711; van Marle, Guido/0000-0002-5148-6229	National Health Research and Development Program (NHRDP) [6609-1782-AIDS]; Canadian Institutes of Health Research (CIHR) [CIHR-III HIV/AIDS HOP-9018]	National Health Research and Development Program (NHRDP); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Supported by: The National Health Research and Development Program (NHRDP) (Grant No. 6609-1782-AIDS, DLC-Principal Investigator) and the Canadian Institutes of Health Research (CIHR) (CIHR-III HIV/AIDS HOP-9018 GvM Principle Investigator) www.cihr-irsc.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; AlMulla W, 1997, J MED VIROL, V52, P31, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;31::AID-JMV6&gt;3.0.CO;2-S; Batman PA, 2007, AIDS, V21, P433, DOI 10.1097/QAD.0b013e3280142ee8; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Byakwaga Helen, 2009, J HIV Ther, V14, P57; CARLSON S, 1994, J LAB CLIN MED, V124, P652; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; CHURCH DL, 1992, SCAND J INFECT DIS, V24, P567, DOI 10.3109/00365549209054642; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; Costiniuk CT, 2012, MUCOSAL IMMUNOL, V5, P596, DOI 10.1038/mi.2012.82; Deiman B, 2002, MOL BIOTECHNOL, V20, P163, DOI 10.1385/MB:20:2:163; den Bosch JV, 2009, REGUL PEPTIDES, V156, P1, DOI 10.1016/j.regpep.2009.04.003; Douek Daniel, 2007, Top HIV Med, V15, P114; Gershon MD, 2007, NEUROGASTROENT MOTIL, V19, P19, DOI 10.1111/j.1365-2982.2007.00962.x; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; GILL MJ, 1992, AIDS, V6, P553, DOI 10.1097/00002030-199206000-00005; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; GREENSON JK, 1991, ANN INTERN MED, V114, P366, DOI 10.7326/0003-4819-114-5-366; Griffith BP, 1997, J CLIN MICROBIOL, V35, P3288, DOI 10.1128/JCM.35.12.3288-3291.1997; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HOLLINGER FB, 1992, J CLIN MICROBIOL, V30, P1787, DOI 10.1128/JCM.30.7.1787-1794.1992; JANOFF EN, 1988, GASTROENTEROL CLIN N, V17, P451; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; Kotler D P, 1995, Adv Intern Med, V40, P197; Kotler DP, 1998, SEMIN ONCOL, V25, P70; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Lane H Clifford, 2010, Top HIV Med, V18, P2; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lomax AE, 2006, AUTON NEUROSCI-BASIC, V126, P250, DOI 10.1016/j.autneu.2006.02.015; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MAY GR, 1993, DIGEST DIS SCI, V38, P1388, DOI 10.1007/BF01308593; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; Motomura Y, 2008, GUT, V57, P475, DOI 10.1136/gut.2007.129296; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SHARKEY KA, 1992, GASTROENTEROLOGY, V103, P18, DOI 10.1016/0016-5085(92)91090-Q; Spijkerman I, 1998, J INFECT DIS, V178, P397, DOI 10.1086/515627; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; SUTHERLAND LR, 1990, CAN MED ASSOC J, V143, P641; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; ULLRICH R, 1989, ANN INTERN MED, V111, P15, DOI 10.7326/0003-4819-111-1-15; ULLRICH R, 1991, IMMUNOL RES, V10, P456, DOI 10.1007/BF02919742; van Marle G, 2005, J NEUROVIROL, V11, P107, DOI 10.1080/13550280590922838; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; van Marle G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-74; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Yang GB, 2004, J NEUROIMMUNOL, V146, P46, DOI 10.1016/j.jneuroim.2003.10.044; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Zeitz M, 1998, ANN NY ACAD SCI, V859, P139, DOI 10.1111/j.1749-6632.1998.tb11118.x	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75967	10.1371/journal.pone.0075967	http://dx.doi.org/10.1371/journal.pone.0075967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146801	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400027
J	Gong, YX; Scott, E; Lu, R; Xu, Y; Oh, WK; Yu, Q				Gong, Yixuan; Scott, Evita; Lu, Rong; Xu, Yin; Oh, William K.; Yu, Qin			TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; PLASMA TISSUE INHIBITOR; LONG-TERM SURVIVAL; MATRIX METALLOPROTEINASES; COLORECTAL-CANCER; BREAST CARCINOMAS; CELL-SURFACE; TUMOR-GROWTH; EXPRESSION; RNA	Treatment options for late stage prostate and colon cancer are limited and there is an urgent need to develop more effective and targeted novel therapies, which starts with identification and validation of novel therapeutic targets. Recent clinical studies have demonstrated that tissue inhibitor matrix metalloproteinase-1 (TIMP-1) levels are elevated in cancer patient plasma and elevated TIMP-1 levels are associated with worse clinical outcomes. However, it is unknown whether TIMP-1 serves merely as a biomarker of cancer progression or has a functional role in promoting cancer progression and can serve as a cancer therapeutic target, which is the main objective of this study. Here, we show that stroma of human prostate and colon cancer express higher levels of TIMP-1 compared to their normal counterparts and increased expression of TIMP-1 promotes in vivo growth of both cancer types. We demonstrate for the first time that increased TIMP-1 expression stimulates accumulation of cancer associated fibroblasts (CAFs) within prostate and colon cancer tissues and that TIMP-1 enhances prostate CAF proliferation and migration in vitro and promotes ERK1/2 kinase activation in these CAF cells. Our results establish the novel promotive effects of TIMP-1 on cancer progression and on accumulation of CAFs that in turn provides a pro-tumor microenvironment. Together, these results establish the potential of TIMP-1 as a novel target for cancer therapy and the mechanism underlying the pro-tumor activity of TIMP-1.	[Scott, Evita; Lu, Rong; Xu, Yin; Yu, Qin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Dept Oncol Sci, Mt Sinai, NY USA; [Gong, Yixuan; Oh, William K.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Med Oncol, Mt Sinai, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Oh, WK (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Med Oncol, Mt Sinai, NY USA.	william.oh@mssm.edu; qin.yu@mssm.edu	Oh, William/B-9163-2012	Oh, William/0000-0001-5113-8147	United States Army Medical Research (Department of Defense) [W81XWH-10-1-0321]; NATIONAL CANCER INSTITUTE [R01CA150355, R01CA135158] Funding Source: NIH RePORTER	United States Army Medical Research (Department of Defense)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a United States Army Medical Research (Department of Defense) grant, W81XWH-10-1-0321. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldulaymi B, 2010, ONCOLOGY-BASEL, V79, P144, DOI 10.1159/000320686; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Cai J, 2012, CARCINOGENESIS, V33, P20, DOI 10.1093/carcin/bgr230; Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Corcoran NM, 2012, HISTOPATHOLOGY, V60, P216, DOI 10.1111/j.1365-2559.2011.04030.x; Courtney KD, 2012, CURR OPIN ONCOL, V24, P272, DOI 10.1097/CCO.0b013e328351059d; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; Deng XY, 2008, INT J CANCER, V122, P209, DOI 10.1002/ijc.23053; Fisher JF, 2010, METHODS MOL BIOL, V622, P471, DOI 10.1007/978-1-60327-299-5_27; Frederiksen C, 2009, ANTICANCER RES, V29, P75; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Gu P, 2008, NEOPLASIA, V10, P563, DOI 10.1593/neo.08208; Guedez L, 2010, LEUKEMIA RES, V34, P576, DOI 10.1016/j.leukres.2009.10.005; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Huang M, 2011, CARCINOGENESIS; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Jung YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038773; KAWAMATA H, 1995, INT J CANCER, V63, P680, DOI 10.1002/ijc.2910630513; Kawashiri S, 2009, HEAD NECK-J SCI SPEC, V31, P1346, DOI 10.1002/hed.21097; Li GY, 1999, CANCER RES, V59, P6267; Lipton A, 2008, J CLIN ONCOL, V26, P2653, DOI 10.1200/JCO.2007.15.4336; Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8; Luparello C, 1999, BREAST CANCER RES TR, V54, P235, DOI 10.1023/A:1006121129382; Marech I, 2012, INT J ONCOL, V40, P1313, DOI 10.3892/ijo.2012.1364; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Nakopoulou L, 2002, J PATHOL, V197, P307, DOI 10.1002/path.1129; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Oh WK, 2011, CANCER-AM CANCER SOC, V117, P517, DOI 10.1002/cncr.25394; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Osanto S, 2012, THER ADV UROL, V4, P3, DOI 10.1177/1756287211432777; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Rivette AS, 2005, J EXP THER ONCOL, V5, P111; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Ross RW, 2012, LANCET ONCOL, V13, P1105, DOI 10.1016/S1470-2045(12)70263-2; Schelter F, 2011, CLIN EXP METASTAS, V28, P793, DOI 10.1007/s10585-011-9410-z; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tsao CK, 2012, CURR OPIN UROL, V22, P167, DOI 10.1097/MOU.0b013e3283523b8b; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Xu Y, 2004, J BIOL CHEM, V279, P41179, DOI 10.1074/jbc.M400292200; Yamada S, 2008, CURR PROTOC CELL BIO; Yoshikawa T, 2009, GASTRIC CANCER, V12, P31, DOI 10.1007/s10120-008-0494-3; Yoshino Y, 2008, J DERMATOL, V35, P206, DOI 10.1111/j.1346-8138.2008.00446.x; Yukawa N, 2007, ONCOLOGY-BASEL, V72, P205, DOI 10.1159/000112827; Zagouri F, 2011, CLIN CHIM ACTA, V412, P537, DOI 10.1016/j.cca.2010.11.037; Zeng ZS, 1995, CLIN CANCER RES, V1, P899; Zhang H, 2007, HEPATOB PANCREAT DIS, V6, P487; Zhang YA, 2011, CANCER LETT, V303, P47, DOI 10.1016/j.canlet.2011.01.011	56	71	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77366	10.1371/journal.pone.0077366	http://dx.doi.org/10.1371/journal.pone.0077366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143225	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100062
J	Haddad, G; Zhu, LF; Rayner, DC; Murray, AG				Haddad, George; Zhu, Lin Fu; Rayner, David C.; Murray, Allan G.			Experimental Glomerular Endothelial Injury In Vivo	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACUTE HUMORAL REJECTION; RENAL-ALLOGRAFT REJECTION; THROMBOTIC MICROANGIOPATHY; SHIGA TOXIN; PERITUBULAR CAPILLARIES; INDUCED APOPTOSIS; MURINE MODEL; CELLS; MICE	The microvascular endothelium of the kidney glomerulus is injured in Shiga-like toxigenic bacterial infection, genetic or acquired loss of complement regulatory protein function, and allo-immune responses of solid-organ or bone marrow transplantation. Existing models of diseases with glomerular endothelial cell (EC) injury, collectively grouped as thrombotic microangiopathies, are problematic, impeding investigation of the mechanisms of microvascular defense and repair. To develop a model of glomerular endothelial injury in the mouse, we conjugated the M. oreades lectin to the cytotoxin, saporin, (LS) to selectively injure the glomerular endothelium. Injury of the microvasculature was evaluated by light, immunofluorescence, and electron microscopy, and by quantitative RT-PCR of cell-type specific transcripts. Renal function was evaluated by quantitation of serum creatinine. The toxin conjugate induced apoptosis of microvascular ECs in vitro, and subtle histologic features of thrombotic microangiopathy in vivo that were enhanced by co-injection of 50 mu g/kg LPS. Among LS/LPS-treated animals, loss of glomerular EC staining correlated with decreased expression of EC-specific transcripts, and impaired kidney function. Selective injury of the glomerular microvasculature with LS toxin conjugate and LPS elicits histologic features of thrombotic microangiopathy and acute kidney failure.	[Haddad, George; Murray, Allan G.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Zhu, Lin Fu] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Rayner, David C.] Univ Alberta, Dept Pathol & Lab Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	allan.murray@ualberta.ca	Haddad, George/AAL-5942-2021		Canadian Institutes for Health Research [MOP 53319]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this work was obtained in part from the Canadian Institutes for Health Research operating grant (MOP 53319) to AGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri L, 1997, NUCLEIC ACIDS RES, V25, P518, DOI 10.1093/nar/25.3.518; Barbieri SS, 2008, ARTERIOSCL THROM VAS, V28, P732, DOI 10.1161/ATVBAHA.107.159434; BELLONI PN, 1988, J CELL PHYSIOL, V136, P398, DOI 10.1002/jcp.1041360303; Bickerstaff A, 2008, AM J PATHOL, V173, P347, DOI 10.2353/ajpath.2008.070391; Brigotti M, 2002, FASEB J, V16, DOI 10.1096/fj.01-0521com; BURNS ER, 1982, BLOOD, V60, P1030; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; Choo JK, 1997, TRANSPLANTATION, V64, P1315, DOI 10.1097/00007890-199711150-00014; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Erwert RD, 2002, J BIOL CHEM, V277, P40567, DOI 10.1074/jbc.M206351200; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Gloor JM, 2007, AM J TRANSPLANT, V7, P2124, DOI 10.1111/j.1600-6143.2007.01895.x; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P1144, DOI 10.1093/ndt/gfm774; Ishii Y, 2005, KIDNEY INT, V67, P321, DOI 10.1111/j.1523-1755.2005.00085.x; JOHN HD, 1982, PATHOL RES PRACT, V173, P236, DOI 10.1016/S0344-0338(82)80087-3; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; Lajoie G, 1997, ULTRASTRUCT PATHOL, V21, P235; Laskin BL, 2011, BLOOD, V118, P1452, DOI 10.1182/blood-2011-02-321315; Li JH, 2009, AM J PATHOL, V175, P1124, DOI 10.2353/ajpath.2009.090113; Liptak P, 2005, AM J TRANSPLANT, V5, P2870, DOI 10.1111/j.1600-6143.2005.01102.x; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Magro CM, 2005, ULTRASTRUCT PATHOL, V29, P95, DOI 10.1080/019131290924108; Matsumoto M, 2004, J AM SOC NEPHROL, V15, P1574, DOI 10.1097/01.ASN.0000128047.13396.48; Matussek A, 2003, BLOOD, V102, P1323, DOI 10.1182/blood-2002-10-3301; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Mitra D, 1998, AM J HEMATOL, V59, P279, DOI 10.1002/(SICI)1096-8652(199812)59:4<279::AID-AJH3>3.0.CO;2-J; Nozaki T, 2009, AM J TRANSPLANT, V9, P2251, DOI 10.1111/j.1600-6143.2009.02786.x; Oakes RS, 2008, PEDIATR NEPHROL, V23, P1303, DOI 10.1007/s00467-008-0799-9; Paixao-Cavalcante D, 2009, CLIN EXP IMMUNOL, V155, P339, DOI 10.1111/j.1365-2249.2008.03826.x; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pijpers AHJM, 2001, J AM SOC NEPHROL, V12, P767, DOI 10.1681/ASN.V124767; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Sellares J, 2011, AM J TRANSPLANT, V11, P489, DOI 10.1111/j.1600-6143.2010.03415.x; SIEGLER RL, 1994, PEDIATRICS, V94, P35; Smith JD, 2011, AM J TRANSPLANT, V11, P312, DOI 10.1111/j.1600-6143.2010.03383.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007; Warner RL, 2004, EXP MOL PATHOL, V77, P77, DOI 10.1016/j.yexmp.2004.04.003; Yamamoto K, 1997, AM J PATHOL, V151, P725	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e78244	10.1371/journal.pone.0078244	http://dx.doi.org/10.1371/journal.pone.0078244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143262	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100101
J	Wei, YY; Wang, ZX; Chang, CY; Fan, TT; Su, L; Chen, F; Christiani, DC				Wei, Yongyue; Wang, Zhaoxi; Chang, Chiung-yu; Fan, Tianteng; Su, Li; Chen, Feng; Christiani, David C.			Global Metabolomic Profiling Reveals an Association of Metal Fume Exposure and Plasma Unsaturated Fatty Acids	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BOILERMAKER CONSTRUCTION WORKERS; WELDING FUMES; STAINLESS-STEEL; DOCOSAHEXAENOIC ACID; DUTCH INDUSTRIES; OMEGA-3-FATTY-ACIDS; RESPONSES; WELDERS; ADULTS	Background: Welding-associated air pollutants negatively affect the health of exposed workers; however, their molecular mechanisms in causing disease remain largely unclear. Few studies have systematically investigated the systemic toxic effects of welding fumes on humans. Objectives: To explore the effects of welding fumes on the plasma metabolome, and to identify biomarkers for risk assessment of welding fume exposure. Methods: The two-stage, self-controlled exploratory study included 11 boilermakers from a 2011 discovery panel and 8 boilermakers from a 2012 validation panel. Plasma samples were collected pre- and post-welding fume exposure and analyzed by chromatography/mass spectrometry. Results: Eicosapentaenoic or docosapentaenoic acid metabolic changes post-welding were significantly associated with particulate (PM2.5) exposure (p<0.05). The combined analysis by linear mixed-effects model showed that exposure was associated with a statistically significant decline in metabolite change of eicosapentaenoic acid [<(beta)over cap>(95% CI) = -0.013(-0.022 similar to-0.004); p = 0.005], docosapentaenoic acid n(3) [(beta) over cap (95% CI) = -0.010(-0.018 similar to-0.002); p = 0.017], and docosapentaenoic acid n(6) [(beta) over cap (95% CI) = -0.007(-0.013 similar to-0.001); p = 0.021]. Pathway analysis identified an association of the unsaturated fatty acid pathway with exposure (p(Study)-(2011) = 0.025; p(Study)-(2012) = 0.021; p(Combined) = 0.009). The functional network built by these fatty acids and their interactive genes contained significant enrichment of genes associated with various diseases, including neoplasms, cardiovascular diseases, and lipid metabolism disorders. Conclusions: High-dose exposure of metal welding fumes decreases unsaturated fatty acids with an exposure-response relationship. This alteration in fatty acids is a potential biological mediator and biomarker for exposure-related health disorders.	[Wei, Yongyue; Wang, Zhaoxi; Chang, Chiung-yu; Fan, Tianteng; Su, Li; Christiani, David C.] Harvard Univ, Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Chen, Feng] Nanjing Med Univ, Dept Epidemiol & Biostat, Key Lab Modern Toxicol, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Nanjing Medical University	Christiani, DC (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dchris@hsph.harvard.edu	Wei, Yongyue/GYV-5660-2022	Wei, Yongyue/0000-0002-1132-1796	US NIH [ES009860, ES00002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009860, P30ES000002] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by US NIH grants ES009860 and ES00002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Antonini JM, 2005, MOL CELL BIOCHEM, V279, P17, DOI 10.1007/s11010-005-8211-6; Antonini JM, 1997, EXP LUNG RES, V23, P205, DOI 10.3109/01902149709087368; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Cavallari JM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-36; Chen JC, 2007, ENVIRON HEALTH PERSP, V115, P1002, DOI 10.1289/ehp.9609; Chuang CH, 2010, MUTAGENESIS, V25, P71, DOI 10.1093/mutage/gep047; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dieterle F, 2006, CHEM RES TOXICOL, V19, P1175, DOI 10.1021/tx060094b; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Geleskul Iu F, 1987, VRACHEBNOE DELO, P108; Goldstein JT, 2003, ARCH BIOCHEM BIOPHYS, V420, P185, DOI 10.1016/j.abb.2003.09.034; Hassaballa HA, 2005, OCCUP MED-OXFORD, V55, P638, DOI 10.1093/occmed/kqi141; Hauser R, 2002, CHEST, V121, P2052, DOI 10.1378/chest.121.6.2052; Hobson A, 2011, ANN OCCUP HYG, V55, P113, DOI 10.1093/annhyg/meq069; Ibfelt E, 2010, OCCUP ENVIRON MED, V67, P772, DOI 10.1136/oem.2009.051086; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; KESKINEN H, 1980, CLIN ALLERGY, V10, P151, DOI 10.1111/j.1365-2222.1980.tb02092.x; Kim JY, 2003, ENVIRON RES, V93, P158, DOI 10.1016/S0013-9351(03)00017-3; Kuo CH, 2012, CHEM RES TOXICOL, V25, P676, DOI 10.1021/tx200465e; Mozaffarian D, 2008, CIRCULATION, V117, P1130, DOI 10.1161/CIRCULATIONAHA.107.732826; Mukherjee S, 2004, CANCER EPIDEM BIOMAR, V13, P454; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Ninio DM, 2008, BRIT J NUTR, V100, P1097, DOI 10.1017/S0007114508959225; Picard E, 1999, J NATL CANCER I, V91, P1059, DOI 10.1093/jnci/91.12.1059; Poole CD, 2013, CLIN THER, V35, P40, DOI 10.1016/j.clinthera.2012.11.008; Ringbom T, 2001, J NAT PROD, V64, P745, DOI 10.1021/np000620d; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Sauder KA, 2013, PSYCHOSOM MED, V75, P382, DOI 10.1097/PSY.0b013e318290a107; Scharrer E, 2007, INT ARCH OCC ENV HEA, V80, P265, DOI 10.1007/s00420-006-0127-2; Stewart JD, 2011, ARCH TOXICOL, V85, P3, DOI 10.1007/s00204-010-0635-4; SULOCHANA G, 1978, INDIAN J EXP BIOL, V16, P507; Szram J, 2012, EUR RESP J; 't Mannetje A, 2012, AM J EPIDEMIOL, V175, P706, DOI 10.1093/aje/kwr358; Tessier DM, 2006, TOXICOL LETT, V167, P114, DOI 10.1016/j.toxlet.2006.08.015; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tsuji M, 2003, PROSTAG LEUKOTR ESS, V68, P337, DOI 10.1016/S0952-3278(03)00025-5; VANDERWAL JF, 1985, ANN OCCUP HYG, V29, P377, DOI 10.1093/annhyg/29.3.377; VANDERWAL JF, 1986, ANN OCCUP HYG, V30, P153, DOI 10.1093/annhyg/30.2.153; Villa B, 2002, PHARMACOL RES, V45, P475, DOI 10.1006/phrs.2002.0989; von Schacky C, 2012, EVID BASED MED; Wang ZX, 2005, ENVIRON HEALTH PERSP, V113, P233, DOI 10.1289/txg.7273; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602	49	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77413	10.1371/journal.pone.0077413	http://dx.doi.org/10.1371/journal.pone.0077413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143234	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100071
J	Yarotskyy, V; Protasi, F; Dirksen, RT				Yarotskyy, Viktor; Protasi, Feliciano; Dirksen, Robert T.			Accelerated Activation of SOCE Current in Myotubes from Two Mouse Models of Anesthetic- and Heat-Induced Sudden Death	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; EXERCISE-INDUCED RHABDOMYOLYSIS; MAMMALIAN SKELETAL-MUSCLE; KNOCK-IN MOUSE; MALIGNANT HYPERTHERMIA; RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; RETROGRADE SIGNAL; BINDING-SITES; CALCIUM STORE	Store-operated calcium entry (SOCE) channels play an important role in Ca2+ signaling. Recently, excessive SOCE was proposed to play a central role in the pathogenesis of malignant hyperthermia (MH), a pharmacogenic disorder of skeletal muscle. We tested this hypothesis by characterizing SOCE current (I-SkCRAC) magnitude, voltage dependence, and rate of activation in myotubes derived from two mouse models of anesthetic-and heat-induced sudden death: 1) type 1 ryanodine receptor (RyR1) knock-in mice (Y524S/+) and 2) calsequestrin 1 and 2 double knock-out (dCasq-null) mice. ISkCRAC voltage dependence and magnitude at -80 mV were not significantly different in myotubes derived from wild type (WT), Y524S/+ and dCasq-null mice. However, the rate of I-SkCRAC activation upon repetitive depolarization was significantly faster at room temperature in myotubes from Y524S/+ and dCasq-null mice. In addition, the maximum rate of I-SkCRAC activation in dCasq-null myotubes was also faster than WT at more physiological temperatures (35-37 degrees C). Azumolene (50 mu M), a more water-soluble analog of dantrolene that is used to reverse MH crises, failed to alter I-SkCRAC density or rate of activation. Together, these results indicate that while an increased rate of I-SkCRAC activation is a common characteristic of myotubes derived from Y524S/+ and dCasq-null mice and that the protective effects of azumolene are not due to a direct inhibition of SOCE channels.	[Yarotskyy, Viktor; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Protasi, Feliciano] Univ Gabriele dAnnunzio, Ctr Res Ageing, Chieti, Italy; [Protasi, Feliciano] Univ Gabriele dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	University of Rochester; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Dirksen, RT (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	robert_dirksen@urmc.rochester.edu			National Institutes of Health (NIH) [AR059646]; Italian Telethon Foundation [GGP08153]; NIH [AR060831]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646, K01AR060831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon Foundation(Fondazione Telethon); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by: a research grant from the National Institutes of Health (NIH) (AR059646 to RTD), the Italian Telethon Foundation (GGP08153 to FP), and a career development K01 award from the NIH (AR060831 to VY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNET PJ, 1991, ANESTHESIOLOGY, V75, P413, DOI 10.1097/00000542-199109000-00006; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Avila G, 2000, J GEN PHYSIOL, V115, P467, DOI 10.1085/jgp.115.4.467; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Capacchione JF, 2009, ANESTH ANALG, V109, P1065, DOI 10.1213/ane.0b013e3181a9d8d9; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Dirksen R. T, 1997, GENEREVIEWS GENETEST; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Edwards JN, 2010, CELL CALCIUM, V47, P458, DOI 10.1016/j.ceca.2010.04.001; FLETCHER JE, 1990, CAN J ANAESTH, V37, P695, DOI 10.1007/BF03006495; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; HARRISON GG, 1975, BRIT J ANAESTH, V47, P62, DOI 10.1093/bja/47.1.62; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Larach MG, 2008, ANESTHESIOLOGY, V108, P603, DOI 10.1097/ALN.0b013e318167aee2; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Launikonis BS, 2003, P NATL ACAD SCI USA, V100, P2941, DOI 10.1073/pnas.0536227100; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; NELSON TE, 1981, J PHARMACOL EXP THER, V219, P107; NELSON TE, 1975, ANESTHESIOLOGY, V42, P301, DOI 10.1097/00000542-197503000-00011; Nishio Hajime, 2009, Legal Medicine, V11, P142, DOI 10.1016/j.legalmed.2008.12.004; Palnitkar SS, 1997, BIOCHEM J, V326, P847, DOI 10.1042/bj3260847; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Paolini C, 2011, J BIOMED BI IN PRESS; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; PARNESS J, 1995, J BIOL CHEM, V270, P18465, DOI 10.1074/jbc.270.31.18465; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Shin DW, 2003, J BIOL CHEM, V278, P3286, DOI 10.1074/jbc.M209045200; Szentesi P, 2001, J GEN PHYSIOL, V118, P355, DOI 10.1085/jgp.118.4.355; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Wappler F, 2010, CURR OPIN ANESTHESIO, V23, P417, DOI 10.1097/ACO.0b013e328337ffe0; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yarotskyy V, 2012, BIOPHYS J, V103, P202, DOI 10.1016/j.bpj.2012.06.001; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	49	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77633	10.1371/journal.pone.0077633	http://dx.doi.org/10.1371/journal.pone.0077633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143248	Green Submitted, gold, Green Published			2022-12-25	WOS:000325894100086
J	Yuan, Y; Wu, C; Liu, YJ; Yang, J; Huang, LQ				Yuan, Yuan; Wu, Chong; Liu, Yunjun; Yang, Jian; Huang, Luqi			The Scutellaria baicalensis R2R3-MYB Transcription Factors Modulates Flavonoid Biosynthesis by Regulating GA Metabolism in Transgenic Tobacco Plants	PLOS ONE			English	Article							PHENYLALANINE-AMMONIA-LYASE; GENE FAMILY; FUNCTIONAL-ANALYSIS; GIBBERELLIC-ACID; WALL FORMATION; ARABIDOPSIS; PROTEIN; ACCUMULATION; SEQUENCE; PURIFICATION	R2R3-MYB proteins play role in plant development, response to biotic and abiotic stress, and regulation of primary and secondary metabolism. Little is known about the R2R3-MYB proteins in Scutellaria baicalensis which is an important Chinese medical plant. In this paper, nineteen putative SbMYB genes were identified from a S. baicalensis cDNA library, and eleven R2R3-MYBs were clustered into 5 subgroups according to phylogenetic reconstruction. In the S. baicalensis leaves which were sprayed with GA(3), SbMYB2 and SbMYB7 had similar expression pattern with SbPALs, indicating that SbMYB2 and SbMYB7 might be involved in the flavonoid metabolism. Transactivation assay results showed that SbMYB2 and SbMYB7 can function as transcriptional activator. The expression of several flavonoid biosynthesis-related genes were induced or suppressed by overexpression of SbMYB2 or SbMYB7 in transgenic tobacco plants. Consistent with the change of the expression of NtDH29 and NtCHI, the contents of dicaffeoylspermidine and quercetin-3,7-O-diglucoside in SbMYB2-overexpressing or SbMYB7-overexpressing transgenic tobacco plants were decreased. The transcriptional level of NtUFGT in transgenic tobacco overexpressing SbMYB7 and the transcriptional level of NtHCT in SbMYB2-overexpressing tobacco plants were increased; however the application of GA3 inhibited the transcriptional level of these two genes. These results suggest that SbMYB2 and SbMYB7 might regulate the flavonoid biosynthesis through GA metabolism.	[Yuan, Yuan; Wu, Chong; Yang, Jian; Huang, Luqi] Chinese Acad Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100730, Peoples R China; [Liu, Yunjun] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; National Resource Center for Chinese Materia Medica, CACMS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Liu, YJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	liuyunjun@caas.cn; huangluqi@263.net			Scientific and technological research of Chinese medicine Program [06-07ZP51]; Beijing nova program [2008B82]; China Academy of Traditional Chinese Medicine [ZZ2008062]	Scientific and technological research of Chinese medicine Program; Beijing nova program(Beijing Municipal Science & Technology Commission); China Academy of Traditional Chinese Medicine	This work was supported by the Scientific and technological research of Chinese medicine Program (06-07ZP51), Beijing nova program (2008B82) and the Self-selection program of China Academy of Traditional Chinese Medicine (ZZ2008062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bailey PC, 2008, PHYTOCHEMISTRY, V69, P2417, DOI 10.1016/j.phytochem.2008.08.003; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blach-Olszewska Z, 2008, J INTERF CYTOK RES, V28, P571, DOI 10.1089/jir.2008.0125; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cook CM, 2012, PHYTOCHEMISTRY, V74, P79, DOI 10.1016/j.phytochem.2011.10.009; Craven-Bartle B, 2013, PLANT J, V74, P755, DOI 10.1111/tpj.12158; Czemmel S, 2012, PROTOPLASMA, V249, P109, DOI 10.1007/s00709-012-0380-z; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; El-kereamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052030; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HINDERER W, 1984, PLANTA, V160, P544, DOI 10.1007/BF00411143; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; HORSCH RB, 1985, COLD SPRING HARB SYM, V50, P433, DOI 10.1101/SQB.1985.050.01.054; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kumar V, 2013, MOL BIOTECHNOL, V54, P426, DOI 10.1007/s12033-012-9580-1; Lee MM, 2001, DEVELOPMENT, V128, P1539; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li DF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-109; Li XJ, 2003, PLANT SCI, V164, P549, DOI 10.1016/S0168-9452(03)00004-9; Liu RX, 2010, J BIOSCIENCES, V35, P435, DOI 10.1007/s12038-010-0049-8; Maeda K, 2005, PLANT MOL BIOL, V59, P739, DOI 10.1007/s11103-005-0910-6; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Mulder Nicola, 2007, V396, P59; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Onkokesung N, 2012, PLANT PHYSIOL, V158, P389, DOI 10.1104/pp.111.187229; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; RUSSELL DW, 1969, PLANT PHYSIOL, V44, P1211, DOI 10.1104/pp.44.9.1211; Sasaki K, 2000, J BIOL CHEM, V275, P27466; Senthil-Kumar M, 2010, PLANT PHYSIOL BIOCH, V48, P35, DOI 10.1016/j.plaphy.2009.09.005; SHINOZAKI K, 1992, PLANT MOL BIOL, V19, P493, DOI 10.1007/BF00023398; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Spitzer-Rimon B, 2012, PLANT CELL, V24, P5089, DOI 10.1105/tpc.112.105247; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Taguchi G, 1998, J PLANT BIOCHEM BIOT, V7, P79, DOI 10.1007/BF03263040; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946; Zhao CS, 2011, PLANT J, V66, P502, DOI 10.1111/j.1365-313X.2011.04508.x	55	19	28	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77275	10.1371/journal.pone.0077275	http://dx.doi.org/10.1371/journal.pone.0077275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143216	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100053
J	Luo, HJ; Yang, T; Jin, XJ; Pang, XH; Li, JP; Chai, YC; Li, L; Zhang, Y; Zhang, LP; Zhang, ZH; Wu, WJ; Zhang, Q; Hu, XT; Sun, JW; Jiang, XM; Fan, ZP; Huang, ZW; Wu, H				Luo, Huajie; Yang, Tao; Jin, Xiaojie; Pang, Xiuhong; Li, Jiping; Chai, Yongchuan; Li, Lei; Zhang, Yi; Zhang, Luping; Zhang, Zhihua; Wu, Wenjing; Zhang, Qin; Hu, Xianting; Sun, Jingwen; Jiang, Xuemei; Fan, Zhuping; Huang, Zhiwu; Wu, Hao			Association of GRM7 Variants with Different Phenotype Patterns of Age-Related Hearing Impairment in an Elderly Male Han Chinese Population	PLOS ONE			English	Article							GENE POLYMORPHISM; PRESBYCUSIS; SUSCEPTIBILITY; THRESHOLDS; PREVALENCE; PATHOLOGY; ENZYMES; GRHL2	Several single nucleotide polymorphisms (SNPs) of the Glutamate metabotrophic receptor 7 gene (GRM7) have recently been identified by the genome-wide association study (GWAS) as potentially playing a role in susceptibility to age-related hearing impairment (ARHI), however this has not been validated in the Han Chinese population. The aim of this study was to determine if these SNPs are also associated with ARHI in an elderly male Han Chinese population. In this case-control candidate genes association study, a total of 982 men with ARHI and 324 normal-hearing controls subjects were studied. Using K-means cluster analysis, four audiogram shape subtypes of ARHI were identified in the case group: "flat shape (FL)'', "sloping shape (SL)", "2-4 kHz abrupt loss (AL) shape" and "8 kHz dip (8D) shape''. Results suggested that the SNP rs11928865 (A> T) of GRM7 was significantly associated with ARHI after adjusting for non-genetic factors (p= 0.000472, OR= 1.599, 95% CI= 1.229 similar to 2.081). Furthermore, frequency of TT genotype (rs11928865) were significant higher in the SL subgroup and AL subgroup with compared to controls group (p= 9.41E-05, OR= 1.945, 95% CI= 1.393 similar to 2.715; p= 0.000109, OR= 1.915, 95% CI= 1.378-2.661 adjusted, respectively) after Bonferroni correction. However, there wasn't significant difference in the frequency of the TT genotype between cases in the FL subgroup or the 8D subgroup with when compared with controls. Results of the current study suggest that, in an elderly male Han Chinese population, GRM7 SNP rs11928865 (TT) occurs more frequently in ARHI patients with SL and AL phenotype patterns.	[Luo, Huajie; Yang, Tao; Pang, Xiuhong; Chai, Yongchuan; Li, Lei; Zhang, Luping; Zhang, Zhihua; Wu, Wenjing; Zhang, Qin; Hu, Xianting; Sun, Jingwen; Huang, Zhiwu; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Luo, Huajie; Yang, Tao; Pang, Xiuhong; Chai, Yongchuan; Li, Lei; Zhang, Luping; Zhang, Zhihua; Wu, Wenjing; Zhang, Qin; Hu, Xianting; Sun, Jingwen; Huang, Zhiwu; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai 200030, Peoples R China; [Jiang, Xuemei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Hlth Check Up Ctr, Shanghai 200030, Peoples R China; [Luo, Huajie; Jin, Xiaojie; Li, Jiping; Zhang, Yi] Shanghai Jiao Tong Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, RenJi Hosp, Shanghai 200030, Peoples R China; [Fan, Zhuping] Shanghai Jiao Tong Univ, Sch Med, RenJi Hosp, Hlth Check Up Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	huangzw086@hotmail.com; wuhao7622@sina.com	zhang, luping/AAQ-2069-2020; Pang, Xiuhong/ABE-2751-2021; zhang, zh/GWV-4677-2022	Yang, Tao/0000-0001-6011-987X	National Basic Research Program of China [2011CB504501]; Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China [201202005]; 12th Five-Year National Key Technologies Research & Development program [2012BAI12B01]; National Science Foundation of China [81222010]; Shanghai Municipal Science and Technology Commission [11PJ1407000]	National Basic Research Program of China(National Basic Research Program of China); Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China; 12th Five-Year National Key Technologies Research & Development program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by a grant from National Basic Research Program of China 2011CB504501 (HW); grant from the Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China No. 201202005 (HW); grant from the 12th Five-Year National Key Technologies Research & Development program No. 2012BAI12B01 (ZH); grants from National Science Foundation of China 81222010 (TY) and grants from Shanghai Municipal Science and Technology Commission 11PJ1407000 (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bared A, 2010, OTOLARYNG HEAD NECK, V143, P263, DOI 10.1016/j.otohns.2010.03.024; Christensen K, 2001, J AM GERIATR SOC, V49, P1512, DOI 10.1046/j.1532-5415.2001.4911245.x; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; DeStefano AL, 2003, ARCH OTOLARYNGOL, V129, P285, DOI 10.1001/archotol.129.3.285; Dubno JR, 1997, J SPEECH LANG HEAR R, V40, P444, DOI 10.1044/jslhr.4002.444; Dupret JM, 2005, CURR MED CHEM, V12, P311, DOI 10.2174/0929867053363289; *EN ISO, 2000, BS70292000 EN ISO; Fay R.R, 2010, AGING AUDITORY SYSTE, p[18, 31]; Fitzgibbons P J, 1996, J Am Acad Audiol, V7, P183; Fransen E, 2004, EAR HEARING, V25, P133, DOI 10.1097/01.AUD.0000120362.69077.0B; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Garringer HJ, 2006, ARCH OTOLARYNGOL, V132, P506, DOI 10.1001/archotol.132.5.506; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Helfer KS, 2009, J AM ACAD AUDIOL, V20, P264, DOI 10.3766/jaaa.20.4.6; Huang Q, 2010, EUR ARCH OTO-RHINO-L, V267, P1179, DOI 10.1007/s00405-010-1270-7; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Karlsson KK, 1997, EAR HEARING, V18, P114, DOI 10.1097/00003446-199704000-00003; Lee CY, 2010, INT J AUDIOL, V49, P628, DOI 10.3109/14992021003796887; Lin YH, 2011, LARYNGOSCOPE, V121, P1303, DOI 10.1002/lary.21771; Margolis RH, 2007, INT J AUDIOL, V46, P746, DOI 10.1080/14992020701572652; Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; O'Grady G, 2007, INT J AUDIOL, V46, P183, DOI 10.1080/14992020601145294; Ohlemiller Kevin K, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P439, DOI 10.1097/01.moo.0000134450.99615.22; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; PARMET S, 2007, JAMA PATIENT, P298; Price K, 2009, HEARING RES, V252, P29, DOI 10.1016/j.heares.2009.02.010; Pujol R, 1990, Acta Otolaryngol Suppl, V476, P32; SCHERER EQ, 2005, BMC EAR NOSE THROAT, V29, P5; SCHUKNECHT HF, 1964, ARCHIV OTOLARYNGOL, V80, P369; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Seidman MD, 2000, AM J OTOL, V21, P161, DOI 10.1016/S0196-0709(00)80003-4; Stenklev NC, 2004, INT J AUDIOL, V43, P295, DOI 10.1080/14992020400050039; Sugiura S, 2010, ACTA OTO-LARYNGOL, V130, P487, DOI 10.3109/00016480903283758; Uchida Y, 2009, LARYNGOSCOPE, V119, P938, DOI 10.1002/lary.20181; Unal M, 2005, LARYNGOSCOPE, V115, P2238, DOI 10.1097/01.mlg.0000183694.10583.12; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Van Eyken E, 2006, HUM MUTAT, V27, P1007, DOI 10.1002/humu.20375; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VANLAER L, 2007, GENES HEARING DEAFNE, P79; Wiley TL, 2008, J AM ACAD AUDIOL, V19, P281, DOI 10.3766/jaaa.19.4.2; Wingfield A, 2007, J GERONTOL A-BIOL, V62, P1294, DOI 10.1093/gerona/62.11.1294; World Health Organization, 2012, WORLD HLTH STAT; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976	48	16	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77153	10.1371/journal.pone.0077153	http://dx.doi.org/10.1371/journal.pone.0077153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146964	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400101
J	Shan, M; Zhang, XY; Liu, XL; Qin, Y; Liu, T; Liu, Y; Wang, J; Zhong, ZB; Zhang, YX; Geng, JS; Pang, D				Shan, Ming; Zhang, Xianyu; Liu, Xiaolong; Qin, Yu; Liu, Tong; Liu, Yang; Wang, Ji; Zhong, Zhenbin; Zhang, Youxue; Geng, Jingshu; Pang, Da			P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; BASAL-LIKE; TUMOR-SUPPRESSOR; TP53 MUTATION; IN-SITU; OVEREXPRESSION; CARCINOMAS; INACTIVATION; PATHWAYS	Breast cancers are heterogeneous and complex diseases, and subtypes of breast cancers may involve unique molecular mechanisms. The p16(INK4a) and p53 pathways are two of the major pathways involved in control of the cell cycle. They also play key roles in tumorigenesis. However, whether the roles of these pathways differ in the subtypes of breast cancer is unclear. Therefore, p16 and p53 expression were investigated in different breast cancer subtypes to ascertain their contributions to these cancers. A total of 400 cases of non-invasive ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC), including the major molecular subtypes luminal-A, luminal-B, Her-2, and triple-negative subtypes, and 50 cases of normal controls were compared. Luminal-A cancers expressed the lowest level of p16 among the subtypes in DCIS, and the level of p16 expression was up-regulated in the luminal-A of IDC (P<0.008). Triple-negative breast cancers were characterized by a correlation of p53 overexpression with a high level of p16 expression. Luminal lesion types with high p16 expression in DCIS were found to be more likely to develop into aggressive breast cancers, possibly promoted by p53 dysfunction. Taken together, the present study suggest that p16 expression in luminal-A breast cancers is associated with their progression from DCIS to IDC, and both p53 and p16 expressions are important for the development of triple-negative breast cancers in DCIS and IDC.	[Shan, Ming; Zhang, Xianyu; Liu, Tong; Liu, Yang; Wang, Ji; Zhong, Zhenbin; Zhang, Youxue; Pang, Da] Harbin Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Harbin, Peoples R China; [Liu, Xiaolong; Qin, Yu; Geng, Jingshu] Harbin Med Univ, Dept Pathol, Affiliated Tumor Hosp, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Harbin, Peoples R China.	pangdasir@163.com		LIU, TONG/0000-0001-9234-1328	Affiliated Tumour Hospital of Harbin Medical University [JJZ2010-04]; Harbin Medical University [WLD-QN1118]; National Natural Science Fund [81172498]; Technological innovation talent research special funds of Harbin [2011RFXYS056]	Affiliated Tumour Hospital of Harbin Medical University; Harbin Medical University; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Technological innovation talent research special funds of Harbin	This study was supported by the funding of The Affiliated Tumour Hospital of Harbin Medical University (JJZ2010-04), the "Wu Liande" funding of Harbin Medical University (WLD-QN1118), The National Natural Science Fund (81172498) and the Technological innovation talent research special funds of Harbin (2011RFXYS056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley AN, 2002, ARCH PATHOL LAB MED, V126, P456; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; Derenzini M, 2009, J PATHOL, V219, P373, DOI 10.1002/path.2612; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Geradts J, 2000, MODERN PATHOL, V13, P945, DOI 10.1038/modpathol.3880172; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Hui R, 2000, CLIN CANCER RES, V6, P2777; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Levine Arnold J., 2004, Cell, VS116, pS67, DOI 10.1016/S0092-8674(04)00036-4; Livasy CA, 2007, HUM PATHOL, V38, P197, DOI 10.1016/j.humpath.2006.08.017; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Montanari M, 2005, J CELL PHYSIOL, V202, P215, DOI 10.1002/jcp.20120; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Soong R, 1996, HUM PATHOL, V27, P1050, DOI 10.1016/S0046-8177(96)90282-8; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stewart CL, 2001, J NEURO-ONCOL, V51, P183, DOI 10.1023/A:1010615822317; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Zhang D, 2008, ONCOGENE, V27, P4305, DOI 10.1038/onc.2008.76; Zhang JM, 2006, CANCER RES, V66, P10325, DOI 10.1158/0008-5472.CAN-06-1594	41	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76408	10.1371/journal.pone.0076408	http://dx.doi.org/10.1371/journal.pone.0076408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146864	gold, Green Submitted, Green Published			2022-12-25	WOS:000325819400056
J	Tessereau, C; Buisson, M; Monnet, N; Imbert, M; Barjhoux, L; Schluth-Bolard, C; Sanlaville, D; Conseiller, E; Ceppi, M; Sinilnikova, OM; Mazoyer, S				Tessereau, Chloe; Buisson, Monique; Monnet, Nastasia; Imbert, Marine; Barjhoux, Laure; Schluth-Bolard, Caroline; Sanlaville, Damien; Conseiller, Emmanuel; Ceppi, Maurizio; Sinilnikova, Olga M.; Mazoyer, Sylvie			Direct Visualization of the Highly Polymorphic RNU2 Locus in Proximity to the BRCA1 Gene	PLOS ONE			English	Article							COPY NUMBER VARIATION; SMALL NUCLEAR-RNA; PRIMATE U2 SNRNA; HUMAN GENOME; CONCERTED EVOLUTION; CHROMOSOME 17Q21; PHYSICAL MAP; HYBRID MAP; BREAST; REGION	Although the breast cancer susceptibility gene BRCA1 is one of the most extensively characterized genetic loci, much less is known about its upstream variable number tandem repeat element, the RNU2 locus. RNU2 encodes the U2 small nuclear RNA, an essential splicing element, but this locus is missing from the human genome assembly due to the inherent difficulty in the assembly of repetitive sequences. To fill the gap between RNU2 and BRCA1, we have reconstructed the physical map of this region by re-examining genomic clone sequences of public databases, which allowed us to precisely localize the RNU2 array 124 kb telomeric to BRCA1. We measured by performing FISH analyses on combed DNA for the first time the exact number of repeats carried by each of the two alleles in 41 individuals and found a range of 6-82 copies and a level of heterozygosity of 98%. The precise localisation of the RNU2 locus in the genome reference assembly and the implementation of a new technical tool to study it will make the detailed exploration of this locus possible. This recently neglected macrosatellite could be valuable for evaluating the potential role of structural variations in disease due to its location next to a major cancer susceptibility gene.	[Tessereau, Chloe; Buisson, Monique; Monnet, Nastasia; Imbert, Marine; Barjhoux, Laure; Sinilnikova, Olga M.; Mazoyer, Sylvie] Univ Lyon 1, Ctr Berard Lyon, Genet Breast Canc Team, Canc Res Ctr Lyon,CNRS,Inserm,U1052,UMR5286, F-69365 Lyon, France; [Tessereau, Chloe; Conseiller, Emmanuel; Ceppi, Maurizio] Genom Vis, Bagneux, France; [Schluth-Bolard, Caroline; Sanlaville, Damien] Univ Lyon 1, Equipe TIGER, Hosp Civils Lyon, Serv Genet,Lab Cytogenet Constitut,Ctr Biol & Est, F-69365 Lyon, France; [Schluth-Bolard, Caroline; Sanlaville, Damien] Univ Lyon 1, Equipe TIGER, INSERM, CNRS,UMR5292,U1028, F-69365 Lyon, France; [Sinilnikova, Olga M.] Hosp Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitut Canc Frequents, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UNICANCER; Centre Leon Berard	Mazoyer, S (corresponding author), Univ Lyon 1, Ctr Berard Lyon, Genet Breast Canc Team, Canc Res Ctr Lyon,CNRS,Inserm,U1052,UMR5286, F-69365 Lyon, France.	sylvie.mazoyer@lyon.unicancer.fr	Mazoyer, Sylvie/N-7559-2017; Sanlaville, Damien/M-4716-2014; Schluth-Bolard, Caroline/AAF-3862-2019	Sanlaville, Damien/0000-0001-9939-2849; Mazoyer, Sylvie/0000-0002-2135-0160; Schluth-Bolard, Caroline/0000-0002-2279-4273	Fondation ARC pour la Recherche sur le Cancer	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by a grant from the "Fondation ARC pour la Recherche sur le Cancer" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; BAILEY AD, 1995, MOL CELL BIOL, V15, P6246; BLACK DM, 1993, AM J HUM GENET, V52, P702; Cheeseman K, 2012, HUM MUTAT, V33, P998, DOI 10.1002/humu.22060; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; HAMMARSTROM K, 1985, EXP CELL RES, V159, P473, DOI 10.1016/S0014-4827(85)80020-3; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Jia YC, 2012, CELL, V148, P296, DOI 10.1016/j.cell.2011.11.057; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; LINDGREN V, 1985, NATURE, V314, P115, DOI 10.1038/314115a0; Liu XD, 1999, AM J HUM GENET, V64, P1427, DOI 10.1086/302358; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Pavelitz T, 1999, EMBO J, V18, P3783, DOI 10.1093/emboj/18.13.3783; PAVELITZ T, 1995, EMBO J, V14, P169, DOI 10.1002/j.1460-2075.1995.tb06987.x; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schaap M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-143; Schluth-Bolard C, 2009, EUR J MED GENET, V52, P291, DOI 10.1016/j.ejmg.2009.05.011; Sinilnikova OM, 2006, FAM CANCER, V5, P15, DOI 10.1007/s10689-005-2571-7; Tremblay DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-632; VANARSDELL SW, 1984, MOL CELL BIOL, V4, P492, DOI 10.1128/MCB.4.3.492; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; WESTIN G, 1984, P NATL ACAD SCI-BIOL, V81, P3811, DOI 10.1073/pnas.81.12.3811; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2	36	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76054	10.1371/journal.pone.0076054	http://dx.doi.org/10.1371/journal.pone.0076054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146815	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400036
J	Tey, SK; Kennedy, GA; Cromer, D; Davenport, MP; Walker, S; Jones, LI; Crough, T; Durrant, ST; Morton, JA; Butler, JP; Misra, AK; Hill, GR; Khanna, R				Tey, Siok-Keen; Kennedy, Glen A.; Cromer, Deborah; Davenport, Miles P.; Walker, Susan; Jones, Linda I.; Crough, Tania; Durrant, Simon T.; Morton, James A.; Butler, Jason P.; Misra, Ashish K.; Hill, Geoffrey R.; Khanna, Rajiv			Clinical Assessment of Anti-Viral CD8+T Cell Immune Monitoring Using QuantiFERON-CMV (R) Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications	PLOS ONE			English	Article							CYTOMEGALOVIRUS-SPECIFIC CD4(+); MEDIATED-IMMUNITY; QUANTIFERON(R)-CMV ASSAY; RECIPIENTS; RECONSTITUTION; RESPONSES; PREDICTION; RECURRENT; THERAPY; DISEASE	The reconstitution of anti-viral cellular immunity following hematopoietic stem cell transplantation (HSCT) is crucial in preventing cytomegalovirus (CMV)-associated complications. Thus immunological monitoring has emerged as an important tool to better target pre-emptive anti-viral therapies. However, traditional laboratory-based assays are too cumbersome and complicated to implement in a clinical setting. Here we conducted a prospective study of a new whole blood assay (referred to as QuantiFERON-CMV (R)) to determine the clinical utility of measuring CMV-specific CD8+ T-cell responses as a prognostic tool. Forty-one evaluable allogeneic HSCT recipients underwent weekly immunological monitoring from day 21 post-transplant and of these 21 (51.2%) showed CMV reactivation and 29 (70.7%) developed acute graft-versus-host disease (GvHD). Patients with acute GvHD (grade >= 2) within 6 weeks of transplant showed delayed reconstitution of CMV-specific T-cell immunity (p = 0.013) and a higher risk of CMV viremia (p = 0.026). The median time to stable CMV-specific immune reconstitution was 59 days and the incidence of CMV reactivation was lower in patients who developed this than those who did not (27% versus 65%; p = 0.031). Furthermore, a failure to reconstitute CMV-specific immunity soon after the onset of CMV viraemia was associated with higher peak viral loads (5685 copies/ml versus 875 copies/ml; p = 0.002). Hence, QuantiFERON-CMV (R) testing in the week following CMV viremia can be useful in identifying HSCT recipients at risk of complicated reactivation.	[Tey, Siok-Keen; Walker, Susan; Jones, Linda I.; Crough, Tania; Khanna, Rajiv] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Herston, Qld 4006, Australia; [Tey, Siok-Keen; Walker, Susan; Jones, Linda I.; Crough, Tania; Khanna, Rajiv] Queensland Inst Med Res, Tumour Immunol Lab, Herston, Qld 4006, Australia; [Tey, Siok-Keen; Kennedy, Glen A.; Durrant, Simon T.; Morton, James A.; Butler, Jason P.; Misra, Ashish K.; Hill, Geoffrey R.] Royal Brisbane & Womens Hosp, Dept Haematol & Bone Marrow Transplantat, Herston, Qld, Australia; [Hill, Geoffrey R.] Queensland Inst Med Res, Bone Marrow Transplant Lab, Herston, Qld 4006, Australia; [Tey, Siok-Keen; Kennedy, Glen A.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Cromer, Deborah; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Kensington, NSW 2033, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; University of Queensland; University of New South Wales Sydney	Khanna, R (corresponding author), Queensland Inst Med Res, Australian Ctr Vaccine Dev, Bramston Terrace, Herston, Qld 4006, Australia.	rajiv.khanna@qimr.edu.au	Hill, Geoffrey/O-2630-2016; Tey, Siok-Keen/I-6380-2015; Khanna, Rajiv/A-7691-2008; Kennedy, Glen/AAK-1644-2021; Kennedy, Glen/F-4728-2013	Hill, Geoffrey/0000-0003-2994-0429; Tey, Siok-Keen/0000-0001-9567-382X; Khanna, Rajiv/0000-0003-2241-0353; Kennedy, Glen/0000-0002-7171-0435; Davenport, Miles/0000-0002-4751-1831; Cromer, Deborah/0000-0002-5276-5094	National Health and Medical Research Council (NHMRC), Australia; NHMRC; Leukaemia Foundation of Australia	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation of Australia	RK is supported by a Senior Principal Research Fellowship by the National Health and Medical Research Council (NH&MRC), Australia. GRH is supported by an Australia Fellowship by NH&MRC. SKT was supported by a PhD Fellowship by the Leukaemia Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avetisyan G, 2007, BONE MARROW TRANSPL, V40, P865, DOI 10.1038/sj.bmt.1705825; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Borchers S, 2011, TRANSPL INFECT DIS, V13, P222, DOI 10.1111/j.1399-3062.2011.00626.x; Cantoni N, 2010, BIOL BLOOD MARROW TR, V16, P1309, DOI 10.1016/j.bbmt.2010.03.020; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Feuchtinger T, BLOOD, V116, P4360; Fleming T, 2010, J MED VIROL, V82, P433, DOI 10.1002/jmv.21727; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Giulieri S, 2011, EXPERT REV MOL DIAGN, V11, P17, DOI [10.1586/erm.10.109, 10.1586/ERM.10.109]; Gratama JW, 2008, CYTOM PART B-CLIN CY, V74B, P211, DOI 10.1002/cyto.b.20420; Gratama JW, 2010, BLOOD, V116, P1655, DOI 10.1182/blood-2010-03-273508; Kumar D, 2009, AM J TRANSPLANT, V9, P1214, DOI 10.1111/j.1600-6143.2009.02618.x; Lamba R, 2005, BONE MARROW TRANSPL, V36, P797, DOI 10.1038/sj.bmt.1705121; Lilleri D, 2008, HAEMATOLOGICA, V93, P248, DOI 10.3324/haematol.11912; Lilleri D, 2006, BLOOD, V108, P1406, DOI 10.1182/blood-2005-11-012864; Lilleri D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041648; Lilleri D, 2009, CLIN IMMUNOL, V131, P395, DOI 10.1016/j.clim.2009.02.002; Lisboa LF, 2012, TRANSPLANTATION, V93, P195, DOI 10.1097/TP.0b013e31823c1cd4; Lochmanova A, 2010, TRANSPL P, V42, P3574, DOI 10.1016/j.transproceed.2010.07.101; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Moins-Teisserenc H, 2008, J INFECT DIS, V198, P818, DOI 10.1086/591185; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Solano C, 2011, TRANSPLANTATION, V92, pE17, DOI 10.1097/TP.0b013e318224f263; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x	25	59	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e74744	10.1371/journal.pone.0074744	http://dx.doi.org/10.1371/journal.pone.0074744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146744	Green Submitted, Green Published, gold			2022-12-25	WOS:000325819400003
J	Gonsalves, L; Bicknell, B; Law, B; Webb, C; Monamy, V				Gonsalves, Leroy; Bicknell, Brian; Law, Brad; Webb, Cameron; Monamy, Vaughan			Mosquito Consumption by Insectivorous Bats: Does Size Matter?	PLOS ONE			English	Article							LONG-EARED BATS; LUCIFUGUS CHIROPTERA-VESPERTILIONIDAE; NYCTALUS-LEISLERI; ARTHROPOD PREY; BODY SIZE; ECHOLOCATION; DIET; MYOTIS; ASSEMBLAGES; AUSTRALIA	Insectivorous bats have often been touted as biological control for mosquito populations. However, mosquitoes generally represent only a small proportion of bat diet. Given the small size of mosquitoes, restrictions imposed on prey detectability by low frequency echolocation, and variable field metabolic rates (FMR), mosquitoes may not be available to or profitable for all bats. This study investigated whether consumption of mosquitoes was influenced by bat size, which is negatively correlated with echolocation frequency but positively correlated with bat FMR. To assess this, we investigated diets of five eastern Australian bat species (Vespadelus vulturnus Thomas, V. pumilus Gray, Miniopterus australis Tomes, Nyctophilus gouldi Tomes and Chalinolobus gouldii Gray) ranging in size from 4-14 g in coastal forest, using molecular analysis of fecal DNA. Abundances of potential mosquito and non-mosquito prey were concurrently measured to provide data on relative prey abundance. Aedes vigilax was locally the most abundant mosquito species, while Lepidoptera the most abundant insect order. A diverse range of prey was detected in bat feces, although members of Lepidoptera dominated, reflecting relative abundance at trap sites. Consumption of mosquitoes was restricted to V. vulturnus and V. pumilus, two smaller sized bats (4 and 4.5 g). Although mosquitoes were not commonly detected in feces of V. pumilus, they were present in feces of 55 % of V. vulturnus individuals. To meet nightly FMR requirements, Vespadelus spp. would need to consume similar to 600-660 mosquitoes on a mosquito-only diet, or similar to 160-180 similar sized moths on a moth-only diet. Lower relative profitability of mosquitoes may provide an explanation for the low level of mosquito consumption among these bats and the absence of mosquitoes in feces of larger bats. Smaller sized bats, especially V. vulturnus, are likely to be those most sensitive to reductions in mosquito abundance and should be monitored during mosquito control activities.	[Gonsalves, Leroy; Bicknell, Brian; Monamy, Vaughan] Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia; [Law, Brad] Forest Sci Ctr, Dept Primary Ind, North Parramatta, NSW, Australia; [Webb, Cameron] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Med Entomol, Westmead, NSW 2145, Australia; [Webb, Cameron] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW 2145, Australia	Australian Catholic University; University of Sydney; University of Sydney	Gonsalves, L (corresponding author), Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia.	leroy.gonsalves@acu.edu.au		Law, Bradley/0000-0002-3991-3865; Webb, Cameron/0000-0003-1029-5140	New South Wales Environmental Trust	New South Wales Environmental Trust	Funding for this research was provided by the New South Wales Environmental Trust (http://www.environment.nsw.gov.au/grants?/envtrust.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BARCLAY RMR, 1991, CAN J ZOOL, V69, P1853, DOI 10.1139/z91-256; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Bell K. M., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P168; Bell SAJ, 2004, NATURAL VEGETATION G, V2; BELWOOD JJ, 1976, CAN J ZOOL, V54, P1674, DOI 10.1139/z76-194; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Bradshaw PA, 1996, BC MIN FOR RES PROGR, V23, P199; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; BUCHLER ER, 1976, AM NAT, V110, P619, DOI 10.1086/283094; Churchill S., 2009, AUSTR BATS; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; GERELL R, 1993, BIOL CONSERV, V65, P153, DOI 10.1016/0006-3207(93)90444-6; Gonsalves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064081; Gonsalves L, 2013, WILDLIFE RES, V40, P10, DOI 10.1071/WR12148; GRANT JDA, 1991, AUST J ZOOL, V39, P45, DOI 10.1071/ZO9910045; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; JONES G, 1995, J ZOOL, V237, P303, DOI 10.1111/j.1469-7998.1995.tb02764.x; Jones G, 1999, J EXP BIOL, V202, P3359; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; KALKO EKV, 1995, ANIM BEHAV, V50, P861, DOI 10.1016/0003-3472(95)80090-5; Kokkinn MJ, 2009, MED VET ENTOMOL, V23, P85, DOI 10.1111/j.1365-2915.2008.00787.x; Kunz T.H., 1988, P191; Lloyd A, 2006, BIOL CONSERV, V129, P207, DOI 10.1016/j.biocon.2005.10.035; LOWMAN MD, 1982, AUST J ECOL, V7, P353, DOI 10.1111/j.1442-9993.1982.tb01310.x; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Mehl B., 1988, ANIMAL SONAR PROCESS, P435, DOI DOI 10.1007/978-1-4684-7493-0_43; ONEILL MG, 1989, AUST J ECOL, V14, P19; Pavey CR, 2001, BIOTROPICA, V33, P670, DOI 10.1646/0006-3606(2001)033[0670:DBOTFB]2.0.CO;2; Payne R, 2006, MICROBAT SMALL MAMMA; POOLE EARL L., 1932, JOUR MAMMALOGY, V13, P365; RABINOWITZ AR, 1982, ACTA THERIOL, V27, P283, DOI 10.4098/AT.arch.82-25; Reinhold L, 2001, KEY BAT CALLS S E; Reiskind MH, 2009, J MED ENTOMOL, V46, P1037, DOI 10.1603/033.046.0510; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8; RUSSELL RC, 1996, COLOUR PHOTO ATLAS M; Russell TL, 2008, AUST J ENTOMOL, V47, P232, DOI 10.1111/j.1440-6055.2008.00642.x; Rydell J., 1990, Bats (Austin), V8, P8; Rydell J, 1989, ECOGRAPHY, V12, P16, DOI [10.1111/j.1600-0587.1989.tb00817.x, DOI 10.1111/J.1600-0587.1989.TB00817.X]; Shiel CB, 1998, J ZOOL, V246, P417, DOI 10.1111/j.1469-7998.1998.tb00173.x; Speakman JR, 2003, BAT ECOLOGY, P430; SUTHERLAND RM, 2000, THESIS U OXFORD OXFO; TIDEMANN CR, 1978, AUST WILDLIFE RES, V5, P355, DOI 10.1071/WR9780355; Tuttle M.D., 2005, AM NEIGHBORHOOD BATS AM NEIGHBORHOOD BATS; VESTJENS WJM, 1977, AUST WILDLIFE RES, V4, P25; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; Webb CE, 2011, ANN REPORT MOSQUITO, P2010; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	53	36	38	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77183	10.1371/journal.pone.0077183	http://dx.doi.org/10.1371/journal.pone.0077183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130851	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200066
J	Gu, Y; Wei, JF; Yang, J; Huang, JJ; Yang, XD; Zhu, XP				Gu, Yuan; Wei, Junfei; Yang, Jing; Huang, Jingjing; Yang, Xiaodi; Zhu, Xinping			Protective Immunity against Trichinella spiralis Infection Induced by a Multi-Epitope Vaccine in a Murine Model	PLOS ONE			English	Article							PARAMYOSIN; ANTIGEN; MICE; CELL; IDENTIFICATION; TRICHINOSIS; ANTIBODIES; RESPONSES; MIMOTOPE; NEMATODE	Trichinellosis is one of the most important food-borne parasitic zoonoses throughout the world. Because infected pigs are the major source of human infections, and China is becoming the largest international producer of pork, the development of a transmission-blocking vaccine to prevent swine from being infected is urgently needed for trichinellosis control in China. Our previous studies have demonstrated that specific Trichinella spiralis paramyosin (Ts-Pmy) and Ts-87 antigen could provide protective immunity against T. spiralis infection in immunized mice. Certain protective epitopes of Ts-Pmy and Ts-87 antigen have been identified. To identify more Ts-Pmy protective epitopes, a new monoclonal antibody, termed 8F12, was produced against the N-terminus of Ts-Pmy. This antibody elicited significant protective immunity in mice against T. spiralis infection by passive transfer and was subsequently used to screen a random phage display peptide library to identify recognized epitopes. Seven distinct positive phage clones were identified and their displayed peptides were sequenced. Synthesized epitope peptides conjugated to keyhole limpet hemocyanin were used to immunize mice, four of which exhibited larval reduction (from 18.7% to 26.3%, respectively) in vaccinated mice in comparison to the KLH control. To increase more effective protection, the epitope 8F7 that was found to induce the highest protection in this study was combined with two other previously identified epitopes (YX1 from Ts-Pmy and M7 from Ts-87) to formulate a multi-epitope vaccine. Mice immunized with this multi-epitope vaccine experienced a 35.0% reduction in muscle larvae burden after being challenged with T. spiralis larvae. This protection is significantly higher than that induced by individual-epitope peptides and is associated with high levels of subclasses IgG and IgG1. These results showed that a multi-epitope vaccine induced better protective immunity than an individual epitope and provided a feasible approach for developing a safer and more effective vaccine against trichinellosis.	[Gu, Yuan; Wei, Junfei; Yang, Jing; Huang, Jingjing; Yang, Xiaodi; Zhu, Xinping] Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China	Capital Medical University	Zhu, XP (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China.	zhuxping@ccmu.edu.cn			National Natural Science Foundation of China [81171598, 81201312]; National Science and Technology Major Project [2012ZX10004220-012]; PhD Programs Foundation of the Municipal Education Commission of Beijing [20111002503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; PhD Programs Foundation of the Municipal Education Commission of Beijing	This work was supported by grants from the National Natural Science Foundation of China (81171598, 81201312), the National Science and Technology Major Project (2012ZX10004220-012), and the PhD Programs Foundation of the Municipal Education Commission of Beijing (20111002503). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anders RF, 2011, TRENDS PARASITOL, V27, P330, DOI 10.1016/j.pt.2011.04.003; Arnon R, 2000, IMMUNOLOGY, V101, P555, DOI 10.1046/j.1365-2567.2000.00139.x; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Boireau P, 1997, PARASITOLOGY, V115, P641, DOI 10.1017/S0031182097001716; CAPRON A, 1994, TROP GEOGR MED, V46, P242; Casey JL, 2004, INFECT IMMUN, V72, P1126, DOI 10.1128/IAI.72.2.1126-1134.2004; Chen XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049913; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Cui J, 2011, VET J, V190, P323, DOI 10.1016/j.tvjl.2010.12.025; Dea-Ayuela MA, 2006, VACCINE, V24, P2772, DOI 10.1016/j.vaccine.2006.01.006; Deville S, 2005, VET PARASITOL, V132, P75, DOI 10.1016/j.vetpar.2005.05.029; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Dupouy-Camet J, 2007, FAO WHO OIE GUIDELIN, P37; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Fodey TL, 2008, VET IMMUNOL IMMUNOP, V122, P25, DOI 10.1016/j.vetimm.2007.10.016; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Gobert GN, 2005, PARASITOL INT, V54, P101, DOI 10.1016/j.parint.2005.02.004; Goding JW, 1996, MONOCLONAL ANTIBODIE, P141; Goldstein G, 2012, HUM VACC IMMUNOTHER, V8, P479, DOI 10.4161/hv.19184; Goodman AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025938; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; GRENCIS RK, 1991, IMMUNOLOGY, V74, P329; Gu Y, 2008, EXP PARASITOL, V118, P66, DOI 10.1016/j.exppara.2007.06.014; HELLING F, 1994, CANCER RES, V54, P197; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Kaba SA, 2008, CLIN VACCINE IMMUNOL, V15, P1674, DOI 10.1128/CVI.00164-08; Kang SA, 2012, VET PARASITOL, V186, P319, DOI 10.1016/j.vetpar.2011.12.002; Kurdova-Mintcheva R, 2009, VET PARASITOL, V159, P316, DOI 10.1016/j.vetpar.2008.10.070; LI BW, 1993, J IMMUNOL, V150, P1881; Li Qiang, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P101; Li Y, 2013, RES VET SCI, V94, P490, DOI 10.1016/j.rvsc.2012.10.013; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; Meloen RH, 2000, J MOL RECOGNIT, V13, P352, DOI 10.1002/1099-1352(200011/12)13:6<352::AID-JMR509>3.0.CO;2-C; Oscherwitz J, 2009, INFECT IMMUN, V77, P3380, DOI 10.1128/IAI.00358-09; Paul S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-212; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Ramirez BL, 1996, PARASITE IMMUNOL, V18, P49, DOI 10.1046/j.1365-3024.1996.d01-4.x; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Sharma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056996; Skwarczynski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046870; Solis CF, 2005, INFECT IMMUN, V73, P1895, DOI 10.1128/IAI.73.3.1895-1897.2005; STEWARD MW, 1995, J VIROL, V69, P7668, DOI 10.1128/JVI.69.12.7668-7673.1995; Wang FJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-204; Wang SH, 2009, ACTA TROP, V110, P46, DOI 10.1016/j.actatropica.2009.01.003; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072; Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842; Yang J, 2008, BIOCHEM BIOPH RES CO, V365, P528, DOI 10.1016/j.bbrc.2007.11.012; Yang J, 2010, EXP PARASITOL, V124, P403, DOI 10.1016/j.exppara.2009.12.010; Yang Y, 2003, J CAPITAL U MED SCI, V24, P108, DOI DOI 10.3969/J.ISSN.1006-7795.2003.02.005; Yang Ya-ping, 2002, Chinese Journal of Parasitology and Parasitic Diseases, V20, P270; Yang YP, 2013, VET PARASITOL, V194, P207, DOI 10.1016/j.vetpar.2013.01.057; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Zhang ZF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001225	58	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77238	10.1371/journal.pone.0077238	http://dx.doi.org/10.1371/journal.pone.0077238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130862	Green Published, Green Submitted, gold			2022-12-25	WOS:000325814200072
J	Jain, D; Siede, W				Jain, Dilip; Siede, Wolfram			Rad5 Template Switch Pathway of DNA Damage Tolerance Determines Synergism between Cisplatin and NSC109268 in Saccharomyces cerevisiae	PLOS ONE			English	Article							ANTICANCER DRUG CISPLATIN; REPLICATION FORK; HOMOLOGOUS RECOMBINATION; PROTEASOME INHIBITORS; MOLECULAR-MECHANISMS; APOPTOSIS INDUCERS; TRANSPORTER CTR1; HUMAN CANCER; CELL-LINES; RESISTANCE	The success of cisplatin (CP) based therapy is often hindered by acquisition of CP resistance. We isolated NSC109268 as a compound altering cellular sensitivity to DNA damaging agents. Previous investigation revealed an enhancement of CP sensitivity by NSC109268 in wild-type Saccharomyces cerevisiae and CP-sensitive and - resistant cancer cell lines that correlated with a slower S phase traversal. Here, we extended these studies to determine the target pathway(s) of NSC109268 in mediating CP sensitization, using yeast as a model. We reasoned that mutants defective in the relevant target of NSC109268 should be hypersensitive to CP and the sensitization effect by NSC109268 should be absent or strongly reduced. A survey of various yeast deletion mutants converged on the Rad5 pathway of DNA damage tolerance by template switching as the likely target pathway of NSC109268 in mediating cellular sensitization to CP. Additionally, cell cycle delays following CP treatment were not synergistically influenced by NSC109268 in the CP hypersensitive rad5 Delta mutant. The involvement of the known inhibitory activities of NSC109268 on 20S proteasome and phosphatases 2C alpha and 2A was tested. In the CP hypersensitive ptc2 Delta ptc3 Delta pph3 Delta yeast strain, deficient for 2C and 2A-type phosphatases, cellular sensitization to CP by NSC109268 was greatly reduced. It is therefore suggested that NSC109268 affects CP sensitivity by inhibiting the activity of unknown protein(s) whose dephosphorylation is required for the template switch pathway.	[Jain, Dilip; Siede, Wolfram] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Siede, W (corresponding author), Santa Fe Biolabs LLC 808, PMB 313, Ft Worth, TX USA.	wolfram@santafebiolabs.com			Developmental Therapeutics Branch of the National Cancer Institute [NSC109268]; Joe and Jessie Crump Fund for Medical Education	Developmental Therapeutics Branch of the National Cancer Institute; Joe and Jessie Crump Fund for Medical Education	NSC109268 was initially provided by the Developmental Therapeutics Branch of the National Cancer Institute. These studies were supported by a grant from the Joe and Jessie Crump Fund for Medical Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Amberg DC., 2005, METHODS YEAST GENETI; ANDREWS PA, 1988, CANCER RES, V48, P68; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Chabner B. A., 1996, CANC CHEMOTHERAPY BI; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chatterjee B, 2013, COLD SPRING IN PRESS; Cho S, 2011, J CANCER RES CLIN, V137, P629, DOI 10.1007/s00432-010-0925-5; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Daniel KG, 2007, FRONT BIOSCI-LANDMRK, V12, P135, DOI 10.2741/2054; Daniel KG, 2004, BIOCHEM PHARMACOL, V67, P1139, DOI 10.1016/j.bcp.2003.10.031; Davis AP, 2001, GENETICS, V159, P515; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Fortuna M, 2001, CURRENT PROTOC CYTOM, V11, P13; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gong J, 2011, INTERNET J MICROBIOL, V9, P2; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Haynes R.H., 1981, MOL BIOL YEAST SACCH, P371; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; JACKEL M, 1991, CANCER CHEMOTH PHARM, V27, P464, DOI 10.1007/BF00685161; Jain D, 2010, CANCER CHEMOTH PHARM, V66, P945, DOI 10.1007/s00280-010-1246-8; Johnson SW, 1997, CANCER RES, V57, P850; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim JA, 2011, MOL CELL BIOL, V31, P507, DOI 10.1128/MCB.01168-10; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Liaw H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021424; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; MAMENTA EL, 1994, CANCER RES, V54, P3500; Mieczkowski P, 2000, CURR GENET, V38, P53, DOI 10.1007/s002940000136; Minca EC, 2011, NUCLEIC ACIDS RES, V39, P2610, DOI 10.1093/nar/gkq1215; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; OCONNELL D, 2007, INT J PHARM MED, V21, P339; Perego P, 1998, MOL PHARMACOL, V54, P213, DOI 10.1124/mol.54.1.213; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Shankar Eswar, 2010, J Mol Signal, V5, P4, DOI 10.1186/1750-2187-5-4; SHERMAN SE, 1985, SCIENCE, V230, P412, DOI 10.1126/science.4048939; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Simon JA, 2000, CANCER RES, V60, P328; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; van Waardenburg RCA, 2004, MOL CANCER THER, V3, P393; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wu F, 2004, CANCER RES, V64, P8029, DOI 10.1158/0008-5472.CAN-03-3942; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zhang H, 2003, MUTAT RES-FUND MOL M, V527, P37, DOI 10.1016/S0027-5107(03)00074-5; ZIMMERMANN FK, 1975, MUTAT RES, V28, P381, DOI 10.1016/0165-1218(75)90141-X	61	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77666	10.1371/journal.pone.0077666	http://dx.doi.org/10.1371/journal.pone.0077666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130896	gold, Green Published, Green Submitted			2022-12-25	WOS:000325814200093
J	Chang, YW; Mai, RT; Fang, WH; Lin, CC; Chiu, CC; Lee, YHW				Chang, Y-W; Mai, R-T; Fang, W-H; Lin, C-C; Chiu, C-C; Lee, Y-H Wu			YB-1 disrupts mismatch repair complex formation, interferes with MutS alpha recruitment on mismatch and inhibits mismatch repair through interacting with PCNA	ONCOGENE			English	Article						YB-1; PCNA; PIP-box; mismatch repair; MutS alpha; genome instability	CELL NUCLEAR ANTIGEN; VIRUS CORE PROTEIN; BOX BINDING-PROTEIN; MICROSATELLITE INSTABILITY; ALKYLATING-AGENTS; MISPAIRED BASES; DNA-DAMAGE; GLIOBLASTOMA-MULTIFORME; GENE-EXPRESSION; REPLICATION	Y-box binding protein-1 (YB-1) is highly expressed in tumors and it participates in various cellular processes. Previous studies indicated that YB-1 binds to mispaired DNA and interacts with several mismatch repair (MMR)-related factors. However, its role in the MMR system remains undefined. Here, we found that YB-1 represses mutS homolog 6 (MSH6)-containing MMR complex formation and reduces MutS alpha mismatch binding activity by disrupting interactions among MMR-related factors. In an effort to elucidate how YB-1 exerts this inhibitory effect, we have identified two functional proliferating cell nuclear antigen (PCNA)interacting protein (PIP)-boxes that mediate YB-1/PCNA interaction and locate within the C-terminal region of YB-1. This interaction is critical for the regulatory role of YB-1 in repressing MutSa mismatch binding activity, disrupting MutS alpha/PCNA/G/T heteroduplex ternary complex formation and inhibiting in vitro MMR activity. The differential regulation of 3' and 5' nick-directed MMR activity by YB-1 was also observed. Moreover, YB-1 overexpression is associated with the alteration of microsatellite pattern and the enhancement of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced and spontaneous mutations. Furthermore, upregulation of other PIP-box-containing proteins, such as myeloid cell leukemia-1 (Mcl-1) and inhibitor of growth protein 1b (ING1b), has no impact on MMR complex formation and mutation accumulation, thus revealing the significant effect of YB-1 on regulating the MMR system. In conclusion, our study suggests that YB-1 functions as a PCNA-interacting factor to exert its regulatory role on the MMR process and involves in the induction of genome instability, which may partially account for the oncogenic potential of YB-1.	[Chang, Y-W; Mai, R-T; Lin, C-C; Chiu, C-C; Lee, Y-H Wu] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Mai, R-T; Lee, Y-H Wu] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Fang, W-H] Natl Taiwan Univ Hosp, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Lee, YHW (corresponding author), Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, 1001 Ta Hsueh Rd, Hsinchu 300, Taiwan.	yhwulee@nctu.edu.tw		FANG, WOEI-HORNG/0000-0003-4728-5931	National Health Research Institute [NHRI-EX100-10014BI, NHRI-EX101-10014BI, NHRI-EX102-10014BI]; National Science Council [NSC-94-2320-B-010-005, NSC-95-2320-B-010-049-MY3, NSC-97-2320-B-010-014-MY3, NSC-97-2320-B-009-003-MY3, NSC-100-2320-B-009-007-MY3, NSC-101-2811-B-009-006, NSC-102-2811-B-009-007]; National Yang-Ming University; National Chiao-Tung University; Ministry of Education, Taiwan, Republic of China	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University; National Chiao-Tung University; Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This study was supported by the following grants to Dr Yan-Hwa Wu Lee: the National Health Research Institute (NHRI-EX100-10014BI, NHRI-EX101-10014BI and NHRI-EX102-10014BI), the National Science Council (NSC-94-2320-B-010-005, NSC-95-2320-B-010-049-MY3, NSC-97-2320-B-010-014-MY3, NSC-97-2320-B-009-003-MY3, NSC-100-2320-B-009-007-MY3, NSC-101-2811-B-009-006 and NSC-102-2811-B-009-007) and the 'Aim for the Top University Program' of the National Yang-Ming University, the National Chiao-Tung University and the Ministry of Education, Taiwan, Republic of China. We thank Dr Tsung-Sheng Su and Dr Tzu-Hao Cheng for helpful discussions and suggestions, Dr Josef Jiricny, Dr Hsin-Fang Yang-Yen and Dr Zee-Fen Chang for kindly providing plasmids used in this study, Dr Shr-Jeng Leu for sharing experiences on baculovirus expression system and Dr Li-Li Li for critical reading and comments on this manuscript. We acknowledge the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan (NSC 101-2319-B-010-001), for capillary electrophoresis and DNA sequencing.	Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Casorelli I, 2008, ANTI-CANCER AGENT ME, V8, P368, DOI 10.2174/187152008784220276; Chen C, 1999, MOL CELL BIOL, V19, P7801; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Dietmaier W, 1997, CANCER RES, V57, P4749; Drobinskaya I, 2005, ANTICANCER RES, V25, P3251; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Huang DY, 2001, BIOCHEM J, V356, P829, DOI 10.1042/0264-6021:3560829; Huang YM, 2004, J BIOL CHEM, V279, P30228, DOI 10.1074/jbc.M401675200; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Ise T, 1999, CANCER RES, V59, P342; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jascur T, 2011, J BIOL CHEM, V286, P29531, DOI 10.1074/jbc.M111.221341; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; JIRICNY J, 1988, P NATL ACAD SCI USA, V85, P8860, DOI 10.1073/pnas.85.23.8860; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunz C, 2009, CELL MOL LIFE SCI, V66, P1021, DOI 10.1007/s00018-009-8739-9; Lau PJ, 2003, J BIOL CHEM, V278, P14, DOI 10.1074/jbc.C200627200; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liberti SE, 2011, DNA REPAIR, V10, P73, DOI 10.1016/j.dnarep.2010.09.023; Lingrel JB, 1998, ACTA PHYSIOL SCAND, V163, P69; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Mai RT, 2006, ONCOGENE, V25, P448, DOI 10.1038/sj.onc.1209052; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Martinez R, 2004, ONCOLOGY-BASEL, V66, P395, DOI 10.1159/000079488; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Oda Y, 2003, J PATHOL, V199, P251, DOI 10.1002/path.1282; Perez-Garcia A, 2012, FRONT BIOSCI-LANDMRK, V17, P1469, DOI 10.2741/3998; Pizzi C, 2007, ONCOL REP, V17, P193; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Scott M, 2001, J CELL SCI, V114, P3455; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; Soreide K, 2007, TUMOR BIOL, V28, P290, DOI 10.1159/000110427; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stoklosa T, 2008, CANCER RES, V68, P2576, DOI 10.1158/0008-5472.CAN-07-6858; Tomita-Mitchell A, 2000, MUTAT RES-FUND MOL M, V450, P125, DOI 10.1016/S0027-5107(00)00020-8; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Umar A, 1997, CANCER RES, V57, P3949; Valentini AM, 2006, CANCER TREAT REV, V32, P607, DOI 10.1016/j.ctrv.2006.08.001; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Woolley AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020603; Xie WX, 2012, TUMOR BIOL, V33, P63, DOI 10.1007/s13277-011-0246-6; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	85	15	16	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 23	2014	33	43					5065	5077		10.1038/onc.2013.450	http://dx.doi.org/10.1038/onc.2013.450			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OF	24141788				2022-12-25	WOS:000343768400002
J	Yu, ZH; Zhao, XP; Huang, LQ; Zhang, T; Yang, FJ; Xie, L; Song, SL; Miao, P; Zhao, L; Sun, XG; Liu, JJ; Huang, G				Yu, Zhenhai; Zhao, Xiaoping; Huang, Liangqian; Zhang, Teng; Yang, Fajun; Xie, Lei; Song, Shaoli; Miao, Ping; Zhao, Li; Sun, Xiaoguang; Liu, Jianjun; Huang, Gang			Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Proliferation; Glycolysis; Phosphorylation; Pyruvate Kinase	HYPOXIA-INDUCIBLE FACTOR-1; ROUS-SARCOMA-VIRUS; SERINE/THREONINE KINASES; GENE-TRANSCRIPTION; PROTEIN-KINASE; TUMOR-GROWTH; TUMORIGENESIS; METABOLISM; ACTIVATION; EXPRESSION	Pyruvate kinase M2 (PKM2) is a key player in the Warburg effect of cancer cells. However, the mechanisms of regulating PKM2 are not fully elucidated. Here, we identified the protein-serine/threonine kinase PIM2, a known oncogene, as a novel binding partner of PKM2. The interaction between PIM2 and PKM2 was confirmed by multiple biochemical approaches in vitro and in cultured cells. Importantly, we found that PIM2 could directly phosphorylate PKM2 on the Thr-454 residue, resulting in an increase of PKM2 protein levels. Compared with wild type, PKM2 with the phosphorylation-defective mutation displayed a reduced effect on glycolysis, co-activating HIF-1 and -catenin, and cell proliferation, while enhancing mitochondrial respiration of cancer cells. These findings demonstrate that PIM2-dependent phosphorylation of PKM2 is critical for regulating the Warburg effect in cancer, highlighting PIM2 as a potential therapeutic target.	[Yu, Zhenhai; Huang, Gang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhao, Xiaoping; Zhang, Teng; Xie, Lei; Song, Shaoli; Miao, Ping; Zhao, Li; Sun, Xiaoguang; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Renji Hosp, Dept Nucl Med, Sch Med, Shanghai 200127, Peoples R China; [Huang, Liangqian; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Inst Hlth Sci,Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Yang, Fajun] Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, Bronx, NY 10461 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Yeshiva University; Albert Einstein College of Medicine	Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Nucl Med, Sch Med, Shanghai 200127, Peoples R China.	ljjsh@133sh.com; huang2802@163.com	song, sl/GRS-1884-2022		973 Project [201203932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; National Natural Science Foundation of China [81071180, 81001008, 81372195]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]	973 Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by research grants from 973 Project 201203932604, New Drug Discovery Project 2012ZX09506-001-005, Shanghai Leading Academic Discipline Project S30203, National Natural Science Foundation of China 81071180, 81001008, and 81372195, Shanghai Pujiang Program 13PJ1406000, and Science and Technology Commission of Shanghai Municipality 134119a5600.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ding G, 2013, FEBS LETT, V587, P930, DOI 10.1016/j.febslet.2013.02.020; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Le Mellay V, 2002, ADV ENZYME REGUL, V42, P317, DOI 10.1016/S0065-2571(01)00036-X; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; NETZKER R, 1992, J BIOL CHEM, V267, P6421; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; PRESEK P, 1980, CANCER RES, V40, P1733; PRESEK P, 1988, FEBS LETT, V242, P194, DOI 10.1016/0014-5793(88)81014-7; Schatz JH, 2011, CELL CYCLE, V10, P3830, DOI 10.4161/cc.10.22.18288; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Tang S., 2013, PLOS ONE, V8; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Wong N., 2013, INT J CELL BIOL, V2013; Xue HP, 2011, INT J BIOCHEM CELL B, V43, P348, DOI 10.1016/j.biocel.2010.11.002; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yan SH, 1999, IUBMB LIFE, V48, P409; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	42	62	65	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35406	35416		10.1074/jbc.M113.508226	http://dx.doi.org/10.1074/jbc.M113.508226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142698	Green Published, hybrid			2022-12-25	WOS:000329867600037
J	Kang, T; Lu, W; Xu, W; Anderson, L; Bacanamwo, M; Thompson, W; Chen, YE; Liu, D				Kang, Ting; Lu, Wan; Xu, Wei; Anderson, Leonard; Bacanamwo, Methode; Thompson, Winston; Chen, Y. Eugene; Liu, Dong			MicroRNA-27 (miR-27) Targets Prohibitin and Impairs Adipocyte Differentiation and Mitochondria! Function in Human Adipose-derived Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Cell Differentiation; MicroRNA; Mitochondria; Stem Cells; miR-27; Prohibitin	TUMOR-SUPPRESSOR; ADIPOGENESIS; EXPRESSION; MIR-128; OVEREXPRESSION; IDENTIFICATION; MAINTAINS; APOPTOSIS; OBESITY; PROFILE	Background: Prohibitin is essential in adipocyte differentiation and mitochondrial functions, but the regulative mechanisms of prohibitin by microRNA remain unclear. Results: miR-27 negatively regulates adipogenesis by targeting prohibitin and impairing mitochondrial biogenesis, structure, and activity. Conclusion: miR-27 targets prohibitin and suppresses adipocyte differentiation. Significance: Manipulation of miR-27 may offer opportunities for the therapeutic modulation of adipogenesis in obesity. Prohibitin (PHB) has been reported to play a crucial role in adipocyte differentiation and mitochondrial function. However, the regulative mechanism of PHB during adipogenesis remains unclear. In this study, we determined that the levels of both microRNA (miR)-27a and miR-27b were down-regulated following adipogenic induction of human adipose-derived stem cells, whereas the mRNA level of PHB was up-regulated. Overexpression of miR-27a or miR-27b inhibited PHB expression and adipocyte differentiation. Using PHB 3-UTR luciferase reporter assay, we observed that miR-27a and miR-27b directly targeted PHB in human adipose-derived stem cells. A compensation of PHB partially restored the adipogenesis inhibited by miR-27. Moreover, we demonstrated the novel finding that ectopic expression of miR-27a or miR-27b impaired mitochondrial biogenesis, structure integrity, and complex I activity accompanied by excessive reactive oxygen species production. Our data suggest that miR-27 is an anti-adipogenic microRNA partly by targeting PHB and impairing mitochondrial function. Pharmacological modulation of miR-27 function may provide a new therapeutic strategy for the treatment of obesity.	[Kang, Ting; Lu, Wan; Anderson, Leonard; Bacanamwo, Methode; Liu, Dong] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Xu, Wei; Thompson, Winston] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA; [Liu, Dong] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Kang, Ting] Nanchang Univ, Div Cardiol, Affiliated Hosp 1, Nanchang 330006, Peoples R China; [Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine; Nanchang University; University of Michigan System; University of Michigan	Liu, D (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA.	dliu@msm.edu			National Institutes of Health [G12RR003034, SC2GM099629]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM099629] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants G12RR003034 and SC2GM099629 (to D. L.).	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.46; Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Ande SR, 2012, INT J OBESITY, V36, P1236, DOI 10.1038/ijo.2011.227; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Cho JA, 2011, J GENET, V90, P81, DOI 10.1007/s12041-011-0041-6; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034315; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; McGregor RA, 2011, CURR MOL MED, V11, P304; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang KH, 2010, KAOHSIUNG J MED SCI, V26, P113, DOI 10.1016/S1607-551X(10)70017-6; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007; Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071	52	128	135	1	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34394	34402		10.1074/jbc.M113.514372	http://dx.doi.org/10.1074/jbc.M113.514372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133204	hybrid, Green Published			2022-12-25	WOS:000329812800011
J	Xu, JK; Patrick, BA; Jaiswal, AK				Xu, Junkang; Patrick, Brad Allen; Jaiswal, Anil K.			NRH:Quinone Oxidoreductase 2 (NQO2) Protein Competes with the 20 S Proteasome to Stabilize Transcription Factor CCAAT Enhancer-binding Protein alpha (C/EBP alpha), Leading to Protection against gamma Radiation-induced Myeloproliferative Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemoprevention; Protein Degradation; Protein Stability; Protein-Protein Interactions; Signal Transduction; 20 S Proteasome; C; EBP; Myeloproliferative Diseases; NQO2	ACUTE MYELOID-LEUKEMIA; DT-DIAPHORASE; GENE PROMOTER; MICE LEADS; DEGRADATION; DISRUPTION; PU.1; NRH-QUINONE-OXIDOREDUCTASE-2; EXPRESSION; MUTATIONS	Background: NQO2 protects against radiation-induced myeloproliferative disease, but the mechanism remains unknown. Results: Radiation-induced NQO2, independent of NQO1, competes with the 20 S proteasome for interaction with C/EBP region Ser-268 to Val-279 to stabilize C/EBP, leading to protection against myeloproliferative disease. Conclusion: NQO2 stabilizes C/EBP against 20 S degradation to protect against myeloproliferative disease. Significance: Stress-responsive NQO2 functions as an endogenous factor against myeloproliferative diseases. NRH:quinone oxidoreductase 2 (NQO2) is a flavoprotein that protects cells against radiation and chemical-induced oxidative stress. Disruption of the NQO2 gene in mice leads to radiation-induced myeloproliferative diseases. In this report, we showed that the 20 S proteasome and NQO2 both interact with myeloid differentiation factor CCAAT-enhancer-binding protein (C/EBP). The interaction of the 20 S proteasome with C/EBP led to the degradation of C/EBP. NQO2, in the presence of its cofactor NRH, protected C/EBP against 20 S degradation. Deletion and site-directed mutagenesis demonstrated that NQO2 and 20 S competed for the same binding region of S(268)GAGAGKAKKSV(279) in C/EBP. Exposure of mice and HL-60 cells to radiation enhanced the levels of NQO2, which led to an increased NQO2 interaction with C/EBP and decreased 20 S interaction with C/EBP. NQO2 stabilization of C/EBP was independent of NQO1, even though both interacted with the same C/EBP domain. NQO2(-/-) mice, deficient in NQO2, failed to stabilize C/EBP. This contributed to the development of radiation-induced myeloproliferative disease in NQO2(-/-) mice.	[Xu, Junkang; Patrick, Brad Allen; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			National Institutes of Health [RO1 ES007943]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES007943 (to A. K J.).	Bianchet MA, 1999, BIOCHEM SOC T, V27, P610, DOI 10.1042/bst0270610; Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Iskander K, 2008, CANCER RES, V68, P7915, DOI 10.1158/0008-5472.CAN-08-0766; Iskander K, 2009, CLIN CANCER RES, V15, P1534, DOI 10.1158/1078-0432.CCR-08-1783; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Patrick BA, 2011, ONCOGENE, V30, P1098, DOI 10.1038/onc.2010.491; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SCOTT LM, 1992, BLOOD, V80, P1725; Smith MT, 2002, BLOOD, V100, P4590, DOI 10.1182/blood-2001-12-0264; Wang W, 2004, FREE RADICAL BIO MED, V37, P1231, DOI 10.1016/j.freeradbiomed.2004.06.042; Wang W, 2008, J GERONTOL A-BIOL, V63, P127, DOI 10.1093/gerona/63.2.127; Xu JK, 2012, J BIOL CHEM, V287, P41608, DOI 10.1074/jbc.M112.387738; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhao QJ, 1997, P NATL ACAD SCI USA, V94, P1669, DOI 10.1073/pnas.94.5.1669	20	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34799	34808		10.1074/jbc.M113.495580	http://dx.doi.org/10.1074/jbc.M113.495580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142791	Green Published, hybrid			2022-12-25	WOS:000329812800048
J	Cho, T; Ryu, JK; Taghibiglou, C; Ge, Y; Chan, AW; Liu, LD; Lu, J; McLarnon, JG; Wang, YT				Cho, Taesup; Ryu, Jae K.; Taghibiglou, Changiz; Ge, Yuan; Chan, Allen W.; Liu, Lidong; Lu, Jie; McLarnon, James G.; Wang, Yu Tian			Long-Term Potentiation Promotes Proliferation/Survival and Neuronal Differentiation of Neural Stem/Progenitor Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADULT DENTATE GYRUS; CULTURED HIPPOCAMPAL-NEURONS; NEWLY GENERATED NEURONS; MICROTUBULE-ASSOCIATED PROTEIN; INTERMEDIATE-FILAMENT PROTEIN; NMDA RECEPTOR ACTIVATION; DEEP BRAIN-STIMULATION; STEM-CELLS; PROGENITOR CELLS	Neural stem cell (NSC) replacement therapy is considered a promising cell replacement therapy for various neurodegenerative diseases. However, the low rate of NSC survival and neurogenesis currently limits its clinical potential. Here, we examined if hippocampal long-term potentiation (LTP), one of the most well characterized forms of synaptic plasticity, promotes neurogenesis by facilitating proliferation/survival and neuronal differentiation of NSCs. We found that the induction of hippocampal LTP significantly facilitates proliferation/survival and neuronal differentiation of both endogenous neural progenitor cells (NPCs) and exogenously transplanted NSCs in the hippocampus in rats. These effects were eliminated by preventing LTP induction by pharmacological blockade of the N-methyl-D-aspartate glutamate receptor (NMDAR) via systemic application of the receptor antagonist, 3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP). Moreover, using a NPC-neuron co-culture system, we were able to demonstrate that the LTP-promoted NPC neurogenesis is at least in part mediated by a LTP-increased neuronal release of brain-derived neurotrophic factor (BDNF) and its consequent activation of tropomysosin receptor kinase B (TrkB) receptors on NSCs. Our results indicate that LTP promotes the neurogenesis of both endogenous and exogenously transplanted NSCs in the brain. The study suggests that pre-conditioning of the host brain receiving area with a LTP-inducing deep brain stimulation protocol prior to NSC transplantation may increase the likelihood of success of using NSC transplantation as an effective cell therapy for various neurodegenerative diseases.	[Cho, Taesup; Taghibiglou, Changiz; Ge, Yuan; Chan, Allen W.; Liu, Lidong; Lu, Jie; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Cho, Taesup; Taghibiglou, Changiz; Ge, Yuan; Chan, Allen W.; Liu, Lidong; Lu, Jie; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Ryu, Jae K.; McLarnon, James G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Wang, Yu Tian] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Wang, Yu Tian] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	University of British Columbia; University of British Columbia; University of British Columbia; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ytwang@brain.ubc.ca	Chan, Allen/AAF-4718-2020; Wang, Yu Tian/J-8255-2015; Taghibiglou, Changiz/H-4590-2019	Liu, Lidong/0000-0002-7026-690X	Canadian Institutes of Health Research (CIHR); Howard Hughes Medical Institute; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; HSFBC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Taiwan Department of Health Clinical Trial and Research Center of Excellence; HSFBC	This work was supported in part by the Canadian Institutes of Health Research (CIHR), Howard Hughes Medical Institute and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004). YTW is the holder of the Heart and Stroke Foundation of British Columbia and the Yukon (HSFBC & Y) Chair in Stroke Research. T. C was supported by a Doctoral Award from the HSFBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; AHMED S, 1995, J NEUROSCI, V15, P5765; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arias-Carrion O, 2007, REV NEUROLOGIA, V44, P541, DOI 10.33588/rn.4409.2006426; Babu H, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.001.2009; Bading JR, 2002, J DRUG TARGET, V10, P359, DOI 10.1080/10611860290031831; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Chawla S, 1998, Indian J Pathol Microbiol, V41, P355; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goldman SA, 1997, J NEUROBIOL, V32, P554, DOI 10.1002/(SICI)1097-4695(19970605)32:6<554::AID-NEU2>3.0.CO;2-Z; Gould E, 1997, J NEUROSCI, V17, P2492; Haniu M, 1997, J BIOL CHEM, V272, P25296, DOI 10.1074/jbc.272.40.25296; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Joo JY, 2007, J CELL SCI, V120, P1358, DOI 10.1242/jcs.002154; Kameda M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.70; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kinoshita M, 2005, J COMP NEUROL, V484, P249, DOI 10.1002/cne.20473; Kitamura T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-13; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; KURKI P, 1986, EXP CELL RES, V166, P209, DOI 10.1016/0014-4827(86)90520-3; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Li Guo Hua, 2009, Int J Physiol Pathophysiol Pharmacol, V2, P47; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lledo PM, 2006, B ACAD NAT MED PARIS, V190, P385, DOI 10.1016/S0001-4079(19)33325-4; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Skarsgard ED, 2005, J PEDIATR SURG, V40, P1817, DOI 10.1016/j.jpedsurg.2005.08.047; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; TAPLEY P, 1992, ONCOGENE, V7, P371; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tronnier VM, 1997, STEREOT FUNCT NEUROS, V69, P62, DOI 10.1159/000099853; Tronnier VM, 1997, J NEUROSURG, V87, P700, DOI 10.3171/jns.1997.87.5.0700; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	106	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76860	10.1371/journal.pone.0076860	http://dx.doi.org/10.1371/journal.pone.0076860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146937	gold, Green Published, Green Submitted			2022-12-25	WOS:000326022200022
J	Meng, JR; Majidi, M; Fang, BL; Ji, L; Bekele, BN; Minna, JD; Roth, JA				Meng, Jieru; Majidi, Mourad; Fang, Bingliang; Ji, Lin; Bekele, B. Nebiyou; Minna, John D.; Roth, Jack A.			The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner	PLOS ONE			English	Article							CELL LUNG-CANCER; HOMOZYGOUS DELETION REGION; TYROSINE KINASE INHIBITOR; POTENT ANTITUMOR-ACTIVITY; HUMAN-CHROMOSOME 3P21.3; PROTEIN EXPRESSION; SIGNALING PATHWAY; IN-VIVO; PHASE-I; GEFITINIB	TUSC2-defective gene expression is detected in the majority of lung cancers and is associated with worse overall survival. We analyzed the effects of TUSC2 re-expression on tumor cell sensitivity to the AKT inhibitor, MK2206, and explored their mutual signaling connections, in vitro and in vivo. TUSC2 transient expression in three LKB1-defective non-small cell lung cancer (NSCLC) cell lines combined with MK2206 treatment resulted in increased repression of cell viability and colony formation, and increased apoptotic activity. In contrast, TUSC2 did not affect the response to MK2206 treatment for two LKB1-wild type NSCLC cell lines. In vivo, TUSC2 systemic delivery, by nanoparticle gene transfer, combined with MK2206 treatment markedly inhibited growth of tumors in a human LKB1-defective H322 lung cancer xenograft mouse model. Biochemical analysis showed that TUSC2 transient expression in LKB1-defective NSCLC cells significantly stimulated AMP-activated protein kinase (AMPK) phosphorylation and enzymatic activity. More importantly, AMPK gene knockdown abrogated TUSC2-MK2206 cooperation, as evidenced by reduced sensitivity to the combined treatment. Together, TUSC2 re-expression and MK2206 treatment was more effective in inhibiting the phosphorylation and kinase activities of AKT and mTOR proteins than either single agent alone. In conclusion, these findings support the hypothesis that TUSC2 expression status is a biological variable that potentiates MK2206 sensitivity in LKB1-defective NSCLC cells, and identifies the AMPK/AKT/mTOR signaling axis as an important regulator of this activity.	[Meng, Jieru; Majidi, Mourad; Fang, Bingliang; Ji, Lin; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA; [Bekele, B. Nebiyou] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Meng, JR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA.	jennymeng@hotmail.com			National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant [CA-70907]; Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant CA-70907 (J. Minna and J. Roth) and Cancer Center Support Grant CA16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bortul R, 2003, LEUKEMIA, V17, P379, DOI 10.1038/sj.leu.2402793; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Goff LW, 2012, INVEST NEW DRUG, V30, P290, DOI 10.1007/s10637-010-9528-x; Gopalan B, 2004, TECHNOL CANCER RES T, V3, P647, DOI 10.1177/153303460400300615; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Ivanova AV, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-91; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Lerman MI, 2000, CANCER RES, V60, P6116; Li GD, 2011, ANTICANCER RES, V31, P11; Liang XY, 2010, CANCER BIOL THER, V9, P156, DOI 10.4161/cbt.9.2.10452; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Ono M, 2004, MOL CANCER THER, V3, P465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Seufferlein T, 1996, CANCER RES, V56, P3895; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77067	10.1371/journal.pone.0077067	http://dx.doi.org/10.1371/journal.pone.0077067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146957	Green Submitted, Green Published, gold			2022-12-25	WOS:000326022200031
J	Pooja, S; Francis, A; Rajender, S; Tamang, R; Rajkumar, R; Saini, KS; Megu, K; Goel, MM; Surekha, D; Rao, DR; Rao, L; Ramachandra, L; Kumar, S; Kumar, S; Vishnupriya, S; Satyamoorthy, K; Negi, MPS; Thangaraj, K; Konwar, R				Pooja, Singh; Francis, Amirtharaj; Rajender, Singh; Tamang, Rakesh; Rajkumar, Raja; Saini, Karan Singh; Megu, Kaling; Goel, Madhu Mati; Surekha, Daminani; Rao, Digumarthi Raghunatha; Rao, Lakshmi; Ramachandra, Lingadakai; Kumar, Sandeep; Kumar, Surender; Vishnupriya, Satti; Satyamoorthy, Kapaettu; Negi, Mahendra Pal Singh; Thangaraj, Kumarasamy; Konwar, Rituraj			Strong Impact of TGF-beta 1 Gene Polymorphisms on Breast Cancer Risk in Indian Women: A Case-Control and Population-Based Study	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; TUMOR-SUPPRESSOR; THERAPEUTIC TARGET; SIGNALING PATHWAY; METASTASIS; INHIBITION; SURVIVAL; ROLES; CELLS	Introduction: TGF-beta 1 is a multi-functional cytokine that plays an important role in breast carcinogenesis. Critical role of TGF-beta 1 signaling in breast cancer progression is well documented. Some TGF-beta 1 polymorphisms influence its expression; however, their impact on breast cancer risk is not clear. Methods: We analyzed 1222 samples in a candidate gene-based genetic association study on two distantly located and ethnically divergent case-control groups of Indian women, followed by a population-based genetic epidemiology study analyzing these polymorphisms in other Indian populations. The c.29C>T (Pro10Leu, rs1982073 or rs1800470) and c.74G>C (Arg25Pro, rs1800471) polymorphisms in the TGF-beta 1 gene were analyzed using direct DNA sequencing, and peripheral level of TGF-beta 1 were measured by ELISA. Results: c.29C>T substitution increased breast cancer risk, irrespective of ethnicity and menopausal status. On the other hand, c.74G>C substitution reduced breast cancer risk significantly in the north Indian group (p=0.0005) and only in the pre-menopausal women. The protective effect of c.74G>C polymorphism may be ethnicity-specific, as no association was seen in south Indian group. The polymorphic status of c.29C>T was comparable among Indo-Europeans, Dravidians, and Tibeto-Burmans. Interestingly, we found that Tibeto-Burmans lack polymorphism at c.74G>C locus as true for the Chinese populations. However, the Brahmins of Nepal (Indo-Europeans) showed polymorphism in 2.08% of alleles. Mean TGF-beta 1 was significantly elevated in patients in comparison to controls (p<0.001). Conclusion: c.29C>T and c.74G>C polymorphisms in the TGF-beta 1 gene significantly affect breast cancer risk, which correlates with elevated TGF-beta 1 level in the patients. The c.29C>T locus is polymorphic across ethnically different populations, but c.74G>C locus is monomorphic in Tibeto-Burmans and polymorphic in other Indian populations.	[Pooja, Singh; Rajender, Singh; Saini, Karan Singh; Konwar, Rituraj] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Pooja, Singh; Goel, Madhu Mati] King Georges Med Univ, Dept Pathol, Lucknow, Uttar Pradesh, India; [Francis, Amirtharaj; Tamang, Rakesh; Rajkumar, Raja; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Tamang, Rakesh; Surekha, Daminani; Vishnupriya, Satti] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Megu, Kaling; Kumar, Sandeep; Kumar, Surender] King Georges Med Univ, Dept Surg, Lucknow, Uttar Pradesh, India; [Rao, Digumarthi Raghunatha] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Rao, Lakshmi] Manipal Univ, Kasturba Med Coll, Dept Pathol, Manipal, Karnataka, India; [Ramachandra, Lingadakai] Manipal Univ, Kasturba Med Coll, Dept Surg, Manipal, Karnataka, India; [Kumar, Sandeep] All India Inst Med Sci, Bhopal, India; [Satyamoorthy, Kapaettu] Manipal Univ, Manipal Life Sci Ctr, Manipal, Karnataka, India; [Negi, Mahendra Pal Singh] CSIR Cent Drug Res Inst, Biometr & Stat Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Osmania University; King George's Medical University; Nizam's Institute of Medical Sciences; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; All India Institute of Medical Sciences (AIIMS) Bhopal; Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Thangaraj, K (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	thangs@ccmb.res.in; r_konwar@cdri.res.in	Kumar, Sandeep/AAG-6866-2021; kumar, sandeep/GMX-3097-2022; KUMAR, SANDEEP/GZA-7182-2022; Konwar, Rituraj/B-2272-2010; Satyamoorthy, Kapaettu/H-3254-2015; Singh, Rajender/ABE-3512-2020	Konwar, Rituraj/0000-0002-3740-8363; Amirtharaj, Francis/0000-0001-6862-2875; Satyamoorthy, Kapaettu/0000-0002-2368-5490; Rajender, Singh/0000-0002-4592-6566; Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Council of Medical Research (ICMR) [5/13/12/2007-NCDIII]; SRF from ICMR [3/2/2/72/2011-NCD-III]; CSIR-CDRI from MOH &FW, Govt. of India [GAP0001]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); SRF from ICMR; CSIR-CDRI from MOH &FW, Govt. of India	This work was supported by the ad-hoc extramural project of the Indian Council of Medical Research (ICMR) through Grant Number 5/13/12/2007-NCDIII). In addition, this research was also supported by SRF project (No 3/2/2/72/2011-NCD-III) from ICMR and CSIR-CDRI Reproductive Health Research Programme (GAP0001) from MOH &FW, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Beisner J, 2006, CANCER RES, V66, P7554, DOI 10.1158/0008-5472.CAN-06-0634; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biswas S, 2006, CLIN CANCER RES, V12, P4142, DOI 10.1158/1078-0432.CCR-06-0952; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Colleran G, 2010, BREAST CANCER RES TR, V119, P437, DOI 10.1007/s10549-009-0395-0; Cox DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-175; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Dunning AM, 2003, CANCER RES, V63, P2610; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Gu DY, 2010, BREAST CANCER RES TR, V123, P857, DOI 10.1007/s10549-010-0766-6; Gupta S., 2009, Indian Journal of Cancer, V46, P303, DOI 10.4103/0019-509X.55550; Huang YS, 2010, BREAST CANCER RES TR, V123, P863, DOI 10.1007/s10549-010-0796-0; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jin QR, 2004, INT J CANCER, V112, P94, DOI 10.1002/ijc.20370; Joshi NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021866; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kao JY, 2003, J IMMUNOL, V170, P3806, DOI 10.4049/jimmunol.170.7.3806; Kelly RJ, 2010, J IMMUNOTOXICOL, V7, P15, DOI 10.3109/15476910903389920; Ma XY, 2010, BREAST CANCER RES TR, V124, P453, DOI 10.1007/s10549-010-0843-x; MacCallum J, 1996, BRIT J CANCER, V74, P474, DOI 10.1038/bjc.1996.385; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Mu L, 2008, BRIT J CANCER, V99, P1357, DOI 10.1038/sj.bjc.6604689; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pinkas J, 2006, BIOCHEM PHARMACOL, V72, P523, DOI 10.1016/j.bcp.2006.03.004; Pooja S, 2012, CYTOKINE, V60, P122, DOI 10.1016/j.cyto.2012.06.241; Qi XW, 2010, BREAST CANCER RES TR, V122, P273, DOI 10.1007/s10549-010-0847-6; Qiu LX, 2010, BREAST CANCER RES TR, V123, P563, DOI 10.1007/s10549-010-0781-7; Rajkumar T, 2008, BREAST CANCER RES TR, V112, P81, DOI 10.1007/s10549-007-9821-3; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reiss M, 1999, MICROBES INFECT, V1, P1327, DOI 10.1016/S1286-4579(99)00251-8; Saha A, 2004, EUR J IMMUNOGENET, V31, P37, DOI 10.1111/j.1365-2370.2004.00442.x; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Seoane J, 2008, CLIN TRANSL ONCOL, V10, P14, DOI 10.1007/s12094-008-0148-2; Shin AS, 2005, CANCER EPIDEM BIOMAR, V14, P1567, DOI 10.1158/1055-9965.EPI-05-0078; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; TGF{&beta} Blockade as Anticancer Therapy, 2008, AACR ED BOOK, P71; Tomita S, 1999, BREAST CANCER RES TR, V53, P33, DOI 10.1023/A:1006167210269; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watanabe Y, 2002, J HUM GENET, V47, P478, DOI 10.1007/s100380200069; Welm AL, 2008, CELL, V133, P27, DOI 10.1016/j.cell.2008.03.012; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zheng Wei, 2009, V472, P265, DOI 10.1007/978-1-60327-492-0_11	57	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e75979	10.1371/journal.pone.0075979	http://dx.doi.org/10.1371/journal.pone.0075979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146803	Green Published, gold, Green Submitted			2022-12-25	WOS:000326022200006
J	Madsen, EA; Persson, T; Sayehli, S; Lenninger, S; Sonesson, G				Madsen, Elainie Alenkr; Persson, Tomas; Sayehli, Susan; Lenninger, Sara; Sonesson, Goran			Chimpanzees Show a Developmental Increase in Susceptibility to Contagious Yawning: A Test of the Effect of Ontogeny and Emotional Closeness on Yawn Contagion	PLOS ONE			English	Article							ASPERGER-SYNDROME; FACIAL EXPRESSIONS; NEONATAL IMITATION; SOCIAL MODULATION; PAN-TROGLODYTES; EMPATHY; SELF; DISSOCIATION; RECOGNITION; AFFILIATION	Contagious yawning has been reported for humans, dogs and several non-human primate species, and associated with empathy in humans and other primates. Still, the function, development and underlying mechanisms of contagious yawning remain unclear. Humans and dogs show a developmental increase in susceptibility to yawn contagion, with children showing an increase around the age of four, when also empathy-related behaviours and accurate identification of others' emotions begin to clearly evince. Explicit tests of yawn contagion in non-human apes have only involved adult individuals and examined the existence of conspecific yawn contagion. Here we report the first study of heterospecific contagious yawning in primates, and the ontogeny of susceptibility thereto in chimpanzees, Pan troglodytes verus. We examined whether emotional closeness, defined as attachment history with the yawning model, affected the strength of contagion, and compared the contagiousness of yawning to nose-wiping. Thirty-three orphaned chimpanzees observed an unfamiliar and familiar human (their surrogate human mother) yawn, gape and nose-wipe. Yawning, but not nose-wiping, was contagious for juvenile chimpanzees, while infants were immune to contagion. Like humans and dogs, chimpanzees are subject to a developmental trend in susceptibility to contagious yawning, and respond to heterospecific yawn stimuli. Emotional closeness with the model did not affect contagion. The familiarity-biased social modulatory effect on yawn contagion previously found among some adult primates, seem to only emerge later in development, or be limited to interactions with conspecifics. The influence of the 'chameleon effect', targeted vs. generalised empathy, perspective-taking and visual attention on contagious yawning is discussed.	[Madsen, Elainie Alenkr; Persson, Tomas] Lund Univ, Dept Cognit Sci, Lund, Sweden; [Madsen, Elainie Alenkr; Lenninger, Sara; Sonesson, Goran] Lund Univ, Dept Semiot, Ctr Languages & Literature, Lund, Sweden; [Sayehli, Susan] Lund Univ, Dept Linguist, Ctr Languages & Literature, Lund, Sweden; [Sayehli, Susan] Lund Univ, Humanities Lab, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Madsen, EA (corresponding author), Lund Univ, Dept Cognit Sci, Lund, Sweden.	Elainie.Madsen@gmail.com	Sonesson, Göran/L-8470-2013	Sonesson, Göran/0000-0003-2517-2397	Swedish Research Council [2008-28315-58867-29]; Centre for Cognitive Semiotics, Lund University; Riksbankens Jubileumsfond [M2008-0408:1-E]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Cognitive Semiotics, Lund University; Riksbankens Jubileumsfond	The research was part of the project 'Precursors of Sign Use in Intersubjectivity and Imitation', (2008-28315-58867-29), funded by Swedish Research Council (http://www.vr.se/inenglish). Financial support was also given by the Centre for Cognitive Semiotics, Lund University (http://project.sol.lu.se/en/ccs/), funded by Riksbankens Jubileumsfond (M2008-0408:1-E; http://www.rj.se/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMANN PK, 1989, ANNU REV PSYCHOL, V40, P249, DOI 10.1146/annurev.ps.40.020189.001341; Anderson JR, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P233, DOI 10.1007/4-431-30248-4_15; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; Bard KA, 2007, ANIM COGN, V10, P233, DOI 10.1007/s10071-006-0062-3; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; BLOOMSMITH M, 2005, NURSERY REARING NONH, P289; BORKE H, 1973, DEV PSYCHOL, V9, P102, DOI 10.1037/h0035080; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Campbell MW, 2010, FRONT NEUROL NEUROSC, V28, P120, DOI 10.1159/000307090; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Carpenter M, CHILD DEV IN PRESS; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cook R, BBS IN PRESS; Cooper NR, 2012, COGN AFFECT BEHAV NE, V12, P393, DOI 10.3758/s13415-011-0081-7; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de Waal F., 2001, APE SUSHI MASTER CUL; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; DEPUTTE BL, 1994, ETHOLOGY, V98, P221; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; Giganti F, 2009, CURR PSYCHOL LETT, V25, P2; Giganti F, 2012, J DEV PSYCH, V101, P111; Guggisberg AG, 2011, NEUROSCI BIOBEHAV R, V35, P1302, DOI 10.1016/j.neubiorev.2010.12.004; Haker H, 2012, BRAIN IMAGING BEHAV; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; HARRIGAN JA, 1984, MOTIV EMOTION, V8, P157, DOI 10.1007/BF00993071; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; Holle H, 2012, P NATL ACAD SCI; Jefferis VE, 2003, FUNCTIONAL PUR UNPUB; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LEHMANN HE, 1979, B MENNINGER CLIN, V43, P123; Lewis M, 2002, BEHAV BRAIN SCI, V25, P42, DOI 10.1017/S0140525X02450017; Madsen EA, 2013, ANIM COGN, V16, P233, DOI 10.1007/s10071-012-0568-9; Maginnity M., 2007, THESIS U CANTERBURY; Massen JJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040697; McGrew WC, 2001, BEHAVIOUR, V138, P329, DOI 10.1163/15685390152032497; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31, DOI DOI 10.3389/FPSYG.2016.00458; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meno P, 2003, CURR PSYCHOL LETT, V11, P1; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Miller ML, 2012, BEHAV PROCESS, V89, P264, DOI 10.1016/j.beproc.2011.12.012; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Paukner A, 2006, BIOL LETTERS, V2, P36, DOI 10.1098/rsbl.2005.0411; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; POVINELLI DJ, 1994, J COMP PSYCHOL, V108, P74, DOI 10.1037/0735-7036.108.1.74; Preston SD, 2002, BBS, V25, P279; Preston SD, 2007, EMPATHY IN MENTAL ILLNESS, P428, DOI 10.1017/CBO9780511543753.024; PROVINE RR, 1986, ETHOLOGY, V72, P109, DOI 10.1111/j.1439-0310.1986.tb00611.x; PROVINE RR, 1992, B PSYCHONOMIC SOC, V30, P1; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Senju A, 2009, J AUTISM DEV DISORD, V39, P1598, DOI 10.1007/s10803-009-0785-5; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Tinbergen, 1951, STUDY INSTINCT; Usui S, 2013, AUTISM RES TREAT, V2013, P1; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Walusinski O, 2013, CLIN ANAT, V26; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114; WIGGERS M, 1985, DEV PSYCHOL, V21, P338, DOI 10.1037/0012-1649.21.2.338; Wilkinson A, 2011, CURR ZOOL, V57, P477, DOI 10.1093/czoolo/57.4.477; Wobber V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017147; Yoon JMD, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.02.011; Zlatev J, 2008, J PHYSIOL-PARIS, V102, P137, DOI 10.1016/j.jphysparis.2008.03.016	86	29	29	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76266	10.1371/journal.pone.0076266	http://dx.doi.org/10.1371/journal.pone.0076266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146848	Green Published, gold, Green Submitted			2022-12-25	WOS:000326019400048
J	Wang, GH; Mao, WB; Byler, R; Patel, K; Henegar, C; Alexeev, A; Sulchek, T				Wang, Gonghao; Mao, Wenbin; Byler, Rebecca; Patel, Krishna; Henegar, Caitlin; Alexeev, Alexander; Sulchek, Todd			Stiffness Dependent Separation of Cells in a Microfluidic Device	PLOS ONE			English	Article							CONTINUOUS-FLOW; CANCER-PATIENTS; CYTOCHALASIN-D; SINGLE CELLS; WHOLE-BLOOD; DEFORMABILITY; CHIP; DIELECTROPHORESIS; FLUID; MICROCAPSULES	Abnormal cell mechanical stiffness can point to the development of various diseases including cancers and infections. We report a new microfluidic technique for continuous cell separation utilizing variation in cell stiffness. We use a microfluidic channel decorated by periodic diagonal ridges that compress the flowing cells in rapid succession. The compression in combination with secondary flows in the ridged microfluidic channel translates each cell perpendicular to the channel axis in proportion to its stiffness. We demonstrate the physical principle of the cell sorting mechanism and show that our microfluidic approach can be effectively used to separate a variety of cell types which are similar in size but of different stiffnesses, spanning a range from 210 Pa to 23 kPa. Atomic force microscopy is used to directly measure the stiffness of the separated cells and we found that the trajectories in the microchannel correlated to stiffness. We have demonstrated that the current processing throughput is 250 cells per second. This microfluidic separation technique opens new ways for conducting rapid and low-cost cell analysis and disease diagnostics through biophysical markers.	[Wang, Gonghao; Mao, Wenbin; Henegar, Caitlin; Alexeev, Alexander; Sulchek, Todd] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Byler, Rebecca; Patel, Krishna; Sulchek, Todd] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Sulchek, Todd] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sulchek, T (corresponding author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	todd.sulchek@me.gatech.edu	Mao, Wenbin/J-4546-2014; Alexeev, Alexander/B-1322-2011	Mao, Wenbin/0000-0002-8582-0205; Alexeev, Alexander/0000-0002-8285-0003	National Science Foundation [CBET-0932510]; TI:GER program at Scheller College of Business at Georgia Institute of Technology; Georgia Tech; Petit Fellowship	National Science Foundation(National Science Foundation (NSF)); TI:GER program at Scheller College of Business at Georgia Institute of Technology; Georgia Tech; Petit Fellowship	The authors thank National Science Foundation (project number CBET-0932510) and TI:GER program at Scheller College of Business at Georgia Institute of Technology for financial support of this project. The authors also thank the President's Undergraduate Research Award (PURA) program at Georgia Tech for providing funding to CH and the Petit Fellowship for support to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148103; Alexeev A, 2005, MACROMOLECULES, V38, P10244, DOI 10.1021/ma0516135; Alexeev A, 2007, LANGMUIR, V23, P983, DOI 10.1021/la062914q; Arata JP, 2009, SOFT MATTER, V5, P2721, DOI 10.1039/b908213a; Beech JP, 2012, LAB CHIP, V12, P1048, DOI 10.1039/c2lc21083e; Bouzidi M, 2001, PHYS FLUIDS, V13, P3452, DOI 10.1063/1.1399290; Buxton GA, 2001, MODEL SIMUL MATER SC, V9, P485, DOI 10.1088/0965-0393/9/6/302; Choi S, 2007, LAB CHIP, V7, P1532, DOI 10.1039/b705203k; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Didar TF, 2010, LAB CHIP, V10, P3043, DOI [10.1039/c0lc00130a, 10.1039/c01c00130a]; Doh I, 2005, SENSOR ACTUAT A-PHYS, V121, P59, DOI 10.1016/j.sna.2005.01.030; Ekpenyong AE, 2012, PLOS ONE, V7; Fedosov DA, 2010, COMPUT METHOD APPL M, V199, P1937, DOI 10.1016/j.cma.2010.02.001; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Han KH, 2006, LAB CHIP, V6, P265, DOI 10.1039/b514539b; Hou HW, 2010, LAB CHIP, V10, P2605, DOI 10.1039/c003873c; Hur SC, 2011, LAB CHIP, V11, P912, DOI 10.1039/c01c00595a; Kilimnik A, 2011, PHYS FLUIDS, V23; Kim U, 2008, ANAL CHEM, V80, P8656, DOI 10.1021/ac8015938; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Ladd AJC, 1997, PHYS REV E, V55, P3271, DOI 10.1103/PhysRevE.55.3271; Ladd AJC, 2001, J STAT PHYS, V104, P1191, DOI 10.1023/A:1010414013942; Lee WG, 2007, LAB CHIP, V7, P516, DOI 10.1039/b614912j; Lenshof A, 2009, ANAL CHEM, V81, P6030, DOI 10.1021/ac9013572; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Lincoln B, 2004, CYTOM PART A, V59A, P203, DOI 10.1002/cyto.a.20050; Mao WB, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3590264; Mao XL, 2012, LAB CHIP, V12, P4006, DOI 10.1039/c2lc90100e; MILLS GB, 1990, J CLIN INVEST, V86, P851, DOI 10.1172/JCI114784; Mohamed H, 2009, J CHROMATOGR A, V1216, P8289, DOI 10.1016/j.chroma.2009.05.036; Moreno-Flores S, 2010, NANOTECHNOLOGY, P21; Moreno-Flores S, 2010, J BIOMECH, V43, P349, DOI 10.1016/j.jbiomech.2009.07.037; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Perroud TD, 2008, ANAL CHEM, V80, P6365, DOI 10.1021/ac8007779; Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e; Pommer MS, 2008, ELECTROPHORESIS, V29, P1213, DOI 10.1002/elps.200700607; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rosenbluth MJ, 2008, LAB CHIP, V8, P1062, DOI 10.1039/b802931h; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Schulze C, 2009, CELL MOTIL CYTOSKEL, V66, P193, DOI 10.1002/cm.20341; Shi JJ, 2009, LAB CHIP, V9, P3354, DOI 10.1039/b915113c; Succi S, 2001, LATTICE BOLTZMANN EQ, P290; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Vahey MD, 2008, ANAL CHEM, V80, P3135, DOI 10.1021/ac7020568; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Xu WW, 2012, PLOS ONE, P7; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189; Zhu GD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2753150	55	69	71	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75901	10.1371/journal.pone.0075901	http://dx.doi.org/10.1371/journal.pone.0075901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146787	gold, Green Published, Green Submitted			2022-12-25	WOS:000326019400022
J	Clotuche, G; Navajas, M; Mailleux, AC; Hance, T				Clotuche, Gwendoline; Navajas, Maria; Mailleux, Anne-Catherine; Hance, Thierry			Reaching the Ball or Missing the Flight? Collective Dispersal in the Two-Spotted Spider Mite Tetranychus urticae	PLOS ONE			English	Article							AERIAL-DISPERSAL; COCKROACH AGGREGATION; EVOLUTION; BEHAVIOR; ACARI; DISCRIMINATION; CONSEQUENCES; RECOGNITION	The two-spotted spider mite is a worldwide phytophagous pest displaying a peculiar dispersal. At high density, when plants are exhausted, individuals gather at the plant apex to form a collective silk-ball. This structure can be dispersed by wind or phoresy. Individuals initiating the ball are enclosed in the centre and have a high risk to die. For the first time, the ultimate and proximate mechanisms leading to this group dispersal are examined. To explore if a particular mite genotype was involved in the ball formation, plants were infested with individuals of different genetic background. After the silk-ball formation, the mites in the ball and those remaining on the plant were collected and genotyped. The balls were harvested after 4h and 24h to determine the role of timing between the formation and dispersal on the mortality of mites. Mites do not segregate according to their degree of relatedness, stage, or sex. Mites parallel humans using public transportation: they climb up in the ball whatever their genetic background. Silk-balls composed of unrelated individuals may help avoiding inbreeding when colonizing a new plant. Our results also emphasize the importance of an adequate timing for efficient dispersal between the time spent between ball formation and dispersal.	[Clotuche, Gwendoline; Mailleux, Anne-Catherine; Hance, Thierry] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium; [Navajas, Maria] UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Montferrier Sur Lez, France	Universite Catholique Louvain; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Clotuche, G (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium.	gwendoline.clotuche@gmail.com	NAVAJAS, Maria/AAM-2294-2020	NAVAJAS, Maria/0000-0002-0702-4238	Belgian Fund "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)"; Fund for Fundamental and Collective Research (FRFC)	Belgian Fund "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)"(Fonds de la Recherche Scientifique - FNRS); Fund for Fundamental and Collective Research (FRFC)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian Fund "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)" and by the Fund for Fundamental and Collective Research (FRFC, convention 2.4622.06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BRANDENBURG RL, 1982, ENTOMOL EXP APPL, V32, P269, DOI 10.1111/j.1570-7458.1982.tb03217.x; Clotuche G, 2009, MICROSC RES TECHNIQ, V72, P659, DOI 10.1002/jemt.20712; CLOTUCHE G, 2011, THESIS LOUVAIN LA NE; Clotuche G, 2012, CR BIOL, V335, P535, DOI 10.1016/j.crvi.2012.07.001; Clotuche G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018854; Costa J., 2006, OTHER INSECT SOC; Frankham R., 2002, INTRO CONSERVATION G; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HUSSEY N. W., 1963, ENTOMOL EXP APPL, V6, P207, DOI 10.1007/BF00300527; Ims Rolf A., 2001, P203; Kennedy G.G., 1985, P233; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Le Goff G., 2011, THESIS LOUVAIN LA NE; Le Goff G, 2009, CR BIOL, V332, P927, DOI 10.1016/j.crvi.2009.06.002; LI JB, 1993, ENTOMOL EXP APPL, V68, P79, DOI 10.1007/BF02380584; Mailleux AC, 2008, INSECT SOC, V55, P355, DOI 10.1007/s00040-008-1011-8; Mailleux AC, 2006, J EXP BIOL, V209, P4224, DOI 10.1242/jeb.02461; Navajas M, 2002, INSECT MOL BIOL, V11, P157, DOI 10.1046/j.1365-2583.2002.00320.x; Nichols J., 2001, DISPERSAL; Osakabe M, 2008, EXP APPL ACAROL, V44, P165, DOI 10.1007/s10493-008-9141-2; Page RE, 1997, ENDEAVOUR, V21, P114, DOI 10.1016/S0160-9327(97)80220-7; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; PRALAVORIO M, 1989, ENTOMOPHAGA, V34, P129, DOI 10.1007/BF02372596; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rivault C, 1998, ANIM BEHAV, V55, P177, DOI 10.1006/anbe.1997.0628; ROBSON SK, 1998, INFORM PROCESSING SO, P239; Roeder C, 1996, J EVOLUTION BIOL, V9, P143, DOI 10.1046/j.1420-9101.1996.9020143.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITO Y, 1983, ACAROLOGIA, V24, P377; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sherwin WB, 2000, CONSERV BIOL SER, V4, P9; Singer TL, 1998, AM ZOOL, V38, P394; SMITLEY DR, 1985, ANN ENTOMOL SOC AM, V78, P609, DOI 10.1093/aesa/78.5.609; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Tien NSH, 2011, EXP APPL ACAROL, V54, P119, DOI 10.1007/s10493-011-9431-y; TREHERNE JE, 1981, ANIM BEHAV, V29, P911, DOI 10.1016/S0003-3472(81)80028-0; Turchin Peter, 1998; Uesugi R, 2007, MOL ECOL NOTES, V7, P290, DOI 10.1111/j.1471-8286.2006.01583.x; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; WRANGHAM RW, 1979, SOC SCI INFORM, V18, P335; Yano S, 2004, EXP APPL ACAROL, V32, P243, DOI 10.1023/B:APPA.0000023241.73640.e4	50	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77573	10.1371/journal.pone.0077573	http://dx.doi.org/10.1371/journal.pone.0077573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143242	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100080
J	Francis, O; Han, FJ; Adams, JC				Francis, Ore; Han, Fujun; Adams, Josephine C.			Molecular Phylogeny of a RING E3 Ubiquitin Ligase, Conserved in Eukaryotic Cells and Dominated by Homologous Components, the Muskelin/RanBPM/CTLH Complex	PLOS ONE			English	Article							SCAFFOLDING PROTEIN RANBPM; N-TERMINAL DOMAIN; GID COMPLEX; DROSOPHILA-MELANOGASTER; CATABOLITE DEGRADATION; GENOME-WIDE; MUSKELIN; SEQUENCE; FRUCTOSE-1,6-BISPHOSPHATASE; EVOLUTION	Ubiquitination is an essential post-translational modification that regulates signalling and protein turnover in eukaryotic cells. Specificity of ubiquitination is driven by ubiquitin E3 ligases, many of which remain poorly understood. One such is the mammalian muskelin/RanBP9/CTLH complex that includes eight proteins, five of which (RanBP9/RanBPM, TWA1, MAEA, Rmnd5 and muskelin), share striking similarities of domain architecture and have been implicated in regulation of cell organisation. In budding yeast, the homologous GID complex acts to down-regulate gluconeogenesis. In both complexes, Rmnd5/GID2 corresponds to a RING ubiquitin ligase. To better understand this E3 ligase system, we conducted molecular phylogenetic and sequence analyses of the related components. TWA1, Rmnd5, MAEA and WDR26 are conserved throughout all eukaryotic supergroups, albeit WDR26 was not identified in Rhizaria. RanBPM is absent from Excavates and from some sub-lineages. Armc8 and c17orf39 were represented across unikonts but in bikonts were identified only in Viridiplantae and in O. trifallax within alveolates. Muskelin is present only in Opisthokonts. Phylogenetic and sequence analyses of the shared LisH and CTLH domains of RanBPM, TWA1, MAEA and Rmnd5 revealed closer relationships and profiles of conserved residues between, respectively, Rmnd5 and MAEA, and RanBPM and TWA1. Rmnd5 and MAEA are also related by the presence of conserved, variant RING domains. Examination of how N- or C-terminal domain deletions alter the sub-cellular localisation of each protein in mammalian cells identified distinct contributions of the LisH domains to protein localisation or folding/stability. In conclusion, all components except muskelin are inferred to have been present in the last eukaryotic common ancestor. Diversification of this ligase complex in different eukaryotic lineages may result from the apparently fast evolution of RanBPM, differing requirements for WDR26, Armc8 or c17orf39, and the origin of muskelin in opisthokonts as a RanBPM-binding protein.	[Francis, Ore; Han, Fujun; Adams, Josephine C.] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol	Adams, JC (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	jo.adams@bristol.ac.uk	Adams, Josephine C/B-1121-2009	Adams, Josephine C/0000-0002-2225-4947; Francis, Ore/0000-0003-2678-917X	BBSRC; Wellcome Trust [090300]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	Financial support of BBSRC (OF is supported by a BBSRC Doctoral Training grant) and the Wellcome Trust (090300 to JCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams JC, 2002, GENE, V297, P69, DOI 10.1016/S0378-1119(02)00887-9; Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; Bala S, 2006, BIOCHEM BIOPH RES CO, V342, P1040, DOI 10.1016/j.bbrc.2006.02.060; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Burger A, 2006, NEOPLASIA, V8, P689, DOI 10.1593/neo.06469; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hosono K, 2010, GENOMICS, V96, P102, DOI 10.1016/j.ygeno.2010.05.003; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Keeling PJ, 2007, SCIENCE, V317, P1875, DOI 10.1126/science.1149593; Kim MH, 2004, STRUCTURE, V12, P987, DOI 10.1016/j.str.2004.03.024; Kim YE, 2005, BIOCHEM BIOPH RES CO, V330, P746, DOI 10.1016/j.bbrc.2005.03.052; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Koonin EV, 2010, CELL, V140, P606, DOI 10.1016/j.cell.2010.02.022; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MARCUS F, 1987, ARCH BIOL MED EXP, V20, P371; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Prag S, 2004, BIOCHEM J, V381, P547, DOI 10.1042/BJ20040253; Puverel S, 2011, DEVELOPMENT, V138, P2511, DOI 10.1242/dev.062505; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Rogozin IB, 2009, GENOME BIOL EVOL, V1, P99, DOI 10.1093/gbe/evp011; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Soni S, 2008, BLOOD CELL MOL DIS, V41, P141, DOI 10.1016/j.bcmd.2008.03.008; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Suresh B, 2010, J BIOL CHEM, V285, P35340, DOI 10.1074/jbc.M110.156836; Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tillmann H, 2002, GENE, V291, P57, DOI 10.1016/S0378-1119(02)00627-3; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Tomastikova E, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-83; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuan SL, 2012, PLANT PHYSIOL, V160, P106, DOI 10.1104/pp.112.199000; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	70	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e75217	10.1371/journal.pone.0075217	http://dx.doi.org/10.1371/journal.pone.0075217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143168	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100003
J	Kang, SY; McGree, J; Mengersen, K				Kang, Su Yun; McGree, James; Mengersen, Kerrie			The Impact of Spatial Scales and Spatial Smoothing on the Outcome of Bayesian Spatial Model	PLOS ONE			English	Article							NESTED LAPLACE APPROXIMATIONS; COUNT DATA; REGRESSION; COMPUTATION; INLA	Discretization of a geographical region is quite common in spatial analysis. There have been few studies into the impact of different geographical scales on the outcome of spatial models for different spatial patterns. This study aims to investigate the impact of spatial scales and spatial smoothing on the outcomes of modelling spatial point-based data. Given a spatial point-based dataset (such as occurrence of a disease), we study the geographical variation of residual disease risk using regular grid cells. The individual disease risk is modelled using a logistic model with the inclusion of spatially unstructured and/or spatially structured random effects. Three spatial smoothness priors for the spatially structured component are employed in modelling, namely an intrinsic Gaussian Markov random field, a second-order random walk on a lattice, and a Gaussian field with Matern correlation function. We investigate how changes in grid cell size affect model outcomes under different spatial structures and different smoothness priors for the spatial component. A realistic example (the Humberside data) is analyzed and a simulation study is described. Bayesian computation is carried out using an integrated nested Laplace approximation. The results suggest that the performance and predictive capacity of the spatial models improve as the grid cell size decreases for certain spatial structures. It also appears that different spatial smoothness priors should be applied for different patterns of point data.	[Kang, Su Yun; McGree, James; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Kang, Su Yun; McGree, James; Mengersen, Kerrie] Cooperat Res Ctr Spatial Informat, Melbourne, Vic, Australia	Queensland University of Technology (QUT)	Kang, SY (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	s7.kang@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	McGree, James/0000-0003-2997-8929; Mengersen, Kerrie/0000-0001-8625-9168; Kang, Su Yun/0000-0003-4648-9844	Cooperative Research Centre for Spatial Information; Australian Commonwealth's Cooperative Research Centres Programme	Cooperative Research Centre for Spatial Information(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Commonwealth's Cooperative Research Centres Programme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The work has been supported by the Cooperative Research Centre for Spatial Information, whose activities are funded by the Australian Commonwealth's Cooperative Research Centres Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin M., 2010, STAT INFERENCE INTEG; [Anonymous], 2000, SPATIAL EPIDEMIOLOGY; Baddeley A, 2010, ELECTRON J STAT, V4, P1151, DOI 10.1214/10-EJS581; Banerjee S., 2004, HIERARCHICAL MODELIN; BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Biggeri A, 2006, STAT METHODS MED RES, V15, P337, DOI 10.1191/0962280206sm455oa; Bivand R., 2020, SPDEP SPATIAL DEPEND; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Clayton DG, 1992, GEOGRAPHICAL ENV EPI; CRESSIE N, 1989, J AM STAT ASSOC, V84, P393, DOI 10.2307/2289922; CUZICK J, 1990, J ROY STAT SOC B MET, V52, P73; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; HANDCOCK MS, 1993, TECHNOMETRICS, V35, P403, DOI 10.2307/1270273; Held L, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P91, DOI 10.1007/978-3-7908-2413-1_6; Hossain MM, 2009, COMPUT STAT DATA AN, V53, P2831, DOI 10.1016/j.csda.2008.05.017; Illian JB, 2012, ANN APPL STAT, V6, P1499, DOI 10.1214/11-AOAS530; Illian JB, 2012, J ENV STAT, V3, P1; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Li Y, 2012, J R STAT SOC C-APPL, V61, P99, DOI 10.1111/j.1467-9876.2011.01004.x; Meliker JR, 2011, SPAT SPATIO-TEMPORAL, V2, P1, DOI 10.1016/j.sste.2010.10.001; Minasny B, 2005, GEODERMA, V128, P192, DOI 10.1016/j.geoderma.2005.04.003; Mollie A., 1996, MARKOV CHAIN MONTE C, P359; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Roos M, 2011, BAYESIAN ANAL, V6, P259, DOI 10.1214/11-BA609; Rue H., 2005, GAUSSIAN MARKOV RAND, V104; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Rytkonen Mika J, 2004, Int J Circumpolar Health, V63, P9; Sauleau EA, 2010, ARXIV10063764; Schrodle B, 2011, COMPUTATION STAT, V26, P241, DOI 10.1007/s00180-010-0208-2; Schrodle B, 2011, J R STAT SOC C-APPL, V60, P261, DOI 10.1111/j.1467-9876.2010.00740.x; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Simpson D, 2011, ARXIV11052982; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stein M.L., 1999, INTERPOLATION SPATIA; Tango T, 2000, STAT MED, V19, P191, DOI 10.1002/(SICI)1097-0258(20000130)19:2<191::AID-SIM281>3.0.CO;2-Q; TERZOPOULOS D, 1988, IEEE T PATTERN ANAL, V10, P417, DOI 10.1109/34.3908; VANHATALO J, 2007, J MACHINE LEARNING R, V1, P73; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Willgert KJE, 2011, GEOSPATIAL HEALTH, V5, P227, DOI 10.4081/gh.2011.175	46	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e75957	10.1371/journal.pone.0075957	http://dx.doi.org/10.1371/journal.pone.0075957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146799	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400030
J	Schlegel, W; Raimann, A; Halbauer, D; Scharmer, D; Sagmeister, S; Wessner, B; Helmreich, M; Haeusler, G; Egerbacher, M				Schlegel, Werner; Raimann, Adalbert; Halbauer, Daniel; Scharmer, Daniela; Sagmeister, Susanne; Wessner, Barbara; Helmreich, Magdalena; Haeusler, Gabriele; Egerbacher, Monika			Insulin-Like Growth Factor I (IGF-1) Ec/Mechano Growth Factor - A Splice Variant of IGF-1 within the Growth Plate	PLOS ONE			English	Article							E-PEPTIDE ACTIONS; ARTICULAR CHONDROCYTES; MONOCLONAL-ANTIBODIES; MECHANICAL OVERLOAD; MUSCLE FUNCTION; MGF EXPRESSION; BONE-GROWTH; HORMONE; GENE; CELLS	Human insulin-like growth factor 1 Ec (IGF-1Ec), also called mechano growth factor (MGF), is a splice variant of insulin-like growth factor 1 (IGF-1), which has been shown in vitro as well as in vivo to induce growth and hypertrophy in mechanically stimulated or damaged muscle. Growth, hypertrophy and responses to mechanical stimulation are important reactions of cartilaginous tissues, especially those in growth plates. Therefore, we wanted to ascertain if MGF is expressed in growth plate cartilage and if it influences proliferation of chondrocytes, as it does in musculoskeletal tissues. MGF expression was analyzed in growth plate and control tissue samples from piglets aged 3 to 6 weeks. Furthermore, growth plate chondrocyte cell culture was used to evaluate the effects of the MGF peptide on proliferation. We showed that MGF is expressed in considerable amounts in the tissues evaluated. We found the MGF peptide to be primarily located in the cytoplasm, and in some instances, it was also found in the nucleus of the cells. Addition of MGF peptides was not associated with growth plate chondrocyte proliferation.	[Schlegel, Werner; Raimann, Adalbert; Halbauer, Daniel; Sagmeister, Susanne] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria; [Scharmer, Daniela; Helmreich, Magdalena; Haeusler, Gabriele; Egerbacher, Monika] Vet Univ Vienna, Inst Anat Histol & Embryol, A-1030 Vienna, Austria; [Wessner, Barbara] Univ Vienna, Ctr Sports Sci & Univ Sports, Dept Sports & Exercise Physiol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Raimann, A (corresponding author), Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria.	adalbert.raimann@meduniwien.ac.at	Raimann, Adalbert/N-7215-2017; Wessner, Barbara/J-8244-2012	Raimann, Adalbert/0000-0002-3551-594X; Wessner, Barbara/0000-0002-9061-7914; Haeusler, Gabriele/0000-0001-7919-3447				ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677; Albrecht C, 2010, INT J MOL MED, V26, P317, DOI 10.3892/ijmm_00000468; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; BENYA PD, 1993, EXP CELL RES, V204, P268, DOI 10.1006/excr.1993.1033; Brisson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045588; Burniston JG, 2005, MUSCLE NERVE, V32, P767, DOI 10.1002/mus.20407; Chan SJ, 2000, AM ZOOL, V40, P213; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2010, AGING CELL, V9, P126, DOI 10.1111/j.1474-9726.2009.00541.x; Connolly SA, 2004, RADIOLOGY, V233, P505, DOI 10.1148/radiol.2332030131; CONOVER CA, 1993, REGUL PEPTIDES, V48, P1, DOI 10.1016/0167-0115(93)90330-B; CONOVER CA, 1989, J CLIN ENDOCR METAB, V69, P25, DOI 10.1210/jcem-69-1-25; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005; Deng MY, 2011, INT ORTHOP, V35, P1099, DOI 10.1007/s00264-010-1141-2; DICKSON MC, 1991, J MOL ENDOCRINOL, V6, P17, DOI 10.1677/jme.0.0060017; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Gohring AR, 2010, BIOTECHNOL PROGR, V26, P1116, DOI 10.1002/btpr.402; Goldspink G, 1996, RES VET SCI, V60, P193, DOI 10.1016/S0034-5288(96)90038-7; Goldspink G, 2005, PHYSIOLOGY, V20, P232, DOI 10.1152/physiol.00004.2005; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; GREEN H, 1985, DIFFERENTIATION, V29, P195, DOI 10.1111/j.1432-0436.1985.tb00316.x; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; HUNZIKER EB, 1994, J CLIN INVEST, V93, P1078, DOI 10.1172/JCI117058; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Langenskiold A, 1998, J PEDIATR ORTHOPED, V18, P173, DOI 10.1097/00004694-199803000-00008; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lewis DA, 2009, J INVEST DERMATOL, V129, P787, DOI 10.1038/jid.2008.293; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528; Manes S, 1997, ENDOCRINOLOGY, V138, P905, DOI 10.1210/en.138.3.905; Marlovits S, 2004, INT J MOL MED, V13, P281; McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x; Milingos D, 2006, ANN NY ACAD SCI, V1092, P434, DOI 10.1196/annals.1365.042; Milingos DS, 2011, MOL MED, V17, P21, DOI 10.2119/molmed.2010.00043; Mills P, 2007, AM J TRANSPLANT, V7, P2247, DOI 10.1111/j.1600-6143.2007.01927.x; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Moschos MM, 2011, IN VIVO, V25, P179; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Owino V, 2001, FEBS LETT, V505, P259, DOI 10.1016/S0014-5793(01)02825-3; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Perry RJ, 2008, CLIN ENDOCRINOL, V68, P4; Philippou A, 2008, IN VIVO, V22, P27; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; SAUNDERS JC, 1991, J MOL ENDOCRINOL, V7, P233, DOI 10.1677/jme.0.0070233; Savendahl L, 2005, HORM RES, V64, P94, DOI 10.1159/000087764; Schlegel W, 2010, MOL CELL ENDOCRINOL, V327, P65, DOI 10.1016/j.mce.2010.06.005; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Stavropoulou A, 2009, MOL MED, V15, P127, DOI 10.2119/molmed.2009.00012; Tan DSW, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-17; Tang LL, 2006, ARCH ORAL BIOL, V51, P1080, DOI 10.1016/j.archoralbio.2006.06.009; THURSTON MN, 1985, CELL TISSUE KINET, V18, P575, DOI 10.1111/j.1365-2184.1985.tb00700.x; van der Eerden B C, 2001, J Pediatr Endocrinol Metab, V14 Suppl 6, P1527; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wilson HE, 2001, GROWTH HORM IGF RES, V11, P10, DOI 10.1054/ghir.2000.0182; Xin C, 2012, ARCH ORAL BIOL, V57, P720, DOI 10.1016/j.archoralbio.2011.11.016; Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6	68	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76133	10.1371/journal.pone.0076133	http://dx.doi.org/10.1371/journal.pone.0076133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146828	Green Published, Green Submitted, gold			2022-12-25	WOS:000325819400041
J	Shaik, R; Ramakrishna, W				Shaik, Rafi; Ramakrishna, Wusirika			Genes and Co-Expression Modules Common to Drought and Bacterial Stress Responses in Arabidopsis and Rice	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; TRANSCRIPTION FACTOR; BINDING-PROTEINS; SALICYLIC-ACID; JASMONATE; NETWORKS; BIOSYNTHESIS; DATABASE; PLANTS; IDENTIFICATION	Plants are simultaneously exposed to multiple stresses resulting in enormous changes in the molecular landscape within the cell. Identification and characterization of the synergistic and antagonistic components of stress response mechanisms contributing to the cross talk between stresses is of high priority to explore and enhance multiple stress responses. To this end, we performed meta-analysis of drought (abiotic), bacterial (biotic) stress response in rice and Arabidopsis by analyzing a total of 386 microarray samples belonging to 20 microarray studies and identified approximately 3100 and 900 DEGs in rice and Arabidopsis, respectively. About 38.5% (1214) and 28.7% (272) DEGs were common to drought and bacterial stresses in rice and Arabidopsis, respectively. A majority of these common DEGs showed conserved expression status in both stresses. Gene ontology enrichment analysis clearly demarcated the response and regulation of various plant hormones and related biological processes. Fatty acid metabolism and biosynthesis of alkaloids were upregulated and, nitrogen metabolism and photosynthesis was downregulated in both stress conditions. WRKY transcription family genes were highly enriched in all upregulated gene sets while 'CO-like' TF family showed inverse relationship of expression between drought and bacterial stresses. Weighted gene co-expression network analysis divided DEG sets into multiple modules that show high co-expression and identified stress specific hub genes with high connectivity. Detection of consensus modules based on DEGs common to drought and bacterial stress revealed 9 and 4 modules in rice and Arabidopsis, respectively, with conserved and reversed co-expression patterns.	[Shaik, Rafi; Ramakrishna, Wusirika] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Michigan Technological University	Ramakrishna, W (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.	wusirika@mtu.edu	Wusirika, Ramakrishna/O-9116-2019; Ramakrishna, Wusirika/M-6646-2017	Ramakrishna, Wusirika/0000-0002-8571-5827				Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brossa R, 2011, J PLANT GROWTH REGUL, V30, P322, DOI 10.1007/s00344-011-9194-z; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Cui XF, 2012, MOL PLANT, V5, P959, DOI 10.1093/mp/sss090; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Demmig-Adams B, 2013, NEW PHYTOL, V197, P720, DOI 10.1111/nph.12100; DOWNS GS, 2013, PLANT PHYSL; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; DUAN L, 2013, PLANT CELL; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; GHANEKAR R, 2008, INT J PLANTS GENOMIC, V2008; Godfray HCJ, 2011, P NATL ACAD SCI USA, V108, P19845, DOI 10.1073/pnas.1118568109; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Hamada K, 2011, PLANT CELL PHYSIOL, V52, P220, DOI 10.1093/pcp/pcq195; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jorgensen RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00191; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kim CY, 2008, NEW PHYTOL, V180, P57, DOI 10.1111/j.1469-8137.2008.02557.x; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meier S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-24; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Muench DG, 2012, WIRES RNA, V3, P178, DOI 10.1002/wrna.1104; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pantin F, 2013, NEW PHYTOL, V197, P65, DOI 10.1111/nph.12013; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Reynolds MP, 2012, J EXP BOT, V63, P1, DOI 10.1093/jxb/err241; Rodrigo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040526; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1214, DOI 10.1093/nar/gks1122; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shu LB, 2011, PROTEOMICS, V11, P4122, DOI 10.1002/pmic.201000485; Song XQ, 2013, MOL PLANT, V6, P768, DOI 10.1093/mp/sst025; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; TOHGE T, 2013, CRIT REV BIOCH MOL B; Tsai YC, 2012, PLANT PHYSIOL, V158, P1666, DOI 10.1104/pp.111.192765; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; *WASDE, 2012, US DROUGHT 2012 FARM; Weston DJ, 2011, PLANT CELL ENVIRON, V34, P1488, DOI 10.1111/j.1365-3040.2011.02347.x; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhang JH, 2013, MOL BIOL REP, V40, P2633, DOI 10.1007/s11033-012-2350-0; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	95	71	76	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77261	10.1371/journal.pone.0077261	http://dx.doi.org/10.1371/journal.pone.0077261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130868	gold, Green Submitted, Green Published			2022-12-25	WOS:000325814200075
J	Deshpande, DA; Yan, HD; Kong, KC; Tiegs, BC; Morgan, SJ; Pera, T; Panettieri, RA; Eckhart, AD; Penn, RB				Deshpande, Deepak A.; Yan, Huandong; Kong, Kok-Choi; Tiegs, Brian C.; Morgan, Sarah J.; Pera, Tonio; Panettieri, Reynold A.; Eckhart, Andrea D.; Penn, Raymond B.			Exploiting functional domains of GRK2/3 to alter the competitive balance of pro- and anticontractile signaling in airway smooth muscle	FASEB JOURNAL			English	Article						asthma; -agonist; bronchodilation; desensitization; G-protein-coupled receptor	ADRENERGIC-RECEPTOR KINASE; PROTEIN-COUPLED RECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; DESENSITIZATION; SPECIFICITY; INHIBITION; ACTIVATION; MECHANISM	To clarify the potential utility of targeting GRK2/3-mediated desensitization as a means of manipulating airway smooth muscle (ASM) contractile state, we assessed the specificity of GRK2/3 regulation of procontractile and relaxant G-protein-coupled receptors in ASM. Functional domains of GRK2/3 were stably expressed, or siRNA-mediated GRK2/3 knockdown was performed, in human ASM cultures, and agonist-induced signaling was assessed. Regulation of contraction of murine tracheal rings expressing GRK2 C terminus was also assessed. GRK2/3 knockdown or expression of the GRK2 C terminus caused a significant (approximate to 30-90%) increase in maximal -agonist and histamine [phosphoinositide (PI) hydrolysis] signaling, without affecting the calculated EC50. GRK2 C-terminal expression did not affect signaling by methacholine, thrombin, or LTD4. Expression of the GRK2 N terminus or kinase-dead holo-GRK2 diminished (approximate to 30-70%) both PI hydrolysis and Ca2+ mobilization by every G(q)-coupled receptor examined. Under conditions of GRK2 C-terminal expression, -agonist inhibition of methacholine-stimulated PI hydrolysis was greater. Finally, transgenic expression of the GRK2 C terminus in murine ASM enabled approximate to 30-50% greater -agonist-mediated relaxation of methacholine-induced contraction. Collectively these data demonstrate the relative selectivity of GRKs for the (2)AR in ASM and the ability to exploit GRK2/3 functional domains to render ASM hyporesponsive to contractile agents while increasing responsiveness to bronchodilating -agonist.Deshpande, D. A., Yan, H., Kong, K.-C., Tiegs, B. C., Morgan, S. J., Pera, T., Panettieri, R. A., Eckhart, A. D., Penn, R. B. Exploiting functional domains of GRK2/3 to alter the competitive balance of pro- and anticontractile signaling in airway smooth muscle.	[Deshpande, Deepak A.; Yan, Huandong; Morgan, Sarah J.; Penn, Raymond B.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Kong, Kok-Choi; Penn, Raymond B.] Wake Forest Univ Hlth Sci, Dept Internal Med, Winston Salem, NC USA; [Tiegs, Brian C.; Pera, Tonio; Eckhart, Andrea D.; Penn, Raymond B.] Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Ctr Translat Med, Dept Med, Philadelphia, PA 19107 USA; [Panettieri, Reynold A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest University School of Medicine; Jefferson University; University of Pennsylvania	Penn, RB (corresponding author), Thomas Jefferson Univ, Dept Med, Room 317,Coll Bldg,1025 Walnut St, Philadelphia, PA 19107 USA.	raymond.penn@jefferson.edu	panettieri, reynold/AAG-9485-2019		U.S. National Institutes of Health [HL58506, AG041265, HL087560]; U.S. National Institute of Arthritis and Musculoskeletal and Skin Disease [T32 AR07592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104119, R01HL058506, R00HL087560, P01HL114471, R29HL058506, K99HL087560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by U.S. National Institutes of Health grants HL58506 (R. B. P.) and AG041265 and HL087560 (D. A. D.). S.J.M. is supported by U.S. National Institute of Arthritis and Musculoskeletal and Skin Disease grant T32 AR07592.	Abisheganaden J, 1998, AM J MED, V104, P494; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Bond D, 2008, BIOL PROCED ONLINE, V10, P20, DOI 10.1251/bpo139; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Cohn HI, 2008, AM J PHYSIOL-HEART C, V295, pH1695, DOI 10.1152/ajpheart.00564.2008; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Finney PA, 2000, J CLIN INVEST, V106, P125, DOI 10.1172/JCI8374; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gros R, 2000, HYPERTENSION, V35, P38, DOI 10.1161/01.HYP.35.1.38; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; HAUCK RW, 1999, AM J PHYSIOL, V277, P22; ISHII K, 1994, J BIOL CHEM, V269, P1125; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; KIM CM, 1993, J BIOL CHEM, V268, P15412; Koch WJ, 1999, TRENDS CARDIOVAS MED, V9, P77, DOI 10.1016/S1050-1738(99)00009-2; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; Krymskaya VP, 1999, AM J PHYSIOL-LUNG C, V277, pL65; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MURRAY RK, 1993, AM J PHYSIOL, V264, pC485, DOI 10.1152/ajpcell.1993.264.2.C485; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Penn RB, 1998, HANDBK PHYS, V1, P125; Peters SP, 1999, AM J MED, V107, P283; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002; Willets JM, 2001, MOL PHARMACOL, V60, P321, DOI 10.1124/mol.60.2.321; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026	44	16	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					956	965		10.1096/fj.13-240226	http://dx.doi.org/10.1096/fj.13-240226			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24132623	Green Published			2022-12-25	WOS:000331072200040
J	Eckenroth, BE; Towle-Weicksel, JB; Sweasy, JB; Doublie, S				Eckenroth, Brian E.; Towle-Weicksel, Jamie B.; Sweasy, Joann B.; Doublie, Sylvie			The E295K Cancer Variant of Human Polymerase beta Favors the Mismatch Conformational Pathway during Nucleotide Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; DNA Polymerase; DNA Repair; Mutagenesis; Protein Conformation	HIV-1 REVERSE-TRANSCRIPTASE; BASE EXCISION-REPAIR; CRYSTAL-STRUCTURES; KLENOW FRAGMENT; FINGERS SUBDOMAIN; KINETIC ANALYSES; DNA-REPLICATION; GASTRIC-CANCER; FIDELITY; MECHANISM	Background: Human DNA polymerase is mutated in a high percentage of cancers with specific variants impacting enzymatic activity and/or fidelity. Results: In the E295K carcinoma variant, dCTP competes with cognate dTTP with dA as templating base. Conclusion: Structures verify that the E295K variant favors the mismatch over cognate dNTP. Significance: Relevant mutations may have the potential to lower the mismatch energy barrier to catalysis. DNA polymerase (pol ) is responsible for gap filling synthesis during repair of damaged DNA as part of the base excision repair pathway. Human pol mutations were recently identified in a high percentage (approximate to 30%) of tumors. Characterization of specific cancer variants is particularly useful to further the understanding of the general mechanism of pol while providing context to disease contribution. We showed that expression of the carcinoma variant E295K induces cellular transformation. The poor polymerase activity exhibited by the variant was hypothesized to be caused by the destabilization of proper active site assembly by the glutamate to lysine mutation. Here, we show that this variant exhibits an unusual preference for binding dCTP opposite a templating adenine over the cognate dTTP. Biochemical studies indicate that the noncognate competes with the cognate nucleotide for binding to the polymerase active site with the noncognate incorporation a function of higher affinity and not increased activity. In the crystal structure of the variant bound to dA:dCTP, the fingers domain closes around the mismatched base pair. Nucleotide incorporation is hindered because key residues in the polymerase active site are not properly positioned for nucleotidyl transfer. In contrast to the noncognate dCTP, neither the cognate dTTP nor its nonhydrolyzable analog induced fingers closure, as isomorphous difference Fourier maps show that the cognate nucleotides are bound to the open state of the polymerase. Comparison with published structures provides insight into the structural rearrangements within pol that occur during the process of nucleotide discrimination.	[Eckenroth, Brian E.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Towle-Weicksel, Jamie B.; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	University of Vermont; Yale University	Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St,POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu; sdoublie@uvm.edu		Doublie, Sylvie/0000-0002-6294-5304; Eckenroth, Brian/0000-0003-4818-311X	National Institutes of Health from NCI [R01 CA080830]; NATIONAL CANCER INSTITUTE [R01CA080830] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA080830 from NCI (to J.B.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Berlow RB, 2012, J MOL BIOL, V419, P171, DOI 10.1016/j.jmb.2012.03.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P6751, DOI 10.1021/bi049975c; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Hariharan C, 2006, BIOCHEMISTRY-US, V45, P2836, DOI 10.1021/bi051644s; Iwanaga A, 1999, MUTAT RES-DNA REPAIR, V435, P121, DOI 10.1016/S0921-8777(99)00036-1; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kraynov VS, 1997, BIOCHEM J, V323, P103, DOI 10.1042/bj3230103; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Li YL, 2012, J AM CHEM SOC, V134, P9999, DOI 10.1021/ja300361r; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Rothwell PJ, 2013, J BIOL CHEM, V288, P13575, DOI 10.1074/jbc.M112.432690; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Rould Mark A, 2007, Methods Mol Biol, V364, P159; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Schlick T, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1287-7; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; STEITZ TA, 1993, COLD SPRING HARB SYM, V58, P495, DOI 10.1101/SQB.1993.058.01.056; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang LJ, 2002, J MOL BIOL, V317, P651, DOI 10.1006/jmbi.2002.5450; Yang LJ, 2002, J MOL BIOL, V321, P459, DOI 10.1016/S0022-2836(02)00617-4; Zhang H, 2007, NUCLEIC ACIDS RES, V35, P6052, DOI 10.1093/nar/gkm587; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	56	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34850	34860		10.1074/jbc.M113.510891	http://dx.doi.org/10.1074/jbc.M113.510891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133209	Green Published, hybrid			2022-12-25	WOS:000329812800052
J	Sidharthan, NP; Minchin, RF; Butcher, NJ				Sidharthan, Neelima P.; Minchin, Rodney F.; Butcher, Neville J.			Cytosolic Sulfotransferase 1A3 Is Induced by Dopamine and Protects Neuronal Cells from Dopamine Toxicity ROLE OF D1 RECEPTOR-N-METHYL-D-ASPARTATE RECEPTOR COUPLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Dopamine Receptors; ERK; Glutamate Receptors Ionotropic (AMPA; NMDA); Metabolism; Sulfotransferase	CATECHOL-O-METHYLTRANSFERASE; ELEMENT-BINDING PROTEIN; NMDA-RECEPTOR; CALCINEURIN-NFAT; GENE-EXPRESSION; ACTIVATING TRANSCRIPTION; OXIDATIVE STRESS; SULT1A3; BRAIN; ALPHA	Background: Dopaminergic neurons are susceptible to dopamine-induced toxicity. Results: Dopamine induces the cytosolic sulfotransferase SULT1A3 via a dopamine D1-NMDA receptor-coupled mechanism. Conclusion: Induction of SULT1A3 significantly protects cells from dopamine neurotoxicity. Significance: The dysregulation of SULT1A3 expression may be a risk factor for neurodegenerative diseases involving dopamine. Dopamine neurotoxicity is associated with several neurodegenerative diseases, and neurons utilize several mechanisms, including uptake and metabolism, to protect them from injury. Metabolism of dopamine involves three enzymes: monoamine oxidase, catechol O-methyltransferase, and sulfotransferase. In primates but not lower order animals, a sulfotransferase (SULT1A3) is present that can rapidly metabolize dopamine to dopamine sulfate. Here, we show that SULT1A3 and a closely related protein SULT1A1 are highly inducible by dopamine. This involves activation of the D1 and NMDA receptors. Both ERK1/2 phosphorylation and calcineurin activation are required for induction. Pharmacological agents that inhibited induction or siRNA targeting SULT1A3 significantly increased the susceptibility of cells to dopamine toxicity. Taken together, these results show that dopamine can induce its own metabolism and protect neuron-like cells from damage, suggesting that SULT1A3 activity may be a risk factor for dopamine-dependent neurodegenerative diseases.	[Sidharthan, Neelima P.; Minchin, Rodney F.; Butcher, Neville J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland	Minchin, RF (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	r.minchin@uq.edu.au		Nair, Neelima/0000-0003-1729-2575; Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589	National Health and Medical Research Council of Australia [GNT1005899]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Grant GNT1005899.	Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Avramovich-Tirosh Y, 2007, J NEUROCHEM, V100, P490, DOI 10.1111/j.1471-4159.2006.04258.x; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Blum K, 2012, J PSYCHOACTIVE DRUGS, V44, P134, DOI 10.1080/02791072.2012.685407; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Butcher NJ, 2010, MOL PHARMACOL, V78, P503, DOI 10.1124/mol.110.063404; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; CEDARBAUM JM, 1991, NEUROLOGY, V41, P1567, DOI 10.1212/WNL.41.10.1567; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gandhi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037564; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Hempel N, 2004, MOL PHARMACOL, V66, P1690, DOI 10.1124/mol.104.003350; Hildebrandt HAT, 2004, BIOCHEM BIOPH RES CO, V321, P870, DOI 10.1016/j.bbrc.2004.07.038; Jassen AK, 2006, MOL PHARMACOL, V70, P71, DOI 10.1124/mol.105.021998; Jeon Sung-Man, 2010, Exp Neurobiol, V19, P155, DOI 10.5607/en.2010.19.3.155; Kaphzan H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000138; Kurogi K, 2012, BIOCHEM PHARMACOL, V84, P1186, DOI 10.1016/j.bcp.2012.08.009; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Richard K, 2001, J CLIN ENDOCR METAB, V86, P2734, DOI 10.1210/jc.86.6.2734; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sai Y, 2008, TOXICOL IN VITRO, V22, P1461, DOI 10.1016/j.tiv.2008.04.019; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Snyder GL, 1998, J NEUROSCI, V18, P10297; Tayebati SK, 2011, CURR NEUROVASC RES, V8, P246; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Thomae BA, 2003, J NEUROCHEM, V87, P809, DOI 10.1046/j.1471-4159.2003.02027.x; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Wu J, 2012, MOL NEUROBIOL, V45, P605, DOI 10.1007/s12035-012-8278-5; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yan MH, 2002, J PHARMACOL EXP THER, V301, P315, DOI 10.1124/jpet.301.1.315; ZHU XY, 1993, BIOCHEM BIOPH RES CO, V195, P120, DOI 10.1006/bbrc.1993.2018; ZIV I, 1994, NEUROSCI LETT, V170, P136, DOI 10.1016/0304-3940(94)90258-5	51	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34364	34374		10.1074/jbc.M113.493239	http://dx.doi.org/10.1074/jbc.M113.493239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24136195	Green Published, hybrid			2022-12-25	WOS:000329812800008
J	Santa-Ana-Tellez, Y; Mantel-Teeuwisse, AK; Dreser, A; Leufkens, HGM; Wirtz, VJ				Santa-Ana-Tellez, Yared; Mantel-Teeuwisse, Aukje K.; Dreser, Anahi; Leufkens, Hubert G. M.; Wirtz, Veronika J.			Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico	PLOS ONE			English	Article							RESISTANCE	Background: In Latin American countries over-the-counter (OTC) dispensing of antibiotics is common. In 2010, both Mexico and Brazil implemented policies to enforce existing laws of restricting consumption of antibiotics only to patients presenting a prescription. The objective of the present study is therefore to evaluate the impact of OTC restrictions (2010) on antibiotics consumption in Brazil and Mexico. Methods and Findings: Retail quarterly sales data in kilograms of oral and injectable antibiotics between January 2007 and June 2012 for Brazil and Mexico were obtained from IMS Health. The unit of analysis for antibiotics consumption was the defined daily dose per 1,000 inhabitants per day (DDD/TID) according to the WHO ATC classification system. Interrupted time series analysis was conducted using antihypertensives as reference group to account for changes occurring independently of the OTC restrictions directed at antibiotics. To reduce the effect of (a) seasonality and (b) autocorrelation, dummy variables and Prais-Winsten regression were used respectively. Between 2007 and 2012 total antibiotic usage increased in Brazil (from 5.7 to 8.5 DDD/TID, +49.3%) and decreased in Mexico (10.5 to 7.5 DDD/TID, -29.2%). Interrupted time series analysis showed a change in level of consumption of -1.35 DDD/TID (p<0.01) for Brazil and -1.17 DDD/TID (p<0.00) for Mexico. In Brazil the penicillins, sulfonamides and macrolides consumption had a decrease in level after the intervention of 0.64 DDD/TID (p = 0.02), 0.41 (p = 0.02) and 0.47 (p = 0.01) respectively. While in Mexico it was found that only penicillins and sulfonamides had significant changes in level of 20.86 DDD/TID (p<0.00) and -0.17 DDD/TID (p = 0.07). Conclusions: Despite different overall usage patterns of antibiotics in Brazil and Mexico, the effect of the OTC restrictions on antibiotics usage was similar. In Brazil the trend of increased usage of antibiotics was tempered after the OTC restrictions; in Mexico the trend of decreased usage was boosted.	[Santa-Ana-Tellez, Yared; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M.] UIPS, WHO Collaborating Ctr Pharmaceut Policy & Regulat, Utrecht, Netherlands; [Dreser, Anahi; Wirtz, Veronika J.] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA	Utrecht University; Instituto Nacional de Salud Publica; Boston University	Wirtz, VJ (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	vwirtz@bu.edu	Wirtz, Veornika/AAG-9712-2019; Dreser, Anahí/AAS-5886-2021; Mantel-Teeuwisse, Aukje/I-8902-2016; Dreser, Anahi/A-8317-2013	Dreser, Anahí/0000-0001-9019-2330; Dreser, Anahi/0000-0001-9019-2330; Wirtz, Veronika J./0000-0002-0863-8768; Santa-Ana-Tellez, Yared/0000-0003-3086-446X	CONACYT (National Council of Science and Technology Mexico)	CONACYT (National Council of Science and Technology Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Yared Santa-Ana-Tellez received funding from CONACYT (National Council of Science and Technology Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVISA, 2012, SIST GER PROD CONTR; ANVISA, 2013, DEF NOV DAT CONTR EL; Bavestrello L, 2002, REV MED CHILE, V130, P1265; CHIPMAN JS, 1979, ECONOMETRICA, V47, P115, DOI 10.2307/1912350; Diario Oficial de la Federacino, 2010, AC QUE SE SET LIN QU; Diekema DJ, 2000, EMERG INFECT DIS, V6, P552, DOI 10.3201/eid0605.000519; Dreser A, 2008, SALUD PUBLICA MEXICO, V50, pS480, DOI 10.1590/S0036-36342008001000009; Dreser A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1051; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Health IMS, 2008, PHARM MARK; IMS Health, 2006, PHARM SHAK UP; Luis BF, 2011, REV CHIL INFECTOL, V28, P107, DOI /S0716-10182011000200001; Pan American Health Organization, 2004, LEG ANT AM LAT; Pan American Health Organization, 1999, PREV CONTR ANT RES; Pan American Health Organization (n.d.), PAN AM HLTH ORG DAT; StataCorp, 2011, STAT STAT SOFTW REL, P173; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wirtz VJ, 2013, TROP MED INT HEALTH, V18, P665, DOI 10.1111/tmi.12096; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; World Health Organization Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health, 2012, ATC DDD IND	21	77	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e75550	10.1371/journal.pone.0075550	http://dx.doi.org/10.1371/journal.pone.0075550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146761	Green Published, Green Submitted, gold			2022-12-25	WOS:000326019400010
J	Boonyanugomol, W; Chomvarin, C; Hahnvajanawong, C; Sripa, B; Kaparakis-Liaskos, M; Ferrero, RL				Boonyanugomol, Wongwarut; Chomvarin, Chariya; Hahnvajanawong, Chariya; Sripa, Banchob; Kaparakis-Liaskos, Maria; Ferrero, Richard L.			Helicobacter pylori cag Pathogenicity Island (cagPAI) Involved in Bacterial Internalization and IL-8 Induced Responses via NOD1-and MyD88-Dependent Mechanisms in Human Biliary Epithelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; KAPPA-B; IV SECRETION; EXPRESSION; PEPTIDOGLYCAN; INDUCTION; ACTIVATION; INTEGRINS; ADHERENCE; INVASION	Helicobacter pylori infection has been proposed to be associated with various diseases of the hepatobiliary tract, including cancer of the bile duct epithelial cells (cholangiocarcinoma, CCA). The ability of H. pylori bacteria to cause pathogenic effects in these cells has, however, yet to be investigated. Given that the cag pathogenicity island (cagPAI) is required for H. pylori pathogenesis in gastric epithelial cells, we investigated wild-type and cag mutant strains for their ability to adhere, be internalized and induce pro-inflammatory responses in two bile duct epithelial cell lines derived from cases of CCA. The findings from these experiments were compared to results obtained with the well-characterized AGS gastric cancer cell line. We showed that the cagPAI encodes factors involved in H. pylori internalization in CCA cells, but not for adhesion to these cells. Consistent with previous studies in hepatocytes, actin polymerization and alpha 5 beta 1 integrin may be involved in H. pylori internalization in CCA cells. As for AGS cells, we observed significantly reduced levels of NF-kappa B activation and IL-8 production in CCA cells stimulated with either cagA, cagL or cagPAI bacteria, when compared with wild-type bacteria. Importantly, these IL-8 responses could be inhibited via either pre-treatment of cells with antibodies to alpha 5 beta 1 integrins, or via siRNA-mediated knockdown of the innate immune signaling molecules, nucleotide oligomerization domain 1 (NOD1) and myeloid differentiation response gene 88 (MyD88). Taken together, the data demonstrate that the cagPAI is critical for H. pylori pathogenesis in bile duct cells, thus providing a potential causal link for H. pylori in biliary tract disease.	[Boonyanugomol, Wongwarut; Chomvarin, Chariya; Hahnvajanawong, Chariya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Sripa, Banchob] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Boonyanugomol, Wongwarut; Chomvarin, Chariya; Hahnvajanawong, Chariya; Sripa, Banchob] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Kaparakis-Liaskos, Maria; Ferrero, Richard L.] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia	Khon Kaen University; Khon Kaen University; Khon Kaen University; Monash University	Chomvarin, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	chariya@kku.ac.th	Kaparakis-Liaskos, Maria/R-9321-2019; Ferrero, Richard/U-1332-2017	Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Sripa, Banchob/0000-0001-8899-5919; Ferrero, Richard/0000-0001-6817-6211	Commission on Higher Education of Thailand; Faculty of Medicine, Khon Kaen University	Commission on Higher Education of Thailand(Office of Higher Education Commission (OHEC)); Faculty of Medicine, Khon Kaen University	This work was supported by the Commission on Higher Education of Thailand for grant support under the program Strategic Scholarships for Frontier Research Network under the Joint Ph.D. Program for Thai Doctoral degrees, and some parts of this work was supported by Faculty of Medicine, Khon Kaen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 1999, J LEUKOCYTE BIOL, V66, P753, DOI 10.1002/jlb.66.5.753; Allison CC, 2010, FUTURE MICROBIOL, V5, P1233, DOI 10.2217/FMB.10.84; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Birkness KA, 1996, ANN NY ACAD SCI, V797, P293, DOI 10.1111/j.1749-6632.1996.tb52983.x; Boonyanugomol W, 2012, HPB, V14, P754, DOI 10.1111/j.1477-2574.2012.00533.x; Boonyanugomol W, 2012, DIGEST DIS SCI, V57, P2615, DOI 10.1007/s10620-012-2216-2; Boonyanugomol W, 2012, HPB, V14, P177, DOI 10.1111/j.1477-2574.2011.00423.x; Boonyanugomol W, 2011, DIGEST DIS SCI, V56, P1682, DOI 10.1007/s10620-010-1512-y; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Cho SO, 2006, ANN NY ACAD SCI, V1090, P298, DOI 10.1196/annals.1378.032; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; Gorrell RJ, 2012, CELL MICROBIOL, DOI 10.1111/cmi.12055; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Grubman A, 2010, CELL MICROBIOL, V12, P626, DOI 10.1111/j.1462-5822.2009.01421.x; Hahnvajanawong C, 2012, BIOL PHARM BULL, V35, P1914, DOI 10.1248/bpb.b12-00118; Hirata Y, 2006, J IMMUNOL, V176, P3796, DOI 10.4049/jimmunol.176.6.3796; Huang Y, 2004, J CLIN PATHOL, V57, P1273, DOI 10.1136/jcp.2004.018556; Hutton ML, 2010, INFECT IMMUN, V78, P4523, DOI 10.1128/IAI.00439-10; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ito K, 2008, DIGEST DIS SCI, V53, P2541, DOI 10.1007/s10620-007-0164-z; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Leelawat Kawin, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P881; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Namwat N, 2008, CHEMOTHERAPY, V54, P343, DOI 10.1159/000151541; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 1995, LAB INVEST, V73, P760; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Petersen AM, 2001, FEMS IMMUNOL MED MIC, V30, P103, DOI 10.1016/S0928-8244(00)00246-7; Petersen AM, 2000, FEMS IMMUNOL MED MIC, V29, P59, DOI 10.1016/S0928-8244(00)00189-9; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sharma SA, 1998, J IMMUNOL, V160, P2401; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Su B, 1999, GASTROENTEROLOGY, V117, P595, DOI 10.1016/S0016-5085(99)70452-X; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tepsiri N, 2005, WORLD J GASTROENTERO, V11, P2748, DOI 10.3748/wjg.v11.i18.2748; Tiwari SK, 2006, WORLD J GASTROENTERO, V12, P2181, DOI 10.3748/wjg.v12.i14.2181; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/476482; Yamaoka Y, 2004, GASTROENTEROLOGY, V126, P1030, DOI 10.1053/j.gastro.2003.12.048; Zhang Y, 2005, WORLD J GASTROENTERO, V11, P3485, DOI 10.3748/wjg.v11.i22.3485	53	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77358	10.1371/journal.pone.0077358	http://dx.doi.org/10.1371/journal.pone.0077358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143223	gold, Green Submitted, Green Published			2022-12-25	WOS:000325894100060
J	Chi, XL; Zeng, XC; Hao, WB; Li, M; Li, W; Huang, XH; Wang, SH; Luo, SH				Chi, Xuelin; Zeng, Xiancheng; Hao, Wenbo; Li, Ming; Li, Wei; Huang, Xiaohong; Wang, Shihua; Luo, Shuhong			Heterogeneity among Orf Virus Isolates from Goats in Fujian Province, Southern China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; IDENTIFICATION; SHEEP; INFECTION; LAMBS; ANTIBODIES; OUTBREAK; LESIONS	Orf virus is a parapoxvirus that causes recurring contagious ecthyma or orf disease in goat, sheep and other wild and domestic ruminants. Infected animals show signs of pustular lesions on the mouth and muzzle and develop scabs over the lesions. Although the infection is usually cleared within 1-2 months, delayed growth and associated secondary infections could still impact the herds. Orf virus can also infect humans, causing lesions similar to the animals in pathological histology. Prior infection of orf virus apparently offers little protective immunity against future infections. Several gene products of orf virus have been identified as responsible for immunomodulatory functions. In our recent study of orf virus isolates from an area along the Minjiang River in northern Fujian Province, we found a high heterogeneity among isolates from 10 farms within a 120-kilometer distance. Only two isolates from locations within 1 km to each other had same viral genes. There is no correlation between the geographical distance between the corresponding collection sites and the phylogenetic distance in ORFV011 or ORV059 genes for any two isolates. This finding suggests that there are diverse populations of orf virus present in the environment. This may in part contribute to the phenomenon of recurring outbreaks and heighten the need for better surveillance.	[Chi, Xuelin; Zeng, Xiancheng; Wang, Shihua; Luo, Shuhong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Chi, Xuelin; Zeng, Xiancheng; Huang, Xiaohong] Fujian Agr & Forestry Univ, Univ Key Lab Integrated Chinese Tradit & Western, Coll Anim Sci, Fuzhou, Peoples R China; [Hao, Wenbo; Li, Ming; Li, Wei; Luo, Shuhong] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Southern Medical University - China	Wang, SH (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China.	1094324057@qq.com; sluo815@gmail.com			National Natural Science Foundation of China (NSFC) [31070138, 31170147]; Special Funds for Colleges and Universities Talents by Guangdong Province; Scientific Research Foundation of Introducing Talents of Southern Medical University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Funds for Colleges and Universities Talents by Guangdong Province; Scientific Research Foundation of Introducing Talents of Southern Medical University	The study was supported by the grant (No. 31070138 and No. 31170147) from the National Natural Science Foundation of China (NSFC) and Special Funds for Colleges and Universities Talents by Guangdong Province (2011) and Scientific Research Foundation of Introducing Talents of Southern Medical University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billinis C., 2012, VIROL J, V19, P9; Bora DP, 2012, VIRUS GENES, V45, P98, DOI 10.1007/s11262-012-0740-y; CHAHIDI N, 1993, BRIT J PLAST SURG, V46, P532, DOI 10.1016/0007-1226(93)90231-Y; Chan KW, 2007, VIRUS GENES, V35, P705, DOI 10.1007/s11262-007-0144-6; de Oliveira CHS, 2012, VECTOR-BORNE ZOONOT, V12, P336, DOI 10.1089/vbz.2011.0725; Guibal F, 1996, EUR J DERMATOL, V6, P41; Haig DM, 2002, VIRUS RES, V88, P3, DOI 10.1016/S0168-1702(02)00117-X; Haig DM, 1998, VET RES, V29, P311; Hosamani M, 2006, VET MICROBIOL, V116, P317, DOI 10.1016/j.vetmic.2006.04.028; HOUSAWI FMT, 1992, J COMP PATHOL, V106, P153, DOI 10.1016/0021-9975(92)90044-U; Hu G, 2005, TURK J VET ANIM SCI, V29, P95; Li H, 2012, VIRUS GENES, V44, P429, DOI 10.1007/s11262-011-0710-9; Li W, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-229; Mavrogianni VS, 2006, VET RES, V37, P89, DOI 10.1051/vetres:2005042; McElroy MC, 2007, VET J, V174, P663, DOI 10.1016/j.tvjl.2006.10.024; MCKEEVER DJ, 1987, VET MICROBIOL, V15, P229, DOI 10.1016/0378-1135(87)90077-0; MEYNINK SE, 1987, VET REC, V121, P594; ROBINSON AJ, 1983, NEW ZEAL VET J, V31, P161, DOI 10.1080/00480169.1983.35008; SULLIVAN JT, 1994, VIROLOGY, V202, P968, DOI 10.1006/viro.1994.1420; Uzel M, 2005, EPIDEMIOL INFECT, V133, P653, DOI 10.1017/S0950268805003778; Zhao K, 2010, VET MICROBIOL, V142, P408, DOI 10.1016/j.vetmic.2009.10.006	21	13	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e66958	10.1371/journal.pone.0066958	http://dx.doi.org/10.1371/journal.pone.0066958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143166	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100001
J	Zhao, L; Hu, YL; Lin, GG; Gao, YC; Fang, YT; Zeng, DH				Zhao, Lei; Hu, Ya-Lin; Lin, Gui-Gang; Gao, Yong-chao; Fang, Yun-Ting; Zeng, De-Hui			Mixing Effects of Understory Plant Litter on Decomposition and Nutrient Release of Tree Litter in Two Plantations in Northeast China	PLOS ONE			English	Article							LEAF-LITTER; DECAY-RATES; NITROGEN; PINE; DYNAMICS; FORESTS; LIGNIN; BIODIVERSITY; COMMUNITIES; VEGETATION	Understory vegetation plays a crucial role in carbon and nutrient cycling in forest ecosystems; however, it is not clear how understory species affect tree litter decomposition and nutrient dynamics. In this study, we examined the impacts of understory litter on the decomposition and nutrient release of tree litter both in a pine (Pinus sylvestris var. mongolica) and a poplar (Populus x xiaozhuanica) plantation in Northeast China. Leaf litter of tree species, and senesced aboveground materials from two dominant understory species, Artemisia scoparia and Setaria viridis in the pine stand and Elymus villifer and A. sieversiana in the poplar stand, were collected. Mass loss and N and P fluxes of single-species litter and three-species mixtures in each of the two forests were quantified. Data from single-species litterbags were used to generate predicted mass loss and N and P fluxes for the mixed-species litterbags. In the mixture from the pine stand, the observed mass loss and N release did not differ from the predicted value, whereas the observed P release was greater than the predicted value. However, the presence of understory litter decelerated the mass loss and did not affect N and P releases from the pine litter. In the poplar stand, litter mixture presented a positive non-additive effect on litter mass loss and P release, but an addition effect on N release. The presence of understory species accelerated only N release of poplar litter. Moreover, the responses of mass loss and N and P releases of understory litter in the mixtures varied with species in both pine and poplar plantations. Our results suggest that the effects of understory species on tree litter decomposition vary with tree species, and also highlight the importance of understory species in litter decomposition and nutrient cycles in forest ecosystems.	[Zhao, Lei; Hu, Ya-Lin; Lin, Gui-Gang; Gao, Yong-chao; Fang, Yun-Ting; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China; [Zhao, Lei; Lin, Gui-Gang; Gao, Yong-chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Lei; Hu, Ya-Lin; Zeng, De-Hui] Chinese Acad Sci, Inst Appl Ecol, Daqinggou Ecol Stn, Shenyang 110016, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Zeng, DH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China.	zengdh@iae.ac.cn	Fang, Yunting/G-4456-2012	Fang, Yunting/0000-0001-7531-546X; Lin, Guigang/0000-0003-4473-2708	National Basic Research Program of China [2012CB416902]; National Natural Science Foundation of China [31270668]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB416902) and the National Natural Science Foundation of China (31270668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Ball BA, 2008, J ECOL, V96, P303, DOI 10.1111/j.1365-2745.2007.01346.x; Ball BA, 2009, ECOSYSTEMS, V12, P87, DOI 10.1007/s10021-008-9208-2; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; BLAIR JM, 1988, SOIL BIOL BIOCHEM, V20, P693, DOI 10.1016/0038-0717(88)90154-X; Bonanomi G, 2010, PLANT SOIL, V331, P481, DOI 10.1007/s11104-009-0269-6; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chastain RA, 2006, FOREST ECOL MANAG, V231, P63, DOI 10.1016/j.foreco.2006.04.040; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; FYLES JW, 1993, CAN J FOREST RES, V23, P358, DOI 10.1139/x93-052; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gartner TB, 2006, SOIL BIOL BIOCHEM, V38, P2307, DOI 10.1016/j.soilbio.2006.02.014; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Girisha GK, 2003, FOREST ECOL MANAG, V179, P169, DOI 10.1016/S0378-1127(02)00518-2; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Laganiere J, 2009, APPL SOIL ECOL, V41, P19, DOI 10.1016/j.apsoil.2008.08.005; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Liu P, 2007, BIOL FERT SOILS, V44, P211, DOI 10.1007/s00374-007-0195-9; Mao R, 2012, GEODERMA, V170, P112, DOI 10.1016/j.geoderma.2011.11.008; McLaren JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023702; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Muller Robert N., 2003, P15; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Polyakova O, 2007, FOREST ECOL MANAG, V253, P11, DOI 10.1016/j.foreco.2007.06.049; PRESCOTT CE, 1993, CAN J FOREST RES, V23, P1576, DOI 10.1139/x93-198; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Strickland MS, 2009, FUNCT ECOL, V23, P627, DOI 10.1111/j.1365-2435.2008.01515.x; Sundarapandian SM, 1999, FOREST ECOL MANAG, V123, P231, DOI 10.1016/S0378-1127(99)00062-6; Swan CM, 2009, ECOLOGY, V90, P1650, DOI 10.1890/08-0329.1; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Vance ED, 2001, SOIL BIOL BIOCHEM, V33, P173, DOI 10.1016/S0038-0717(00)00127-9; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2006, SOIL BIOL BIOCHEM, V35, P827; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057; Zeng DH, 2009, PLANT SOIL, V317, P121, DOI 10.1007/s11104-008-9793-z	49	17	23	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76334	10.1371/journal.pone.0076334	http://dx.doi.org/10.1371/journal.pone.0076334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143184	Green Published, gold, Green Submitted			2022-12-25	WOS:000325894100019
J	Coghill, LM; Hulsey, CD; Chaves-Campos, J; de Leon, FJG; Johnson, SG				Coghill, Lyndon M.; Hulsey, C. Darrin; Chaves-Campos, Johel; Garcia de Leon, Francisco J.; Johnson, Steven G.			Phylogeography and Conservation Genetics of a Distinct Lineage of Sunfish in the Cuatro Cienegas Valley of Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; BLACK BASSES; ACTINOPTERYGII; BIOGEOGRAPHY; EVOLUTION; INFERENCE; MODELS; SNAIL; FLOW	The valley of Cuatro Cienegas, an aquatic oasis located in the Mexican Chihuahuan Desert, exhibits the highest level of endemism in North America and is a Mexican National Protected Area. However, little is known about the evolutionary distinctiveness of several vertebrate species present in the Cuatro Cienegas valley. We conducted a phylogeographic study using mitochondrial haplotypes from the centrarchid fish Lepomis megalotis to determine if the populations found within the valley were evolutionarily distinct from populations outside the valley. We also examined if there was evidence of unique haplotypes of this sunfish within the valley. Genetic divergence of L. megalotis suggests populations within the valley are evolutionarily unique when compared to L. megalotis outside the valley. Significant mitochondrial sequence divergence was also discovered between L. megalotis populations on either side of the Sierra de San Marcos that bisects the valley. Our results reinforce previous studies that suggest the organisms occupying aquatic habitats not only within Cuatro Cienegas but also in each of the two lobes of the valley generally deserve independent consideration during management decisions.	[Coghill, Lyndon M.; Chaves-Campos, Johel; Johnson, Steven G.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Hulsey, C. Darrin] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Garcia de Leon, Francisco J.] Ctr Invest Biol Noroeste, Lab Genet Conservac, La Paz, Baja California, Mexico	University of Louisiana System; University of New Orleans; University of Tennessee System; University of Tennessee Knoxville; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Coghill, LM (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	lcoghill@uno.edu	León, Francisco García-De/AAH-9391-2019; Chaves-Campos, Johel/AAF-9147-2020	León, Francisco García-De/0000-0003-2323-2560; Chaves-Campos, Johel/0000-0001-8026-7626; Hulsey, C. Darrin/0000-0002-9653-6728	University of Tennessee, Knoxville; The University of New Orleans; Northwestern Center of Biological Research for Mexico (CIBNOR)	University of Tennessee, Knoxville; The University of New Orleans; Northwestern Center of Biological Research for Mexico (CIBNOR)	Support was provided to C. D. Hulsey by the University of Tennessee, Knoxville and S. G. Johnson, L. M. Coghill and Johel Chaves-Campos were supported by The University of New Orleans. Northwestern Center of Biological Research for Mexico (CIBNOR) provided support to F. J. Garcia de Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Biomatters, 2010, GENEIOUS; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; Castiglia PJ, 2006, GEOLOGY, V34, P113, DOI 10.1130/G22036.1; Chaves-Campos J, 2011, CONSERV GENET, V12, P557, DOI 10.1007/s10592-010-0163-z; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Guia APO, 2007, ECOL RES, V22, P604, DOI 10.1007/s11284-006-0059-z; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; du Toit JT, 2010, ANIM CONSERV, V13, P229, DOI 10.1111/j.1469-1795.2010.00355.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fluxus-Engineering, 2012, NETWORK; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hawkins JP, 2000, ANIM CONSERV, V3, P81, DOI 10.1111/j.1469-1795.2000.tb00089.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HENDRICKSON DA, 2008, ARIDLAND SPRINGS N A; Howeth JG, 2008, MOL ECOL, V17, P4209, DOI 10.1111/j.1365-294X.2008.03904.x; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Hulsey CD, 2006, J FISH BIOL, V68, P1399, DOI 10.1111/j.0022-1112.2006.01021.x; Husemann M, 2012, BIOL J LINN SOC, V107, P867, DOI 10.1111/j.1095-8312.2012.01973.x; Johnson SG, 2005, MOL ECOL, V14, P2299, DOI 10.1111/j.1365-294X.2005.02580.x; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Lee DS, 1980, ATLAS N AM FRESHWATE; McGaugh SE, 2012, CONSERV GENET, V13, P1561, DOI 10.1007/s10592-012-0403-5; Miller RR, 2006, FRESHWATER FISHES ME; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Near TJ, 2003, EVOLUTION, V57, P1610; Near TJ, 2004, MOL PHYLOGENET EVOL, V32, P344, DOI 10.1016/j.ympev.2003.12.010; Rafinesque CS, 1820, W REV MISCELLANEOUS, P49; Rambaut A, 2013, TRACER VERSION 1 6; Rodriguez-Martinez R, 2004, DIVERSIDAD GENETICA; Sinclair EA, 2011, ANIM CONSERV, V14, P87, DOI 10.1111/j.1469-1795.2010.00395.x; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Suchard MA, 2005, BIOMETRICS, V61, P665, DOI 10.1111/j.1541-0420.2005.00352.x; Vignieri SN, 2006, ANIM CONSERV, V9, P237, DOI 10.1111/j.1469-1795.2006.00038.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wesner JS, 2012, ANIM CONSERV, V15, P445, DOI 10.1111/j.1469-1795.2012.00538.x	47	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2013	8	10							e77013	10.1371/journal.pone.0077013	http://dx.doi.org/10.1371/journal.pone.0077013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236QM	24130826	Green Published, gold			2022-12-25	WOS:000325814200048
J	Lambie, EJ; Tieu, PJ; Lebedeva, N; Church, DL; Conradt, B				Lambie, Eric J.; Tieu, Pamela J.; Lebedeva, Nadja; Church, Diane L.; Conradt, Barbara			CATP-6, a C. elegans Ortholog of ATP13A2 PARK9, Positively Regulates GEM-1, an SLC16A Transporter	PLOS ONE			English	Article							P-TYPE ATPASE; CAENORHABDITIS-ELEGANS; ALPHA-SYNUCLEIN; GENE; PARKINSONISM; SUPERFAMILY; HOMEOSTASIS; EXPRESSION; MUTATIONS; TOXICITY	In previous work, we found that gain-of-function mutations that hyperactivate GEM-1 (an SLC16A transporter protein) can bypass the requirement for GON-2 (a TRPM channel protein) during the initiation of gonadogenesis in C. elegans. Consequently, we proposed that GEM-1 might function as part of a Mg2+ uptake pathway that functions in parallel to GON-2. In this study, we report that CATP-6, a C. elegans ortholog of the P5B ATPase, ATP13A2 (PARK9), is necessary for gem-1 gain-of-function mutations to suppress the effects of gon-2 inactivation. One possible explanation for this observation is that GEM-1 serves to activate CATP-6, which then functions as a Mg2+ transporter. However, we found that overexpression of GEM-1 can alleviate the requirement for CATP-6 activity, suggesting that CATP-6 probably acts as a non-essential upstream positive regulator of GEM-1. Our results are consistent with the notion that P5B ATPases govern intracellular levels of Mg2+ and/or Mn2+ by regulating the trafficking of transporters and other proteins associated with the plasma membrane.	[Lambie, Eric J.; Lebedeva, Nadja; Conradt, Barbara] Univ Munich, Dept Cell & Dev Biol, Munich, Planegg Martins, Germany; [Tieu, Pamela J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Church, Diane L.] Dartmouth Hitchcock Med Ctr, Parkinsons Ctr, Lebanon, NH 03766 USA; [Conradt, Barbara] Univ Munich, CIPS M Ctr Integrated Prot Sci, Munich, Germany	University of Munich; Dartmouth College; Dartmouth College; University of Munich	Lambie, EJ (corresponding author), Univ Munich, Dept Cell & Dev Biol, Munich, Planegg Martins, Germany.	lambie@bio.lmu.du	Conradt, Barbara/K-2665-2014; Lambie, Eric/K-5657-2014	Lambie, Eric/0000-0002-7371-128X; Conradt, Barbara/0000-0002-3731-4308	NIH [GM076651, GM069950, GM49785]; Center for Integrated Protein Science; Ludwig-Maximilians-University, Munich; Dartmouth Women in Science Project; Dartmouth Presidential Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076651, R01GM069950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrated Protein Science; Ludwig-Maximilians-University, Munich; Dartmouth Women in Science Project; Dartmouth Presidential Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants: GM076651, GM069950, GM49785. Center for Integrated Protein Science and Ludwig-Maximilians-University, Munich. Dartmouth Women in Science Project. Dartmouth Presidential Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BRENNER S, 1974, GENETICS, V77, P71; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; Chan H, 2010, J MOL MICROB BIOTECH, V19, P5, DOI 10.1159/000319588; Covy JP, 2012, J NEUROSCI RES, V90, P2306, DOI 10.1002/jnr.23112; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Habtemichael N, 2002, GENE, V283, P271, DOI 10.1016/S0378-1119(01)00881-2; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; HODGKIN J, 1989, GENETICS, V123, P301; Jakubowski J, 1999, GENETICS, V153, P743; Kemp BJ, 2009, GENETICS, V181, P581, DOI 10.1534/genetics.108.094870; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Patchornik G, 2002, BIOCHEMISTRY-US, V41, P11740, DOI 10.1021/bi026334d; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sun AY, 1997, GENETICS, V147, P1077; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Usenovic M, 2012, AUTOPHAGY, V8, P987, DOI 10.4161/auto.20256; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0	35	9	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e77202	10.1371/journal.pone.0077202	http://dx.doi.org/10.1371/journal.pone.0077202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130856	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900126
J	Wortham, BW; Eppert, BL; Flury, JL; Garcia, SM; Borchers, MT				Wortham, Brian W.; Eppert, Bryan L.; Flury, Jennifer L.; Garcia, Sara Morgado; Borchers, Michael T.			TLR and NKG2D Signaling Pathways Mediate CS-Induced Pulmonary Pathologies	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NATURAL-KILLER-CELLS; CIGARETTE-SMOKE; MOUSE MODEL; EPITHELIAL-CELLS; INNATE IMMUNE; LUNG; ACTIVATION; STIMULATION; LIGANDS	Long-term exposure to cigarette smoke (CS) can have deleterious effects on lung epithelial cells including cell death and the initiation of inflammatory responses. CS-induced cell injury can elaborate cell surface signals and cellular byproducts that stimulate immune system surveillance. Our previous work has shown that the expression of ligands for the cytotoxic lymphocyte activating receptor NKG2D is enhanced in patients with COPD and that the induction of these ligands in a mouse model can replicate COPD pathologies. Here, we extend these findings to demonstrate a role for the NKG2D receptor in CS-induced pathophysiology and provide evidence linking nucleic acid-sensing endosomal toll-like receptor (TLR) signaling to COPD pathology through NKG2D activation. Specifically, we show that mice deficient in NKG2D exhibit attenuated pulmonary inflammation and airspace enlargement in a model of CS-induced emphysema. Additionally, we show that CS exposure induces the release of free nucleic acids in the bronchoalveolar lavage and that direct exposure of mouse lung epithelial cells to cigarette smoke extract similarly induces functional nucleic acids as assessed by TLR3, 7, and 9 reporter cell lines. We demonstrate that exposure of mouse lung epithelial cells to TLR ligands stimulates the surface expression of RAET1, a ligand for NKG2D, and that mice deficient in TLR3/7/9 receptor signaling do not exhibit CS-induced NK cell hyperresponsiveness and airspace enlargement. The findings indicate that CS-induced airway injury stimulates TLR signaling by endogenous nucleic acids leading to elevated NKG2D ligand expression. Activation of these pathways plays a major role in the altered NK cell function, pulmonary inflammation and remodeling related to long-term CS exposure.	[Wortham, Brian W.; Eppert, Bryan L.; Flury, Jennifer L.; Garcia, Sara Morgado; Borchers, Michael T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Borchers, MT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45221 USA.	BORCHEMT@UCMAIL.UC.EDU			National Institutes of Health [R01 ES015036, T32 ES016646]; University of Cincinnati Center for Environmental Genetics [P30 ES006096]; Flight Attendant Medical Research Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES015036, T32ES016646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Center for Environmental Genetics; Flight Attendant Medical Research Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health research Grants R01 ES015036 (to M.T.B.), T32 ES016646 (to B.W.W.), the University of Cincinnati Center for Environmental Genetics P30 ES006096, a Flight Attendant Medical Research Institute grant (to M.T.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Eppert BL, 2013, J IMMUNOL, V190, P1331, DOI 10.4049/jimmunol.1202442; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hue S, 2003, J IMMUNOL, V171, P1909, DOI 10.4049/jimmunol.171.4.1909; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Murray LA, 2008, AM J RESP CRIT CARE, V178, P1227, DOI 10.1164/rccm.200807-1020OC; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Pauwels R, 2001, EUR RESPIR J, V18, P901, DOI 10.1183/09031936.01.0027401; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Schrambach S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000518; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Vayssier M, 1998, AM J PHYSIOL-LUNG C, V275, pL771, DOI 10.1152/ajplung.1998.275.4.L771; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104	40	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2013	8	10							e78735	10.1371/journal.pone.0078735	http://dx.doi.org/10.1371/journal.pone.0078735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236PJ	24130907	Green Published, gold, Green Submitted			2022-12-25	WOS:000325810900146
J	Seo, YJ; Pritzl, CJ; Vijayan, M; Bomb, K; McClain, ME; Alexander, S; Hahm, B				Seo, Young-Jin; Pritzl, Curtis J.; Vijayan, Madhuvanthi; Bomb, Kavita; McClain, Mariah E.; Alexander, Stephen; Hahm, Bumsuk			Sphingosine Kinase 1 Serves as a Pro-Viral Factor by Regulating Viral RNA Synthesis and Nuclear Export of Viral Ribonucleoprotein Complex upon Influenza Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; RAN-BINDING PROTEIN-3; MATRIX PROTEIN; A VIRUSES; ACTIVATION; INHIBITION; PROPAGATION; 1-PHOSPHATE; INDUCTION; TARGET	Influenza continues to pose a threat to humans by causing significant morbidity and mortality. Thus, it is imperative to investigate mechanisms by which influenza virus manipulates the function of host factors and cellular signal pathways. In this study, we demonstrate that influenza virus increases the expression and activation of sphingosine kinase (SK) 1, which in turn regulates diverse cellular signaling pathways. Inhibition of SK suppressed virus-induced NF-kappa B activation and markedly reduced the synthesis of viral RNAs and proteins. Further, SK blockade interfered with activation of Ran-binding protein 3 (RanBP3), a cofactor of chromosome region maintenance 1 (CRM1), to inhibit CRM1-mediated nuclear export of the influenza viral ribonucleoprotein complex. In support of this observation, SK inhibition altered the phosphorylation of ERK, p90RSK, and AKT, which is the upstream signal of RanBP3/CRM1 activation. Collectively, these results indicate that SK is a key pro-viral factor regulating multiple cellular signal pathways triggered by influenza virus infection.	[Seo, Young-Jin; Pritzl, Curtis J.; Vijayan, Madhuvanthi; Bomb, Kavita; McClain, Mariah E.; Hahm, Bumsuk] Univ Missouri, Dept Surg & Mol Microbiol, Columbia, MO 65211 USA; [Seo, Young-Jin; Pritzl, Curtis J.; Vijayan, Madhuvanthi; Bomb, Kavita; McClain, Mariah E.; Hahm, Bumsuk] Univ Missouri, Dept Immunol, Columbia, MO USA; [Alexander, Stephen] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Hahm, B (corresponding author), Univ Missouri, Dept Surg & Mol Microbiol, Columbia, MO 65211 USA.	hahmb@health.missouri.edu	Vijayan, Madhuvanthi/U-3524-2019		NIH/NIAID [R01AI091797, R21AI088363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091797, R21AI088363] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grants R01AI091797 and R21AI088363 (B.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P497; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Carr JM, 2013, REV MED VIROL, V23, P73, DOI 10.1002/rmv.1718; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Eierhoff T, 2009, BIOL CHEM, V390, P509, DOI 10.1515/BC.2009.053; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; French KJ, 2003, CANCER RES, V63, P5962; Gandy KAO, 2013, BBA-MOL CELL BIOL L, V1831, P157, DOI 10.1016/j.bbalip.2012.07.002; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gault CR, 2011, CRIT REV BIOCHEM MOL, V46, P342, DOI 10.3109/10409238.2011.597737; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Machesky NJ, 2008, J BIOL CHEM, V283, P26148, DOI 10.1074/jbc.M710181200; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pchejetski D, 2011, IMMUNOL CELL BIOL, V89, P268, DOI 10.1038/icb.2010.91; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pleschka Stephan, 2009, P109, DOI 10.1142/9789812833808_0005; Predicala R, 2013, J GEN VIROL; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697; Seo YJ, 2011, CYTOKINE GROWTH F R, V22, P55, DOI 10.1016/j.cytogfr.2010.12.001; Seo YJ, 2010, ADV APPL MICROBIOL, V73, P83, DOI 10.1016/S0065-2164(10)73004-5; Seo YJ, 2010, J VIROL, V84, P8124, DOI 10.1128/JVI.00510-10; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Voisset C, 2008, CELL MICROBIOL, V10, P606, DOI 10.1111/j.1462-5822.2007.01070.x; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Watanabe K, 2001, VIRUS RES, V77, P31, DOI 10.1016/S0168-1702(01)00263-5; Watanabe K, 2008, DRUG DISCOV THER, V2, P77; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yamane D, 2009, J BIOL CHEM, V284, P13648, DOI 10.1074/jbc.M807498200; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024	70	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e75005	10.1371/journal.pone.0075005	http://dx.doi.org/10.1371/journal.pone.0075005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24137500	gold, Green Published, Green Submitted			2022-12-25	WOS:000323880200104
J	Cao, HL; Auguet, JC; Gu, JD				Cao, Huiluo; Auguet, Jean-Christophe; Gu, Ji-Dong			Global Ecological Pattern of Ammonia-Oxidizing Archaea	PLOS ONE			English	Article							AUSTRIAN CENTRAL ALPS; NITROSOPUMILUS-MARITIMUS; COMMUNITY STRUCTURE; RELATIVE ABUNDANCE; HOT-SPRINGS; AMOA GENES; SOIL-PH; DIVERSITY; BACTERIA; CRENARCHAEOTA	Background: The global distribution of ammonia-oxidizing archaea (AOA), which play a pivotal role in the nitrification process, has been confirmed through numerous ecological studies. Though newly available amoA (ammonia monooxygenase subunit A) gene sequences from new environments are accumulating rapidly in public repositories, a lack of information on the ecological and evolutionary factors shaping community assembly of AOA on the global scale is apparent. Methodology and Results: We conducted a meta-analysis on uncultured AOA using over ca. 6,200 archaeal amoA gene sequences, so as to reveal their community distribution patterns along a wide spectrum of physicochemical conditions and habitat types. The sequences were dereplicated at 95% identity level resulting in a dataset containing 1,476 archaeal amoA gene sequences from eight habitat types: namely soil, freshwater, freshwater sediment, estuarine sediment, marine water, marine sediment, geothermal system, and symbiosis. The updated comprehensive amoA phylogeny was composed of three major monophyletic clusters (i.e. Nitrosopumilus, Nitrosotalea, Nitrosocaldus) and a non-monophyletic cluster constituted mostly by soil and sediment sequences that we named Nitrososphaera. Diversity measurements indicated that marine and estuarine sediments as well as symbionts might be the largest reservoirs of AOA diversity. Phylogenetic analyses were further carried out using macroevolutionary analyses to explore the diversification pattern and rates of nitrifying archaea. In contrast to other habitats that displayed constant diversification rates, marine planktonic AOA interestingly exhibit a very recent and accelerating diversification rate congruent with the lowest phylogenetic diversity observed in their habitats. This result suggested the existence of AOA communities with different evolutionary history in the different habitats. Conclusion and Significance: Based on an up-to-date amoA phylogeny, this analysis provided insights into the possible evolutionary mechanisms and environmental parameters that shape AOA community assembly at global scale.	[Cao, Huiluo; Gu, Ji-Dong] Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China; [Auguet, Jean-Christophe] Univ Pau & Pays Adour, UMR CNRS IPREM 5254, Equipe Environm Microbiol, Pau, France; [Gu, Ji-Dong] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Universite de Pau et des Pays de l'Adour; University of Hong Kong	Gu, JD (corresponding author), Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China.	jdgu@hkucc.hku.hk	Auguet, Jean-Christophe/H-5697-2015; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Cao, Heping/AAC-1666-2021	Auguet, Jean-Christophe/0000-0003-4340-7161; Klasson, K. Thomas/0000-0003-3358-3081; Cao, Heping/0000-0002-0958-1468; Scheffler, Brian/0000-0003-1968-8952; Shockey, Jay/0000-0002-5057-5457	University of Hong Kong	University of Hong Kong(University of Hong Kong)	PhD studentship (HC) from The University of Hong Kong supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bernhard AE, 2010, APPL ENVIRON MICROB, V76, P1285, DOI 10.1128/AEM.02018-09; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Cao HL, 2011, METHOD ENZYMOL, V496, P35, DOI 10.1016/B978-0-12-386489-5.00002-6; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Enwall K, 2005, APPL ENVIRON MICROB, V71, P8335, DOI 10.1128/AEM.71.12.8335-8343.2005; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernandez-Guerra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047330; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Junier P, 2010, APPL MICROBIOL BIOT, V85, P425, DOI 10.1007/s00253-009-2228-9; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kim JG, 2012, ENV MICROBIOL; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu ZH, 2011, MICROBIOL RES, V166, P337, DOI 10.1016/j.micres.2010.08.002; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin AP, 2004, EVOLUTION, V58, P946; Molina V, 2010, ENVIRON MICROBIOL, V12, P2450, DOI 10.1111/j.1462-2920.2010.02218.x; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rogers DR, 2010, APPL ENVIRON MICROB, V76, P7938, DOI 10.1128/AEM.02056-09; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027597; Weidler GW, 2008, APPL ENVIRON MICROB, V74, P5934, DOI 10.1128/AEM.02602-07; Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06; Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08	69	184	195	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52853	10.1371/journal.pone.0052853	http://dx.doi.org/10.1371/journal.pone.0052853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24146944	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900006
J	Chapman, R; Stutz, H; Jacobs, W; Shephard, E; Williamson, AL				Chapman, Rosamund; Stutz, Helen; Jacobs, William, Jr.; Shephard, Enid; Williamson, Anna-Lise			Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; TYPE-1 SUBTYPE-C; IMMUNODEFICIENCY-VIRUS TYPE-1; BACILLUS-CALMETTE-GUERIN; DNA VACCINE; LISTERIA-MONOCYTOGENES; ELITE CONTROLLERS; IMMUNE-RESPONSES; TUBERCULOSIS; INFECTION	In previous studies we have shown that a pantothenate auxotroph of Myocbacterium bovis BCG (BCG Delta panCD) expressing HIV-1 subtype C Gag induced Gag-specific immune responses in mice and Chacma baboons after prime-boost immunization in combination with matched rMVA and VLP vaccines respectively. In this study recombinant BCG (rBCG) expressing HIV-1 subtype C reverse transcriptase and a truncated envelope were constructed using both the wild type BCG Pasteur strain as a vector and the pantothenate auxotroph. Mice were primed with rBCG expressing Gag and RT and boosted with a recombinant MVA, expressing a polyprotein of Gag, RT, Tat and Nef (SAAVI MVA-C). Priming with rBCG Delta panCD expressing Gag or RT rather than the wild type rBCG expressing Gag or RT resulted in higher frequencies of total HIV-specific CD8(+) T cells and increased numbers of T cells specific to the subdominant Gag and RT epitopes. Increasing the dose of rBCG from 10(5) cfu to 10(7) cfu also led to an increase in the frequency of responses to subdominant HIV epitopes. A mix of the individual rBCG Delta panCD vaccines expressing either Gag, RT or the truncated Env primed the immune system for a boost with SAAVI MVA-C and generated five-fold higher numbers of HIV-specific IFN-gamma-spot forming cells than mice primed with rBCG Delta panCD containing an empty vector control. Priming with the individual rBCG Delta panCD vaccines or the mix and boosting with SAAVI MVA-C also resulted in the generation of HIV-specific CD4(+) and CD8(+) T cells producing IFN-gamma and TNF-alpha and CD4(+) cells producing IL-2. The rBCG vaccines tested in this study were able to prime the immune system for a boost with rMVA expressing matching antigens, inducing robust, HIV-specific T cell responses to both dominant and subdominant epitopes in the individual proteins when used as individual vaccines or in a mix.	[Chapman, Rosamund; Stutz, Helen; Shephard, Enid; Williamson, Anna-Lise] Albert Einstein Coll Med, Inst Infect Dis & Mol Med, Bronx, NY 10467 USA; [Chapman, Rosamund; Stutz, Helen; Williamson, Anna-Lise] Albert Einstein Coll Med, Dept Clin Lab Sci, Div Med Virol, Bronx, NY 10467 USA; [Jacobs, William, Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Shephard, Enid] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Shephard, Enid] MRC, Cape Town, South Africa; [Williamson, Anna-Lise] Natl Hlth Lab Serv, Cape Town, South Africa	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Cape Town	Chapman, R (corresponding author), Albert Einstein Coll Med, Inst Infect Dis & Mol Med, Bronx, NY 10467 USA.	Ros.Chapman@uct.ac.za	Chapman, Rosamund/AAJ-6490-2020	Chapman, Rosamund/0000-0001-9162-2099; Waller, Karen/0000-0002-0530-3292; Williamson, Anna-Lise/0000-0002-5467-1200	South African AIDS Vaccine Initiative (SAAVI) [PIA R21/R33, 5R33AI73182-4]; National Institutes of Health (NIH USA) [PIA R21/R33, 5R33AI73182-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI073182, R01AI026170, R37AI026170] Funding Source: NIH RePORTER	South African AIDS Vaccine Initiative (SAAVI); National Institutes of Health (NIH USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the South African AIDS Vaccine Initiative (SAAVI) and National Institutes of Health (NIH USA) for funding from the Phased Innovation Awards (PIA R21/R33) in AIDS Vaccine Research; grant number 5R33AI73182-4. This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami Y, 2006, J VIROL, V80, P10288, DOI 10.1128/JVI.01681-06; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Chapman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032769; Chege GK, 2013, J VIROL, V87, P5151, DOI 10.1128/JVI.03178-12; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Mata M, 1998, J IMMUNOL, V161, P2985; Mata M, 1999, J IMMUNOL, V163, P1449; Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x; Mederle I, 2003, VACCINE, V21, P4153, DOI 10.1016/S0264-410X(03)00537-1; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Russell MS, 2009, J IMMUNOL, V183, P7710, DOI 10.4049/jimmunol.0901274; Sad S, 2008, J IMMUNOL, V180, P5853, DOI 10.4049/jimmunol.180.9.5853; Shephard E, 2008, AIDS RES HUM RETROV, V24, P207, DOI 10.1089/aid.2007.0206; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Harmelen JH, 2003, VACCINE, V21, P4380, DOI 10.1016/S0264-410X(03)00406-7; Williamson AL, 2012, SAMJ S AFR MED J, V102, P452, DOI 10.7196/SAMJ.5668; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000	38	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71601	10.1371/journal.pone.0071601	http://dx.doi.org/10.1371/journal.pone.0071601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977084	gold, Green Submitted, Green Published			2022-12-25	WOS:000324527300024
J	Cao, HP; Shockey, JM; Klasson, KT; Chapital, DC; Mason, CB; Scheffler, BE				Cao, Heping; Shockey, Jay M.; Klasson, K. Thomas; Chapital, Dorselyn C.; Mason, Catherine B.; Scheffler, Brian E.			Developmental Regulation of Diacylglycerol Acyltransferase Family Gene Expression in Tung Tree Tissues	PLOS ONE			English	Article							TRIACYLGLYCEROL BIOSYNTHESIS; TRIGLYCERIDE SYNTHESIS; ARABIDOPSIS-THALIANA; QUANTITATIVE PCR; SKELETAL-MUSCLE; MESSENGER-RNA; CLUSTAL-W; RT-PCR; OIL; CLONING	Diacylglycerol acyltransferases (DGAT) catalyze the final and rate-limiting step of triacylglycerol (TAG) biosynthesis in eukaryotic organisms. DGAT genes have been identified in numerous organisms. Multiple isoforms of DGAT are present in eukaryotes. We previously cloned DGAT1 and DGAT2 genes of tung tree (Vernicia fordii), whose novel seed TAGs are useful in a wide range of industrial applications. The objective of this study was to understand the developmental regulation of DGAT family gene expression in tung tree. To this end, we first cloned a tung tree gene encoding DGAT3, a putatively soluble form of DGAT that possesses 11 completely conserved amino acid residues shared among 27 DGAT3s from 19 plant species. Unlike DGAT1 and DGAT2 subfamilies, DGAT3 is absent from animals. We then used TaqMan and SYBR Green quantitative real-time PCR, along with northern and western blotting, to study the expression patterns of the three DGAT genes in tung tree tissues. Expression results demonstrate that 1) all three isoforms of DGAT genes are expressed in developing seeds, leaves and flowers; 2) DGAT2 is the major DGAT mRNA in tung seeds, whose expression profile is well-coordinated with the oil profile in developing tung seeds; and 3) DGAT3 is the major form of DGAT mRNA in tung leaves, flowers and immature seeds prior to active tung oil biosynthesis. These results suggest that DGAT2 is probably the major TAG biosynthetic isoform in tung seeds and that DGAT3 gene likely plays a significant role in TAG metabolism in other tissues. Therefore, DGAT2 should be a primary target for tung oil engineering in transgenic organisms.	[Cao, Heping; Shockey, Jay M.; Klasson, K. Thomas; Chapital, Dorselyn C.; Mason, Catherine B.] ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA; [Scheffler, Brian E.] ARS, USDA, Genom & Bioinformat Res Unit, Stoneville, MS USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA.	Heping.Cao@ars.usda.gov	Auguet, Jean-Christophe/H-5697-2015; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Cao, Heping/AAC-1666-2021	Auguet, Jean-Christophe/0000-0003-4340-7161; Klasson, K. Thomas/0000-0003-3358-3081; Cao, Heping/0000-0002-0958-1468; Scheffler, Brian/0000-0003-1968-8952; Shockey, Jay/0000-0002-5057-5457	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS [6435-41000-106-00D]	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS	This work was supported by the USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-106-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CE, 1929, J AGRIC RES, V38, P0679; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Aranguren MI, 2012, POLYM TEST, V31, P7, DOI 10.1016/j.polymertesting.2011.09.001; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Cao HP, 2013, IND CROP PROD, V50, P248, DOI 10.1016/j.indcrop.2013.07.030; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2004, DIABETES, V53, P1445, DOI 10.2337/diabetes.53.6.1445; Chen YH, 2012, RENEW ENERG, V44, P305, DOI 10.1016/j.renene.2012.01.098; Chen YH, 2010, BIORESOURCE TECHNOL, V101, P9521, DOI 10.1016/j.biortech.2010.06.117; Chen YC, 2010, IND CROP PROD, V32, P684, DOI 10.1016/j.indcrop.2010.06.009; Manh DV, 2012, ENERGY, V48, P519, DOI 10.1016/j.energy.2012.09.065; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; ICHIHARA K, 1988, BIOCHIM BIOPHYS ACTA, V958, P125, DOI 10.1016/0005-2760(88)90253-6; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kamisaka Y, 2007, BIOCHEM J, V408, P61, DOI 10.1042/BJ20070449; Kamisaka Y, 2010, APPL MICROBIOL BIOT, V88, P105, DOI 10.1007/s00253-010-2725-x; KOPACZ BM, 1968, J AM OIL CHEM SOC, V45, P285, DOI 10.1007/BF02652428; Kwiatkowska M, 2012, FOLIA HISTOCHEM CYTO, V50, P427, DOI [10.5603/19752, 10.5603/FHC.2012.0058]; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin JT, 1998, LIPIDS, V33, P59, DOI 10.1007/s11745-998-0180-3; Liu CG, 2013, IND CROP PROD, V43, P677, DOI 10.1016/j.indcrop.2012.07.072; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park JY, 2008, APPL BIOCHEM BIOTECH, V148, P109, DOI 10.1007/s12010-007-8082-2; Pastor S, 2013, PLANT SCI, V203, P79, DOI 10.1016/j.plantsci.2012.12.009; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Peng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061363; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTER GF, 1968, J AM OIL CHEM SOC, V45, P281, DOI 10.1007/BF02652427; PRYDE EH, 1979, J AM OIL CHEM SOC, V56, pA719, DOI 10.1007/BF02667427; Rani SH, 2013, MICROBIOL-SGM, V159, P155, DOI 10.1099/mic.0.063156-0; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samadzadeh M, 2011, PROG ORG COAT, V70, P383, DOI 10.1016/j.porgcoat.2010.08.017; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; Schneider UV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038451; Shang Q, 2012, APPL BIOCHEM BIOTECH, V168, P106, DOI 10.1007/s12010-011-9364-2; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2005, PLANT SCI, V169, P375, DOI 10.1016/j.plantsci.2005.03.023; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tang F, 1998, PLANT PHYSIOL, V117, P717; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	88	184	195	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76946	10.1371/journal.pone.0076946	http://dx.doi.org/10.1371/journal.pone.0076946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146944	Green Submitted, gold, Green Published			2022-12-25	WOS:000325819400090
J	Wang, FM; Xu, X; Zou, B; Guo, ZH; Li, ZA; Zhu, WX				Wang, Faming; Xu, Xin; Zou, Bi; Guo, Zhihua; Li, Zhian; Zhu, Weixing			Biomass Accumulation and Carbon Sequestration in Four Different Aged Casuarina equisetifolia Coastal Shelterbelt Plantations in South China	PLOS ONE			English	Article							FINE-ROOT BIOMASS; SOIL CARBON; SECONDARY FORESTS; STAND DEVELOPMENT; DRY TROPICS; NITROGEN; DYNAMICS; CHRONOSEQUENCE; EUCALYPTUS; FIXATION	Thousands of kilometers of shelterbelt plantations of Casuarina equisetifolia have been planted to protect the southeast coastline of China. These plantations also play an important role in the regional carbon (C) cycling. In this study, we examined plant biomass increment and C accumulation in four different aged C. equisetifolia plantations in sandy beaches in South China. The C accumulated in the C. equisetifolia plant biomass increased markedly with stand age. The annual rate of C accumulation in the C. equisetifolia plant biomass during 0-3, 3-6, 6-13 and 13-18 years stage was 2.9, 8.2, 4.2 and 1.0 Mg C ha(-1) yr(-1), respectively. Soil organic C (SOC) at the top 1 m soil layer in these plantations was 17.74, 5.14, 6.93, and 11.87 Mg C ha(-1), respectively, with SOC density decreasing with increasing soil depth. Total C storage in the plantation ecosystem averaged 26.57, 38.50, 69.78, and 79.79 Mg C ha(-1) in the 3, 6, 13 and 18-yrs plantation, with most of the C accumulated in the aboveground biomass rather than in the belowground root biomass and soil organic C. Though our results suggest that C. equisetifolia plantations have the characteristics of fast growth, high biomass accumulation, and the potential of high C sequestration despite planting in poor soil conditions, the interactive effects of soil condition, natural disturbance, and human policies on the ecosystem health of the plantation need to be further studied to fully realize the ecological and social benefits of the C equisetifolia shelterbelt forests in South China.	[Wang, Faming; Xu, Xin; Zou, Bi; Li, Zhian; Zhu, Weixing] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Guo, Zhihua] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Zhu, Weixing] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Forestry; Institute of Wetland Research, CAF; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Li, ZA (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lizan@scbg.ac.cn; wxzhu@binghamton.edu	Wang, Faming/J-9342-2014	Wang, Faming/0000-0002-7543-6779; Zhu, Weixing/0000-0002-4274-6973	National Basic Research Program of China [2011CB403200]; NSFC [U1131001]; Natural Science Foundation of China [31300419]; Chinese Academy of Sciences [KSCX2-EW-J-28, XDA05070307]; National Science and Technology Pillar program [2009BAD2B0604]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Pillar program	This work was funded by National Basic Research Program of China (2011CB403200), NSFC-Guangdong Joint Project (U1131001), Natural Science Foundation of China (31300419), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-28), the "Strategic Priority Research Program - Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (XDA05070307) and the key projects in the National Science and Technology Pillar program (2009BAD2B0604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Borja I, 2008, TREE PHYSIOL, V28, P773, DOI 10.1093/treephys/28.5.773; Campo J, 2001, BIOGEOCHEMISTRY, V53, P161, DOI 10.1023/A:1010663516029; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; Clements F.E., 1916, PLANT SUCCESSION ANA; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; El-Lankany M, 1990, ADV CASUARINA RES UT; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; GAUTHIER D, 1985, SOIL BIOL BIOCHEM, V17, P375, DOI 10.1016/0038-0717(85)90076-8; Goulden ML, 2011, GLOBAL CHANGE BIOL, V17, P855, DOI 10.1111/j.1365-2486.2010.02274.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hardman CJ, 2012, ORYX, V46, P204, DOI 10.1017/S0030605311000251; Harmand JM, 2004, FOREST ECOL MANAG, V188, P249, DOI 10.1016/j.foreco.2003.07.026; HARRISON AF, 1995, FORESTRY, V68, P335, DOI 10.1093/forestry/68.4.335; Hong YuanCheng, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P66; Hughes RF, 1999, ECOLOGY, V80, P1892; Johnston MH, 1996, FOREST ECOL MANAG, V83, P17, DOI 10.1016/0378-1127(96)03704-8; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Usuga JCL, 2010, FOREST ECOL MANAG, V260, P1906, DOI 10.1016/j.foreco.2010.08.040; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Mascarenhas A, 2008, J ENVIRON MANAGE, V89, P24, DOI 10.1016/j.jenvman.2007.01.053; Mather A, 2003, LAND USE POLICY, V20, P195, DOI 10.1016/S0264-8377(03)00003-6; Miao S.Y., 1998, GUIHAIA, V18, P16; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Muthukumar T, 2010, NEW FOREST, V40, P101, DOI 10.1007/s11056-009-9186-z; Parrotta JA, 1996, CAN J FOREST RES, V26, P1684, DOI 10.1139/x26-190; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Rokityanskiy D, 2007, TECHNOL FORECAST SOC, V74, P1057, DOI 10.1016/j.techfore.2006.05.022; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; Schedlbauer JL, 2008, FOREST ECOL MANAG, V255, P1326, DOI 10.1016/j.foreco.2007.10.039; Schlamadinger B, 1996, BIOMASS BIOENERG, V10, P275, DOI 10.1016/0961-9534(95)00113-1; Srivastava AK, 1995, BIOMASS BIOENERG, V9, P465, DOI 10.1016/0961-9534(95)00048-8; State Forestry Administration (SFA), 2009, CHIN FOR STAT YB 200; TROUVE C, 1994, SOIL BIOL BIOCHEM, V26, P287, DOI 10.1016/0038-0717(94)90169-4; WILDE SERGIUS A., 1964, SOIL SCI, V97, P276, DOI 10.1097/00010694-196404000-00009; WILLIAMSLINERA G, 1983, BIOTROPICA, V15, P275, DOI 10.2307/2387652; [杨昆 YANG Kun], 2006, [生态环境, Ecology and Environment], V15, P84; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; Zhang H.L., 1996, CHINESE ECOSYSTEM RE, P1; Zhong C., 2003, CHINA FOREST SCI TEC, V17, P3, DOI DOI 10.3969/J.ISSN.1000-8101.2003.02.001; Zhong CL, 2010, SYMBIOSIS, V50, P107, DOI 10.1007/s13199-009-0039-5; Zoysa M. de, 2008, Small-scale Forestry, V7, P17, DOI 10.1007/s11842-008-9038-2	46	18	20	8	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77449	10.1371/journal.pone.0077449	http://dx.doi.org/10.1371/journal.pone.0077449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143236	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100073
J	Shi, JR; Jiang, BB; Qiu, YL; Guan, J; Jain, M; Cao, X; Bauer, M; Su, LH; Burkly, LC; Leone, TC; Kelly, DP; Liao, RL				Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Su, Lihe; Burkly, Linda C.; Leone, Teresa C.; Kelly, Daniel P.; Liao, Ronglih			PGC1 alpha Plays a Critical Role in TWEAK-Induced Cardiac Dysfunction	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MULTIFUNCTIONAL CYTOKINE; PGC-1 COACTIVATORS; WEAK INDUCER; RECEPTOR; PGC-1-ALPHA; METABOLISM; APOPTOSIS; BINDS; FN14	Background: Inflammatory cytokines play an important role in the pathogenesis of heart failure. We have recently found the cytokine TWEAK (tumor necrosis factor (TNF)-like weak inducer of apoptosis), a member of the TNF superfamily, to be increased in patients with cardiomyopathy and result in the development of heart failure when overexpressed in mice. The molecular mechanisms underlying TWEAK-induced cardiac pathology, however, remain unknown. Methodology and Critical Finding: Using mouse models of elevated circulating TWEAK levels, established through intravenous injection of adenovirus expressing TWEAK or recombinant TWEAK protein, we find that TWEAK induces a progressive dilated cardiomyopathy with impaired contractile function in mice. Moreover, TWEAK treatment is associated with decreased expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1 alpha) and genes required for mitochondrial oxidative phosphorylation, which precede the onset of cardiac dysfunction. TWEAK-induced downregulation of PGC1 alpha requires expression of its cell surface receptor, fibroblast growth factor-inducible 14 (Fn14). We further find that TWEAK downregulates PGC1 alpha gene expression via the TNF receptor-associated factor 2 (TRAF2) and NFkB signaling pathways. Maintaining PGC1 alpha levels through adenoviral-mediated gene expression is sufficient to protect against TWEAK-induced cardiomyocyte dysfunction. Conclusion: Collectively, our data suggest that TWEAK induces cardiac dysfunction via downregulation of PGC1 alpha, through FN14-TRAF2-NF kappa B-dependent signaling. Selective targeting of the FN14-TRAF2-NF kappa B-dependent signaling pathway or augmenting PGC1 alpha levels may serve as novel therapeutic strategies for cardiomyopathy and heart failure.	[Shi, Jianru; Jiang, Bingbing; Qiu, Yiling; Guan, Jian; Jain, Mohit; Cao, Xin; Bauer, Michael; Liao, Ronglih] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA; [Su, Lihe] Biogen Idec Inc, Dept Prot Biochem, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Immunol, Cambridge, MA USA; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orlando, FL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Biogen; Biogen; Sanford Burnham Prebys Medical Discovery Institute	Liao, RL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Cardiac Muscle Res Lab, Boston, MA 02115 USA.	rliao@rics.bwh.harvard.edu	Qiu, Yiling/C-7138-2013; Kelly, Daniel/ABG-2056-2021	Liao, Ronglih/0000-0002-9598-9020; Bai, Chunxue/0000-0001-5798-3130	National Institute of Health [HL099073, HL086967, HL093147, R01HL058493, R01HL101189, R01DK045416, K08 HL107451]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101189, R01HL058493, R01HL086967, K08HL107451, R01HL099073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institute of Health research grants HL099073 HL086967 and HL093147 (R.L.), R01HL058493, R01HL101189, and R01DK045416 (D.P.K.) grants. M.J. is the recipient of NIH mentored award (K08 HL107451). J.S. and M.B. were supported by a postdoctoral fellowship from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kumar A, 2012, CURR OPIN CLIN NUTR, V15, P233, DOI 10.1097/MCO.0b013e328351c3fc; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liao Ronglih, 2007, V139, P251; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schilling J, 2011, J MOL CELL CARDIOL, V51, P578, DOI 10.1016/j.yjmcc.2010.09.021; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Weinberg JM, 2011, KIDNEY INT, V79, P151, DOI 10.1038/ki.2010.435; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yepes M, 2006, DRUG NEWS PERSPECT, V19, P589, DOI 10.1358/dnp.2006.19.10.1068005	35	43	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54054	10.1371/journal.pone.0054054	http://dx.doi.org/10.1371/journal.pone.0054054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342071	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700080
J	Luo, JD; Lu, ZH; Lu, XJ; Chen, L; Cao, JP; Zhang, SY; Ling, Y; Zhou, XF				Luo, Judong; Lu, Zhonghua; Lu, Xujing; Chen, Ling; Cao, Jianping; Zhang, Shuyu; Ling, Yang; Zhou, Xifa			OTUD5 Regulates p53 Stability by Deubiquitinating p53	PLOS ONE			English	Article							HAUSP; MDM2; PATHWAY; DESTABILIZATION; STRESS; P300	Background: The p53 tumour suppressor protein is a transcription factor that prevents oncogenic progression by activating the expression of apoptosis and cell-cycle arrest genes in stressed cells. The stability of p53 is tightly regulated by ubiquitin-dependent degradation, driven mainly by its negative regulators ubiquitin ligase MDM2. Principal Findings: In this study, we have identified OTUD5 as a DUB that interacts with and deubiquitinates p53. OTUD5 forms a direct complex with p53 and controls level of ubiquitination. The function of OTUD5 is required to allow the rapid activation of p53-dependent transcription and a p53-dependent apoptosis in response to DNA damage stress. Conclusions: As a novel deubiquitinating enzyme for p53, OTUD5 is required for the stabilization and the activation of a p53 response.	[Luo, Judong; Lu, Zhonghua; Lu, Xujing; Chen, Ling; Ling, Yang; Zhou, Xifa] Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China; [Luo, Judong; Cao, Jianping; Zhang, Shuyu] Soochow Univ, Sch Radiat Med & Protect, Suzhou, Peoples R China; [Luo, Judong; Cao, Jianping; Zhang, Shuyu] Soochow Univ, Jiangsu Prov Key Lab Radiat Med & Protect, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Ling, Y (corresponding author), Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China.	medilyn2001@yahoo.com.cn; 756035311@qq.com			National Natural Science Foundation of China [81102078, 81172597]; Natural Science Foundation of Jiangsu Province [BK2009102]; Innovative Project of Jiangsu Province [BL2012046]; Changzhou Social Development [CE20125026]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Innovative Project of Jiangsu Province; Changzhou Social Development; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is supported by the National Natural Science Foundation of China (81102078 and 81172597), Natural Science Foundation of Jiangsu Province (BK2009102), Innovative Project of Jiangsu Province (BL2012046), Changzhou Social Development (CE20125026) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; COX RF, 1984, AM J HOSP PHARM, V41, P2410, DOI 10.1093/ajhp/41.11.2410; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miao L, 2010, ONCOGENE, V29, P711, DOI 10.1038/onc.2009.372; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	27	65	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77682	10.1371/journal.pone.0077682	http://dx.doi.org/10.1371/journal.pone.0077682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143256	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100095
J	Maire, V; Baldeyron, C; Richardson, M; Tesson, B; Vincent-Salomon, A; Gravier, E; Marty-Prouvost, B; De Koning, L; Rigaill, G; Dumont, A; Gentien, D; Barillot, E; Roman-Roman, S; Depil, S; Cruzalegui, F; Pierre, A; Tucker, GC; Dubois, T				Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.; Dubois, Thierry			TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer	PLOS ONE			English	Article							P53-DEPENDENT POSTMITOTIC CHECKPOINT; SPINDLE-ASSEMBLY CHECKPOINT; GENE-EXPRESSION PATTERNS; BASAL-LIKE CARCINOMAS; MOLECULAR PORTRAITS; MITOTIC CHECKPOINT; KINASE INHIBITORS; DNA-DAMAGE; MPS1; CELLS	Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death. A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level. The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues. We confirmed by immunohistochemistry and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups. We then determined the biological effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines. We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner. Moreover, we observed that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy. Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis. These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis associated subgroup of breast cancer.	[Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Dubois, Thierry] Inst Curie, Res Ctr, Paris, France; [Maire, Virginie; Baldeyron, Celine; Tesson, Bruno; Marty-Prouvost, Berengere; Rigaill, Guillem; Dumont, Aurelie; Roman-Roman, Sergio; Dubois, Thierry] Dept Translat Res, Breast Canc Biol Grp, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] INSERM, U900, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [De Koning, Leanne] RPPA Platform, Dept Translat Res, Paris, France; [Rigaill, Guillem] AgroParisTech, INRA, UMR 518, MIA, Paris, France; [Gentien, David] Dept Translat Res, Platform Mol Biol Facil, Paris, France; [Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.] Inst Rech SERVIER, Oncol Res & Dev Unit, Croissy Sur Seine, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier	Dubois, T (corresponding author), Inst Curie, Res Ctr, Paris, France.	thierry.dubois@curie.fr	Gentien, David/O-9356-2019; Roman-Roman, Sergio/K-9993-2014; Baldeyron, Céline/F-6990-2019; Gentien, David/L-7757-2017; Soussana, Jean-Francois/P-2094-2016; Gross, Nicolas/I-2368-2016; Dubois, Thierry/D-2852-2017; Wright, Ian/G-4979-2012	Roman-Roman, Sergio/0000-0001-6459-2613; Baldeyron, Céline/0000-0003-2311-1523; Gentien, David/0000-0001-8317-5188; Soussana, Jean-Francois/0000-0002-1932-6583; Gross, Nicolas/0000-0001-9730-3240; Dubois, Thierry/0000-0003-4739-6164; Wright, Ian/0000-0001-8338-9143; Rigaill, Guillem/0000-0002-7176-7511; Maire, Vincent/0000-0002-3245-2568; BARILLOT, Emmanuel/0000-0003-2724-2002; Martin, Raphael/0000-0001-8778-7915	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa); Canceropole Ile de France	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France)	This work was supported by Institut de Recherches Servier and Institut Curie. GR is supported by a grant of Institut National du Cancer (INCa) and LDK by a grant from Canceropole Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Azoulay S, 2005, MODERN PATHOL, V18, P1623, DOI 10.1038/modpathol.3800483; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Fadare O, 2008, NAT CLIN PRACT ONCOL, V5, P149, DOI 10.1038/ncponc1038; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kilpinen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015068; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; RIGAILL G, 2010, ARXIV10040887V1, P40887; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Thykjaer T, 2001, CANCER RES, V61, P2492; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; VALENTIN MD, 2012, BREAST CANC RES TREA; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zafrani B, 2000, HISTOPATHOLOGY, V37, P536, DOI 10.1046/j.1365-2559.2000.01006.x	71	118	120	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63712	10.1371/journal.pone.0063712	http://dx.doi.org/10.1371/journal.pone.0063712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	24130879	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400027
J	Zhang, DY; Ali, Z; Wang, CB; Xu, L; Yi, JX; Xu, ZL; Liu, XQ; He, XL; Huang, YH; Khan, IA; Trethowan, RM; Ma, HX				Zhang, Da Yong; Ali, Zulfiqar; Wang, Chang Biao; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Khan, Iqrar Ahmad; Trethowan, Richard M.; Ma, Hong Xiang			Genome-Wide Sequence Characterization and Expression Analysis of Major Intrinsic Proteins in Soybean (Glycine max L.)	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; PLANT AQUAPORINS; PLASMA-MEMBRANE; WATER TRANSPORT; GENE FAMILY; ARABIDOPSIS; IDENTIFICATION; CHANNELS; NODULIN; SELECTIVITY	Water is essential for all living organisms. Aquaporin proteins are the major facilitator of water transport activity through cell membranes of plants including soybean. These proteins are diverse in plants and belong to a large major intrinsic (MIP) protein family. In higher plants, MIPs are classified into five subfamilies including plasma membrane intrinsic proteins (PIP), tonoplast intrinsic proteins (TIP), NOD26-like intrinsic proteins (NIP), small basic intrinsic proteins (SIP), and the recently discovered X intrinsic proteins (XIP). This paper reports genome wide assembly of soybean MIPs, their functional prediction and expression analysis. Using a bioinformatic homology search, 66 GmMIPs were identified in the soybean genome. Phylogenetic analysis of amino acid sequences of GmMIPs divided the large and highly similar multi-gene family into 5 subfamilies: GmPIPs, GmTIPs, GmNIPs, GmSIPs and GmXIPs. GmPIPs consisted of 22 genes and GmTIPs 23, which showed high sequence similarity within subfamilies. GmNIPs contained 13 and GmSIPs 6 members which were diverse. In addition, we also identified a two member GmXIP, a distinct 5th subfamily. GmMIPs were further classified into twelve subgroups based on substrate selectivity filter analysis. Expression analyses were performed for a selected set of GmMIPs using semi-quantitative reverse transcription (semi-RT-qPCR) and qPCR. Our results suggested that many GmMIPs have high sequence similarity but diverse roles as evidenced by analysis of sequences and their expression. It can be speculated that GmMIPs contains true aquaporins, glyceroporins, aquaglyceroporins and mixed transport facilitators.	[Zhang, Da Yong; Ali, Zulfiqar; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Ma, Hong Xiang] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Ali, Zulfiqar] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Wang, Chang Biao] Shanxi Agr Sci, Cotton Res Inst, Yuncheng, Peoples R China; [Xu, Zhao Long] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China; [Khan, Iqrar Ahmad] Univ Agr Faisalabad, Coll Agr & Appl Biol, Faisalabad, Pakistan; [Trethowan, Richard M.] Univ Sydney, Plant Breeding Inst, Sydney, NSW 2006, Australia	Jiangsu Academy of Agricultural Sciences; University of Agriculture Faisalabad; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; University of Agriculture Faisalabad; University of Sydney	Ali, Z (corresponding author), Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China.	zulfiqarpbg@hotmail.com; hxma@jaas.ac.cn	Ali, Zulfiqar/AAF-2663-2019; Wang, Changbiao/S-8473-2019; Ali, Zulfiqar/AAF-4171-2021; Trethowan, Richard/ADZ-7680-2022	Ali, Zulfiqar/0000-0003-1228-3338; Zhang, Dan-Dan/0000-0002-1498-6718; Trethowan, Richard/0000-0003-0105-875X	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China [31101166, 30971798]; Jiangsu Natural Science Foundation, China [BK2010474]; Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu [CX(12)5132, CX(12)1005-2]; Jiangsu Key Laboratory for Bioresources of Saline Soils [JKLBS2012002]; Project in the National Science & Technology Pillar Program [2011BAD35B06-4-3]	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation, China(Natural Science Foundation of Jiangsu Province); Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu; Jiangsu Key Laboratory for Bioresources of Saline Soils; Project in the National Science & Technology Pillar Program	ZA is thankful for financial assistance from Jiangsu and Punjab sister provinces of China and Pakistan for his visit at Jiangsu Academy of Agricultural Sciences, Nanjing, People's Republic of China. This study was sponsored by National Science Foundation of China (31101166, 30971798); the Jiangsu Natural Science Foundation, China (BK2010474); the Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu (CX(12)5132, CX(12) 1005-2); Jiangsu Key Laboratory for Bioresources of Saline Soils (JKLBS2012002) and the Project in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAD35B06-4-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Barkla BJ, 1999, TRENDS PLANT SCI, V4, P86, DOI 10.1016/S1360-1385(99)01388-6; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; DENKER BM, 1988, J BIOL CHEM, V263, P15634; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Guenther JF, 2000, PLANTA, V210, P741, DOI 10.1007/s004250050675; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; Maurel C, 2002, INT REV CYTOL, V215, P105; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	44	116	128	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56312	10.1371/journal.pone.0056312	http://dx.doi.org/10.1371/journal.pone.0056312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437113	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200059
J	Guo, FD; Liu, CL; Xia, H; Bi, YP; Zhao, CZ; Zhao, SZ; Hou, L; Li, FG; Wang, XJ				Guo, Fengdan; Liu, Chuanliang; Xia, Han; Bi, Yuping; Zhao, Chuanzhi; Zhao, Shuzhen; Hou, Lei; Li, Fuguang; Wang, Xingjun			Induced Expression of AtLEC1 and AtLEC2 Differentially Promotes Somatic Embryogenesis in Transgenic Tobacco Plants	PLOS ONE			English	Article							AUXIN RESPONSE FACTORS; TRANSCRIPTION FACTOR; LEAFY COTYLEDON1; MERISTEM GENE; ARABIDOPSIS; ETHYLENE; ENCODES; LEAFY-COTYLEDON1; BIOSYNTHESIS; MAINTENANCE	Arabidopsis LEAFY COTYLEDON (LEC) genes, AtLEC1 and AtLEC2, are important embryonic regulators that play key roles in morphogenesis and maturation phases during embryo development. Ectopic expression of AtLEC1 and AtLEC2 in tobacco caused abnormality in transgenic seedling. When transgenic seeds germinated on medium containing 30 mM DEX, LEC1 transgenic seedlings were ivory and fleshy, with unexpanded cotyledons, stubby hypocotyls, short roots and no obvious callus formation at the shoot meristem position. While LEC2 transgenic seedlings formed embryonic callus on the shoot apical meristem and somatic embryo-like structures emerged from the surface of the callus. When callus were transferred to hormone free MS0 medium more shoots were regenerated from each callus. However, shoot formation was not observed in LEC1 overexpressors. To investigate the mechanisms of LEC2 in somatic embryogenesis, we studied global gene expression by digital gene expression profiling analysis. The results indicated that ectopic expression of LEC2 genes induced accumulation of embryo-specific proteins such as seed storage proteins, late embryogenesis abundant (LEA) proteins, fatty acid biosynthetic enzymes, products of steroid biosynthesis related genes and key regulatory genes of the embryo development. Genes of plant-specific transcription factors such as NAC domain protein, AP2 and GRAS family, resistance-related as well as salicylic acid signaling related genes were up-regulated in LEC2 transgenic seedlings. Ectopi c expression of LEC2 induced large number of somatic embryo formation and shoot regeneration but 20 d DEX induction of LEC1 is not sufficient to induce somatic embryogenesis and shoot formation. Our data provide new information to understand the mechanisms on LEC2 gene's induction of somatic embryogenesis.	[Guo, Fengdan; Xia, Han; Bi, Yuping; Zhao, Chuanzhi; Zhao, Shuzhen; Hou, Lei; Wang, Xingjun] Shandong Acad Agr Sci, High Tech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Liu, Chuanliang; Li, Fuguang] Cotton Res Inst CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China; [Guo, Fengdan; Bi, Yuping; Wang, Xingjun] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Normal University	Li, FG (corresponding author), Cotton Res Inst CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China.	aylifug@163.com; xingjunw@hotmail.com	Zhao, Chuanzhi/AAC-9232-2022	Zhang, Tong/0000-0003-1148-4322; Ju, Feng/0000-0003-4137-5928	genetically modified organisms breeding major projects [2011ZX08010-004]; National Natural Science Foundation of China [30871324, 31000720, 31101427]; Shandong Province Natural Science Foundation [ZR2010CZ002, ZR2011CZ002, ZR2010CQ008]; Shandong Province "Taishan Scholar'' foundation [tshw20100416]	genetically modified organisms breeding major projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Province "Taishan Scholar'' foundation	This study was supported by genetically modified organisms breeding major projects (2011ZX08010-004); National Natural Science Foundation of China (30871324, 31000720, 31101427); Shandong Province Natural Science Foundation (ZR2010CZ002, ZR2011CZ002, ZR2010CQ008); and Shandong Province "Taishan Scholar'' foundation (tshw20100416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Casson SA, 2006, PLANT PHYSIOL, V142, P526, DOI 10.1104/pp.106.080895; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Harding EW, 2003, PLANT PHYSIOL, V133, P653, DOI 10.1104/pp.103.023499; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; HORSCH RB, 1986, P NATL ACAD SCI USA, V83, P2571, DOI 10.1073/pnas.83.8.2571; Imin N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-110; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Karami Omid, 2009, J Chem Biol, V2, P177, DOI 10.1007/s12154-009-0028-4; Kumar V, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-1; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; ROUSTAN JP, 1990, BIOL PLANTARUM, V32, P273, DOI 10.1007/BF02886947; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shkolnik-Inbar D, 2011, PLANT SIGNAL BEHAV, V6, P694, DOI 10.4161/psb.6.5.14978; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang H, 2004, PLANT CELL, V16, P1206, DOI 10.1105/tpc.021261; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	44	109	117	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71714	10.1371/journal.pone.0071714	http://dx.doi.org/10.1371/journal.pone.0071714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	24146837	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300146
J	Liu, XQ; Zhou, CL; Li, YJ; Ji, Y; Xu, GP; Wang, XT; Yan, JL				Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong			SDF-1 Promotes Endochondral Bone Repair during Fracture Healing at the Traumatic Brain Injury Condition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEAD-INJURY; ENHANCED OSTEOGENESIS; IN-VITRO; MYOCARDIAL-INFARCTION; MARROW; GROWTH; MIGRATION; MODEL; RATS	Purposes: The objective of this study was to investigate the role of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, on bone healing and whether SDF-1 contributes to accelerating bone repair in traumatic brain injury (TBI)/fracture model. Materials and Methods: Real-time polymerase chain reaction and immunohistochemical analysis were used to detect the expression of SDF-1 during the repair of femoral bone in TBI/fracture model. The TBI/fracture model was treated with anti-SDF-1 neutralizing antibody or AMD3100, an antagonist for CXCR4, and evaluated by histomorphometry. In vitro and in vivo migration assays were used to evaluate the functional effect of SDF-1 on primary mesenchymal stem cells. Results: The expression of SDF1 and CXCR4 messenger RNA was increased during the bone healing in TBI/fracture model but was less increased in fracture only model. High expression of SDF-1 protein was observed in the surrounding tissue of the damaged bone. Treated with anti-SDF-1 antibody or AMD3100 could inhibit new bone formation. SDF-1 increased mesenchymal stem cell chemotaxis in vitro in a dose-dependent manner. The in vivo migration study demonstrated that mesenchymal stem cells recruited by SDF-1 participate in endochondral bone repair. Conclusion: The SDF-1/CXCR4 axis plays a crucial role in the accelerating fracture healing under the condition of TBI and contributes to endochondral bone repair.	[Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China	Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China.	yanjlhyd@hotmail.com		John, Ciny/0000-0003-3688-0751; Liu, Geoffrey/0000-0002-2603-7296	National Natural Science Foundation of China [100334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (100334) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Khare G N, 1995, Indian J Med Sci, V49, P281; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Liu XQ, 2012, BIOTECHNOL LETT, V34, P387, DOI 10.1007/s10529-011-0757-7; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mori T, 2004, MOL CANCER THER, V3, P29; Otfinowski Janusz, 1993, Patologia Polska, V44, P133; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; SPENCER RF, 1990, S AFR J SURG, V28, P51; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Tiyapatanaputi P, 2004, J ORTHOP RES, V22, P1254, DOI 10.1016/j.orthres.2004.03.017; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	35	100	110	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54077	10.1371/journal.pone.0054077	http://dx.doi.org/10.1371/journal.pone.0054077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	24130878	Green Published, gold, Green Submitted			2022-12-25	WOS:000314019100041
J	Wang, CJ; Song, XD; Li, YJ; Han, F; Gao, SY; Wang, XZ; Xie, SY; Lv, CJ				Wang, Congjie; Song, Xiaodong; Li, Youjie; Han, Fang; Gao, Shuyan; Wang, Xiaozhi; Xie, Shuyang; Lv, Changjun			Low-Dose Paclitaxel Ameliorates Pulmonary Fibrosis by Suppressing TGF-beta 1/Smad3 Pathway via miR-140 Upregulation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MONOCLONAL-ANTIBODY; CELLS; SMAD3; INHIBITION; MODEL; FIBROBLASTS; TISSUE	Abnormal TGF-beta 1/Smad3 activation plays an important role in the pathogenesis of pulmonary fibrosis, which can be prevented by paclitaxel (PTX). This study aimed to investigate an antifibrotic effect of the low-dose PTX (10 to 50 nM in vitro, and 0.6 mg/kg in vivo). PTX treatment resulted in phenotype reversion of epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AECs) with increase of miR-140. PTX resulted in an amelioration of bleomycin (BLM)-induced pulmonary fibrosis in rats with reduction of the wet lung weight to body weight ratios and the collagen deposition. Our results further demonstrated that PTX inhibited the effect of TGF-beta 1 on regulating the expression of Smad3 and phosphorylated Smad3 (p-Smad3), and restored the levels of E-cadherin, vimentin and alpha-SMA. Moreover, lower miR-140 levels were found in idiopathic pulmonary fibrosis (IPF) patients, TGF-beta 1-treated AECs and BLM-instilled rat lungs. Through decreasing Smad3/p-Smad3 expression and upregulating miR-140, PTX treatment could significantly reverse the EMT of AECs and prevent pulmonary fibrosis of rats. The action of PTX to ameliorate TGF-beta 1-induced EMT was promoted by miR-140, which increased E-cadherin levels and reduced the expression of vimentin, Smad3 and p-Smad3. Collectively, our results demonstrate that low-dose PTX prevents pulmonary fibrosis by suppressing the TGF-beta 1/Smad3 pathway via upregulating miR-140.	[Wang, Congjie; Han, Fang; Gao, Shuyan; Lv, Changjun] Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China; [Song, Xiaodong] Binzhou Med Univ, Med Res Ctr, Yantai, Peoples R China; [Li, Youjie; Gao, Shuyan; Xie, Shuyang] Binzhou Med Univ, Key Lab Tumor Mol Biol, Dept Biochem & Mol Biol, Yantai, Peoples R China; [Wang, Xiaozhi] Binzhou Med Univ, Affiliated Hosp, Dept Resp Med, Binzhou, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Binzhou Medical University	Lv, CJ (corresponding author), Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China.	shuyangxie@yahoo.com.cn	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [81273957]; Taishan Scholar Project; Important Project of Science and Technology of Shandong Province [2010GWZ20254, 2011GHY11501];  [NCET-10-0919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project; Important Project of Science and Technology of Shandong Province; 	This work was supported by the National Natural Science Foundation of China (Grant No. 81273957), NCET-10-0919, "Taishan Scholar Project" and Important Project of Science and Technology of Shandong Province (Grant No. 2010GWZ20254, 2011GHY11501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; ALLEN EM, 1977, J IMMUNOL, V119, P343; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRAHN E, 1994, ARTHRITIS RHEUM, V37, P839, DOI 10.1002/art.1780370611; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi HS, 2007, J SURG RES, V141, P183, DOI 10.1016/j.jss.2006.12.558; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dutsch-Wicherek M, 2010, AM J REPROD IMMUNOL, V63, P181, DOI 10.1111/j.1600-0897.2009.00803.x; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hay ED, 1995, ACTA ANAT, V154, P8; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; JULESELYSEE K, 1990, CLIN CHEST MED, V11, P1; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Liu SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047482; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MCDONALD JA, 1986, J CLIN INVEST, V78, P1237, DOI 10.1172/JCI112707; Mitsuhashi H, 1996, AM J RESP CRIT CARE, V153, P369, DOI 10.1164/ajrccm.153.1.8542145; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Sato N, 2000, AM J RESP CRIT CARE, V161, P1681, DOI 10.1164/ajrccm.161.5.9907104; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sharma SK, 1996, AM J RESP CRIT CARE, V154, P193, DOI 10.1164/ajrccm.154.1.8680680; Silva CIS, 2007, J THORAC IMAG, V22, P221, DOI 10.1097/01.rti.0000213588.52343.13; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THRALL RS, 1979, AM J PATHOL, V95, P117; Tran PL, 1997, J CLIN INVEST, V99, P608, DOI 10.1172/JCI119203; Uhal Bruce D., 1998, American Journal of Physiology, V275, pL1192; Vanderburg CR, 1996, ACTA ANAT, V157, P87; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wang HD, 2002, AM J RESP CRIT CARE, V165, P406, DOI 10.1164/ajrccm.165.3.2003149; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zhou J, 2010, WORLD J GASTROENTERO, V16, P3330, DOI 10.3748/wjg.v16.i26.3330; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	68	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e70725	10.1371/journal.pone.0070725	http://dx.doi.org/10.1371/journal.pone.0070725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	23967091	Green Published, Green Submitted, gold			2022-12-25	WOS:000323378000012
J	Wang, C; Tian, LL; Li, S; Li, HB; Zhou, Y; Wang, H; Yang, QZ; Ma, LJ; Shang, DJ				Wang, Che; Tian, Li-Li; Li, Song; Li, Hui-Bing; Zhou, Yang; Wang, He; Yang, Qing-Zhu; Ma, Li-Jie; Shang, De-Jing			Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CHINESE BROWN FROG; SYSTEMIC INOCULATION; RANA-CHENSINENSIS; TUMOR-GROWTH; APOPTOSIS; DEATH; LINES; PHOSPHATIDYLSERINE; MITOCHONDRIA	Temporin-1CEa is an antimicrobial peptide isolated from the skin secretions of the Chinese brown frog (Rana chensinensis). We have previously reported the rapid and broad-spectrum anticancer activity of temporin-1CEa in vitro. However, the detailed mechanisms for temporin-1CEa-induced cancer cell death are still weakly understood. In the present study, the mechanisms of temporin-1CEa-induced rapid cytotoxicity on two human breast cancer cell lines, MDA-MB-231 and MCF-7, were investigated. The MTT assay and the LDH leakage assay indicated that one-hour of incubation with temporin-1CEa led to cytotoxicity in a dose-dependent manner. The morphological observation using electronic microscopes suggested that one-hour exposure of temporin-1CEa resulted in profound morphological changes in both MDA-MB-231 and MCF-7 cells. The membrane-disrupting property of temporin-1CEa was further characterized by induction of cell-surface exposure of phosphatidylserine, elevation of plasma membrane permeability and rapid depolarization of transmembrane potential. Moreover, temporin-1CEa evoked intracellular calcium ion and reactive oxygen species (ROS) elevations as well as collapse of mitochondrial membrane potential (Delta phi m). In summary, the present study indicates that temporin-1CEa triggers rapid cell death in breast cancer cells. This rapid cytotoxic activity might be mediated by both membrane destruction and intracellular calcium mechanism.	[Wang, Che; Tian, Li-Li; Wang, He; Yang, Qing-Zhu; Shang, De-Jing] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Wang, Che; Li, Hui-Bing; Zhou, Yang; Ma, Li-Jie] Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian, Peoples R China; [Li, Song] Dalian Univ Technol, Lab Biophys & Pharmacol, Sch Phys & Optoelect Engn, Dalian, Peoples R China; [Shang, De-Jing] Liaoning Normal Univ, Fac Life Sci, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Liaoning Normal University	Shang, DJ (corresponding author), Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	dejingshang@yahoo.com	Wang, Che/A-2784-2015; Li, Song/C-6701-2014; Zheng, Po Xing/M-3244-2014	Li, Song/0000-0003-2713-9136; Chiang-Ni, Chuan/0000-0002-0753-035X; Zheng, Po Xing/0000-0001-5827-5865; Jiang, Xun/0000-0002-3344-4797	National Natural Science Foundation of China [30970352, 81202448, 31272314]; Scientific Research Fund of Liaoning Provincial Education Department [L2012382]; Program for Liaoning Innovative Research Team in University [LT2012019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Liaoning Provincial Education Department; Program for Liaoning Innovative Research Team in University	This work was supported by the National Natural Science Foundation of China (30970352, 81202448 and 31272314), the Scientific Research Fund of Liaoning Provincial Education Department (L2012382), and the Program for Liaoning Innovative Research Team in University (LT2012019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Chan SC, 1998, ANTICANCER RES, V18, P4467; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lin VCL, 2003, AM J PATHOL, V162, P1781, DOI 10.1016/S0002-9440(10)64313-1; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Segura C, 2007, BIOCHEM BIOPH RES CO, V353, P908, DOI 10.1016/j.bbrc.2006.12.113; Shang DJ, 2009, ZOOL SCI, V26, P220, DOI 10.2108/zsj.26.220; Steinstraesser L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018321; Sureda FX, 1997, CYTOMETRY, V28, P74, DOI 10.1002/(SICI)1097-0320(19970501)28:1<74::AID-CYTO9>3.0.CO;2-H; Tan JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022836; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; UTSUGI T, 1991, CANCER RES, V51, P3062; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang C, 2012, BIOCHIMIE, V94, P434, DOI 10.1016/j.biochi.2011.08.011; Yoon WH, 1996, BIOCHEM BIOPH RES CO, V222, P694, DOI 10.1006/bbrc.1996.0806	36	107	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2013	8	4							e60462	10.1371/journal.pone.0060462	http://dx.doi.org/10.1371/journal.pone.0060462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RZ	23967091	gold, Green Published			2022-12-25	WOS:000319109800052
